PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ofman, R; Ruiter, JPN; Feenstra, M; Duran, M; Poll-The, BT; Zschocke, J; Ensenauer, R; Lehnert, W; Sass, JO; Sperl, W; Wanders, RJA				Ofman, R; Ruiter, JPN; Feenstra, M; Duran, M; Poll-The, BT; Zschocke, J; Ensenauer, R; Lehnert, W; Sass, JO; Sperl, W; Wanders, RJA			2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME-A DEHYDROGENASE; ISOLEUCINE METABOLISM; BETA-OXIDATION; AMYLOID-BETA; BOVINE LIVER; INBORN ERROR; FATTY-ACID; RAT-LIVER; DISORDERS; PROTEIN	2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency is a novel inborn error of isoleucine degradation. In this article, we report the elucidation of the molecular basis of MHBD deficiency. To this end, we purified the enzyme from bovine liver. MALDI-TOF mass spectrometry analysis revealed that the purified protein was identical to bovine 3-hydroxyacyl-CoA dehydrogenase type II. The human homolog of this bovine enzyme is a short-chain 3-hydroxyacyl-CoA dehydrogenase, also known as the "endoplasmic reticulum-associated amyloid-beta binding protein" (ERAB). This led to the identification of the X-chromosomal gene involved, which previously had been denoted "HADH2." Sequence analysis of the HADH2 gene from patients with MHBD deficiency revealed the presence of two missense mutations (R130C and L122V). Heterologous expression of the mutant cDNAs in Escherichia coli showed that both mutations almost completely abolish enzyme activity. This confirms that MHBD deficiency is caused by mutations in the HADH2 gene.	Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; Inst Human Genet, Heidelberg, Germany; Univ Childrens Hosp, Metab Unit, Freiburg, Germany; Univ Freiburg Klinikum, Zentrum Kinderheilkunde & Jugendmed, Stoffwechsellabor, Freiburg, Germany; Childrens Hosp LKA Salzburg, Salzburg, Austria	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg	Wanders, RJA (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Room F0-224,POB 22700, NL-1100 DE Amsterdam, Netherlands.	r.j.wanders@amc.uva.nl	Zschocke, Johannes/C-5885-2013	Zschocke, Johannes/0000-0002-0046-8274; Poll-The, Bwee Tien/0000-0002-8118-5419				BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145; Ensenauer R, 2002, ANN NEUROL, V51, P656, DOI 10.1002/ana.10169; Frackowiak J, 2001, BRAIN RES, V907, P44, DOI 10.1016/S0006-8993(01)02497-0; Furuta S, 1997, BBA-GENE STRUCT EXPR, V1350, P317, DOI 10.1016/S0167-4781(96)00171-6; Ghaedi K, 1999, EXP CELL RES, V248, P482, DOI 10.1006/excr.1999.4412; Gibson KM, 2000, PEDIATR RES, V47, P830, DOI 10.1203/00006450-200006000-00025; Gross U, 2001, J INHERIT METAB DIS, V24, P60, DOI 10.1023/A:1005610922789; He XY, 1999, J BIOL CHEM, V274, P15014, DOI 10.1074/jbc.274.21.15014; He XY, 1998, J BIOL CHEM, V273, P10741, DOI 10.1074/jbc.273.17.10741; He XY, 2000, BBA-MOL CELL BIOL L, V1484, P267, DOI 10.1016/S1388-1981(00)00014-7; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; Jansen GA, 2000, HUM MOL GENET, V9, P1195, DOI 10.1093/hmg/9.8.1195; Kobayashi A, 1996, J BIOCHEM-TOKYO, V119, P775, DOI 10.1093/oxfordjournals.jbchem.a021307; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LUO MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P214, DOI 10.1006/abbi.1995.1388; MAO LF, 1995, ARCH BIOCHEM BIOPHYS, V321, P221, DOI 10.1006/abbi.1995.1389; Mitchell GA, 2001, METABOLIC MOL BASIS, P2327; Poll-The B. T., 2001, Journal of Inherited Metabolic Disease, V24, P59; RABILLOUD T, 1988, ELECTROPHORESIS, V9, P288, DOI 10.1002/elps.1150090608; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Wanders RJA, 1999, J INHERIT METAB DIS, V22, P442, DOI 10.1023/A:1005504223140; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P101, DOI 10.1007/BF00711433; Yan SD, 1997, NATURE, V389, P689; Zschocke J, 2000, PEDIATR RES, V48, P852, DOI 10.1203/00006450-200012000-00025	27	98	121	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2003	72	5					1300	1307		10.1086/375116	http://dx.doi.org/10.1086/375116			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	671PZ	12696021	Green Published, Bronze			2022-12-18	WOS:000182474400023
J	Yoshida, T; Kanegane, H; Osato, M; Yanagida, M; Miyawaki, T; Ito, Y; Shigesada, K				Yoshida, T; Kanegane, H; Osato, M; Yanagida, M; Miyawaki, T; Ito, Y; Shigesada, K			Functional analysis of RUNX2 mutations in Japanese patients with cleidocranial dysplasia demonstrates novel genotype-phenotype correlations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; FETAL LIVER HEMATOPOIESIS; BINDING-FACTOR-BETA; POLYOMAVIRUS ENHANCER; ALPHA-SUBUNIT; DNA-BINDING; CBF-BETA; OSTEOBLAST DIFFERENTIATION; AML1/PEBP2-ALPHA-B GENE; OSTEOCALCIN PROMOTER	Cleidocranial dysplasia (CCD) is an autosomal dominant heritable skeletal disease caused by heterozygous mutations in the osteoblast-specific transcription factor RUNX2. We have performed mutational analysis of RUNX2 on 24 unrelated patients with CCD. In 17 patients, 16 distinct mutations were detected in the coding region of RUNX2: 4 frameshift, 3 nonsense, 6 missense, and 2 splicing mutations, in addition to 1 polymorphism. The missense mutations were all clustered within the Runt domain, and their protein products were severely impaired in DNA binding and transactivation. In contrast, two RUNX2 mutants had the Runt domain intact and remained partially competent for transactivation. One criterion of CCD, short stature, was much milder in the patients with the intact Runt domain than in those without. Furthermore, a significant correlation was found between short stature and the number of supernumerary teeth. On the one hand, these genotype-phenotype correlations highlight a general, quantitative dependency, by skeleto-dental developments, on the gene dosage of RUNX2, which has hitherto been obscured by extreme clinical diversities of CCD; this gene-dosage effect is presumed to manifest on small reductions in the total RUNX2 activity, by approximately one-fourth of the normal level at minimum. On the other hand, the classic CCD phenotype, hypoplastic clavicles or open fontanelles, was invariably observed in all patients, including those with normal height. Thus, the cleidocranial bone formation, as mediated by intramembranous ossification, may require a higher level of RUNX2 than does skeletogenesis (mediated by endochondral ossification), as well as odontogenesis (involving still different complex processes). Overall, these results suggest that CCD could result from much smaller losses in the RUNX2 function than has been envisioned on the basis of the conventional haploinsufficiency model.	Kyoto Univ, Dept Genet & Mol Biol, Inst Virus Res, Kyoto 6068507, Japan; Kyoto Univ, Inst Virus Res, Dept Viral Oncol, Kyoto 6068507, Japan; Toyama Med & Pharmaceut Univ, Dept Pediat, Fac Med, Toyama, Japan	Kyoto University; Kyoto University; University of Toyama	Shigesada, K (corresponding author), Kyoto Univ, Dept Genet & Mol Biol, Inst Virus Res, Kyoto 6068507, Japan.		Osato, Motomi/N-5056-2014	Osato, Motomi/0000-0003-3982-9054; Yanagida, Masatoshi/0000-0002-4407-8120				Adya N, 1998, MOL CELL BIOL, V18, P7432, DOI 10.1128/MCB.18.12.7432; BAE SC, 1993, ONCOGENE, V8, P809; BAE SC, 1995, GENE, V159, P245, DOI 10.1016/0378-1119(95)00060-J; Bravo J, 2001, NAT STRUCT BIOL, V8, P371, DOI 10.1038/86264; CHITAYAT D, 1992, AM J MED GENET, V42, P298, DOI 10.1002/ajmg.1320420307; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; DUFFY JB, 1991, GENE DEV, V5, P2176, DOI 10.1101/gad.5.12a.2176; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Golan L, 2000, J CRAN GENET DEV BIO, V20, P113; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; JARVIS JL, 1974, AM J ROENTGENOL, V121, P5, DOI 10.2214/ajr.121.1.5; Javed A, 1999, MOL CELL BIOL, V19, P7491; JENSEN BL, 1990, AM J MED GENET, V35, P69, DOI 10.1002/ajmg.1320350113; JENSEN BL, 1992, BRIT DENT J, V172, P243, DOI 10.1038/sj.bdj.4807836; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; Kagoshima H, 1996, J BIOL CHEM, V271, P33074, DOI 10.1074/jbc.271.51.33074; KAMACHI Y, 1990, J VIROL, V64, P4808, DOI 10.1128/JVI.64.10.4808-4819.1990; KANIA MA, 1990, GENE DEV, V4, P1701, DOI 10.1101/gad.4.10.1701; Kanno T, 1998, MOL CELL BIOL, V18, P2444, DOI 10.1128/MCB.18.5.2444; Kanno Y, 1998, MOL CELL BIOL, V18, P4252, DOI 10.1128/MCB.18.7.4252; Kaplowitz PB, 2001, J CLIN ENDOCR METAB, V86, P2965, DOI 10.1210/jc.86.7.2965; Kawai M, 1997, J PEDIATR-US, V130, P205, DOI 10.1016/S0022-3476(97)70344-5; Kim WY, 1999, EMBO J, V18, P1609, DOI 10.1093/emboj/18.6.1609; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LEE J, 1997, CARBOHYDR LETT, V2, P307; LEVANON D, 1994, GENOMICS, V23, P425, DOI 10.1006/geno.1994.1519; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; LU J, 1995, MOL CELL BIOL, V15, P1651; MERRIMAN HL, 1995, BIOCHEMISTRY-US, V34, P13125, DOI 10.1021/bi00040a025; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; MIYOSHI H, 1991, P NATL ACAD SCI USA, V88, P10431, DOI 10.1073/pnas.88.23.10431; Mundlos S, 1999, J MED GENET, V36, P177; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nagata C, 1999, Climacteric, V2, P6, DOI 10.3109/13697139909025557; Nagata T, 2001, J MOL BIOL, V308, P191, DOI 10.1006/jmbi.2001.4596; Ogata T, 2001, J MED GENET, V38, P1, DOI 10.1136/jmg.38.1.1; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; OGAWA E, 1993, VIROLOGY, V194, P314, DOI 10.1006/viro.1993.1262; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Preudhomme C, 2000, BLOOD, V96, P2862, DOI 10.1182/blood.V96.8.2862.h8002862_2862_2869; Quack I, 1999, AM J HUM GENET, V65, P1268, DOI 10.1086/302622; Sasaki K, 1996, P NATL ACAD SCI USA, V93, P12359, DOI 10.1073/pnas.93.22.12359; SILLENCE DO, 1987, AM J MED GENET, V27, P75, DOI 10.1002/ajmg.1320270109; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(02)02053-6; Tanaka K, 1998, BLOOD, V91, P1688, DOI 10.1182/blood.V91.5.1688.1688_1688_1699; TOWLER DA, 1994, MOL ENDOCRINOL, V8, P614, DOI 10.1210/me.8.5.614; Wang Q, 1996, CELL, V87, P697, DOI 10.1016/S0092-8674(00)81389-6; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; WANG SW, 1993, MOL CELL BIOL, V13, P3324, DOI 10.1128/MCB.13.6.3324; Warren AJ, 2000, EMBO J, V19, P3004, DOI 10.1093/emboj/19.12.3004; Werner MH, 1999, NAT MED, V5, P1356, DOI 10.1038/70920; WIJMENGA C, 1995, GENOMICS, V26, P611, DOI 10.1016/0888-7543(95)80185-O; Yamachika E, 2001, J ORAL PATHOL MED, V30, P381, DOI 10.1034/j.1600-0714.2001.300610.x; Yokozeki M, 2000, J CRAN GENET DEV BIO, V20, P121; YOSHIDA CA, IN PRESS NAT GENET; Zhang YW, 2000, GENE, V244, P21, DOI 10.1016/S0378-1119(99)00558-2; Zhou G, 1999, HUM MOL GENET, V8, P2311, DOI 10.1093/hmg/8.12.2311	63	98	115	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					724	738		10.1086/342717	http://dx.doi.org/10.1086/342717			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12196916	Green Published, Bronze			2022-12-18	WOS:000178613800003
J	Zhu, XF; McKenzie, CA; Forrester, T; Nickerson, DA; Broeckel, U; Schunkert, H; Doering, A; Jacob, HJ; Cooper, RS; Rieder, MJ				Zhu, XF; McKenzie, CA; Forrester, T; Nickerson, DA; Broeckel, U; Schunkert, H; Doering, A; Jacob, HJ; Cooper, RS; Rieder, MJ			Localization of a small genomic region associated with elevated ACE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANGIOTENSIN-CONVERTING-ENZYME; LINKAGE DISEQUILIBRIUM; HAPLOTYPE ANALYSIS; CLADISTIC-ANALYSIS; GENE; HYPERTENSION; POLYMORPHISM; POPULATIONS; SEGREGATION; LOCUS	Defining the relationship between multiple polymorphisms in a small genomic region and an underlying quantitative trait locus (QTL) represents a major challenge in human genetics. Pedigree analyses have shown that angiotensin I-converting enzyme (ACE) levels are influenced by a QTL located within or close to the ACE gene and most likely resides in the 3' region of this locus. We genotyped seven polymorphisms spanning 13 kb in the 3' end of ACE in 159 Afro-Caribbean subjects to evaluate the linkage disequilibrium between these sites and to narrow the genomic region associated with an elevated ACE level using a cladistic analysis. The linkage disequilibrium measurement D' and a haplotype tree revealed three distinct haplotype segments, presumably because of recombination, The value of the linkage disequilibrium parameter p(excess) was highest for site 22982, which is located in the middle segment. A series of nested, cladistic analyses confirmed that the ether two regions are unlikely to be the ACE-linked QTL and that the variant resides in the middle region. Analyses of the same polymorphisms in 98 unrelated Europeans in the Monitoring Trends and Determinants in Cardiovascular Diseases (MONICA) study resulted in fewer haplotypes than were observed among the Afro-Caribbean subjects, suggesting that populations with greater genetic diversity may be especially informative for fine-scale mapping.	Loyola Univ, Dept Prevent Med, Maywood, IL 60153 USA; Univ W Indies, Trop Metab Res Unit, Kingston 7, Jamaica; Univ Washington, Dept Mol Biotechnol, Seattle, WA 98195 USA; Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; Univ Regensburg, Dept Internal Med 2, D-8400 Regensburg, Germany; GSF Forschungszentrum, Inst Epidemiol, Munich, Germany	Loyola University Chicago; University West Indies Mona Jamaica; University of Washington; University of Washington Seattle; Medical College of Wisconsin; University of Regensburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Zhu, XF (corresponding author), Loyola Univ, Dept Prevent Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	xzhu1@luc.edu	Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X	NHGRI NIH HHS [1F32HG00187-01, F32 HG000187] Funding Source: Medline; NHLBI NIH HHS [R37 HL045508, R01 HL053353, HL45508, HL53353] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053353, R01HL045508, R37HL045508] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG000187] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; CASTIGLIONE CM, 1995, AM J HUM GENET, V57, P1445; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Crandall KA, 1999, EVOLUTION OF HIV, P153; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Eaves IA, 2000, NAT GENET, V25, P320; EVANS AE, 1994, Q J MED, V87, P211; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Farrall M, 1999, NAT GENET, V23, P270, DOI 10.1038/15449; Galinsky D, 1997, ATHEROSCLEROSIS, V129, P177, DOI 10.1016/S0021-9150(96)06027-3; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Keavney B, 1998, HUM MOL GENET, V7, P1745, DOI 10.1093/hmg/7.11.1745; Keavney B, 2000, LANCET, V355, P434; KEIL U, 1988, ACTA MED SCAND, P119; MCKENZIE CA, 1995, AM J HUM GENET, V57, P1426; Neter J, 1990, APPL LINEAR STAT MOD; Oren I, 1999, ATHEROSCLEROSIS, V145, P267, DOI 10.1016/S0021-9150(99)00075-1; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SCHUNKERT H, 1990, J CLIN INVEST, V86, P1913, DOI 10.1172/JCI114924; Schunkert H, 1997, J MOL MED-JMM, V75, P867, DOI 10.1007/s001090050178; SOUBRIER F, 1994, EUR HEART J, V15, P24, DOI 10.1093/eurheartj/15.suppl_D.24; Sugimura K, 1998, BIOCHEM BIOPH RES CO, V247, P466, DOI 10.1006/bbrc.1998.8813; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Taittonen L, 1999, AM J HYPERTENS, V12, P858, DOI 10.1016/S0895-7061(99)00060-6; TEMPLETON AR, 1987, GENETICS, V117, P343; TEMPLETON AR, 1987, GENET RES, V49, P69, DOI 10.1017/S0016672300026756; TEMPLETON AR, 1988, GENETICS, V120, P1145; TIRET L, 1992, AM J HUM GENET, V51, P197; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Tobe VO, 1996, NUCLEIC ACIDS RES, V24, P3728, DOI 10.1093/nar/24.19.3728; Villard E, 1996, AM J HUM GENET, V58, P1268; WEBER B, 1995, HYPERTENSION PATHOPH, P2861; Weir B., 1996, GENETIC DATA ANAL; WILLIAMS GH, 1988, NEW ENGL J MED, V319, P1517	39	98	101	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2000	67	5					1144	1153						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	369WW	11001581				2022-12-18	WOS:000165091600012
J	Hagan, DM; Ross, AJ; Strachan, T; Lynch, SA; Ruiz-Perez, V; Wang, YM; Scambler, P; Custard, E; Reardon, W; Hassan, S; Muenke, M; Nixon, P; Papapetrou, C; Winter, RM; Edwards, Y; Morrison, K; Barrow, M; Cordier-Alex, MP; Correia, P; Galvin-Parton, PA; Gaskill, S; Gaskin, KJ; Garcia-Minaur, S; Gereige, R; Hayward, R; Homfray, T; McKeown, C; Murday, V; Plauchu, H; Shannon, N; Spitz, L; Lindsay, S				Hagan, DM; Ross, AJ; Strachan, T; Lynch, SA; Ruiz-Perez, V; Wang, YM; Scambler, P; Custard, E; Reardon, W; Hassan, S; Muenke, M; Nixon, P; Papapetrou, C; Winter, RM; Edwards, Y; Morrison, K; Barrow, M; Cordier-Alex, MP; Correia, P; Galvin-Parton, PA; Gaskill, S; Gaskin, KJ; Garcia-Minaur, S; Gereige, R; Hayward, R; Homfray, T; McKeown, C; Murday, V; Plauchu, H; Shannon, N; Spitz, L; Lindsay, S			Mutation analysis and embryonic expression of the HLXB9 Currarino syndrome gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MOTOR-NEURON IDENTITY; SACRAL AGENESIS; HOMEOBOX GENE; HOMEODOMAIN; HB9; MALFORMATIONS; REQUIREMENT; PANCREAS; HEDGEHOG; COMPLEX	The HLXB9 homeobox gene was recently identified as a locus for autosomal dominant Currarino syndrome, also known as hereditary sacral agenesis (HSA), This gene specifies a 403-amino acid protein containing a homeodomain preceded by a very highly conserved 82-amino acid domain of unknown function; the remainder of the protein is not well conserved. Here we report an extensive mutation survey that has identified mutations in the HLXB9 gene in 20 of 21 patients tested with familial Currarino syndrome. Mutations were also detected in two of seven sporadic Currarino syndrome patients; the remainder could be explained by undetected mosaicism for an HLXB9 mutation or by genetic heterogeneity in the sporadic patients. Of the mutations identified in the 22 index patients, 19 were intragenic and included 11 mutations that could lead to the introduction of a premature termination codon, The other eight mutations were missense mutations that were significantly clustered in the homeodomain, resulting, in each patient, in nonconservative substitution of a highly conserved amino acid. All of the intragenic mutations were associated with comparable phenotypes. The only genotype-phenotype correlation appeared to be the occurrence of developmental delay in the case of three patients with microdeletions. HLXB9 expression was analyzed during early human development in a period spanning Carnegie stages 12-21, Signal was detected in the basal plate of the spinal cord and hindbrain and in the pharynx, esophagus, stomach, and pancreas, Significant spatial and temporal expression differences were evident when compared with expression of the mouse Hlxb9 gene, which may partly explain the significant human-mouse differences in mutant phenotype.	Univ Newcastle Upon Tyne, Sch Biochem & Genet, Human Genet Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Inst Child Hlth, Mol Med Unit, London, England; Inst Child Hlth, Dept Clin Genet & Fetal Med, London, England; UCL, MRC Human Biochem Genet Unit, London, England; Great Ormond St Hosp Sick Children, Dept Neurosurg, London WC1N 3JH, England; Great Ormond St Hosp Sick Children, Nuffield Dept Surg, London WC1N 3JH, England; St George Hosp, Sch Med, Dept Med Genet, London, England; Natl Human Genome Res Inst, Bethesda, MD USA; Leicester Royal Infirm, Dept Clin Genet, Leicester, Leics, England; Hop Hotel Dieu, Lyon, France; IFF Fiocruz, Rio De Janeiro, Brazil; SUNY Stony Brook, Dept Pediat, Stony Brook, NY 11794 USA; Royal Alexandra Hosp Sick Children, Camperdown, NSW, Australia; Hosp Crices, Clin Materno Infantil, Baracaldo, Spain; All Childrens Hosp, St Petersburg, FL USA; Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; Ctr Human Genet, Sheffield, S Yorkshire, England	Newcastle University - UK; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; St Georges University London; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Leicester; CHU Lyon; Fundacao Oswaldo Cruz; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Birmingham Women's Hospital	Strachan, T (corresponding author), Univ Newcastle Upon Tyne, Sch Biochem & Genet, Human Mol Genet Unit, Ridley Bldg,Claremont Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	tom.strachan@ncl.ac.uk; s.lindsay@newcastle.ac.uk	Pillay, Nischalan/F-9536-2012; Scambler, Peter J/C-4998-2008; Ruiz-Perez, Victor L/K-6066-2014; Scambler, Peter/AAZ-6026-2020	Scambler, Peter J/0000-0002-1487-4628; Ruiz-Perez, Victor L/0000-0003-0635-3619; Scambler, Peter/0000-0002-1487-4628; Reardon, Willie/0000-0001-7329-9179; garcia, sixto/0000-0003-3406-3424; Muenke, Maximilian/0000-0002-7719-6545; Lynch, Sally Ann/0000-0003-3540-1333	MRC [G9826762, G9900837] Funding Source: UKRI; Medical Research Council [G9900837, G9826762] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alles A J, 1993, Birth Defects Orig Artic Ser, V29, P83; ANDERSON FM, 1975, PEDIATRICS, V55, P826; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Bellomonte D, 1998, MECH DEVELOP, V74, P185, DOI 10.1016/S0925-4773(98)00064-1; Belloni E, 2000, AM J HUM GENET, V66, P312, DOI 10.1086/302723; Bullen PJ, 1998, EARLY HUM DEV, V51, P213, DOI 10.1016/S0378-3782(97)00118-7; CURRARINO G, 1981, AM J ROENTGENOL, V137, P395, DOI 10.2214/ajr.137.2.395; Dattani MT, 1998, NAT GENET, V19, P125, DOI 10.1038/477; DiRocco G, 1997, EMBO J, V16, P3644, DOI 10.1093/emboj/16.12.3644; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; Gaskill SJ, 1996, PEDIATR NEUROSURG, V25, P143, DOI 10.1159/000121112; GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5; HARDWICK RJ, 1992, J PAEDIATR CHILD H, V28, P328, DOI 10.1111/j.1440-1754.1992.tb02680.x; Harrison KA, 1999, NAT GENET, V23, P71, DOI 10.1038/12674; HARRISON KA, 1994, J BIOL CHEM, V269, P19968; Heus HC, 1999, GENOMICS, V57, P342, DOI 10.1006/geno.1999.5796; KALTER H, 1993, CLIN GENET, V43, P174, DOI 10.1111/j.1399-0004.1993.tb04443.x; KEDINGER M, 1994, SMALL BOWEL ENTEROCY, P1; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KLEIN RM, 1989, HUMAN GASTROINTESTIN, P367; Li H, 1999, NAT GENET, V23, P67; LINDSAY S, 1997, MOL GENETICS EARLY H, P193; LYNCH SA, 1995, NAT GENET, V11, P93, DOI 10.1038/ng0995-93; MCLONE DG, 1994, PEDIAT NEUROSURGERY, P3; McLone DG, 1994, PEDIAT NEUROSURGERY, P40; Ming JE, 1998, CLIN GENET, V53, P155; MORICHONDELVALLEZ N, 1993, J MED GENET, V30, P521, DOI 10.1136/jmg.30.6.521; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; PANG D, 1993, NEUROSURGERY, V32, P755, DOI 10.1227/00006123-199305000-00009; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; RIGGS AC, 1995, DIABETES, V44, P689, DOI 10.2337/diabetes.44.6.689; Ross AJ, 1998, NAT GENET, V20, P358, DOI 10.1038/3828; Saha MS, 1997, DEV BIOL, V187, P209, DOI 10.1006/dbio.1997.8625; Savage NM, 1997, J MED GENET, V34, P866, DOI 10.1136/jmg.34.10.866; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; VARGAS EC, 1992, PEDIATRIE, V47, P273; Vargas FR, 1998, HUM GENET, V102, P387, DOI 10.1007/s004390050709; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211	41	98	104	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1504	1515		10.1086/302899	http://dx.doi.org/10.1086/302899			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10749657	Green Published, Bronze			2022-12-18	WOS:000088373700004
J	Schwab, SG; Hallmayer, J; Lerer, B; Albus, M; Borrmann, M; Honig, S; Strauss, M; Segman, R; Lichtermann, D; Knapp, M; Trixler, M; Maier, W; Wildenauer, DB				Schwab, SG; Hallmayer, J; Lerer, B; Albus, M; Borrmann, M; Honig, S; Strauss, M; Segman, R; Lichtermann, D; Knapp, M; Trixler, M; Maier, W; Wildenauer, DB			Support for a chromosome 18p locus conferring susceptibility to functional psychoses in families with schizophrenia, by association and linkage analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BIPOLAR AFFECTIVE-DISORDER; MANIC-DEPRESSIVE ILLNESS; OLD-ORDER AMISH; SIB-PAIR TESTS; RECEPTOR GENE; NUCLEAR FAMILIES; SCHIZOAFFECTIVE DISORDER; ADENYLYL-CYCLASE; COMPLEX TRAITS; HUMAN GENOME	The action of antipsychotic drugs on dopamine receptors suggests that dopaminergic signal transmission may play a role in the development of schizophrenia. We tested eight candidate genes (coding for dopamine receptors, the dopamine transporter, and G-proteins) in 59 families from Germany and Israel, for association. A P value of .00055 (.0044 when corrected for the no. of markers tested) was obtained for the intronic CA-repeat marker G-olf(alpha) on chromosome 18p. The value decreased to .000088 (.0007) when nine sibs with recurrent unipolar depressive disorder were included. Linkage analysis using SSLP markers densely spaced around G-olf(alpha) yielded a maximum two-point LOD score of 3.1 for a marker 0.5 cM distal to G-olf(alpha). Multipoint analysis under the assumption of heterogeneity supported this linkage-whether the affected pheotype was defined narrowly or broadly-as did nonparametric linkage (NPL). In 12 families with exclusively maternal transmission of the disease, the NPL value also supported linkage to this marker. In order to test for association/linkage disequilibrium in the presence of linkage, the sample was restricted to independent offspring. When this sample was combined with 65 additional simplex families (each of them comprising one schizophrenic offspring and his or her parents), the 124-bp allele of G-olf(alpha) was transmitted 47 times and was not transmitted 21 times (P = .009). These results suggest the existence, on chromosome 18p, of a potential susceptibility locus for functional psychoses.	Univ Bonn, Dept Psychiat, Genet Mol Lab, D-53111 Bonn, Germany; Univ Bonn, Dept Med Stat, D-53111 Bonn, Germany; Univ Western Australia, Graylands Hosp, Ctr Clin Res Neuropsychiat, Mt Claremont, WA, Australia; Hadassah Hebrew Univ, Med Ctr, Dept Psychiat, Jerusalem, Israel; Mental State Hosp, Haar, Germany; Univ Munich, Dept Psychiat, Munich, Germany; Univ Pecs, Sch Med, Dept Psychiat, Pecs, Hungary	University of Bonn; University of Bonn; University of Western Australia; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Munich; University of Pecs	Wildenauer, DB (corresponding author), Univ Bonn, Dept Psychiat, Genet Mol Lab, Wilhelmstr 31, D-53111 Bonn, Germany.							ALAKOKKO L, 1995, 3 INT WORKSH HUM CHR; ASHERSON P, 1994, BRIT J PSYCHIAT, V164, P619, DOI 10.1192/bjp.164.5.619; BARON M, 1986, BIOL PSYCHIAT, V21, P1051, DOI 10.1016/0006-3223(86)90286-6; Berrettini WH, 1997, ARCH GEN PSYCHIAT, V54, P27; BERRETTINI WH, 1994, P NATL ACAD SCI USA, V91, P5918, DOI 10.1073/pnas.91.13.5918; BrayWard P, 1996, GENOMICS, V32, P1, DOI 10.1006/geno.1996.0070; CASTLE DJ, 1995, SCHIZOPHRENIA BULL, V21, P1; Cichon S, 1996, AM J MED GENET, V67, P424, DOI 10.1002/(SICI)1096-8628(19960726)67:4<424::AID-AJMG21>3.0.CO;2-K; Coon H, 1996, BIOL PSYCHIAT, V39, P689, DOI 10.1016/0006-3223(95)00292-8; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; CORYELL W, 1985, J AFFECT DISORDERS, V9, P13, DOI 10.1016/0165-0327(85)90004-7; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CROW TJ, 1986, BRIT J PSYCHIAT, V149, P419, DOI 10.1192/bjp.149.4.419; Debruyn A, 1996, BIOL PSYCHIAT, V39, P679, DOI 10.1016/0006-3223(95)00293-6; DeLisi LE, 1995, AM J MED GENET, V60, P532, DOI 10.1002/ajmg.1320600609; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; DETERAWADLEIGH SD, 1995, AM J MED GENET, V60, P317, DOI 10.1002/ajmg.1320600411; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Esterling LE, 1997, MOL PSYCHIATR, V2, P501, DOI 10.1038/sj.mp.4000317; Freimer NB, 1996, NAT GENET, V12, P436, DOI 10.1038/ng0496-436; Fyer A, 1985, SCHEDULE AFFECTIVE D; Gershon ES, 1996, AM J MED GENET, V67, P202, DOI 10.1002/(SICI)1096-8628(19960409)67:2<202::AID-AJMG11>3.0.CO;2-N; GERSHON ES, 1988, ARCH GEN PSYCHIAT, V45, P328; Giacalone J, 1996, GENOMICS, V37, P9, DOI 10.1006/geno.1996.0514; HALLMAYER J, 1994, PSYCHIAT RES, V53, P203, DOI 10.1016/0165-1781(94)90111-2; HERVE D, 1993, J NEUROSCI, V13, P2237, DOI 10.1523/jneurosci.13-05-02237.1993; HERVE D, 1995, MOL BRAIN RES, V32, P125, DOI 10.1016/0169-328X(95)00070-9; JORDE LB, 1995, AM J HUM GENET, V56, P11; KELSOE JR, 1995, PSYCHIAT GENET, V5, pS17; KENDELL RE, 1970, BRIT J PSYCHIAT, V117, P261, DOI 10.1192/S0007125000193225; KNAPP M, 1994, HUM HERED, V44, P37, DOI 10.1159/000154187; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; Kraepelin E, 1899, PSYCHIATRIE; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LaBuda MC, 1996, AM J HUM GENET, V59, P1343; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Maier W, 1995, PSYCHIAT RES, V59, P7, DOI 10.1016/0165-1781(95)02799-8; Maier W, 1996, SCHIZOPHR RES, V20, P175, DOI 10.1016/0920-9964(95)00083-6; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; MAIER W, 1994, PSYCHIAT RES, V53, P77, DOI 10.1016/0165-1781(94)90096-5; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; MCGUFFIN P, 1991, ARCH GEN PSYCHIAT, V48, P764; McInnes LA, 1996, P NATL ACAD SCI USA, V93, P13060, DOI 10.1073/pnas.93.23.13060; McMahon FJ, 1997, AM J HUM GENET, V61, P1397, DOI 10.1086/301630; Morris AP, 1997, ANN HUM GENET, V61, P49; NOTHEN MM, 1993, J MED GENET, V30, P708, DOI 10.1136/jmg.30.8.708; NOTHEN MM, 1994, LANCET, V343, P1301, DOI 10.1016/S0140-6736(94)92194-6; OROURKE DH, 1983, AM J PHYS ANTHROPOL, V62, P51, DOI 10.1002/ajpa.1330620108; PAULS DL, 1995, AM J HUM GENET, V57, P636; PENROSE LS, 1953, ANN EUGENIC, V18, P120; RICE J, 1987, ARCH GEN PSYCHIAT, V44, P441; RISCH N, 1984, AM J HUM GENET, V36, P1039; RISCH N, 1990, AM J HUM GENET, V46, P229; SAKAGAMI H, 1995, MOL BRAIN RES, V33, P185, DOI 10.1016/0169-328X(95)00123-A; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SCHWAB SG, 1995, NAT GENET, V11, P325, DOI 10.1038/ng1195-325; Schwab SG, 1997, MOL PSYCHIATR, V2, P156, DOI 10.1038/sj.mp.4000263; SMYTH C, 1995, PSYCHIAT GENET, V5, pS19; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spitzer R., 1985, STRUCTURED CLIN INTE; Spitzer RL, 1978, RES DIAGNOSTIC CRITE; STINE OC, 1995, AM J HUM GENET, V57, P1384; STRAUB RE, 1993, GENOMICS, V15, P48, DOI 10.1006/geno.1993.1008; SU Y, 1993, ARCH GEN PSYCHIAT, V50, P205; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; TAYLOR MA, 1994, COMPR PSYCHIAT, V35, P420, DOI 10.1016/0010-440X(94)90224-0; TAYLOR MA, 1992, AM J PSYCHIAT, V149, P22; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Tsiouris SJ, 1996, AM J MED GENET, V67, P491, DOI 10.1002/(SICI)1096-8628(19960920)67:5<491::AID-AJMG11>3.0.CO;2-I; Yaw J, 1996, PSYCHIAT GENET, V6, P7, DOI 10.1097/00041444-199621000-00002; Yoshikawa T, 1997, MOL PSYCHIATR, V2, P393, DOI 10.1038/sj.mp.4000325	75	98	101	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1139	1152		10.1086/302046	http://dx.doi.org/10.1086/302046			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	131LP	9758604	Green Published, Bronze			2022-12-18	WOS:000076577800028
J	Lau, AW; Brown, CJ; Penaherrera, M; Langlois, S; Kalousek, DK; Robinson, WP				Lau, AW; Brown, CJ; Penaherrera, M; Langlois, S; Kalousek, DK; Robinson, WP			Skewed X-chromosome inactivation is common in fetuses or newborns associated with confined placental mosaicism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; UNIPARENTAL DISOMY; CHORIONIC VILLI; MOUSE; CELLS; BLASTOCYSTS; CONCEPTIONS; TRISOMY-15; SELECTION; CHIMERAS	The inactivation of one X chromosome in females is normally random with regard to which X is inactivated. However, exclusive or almost-exclusive inactivation of one X may be observed in association with some X-autosomal rearrangements, mutations of the XIST gene, certain X-linked diseases, and MZ twinning. In the present study, a methylation difference near a polymorphism in the X-linked androgen-receptor gene was used to investigate the possibility that nonrandom X inactivation is increases in fetuses and newborns that are associated with confined placental mosaicism (CPM) involving an autosomal trisomy. Extreme skewing was observed in 7 (58%) of 12 cases with a meiotic origin of the trisomy, but in none of 10 cases examined with a somatic origin of the trisomy, and in only 1 (4%) of 27 control adult females. In addition, an extremely skewed X-inactivation pattern was observed in 3 of 10 informative cases of female uniparental disomy (UPD) of chromosome 15. This may reflect the fact that a proportion of UPD cases arise by "rescue" of a chromosomally abnormal conceptus and are therefore associated with CPM. A skewed pattern of X inactivation in CPM cases is hypothesized to result from a reduction in the size of the early-embryonic cell pool, because of either poor early growth or subsequent selection against the trisomic cells. Since similar to 2% of pregnancies detected by chorionic villus sampling are associated with CPM, this is likely a significant contributor to both skewed X inactivation observed in the newborn population and the expression of recessive X-linked diseases in females.	Univ British Columbia, Dept Pathol, Vancouver, BC, Canada; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Robinson, WP (corresponding author), British Columbia Res Inst Childrens & Womens Hlth, Room 170,950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.		Robinson, Wendy P/I-9590-2014; Langlois, Sylvie/AAR-7978-2021; Brown, Carolyn J/A-5159-2014; Robinson, Wendy/AAB-6420-2020	Robinson, Wendy P/0000-0002-2010-6174; Brown, Carolyn J/0000-0002-8959-0101; Robinson, Wendy/0000-0002-2010-6174				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Belmont JW, 1996, AM J HUM GENET, V58, P1101; BOGART MH, 1990, ANAT EMBRYOL, V181, P137; Brown CJ, 1997, AM J HUM GENET, V61, P5, DOI 10.1086/513914; Busque L, 1996, BLOOD, V88, P59; CASSIDY SB, 1992, AM J HUM GENET, V51, P701; Everett CA, 1996, ZYGOTE, V4, P59, DOI 10.1017/S0967199400002896; GARDNER RL, 1971, NATURE, V231, P385, DOI 10.1038/231385a0; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GODSEN CM, 1995, DIS FETUS NEWBORN; Goodship J, 1996, AM J MED GENET, V61, P205, DOI 10.1002/(SICI)1096-8628(19960122)61:3<205::AID-AJMG3>3.0.CO;2-T; GOTO J, 1992, NUCLEIC ACIDS RES, V20, P923, DOI 10.1093/nar/20.4.923; GROPP A, 1983, J EXP ZOOL, V228, P253, DOI 10.1002/jez.1402280210; Hall JG, 1996, AM J MED GENET, V61, P202, DOI 10.1002/(SICI)1096-8628(19960122)61:3<202::AID-AJMG2>3.0.CO;2-W; HARRISON KB, 1989, CYTOGENET CELL GENET, V52, P37, DOI 10.1159/000132835; HARRISON KJ, 1993, HUM GENET, V92, P353, DOI 10.1007/BF01247334; Henderson KG, 1996, HUM GENET, V97, P650; JAMES RM, 1995, DEV BIOL, V167, P213, DOI 10.1006/dbio.1995.1018; KALOUSEK DK, 1983, SCIENCE, V221, P665, DOI 10.1126/science.6867735; KALOUSEK DK, 1994, PLACENTA, V15, P219, DOI 10.1016/0143-4004(94)90014-0; KALOUSEK DK, 1993, AM J HUM GENET, V52, P8; KALOUSEK DK, 1991, PRENATAL DIAG, V11, P743, DOI 10.1002/pd.1970111002; KALOUSEK DK, 1993, EFFECT CONFINED PLAC, V29, P39; LEDBETTER DH, 1992, PRENATAL DIAG, V12, P317, DOI 10.1002/pd.1970120503; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MIGEON BR, 1981, P NATL ACAD SCI-BIOL, V78, P5066, DOI 10.1073/pnas.78.8.5066; Migeon BR, 1996, AM J HUM GENET, V58, P161; MIGEON BR, 1985, P NATL ACAD SCI USA, V82, P3390, DOI 10.1073/pnas.82.10.3390; MIKKELSEN M, 1987, HUM GENET, P596; MOHANDAS TK, 1989, SOMAT CELL MOLEC GEN, V15, P131, DOI 10.1007/BF01535073; NESBITT MN, 1971, DEV BIOL, V26, P252, DOI 10.1016/0012-1606(71)90125-4; NEUMOVA AK, 1996, AM J HUM GENET, V58, P1111; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; PURVISSMITH SG, 1992, AM J HUM GENET, V50, P1348; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROBINSON WP, 1993, AM J HUM GENET, V53, P740; Robinson WP, 1997, AM J HUM GENET, V60, P917; SCHMIDT M, 1992, AM J MED GENET, V42, P161, DOI 10.1002/ajmg.1320420205; Snow M H, 1985, Prog Clin Biol Res, V163C, P295; STAVROPOULOS DJ, 1997, INVESTIGATION CONCEP; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; WANG BBT, 1993, PRENATAL DIAG, V13, P179, DOI 10.1002/pd.1970130305; ZABEL BU, 1978, AM J MED GENET, V1, P309, DOI 10.1002/ajmg.1320010307	45	98	103	2	9	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1353	1361		10.1086/301651	http://dx.doi.org/10.1086/301651			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399909	Green Published, Bronze			2022-12-18	WOS:000071555900019
J	Marrosu, MG; Murru, MR; Costa, G; Cucca, F; Sotgiu, S; Rosati, G; Muntoni, F				Marrosu, MG; Murru, MR; Costa, G; Cucca, F; Sotgiu, S; Rosati, G; Muntoni, F			Multiple Sclerosis in sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DEPENDENT DIABETES-MELLITUS; HLA; HAPLOTYPE; GENES		UNIV CAGLIARI,DEPT NEUROSCI,CLIN CHILD NEUROPSYCHIAT,CAGLIARI,ITALY; OSPED BROTZU CAGLIARI,DEPT PEDIAT,CAGLIARI,ITALY; UNIV SASSARI,NEUROL CLIN,I-07100 SASSARI,ITALY	University of Cagliari; University of Sassari			sotgiu, stefano/M-1011-2017	CUCCA, Francesco/0000-0002-7414-1995				BODMER JG, 1995, TISSUE ANTIGENS, V46, P1; CAVALLISFORZA LL, 1988, P NATL ACAD SCI USA, V85, P6002, DOI 10.1073/pnas.85.16.6002; EBERS GC, 1982, LANCET, V2, P88; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; HAEGERT DG, 1994, ANN NEUROL, V36, pS204, DOI 10.1002/ana.410360807; HAUSER SL, 1989, NEUROLOGY, V39, P275, DOI 10.1212/WNL.39.2.275; HILLERT J, 1993, NEUROLOGY, V43, P163, DOI 10.1212/WNL.43.1_Part_1.163; MARROSU MG, 1988, NEUROLOGY, V38, P1749, DOI 10.1212/WNL.38.11.1749; MARSH SGE, 1995, TISSUE ANTIGENS, V45, P258; *MULT SCLER GEN GR, 1996, NAT GENET, V13, P469; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rosati G, 1996, NEUROEPIDEMIOLOGY, V15, P10, DOI 10.1159/000109884; ROSATI G, 1994, ANN NEUROL, V36, pS164, DOI 10.1002/ana.410360803; SADOVNICK AD, 1991, ANN NEUROL, V29, P252, DOI 10.1002/ana.410290304; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SVEJGAARD A, 1989, GENET EPIDEMIOL, V6, P1, DOI 10.1002/gepi.1370060104; THOMSON G, 1995, AM J HUM GENET, V57, P487; TODD JA, 1989, ADV HUM GENET, P10; Voskuhl RR, 1996, ANN NEUROL, V39, P804, DOI 10.1002/ana.410390618	22	98	99	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1997	61	2					454	457						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XX701	9311753				2022-12-18	WOS:A1997XX70100026
J	Davis, S; Schroeder, M; Goldin, LR; Weeks, DE				Davis, S; Schroeder, M; Goldin, LR; Weeks, DE			Nonparametric simulation-based statistics for detecting linkage in general pedigrees	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MEMBER METHOD; TRAITS; PAIRS	We present here four nonparametric statistics for linkage analysis that test whether pairs of affected relatives share marker alleles more often than expected. These statistics are based on simulating the null distribution of a given statistic conditional on the unaffecteds' marker genotypes. Each statistic uses a different measure of marker sharing: the SimAPM statistic uses the simulation-based affected-pedigree-member measure based on identity-by-state (IBS) sharing. The SimKIN (kinship) measure is 1.0 for identity-by-descent (IBD) sharing, 0.0 for no IBD sharing, and the kinship coefficient when the IBD status is ambiguous. The simulation-based IBD (SimIBD) statistic uses a recursive algorithm to determine the probability of two affecteds sharing a specific allele IBD. The SimISO statistic is identical to SimIBD, except that it also measures marker similarity between unaffected pairs. We evaluated our statistics on data simulated under different two-locus disease models, comparing our results to those obtained with several other nonparametric statistics. Use of IBD information produces dramatic increases in power over the SimAPM method, which uses only IBS information. The power of our best statistic in most cases meets or exceeds the power of the other nonparametric statistics. Furthermore, our statistics perform comparisons between all affected relative pairs within general pedigrees and are not restricted to sib pairs or nuclear families.	UNIV PITTSBURGH,DEPT HUMAN GENET,PITTSBURGH,PA 15261; UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA; NIMH,CLIN NEUROGENET BRANCH,BETHESDA,MD 20892; UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,OXFORD,ENGLAND	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Oxford; Wellcome Centre for Human Genetics			Weeks, Daniel E/B-2995-2012; Davis, Sean/AAD-1801-2021	Weeks, Daniel E/0000-0001-9410-7228; Davis, Sean/0000-0002-8991-6458	NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline; NHGRI NIH HHS [HG00719] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R29HG000719] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AMOS CI, 1990, AM J HUM GENET, V47, P842; AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; BABRON MC, 1993, GENET EPIDEMIOL, V10, P389, DOI 10.1002/gepi.1370100610; BEGUELIN A, 1992, PARALLEL VIRTUAL MAC; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CHURCHILL GA, 1994, GENETICS, V138, P963; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; COX NJ, 1974, THEORETICAL STAT; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; DEMENAIS FM, 1989, MULTIPOINT MAPPING L, V6, P201; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; Jacquard A., 1974, GENETIC STRUCTURE PO; KONG A, 1992, AM J HUM GENET, V51, P1413; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANGE K, 1991, AM J HUM GENET, V49, P1320; LANGE K, 1989, AM J HUM GENET, V45, P959; LANGE K, 1987, AM J HUM GENET, V40, P250; LITT M, 1994, AM J HUM GENET, V55, P702; MARTINEZ M, 1990, GENET EPIDEMIOL, V7, P219, DOI 10.1002/gepi.1370070306; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; RISCH N, 1990, AM J HUM GENET, V46, P242; VANEERDEWEGH P, 1993, GENET EPIDEMIOL, V10, P395, DOI 10.1002/gepi.1370100611; WARD PJ, 1993, AM J HUM GENET, V52, P1200; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WHITTEMORE AS, 1994, BIOMETRICS, V50, P109, DOI 10.2307/2533201; 1994, STAT ANAL GENETIC EP	32	98	99	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1996	58	4					867	880						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UA380	8644751				2022-12-18	WOS:A1996UA38000025
J	SHAFFER, LG; MCCASKILL, C; HAN, JY; CHOO, KHA; CUTILLO, DM; DONNENFELD, AE; WEISS, L; VANDYKE, DL				SHAFFER, LG; MCCASKILL, C; HAN, JY; CHOO, KHA; CUTILLO, DM; DONNENFELD, AE; WEISS, L; VANDYKE, DL			MOLECULAR CHARACTERIZATION OF DE-NOVO SECONDARY TRISOMY-13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FLUORESCENCE INSITU HYBRIDIZATION; ROBERTSONIAN TRANSLOCATIONS; DOWN-SYNDROME; CHROMOSOME REARRANGEMENTS; PARENTAL ORIGIN; MUTATION-RATES; DNA; ISOCHROMOSOMES; IDENTIFICATION; SUGGESTS	Unbalanced Robertsonian translocations are a significant cause of mental retardation and fetal wastage. The majority of homologous rearrangements of chromosome 21 in Down syndrome have been shown to be isochromosomes. Aside from chromosome 21, very little is known about other acrocentric homologous rearrangements. In this study, four cases of de novo secondary trisomy 13 are presented. FISH using alpha-satellite sequences, rDNA, and a pTRI-6 satellite I sequence specific to the short arm of chromosome 13 showed all four rearrangements to be dicentric and apparently devoid of ribosomal genes. Three of four rearrangements retained the pTRI-6 satellite I sequence. Case 1 was the exception, showing a deletion of this sequence in the rearrangement, although both parental chromosomes 13 had strong positive hybridization signals. Eleven microsatellite markers from chromosome 13 were also used to characterize the rearrangements. Of the four possible outcomes, one maternal Robertsonian translocation, two paternal isochromosomes, and one maternal isochromosome were observed. A double recombination was observed in the maternally derived rob(13q13q). No recombination events were detected in any isochromosome. The parental origins and molecular chromosomal structure of these cases are compared with previous studies of de novo acrocentric rearrangements.	ROYAL CHILDRENS HOSP,MURDOCH INST,MELBOURNE,VIC,AUSTRALIA; PENN HOSP,GENET SECT,PHILADELPHIA,PA; HENRY FORD HOSP,CTR MED GENET & BIRTH DEFECTS,DETROIT,MI	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Pennsylvania; Pennsylvania Medicine; Henry Ford Health System; Henry Ford Hospital	SHAFFER, LG (corresponding author), BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030, USA.				NCRR NIH HHS [RR-05425] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANTONARAKIS SE, 1990, AM J HUM GENET, V47, P968; BOWCOCK A, 1993, GENOMICS, V15, P376, DOI 10.1006/geno.1993.1071; CHAMBERLIN J, 1980, HUM GENET, V53, P343, DOI 10.1007/BF00287054; DEGROUCHY J, 1984, CLIN ATLAS HUMAN CHR, P226; EARLE E, 1992, AM J HUM GENET, V50, P717; GRAVHOLT CH, 1992, GENOMICS, V14, P924, DOI 10.1016/S0888-7543(05)80113-2; HASSOLD T, 1987, J MED GENET, V24, P725, DOI 10.1136/jmg.24.12.725; HOOK EB, 1981, HUM GENET, V59, P235; JACOBS PA, 1981, AM J HUM GENET, V33, P44; JACOBS PA, 1987, J MED GENET, V24, P721, DOI 10.1136/jmg.24.12.721; KALITSIS P, 1993, GENOMICS, V16, P104, DOI 10.1006/geno.1993.1147; LEPPERT M, 1986, AM J HUM GENET, V39, P425; PETERSEN MB, 1991, AM J HUM GENET, V49, P529; ROBINSON WP, 1994, AM J HUM GENET, V54, P290; SHAFFER LG, 1991, HUM GENET, V86, P375; SHAFFER LG, 1993, AM J MED GENET, V47, P1218, DOI 10.1002/ajmg.1320470818; SHAFFER LG, 1992, AM J MED GENET, V43, P957, DOI 10.1002/ajmg.1320430611; SYLVESTER JE, 1986, HUM GENET, V73, P193, DOI 10.1007/BF00401226; WILSON GN, 1978, P NATL ACAD SCI USA, V75, P5367, DOI 10.1073/pnas.75.11.5367; WOLFF DJ, 1992, AM J HUM GENET, V50, P174	20	98	98	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1994	55	5					968	974						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QB682	7977360				2022-12-18	WOS:A1994QB68200017
J	BILLINGSLEY, GD; WALTER, MA; HAMMOND, GL; COX, DW				BILLINGSLEY, GD; WALTER, MA; HAMMOND, GL; COX, DW			PHYSICAL MAPPING OF 4 SERPIN GENES - ALPHA-1-ANTITRYPSIN, ALPHA-1-ANTICHYMOTRYPSIN, CORTICOSTEROID-BINDING GLOBULIN, AND PROTEIN-C INHIBITOR, WITHIN A 280-KB REGION ON CHROMOSOME I4Q32.1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-3; SEQUENCE HOMOLOGY; MULTIGENE FAMILY; PLASMA; CLONING; LOCUS; ORGANIZATION; SUPERFAMILY; DIVERGENCE; ASSIGNMENT	Alpha1-antitrypsin (alpha1AT; protease inhibitor [PI] locus), alpha1-antichymotrypsin (alpha1ACT; AACT locus), corticosteroid-binding globulin (CBG; CBG locus), and protein C inhibitor (PCI; PCI locus) are members of the serine protease inhibitor (serpin) superfamily. A noncoding PI-like (PIL) gene has been located 12 kb 3' of the PI gene. The PI, PIL, and AACT loci have been localized to 14q32.1, the CBG locus has been localized to 14q31-14q32.1, and PCI has been mapped to chromosome 14. Genetic linkage analysis suggests tight linkage between PI and AACT. We have used pulsed-field gel electrophoresis to generate a physical map linking these five serpin genes. The order of the genetic loci is AACT/PCI-PI-PIL-CBG, with a maximum distance of about 220 kb between the AACT/PCI and PI genes. These genes form a PI cluster at 14q32.1, similar to that of the homologous genes on murine chromosome 12. The close proximity of these genes has implications for disease-association studies.	HOSP SICK CHILDREN,RES INST,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; IMPERIAL CANC RES FUND,HUMAN GENET LAB,LONDON WC2A 3PX,ENGLAND; UNIV WESTERN ONTARIO,DEPT OBSTET & GYNECOL ONCOL & BIOCHEM,LONDON N6A 3K7,ONTARIO,CANADA; UNIV TORONTO,DEPT PAEDIAT,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Cancer Research UK; Western University (University of Western Ontario); University of Toronto; University of Toronto				Hammond, Geoffrey/0000-0002-4639-7336				BAO J-J, 1988, Genomics, V2, P165, DOI 10.1016/0888-7543(88)90099-7; BORRIELLO F, 1991, P NATL ACAD SCI USA, V88, P9417, DOI 10.1073/pnas.88.21.9417; CARRELL R, 1985, TRENDS BIOCHEM SCI, V10, P20, DOI 10.1016/0968-0004(85)90011-8; CHANDRA T, 1983, BIOCHEMISTRY-US, V22, P5055, DOI 10.1021/bi00291a001; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COX DW, 1987, CYTOGENET CELL GENET, V46, P600; COX DW, 1989, CYTOGENET CELL GENET, V51, P980; COX DW, 1987, AM J HUM GENET, V41, P891; Cox DW, 1989, METABOLIC BASIS INHE, P2409; COX DW, 1985, LANCET, P230; HAMMOND GL, 1990, J CLIN ENDOCR METAB, V71, P34, DOI 10.1210/jcem-71-1-34; HAMMOND GL, 1987, P NATL ACAD SCI USA, V84, P5153, DOI 10.1073/pnas.84.15.5153; HAMMOND GL, 1990, ENDOCR REV, V11, P65, DOI 10.1210/edrv-11-1-65; HEEB MJ, 1987, J BIOL CHEM, V262, P15813; HEEB MJ, 1988, J BIOL CHEM, V263, P11613; HILL RE, 1985, MOL CELL BIOL, V5, P2114, DOI 10.1128/MCB.5.8.2114; HILL RE, 1984, NATURE, V311, P175, DOI 10.1038/311175a0; HODGSON I, 1986, NUCLEIC ACIDS RES, V14, P6779, DOI 10.1093/nar/14.16.6779; HOFKER MH, 1988, BIOCHEM BIOPH RES CO, V155, P634, DOI 10.1016/S0006-291X(88)80542-4; HOFKER MH, 1986, HUM GENET, V74, P270, DOI 10.1007/BF00282547; HOFKER MH, 1987, CYTOGENET CELL GENET, V46, P629; INGLIS JD, 1991, EMBO J, V10, P255, DOI 10.1002/j.1460-2075.1991.tb07945.x; INGLIS JD, 1991, GENE, V106, P213, DOI 10.1016/0378-1119(91)90201-L; KELSEY GD, 1988, ANN HUM GENET, V52, P151, DOI 10.1111/j.1469-1809.1988.tb01091.x; KELSEY GD, 1988, J MED GENET, V25, P361, DOI 10.1136/jmg.25.6.361; LAI EC, 1983, AM J HUM GENET, V35, P385; LEICHT M, 1982, NATURE, V297, P655, DOI 10.1038/297655a0; LONG GL, 1984, BIOCHEMISTRY-US, V23, P4828, DOI 10.1021/bi00316a003; MEIJERS JCM, 1991, J BIOL CHEM, V266, P15028; PATTERSON SD, 1991, BIOCHEM GENET, V29, P477, DOI 10.1007/BF02399689; PEMBERTON PA, 1988, NATURE, V336, P257, DOI 10.1038/336257a0; PROCHOWNIK EV, 1985, J BIOL CHEM, V260, P9608; PURELLO M, 1987, CYTOGENET CELL GENET, V44, P32; RABIN M, 1986, SOMAT CELL MOLEC GEN, V12, P209, DOI 10.1007/BF01560668; SEFTON L, 1990, GENOMICS, V7, P382, DOI 10.1016/0888-7543(90)90172-Q; SERALINI GE, 1990, HUM GENET, V86, P73; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; STIEF TW, 1987, BIOL CHEM H-S, V368, P1427, DOI 10.1515/bchm3.1987.368.2.1427; SUZUKI K, 1987, J BIOL CHEM, V262, P611; TRAVIS J, 1983, ANNU REV BIOCHEM, V52, P655, DOI 10.1146/annurev.bi.52.070183.003255; UNDERHILL DA, 1989, MOL ENDOCRINOL, V3, P1448, DOI 10.1210/mend-3-9-1448; WALTER MA, 1989, GENOMICS, V5, P157, DOI 10.1016/0888-7543(89)90102-X; 1992, SITE PREFERENCES RES; [No title captured]	44	98	98	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					343	353						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8381582				2022-12-18	WOS:A1993KN27500013
J	AHMAD, NN; MCDONALDMCGINN, DM; ZACKAI, EH; KNOWLTON, RG; LAROSSA, D; DIMASCIO, J; PROCKOP, DJ				AHMAD, NN; MCDONALDMCGINN, DM; ZACKAI, EH; KNOWLTON, RG; LAROSSA, D; DIMASCIO, J; PROCKOP, DJ			A 2ND MUTATION IN THE TYPE-II PROCOLLAGEN GENE (COL2AI) CAUSING STICKLER SYNDROME (ARTHROOPHTHALMOPATHY) IS ALSO A PREMATURE TERMINATION CODON	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA-1(II) COLLAGEN GENE; SPONDYLOEPIPHYSEAL DYSPLASIA; TRANSIENT EXPRESSION; SERINE SUBSTITUTION; SEQUENCES; DISEASES; FAMILY; DOMAIN; IDENTIFICATION; ORGANIZATION	Genetic linkage analyses suggest that mutations in type II collagen may be responsible for Stikler syndrome, or arthro-ophthalmopathy (AO), in many families. In the present study oligonucleotide primers were developed to amplify and directly sequence eight of the first nine exons of the gene for type II procollagen (COL2A1). Analysis of the eight exons in 10 unrelated probands with AO revealed that one had a single-base mutation in one allele that changed the codon of -CGA- for arginine at amino acid position alpha1-9 in exon 7 to a premature termination signal for translation. The second mutation found to cause AO was, therefore, similar to the first in that both created premature termination signals in the COL2A1 gene. Since mutations producing premature termination signals have not previously been detected in genes for fibrillar collagens, the results raise the possibility that such mutations in the COL2A1 gene arc a common cause of AO.	THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, JEFFERSON INST MOLEC MED, DEPT BIOCHEM & MOLEC BIOL, PHILADELPHIA, PA 19107 USA; CHILDRENS HOSP, CTR CLIN GENET, PHILADELPHIA, PA 19104 USA; CHILDRENS HOSP, DIV PLAST SURG, PHILADELPHIA, PA 19104 USA	Jefferson University; University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania; Childrens Hospital of Philadelphia			McDonald-McGinn, Donna/L-8643-2019		NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039740] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39740] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; ALAKOKKO L, 1990, P NATL ACAD SCI USA, V87, P6565, DOI 10.1073/pnas.87.17.6565; ALAKOKKO L, 1990, GENOMICS, V8, P454, DOI 10.1016/0888-7543(90)90031-O; BALDWIN CT, 1989, BIOCHEM J, V262, P521, DOI 10.1042/bj2620521; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BLAIR NP, 1979, AM J OPHTHALMOL, V88, P876, DOI 10.1016/0002-9394(79)90566-X; BYERS PH, 1990, TRENDS GENET, V6, P293, DOI 10.1016/0168-9525(90)90235-X; CHAN D, 1991, J BIOL CHEM, V266, P12487; CHEAH KSE, 1991, DEVELOPMENT, V111, P945; FRANCOMANO C A, 1987, Genomics, V1, P293, DOI 10.1016/0888-7543(87)90027-9; FRANCOMANO C A, 1988, American Journal of Human Genetics, V43, pA83; FRYER AE, 1990, J MED GENET, V27, P91, DOI 10.1136/jmg.27.2.91; HUANG MC, 1991, EUR J BIOCHEM, V195, P593, DOI 10.1111/j.1432-1033.1991.tb15742.x; KNOWLTON RG, 1989, AM J HUM GENET, V45, P681; KUHN K, 1987, STRUCTURE FUNCTION C, P1; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; LEE B, 1989, SCIENCE, V244, P978, DOI 10.1126/science.2543071; LEE B, 1991, AM J HUM GENET S, V49, pA474; MAUMENEE IH, 1979, AM J OPHTHALMOL, V88, P432, DOI 10.1016/0002-9394(79)90645-7; OPITZ JM, 1972, NEW ENGL J MED, V286, P546; PROCKOP DJ, 1990, J BIOL CHEM, V265, P15349; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; Pyeritz RE, 1989, ARTHRITIS ALLIED CON, P1332; RYAN MC, 1990, GENOMICS, V8, P41, DOI 10.1016/0888-7543(90)90224-I; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STICKLER GB, 1965, MAYO CLIN PROC, V40, P433; SU MW, 1989, GENOMICS, V4, P438, DOI 10.1016/0888-7543(89)90353-4; THOROGOOD P, 1986, DEV BIOL, V116, P497, DOI 10.1016/0012-1606(86)90150-8; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; VISSING H, 1989, J BIOL CHEM, V264, P18265; WOOD A, 1991, DEVELOPMENT, V111, P955; WYNNEDAVIS R, 1985, ATLAS SKELETAL DYSPL	33	98	99	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					39	45						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434604				2022-12-18	WOS:A1993KK90800005
J	NATOWICZ, MR; ALPER, JK; ALPER, JS				NATOWICZ, MR; ALPER, JK; ALPER, JS			GENETIC DISCRIMINATION AND THE LAW	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								The use of genetic tests can lead to genetic discrimination, discrimination based solely on the nature of an individual's genotype. Instances of the discriminatory uses of genetic tests by employers and insurance companies have already been reported. The recently enacted Americans with Disabilities Act of 1990 (ADA), together with other federal and state laws, can be used to combat some forms of this discrimination. In this article we define and characterize genetic discrimination, discuss the applicability of the various relevant federal and state laws, including the ADA, in the areas of employment and insurance discrimination, explore the limitations of these laws, and, finally, suggest some means of overcoming these limitations.	HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,DEPT PATHOL,BOSTON,MA 02114; UNIV MASSACHUSETTS,CTR DISABIL LAW,BOSTON,MA 02125; UNIV MASSACHUSETTS,DEPT CHEM,BOSTON,MA 02125	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston	NATOWICZ, MR (corresponding author), SHRIVER CTR MENTAL RETARDAT,DIV MED GENET,200 TRAPELO RD,WALTHAM,MA 02254, USA.							ANDREWS, 1991, AM JL MED, V17, P75; ANDREWS LB, 1991, YALE J BIOL MED, V64, P29; ANDREWS LB, 1987, MED GENETICS LEGAL F, P187; [Anonymous], 1989, METABOLIC BASIS INHE, V34, P253; ANTONARAKIS SE, 1989, NEW ENGL J MED, V320, P153, DOI 10.1056/NEJM198901193200305; BILLINGS PR, 1992, AM J HUM GENET, V50, P476; CHILDS B, 1988, MOL GENETICS MED; Cone LA, 1989, MENT PHYS DISABIL LA, V13, P70; CUNNINGHAM GC, 1990, GENETIC SCREENING NE, P205; DANIELS CR, 1990, J PUBLIC HLTH POLICY, V10, P449; DEGORGEY A, 1990, AM J LAW MED, V16, P381; GOSTIN L, 1991, AM J LAW MED, V17, P109; HOLTZMAN NA, 1989, PROCEED CAUTION PRED; KARK JA, 1987, NEW ENGL J MED, V317, P781, DOI 10.1056/NEJM198709243171301; MILLER JM, 1989, DICK L REV, V93, P729; Nelkin D., 1989, DANGEROUS DIAGNOSTIC; NORTON C, 1989, HIPPOCRATES      MAR, P53; ROTHSTEIN M, 1990, INT J BIOETHICS, V1, P239; ROWLEY PT, 1984, SCIENCE, V225, P138, DOI 10.1126/science.6729472; STONE D, 1990, LAW SOCIAL INQUIRY, V15, P385; UZYCH L, 1986, Journal of Public Health Policy, V7, P37, DOI 10.2307/3342124; WEATHERALL DJ, 1989, METABOLIC BASIS INHE, P2281; 1990, GENETIC MONITORING S	23	98	98	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					465	475						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1342778				2022-12-18	WOS:A1992HH97400003
J	MEEHAN, RR; GOSDEN, JR; ROUT, D; HASTIE, ND; FRIEDBERG, T; ADESNIK, M; BUCKLAND, R; VANHEYNINGEN, V; FLETCHER, J; SPURR, NK; SWEENEY, J; WOLF, CR				MEEHAN, RR; GOSDEN, JR; ROUT, D; HASTIE, ND; FRIEDBERG, T; ADESNIK, M; BUCKLAND, R; VANHEYNINGEN, V; FLETCHER, J; SPURR, NK; SWEENEY, J; WOLF, CR			HUMAN CYTOCHROME-P-450 PB-I - A MULTIGENE FAMILY INVOLVED IN MEPHENYTOIN AND STEROID OXIDATIONS THAT MAPS TO CHROMOSOME-10	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									IMPERIAL CANC RES FUND,DEPT BIOCHEM,MOLEC PHARMACOL & DRUG METAB LAB,EDINBURGH,SCOTLAND; UNIV MAINZ,D-6500 MAINZ,FED REP GER; NYU,SCH MED,DEPT CELL BIOL,NEW YORK,NY 10003; NYU,SCH MED,KAPLAN CANC CTR,NEW YORK,NY 10003; IMPERIAL CANC RES FUND,HUMAN GENET RESOURCES LAB,CLAIRE HALL LABS,S MIMMS,ENGLAND	University of Edinburgh; Johannes Gutenberg University of Mainz; New York University; New York University	MEEHAN, RR (corresponding author), WESTERN GEN HOSP,MRC,POPULAT CYTOGENET UNIT,MOLEC GENET SECT,CREWE RD,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.		VAN HEYNINGEN, Veronica/GYE-0531-2022; van Heyningen, Veronica/B-8039-2008	van Heyningen, Veronica/0000-0003-0359-0141; Meehan, Richard/0000-0001-6471-6882				ADAMS DJ, 1985, BIOCHEM J, V232, P869, DOI 10.1042/bj2320869; ADESNIK M, 1986, CRIT REV BIOCHEM MOL, V19, P247, DOI 10.3109/10409238609084657; AYESH R, 1985, NATURE, V311, P169; BARBEAU A, 1985, LANCET, V2, P1213; BLACK SD, 1986, CYTOCHROME P450 STRU, P161; CHENG KC, 1983, J BIOL CHEM, V258, P1738; DENTE L, 1983, NUCLEIC ACIDS RES, V11, P1645, DOI 10.1093/nar/11.6.1645; DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057; EICHELBAUM M, 1984, FED PROC, V43, P2298; EVANS DAP, 1980, J MED GENET, V17, P102, DOI 10.1136/jmg.17.2.102; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FEINBERG AP, 1983, ANAL BIOCHEM, V136, P6; FREIDBERG T, 1986, BIOCHEMISTRY-US, V25, P7975; FUJIIKURIYAMA Y, 1982, P NATL ACAD SCI-BIOL, V79, P2793, DOI 10.1073/pnas.79.9.2793; GONZALEZ FJ, 1986, J BIOL CHEM, V261, P667; GOSDEN JR, 1986, CYTOGENET CELL GENET, V43, P150, DOI 10.1159/000132313; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; GRZESCHIK KH, 1985, CYTOGENET CELL GENET, V40, P179, DOI 10.1159/000132174; GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051; GUT J, 1986, J BIOL CHEM, V261, P1734; HANIU M, 1984, ARCH BIOCHEM BIOPHYS, V235, P304, DOI 10.1016/0003-9861(84)90202-9; HEISTERKAMP N, 1982, NATURE, V299, P747, DOI 10.1038/299747a0; HILDEBRAND CE, 1985, NUCLEIC ACIDS RES, V13, P2009, DOI 10.1093/nar/13.6.2009; HILL RE, 1985, MOL CELL BIOL, V5, P2114, DOI 10.1128/MCB.5.8.2114; HOBART MJ, 1981, ANN HUM GENET, V45, P331, DOI 10.1111/j.1469-1809.1981.tb00346.x; IDLE JR, 1983, HUMAN CARCINOGENESIS, P857; INABA T, 1986, AM J HUM GENET, V38, P768; ISHII K, 1986, MUTAT RES, V174, P85, DOI 10.1016/0165-7992(86)90095-3; Jefcoate C.R., 1986, CYTOCHROME P 450 STR, P387; JURIMA M, 1985, BRIT J CLIN PHARMACO, V19, P483, DOI 10.1111/j.1365-2125.1985.tb02673.x; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KUPFER A, 1984, EUR J CLIN PHARMACOL, V26, P753, DOI 10.1007/BF00541938; LEIGHTON JK, 1984, BIOCHEMISTRY-US, V23, P204, DOI 10.1021/bi00297a005; LU AYH, 1980, PHARMACOL REV, V31, P277; LUND E, 1983, MOL CELL BIOL, V3, P2210; MAHGOUB A, 1977, LANCET, V2, P584, DOI 10.1016/S0140-6736(77)91430-1; MANIATIS T, 1982, MOL CLONING LABORATO; MEEHAN RR, 1984, EMBO J, V3, P1881, DOI 10.1002/j.1460-2075.1984.tb02062.x; MESSING J, 1983, METHOD ENZYMOL, V101, P20; NABHOLZ M, 1969, NATURE, V223, P358, DOI 10.1038/223358a0; NEBERT DW, 1987, DNA-J MOLEC CELL BIO, V6, P1, DOI 10.1089/dna.1987.6.1; NEBERT DW, 1979, CRC CR REV BIOCH MOL, V6, P401, DOI 10.3109/10409237909105427; NEBERT DW, 1982, BIOCHEM PHARMACOL, V31, P2311, DOI 10.1016/0006-2952(82)90523-8; PHILLIPS IR, 1985, ANN HUM GENET, V49, P267, DOI 10.1111/j.1469-1809.1985.tb01702.x; PORTEOUS DJ, 1985, SOMAT CELL MOLEC GEN, V11, P445, DOI 10.1007/BF01534838; PORTEOUS DJ, 1987, P NATL ACAD SCI USA, V84, P5355, DOI 10.1073/pnas.84.15.5355; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; RYAN DE, 1982, XENOBIOTICA, V12, P727, DOI 10.3109/00498258209038947; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SHIMADA T, 1986, J BIOL CHEM, V261, P909; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TUKEY RH, 1985, J BIOL CHEM, V260, P3347; VANHEYNINGEN V, 1975, ANN HUM GENET, V38, P295; Waterman MR, 1986, CYTOCHROME P450 STRU, P345; WAXMAN DJ, 1984, J BIOL CHEM, V259, P5481; WAXMAN DJ, 1983, BIOCHEMISTRY-US, V22, P4846, DOI 10.1021/bi00289a035; WOLF CR, 1984, CARCINOGENESIS, V5, P993, DOI 10.1093/carcin/5.8.993; WOLF CR, 1986, BIOCHEM J, V240, P27, DOI 10.1042/bj2400027; WOLF CR, 1986, TRENDS GENET, V2, P209, DOI 10.1016/0168-9525(86)90232-5; WOLF CR, 10TH EUR C MICR DRUG, P14; WOODS DE, 1982, P NATL ACAD SCI-BIOL, V79, P5661, DOI 10.1073/pnas.79.18.5661	61	98	101	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					26	37						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	2827463				2022-12-18	WOS:A1988L869700004
J	DRYJA, TP; RAPAPORT, JM; EPSTEIN, J; GOORIN, AM; WEICHSELBAUM, R; KOUFOS, A; CAVENEE, WK				DRYJA, TP; RAPAPORT, JM; EPSTEIN, J; GOORIN, AM; WEICHSELBAUM, R; KOUFOS, A; CAVENEE, WK			CHROMOSOME-13 HOMOZYGOSITY IN OSTEOSARCOMA WITHOUT RETINOBLASTOMA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									DANA FARBER CANC INST,DEPT PEDIAT,BOSTON,MA 02115; DANA FARBER CANC INST,DEPT RADIAT THERAPY,BOSTON,MA 02115; UNIV CINCINNATI,MED CTR,DEPT MICROBIOL & MOLEC GENET,CINCINNATI,OH 45267	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University System of Ohio; University of Cincinnati	DRYJA, TP (corresponding author), MASSACHUSETTS EYE & EAR INFIRM,DEPT OPHTHALMOL,243 CHARLES ST,BOSTON,MA 02114, USA.				NATIONAL EYE INSTITUTE [R01EY005510, R01EY005321] Funding Source: NIH RePORTER; NCI NIH HHS [CA29883] Funding Source: Medline; NEI NIH HHS [EY05321, EY05510] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAMSON DH, 1984, OPHTHALMOLOGY, V91, P1351; ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BENEDICT WF, 1983, SCIENCE, V219, P973, DOI 10.1126/science.6336308; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; DRYJA T, 1984, CYTOGENET CELL GENET, V37, pA457; DRYJA TP, 1984, NEW ENGL J MED, V310, P550, DOI 10.1056/NEJM198403013100902; DRYJA TP, 1984, HUM GENET, V65, P320, DOI 10.1007/BF00291555; DRYJA TP, 1985, HUM GENET; EPSTEIN J, 1981, BIOCHIM BIOPHYS ACTA, V676, P68, DOI 10.1016/0304-4165(81)90010-6; FEARON ER, 1984, NATURE, V309, P176, DOI 10.1038/309176a0; GODBOUT R, 1983, NATURE, V304, P451, DOI 10.1038/304451a0; HOPKINSON DA, 1973, ANN HUM GENET, V37, P119, DOI 10.1111/j.1469-1809.1973.tb01820.x; JACOBS PA, 1980, NATURE, V286, P714, DOI 10.1038/286714a0; KNUDSON AG, 1978, SEMIN ONCOL, V5, P57; KOUFOS A, 1984, NATURE, V309, P170, DOI 10.1038/309170a0; MURRAY JC, 1983, P NATL ACAD SCI-BIOL, V80, P5951, DOI 10.1073/pnas.80.19.5951; NAYLOR SL, 1984, P NATL ACAD SCI-BIOL, V81, P2447, DOI 10.1073/pnas.81.8.2447; ORKIN SH, 1984, NATURE, V309, P172, DOI 10.1038/309172a0; PROCHOWNIK EV, 1983, NEW ENGL J MED, V308, P1549, DOI 10.1056/NEJM198306303082601; REEVE AE, 1984, NATURE, V309, P174, DOI 10.1038/309174a0; SKOLNICK MH, 1984, CYTOGENET CELL GENET, V37, P210, DOI 10.1159/000132011; SPARKES RS, 1983, SCIENCE, V219, P971, DOI 10.1126/science.6823558; SPARKES RS, 1980, SCIENCE, V208, P1042, DOI 10.1126/science.7375916; TSUI L-C, 1984, American Journal of Human Genetics, V36, p156S; VOGEL F, 1979, HUM GENET, V52, P1; WEICHSELBAUM R, 1976, IN VITRO CELL DEV B, V12, P833; WEICHSELBAUM RR, 1976, EUR J CANCER, V12, P47, DOI 10.1016/0014-2964(76)90123-7	28	98	104	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1986	38	1					59	66						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AYP17	3004203				2022-12-18	WOS:A1986AYP1700006
J	ALFI, OS; CHANG, R; AZEN, SP				ALFI, OS; CHANG, R; AZEN, SP			EVIDENCE FOR GENETIC-CONTROL OF NONDISJUNCTION IN MAN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV SO CALIF, SCH MED, DEPT COMMUNITY & FAMILY MED, LOS ANGELES, CA 90033 USA	University of Southern California	ALFI, OS (corresponding author), CHILDRENS HOSP, DIV MED GENET, LOS ANGELES, CA 90027 USA.							ABBO G, 1966, HELV PAEDIATR ACTA, V21, P293; AFIFI AA, 1979, STATISTICAL ANAL COM, P97; BEADLE G. W., 1932, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSLEHRE, V63, P195; Bridges CB, 1916, GENETICS, V1, P107; ELALFI O, 1969, J KWT MED ASS, V3, P227; ELALFI OS, 1968, J KUWAIT MED ASSOC, V2, P99; Gowen JW, 1933, J EXP ZOOL, V65, P83, DOI 10.1002/jez.1400650106; GRIFFITHS AJF, 1977, MUTAT RES, V64, P345; HSU LYF, 1970, ANN HUM GENET, V33, P343, DOI 10.1111/j.1469-1809.1970.tb01660.x; KAPLAN AR, 1968, ANN NY ACAD SCI, V155, P659, DOI 10.1111/j.1749-6632.1968.tb55055.x; KWITEROVICH PO, 1966, B JOHNS HOPKINS HOSP, V119, P268; MANTEL N, 1959, J NATL CANCER I, V22, P719; MATSUNAGA E, 1966, ACTA GENET MED GEMEL, V15, P224, DOI 10.1017/S1120962300013378; PENROSE LS, 1961, BRIT MED BULL, V17, P184, DOI 10.1093/oxfordjournals.bmb.a069906; STERN C, 1960, PRINCIPLES HUMAN GEN, P376; THERMAN E, 1961, AM J HUM GENET, V13, P193; WOOLF CM, 1968, PRINCIPLES BIOMETRY, P239	17	98	99	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1980	32	4					477	483						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KB522	6446853				2022-12-18	WOS:A1980KB52200001
J	Leppa, VM; Kravitz, SN; Martin, CL; Andrieux, J; Le Caignec, C; Martin-Coignard, D; DyBuncio, C; Sanders, SJ; Lowe, JK; Cantor, RM; Geschwind, DH				Leppa, Virpi M.; Kravitz, Stephanie N.; Martin, Christa Lese; Andrieux, Joris; Le Caignec, Cedric; Martin-Coignard, Dominique; DyBuncio, Christina; Sanders, Stephan J.; Lowe, Jennifer K.; Cantor, Rita M.; Geschwind, Daniel H.			Rare Inherited and De Novo CNVs Reveal Complex Contributions to ASD Risk in Multiplex Families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER VARIATION; AUTISM SPECTRUM DISORDER; COMMON GENETIC-VARIANTS; HIDDEN-MARKOV MODEL; HUMAN BRAIN; MUTATIONS; PHENOTYPE; HERITABILITY; INDIVIDUALS; EXPRESSION	Rare mutations, including copy-number variants (CNVs), contribute significantly to autism spectrum disorder (ASD) risk. Although their importance has been established in families with only one affected child (simplex families), the contribution of both de novo and inherited CNVs to ASD in families with multiple affected individuals (multiplex families) is less well understood. We analyzed 1,532 families from the Autism Genetic Resource Exchange (AGRE) to assess the impact of de novo and rare CNVs on ASD risk in multiplex families. We observed a higher burden of large, rare CNVs, including inherited events, in individuals with ASD than in their unaffected siblings (odds ratio [OR] = 1.7), but the rate of de novo events was significantly lower than in simplex families. In previously characterized ASD risk loci, we identified 49 CNVs, comprising 24 inherited events, 19 de novo events, and 6 events of unknown inheritance, a significant enrichment in affected versus control individuals (OR = 3.3). In 21 of the 30 families (71%) in whom at least one affected sibling harbored an established ASD major risk CNV, including five families harboring inherited CNVs, the CNV was not shared by all affected siblings, indicating that other risk factors are contributing. We also identified a rare risk locus for ASD and language delay at chromosomal region 2q24 (implicating NR4A2) and another lower-penetrance locus involving inherited deletions and duplications of WI/VOX. The genetic architecture in multiplex families differs from that in simplex families and is complex, warranting more complete genetic characterization of larger multiplex ASD cohorts.	[Leppa, Virpi M.; Kravitz, Stephanie N.; DyBuncio, Christina; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Leppa, Virpi M.; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA; [Leppa, Virpi M.; Lowe, Jennifer K.; Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Program Neurobehav Genet, Los Angeles, CA 90095 USA; [Martin, Christa Lese] Geisinger Hlth Syst, Autism & Dev Med Inst, Lewisburg, PA 18704 USA; [Andrieux, Joris] Ctr Hosp Reg Univ Lille, Hop Jeanne Flandre, Inst Genet Med, F-59037 Lille, France; [Le Caignec, Cedric] Ctr Hosp Univ Nantes, Serv Genet Med, 9 Quai Moncousu, F-44093 Nantes, France; [Le Caignec, Cedric] INSERM, UMR 957, Lab Physiopathol Resorpt Osseuse & Therapie Tumeu, F-44000 Nantes, France; [Martin-Coignard, Dominique] Ctr Hosp Le Mans, Serv Genet, 194 Ave Rubillard, F-72037 Le Mans, France; [Sanders, Stephan J.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94158 USA; [Cantor, Rita M.; Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Geisinger Health System; Universite de Lille - ISITE; CHU Lille; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre Hospitalier Le Mans; University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Ctr Autism Res & Treatment, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Program Neurobehav Genet, Los Angeles, CA 90095 USA.; Geschwind, DH (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu	Sanders, Stephan/S-8645-2019	Sanders, Stephan/0000-0001-9112-5148; Leppa, Virpi/0000-0003-2942-2656	National Institute for Mental Health (NIMH) [R01 MH081754, R01 MH100027, R01 MH074090]; Sigrid Juselius Foundation; Autism Genetic Resource Exchange (AGRE); Autism Speaks; NIMH [1U24MH081810]; Wellcome Trust; NIH [HD064525, MH074090];  [R01 MH064547-01S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC2HD064525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100027, R01MH064547, R01MH074090, U24MH081810, R01MH081754] Funding Source: NIH RePORTER	National Institute for Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Autism Genetic Resource Exchange (AGRE); Autism Speaks; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project received funding from National Institute for Mental Health (NIMH) grants R01 MH081754 and R01 MH100027 (to D.H.G.) and R01 MH074090 (to C.L.M.) and from the Sigrid Juselius Foundation for Postdoctoral Fellowship (to V.M.L.). We gratefully acknowledge support from the Autism Genetic Resource Exchange (AGRE) and Autism Speaks, the participating AGRE families, and resources provided by the AGRE Consortium, a program of Autism Speaks. The AGRE was supported in part by NIMH grant 1U24MH081810 to Clara M. Lajonchere (principal investigator), as well as previous grant R01 MH064547-01S1 to D.H.G. We gratefully acknowledge the University of California, Los Angeles (UCLA) Department of Statistics and the Institute for Digital Research and Education for statistical and computational support and resources. We thank Brett Abrahams for his work on the in situ hybridizations at UCLA, Jillian Haney for technical assistance, Laura Perez Cano and Neel Parikshak for scripts to ascertain family properties, and Tor Solli-Nowlan for computational support. We acknowledge Erin Kaminsky, Daniel Moreno-De-Luca, Andreas Moreno-De-Luca, and Abby Hare-Harris for technical assistance in the analysis of copy-number-variant pathogenicity in the C.L.M. lab. This study used data generated by the DECIPHER community. A full list of contributing centers is available at http://decipher.sanger.ac.uk and via email at decipher@sanger.ac.uk. Funding for the project was provided by the Wellcome Trust. This study also included data generated by the International Standards for Cytogenomic Arrays Consortium.<SUP>79</SUP> Funding for the project was provided in part by NIH grants HD064525 and MH074090.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Bailey A, 1998, HUM MOL GENET, V7, P571; Ball LJ, 2005, AM J MED GENET A, V136A, P363, DOI 10.1002/ajmg.a.30799; Barge-Schaapveld DQCM, 2013, AM J MED GENET A, V161A, P1044, DOI 10.1002/ajmg.a.35873; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bayer S. A., 2002, ATLAS HUMAN CENTRAL; Bucan M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000536; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Colvert E, 2015, JAMA PSYCHIAT, V72, P415, DOI 10.1001/jamapsychiatry.2014.3028; Constantino JN, 2010, AM J PSYCHIAT, V167, P1349, DOI 10.1176/appi.ajp.2010.09101470; Cotney J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7404; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dikker S, 2014, J NEUROSCI, V34, P6267, DOI 10.1523/JNEUROSCI.3796-13.2014; Easterday MC, 2003, DEV BIOL, V264, P309, DOI 10.1016/j.ydbio.2003.09.003; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Gerdts JA, 2013, J AUTISM DEV DISORD, V43, P1597, DOI 10.1007/s10803-012-1706-6; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Girirajan S, 2013, HUM MOL GENET, V22, P2870, DOI 10.1093/hmg/ddt136; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Girirajan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002334; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hoffmann TJ, 2014, JAMA PSYCHIAT, V71, P943, DOI 10.1001/jamapsychiatry.2014.420; Huang N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001154; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lajonchere CM, 2010, NEURON, V68, P187, DOI 10.1016/j.neuron.2010.10.009; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Liu L, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-22; Lowe JK, 2015, AM J PSYCHIAT, V172, P266, DOI 10.1176/appi.ajp.2014.14050576; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Martin CL, 2007, AM J MED GENET B, V144B, P869, DOI 10.1002/ajmg.b.30530; Matsunami N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052239; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Mignot C, 2015, J MED GENET, V52, P61, DOI 10.1136/jmedgenet-2014-102748; Miller DT, 2009, J MED GENET, V46, P242, DOI 10.1136/jmg.2008.059907; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Moreno-De-Luca D, 2013, MOL PSYCHIATR, V18, P1090, DOI 10.1038/mp.2012.138; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Philippe A, 1999, HUM MOL GENET, V8, P805, DOI 10.1093/hmg/8.5.805; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Prasad A, 2012, G3-GENES GENOM GENET, V2, P1665, DOI 10.1534/g3.112.004689; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Robinson EB, 2012, BEHAV GENET, V42, P245, DOI 10.1007/s10519-011-9500-3; Ronemus M, 2014, NAT REV GENET, V15, P133, DOI 10.1038/nrg3585; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sandin S, 2014, JAMA-J AM MED ASSOC, V311, P1770, DOI 10.1001/jama.2014.4144; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Seiser EL, 2014, CANCER INFORM, V13, P77, DOI [10.4137/CIN.s16345, 10.4137/CIN.S16345]; Szymanska K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/424796; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Tick B, 2016, J CHILD PSYCHOL PSYC, V57, P585, DOI 10.1111/jcpp.12499; Trager EH, 2007, BIOINFORMATICS, V23, P1854, DOI 10.1093/bioinformatics/btm242; Valduga M, 2015, J HUM GENET, V60, P267, DOI 10.1038/jhg.2015.17; Virkud YV, 2009, AM J MED GENET B, V150B, P328, DOI 10.1002/ajmg.b.30810; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Wingate M, 2014, MMWR SURVEILL SUMM, V63; Yuen RKC, 2015, NAT MED, V21, P185, DOI 10.1038/nm.3792; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	78	97	99	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 1	2016	99	3					540	554		10.1016/j.ajhg.2016.06.036	http://dx.doi.org/10.1016/j.ajhg.2016.06.036			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DV7KM	27569545	Green Submitted, Bronze, Green Published			2022-12-18	WOS:000383114800002
J	Chen, DH; Below, JE; Shimamura, A; Keel, SB; Matsushita, M; Wolff, J; Sul, Y; Bonkowski, E; Castella, M; Taniguchi, T; Nickerson, D; Papayannopoulou, T; Bird, TD; Raskind, WH				Chen, Dong-Hui; Below, Jennifer E.; Shimamura, Akiko; Keel, Sioban B.; Matsushita, Mark; Wolff, John; Sul, Youngmee; Bonkowski, Emily; Castella, Maria; Taniguchi, Toshiyasu; Nickerson, Deborah; Papayannopoulou, Thalia; Bird, Thomas D.; Raskind, Wendy H.			Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOYERAAL-HREIDARSSON-SYNDROME; BONE-MARROW FAILURE; FAMILIAL TUMORAL CALCINOSIS; LINKED SIDEROBLASTIC ANEMIA; FACIAL MYOKYMIA FDFM; FANCONI-ANEMIA; MYELODYSPLASTIC SYNDROMES; DYSKERATOSIS-CONGENITA; LINKAGE ANALYSIS; HEPATOCELLULAR-CARCINOMA	Ataxia-pancytopenia (AP) syndrome is characterized by cerebellar ataxia, variable hematologic cytopenias, and predisposition to marrow failure and myeloid leukemia, sometimes associated with monosomy 7. Here, in the four-generation family UW-AP, linkage analysis revealed four regions that provided the maximal LOD scores possible, one of which was in a commonly microdeleted chromosome 7q region. Exome sequencing identified a missense mutation (c.2640C>A, p. His880Gln) in the sterile alpha motif domain containing 9-like gene (SAMD9L) that completely cosegregated with disease. By targeted sequencing of SAMD9L, we subsequently identified a different missense mutation (c.3587G>C, p. Cys1196Ser) in affected members of the first described family with AP syndrome, Li-AP. Neither variant is reported in the public databases, both affect highly conserved amino acid residues, and both are predicted to be damaging. With time in culture, lymphoblastic cell lines (LCLs) from two affected individuals in family UW-AP exhibited copy-neutral loss of heterozygosity for large portions of the long arm of chromosome 7, resulting in retention of only the wild-type SAMD9L allele. Newly established LCLs from both individuals demonstrated the same phenomenon. In addition, targeted capture and sequencing of SAMD9L in uncultured blood DNA from both individuals showed bias toward the wild-type allele. These observations indicate in vivo hematopoietic mosaicism. The hematopoietic cytopenias that characterize AP syndrome and the selective advantage for clones that have lost the mutant allele support the postulated role of SAMD9L in the regulation of cell proliferation. Furthermore, we show that AP syndrome is distinct from the dyskeratoses congenita telomeropathies, with which it shares some clinical characteristics.	[Chen, Dong-Hui; Bonkowski, Emily; Bird, Thomas D.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; [Below, Jennifer E.; Nickerson, Deborah] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Shimamura, Akiko] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Shimamura, Akiko; Keel, Sioban B.; Papayannopoulou, Thalia] Univ Washington, Sch Med, Div Hematol, Seattle, WA 98195 USA; [Shimamura, Akiko] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Shimamura, Akiko; Castella, Maria; Taniguchi, Toshiyasu] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Matsushita, Mark; Wolff, John; Sul, Youngmee; Bird, Thomas D.; Raskind, Wendy H.] Univ Washington, Sch Med, Div Med Genet, Seattle, WA 98195 USA; [Bird, Thomas D.; Raskind, Wendy H.] Vet Adm Puget Sound Vet Hlth Care Ctr, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA; [Raskind, Wendy H.] Univ Washington, Sch Med, Div Psychiat & Behav Sci, Seattle, WA 98195 USA; [Below, Jennifer E.] Univ Texas Houston, Sch Publ Hlth, POB 20186, Houston, TX 77225 USA; [Shimamura, Akiko] Harvard Univ, Sch Med, Boston Childrens Hosp, Boston, MA 02115 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Harvard University; Boston Children's Hospital; Harvard Medical School	Bird, TD (corresponding author), Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA.; Bird, TD; Raskind, WH (corresponding author), Univ Washington, Sch Med, Div Med Genet, Seattle, WA 98195 USA.; Bird, TD; Raskind, WH (corresponding author), Vet Adm Puget Sound Vet Hlth Care Ctr, Geriatr Res Educ & Clin Ctr, Seattle, WA 98108 USA.; Raskind, WH (corresponding author), Univ Washington, Sch Med, Div Psychiat & Behav Sci, Seattle, WA 98195 USA.	tomnroz@uw.edu; wendyrun@uw.edu	Taniguchi, Toshiyasu/ADD-8489-2022; Below, Jennifer E/W-2179-2018	Below, Jennifer E/0000-0002-1346-1872; Taniguchi, Toshiyasu/0000-0002-7746-3658; Below, Jennifer/0000-0002-6372-6402	US Department of Veterans Affairs (GRECC); US Department of Veterans Affairs (VISN-20 MIRECC VA Puget Sound Health Care System); US Department of Veterans Affairs (VA Merit Award); NIH [HG005608]; National Institute of Neurologic Diseases and Stroke [R01NS069719]; National Institute of Diabetes and Digestive and Kidney Diseases [R24DK099808-01]; National Human Genome Research Institute; National Heart, Lung, and Blood Institute (NHLBI) University of Washington Center for Mendelian Genomics [U54HG006493]; NHLBI GO Cohort Sequencing Project [HL1029230]; Women's Health Initiative Sequencing Project [HL102924]; Broad GO Sequencing Project [HL102925]; Seattle GO Sequencing Project [HL102926]; Heart GO Sequencing Project [HL103010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102926, UC2HL102924, RC2HL102925, RC2HL103010, UC2HL103010, UC2HL102925, RC2HL102924, UC2HL102926] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493, RC2HG005608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK099808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069719] Funding Source: NIH RePORTER; Veterans Affairs [I01CX001006] Funding Source: NIH RePORTER	US Department of Veterans Affairs (GRECC); US Department of Veterans Affairs (VISN-20 MIRECC VA Puget Sound Health Care System); US Department of Veterans Affairs (VA Merit Award); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurologic Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI) University of Washington Center for Mendelian Genomics; NHLBI GO Cohort Sequencing Project; Women's Health Initiative Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	We dedicate this manuscript to Dr. Frederick Li, who astutely recognized the AP syndrome as a distinct inherited disorder. We are grateful to the families for their participation in this study. Drs. Raj Kapur and Harvey Sarnat, Department of Pathology, Seattle Children's Hospital, were extremely helpful in obtaining tissues and records and in reviewing the neuropathology in case III-5 in the UW-AP family. This work was supported by the US Department of Veterans Affairs (GRECC and VISN-20 MIRECC VA Puget Sound Health Care System and VA Merit Award to T.D.B. and W.H.R.), the American Recovery and Reinvestment Act funds (through RC2 HG005608 from the NIH to D.N. and W.H.R.), the National Institute of Neurologic Diseases and Stroke (R01NS069719 to W.H.R.), the National Institute of Diabetes and Digestive and Kidney Diseases (R24DK099808-01 to A.S.), and the National Human Genome Research Institute and the National Heart, Lung, and Blood Institute (NHLBI) University of Washington Center for Mendelian Genomics (U54HG006493 to Drs. D.N., Michael Bamshad, and Suzanne Leal). We would also like to recognize the ongoing studies that produced and provided exome variant calls for comparison: the NHLBI GO Cohort Sequencing Project (HL1029230), Women's Health Initiative Sequencing Project (HL102924), Broad GO Sequencing Project (HL102925), Seattle GO Sequencing Project (HL102926), and Heart GO Sequencing Project (HL103010).	Ahmed M, 2006, ONCOGENE, V25, P5906, DOI 10.1038/sj.onc.1209873; Akaboshi S, 2000, NEUROPEDIATRICS, V31, P141, DOI 10.1055/s-2000-7531; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Alter BP, 2015, HAEMATOLOGICA, V100, P49, DOI 10.3324/haematol.2014.114389; Ambrose M, 2013, BLOOD, V121, P4036, DOI 10.1182/blood-2012-09-456897; Asou H, 2009, BIOCHEM BIOPH RES CO, V383, P245, DOI 10.1016/j.bbrc.2009.04.004; Aviv T, 2003, NAT STRUCT BIOL, V10, P614, DOI 10.1038/nsb956; Bird TD, 1998, GENEREVIEWS, P1993; Chefetz I, 2008, J INVEST DERMATOL, V128, P1423, DOI 10.1038/sj.jid.5701203; Chen YZ, 2012, ARCH NEUROL-CHICAGO, V69, P630, DOI 10.1001/archneurol.2012.54; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; D'Hooghe M, 2012, EUR J PAEDIATR NEURO, V16, P730, DOI 10.1016/j.ejpn.2012.02.003; DAGHISTANI D, 1989, J PEDIATR-US, V115, P108, DOI 10.1016/S0022-3476(89)80342-7; Fernandez M, 2001, ANN NEUROL, V49, P486; Gallant-Behm CL, 2012, GENE DEV, V26, P2325, DOI 10.1101/gad.198069.112; Glousker G, 2015, BRIT J HAEMATOL, V170, P457, DOI 10.1111/bjh.13442; Gonzalez-del Angel A, 2000, AM J MED GENET, V90, P252; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Haase D, 2008, ANN HEMATOL, V87, P515, DOI 10.1007/s00277-008-0483-y; Hersheson J, 2012, HUM MUTAT, V33, P1324, DOI 10.1002/humu.22132; Hershkovitz D, 2011, J INVEST DERMATOL, V131, P662, DOI 10.1038/jid.2010.387; Honda H, 2015, ONCOGENE, V34, P2413, DOI 10.1038/onc.2014.196; Huang JN, 2011, CURR OPIN HEMATOL, V18, P30, DOI 10.1097/MOH.0b013e32834114a5; Huang J, 2012, NAT GENET, V44, P1117, DOI 10.1038/ng.2391; Hussain FTN, 2012, AM J HEMATOL, V87, P684, DOI 10.1002/ajh.23230; Jerez A, 2012, BLOOD, V119, P6109, DOI 10.1182/blood-2011-12-397620; Kim CA, 2003, TRENDS BIOCHEM SCI, V28, P625, DOI 10.1016/j.tibs.2003.11.001; Knight SW, 1999, AM J HUM GENET, V65, P50, DOI 10.1086/302446; Kocak H, 2014, GENE DEV, V28, P2090, DOI 10.1101/gad.248567.114; Korvatska O, 2013, HUM MOL GENET, V22, P3259, DOI 10.1093/hmg/ddt180; Kotini AG, 2015, NAT BIOTECHNOL, V33, P646, DOI 10.1038/nbt.3178; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Le Guen T, 2013, HUM MOL GENET, V22, P3239, DOI 10.1093/hmg/ddt178; Leone G, 2007, HAEMATOLOGICA, V92, P1389, DOI 10.3324/haematol.11034; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Li CF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-92; LI FP, 1969, J NATL CANCER I, V43, P1365; LI FP, 1978, AM J MED, V65, P933, DOI 10.1016/0002-9343(78)90744-1; LI FP, 1981, CANCER GENET CYTOGEN, V4, P189, DOI 10.1016/0165-4608(81)90013-3; Li QL, 2012, EXP DERMATOL, V21, P554, DOI 10.1111/j.1600-0625.2012.01524.x; Ma Q, 2014, BIOCHEM BIOPH RES CO, V454, P157, DOI 10.1016/j.bbrc.2014.10.054; Maciejewski JP, 2002, BLOOD, V99, P3129, DOI 10.1182/blood.V99.9.3129; Mahmood F, 1998, NEUROPEDIATRICS, V29, P302, DOI 10.1055/s-2007-973582; Marrone A, 2007, BLOOD, V110, P4198, DOI 10.1182/blood-2006-12-062851; Maserati E, 2006, GENE CHROMOSOME CANC, V45, P375, DOI 10.1002/gcc.20301; McLaughlin P, 2005, BLOOD, V105, P4573, DOI 10.1182/blood-2004-08-3035; Nagamachi A, 2013, CANCER CELL, V24, P305, DOI 10.1016/j.ccr.2013.08.011; Navarro JT, 2007, AM J HEMATOL, V82, P849, DOI 10.1002/ajh.20859; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Perlman Susan L, 2012, Handb Clin Neurol, V103, P307, DOI 10.1016/B978-0-444-51892-7.00019-X; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Raskind WH, 2009, AM J MED GENET B, V150B, P570, DOI 10.1002/ajmg.b.30879; Ruggero D, 2014, BLOOD, V124, P2784, DOI 10.1182/blood-2014-04-526301; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Savage SA, 2010, GENET MED, V12, P753, DOI 10.1097/GIM.0b013e3181f415b5; Shimamura A, 2010, BLOOD REV, V24, P101, DOI 10.1016/j.blre.2010.03.002; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Topaz O, 2006, AM J HUM GENET, V79, P759, DOI 10.1086/508069; Townsley DM, 2014, BLOOD, V124, P2775, DOI 10.1182/blood-2014-05-526285; Tsangaris E, 2008, HUM GENET, V124, P507, DOI 10.1007/s00439-008-0576-7; Vulliamy T, 2012, CLIN GENET, V81, P76, DOI 10.1111/j.1399-0004.2010.01605.x; Vulliamy TJ, 2005, BLOOD CELL MOL DIS, V34, P257, DOI 10.1016/j.bcmd.2004.12.008; Vulliamy TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024383; Wang Q, 2014, INT J BIOL SCI, V10, P807, DOI 10.7150/ijbs.9143; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; YAMASHITA T, 1994, P NATL ACAD SCI USA, V91, P6712, DOI 10.1073/pnas.91.14.6712; Zhang MY, 2015, HAEMATOLOGICA, V100, P42, DOI 10.3324/haematol.2014.113456	76	97	99	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 2	2016	98	6					1146	1158		10.1016/j.ajhg.2016.04.009	http://dx.doi.org/10.1016/j.ajhg.2016.04.009			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DN7US	27259050	Bronze, Green Published			2022-12-18	WOS:000377286000009
J	Leslie, EJ; Liu, H; Carlson, JC; Shaffer, JR; Feingold, E; Wehby, G; Laurie, CA; Jain, D; Laurie, CC; Doheny, KF; McHenry, T; Resick, J; Sanchez, C; Jacobs, J; Emanuele, B; Vieira, AR; Neiswanger, K; Standley, J; Czeize, AE; Deleyiannis, F; Christensen, K; Munger, RG; Lie, RT; Wilcox, A; Romitti, PA; Field, LL; Padilla, CD; Cutiongco-de la Paz, EMC; Lidral, AC; Valencia-Ramirez, LC; Lopez-Palacio, AM; Valencia, DR; Arcos-Burgos, M; Castilla, EE; Mereb, JC; Poletta, FA; Orioli, IM; Carvalho, FM; Hecht, JT; Blanton, SH; Buxo, CJ; Butali, A; Mossey, PA; Adeyemo, WL; James, O; Braimah, RO; Aregbesola, BS; Eshete, MA; Deribew, M; Koruyucu, M; Seymen, F; Ma, L; de Salamanca, JE; Weinberg, SM; Moreno, L; Cornell, RA; Murray, JC; Marazita, ML				Leslie, Elizabeth J.; Liu, Huan; Carlson, Jenna C.; Shaffer, John R.; Feingold, Eleanor; Wehby, George; Laurie, Cecelia A.; Jain, Deepti; Laurie, Cathy C.; Doheny, Kimberly F.; McHenry, Toby; Resick, Judith; Sanchez, Carla; Jacobs, Jennifer; Emanuele, Beth; Vieira, Alexandre R.; Neiswanger, Katherine; Standley, Jennifer; Czeize, Andrew E.; Deleyiannis, Frederic; Christensen, Kaare; Munger, Ronald G.; Lie, Rolv T.; Wilcox, Allen; Romitti, Paul A.; Field, L. Leigh; Padilla, Carmencita D.; Cutiongco-de la Paz, Eva Maria C.; Lidral, Andrew C.; Valencia-Ramirez, Luz Consuelo; Lopez-Palacio, Ana Maria; Valencia, Dora Rivera; Arcos-Burgos, Mauricio; Castilla, Eduardo E.; Mereb, Juan C.; Poletta, Fernando A.; Orioli, Ieda M.; Carvalho, Flavia M.; Hecht, Jacqueline T.; Blanton, Susan H.; Buxo, Carmen J.; Butali, Azeez; Mossey, Peter A.; Adeyemo, Wasiu L.; James, Olutayo; Braimah, Ramat O.; Aregbesola, Babatunde S.; Eshete, Mekonen A.; Deribew, Milliard; Koruyucu, Mine; Seymen, Figen; Ma, Lian; de Salamanca, Javier Enriquez; Weinberg, Seth M.; Moreno, Lina; Cornell, Robert A.; Murray, Jeffrey C.; Marazita, Mary L.			A Genome-wide Association Study of Nonsyndromic Cleft Palate Identifies an Etiologic Missense Variant in GRHL3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAUSE VAN; LIP; RISK; LINKAGE; LOCI; MUTATIONS; DEFECTS; COHORT; GENES; WOUDE	Cleft palate (CP) is a common birth defect occurring in 1 in 2,500 live births. Approximately half of infants with CP have a syndromic form, exhibiting other physical and cognitive disabilities. The other half have nonsyndromic CP, and to date, few genes associated with risk for nonsyndromic CP have been characterized. To identify such risk factors, we performed a genome-wide association study of this disorder. We discovered a genome-wide significant association with a missense variant in GRHL3 (p.Thr454Met [c.1361C>T]; rs41268753; p = 4.08 x 10(-9)) and replicated the result in an independent sample of case and control subjects. In both the discovery and replication samples, rs41268753 conferred increased risk for CP (OR = 8.3, 95% CI 4.1-16.8; OR = 2.16, 95% CI 1.43-3.27, respectively). In luciferase transactivation assays, p.Thr454Met had about one-third of the activity of wild-type GRHL3, and in zebrafish embryos, perturbed periderm development. We conclude that this mutation is an etiologic variant for nonsyndromic CP and is one of few functional variants identified to date for nonsyndromic orofacial clefting. This finding advances our understanding of the genetic basis of craniofacial development and might ultimately lead to improvements in recurrence risk prediction, treatment, and prognosis.	[Leslie, Elizabeth J.; Carlson, Jenna C.; Shaffer, John R.; Feingold, Eleanor; McHenry, Toby; Resick, Judith; Sanchez, Carla; Jacobs, Jennifer; Emanuele, Beth; Vieira, Alexandre R.; Neiswanger, Katherine; Weinberg, Seth M.; Marazita, Mary L.] Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Dept Oral Biol, Sch Dent Med, Pittsburgh, PA 15219 USA; [Liu, Huan; Cornell, Robert A.] Univ Iowa, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Liu, Huan] Wuhan Univ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Sch & Hosp Stomatol, Wuhan 430079, Peoples R China; [Liu, Huan] Wuhan Univ, Key Lab Oral Biomed, Minist Educ, Sch & Hosp Stomatol, Wuhan 430079, Peoples R China; [Carlson, Jenna C.; Feingold, Eleanor] Univ Pittsburgh, Depat Biostat, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Shaffer, John R.; Feingold, Eleanor; Vieira, Alexandre R.; Marazita, Mary L.] Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA; [Wehby, George] Univ Iowa, Dept Hlth Management & Policy, Coll Publ Hlth, Iowa City, IA 52246 USA; [Laurie, Cecelia A.; Jain, Deepti; Laurie, Cathy C.] Univ Washington, Dept Biostat, Genet Coordinating Ctr, Seattle, WA 98195 USA; [Doheny, Kimberly F.] Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD 21224 USA; [Standley, Jennifer; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Czeize, Andrew E.] Fdn Community Control Hereditary Dis, H-1051 Budapest, Hungary; [Deleyiannis, Frederic] Univ Colorado, Sch Med, Dept Surg Plast & Reconstruct Surg, Denver, CO 80045 USA; [Christensen, Kaare] Univ Southern Denmark, Dept Epidemiol, Inst Publ Hlth, DK-5230 Odense, Denmark; [Munger, Ronald G.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA; [Lie, Rolv T.] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway; [Wilcox, Allen] NIEHS, Epidemiol Branch, POB 12233, Res Triangle Pk, NC 27709 USA; [Romitti, Paul A.] Univ Iowa, Dept Epidemiol, Coll Publ Hlth, Iowa City, IA 52246 USA; [Field, L. Leigh] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Padilla, Carmencita D.; Cutiongco-de la Paz, Eva Maria C.] Univ Philippines Manila, Inst Human Genet, Natl Inst Hlth, Manila 1000, Philippines; [Cutiongco-de la Paz, Eva Maria C.] Univ Philippines Manila, Dept Pediat, Coll Med, Manila 1000, Philippines; [Cutiongco-de la Paz, Eva Maria C.] Univ Philippines, Philippine Genome Ctr, Manila 1101, Philippines; [Lidral, Andrew C.; Moreno, Lina] Univ Iowa, Dept Orthodont, Coll Dent, Iowa City, IA 52242 USA; [Valencia-Ramirez, Luz Consuelo] Fdn Unica Noel, Medellin 050012, Colombia; [Lopez-Palacio, Ana Maria] Univ Antioquia, Dept Basic Integrated Studies, Coll Dent, Medellin 050001, Colombia; [Valencia, Dora Rivera] Univ Antioquia, Populat Genet & Mutacarcinogenesis Grp, Medellin 050001, Colombia; [Arcos-Burgos, Mauricio] Australian Natl Univ, Genom & Predict Med, Genome Biol Dept, John Curtin Sch Med Res,ANU Coll Med Biol & Envir, Canberra, ACT 0200, Australia; [Castilla, Eduardo E.; Poletta, Fernando A.; Carvalho, Flavia M.] CEMIC Ctr Med Educ & Clin Res, RA-1431 Buenos Aires, DF, Argentina; [Castilla, Eduardo E.; Poletta, Fernando A.; Carvalho, Flavia M.] Fiocruz MS, Lab Congenital Malformat Epidemiol, Inst Oswaldo Cruz, BR-21040360 Rio De Janeiro, Brazil; [Castilla, Eduardo E.; Poletta, Fernando A.; Orioli, Ieda M.] INAGEMP Natl Inst Populat Med Genet, ECLAMC Latin Amer Collaborat Study Congenital Mal, BR-21941617 Rio De Janeiro, Brazil; [Mereb, Juan C.] Hosp Area, ECLAMC Latin Amer Collaborat Study Congenital Mal, RA-8430 El Bolson, Argentina; [Orioli, Ieda M.] Univ Fed Rio de Janeiro, Dept Genet, Inst Biol, BR-21941617 Rio De Janeiro, Brazil; [Hecht, Jacqueline T.] Univ Texas Houston, Hlth Sci Ctr, Dept Pediat, Houston, TX 77030 USA; [Blanton, Susan H.] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Hussman Inst Human Gen,Mailman Sch Med, Miami, FL 33124 USA; [Buxo, Carmen J.] Univ Puerto Rico, Sch Dent Med, San Juan, PR 00936 USA; [Butali, Azeez] Univ Iowa, Dept Oral Pathol Radiol & Med, Dows Inst Dent Res, Coll Dent, Iowa City, IA 52242 USA; [Mossey, Peter A.] Univ Dundee, Dept Orthodont, Dundee DD1 4HN, Scotland; [Adeyemo, Wasiu L.; James, Olutayo] Univ Lagos, Dept Oral & Maxillofacial Surg, Coll Med, PMB 12003, Lagos, Nigeria; [Braimah, Ramat O.; Aregbesola, Babatunde S.] Obafemi Awolowo Univ Ile Ife, Dept Oral & Maxillofacial Surg, PMB 13, Ife, Nigeria; [Eshete, Mekonen A.; Deribew, Milliard] Univ Addis Ababa, Dept Surg, Sch Med, POB 26493, Addis Ababa, Ethiopia; [Koruyucu, Mine; Seymen, Figen] Istanbul Univ, Dept Pedodont, TR-34116 Istanbul, Turkey; [Ma, Lian] Peking Univ, Sch Stomatol, Beijing 100081, Peoples R China; [de Salamanca, Javier Enriquez] Univ Nino Jesus, Hosp Infantil, Unidad Cirugia Plast, Madrid 28009, Spain; [Marazita, Mary L.] Univ Pittsburgh, Sch Med, Clin & Translat Sci, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; Wuhan University; Wuhan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Washington; University of Washington Seattle; Johns Hopkins University; University of Iowa; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Southern Denmark; Utah System of Higher Education; Utah State University; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Iowa; University of British Columbia; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; University of Iowa; Universidad de Antioquia; Universidad de Antioquia; Australian National University; John Curtin School of Medical Research; Centro de Educacion Medica e Investigaciones Clinicas (CEMIC); Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; University of Texas System; University of Texas Health Science Center Houston; University of Miami; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Iowa; University of Dundee; University of Lagos; Obafemi Awolowo University; Addis Ababa University; Istanbul University; Peking University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Marazita, ML (corresponding author), Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Dept Oral Biol, Sch Dent Med, Pittsburgh, PA 15219 USA.; Marazita, ML (corresponding author), Univ Pittsburgh, Dept Human Genet, Grad Sch Publ Hlth, Pittsburgh, PA 15261 USA.; Marazita, ML (corresponding author), Univ Pittsburgh, Sch Med, Clin & Translat Sci, Pittsburgh, PA 15213 USA.	marazita@pitt.edu	eshete, mekonen/AAA-7522-2020; Leslie, Elizabeth/AAP-8941-2021; DE CARVALHO, FLAVIA MARTINEZ/H-6932-2012; de Carvalho, Flavia/AAF-3922-2019; Blanton, Susan Halloran/ABF-1323-2021; Liu, Huan/AAJ-1566-2020; Christensen, Kaare/C-2360-2009; Braimah, Ramat Oyebunmi/W-4121-2019; Seymen, Figen/AAC-6736-2020; Koruyucu, M/AAC-6713-2020; Wilcox, Allen J/C-7723-2019; Sánchez, Carla/HDO-0444-2022; Arcos-Burgos, Mauricio/H-1326-2017	Leslie, Elizabeth/0000-0002-5735-1712; Liu, Huan/0000-0002-9947-6687; Christensen, Kaare/0000-0002-5429-5292; Braimah, Ramat Oyebunmi/0000-0002-7608-1965; Seymen, Figen/0000-0001-7010-2035; Koruyucu, M/0000-0002-2077-5095; Wilcox, Allen J/0000-0002-3376-1311; Poletta, Fernando/0000-0002-6102-8416; Buxo, Carmen J./0000-0002-8819-1643; Arcos-Burgos, Mauricio/0000-0002-8529-0574; Weinberg, Seth/0000-0001-9467-4556; Shaffer, John/0000-0003-1897-1131; Mossey, Peter/0000-0002-9914-6901; James, Olutayo/0000-0002-4788-5235; Cornell, Robert/0000-0003-4207-9100; Carlson, Jenna/0000-0001-5483-0833	NIH [X01-HG007845, R01-DE016148, HHSN268201200008I, R01-DE020895, U01-DE018993]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000084] Funding Source: NIH RePORTER; National Center on Birth Defects and Developmental Disabilities [U01DD001035] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [S21MD001830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016148, K99DE025060, R00DE022378, R01DE023575, R01DE020895, R37DE008559, K99DE024571, U01DE024425, R01DE011931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009886, R21DE016930, R01DE011948, U01DE018993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049027, ZIAES044003] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007587, R25MD007607] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	We dedicate this paper to the memory of our colleagues Dr. Andrew Czeizel and Dr. Juan C. Mereb; they will be missed. Many thanks to the participating families who made the studies summarized here possible and who provided on-going inspiration to the investigators. The tireless effort by the dedicated field staff and collaborators was similarly essential to the success of this study. This work was supported by grants from the NIH including X01-HG007845 and R01-DE016148 (to M.L.M.), and genotyping and data cleaning were provided via an NIH contract to the Johns Hopkins Center for Inherited Disease Research (HHSN268201200008I). The replication studies were funded by NIH grants R01-DE020895 (to G.L.W.) and U01-DE018993 to Dr. Tern Beaty at Johns Hopkins University School of Public Health. See the Supplemental Acknowledgments for additional grant support and full acknowledgments.	Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Beaty TH, 2011, GENET EPIDEMIOL, V35, P469, DOI 10.1002/gepi.20595; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Boglev Y, 2011, DEV BIOL, V349, P512, DOI 10.1016/j.ydbio.2010.11.011; Caddy J, 2010, DEV CELL, V19, P138, DOI 10.1016/j.devcel.2010.06.008; de la Garza G, 2013, J INVEST DERMATOL, V133, P68, DOI 10.1038/jid.2012.269; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Dworkin S, 2014, MECH DEVELOP, V133, P77, DOI 10.1016/j.mod.2014.05.005; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fogh-Andersen, 1942, INHERITANCE HARELIP; FRASER F C, 1955, Acta Genet Stat Med, V5, P358; Ghassibe-Sabbagh M, 2011, AM J HUM GENET, V88, P150, DOI 10.1016/j.ajhg.2011.01.003; Gilchrist EP, 2000, ORAL SURG ORAL MED O, V90, P340, DOI 10.1067/moe.2000.107360; Haller G, 2016, HUM MOL GENET, V25, P202, DOI 10.1093/hmg/ddv463; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; JONES MC, 1988, CLEFT PALATE J, V25, P16; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Leslie E. J., 2015, CLIN GENET; Leslie EJ, 2015, AM J HUM GENET, V96, P397, DOI 10.1016/j.ajhg.2015.01.004; Leslie EJ, 2013, AM J MED GENET C, V163, P246, DOI 10.1002/ajmg.c.31381; Li L, 2010, AM J MED GENET A, V152A, P856, DOI 10.1002/ajmg.a.33236; Ludwig KU, 2014, J DENT RES, V93, P376, DOI 10.1177/0022034514523987; Ludwig KU, 2012, NAT GENET, V44, P968, DOI 10.1038/ng.2360; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Munger RG, 1996, TERATOLOGY, V54, P27, DOI 10.1002/(SICI)1096-9926(199607)54:1<27::AID-TERA4>3.0.CO;2-0; Munger RG, 2011, BIRTH DEFECTS RES A, V91, P153, DOI 10.1002/bdra.20762; MURRAY JC, 1990, AM J HUM GENET, V46, P486; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Peyrard-Janvid M, 2014, AM J HUM GENET, V94, P23, DOI 10.1016/j.ajhg.2013.11.009; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Reiter R, 2015, AM J MED GENET A, V167, P670, DOI 10.1002/ajmg.a.36891; Sabel JL, 2009, DEV BIOL, V325, P249, DOI 10.1016/j.ydbio.2008.10.031; Spielman RS, 1996, AM J HUM GENET, V59, P983; Sun YM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7414; TESSIER P, 1976, Journal of Maxillofacial Surgery, V4, P69, DOI 10.1016/S0301-0503(76)80013-6; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ting SB, 2003, NAT MED, V9, P1513, DOI 10.1038/nm961; Westerfield M, 1993, ZEBRAFISH BOOK; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	49	97	98	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					744	754		10.1016/j.ajhg.2016.02.014	http://dx.doi.org/10.1016/j.ajhg.2016.02.014			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27018472	Green Published, Bronze			2022-12-18	WOS:000374203800012
J	Qin, HD; Liao, XY; Chen, YB; Huang, SY; Xue, WQ; Li, FF; Ge, XS; Liu, DQ; Cai, QY; Long, JR; Li, XZ; Hu, YZ; Zhang, SD; Zhang, LJ; Lehrman, B; Scott, AF; Lin, DX; Zeng, YX; Shugart, YY; Jia, WH				Qin, Hai-De; Liao, Xiao-Yu; Chen, Yuan-Bin; Huang, Shao-Yi; Xue, Wen-Qiong; Li, Fang-Fang; Ge, Xiao-Song; Liu, De-Qing; Cai, Qiuyin; Long, Jirong; Li, Xi-Zhao; Hu, Ye-Zhu; Zhang, Shao-Dan; Zhang, Lan-Jun; Lehrman, Benjamin; Scott, Alan F.; Lin, Dongxin; Zeng, Yi-Xin; Shugart, Yin Yao; Jia, Wei-Hua			Genomic Characterization of Esophageal Squamous Cell Carcinoma Reveals Critical Genes Underlying Tumorigenesis and Poor Prognosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN HEPATOCELLULAR-CARCINOMA; COPY-NUMBER ALTERATION; WIDE ASSOCIATION; CANCER-CELLS; FUNCTIONAL ANNOTATION; SUSCEPTIBILITY LOCI; TUMOR PROGRESSION; MICRORNA TARGETS; SEQUENCING DATA; KITENIN	The genetic mechanisms underlying the poor prognosis of esophageal squamous cell carcinoma (ESCC) are not well understood. Here, we report somatic mutations found in ESCC from sequencing 10 whole-genome and 57 whole-exome matched tumor-normal sample pairs. Among the identified genes, we characterized mutations in VANGL1 and showed that they accelerated cell growth in vitro. We also found that five other genes, including three coding genes (SHANK2, MYBL2, FADD) and two non-coding genes (miR-4707-5p, PCAT1), were involved in somatic copy-number alterations (SCNAs) or structural variants (SVs). A survival analysis based on the expression profiles of 321 individuals with ESCC indicated that these genes were significantly associated with poorer survival. Subsequently, we performed functional studies, which showed that miR-4707-5p and MYBL2 promoted proliferation and metastasis. Together, our results shed light on somatic mutations and genomic events that contribute to ESCC tumorigenesis and prognosis and might suggest therapeutic targets.	[Qin, Hai-De; Liao, Xiao-Yu; Chen, Yuan-Bin; Huang, Shao-Yi; Xue, Wen-Qiong; Li, Fang-Fang; Ge, Xiao-Song; Liu, De-Qing; Li, Xi-Zhao; Hu, Ye-Zhu; Zhang, Shao-Dan; Zhang, Lan-Jun; Zeng, Yi-Xin; Jia, Wei-Hua] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China; [Qin, Hai-De; Lehrman, Benjamin; Shugart, Yin Yao] NIMH, Unit Stat Genom, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA; [Ge, Xiao-Song] Jiangnan Univ, Affiliated Hosp, Wuxi 214062, Peoples R China; [Cai, Qiuyin; Long, Jirong] Vanderbilt Univ, Sch Med, Div Epidemiol, Dept Med,Vanderbilt Ingram Canc Ctr, Nashville, TN 37240 USA; [Cai, Qiuyin; Long, Jirong] Vanderbilt Univ, Sch Med, Vanderbilt Epidemiol Ctr, Nashville, TN 37240 USA; [Scott, Alan F.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21287 USA; [Lin, Dongxin] Chinese Acad Med Sci, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Lin, Dongxin] Peking Union Med Coll, Beijing 100021, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Jiangnan University; Vanderbilt University; Vanderbilt University; Johns Hopkins University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Jia, WH (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510060, Guangdong, Peoples R China.; Shugart, YY (corresponding author), NIMH, Unit Stat Genom, Div Intramural Res Programs, NIH, Bethesda, MD 20892 USA.	kay1yao@mail.nih.gov; jiawh@sysucc.org.cn		Lin, Dongxin/0000-0002-8723-8868; YAO, YIN/0000-0003-3053-8429; Liao, Xiaoyu/0000-0001-9851-3848	National Science Fund for Distinguished Young Scholars of China [81325018]; Key Project for International Cooperation and Exchange of the National Natural Science Foundation of China [81220108022]; National Basic Research Program of China (973 program) [2011CB504303]; Intramural Research Program, National Institute of Mental Health (NIMH), NIH (IRP-NIMH-NIH) [MH002930-05]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002930] Funding Source: NIH RePORTER	National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Project for International Cooperation and Exchange of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China); Intramural Research Program, National Institute of Mental Health (NIMH), NIH (IRP-NIMH-NIH); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We'd like to thank Profs. Xiao-ou Shu and Wei Zheng of the Vanderbilt-Ingram Cancer Center for their kind advice in the course of sample preparation, exon capture, and deep sequencing. We thank Prof. Song Gao for his kind help in protein structure prediction. We also thank Bank of Tumor Resources, Cancer Center Sun Yat-sen University for providing the ESCC samples in this study. This work was supported by the grants from the National Science Fund for Distinguished Young Scholars of China (grant no. 81325018), the Key Project for International Cooperation and Exchange of the National Natural Science Foundation of China (grant no. 81220108022), the National Basic Research Program of China (973 program no. 2011CB504303). The authors gratefully acknowledge the support of the Intramural Research Program, National Institute of Mental Health (NIMH), NIH (IRP-NIMH-NIH, grant no. MH002930-05). The views expressed in this presentation do not necessarily represent the views of the the NIMH, the NIH, the US Department of Health and Human Services, or the United States Government.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2014, GVIZ PLOTTING DATA A; Bass AJ, 2009, GASTROENTEROLOGY, V137, P1573, DOI 10.1053/j.gastro.2009.09.026; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Carnevali P, 2012, J COMPUT BIOL, V19, P279, DOI 10.1089/cmb.2011.0201; Casson AG, 1998, J CLIN PATHOL-MOL PA, V51, P71, DOI 10.1136/mp.51.2.71; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chang DT, 2009, AM J CLIN ONCOL-CANC, V32, P405, DOI 10.1097/COC.0b013e3181917158; Cho SB, 2010, ONCOL RES, V19, P115, DOI 10.3727/096504011X12935427587722; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Exome Variant Server, 2014, NHLBI GO EX SEQ PROJ; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Gen Y, 2010, CANCER GENET CYTOGEN, V202, P82, DOI 10.1016/j.cancergencyto.2010.01.023; Hashimoto Y, 2005, CLIN CANCER RES, V11, P2597, DOI 10.1158/1078-0432.CCR-04-1378; HOLLSTEIN MC, 1990, P NATL ACAD SCI USA, V87, P9958, DOI 10.1073/pnas.87.24.9958; Hu N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-576; Ito T, 2006, CLIN CANCER RES, V12, P1308, DOI 10.1158/1078-0432.CCR-05-1611; Kho DH, 2009, GUT, V58, P509, DOI 10.1136/gut.2008.150938; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kong KL, 2012, GUT, V61, P33, DOI 10.1136/gutjnl-2011-300178; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee DH, 2011, CANCER LETT, V306, P161, DOI 10.1016/j.canlet.2011.03.001; Lee KH, 2015, ONCOTARGET, V6, P3240, DOI 10.18632/oncotarget.3087; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XH, 2014, CANCER PREV RES, V7, P114, DOI 10.1158/1940-6207.CAPR-13-0289; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyawaki Y, 2012, CANCER SCI, V103, P1558, DOI 10.1111/j.1349-7006.2012.02329.x; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ogawa R, 2013, EUR SURG RES, V51, P101, DOI 10.1159/000355674; Papetti M, 2011, J CELL PHYSIOL, V226, P785, DOI 10.1002/jcp.22399; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; PicardTeam, 2009, PIC SET TOOLS JAV WO; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Development Core Team, 2014, R FDN STAT COMP; Ryu HS, 2010, ANTICANCER RES, V30, P3479; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Wan XH, 2012, CLIN CANCER RES, V18, P726, DOI 10.1158/1078-0432.CCR-11-2521; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LD, 2010, NAT GENET, V42, P759, DOI 10.1038/ng.648; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Warnes GR, 2014, GPLOTS VARIOUS R PRO; Wu C, 2013, NAT GENET, V45, P632, DOI 10.1038/ng.2638; Wu C, 2011, NAT GENET, V43, P679, DOI 10.1038/ng.849; Ying JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039797; Yokobori T, 2012, INT J ONCOL, V41, P253, DOI 10.3892/ijo.2012.1436; Yoon TM, 2013, AURIS NASUS LARYNX, V40, P222, DOI 10.1016/j.anl.2012.07.006; Zhang HE, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-244; Zhang L, 2015, AM J HUM GENET, V96, P597, DOI 10.1016/j.ajhg.2015.02.017; Zhao J. H., 2014, GAP GENETIC ANAL PAC	59	97	104	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					709	727		10.1016/j.ajhg.2016.02.021	http://dx.doi.org/10.1016/j.ajhg.2016.02.021			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27058444	Bronze, Green Published			2022-12-18	WOS:000374203800009
J	Stessman, HAF; Willemsen, MH; Fenckova, M; Penn, O; Hoischen, A; Xiong, B; Wang, TY; Hoekzema, K; Vives, L; Voge, I; Brunner, HG; van der Burgt, I; Ockeloen, CW; Schuurs-Hoeijmakers, JH; Wassink-Ruiter, JSK; Stumpel, C; Stevens, SJC; Vles, HS; Marcelis, CM; van Bokhoven, H; Cantagrel, V; Colleaux, L; Nicouleau, M; Lyonnet, S; Bernier, RA; Gerdts, J; Coe, BP; Romano, C; Alberti, A; Grillo, L; Scuderi, C; Nordenskjold, M; Kvarnung, M; Guo, H; Xia, K; Piton, A; Gerard, B; Genevieve, D; Delobel, B; Lehalle, D; Perrin, L; Prieur, F; Thevenon, J; Gecz, J; Shaw, M; Pfundt, R; Keren, B; Jacquette, A; Schenck, A; Eichler, EE; Kleefstra, Tz				Stessman, Holly A. F.; Willemsen, Marjolein H.; Fenckova, Michaela; Penn, Osnat; Hoischen, Alexander; Xiong, Bo; Wang, Tianyun; Hoekzema, Kendra; Vives, Laura; Voge, Ida; Brunner, Han G.; van der Burgt, Ineke; Ockeloen, Charlotte W.; Schuurs-Hoeijmakers, Janneke H.; Wassink-Ruiter, Jolien S. Klein; Stumpel, Connie; Stevens, Servi J. C.; Vles, Hans S.; Marcelis, Carlo M.; van Bokhoven, Hans; Cantagrel, Vincent; Colleaux, Laurence; Nicouleau, Michael; Lyonnet, Stanislas; Bernier, Raphael A.; Gerdts, Jennifer; Coe, Bradley P.; Romano, Corrado; Alberti, Antonino; Grillo, Lucia; Scuderi, Carmela; Nordenskjold, Magnus; Kvarnung, Malin; Guo, Hui; Xia, Kun; Piton, Amelie; Gerard, Benedicte; Genevieve, David; Delobel, Bruno; Lehalle, Daphne; Perrin, Laurence; Prieur, Fabienne; Thevenon, Julien; Gecz, Jozef; Shaw, Marie; Pfundt, Rolph; Keren, Boris; Jacquette, Aurelia; Schenck, Annette; Eichler, Evan E.; Kleefstra, Tjitske			Disruption of POGZ Is Associated with Intellectual Disability and Autism Spectrum Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; SIMPLEX COLLECTION; HUMAN-DISEASE; DROSOPHILA; GENES; EXPRESSION; NETWORKS; RISK; SCHIZOPHRENIA; HABITUATION	Intellectual disability (ID) and autism spectrum disorders (ASD) are genetically heterogeneous, and a significant number of genes have been associated with both conditions. A few mutations in POGZ have been reported in recent exome studies; however, these studies do not provide detailed clinical information. We collected the clinical and molecular data of 25 individuals with disruptive mutations in POGZ by diagnostic whole-exome, whole-genome, or targeted sequencing of 5,223 individuals with neurodevelopmental disorders (ID primarily) or by targeted resequencing of this locus in 12,041 individuals with ASD and/or ID. The rarity of disruptive mutations among unaffected individuals (2/49,401) highlights the significance (p = 4.19 x 10(-13); odds ratio = 35.8) and penetrance (65.9%) of this genetic subtype with respect to ASD and ID. By studying the entire cohort, we defined common phenotypic features of POGZ individuals, including variable levels of developmental delay (DD) and more severe speech and language delay in comparison to the severity of motor delay and coordination issues. We also identified significant associations with vision problems, microcephaly, hyperactivity, a tendency to obesity, and feeding difficulties. Some features might be explained by the high expression of POGZ, particularly in the cerebellum and pituitary, early in fetal brain development. We conducted parallel studies in Drosophila by inducing conditional knockdown of the POGZ ortholog row, further confirming that dosage of POGZ, specifically in neurons, is essential for normal learning in a habituation paradigm. Combined, the data underscore the pathogenicity of loss-of-function mutations in POGZ and define a POGZ-related phenotype enriched in specific features.	[Stessman, Holly A. F.; Penn, Osnat; Xiong, Bo; Hoekzema, Kendra; Vives, Laura; Coe, Bradley P.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA; [Willemsen, Marjolein H.; Fenckova, Michaela; Hoischen, Alexander; Brunner, Han G.; van der Burgt, Ineke; Ockeloen, Charlotte W.; Schuurs-Hoeijmakers, Janneke H.; Marcelis, Carlo M.; van Bokhoven, Hans; Pfundt, Rolph; Schenck, Annette; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Willemsen, Marjolein H.; Fenckova, Michaela; Hoischen, Alexander; Brunner, Han G.; van Bokhoven, Hans; Schenck, Annette; Kleefstra, Tjitske] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands; [Wang, Tianyun; Guo, Hui; Xia, Kun] Cent S Univ, Sch Life Sci, State Key Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Voge, Ida] Aarhus Univ Hosp, Dept Clin Genet, DK-8000 Aarhus, Denmark; [Brunner, Han G.; Stumpel, Connie; Stevens, Servi J. C.] Maastricht Univ, Med Ctr, Dept Clin Genet, NL-6229 HX Maastricht, Netherlands; [Wassink-Ruiter, Jolien S. Klein] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Wassink-Ruiter, Jolien S. Klein] Univ Groningen, Univ Med Ctr Groningen, NL-9700 RB Groningen, Netherlands; [Vles, Hans S.] Maastricht Univ, Med Ctr, Dept Neurol, NL-6229 HX Maastricht, Netherlands; [Cantagrel, Vincent; Colleaux, Laurence; Nicouleau, Michael; Lyonnet, Stanislas] INSERM, Imagine Inst, Lab Mol & Pathophysiol Bases Cognit Disorders, UMR 1163, F-75015 Paris, France; [Cantagrel, Vincent; Colleaux, Laurence; Nicouleau, Michael; Lyonnet, Stanislas] Paris Descartes Univ, Sorbonne Paris Cite, Imagine Inst, F-75015 Paris, France; [Lyonnet, Stanislas] Hop Necker Enfants Malad, AP HP, Dept Genet, F-75015 Paris, France; [Bernier, Raphael A.; Gerdts, Jennifer] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98105 USA; [Romano, Corrado; Alberti, Antonino] Ist Ricovero & Cura A Carattere Sci Associaz Oasi, Pediat & Med Genet, I-94018 Troina, Italy; [Grillo, Lucia] Ist Ricovero & Cura A Carattere Sci Associaz Oasi, Med Genet Lab, I-94018 Troina, Italy; [Scuderi, Carmela] Ist Ricovero & Cura A Carattere Sci Associaz Oasi, Neuromuscular Dis Unit, I-94018 Troina, Italy; [Nordenskjold, Magnus; Kvarnung, Malin] Karolinska Inst, Ctr Mol Med, Dept Mol Med & Surg, S-17177 Solna, Sweden; [Piton, Amelie] Inst Genet Biol Mol Cellulaire, Dept Translat Med & Neurogenet, F-67400 Illkirch Graffenstaden, France; [Piton, Amelie; Gerard, Benedicte] Hop Univ Strasbourg, Lab Diagnost Genet, F-67000 Strasbourg, France; [Genevieve, David] Hop Arnaud Villeneuve, Dept Med Genet, Ctr Reference Malad Rares Anomalies Dev & Syndrom, F-34090 Montpellier, France; [Delobel, Bruno] Hop St Vincent de Paul, Groupement Hop, Inst Catholique Lille, Ctr Genet Chromosom, F-59000 Lille, France; [Lehalle, Daphne; Thevenon, Julien] Federat Hosp Univ TRANSLAD, Equipe GAD EA4271, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21079 Dijon, France; [Perrin, Laurence] Hop Robert Debre, Serv Genet Clin, F-75019 Paris, France; [Prieur, Fabienne] CHU St Etienne, Serv Genet Clin Chromosom & Mol, F-42100 St Etienne, France; [Gecz, Jozef; Shaw, Marie] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5006, Australia; [Gecz, Jozef; Shaw, Marie] Womens & Childrens Hosp, Adelaide, SA 5006, Australia; [Keren, Boris; Jacquette, Aurelia] Hop La Pitie Salpetriere, AP HP, Dept Genet, F-75013 Paris, France; [Keren, Boris] Univ Paris 06, INSERM, UM75, F-75013 Paris, France; [Keren, Boris] Univ Paris 06, CNRS, UMR7225, U1127, F-75013 Paris, France; [Keren, Boris] Inst Cerveau & Moelle Epiniere, F-75013 Paris, France; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Radboud University Nijmegen; Radboud University Nijmegen; Central South University; Aarhus University; Maastricht University; University of Groningen; University of Groningen; Maastricht University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Washington; University of Washington Seattle; Karolinska Institutet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Montpellier; CHU de Montpellier; Universite Catholique de Lille; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de St Etienne; Robinson Research Institute; University of Adelaide; Womens & Childrens Hospital Australia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98105 USA.; Willemsen, MH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.; Willemsen, MH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, NL-6500 HB Nijmegen, Netherlands.	marjolein.willemsen@radboudumc.nl; eee@gs.washington.edu	Scuderi, Carmela/D-4734-2017; Bokhoven, J.H.L.M. van van/H-8015-2014; Lyonnet, Stanislas/H-5483-2017; Schenck, Annette/E-4514-2012; Hoischen, Alexander/AGF-7293-2022; Grillo, Lucia/K-5014-2016; Willemsen, Marjolein/R-5958-2019; Romano, Corrado/B-9695-2008; Coe, Bradley/A-2878-2009; Vogel, Ida/AAD-1087-2019; , WaNgtJ/AAR-7045-2020; WANG, JINGYI/GSJ-1241-2022; Fenckova, Michaela/AGY-9276-2022; Pfundt, Rolph/L-4576-2015; Marcelis, C.L.M./L-4504-2015; COLLEAUX, Laurence/H-6455-2017; Fenckova, Michaela/H-8622-2017; piton, amelie/F-1201-2013; Ockeloen, Charlotte/P-5732-2015; COLLEAUX, LAURENCE/AAA-8144-2022; XIA, KUN/AAO-3525-2020; Alberti, Antonino/D-5653-2017; Hoischen, Alexander/D-1282-2013; wang, jie/GRS-0942-2022; Vincent, Cantagrel/H-8698-2017; Gecz, Jozef/X-3469-2019; Kleefstra, Tjitske/G-2619-2012; Stevens, Servi/P-8450-2015	Scuderi, Carmela/0000-0001-5901-0041; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Lyonnet, Stanislas/0000-0001-5426-9417; Schenck, Annette/0000-0002-6918-3314; Hoischen, Alexander/0000-0002-8072-4476; Grillo, Lucia/0000-0003-4848-8060; Romano, Corrado/0000-0003-1049-0683; Vogel, Ida/0000-0002-1125-0393; Fenckova, Michaela/0000-0002-5716-1652; Marcelis, C.L.M./0000-0001-7095-4641; Fenckova, Michaela/0000-0002-5716-1652; piton, amelie/0000-0003-0408-7468; Ockeloen, Charlotte/0000-0003-0329-1520; COLLEAUX, LAURENCE/0000-0002-0987-7648; Alberti, Antonino/0000-0001-6742-7429; Hoischen, Alexander/0000-0002-8072-4476; Vincent, Cantagrel/0000-0002-5180-4848; Gecz, Jozef/0000-0002-7884-6861; Stevens, Servi/0000-0001-8769-3150; Nordenskjold, Magnus/0000-0002-4974-425X; Stessman, Holly/0000-0002-0764-3493; Xiong, Bo/0000-0002-2695-9100; Coe, Bradley/0000-0001-8471-4016; Nicouleau, Michael/0000-0001-9319-3355	NHGRI NIH HHS [T32 HG000035] Funding Source: Medline; NICHD NIH HHS [U54 HD083091] Funding Source: Medline; NIMH NIH HHS [R01 MH101221, R01 MH100047] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100047, R01MH101221] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ACHENBACH TM, 1991, MONOGR SOC RES CHILD, V56, pR5; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Bernier R, 2014, CELL, V158, P263, DOI 10.1016/j.cell.2014.06.017; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buxbaum JD, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-34; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Chylack LT, 2004, EXP EYE RES, V79, P941, DOI 10.1016/j.exer.2004.08.022; Coe BP, 2014, NAT GENET, V46, P1063, DOI 10.1038/ng.3092; D'Mello AM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00408; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Engel JE, 1996, J NEUROSCI, V16, P3486; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Francioli LC, 2015, NAT GENET, V47, P822, DOI 10.1038/ng.3292; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fukai R, 2015, J HUM GENET, V60, P277, DOI 10.1038/jhg.2015.13; Giannandrea M, 2010, AM J HUM GENET, V86, P185, DOI 10.1016/j.ajhg.2010.01.011; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Gowen E, 2007, CEREBELLUM, V6, P268, DOI 10.1080/14734220601184821; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hashimoto R, 2016, J HUM GENET, V61, P199, DOI 10.1038/jhg.2015.141; Helsmoortel C, 2014, NAT GENET, V46, P380, DOI 10.1038/ng.2899; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Isidor B, 2016, HUM MUTAT, V37, P354, DOI 10.1002/humu.22952; Kochinke K, 2016, AM J HUM GENET, V98, P149, DOI 10.1016/j.ajhg.2015.11.024; Kramer JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000569; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Matson JL, 2009, RES DEV DISABIL, V30, P1317, DOI 10.1016/j.ridd.2009.05.008; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Mullegama SV, 2015, INT J MOL SCI, V16, P7627, DOI 10.3390/ijms16047627; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; Ramaswami M, 2014, NEURON, V82, P1216, DOI 10.1016/j.neuron.2014.04.035; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Rosenfeld JA, 2013, GENET MED, V15, P478, DOI 10.1038/gim.2012.164; Ruan J, 2008, NUCLEIC ACIDS RES, V36, pD735, DOI 10.1093/nar/gkm1005; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Srivastava AK, 2014, NEUROSCI BIOBEHAV R, V46, P161, DOI 10.1016/j.neubiorev.2014.02.015; Stessman HA, 2014, CELL, V156, P872, DOI 10.1016/j.cell.2014.02.002; Taylor M, 2012, J PEDIATR-US, V161, P855, DOI 10.1016/j.jpeds.2012.05.014; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; van Bon BWM, 2016, MOL PSYCHIATR, V21, P126, DOI 10.1038/mp.2015.5; van Bon BWM, 2013, HUM MOL GENET, V22, P3138, DOI 10.1093/hmg/ddt170; van der Voet M, 2014, NEUROSCI BIOBEHAV R, V46, P326, DOI 10.1016/j.neubiorev.2014.01.013; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; White J, 2016, GENOME MED, V8, DOI 10.1186/s13073-015-0253-0; Willemsen MH, 2013, J MED GENET, V50, P507, DOI 10.1136/jmedgenet-2012-101490; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145; Ye Y., 2015, COLD SPRING HARB MOL, V1	62	97	101	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 3	2016	98	3					541	552		10.1016/j.ajhg.2016.02.004	http://dx.doi.org/10.1016/j.ajhg.2016.02.004			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DG9DN	26942287	Green Published, Bronze			2022-12-18	WOS:000372383100016
J	Carmona, FD; Mackie, SL; Martin, JE; Taylor, JC; Vaglio, A; Eyre, S; Bossini-Castillo, L; Castaneda, S; Cid, MC; Hernandez-Rodriguez, J; Prieto-Gonzalez, S; Solans, R; Ramentol-Sintas, M; Gonzalez-Escribano, MF; Ortiz-Fernandez, L; Morado, IC; Narvaez, J; Miranda-Filloy, JA; Beretta, L; Lunardi, C; Cimmino, MA; Gianfreda, D; Santilli, D; Ramirez, GA; Soriano, A; Muratore, F; Pazzola, G; Addimanda, O; Wijmenga, C; Witte, T; Schirmer, JH; Moosig, F; Schonau, V; Franke, A; Palm, O; Molberg, O; Diamantopoulos, AP; Carette, S; Cuthbertson, D; Forbess, LJ; Hoffman, GS; Khalidi, NA; Koening, CL; Langford, CA; McAlear, CA; Moreland, L; Monach, PA; Pagnoux, C; Seo, P; Spiera, R; Sreih, AG; Warrington, KJ; Ytterberg, SR; Gregersen, PK; Pease, CT; Gough, A; Green, M; Hordon, L; Jarrett, S; Watts, R; Levy, S; Patel, Y; Kamath, S; Dasgupta, B; Worthington, J; Koeleman, BPC; de Bakker, PIW; Barrett, JH; Salvarani, C; Merkel, PA; Gonzalez-Gay, MA; Morgan, AW; Martin, J				David Carmona, F.; Mackie, Sarah L.; Martin, Jose-Ezequiel; Taylor, John C.; Vaglio, Augusto; Eyre, Stephen; Bossini-Castillo, Lara; Castaneda, Santos; Cid, Maria C.; Hernandez-Rodriguez, Jose; Prieto-Gonzalez, Sergio; Solans, Roser; Ramentol-Sintas, Marc; Francisca Gonzalez-Escribano, M.; Ortiz-Fernandez, Lourdes; Morado, Inmaculada C.; Narvaez, Javier; Miranda-Filloy, Jose A.; Beretta, Lorenzo; Lunardi, Claudio; Cimmino, Marco A.; Gianfreda, Davide; Santilli, Daniele; Ramirez, Giuseppe A.; Soriano, Alessandra; Muratore, Francesco; Pazzola, Giulia; Addimanda, Olga; Wijmenga, Cisca; Witte, Torsten; Schirmer, Jan H.; Moosig, Frank; Schoenau, Verena; Franke, Andre; Palm, Oyvind; Molberg, Oyvind; Diamantopoulos, Andreas P.; Carette, Simon; Cuthbertson, David; Forbess, Lindsy J.; Hoffman, Gary S.; Khalidi, Nader A.; Koening, Curry L.; Langford, Carol A.; McAlear, Carol A.; Moreland, Larry; Monach, Paul A.; Pagnoux, Christian; Seo, Philip; Spiera, Robert; Sreih, Antoine G.; Warrington, Kenneth J.; Ytterberg, Steven R.; Gregersen, Peter K.; Pease, Colin T.; Gough, Andrew; Green, Michael; Hordon, Lesley; Jarrett, Stephen; Watts, Richard; Levy, Sarah; Patel, Yusuf; Kamath, Sanjeet; Dasgupta, Bhaskar; Worthington, Jane; Koeleman, Bobby P. C.; de Bakker, Paul I. W.; Barrett, Jennifer H.; Salvarani, Carlo; Merkel, Peter A.; Gonzalez-Gay, Miguel A.; Morgan, Ann W.; Martin, Javier		Spanish GCA Grp	A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TYROSINE-PHOSPHATASE PTPN22; PRIMARY BILIARY-CIRRHOSIS; EXTENDED HUMAN MHC; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; POLYMYALGIA-RHEUMATICA; RISK LOCI; ATOPIC-DERMATITIS; FOXP3 EXPRESSION	We conducted a large-scale genetic analysis on giant cell arteritis (GCA), a polygenic immune-mediated vasculitis. A case-control cohort, comprising 1,651 case subjects with GCA and 15,306 unrelated control subjects from six different countries of European ancestry, was genotyped by the Immunochip array. We also imputed HLA data with a previously validated imputation method to perform a more comprehensive analysis of this genomic region. The strongest association signals were observed in the HLA region, with rs477515 representing the highest peak (p = 4.05 x 10(-40), OR = 1.73). A multivariate model including class II amino acids of HLA-DR beta 1 and HLA-DQ alpha 1 and one class I amino acid of HLA-B explained most of the HLA association with GCA, consistent with previously reported associations of classical HLA alleles like HLA-DRB1*04. An omnibus test on polymorphic amino acid positions highlighted DR beta 1 13 (p = 4.08 x 10(-43)) and HLA-DQ alpha 1 47 (p = 4.02 x 10(-46)), 56, and 76 (both p = 1.84 x 10(-45)) as relevant positions for disease susceptibility. Outside the HLA region, the most significant loci included PTPN22 (rs2476601, p = 1.73 x 10(-6), OR = 1.38), LRRC32 (rs10160518, p = 4.39 x 10(-6), OR = 1.20), and REL (rs115674477, p = 1.10 x 10(-5), OR = 1.63). Our study provides evidence of a strong contribution of HLA class I and II molecules to susceptibility to GCA. In the non-HLA region, we confirmed a key role for the functional PTPN22 rs2476601 variant and proposed other putative risk loci for GCA involved in Th1, Th17, and Treg cell function.	[David Carmona, F.; Martin, Jose-Ezequiel; Bossini-Castillo, Lara; Martin, Javier] PTS Granada, CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18016, Spain; [Mackie, Sarah L.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds LS7 4SA, W Yorkshire, England; [Mackie, Sarah L.] Univ Leeds, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds LS7 4SA, W Yorkshire, England; [Taylor, John C.; Barrett, Jennifer H.; Morgan, Ann W.] Univ Leeds, Sch Med, Leeds LS9 7TF, W Yorkshire, England; [Taylor, John C.; Barrett, Jennifer H.; Morgan, Ann W.] Univ Leeds, NIHR Leeds Musculoskeletal Biomed Res Unit, Leeds LS9 7TF, W Yorkshire, England; [Vaglio, Augusto] Univ Hosp Parma, Nephrol Unit, I-43126 Parma, Italy; [Eyre, Stephen; Worthington, Jane] Manchester Acad Hlth Sci, NIHR Manchester Musculoskeletal Biomed Res Unit, Manchester, Lancs, England; [Eyre, Stephen; Worthington, Jane] Univ Manchester, Arthrit Res UK Epidemiol Unit, Manchester M13 9NT, Lancs, England; [Castaneda, Santos] Hosp Princesa, IIS Princesa, Dept Rheumatol, Madrid 28006, Spain; [Cid, Maria C.; Hernandez-Rodriguez, Jose; Prieto-Gonzalez, Sergio] Univ Barcelona, Hosp Clin, Dept Autoimmune Dis, Vasculitis Res Unit,IDIBAPS, E-08036 Barcelona, Spain; [Solans, Roser; Ramentol-Sintas, Marc] Autonomous Univ Barcelona, Dept Internal Med, Hosp Vall Hebron, Autoimmune Syst Dis Unit, E-08035 Barcelona, Spain; [Francisca Gonzalez-Escribano, M.; Ortiz-Fernandez, Lourdes] US, CSIC, Hosp Univ Virgen Rocio, Dept Immunol,IBiS, Seville 41013, Spain; [Morado, Inmaculada C.] Hosp Clin San Carlos, Dept Rheumatol, Madrid 28040, Spain; [Narvaez, Javier] Hosp Univ Bellvitge IDIBELL, Dept Rheumatol, Barcelona 08907, Spain; [Miranda-Filloy, Jose A.] Hosp Xeral Calde, Dept Rheumatol, Lugo 27004, Spain; [Beretta, Lorenzo] Fdn IRCCS Ca Granda Osped Maggiore Policlin Milan, Referral Ctr Syst Autoimmune Dis, I-20122 Milan, Italy; [Lunardi, Claudio] Univ Verona, Dept Med, I-37134 Verona, Italy; [Cimmino, Marco A.] Univ Genoa, Dept Internal Med, Div Clin Rheumatol, Res Lab & Acad Div Clin Rheumatol, I-16132 Genoa, Italy; [Gianfreda, Davide] Univ Parma, Sch Med, Dept Clin & Expt Med, I-43126 Parma, Italy; [Santilli, Daniele] Univ Hosp Parma, Unit Internal Med & Rheumatol, I-43126 Parma, Italy; [Ramirez, Giuseppe A.] IRCCS Osped San Raffaele, Unit Internal Med & Immunol, I-20132 Milan, Italy; [Ramirez, Giuseppe A.] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Soriano, Alessandra] Campus Biomedico Univ, Dept Clin Med & Rheumatol, I-00128 Rome, Italy; [Muratore, Francesco; Pazzola, Giulia; Addimanda, Olga; Salvarani, Carlo] Azienda Osped Arcispedale Santa Maria Nuova, Ist Ricovero & Cura Carattere Sci, Dept Internal Med, Rheumatol Unit, I-42123 Reggio Emilia, Italy; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 Groningen, Netherlands; [Witte, Torsten] Hannover Med Sch, D-30625 Hannover, Germany; [Schirmer, Jan H.; Moosig, Frank] Klinikum Bad Bramstedt, Vasculitis Clin, D-24576 Bad Bramstedt, Germany; [Schirmer, Jan H.; Moosig, Frank] Univ Hosp Schleswig Holstein, D-24576 Bad Bramstedt, Germany; [Schoenau, Verena] Univ Klinikum Erlangen, Dept Rheumatol & Immunol, D-91054 Erlangen, Germany; [Franke, Andre] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Palm, Oyvind; Molberg, Oyvind] Oslo Univ Hosp, Dept Rheumatol, N-0424 Oslo, Norway; [Diamantopoulos, Andreas P.] Hosp Southern Norway Trust, Dept Rheumatol, N-4604 Kristiansand, Norway; [Carette, Simon; Pagnoux, Christian] Mt Sinai Hosp, Div Rheumatol, Toronto, ON M5T 3L9, Canada; [Cuthbertson, David] Univ S Florida, Dept Biostat, Tampa, FL 33612 USA; [Forbess, Lindsy J.] Cedars Sinai Med Ctr, Div Rheumatol, Los Angeles, CA 90048 USA; [Hoffman, Gary S.; Langford, Carol A.] Cleveland Clin Fdn, Ctr Vasculitis Care & Res, Cleveland, OH 44195 USA; [Khalidi, Nader A.] McMaster Univ, St Josephs Healthcare, Div Rheumatol, Hamilton, ON L8N 1Y2, Canada; [Koening, Curry L.] Univ Utah, Div Rheumatol, Salt Lake City, UT 84132 USA; [McAlear, Carol A.; Sreih, Antoine G.; Merkel, Peter A.] Univ Penn, Div Rheumatol, Penn Vasculitis Ctr, Philadelphia, PA 19104 USA; [Moreland, Larry] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15261 USA; [Monach, Paul A.] Boston Univ, Sch Med, Rheumatol Sect, Boston, MA 02118 USA; [Seo, Philip] Johns Hopkins Univ, Div Rheumatol, Baltimore, MD 21224 USA; [Spiera, Robert] Hosp Special Surg, Dept Rheumatol, New York, NY 10021 USA; [Warrington, Kenneth J.; Ytterberg, Steven R.] Mayo Clin, Coll Med, Div Rheumatol, Rochester, MN 55905 USA; [Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Pease, Colin T.] Leeds Teaching Hosp NHS Trust, Dept Rheumatol, Leeds LS7 4SA, W Yorkshire, England; [Gough, Andrew] Harrogate & Dist NHS Fdn Trust, Dept Rheumatol, Harrogate HG2 7SX, England; [Green, Michael] York Teaching Hosp NHS Fdn Trust, Dept Rheumatol, York YO31 8HE, N Yorkshire, England; [Hordon, Lesley] Mid Yorkshire Hosp NHS Trust, Dewsbury & Dist Hosp, Dept Rheumatol, Dewsbury WF13 4HS, England; [Jarrett, Stephen] Mid Yorkshire Hosp NHS Trust, Pinderfields Hosp, Dept Rheumatol, Wakefield WF1 4DG, England; [Watts, Richard] Ipswich Hosp NHS Trust, Dept Rheumatol, Ipswich IP4 5PD, Suffolk, England; [Levy, Sarah] Croydon Hlth Serv NHS Trust, Dept Rheumatol, Croydon CR7 7YE, England; [Patel, Yusuf] Hull & East Yorkshire NHS Trust, Dept Rheumatol, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Kamath, Sanjeet] Staffordshire & Stoke On Trent Partnership NHS Tr, Dept Rheumatol, Stoke On Trent ST6 7AG, Staffs, England; [Dasgupta, Bhaskar] Southend Univ Hosp NHS Fdn Trust, Dept Rheumatol, Westcliff On Sea SS0 0RY, England; [Koeleman, Bobby P. C.; de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Med Genet, Ctr Mol Med, NL-3584 CX Utrecht, Netherlands; [de Bakker, Paul I. W.] Univ Med Ctr Utrecht, Dept Epidemiol, Julius Ctr Hlth Sci & Primary Care, NL-3584 CX Utrecht, Netherlands; [Gonzalez-Gay, Miguel A.] Hosp Univ Marques de Valdecilla, Dept Rheumatol, IDIVAL, Santander 39008, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Leeds; Leeds Biomedical Research Centre; University of Leeds; University of Leeds; Leeds Biomedical Research Centre; University of Leeds; University of Parma; University Hospital of Parma; University of Manchester; University of Manchester; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Clinico San Carlos; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Hospital Universitario Lucus Augusti-Lugo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Verona; University of Genoa; University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University Campus Bio-Medico - Rome Italy; IRCCS Arcispedale S. Maria Nuova; University of Groningen; Hannover Medical School; University of Kiel; Schleswig Holstein University Hospital; University of Erlangen Nuremberg; University of Kiel; University of Oslo; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; State University System of Florida; University of South Florida; Cedars Sinai Medical Center; Cleveland Clinic Foundation; McMaster University; Utah System of Higher Education; University of Utah; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Boston University; Johns Hopkins University; Mayo Clinic; Northwell Health; University of Leeds; Pinderfields Hospital; Ipswich Hospital NHS Trust; Ipswich Hospital; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Hospital Universitario Marques de Valdecilla (HUMV)	Carmona, FD (corresponding author), PTS Granada, CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18016, Spain.	dcarmona@ipb.csic.es	Franke, Andre/B-2151-2010; González-Gay, Miguel A./B-2306-2008; Comet, Luis Sáez/I-7301-2017; Vaglio, Augusto/AHE-8117-2022; blanco, ricardo/AAA-1248-2020; Cuthbertson, David/AAC-7703-2019; Warrington, Kenneth/CAG-1626-2022; Narvaez, Javier/AAD-7434-2020; Centeno, Norberto Ortego/C-4793-2019; Martin, Javier/B-8141-2008; Ortiz-Fernández, Lourdes/GOJ-7451-2022; Sanchez-Pernaute, Olga/AAG-2811-2021; Muratore, Francesco/J-6997-2016; Ortiz-Fernández, Lourdes/AAA-6647-2020; Witte, Torsten/B-5783-2016; Salvarani, Carlo/K-2431-2018; Narvaez, Javier/AAD-7456-2020; Spiera, Robert/W-7479-2019; Bossini-Castillo, Lara/G-1234-2016; Cid, Maria C./J-4553-2016; González-Escribano, María Francisca/X-5554-2019; Soriano, Alessandra/AAB-3057-2021; Martín, María/HDL-9512-2022; Wijmenga, Cisca/AAE-7719-2019; Pagnoux, Christian/C-4612-2015; Ramirez, Giuseppe Alvise/K-4923-2018; de Bakker, Paul IW/B-8730-2009; Beretta, Lorenzo/AAB-8605-2019; Carmona, F. David/F-9953-2016; Martín, Javier/AAV-5209-2021; Hernandez-Rodriguez, Jose/L-2073-2017; Fernandez-Nebro, Antonio/K-7628-2012; Martin, Jose Ezequiel/F-4869-2012	Franke, Andre/0000-0003-1530-5811; González-Gay, Miguel A./0000-0002-7924-7406; Vaglio, Augusto/0000-0002-3814-9172; blanco, ricardo/0000-0003-2344-2285; Centeno, Norberto Ortego/0000-0003-2325-0937; Martin, Javier/0000-0002-2202-0622; Sanchez-Pernaute, Olga/0000-0002-9894-5699; Muratore, Francesco/0000-0003-0362-2668; Ortiz-Fernández, Lourdes/0000-0002-0247-4280; Narvaez, Javier/0000-0002-1614-8064; Bossini-Castillo, Lara/0000-0002-5471-5824; Cid, Maria C./0000-0002-4730-0938; Soriano, Alessandra/0000-0002-4554-8198; Wijmenga, Cisca/0000-0002-5635-1614; Ramirez, Giuseppe Alvise/0000-0002-2889-366X; de Bakker, Paul IW/0000-0001-7735-7858; Beretta, Lorenzo/0000-0002-6529-6258; Carmona, F. David/0000-0002-1427-7639; Hernandez-Rodriguez, Jose/0000-0002-2357-2015; Alegre Sancho, Juan Jose/0000-0003-1641-0875; Seo, Philip/0000-0003-3435-6737; Tio Barrera, Laura/0000-0003-1408-7381; Palm, Oyvind/0000-0001-5395-0665; Rios-Fernandez, Raquel/0000-0001-6630-8292; Fernandez-Nebro, Antonio/0000-0002-2962-9844; Moosig, Frank/0000-0002-7341-9844; Schirmer, Jan Henrik/0000-0001-5467-2783; Warrington, Kenneth/0000-0001-7708-2487; Salvarani, Carlo/0000-0001-5426-5133; Moreland, Larry/0000-0003-4483-0359; Martin, Jose Ezequiel/0000-0002-0051-8868; Barrett, Jenny/0000-0002-1720-7724; MARTINEZ ZAPICO, ALEIDA/0000-0001-9443-8043; Ordonez Canizares, Maria del Carmen/0000-0002-6669-2279; Morgan, Ann/0000-0003-1109-624X; Magro Checa, Cesar/0000-0002-5685-3091	Instituto de Salud Carlos III (ISCIII), Spain through the RETICS [RD12/0009/0004]; Ministerio de Economia y Competitividad, Spain [SAF 11/30073]; Research into Ageing; Wellcome Trust/AMS Starter Grant for Clinical Lecturers; Leeds Teaching Hospitals Charitable Trustees; Mason Medical Research Foundation; NIH Research Clinician Scientist Award; NIHR-Leeds Musculoskeletal Biomedical Research Unit; Ann Wilks Memorial Fund; United States National Institute of Arthritis and Musculoskeletal and Skin Diseases [U54AR057319]; National Center for Research Resources [U54 RR019497]; Office of Rare Diseases Research; National Center for Advancing Translational Science; Agder Medforsk;  [DFG KFO TP03]; MRC [MR/L01629X/1] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-SGCL4-Mackie] Funding Source: researchfish; Medical Research Council [MR/L01629X/1] Funding Source: researchfish; National Institute for Health Research [NIHR-CS-012-016, CL-2009-02-002] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR057319] Funding Source: NIH RePORTER	Instituto de Salud Carlos III (ISCIII), Spain through the RETICS(Instituto de Salud Carlos III); Ministerio de Economia y Competitividad, Spain; Research into Ageing; Wellcome Trust/AMS Starter Grant for Clinical Lecturers; Leeds Teaching Hospitals Charitable Trustees; Mason Medical Research Foundation; NIH Research Clinician Scientist Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIHR-Leeds Musculoskeletal Biomedical Research Unit; Ann Wilks Memorial Fund; United States National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Rare Diseases Research; National Center for Advancing Translational Science; Agder Medforsk; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Sofia Vargas, Sonia Garcia, Gema Robledo, Steve Martin, Lubna-Haroon Raashid, and Edward Flynn for their excellent technical assistance and the participants for kindly accepting their collaboration. Steve Rich, Stephen Suna Onengut-Gumuscu, and Wei-Min Chen are thanked for genotyping and quality control. Marta Conde-Jaldon is thanked for assisting in HLA typing. The Norwegian Systemic Vasculitis and Connective Tissue Disease Registry (NOSVAR) at Oslo University Hospital is acknowledged for providing data on the Norwegian cases. F.D.C., J.M., and M.A.G.-G. were supported by Instituto de Salud Carlos III (ISCIII), Spain, through the RETICS Program RD12/0009/0004 (RIER). M.C.C., J.H.-R., and S.P.-G. were supported by Ministerio de Economia y Competitividad, Spain (SAF 11/30073). S.L.M. received grant funding from Research into Ageing, a Wellcome Trust/AMS Starter Grant for Clinical Lecturers, the Leeds Teaching Hospitals Charitable Trustees, and the Mason Medical Research Foundation and is funded by a NIH Research Clinician Scientist Award. A.W.M., J.H.B., and J.C.T. were supported by the NIHR-Leeds Musculoskeletal Biomedical Research Unit and the Ann Wilks Memorial Fund. The Vasculitis Clinical Research Consortium (VCRC) received support from the United States National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54AR057319), the National Center for Research Resources (U54 RR019497), the Office of Rare Diseases Research, and the National Center for Advancing Translational Science. The VCRC is part of the Rare Diseases Clinical Research Network (RDCRN). A.P.D. was funded by Agder Medforsk (non-profit research organization stationed in Southern Norway). T.W. was funded by the grant DFG KFO TP03.	Achkar JP, 2012, GENES IMMUN, V13, P245, DOI 10.1038/gene.2011.79; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Badrinath S, 2012, IMMUNOGENETICS, V64, P245, DOI 10.1007/s00251-011-0583-z; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bossini-Castillo L, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204591; Bottini N, 2014, ANNU REV IMMUNOL, V32, P83, DOI 10.1146/annurev-immunol-032713-120249; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Brown WM, 2009, DIABETES OBES METAB, V11, P2, DOI 10.1111/j.1463-1326.2008.00997.x; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Chan DV, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-27; CID MC, 1988, ARTHRITIS RHEUM, V31, P678, DOI 10.1002/art.1780310515; Cooper JD, 2012, HUM MOL GENET, V21, P5202, DOI 10.1093/hmg/dds357; Cortes A, 2013, NAT GENET, V45, P730, DOI 10.1038/ng.2667; Cortes A, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3204; Dababneh A, 1998, J RHEUMATOL, V25, P2140; Carmona FD, 2014, RHEUMATOLOGY, V53, P6, DOI 10.1093/rheumatology/ket231; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Espigol-Frigole G, 2013, ANN RHEUM DIS, V72, P1481, DOI 10.1136/annrheumdis-2012-201836; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Gonzalez-Gay MA, 2000, MEDICINE, V79, P283, DOI 10.1097/00005792-200009000-00001; Gonzalez-Gay MA, 1998, ARTHRITIS RHEUM, V41, P1497, DOI 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z; Gonzalez-Gay MA, 2003, SEMIN ARTHRITIS RHEU, V33, P38, DOI 10.1053/sarh.2002.50025; Gonzalez-Gay Miguel A, 2010, Curr Rheumatol Rep, V12, P436, DOI 10.1007/s11926-010-0135-9; Gonzalez-Gay MA, 2009, ARTHRIT CARE RES, V61, P1454, DOI 10.1002/art.24459; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Grumont R, 2001, J EXP MED, V194, P1021, DOI 10.1084/jem.194.8.1021; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Heide A, 2015, IMMUNOGENETICS, V67, P1, DOI 10.1007/s00251-014-0808-z; Hinks A, 2013, NAT GENET, V45, P664, DOI 10.1038/ng.2614; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Jacobsen S, 2002, J RHEUMATOL, V29, P2148; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jia X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057858; Juran BD, 2012, HUM MOL GENET, V21, P5209, DOI 10.1093/hmg/dds359; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Lio CWJ, 2011, CURR OPIN IMMUNOL, V23, P213, DOI 10.1016/j.coi.2010.11.010; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Liu JZ, 2012, NAT GENET, V44, P1137, DOI 10.1038/ng.2395; Ly KH, 2010, AUTOIMMUN REV, V9, P635, DOI 10.1016/j.autrev.2010.05.002; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Morris DL, 2012, AM J HUM GENET, V91, P778, DOI 10.1016/j.ajhg.2012.08.026; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Ombrello MJ, 2014, P NATL ACAD SCI USA, V111, P8867, DOI 10.1073/pnas.1406575111; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Rauzy O, 1998, ANN RHEUM DIS, V57, P380, DOI 10.1136/ard.57.6.380; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Ricano-Ponce I, 2013, ANNU REV GENOM HUM G, V14, P325, DOI 10.1146/annurev-genom-091212-153450; Roder G, 2006, ACTA CRYSTALLOGR D, V62, P1300, DOI 10.1107/S0907444906027636; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P3788, DOI 10.1002/art.34647; Saruhan-Direskeneli G, 2013, AM J HUM GENET, V93, P298, DOI 10.1016/j.ajhg.2013.05.026; Serrano A, 2013, ANN RHEUM DIS, V72, P1882, DOI 10.1136/annrheumdis-2013-203641; Sham PC, 2014, NAT REV GENET, V15, P335, DOI 10.1038/nrg3706; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Tollefsen S, 2012, J BIOL CHEM, V287, P13611, DOI 10.1074/jbc.M111.320374; Trynka G, 2011, NAT GENET, V43, P1193, DOI 10.1038/ng.998; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Viatte S, 2013, NAT REV RHEUMATOL, V9, P141, DOI 10.1038/nrrheum.2012.237; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; WEYAND CM, 1992, J CLIN INVEST, V90, P2355, DOI 10.1172/JCI116125; WEYAND CM, 1994, ARTHRITIS RHEUM, V37, P514, DOI 10.1002/art.1780370411; Weyand CM, 2013, NAT REV RHEUMATOL, V9, P731, DOI 10.1038/nrrheum.2013.161; Zhang JY, 2011, NAT GENET, V43, P902, DOI 10.1038/ng.904; Zhang LJ, 2007, J CELL PHYSIOL, V211, P590, DOI 10.1002/jcp.21001	77	97	100	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					565	580		10.1016/j.ajhg.2015.02.009	http://dx.doi.org/10.1016/j.ajhg.2015.02.009			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25817017	Green Published, hybrid			2022-12-18	WOS:000352212600005
J	Agrawal, PB; Pierson, CR; Joshi, M; Liu, XL; Ravenscroft, G; Moghadaszadeh, B; Talabere, T; Viola, M; Swanson, LC; Haliloglu, G; Talim, B; Yau, KS; Allcock, RJN; Laing, NG; Perrella, MA; Beggs, AH				Agrawal, Pankaj B.; Pierson, Christopher R.; Joshi, Mugdha; Liu, Xiaoli; Ravenscroft, Gianina; Moghadaszadeh, Behzad; Talabere, Tiffany; Viola, Marissa; Swanson, Lindsay C.; Haliloglu, Goknur; Talim, Beril; Yau, Kyle S.; Allcock, Richard J. N.; Laing, Nigel G.; Perrella, Mark A.; Beggs, Alan H.			SPEG Interacts with Myotubularin, and Its Deficiency Causes Centronuclear Myopathy with Dilated Cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SARCOPLASMIC-RETICULUM; CONGENITAL MYOPATHY; LIPID PHOSPHATASE; SKELETAL-MUSCLE; GENE; MUTATIONS; MICE; DISORGANIZATION; ARCHITECTURE; DYNAMIN-2	Centronuclear myopathies (CNMs) are characterized by muscle weakness and increased numbers of central nuclei within myofibers. X-linked myotubular myopathy, the most common severe form of CNM, is caused by mutations in MTM1, encoding myotubularin (MTM1), a lipid phosphatase. To increase our understanding of MTM1 function, we conducted a yeast two-hybrid screen to identify MTM1-interacting proteins. Striated muscle preferentially expressed protein kinase (SPEG), the product of SPEG complex locus (SPEG), was identified as an MTM1-interacting protein, confirmed by immunoprecipitation and immunofluorescence studies. SPEG knockout has been previously associated with severe dilated cardiomyopathy in a mouse model. Using whole-exome sequencing, we identified three unrelated CNM-affected probands, including two with documented dilated cardiomyopathy, carrying homozygous or compound-heterozygous SPEG mutations. SPEG was markedly reduced or absent in two individuals whose muscle was available for immunofluorescence and immunoblot studies. Examination of muscle samples from Speg-knockout mice revealed an increased frequency of central nuclei, as seen in human subjects. SPEG localizes in a double line, flanking desmin over the Z lines, and is apparently in alignment with the terminal cisternae of the sarcoplasmic reticulum. Examination of human and murine MTM1-deficient muscles revealed similar abnormalities in staining patterns for both desmin and SPEG. Our results suggest that mutations in SPEG, encoding SPEG, cause a CNM phenotype as a result of its interaction with MTM1. SPEG is present in cardiac muscle, where it plays a critical role; therefore, individuals with SPEG mutations additionally present with dilated cardiomyopathy.	[Agrawal, Pankaj B.; Joshi, Mugdha; Moghadaszadeh, Behzad; Viola, Marissa; Swanson, Lindsay C.; Beggs, Alan H.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Agrawal, Pankaj B.; Joshi, Mugdha; Moghadaszadeh, Behzad; Viola, Marissa; Swanson, Lindsay C.; Beggs, Alan H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Agrawal, Pankaj B.] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Agrawal, Pankaj B.; Joshi, Mugdha; Moghadaszadeh, Behzad; Swanson, Lindsay C.; Beggs, Alan H.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Pierson, Christopher R.] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH 43205 USA; [Pierson, Christopher R.; Talabere, Tiffany] Ohio State Univ, Coll Med, Columbus, OH 43205 USA; [Liu, Xiaoli; Perrella, Mark A.] Brigham & Womens Hosp, Dept Pulm & Crit Care Med, Boston, MA 02115 USA; [Ravenscroft, Gianina; Yau, Kyle S.; Laing, Nigel G.] Univ Western Australia, Harry Perkins Inst Med Res, Nedlands, WA 6009, Australia; [Ravenscroft, Gianina; Yau, Kyle S.; Laing, Nigel G.] Univ Western Australia, Med Res Ctr, Nedlands, WA 6009, Australia; [Talabere, Tiffany] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [Haliloglu, Goknur] Hacettepe Univ, Childrens Hosp, Neurol Unit, Dept Pediat, TR-06100 Ankara, Turkey; [Talim, Beril] Hacettepe Univ, Childrens Hosp, Pathol Unit, Dept Pediat, TR-06100 Ankara, Turkey; [Allcock, Richard J. N.] Univ Western Australia, Lotterywest State Biomed Facil Genom, Perth, WA 6009, Australia; [Allcock, Richard J. N.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Perrella, Mark A.] Brigham & Womens Hosp, Dept Newborn Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Harvard University; Brigham & Women's Hospital; Harry Perkins Institute of Medical Research; University of Western Australia; University of Western Australia; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Hacettepe University; Hacettepe University; University of Western Australia; University of Western Australia; Harvard University; Brigham & Women's Hospital	Agrawal, PB (corresponding author), Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA.	pagrawal@enders.tch.harvard.edu; beggs@enders.tch.harvard.edu	Liu, Xiaoli/HGE-7614-2022; Agrawal, Pankaj/ABG-8957-2021; Ravenscroft, Gina/H-5695-2014	Ravenscroft, Gina/0000-0003-3634-211X; Moghadaszadeh, Behzad/0000-0001-9787-0106; Beggs, Alan/0000-0001-8818-0568; Laing, Nigel/0000-0001-5111-3732; Liu, Xiaoli/0000-0003-2904-4413	NIH National Institute of Arthritis and Musculoskeletal and Skeletal Diseases (NIAMS) [K08 AR055072]; Muscular Dystrophy Association [MDA201302]; NIH NIAMS [R01 AR044345]; AUism Charitable Foundation; A Foundation Building Strength; National Health and Medical Research Council of Australia [1035955, APP1002147, APP1022707]; American Heart Association; NIH NHLBI [R01 HL102897, HL 108801]; NIH [P30 HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL108801, R01HL102897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055072, R01AR044345] Funding Source: NIH RePORTER	NIH National Institute of Arthritis and Musculoskeletal and Skeletal Diseases (NIAMS); Muscular Dystrophy Association(Muscular Dystrophy Association); NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AUism Charitable Foundation; A Foundation Building Strength; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); American Heart Association(American Heart Association); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to the several centronuclear-myopathy-affected individuals, their families, and their caregivers. We would like to thank Vandana Gupta and Ozge Ceyhan-Birsoy for helpful discussions during this work, Melissa Mercier for sequencing SPEG, and Louise Trakimas of the electron-microscope facility at Harvard Medical School for help with mouse muscle histology. P.B.A. was supported by K08 AR055072 from the NIH National Institute of Arthritis and Musculoskeletal and Skeletal Diseases (NIAMS). This work was also supported by the Muscular Dystrophy Association (MDA201302), NIH NIAMS grant R01 AR044345, the AUism Charitable Foundation and A Foundation Building Strength (to A.H.B.), the National Health and Medical Research Council of Australia (Early Career Researcher Fellowship 1035955 to G.R. and Research Fellowship APP1002147 and Project Grant APP1022707 to N.G.L.), an American Heart Association Scientist Development Grant (to X.L.), and NIH NHLBI grants R01 HL102897 and HL 108801 (to M.A.P.). DNA sequencing was performed by the Boston Children's Hospital Genomics Program Molecular Genetics Core, supported by NIH grant P30 HD18655. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qusairi L, 2009, P NATL ACAD SCI USA, V106, P18763, DOI 10.1073/pnas.0900705106; Amoasii L, 2013, J CELL SCI, V126, P1806, DOI 10.1242/jcs.118505; Amoasii L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002965; Bevilacqua JA, 2011, NEUROPATH APPL NEURO, V37, P271, DOI 10.1111/j.1365-2990.2010.01149.x; Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Buj-Bello A, 2008, HUM MOL GENET, V17, P2132, DOI 10.1093/hmg/ddn112; Ceyhan-Birsoy O, 2013, NEUROLOGY, V81, P1205, DOI 10.1212/WNL.0b013e3182a6ca62; Dowling JJ, 2012, DIS MODEL MECH, V5, P852, DOI 10.1242/dmm.009746; Dowling JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000372; Gautel M, 2011, PFLUG ARCH EUR J PHY, V462, P119, DOI 10.1007/s00424-011-0946-1; Gibbs EM, 2014, DIS MODEL MECH, V7, P157, DOI 10.1242/dmm.012286; Hnia K, 2011, J CLIN INVEST, V121, P70, DOI 10.1172/JCI44021; Hsieh CM, 2000, J BIOL CHEM, V275, P36966, DOI 10.1074/jbc.M006028200; Lange S, 2009, J CELL SCI, V122, P2640, DOI 10.1242/jcs.046193; Laporte J, 1996, NAT GENET, V13, P175, DOI 10.1038/ng0696-175; Liu XL, 2009, CIRCULATION, V119, P261, DOI 10.1161/CIRCULATIONAHA.108.799536; Nance JR, 2012, CURR NEUROL NEUROSCI, V12, P165, DOI 10.1007/s11910-012-0255-x; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Pierson CR, 2005, J NEUROPATH EXP NEUR, V64, P555, DOI 10.1097/01.jnen.0000171653.17213.2e; Romero NB, 2011, SEMIN PEDIATR NEUROL, V18, P250, DOI 10.1016/j.spen.2011.10.006; Tam JLY, 2006, GENOMICS, V87, P733, DOI 10.1016/j.ygeno.2006.01.009; Zvaritch E, 2009, P NATL ACAD SCI USA, V106, P21813, DOI 10.1073/pnas.0912126106	23	97	101	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 7	2014	95	2					218	226		10.1016/j.ajhg.2014.07.004	http://dx.doi.org/10.1016/j.ajhg.2014.07.004			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AM7VE	25087613	Bronze, Green Published			2022-12-18	WOS:000340076000008
J	Li, M; Cheng, RH; Liang, JY; Yan, H; Zhang, H; Yang, LJ; Li, CR; Jiao, QQ; Lu, ZY; He, JH; Ji, J; Shen, Z; Li, CQ; Hao, F; Yu, H; Yao, ZR				Li, Ming; Cheng, Ruhong; Liang, Jianying; Yan, Heng; Zhang, Hui; Yang, Lijia; Li, Chengrang; Jiao, Qingqing; Lu, Zhiyong; He, Jianhui; Ji, Jin; Shen, Zhu; Li, Chunqi; Hao, Fei; Yu, Hong; Yao, Zhirong			Mutations in POFUT1, Encoding Protein O-fucosyltransferase 1, Cause Generalized Dowling-Degos Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYSCHROMATOSIS UNIVERSALIS HEREDITARIA; AORTIC-VALVE DISEASE; ALAGILLE-SYNDROME; NOTCH2 CAUSE; GENE; MELANOBLASTS; HOMEOSTASIS; RECEPTORS; PHENOTYPE; DISORDER	Dowling-Degos disease (DDD), or reticular pigmented anomaly of the flexures, is a type of rare autosomal-dominant genodermatosis characterized by reticular hyperpigmentation and hypopigmentation of the flexures, such as the neck, axilla, and areas below the breasts and groin, and shows considerable heterogeneity. Loss-of-function mutations of keratin 5 (KRT5) have been identified in DDD individuals. In this study, we collected DNA samples from a large Chinese family affected by generalized DDD and found no mutation of KRT5. We performed a genome-wide linkage analysis of this family and mapped generalized DDD to a region between rs1293713 and rs244123 on chromosome 20. By exome sequencing, we identified nonsense mutation c.430G>T (p.Glu144*) in POFUT1, which encodes protein O-fucosyltransferase 1, in the family. Study of an additional generalized DDD individual revealed the heterozygous deletion mutation c.482delA (p.Lys161Serfs*42) in POFUT1. Knockdown of POFUT1 reduces the expression of NOTCH1, NOTCH2, HES1, and KRT5 in HaCaT cells. Using zebrafish, we showed that pofut1 is expressed in the skin and other organs. Morpholino knockdown of pofut1 in zebrafish produced a phenotype characteristic of hypopigmentation at 48 hr postfertilization (hpf) and abnormal melanin distribution at 72 hpf, replicating the clinical phenotype observed in our DDD individuals. At 48 and 72 hpf, tyrosinase activities decreased by 33% and 45%, respectively, and melanin protein contents decreased by 20% and 25%, respectively. Our findings demonstrate that POFUT1 mutations cause generalized DDD. These results strongly suggest that the protein product of POFUT1 plays a significant and conserved role in melanin synthesis and transport.	[Li, Ming; Cheng, Ruhong; Liang, Jianying; Zhang, Hui; Jiao, Qingqing; Lu, Zhiyong; Yu, Hong; Yao, Zhirong] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Dermatol, Sch Med, Shanghai 200092, Peoples R China; [Yan, Heng; Shen, Zhu; Hao, Fei] Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing 400038, Peoples R China; [Yang, Lijia; Ji, Jin] Wuxi 2 Peoples Hosp, Dept Dermatol, Wuxi 234002, Jiangsu, Peoples R China; [Li, Chengrang] Chinese Acad Med Sci, Inst Dermatol, Peking Union Med Coll, Nanjing 230042, Jiangsu, Peoples R China; [He, Jianhui; Li, Chunqi] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Lab Technol & Applicat Model Organi, Wenzhou 325035, Zhejiang, Peoples R China	Shanghai Jiao Tong University; Army Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College; Wenzhou Medical University	Yao, ZR (corresponding author), Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Dermatol, Sch Med, Shanghai 200092, Peoples R China.	smallgrass6@163.com; dermatology.yao@sohu.com		Li, Chengrang/0000-0003-0537-6608	Shanghai Municipal Natural Science Foundation [12ZR1420000]; National Nature Science Foundation of China [81171544]	Shanghai Municipal Natural Science Foundation; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank all subjects for their ongoing participation in this study. We also thank Mianzhi Yao for critical reading and comments concerning this manuscript. We thank Tao Yang, Jiangbo Liu, Ronghu Ke, Guolong Zhang, Bo Ling, and Qianqian Wang for their support. This study was funded by a grant from the Shanghai Municipal Natural Science Foundation (#12ZR1420000) and a grant from the National Nature Science Foundation of China (81171544).	Aubin-Houzelstein G, 2008, J INVEST DERMATOL, V128, P2686, DOI 10.1038/jid.2008.120; Bauer RC, 2010, HUM MUTAT, V31, P594, DOI 10.1002/humu.21231; Betz RC, 2006, AM J HUM GENET, V78, P510, DOI 10.1086/500850; Bukhari IA, 2006, J EUR ACAD DERMATOL, V20, P628, DOI 10.1111/j.1468-3083.2006.01522.x; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Choi TY, 2007, PIGM CELL RES, V20, P120, DOI 10.1111/j.1600-0749.2007.00365.x; DEGOS R, 1954, Ann Dermatol Syphiligr (Paris), V81, P147; Dowling G B, 1938, Proc R Soc Med, V31, P1147; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Garg V, 2005, NATURE, V437, P270, DOI 10.1038/nature03940; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hassed SJ, 2012, AM J HUM GENET, V91, P391, DOI 10.1016/j.ajhg.2012.07.005; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kamath BM, 2012, J MED GENET, V49, P138, DOI 10.1136/jmedgenet-2011-100544; Kumano K, 2008, PIGM CELL MELANOMA R, V21, P70, DOI 10.1111/j.1755-148X.2007.00423.x; Lee S J, 2000, J Dermatol, V27, P591; Lestringant GG, 1997, DERMATOLOGY, V195, P337, DOI 10.1159/000245984; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li CR, 2006, J INVEST DERMATOL, V126, P1297, DOI 10.1038/sj.jid.5700271; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Li M, 2010, ARCH DERMATOL RES, V302, P469, DOI 10.1007/s00403-010-1039-2; Lin HY, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015842, 10.1371/journal.pone.0019135]; Lu FM, 2003, AM J HUM GENET, V72, P1065, DOI 10.1086/374386; McElhinney DB, 2002, CIRCULATION, V106, P2567, DOI 10.1161/01.CIR.0000037221.45902.69; McKellar SH, 2007, J THORAC CARDIOV SUR, V134, P290, DOI 10.1016/j.jtcvs.2007.02.041; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Pickup TL, 2011, J AM ACAD DERMATOL, V64, P1224, DOI 10.1016/j.jaad.2009.11.015; Sandhu K, 2004, J EUR ACAD DERMATOL, V18, P702, DOI 10.1111/j.1468-3083.2004.01028.x; Schouwey K, 2007, DEV DYNAM, V236, P282, DOI 10.1002/dvdy.21000; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Shibahara S, 2001, J INVEST DERM SYMP P, V6, P99, DOI 10.1046/j.0022-202x.2001.00010.x; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Wu YH, 2007, J AM ACAD DERMATOL, V57, P327, DOI 10.1016/j.jaad.2006.12.023; Yao D, 2011, BLOOD, V117, P5652, DOI 10.1182/blood-2010-12-326074	37	97	102	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					895	903		10.1016/j.ajhg.2013.04.022	http://dx.doi.org/10.1016/j.ajhg.2013.04.022			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23684010	Green Published, Bronze			2022-12-18	WOS:000320415300006
J	Michot, C; Le Goff, C; Goldenberg, A; Abhyankar, A; Klein, C; Kinning, E; Guerrot, AM; Flahaut, P; Duncombe, A; Baujat, G; Lyonnet, S; Thalassinos, C; Nitschke, P; Casanova, JL; Le Merrer, M; Munnich, A; Cormier-Daire, V				Michot, Caroline; Le Goff, Carine; Goldenberg, Alice; Abhyankar, Avinash; Klein, Celine; Kinning, Esther; Guerrot, Anne-Marie; Flahaut, Philippe; Duncombe, Alice; Baujat, Genevieve; Lyonnet, Stanislas; Thalassinos, Caroline; Nitschke, Patrick; Casanova, Jean-Laurent; Le Merrer, Martine; Munnich, Arnold; Cormier-Daire, Valerie			Exome Sequencing Identifies PDE4D Mutations as Another Cause of Acrodysostosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYCLIC ADENINE RIBONUCLEOTIDE; TISSUE PARTICLES; PSEUDOHYPOPARATHYROIDISM	Acrodysostosis is a rare autosomal-dominant condition characterized by facial dysostosis, severe brachydactyly with cone-shaped epiphyses, and short stature. Moderate intellectual disability and resistance to multiple hormones might also be present. Recently, a recurrent mutation (c.1102C>T [p.Arg368*]) in PRKAR1A has been identified in three individuals with acrodysostosis and resistance to multiple hormones. After studying ten unrelated acrodysostosis cases, we report here de novo PRKAR1A mutations in five out of the ten individuals (we found c.1102C>T [p.Arg368*] in four of the ten and c.1117T>C [p.Tyr373His] in one of the ten). We performed exome sequencing in two of the five remaining individuals and selected phosphodiesterase 4D (PDE4D) as a candidate gene. PDE4D encodes a class IV cyclic AMP (cAMP)-specific phosphodiesterase that regulates cAMP concentration. Exome analysis detected heterozygous PDE4D mutations (c.673C>A [p.Pro225Thr] and c.677T>C [p.Phe226Ser]) in these two individuals. Screening of PDE4D identified heterozygous mutations (c.568T>G [p.Ser190Ala] and c.1759A>C [p.Thr587Pro]) in two additional acrodysostosis cases. These mutations occurred de novo in all four cases. The four individuals with PDE4D mutations shared common clinical features, namely characteristic midface and nasal hypoplasia and moderate intellectual disability. Metabolic screening was normal in three of these four individuals. However, resistance to parathyroid hormone and thyrotropin was consistently observed in the five cases with PRKAR1A mutations. Finally, our study further supports the key role of the cAMP signaling pathway in skeletogenesis.	[Michot, Caroline; Le Goff, Carine; Klein, Celine; Baujat, Genevieve; Lyonnet, Stanislas; Le Merrer, Martine; Munnich, Arnold; Cormier-Daire, Valerie] Univ Paris 05, Unite Inst Natl Sante & Rech Med U781, Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Goldenberg, Alice; Guerrot, Anne-Marie] Ctr Hosp Univ Rouen, Serv Genet Med, F-76100 Rouen, France; [Abhyankar, Avinash; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Kinning, Esther] Royal Hosp Sick Children Yorkhill, Ferguson Smith Ctr Clin Genet, Glasgow G3 8SJ, Lanark, Scotland; [Flahaut, Philippe] Ctr Hosp Univ Rouen, Serv Pediat, F-76100 Rouen, France; [Duncombe, Alice] Ctr Hosp Univ Rouen, Serv Ophtalmol, F-76100 Rouen, France; [Thalassinos, Caroline] AP HP, F-75015 Paris, France; [Casanova, Jean-Laurent] Univ Paris 05, Unite Inst Natl Sante & Rech Med U980, Lab Human Genet Infect Dis, Necker Med Sch, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; Rockefeller University; CHU de Rouen; CHU de Rouen; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Univ Paris 05, Unite Inst Natl Sante & Rech Med U781, Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France.	valerie.cormier-daire@inserm.fr	Lyonnet, Stanislas/H-5483-2017; Casanova, Jean-Laurent/I-3418-2017; Le Goff, Carine/N-9940-2017; LE GOFF, Carine/AAG-2390-2020; Michot, Caroline/H-2862-2017; cormier-daire, valerie/H-6520-2017	Lyonnet, Stanislas/0000-0001-5426-9417; LE GOFF, Carine/0000-0002-7788-708X; Michot, Caroline/0000-0002-8749-5899; Casanova, Jean-Laurent/0000-0002-7782-4169; cormier-daire, valerie/0000-0002-2839-9856				Bastepe M, 2005, HORM RES, V63, P65, DOI 10.1159/000083895; Byun M, 2010, J EXP MED, V207, P2307, DOI 10.1084/jem.20101597; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Graham JM, 2001, PEDIATR RADIOL, V31, P2, DOI 10.1007/s002470000355; Jin SLC, 1999, P NATL ACAD SCI USA, V96, P11998, DOI 10.1073/pnas.96.21.11998; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YF, 2011, J NEUROSCI, V31, P172, DOI 10.1523/JNEUROSCI.5236-10.2011; Linglart A, 2011, NEW ENGL J MED, V364, P2218, DOI 10.1056/NEJMoa1012717; MAROTEAUX P, 1968, Presse Medicale, V76, P2189; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; RALL TW, 1958, J BIOL CHEM, V232, P1065; ROBINOW M, 1971, AM J DIS CHILD, V121, P195, DOI 10.1001/archpedi.1971.02100140061002; SUTHERLAND EW, 1958, J BIOL CHEM, V232, P1077	15	97	102	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					740	745		10.1016/j.ajhg.2012.03.003	http://dx.doi.org/10.1016/j.ajhg.2012.03.003			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22464250	Green Published, Bronze			2022-12-18	WOS:000302833400019
J	Audo, I; Bujakowska, K; Orhan, E; Poloschek, CM; Defoort-Dhellemmes, S; Drumare, I; Kohl, S; Luu, TD; Lecompte, O; Zrenner, E; Lancelot, ME; Antonio, A; Germain, A; Michiels, C; Audier, C; Letexier, M; Saraiva, JP; Leroy, BP; Munier, FL; Mohand-Said, S; Lorenz, B; Friedburg, C; Preising, M; Kellner, U; Renner, AB; Moskova-Doumanova, V; Berger, W; Wissinger, B; Hamel, CR; Schorderet, DF; De Baere, E; Sharon, D; Banin, E; Jacobson, SG; Bonneau, D; Zanlonghi, X; Le Meur, G; Casteels, I; Koenekoop, R; Long, VW; Meire, F; Prescott, K; de Ravel, T; Simmons, I; Nguyen, H; Dollfus, H; Poch, O; Leveillard, T; Nguyen-Ba-Charvet, K; Sahel, JA; Bhattacharya, SS; Zeitz, C				Audo, Isabelle; Bujakowska, Kinga; Orhan, Elise; Poloschek, Charlotte M.; Defoort-Dhellemmes, Sabine; Drumare, Isabelle; Kohl, Susanne; Luu, Tien D.; Lecompte, Odile; Zrenner, Eberhart; Lancelot, Marie-Elise; Antonio, Aline; Germain, Aurore; Michiels, Christelle; Audier, Claire; Letexier, Melanie; Saraiva, Jean-Paul; Leroy, Bart P.; Munier, Francis L.; Mohand-Said, Saddek; Lorenz, Birgit; Friedburg, Christoph; Preising, Markus; Kellner, Ulrich; Renner, Agnes B.; Moskova-Doumanova, Veselina; Berger, Wolfgang; Wissinger, Bernd; Hamel, Christian R.; Schorderet, Daniel F.; De Baere, Elfride; Sharon, Dror; Banin, Eyal; Jacobson, Samuel G.; Bonneau, Dominique; Zanlonghi, Xavier; Le Meur, Guylene; Casteels, Ingele; Koenekoop, Robert; Long, Vernon W.; Meire, Francoise; Prescott, Katrina; de Ravel, Thomy; Simmons, Ian; Nguyen, Hoan; Dollfus, Helene; Poch, Olivier; Leveillard, Thierry; Nguyen-Ba-Charvet, Kim; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Zeitz, Christina			Whole-Exome Sequencing Identifies Mutations in GPR179 Leading to Autosomal-Recessive Complete Congenital Stationary Night Blindness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUSCULAR-DYSTROPHY; PHENOTYPIC IMPACT; CHANNEL SUBUNIT; BIPOLAR CELLS; GAMMA-SUBUNIT; COMPLETE FORM; PROTEIN; MICE; NYCTALOPIN; TRPM1	Congenital stationary night blindness (CSNB) is a heterogeneous retinal disorder characterized by visual impairment under low light conditions. This disorder is due to a signal transmission defect from rod photoreceptors to adjacent bipolar cells in the retina. Two forms can be distinguished clinically, complete CSNB (cCSNB) or incomplete CSNB; the two forms are distinguished on the basis of the affected signaling pathway Mutations in NYX, GRM6, and TRPM1, expressed in the outer plexiform layer (Oft) lead to disruption of the ON-bipolar cell response and have been seen in patients with cCSNB. Whole-exome sequencing in cCSNB patients lacking mutations in the known genes led to the identification of a homozygous missense mutation (c.1.807C>T [p.His603Tyr]) in one consanguineous autosomal-recessive cCSNB family and a homozygous frameshift mutation in GPR179 (c.278delC [p.Pro93Glnfs*57]) in a simplex male cCSNB patient. Additional screening with Sanger sequencing of 40 patients identified three other cCSNB patients harboring additional allelic mutations in GPR179. Although, immunhistological studies revealed Gpr179 in the OM in wild-type mouse retina, Gpr179 did not colocalize with specific ON-bipolar markers. Interestingly, Gpr179 was highly concentrated in horizontal cells and Muller cell endfeet. The involvement of these cells in cCSNB and the specific function of GPR179 remain to be elucidated.	[Audo, Isabelle; Bujakowska, Kinga; Orhan, Elise; Lancelot, Marie-Elise; Antonio, Aline; Germain, Aurore; Michiels, Christelle; Audier, Claire; Mohand-Said, Saddek; Moskova-Doumanova, Veselina; Leveillard, Thierry; Nguyen-Ba-Charvet, Kim; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Zeitz, Christina] INSERM, U968, F-75012 Paris, France; [Audo, Isabelle; Bujakowska, Kinga; Orhan, Elise; Lancelot, Marie-Elise; Antonio, Aline; Germain, Aurore; Michiels, Christelle; Audier, Claire; Mohand-Said, Saddek; Moskova-Doumanova, Veselina; Leveillard, Thierry; Nguyen-Ba-Charvet, Kim; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Zeitz, Christina] Univ Paris 06, UMR S 968, Inst Vis, F-75012 Paris, France; [Audo, Isabelle; Bujakowska, Kinga; Orhan, Elise; Lancelot, Marie-Elise; Antonio, Aline; Germain, Aurore; Michiels, Christelle; Audier, Claire; Mohand-Said, Saddek; Moskova-Doumanova, Veselina; Leveillard, Thierry; Nguyen-Ba-Charvet, Kim; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Zeitz, Christina] CNRS, UMR 7210, F-75012 Paris, France; [Audo, Isabelle; Antonio, Aline; Mohand-Said, Saddek; Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM DHOS CIC 503, F-75012 Paris, France; [Audo, Isabelle; Sahel, Jose-Alain; Bhattacharya, Shomi S.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Poloschek, Charlotte M.] Univ Freiburg, Dept Ophthalmol, D-79106 Freiburg, Germany; [Defoort-Dhellemmes, Sabine; Drumare, Isabelle] Hop Roger Salengro, CNRS, FRE 2726, Lab Neurosci Fonct & Pathol, F-59037 Lille, France; [Kohl, Susanne; Wissinger, Bernd] Univ Tubingen, Dept Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, D-72076 Tubingen, Germany; [Luu, Tien D.; Lecompte, Odile; Nguyen, Hoan; Poch, Olivier] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Zrenner, Eberhart] Univ Tubingen, Dept Ophthalmol, Ctr Ophthalmol, D-72076 Tubingen, Germany; [Letexier, Melanie; Saraiva, Jean-Paul] IntegraGen, F-91000 Evry, France; [Leroy, Bart P.; De Baere, Elfride] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Leroy, Bart P.] Univ Ghent, Dept Ophthalmol, B-9000 Ghent, Belgium; [Munier, Francis L.] Jules Gonin Eye Hosp, Unit Oculogenet, CH-1004 Lausanne, Switzerland; [Lorenz, Birgit; Friedburg, Christoph; Preising, Markus] Univ Giessen, Univ Giessen Klinikum, Dept Ophthalmol, D-35385 Giessen, Germany; [Lorenz, Birgit; Friedburg, Christoph; Preising, Markus] Marburg GmbH Giessen Campus, D-35385 Giessen, Germany; [Kellner, Ulrich] AugenZentrum Siegburg, D-53721 Siegburg, Germany; [Renner, Agnes B.] Univ Med Ctr Regensburg, Dept Ophthalmol, D-93053 Regensburg, Germany; [Berger, Wolfgang] Univ Zurich, Inst Med Mol Genet, CH-8057 Zurich, Switzerland; [Berger, Wolfgang] Univ Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Berger, Wolfgang] Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland; [Berger, Wolfgang] Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland; [Hamel, Christian R.] Natl Ctr Genet Sensory Dis, F-34295 Montpellier 05, France; [Schorderet, Daniel F.] Univ Lausanne, Ecole Polytech Fed Lausanne, IRO Inst Rech Ophtalmol, CH-1950 Sion, Switzerland; [Schorderet, Daniel F.] Univ Lausanne, Ecole Polytech Fed Lausanne, Fac Sci Vivant, CH-1950 Sion, Switzerland; [Sharon, Dror; Banin, Eyal] Hadassah Hebrew Univ, Med Ctr, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Bonneau, Dominique] CNRS6214, UMR Inst Natl Sante & Rech Med, U771, F-49000 Angers, France; [Bonneau, Dominique] CHU Angers, F-49000 Angers, France; [Zanlonghi, Xavier] Clin Sourdille, Serv Explorat Fonct Vis, F-44000 Nantes, France; [Zanlonghi, Xavier] Clin Sourdille, Ctr Basse Vis, F-44000 Nantes, France; [Le Meur, Guylene] CHU Hotel Dieu, Serv Ophtalmol, F-44093 Nantes, France; [Casteels, Ingele] Univ Hosp, Dept Ophthalmol, B-3000 Louvain, Belgium; [Koenekoop, Robert] McGill Univ, McGill Ocular Genet Lab, Montreal, PQ H3H 1P3, Canada; [Long, Vernon W.; Simmons, Ian] St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England; [Meire, Francoise] Hop Enfants Reine Fabiola, B-1020 Brussels, Belgium; [Prescott, Katrina] Chapel Allerton Hosp, Dept Clin Genet, Yorkshire Reg Genet Serv, Leeds LS7 4SA, W Yorkshire, England; [de Ravel, Thomy] Leuven Univ Hosp, Ctr Human Genet, B-3000 Louvain, Belgium; [Dollfus, Helene] Hop Univ Strasbourg, Ctr Reference Affect Rares Genet Ophtalmol, F-67000 Strasbourg, France; [Dollfus, Helene] Univ Strasbourg, Lab Physiopathol Syndromes Rares Hereditaires, Equipe Avenir, INSERM,Fac Med, F-67000 Strasbourg, France; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, F-75019 Paris, France; [Sahel, Jose-Alain] Inst France, Acad Sci, F-75006 Paris, France; [Bhattacharya, Shomi S.] Andalusian Mol Biol & Regenerat Med Ctr CABIMER, Dept Celular Therapy & Regenerat Med, Seville 41902, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Ghent University; Ghent University; Justus Liebig University Giessen; University Hospital of Giessen & Marburg; University of Regensburg; University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Nantes Universite; CHU de Nantes; McGill University; Saint James's University Hospital; Chapel Allerton Hospital; KU Leuven; University Hospital Leuven; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Fondation Adolphe de Rothschild; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Zeitz, C (corresponding author), INSERM, U968, F-75012 Paris, France.	christina.zeitz@inserm.fr	NGUYEN, Hoan/K-3976-2012; Sahel, Jose-Alain/F-3172-2017; Nguyen-Ba-Charvet, Kim/J-3507-2017; Bhattacharya, Shom/N-2926-2016; Léveillard, Thierry/AAR-1804-2020; Koenekoop, Robert/AAT-6676-2021; Preising, Markus/GQA-9591-2022; Moskova-Doumanova, Veselina/S-5757-2019; Sharon, Dror/P-4539-2015; Bujakowska, Kinga Maria/AGL-1293-2022; Lecompte, Odile/F-4741-2011; Zeitz, Christina/F-2757-2017; Lecompte, Odile/N-7992-2019; De Baere, Elfride/E-7405-2017; Bonneau, Dominique/K-6110-2015	Sahel, Jose-Alain/0000-0002-4831-1153; Nguyen-Ba-Charvet, Kim/0000-0001-5398-0872; Bhattacharya, Shom/0000-0002-1601-6344; Léveillard, Thierry/0000-0001-5692-8770; Moskova-Doumanova, Veselina/0000-0001-5316-5835; Sharon, Dror/0000-0002-1789-5811; Lecompte, Odile/0000-0002-2005-460X; Zeitz, Christina/0000-0002-3510-1712; Lecompte, Odile/0000-0002-2005-460X; De Baere, Elfride/0000-0002-5609-6895; de Ravel, Thomy/0000-0002-3361-3781; Kohl, Susanne/0000-0002-6438-6331; Jacobson, Samuel/0000-0003-2122-169X; Orhan, Elise/0000-0002-8306-5250; Bonneau, Dominique/0000-0002-6886-0969; Dollfus, Helene/0000-0002-2249-895X; Audo, Isabelle/0000-0003-0698-5309; Bujakowska, Kinga/0000-0001-6809-9818	GIS-maladies rares; Foundation Voir et Entendre; Agence National de la Recherche; Foundation Fighting Blindness (FFB) [CD-CL-0808-0466-CHNO, CIC503, C-CMM-0907-0428-INSERM04]; Ville de Paris and Region Ille de France; French Association against Myopathy [KBM-14390]; National Institutes of Health [1R01EY020902-01A1]; Retina France; NATIONAL EYE INSTITUTE [R01EY020902] Funding Source: NIH RePORTER	GIS-maladies rares; Foundation Voir et Entendre; Agence National de la Recherche(French National Research Agency (ANR)); Foundation Fighting Blindness (FFB); Ville de Paris and Region Ille de France; French Association against Myopathy; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Retina France; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors are grateful to the families described in this study; to Dominique Santiard-Baron and Christine Chaumeil for their help in DNA collection; to the clinical staff; and to Olivier Goreau, Serge Picaud, and Alvaro Rendon for antibodies used in the colocalization experiments. The project was supported by GIS-maladies rares (C.Z.), Retina France apart of the 100-Exome Project] I.A., C.P.H., J-A.S., H.D. and C.Z.), Foundation Voir et Entendre (C.Z.), Agence National de la Recherche (S.S.B), Foundation Fighting Blindness (FFB) grant CD-CL-0808-0466-CHNO (I.A. and the CIC503, recognized as an FFB center), FFB grant C-CMM-0907-0428-INSERM04, Ville de Paris and Region Ille de France, the French Association against Myopathy (AFM) grant KBM-14390 (O.P.), and National Institutes of Health grant 1R01EY020902-01A1 (KB.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Audo I, 2008, SURV OPHTHALMOL, V53, P16, DOI 10.1016/j.survophthal.2007.10.010; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CIBIS GW, 1993, INVEST OPHTH VIS SCI, V34, P3646; Claudepierre T, 1999, INVEST OPHTH VIS SCI, V40, P1520; Connors NC, 2006, GLIA, V53, P124, DOI 10.1002/glia.20271; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; DEBECKER I, 1994, BRIT J OPHTHALMOL, V78, P719, DOI 10.1136/bjo.78.9.719; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Dvir L, 2010, AM J HUM GENET, V87, P258, DOI 10.1016/j.ajhg.2010.06.016; Eramian D, 2008, PROTEIN SCI, V17, P1881, DOI 10.1110/ps.036061.108; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Friedrich A, 2010, HUM MUTAT, V31, P127, DOI 10.1002/humu.21155; Gregg RG, 2007, J NEUROPHYSIOL, V98, P3023, DOI 10.1152/jn.00608.2007; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Li J, 2002, INVEST OPHTH VIS SCI, V43, P573; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Luu T., 2011, IACSIT, V5, P83; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Morgans CW, 2006, EUR J NEUROSCI, V23, P1163, DOI 10.1111/j.1460-9568.2006.04647.x; Nakamura M, 2010, MOL VIS, V16, P425; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Pillers DAH, 1999, HUM GENET, V105, P2, DOI 10.1007/s004390051056; PILLERS DAM, 1993, NAT GENET, V4, P82, DOI 10.1038/ng0593-82; Piri N, 2005, OPHTHALMOLOGY, V112, P159, DOI 10.1016/j.ophtha.2004.07.011; Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; VICZIAN A, 1992, EXP EYE RES, V54, P853, DOI 10.1016/0014-4835(92)90148-L; Wycisk KA, 2006, AM J HUM GENET, V79, P973, DOI 10.1086/508944; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2007, EXPERT REV OPHTHALMO, V2, P467, DOI 10.1586/17469899.2.3.467; Zeitz C, 2007, HUM MUTAT, V28, P771, DOI 10.1002/humu.20499; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zeitz C, 2009, INVEST OPHTH VIS SCI, V50, P5919, DOI 10.1167/iovs.09-3548	47	97	99	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					321	330		10.1016/j.ajhg.2011.12.007	http://dx.doi.org/10.1016/j.ajhg.2011.12.007			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22325361	Green Published, Bronze			2022-12-18	WOS:000300742200014
J	Dulik, MC; Zhadanov, SI; Osipova, LP; Askapuli, A; Gau, L; Gokcumen, O; Rubinstein, S; Schurr, TG				Dulik, Matthew C.; Zhadanov, Sergey I.; Osipova, Ludmila P.; Askapuli, Ayken; Gau, Lydia; Gokcumen, Omer; Rubinstein, Samara; Schurr, Theodore G.			Mitochondrial DNA and Y Chromosome Variation Provides Evidence for a Recent Common Ancestry between Native Americans and Indigenous Altaians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CENTRAL-ASIAN POPULATIONS; NEW-WORLD; MTDNA VARIATION; MUTATION-RATE; SIBERIAN POPULATIONS; EVOLUTIONARY HISTORY; GENETIC-STRUCTURE; FOUNDER LINEAGES; CONTROL-REGION; SOUTH-AMERICA	The Altai region of southern Siberia has played a critical role in the peopling of northern Asia as an entry point into Siberia and a possible homeland for ancestral Native Americans. It has an old and rich history because humans have inhabited this area since the Paleolithic. Today, the Altai region is home to numerous Turkic-speaking ethnic groups, which have been divided into northern and southern clusters based on linguistic, cultural, and anthropological traits. To untangle Altaian genetic histories, we analyzed mtDNA and Y chromosome variation in northern and southern Altaian populations. All mtDNAs were assayed by PCR-RFLP analysis and control region sequencing, and the nonrecombining portion of the Y chromosome was scored for more than 100 biallelic markers and 17 Y-STRs. Based on these data, we noted differences in the origin and population history of Altaian ethnic groups, with northern Altaians appearing more like Yeniseian, Ugric, and Samoyedic speakers to the north, and southern Altaians having greater affinities to other Turkic speaking populations of southern Siberia and Central Asia. Moreover, high-resolution analysis of Y chromosome haplogroup Q has allowed us to reshape the phylogeny of this branch, making connections between populations of the New World and Old World more apparent and demonstrating that southern Altaians and Native Americans share a recent common ancestor. These results greatly enhance our understanding of the peopling of Siberia and the Americas.	[Dulik, Matthew C.; Zhadanov, Sergey I.; Askapuli, Ayken; Gau, Lydia; Gokcumen, Omer; Rubinstein, Samara; Schurr, Theodore G.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Zhadanov, Sergey I.; Osipova, Ludmila P.] SB RAS, Inst Cytol & Genet, Novosibirsk 630090, Russia; [Askapuli, Ayken] Inst Gen Genet & Cytol, Alma Ata 050060, Kazakhstan	University of Pennsylvania; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Institute of Genetics & Physiology of the Ministry of Science & Higher Education	Schurr, TG (corresponding author), Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA.	tgschurr@sas.upenn.edu	Osipova, Ludmila P/O-6480-2014; Gokcumen, Omer/J-6984-2013	Osipova, Ludmila P/0000-0001-7602-1156; Gokcumen, Omer/0000-0003-4371-679X	University of Pennsylvania; National Science Foundation [BCS-0726623]; Social Sciences and Humanities Research Council of Canada [MCRI 412-2005-1004]; Russian Basic Fund for Research	University of Pennsylvania; National Science Foundation(National Science Foundation (NSF)); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Russian Basic Fund for Research	The authors would like to thank all of the indigenous Altaian participants for their involvement in this study. We also thank Fabricio Santos for his careful review of and helpful suggestions for the manuscript, and two anonymous reviewers for their constructive comments. In addition, we would like to acknowledge the people who facilitated and provided assistance with our field research in the Altai Republic. They include Vasiliy Semenovich Palchikov, the staff of the Biochemistry Lab at the Turochak Hospital, Dr. Maria Nikolaevna Trishina, Vitaliy Trishin, Alexander A. Guryanov, the staff of the Native Affairs office in Gorniy Altaiask, Galina Nikolaevna Makhalina, and Tatiana Kunduchinovna Babrasheva. In addition, we received help from a number of people living in local villages around the Turochakskiy Raion, particularly Alexander Adonyov. This project was supported by funds from the University of Pennsylvania (T.G.S.), the National Science Foundation (BCS-0726623) (T.G.S., M.C.D.), the Social Sciences and Humanities Research Council of Canada (MCRI 412-2005-1004) (T.G.S.), and the Russian Basic Fund for Research (L.P.O.). T.G.S. would also like to acknowledge the infrastructural support provided by the National Geographic Society.	Achilli A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001764; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Anthony D.W., 2007, HORSE WHEEL IN PRESS; Bailliet G, 2009, AM J PHYS ANTHROPOL, V140, P578, DOI 10.1002/ajpa.21133; Balaresque P, 2009, INT J LEGAL MED, V123, P15, DOI 10.1007/s00414-008-0253-3; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; Bortolini MC, 2003, AM J HUM GENET, V73, P524, DOI 10.1086/377588; Bortolini MC, 2002, ANN HUM GENET, V66, P255, DOI 10.1017/S0003480002001148; Brace CL, 2001, P NATL ACAD SCI USA, V98, P10017, DOI 10.1073/pnas.171305898; Brown MD, 1998, AM J HUM GENET, V63, P1852, DOI 10.1086/302155; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Cox MP, 2006, ANTHROPOL SCI, V114, P69, DOI 10.1537/ase.050712; CRAWFORD MH, 1998, ORIGINS NATIVE AM EV; David-Kimball J., 1995, NOMADS EURASIAN STEP; Derbeneva O. A., 2002, Genetika, V38, P1554; Derbeneva OA, 2002, AM J HUM GENET, V70, P1009, DOI 10.1086/339524; Derenko M, 2006, HUM GENET, V118, P591, DOI 10.1007/s00439-005-0076-y; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015214; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Di Giacomo F, 2004, HUM GENET, V115, P357, DOI 10.1007/s00439-004-1168-9; Dulik M.C., 2011, THESIS U PENNSYLVANI; Dulik MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017548; Dupuy BM, 2004, HUM MUTAT, V23, P117, DOI 10.1002/humu.10294; Ellis N, 2002, GENOME RES, V12, P339; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fiedel SJ, 2000, J ARCHAEOL RES, V8, P39, DOI 10.1023/A:1009400309773; Forster P, 1996, AM J HUM GENET, V59, P935; Forsyth James, 1992, HIST PEOPLES SIBERIA; Geppert M, 2011, FORENSIC SCI INT-GEN, V5, P100, DOI 10.1016/j.fsigen.2010.08.016; Goebel T, 1999, EVOL ANTHROPOL, V8, P208; Gokcumen O, 2008, AM J PHYS ANTHROPOL, V136, P278, DOI 10.1002/ajpa.20802; Golden Peter B., 1992, INTRO HIST TURKIC PE, P266; Gonzalez-Jose R, 2008, AM J PHYS ANTHROPOL, V137, P175, DOI 10.1002/ajpa.20854; Grousset R., 1970, EMPIRE STEPPES HIST; Gryaznov Mikhail P., 1969, ANCIENT CIVILIZATION; Gusmao L, 2006, FORENSIC SCI INT, V157, P187, DOI 10.1016/j.forsciint.2005.04.002; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Helgason A, 2006, AM J PHYS ANTHROPOL, V130, P123, DOI 10.1002/ajpa.20313; Ho SYW, 2008, AM J HUM GENET, V83, P142, DOI 10.1016/j.ajhg.2008.06.014; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; HORAI S, 1993, MOL BIOL EVOL, V10, P23; Hrdlicka A, 1942, AM J PHYS ANTHROPOL, V29, P435, DOI 10.1002/ajpa.1330290402; Kaessmann H, 2002, AM J HUM GENET, V70, P673, DOI 10.1086/339258; Karafet T, 1997, AM J PHYS ANTHROPOL, V102, P301, DOI 10.1002/(SICI)1096-8644(199703)102:3<301::AID-AJPA1>3.0.CO;2-Y; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Karafet TM, 2002, HUM BIOL, V74, P761, DOI 10.1353/hub.2003.0006; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; Khar'kov V N, 2011, Mol Biol (Mosk), V45, P446; Khar'kov V N, 2009, Genetika, V45, P1132; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; Kolman CJ, 1996, GENETICS, V142, P1321; Kozintsev AG, 1999, AM J PHYS ANTHROPOL, V108, P193, DOI 10.1002/(SICI)1096-8644(199902)108:2<193::AID-AJPA5>3.3.CO;2-M; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Kuzmina EE, 2008, ENCOUNTERS ASIA, P1; Lell JT, 1997, HUM GENET, V100, P536, DOI 10.1007/s004390050548; Lell JT, 2002, AM J HUM GENET, V70, P192, DOI 10.1086/338457; Levin M.G., 1964, PEOPLES SIBERIA, P99; Levin MG, 1964, PEOPLES SIBERIA; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malyarchuk B, 2011, J HUM GENET, V56, P583, DOI 10.1038/jhg.2011.64; Martinez-Cruz B, 2011, EUR J HUM GENET, V19, P216, DOI 10.1038/ejhg.2010.153; Menges K.H., 1995, VER FFENTLICHUNGEN S; Merriwether DA, 1996, MOL PHYLOGENET EVOL, V5, P241, DOI 10.1006/mpev.1996.0017; Merriwether DA, 1996, AM J HUM GENET, V59, P204; Mirabal S, 2009, EUR J HUM GENET, V17, P1260, DOI 10.1038/ejhg.2009.6; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; NEEL JV, 1994, P NATL ACAD SCI USA, V91, P10737, DOI 10.1073/pnas.91.22.10737; OKLADNIKOV AP, 1964, PEOPLES SIBERIA, P13; OSIPOVA LP, 1978, GENETIKA+, V14, P1272; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pimenoff VN, 2008, EUR J HUM GENET, V16, P1254, DOI 10.1038/ejhg.2008.101; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Posukh OL, 1998, GENETIKA+, V34, P106; Potapov L.P., 1962, STUDIES SIBERIAN ETH, P169; POTAPOV L. P., 1964, PEOPLES SIBERIA, P305; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Roewer L, 2007, FORENSIC SCI INT, V173, P204, DOI 10.1016/j.forsciint.2006.11.013; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Rubinstein S, 2008, HUM BIOL, V80, P203, DOI 10.3378/1534-6617-80.3.203; Rudenko Sergei, 1970, FROZEN TOMBS SIBERIA; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; Schurr T. G, 2003, CONSTRUCTING CULTURE, P239; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; Schurr TG, 2004, AM J HUM BIOL, V16, P420, DOI 10.1002/ajhb.20041; SCHURR TG, 1990, AM J HUM GENET, V46, P613; Schurr TG, 2010, PREHISTORIC HUNTER-GATHERERS OF THE BAIKAL REGION, SIBERIA, P121; Seielstad M, 2003, AM J HUM GENET, V73, P700, DOI 10.1086/377589; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Shi H, 2005, AM J HUM GENET, V77, P408, DOI 10.1086/444436; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Soucek S., 2000, HIST INNER ASIA, DOI 10.1017/CBO9780511991523; SPSS Inc, 2001, SPSS WIND REL 11 0 0; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; SUKERNIK RI, 1977, GENETIKA+, V13, P911; Sukernik RI, 1996, GENETIKA+, V32, P432; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Torroni A, 1996, GENETICS, V144, P1835; TORRONI A, 1994, AM J HUM GENET, V55, P760; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1992, GENETICS, V130, P153; TORRONI A, 1993, AM J HUM GENET, V53, P563; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Underhill PA, 2010, EUR J HUM GENET, V18, P479, DOI 10.1038/ejhg.2009.194; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019; WALLACE DC, 1992, HUM BIOL, V64, P403; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Xue Y., 2008, SIMULATIONS GENETICS, P79; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhadanov SI, 2010, AM J PHYS ANTHROPOL, V142, P579, DOI 10.1002/ajpa.21281; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2005, HUM GENET, V116, P529, DOI 10.1007/s00439-005-1281-4; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105; Zhong H, 2011, MOL BIOL EVOL, V28, P717, DOI 10.1093/molbev/msq247	138	97	98	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					229	246		10.1016/j.ajhg.2011.12.014	http://dx.doi.org/10.1016/j.ajhg.2011.12.014			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	898KV	22281367	Bronze, Green Published			2022-12-18	WOS:000300742200004
J	Tao, H; Manak, JR; Sowers, L; Mei, X; Kiyonari, H; Abe, T; Dandaleh, NS; Yang, TA; Wu, S; Chen, S; Fox, MH; Gurnett, C; Montine, T; Bird, T; Shaffer, LG; Rosenfeld, JA; McConne, J; Madan-Khetarpal, S; Berry-Kravis, E; Griesbach, H; Saneto, RP; Scott, MP; Antic, D; Reed, J; Boland, R; Ehaideb, SN; El-Shanti, H; Mahajan, VB; Ferguson, PJ; Axelrod, JD; Lehesjoki, AE; Fritzsch, B; Slusarski, DC; Wemmie, J; Ueno, N; Bassuk, AG				Tao, Hirotaka; Manak, J. Robert; Sowers, Levi; Mei, Xue; Kiyonari, Hiroshi; Abe, Takaya; Dandaleh, Nader S.; Yang, Tian; Wu, Shu; Chen, Shan; Fox, Mark H.; Gurnett, Christina; Montine, Thomas; Bird, Thomas; Shaffer, Lisa G.; Rosenfeld, Jill A.; McConne, Juliann; Madan-Khetarpal, Suneeta; Berry-Kravis, Elizabeth; Griesbach, Hilary; Saneto, Russell P.; Scott, Matthew P.; Antic, Dragana; Reed, Jordan; Boland, Riley; Ehaideb, Salleh N.; El-Shanti, Hatem; Mahajan, Vinit B.; Ferguson, Polly J.; Axelrod, Jeffrey D.; Lehesjoki, Anna-Elina; Fritzsch, Bernd; Slusarski, Diane C.; Wemmie, John; Ueno, Naoto; Bassuk, Alexander G.			Mutations in Prickle Orthologs Cause Seizures in Flies, Mice, and Humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; PLANAR CELL POLARITY; DROSOPHILA-MELANOGASTER; NEURON MIGRATION; MOUSE PRICKLE1; GENE; ZEBRAFISH; GASTRULATION; MOVEMENTS; CHANNEL	Epilepsy is heritable, yet few causative gene mutations have been identified, and thus far no human epilepsy gene mutations have been found to produce seizures in invertebrates. Here we show that mutations in prickle genes are associated with seizures in humans, mice, and flies. We identified human epilepsy patients with heterozygous mutations in either PRICKLE1 or PRICKLE2. In overexpression assays in zebrafish, prickle mutations resulted in aberrant prickle function. A seizure phenotype was present in the Prickle1-null mutant mouse, two Prickle1 point mutant (missense and nonsense) mice, and a Prickle2-null mutant mouse. Drosophila with prickle mutations displayed seizures that were responsive to anti-epileptic medication, and homozygous mutant embryos showed neuronal defects. These results suggest that prickle mutations have caused seizures throughout evolution.	[Tao, Hirotaka; Ueno, Naoto] Natl Inst Basic Biol, Div Morphogenesis, Okazaki, Aichi 4448585, Japan; [Manak, J. Robert; Mei, Xue; Yang, Tian; Reed, Jordan; Boland, Riley; Ehaideb, Salleh N.; Fritzsch, Bernd; Slusarski, Diane C.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Sowers, Levi; Wu, Shu; Chen, Shan; Fox, Mark H.; El-Shanti, Hatem; Ferguson, Polly J.; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Carver Coll Med, Iowa City, IA 52242 USA; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN Ctr Dev Biol, Lab Anim Resources & Genet Engn, Chuo Ku, Kobe, Hyogo 650047, Japan; [Dandaleh, Nader S.] Univ Iowa, Dept Neurosurg, Carver Coll Med, Iowa City, IA 52242 USA; [Gurnett, Christina] Washington Univ, Dept Neurol, St Louis, MO 63310 USA; [Montine, Thomas] Univ Washington, Dept Pathol, Seattle, WA 98104 USA; [Bird, Thomas] Univ Washington, Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA 98104 USA; [Shaffer, Lisa G.; Rosenfeld, Jill A.] Signature Genom Labs, Spokane, WA 99202 USA; [McConne, Juliann; Madan-Khetarpal, Suneeta] Childrens Hosp Pittsburgh UPMC, Pittsburgh, PA 15224 USA; [Berry-Kravis, Elizabeth] Rush Presbyterian St Lukes Med Ctr, Dept Pediat, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth] Rush Presbyterian St Lukes Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Berry-Kravis, Elizabeth] Rush Presbyterian St Lukes Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Saneto, Russell P.] Seattle Childrens Hosp, Div Pediat Neurol, Seattle, WA 98105 USA; [Scott, Matthew P.; Antic, Dragana] Stanford Univ, Sch Med, Dept Dev Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Scott, Matthew P.; Antic, Dragana] Stanford Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Scott, Matthew P.; Antic, Dragana] Stanford Univ, Sch Med, Dept Bioengn, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Antic, Dragana; Axelrod, Jeffrey D.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [El-Shanti, Hatem] Shafallah Med Genet Ctr, Doha 33123, Qatar; [Mahajan, Vinit B.] Univ Iowa, Dept Ophthalmol & Visual Sci, Carver Coll Med, Iowa City, IA 52242 USA; [Lehesjoki, Anna-Elina] Univ Helsinki, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; [Lehesjoki, Anna-Elina] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; [Wemmie, John] Univ Iowa, Dept Psychiat, Ia City, IA 52242 USA; [Wemmie, John] Univ Iowa, Dept Neurosurg, Neurosci Program, Roy J & Lucille A Carver Coll Med, Ia City, IA 52242 USA; [Wemmie, John] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Ueno, Naoto] Grad Univ Adv Studies SOKENDAI, Dept Basic Biol, Sch Life Sci, Okazaki, Aichi 4448585, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); University of Iowa; University of Iowa; RIKEN; University of Iowa; Washington University (WUSTL); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Rush University; Rush University; Rush University; Seattle Children's Hospital; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Al Shafallah Center; University of Iowa; University of Helsinki; University of Helsinki; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Ueno, N (corresponding author), Natl Inst Basic Biol, Div Morphogenesis, 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	nueno@nibb.ac.jp; alexander-bassuk@uiowa.edu	Kiyonari, Hiroshi/N-7936-2015; El-Shanti, Hatem/O-5990-2014; EL-SHANTI, HATEM/Q-4932-2016	El-Shanti, Hatem/0000-0001-6230-8316; EL-SHANTI, HATEM/0000-0001-6230-8316; Gurnett, Christina/0000-0001-9129-315X; Wemmie, John/0000-0001-7531-9065; Mahajan, Vinit/0000-0003-1886-1741; Tao, Hirotaka/0000-0002-3023-9958; Slusarski, Diane/0000-0003-3793-8636; Ueno, Naoto/0000-0002-8375-2317; Bassuk, Alexander/0000-0002-4067-2157; Manak, John/0000-0002-6562-7694; Fritzsch, Bernd/0000-0002-4882-8398	National Institutes of Health [R01 NS064159, 3R01NS064159-02S1, R01 GM059823, RO1 CA112369, P50 AG05136, 1R21NS058309-01A1]; VA; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA112369] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059823, R01GM097081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064159, R21NS058309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA(US Department of Veterans Affairs); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants R01 NS064159 and 3R01NS064159-02S1 (to A.G.B.), R01 GM059823 (to J.D.A.), RO1 CA112369 (to D.C.S.), and P50 AG05136 (to T.M.), by 1R21NS058309-01A1 (to J.W.), by a VA Merit Review Award (to J.W.), and by a grant from the Howard Hughes Medical Institute (to M.S.). We thank Jeff Murray, Jeff Neul, Val Sheffield, Bev Davidson, Zoha Kibar, Heather Mefford, and Sam Berkovic for their thoughtful reviews. We thank Jeff Murray for access to the CEPH-HGD samples and Taqman assay. L.G.S. and J.A.R. are employed by Signature Genomics Laboratories.	Alakurtti K, 2000, GENE, V242, P65, DOI 10.1016/S0378-1119(99)00550-8; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; Berkovic SE, 2008, AM J HUM GENET, V82, P673, DOI 10.1016/j.ajhg.2007.12.019; Bingham SM, 2010, DEV NEUROBIOL, V70, P87, DOI 10.1002/dneu.20761; BIRD TD, 1978, J NEUROL NEUROSUR PS, V41, P140, DOI 10.1136/jnnp.41.2.140; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; Cao Y, 2010, J AM SOC NEPHROL, V21, P1326, DOI 10.1681/ASN.2009091001; Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Chioza B, 2002, LANCET, V359, P258, DOI 10.1016/S0140-6736(02)07416-0; Copp AJ, 2010, J PATHOL, V220, P217, DOI 10.1002/path.2643; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Eickholt BJ, 2005, MOL PHARMACOL, V67, P1426, DOI 10.1124/mol.104.009308; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Fergestad T, 2008, GENETICS, V178, P947, DOI 10.1534/genetics.107.082115; Frankel WN, 2009, TRENDS GENET, V25, P361, DOI 10.1016/j.tig.2009.07.001; Ganesh S, 2002, HUM MOL GENET, V11, P1263, DOI 10.1093/hmg/11.11.1263; GANETZKY B, 1982, GENETICS, V100, P597; Gokben S, 2009, NEUROPEDIATRICS, V40, P82, DOI 10.1055/s-0029-1234083; GOLDSCHMIDT RB, 1945, U CALIFORNIA PUBLICA, V49, P503; GREEN MM, 1961, GENETICS, V46, P671; Gubb D, 1999, GENE DEV, V13, P2315, DOI 10.1101/gad.13.17.2315; Kaasik A, 2007, EPILEPSIA, V48, P752, DOI 10.1111/j.1528-1167.2007.00985.x; KELLY KM, 1990, NEUROSCI LETT, V116, P233, DOI 10.1016/0304-3940(90)90416-7; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOSKINIEMI M, 1974, ACTA NEUROL SCAND, V50, P307; Krampfl K, 2005, EUR J NEUROSCI, V22, P10, DOI 10.1111/j.1460-9568.2005.04168.x; Kuebler D, 2002, BRAIN RES, V958, P36, DOI 10.1016/S0006-8993(02)03431-5; LEFEVRE G, 1952, DROSOPH INF SERV, V26, P108; Lin YY, 2009, DEV BIOL, V325, P386, DOI 10.1016/j.ydbio.2008.10.042; LINDSLEY, 1968, GENETIC VARIATIONS D, P472; LINDSLEY G, 1961, GENETICS, V46, P11; Long JM, 2004, GENES BRAIN BEHAV, V3, P51, DOI 10.1046/j.1601-183x.2003.00045.x; Mapp OM, 2010, DEV DYNAM, V239, P1596, DOI 10.1002/dvdy.22283; Mares P, 2006, MODELS OF SEIZURES AND EPILEPSY, P153, DOI 10.1016/B978-012088554-1/50014-1; MATHIES LD, 1994, DEVELOPMENT, V120, P2799; Medina MT, 2008, NEUROLOGY, V70, P2137, DOI 10.1212/01.wnl.0000313149.73035.99; Mirzadeh Z, 2010, J NEUROSCI, V30, P2600, DOI 10.1523/JNEUROSCI.3744-09.2010; Moreau MM, 2010, J NEUROSCI, V30, P9738, DOI 10.1523/JNEUROSCI.6007-09.2010; Murata T, 2004, GENE EXPR PATTERNS, V5, P171, DOI 10.1016/j.modgep.2004.08.007; Ohmori I, 2008, NEUROBIOL DIS, V32, P349, DOI 10.1016/j.nbd.2008.07.017; Okuda H, 2007, FEBS LETT, V581, P4754, DOI 10.1016/j.febslet.2007.08.075; Panakova D, 2010, NATURE, V466, P874, DOI 10.1038/nature09249; Rocha PP, 2010, DEVELOPMENT, V137, P2723, DOI 10.1242/dev.053660; Roszko I, 2009, SEMIN CELL DEV BIOL, V20, P986, DOI 10.1016/j.semcdb.2009.09.004; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Song H, 2010, NATURE, V466, P378, DOI 10.1038/nature09129; Song J, 2008, PROG NEUROBIOL, V84, P182, DOI 10.1016/j.pneurobio.2007.10.006; Suzuki T, 2004, NAT GENET, V36, P842, DOI 10.1038/ng1393; Takeuchi M, 2003, CURR BIOL, V13, P674, DOI 10.1016/S0960-9822(03)00245-8; Tao H, 2009, P NATL ACAD SCI USA, V106, P14426, DOI 10.1073/pnas.0901332106; Tissir F, 2010, CURR OPIN NEUROBIOL, V20, P572, DOI 10.1016/j.conb.2010.05.006; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458	57	97	101	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					138	149		10.1016/j.ajhg.2010.12.012	http://dx.doi.org/10.1016/j.ajhg.2010.12.012			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21276947	Green Published, Bronze			2022-12-18	WOS:000287684100002
J	Corbett, MA; Bahlo, M; Jolly, L; Afawi, Z; Gardner, AE; Oliver, KL; Tan, S; Coffey, A; Mulley, JC; Dibbens, LM; Simri, W; Shalata, A; Kivity, S; Jackson, GD; Berkovic, SF; Gecz, J				Corbett, Mark A.; Bahlo, Melanie; Jolly, Lachlan; Afawi, Zaid; Gardner, Alison E.; Oliver, Karen L.; Tan, Stanley; Coffey, Amy; Mulley, John C.; Dibbens, Leanne M.; Simri, Walid; Shalata, Adel; Kivity, Sara; Jackson, Graeme D.; Berkovic, Samuel F.; Gecz, Jozef			A Focal Epilepsy and Intellectual Disability Syndrome Is Due to a Mutation in TBC1D24	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION; SELECTION	We characterized an autosomal-recessive syndrome of focal epilepsy, dysarthria, and mild to moderate intellectual disability in a consanguineous Arab-Israeli family associated with subtle cortical thickening. We used multipoint linkage analysis to map the causative mutation to a 3.2 Mb interval within 16p13.3 with a LOD score of 3.86. The linked interval contained 160 genes, many of which were considered to be plausible candidates to harbor the disease-causing mutation. To interrogate the interval in an efficient and unbiased manner, we used targeted sequence enrichment and massively parallel sequencing. By prioritizing unique variants that affected protein translation, a pathogenic mutation was identified in TBC1D24 (p.F251L), a gene of unknown function. It is a member of a large gene family encoding TBC domain proteins with predicted function as Rab GTPase activators. We show that TBC1D24 is expressed early in mouse brain and that TBC1D24 protein is a potent modulator of primary axonal arborization and specification in neuronal cells, consistent with the phenotypic abnormality described.	[Oliver, Karen L.; Berkovic, Samuel F.] Univ Melbourne, Epilepsy Res Ctr, Austin Hlth, West Heidelberg 3084, Australia; [Corbett, Mark A.; Jolly, Lachlan; Tan, Stanley; Coffey, Amy; Mulley, John C.; Dibbens, Leanne M.; Gecz, Jozef] SA Pathol, Adelaide, SA 5000, Australia; [Bahlo, Melanie] Walter & Eliza Hall Res Inst Med Res, Melbourne, Vic 3052, Australia; [Afawi, Zaid] Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-64239 Tel Aviv, Israel; [Gardner, Alison E.; Gecz, Jozef] Womens & Childrens Hlth Res Inst, Adelaide, SA 5006, Australia; [Mulley, John C.; Gecz, Jozef] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5000, Australia; [Simri, Walid] Western Galilee Hosp, Dept Neurol, IL-22100 Nahariyya, Israel; [Shalata, Adel] Ginatuna Assoc, IL-20173 Sakhnin City, West Galilee, Israel; [Kivity, Sara] Schneider Childrens Med Ctr Israel, Epilepsy Unit, IL-49100 Petah Tiqwa, Israel; [Jackson, Graeme D.] Florey Neurosci Inst, Brain Res Inst, Heidelberg West 3084, Australia	University of Melbourne; SA Pathology; Walter & Eliza Hall Institute; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Womens & Childrens Hospital Australia; University of Adelaide; Western Galilee Hospital; Florey Institute of Neuroscience & Mental Health	Berkovic, SF (corresponding author), Univ Melbourne, Epilepsy Res Ctr, Austin Hlth, West Heidelberg 3084, Australia.	samuelfb@unimelb.edu.au; jozef.gecz@adelaide.edu.au	Gecz, Jozef/X-3469-2019; Jackson, Graeme D/A-9064-2013; Jolly, Lachlan/B-5892-2015; Afawi, Zaid/AAE-7848-2022; Corbett, Mark/A-8063-2010; Jackson, Graeme/AAD-9070-2019; Oliver, Karen Louise/O-6159-2018; jiang, yu/HGU-0029-2022	Gecz, Jozef/0000-0002-7884-6861; Jackson, Graeme D/0000-0002-7917-5326; Jolly, Lachlan/0000-0003-4538-2658; Corbett, Mark/0000-0001-9298-3072; Jackson, Graeme/0000-0002-7917-5326; Oliver, Karen Louise/0000-0001-5188-6153; Berkovic, Samuel/0000-0003-4580-841X; Bahlo, Melanie/0000-0001-5132-0774; Dibbens, Leanne/0000-0002-5824-3342	National Health and Medical Research Council (NHMRC) [400121]; International Science Linkages	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); International Science Linkages(Australian GovernmentDepartment of Industry, Innovation and Science)	We are grateful for the cooperation of the family involved in this study, as well as to Bev Johns for technical assistance and Rob King, Andre Rickers, and Graeme Woolford from Gene Works for help with the resequencing. M.B. and J.G. were supported by the National Health and Medical Research Council (NH&MRC) with a Career Development Award and a Principal Research Fellowship, respectively. This project was supported by NH&MRC program grant 400121 and also by International Science Linkages, established under the Australian Government's innovation statement, "Backing Australia's Ability."	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Airaksinen EM, 2000, EPILEPSIA, V41, P1214, DOI 10.1111/j.1528-1157.2000.tb00328.x; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Bahlo M, 2009, BIOINFORMATICS, V25, P1961, DOI 10.1093/bioinformatics/btp313; Billuart P, 1998, NATURE, V392, P923, DOI 10.1038/31940; Carvalho B, 2007, BIOSTATISTICS, V8, P485, DOI 10.1093/biostatistics/kxl042; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; Gao X, 2008, PROTEIN PEPTIDE LETT, V15, P505, DOI 10.2174/092986608784567483; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Gordon D., 2003, CURR PROTOC BIOINFOR, V11, P1, DOI DOI 10.1002/0471250953.BI1102S02; Helbig I, 2008, LANCET NEUROL, V7, P231, DOI 10.1016/S1474-4422(08)70039-5; Heron SE, 2007, ANN NEUROL, V62, P560, DOI 10.1002/ana.21169; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Mefford HC, 2009, CURR OPIN GENET DEV, V19, P196, DOI 10.1016/j.gde.2009.04.003; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	20	97	107	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					371	375		10.1016/j.ajhg.2010.08.001	http://dx.doi.org/10.1016/j.ajhg.2010.08.001			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20797691	Green Published, Bronze			2022-12-18	WOS:000281923500006
J	Uz, E; Alanay, Y; Aktas, D; Vargel, I; Gucer, S; Tuncbilek, G; von Eggeling, F; Yilmaz, E; Deren, O; Posorski, N; Ozdag, H; Liehr, T; Balci, S; Alikasifoglu, M; Wollnik, B; Akarsu, NA				Uz, Elif; Alanay, Yasemin; Aktas, Dilek; Vargel, Ibrahim; Gucer, Safak; Tuncbilek, Gokhan; von Eggeling, Ferdinand; Yilmaz, Engin; Deren, Ozgur; Posorski, Nicole; Ozdag, Hilal; Liehr, Thomas; Balci, Sevim; Alikasifoglu, Mehmet; Wollnik, Bernd; Akarsu, Nurten A.			Disruption of ALX1 Causes Extreme Microphthalmia and Severe Facial Clefting: Expanding the Spectrum of Autosomal-Recessive ALX-Related Frontonasal Dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ANOPHTHALMIA-PLUS SYNDROME; CAUSE CRANIOFRONTONASAL SYNDROME; CNS STRUCTURAL ANOMALIES; MENTAL-RETARDATION; EYELID COLOBOMAS; EAR ANOMALIES; MUTATIONS; GENES; MACROBLEPHARON; INHERITANCE	We present an autosomal-recessive frontonasal dysplasia (FND) characterized by bilateral extreme microphthalmia, bilateral oblique facial cleft, complete cleft palate, hypertelorism, wide nasal bridge with hypoplasia of the ala nasi, and low-set, posteriorly rotated ears in two distinct families. Using Affymetrix 250K SNP array genotyping and homozygosity mapping, we mapped this clinical entity to chromosome 12q21. In one of the families, three siblings were affected, and CNV analysis of the critical region showed a homozygous 3.7 Mb deletion containing the ALX1 (CART1) gene, which encodes the aristaless-like homeobox 1 transcription factor. In the second family we identified a homozygous donor-splice-site mutation (c.531+1G > A) in the ALX1 gene, providing evidence that complete loss of function of ALX1 protein causes severe disruption of early craniofacial development. Unlike loss of its murine ortholog, loss of human ALX1 does not result in neural-tube defects; however, it does severely affect the orchestrated fusion between frontonasal, nasomedial, nasolateral, and maxillary processes during early-stage embryogenesis. This study further expands the spectrum of the recently recognized autosomal-recessive ALX-related FND phenotype in humans.	[Uz, Elif; Aktas, Dilek; Alikasifoglu, Mehmet; Akarsu, Nurten A.] Hacettepe Univ, Fac Med, Dept Med Genet, Gene Mapping Lab, TR-06100 Ankara, Turkey; [Alanay, Yasemin; Aktas, Dilek; Balci, Sevim; Alikasifoglu, Mehmet] Hacettepe Univ, Fac Med, Dept Pediat, Pediat Genet Unit, TR-06100 Ankara, Turkey; [Vargel, Ibrahim] Kirikkale Univ, Fac Med, Dept Plast & Reconstruct Surg, TR-71001 Kirikkale, Turkey; [Vargel, Ibrahim; Tuncbilek, Gokhan] Hacettepe Univ, Fac Med, Dept Plast & Reconstruct Surg, TR-06100 Ankara, Turkey; [Gucer, Safak] Hacettepe Univ, Fac Med, Dept Pediat, Pathol Unit, TR-06100 Ankara, Turkey; [von Eggeling, Ferdinand; Posorski, Nicole; Liehr, Thomas] Jena Univ Hosp, Inst Human Genet & Anthropol, D-07740 Jena, Germany; [Yilmaz, Engin] Hacettepe Univ, Fac Med, Dept Med Biol, TR-06100 Ankara, Turkey; [Deren, Ozgur] Hacettepe Univ, Fac Med, Dept Obstet & Gynecol, TR-06100 Ankara, Turkey; [Ozdag, Hilal] Ankara Univ, Inst Biotechnol, TR-06501 Ankara, Turkey; [Wollnik, Bernd] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Wollnik, Bernd] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	Hacettepe University; Hacettepe University; Kirikkale University; Hacettepe University; Hacettepe University; Friedrich Schiller University of Jena; Hacettepe University; Hacettepe University; Ankara University; University of Cologne; University of Cologne; University of Cologne	Akarsu, NA (corresponding author), Hacettepe Univ, Fac Med, Dept Med Genet, Gene Mapping Lab, TR-06100 Ankara, Turkey.	nakarsu@hacettepe.edu.tr	Liehr, Thomas/H-2852-2019; VARGEL, IBRAHIM/I-9776-2013; Uz, Elif/A-4666-2012; Akarsu, Nurten/E-9758-2013; vargel, ibrahim/GOP-0344-2022; Wollnik, Bernd/GRY-6062-2022; von Eggeling, Ferdinand/AAC-8349-2022; YILMAZ, Engin/W-4160-2018; YILMAZ, ENGIN/I-8278-2013; von Eggeling, Ferdinand/B-4033-2014; Özdag, Hilal/C-9929-2009; Alanay, Yasemin/A-1516-2016	Liehr, Thomas/0000-0003-1672-3054; Akarsu, Nurten/0000-0001-5432-0032; Wollnik, Bernd/0000-0003-2589-0364; von Eggeling, Ferdinand/0000-0002-8062-6999; YILMAZ, Engin/0000-0001-8873-7645; von Eggeling, Ferdinand/0000-0002-8062-6999; Özdag, Hilal/0000-0001-7940-2499; Alanay, Yasemin/0000-0003-0683-9731	Scientific and Technological Research Council of Turkey (TUBITAK) [108S420]; European Research Area Network (E-RARE) [R07197KS]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); European Research Area Network (E-RARE)	We are grateful to the families for their participation in the study. We thank Han Brunner for critical reading and comments, Ebru Oralli Bircan for illustrations, Hacettepe University Craniofacial Surgery Study Group members Yucel Erk, Emin Mavili, Aycan Kayikcioglu (Plastic and Reconstructive Surgery), Kemal Benli (Neurosurgery), Aysenur Cila (Radiology), Tulin Taner, and liken Kocadereli (Orthodonty) for evaluating the frontonasal malformation cases in the registry. This work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) (grant numbers 108S420 to N.A.A), and the overall consortium (CRANIRARE) was supported by the European Research Area Network (E-RARE) (project number R07197KS).	Akalin I, 2005, GENET COUNSEL, V16, P145; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Carlson BM., 2014, HUMAN EMBRYOLOGY DEV, V5 th edn, P117; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; DAO AH, 1984, HUM PATHOL, V15, P449, DOI 10.1016/S0046-8177(84)80079-9; FRYNS JP, 1995, AM J MED GENET, V58, P113, DOI 10.1002/ajmg.1320580204; GOLLOP TR, 1984, AM J MED GENET, V19, P301, DOI 10.1002/ajmg.1320190212; Guion-Almeida ML, 2001, CLIN DYSMORPHOL, V10, P81, DOI 10.1097/00019605-200104000-00002; Hing AV, 2004, AM J MED GENET A, V128A, P374, DOI 10.1002/ajmg.a.30091; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Kaufman BA, 2004, PEDIATR CLIN N AM, V51, P389, DOI 10.1016/S0031-3955(03)00207-4; Kayserili H, 2009, HUM MOL GENET, V18, P4357, DOI 10.1093/hmg/ddp391; Lees MM, 1998, CLIN DYSMORPHOL, V7, P157, DOI 10.1097/00019605-199807000-00001; Masuno M, 2000, CLIN DYSMORPHOL, V9, P59, DOI 10.1097/00019605-200009010-00012; Meijlink F, 1999, INT J DEV BIOL, V43, P651; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Ozalp O, 2008, GENET COUNSEL, V19, P43; PAI GS, 1987, AM J MED GENET, V26, P921, DOI 10.1002/ajmg.1320260421; REARDON W, 1994, AM J MED GENET, V52, P58, DOI 10.1002/ajmg.1320520112; SEDANO HO, 1970, J PEDIATR, V76, P906, DOI 10.1016/S0022-3476(70)80374-2; SEDANO HO, 1988, ORAL SURG ORAL MED O, V65, P704, DOI 10.1016/0030-4220(88)90014-X; SPIEGELMANN R, 1985, J NEUROSURG, V63, P461, DOI 10.3171/jns.1985.63.3.0461; Toriello H V, 1986, Am J Med Genet Suppl, V2, P89; TORIELLO HV, 1995, CLIN DYSMORPHOL, V4, P338, DOI 10.1097/00019605-199510000-00010; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; Twigg SRF, 2009, AM J HUM GENET, V84, P698, DOI 10.1016/j.ajhg.2009.04.009; Warburg M, 1997, AM J MED GENET, V73, P36, DOI 10.1002/(SICI)1096-8628(19971128)73:1<36::AID-AJMG8>3.0.CO;2-N; Wieland I, 2004, AM J HUM GENET, V74, P1209, DOI 10.1086/421532; ZHAO GQ, 1994, MECH DEVELOP, V48, P245, DOI 10.1016/0925-4773(94)90063-9; ZHAO GQ, 1993, P NATL ACAD SCI USA, V90, P8633, DOI 10.1073/pnas.90.18.8633; Zhao Q, 1996, NAT GENET, V13, P275, DOI 10.1038/ng0796-275	32	97	101	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					789	796		10.1016/j.ajhg.2010.04.002	http://dx.doi.org/10.1016/j.ajhg.2010.04.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20451171	Bronze, Green Published			2022-12-18	WOS:000278045300015
J	Lin, DY; Sullivan, PF				Lin, Dan-Yu; Sullivan, Patrick F.			Meta-Analysis of Genome-wide Association Studies with Overlapping Subjects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOCI; SCHIZOPHRENIA; REPLICATION; VARIANTS; DISEASES	Data from multiple genome-wide association studies are often analyzed together for the purposes of combining information from several studies of the same disease or comparing results across different disorders. We provide a valid and efficient approach to such meta-analysis, allowing for overlapping study subjects. The available data may contain individual participant records or only meta-analytic summary results. Simulation studies demonstrate that failure to account for overlapping subjects can greatly inflate type I error when combining results from multiple studies of the same disease and can drastically reduce power when comparing results across different disorders. In addition, the proposed approach can be substantially more powerful than the simple approach of splitting the overlapping subjects among studies, especially for comparing results across different disorders. The advantages of the new approach are illustrated with empirical data from two sets of genome-wide association studies.	[Lin, Dan-Yu] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lin, DY (corresponding author), Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA.	lin@bios.unc.edu			NATIONAL CANCER INSTITUTE [R01CA082659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074027, R01MH077139] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA082659] Funding Source: Medline; NIMH NIH HHS [R01 MH085520, R01 MH077139, U01 MH085520, R01 MH074027] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cichon S, 2009, MOL PSYCHIATR, V14, P10, DOI 10.1038/mp.2008.126; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Kavvoura FK, 2008, HUM GENET, V123, P1, DOI 10.1007/s00439-007-0445-9; Lin DY, 2009, GENET EPIDEMIOL, V33, P256, DOI 10.1002/gepi.20377; LIN DY, 2009, GENET EPIDEMIOL, DOI DOI 10.1002/GEPI.20435; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Sullivan PF, 2008, MOL PSYCHIATR, V13, P570, DOI 10.1038/mp.2008.25; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	15	97	98	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					862	872		10.1016/j.ajhg.2009.11.001	http://dx.doi.org/10.1016/j.ajhg.2009.11.001			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	20004761	Green Published, Bronze			2022-12-18	WOS:000272797100009
J	Gersting, SW; Kemter, KF; Staudigl, M; Messing, DD; Danecka, MK; Lagler, FB; Sommerhoff, CP; Roscher, AA; Muntau, AC				Gersting, Soren W.; Kemter, Kristina F.; Staudigl, Michael; Messing, Dunja D.; Danecka, Marta K.; Lagler, Florian B.; Sommerhoff, Christian P.; Roscher, Adelbert A.; Muntau, Ania C.			Loss of function in phenylketonuria is caused by impaired molecular motions and conformational instability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN PHENYLALANINE-HYDROXYLASE; STRUCTURAL BASIS; MILD PHENYLKETONURIA; EXPRESSION ANALYSIS; MISSENSE MUTATIONS; SUBSTRATE-BINDING; CATALYTIC DOMAIN; PKU MUTATIONS; ACTIVE-SITE; WILD-TYPE	A significant share of patients with phenylalanine hydroxylase (PAH) deficiency benefits from pharmacological doses of tetrahydrobiopterin (BH4), the natural PAH cofactor. Phenylketonuria (PKU) is hypothesized to be a conformational disease, with loss of function due to protein destabilization, and the restoration of enzyme function that is observed in BH4 treatment might be transmitted by correction of protein misfolding. To elucidate the molecular basis of functional impairment in PAH deficiency, we investigated the impact of ten PAH gene mutations identified in patients with BH4-responsiveness on enzyme kinetics, stability, and conformation of the protein (F55L, 165S, H170Q, P275L, A300S, S310Y, P314S, R408W, Y414C, Y417H). Residual enzyme activity was generally high, but allostery was disturbed in almost all cases and pointed to altered protein conformation. This was confirmed by reduced proteolytic stability, impaired tetramer assembly or aggregation, increased hydrophobicity, and accelerated thermal unfolding-with particular impact on the regulatory domain-observed in most variants. Three-dimensional modeling revealed the involvement of functionally relevant amino acid networks that may communicate misfolding throughout the protein. Our results substantiate the view that PAH deficiency is a protein-misfolding disease in which global conformational changes hinder molecular motions essential for physiological enzyme function. Thus, PKU has evolved from a model of a genetic disease that leads to severe neurological impairment to a model of a treatable protein-folding disease with loss of function.	[Gersting, Soren W.; Kemter, Kristina F.; Staudigl, Michael; Messing, Dunja D.; Danecka, Marta K.; Roscher, Adelbert A.; Muntau, Ania C.] Univ Munich, Dr Von Hauner Childrens Hosp, Dept Mol Pediatr, Childrens Res Ctr, D-80337 Munich, Germany; [Lagler, Florian B.] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Sommerhoff, Christian P.] Univ Munich, Dept Clin Chem & Clin Biochem, Surg Clin, D-80337 Munich, Germany	University of Munich; Medical University of Innsbruck; University of Munich	Muntau, AC (corresponding author), Univ Munich, Dr Von Hauner Childrens Hosp, Dept Mol Pediatr, Childrens Res Ctr, Lindwurmstr 4, D-80337 Munich, Germany.	ania.muntau@med.uni-muenchen.de	Gersting, Soeren W/D-4612-2011	Gersting, Soeren W/0000-0001-7482-4748; Lagler, Florian B/0000-0002-1439-6961				Andersen OA, 2003, J MOL BIOL, V333, P747, DOI 10.1016/j.jmb.2003.09.004; Bjorgo E, 1998, EUR J BIOCHEM, V257, P1, DOI 10.1046/j.1432-1327.1998.2570001.x; Copeland R.A., 2000, ENZYMES PRACTICAL IN, Vsecond; Erlandsen H, 2004, P NATL ACAD SCI USA, V101, P16903, DOI 10.1073/pnas.0407256101; Erlandsen H, 1997, NAT STRUCT BIOL, V4, P995, DOI 10.1038/nsb1297-995; Erlandsen H, 1999, MOL GENET METAB, V68, P103, DOI 10.1006/mgme.1999.2922; Flatmark T, 1999, CHEM REV, V99, P2137, DOI 10.1021/cr980450y; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Fusetti F, 1998, J BIOL CHEM, V273, P16962, DOI 10.1074/jbc.273.27.16962; Gamez A, 2000, J BIOL CHEM, V275, P29737, DOI 10.1074/jbc.M003231200; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guldberg P, 1998, AM J HUM GENET, V63, P71, DOI 10.1086/301920; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Knappskog PM, 1996, EUR J BIOCHEM, V242, P813, DOI 10.1111/j.1432-1033.1996.0813r.x; Kobe B, 1999, NAT STRUCT BIOL, V6, P442, DOI 10.1038/8247; Leiros HKS, 2007, J BIOL CHEM, V282, P21973, DOI 10.1074/jbc.M610174200; Liberles JS, 2005, AMINO ACIDS, V28, P1, DOI 10.1007/s00726-004-0152-y; MARTINEZ A, 1995, BIOCHEM J, V306, P589, DOI 10.1042/bj3060589; Miranda FF, 2002, J BIOL CHEM, V277, P40937, DOI 10.1074/jbc.M112197200; Muntau AC, 2002, NEW ENGL J MED, V347, P2122, DOI 10.1056/NEJMoa021654; NASCIMENTO C, 2007, J INHERIT METAB D S1, V30, P11; Novokhatny V, 1997, PROTEIN SCI, V6, P141; Perez B, 2005, MOL GENET METAB, V86, pS11, DOI 10.1016/j.ymgme.2005.06.009; Pey AL, 2005, MOL GENET METAB, V86, pS43, DOI 10.1016/j.ymgme.2005.04.008; Pey AL, 2004, HUM MUTAT, V24, P388, DOI 10.1002/humu.20097; Pey AL, 2004, J AM CHEM SOC, V126, P13670, DOI 10.1021/ja047713s; Pey AL, 2003, HUM MUTAT, V21, P370, DOI 10.1002/humu.10198; Pey AL, 2007, AM J HUM GENET, V81, P1006, DOI 10.1086/521879; Royer C A, 1995, Methods Mol Biol, V40, P65; Scriver CR, 2007, HUM MUTAT, V28, P831, DOI 10.1002/humu.20526; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; SCRIVER CR, 2006, PKU BH4 ADV PHENYLKE, P23; Solstad T, 2000, EUR J BIOCHEM, V267, P6302, DOI 10.1046/j.1432-1327.2000.01715.x; Stokka AJ, 2004, J BIOL CHEM, V279, P26571, DOI 10.1074/jbc.M400879200; Thorolfsson M, 2003, BIOCHEMISTRY-US, V42, P3419, DOI 10.1021/bi034021s; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Waters PJ, 1998, HUM MUTAT, V12, P344, DOI 10.1002/(SICI)1098-1004(1998)12:5<344::AID-HUMU8>3.0.CO;2-D; Waters PJ, 2000, MOL GENET METAB, V69, P101, DOI 10.1006/mgme.2000.2965; Waters PJ, 2003, HUM MUTAT, V21, P357, DOI 10.1002/humu.10197	40	97	101	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					5	17		10.1016/j.ajhg.2008.05.013	http://dx.doi.org/10.1016/j.ajhg.2008.05.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18538294	Green Published, Bronze			2022-12-18	WOS:000257784000003
J	Uitterlinden, AG; Arp, PP; Paeper, BW; Charmley, P; Proll, S; Rivadeneira, F; Fang, Y; van Meurs, JBJ; Britschgi, TB; Latham, JA; Schatzman, RC; Pols, HAP; Brunkow, ME				Uitterlinden, AG; Arp, PP; Paeper, BW; Charmley, P; Proll, S; Rivadeneira, F; Fang, Y; van Meurs, JBJ; Britschgi, TB; Latham, JA; Schatzman, RC; Pols, HAP; Brunkow, ME			Polymorphisms in the sclerosteosis/van Buchem disease gene (SOST) region are associated with bone-mineral density in elderly whites	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SP1 BINDING-SITE; LINKAGE DISEQUILIBRIUM; EXPRESSION REGULATION; COMMON DISEASE; BMP ANTAGONIST; GENOME SCREEN; RECEPTOR GENE; WOMEN; OSTEOPOROSIS; DETERMINANTS	Osteoporosis has a strong genetic component, but the genes involved are poorly defined. We studied whether the sclerosteosis/van Buchem disease gene ( SOST) is an osteoporosis-risk gene by examining its association with bone-mineral density (BMD). Mutations in SOST result in sclerosteosis, and alterations in the SOST gene expression may be causal in the closely related van Buchem disease. We used a set of eight polymorphisms from the SOST gene region to genotype 1,939 elderly men and women from a large population-based prospective-cohort study of Dutch whites. A 3-bp insertion (f = 0.38) in the presumed SOST promoter region (SRP3) was associated with decreased BMD in women at the femoral neck (FN) (P = .05) and lumbar spine (LS) (P = .01), with evidence of an allele-dose effect in the oldest age group (P = .006). Similarly, a G variant (f = 0.40) in the van Buchem deletion region (SRP9) was associated with increased BMD in men at the FN (P = .007) and LS (P = .02). In both cases, differences between extreme genotypes reached 0.2 SD. We observed no genotype effects on fracture risk, for the 234 osteoporotic fractures validated during 8.2 years of follow-up and for the 146 vertebral prevalent fractures analyzed. We did not find association between any of several frequent haplotypes across the SOST gene region and BMD. We did find evidence of additive effects of SRP3 with the COLIA1 Sp1 polymorphism but not with haplotypes of 3' polymorphisms in the vitamin-D receptor gene. The SOST-COLIA1 additive effect increased with age and reached 0.5 SD difference in BMD at LS in the oldest age group (P = .02). The molecular mechanism whereby these moderate SOST genotype effects are mediated remains to be elucidated, but it is likely to involve differences in regulation of SOST gene expression.	Erasmus Med Ctr, Dept Internal Med, Genet Lab, NL-3000 DR Rotterdam, Netherlands; Erasmus Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands; Celltech R&D, Bothell, WA USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Uitterlinden, AG (corresponding author), Erasmus Med Ctr, Dept Internal Med, Genet Lab, Room EE575,POB 1738, NL-3000 DR Rotterdam, Netherlands.	a.g.uitterlinden@erasmusmc.nl	Rivadeneira, Fernando/O-5385-2015	Rivadeneira, Fernando/0000-0001-9435-9441; van Meurs, Joyce/0000-0001-6245-2123				Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Balemans W, 2002, BONE, V31, P515, DOI 10.1016/S8756-3282(02)00844-X; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Becherini L, 2000, HUM MOL GENET, V9, P2043, DOI 10.1093/hmg/9.13.2043; BEIGHTON P, 1988, J MED GENET, V25, P200, DOI 10.1136/jmg.25.3.200; BEIGHTON P, 1984, CLIN GENET, V25, P175; Brunkow ME, 2001, AM J HUM GENET, V68, P577, DOI 10.1086/318811; BURGER H, 1994, BONE MINER, V25, P1, DOI 10.1016/S0169-6009(08)80203-6; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Devoto M, 1998, EUR J HUM GENET, V6, P151, DOI 10.1038/sj.ejhg.5200169; Devoto M, 2001, HUM MOL GENET, V10, P2447, DOI 10.1093/hmg/10.21.2447; Duncan EL, 1999, J BONE MINER RES, V14, P1993, DOI 10.1359/jbmr.1999.14.12.1993; Dunning AM, 2000, AM J HUM GENET, V67, P1544, DOI 10.1086/316906; Efstathiadou Z, 2001, J BONE MINER RES, V16, P1586, DOI 10.1359/jbmr.2001.16.9.1586; EPSTEIN S, 1979, S AFR MED J, V55, P1105; FLICKER L, 1995, J BONE MINER RES, V10, P1607; Flicker L, 1996, BONE, V18, P41, DOI 10.1016/8756-3282(95)00418-1; Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; Hansen H. G., 1967, HDB KINDERHEILKUNDE, V6, P351; HOFMAN A, 1991, EUR J EPIDEMIOL, V7, P403, DOI 10.1007/BF00145007; Hsu DR, 1998, MOL CELL, V1, P673, DOI 10.1016/S1097-2765(00)80067-2; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Kobayashi S, 1996, J BONE MINER RES, V11, P306; Koller DL, 2000, J CLIN ENDOCR METAB, V85, P3116, DOI 10.1210/jc.85.9.3116; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mann V, 2001, J CLIN INVEST, V107, P899, DOI 10.1172/JCI10347; MCCLOSKEY EV, 1993, OSTEOPOROSIS INT, V3, P138, DOI 10.1007/BF01623275; MORRISON NA, 1994, NATURE, V367, P284, DOI 10.1038/367284a0; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; POCOCK NA, 1987, J CLIN INVEST, V80, P706, DOI 10.1172/JCI113125; Ralston SH, 2002, J CLIN ENDOCR METAB, V87, P2460, DOI 10.1210/jc.87.6.2460; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Sevetson B, 2004, J BIOL CHEM, V279, P13849, DOI 10.1074/jbc.M306249200; SMITH DM, 1973, J CLIN INVEST, V52, P2800, DOI 10.1172/JCI107476; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; STEIN SA, 1983, NEUROLOGY, V33, P267, DOI 10.1212/WNL.33.3.267; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Uitterlinden AG, 1996, J BONE MINER RES, V11, P1241; Uitterlinden AG, 1998, NEW ENGL J MED, V338, P1016, DOI 10.1056/NEJM199804093381502; UITTERLINDEN AG, 2001, OSTEOPOROSIS, P639; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Van Der Klift M, 2002, J BONE MINER RES, V17, P1051, DOI 10.1359/jbmr.2002.17.6.1051; van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176; VANBUCHEM F, 1976, EXCERPTA MED AMSTERD; VANBUCHEM FSP, 1955, ACTA RADIOL, V44, P109, DOI 10.3109/00016925509170789; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wingender E, 2001, NUCLEIC ACIDS RES, V29, P281, DOI 10.1093/nar/29.1.281; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599	52	97	112	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1032	1045		10.1086/426458	http://dx.doi.org/10.1086/426458			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15514891	Green Published, Bronze			2022-12-18	WOS:000224866400008
J	Freude, K; Hoffmann, K; Jensen, LR; Delatycki, MB; des Portes, V; Moser, B; Hamel, B; van Bokhoven, H; Moraine, C; Fryns, JP; Chelly, J; Gecz, J; Lenzner, S; Kalscheuer, VM; Ropers, HH				Freude, K; Hoffmann, K; Jensen, LR; Delatycki, MB; des Portes, V; Moser, B; Hamel, B; van Bokhoven, H; Moraine, C; Fryns, JP; Chelly, J; Gecz, J; Lenzner, S; Kalscheuer, VM; Ropers, HH			Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine- binding protein cause nonsyndromic X-linked mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RNA; METHYLATION; SPB1P	Nonsyndromic X-linked mental retardation (NSXLMR) is a very heterogeneous condition, and most of the underlying gene defects are still unknown. Recently, we have shown that similar to 30% of these genes cluster on the proximal Xp, which prompted us to perform systematic mutation screening in brain-expressed genes from this region. Here, we report on a novel NSXLMR gene, FTSJ1, which harbors mutations in three unrelated families - one with a splicing defect, one with a nonsense mutation, and one with a deletion of one nucleotide. In two families, subsequent expression studies showed complete absence or significant reduction of mutant FTSJ1 transcripts. FTSJ1 protein is a homolog of Escherichia coli RNA methyltransferase FtsJ/RrmJ and may play a role in the regulation of translation. Further studies aim to elucidate the function of human FTSJ1 and its role during brain development.	Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; Univ Melbourne, Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic 3052, Australia; Hospices Civils Lyon, Ctr Hosp Lyon Sud, Dept Pediat, Lyon, France; Univ Med Ctr, Dept Human Genet, Nijmegen, Netherlands; CHU Bretonneau, INSERM, U316, Serv Genet, F-37044 Tours, France; Catholic Univ Louvain, Ctr Human Genet, Clin Genet Unit, B-3000 Louvain, Belgium; CHU Cochin, CNRS, INSERM, Inst Cochin Genet Mol, Paris, France; Womens & Childrens Hosp, Adelaide, SA, Australia; Univ Adelaide, Adelaide, SA, Australia	Max Planck Society; University of Melbourne; Murdoch Children's Research Institute; University of Melbourne; CHU Lyon; Radboud University Nijmegen; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Catholique Louvain; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Womens & Childrens Hospital Australia; University of Adelaide	Kalscheuer, VM (corresponding author), Max Planck Inst Mol Genet, Ihnestr 73, D-14195 Berlin, Germany.	kalscheu@molgen.mpg.de	Gecz, Jozef/X-3469-2019; Chelly, Jamel/J-7528-2015; van Bokhoven, Hans/D-8764-2012; Delatycki, Martin B/A-5409-2013; Bokhoven, J.H.L.M. van van/H-8015-2014	Gecz, Jozef/0000-0002-7884-6861; Chelly, Jamel/0000-0002-0939-8719; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Freude, Kristine/0000-0001-9480-2386; Kalscheuer, Vera/0000-0001-6898-3259				Bonnerot C, 2003, MOL CELL, V12, P1309, DOI 10.1016/S1097-2765(03)00435-0; Bugl H, 2000, MOL CELL, V6, P349, DOI 10.1016/S1097-2765(00)00035-6; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Feder M, 2003, GENE, V302, P129, DOI 10.1016/S0378-1119(02)01097-1; Gecz J, 2000, GENOME RES, V10, P157, DOI 10.1101/gr.10.2.157; Hamel BCJ, 1999, AM J MED GENET, V85, P290, DOI 10.1002/(SICI)1096-8628(19990730)85:3<290::AID-AJMG21>3.3.CO;2-8; HERBST DS, 1980, AM J MED GENET, V7, P461, DOI 10.1002/ajmg.1320070407; Kalscheuer VM, 2003, NAT GENET, V35, P313, DOI 10.1038/ng1264; OGURA T, 1991, RES MICROBIOL, V142, P279, DOI 10.1016/0923-2508(91)90041-8; Pintard L, 2002, EMBO J, V21, P1139, DOI 10.1093/emboj/21.5.1139; Pintard L, 2002, EMBO J, V21, P1811, DOI 10.1093/emboj/21.7.1811; Pintard L, 2000, MOL CELL BIOL, V20, P1370, DOI 10.1128/MCB.20.4.1370-1381.2000; Ropers HH, 2003, TRENDS GENET, V19, P316, DOI 10.1016/S0168-9525(03)00113-6; Shoichet SA, 2003, AM J HUM GENET, V73, P1341, DOI 10.1086/380309; Tan J, 2002, J BACTERIOL, V184, P2692, DOI 10.1128/JB.184.10.2692-2698.2002	15	97	102	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					305	309		10.1086/422507	http://dx.doi.org/10.1086/422507			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15162322	Green Published, Bronze			2022-12-18	WOS:000222702000014
J	Inagaki, K; Suzuki, T; Shimizu, H; Ishii, N; Umezawa, Y; Tada, J; Kikuchi, N; Takata, M; Takamori, K; Kishibe, M; Tanaka, M; Miyamura, Y; Ito, S; Tomita, Y				Inagaki, K; Suzuki, T; Shimizu, H; Ishii, N; Umezawa, Y; Tada, J; Kikuchi, N; Takata, M; Takamori, K; Kishibe, M; Tanaka, M; Miyamura, Y; Ito, S; Tomita, Y			Oculocutaneous albinism type 4 is one of the most common types of albinism in Japan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNDERWHITE GENE; P-GENE; MUTATIONS	Oculocutaneous albinism (OCA) is a complex genetic disease with great clinical heterogeneity. Four different types of OCA have been reported to date (OCA1, OCA2, OCA3, and OCA4). MATP was recently reported in a single Turkish OCA patient as the fourth pathological gene, but no other patients with OCA4 have been reported. Here, we report the mutational profile of OCA4, determined by genetic analysis of the MATP gene in a large Japanese population with OCA. Of 75 unrelated patients that were screened, 18 individuals (24%) were identified as having OCA4; they harbored seven novel mutations, including four missense mutations (P58S, D157N, G188V, and V507L) and three frameshift mutations (S90CGGCCA-->GC, V144insAAGT, and V469delG), showing that MATP is the most frequent locus for tyrosinase-positive OCA in Japanese patients. We discuss the functional melanogenic activity of each mutant allele, judging from the relationship between the phenotypes and genotypes of the patients. This is the first report on a large group of patients with OCA4.	Nagoya Univ, Grad Sch Med, Dept Dermatol, Showa Ku, Nagoya, Aichi, Japan; Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido, Japan; Natl Inst Infect Dis, Dept Bioregulat, Leprosy Res Ctr, Tokyo, Japan; Tokai Univ, Sch Med, Dept Dermatol, Isehara, Kanagawa 25911, Japan; Okayama Municipal Hosp, Dept Dermatol, Okayama, Japan; Nihonkai Hosp, Dept Plast Surg, Sakata, Japan; Toyama Prefectural Cent Hosp, Dept Dermatol, Toyama, Japan; Juntendo Univ, Urayasu Hosp, Dept Dermatol, Urayasu, Japan; Asahikawa Med Coll, Dept Dermatol, Asahikawa, Hokkaido 078, Japan; Mito Natl Hosp, Dept Dermatol, Mito, Ibaraki, Japan	Nagoya University; Hokkaido University; National Institute of Infectious Diseases (NIID); Tokai University; Juntendo University; Asahikawa Medical College	Suzuki, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Dermatol, Showa Ku, 65 Tsurumai, Nagoya, Aichi, Japan.	tasuzuki@med.nagoya-u.ac.jp	Shimizu, Hiroshi/A-5193-2012					Boissy RE, 1996, AM J HUM GENET, V58, P1145; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Harada M, 2001, CANCER RES, V61, P1089; LEE ST, 1994, NEW ENGL J MED, V330, P529, DOI 10.1056/NEJM199402243300803; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; SPRITZ RA, 1992, AM J HUM GENET, V51, P1058; SPRITZ RA, 1994, HUM MOL GENET, V3, P1469, DOI 10.1093/hmg/3.suppl_1.1469; Suzuki T, 2003, J INVEST DERMATOL, V120, P781, DOI 10.1046/j.1523-1747.2003.12127.x; Sweet HO, 1998, J HERED, V89, P546, DOI 10.1093/jhered/89.6.546; TOMITA Y, 1989, BIOCHEM BIOPH RES CO, V164, P990, DOI 10.1016/0006-291X(89)91767-1; Tomita Y, 2000, PIGM CELL RES, V13, P130, DOI 10.1034/j.1600-0749.13.s8.23.x	13	97	102	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2004	74	3					466	471		10.1086/382195	http://dx.doi.org/10.1086/382195			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	801TP	14961451	Green Published, Bronze			2022-12-18	WOS:000220118500013
J	Abe, S; Katagiri, T; Saito-Hisaminato, A; Usami, S; Inoue, Y; Tsunoda, T; Nakamura, Y				Abe, S; Katagiri, T; Saito-Hisaminato, A; Usami, S; Inoue, Y; Tsunoda, T; Nakamura, Y			Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							THYROID-HORMONE; PROTEIN; EXPRESSION; MUTATIONS; GENES; CELLS; FORM	Through cDNA microarray analysis of gene expression in human cochlea and vestibule, we detected strong expression of mu-crystallin (CRYM; also known as "NADP-regulated thyroid hormone-binding protein") only in these inner-ear tissues. In a subsequent search for mutations of CRYM, among 192 patients with nonsyndromic deafness, we identified two mutations at the C-terminus; one was a de novo change (X315Y) in a patient with unaffected parents, and the other was a missense mutation (K314T) that segregated dominantly in the proband's family. When the mutated proteins were expressed in COS-7 cells, their subcellular localizations were different from that of the normal protein: the X315Y mutant showed vacuolated distribution in the cytoplasm, and the K314T mutant localized in perinuclear areas, whereas normal protein was distributed homogeneously in the cytoplasm. Aberrant intracellular localization of the mutated proteins might cause dysfunction of the CRYM product and result in hearing impairment. In situ hybridization analysis using mouse tissues indicated its expression in the lateral region of the spiral ligament and the fibrocytes of the spiral limbus, implying its possible involvement in the potassium-ion recycling system. Our results strongly implicate CRYM in normal auditory function and identify it as one of the genes that can be responsible for nonsyndromic deafness.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan; RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Med Informat, Tokyo, Japan; Keio Univ, Sch Med, Dept Otorhinolaryngol, Tokyo, Japan	University of Tokyo; Shinshu University; RIKEN; Keio University	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan.	yu-suke@ims.u-tokyo.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918				Abe S, 2000, J MED GENET, V37, P41, DOI 10.1136/jmg.37.1.41; ARLT G, 1994, J BIOL CHEM, V269, P9638; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; KIM RY, 1992, P NATL ACAD SCI USA, V89, P9292, DOI 10.1073/pnas.89.19.9292; Luo L, 1999, NAT MED, V5, P117, DOI 10.1038/4806; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; Marr N, 2002, HUM MOL GENET, V11, P779, DOI 10.1093/hmg/11.7.779; Ono K, 2000, CANCER RES, V60, P5007; ROBERTSON NG, 1994, GENOMICS, V23, P42, DOI 10.1006/geno.1994.1457; Saito-Hisaminato A, 2002, DNA RES, V9, P35, DOI 10.1093/dnares/9.2.35; Segovia L, 1997, Mol Vis, V3, P9; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Spicer SS, 1996, HEARING RES, V100, P80, DOI 10.1016/0378-5955(96)00106-2; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Tsujikawa M, 1999, NAT GENET, V21, P420, DOI 10.1038/7759; Usami S, 2000, J MED GENET, V37, P38, DOI 10.1136/jmg.37.1.38; UZIEL A, 1986, ACTA OTO-LARYNGOL, P23; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Vie MP, 1997, MOL ENDOCRINOL, V11, P1728, DOI 10.1210/me.11.11.1728; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zuo J, 1996, ACTA OTO-LARYNGOL, V116, P422, DOI 10.3109/00016489609137867	21	97	107	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					73	82		10.1086/345398	http://dx.doi.org/10.1086/345398			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12471561	Green Published, Bronze			2022-12-18	WOS:000180186800007
J	Brouha, B; Meischl, C; Ostertag, E; de Boer, M; Zhang, Y; Neijens, H; Roos, D; Kazazian, HH				Brouha, B; Meischl, C; Ostertag, E; de Boer, M; Zhang, Y; Neijens, H; Roos, D; Kazazian, HH			Evidence consistent with human L1 retrotransposition in maternal meiosis I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHRONIC GRANULOMATOUS-DISEASE; HIGH-FREQUENCY RETROTRANSPOSITION; HUMAN TRANSPOSABLE ELEMENT; REVERSE TRANSCRIPTION; MUSCULAR-DYSTROPHY; LINE-1 ELEMENT; CULTURED-CELLS; TARGET SITE; GENE; INSERTION	We have used a unique polymorphic 3' transduction to show that a human L1, or LINE-1 ((l) under bar ong (i) under bar nterspersed (n) under bar ucleotide (e) under bar lement-1), retrotransposition event most likely occurred in the maternal primary oocyte during meiosis I. We characterized a truncated L1 retrotransposon with a 3' transduction that was inserted, in a Dutch male patient, into the X-linked gene CYBB, thereby causing chronic granulomatous disease. We used the unique flanking sequence to localize the precursor L1 locus, LRE3, to chromosome 2q24.1. In a cell culture assay, the retrotransposition frequency of LRE3 is greater than that for any other element that has been tested to date. The patient's mother had two LRE3 alleles that differed slightly in the 3'-flanking genomic DNA. The patient had a single LRE3 allele that was identical to one of the maternal alleles; however, the patient's insertion matched the maternal LRE3 allele that he did not inherit. Other data indicate that there is only a small chance that the father (unavailable for analysis) carries the precursor LRE3 allele. In addition, paternal origin of the insertion would have required that an LRE3 mRNA transcribed before meiosis II be carried separately from its precursor LRE3 allele in the fertilizing sperm. Since the mother carries a potential precursor allele and the insertion was on the patient's maternal X chromosome, it is highly likely that the insertion originated during maternal meiosis I.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; Sanquin Res CLB, Amsterdam, Netherlands; Sophia Childrens Univ Hosp, Dept Pediat, Rotterdam, Netherlands	University of Pennsylvania; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC - Sophia Children's Hospital	Kazazian, HH (corresponding author), 475 Clin Res Bldg,415 Curie Blvd, Philadelphia, PA 19104 USA.	kazazian@mail.med.upenn.edu						Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; Browning VL, 2001, GENOMICS, V73, P291, DOI 10.1006/geno.2001.6523; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DOMBROSKI BA, 1991, SCIENCE, V254, P1805, DOI 10.1126/science.1662412; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; JENSEN S, 1994, BIOCHEM BIOPH RES CO, V202, P111, DOI 10.1006/bbrc.1994.1900; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kondo-Iida E, 1999, HUM MOL GENET, V8, P2303, DOI 10.1093/hmg/8.12.2303; Kumatori A, 1998, GENOMICS, V53, P123, DOI 10.1006/geno.1998.5510; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XM, 2001, HUM MUTAT, V17, P511, DOI 10.1002/humu.1134; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; MAGER DL, 1985, NUCLEIC ACIDS RES, V13, P6559, DOI 10.1093/nar/13.18.6559; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; Meischl C, 2000, EUR J HUM GENET, V8, P697, DOI 10.1038/sj.ejhg.5200523; MIKI Y, 1992, CANCER RES, V52, P643; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Naas TP, 1998, EMBO J, V17, P590, DOI 10.1093/emboj/17.2.590; Naas TP, 2001, EMBO J, V20, P2608; NARITA N, 1993, J CLIN INVEST, V91, P1862, DOI 10.1172/JCI116402; Ostertag EM, 2000, NUCLEIC ACIDS RES, V28, P1418, DOI 10.1093/nar/28.6.1418; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Roos D, 1996, BLOOD, V87, P1663; Sambrook J, 1989, MOL CLONING LAB MANU; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; SCOTT A F, 1987, Genomics, V1, P113, DOI 10.1016/0888-7543(87)90003-6; TRELOGAN SA, 1995, P NATL ACAD SCI USA, V92, P1520, DOI 10.1073/pnas.92.5.1520; Van de Water N, 1998, THROMB HAEMOSTASIS, V79, P938; WEENING RS, 1985, J CLIN INVEST, V75, P915, DOI 10.1172/JCI111792; WHITCOMB JM, 1992, ANNU REV CELL BIOL, V8, P275, DOI 10.1146/annurev.cb.08.110192.001423	38	97	99	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					327	336		10.1086/341722	http://dx.doi.org/10.1086/341722			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12094329	Bronze, Green Published			2022-12-18	WOS:000176977700011
J	Klauck, SM; Lindsay, S; Beyer, KS; Splitt, M; Burn, J; Poustka, A				Klauck, SM; Lindsay, S; Beyer, KS; Splitt, M; Burn, J; Poustka, A			A mutation hot spot for nonspecific X-linked mental retardation in the MECP2 gene causes the PPM-X syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CPG-BINDING PROTEIN-2; RETT-SYNDROME; CHROMOSOME INACTIVATION; INHERITANCE; MALES; XQ28; BOYS	We report here the genetic cause of the X-linked syndrome of psychosis, pyramidal signs, and macro-orchidism (PPM-X) in a three-generation family manifesting the disorder as a mutation in the methyl-CpG binding-protein 2 (MECP2) gene in Xq28. The A140V mutation was found in all affected males and all carrier females in the family. To date, descriptions have been published of two patients with independent familial mental retardation (MR) and two patients with sporadic MR who harbor this specific mutation in the MECP2 gene. This strongly suggests that A140V is a hot spot of mutation resulting in moderate to severe MR in males. A simple and reliable PCR approach has been developed for detection of the hot spot A140V mutation to prescreen any other unexplained cases of MR before further extensive mutation analyses.	Deutsch Krebsforschungszentrum, Dept Mol Genome Anal, D-69120 Heidelberg, Germany; Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; Guys Hosp, SE Thames Reg Genet Serv, London SE1 9RT, England	Helmholtz Association; German Cancer Research Center (DKFZ); Newcastle University - UK; Guy's & St Thomas' NHS Foundation Trust	Poustka, A (corresponding author), Deutsch Krebsforschungszentrum, Dept Mol Genome Anal, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.			Burn, John/0000-0002-9823-2322; Lindsay, Susan/0000-0003-2980-4582				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Amir RE, 2000, AM J MED GENET, V97, P147, DOI 10.1002/1096-8628(200022)97:2<147::AID-AJMG6>3.0.CO;2-O; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; Bourdon V, 2001, HUM GENET, V108, P43, DOI 10.1007/s004390000422; Buyse IM, 2000, AM J HUM GENET, V67, P1428, DOI 10.1086/316913; Cheadle JP, 2000, HUM MOL GENET, V9, P1119, DOI 10.1093/hmg/9.7.1119; Clayton-Smith J, 2000, LANCET, V356, P830, DOI 10.1016/S0140-6736(00)02661-1; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; Lindsay S, 1996, AM J HUM GENET, V58, P1120; Meloni I, 2000, AM J HUM GENET, V67, P982, DOI 10.1086/303078; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Schanen C, 1998, AM J HUM GENET, V63, P267, DOI 10.1086/301932; Schanen NC, 1998, J CHILD NEUROL, V13, P229, DOI 10.1177/088307389801300507; Sirianni N, 1998, AM J HUM GENET, V63, P1552, DOI 10.1086/302105; Stevenson RE, 2000, AM J MED GENET, V97, P174, DOI 10.1002/1096-8628(200023)97:3<174::AID-AJMG1034>3.0.CO;2-4; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Wan MM, 1999, AM J HUM GENET, V65, P1520, DOI 10.1086/302690; Yntema HG, 2002, AM J MED GENET, V107, P81, DOI 10.1002/ajmg.10085	20	97	100	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1034	1037		10.1086/339553	http://dx.doi.org/10.1086/339553			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11885030	Bronze, Green Published			2022-12-18	WOS:000174252100022
J	Currat, M; Trabuchet, G; Rees, D; Perrin, P; Harding, RM; Clegg, JB; Langaney, A; Excoffier, L				Currat, M; Trabuchet, G; Rees, D; Perrin, P; Harding, RM; Clegg, JB; Langaney, A; Excoffier, L			Molecular analysis of the beta-globin gene cluster in the niokholo mandenka population reveals a recent origin of the beta(S) senegal mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SICKLE-CELL-ANEMIA; PLASMODIUM-FALCIPARUM INFECTION; LINKAGE-DISEQUILIBRIUM; DNA POLYMORPHISM; COMMON ANCESTOR; HAPLOTYPE FREQUENCIES; MULTICENTRIC ORIGIN; SEQUENCE DIVERSITY; TRIBAL POPULATIONS; FLANKING REGION	A large and ethnically well-defined Mandenka sample from eastern Senegal was analyzed for the polymorphism of the beta -globin gene cluster on chromosome 11. Five RFLP sites of the 5' region were investigated in 193 individuals revealing the presence of 10 different haplotypes. The frequency of the sickle-cell anemia causing mutation (beta (S))in the Mandenka estimated from this sample is 11.7%. This mutation was found strictly associated with the single Senegal haplotype. Approximately 600 bp of the upstream region of the beta -globin gene were sequenced for a subset of 94 chromosomes, showing the presence of four transversions, five transitions, and a composite microsatellite polymorphism. The sequence of 22 beta (S) chromosomes was also identical to the previously defined Senegal haplotype, suggesting that this mutation is very recent. Monte Carlo simulations (allowing for a specific balancing selection model, a logistic growth of the population, and variable initial frequencies of the Senegal haplotype) were used to estimate the age of the beta (S) mutation. Resulting maximum-likelihood estimates are 45-70 generations (1,350-2,100 years) for very different demographic scenarios. Smallest confidence intervals (25-690 generations) are obtained under the hypothesis that the Mandenka population is large (N-c >5,000) and stationary or that it has undergone a rapid demographic expansion to a current size of >5,000 reproducing individuals, which is quite likely in view of the great diversity found on beta (A) chromosomes.	Univ Genoa, Dept Anthropol & Ecol, Genet & Biometry Lab, CH-1227 Carouge, Switzerland; Univ Bern, Inst Zool, Computat & Mol Populat Genet Lab, Bern, Switzerland; Univ Lyon 1, Ctr Genet Mol & Cellulaire, F-69622 Villeurbanne, France; John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Mol Haematol Unit, Oxford, England	University of Geneva; University of Bern; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Oxford	Currat, M (corresponding author), Univ Genoa, Dept Anthropol & Ecol, Genet & Biometry Lab, Rue Gustave Revilliod 12, CH-1227 Carouge, Switzerland.	mathias.currat@anthro.unige.ch	Excoffier, Laurent/D-3498-2013; Rees, David/B-6789-2011	Excoffier, Laurent/0000-0002-7507-6494; Rees, David/0000-0003-3647-1050				ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P137, DOI 10.1073/pnas.79.1.137; ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; Ayala FJ, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P55; Ayres KL, 1998, HEREDITY, V80, P769, DOI 10.1046/j.1365-2540.1998.00360.x; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; BLANC M, 1990, AM J HUM GENET, V46, P383; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CHAKRABORTY R, 1988, AM J HUM GENET, V43, P709; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; CHANG JC, 1981, LANCET, V2, P1127; CHEBLOUNE Y, 1988, P NATL ACAD SCI USA, V85, P4431, DOI 10.1073/pnas.85.12.4431; CHEN LZ, 1990, MOL BIOL EVOL, V7, P423; CHEN YS, 1995, AM J HUM GENET, V57, P133; Coluzzi M, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P277; Daar S, 2000, AM J HEMATOL, V64, P39, DOI 10.1002/(SICI)1096-8652(200005)64:1<39::AID-AJH7>3.0.CO;2-#; DARD P, 1992, CR ACAD SCI III-VIE, V314, P573; DEMONTAL G, 1985, MALINKES HABITANTS D; Donnelly P, 1996, SCIENCE, V272, P1357, DOI 10.1126/science.272.5266.1357; DORIT RL, 1995, SCIENCE, V268, P1183, DOI 10.1126/science.7761836; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; EXCOFFIER L, 1992, GENETICS, V131, P479; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Fay JC, 2000, GENETICS, V155, P1405; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; FLINT J, 1993, HUM GENET, V91, P91; Flint J, 1999, HUM GENET, V105, P567, DOI 10.1007/s004390051147; Frikha M, 1998, TRANSFUS CLIN BIOL, V5, P166, DOI 10.1016/S1246-7820(98)80006-2; Fu YX, 1996, SCIENCE, V272, P1356, DOI 10.1126/science.272.5266.1356; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Fullerton SM, 2000, MOL BIOL EVOL, V17, P179, DOI 10.1093/oxfordjournals.molbev.a026230; FULLERTON SM, 1994, P NATL ACAD SCI USA, V91, P1805, DOI 10.1073/pnas.91.5.1805; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Haldane J. B. S, 1949, RICERCA SCIENTIFIC S, V19, P3; Harding RM, 1997, AM J HUM GENET, V60, P772; Hewitt R, 1996, AM J HUM GENET, V58, P1303; HILL AVS, 1986, HUM GENET, V74, P16; HILL WG, 1972, THEOR POPUL BIOL, V3, P278, DOI 10.1016/0040-5809(72)90004-4; Kalbfleisch JG., 1985, PROBABILITY STAT INF, DOI 10.1007/978-1-4612-1096-2; KAPLAN N, 1991, GENET RES, V57, P83, DOI 10.1017/S0016672300029074; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; LABIE D, 1989, HUM BIOL, V61, P479; LALOUEL JM, 1976, AM J PHYS ANTHROPOL, V45, P453, DOI 10.1002/ajpa.1330450307; LAPOUMEROULIE C, 1992, HUM GENET, V89, P333; LAVINHA J, 1992, HUM BIOL, V64, P891; Le Hesran JY, 1999, INT J EPIDEMIOL, V28, P793, DOI 10.1093/ije/28.4.793; LIEINJO LE, 1987, HEMOGLOBIN, V11, P231, DOI 10.3109/03630268709017889; LIVINGSTONE FB, 1989, HUM BIOL, V61, P297; LONG JC, 1990, AM J PHYS ANTHROPOL, V81, P113, DOI 10.1002/ajpa.1330810112; MARTINSON JJ, 1995, AM J HUM GENET, V57, P1186; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; MUNIZ A, 1995, AM J HEMATOL, V49, P163, DOI 10.1002/ajh.2830490212; Nagel R L, 1985, Prog Clin Biol Res, V191, P93; NAGEL RL, 1992, BAILLIERE CLIN HAEM, V5, P331, DOI 10.1016/S0950-3536(11)80023-5; NAGEL RL, 1985, NEW ENGL J MED, V312, P880, DOI 10.1056/NEJM198504043121403; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Nickerson DA, 1998, NAT GENET, V19, P233, DOI 10.1038/907; ORKIN SH, 1983, PROG HEMATOL, V13, P49; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; Pante-De-Sousa G, 1999, ANN HUM BIOL, V26, P365; PASVOL G, 1980, T ROY SOC TROP MED H, V74, P701, DOI 10.1016/0035-9203(80)90182-0; Perrin P, 1998, GENE, V213, P169, DOI 10.1016/S0378-1119(98)00200-5; Pison G., 1995, POPULATION DYNAMICS; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; POLONI ES, 1995, ANN HUM GENET, V59, P43, DOI 10.1111/j.1469-1809.1995.tb01605.x; POWARS DR, 1989, ANN NY ACAD SCI, V565, P262, DOI 10.1111/j.1749-6632.1989.tb24174.x; POWARS DR, 1994, AM J PEDIAT HEMATOL, V16, P55; RAMSAY M, 1987, AM J HUM GENET, V41, P1132; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; RINGELHANN B, 1976, AM J HUM GENET, V28, P270; RUND D, 1990, HUM GENET, V85, P521; Sanchez-Mazas A, 2000, TISSUE ANTIGENS, V56, P303, DOI 10.1034/j.1399-0039.2000.560402.x; Schierup MH, 2000, GENET RES, V76, P63, DOI 10.1017/S0016672300004547; Schierup MH, 2000, GENET RES, V76, P51, DOI 10.1017/S0016672300004535; Schierup MH, 1998, GENETICS, V149, P1153; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; SEMENZA GL, 1984, J BIOL CHEM, V259, P6045; SHAW CT, 1990, GEN HIST AFRICA, V1, P264; Slatkin M, 1997, AM J HUM GENET, V60, P447; Slatkin M, 1996, HEREDITY, V76, P377, DOI 10.1038/hdy.1996.55; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; SOW A, 1995, AM J HEMATOL, V50, P301, DOI 10.1002/ajh.2830500415; STEINBERG MH, 1995, AM J HEMATOL, V48, P175, DOI 10.1002/ajh.2830480307; STINE OC, 1992, J MOL EVOL, V34, P336; Thomas JJ, 1998, AM J HEMATOL, V59, P51, DOI 10.1002/(SICI)1096-8652(199809)59:1<51::AID-AJH10>3.0.CO;2-4; TIERCY JM, 1992, AM J HUM GENET, V51, P592; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; TRABUCHET G, 1991, HUM BIOL, V63, P241; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; WAINSCOAT JS, 1986, NATURE, V319, P491, DOI 10.1038/319491a0; Weiss G, 1996, SCIENCE, V272, P1359, DOI 10.1126/science.272.5266.1359; Whitlock MC, 1997, GENETICS, V146, P427; WIESENFELD SL, 1967, SCIENCE, V157, P1134, DOI 10.1126/science.157.3793.1134; [No title captured]	100	97	98	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					207	223		10.1086/338304	http://dx.doi.org/10.1086/338304			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11741197	Green Published, Bronze			2022-12-18	WOS:000172571900018
J	Patel, PI; Isaya, G				Patel, PI; Isaya, G			Friedreich ataxia: From GAA triplet-repeat expansion to frataxin deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							MITOCHONDRIAL IRON ACCUMULATION; SUPEROXIDE-DEPENDENT FORMATION; EARLY EMBRYONIC LETHALITY; YEAST FRATAXIN; PROCESSING PEPTIDASE; SACCHAROMYCES-CEREVISIAE; HYDROXYL RADICALS; CRYSTAL-STRUCTURE; IN-VIVO; HOMOLOG		Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Baylor College of Medicine; Baylor College of Medicine; Mayo Clinic; Mayo Clinic	Patel, PI (corresponding author), Baylor Coll Med, Dept Neurol, 1 Baylor Plaza,NB431A, Houston, TX 77030 USA.		Patel, Pragna/H-9129-2017	Patel, Pragna/0000-0003-3584-1072	NIA NIH HHS [R01 AG015709, AG15709] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Adamec J, 2000, AM J HUM GENET, V67, P549, DOI 10.1086/303056; ADAMEC J, 2001, ENZYMES; Airoldi R., 2000, American Journal of Human Genetics, V67, P395; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Bidichandani SI, 1999, HUM MOL GENET, V8, P2425, DOI 10.1093/hmg/8.13.2425; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Branda SS, 1999, HUM MOL GENET, V8, P1099, DOI 10.1093/hmg/8.6.1099; Branda SS, 1999, J BIOL CHEM, V274, P22763, DOI 10.1074/jbc.274.32.22763; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Canizares J, 2000, GENE, V256, P35, DOI 10.1016/S0378-1119(00)00343-7; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Cavadini P, 2000, J BIOL CHEM, V275, P41469, DOI 10.1074/jbc.M006539200; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Cossee M, 2000, HUM MOL GENET, V9, P1219, DOI 10.1093/hmg/9.8.1219; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; De Michele G, 1998, HUM MOL GENET, V7, P1901, DOI 10.1093/hmg/7.12.1901; Delatycki MB, 1999, ANN NEUROL, V45, P673, DOI 10.1002/1531-8249(199905)45:5<673::AID-ANA20>3.3.CO;2-H; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Emond M, 2000, NEUROLOGY, V55, P1752, DOI 10.1212/WNL.55.11.1752; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P221, DOI 10.1007/BF02110037; FLATMARK T, 1975, J BIOL CHEM, V250, P6433; Foury F, 1999, FEBS LETT, V456, P281, DOI 10.1016/S0014-5793(99)00961-8; Foury F, 1997, FEBS LETT, V411, P373, DOI 10.1016/S0014-5793(97)00734-5; Foury F, 2001, J BIOL CHEM, V276, P7762, DOI 10.1074/jbc.M005804200; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; GATTERMANN N, 1993, LEUKEMIA, V7, P2069; GAVEL Y, 1990, PROTEIN ENG, V4, P33, DOI 10.1093/protein/4.1.33; Geissler A, 2000, EUR J BIOCHEM, V267, P3167, DOI 10.1046/j.1432-1327.2000.01334.x; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Gordon DM, 1999, HUM MOL GENET, V8, P2255, DOI 10.1093/hmg/8.12.2255; Gordon DM, 2001, HUM MOL GENET, V10, P259, DOI 10.1093/hmg/10.3.259; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P4930, DOI 10.1093/nar/28.24.4930; GUTTERIDGE JMC, 1981, BIOCHEM J, V199, P263, DOI 10.1042/bj1990263; HALLIWELL B, 1978, FEBS LETT, V96, P238, DOI 10.1016/0014-5793(78)80409-8; HANVEY JC, 1988, P NATL ACAD SCI USA, V85, P6292, DOI 10.1073/pnas.85.17.6292; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hellenbroich Y, 2001, ACTA NEUROL SCAND, V103, P188, DOI 10.1034/j.1600-0404.2001.103003188.x; Knight SAB, 1998, J BIOL CHEM, V273, P18389, DOI 10.1074/jbc.273.29.18389; Koutnikova H, 1998, HUM MOL GENET, V7, P1485, DOI 10.1093/hmg/7.9.1485; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; LeProust EM, 2000, J MOL BIOL, V302, P1063, DOI 10.1006/jmbi.2000.4073; Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492; Lutz T, 2001, J MOL BIOL, V307, P815, DOI 10.1006/jmbi.2001.4527; Mariappan SVS, 1999, J MOL BIOL, V285, P2035, DOI 10.1006/jmbi.1998.2435; Muhlenhoff U, 2000, BBA-BIOENERGETICS, V1459, P370, DOI 10.1016/S0005-2728(00)00174-2; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ohshima K, 1999, NEUROLOGY, V53, P1854, DOI 10.1212/WNL.53.8.1854; Pohjanpelto P, 1996, EMBO J, V15, P1193, DOI 10.1002/j.1460-2075.1996.tb00458.x; Pook M A, 2000, J Med Genet, V37, pE38, DOI 10.1136/jmg.37.11.e38; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Radisky DC, 1999, J BIOL CHEM, V274, P4497, DOI 10.1074/jbc.274.8.4497; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rustin P, 1999, LANCET, V354, P477, DOI 10.1016/S0140-6736(99)01341-0; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; TAKETANI S, 1986, BIOCHIM BIOPHYS ACTA, V883, P277, DOI 10.1016/0304-4165(86)90319-3; Voisine C, 2000, MOL CELL BIOL, V20, P3677, DOI 10.1128/MCB.20.10.3677-3684.2000; WILLIAMS RJP, 1982, FEBS LETT, V140, P3, DOI 10.1016/0014-5793(82)80508-5; Wilson RB, 2000, ANN NEUROL, V47, P659, DOI 10.1002/1531-8249(200005)47:5<659::AID-ANA17>3.3.CO;2-K; Wilson RB, 1997, NAT GENET, V16, P352, DOI 10.1038/ng0897-352; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425	70	97	100	0	8	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					15	24		10.1086/321283	http://dx.doi.org/10.1086/321283			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11391483	Green Published, Bronze			2022-12-18	WOS:000170108100002
J	Yeon, HB; Lindor, NM; Seidman, JG; Seidman, CE				Yeon, HB; Lindor, NM; Seidman, JG; Seidman, CE			Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY BOWEL-DISEASE; LYMPHOCYTE CHEMOATTRACTANT FACTOR; JUVENILE CHRONIC ARTHRITIS; HIDRADENITIS SUPPURATIVA; GUT INFLAMMATION; RETINOIC ACID; HUMAN SKIN; SUSCEPTIBILITY LOCI; MOLECULAR-CLONING; BINDING-PROTEINS	Pyoderma gangrenosum, cystic acne, and aseptic arthritis are clinically distinct disorders within the broad class of inflammatory diseases. Although this triad of symptoms is rarely observed in a single patient, a three-generation kindred with autosomal-dominant transmission of these three disorders has been reported as "PAPA syndrome" (MIM 604416). We report mapping of a disease locus for familial pyoderma gangrenosum-acne-arthritis to the long arm of chromosome 15 (maximum two-point LOD score, 5.83; recombination fraction [theta] 0 at Locus D15S206). Under the assumption of complete penetrance, haplotype analysis of recombination events defined a disease interval of 10 cM, between D15S1023 and D15S979, Successful identification of a single disease locus for this syndrome suggests that these clinically distinct disorders may share a genetic etiology. These data further indicate the role of genes outside the major histocompatibility locus in inflammatory disease.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Mayo Clin, Dept Med Genet, Rochester, MN USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Mayo Clinic	Seidman, CE (corresponding author), Harvard Univ, Sch Med, Dept Genet, Alpert Room 533,200 Longwood Ave, Boston, MA 02115 USA.							ARCHER JR, 1988, BRIT J RHEUMATOL, V27, P306; ASTROM A, 1991, J BIOL CHEM, V266, P17662; BHALLA R, 1994, ANN RHEUM DIS, V53, P64, DOI 10.1136/ard.53.1.64; Binder V, 1996, NETH J MED, V48, P53, DOI 10.1016/0300-2977(95)00093-3; BUNDINO S, 1984, DERMATOLOGICA, V168, P230, DOI 10.1159/000249709; CALLEN JP, 1978, CUTIS, V21, P61; CENTER DM, 1995, J LAB CLIN MED, V125, P167; CLEMENS LE, 1985, J RHEUMATOL, V12, P108; CROS D, 1981, J RHEUMATOL, V8, P336; CRUIKSHANK WW, 1991, J IMMUNOL, V146, P2928; CRUIKSHANK WW, 1994, P NATL ACAD SCI USA, V91, P5109, DOI 10.1073/pnas.91.11.5109; DeFrancesco V, 1997, DERMATOLOGY, V194, P195; DeVos M, 1996, GASTROENTEROLOGY, V110, P1696, DOI 10.1053/gast.1996.v110.pm8964393; Dubourg G, 1996, REV RHUM, V63, P228; ELDER JT, 1992, J INVEST DERMATOL, V98, P673, DOI 10.1111/1523-1747.ep12499896; ELLER MS, 1992, EXP CELL RES, V198, P328, DOI 10.1016/0014-4827(92)90387-N; FINCH W, 1989, POSTGRAD MED, V86, P229; Gilchrest BA, 1996, BRIT J DERMATOL, V135, P867, DOI 10.1046/j.1365-2133.1996.d01-1088.x; GIRARDIN C, 1988, ANN DERMATOL VENER, V115, P1149; GLADMAN DD, 1995, BAILLIERE CLIN RHEUM, V9, P319, DOI 10.1016/S0950-3579(05)80193-1; HOLT PJA, 1980, MEDICINE, V59, P114, DOI 10.1097/00005792-198003000-00003; JACOBS JC, 1975, PEDIATRICS, V56, P570; KNITZER RH, 1991, SEMIN ARTHRITIS RHEU, V20, P247, DOI 10.1016/0049-0172(91)90020-Z; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lindor NM, 1997, MAYO CLIN PROC, V72, P611; MIELANTS H, 1987, J RHEUMATOL, V14, P459; MIELANTS H, 1987, J RHEUMATOL, V14, P466; MIERAU R, 1988, ANN RHEUM DIS, V47, P893, DOI 10.1136/ard.47.11.893; MORLING N, 1985, SCAND J RHEUMATOL, V14, P209, DOI 10.3109/03009748509165506; Naom I, 1997, NEUROMUSCULAR DISORD, V7, P176, DOI 10.1016/S0960-8966(97)00448-3; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; Parkes M, 1996, LANCET, V348, P1588, DOI 10.1016/S0140-6736(05)66204-6; Pfahl M, 1996, ANNU REV NUTR, V16, P257, DOI 10.1146/annurev.nu.16.070196.001353; PIAZZA I, 1991, BRIT J RHEUMATOL, V30, P387; POWELL FC, 1985, Q J MED, V55, P173; PRYSTOWSKY JH, 1989, ARCH DERMATOL, V125, P57, DOI 10.1001/archderm.125.1.57; PUTTICK AH, 1990, ANN RHEUM DIS, V49, P225, DOI 10.1136/ard.49.4.225; ROSNER IA, 1993, J RHEUMATOL, V20, P684; SANQUER S, 1993, J INVEST DERMATOL, V100, P148, DOI 10.1111/1523-1747.ep12462785; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SHANDS JW, 1987, J AM ACAD DERMATOL, V16, P931, DOI 10.1016/S0190-9622(87)70116-9; Shenefelt PD, 1996, CUTIS, V57, P315; Tromp G, 1996, AM J HUM GENET, V59, P1097; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WEBER JL, 1989, AM J HUM GENET, V44, P388; WOODROW JC, 1985, CLIN RHEUM DIS, V11, P1	46	97	104	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1443	1448		10.1086/302866	http://dx.doi.org/10.1086/302866			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10729114	Bronze, Green Published			2022-12-18	WOS:000088373400029
J	Morgan, NV; Tipping, AJ; Joenje, H; Mathew, CG				Morgan, NV; Tipping, AJ; Joenje, H; Mathew, CG			High frequency of large intragenic deletions in the Fanconi anemia group A gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							A FAA GENE; CHEMICAL CLEAVAGE; MUTATIONS; DIAGNOSIS; FACC	Fanconi anemia (FA) is an autosomal recessive disorder exhibiting chromosomal fragility, bone-marrow failure, congenital abnormalities, and cancer. At least eight complementation groups have been described, with group A accounting for 60%-65% of FA patients. Mutation screening of the group A gene (FANCA) is complicated by its highly interrupted genomic structure and heterogeneous mutation spectrum. Recent reports of several large deletions of FANCA, coupled with modest mutation-detection rates, led us to investigate whether many deletions might occur in the heterozygous state and thus fail to be detected by current screening protocols. We used a two-step screening strategy, in which small mutations were detected by fluorescent chemical cleavage of the FANCA transcript, and heterozygosity for gross deletions was detected by quantitative fluorescent multiplex PCR. We screened 26 cell lines from FA complementation group A for FANCA mutations and detected 33 different mutations, 23 of which were novel. Mutations were observed in all 26 cell lines and included 43 of a possible 52 mutant alleles (83%). Of the mutant alleles, 40% were large intragenic deletions that removed up to 31 exons from the gene, indicating that this may be the most prevalent form of mutation in FANCA. Several common deletion breakpoints were observed, and there was a highly significant correlation between the number of breakpoints detected in a given intron and the number of Alu repeats that it contained, which suggests that Alu-mediated recombination may explain the high prevalence of deletions in FANCA. The dual screening strategy that we describe may be useful for mutation screening in other genetic disorders in which mutation-detection rates are unexpectedly low.	Guys Hosp, GKT Sch Med, Div Med & Mol Genet, London SE1 9RT, England; Free Univ Amsterdam, Dept Human Genet, Amsterdam, Netherlands	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Vrije Universiteit Amsterdam	Mathew, CG (corresponding author), Guys Hosp, GKT Sch Med, Div Med & Mol Genet, 8th Floor,Guys Tower, London SE1 9RT, England.		Mathew, Christopher G/G-3434-2015; Morgan, Neil V/A-5475-2009	Mathew, Christopher G/0000-0003-4178-1838; Morgan, Neil V/0000-0001-6433-5692	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; Centra M, 1998, GENOMICS, V51, P463, DOI 10.1006/geno.1998.5353; CHORNCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; de Winter JP, 1998, NAT GENET, V20, P281, DOI 10.1038/3093; Ellis TP, 1998, HUM MUTAT, V11, P345, DOI 10.1002/(SICI)1098-1004(1998)11:5<345::AID-HUMU1>3.3.CO;2-S; Gibson RA, 1996, HUM MUTAT, V8, P140, DOI 10.1002/(SICI)1098-1004(1996)8:2<140::AID-HUMU6>3.0.CO;2-F; Ianzano L, 1997, GENOMICS, V41, P309, DOI 10.1006/geno.1997.4675; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; Kupfer G, 1999, EXP HEMATOL, V27, P587, DOI 10.1016/S0301-472X(99)00022-3; Levran O, 1997, P NATL ACAD SCI USA, V94, P13051, DOI 10.1073/pnas.94.24.13051; Levran O, 1998, HUM MUTAT, V12, P145, DOI 10.1002/(SICI)1098-1004(1998)12:3<145::AID-HUMU2>3.3.CO;2-S; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; Puget N, 1999, CANCER RES, V59, P455; Purandare SM, 1997, GENOME RES, V7, P773, DOI 10.1101/gr.7.8.773; Rowley G, 1995, GENOMICS, V30, P574, DOI 10.1006/geno.1995.1279; Savino M, 1997, AM J HUM GENET, V61, P1246, DOI 10.1086/301632; Savoia A, 1996, HUM GENET, V97, P599; STRATHDEE CA, 1992, NAT GENET, V1, P196, DOI 10.1038/ng0692-196; Tachibana A, 1999, HUM MUTAT, V13, P237, DOI 10.1002/(SICI)1098-1004(1999)13:3<237::AID-HUMU8>3.3.CO;2-6; VERLANDER PC, 1994, AM J HUM GENET, V54, P595; Waisfisz Q, 1999, AM J HUM GENET, V64, P1400, DOI 10.1086/302385; Whitmore SA, 1998, GENOMICS, V50, P1, DOI 10.1006/geno.1998.5316; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; Wijker M, 1999, EUR J HUM GENET, V7, P52, DOI 10.1038/sj.ejhg.5200248; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550	28	97	104	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1330	1341		10.1086/302627	http://dx.doi.org/10.1086/302627			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521298	Green Published, Bronze			2022-12-18	WOS:000083531000014
J	Paassilta, P; Lohiniva, J; Annunen, S; Bonaventure, J; Le Merrer, M; Pai, L; Ala-Kokko, L				Paassilta, P; Lohiniva, J; Annunen, S; Bonaventure, J; Le Merrer, M; Pai, L; Ala-Kokko, L			COL9A3: A third locus for multiple epiphyseal dysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OLIGOMERIC MATRIX PROTEIN; SENSITIVE GEL-ELECTROPHORESIS; IX COLLAGEN; MOLECULAR-CLONING; LARGE FAMILY; COMP GENE; PSEUDOACHONDROPLASIA; MUTATIONS; LINKAGE; EXCLUSION	Multiple epiphyseal dysplasia:(MED), an autosomal dominant osteochondrodysplasia, is a clinically and genetically heterogeneous disorder characterized by mild short stature and early-onset osteoarthritis. The phenotypic spectrum includes the mild Ribbing type, the more severe Fairbank type, and some unclassified forms. Linkage studies have identified two loci for MED. One of these, EDM1, is on chromosome 19, in a region that contains the cartilage oligomeric matrix protein (COMP) gene. Mutations have been identified in this gene in patients with the Ribbing type, the Fairbank type, and unclassified forms of MED. The second locus, EDM2, maps to chromosome 1, in a region spanning COL9A2. Recently, a splice-site mutation was found in COL9A2, causing skipping of exon 3 in one family with MED. Because of the exclusion of the EDM1 and EDM2 loci in some families, the existence of a third locus has been postulated. We report here one family with MED, evaluated clinically and radiologically and tested for linkage with candidate genes, including COMP, COL9A1, COL9A2, and COL9A3. No linkage was found with COMP, COL9A1, or COL9A2, but an inheritance pattern consistent with linkage was observed with COL9A3. Mutation analysis of COL9A3 identified an A-->T transversion in the acceptor splice site of intron 2 in affected family members. The mutation led to skipping of exon 3 and an in-frame deletion of 12 amino acid residues in the COL3 domain of the alpha 3(IX) chain and thus appeared to be similar to that reported for COL9A2. This is the first disease-causing mutation identified in COL9A3. Our results also show that COL9A3, located on chromosome 20, is a third locus for MED.	Univ Oulu, Dept Med Biochem, FIN-90220 Oulu, Finland; Univ Oulu, Collagen Res Unit, FIN-90220 Oulu, Finland; Hop Necker Enfants Malad, INSERM, U393, Paris, France; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	University of Oulu; University of Oulu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Harvard Medical School	Ala-Kokko, L (corresponding author), Univ Oulu, Dept Med Biochem, Kajaanintie 52A, FIN-90220 Oulu, Finland.	Leena.Ala-Kokko@oulu.fi						Ballo R, 1997, AM J MED GENET, V68, P396, DOI 10.1002/(SICI)1096-8628(19970211)68:4<396::AID-AJMG4>3.3.CO;2-R; BARRIE H, 1958, BRIT MED J, V2, P133, DOI 10.1136/bmj.2.5089.133; BREWTON RG, 1995, GENOMICS, V30, P329, DOI 10.1006/geno.1995.9870; BRIGGS MD, 1994, AM J HUM GENET, V55, P678; Briggs MD, 1998, AM J HUM GENET, V62, P311, DOI 10.1086/301713; BRIGGS MD, 1995, NAT GENET, V10, P330, DOI 10.1038/ng0795-330; BRUCKNER P, 1988, J BIOL CHEM, V263, P16911; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cohn DH, 1996, ANN NY ACAD SCI, V785, P188, DOI 10.1111/j.1749-6632.1996.tb56258.x; DEERE M, 1995, AM J HUM GENET, V56, P698; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; FAIRBANK T, 1947, BRIT J SURG, V34, P225, DOI 10.1002/bjs.18003413502; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Haimes H. B., 1995, Inflammation Research, V44, pS127, DOI 10.1007/BF01778295; HECHT JT, 1995, NAT GENET, V10, P325, DOI 10.1038/ng0795-325; Korkko J, 1998, P NATL ACAD SCI USA, V95, P1681, DOI 10.1073/pnas.95.4.1681; Loughlin J, 1998, HUM MUTAT, pS10; Maddox BK, 1997, J BIOL CHEM, V272, P30993, DOI 10.1074/jbc.272.49.30993; MAKELA TP, 1992, HUM MOL GENET, V1, P217, DOI 10.1093/hmg/1.3.217-a; MAROTEAUX P, 1980, EUR J PEDIATR, V133, P227, DOI 10.1007/BF00496081; Mechling DE, 1996, J BIOL CHEM, V271, P13781, DOI 10.1074/jbc.271.23.13781; Muragaki Y, 1996, NAT GENET, V12, P103, DOI 10.1038/ng0196-103; NAKATA K, 1993, P NATL ACAD SCI USA, V90, P2870, DOI 10.1073/pnas.90.7.2870; NEWTON G, 1994, GENOMICS, V24, P435, DOI 10.1006/geno.1994.1649; OEHLMANN R, 1994, AM J HUM GENET, V54, P3; PAASSILTA P, IN PRESS J BIOL CHEM; PERALA M, 1993, FEBS LETT, V319, P177, DOI 10.1016/0014-5793(93)80062-Y; Pihlajamaa T, 1998, MATRIX BIOL, V17, P237, DOI 10.1016/S0945-053X(98)90063-4; Ribbing S, 1937, ACTA RADIOL S, V34, P1; Rimoin DL, 1998, AM J MED GENET, V79, P376; RIMOIN DL, 1994, HUM GENET, V93, P236, DOI 10.1007/BF00212015; SHAW LM, 1991, TRENDS BIOCHEM SCI, V16, P191, DOI 10.1016/0968-0004(91)90074-6; Silverman FN, 1996, AM J ROENTGENOL, V167, P835, DOI 10.2214/ajr.167.4.8819367; Susic S, 1997, CLIN GENET, V51, P219; Van der Rest M, 1987, STRUCTURE FUNCTION C, P195; van Mourik JBA, 1998, AM J MED GENET, V77, P234, DOI 10.1002/(SICI)1096-8628(19980518)77:3<234::AID-AJMG9>3.0.CO;2-P; WEAVER EJ, 1993, AM J MED GENET, V45, P345, DOI 10.1002/ajmg.1320450312; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WYNNEDAVIES R, 1986, J MED GENET, V23, P425, DOI 10.1136/jmg.23.5.425	40	97	104	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1036	1044		10.1086/302328	http://dx.doi.org/10.1086/302328			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090888	Green Published, Bronze			2022-12-18	WOS:000079632900014
J	Lloyd, SE; Pannett, AAJ; Dixon, PH; Whyte, MP; Thakker, RV				Lloyd, SE; Pannett, AAJ; Dixon, PH; Whyte, MP; Thakker, RV			Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CALCIUM-SENSING RECEPTOR; PUTATIVE PHEROMONE RECEPTORS; PARATHYROID-HORMONE LEVELS; HYPOCALCIURIC HYPERCALCEMIA; CA2+-SENSING RECEPTOR; NEONATAL HYPERPARATHYROIDISM; CALMODULIN GENE; MUTATIONS; LINKAGE; IDENTIFICATION	Calcium homeostasis by the kidneys and parathyroids is mediated by the calcium-sensing receptor (CaSR), which is located on 3q21-q24 and belongs to family C of the superfamily of G-protein coupled receptors that includes those for metabotropic glutamate, certain pheromones, and gamma-amino butyric acid (GABA-B). Inactivating CaSR mutations result in familial benign hypercalcemia (FBH), or familial hypocalciuric hypercalcemia (FHH), whereas activating mutations result in hypocalcemic hypercalciuria. However, not all FBH patients have CaSR mutations, which, together with the mapping of another FBH locus to 19p13.3, suggests that additional CaSRs or second messengers may be involved. These may be identified by positional cloning, and we therefore performed a genomewide search, using chromosome-specific sets of microsatellite polymorphisms, in an Oklahoma family with an FBH variant (FBHOk), for which linkage to 3q and 19p had been excluded. Linkage was established between FBHOk and eight chromosome 19q13 loci, with the highest LOD score, 6.67 (recombination fraction .00), obtained with D19S606. Recombinants further mapped FBHOk to a <12-cM interval flanked by D19S908 and D19S866. The calmodulin III gene is located within this interval, and DNA sequence analysis of the coding region, the 5' UTR, and part of the promoter region in an individual affected with FBHOk did not detect any abnormalities, thereby indicating that this gene is unlikely to be implicated in the etiology of FBHOk. This mapping of FBHOk to chromosome 19q13 will facilitate the identification of another CaSR or a mediator of calcium homeostasis.	Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, MRC,Clin Sci Ctr,Mol Endocrinol Grp, London W12 0NN, England; Shriners Hosp Children, Metab Res Unit, St Louis, MO USA; Washington Univ, Sch Med, Div Bone & Mineral Dis, St Louis, MO USA	Imperial College London; Washington University (WUSTL)	Thakker, RV (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Med, Hammersmith Hosp, MRC,Clin Sci Ctr,Mol Endocrinol Grp, Du Cane Rd, London W12 0NN, England.	rthakker@rpms.ac.uk	Centeno, Patricia Pacios/O-8368-2016	Thakker, Rajesh/0000-0002-1438-3220; Dixon, Peter/0000-0002-0197-2632				ASHWORTH LK, 1995, NAT GENET, V11, P422, DOI 10.1038/ng1295-422; BACHS O, 1994, CELL CALCIUM, V16, P289, DOI 10.1016/0143-4160(94)90092-2; Bai M, 1997, J CLIN INVEST, V99, P88, DOI 10.1172/JCI119137; Bassett JHD, 1997, HUM GENET, V100, P657, DOI 10.1007/s004390050569; BERCHTOLD MW, 1993, GENOMICS, V16, P461, DOI 10.1006/geno.1993.1211; BIRNBAUMER M, 1995, J RECEPT SIGNAL TR R, V15, P131, DOI 10.3109/10799899509045213; Brown EM, 1997, HORM RES, V48, P199, DOI 10.1159/000185516; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; DUROCHER F, 1995, GENOMICS, V29, P781, DOI 10.1006/geno.1995.9935; Gnegy M E, 1995, Prog Drug Res, V45, P33; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HEATH H, 1993, AM J HUM GENET, V53, P193; Hebert SC, 1997, J EXP BIOL, V200, P295; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hinson TK, 1997, GENOMICS, V45, P279, DOI 10.1006/geno.1997.4943; Kahn J, 1998, CELL, V92, P809, DOI 10.1016/S0092-8674(00)81408-7; KOLLER M, 1990, BIOCHIM BIOPHYS ACTA, V1087, P180, DOI 10.1016/0167-4781(90)90203-E; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MCKUSICK VA, 1998, MENDELIAN INHERITANC, P951; MCMURTRY CT, 1992, AM J MED, V93, P247, DOI 10.1016/0002-9343(92)90229-5; Naito T, 1998, P NATL ACAD SCI USA, V95, P5178, DOI 10.1073/pnas.95.9.5178; Pearce SHS, 1996, CLIN ENDOCRINOL, V45, P675, DOI 10.1046/j.1365-2265.1996.750891.x; Pearce SHS, 1996, J CLIN INVEST, V98, P1860, DOI 10.1172/JCI118987; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Pearce SHS, 1995, J CLIN INVEST, V96, P2683, DOI 10.1172/JCI118335; POLLAK MR, 1994, NAT GENET, V8, P303, DOI 10.1038/ng1194-303; POLLAK MR, 1993, CELL, V75, P1297, DOI 10.1016/0092-8674(93)90617-Y; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; RHYNER JA, 1994, EUR J BIOCHEM, V225, P71, DOI 10.1111/j.1432-1033.1994.00071.x; THAKKER RV, 1990, J CLIN INVEST, V86, P40, DOI 10.1172/JCI114712; TRUMP D, 1995, HUM GENET, V96, P183, DOI 10.1007/BF00207376	33	97	100	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					189	195		10.1086/302202	http://dx.doi.org/10.1086/302202			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915958	Green Published, Bronze			2022-12-18	WOS:000078477400024
J	Pepe, G; Vanegas, OC; Giusti, B; Brunelli, T; Marcucci, R; Attanasio, M; Rickards, O; De Stefano, GF; Prisco, D; Gensini, GF; Abbate, R				Pepe, G; Vanegas, OC; Giusti, B; Brunelli, T; Marcucci, R; Attanasio, M; Rickards, O; De Stefano, GF; Prisco, D; Gensini, GF; Abbate, R			Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							NEURAL-TUBE DEFECTS; METHYLENE TETRAHYDROFOLATE REDUCTASE; CORONARY-ARTERY DISEASE; GENETIC RISK FACTOR; FACTOR-V-LEIDEN; METHYLENETETRAHYDROFOLATE REDUCTASE; VASCULAR-DISEASE; COMMON MUTATION; HOMOCYSTEINE METABOLISM; VENOUS THROMBOSIS		Univ Roma Tor Vergata, Dept Biol, Human Genet Unit, I-00133 Rome, Italy; Univ Roma Tor Vergata, Dept Biol, Anthropol Unit, I-00133 Rome, Italy; Univ Florence, Inst Internal Med, Florence, Italy; Univ Florence, Inst Cardiol, Florence, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Florence; University of Florence	Pepe, G (corresponding author), Univ Roma Tor Vergata, Dept Biol, Human Genet Unit, Via Ric Sci SNC, I-00133 Rome, Italy.		Giusti, Betti/K-6978-2016; Marcucci, Rossella/K-8471-2016; Pepe, Guglielmina/K-8013-2016; Rickards, Olga/L-7878-2015	Giusti, Betti/0000-0002-8708-9444; Pepe, Guglielmina/0000-0001-9825-6618; Rickards, Olga/0000-0003-2880-7466; Marcucci, Rossella/0000-0001-9549-7176; Prisco, Domenico/0000-0002-7787-9610				Abbate R, 1998, THROMB HAEMOSTASIS, V79, P727; Arruda VR, 1997, THROMB HAEMOSTASIS, V77, P818; Austin H, 1997, THROMB RES, V86, P409, DOI 10.1016/S0049-3848(97)00086-8; Brulhart MC, 1997, AM J HUM GENET, V60, P228; Cattaneo M, 1997, ARTERIOSCL THROM VAS, V17, P1662, DOI 10.1161/01.ATV.17.9.1662; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; DeFranchis R, 1996, AM J HUM GENET, V59, P262; Deloughery TG, 1996, CIRCULATION, V94, P3074, DOI 10.1161/01.CIR.94.12.3074; FaureDelanef L, 1997, AM J HUM GENET, V60, P999; FENTON WA, 1995, METABOLIC MOL BASES, P3129; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Grandone E, 1997, THROMB HAEMOSTASIS, V77, P1052; Harmon DL, 1996, QJM-MON J ASSOC PHYS, V89, P571; Izumi M, 1996, ATHEROSCLEROSIS, V121, P293, DOI 10.1016/0021-9150(95)05764-1; Kirke PN, 1996, LANCET, V348, P1037, DOI 10.1016/S0140-6736(05)64971-9; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; Ma J, 1996, CIRCULATION, V94, P2410, DOI 10.1161/01.CIR.94.10.2410; McAndrew PE, 1996, THROMB RES, V83, P195, DOI 10.1016/0049-3848(96)00121-1; MILLS JL, 1995, LANCET, V345, P149, DOI 10.1016/S0140-6736(95)90165-5; Molloy AM, 1997, LANCET, V349, P1591, DOI 10.1016/S0140-6736(96)12049-3; Morita H, 1997, CIRCULATION, V95, P2032, DOI 10.1161/01.CIR.95.8.2032; Motulsky AG, 1996, AM J HUM GENET, V58, P17; MOZEN R, 1997, THROMB DIATH HAEMO, P523; Narang R, 1996, CIRCULATION, V94, P2322; Papapetrou C, 1996, LANCET, V348, P58, DOI 10.1016/S0140-6736(05)64382-6; Pepe G, 1997, THROMB HAEMOSTASIS, V77, P329; SCACCHI R, 1994, AM J HUM BIOL, V6, P773, DOI 10.1002/ajhb.1310060611; vanBockxmeer FM, 1997, CIRCULATION, V95, P21, DOI 10.1161/01.CIR.95.1.21; Vanegas OC, 1998, THROMB HAEMOSTASIS, V79, P883, DOI 10.1055/s-0037-1615086; Wilcken DEL, 1996, ARTERIOSCL THROM VAS, V16, P878, DOI 10.1161/01.ATV.16.7.878	30	97	106	1	8	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					917	920		10.1086/302015	http://dx.doi.org/10.1086/302015			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718345	Bronze, Green Published			2022-12-18	WOS:000075919000036
J	Schulte-Korne, G; Grimm, T; Nothen, MM; Muller-Myhsok, B; Cichon, S; Vogt, IR; Propping, P; Remschmidt, H				Schulte-Korne, G; Grimm, T; Nothen, MM; Muller-Myhsok, B; Cichon, S; Vogt, IR; Propping, P; Remschmidt, H			Evidence for linkage of spelling disability to chromosome 15	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							READING-DISABILITY; TWIN		Univ Marburg, Dept Child & Adolescent Psychiat, D-35039 Marburg, Germany; Univ Wurzburg, Dept Med Genet, Wurzburg, Germany; Univ Bonn, Inst Human Genet, D-5300 Bonn, Germany; Bernhard Nocht Inst Trop Med, Hamburg, Germany	Philipps University Marburg; University of Wurzburg; University of Bonn; Bernhard Nocht Institut fur Tropenmedizin	Schulte-Korne, G (corresponding author), Univ Marburg, Dept Child & Adolescent Psychiat, Hans Sachs Str 6, D-35039 Marburg, Germany.		Cichon, Sven/B-9618-2014; Müller-Myhsok, Bertram/A-3289-2013; Cichon, Sven/H-8803-2013; Nöthen, Markus/B-2027-2009; Schulte-Körne, Gerd/AAI-4828-2021	Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Nöthen, Markus/0000-0002-8770-2464; Schulte-Körne, Gerd/0000-0002-9960-1572				CARDON LR, 1994, SCIENCE, V266, P276, DOI 10.1126/science.7939663; DEFRIES JC, 1991, READ WRIT, V3, P271, DOI 10.1007/BF00354962; GLOGAUER W, 1977, PSYCHOL ERZ UNTERR, V24, P287; Grigorenko EL, 1997, AM J HUM GENET, V60, P27; Jager R, 1981, MANNHEIMER RECHTSCHR; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Malmquist E., 1958, FACTORS RELATED READ; Osterland J., 1977, GRUNDINTELLIGENZTEST; SchulteKorne G, 1997, READ WRIT, V9, P55, DOI 10.1023/A:1007941403441; SchulteKorne G, 1996, J CHILD PSYCHOL PSYC, V37, P817, DOI 10.1111/j.1469-7610.1996.tb01477.x; SMITH SD, 1991, READ WRIT, V3, P285, DOI 10.1007/BF00354963; STEVENSON J, 1987, J CHILD PSYCHOL PSYC, V28, P229, DOI 10.1111/j.1469-7610.1987.tb00207.x; WEISS RH, 1987, GRUNDINTELLIGENZTEST, V2	15	97	98	0	4	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					279	282		10.1086/301919	http://dx.doi.org/10.1086/301919			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634517	Green Published, Bronze			2022-12-18	WOS:000074761000041
J	Ajioka, RS; Jorde, LB; Gruen, JR; Yu, P; Dimitrova, D; Barrow, J; Radisky, E; Edwards, CQ; Griffen, LM; Kushner, JP				Ajioka, RS; Jorde, LB; Gruen, JR; Yu, P; Dimitrova, D; Barrow, J; Radisky, E; Edwards, CQ; Griffen, LM; Kushner, JP			Haplotype analysis of hemochromatosis: Evaluation of different linkage-disequilibrium approaches and evolution of disease chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-I GENE; HEREDITARY HEMOCHROMATOSIS; IDIOPATHIC HEMOCHROMATOSIS; GAMETIC DISEQUILIBRIUM; ANCESTRAL HAPLOTYPE; MARKER LOCI; HLA-B; REGION; CLONING	We applied several types of linkage-disequilibrium calculations to analyze the hereditary hemochromatosis (hh) locus. Twenty-four polymorphic markers in the major histocompatibility complex (MHC) class I region were used to haplotype hh and normal chromosomes, A total of 169 hh and 161 normal chromosomes were analyzed. Disequilibrium values were found to be high over an unusually large region beginning 150 kb centromeric of HLA-A and extending nearly 5 Mb telomeric of it. Recombination in this region was similar to 28% of the expected value. This low level of recombination contributes to the unusually broad region of linkage disequilibrium found with hh. The strongest disequilibrium was found at locus HLA-H (delta = .84) and at locus D6S2239 (delta = .85), a marker similar to 10 kb telomeric to HLA-H. All disequilibrium methods employed in this study found peak disequilibrium at HLA-H or D6S2233, The cys282tyr mutation in HLA-H, a candidate gene for hh, was found in 85 % of disease chromosomes. A haplotype phylogeny for hh chromosomes was constructed and suggests that the mutation associated with the most common haplotype occurred relatively recently. The age of the hh mutation was estimated to be similar to 60-70 generations. Disequilibrium was maintained over a greater distance for hh-carrying chromosomes, consistent with a recent mutation for hh. Our data provide a reasonable explanation for previous difficulties in localizing the hh Locus and provide an evolutionary history for disease chromosomes.	UNIV UTAH, HLTH SCI CTR, ECCLES INST HUMAN GENET, DEPT HUMAN GENET, SALT LAKE CITY, UT 84132 USA; YALE UNIV, SCH MED, DEPT PEDIAT, NEW HAVEN, CT 06510 USA	Utah System of Higher Education; University of Utah; Yale University	Ajioka, RS (corresponding author), UNIV UTAH, HLTH SCI CTR, DIV HEMATOL ONCOL, ECCLES INST HUMAN GENET, 50 N MED DR, SALT LAKE CITY, UT 84132 USA.		Radisky, Evette S/C-8526-2012	Radisky, Evette S/0000-0003-3121-109X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045819, R01DK020630] Funding Source: NIH RePORTER; NIDDK NIH HHS [1R29DK45819-03, DK-20630] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABDERRAHIM H, 1994, GENOMICS, V23, P520, DOI 10.1006/geno.1994.1538; BENGTSSON BO, 1981, TISSUE ANTIGENS, V18, P356, DOI 10.1111/j.1399-0039.1981.tb01404.x; CARROLL MC, 1987, P NATL ACAD SCI USA, V84, P8535, DOI 10.1073/pnas.84.23.8535; Cartwright G E, 1978, Trans Assoc Am Physicians, V91, P273; CRAWFORD DHG, 1995, AM J HUM GENET, V57, P362; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DADONE MM, 1982, AM J CLIN PATHOL, V78, P196, DOI 10.1093/ajcp/78.2.196; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; EDWARDS CQ, 1982, CLIN HAEMATOL, V11, P411; EDWARDS CQ, 1981, PROG HEMATOL, V12, P43; EDWARDS CQ, 1988, NEW ENGL J MED, V318, P1355, DOI 10.1056/NEJM198805263182103; EISENSMITH RC, 1992, AM J HUM GENET, V51, P1355; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; GERAGHTY DE, 1987, P NATL ACAD SCI USA, V84, P9145, DOI 10.1073/pnas.84.24.9145; GERAGHTY DE, 1992, P NATL ACAD SCI USA, V89, P2669, DOI 10.1073/pnas.89.7.2669; GRUEN JR, 1992, GENOMICS, V14, P232, DOI 10.1016/S0888-7543(05)80211-3; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HEDRICK PW, 1987, GENETICS, V117, P331; HEGELE RA, 1990, GENET EPIDEMIOL, V7, P69, DOI 10.1002/gepi.1370070114; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; JAZWINSKA EC, 1993, AM J HUM GENET, V53, P347; JAZWINSKA EC, 1995, AM J HUM GENET, V56, P428; Jazwinska EC, 1996, NAT GENET, V14, P249, DOI 10.1038/ng1196-249; JORDE LB, 1993, AM J HUM GENET, V53, P1038; JORDE LB, 1994, AM J HUM GENET, V54, P884; JORDE LB, 1995, AM J HUM GENET, V56, P11; Jouanolle AM, 1996, NAT GENET, V14, P251, DOI 10.1038/ng1196-251; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; KOLLER BH, 1989, J EXP MED, V169, P469, DOI 10.1084/jem.169.2.469; LAWRANCE SK, 1987, SCIENCE, V235, P1387, DOI 10.1126/science.3029868; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1964, GENETICS, V49, P49; LIPINSKI M, 1978, TISSUE ANTIGENS, V11, P471, DOI 10.1111/j.1399-0039.1978.tb01286.x; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672300014634, 10.1017/S0016672308009579]; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; PETRUKHIN K, 1993, NAT GENET, V5, P338, DOI 10.1038/ng1293-338; RAHACHOWDHURY R, 1995, HUM MOL GENET, V4, P1869, DOI 10.1093/hmg/4.10.1869; RAHACHOWDHURY R, 1995, J MED GENET, V32, P446, DOI 10.1136/jmg.32.6.446; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; SIMON M, 1977, NEW ENGL J MED, V297, P1017, DOI 10.1056/NEJM197711102971901; SIMON M, 1976, GUT, V17, P332, DOI 10.1136/gut.17.5.332; SIMON M, 1987, AM J HUM GENET, V41, P89; SOOD AK, 1981, P NATL ACAD SCI-BIOL, V78, P616, DOI 10.1073/pnas.78.1.616; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; WATKINS WS, 1994, AM J HUM GENET, V55, P348; WORWOOD M, 1994, BRIT J HAEMATOL, V86, P863, DOI 10.1111/j.1365-2141.1994.tb04843.x; YAOUANQ J, 1994, AM J HUM GENET, V54, P252	49	97	105	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1439	1447		10.1086/515466	http://dx.doi.org/10.1086/515466			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199565	Green Published, Bronze			2022-12-18	WOS:A1997XE29400022
J	MORISSETTE, J; COTE, G; ANCTIL, JL; PLANTE, M; AMYOT, M; HEON, E; TROPE, GE; WEISSENBACH, J; RAYMOND, V				MORISSETTE, J; COTE, G; ANCTIL, JL; PLANTE, M; AMYOT, M; HEON, E; TROPE, GE; WEISSENBACH, J; RAYMOND, V			A COMMON GENE FOR JUVENILE AND ADULT-ONSET PRIMARY OPEN-ANGLE GLAUCOMAS CONFINED ON CHROMOSOME 1Q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTONIC-DYSTROPHY LOCUS; LINKAGE ANALYSIS; DNA; RECOMBINATION; FAMILY	Primary open-angle glaucoma (POAG), which causes progressive loss of the visual fields, was subdivided into two groups according to age at onset: (1) chronic open-angle glaucoma (COAG) diagnosed after age 40 years and (2) juvenile open-angle glaucoma (JOAG) diagnosed between 3 years of age and early adulthood. A JOAG gene (GLC1A) was recently mapped to chromosome 1q. We studied 142 members of a huge multigenerational French Canadian family affected with autosomal dominant POAG. Either JOAG or COAG was diagnosed in 40 patients. Six subjects were also diagnosed with ocular hypertension (OHT), which may lead to POAG. To localize a common disease gene that might be responsible for both glaucoma subsets, we performed linkage analysis considering JOAG and COAG under the same phenotypic category. JOAG/COAG was tightly linked to seven microsatellite markers on chromosome 1q23-q25; a maximum lod score of 6.62 was obtained with AF-M278ye5. To refine the disease locus, we exploited a recombination mapping strategy based on a unique founder effect. The same characteristic haplotype, composed of 14 markers spanning 12 cM between loci D1S196 and D1S212, was recognized in all persons affected by JOAG, COAG, or OHT, but it did not occur in unaffected spouses and in normal family members >35 years of age, except for three obligatory carriers. Key recombination events confined the disease region within a 9-cM interval between loci D1S445 and D1S416/D1S480. These observations demonstrate that the GLC1A gene is responsible for both adult-onset and juvenile glaucomas and suggest that the JOAG and COAG categories within this family may be part of a clinical continuum artificially divided at age 40 years.	CHU LAVAL,CTR RECH,MOLEC ENDOCRINOL LAB,QUEBEC CITY,PQ G1V 4G2,CANADA; UNIV LAVAL,QUEBEC CITY,PQ,CANADA; HOP ST SACREMENT,DEPT OPHTHALMOL,QUEBEC CITY,PQ,CANADA; UNIV MONTREAL,MONTREAL,PQ,CANADA; HOP MAISON NEUVE ROSEMONT,DEPT OPHTHALMOL,MONTREAL,PQ,CANADA; UNIV TORONTO,DEPT OPHTHALMOL,TORONTO,ON M5S 1A1,CANADA; GENETHON,EVRY,FRANCE	Laval University; Laval University; Laval University; Universite de Montreal; Universite de Montreal; University of Toronto								ALMAGHTHEH M, 1994, HUM MOL GENET, V3, P351, DOI 10.1093/hmg/3.2.351; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BOUCHARD G, 1991, HIST UN GENOME POPUL; BOWCOCK AM, 1994, AM J HUM GENET, V54, P79; BUETOW KH, 1994, NAT GENET, V6, P391, DOI 10.1038/ng0494-391; CHURCH GM, 1988, SCIENCE, V240, P185, DOI 10.1126/science.3353714; COHEN D, 1993, NATURE, V366, P698, DOI 10.1038/366698a0; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COTE G, 1968, CAN J OPHTHALMOL, V3, P331; CROMBIE A L, 1964, Br J Ophthalmol, V48, P143, DOI 10.1136/bjo.48.3.143; FARRALL M, 1987, LANCET, V10, P156; FRANCOIS J, 1980, J FR OPHTALMOL, V3, P429; FRANCOIS J, 1966, AM J OPHTHALMOL, V61, P652, DOI 10.1016/0002-9394(66)91201-3; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; GOLDWYN R, 1970, ARCH OPHTHALMOL-CHIC, V84, P579; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HARLEY HG, 1991, AM J HUM GENET, V49, P68; HARLEY HG, 1991, HUM GENET, V87, P73, DOI 10.1007/BF01213096; HARRIS D, 1965, AM J OPHTHALMOL, V60, P91, DOI 10.1016/0002-9394(65)92398-6; HOSKINS HD, 1989, BECKERSHAFFERS DIAGN; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; JOHNSON AT, 1993, OPHTHALMOLOGY, V100, P524; JOHNSON AT, 1991, INVEST OPHTH VIS SCI, V32, P813; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEE DA, 1985, ANN OPHTHALMOL, V17, P739; LEIGHTON DA, 1976, T OPHTHAL SOC UK, V96, P28; LERNER TJ, 1994, AM J HUM GENET, V54, P88; LESKE MC, 1983, AM J EPIDEMIOL, V118, P166, DOI 10.1093/oxfordjournals.aje.a113626; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; Mckusick V.A., 1994, MENDELIAN INHERITANC; Miller S J, 1962, Br J Ophthalmol, V46, P513, DOI 10.1136/bjo.46.9.513; MORISSETTE J, 1991, CYTOGENET CELL GENET, V58, P27203; MORISSETTE J, 1992, INFORMATISATION INFO, P89; NETLAND PA, 1993, INT OPHTHALMOL CLIN, V33, P101, DOI 10.1097/00004397-199303320-00011; RICHARDS JE, 1994, AM J HUM GENET, V54, P62; SCHMIDT CM, 1992, DUANES F CLIN OPHTHA, V3, P1; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; SIMARD LR, 1994, HUM MOL GENET, V3, P459, DOI 10.1093/hmg/3.3.459; Stokes WH, 1940, ARCH OPHTHALMOL-CHIC, V24, P885, DOI 10.1001/archopht.1940.00870050035002; STONE EM, 1994, NAT GENET, V6, P47, DOI 10.1038/ng0194-47; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; Vignal Alain, 1993, V1, P211; WAARDENBURG P. J., 1950, GENETICA, V25, P79; WEISSENBACK J, 1992, NATURE, V359, P795; WIGGS JL, 1994, GENOMICS, V21, P299, DOI 10.1006/geno.1994.1269; 1993, CELL, V72, P971	49	97	105	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1995	56	6					1431	1442						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RA794	7762566				2022-12-18	WOS:A1995RA79400022
J	WHITEHOUSE, WP; REES, M; CURTIS, D; SUNDQVIST, A; PARKER, K; CHUNG, E; BARALLE, D; GARDINER, RM				WHITEHOUSE, WP; REES, M; CURTIS, D; SUNDQVIST, A; PARKER, K; CHUNG, E; BARALLE, D; GARDINER, RM			LINKAGE ANALYSIS OF IDIOPATHIC GENERALIZED EPILEPSY (IGE) AND MARKER LOCI ON CHROMOSOME-6P IN FAMILIES OF PATIENTS WITH JUVENILE MYOCLONIC EPILEPSY - NO EVIDENCE FOR AN EPILEPSY LOCUS IN THE HLA REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; COMPLEX DISEASES; LOD SCORES; INHERITANCE; TESTS; MODE; 6P	Evidence for a locus (EJM1) in the HLA region of chromosome 6p predisposing to idiopathic generalized epilepsy (IGE) in the families of patients with juvenile myoclonic epilepsy (JME) has been obtained in two previous studies of separately ascertained groups of kindreds. Linkage analysis has been undertaken in a third set of 25 families including a patient with JME and at least one first-degree relative with IGE. Family members were typed for eight polymorphic loci on chromosome 6p: F13A, D6S89, D6S109, D6S105, D6S10, C4B, DQA1/A2, and TCTE1. Pairwise and multipoint linkage analysis was carried out assuming autosomal dominant and autosomal recessive inheritance and age-dependent high or low penetrance. No significant evidence in favor of linkage was obtained at any locus. Multipoint linkage analysis generated significant exclusion data (lod score < -2.0) at HLA and for a region 10-30 cM telomeric to HLA, the extent of which varied with the level of penetrance assumed. These observations indicate that genetic heterogeneity exists within this epilepsy phenotype.	UNIV LONDON UNIV COLL,SCH MED,RAYNE INST,DEPT PAEDIAT,UNIV ST,LONDON WC1E 6JJ,ENGLAND; ST MARKS HOSP,DEPT PSYCHIAT,LONDON EC1V 2PS,ENGLAND; SODER HOSP,DEPT NEUROL,STOCKHOLM,SWEDEN	University of London; King's College London; University College London; UCL Medical School; Imperial College London			Curtis, David/HGB-3921-2022; Whitehouse, William P/F-9065-2017	Curtis, David/0000-0002-4089-9183; Whitehouse, William P/0000-0001-5207-5731; Baralle, Diana/0000-0003-3217-4833	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aicardi J., 1986, EPILEPSY CHILDREN; ANDERSON VE, 1990, PAEDIATRIC EPILEPSY, P37; [Anonymous], 1989, EPILEPSIA, V30, P389; BERKOVIC SF, 1990, EPILEPSIA, V31, P813; Bidwell J L, 1990, Baillieres Clin Haematol, V3, P355, DOI 10.1016/S0950-3536(05)80055-1; CAMPBELL RD, 1990, EXP CLIN IMMUNOGENET, V7, P69; CLERGETDARPOUX F, 1990, GENET EPIDEMIOL, V7, P245, DOI 10.1002/gepi.1370070403; CRUTIS D, 1993, HUM HERED, V43, P173; DELGADOESCUETA AV, 1990, EPILEPSIA, V31, pS19, DOI 10.1111/j.1528-1157.1990.tb05855.x; DURNER M, 1991, NEUROLOGY, V41, P1651, DOI 10.1212/WNL.41.10.1651; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GREENBERG DA, 1989, AM J MED GENET, V34, P480, DOI 10.1002/ajmg.1320340406; GREENBERG DA, 1988, AM J MED GENET, V31, P185, DOI 10.1002/ajmg.1320310125; GREENBERG DA, 1989, GENETICS EPILEPSIES, P53; Herpin T, 1867, ACCES INCOMPLETS EPI; Janz D., 1957, DTSCH Z NERVENHEILKD, V176, P346, DOI [DOI 10.1007/BF00242439, 10.1007/BF00242439]; Janz D, 1989, GENETICS EPILEPSIES, P43; KWIATKOWSKI TJ, 1991, GENOMICS, V10, P921, DOI 10.1016/0888-7543(91)90180-M; LANDER ES, 1989, GENOME ANAL PRACTICA, P171; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LEACH R, 1986, P NATL ACAD SCI USA, V83, P3909, DOI 10.1073/pnas.83.11.3909; LITT M, 1990, NUCLEIC ACIDS RES, V18, P4301, DOI 10.1093/nar/18.14.4301; LIU A W H, 1991, Epilepsia, V32, P100; LIU AWH, 1992, 1ST INT WORKSH CHROM; Old JM, 1986, HUMAN GENETIC DISEAS, P1; OTT J, 1990, P NATL ACAD SCI USA, V87, P701, DOI 10.1073/pnas.87.2.701; OTT J, 1990, AM J HUM GENET, V46, P219; PANAYIOTOPOULOS CP, 1989, ANN NEUROL, V25, P440, DOI 10.1002/ana.410250504; RANUM LPW, 1991, NUCLEIC ACIDS RES, V19, P1171, DOI 10.1093/nar/19.5.1171-a; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; Roger Joseph, 1985, EPILEPTIC SYNDROMES; Sambrook J., 1989, MOL CLONING LAB MANU; TSUBOI T, 1973, HUMANGENETIK, V19, P155; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1991, NUCLEIC ACIDS RES, V19, P968, DOI 10.1093/nar/19.4.968; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEISSBECKER KA, 1991, AM J MED GENET, V38, P32, DOI 10.1002/ajmg.1320380109; Wolf Peter, 1992, P313; ZOGHBI HY, 1988, AM J HUM GENET, V42, P877; 1991, HUMAN GENE MAPPING, V58, P1; 1985, EPILEPSIA, V26, P268	42	97	97	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					652	662						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352275				2022-12-18	WOS:A1993LU55900009
J	KNAPP, M; SEUCHTER, SA; BAUR, MP				KNAPP, M; SEUCHTER, SA; BAUR, MP			THE HAPLOTYPE-RELATIVE-RISK (HRR) METHOD FOR ANALYSIS OF ASSOCIATION IN NUCLEAR FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HLA-DISEASE ASSOCIATIONS	One major problem in studying an association between a marker locus and a disease is the selection of an appropriate group of controls. However, this problem of population stratification can be circumvented in a quite elegant. manner by family-based methods. The haplotype-relative-risk (HRR) method, which samples nuclear families with a single affected child and uses the parental haplotypes not transmitted to that child as a control individual, represents such a method for estimating the relative risk of a marker phenotype. In the special case of a recessive disease, it was already known that the equivalence of the HRR method with the classical relative risk (RR) obtained from independent samples holds only if the probability theta of a recombination between marker and disease locus is zero. We extend this result to an arbitrary mode of inheritance. Furthermore, we compare the distribution of the estimators for HRR and RR and show that, in the case of a positive linkage disequilibrium between a marker and disease allele, the distribution of the estimator for HRR is (stochastically) smaller than that for RR, irrespective of the recombination fraction. The practical implication of this result is that, for the HRR method, there is no tendency to give unduly high risk estimators, even for theta > 0. Finally, we give an expression for the standard error of the estimator for HRR by taking into account the nonindependence of transmitted and nontransmitted parental marker alleles in the case of theta > 0.			KNAPP, M (corresponding author), UNIV BONN, INST MED STAT, SIGMUND FREUD STR 25, W-5300 BONN 1, GERMANY.							BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; CAMPION D, 1992, PSYCHIAT RES, V41, P99, DOI 10.1016/0165-1781(92)90102-9; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FIELD LL, 1986, GENET EPIDEMIOL, P323; FLEISS JL, 1973, STATISTICAL METHODS; KNAPP M, 1991, THESIS RHEINISCHE F; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; RAO CR, 1973, LINEAR STATISTICAL I; RUBINSTEIN P, 1981, HUM IMMUNOL, V3, P384; SEUCHTER SA, 1991, GENET EPIDEMIOL, V8, P409, DOI 10.1002/gepi.1370080607; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; THOMSON G, 1979, TISSUE ANTIGENS, V13, P91; THOMSON G, 1981, THEOR POPUL BIOL, V20, P168, DOI 10.1016/0040-5809(81)90009-5; THOMSON G, 1988, ANNU REV GENET, V22, P31; THOMSON G, UNPUB ANAL COMPLEX H; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	16	97	102	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1085	1093						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503442				2022-12-18	WOS:A1993LG13300009
J	BERG, MA; ARGENTE, J; CHERNAUSEK, S; GRACIA, R; GUEVARAAGUIRRE, J; HOPP, M; PEREZJURADO, L; ROSENBLOOM, A; TOLEDO, SPA; FRANCKE, U				BERG, MA; ARGENTE, J; CHERNAUSEK, S; GRACIA, R; GUEVARAAGUIRRE, J; HOPP, M; PEREZJURADO, L; ROSENBLOOM, A; TOLEDO, SPA; FRANCKE, U			DIVERSE GROWTH-HORMONE RECEPTOR GENE-MUTATIONS IN LARON SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; SINGLE-BASE CHANGES; SYNDROME TYPE-IV; III PROCOLLAGEN; BINDING-PROTEIN; DWARFISM; DNA; EXON; EXPRESSION; DEFICIENCY	To better understand the molecular genetic basis and genetic epidemiology of Laron syndrome (growth-hormone insensitivity syndrome), we analyzed the growth-hormone receptor (GHR) genes of seven unrelated affected individuals from the United States, South America, Europe, and Africa. We amplified all nine GHR gene exons and splice junctions from these individuals by PCR and screened the products for mutations by using denaturing gradient gel electrophoresis (DGGE). We identified a single GHR gene fragment with abnormal DGGE results for each affected individual, sequenced this fragment, and, in each case, identified a mutation likely to cause Laron syndrome, including two nonsense mutations (R43X and R217X), two splice-junction mutations, (189-1 G to T and 71+1 G to A), and two frameshift mutations (46 del TT and 230 del TA or AT). Only one of these mutations, R43X, has been previously reported. Using haplotype analysis, we determined that this mutation, which involves a CpG dinucleotide hot spot, likely arose as a separate event in this case, relative to the two prior reports of R43X. Aside from R43X, the mutations we identified are unique to patients from particular geographic regions. Ten GHR gene mutations have now been described in this disorder. We conclude that Laron syndrome is caused by diverse GHR gene mutations, including deletions, RNA processing defects, translational stop codons, and missense codons. All the identified mutations involve the extracellular domain of the receptor, and most are unique to particular families or geographic areas.	STANFORD UNIV,MED CTR,SCH MED,BECKMAN CTR MOLEC & GENET MED,HOWARD HUGHES MED INST,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305; STANFORD UNIV,MED CTR,SCH MED,DEPT PEDIAT,STANFORD,CA 94305; CHILDRENS HOSP MED CTR,CINCINNATI,OH 45229; UNIV AUTONOMA MADRID,HOSP LA PAZ,MADRID 34,SPAIN; UNIV AUTONOMA MADRID,HOSP NINO JESUS,MADRID 34,SPAIN; INST ENDOCRINOL METAB & REPROD,QUITO,ECUADOR; UNIV WITWATERSRAND,JOHANNESBURG 2001,SOUTH AFRICA; UNIV FLORIDA,GAINESVILLE,FL 32611; UNIV SAO PAULO,SAO PAULO,BRAZIL	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Cincinnati Children's Hospital Medical Center; Autonomous University of Madrid; Hospital Universitario La Paz; Autonomous University of Madrid; University of Witwatersrand; State University System of Florida; University of Florida; Universidade de Sao Paulo			Rosenbloom, Arlan L./A-8194-2009; Argente, Jesús/K-1167-2014; Pérez Jurado, Luis Alberto/M-7706-2015; Argente, Jesús/M-5226-2019; Toledo, Sergio P. A./S-9291-2018	Argente, Jesús/0000-0001-5826-0276; Argente, Jesús/0000-0001-5826-0276; Toledo, Sergio P. A./0000-0002-2590-3519				ALBERTSSONWIKLAND K, 1976, METABOLISM, V25, P747, DOI 10.1016/0026-0495(76)90146-3; AMSELEM S, 1991, J CLIN INVEST, V87, P1098, DOI 10.1172/JCI115071; AMSELEM S, 1989, NEW ENGL J MED, V321, P989, DOI 10.1056/NEJM198910123211501; ANDREWS LG, 1992, J BIOL CHEM, V267, P7834; Berg Mary Anne, 1992, Human Mutation, V1, P24, DOI 10.1002/humu.1380010105; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CHIODO AA, 1992, J BIOL CHEM, V267, P6361; COLE WG, 1990, J BIOL CHEM, V265, P17070; DAUGHADAY WH, 1987, P NATL ACAD SCI USA, V84, P4636, DOI 10.1073/pnas.84.13.4636; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; DUQUESNOY P, 1991, P NATL ACAD SCI USA, V88, P10272, DOI 10.1073/pnas.88.22.10272; ESHET R, 1984, ISRAEL J MED SCI, V20, P8; GODOWSKI PJ, 1989, P NATL ACAD SCI USA, V86, P8083, DOI 10.1073/pnas.86.20.8083; ISAKSSON OGP, 1985, ANNU REV PHYSIOL, V47, P483, DOI 10.1146/annurev.ph.47.030185.002411; KRAWCZAK M, 1991, HUM GENET, V86, P425; KUIVANIEMI H, 1990, J BIOL CHEM, V265, P12067; LARON Z, 1966, ISRAEL J MED SCI, V2, P152; LARON Z, 1974, Birth Defects Original Article Series, V10, P231; LEE B, 1991, J BIOL CHEM, V266, P5256; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; MEACHAM LR, 1992, ACTA PAEDIATR S, V383, P145; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; ORKIN SH, 1982, NATURE, V300, P768, DOI 10.1038/300768a0; REID JD, 1960, J PEDIATR-US, V56, P658, DOI 10.1016/S0022-3476(60)80341-1; ROSENBLOOM AL, 1990, NEW ENGL J MED, V323, P1367, DOI 10.1056/NEJM199011153232002; ROSENBLOOM AL, IN PRESS PEDIATR ADO; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SALDANHA PH, 1981, HUM GENET, V59, P367, DOI 10.1007/BF00295474; SALMON WD, 1957, J LAB CLIN MED, V49, P825; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; TRIVEDI B, 1988, ENDOCRINOLOGY, V123, P2201, DOI 10.1210/endo-123-5-2201; VASAN NS, 1991, AM J HUM GENET, V48, P305	35	97	100	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					998	1005						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488849				2022-12-18	WOS:A1993LB88900018
J	DEKA, R; CHAKRABORTY, R; DECROO, S; ROTHHAMMER, F; BARTON, SA; FERRELL, RE				DEKA, R; CHAKRABORTY, R; DECROO, S; ROTHHAMMER, F; BARTON, SA; FERRELL, RE			CHARACTERISTICS OF POLYMORPHISM AT A VNTR LOCUS 3' TO THE APOLIPOPROTEIN-B GENE IN 5 HUMAN-POPULATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; PAPUA-NEW-GUINEA; HYPERVARIABLE REGION; MAJOR MECHANISM; SERUM-PROTEIN; ALLELES; DNA; NUMBER; DIFFERENTIATION; HETEROZYGOSITY	We have analyzed the allele frequency distribution at the hypervariable locus 3' to the apolipoprotein B gene (ApoB 3' VNTR) in five well-defined human populations (Kacharis of northeast India, New Guinea Highlanders of Papua New Guinea, Dogrib Indians of Canada, Pehuenche Indians of Chile, and a relatively homogeneous Caucasian population of northern German extraction) by using the PCR technique. A total of 12 segregating alleles were detected in the pooled sample of 319 individuals. A fairly consistent bimodal pattern of allele frequency distribution, apparent in most of these geographically and genetically diverse populations, suggests that the ApoB 3' VNTR polymorphism predates the geographic dispersal of ancestral human populations. In spite of the observed high degree of polymorphism at this locus (expected heterozygosity levels 55%-78%), the genotype distributions in all populations (irrespective of their tribal or cosmopolitan nature) conform to their respective Hardy-Weinberg predictions. Furthermore, analysis of the congruence between expected heterozygosity and the observed number of alleles reveals that, in general, the allele frequency distributions at this locus are in agreement with the predictions of the classical mutation-drift models. The data also show that alleles that are shared by all populations have the highest average frequency within populations. These findings demonstrate the potential utility of highly informative hypervariable loci such as the ApoB 3' VNTR locus in population genetic research, as well as in forensic medicine and determination of biological relatedness of individuals.	UNIV TEXAS,GRAD SCH BIOMED SCI,CTR DEMOG & POPULAT GENET,HOUSTON,TX 77025; UNIV CHILE,FAC MED,DEPT BIOL CELULAR & GENET,SANTIAGO,CHILE	University of Texas System; Universidad de Chile	DEKA, R (corresponding author), UNIV PITTSBURGH,DEPT HUMAN GENET,E-1654 BIOMED SCI TOWER,PITTSBURGH,PA 15261, USA.			Barton, Sara Ann/0000-0002-6196-3324	NIGMS NIH HHS [GM-41399] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041399] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARMOUR JAL, 1992, GENOMICS, V12, P116, DOI 10.1016/0888-7543(92)90413-M; BATANIAN JR, 1990, HUM GENET, V85, P555; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BUDOWLE B, 1991, AM J HUM GENET, V48, P137; CHAKRABORTY R, 1982, THEOR POPUL BIOL, V21, P205, DOI 10.1016/0040-5809(82)90014-4; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; CHAKRABORTY R, 1992, HUM BIOL, V64, P141; CHAKRABORTY R, 1991, AM J PHYS ANTHROPOL, V86, P497, DOI 10.1002/ajpa.1330860405; CHAKRABORTY R, 1991, DNA FINGERPRINTING A, P127; DEKA R, 1987, HEMOGLOBIN, V11, P531, DOI 10.3109/03630268708998016; DEKA R, 1991, GENOMICS, V11, P83, DOI 10.1016/0888-7543(91)90104-M; DEKA R, IN PRESS HUM GENET; FRIEDL W, 1990, J LIPID RES, V31, P659; GECZ J, 1991, NUCLEIC ACIDS RES, V19, P5806, DOI 10.1093/nar/19.20.5806; HELIO T, 1991, BIOCHEM BIOPH RES CO, V181, P846, DOI 10.1016/0006-291X(91)91267-G; HUANG LS, 1987, J BIOL CHEM, V262, P8952; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KIMURA M, 1964, GENETICS, V49, P725; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; KNOTT TJ, 1986, NUCLEIC ACIDS RES, V14, P9215, DOI 10.1093/nar/14.22.9215; LABELLE M, 1991, GENET EPIDEMIOL, V8, P269, DOI 10.1002/gepi.1370080407; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; LI CC, 1976, FIRST COURSE POPULAT; LONG JC, 1986, AM J PHYS ANTHROPOL, V70, P75, DOI 10.1002/ajpa.1330700113; LUDWIG EH, 1989, AM J HUM GENET, V45, P458; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEI M, 1978, GENETICS, V89, P583; ODELBERG SJ, 1989, GENOMICS, V5, P915, DOI 10.1016/0888-7543(89)90134-1; RENGES HH, 1992, ANN HUM GENET, V56, P11, DOI 10.1111/j.1469-1809.1992.tb01126.x; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAJANTILA A, 1992, AM J HUM GENET, V50, P816; SHRIVER M, 1991, CRIME LAB DIGEST, V18, P144; SOKAL RR, 1981, BIOMEETRY; SZATHMARY EJE, 1983, AM J PHYS ANTHROPOL, V62, P249, DOI 10.1002/ajpa.1330620304; WOLFF R, 1991, DNA FINGERPRINTING A, P20; WOLFF RK, 1989, GENOMICS, V5, P382, DOI 10.1016/0888-7543(89)90076-1; WOOD JW, 1982, AM J PHYS ANTHROPOL, V57, P15, DOI 10.1002/ajpa.1330570105; WYMAN AR, 1980, P NATL ACAD SCI-BIOL, V77, P6754, DOI 10.1073/pnas.77.11.6754	38	97	102	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1325	1333						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463014				2022-12-18	WOS:A1992KC99500014
J	SPOTILA, LD; SEREDA, L; PROCKOP, DJ				SPOTILA, LD; SEREDA, L; PROCKOP, DJ			PARTIAL ISODISOMY FOR MATERNAL CHROMOSOME-7 AND SHORT STATURE IN AN INDIVIDUAL WITH A MUTATION AT THE COLIA2 LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; FACTOR-BINDING-PROTEIN; GENETIC-LINKAGE MAP; UNIPARENTAL DISOMY; OSTEOGENESIS IMPERFECTA; CYSTIC-FIBROSIS; NORMAL DAUGHTER; TRANSLOCATION; LOCALIZATION; TRANSMISSION	Uniparental disomy for chromosome 7 has been described previously in two individuals with cystic fibrosis. Here, we describe a third case that was discovered because the proband was homozygous for a mutation in the COL1A2 gene for type I procollagen, although his mother was heterozygous and his father did not have the mutation. Phenotypically, the proband was similar to the two previously reported cases with uniparental disomy for chromosome 7, in that he was short in stature and growth retarded. Paternity was assessed with five polymorphic markers. Chromosome 7 inheritance in the proband was analyzed using 12 polymorphic markers distributed along the entire chromosome. Similar analysis of the proband's two brothers established the phase of the alleles at the various loci, assuming minimal recombination. The proband inherited only maternal alleles at five loci and was homozygous at all loci examined, except one. He was heterozygous for an RFLP at the IGBP-1 locus at 7p13-p12. The results suggest that the isodisomy was not complete because of a recombination event involving the proximal short arms of two maternal chromosomes. In addition, the phenotype of proportional dwarfism in the proband suggests imprinting of one or more growth-related genes on chromosome 7.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107	Jefferson University	PROCKOP, DJ (corresponding author), THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038188] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-38188] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALITALO T, 1989, HUM GENET, V83, P335, DOI 10.1007/BF00291377; BARKER D, 1987, P NATL ACAD SCI USA, V84, P8006, DOI 10.1073/pnas.84.22.8006; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BREWER MT, 1988, BIOCHEM BIOPH RES CO, V152, P1289, DOI 10.1016/S0006-291X(88)80425-X; BYERS PH, 1991, J MED GENET, V28, P433, DOI 10.1136/jmg.28.7.433; CATTANACH BM, 1990, DEVELOPMENT, P63; CATTANACH BM, 1985, NATURE, V315, P496, DOI 10.1038/315496a0; Chi D. D., 1992, Human Molecular Genetics, V1, P135, DOI 10.1093/hmg/1.2.135; DEAN M, 1990, NUCLEIC ACIDS RES, V18, P345, DOI 10.1093/nar/18.2.345; DICHIARA TM, 1991, CELL, V64, P849; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EHRENBORG E, 1992, GENOMICS, V12, P497, DOI 10.1016/0888-7543(92)90440-4; EKSTRAND J, 1990, GENOMICS, V6, P413, DOI 10.1016/0888-7543(90)90470-F; ENGEL E, 1991, AM J MED GENET, V40, P432, DOI 10.1002/ajmg.1320400411; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; FAZIO MJ, 1991, AM J HUM GENET, V48, P696; JULKUNEN M, 1988, FEBS LETT, V236, P295, DOI 10.1016/0014-5793(88)80041-3; KIRKELS VGHJ, 1980, CLIN GENET, V18, P456; KONTUSAARI S, 1990, J CLIN INVEST, V86, P1465, DOI 10.1172/JCI114863; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; LATHROP GM, 1989, GENOMICS, V5, P866, DOI 10.1016/0888-7543(89)90128-6; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; Maniatis T., 1982, MOL CLONING; Marini J C, 1988, Adv Pediatr, V35, P391; NGO KY, 1986, AM J HUM GENET, V38, P407; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; PALMER CG, 1980, CLIN GENET, V17, P418; PENTAO L, 1992, AM J HUM GENET, V50, P690; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1991, P NATL ACAD SCI USA, V88, P5423, DOI 10.1073/pnas.88.12.5423; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; TROMP G, 1991, NUCLEIC ACIDS RES, V19, P4314, DOI 10.1093/nar/19.15.4314-a; VOSS R, 1989, AM J HUM GENET, V45, P373; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4636, DOI 10.1093/nar/18.15.4636-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4039, DOI 10.1093/nar/18.13.4039; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2201; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2199; 1991, CYTOGENET CELL GENET, V58, P369	43	97	97	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1992	51	6					1396	1405						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KC995	1463018				2022-12-18	WOS:A1992KC99500023
J	HILL, AVS; BOWDEN, DK; TRENT, RJ; HIGGS, DR; OPPENHEIMER, SJ; THEIN, SL; MICKLESON, KNP; WEATHERALL, DJ; CLEGG, JB				HILL, AVS; BOWDEN, DK; TRENT, RJ; HIGGS, DR; OPPENHEIMER, SJ; THEIN, SL; MICKLESON, KNP; WEATHERALL, DJ; CLEGG, JB			MELANESIANS AND POLYNESIANS SHARE A UNIQUE ALPHA-THALASSEMIA MUTATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MONASH UNIV, DEPT ANAT, CLAYTON, VIC 3168, AUSTRALIA; ROYAL PRINCE ALFRED HOSP, DEPT HAEMATOL, CAMPERDOWN, NSW 2050, AUSTRALIA; MIDDLEMORE HOSP, DEPT PAEDIAT, AUCKLAND, NEW ZEALAND; MIDDLEMORE HOSP, DEPT HAEMATOL, AUCKLAND, NEW ZEALAND; LIVERPOOL SCH TROP MED, DEPT TROP PAEDIAT, LIVERPOOL L3 5QA, ENGLAND	Monash University; University of Sydney; Liverpool School of Tropical Medicine	HILL, AVS (corresponding author), UNIV OXFORD, JOHN RADCLIFFE HOSP, NUFFIELD DEPT CLIN MED, MRC, MOLEC HAEMATOL UNIT, OXFORD OX3 9DU, ENGLAND.		HILL, Adrian V>S>/C-1306-2008					ANTONARAKIS SE, 1984, P NATL ACAD SCI-BIOL, V81, P853, DOI 10.1073/pnas.81.3.853; BEAVEN GH, 1972, NATURE, V235, P46, DOI 10.1038/235046a0; Bellwood P., 1978, MANS CONQUEST PACIFI; BLAKE NM, 1983, AM J PHYS ANTHROPOL, V62, P343, DOI 10.1002/ajpa.1330620402; BOWDEN DK, 1982, BRIT J HAEMATOL, V51, P243, DOI 10.1111/j.1365-2141.1982.tb08481.x; CLEVE H, 1967, ACTA GENET STAT MED, V17, P511; COOPER DN, 1984, HUM GENET, V66, P1, DOI 10.1007/BF00275182; CRAIB JL, 1983, SCIENCE, V219, P922, DOI 10.1126/science.219.4587.922; Dacie J.V., 1984, PRACTICAL HAEMATOLOG, V6th; DEISSEROTH A, 1977, CELL, V12, P205, DOI 10.1016/0092-8674(77)90198-2; EMBURY SH, 1980, J CLIN INVEST, V66, P1319, DOI 10.1172/JCI109984; FELICE AE, 1984, BLOOD, V63, P1253; GAJDUSEK D. C., 1967, J MED GENET, V4, P1, DOI 10.1136/jmg.4.1.1; GOODBOURN SEY, 1983, P NATL ACAD SCI-BIOL, V80, P5022, DOI 10.1073/pnas.80.16.5022; GOOSSENS M, 1980, P NATL ACAD SCI-BIOL, V77, P518, DOI 10.1073/pnas.77.1.518; HARRISON GA, 1984, SOC STUDY HUMAN BIOL, V23, P57; Higgs D R, 1983, Curr Top Hematol, V4, P37; HIGGS DR, 1980, NATURE, V284, P632, DOI 10.1038/284632a0; HIGGS DR, 1984, NUCLEIC ACIDS RES, V12, P6965, DOI 10.1093/nar/12.18.6965; HIGGS DR, 1981, NUCLEIC ACIDS RES, V9, P4213, DOI 10.1093/nar/9.17.4213; Howells, 1973, PACIFIC ISLANDERS; KAZAZIAN HH, 1984, AM J HUM GENET, V36, P212; Kirk RL, 1979, 1ST AM ORIGINS AFFIN, P211; KIRK RL, 1980, POPULATION STRUCTURE, P113; KOENIG HM, 1975, J PEDIATR-US, V87, P756, DOI 10.1016/S0022-3476(75)80301-5; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LIEINJO LE, 1959, NATURE, V183, P1125, DOI 10.1038/1831125a0; MICHELSON AM, 1983, J BIOL CHEM, V258, P5245; MOTULSKY A G, 1964, J Med Genet, V1, P102, DOI 10.1136/jmg.1.2.102; OLD JM, 1978, NATURE, V273, P319, DOI 10.1038/273319a0; OLD JM, 1983, THALASSAEMIAS METHOD; OPPENHEIMER SJ, 1984, LANCET, V1, P424; ORKIN SH, 1983, PROG HEMATOL, V13, P49; Pawley A., 1974, MACROPAEDIA, P484; SERJEANTSON SW, 1982, AM J HUM GENET, V34, P904; SERJEANTSON SW, 1983, J HUM EVOL, V12, P77, DOI 10.1016/S0047-2484(83)80014-1; SIMMONS RT, 1962, OCEANIA, V32, P198, DOI 10.1002/j.1834-4461.1962.tb01763.x; SUKUMARAN PK, 1983, NUCLEIC ACIDS RES, V11, P4635; THEIN SL, 1984, BRIT J HAEMATOL, V57, P271, DOI 10.1111/j.1365-2141.1984.tb08530.x; TRENT RJ, 1985, AM J HEMATOL; Weatherall D.J., 1981, THALASSAEMIA SYNDROM, V3rd ed.; WINICHAGOON P, 1982, NUCLEIC ACIDS RES, V10, P5853, DOI 10.1093/nar/10.19.5853	42	97	98	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	3					571	580						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AKE07	2988335				2022-12-18	WOS:A1985AKE0700013
J	HASSOLD, TJ				HASSOLD, TJ			A CYTOGENETIC STUDY OF REPEATED SPONTANEOUS-ABORTIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											HASSOLD, TJ (corresponding author), UNIV HAWAII,JOHN A BURNS SCH MED,DEPT ANAT & REPROD BIOL,HONOLULU,HI 96822, USA.				NICHD NIH HHS [HD-05576, HD-07879] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALBERMAN E, 1975, BRIT J OBSTET GYNAEC, V82, P366, DOI 10.1111/j.1471-0528.1975.tb00651.x; BOUE J, 1973, HUMANGENETIK, V19, P275, DOI 10.1007/BF00278402; CARTER C, 1961, LANCET, P785; GLASS RH, 1978, FERTIL STERIL, V29, P257; HASSOLD TJ, 1978, ANN HUM GENET, V41, P443, DOI 10.1111/j.1469-1809.1978.tb00914.x; HECHT F, 1964, NEW ENGL J MED, V271, P1081, DOI 10.1056/NEJM196411192712102; KAJII T, 1978, AM J OBSTET GYNECOL, V131, P33, DOI 10.1016/0002-9378(78)90470-2; Lauritsen J G, 1976, Acta Obstet Gynecol Scand Suppl, V52, P1; MARCH C, 1979, REPRODUCTIVE ENDOCRI, P459; OSTER J, 1956, Dan Med Bull, V3, P158; STENE J, 1970, HUM HERED, V20, P112, DOI 10.1159/000152301	11	97	103	1	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1980	32	5					723	730						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	KJ795	7424911				2022-12-18	WOS:A1980KJ79500011
J	BOARD, PG				BOARD, PG			GENETIC-POLYMORPHISM OF THE A SUBUNIT OF HUMAN COAGULATION FACTOR-XIII	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											BOARD, PG (corresponding author), AUSTRALIAN NATL UNIV,JOHN CURTIN SCH MED RES,DEPT HUMAN BIOL,CANBERRA 2601,ACT,AUSTRALIA.							ARDLIE NG, 1974, BRIT J HAEMATOL, V26, P331, DOI 10.1111/j.1365-2141.1974.tb00477.x; ASHTON GC, 1961, AUST J BIOL SCI, V14, P248, DOI 10.1071/BI9610248; BARBUI T, 1978, BRIT J HAEMATOL, V38, P267, DOI 10.1111/j.1365-2141.1978.tb01042.x; CHUNG SI, 1975, ISOENZYMES, P259; DUCKERT F, 1960, THROMB DIATH HAEMOST, V5, P179, DOI 10.1055/s-0038-1654918; HAMPTON JW, 1966, J LAB CLIN MED, V67, P914; LORAND L, 1971, ANAL BIOCHEM, V44, P207, DOI 10.1016/0003-2697(71)90362-9; LORAND L, 1974, BIOCHEM BIOPH RES CO, V56, P914, DOI 10.1016/S0006-291X(74)80275-5; LOSOWSKY MS, 1977, BRIT J HAEMATOL, V37, P1; MCDONAGH J, 1971, ANN HUM GENET, V35, P197, DOI 10.1111/j.1469-1809.1956.tb01392.x; McDonagh J, 1972, THROMB RES, V1, P147; MIKUNI Y, 1973, BIOCHEM BIOPH RES CO, V54, P1393, DOI 10.1016/0006-291X(73)91141-8; RATNOFF OD, 1968, LANCET, V1, P25; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; TSUKADA T, 1977, ACTA HAEMATOL JAPON, V40, P984	15	97	97	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	2					116	124						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GZ386	88180				2022-12-18	WOS:A1979GZ38600003
J	GRAHN, D; KRATCHMAN, J				GRAHN, D; KRATCHMAN, J			VARIATION IN NEONATAL DEATH RATE AND BIRTH WEIGHT IN UNITED STATES AND POSSIBLE RELATIONS TO ENVIRONMENTAL RADIATION,GEOLOGY AND ALTITUDE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ACHESON GH, 1957, J PHYSIOL-LONDON, V135, P623, DOI 10.1113/jphysiol.1957.sp005735; ALTLAND PD, 1949, PHYSIOL ZOOL, V22, P235, DOI 10.1086/physzool.22.3.30152048; Barcroft J, 1938, FEATURES ARCHITECTUR; BOELL EJ, 1955, ANALYSIS DEVELOPMENT, P520; BROWN SO, 1962, ANN PROG REPORT RAD; BROWN WMC, 1960, BRIT MED J, V1, P1753, DOI 10.1136/bmj.1.5188.1753; BUGHER JC, 1958, 2 P INT C PEAC US, V23, P165; CHIODI H, 1953, JAMA-J AM MED ASSOC, V153, P162; CRAIG L, 1961, BLOOD, V17, P319, DOI 10.1182/blood.V17.3.319.319; DAVIS GT, 1955, POULTRY SCI, V34, P107, DOI 10.3382/ps.0340107; FRASER GR, 1962, ANN HUM GENET, V25, P387, DOI 10.1111/j.1469-1809.1962.tb01774.x; GENTRY JT, 1959, AM J PUBLIC HEALTH N, V49, P497, DOI 10.2105/AJPH.49.4.497; HOWARD R C, 1957, AMA J Dis Child, V93, P670; INGALLS TH, 1952, NEW ENGL J MED, V247, P758, DOI 10.1056/NEJM195211132472004; KRATCHMAN J, 1959, TID8204 US AT EN COM; Lerner I. M., 1950, POPULATION GENETICS; LICHTY JA, 1957, AMA J DIS CHILD, V93, P666, DOI 10.1001/archpedi.1957.02060040668009; METCALFE J, 1962, Q J EXP PHYSIOL CMS, V47, P74, DOI 10.1113/expphysiol.1962.sp001578; Monge Carlos, 1948, ACCLIMATIZATION ANDE; MORENG RE, 1959, 502S COL STAT U EXP; MORTON NE, 1958, AM J HUM GENET, V10, P344; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MORTON NE, 1955, ANN HUM GENET, V20, P125; NEEL JV, 1956, 461 NAT AC SCI NAT R; PENROSE LS, 1954, 9 P INT C GEN CARY S, V6, P521; PLUMMER G, 1952, PEDIATRICS, V10, P687; Russell L.B., 1960, IMMEDIATE LOW LEVEL, P343; Smith A. H., 1961, Poultry Science, V40, P1459; SOLON LR, 1960, SCIENCE, V131, P903, DOI 10.1126/science.131.3404.903; SOLON LR, 1959, HASL73 US AT EN COMM; STERN C, 1960, HUMAN GENETICS; SUTOW WW, 1955, AMER J ROENTGENOL RA, V74, P493; WESLEY JP, 1960, INT J RADIAT BIOL RE, V2, P97, DOI 10.1080/09553006014550101; WINDLE WF, 1941, PHYSIOLOGY FETUS	34	97	97	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1963	15	4					329	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2968A	14097229				2022-12-18	WOS:A19632968A00006
J	Forbes, TA; Howden, SE; Lawlor, K; Phipson, B; Maksimovic, J; Hale, L; Wilson, S; Quinlan, C; Ho, G; Holman, K; Bennetts, B; Crawford, J; Trnka, P; Oshlack, A; Patel, C; Mallett, A; Simons, C; Little, MH				Forbes, Thomas A.; Howden, Sara E.; Lawlor, Kynan; Phipson, Belinda; Maksimovic, Jovana; Hale, Lorna; Wilson, Sean; Quinlan, Catherine; Ho, Gladys; Holman, Katherine; Bennetts, Bruce; Crawford, Joanna; Trnka, Peter; Oshlack, Alicia; Patel, Chirag; Mallett, Andrew; Simons, Cas; Little, Melissa H.			Patient-iPSC-Derived Kidney Organoids Show Functional Validation of a Ciliopathic Renal Phenotype and Reveal Underlying Pathogenetic Mechanisms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLURIPOTENT STEM-CELLS; PROTEIN-COUPLED RECEPTORS; IFT-A COMPLEX; JOUBERT SYNDROME; RETINITIS-PIGMENTOSA; CYSTIC KIDNEYS; PRIMARY CILIA; IN-VIVO; MUTATIONS; DISEASE	Despite the increasing diagnostic rate of genomic sequencing, the genetic basis of more than 50% of heritable kidney disease remains unresolved. Kidney organoids differentiated from induced pluripotent stem cells (iPSCs) of individuals affected by inherited renal disease represent a potential, but unvalidated, platform for the functional validation of novel gene variants and investigation of underlying pathogenetic mechanisms. In this study, trio whole-exome sequencing of a prospectively identified nephronophthisis (NPHP) proband and her parents identified compound-heterozygous variants in IFT140, a gene previously associated with NPHP-related ciliopathies. IFT140 plays a key role in retrograde intraflagellar transport, but the precise downstream cellular mechanisms responsible for disease presentation remain unknown. A one-step reprogramming and gene-editing protocol was used to derive both uncorrected proband iPSCs and isogenic gene-corrected iPSCs, which were differentiated to kidney organoids. Proband organoid tubules demonstrated shortened, club-shaped primary cilia, whereas gene correction rescued this phenotype. Differential expression analysis of epithelial cells isolated from organoids suggested downregulation of genes associated with apicobasal polarity, cell-cell junctions, and dynein motor assembly in proband epithelial cells. Matrigel cyst cultures confirmed a polarization defect in proband versus gene-corrected renal epithelium. As such, this study represents a "proof of concept" for using proband-derived iPSCs to model renal disease and illustrates dysfunctional cellular pathways beyond the primary cilium in the setting of IFT140 mutations, which are established for other NPHP genotypes. Despite the increasing diagnostic rate of genomic sequencing, the genetic basis of more than 50% of heritable kidney disease remains unresolved. Kidney organoids differentiated from induced pluripotent stem cells (iPSCs) of individuals affected by inherited renal disease represent a potential, but unvalidated, platform for the functional validation of novel gene variants and investigation of underlying pathogenetic mechanisms. In this study, trio whole-exome sequencing of a prospectively identified nephronophthisis (NPHP) proband and her parents identified compound-heterozygous variants in IFT140, a gene previously associated with NPHP-related ciliopathies. IFT140 plays a key role in retrograde intraflagellar transport, but the precise downstream cellular mechanisms responsible for disease presentation remain unknown. A one-step reprogramming and gene-editing protocol was used to derive both uncorrected proband iPSCs and isogenic gene-corrected iPSCs, which were differentiated to kidney organoids. Proband organoid tubules demonstrated shortened, club-shaped primary cilia, whereas gene correction rescued this phenotype. Differential expression analysis of epithelial cells isolated from organoids suggested downregulation of genes associated with apicobasal polarity, cell-cell junctions, and dynein motor assembly in proband epithelial cells. Matrigel cyst cultures confirmed a polarization defect in proband versus gene-corrected renal epithelium. As such, this study represents a "proof of concept" for using proband-derived iPSCs to model renal disease and illustrates dysfunctional cellular pathways beyond the primary cilium in the setting of IFT140 mutations, which are established for other NPHP genotypes.	[Forbes, Thomas A.; Howden, Sara E.; Lawlor, Kynan; Phipson, Belinda; Hale, Lorna; Wilson, Sean; Quinlan, Catherine; Oshlack, Alicia; Little, Melissa H.] Murdoch Childrens Res Inst, Kidney Dev Dis & Regenerat Grp, Parkville, Vic 3052, Australia; [Forbes, Thomas A.; Howden, Sara E.; Hale, Lorna; Quinlan, Catherine; Little, Melissa H.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Forbes, Thomas A.; Quinlan, Catherine] Royal Childrens Hosp, Dept Nephrol, Parkville, Vic 3052, Australia; [Phipson, Belinda; Maksimovic, Jovana; Oshlack, Alicia] Murdoch Childrens Res Inst, Bioinformat Grp, Parkville, Vic 3052, Australia; [Ho, Gladys; Holman, Katherine; Bennetts, Bruce] Childrens Hosp Westmead, Dept Mol Genet, Sydney, NSW 2145, Australia; [Bennetts, Bruce] Childrens Hosp Westmead, Western Sydney Genet Program, Sydney, NSW 2145, Australia; [Bennetts, Bruce] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW 2000, Australia; [Bennetts, Bruce] Univ Sydney, Sydney Med Sch, Discipline Genet Med, Sydney, NSW 2000, Australia; [Crawford, Joanna; Simons, Cas] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Trnka, Peter] Lady Cilento Childrens Hosp, Child & Adolescent Renal Serv, Brisbane, Qld 4101, Australia; [Trnka, Peter; Mallett, Andrew] Univ Queensland, Fac Med, Brisbane, Qld 4072, Australia; [Patel, Chirag] Royal Brisbane & Womens Hosp, Genet Hlth Queensland, Brisbane, Qld 4029, Australia; [Mallett, Andrew] Royal Brisbane & Womens Hosp, Dept Renal Med, Brisbane, Qld 4029, Australia	Murdoch Children's Research Institute; University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital	Little, MH (corresponding author), Murdoch Childrens Res Inst, Kidney Dev Dis & Regenerat Grp, Parkville, Vic 3052, Australia.; Little, MH (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.	melissa.little@mcri.edu.au	Mallett, Andrew John/L-7562-2013; Phipson, Belinda/AAP-2213-2020; Simons, Cas/A-7905-2011; Forbes, Thomas A/C-8602-2016; Trnka, Peter/I-7700-2016; Quinlan, Catherine/AAY-1240-2020; Little, Melissa H/A-6170-2010; Maksimovic, Jovana/H-8654-2019; Oshlack, Alicia/P-6139-2014; de Andrés San Cristóbal, Marta/ABF-5806-2021; Patel, Chirag/AAF-4953-2019; Lawlor, Kynan/AAC-2407-2021; Howden, Sara/AAP-5132-2020; Crawford, Joanna/F-9135-2013	Mallett, Andrew John/0000-0002-8752-2551; Phipson, Belinda/0000-0002-1711-7454; Simons, Cas/0000-0003-3147-8042; Forbes, Thomas A/0000-0001-6635-8855; Trnka, Peter/0000-0002-5584-2622; Quinlan, Catherine/0000-0003-2746-6903; Little, Melissa H/0000-0003-0380-2263; Maksimovic, Jovana/0000-0002-9458-3061; Oshlack, Alicia/0000-0001-9788-5690; Patel, Chirag/0000-0002-6374-5224; Crawford, Joanna/0000-0003-0786-6889; Wilson, Sean/0000-0002-8994-0781; Ho, Gladys/0000-0003-2889-0407; Hale, Lorna/0000-0003-4644-7839; Lawlor, Kynan/0000-0003-4080-5439	National Health and Medical Research Council of Australia (NHMRC) [GNT1098654]; Kidney Health Australia; Royal Brisbane and Women's Hospital Foundation; Royal Children's Hospital Foundation; Murdoch Children's Research Institute; Victorian Government's Operational Infrastructure Support Program; NHMRC Postgraduate Scholarship [GNT1114409]; RACP Jacquot Award; Organovo Inc.	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Kidney Health Australia; Royal Brisbane and Women's Hospital Foundation; Royal Children's Hospital Foundation; Murdoch Children's Research Institute; Victorian Government's Operational Infrastructure Support Program; NHMRC Postgraduate Scholarship(National Health and Medical Research Council (NHMRC) of Australia); RACP Jacquot Award; Organovo Inc.	We thank Pei Xuan Er and Irene Ghobrial for assistance with iPSC derivation and maintenance, Alison Graham for iPSC pluripotency flow cytometry, and Andrew Lonsdale for assistance with bioinformatic graphical outputs. This study was funded by the National Health and Medical Research Council of Australia (NHMRC) (GNT1098654), Kidney Health Australia, the Royal Brisbane and Women's Hospital Foundation, the Royal Children's Hospital Foundation, and the Murdoch Children's Research Institute. The Murdoch Childrens Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program. T.A.F. is a recipient of the NHMRC Postgraduate Scholarship (GNT1114409) and RACP Jacquot Award. M.H.L. is an NHMRC Senior Principal Research Fellow and has consulted for and received research funding from Organovo Inc.	Beals RK, 2007, AM J MED GENET A, V143A, P2444, DOI 10.1002/ajmg.a.31948; Benzing T, 2001, P NATL ACAD SCI USA, V98, P9784, DOI 10.1073/pnas.171269898; Bizet AA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9666; Blisnick T, 2014, MOL BIOL CELL, V25, P2620, DOI 10.1091/mbc.E14-05-0961; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Booij TH, 2017, SLAS DISCOV, V22, P974, DOI 10.1177/2472555217716056; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Bukanov NO, 2012, CELL CYCLE, V11, P4040, DOI 10.4161/cc.22375; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Choi HJC, 2013, MOL CELL, V51, P423, DOI 10.1016/j.molcel.2013.08.006; Choi SY, 2013, J AM SOC NEPHROL, V24, P1435, DOI 10.1681/ASN.2012121236; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cleary JG, 2014, J COMPUT BIOL, V21, P405, DOI 10.1089/cmb.2014.0029; Cruz NM, 2017, NAT MATER, V16, P1112, DOI [10.1038/NMAT4994, 10.1038/nmat4994]; Delous M, 2009, HUM MOL GENET, V18, P4711, DOI 10.1093/hmg/ddp434; den Hollander AI, 2001, AM J HUM GENET, V69, P198; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donaldson JC, 2002, J BIOL CHEM, V277, P29028, DOI 10.1074/jbc.M111697200; Fletcher J, 2013, PEDIATR NEPHROL, V28, P251, DOI 10.1007/s00467-012-2306-6; Freedman BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9715; Giles RH, 2014, NAT PROTOC, V9, P2725, DOI 10.1038/nprot.2014.181; Habbig S, 2011, J CELL BIOL, V193, P633, DOI 10.1083/jcb.201009069; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Harskamp LR, 2016, NAT REV NEPHROL, V12, P496, DOI 10.1038/nrneph.2016.91; Hirano T, 2017, MOL BIOL CELL, V28, P429, DOI 10.1091/mbc.E16-11-0813; Homan KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34845; Howden SE, 2016, STEM CELL REP, V7, P508, DOI 10.1016/j.stemcr.2016.07.001; Howden SE, 2015, STEM CELL REP, V5, P1109, DOI 10.1016/j.stemcr.2015.10.009; Hynes AM, 2014, P NATL ACAD SCI USA, V111, P9893, DOI 10.1073/pnas.1322373111; Jansen J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16702; Jonassen JA, 2012, J AM SOC NEPHROL, V23, P641, DOI 10.1681/ASN.2011080829; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Legland D, 2016, BIOINFORMATICS, V32, P3532, DOI 10.1093/bioinformatics/btw413; Levy M, 2000, KIDNEY INT, V58, P925, DOI 10.1046/j.1523-1755.2000.00250.x; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liem KF, 2012, J CELL BIOL, V197, P789, DOI 10.1083/jcb.201110049; Lu WN, 1999, NAT GENET, V21, P160, DOI 10.1038/5944; Mallett A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-98; Mallett AJ, 2017, KIDNEY INT, V92, P1493, DOI 10.1016/j.kint.2017.06.013; Miller KA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003746; Moreno S, 2008, CELL CYCLE, V7, P1856, DOI 10.4161/cc.7.12.6055; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Otto EA, 2011, J MED GENET, V48, P105, DOI 10.1136/jmg.2010.082552; Park HL, 2000, DEVELOPMENT, V127, P1593; Perrault I, 2012, AM J HUM GENET, V90, P864, DOI 10.1016/j.ajhg.2012.03.006; Phipson B., 2017, BIORXIV, DOI [10.1101/238428, DOI 10.1101/238428]; Pieczynski J, 2011, AM J PHYSIOL-RENAL, V300, pF589, DOI 10.1152/ajprenal.00615.2010; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schluter MA, 2009, MOL BIOL CELL, V20, P4652, DOI 10.1091/mbc.E09-02-0137; Schmidts M, 2013, HUM MUTAT, V34, P714, DOI 10.1002/humu.22294; Shimada H, 2017, CELL REP, V20, P384, DOI 10.1016/j.celrep.2017.06.045; Shimeld SM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000864; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Slaats GG, 2016, PEDIATR NEPHROL, V31, P545, DOI 10.1007/s00467-015-3162-y; Slaats GG, 2015, J CLIN INVEST, V125, P3657, DOI 10.1172/JCI80657; Srivastava S, 2017, HUM MOL GENET, V26, P4657, DOI 10.1093/hmg/ddx347; Stepanek L, 2016, SCIENCE, V352, P721, DOI 10.1126/science.aaf4594; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takasato M, 2016, NAT PROTOC, V11, P1681, DOI 10.1038/nprot.2016.098; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Tammachote R, 2009, HUM MOL GENET, V18, P3311, DOI 10.1093/hmg/ddp272; van den Berg CW, 2018, STEM CELL REP, V10, P751, DOI 10.1016/j.stemcr.2018.01.041; Vanderver A, 2016, ANN NEUROL, V79, P1031, DOI 10.1002/ana.24650; WALDHERR R, 1982, VIRCHOWS ARCH A, V394, P235, DOI 10.1007/BF00430668; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu GQ, 2002, HUM MOL GENET, V11, P1845, DOI 10.1093/hmg/11.16.1845; Yasunaga T, 2015, J CELL BIOL, V211, P963, DOI 10.1083/jcb.201502043	77	96	98	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 3	2018	102	5					816	831		10.1016/j.ajhg.2018.03.014	http://dx.doi.org/10.1016/j.ajhg.2018.03.014			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GG1IH	29706353	Green Published, Bronze			2022-12-18	WOS:000432440100008
J	Krupp, DR; Barnard, RA; Duffourd, Y; Evans, SA; Mulqueen, RM; Bernier, R; Riviere, JB; Fombonne, E; O'Roak, BJ				Krupp, Deidre R.; Barnard, Rebecca A.; Duffourd, Yannis; Evans, Sara A.; Mulqueen, Ryan M.; Bernier, Raphael; Riviere, Jean-Baptiste; Fombonne, Eric; O'Roak, Brian J.			Exonic Mosaic Mutations Contribute Risk for Autism Spectrum Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; EPILEPTIC ENCEPHALOPATHIES; INTELLECTUAL DISABILITY; TRANSMISSION GENETICS; SYNONYMOUS MUTATIONS; CLONAL HEMATOPOIESIS; ACTIVATING MUTATIONS; SOMATIC MOSAICISM; RECURRENCE RISK; SEQUENCING DATA	Genetic risk factors for autism spectrum disorder (ASD) have yet to be fully elucidated. Postzygotic mosaic mutations (PMMs) have been implicated in several neurodevelopmental disorders and overgrowth syndromes. By leveraging whole-exome sequencing data on a large family-based ASD cohort, the Simons Simplex Collection, we systematically evaluated the potential role of PMMs in autism risk. Initial re-evaluation of published single-nucleotide variant (SNV) de novo mutations showed evidence consistent with putative PMMs for 11% of mutations. We developed a robust and sensitive SNV PMM calling approach integrating complementary callers, logistic regression modeling, and additional heuristics. In our high-confidence call set, we identified 470 PMMs in children, increasing the proportion of mosaic SNVs to 22%. Probands have a significant burden of synonymous PMMs and these mutations are enriched for computationally predicted impacts on splicing. Evidence of increased missense PMM burden was not seen in the full cohort. However, missense burden signal increased in subcohorts of families where probands lacked nonsynonymous germline mutations, especially in genes intolerant to mutations. Parental mosaic mutations that were transmitted account for 6.8% of the presumed de novo mutations in the children. PMMs were identified in previously implicated high-confidence neurodevelopmental disorder risk genes, such as CHD2, CTNNB1, SCN2A, and SYNGAP1, as well as candidate risk genes with predicted functions in chromatin remodeling or neurodevelopment, including ACTL6B, BAZ2B, COL5A3, SSRP1, and UNC79. We estimate that PMMs potentially contribute risk to 3%-4% of simplex ASD case subjects and future studies of PMMs in ASD and related disorders are warranted.	[Krupp, Deidre R.; Barnard, Rebecca A.; Evans, Sara A.; Mulqueen, Ryan M.; O'Roak, Brian J.] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Duffourd, Yannis] Univ Bourgogne Franche Comte, Genet Anomalies Dev, Equipe Accueil 4271, F-21000 Dijon, France; [Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Riviere, Jean-Baptiste] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Fombonne, Eric] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97239 USA	Oregon Health & Science University; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Washington; University of Washington Seattle; McGill University; Oregon Health & Science University	O'Roak, BJ (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA.	oroak@ohsu.edu	Fombonne, Eric/M-4893-2018	Fombonne, Eric/0000-0002-8605-3538; Krupp, Deidre/0000-0002-8346-055X; O'Roak, Brian/0000-0002-4141-0095	Simons Foundation [SFARI 305927]; Agence Nationale de la Recherche [ANR-13-PDOC-0029]; NARSAD Young Investigator Award from the Brain and Behavior Research Foundation [22935]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER	Simons Foundation; Agence Nationale de la Recherche(French National Research Agency (ANR)); NARSAD Young Investigator Award from the Brain and Behavior Research Foundation(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the Simons Foundation (SFARI 305927, B.J.O.) and the Agence Nationale de la Recherche (ANR-13-PDOC-0029, Y.D. and J.-B.R.). B.J.O. is currently a Klingenstein-Simons Fellow in Neurosciences and Alfred P. Sloan Foundation Fellow in Neuroscience (FG-2015-65608) and was supported by the NARSAD Young Investigator Award (22935) from the Brain and Behavior Research Foundation. We are grateful for the use of the Exacloud high performance computing environment developed jointly by OHSU and Intel and the technical support of the OHSU Advanced Computing Center. We would like to thank S.J. Webb, A.C. Adey, K.M. Wright, I. Iossifov, S. Bedrick, J. Burchard, and A. Presmanes Hill for helpful discussions regarding the manuscript. We also thank I. Fisk, N. Volfovsky, N. Krumm, and T.N. Turner for their assistance accessing the WES datasets. We are grateful to all of the families at the participating Simons Simplex Collections (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, R., Goin-Kochel, E. Hanson, D. Grice, A. Klin, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren, E. Wijsman). Approved researchers can obtain the SSC population dataset described in this study by applying at https://base.sfari.org.	Acuna-Hidalgo R, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1110-1; Acuna-Hidalgo R, 2015, AM J HUM GENET, V97, P67, DOI 10.1016/j.ajhg.2015.05.008; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Benjamini Y, 2001, ANN STAT, V29, P1165; Boyle EA, 2014, BIOINFORMATICS, V30, P2670, DOI 10.1093/bioinformatics/btu353; Caceres EF, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r143; Campbell IM, 2015, TRENDS GENET, V31, P382, DOI 10.1016/j.tig.2015.03.013; Campbell IM, 2014, AM J HUM GENET, V95, P345, DOI 10.1016/j.ajhg.2014.08.010; Campbell IM, 2014, AM J HUM GENET, V95, P173, DOI 10.1016/j.ajhg.2014.07.003; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chen ES, 2014, AM J HUM GENET, V95, P490, DOI 10.1016/j.ajhg.2014.09.013; D'Gama AM, 2015, NEURON, V88, P910, DOI 10.1016/j.neuron.2015.11.009; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Forsberg LA, 2017, NAT REV GENET, V18, P128, DOI 10.1038/nrg.2016.145; Freed D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006245; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Georgi B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003484; HAPPLE R, 1987, J AM ACAD DERMATOL, V16, P899, DOI 10.1016/S0190-9622(87)80249-9; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Iossifov I, 2015, P NATL ACAD SCI USA, V112, pE5600, DOI 10.1073/pnas.1516376112; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jamuar SS, 2014, NEW ENGL J MED, V371, P733, DOI 10.1056/NEJMoa1314432; Ji X, 2016, P NATL ACAD SCI USA, V113, P15054, DOI 10.1073/pnas.1613195113; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Keppler-Noreuil KM, 2015, AM J MED GENET A, V167, P287, DOI 10.1002/ajmg.a.36836; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krishnan A, 2016, NAT NEUROSCI, V19, P1454, DOI 10.1038/nn.4353; Krumm N, 2015, NAT GENET, V47, P582, DOI 10.1038/ng.3303; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Lindhurst MJ, 2012, NAT GENET, V44, P928, DOI 10.1038/ng.2332; Liu GF, 2004, NAT NEUROSCI, V7, P1222, DOI 10.1038/nn1331; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Riazuddin S., 2016, MOL PSYCHIAT; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sanders SJ, 2015, NEURON, V87, P1215, DOI 10.1016/j.neuron.2015.09.016; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Supek F, 2014, CELL, V156, P1324, DOI 10.1016/j.cell.2014.01.051; Takata A, 2016, NEURON, V89, P940, DOI 10.1016/j.neuron.2016.02.024; Vogel-Ciernia A, 2013, NAT NEUROSCI, V16, P552, DOI 10.1038/nn.3359; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wen HL, 2010, HUM MOL GENET, V19, P1766, DOI 10.1093/hmg/ddq058; Willsey AJ, 2013, CELL, V155, P997, DOI 10.1016/j.cell.2013.10.020; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806	72	96	98	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2017	101	3					369	390		10.1016/j.ajhg.2017.07.016	http://dx.doi.org/10.1016/j.ajhg.2017.07.016			22	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	FG1CS	28867142	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000409530900005
J	Kott, E; Legendre, M; Copin, B; Papon, JF; Moal, FDL; Montantin, G; Duquesnoy, P; Piterboth, W; Amram, D; Bassinet, L; Beucher, J; Beydon, N; Deneuville, E; Houdouin, V; Journel, H; Just, J; Nathan, N; Tamalet, A; Collot, N; Jeanson, L; Le Gouez, M; Vallette, B; Vojtek, AM; Epaud, R; Coste, A; Clement, A; Housset, B; Louis, B; Escudier, E; Amselem, S				Kott, Esther; Legendre, Marie; Copin, Bruno; Papon, Jean-Francois; Moal, Florence Dastot-Le; Montantin, Guy; Duquesnoy, Philippe; Piterboth, William; Amram, Daniel; Bassinet, Laurence; Beucher, Julie; Beydon, Nicole; Deneuville, Eric; Houdouin, Veronique; Journel, Hubert; Just, Jocelyne; Nathan, Nadia; Tamalet, Aline; Collot, Nathalie; Jeanson, Ludovic; Le Gouez, Morgane; Vallette, Benoit; Vojtek, Anne-Marie; Epaud, Ralph; Coste, Andre; Clement, Annick; Housset, Bruno; Louis, Bruno; Escudier, Estelle; Amselem, Serge			Loss-of-Function Mutations in RSPH1 Cause Primary Ciliary Dyskinesia with Central-Complex and Radial-Spoke Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DYNEIN REGULATORY COMPLEX; NITRIC-OXIDE; CHLAMYDOMONAS-REINHARDTII; IMMOTILE-CILIA; HEAD PROTEIN; GENE; CHILDREN; ARM; ASYMMETRY; MOTILITY	Primary ciliary dyskinesia (PCD) is a rare autosomal-recessive respiratory disorder resulting from defects of motile cilia. Various axonemal ultrastructural phenotypes have been observed, including one with so-called central-complex (CC) defects, whose molecular basis remains unexplained in most cases. To identify genes involved in this phenotype, whose diagnosis can be particularly difficult to establish, we combined homozygosity mapping and whole-exome sequencing in a consanguineous individual with CC defects. This identified a nonsense mutation in RSPH1, a gene whose ortholog in Chlamydomonas reinhardtii encodes a radial-spoke (RS)-head protein and is mainly expressed in respiratory and testis cells. Subsequent analyses of RSPH1 identified biallelic mutations in 10 of 48 independent families affected by CC defects. These mutations include splicing defects, as demonstrated by the study of RSPH1 transcripts obtained from airway cells of affected individuals. Wild-type RSPH1 localizes within cilia of airway cells, but we were unable to detect it in an individual with RSPH1 loss-of-function mutations. High-speed-videomicroscopy analyses revealed the coexistence of different ciliary beating patterns-cilia with a normal beat frequency but abnormal motion alongside immotile cilia or cilia with a slowed beat frequency-in each individual. This study shows that this gene is mutated in 20.8% of individuals with CC defects, whose diagnosis could now be improved by molecular screening. RSPH1 mutations thus appear as a major etiology for this PCD phenotype, which in fact includes RS defects, thereby unveiling the importance of RSPH1 in the proper building of CCs and RSs in humans.	[Kott, Esther; Legendre, Marie; Copin, Bruno; Moal, Florence Dastot-Le; Montantin, Guy; Duquesnoy, Philippe; Piterboth, William; Collot, Nathalie; Jeanson, Ludovic; Le Gouez, Morgane; Vallette, Benoit; Escudier, Estelle; Amselem, Serge] Univ Paris 06, INSERM, Unite Mixte Rech S933, F-75012 Paris, France; [Kott, Esther; Legendre, Marie; Copin, Bruno; Moal, Florence Dastot-Le; Montantin, Guy; Duquesnoy, Philippe; Piterboth, William; Collot, Nathalie; Jeanson, Ludovic; Le Gouez, Morgane; Vallette, Benoit; Escudier, Estelle; Amselem, Serge] Hop Armand Trousseau, AP HP, Serv Genet & Embryol Med, F-75012 Paris, France; [Papon, Jean-Francois; Coste, Andre] Univ Paris Est, INSERM, Unite Mixte Rech S955, Equipe 13, F-94000 Creteil, France; [Papon, Jean-Francois; Coste, Andre] Ctr Hosp Intercommunal, Serv ORL & Chirurg Cervicofaciale, F-94000 Creteil, France; [Papon, Jean-Francois; Coste, Andre] Grp Hosp Henri Mondor Albert Chenevier, AP HP, F-94000 Creteil, France; [Amram, Daniel] Ctr Hosp Intercommunal, Unite Fonct Genet Clin, F-94000 Creteil, France; [Bassinet, Laurence; Housset, Bruno] Ctr Hosp Intercommunal, Serv Pneumol, F-94000 Creteil, France; [Beucher, Julie; Deneuville, Eric] Univ Hop Sud, Ctr Hosp, Serv Pneumol Pediat, F-35000 Rennes, France; [Beydon, Nicole] Hop Armand Trousseau, AP HP, Serv Explorat Fonct Respiratoires, F-75012 Paris, France; [Houdouin, Veronique] Hop Robert Debre, AP HP, Serv Pneumol Pediat, F-75019 Paris, France; [Journel, Hubert] Ctr Hosp Bretagne Atlantique, Serv Genet Med & Oncogenet, F-56017 Vannes, France; [Just, Jocelyne] Hop Armand Trousseau, AP HP, Ctr Asthme & Allergies, F-75012 Paris, France; [Nathan, Nadia; Tamalet, Aline; Clement, Annick] Hop Armand Trousseau, AP HP, Ctr Natl Reference Malad Respiratoires Rares, Unite Pneumol Pediat, F-75012 Paris, France; [Vojtek, Anne-Marie] Ctr Hosp Intercommunal, Lab Microscopie Elect, Serv Anatomopathol, F-94000 Creteil, France; [Epaud, Ralph] Ctr Hosp Intercommunal, Serv Pediat, F-94000 Creteil, France; [Louis, Bruno] Univ Paris Est, CNRS ERL7240, Fac Med, INSERM,Equipe 13,Unite Mixte Rech S955, F-94000 Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Amselem, S (corresponding author), Univ Paris 06, INSERM, Unite Mixte Rech S933, F-75012 Paris, France.	serge.amselem@inserm.fr	Nathan, Nadia/P-1030-2019; Louis, Bruno C/R-1862-2018; Legendre, Marie/AAD-7018-2021; Louis, Bruno/AGB-7050-2022	Nathan, Nadia/0000-0001-5149-7975; Louis, Bruno C/0000-0001-9587-9932; Legendre, Marie/0000-0003-2178-0846; Louis, Bruno/0000-0001-9587-9932; COSTE, Andre/0000-0002-8386-3455; Papon, Jean Francois/0000-0002-2323-9239	Fondation pour la Recherche Medicale [DEQ20120323689]; Legs Poix from the Chancellerie des Universites; Milena Carvajal ProKartagener Foundation; Assistance Publique - Hopitaux de Paris [PHRC AOM06053, P060245]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Legs Poix from the Chancellerie des Universites; Milena Carvajal ProKartagener Foundation; Assistance Publique - Hopitaux de Paris	We are grateful to the affected persons and their families, whose cooperation made this study possible, and we thank all referring physicians. This work was supported by grants from the Fondation pour la Recherche Medicale (DEQ20120323689), the Legs Poix from the Chancellerie des Universites, the Milena Carvajal ProKartagener Foundation, and the Assistance Publique - Hopitaux de Paris (PHRC AOM06053 and P060245).	AFZELIUS B A, 1976, Science (Washington D C), V193, P317; AFZELIUS BA, 1985, CRC CR REV BIOCH MOL, V19, P63, DOI 10.3109/10409238509086788; AlSaadi MM, 2012, ANN HUM GENET, V76, P211, DOI 10.1111/j.1469-1809.2012.00704.x; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Carbajal-Gonzalez BI, 2013, CYTOSKELETON, V70, P101, DOI 10.1002/cm.21094; Castleman VH, 2009, AM J HUM GENET, V84, P197, DOI 10.1016/j.ajhg.2009.01.011; Diener DP, 2011, CYTOSKELETON, V68, P389, DOI 10.1002/cm.20520; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Eriksson M, 2001, BIOCHEM BIOPH RES CO, V281, P835, DOI 10.1006/bbrc.2001.4465; ESCALIER D, 1982, BIOL CELL, V44, P271; Garbino A, 2009, PHYSIOL GENOMICS, V37, P175, DOI 10.1152/physiolgenomics.00017.2009; Gingras D, 1998, MOL BIOL CELL, V9, P513, DOI 10.1091/mbc.9.2.513; Heuser T, 2012, MOL BIOL CELL, V23, P3143, DOI 10.1091/mbc.E12-05-0357; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Kartagener M., 1933, BEITR KLIN ERFORSCH, V83, P489, DOI DOI 10.1007/BF02141468; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Kohno T, 2011, CYTOSKELETON, V68, P237, DOI 10.1002/cm.20507; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Landstrom AP, 2007, J MOL CELL CARDIOL, V42, P1026, DOI 10.1016/j.yjmcc.2007.04.006; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; LUCK D, 1977, P NATL ACAD SCI USA, V74, P3456, DOI 10.1073/pnas.74.8.3456; Mahut B, 2006, PEDIATR PULM, V41, P158, DOI 10.1002/ppul.20329; Marthin JK, 2011, EUR RESPIR J, V37, P559, DOI 10.1183/09031936.00032610; Mateos-Corral D, 2011, J PEDIATR-US, V159, P420, DOI 10.1016/j.jpeds.2011.03.007; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Narang I, 2002, THORAX, V57, P586, DOI 10.1136/thorax.57.7.586; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olbrich H, 2012, AM J HUM GENET, V91, P672, DOI 10.1016/j.ajhg.2012.08.016; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Papon JF, 2010, J MED GENET, V47, P829, DOI 10.1136/jmg.2010.077883; Papon JF, 2010, EUR RESPIR J, V35, P1057, DOI 10.1183/09031936.00046209; Papon JF, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-78; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; PIPERNO G, 1977, P NATL ACAD SCI USA, V74, P1600, DOI 10.1073/pnas.74.4.1600; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Schmid A, 2011, BIOL CELL, V103, P159, DOI 10.1042/BC20100120; Smith EF, 2004, CELL MOTIL CYTOSKEL, V57, P8, DOI 10.1002/cm.10155; Stannard W, 2004, AM J RESP CRIT CARE, V169, P634, DOI 10.1164/rccm.200306-782OC; Tamalet A, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.5.e86; Vallet C, 2013, EUR J PEDIATR, V172, P1053, DOI 10.1007/s00431-013-1996-5; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Zietkiewicz E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033667	54	96	102	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					561	570		10.1016/j.ajhg.2013.07.013	http://dx.doi.org/10.1016/j.ajhg.2013.07.013			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23993197	Bronze, Green Published			2022-12-18	WOS:000330268900016
J	Zeitz, C; Jacobson, SG; Hamel, CP; Bujakowska, K; Neuille, M; Orhan, E; Zanlonghi, X; Lancelot, ME; Michiels, C; Schwartz, SB; Bocquet, B; Antonio, A; Audier, C; Letexier, M; Saraiva, JP; Luu, TD; Sennlaub, F; Nguyen, H; Poch, O; Dollfus, H; Lecompte, O; Kohl, S; Sahel, JA; Bhattacharya, SS; Audo, I				Zeitz, Christina; Jacobson, Samuel G.; Hamel, Christian P.; Bujakowska, Kinga; Neuille, Marion; Orhan, Elise; Zanlonghi, Xavier; Lancelot, Marie-Elise; Michiels, Christelle; Schwartz, Sharon B.; Bocquet, Beatrice; Antonio, Aline; Audier, Claire; Letexier, Melanie; Saraiva, Jean-Paul; Luu, Tien D.; Sennlaub, Florian; Nguyen, Hoan; Poch, Olivier; Dollfus, Helene; Lecompte, Odile; Kohl, Susanne; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Audo, Isabelle		Congenital Stationary Night	Whole-Exome Sequencing Identifies LRIT3 Mutations as a Cause of Autosomal-Recessive Complete Congenital Stationary Night Blindness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEUCINE-RICH REPEAT; RETINITIS-PIGMENTOSA; CHANNEL SUBUNIT; BIPOLAR CELLS; COMPLETE FORM; HIGH MYOPIA; GRM6 GENE; PROTEIN; TRPM1; MGLUR6	Congenital stationary night blindness (CSNB) is a clinically and genetically heterogeneous retinal disorder. Two forms can be distinguished clinically: complete CSNB (cCSNB) and incomplete CSNB. Individuals with cCSNB have visual impairment under low-light conditions and show a characteristic electroretinogram (ERG). The b-wave amplitude is severely reduced in the dark-adapted state of the ERG, representing abnormal function of ON bipolar cells. Furthermore, individuals with cCSNB can show other ocular features such as nystagmus, myopia, and strabismus and can have reduced visual acuity and abnormalities of the cone ERG waveform. The mode of inheritance of this form can be X-linked or autosomal recessive, and the dysfunction of four genes (NYX, GRM6, TRPM1, and GPR179) has been described so far. Whole-exome sequencing in one simplex cCSNB case lacking mutations in the known genes led to the identification of a missense mutation (c.983G>A [p.Cys328Tyr]) and a nonsense mutation (c.1318C>T [p.Arg440*]) in LRIT3, encoding leucine-rich-repeat (LRR), immunoglobulin-like, and transmembrane-domain 3 (LRIT3). Subsequent Sanger sequencing of 89 individuals with CSNB identified another cCSNB case harboring a nonsense mutation (c.1151C>G [p.Ser384*]) and a deletion predicted to lead to a premature stop codon (c.1538_1539del [p.Ser513Cysfs*59]) in the same gene. Human LRIT3 antibody staining revealed in the outer plexiform layer of the human retina a punctate-labeling pattern resembling the dendritic tips of bipolar cells; similar patterns have been observed for other proteins implicated in cCSNB. The exact role of this LRR protein in cCSNB remains to be elucidated.	[Zeitz, Christina; Bujakowska, Kinga; Neuille, Marion; Orhan, Elise; Lancelot, Marie-Elise; Michiels, Christelle; Antonio, Aline; Audier, Claire; Sennlaub, Florian; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Audo, Isabelle] INSERM, UMR S968, F-75012 Paris, France; [Zeitz, Christina; Bujakowska, Kinga; Neuille, Marion; Orhan, Elise; Lancelot, Marie-Elise; Michiels, Christelle; Antonio, Aline; Audier, Claire; Sennlaub, Florian; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Audo, Isabelle] CNRS, UMR 7210, F-75012 Paris, France; [Zeitz, Christina; Bujakowska, Kinga; Neuille, Marion; Orhan, Elise; Lancelot, Marie-Elise; Michiels, Christelle; Antonio, Aline; Audier, Claire; Sennlaub, Florian; Sahel, Jose-Alain; Bhattacharya, Shomi S.; Audo, Isabelle] Univ Paris 06, Inst Vis, UMR S968, F-75012 Paris, France; [Jacobson, Samuel G.; Schwartz, Sharon B.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Hamel, Christian P.; Bocquet, Beatrice] Hop St Eloi, Inst Neurosci Montpellier, INSERM, U583, F-34295 Montpellier 5, France; [Zanlonghi, Xavier] Clin Sourdille, Serv Explorat Fonct Vis, F-44000 Nantes, France; [Zanlonghi, Xavier] Clin Sourdille, Ctr Basse Vis, F-44000 Nantes, France; [Letexier, Melanie; Saraiva, Jean-Paul] IntegraGen, F-91000 Evry, France; [Luu, Tien D.; Nguyen, Hoan; Poch, Olivier; Lecompte, Odile] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Dollfus, Helene] Hop Univ Strasbourg, Ctr Reference Affect Rares Genet Ophtalmol, F-67000 Strasbourg, France; [Dollfus, Helene] Hop Univ Strasbourg, Fac Med, Equipe Avenir Inst Natl Sante & Rech Med, Lab Physiopathol Syndromes Rares Hereditaires, F-67000 Strasbourg, France; [Kohl, Susanne] Univ Tubingen, Dept Ophthalmol, Inst Ophthalm Res, Mol Genet Lab, D-72076 Tubingen, Germany; [Audo, Isabelle] INSERM, Ctr Invest Clin 503, Ctr Hosp Natl Ophtalmol Quinze Vingts, F-75012 Paris, France; [Sahel, Jose-Alain; Audo, Isabelle] Direct Hospitalisat & Org Soins, F-75012 Paris, France; [Sahel, Jose-Alain; Bhattacharya, Shomi S.; Audo, Isabelle] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, F-75019 Paris, France; [Sahel, Jose-Alain] Inst France, Acad Sci, F-75006 Paris, France; [Bhattacharya, Shomi S.] Andalusian Mol Biol & Regenerat Med Ctr, Dept Cellular Therapy & Regenerat Med, Seville 41902, Spain	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Pennsylvania; Pennsylvania Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Fondation Adolphe de Rothschild; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER)	Zeitz, C (corresponding author), INSERM, UMR S968, F-75012 Paris, France.	christina.zeitz@inserm.fr	Bhattacharya, Shom/N-2926-2016; Zeitz, Christina/F-2757-2017; Sahel, Jose-Alain/F-3172-2017; Lecompte, Odile/N-7992-2019; Lecompte, Odile/F-4741-2011; Bocquet, Beatrice/AAY-8447-2020; Sennlaub, Florian/F-2756-2017; Bujakowska, Kinga Maria/AGL-1293-2022	Bhattacharya, Shom/0000-0002-1601-6344; Zeitz, Christina/0000-0002-3510-1712; Sahel, Jose-Alain/0000-0002-4831-1153; Lecompte, Odile/0000-0002-2005-460X; Lecompte, Odile/0000-0002-2005-460X; Bocquet, Beatrice/0000-0002-6369-4818; Sennlaub, Florian/0000-0003-4412-1341; Kohl, Susanne/0000-0002-6438-6331; Audo, Isabelle/0000-0003-0698-5309; Orhan, Elise/0000-0002-8306-5250; Jacobson, Samuel/0000-0003-2122-169X; Dollfus, Helene/0000-0002-2249-895X; Bujakowska, Kinga/0000-0001-6809-9818	Retina France (100 Exome Project); Foundation Voir et Entendre; Foundation Fighting Blindness (FFB) [CD-CL-0808-0466-CHNO, C-CMM-0907-0428-INSERM04]; Ville de Paris and Region Ile de France; French Association against Myopathy [KBM-14390]; Institut National de la Sante et de la Recherche Medicale/Indian Council of Medical Research [53/1/Indo-Foreign/Oph/10-NCD-II]	Retina France (100 Exome Project); Foundation Voir et Entendre; Foundation Fighting Blindness (FFB); Ville de Paris and Region Ile de France(Region Ile-de-France); French Association against Myopathy; Institut National de la Sante et de la Recherche Medicale/Indian Council of Medical Research	We thank the families described in this study and the members of the Congenital Stationary Night Blindness Consortium: Tharigopala Arokiasamy, Mario Anastasi, Eyal Banin, Wolfgang Berger, Elfride De Baere, Dominique Bonneau, Kristen Bowles, Ingele Casteels, Sabine Defoort-Dhellemmes, Isabelle Drumare, Christoph Friedburg, Irene Gottlob, John R. Heckenlively, Elise Heon, Graham E. Holder, Bernhard Jurklies, Josseline Kaplan, Ulrich Kellner, Robert Koenekoop, Martin McKibbin, Francoise Meire, Guylene Le Meur, Bart P. Leroy, Vernon W. Long, Birgit Lorenz, Sivasankar Malaichamy, Rebecca McLean, Saddek Mohand-Said, Tony Moore, Francis L. Munier, Sylvie Odent, Charlotte M. Poloschek, Markus Preising, Katrina Prescott, Thorny de Ravel, Agnes B. Renner, Anthony G. Robson, Ramya Sachidanandam, Daniel F. Schorderet, Panagiotis Sergouniotis, Hendrik Scholl, Dror Sharon, Parveen Sen, Ian Simmons, Huibert Simonz, Nagasamy Soumittra, Joanne Sutherland, Annick Toutain, Ajoy Vincent, Andrew Webster, Bernd Wissinger, and Eberhart Zrenner. We also thank Serge Pic-.aud, Main Chedotal, Kim Nguyen-Ba-Charvet, and Xavier Guillonneau for fruitful discussions; Thierry Leveillard and Botond Roska for providing access to retina-specific-expression databases; and Sophie Lavalette for protein extraction of human retina. The project was supported by Retina France (part of the 100 Exome Project) (J.-A.S., I.A., C.Z., C.H., and H.D.), Foundation Voir et Entendre (C.Z.), Foundation Fighting Blindness (FFB) (grant CD-CL-0808-0466-CHNO to I.A. [Centre d'Investigation Clinique 503 is recognized as an FFB center] and grant C-CMM-0907-0428-INSERM04), Ville de Paris and Region Ile de France, French Association against Myopathy grant KBM-14390 (O.P.), and Institut National de la Sante et de la Recherche Medicale/Indian Council of Medical Research accord 53/1/Indo-Foreign/Oph/10-NCD-II (C.Z. and N.S.).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aleman TS, 2009, EYE, V23, P230, DOI 10.1038/eye.2008.264; Audo I, 2008, SURV OPHTHALMOL, V53, P16, DOI 10.1016/j.survophthal.2007.10.010; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Catalani E, 2009, CELL TISSUE RES, V336, P423, DOI 10.1007/s00441-009-0787-9; de Wit J, 2011, ANNU REV CELL DEV BI, V27, P697, DOI 10.1146/annurev-cellbio-092910-154111; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Feldkamper M, 2003, DEV OPHTHALMOL, V37, P34; Hess RF, 2006, CURR BIOL, V16, P687, DOI 10.1016/j.cub.2006.02.065; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Kazmi MA, 1997, INVEST OPHTH VIS SCI, V38, P1074; Kim SD, 2012, FEBS LETT, V586, P1516, DOI 10.1016/j.febslet.2012.04.010; Koike C, 2010, P NATL ACAD SCI USA, V107, P332, DOI 10.1073/pnas.0912730107; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Marmor MF, 2009, DOC OPHTHALMOL, V118, P69, DOI 10.1007/s10633-008-9155-4; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Morgans CW, 2006, EUR J NEUROSCI, V23, P1163, DOI 10.1111/j.1460-9568.2006.04647.x; Nakamura M, 2010, MOL VIS, V16, P425; Nam J, 2011, SEMIN CELL DEV BIOL, V22, P492, DOI 10.1016/j.semcdb.2011.06.005; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; O'Connor E, 2006, BRIT J OPHTHALMOL, V90, P653, DOI 10.1136/bjo.2005.086678; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; Pearring JN, 2011, J NEUROSCI, V31, P10060, DOI 10.1523/JNEUROSCI.1014-11.2011; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Riazuddin SA, 2010, AM J HUM GENET, V87, P523, DOI 10.1016/j.ajhg.2010.08.013; Schaeffel Frank, 2003, Clin Exp Optom, V86, P295; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; Sergouniotis PI, 2012, ACTA OPHTHALMOL, V90, pe192, DOI 10.1111/j.1755-3768.2011.02267.x; Sergouniotis PI, 2011, AM J HUM GENET, V89, P183, DOI 10.1016/j.ajhg.2011.06.002; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Siegert S, 2012, NAT NEUROSCI, V15, P487, DOI 10.1038/nn.3032; Sieving P A, 1993, Trans Am Ophthalmol Soc, V91, P701; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Tian QB, 2006, EUR J NEUROSCI, V23, P2864, DOI 10.1111/j.1460-9568.2006.04846.x; Luu TD, 2012, NUCLEIC ACIDS RES, V40, pW71, DOI 10.1093/nar/gks474; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; Wang Q, 2012, INT J MOL MED, V30, P521, DOI 10.3892/ijmm.2012.1039; Westall Carol A., 2001, Documenta Ophthalmologica, V102, P115, DOI 10.1023/A:1017535207481; Wycisk KA, 2006, AM J HUM GENET, V79, P973, DOI 10.1086/508944; Xu XY, 2009, MOL VIS, V15, P2094; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2007, EXPERT REV OPHTHALMO, V2, P467, DOI 10.1586/17469899.2.3.467; Zeitz C, 2006, AM J HUM GENET, V79, P657, DOI 10.1086/508067; Zeitz C, 2009, INVEST OPHTH VIS SCI, V50, P5919, DOI 10.1167/iovs.09-3548; Zhang QJ, 2007, MOL VIS, V13, P330	53	96	102	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					67	75		10.1016/j.ajhg.2012.10.023	http://dx.doi.org/10.1016/j.ajhg.2012.10.023			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23246293	Green Published, Bronze			2022-12-18	WOS:000313759000006
J	Vuillaumier-Barrot, S; Bouchet-Seraphin, C; Chelbi, M; Devisme, L; Quentin, S; Gazal, S; Laquerriere, A; Fallet-Bianco, C; Loget, P; Odent, S; Carles, D; Bazin, A; Aziza, J; Clemenson, A; Guimiot, F; Bonniere, M; Monnot, S; Bole-Feysot, C; Bernard, JP; Loeuillet, L; Gonzales, M; Socha, K; Grandchamp, B; Attie-Bitach, T; Encha-Razavi, F; Seta, N				Vuillaumier-Barrot, Sandrine; Bouchet-Seraphin, Celine; Chelbi, Malika; Devisme, Louise; Quentin, Samuel; Gazal, Steven; Laquerriere, Annie; Fallet-Bianco, Catherine; Loget, Philippe; Odent, Sylvie; Carles, Dominique; Bazin, Anne; Aziza, Jacqueline; Clemenson, Alix; Guimiot, Fabien; Bonniere, Maryse; Monnot, Sophie; Bole-Feysot, Christine; Bernard, Jean-Pierre; Loeuillet, Laurence; Gonzales, Marie; Socha, Koryna; Grandchamp, Bernard; Attie-Bitach, Tania; Encha-Razavi, Ferechte; Seta, Nathalie			Identification of Mutations in TMEM5 and ISPD as a Cause of Severe Cobblestone Lissencephaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WALKER-WARBURG-SYNDROME; GIRDLE MUSCULAR-DYSTROPHY; HEREDITARY MULTIPLE EXOSTOSES; FUKUTIN-RELATED PROTEIN; EYE-BRAIN DISEASE; ALPHA-DYSTROGLYCAN; HEPARAN-SULFATE; FUKUYAMA-TYPE; DEFECTIVE GLYCOSYLATION; CORTICAL DEVELOPMENT	Cobblestone lissencephaly is a peculiar brain malformation with characteristic radiological anomalies. It is defined as cortical dysplasia that results when neuroglial overmigration into the arachnoid space forms an extracortical layer that produces agyria and/or a "cobblestone" brain surface and ventricular enlargement. Cobblestone lissencephaly is pathognomonic of a continuum of autosomal-recessive diseases characterized by cerebral, ocular, and muscular deficits. These include Walker-Warburg syndrome, muscle-eye-brain disease, and Fukuyama muscular dystrophy. Mutations in POMT1, POMT2, POMGNT1, LARGE, FKTN, and FKRP identified these diseases as alpha-dystroglycanopathies. Our exhaustive screening of these six genes, in a cohort of 90 fetal cases, led to the identification of a mutation in only 53% of the families, suggesting that other genes might also be involved. We therefore decided to perform a genome-wide study in two multiplex families. This allowed us to identify two additional genes: TMEM5 and ISPD. Because TMEM has a glycosyltransferase domain and ISPD has an isoprenoid synthase domain characteristic of nucleotide diP-sugar transferases, these two proteins are thought to be involved in the glycosylation of dystroglycan. Further screening of 40 families with cobblestone lissencephaly identified nonsense and frameshift mutations in another four unrelated cases for each gene, increasing the mutational rate to 64% in our cohort. All these cases displayed a severe phenotype of cobblestone lissencephaly A. TMEM5 mutations were frequently associated with gonadal dysgenesis and neural tube defects, and ISPD mutations were frequently associated with brain vascular anomalies.	[Vuillaumier-Barrot, Sandrine; Bouchet-Seraphin, Celine; Chelbi, Malika; Seta, Nathalie] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Vuillaumier-Barrot, Sandrine] Fac Xavier Bichat Paris, INSERM, U773, CRB3, F-75018 Paris, France; [Devisme, Louise] Univ Lille, Ctr Biol Pathol, Inst Pathol, Ctr Hosp Reg, F-59000 Lille, France; [Quentin, Samuel] Hop St Louis, AP HP, Plateforme Genom IUH, F-75010 Paris, France; [Gazal, Steven] Univ Paris 13, Hop Bichat, Plateforme Genom Constitut Grp Hosp, AP HP, F-75010 Paris, France; [Laquerriere, Annie] Univ Rouen, CHU Rouen, Hop Charles Nicolle, F-76031 Rouen, France; [Fallet-Bianco, Catherine] Hop St Anne, Ctr Hosp Gen, F-75674 St Anne, France; [Loget, Philippe] Ctr Hosp Univ Pontchaillou, F-35000 Rennes, France; [Odent, Sylvie] CHU Rennes, Genet Clin, Hosp Sud, F-35203 Rennes, France; [Odent, Sylvie] Univ Rennes 1, UMR 6290, F-35203 Rennes, France; [Carles, Dominique] Grp Hosp Pellegrin Enfants, F-33076 Bordeaux, France; [Bazin, Anne] Ctr Hosp Rene Dubos, Ctr Diag Prenatal, F-95066 Cergy Pontoise, France; [Aziza, Jacqueline] Hop Purpan, F-31059 Toulouse, France; [Clemenson, Alix] CHU St Etienne, Hop Nord, F-42055 St Etienne, France; [Guimiot, Fabien] Hop Robert Debre, AP HP, F-75019 Paris, France; [Bonniere, Maryse; Monnot, Sophie; Attie-Bitach, Tania; Encha-Razavi, Ferechte] Hop Necker Enfants Malad, AP HP, Dept Genet, F-75015 Paris, France; [Bole-Feysot, Christine] Hop Necker Enfants Malad, Fdn IMAGINE, F-75015 Paris, France; [Bernard, Jean-Pierre] Hop Necker Enfants Malad, Serv Gynecol Obstet, AP HP, F-75015 Paris, France; [Loeuillet, Laurence] Ctr Hosp Intercommunal Poissy St Germain En Laye, Serv Anat & Cytol Pathol, F-78300 Poissy, France; [Gonzales, Marie] Hop Armand Trousseau, AP HP, F-75012 Paris, France; [Gonzales, Marie] Univ Paris 06, F-75005 Paris, France; [Socha, Koryna] Ctr Hosp Troyes, Serv Anat & Cytol Pathol, F-10003 Troyes, France; [Grandchamp, Bernard] Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France; [Attie-Bitach, Tania; Encha-Razavi, Ferechte] Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; [Attie-Bitach, Tania; Encha-Razavi, Ferechte] Hop Necker Enfants Malad, Fdn IMAGINE, F-75015 Paris, France; [Attie-Bitach, Tania; Encha-Razavi, Ferechte; Seta, Nathalie] Univ Paris 05, F-75006 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre Hospitalier Annecy Genevois; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Universite Paris 13; CHU de Rouen; Universite de Rouen Normandie; CHU Rennes; CHU Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes 1; CHU Bordeaux; Centre Hospitalier Rene Dubos, Pontoise; CHU de Toulouse; CHU de St Etienne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Vuillaumier-Barrot, S (corresponding author), Hop Bichat Claude Bernard, AP HP, F-75877 Paris, France.	sandrine.vuillatumier@bch.aphp.fr; celine.bouchet@bch.aphp.fr	Fallet-Bianco, Catherine/AAP-7390-2020; Gazal, Steven/AAK-3764-2020; Seta, Nathalie S/F-1824-2018; ATTIE-BITACH, Tania/K-1453-2017; monnot, sophie/H-6152-2017	Seta, Nathalie S/0000-0002-9240-8630; ATTIE-BITACH, Tania/0000-0002-1155-3626; monnot, sophie/0000-0002-1872-8089; Gazal, Steven/0000-0003-4510-5730	GIS Institute for rare diseases; Direction de L'Hospitalization et de l'Organisation des Soins for rare diseases [OPRC 207/35]; Association IMAGE	GIS Institute for rare diseases; Direction de L'Hospitalization et de l'Organisation des Soins for rare diseases; Association IMAGE	This study was supported by a grant from the GIS Institute for rare diseases. Exome sequencing was performed at the IGBMC (Institut de Genetique et de Biologie Moleculaire, Illkirch). The CGH and SNP analyses were performed by the genomic platform of Groupement Hospitalier Universitaire-Nord with grants from the Direction de L'Hospitalization et de l'Organisation des Soins (OPRC 207/35) for rare diseases and by the Necker genomic platform with funding from Association IMAGE to T.A.-B.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Alhamidi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022968; Balci B, 2005, NEUROMUSCULAR DISORD, V15, P271, DOI 10.1016/j.nmd.2005.01.013; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Barkovich AJ, 2001, NEUROLOGY, V57, P2168, DOI 10.1212/WNL.57.12.2168; Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Biancheri R, 2007, BIOCHEM BIOPH RES CO, V363, P1033, DOI 10.1016/j.bbrc.2007.09.066; Bouchet C, 2007, HUM MUTAT, V28, P1020, DOI 10.1002/humu.20561; Brockington M, 2001, HUM MOL GENET, V10, P2851, DOI 10.1093/hmg/10.25.2851; Cheung PK, 2001, AM J HUM GENET, V69, P55, DOI 10.1086/321278; Clement E, 2008, ANN NEUROL, V64, P573, DOI 10.1002/ana.21482; Clement EM, 2008, ARCH NEUROL-CHICAGO, V65, P137, DOI 10.1001/archneurol.2007.2; Devisme L, 2012, BRAIN, V135, P469, DOI 10.1093/brain/awr357; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; Esapa CT, 2002, HUM MOL GENET, V11, P3319, DOI 10.1093/hmg/11.26.3319; Frost AR, 2010, EUR J HUM GENET, V18, P852, DOI 10.1038/ejhg.2010.28; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Godfrey C, 2007, BRAIN, V130, P2725, DOI 10.1093/brain/awm212; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Hara Y, 2011, P NATL ACAD SCI USA, V108, P17426, DOI 10.1073/pnas.1114836108; Hara Y, 2011, NEW ENGL J MED, V364, P939, DOI 10.1056/NEJMoa1006939; Hu YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016866; Hunter WN, 2007, J BIOL CHEM, V282, P21573, DOI 10.1074/jbc.R700005200; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Lefeber DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002427; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Lind T, 1998, J BIOL CHEM, V273, P26265, DOI 10.1074/jbc.273.41.26265; Messina S, 2009, NEUROLOGY, V73, P1599, DOI 10.1212/WNL.0b013e3181c0d47a; Miziorko HM, 2011, ARCH BIOCHEM BIOPHYS, V505, P131, DOI 10.1016/j.abb.2010.09.028; Nakano I, 1996, ACTA NEUROPATHOL, V91, P313, DOI 10.1007/s004010050431; Pedersen LC, 2000, J BIOL CHEM, V275, P34580, DOI 10.1074/jbc.M007399200; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raducu M, 2012, EUR J HUM GENET, V20, P945, DOI 10.1038/ejhg.2012.40; Richard SB, 2001, NAT STRUCT BIOL, V8, P641, DOI 10.1038/89691; Roscioli T, 2012, NAT GENET, V44, P581, DOI 10.1038/ng.2253; SANTAVUORI P, 1989, BRAIN DEV-JPN, V11, P147, DOI 10.1016/S0387-7604(89)80088-9; Schollen E, 2000, EUR J HUM GENET, V8, P367, DOI 10.1038/sj.ejhg.5200470; Taniguchi K, 2003, HUM MOL GENET, V12, P527, DOI 10.1093/hmg/ddg043; Vajsar J, 2008, NEUROMUSCULAR DISORD, V18, P675, DOI 10.1016/j.nmd.2008.05.014; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; vanderKnaap MS, 1997, ANN NEUROL, V42, P50, DOI 10.1002/ana.410420110; Vuillaumier-Barrot S, 2011, NEUROMUSCULAR DISORD, V21, P782, DOI 10.1016/j.nmd.2011.06.001; Vuillaumier-Barrot S, 2009, NEUROMUSCULAR DISORD, V19, P182, DOI 10.1016/j.nmd.2008.12.005; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Willer T, 2012, NAT GENET, V44, P575, DOI 10.1038/ng.2252; Yamamoto T, 2006, NEUROSCI RES, V56, P391, DOI 10.1016/j.neures.2006.08.009; Yokoyama-Kobayashi M, 1999, GENE, V228, P161, DOI 10.1016/S0378-1119(99)00004-9; Yoshida-Moriguchi T., 2010, AIDS RES HUM RETRO S, V327, P88, DOI DOI 10.1126/SCIENCE.1180512; Zak BM, 2002, BBA-GEN SUBJECTS, V1573, P346, DOI 10.1016/S0304-4165(02)00402-6	51	96	104	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 7	2012	91	6					1135	1143		10.1016/j.ajhg.2012.10.009	http://dx.doi.org/10.1016/j.ajhg.2012.10.009			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	055LI	23217329	Green Published, Bronze			2022-12-18	WOS:000312417400019
J	Baumann, M; Giunta, C; Krabichler, B; Ruschendorf, F; Zoppi, N; Colombi, M; Bittner, RE; Quijano-Roy, S; Muntoni, F; Cirak, S; Schreiber, G; Zou, YQ; Hu, Y; Romero, NB; Carlier, RY; Amberger, A; Deutschmann, A; Straub, V; Rohrbach, M; Steinmann, B; Rostasy, K; Karall, D; Bonnemann, CG; Zschocke, J; Fauth, C				Baumann, Matthias; Giunta, Cecilia; Krabichler, Birgit; Rueschendorf, Franz; Zoppi, Nicoletta; Colombi, Marina; Bittner, Reginald E.; Quijano-Roy, Susana; Muntoni, Francesco; Cirak, Sebahattin; Schreiber, Gudrun; Zou, Yaqun; Hu, Ying; Romero, Norma Beatriz; Carlier, Robert Yves; Amberger, Albert; Deutschmann, Andrea; Straub, Volker; Rohrbach, Marianne; Steinmann, Beat; Rostasy, Kevin; Karall, Daniela; Boennemann, Carsten G.; Zschocke, Johannes; Fauth, Christine			Mutations in FKBP14 Cause a Variant of Ehlers-Danlos Syndrome with Progressive Kyphoscoliosis, Myopathy, and Hearing Loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME EDS; CROSS-LINKS; MUSCLE; VI; FIBRONECTIN; ISOMERASES; INTEGRIN; OVERLAP; MATRIX; CHST14	We report on an autosomal-recessive variant of Ehlers-Danlos syndrome (EDS) characterized by severe muscle hypotonia at birth, progressive scoliosis, joint hypermobility, hyperelastic skin, myopathy, sensorineural hearing impairment, and normal pyridinoline excretion in urine. Clinically, the disorder shares many features with the kyphoscoliotic type of EDS (EDS VIA) and Ullrich congenital muscular dystrophy. Linkage analysis in a large Tyrolean kindred identified a homozygous frameshift mutation in FKBP14 in two affected individuals. Based on the cardinal clinical characteristics of the disorder, four additional individuals originating from different European countries were identified who carried either homozygous or compound heterozygous mutations in FKBP14. FKBP14 belongs to the family of FK506-binding peptidyl-prolyl cis-trans isomerases (PPlases). ER-resident FKBPs have been suggested to act as folding catalysts by accelerating cis-trans isomerization of peptidyl-prolyl bonds and to act occasionally also as chaperones. We demonstrate that FKBP14 is localized in the endoplasmic reticulum (ER) and that deficiency of FKBP14 leads to enlarged ER cisterns in dermal fibroblasts in vivo. Furthermore, indirect immunofluorescence of FKBP14-deficient fibroblasts indicated an altered assembly of the extracellular matrix in vitro. These findings suggest that a disturbance of protein folding in the ER affecting one or more components of the extracellular matrix might cause the generalized connective tissue involvement in this disorder. FKBP14 mutation analysis should be considered in all individuals with apparent kyphoscoliotic type of EDS and normal urinary pyridinoline excretion, in particular in conjunction with sensorineural hearing impairment.	[Baumann, Matthias; Rostasy, Kevin; Karall, Daniela] Innsbruck Med Univ, Dept Paediat Neonatol Paediat Neurol & Inherited, A-6020 Innsbruck, Austria; [Baumann, Matthias; Rohrbach, Marianne; Steinmann, Beat] Univ Childrens Hosp, Div Metab, Connect Tissue Unit, CH-8032 Zurich, Switzerland; [Giunta, Cecilia; Rohrbach, Marianne; Steinmann, Beat] Univ Childrens Hosp, CRC, CH-8032 Zurich, Switzerland; [Krabichler, Birgit; Amberger, Albert; Deutschmann, Andrea; Karall, Daniela; Zschocke, Johannes; Fauth, Christine] Innsbruck Med Univ, Div Human Genet, A-6020 Innsbruck, Austria; [Rueschendorf, Franz] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Zoppi, Nicoletta; Colombi, Marina] Univ Brescia, Dept Biomed Sci & Biotechnol, Div Biol & Genet, I-25123 Brescia, Italy; [Bittner, Reginald E.] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Neuromuscular Res, A-1090 Vienna, Austria; [Quijano-Roy, Susana] UVSQ, Ctr Natl Reference Malad Neuromusculaires Garches, Serv Pediat, Hop Univ Raymond Poincare,APHP, F-92380 Garches, France; [Muntoni, Francesco; Cirak, Sebahattin] Inst Child Hlth, Dubowitz Neuromuscular Ctr, London WC1N 1EH, England; [Schreiber, Gudrun] Klinikum Kassel, Dept Neuropaediat, D-34125 Kassel, Germany; [Zou, Yaqun; Hu, Ying; Boennemann, Carsten G.] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD 20892 USA; [Romero, Norma Beatriz] Grp Hosp Univ Pitie Salpetriere, Inst Myol, Unite Morphol Neuromusculaire, F-75013 Paris, France; [Carlier, Robert Yves] Univ Paris Ile De France, Hop Raymond Poincare, AP HP, Dept Radiol, F-92380 Garches, France; [Straub, Volker] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Medical University of Innsbruck; University Children's Hospital Zurich; University Children's Hospital Zurich; Medical University of Innsbruck; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Brescia; Medical University of Vienna; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Klinikum Kassel; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Newcastle University - UK	Baumann, M (corresponding author), Innsbruck Med Univ, Dept Paediat Neonatol Paediat Neurol & Inherited, A-6020 Innsbruck, Austria.	matthias.baumann@uki.at; christine.fauth@i-med.ac.at	Giunta, Cecilia/T-8222-2019; Quijano-Roy, Susana/GRF-6829-2022; Zschocke, Johannes/C-5885-2013; Cirak, Sebahattin/AAZ-6829-2020; Cirak, Sebahattin/AAX-9593-2020	Giunta, Cecilia/0000-0002-9313-8257; Zschocke, Johannes/0000-0002-0046-8274; Straub, Volker/0000-0001-9046-3540; ZOPPI, Nicoletta/0000-0003-0197-8927; Rohrbach, Marianne/0000-0002-4013-6012; Colombi, Marina/0000-0002-3105-5990	Gottfried und Julia Bangerter-Rhyner Stiftung; Muscular Dystrophy Campaign Centre; Great Ormond Street Hospital Children's Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129] Funding Source: NIH RePORTER; Medical Research Council [G0601943B] Funding Source: researchfish; Rosetrees Trust [M145] Funding Source: researchfish; Muscular Dystrophy UK [RA4/924, RA4/0924] Funding Source: researchfish	Gottfried und Julia Bangerter-Rhyner Stiftung; Muscular Dystrophy Campaign Centre(Muscular Dystrophy Association); Great Ormond Street Hospital Children's Charity; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); Muscular Dystrophy UK	We express our gratitude to all families who participated in this study. We thank Marius Kraenzlin for urinary pyridinoline analysis, Ingrid Hausser-Siller and Patricie Paesold-Burda for helpful discussions, Angelika Schwarze for skilful technical assistance, Rudolf Funke for providing photographs of individual P6, Beril Talim, Haluk Topaloglu, and Julia Wanschitz for providing muscle biopsy data, and Dan Lipsker for skin examination results in individual P4. This work was supported by a grant from the Gottfried und Julia Bangerter-Rhyner Stiftung to C.G. and M.R. The support of the Muscular Dystrophy Campaign Centre grant to the Dubowitz Neuromuscular Centre is gratefully acknowledged. F.M. is supported by the Great Ormond Street Hospital Children's Charity.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Alanay Y, 2010, AM J HUM GENET, V86, P551, DOI 10.1016/j.ajhg.2010.02.022; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; CADLE R G, 1985, American Journal of Human Genetics, V37, pA48; Dundar M, 2009, AM J HUM GENET, V85, P873, DOI 10.1016/j.ajhg.2009.11.010; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Giunta C, 2005, AM J MED GENET A, V133A, P158, DOI 10.1002/ajmg.a.30529; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Jackson SE, 2013, TOP CURR CHEM, V328, P35, DOI 10.1007/128_2011_151; Kelley BP, 2011, J BONE MINER RES, V26, P666, DOI 10.1002/jbmr.250; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Kosho T, 2005, AM J MED GENET A, V138A, P282, DOI 10.1002/ajmg.a.30965; Kraenzlin ME, 2008, CLIN CHEM, V54, P1546, DOI 10.1373/clinchem.2008.105262; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Malfait F, 2010, HUM MUTAT, V31, P1233, DOI 10.1002/humu.21355; Mercuri E, 2005, CURR OPIN NEUROL, V18, P526, DOI 10.1097/01.wco.0000183947.01362.fe; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Nadeau A, 2009, NEUROLOGY, V73, P25, DOI 10.1212/WNL.0b013e3181aae851; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Rohrbach M, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-46; ROYCE PM, 1989, MATRIX, V9, P147, DOI 10.1016/S0934-8832(89)80033-2; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Schievink WI, 2004, NEUROSURGERY, V54, P65, DOI 10.1227/01.NEU.0000097200.18478.7B; SCHMID FX, 1978, P NATL ACAD SCI USA, V75, P4764, DOI 10.1073/pnas.75.10.4764; SCHMID FX, 1993, ADV PROTEIN CHEM, V44, P25, DOI 10.1016/S0065-3233(08)60563-X; Shaheen R, 2010, AM J HUM GENET, V87, P306, DOI 10.1016/j.ajhg.2010.05.020; Shimizu K, 2011, AM J MED GENET A, V155A, P1949, DOI 10.1002/ajmg.a.34115; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Sobel E, 1996, AM J HUM GENET, V58, P1323; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; STEINMANN B, 1984, J BIOL CHEM, V259, P1129; STEINMANN B, 1995, AM J HUM GENET, V57, P1505; Steinmann B., 2002, CONNECTIVE TISSUE IT, P431, DOI DOI 10.1002/0471221929.CH9; Voermans NC, 2008, NEUROMUSCULAR DISORD, V18, P843, DOI 10.1016/j.nmd.2008.05.017; Voermans NC, 2009, AM J MED GENET A, V149A, P2311, DOI 10.1002/ajmg.a.32997; Voermans NC, 2009, ANN NEUROL, V65, P687, DOI 10.1002/ana.21643; VOGEL A, 1979, LAB INVEST, V40, P201; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; Yis U, 2008, NEUROMUSCULAR DISORD, V18, P210, DOI 10.1016/j.nmd.2007.11.006; Zoppi N, 2004, J BIOL CHEM, V279, P18157, DOI 10.1074/jbc.M312609200; Zoppi N, 2008, BBA-MOL CELL RES, V1783, P1177, DOI 10.1016/j.bbamcr.2008.03.003	48	96	99	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					201	216		10.1016/j.ajhg.2011.12.004	http://dx.doi.org/10.1016/j.ajhg.2011.12.004			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22265013	Bronze, Green Published			2022-12-18	WOS:000300742200002
J	Kurreeman, F; Liao, K; Chibnik, L; Hickey, B; Stahl, E; Gainer, V; Li, G; Bry, L; Mahan, S; Ardlie, K; Thomson, B; Szolovits, P; Churchill, S; Murphy, SN; Cai, TX; Raychaudhuri, S; Kohane, I; Karlson, E; Plenge, RM				Kurreeman, Fina; Liao, Katherine; Chibnik, Lori; Hickey, Brendan; Stahl, Eli; Gainer, Vivian; Li, Gang; Bry, Lynn; Mahan, Scott; Ardlie, Kristin; Thomson, Brian; Szolovits, Peter; Churchill, Susanne; Murphy, Shawn N.; Cai, Tianxi; Raychaudhuri, Soumya; Kohane, Isaac; Karlson, Elizabeth; Plenge, Robert M.			Genetic Basis of Autoantibody Positive and Negative Rheumatoid Arthritis Risk in a Multi-ethnic Cohort Derived from Electronic Health Records	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CITRULLINATED PROTEINS; SHARED EPITOPE; ANTIBODIES; LOCUS; STRATIFICATION; SUSCEPTIBILITY; PROGRESSION; DISEASES; AMERICA	Discovering and following up on genetic associations with complex phenotypes require large patient cohorts. This is particularly true for patient cohorts of diverse ancestry and clinically relevant subsets of disease. The ability to mine the electronic health records (EHRs) of patients followed as part of routine clinical care provides a potential opportunity to efficiently identify affected cases and unaffected controls for appropriate-sized genetic studies. Here, we demonstrate proof-of-concept that it is possible to use EHR data linked with biospecimens to establish a multi-ethnic case-control cohort for genetic research of a complex disease, rheumatoid arthritis (RA). In 1,515 EHR-derived RA cases and 1,480 controls matched for both genetic ancestry and disease-specific autoantibodies (anti-citrullinated protein antibodies [ACPA]), we demonstrate that the odds ratios and aggregate genetic risk score (GRS) of known RA risk alleles measured in individuals of European ancestry within our EHR cohort are nearly identical to those derived from a genome-wide association study (GWAS) of 5,539 autoantibody-positive RA cases and 20,169 controls. We extend this approach to other ethnic groups and identify a large overlap in the GRS among individuals of European, African, East Asian, and Hispanic ancestry. We also demonstrate that the distribution of a GRS based on 28 non-HLA risk alleles in ACPA+ cases partially overlaps with ACPA- subgroup of RA cases. Our study demonstrates that the genetic basis of rheumatoid arthritis risk is similar among cases of diverse ancestry divided into subsets based on ACPA status and emphasizes the utility of linking EHR clinical data with biospecimens for genetic studies.	[Kurreeman, Fina; Liao, Katherine; Hickey, Brendan; Stahl, Eli; Li, Gang; Raychaudhuri, Soumya; Karlson, Elizabeth; Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Kurreeman, Fina; Liao, Katherine; Hickey, Brendan; Stahl, Eli; Li, Gang; Raychaudhuri, Soumya; Karlson, Elizabeth; Plenge, Robert M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Kurreeman, Fina; Chibnik, Lori; Hickey, Brendan; Stahl, Eli; Mahan, Scott; Ardlie, Kristin; Thomson, Brian; Raychaudhuri, Soumya; Plenge, Robert M.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kurreeman, Fina] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2333 ZA Leiden, Netherlands; [Chibnik, Lori] Brigham & Womens Hosp, Dept Neurol, Program Translat Neuropsychiat Genom, Boston, MA 02115 USA; [Gainer, Vivian; Murphy, Shawn N.] Partners Healthcare Syst, Informat, Boston, MA 02115 USA; [Bry, Lynn] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Szolovits, Peter] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Churchill, Susanne; Murphy, Shawn N.; Kohane, Isaac] I2b2 Natl Ctr Biomed Comp, Boston, MA 02115 USA; [Cai, Tianxi] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Kohane, Isaac] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Kohane, Isaac] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Plenge, RM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA.	rplenge@partners.org	Kohane, Isaac Kohane/K-3716-2012	Kohane, Isaac Kohane/0000-0003-2192-5160; Bry, Lynn/0000-0002-8792-8527; Chibnik, Lori/0000-0001-6293-806X; Raychaudhuri, Soumya/0000-0002-1901-8265; Szolovits, Peter/0000-0001-8411-6403	National Library of Medicine [U54-LM008748]; National Institutes of Health [R01-AR057108, R01-AR056768, U01-GM092691]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057108, R01AR059648, R01AR056768, K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The project was supported by award number U54-LM008748 from the National Library of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Library of Medicine or the National Institutes of Health. R.M.P. was supported by grants from the National Institutes of Health (R01-AR057108, R01-AR056768, and U01-GM092691) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund.	Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; DesRoches CM, 2010, HEALTH AFFAIR, V29, P639, DOI 10.1377/hlthaff.2009.1086; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Ginsburg GS, 2008, JAMA-J AM MED ASSOC, V299, P1359, DOI 10.1001/jama.299.11.1359; Gregersen PK, 2009, NAT GENET, V41, P820, DOI 10.1038/ng.395; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Irigoyen P, 2005, ARTHRITIS RHEUM-US, V52, P3813, DOI 10.1002/art.21419; Jha AK, 2010, HEALTH AFFAIR, V29, P1951, DOI 10.1377/hlthaff.2010.0502; Karlson EW, 2010, ANN RHEUM DIS, V69, P1077, DOI 10.1136/ard.2009.120170; Kochi Y, 2010, NAT GENET, V42, P515, DOI 10.1038/ng.583; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; LIAO KP, 2010, ELECT MED RECORDS DI; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Team RC., 2022, R LANG ENV STAT COMP; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; van der Woude D, 2009, ARTHRITIS RHEUM-US, V60, P916, DOI 10.1002/art.24385; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037	38	96	99	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 7	2011	88	1					57	69		10.1016/j.ajhg.2010.12.007	http://dx.doi.org/10.1016/j.ajhg.2010.12.007			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	710HJ	21211616	Green Published, Bronze			2022-12-18	WOS:000286501500005
J	Zawistowski, M; Gopalakrishnan, S; Ding, J; Li, Y; Grimm, S; Zollner, S				Zawistowski, Matthew; Gopalakrishnan, Shyam; Ding, Jun; Li, Yun; Grimm, Sara; Zollner, Sebastian			Extending Rare-Variant Testing Strategies Analysis of Noncoding Sequence and Imputed Genotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GENETIC-VARIATION; HUMAN GENOME; COMPLEX DISEASES; ASSOCIATION; TRAITS	Next Generation Sequencing Technology has revolutionized our ability to study the contribution of rare genetic variation to heritable traits However existing single marker association tests are underpowered for detecting rare risk variants A more powerful approach involves pooling methods that combine multiple rare variants from the same gene into a single test statistic Proposed pooling methods can be limited because they generally assume high quality genotypes derived from deep coverage sequencing which may not be avail able In this paper we consider an intuitive and computationally efficient pooling statistic the cumulative minor allele test (CMAT) We assess the performance of the CMAT and other pooling methods on datasets simulated with population genetic models to contain realistic levels of neutral variation We consider study designs ranging from exon only to whole gene analyses that contain noncoding variants For all study designs the CMAT achieves power comparable to that of previously proposed methods We then extend the CMAT to probabilistic genotypes and describe application to low coverage sequencing and imputation data We show that augmenting sequence data with imputed samples is a practical method for increasing the power of rare variant studies We also provide a method of controlling for confounding variables such as population stratification Finally we demonstrate that our method makes it possible to use external imputation templates to analyze rare variants imputed into existing GWAS datasets As proof of principle, we performed a CMAT analysis of more than 8 million SNPs that we imputed Into the GAIN psoriasis dataset by using haplotypes from the 1000 Genomes Project	[Zawistowski, Matthew; Gopalakrishnan, Shyam; Ding, Jun; Zollner, Sebastian] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Zawistowski, Matthew; Gopalakrishnan, Shyam; Ding, Jun; Zollner, Sebastian] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Grimm, Sara] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Zollner, Sebastian] Univ Michigan, Bioinformat Program, Ann Arbor, MI 48109 USA; [Zollner, Sebastian] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zollner, S (corresponding author), Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA.		Gopalakrishnan, Shyam/J-1546-2019; Ding, Jun/G-3918-2011	Gopalakrishnan, Shyam/0000-0002-2004-6810; Zawistowski, Matthew/0000-0002-3005-083X	National Institutes of Health [R01 HL90564, R01 HG005855]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090564] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005855] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank Tanya Teslovich Paul Scheet, Mike Boehnke and Gon calo Abecasis for helpful discussions, Derek Chiang for the 1000 genomes annotation and Matthew Flickinger for assistance with graphical layouts This work was supported by National Institutes of Health grants R01 HL90564 and R01 HG005855	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Haller G, 2009, J ALLERGY CLIN IMMUN, V124, P1204, DOI 10.1016/j.jaci.2009.09.013; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Huang L, 2009, AM J HUM GENET, V85, P692, DOI 10.1016/j.ajhg.2009.09.017; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li BS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000481; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lomelin D, 2010, GENOME RES, V20, P311, DOI 10.1101/gr.094151.109; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pauws E, 2009, J MED GENET, V46, P555, DOI 10.1136/jmg.2009.066902; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reumers J, 2008, NUCLEIC ACIDS RES, V36, pD825, DOI 10.1093/nar/gkm979; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308	30	96	100	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 12	2010	87	5					604	617		10.1016/j.ajhg.2010.10.012	http://dx.doi.org/10.1016/j.ajhg.2010.10.012			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	686AE	21070896	Green Published, Bronze			2022-12-18	WOS:000284668400006
J	Van Camp, G; Snoeckx, RL; Hilgert, N; van den Ende, J; Fukuoka, H; Wagatsuma, M; Suzuki, H; Smets, RME; Vanhoenacker, F; Declau, F; Van De Heyning, P; Usami, S				Van Camp, Guy; Snoeckx, Rikkert L.; Hilgert, Nele; van den Ende, Jenneke; Fukuoka, Hisakumi; Wagatsuma, Michio; Suzuki, Hiroaki; Smets, R. M. Erica; Vanhoenacker, Filip; Declau, Frank; Van De Heyning, Paul; Usami, Shin-ichi			A new autosomal recessive form of Stickler syndrome is caused by a mutation in the COL9A1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE EPIPHYSEAL DYSPLASIA; DISORDER OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; COLLAGEN TYPE-II; COL11A2 GENE; LOCUS HETEROGENEITY; VITREOUS PHENOTYPE; SYNDROME TYPE-2; HEARING-LOSS; KNOCK-OUT; IX	Stickler syndrome is characterized by ophthalmic, articular, orofacial, and auditory manifestations. It has an autosomal dominant inheritance pattern and is caused by mutations in COL2A1, COL11A1, and COL11A2. We describe a family of Moroccan origin that consists of four children with Stickler syndrome, six unaffected children, and two unaffected parents who are distant relatives ( fifth degree). All family members were clinically investigated for ear, nose, and throat; ophthalmologic; and radiological abnormalities. Four children showed symptoms characteristic of Stickler syndrome, including moderate-to-severe sensorineural hearing loss, moderate-to-high myopia with vitreoretinopathy, and epiphyseal dysplasia. We considered the COL9A1 gene, located on chromosome 6q13, to be a candidate gene on the basis of the structural association with collagen types II and XI and because of the high expression in the human inner ear indicated by cDNA microarray. Mutation analysis of the coding region of the COL9A1 gene showed a homozygous R295X mutation in the four affected children. The parents and four unaffected children were heterozygous carriers of the R295X mutation. Two unaffected children were homozygous for the wild-type allele. None of the family members except the homozygous R295X carriers had any signs of Stickler syndrome. Therefore, COL9A1 is the fourth identified gene that can cause Stickler syndrome. In contrast to the three previously reported Stickler syndrome - causing genes, this gene causes a form of Stickler syndrome with an autosomal recessive inheritance pattern. This finding will have a major impact on the genetic counseling of patients with Stickler syndrome and on the understanding of the pathophysiology of collagens. Mutation analysis of this gene is recommended in patients with Stickler syndrome with possible autosomal recessive inheritance.	Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; Univ Antwerp Hosp, Dept Ophthalmol, Antwerp, Belgium; Univ Antwerp Hosp, Dept Radiol, Antwerp, Belgium; Univ Antwerp Hosp, Dept Otorhinolaryngol Head & Neck Surg, Antwerp, Belgium; Univ Antwerp Hosp, Dept Commun Disorders, Antwerp, Belgium; Shinshu Univ, Sch Med, Dept Otorhinolaryngol, Matsumoto, Nagano 390, Japan	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; Shinshu University	Van Camp, G (corresponding author), Univ Antwerp, Dept Med Genet, Univ Pl 1, B-2610 Antwerp, Belgium.	guy.vancamp@ua.ac.be	Van Camp, Guy/F-3386-2013; Heyning, Paul H Vande/I-8278-2017; Declau, Frank/AAH-6784-2021	Van Camp, Guy/0000-0001-5105-9000; Heyning, Paul H Vande/0000-0002-8424-3717; Declau, Frank/0000-0001-6969-1565				Abe S, 2003, AM J HUM GENET, V72, P73, DOI 10.1086/345398; BISHOP PN, 1994, BIOCHEM J, V299, P497, DOI 10.1042/bj2990497; Bishop PN, 2004, INVEST OPHTH VIS SCI, V45, P1041, DOI 10.1167/iovs.03-1017; Bonnemann CG, 2000, P NATL ACAD SCI USA, V97, P1212, DOI 10.1073/pnas.97.3.1212; Briggs MD, 2002, HUM MUTAT, V19, P465, DOI 10.1002/humu.10066; Chen M, 2005, IEEE SPECTRUM, V42, P6; Czarny-Ratajczak M, 2001, AM J HUM GENET, V69, P969, DOI 10.1086/324023; FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070; Hagg R, 1997, J BIOL CHEM, V272, P20650, DOI 10.1074/jbc.272.33.20650; Holden P, 1999, AM J HUM GENET, V65, P31, DOI 10.1086/302440; Ihanamaki T, 2004, PROG RETIN EYE RES, V23, P403, DOI 10.1016/j.preteyeres.2004.04.002; JACENKO O, 1995, J RHEUMATOL, V22, P39; Li SW, 2001, DEV DYNAM, V222, P141, DOI 10.1002/dvdy.1178; Lohiniva J, 2000, AM J MED GENET, V90, P216, DOI 10.1002/(SICI)1096-8628(20000131)90:3<216::AID-AJMG6>3.0.CO;2-1; Martin S, 1999, EUR J HUM GENET, V7, P807, DOI 10.1038/sj.ejhg.5200377; MAYNE R, 1993, J BIOL CHEM, V268, P9381; McGuirt WT, 1999, NAT GENET, V23, P413, DOI 10.1038/70516; McLeod D, 2002, GRAEF ARCH CLIN EXP, V240, P63, DOI 10.1007/s00417-001-0380-8; Melkoniemi M, 2000, AM J HUM GENET, V66, P368, DOI 10.1086/302750; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Muragaki Y, 1996, ANN NY ACAD SCI, V785, P303, DOI 10.1111/j.1749-6632.1996.tb56291.x; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Nakashima E, 2005, AM J MED GENET A, V132A, P181, DOI 10.1002/ajmg.a.30411; Paassilta P, 1999, J BIOL CHEM, V274, P22469, DOI 10.1074/jbc.274.32.22469; Parentin F, 2001, GRAEF ARCH CLIN EXP, V239, P316, DOI 10.1007/s004170100286; Pihlajamaa T, 1998, AM J MED GENET, V80, P115, DOI 10.1002/(SICI)1096-8628(19981102)80:2<115::AID-AJMG5>3.0.CO;2-O; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Rose PS, 2001, SPINE, V26, P403, DOI 10.1097/00007632-200102150-00017; SCOTT JD, 1980, T OPHTHAL SOC UK, V100, P69; SCOTT JE, 1992, EYE, V6, P553, DOI 10.1038/eye.1992.120; SCOTT JE, 1990, BIOCHEM SOC T, V18, P489, DOI 10.1042/bst0180489a; SLEPECKY NB, 1992, MATRIX, V12, P80, DOI 10.1016/S0934-8832(11)80108-3; SNEAD MP, 1994, EYE, V8, P609, DOI 10.1038/eye.1994.153; Snead MP, 1996, ANN NY ACAD SCI, V785, P331, DOI 10.1111/j.1749-6632.1996.tb56300.x; STICKLER GB, 1965, MAYO CLIN PROC, V40, P433; Suzuki N, 2005, NEUROSCI RES, V51, P293, DOI 10.1016/j.neures.2004.12.001; THALMANN I, 1993, CONNECT TISSUE RES, V29, P191, DOI 10.3109/03008209309016826; Valkkila M, 2001, MATRIX BIOL, V20, P357, DOI 10.1016/S0945-053X(01)00145-7; vanSteensel MAM, 1997, AM J MED GENET, V70, P315; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; Williams CJ, 1996, AM J MED GENET, V63, P461, DOI 10.1002/(SICI)1096-8628(19960614)63:3<461::AID-AJMG9>3.0.CO;2-U; ZLOTOGORA J, 1992, AM J MED GENET, V42, P337, DOI 10.1002/ajmg.1320420316	42	96	101	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					449	457		10.1086/506478	http://dx.doi.org/10.1086/506478			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909383	Green Published, Bronze			2022-12-18	WOS:000239830700007
J	Salas, A; Carracedo, A; Richards, M; Macaulay, V				Salas, A; Carracedo, A; Richards, M; Macaulay, V			Charting the ancestry of African Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ATLANTIC SLAVE-TRADE; MTDNA; ADMIXTURE; PROPORTIONS	The Atlantic slave trade promoted by West European empires (15th-19th centuries) forcibly moved at least 11 million people from Africa, including about one-third from west-central Africa, to European and American destinations. The mitochondrial DNA (mtDNA) genome has retained an imprint of this process, but previous analyses lacked west-central African data. Here, we make use of an African database of 4,860 mtDNAs, which include 948 mtDNA sequences from west-central Africa and a further 154 from the southwest, and compare these for the first time with a publicly available database of 1,148 African Americans from the United States that contains 1,053 mtDNAs of sub-Saharan ancestry. We show that > 55% of the U.S. lineages have a West African ancestry, with < 41% coming from west-central or southwestern Africa. These results are remarkably similar to the most up-to-date analyses of the historical record.	Univ Santiago de Compostela, Inst Med Legale, Fac Med, Unidad Xenet, Indiana, PA 15705 USA; Hosp Clin Univ, Ctr Nacl Genotipado, Galicia, Spain; Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; Univ Glasgow, Dept Stat, Glasgow, Lanark, Scotland	University of Leeds; University of Glasgow	Salas, A (corresponding author), Univ Santiago de Compostela, Inst Med Legale, Fac Med, Unidad Xenet, Indiana, PA 15705 USA.	apimlase@usc.es	Carracedo, Angel/D-4257-2012; Salas, Antonio/E-3977-2012; Salas, Antonio/U-2029-2019	Carracedo, Angel/0000-0003-1085-8986; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; RICHARDS, MARTIN/0000-0003-3118-0967				Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; Bandelt HJ, 2004, SCIENCE, V305, P1402; Bandelt HJ, 2001, ANN HUM GENET, V65, P549, DOI 10.1017/S0003480001008892; Bandelt HJ, 2004, INT J LEGAL MED, V118, P267, DOI 10.1007/s00414-004-0455-2; Budowle V, 2004, J FORENSIC SCI, V49, P1256; CHAKRABORTY R, 1992, AM J HUM GENET, V50, P145; Curtin PD, 1969, ATLANTIC SLAVE TRADE, Vxix; ELTIS D, 1998, TRANSATLANTIC SLAVE, P1527; McMillin J.A, 2004, FINAL VICTIMS FOREIG, P1783; Mesa NR, 2000, AM J HUM GENET, V67, P1277, DOI 10.1016/S0002-9297(07)62955-3; MONSON KL, 2002, MTDNA POPULATION DAT; Parra EJ, 2001, AM J PHYS ANTHROPOL, V114, P18, DOI 10.1002/1096-8644(200101)114:1<18::AID-AJPA1002>3.0.CO;2-2; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Richards M., 2004, TRACES ANCESTRY STUD, P75; Salas A, 2004, AM J HUM GENET, V74, P454, DOI 10.1086/382194; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Sans M, 2000, HUM BIOL, V72, P155; Thomas H, 1998, SLAVE TRADE HIST ATL, P1440	19	96	99	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2005	77	4					676	680		10.1086/491675	http://dx.doi.org/10.1086/491675			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	967QS	16175514	Green Published, Bronze			2022-12-18	WOS:000232106900016
J	Ogdie, MN; Fisher, SE; Yang, M; Ishii, J; Francks, C; Loo, SK; Cantor, RM; McCracken, JT; McGough, JJ; Smalley, SL; Nelson, SF				Ogdie, MN; Fisher, SE; Yang, M; Ishii, J; Francks, C; Loo, SK; Cantor, RM; McCracken, JT; McGough, JJ; Smalley, SL; Nelson, SF			Attention deficit hyperactivity disorder: Fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOPAMINE-D4 RECEPTOR GENE; DEFICIT/HYPERACTIVITY DISORDER; COMPLEX TRAITS; TRANSPORTER GENE; GENOMEWIDE SCAN; ASSOCIATION; POLYMORPHISM; SAMPLE; ADHD; DRD5	We completed fine mapping of nine positional candidate regions for attention-deficit/hyperactivity disorder (ADHD) in an extended population sample of 308 affected sibling pairs (ASPs), constituting the largest linkage sample of families with ADHD published to date. The candidate chromosomal regions were selected from all three published genomewide scans for ADHD, and fine mapping was done to comprehensively validate these positional candidate regions in our sample. Multipoint maximum LOD score (MLS) analysis yielded significant evidence of linkage on 6q12 (MLS 3.30; empiric) and 17p11 (MLS 3.63; empiric P = .015), as well as suggestive evidence on 5p13 (MLS 2.55; empiric P = .091). In conjunction with the previously reported significant linkage on the basis of fine mapping 16p13 in the same sample as this report, the analyses presented here indicate that four chromosomal regions - 5p13, 6q12, 16p13, and 17p11 - are likely to harbor susceptibility genes for ADHD. The refinement of linkage within each of these regions lays the foundation for subsequent investigations using association methods to detect risk genes of moderate effect size.	Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Oxford; Wellcome Centre for Human Genetics	Nelson, SF (corresponding author), 5506B Gonda Bldg,695 Young Dr S, Los Angeles, CA 90095 USA.	snelson@ucla.edu	Francks, Clyde/AGU-8875-2022; Nelson, Stanley F/D-4771-2009; Fisher, Simon E./E-9130-2012; Francks, Clyde/E-1384-2012	Nelson, Stanley F/0000-0002-2082-3114; Fisher, Simon E./0000-0002-3132-1996; Francks, Clyde/0000-0002-9098-890X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH001805, R01MH058277] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007104, GM07104] Funding Source: Medline; NIMH NIH HHS [MH01969, K24 MH001805, MH58277, MH01805, R01 MH058277] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; ANDERSON JC, 1987, ARCH GEN PSYCHIAT, V44, P69; Bakker SC, 2003, AM J HUM GENET, V72, P1251, DOI 10.1086/375143; Barrett SR, 2000, CAN J SOCIOL, V25, P405, DOI 10.2307/3341653; Brophy K, 2002, MOL PSYCHIATR, V7, P913, DOI 10.1038/sj.mp.4001092; COOK EH, 1995, AM J HUM GENET, V56, P993; Daly G, 1999, MOL PSYCHIATR, V4, P192, DOI 10.1038/sj.mp.4000510; Faraone SV, 2001, AM J PSYCHIAT, V158, P1052, DOI 10.1176/appi.ajp.158.7.1052; Faraone SV, 2001, CHILD ADOL PSYCH CL, V10, P299; Faraone SV, 2000, GENET EPIDEMIOL, V18, P1; Fisher SE, 2002, AM J HUM GENET, V70, P1183, DOI 10.1086/340112; Gill M, 1997, MOL PSYCHIATR, V2, P311, DOI 10.1038/sj.mp.4000290; Gomez R, 1999, J CHILD PSYCHOL PSYC, V40, P265, DOI 10.1111/1469-7610.00440; Hinds DA, 1996, ASPEX PACKAGE AFFECT; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Holmes J, 2000, MOL PSYCHIATR, V5, P523, DOI 10.1038/sj.mp.4000751; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; Kustanovich V, 2003, MOL PSYCHIATR, V8, P309, DOI 10.1038/sj.mp.4001247; LaHoste GJ, 1996, MOL PSYCHIATR, V1, P121; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Lowe N, 2004, AM J HUM GENET, V74, P348, DOI 10.1086/381561; Manor I, 2001, AM J MED GENET, V105, P91; McCracken JT, 2000, MOL PSYCHIATR, V5, P531, DOI 10.1038/sj.mp.4000770; MCCRACKEN JT, 1998, TXB PEDIAT NEUROPSYC, P483; Mill J, 2001, MOL PSYCHIATR, V6, P440, DOI 10.1038/sj.mp.4000881; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Ogdie MN, 2003, AM J HUM GENET, V72, P1268, DOI 10.1086/375139; Palferman S, 2001, AM J HUM GENET, V69, P570; Palmer K J, 1999, Drugs R D, V1, P9, DOI 10.2165/00126839-199901010-00002; Quist JF, 2003, MOL PSYCHIATR, V8, P98, DOI 10.1038/sj.mp.4001244; RISCH N, 1990, AM J HUM GENET, V46, P229; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Seeger G, 2001, MOL PSYCHIATR, V6, P235, DOI 10.1038/sj.mp.4000820; Smalley SL, 1997, AM J HUM GENET, V60, P1276, DOI 10.1086/515485; Smalley SL, 2000, J AM ACAD CHILD PSY, V39, P1135, DOI 10.1097/00004583-200009000-00013; Smalley SL, 2002, AM J HUM GENET, V71, P959, DOI 10.1086/342732; Smalley SL, 1998, MOL PSYCHIATR, V3, P427, DOI 10.1038/sj.mp.4000457; Sobel E, 1996, AM J HUM GENET, V58, P1323; Swanson JM, 1998, LANCET, V351, P429, DOI 10.1016/S0140-6736(97)11450-7; Tahir E, 2000, MOL PSYCHIATR, V5, P396, DOI 10.1038/sj.mp.4000744; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945; Wiltshire S, 2002, AM J HUM GENET, V71, P1175, DOI 10.1086/342976; Wolraich ML, 1996, J AM ACAD CHILD PSY, V35, P319, DOI 10.1097/00004583-199603000-00013; Yonan AL, 2003, AM J HUM GENET, V73, P886, DOI 10.1086/378778	47	96	102	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					661	668		10.1086/424387	http://dx.doi.org/10.1086/424387			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15297934	Bronze, Green Published			2022-12-18	WOS:000223634100012
J	Thompson, D; Easton, DF; Goldgar, DE				Thompson, D; Easton, DF; Goldgar, DE			A full-likelihood method for the evaluation of causality of sequence variants from family data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; BRCA1; MUTATIONS	In many disease genes, a substantial fraction of all rare variants detected cannot yet be used for genetic counselling because of uncertainty about their association with disease. One approach to the characterization of these unclassified variants is the analysis of patterns of cosegregation with disease in affected carrier families. Petersen et al. previously provided a simplistic Bayesian method for evaluation of causality of such sequence variants. In the present report, we propose a more general method based on the full pedigree likelihood, and we show that the use of this method can provide more accurate and informative assessment of causality than could the previous method. We further show that it is important that the pedigree information be as complete as possible and that the distinction be made between unaffected individuals and those of unknown phenotype.	Int Agcy Res Canc, Unit Genet Epidemiol, F-69008 Lyon, France; Univ Cambridge, Strangeways Res Labs, Cambridge, England	World Health Organization; International Agency for Research on Cancer (IARC); University of Cambridge	Goldgar, DE (corresponding author), Int Agcy Res Canc, Unit Genet Epidemiol, 150 Cours Albert Thomas, F-69008 Lyon, France.				NCI NIH HHS [1R01 CA-81203] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA081203] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barker DF, 1996, GENET EPIDEMIOL, V13, P595; EASTON DF, 1993, AM J HUM GENET, V52, P678; Frank TS, 2002, J CLIN ONCOL, V20, P1480, DOI 10.1200/JCO.20.6.1480; HASSTEDT SJ, 2002, PAP PEDIGREE ANAL PA; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Orelli BJ, 2001, ONCOGENE, V20, P4433, DOI 10.1038/sj.onc.1204485; Petersen GM, 1998, AM J HUM GENET, V62, P1516, DOI 10.1086/301871	8	96	98	0	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2003	73	3					652	655		10.1086/378100	http://dx.doi.org/10.1086/378100			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	718FG	12900794	Green Published, Bronze			2022-12-18	WOS:000185134000018
J	Sung, SS; Brassington, AME; Krakowiak, PA; Carey, JC; Jorde, LB; Bamshad, M				Sung, SS; Brassington, AME; Krakowiak, PA; Carey, JC; Jorde, LB; Bamshad, M			Mutations in TNNT3 cause multiple congenital contractures: A second locus for distal arthrogryposis type 2B	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CARDIAC TROPONIN-T; TROPOMYOSIN; GENES		Univ Utah, Dept Pediat, Eccles Inst Human Genet, Hlth Sci Ctr, Salt Lake City, UT 84112 USA; Univ Utah, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84132 USA; Shriners Hosp Children, Intermt Unit, Salt Lake City, UT USA; Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Arkansas System; University of Arkansas Medical Sciences	Bamshad, M (corresponding author), Univ Utah, Dept Pediat, Eccles Inst Human Genet, Hlth Sci Ctr, 15 North 2030 East, Salt Lake City, UT 84112 USA.	mike@genetics.utah.edu			PHS HHS [M01 00064] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bamshad M, 1996, AM J MED GENET, V65, P277, DOI 10.1002/(SICI)1096-8628(19961111)65:4<277::AID-AJMG6>3.0.CO;2-M; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Hinkle A, 2003, J BIOL CHEM, V278, P506, DOI 10.1074/jbc.M209194200; Krakowiak PA, 1997, AM J HUM GENET, V60, P426; Palm T, 2001, BIOPHYS J, V81, P2827, DOI 10.1016/S0006-3495(01)75924-3; Sung SS, 2003, AM J HUM GENET, V72, P681, DOI 10.1086/368294; Varnava A, 1999, HEART, V82, P621, DOI 10.1136/hrt.82.5.621; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603	8	96	98	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					212	214		10.1086/376418	http://dx.doi.org/10.1086/376418			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12865991	Green Published, Bronze			2022-12-18	WOS:000183904900019
J	Helgason, A; Hrafnkelsson, B; Gulcher, JR; Ward, R; Stefansson, K				Helgason, A; Hrafnkelsson, B; Gulcher, JR; Ward, R; Stefansson, K			A populationwide coalescent analysis of Icelandic matrilineal and patrilineal genealogies: Evidence for a faster evolutionary rate of mtDNA lineages than Y chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GAELIC ANCESTRY; MITOCHONDRIAL; INHERITANCE; MUTATION; FOUNDERS; HISTORY; ORIGIN; GENOME; HUMANS; NORSE	Historical inferences from genetic data increasingly depend on assumptions about the genealogical process that shapes the frequencies of alleles over time. Yet little is known about the structure of human genealogies over long periods of time and how they depart from expectations of standard demographic models, such as that attributed to Wright and Fisher. To obtain such information and to examine the recent evolutionary history of mtDNA and Y-chromosome haplotypes in the Icelandic gene pool, we traced the matrilineal and patrilineal ancestry of all 131,060 Icelanders born after 1972 back to two cohorts of ancestors, one born between 1848 and 1892 and the other between 1798 and 1742. This populationwide coalescent analysis of Icelandic genealogies revealed highly positively skewed distributions of descendants to ancestors, with the vast majority of potential ancestors contributing one or no descendants and a minority of ancestors contributing large numbers of descendants. The expansion and loss of matrilines and patrilines has caused considerable fluctuation in the frequencies of mtDNA and Y-chromosome haplotypes, despite a rapid population expansion in Iceland during the past 300 years. Contrary to a widespread assumption, the rate of evolution caused by this lineage-sorting process was markedly faster in matrilines (mtDNA) than in patrilines (Y chromosomes). The primary cause is a 10% shorter matrilineal generation interval. Variance in the number of offspring produced within each generation was not an important differentiating factor. We observed an intergenerational correlation in offspring number and in the length of generation intervals in the matrilineal and patrilineal genealogies, which was stronger in matrilines and thus contributes to their faster evolutionary rate. These findings may have implications for coalescent date estimates based on mtDNA and Y chromosomes.	deCODE Genet, IS-101 Reykjavik, Iceland; Univ Oxford, Inst Biol Anthropol, Oxford, England	University of Oxford	Helgason, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	agnarh@hi.is	Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019	Helgason, Agnar/0000-0002-8545-3767				Austerlitz F, 1998, P NATL ACAD SCI USA, V95, P15140, DOI 10.1073/pnas.95.25.15140; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Barkardottir RB, 2001, EUR J HUM GENET, V9, P773, DOI 10.1038/sj.ejhg.5200717; Brinkmann B, 1998, AM J HUM GENET, V62, P1408, DOI 10.1086/301869; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; Charlesworth B, 2001, GENET RES, V77, P153, DOI 10.1017/S0016672301004979; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DONNELLY P, 1989, THEOR POPUL BIOL, V35, P22, DOI 10.1016/0040-5809(89)90008-7; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Gulcher J, 1998, CLIN CHEM LAB MED, V36, P523, DOI 10.1515/CCLM.1998.089; Guldberg P, 1997, EUR J HUM GENET, V5, P376, DOI 10.1159/000484795; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Helgason A, 2000, AM J HUM GENET, V66, P999, DOI 10.1086/302816; Helgason A, 2001, AM J HUM GENET, V68, P723, DOI 10.1086/318785; HELGASON A, 2001, THESIS U OXFORD OXFO; HEYER E, 1995, AM J HUM GENET, V56, P1450; Howell N., 2000, DEMOGRAPHY DOBE KUNG; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Jonsson G., 1997, HAGSKINNA ICELANDIC; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; MURDOCK GP, 1969, ETHNOLOGY, V8, P329, DOI 10.2307/3772907; NEI M, 1966, GENET RES, V8, P257, DOI 10.1017/S0016672300010119; Nordborg M., 2001, HDB STAT GENETICS, P179; OBRIEN E, 1994, HUM BIOL, V66, P185; Pfeiffer H, 1999, INT J LEGAL MED, V112, P291, DOI 10.1007/s004140050252; ROBERTS DF, 1980, HUM BIOL, V52, P773; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; SKOLNICK M, 1976, DEMOGRAPHIC EVOLUTIO; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	33	96	97	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1370	1388		10.1086/375453	http://dx.doi.org/10.1086/375453			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12721957	Bronze, Green Published			2022-12-18	WOS:000183275500002
J	Lange, C; Laird, NM				Lange, C; Laird, NM			Power calculations for a general class of family-based association tests: Dichotomous traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNIFIED APPROACH; SIBSHIP TEST; DISEQUILIBRIUM; LINKAGE	Using large-sample theory, we present a unified approach to power calculations for family-based association tests. Currently available methods for power calculations are restricted to special designs or require approximations or simulations. Our analytical approach to power calculations is broadly applicable in many settings. We discuss power calculations for two scenarios that have high practical relevance and in which power previously could only be assessed by simulation studies or by approximations: (1) studies using both affected and unaffected offspring and (2) studies with missing parental information. When the population prevalence is high, it can be worthwhile to genotype unaffected offspring. For many scenarios, high power can be achieved with reasonable sample sizes, even when no parental information is available.	Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Lange, C (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA.	clange@hsph.harvard.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059532] Funding Source: NIH RePORTER; NHLBI NIH HHS [HR16040, HL66383] Funding Source: Medline; NIMH NIH HHS [R01 MH059532, MH59532] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Camp NJ, 1997, AM J HUM GENET, V61, P1424, DOI 10.1086/301648; Chen WM, 2001, GENET EPIDEMIOL, V21, P53, DOI 10.1002/gepi.1018; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Knapp M, 1999, AM J HUM GENET, V65, P1208, DOI 10.1086/302591; Knapp M, 1999, AM J HUM GENET, V64, P1177, DOI 10.1086/302334; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; LANGE C, IN PRESS BIOSTATISTI; OTT J, 1989, GENET EPIDEMIOL, V6, P127, DOI 10.1002/gepi.1370060124; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Schulze TG, 2002, AM J MED GENET, V114, P1, DOI 10.1002/ajmg.10042; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Whittaker JC, 1999, AM J HUM GENET, V65, P578, DOI 10.1086/302485; Zhao HY, 2000, STAT METHODS MED RES, V9, P563, DOI 10.1191/096228000668447080	19	96	97	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					575	584		10.1086/342406	http://dx.doi.org/10.1086/342406			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12181775	Green Published, Bronze			2022-12-18	WOS:000177489600011
J	Hand, CK; Khoris, J; Salachas, F; Gros-Louis, F; Lopes, AAS; Mayeux-Portas, V; Brown, RH; Meininger, V; Camu, W; Rouleau, GA				Hand, CK; Khoris, J; Salachas, F; Gros-Louis, F; Lopes, AAS; Mayeux-Portas, V; Brown, RH; Meininger, V; Camu, W; Rouleau, GA			A novel locus for familial amyotrophic lateral sclerosis, on chromosome 18q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; SPINAL MUSCULAR-ATROPHY; MOTOR-NEURON DISEASE; TRANSGENIC MICE; MUTANT MICE; LINKAGE; GENE; MUTATIONS; DEMENTIA; PARKINSONISM	Amyotrophic lateral sclerosis (ALS) is an adult-onset degenerative disorder characterized by the death of motor neurons in the cortex, brain stem, and spinal cord. Despite intensive research the basic pathophysiology of ALS remains unclear. Although most cases are sporadic, similar to 10% of ALS cases are familial (FALS). Mutations in the Cu/Zn superoxide dismutase (SOD1) gene cause similar to 20% of FALS. The gene(s) responsible for the remaining 80% of FALS remain to be found. Using a large European kindred without SOD1 mutation and with classic autosomal dominant adult-onset ALS, we have identified a novel locus by performing a genome scan and linkage analysis. The maximum LOD score is 4.5 at recombination fraction 0.0, for polymorphism D18S39. Haplotype analysis has identified a 7.5-cM, 8-Mb region of chromosome 18q21, flanked by markers D18S846 and D18S1109, as a novel FALS locus.	McGill Univ, Ctr Res Neurosci, Montreal, PQ H3A 2T5, Canada; Montreal Gen Hosp, Res Inst, Montreal, PQ H3G 1A4, Canada; Hop Gui De Chauliac, Dept Neurol, Montpellier, France; Hop Gui De Chauliac, Inst Biol, INSERM,V336, UNCD Mol Unit, Montpellier, France; Hop La Pitie Salpetriere, Div Mazarin, Serv Neurol, Paris, France; Massachusetts Gen Hosp, Boston, MA 02114 USA	McGill University; McGill University; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Harvard University; Massachusetts General Hospital	Rouleau, GA (corresponding author), Montreal Gen Hosp L7 224, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.		camu, william/AAB-4727-2020; Hand, Collette/GRY-7269-2022	Hand, Collette/0000-0003-2348-5058				Al-Chalabi Ammar, 2000, Current Opinion in Neurology, V13, P397, DOI 10.1097/00019052-200008000-00006; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Andreassen OA, 2000, ANN NEUROL, V47, P447, DOI 10.1002/1531-8249(200004)47:4<447::AID-ANA7>3.3.CO;2-I; Bedlack RS, 2000, ARCH NEUROL-CHICAGO, V57, P1561, DOI 10.1001/archneur.57.11.1561; Boukaftane Y, 1998, CAN J NEUROL SCI, V25, P192, DOI 10.1017/S0317167100034004; BROWN RH, 1995, CELL, V80, P687, DOI 10.1016/0092-8674(95)90346-1; Camu W, 1999, J NEUROL SCI, V165, pS21, DOI 10.1016/S0022-510X(99)00022-2; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DEBELLEROCHE J, 1995, J MED GENET, V32, P841, DOI 10.1136/jmg.32.11.841; Flowers JM, 1999, NEUROSCI LETT, V274, P21, DOI 10.1016/S0304-3940(99)00673-4; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Hayward C, 1999, NEUROLOGY, V52, P1899, DOI 10.1212/WNL.52.9.1899; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; HUDSON AJ, 1981, BRAIN, V104, P217, DOI 10.1093/brain/104.2.217; Julien JP, 1998, BRAIN PATHOL, V8, P759, DOI 10.1111/j.1750-3639.1998.tb00199.x; KING A, 1993, J MED GENET, V30, P318, DOI 10.1136/jmg.30.4.318; Kunst CB, 2000, GENOMICS, V70, P181, DOI 10.1006/geno.2000.6379; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; LYNCH T, 1994, NEUROLOGY, V44, P1878, DOI 10.1212/WNL.44.10.1878; Melov S, 1999, P NATL ACAD SCI USA, V96, P846, DOI 10.1073/pnas.96.3.846; Melov S, 1998, NAT GENET, V18, P159, DOI 10.1038/ng0298-159; Orrell RW, 1997, J NEUROL SCI, V145, P55, DOI 10.1016/S0022-510X(96)00240-7; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Parboosingh JS, 1999, ARCH NEUROL-CHICAGO, V56, P710, DOI 10.1001/archneur.56.6.710; Rabin BA, 1999, BRAIN, V122, P1539, DOI 10.1093/brain/122.8.1539; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1991, NEW ENGL J MED, V324, P1381, DOI 10.1056/NEJM199105163242001; Siddique T, 1996, HUM MOL GENET, V5, P1465, DOI 10.1093/hmg/5.Supplement_1.1465; SIDDIQUE T, 1998, ANN M AM AC NEUR MIN; SMITH RG, 1995, ANNU REV MED, V46, P133; Weeks DE., 1990, AM J HUM GENET, V47, pA203	35	96	100	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2002	70	1					251	256		10.1086/337945	http://dx.doi.org/10.1086/337945			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	499LD	11706389	Green Published, Bronze			2022-12-18	WOS:000172571900023
J	Brunger, JW; Murray, GS; O'Riordan, M; Matthews, AL; Smith, RJH; Robin, NH				Brunger, JW; Murray, GS; O'Riordan, M; Matthews, AL; Smith, RJH; Robin, NH			Parental attitudes toward genetic testing for pediatric deafness	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS; POPULATION; MUTATIONS; DFNB1	Recent molecular genetic advances have resulted in genetic testing becoming an option for deaf individuals and their families. However, there is little information about the interest in such testing. To investigate this issue, parents with normal hearing who have one or more deaf children were surveyed about their attitudes toward diagnostic, carrier, and prenatal genetic testing for deafness. This population was chosen because it represents the majority of individuals who are encountered in clinical practice, given that 90%-95% of deaf individuals are born to persons with normal hearing. Of 328 surveys distributed, 96 were completed and returned. Of the respondents, 96% recorded a positive attitude toward genetic testing for deafness, including prenatal testing, although none would use this information to terminate an affected pregnancy. All respondents had a poor understanding of genetics, with 98% both incorrectly estimating the recurrence risk of deafness and misunderstanding the concept of inheritance. Notably these findings were similar in the group who had had genetic testing for their children and in the group who had not, suggesting either that the parents who received genetic testing did not receive genetic counseling or that the counseling was not effective. On the basis of these results, it was concluded that this population is interested in the use of genetic testing and that testing should not be done without first providing formal genetic counseling. Appropriate counseling can help parents to understand the risks, benefits, and limitations of genetic testing.	Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Otolaryngol & Head & Neck Surg, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Case Western Reserve Univ, Univ Hosp Cleveland, Sch Med, Dept Reprod Biol, Cleveland, OH 44106 USA; Univ Iowa, Dept Otolaryngol & Head & Neck Surg, Iowa City, IA USA; Univ Iowa, Interdepartmental Genet PhD Program, Iowa City, IA USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; University of Iowa; University of Iowa	Robin, NH (corresponding author), Lakeside 1500, Cleveland, OH 44106 USA.	nhr2@po.cwru.edu		Smith, Richard/0000-0003-1201-6731	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002842] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002842, DC02842] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Chapple Alison, 1995, J Genet Couns, V4, P281, DOI 10.1007/BF01408074; Cohn ES, 1999, PEDIATRICS, V103, P546, DOI 10.1542/peds.103.3.546; DECRUYENAERE M, 1992, CLIN GENET, V41, P189; HIETALA M, 1995, AM J HUM GENET, V56, P1493; ISRAEL JN, 1995, INTRO DEAFNESS MANUA; KENEN RH, 1978, AM J PUBLIC HEALTH, V68, P1116, DOI 10.2105/AJPH.68.11.1116; KOEHN D, 1990, Genetic Counseling, V1, P127; MAW MA, 1995, AM J HUM GENET, V57, P629; MENNIE M, 1993, CLIN GENET, V44, P102; Middleton A, 1998, AM J HUM GENET, V63, P1175, DOI 10.1086/302060; National Information Center for Children and Youth With Disabilities, 1998, FACT SHEET GEN INF D; ROWLEY PT, 1984, AM J HUM GENET, V36, P677; SMITH SD, 1991, ANN NY ACAD SCI, V630, P203, DOI 10.1111/j.1749-6632.1991.tb19589.x; WILLIAMSON R, 1989, PRENATAL DIAG, V9, P727, DOI 10.1002/pd.1970091008; Zelante L, 1997, HUM MOL GENET, V6, P1605, DOI 10.1093/hmg/6.9.1605	15	96	99	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1621	1625		10.1086/316901	http://dx.doi.org/10.1086/316901			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11062052	Bronze, Green Published			2022-12-18	WOS:000165607600031
J	Schwarze, U; Atkinson, M; Hoffman, GG; Greenspan, DS; Byers, PH				Schwarze, U; Atkinson, M; Hoffman, GG; Greenspan, DS; Byers, PH			Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OSTEOGENESIS IMPERFECTA; MESSENGER-RNA; GRAVIS FORM; MUTATION; PROCOLLAGEN; CHAIN; PROPEPTIDE; EXCLUSION; EXISTENCE; FAMILIES	Ehlers-Danlos syndrome (EDS) types I. and II, which comprise the classical variety, are well characterized from the clinical perspective, but it has been difficult to identify the molecular basis of the disorder in the majority of affected individuals. Several explanations for this failure to detect mutations have been proposed, including genetic heterogeneity, failure of allele expression, and technical difficulties. Genetic heterogeneity has been confirmed as an explanation for such failure, since causative mutations have been identified in the COL5A1, COL5A2, and tenascin X genes and since they have been inferred in the COL1A2 gene. Nonetheless, in the majority of families with autosomal dominant inheritance of EDS, there appears to be linkage to loci that contain the COL5A1 or COL5A2 genes. To determine whether allele-product instability could explain failure to identify some mutations, we analyzed polymorphic variants in the COL5A1 gene in 16 individuals, and we examined mRNA for the expression of both alleles and for alterations in splicing. We found a splice-site mutation in a single individual, and we determined that, in six individuals, the mRNA from one COL5A1 allele either was not expressed or was very unstable. We identified small insertions or deletions in five of these cell strains, but we could not identify the mutation in the sixth individual. Thus, although as many as one-half of the mutations that give rise to EDS types I and II are likely to lie in the COL5A1 gene, a significant portion of them result in very low levels of mRNA from the mutant allele, as a consequence of nonsense-mediated mRNA decay.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison	Byers, PH (corresponding author), Univ Washington, Dept Pathol, Box 357470, Seattle, WA 98195 USA.			Byers, Peter H./0000-0001-7786-7030; Greenspan, Daniel/0000-0001-8096-7446	NIAMS NIH HHS [AR21557, AR43621] Funding Source: Medline; NIGMS NIH HHS [GM46846] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557, R01AR043621] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; BEIGHTON P, 1993, MCKUSICKS HERITABLE, P189; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Burch GH, 1997, NAT GENET, V17, P104, DOI 10.1038/ng0997-104; Burrows NP, 1996, J INVEST DERMATOL, V106, P1273, DOI 10.1111/1523-1747.ep12348978; Burrows NP, 1997, CLIN EXP DERMATOL, V22, P174, DOI 10.1046/j.1365-2230.1997.2290654.x; Burrows NP, 1998, AM J HUM GENET, V63, P390, DOI 10.1086/301948; CAPPA F, 1995, HUM GENET, V95, P599; DePaepe A, 1997, AM J HUM GENET, V60, P547; EMANUEL BS, 1985, P NATL ACAD SCI USA, V82, P3385, DOI 10.1073/pnas.82.10.3385; FESSLER JH, 1987, STRUCTURE FUNCTION C, P81; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; GRAHAME R, 1969, ANN RHEUM DIS, V28, P246, DOI 10.1136/ard.28.3.246; GREENSPAN DS, 1994, HUM MOL GENET, V3, P385, DOI 10.1093/hmg/3.2.385-a; GREENSPAN DS, 1995, GENOMICS, V25, P737, DOI 10.1016/0888-7543(95)80021-D; GREENSPAN DS, 1991, J BIOL CHEM, V266, P24727; HARALSON MA, 1980, P NATL ACAD SCI-BIOL, V77, P5206, DOI 10.1073/pnas.77.9.5206; HATA R, 1988, EUR J BIOCHEM, V174, P231, DOI 10.1111/j.1432-1033.1988.tb14087.x; HAUSSER I, 1994, HUM GENET, V93, P394; HOLBROOK KA, 1989, AM J MED GENET, V34, P105, DOI 10.1002/ajmg.1320340118; KUMAMOTO CA, 1980, P NATL ACAD SCI-BIOL, V77, P6434, DOI 10.1073/pnas.77.11.6434; LINSENMAYER TF, 1993, J CELL BIOL, V121, P1181, DOI 10.1083/jcb.121.5.1181; LOUGHLIN J, 1995, HUM MOL GENET, V4, P1649, DOI 10.1093/hmg/4.9.1649; MAQUAT LE, 1995, RNA, V1, P453; McCarthy EMS, 1998, HUM MOL GENET, V7, P1491, DOI 10.1093/hmg/7.9.1491; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; Michalickova K, 1998, HUM MOL GENET, V7, P249, DOI 10.1093/hmg/7.2.249; MORADIAMELI M, 1994, EUR J BIOCHEM, V221, P987, DOI 10.1111/j.1432-1033.1994.tb18815.x; Nicholls A. C., 1994, American Journal of Human Genetics, V55, pA233; Nicholls AC, 1996, J MED GENET, V33, P940, DOI 10.1136/jmg.33.11.940; NIYIBIZI C, 1984, J BIOL CHEM, V259, P4170; RHODES RK, 1981, COLLAGEN REL RES, V1, P337; Richards AJ, 1998, J MED GENET, V35, P846, DOI 10.1136/jmg.35.10.846; Sambrook J, 1989, MOL CLONING LAB MANU; SASAKI T, 1987, ARCH DERMATOL, V123, P76, DOI 10.1001/archderm.123.1.76; Schwarze U, 1999, AM J HUM GENET, V65, P336, DOI 10.1086/302512; SMITH LT, 1992, AM J HUM GENET, V51, P235; SOKOLOV BP, 1991, HUM GENET, V88, P125; Steinmann Beat, 1993, P351; TAKAHARA K, 1995, GENOMICS, V29, P588, DOI 10.1006/geno.1995.9961; Toriello HV, 1996, NAT GENET, V13, P361, DOI 10.1038/ng0796-361; TRUTER S, 1993, CONNECT TISSUE RES, V29, P51, DOI 10.3109/03008209309061966; VOGEL A, 1979, LAB INVEST, V40, P201; WEIL D, 1987, NUCLEIC ACIDS RES, V15, P3946, DOI 10.1093/nar/15.9.3946; WEIL D, 1987, NUCLEIC ACIDS RES, V15, P181, DOI 10.1093/nar/15.1.181; Wenstrup RJ, 1996, HUM MOL GENET, V5, P1733, DOI 10.1093/hmg/5.11.1733; WORDSWORTH BP, 1991, BRIT J RHEUMATOL, V30, P173; WORDSWORTH P, 1985, ANN RHEUM DIS, V44, P431, DOI 10.1136/ard.44.7.431	49	96	105	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1757	1765		10.1086/302933	http://dx.doi.org/10.1086/302933			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10796876	Green Published, Bronze			2022-12-18	WOS:000088373800004
J	Duggirala, R; Blangero, D; Almasy, L; Dyer, TD; Williams, KL; Leach, RJ; O'Connell, P; Stern, MP				Duggirala, R; Blangero, D; Almasy, L; Dyer, TD; Williams, KL; Leach, RJ; O'Connell, P; Stern, MP			A major susceptibility locus influencing plasma triglyceride concentrations is located on chromosome 15q in Mexican Americans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIOVASCULAR RISK-FACTORS; LIPOPROTEIN-LIPASE GENE; QUANTITATIVE-TRAIT LOCI; CORONARY-ARTERY DISEASE; ISCHEMIC-HEART-DISEASE; LINKAGE ANALYSIS; DIABETES-MELLITUS; HDL-CHOLESTEROL; HYPERTRIGLYCERIDEMIA; POLYMORPHISMS	Although several genetic forms of rare or syndromic hypertriglyceridemia have been reported, little is known about the specific chromosomal regions across the genome harboring susceptibility genes for common forms of hypertriglyceridemia. Therefore, we conducted a genomewide scan for susceptibility genes influencing plasma triglyceride (TG) levels in a Mexican American population. We used both phenotypic and genotypic data from 418 individuals distributed across 27 low-income, extended Mexican American families. For the analyses, TG values were log transformed (In TC). We used a variance-components technique to conduct multipoint linkage analyses for localizing susceptibility genes that determine variation in TG levels. We used an similar to 10-15-cM map, which was made on the basis of information from 295 microsatellite markers. After accounting for the effects of sex and sex-specific age terms, we found significant evidence for linkage (LOD = 3.88) of In TG levels to a genetic location between the markers GABRB3 and D15S165 on chromosome 15q. This putative locus explains 39.7 +/- 7% (P = .000012) of total phenotypic variation in In TG levels. Suggestive evidence was found for linkage of In TG levels to two different locations on chromosome 7, which are similar to 85 cM apart from each other. Also, there is some evidence for linkage of high-density lipoprotein cholesterol concentrations to a genetic location near one of the regions on chromosome 7. In conclusion, we found strong evidence for linkage of In TG levels to a genetic location on chromosome 15q in a Mexican American population, which is prone to disease conditions such as type 2 diabetes and the insulin-resistance syndrome that are associated with hypertriglyceridemia. This putative locus appears to have a major influence on In TG variation.	Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, San Antonio, TX 78229 USA; Univ Texas, Hlth Sci Ctr, Dept Celular & Struct Biol, San Antonio, TX 78229 USA; SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78284 USA; Baylor Coll Med, Breast Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute; Baylor College of Medicine	Duggirala, R (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Med, Div Clin Epidemiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	ravi@neel.uthscsa.edu	Almasy, Laura/V-3156-2019	Leach, Robin/0000-0002-3201-5579	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042273, R01DK047482, R01DK053889] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1999, AM J HUM GENET, V64, P1686, DOI 10.1086/302425; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; [Anonymous], 1985, World Health Organ Tech Rep Ser, V727, P1; Arya R, 1999, AM J HUM GENET, V65, pA2; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; BEATY TH, 1985, ANN HUM GENET, V49, P315, DOI 10.1111/j.1469-1809.1985.tb01707.x; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; COX NJ, 1989, DIABETES, V38, P947, DOI 10.2337/diabetes.38.8.947; Duggirala R, 1999, AM J HUM GENET, V64, P1127, DOI 10.1086/302316; Duggirala R, 1996, AM J HUM GENET, V59, P694; DYKE B, 1996, 2 PGL SW FDN BIOM RE; Ehrenborg E, 1997, ARTERIOSCL THROM VAS, V17, P2672, DOI 10.1161/01.ATV.17.11.2672; Elston RC, 1998, AM J HUM GENET, V63, P931, DOI 10.1086/302073; Fasman KH, 1996, NUCLEIC ACIDS RES, V24, P57, DOI 10.1093/nar/24.1.57; FERNANDEZRUIZ E, 1993, GENOMICS, V17, P759, DOI 10.1006/geno.1993.1401; FULKER DW, 1995, AM J HUM GENET, V56, P1224; Garg A, 1998, AM J CARDIOL, V81, p47B, DOI 10.1016/S0002-9149(98)00038-1; GERDES C, 1995, CIRCULATION, V92, P1765, DOI 10.1161/01.CIR.92.7.1765; Ginsberg HN, 1996, DIABETES, V45, pS27, DOI 10.2337/diab.45.3.S27; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; Gotto AM, 1998, CIRCULATION, V97, P1027, DOI 10.1161/01.CIR.97.11.1027; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; HAFFNER SM, 1990, JAMA-J AM MED ASSOC, V263, P2893, DOI 10.1001/jama.263.21.2893; HAFFNER SM, 1986, NEW ENGL J MED, V315, P220, DOI 10.1056/NEJM198607243150403; Havel RJ, 1998, J AM COLL CARDIOL, V31, P1258; Hegele RA, 1997, ARTERIOSCL THROM VAS, V17, P2753, DOI 10.1161/01.ATV.17.11.2753; Howard Barbara V., 1996, P792; Hsueh Willa A., 1998, American Journal of Medicine, V105, p4S, DOI 10.1016/S0002-9343(98)00205-8; Humphries SE, 1998, ARTERIOSCL THROM VAS, V18, P526, DOI 10.1161/01.ATV.18.4.526; ISELIUS L, 1988, P 2 INT C QUANT GEN, P341; Jeppesen J, 1998, CIRCULATION, V97, P1029, DOI 10.1161/01.CIR.97.11.1029; Khoury M, 1993, FUNDAMENTALS GENETIC; KLINGER KW, 1987, P NATL ACAD SCI USA, V84, P8548, DOI 10.1073/pnas.84.23.8548; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MACCLUER JW, 1989, GENETIC FACTORS ATHE, P50; MAHANEY MC, 1995, CIRCULATION, V92, P3240, DOI 10.1161/01.CIR.92.11.3240; Miller M, 1998, J AM COLL CARDIOL, V31, P1252, DOI 10.1016/S0735-1097(98)00083-7; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Mochizuki H, 1998, GENE, V213, P149, DOI 10.1016/S0378-1119(98)00193-0; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; Mykkanen L, 1997, ARTERIOSCL THROM VAS, V17, P1447, DOI 10.1161/01.ATV.17.7.1447; OCONNELL P, 1994, GENOMICS, V24, P557, DOI 10.1006/geno.1994.1666; Pajukanta P, 1998, NAT GENET, V18, P369, DOI 10.1038/ng0498-369; Pandya A, 1996, GENOMICS, V38, P227, DOI 10.1006/geno.1996.0620; RICE T, 1991, HUM BIOL, V63, P419; Rust S, 1998, NAT GENET, V20, P96, DOI 10.1038/1770; Sanghera DK, 1998, AM J HUM GENET, V62, P36, DOI 10.1086/301669; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SING CF, 1988, P 2 INT C QUANT GEN, P250; SPARKES R S, 1987, Genomics, V1, P138, DOI 10.1016/0888-7543(87)90005-X; Steiner G, 1996, DIABETES, V45, pS24, DOI 10.2337/diab.45.3.S24; STERN MP, 1984, AM J EPIDEMIOL, V120, P834, DOI 10.1093/oxfordjournals.aje.a113956; STERN MP, 1990, DIABETES METAB REV, V6, P29, DOI 10.1002/dmr.5610060102; Stern MP, 1996, GENOME RES, V6, P724, DOI 10.1101/gr.6.8.724; Surguchov AP, 1996, ARTERIOSCL THROM VAS, V16, P941, DOI 10.1161/01.ATV.16.8.941; Talmud PJ, 1998, J LIPID RES, V39, P1189; Whitcomb DC, 1996, GASTROENTEROLOGY, V110, P1975, DOI 10.1053/gast.1996.v110.pm8964426; Wittrup HH, 1999, CIRCULATION, V99, P2901, DOI 10.1161/01.CIR.99.22.2901; WITTRUP HH, 1997, CIRCULATION, V96, P336; ZENG Q, 1995, HUM GENET, V95, P371	63	96	102	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1237	1245		10.1086/302849	http://dx.doi.org/10.1086/302849			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10729112	Bronze, Green Published			2022-12-18	WOS:000088373400008
J	Gayther, SA; Russell, P; Harrington, P; Antoniou, AC; Easton, DF; Ponder, BAJ				Gayther, SA; Russell, P; Harrington, P; Antoniou, AC; Easton, DF; Ponder, BAJ			The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: No evidence for other ovarian cancer-susceptibility genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BREAST-CANCER; IDENTIFICATION; HETEROGENEITY; FREQUENCY; HOMOLOG; RISKS	To establish the contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer, we have analyzed both genes in DNA samples obtained from an affected individual in each of 112 families containing at least two cases of epithelial. ovarian cancer. Germline mutations were found in 43% of the families; BRCA1 mutations were approximately four times more common than BRCA2 mutations. The extent of family history of ovarian and breast: cancers was strongly predictive of BRCA1-mutation status. Segregation analysis suggests that a combination Df chance clustering of sporadic cases and insensitivity of mutation detection may account for the remaining families; however, the contribution of other genes cannot be excluded. We discuss the implications for genetic testing and clinical management of familial ovarian cancer arising from the data presented in these studies.	CRC, Strangeways Res Lab, Dept Oncol, Cambridge CB1 8RN, England; CRC, Strangeways Res Lab, Genet Epidemiol Unit, Cambridge CB1 8RN, England		Gayther, SA (corresponding author), CRC, Strangeways Res Lab, Dept Oncol, Worts Causeway, Cambridge CB1 8RN, England.							Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; Chen PL, 1998, P NATL ACAD SCI USA, V95, P5287, DOI 10.1073/pnas.95.9.5287; CLAUS EB, 1991, AM J HUM GENET, V48, P232; Easton D, 1997, NAT GENET, V16, P210, DOI 10.1038/ng0797-210; EASTON DF, 1993, AM J HUM GENET, V52, P678; FORD D, 1995, AM J HUM GENET, V57, P1457; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Friedman LS, 1997, AM J HUM GENET, V60, P313; Gayther SA, 1998, DIS MARKERS, V14, P1; Gayther SA, 1997, AM J HUM GENET, V60, P1239; Gayther SA, 1997, NAT GENET, V15, P103, DOI 10.1038/ng0197-103; GAYTHER SA, 1995, NAT GENET, V11, P428, DOI 10.1038/ng1295-428; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LYNCH HT, 1982, OBSTET GYNECOL, V59, P589; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; NAROD SA, 1995, AM J HUM GENET, V56, P254; Neuhausen S, 1996, NAT GENET, V13, P126, DOI 10.1038/ng0596-126; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Pharoah PDP, 1999, CANCER RES, V59, P868; Puget N, 1999, AM J HUM GENET, V64, P300, DOI 10.1086/302211; Puget N, 1997, CANCER RES, V57, P828; Ramus SJ, 1997, AM J HUM GENET, V60, P1242; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; STEICHENGERSDORF E, 1994, AM J HUM GENET, V55, P870; Stratton JF, 1998, BRIT J OBSTET GYNAEC, V105, P493, DOI 10.1111/j.1471-0528.1998.tb10148.x; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Swensen J, 1997, HUM MOL GENET, V6, P1513, DOI 10.1093/hmg/6.9.1513; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Thorlacius S, 1996, NAT GENET, V13, P117, DOI 10.1038/ng0596-117; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Zhang HB, 1998, CELL, V92, P433, DOI 10.1016/S0092-8674(00)80936-8	36	96	99	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1021	1029		10.1086/302583	http://dx.doi.org/10.1086/302583			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486320	Green Published, Bronze			2022-12-18	WOS:000082910000010
J	Corman, B; Avela, K; Pihko, H; Santavuori, P; Talim, B; Topaloglu, H; de la Chapelle, A; Lehesjoki, AE				Corman, B; Avela, K; Pihko, H; Santavuori, P; Talim, B; Topaloglu, H; de la Chapelle, A; Lehesjoki, AE			Assignment of the muscle-eye-brain disease gene to 1p32-p34 by linkage analysis and homozygosity mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG SYNDROME; FUKUYAMA TYPE; HUMAN GENOME; MEB DISEASE; MAP; INVOLVEMENT; LAMININ; DISEQUILIBRIUM; LOCALIZATION	Muscle-eye-brain disease (MEB) is an autosomal recessive disease of unknown etiology characterized by severe mental retardation, ocular abnormalities, congenital muscular dystrophy, and a polymicrogyria-pachygyria-type neuronal migration disorder of the brain. A similar combination of muscle and brain involvement is also seen in Walker-Warburg syndrome (WWS) and Fukuyama congenital muscular dystrophy (FCMD). Whereas the gene underlying FCMD has been mapped and cloned, the genetic location of the WWS gene is still unknown. Here we report the assignment of the MEB gene to chromosome 1p32-p34 by linkage analysis and homozygosity mapping in eight families with 12 affected individuals. After a genomewide search for linkage in four affected sib pairs had pinpointed the assignment to Ip, the MEB locus was more precisely assigned to a 9-cM interval flanked by markers D1S200 proximally and D1S211 distally. Multipoint linkage analysis gave a maximum LOD score of 6.17 at locus D1S2677. These findings provide a starting point for the positional cloning of the disease gene, which may play an important role in muscle function and brain development. It also provides an opportunity to test other congenital muscular dystrophy phenotypes, in particular WWS, for linkage to the same locus.	Folkhalsan Inst Genet, Dept Mol Genet, Helsinki 00280, Finland; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Hosp Children & Adolescents, Dept Pediat Neurol, Helsinki, Finland; Hacettepe Childrens Hosp Med Ctr, Dept Pediat Neurol, Ankara, Turkey	University of Helsinki; Hacettepe University	Lehesjoki, AE (corresponding author), Folkhalsan Inst Genet, Dept Mol Genet, Mannerheimintie 97, Helsinki 00280, Finland.	anna-elina.lehesjoki@hlelsinki.fi	Cormand, Bru/H-5338-2015; TOPALOGLU, HALUK AYDIN/I-9318-2013	Cormand, Bru/0000-0001-5318-4382; 				Avela K, 1997, AM J HUM GENET, V60, P896; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; CALOF AL, 1991, J CELL BIOL, V115, P779, DOI 10.1083/jcb.115.3.779; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; DOBYNS WB, 1990, AM J MED GENET, V36, P373, DOI 10.1002/ajmg.1320360335; Dubowitz V, 1997, NEUROMUSCULAR DISORD, V7, P539; ECHENNE B, 1986, J NEUROL SCI, V75, P7, DOI 10.1016/0022-510X(86)90046-8; ENGVALL E, 1992, EXP CELL RES, V198, P115, DOI 10.1016/0014-4827(92)90156-3; FEDERICO A, 1988, NEUROPEDIATRICS, V19, P109, DOI 10.1055/s-2008-1052412; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; Hagg T, 1997, BRAIN RES, V764, P17, DOI 10.1016/S0006-8993(97)00419-8; Haltia M, 1997, ANN NEUROL, V41, P173, DOI 10.1002/ana.410410208; HAYASHI YK, 1993, J NEUROL SCI, V119, P53, DOI 10.1016/0022-510X(93)90191-Z; Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; HELLSTEN E, 1995, GENOMICS, V25, P404, DOI 10.1016/0888-7543(95)80040-S; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; KORINTHENBERG R, 1984, EUR J PEDIATR, V142, P64, DOI 10.1007/BF00442595; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kruus, 1977, NEUROPAEDIATRIE    S, V8, P553, DOI 10.1055/s-0028-1091594; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEYTEN QH, 1992, NEUROPEDIATRICS, V23, P316, DOI 10.1055/s-2008-1071365; MIELKE R, 1986, HELV PAEDIATR ACTA, V41, P369; Moghadaszadeh B, 1998, AM J HUM GENET, V62, P1439, DOI 10.1086/301882; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; OTT J, 1992, ANAL HUMAN LINKAGE; PIHKO H, 1995, BRAIN DEV-JPN, V17, P57, DOI 10.1016/0387-7604(94)00101-3; RAITTA C, 1978, ACTA OPHTHALMOL, V56, P465; RANTA S, 1995, NEUROMUSCULAR DISORD, V5, P221, DOI 10.1016/0960-8966(94)00058-H; Santavuori P, 1998, Eur J Paediatr Neurol, V2, P41, DOI 10.1016/1090-3798(98)01004-1; SANTAVUORI P, 1990, AM J MED GENET, V36, P371, DOI 10.1002/ajmg.1320360334; SANTAVUORI P, 1989, BRAIN DEV-JPN, V11, P147, DOI 10.1016/S0387-7604(89)80088-9; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Speleman F, 1996, CYTOGENET CELL GENET, V72, P189, DOI 10.1159/000134185; TAKADA K, 1984, J NEUROPATH EXP NEUR, V43, P395, DOI 10.1097/00005072-198407000-00005; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283; TOPALOGLU H, 1995, BRAIN DEV-JPN, V17, P271, DOI 10.1016/0387-7604(95)00047-F; VALANNE L, 1994, NEURORADIOLOGY, V36, P473, DOI 10.1007/BF00593687; vanderKnaap MS, 1997, ANN NEUROL, V42, P50, DOI 10.1002/ana.410420110; Voit T, 1998, BRAIN DEV-JPN, V20, P65, DOI 10.1016/S0387-7604(97)00094-6; Weeks DE., 1990, AM J HUM GENET, V47, pA203	48	96	99	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					126	135		10.1086/302206	http://dx.doi.org/10.1086/302206			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164RM	9915951	Green Published, Bronze			2022-12-18	WOS:000078477400017
J	Schaid, DJ; Rowland, C				Schaid, DJ; Rowland, C			Use of parents, sibs and unrelated controls for detection of associations between genetic markers and disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEQUILIBRIUM	Detecting the association between genetic markers and complex diseases can be a critical first step toward identification of the genetic basis of disease. Misleading associations can be avoided by choosing as controls the parents of diseased cases, but the availability of parents often Limits this design to early-onset: disease. Alternatively, sib controls offer a valid design. A general multivariate score statistic is presented, to detect the association between a multiallelic genetic marker locus and affection status; this general approach is applicable to designs that use parents as controls, sibs as controls, or even unrelated controls whose genotypes do not fit Hardy-Weinberg proportions or that pool any combination of these different designs, The benefit of this multivariate score statistic is that it will tend to be the most powerful method when multiple marker alleles are associated with affection status. To plan these types of studies, we present methods to compute sample size and power, allowing for varying sibship sizes, ascertainment criteria, and genetic models of risk. The results indicate that sib controls have less power than parental controls and that the power of sib controls can be increased by increasing either the number of affected sibs per sibship or the number of unaffected control sibs, The sample-size results indicate that the use of sib controls to test for associations, by use of either a single-marker locus or a genomewide screen, will be feasible for markers that have a dominant effect and for common alleles having a recessive effect. The results presented will be useful for investigators planning studies using sibs as controls.	Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Med Genet, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Schaid, DJ (corresponding author), Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, 200 1st St SW, Rochester, MN 55905 USA.				NIGMS NIH HHS [GM51256] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM051256] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; BRASS W, 1958, B INT STATIST INST, V36, P165; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; COX DR, 1975, BIOMETRIKA, V62, P269, DOI 10.1093/biomet/62.2.269; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; CURTIS D, 1995, AM J HUM GENET, V56, P811; Ewens WJ, 1997, AM J HUM GENET, V61, pA275; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Langefeld CD, 1997, AM J HUM GENET, V61, pA282; MANTEL N, 1959, J NATL CANCER I, V22, P719; MANTEL N, 1980, AM J EPIDEMIOL, V112, P129, DOI 10.1093/oxfordjournals.aje.a112962; MANUILA A, 1958, JAMA-J AM MED ASSOC, V167, P2047, DOI 10.1001/jama.1958.02990340007002; Monks SA, 1997, AM J HUM GENET, V61, pA286; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Schaid DJ, 1997, GENET EPIDEMIOL, V14, P1113, DOI 10.1002/(SICI)1098-2272(1997)14:6<1113::AID-GEPI92>3.0.CO;2-J; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Schaid DJ, 1995, GENET EPIDEMIOL, V12, P813, DOI 10.1002/gepi.1370120647; SCHAID DJ, 1998, IN PRESS AM J EPIDEM; SCHAID DJ, 1998, IN PRESS GENET EPIDE; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548	24	96	100	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1492	1506		10.1086/302094	http://dx.doi.org/10.1086/302094			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792877	Bronze, Green Published			2022-12-18	WOS:000076985200026
J	De Michele, G; De Fusco, M; Cavalcanti, F; Filla, A; Marconi, R; Volpe, G; Monticelli, A; Ballabio, A; Casari, G; Cocozza, S				De Michele, G; De Fusco, M; Cavalcanti, F; Filla, A; Marconi, R; Volpe, G; Monticelli, A; Ballabio, A; Casari, G; Cocozza, S			A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PELIZAEUS-MERZBACHER DISEASE; LINKAGE ANALYSIS; PROTEOLIPID PROTEIN; GENE; MUTATION; FAMILIES; MARKERS; CLONING; 2P	Hereditary spastic paraplegia is a genetically and phenotypically heterogeneous disorder. Both pure and complicated forms have been described, with autosomal dominant, autosomal recessive, and X-linked inheritance. Various loci (SPG1-SPG6) associated with this disorder have been mapped. Here, we report linkage analysis of a large consanguineous family affected with autosomal recessive spastic paraplegia with age at onset of 25-42 years. Linkage analysis of this family excluded all previously described spastic paraplegia loci. A genomewide linkage analysis showed evidence of linkage to chromosome 16q24.3, with markers D16S413 (maximum LOD score 3.37 at recombination fraction [theta] of .00) and D16S303 (maximum LOD score 3.74 at theta = .00). Multipoint analysis localized the disease gene in the most telomeric region, with a LOD score of 4.2. These data indicate the presence of a new locus linked to pure recessive spastic paraplegia, on chromosome 16q24.3, within a candidate region of 6 cM.	TIGEM, I-20132 Milan, Italy; Univ Naples Federico II, Dept Neurol, Naples, Italy; Univ Naples Federico II, Dept Mol & Cellular Biol, Naples, Italy; Univ Naples Federico II, Dept Pathol, Naples, Italy; Univ Naples Federico II, Ctr Endocrinol & Oncol Sperimentale, Naples, Italy; Univ Naples Federico II, CNR, Naples, Italy; Misericordia Hosp, Dept Neurol, Grosseto, Italy; Vita & Salute Univ, Milan, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); University of Naples Federico II; Vita-Salute San Raffaele University	Casari, G (corresponding author), TIGEM, S Raffaele Biomed Sci Pk,Via Olgettina 58, I-20132 Milan, Italy.	casari@tigem.it	Cavalcanti, Francesca/N-3901-2019; BALLABIO, Andrea/AAL-2672-2020; Casari, Giorgio/J-3070-2018; De Fusco, Maurizio/AAN-7358-2020; CAVALCANTI, FRANCESCA/I-3651-2014; Cocozza, Sergio/F-6488-2010	Cavalcanti, Francesca/0000-0001-5769-4582; BALLABIO, Andrea/0000-0003-1381-4604; Casari, Giorgio/0000-0002-0115-8980; CAVALCANTI, FRANCESCA/0000-0001-5769-4582; 	Telethon [TGM06S01, TGM97000, 1025] Funding Source: Medline	Telethon(Fondazione Telethon)		Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DURR A, 1994, NEUROLOGY, V44, P1274, DOI 10.1212/WNL.44.7.1274; FILLA A, 1992, J NEUROL, V239, P351, DOI 10.1007/BF00867594; FINK JK, 1995, AM J HUM GENET, V56, P188; Fink JK, 1996, NEUROLOGY, V46, P1507, DOI 10.1212/WNL.46.6.1507; GENCIC S, 1989, AM J HUM GENET, V45, P435; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HAZAN J, 1993, NAT GENET, V5, P163, DOI 10.1038/ng1093-163; HAZAN J, 1994, HUM MOL GENET, V3, P1569, DOI 10.1093/hmg/3.9.1569; HENTATI A, 1994, HUM MOL GENET, V3, P1263, DOI 10.1093/hmg/3.8.1263; HENTATI A, 1994, HUM MOL GENET, V3, P1867, DOI 10.1093/hmg/3.10.1867; JOUET M, 1994, NAT GENET, V7, P402, DOI 10.1038/ng0794-402; KOBAYASHI H, 1994, NAT GENET, V7, P351, DOI 10.1038/ng0794-351; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOUNTJOY KG, 1992, SCIENCE, V257, P1248, DOI 10.1126/science.1325670; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; POLO JM, 1993, J NEUROL NEUROSUR PS, V56, P175, DOI 10.1136/jnnp.56.2.175; PULLMAN WE, 1992, NATURE, V356, P529, DOI 10.1038/356529a0; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257	23	96	96	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1998	63	1					135	139		10.1086/301930	http://dx.doi.org/10.1086/301930			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZZ726	9634528	Bronze, Green Published			2022-12-18	WOS:000074761000020
J	Griffith, AJ; Sprunger, LK; Sirko-Osadsa, DA; Tiller, GE; Meisler, MH; Warman, ML				Griffith, AJ; Sprunger, LK; Sirko-Osadsa, DA; Tiller, GE; Meisler, MH; Warman, ML			Marshall syndrome associated with a splicing defect at the COL11A1 locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COLLAGEN GENE COL11A1; ALPHA-1(XI) COLLAGEN; PRO-ALPHA-1(XI) COLLAGEN; STICKLER SYNDROME; MOLECULAR-BASIS; EXPRESSION; TISSUE; XI; MUTATION; LINKAGE	Marshall syndrome is a rare, autosomal dominant skeletal dysplasia that is phenotypically similar to the more common disorder Stickler syndrome. For a large kindred with Marshall syndrome, we demonstrate a splice-donor-site mutation in the COL11A1 gene that cosegregates with the phenotype. The G(+1)-->A transition causes in-frame skipping of a 54-bp exon and deletes amino acids 726-743 from the major triple-helical domain of the alpha 1(XI) collagen polypeptide. The data support the hypothesis that the alpha 1(XI) collagen polypeptide has an important role in skeletal morphogenesis that extends beyond its contribution to structural integrity of the cartilage extracellular matrix. Our results also demonstrate allelism of Marshall syndrome with the subset of Stickler syndrome families associated with COL11A1 mutations.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Otolaryngol Head & Neck Surg, Ann Arbor, MI 48109 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Ctr Human Genet, Cleveland, OH 44106 USA; Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Vanderbilt University	Griffith, AJ (corresponding author), NIDCD, NIH, 5 Res Court,Room 2A01, Rockville, MD 20850 USA.		Sprunger, Leslie K/A-7840-2010		NHLBI NIH HHS [K08 HL02792] Funding Source: Medline; NIAMS NIH HHS [AR01925] Funding Source: Medline; NIGMS NIH HHS [GM24872] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL002792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR001925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024872] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AYME S, 1984, J MED GENET, V21, P34, DOI 10.1136/jmg.21.1.34; BERG ES, 1993, GENOMICS, V16, P350, DOI 10.1006/geno.1993.1196; BERNARD M, 1988, J BIOL CHEM, V263, P17159; COHEN MM, 1974, J PEDIATR-US, V85, P878; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Gorlin RJ, 1997, J CRANIO MAXILL SURG, V25, P69, DOI 10.1016/S1010-5182(97)80048-0; Griffith AJ, 1996, GENOMICS, V34, P299, DOI 10.1006/geno.1996.0290; HENRY I, 1988, Genomics, V3, P87, DOI 10.1016/0888-7543(88)90165-6; HOROWITZ DS, 1994, TRENDS GENET, V10, P100, DOI 10.1016/0168-9525(94)90233-X; Howard TD, 1997, NAT GENET, V15, P36, DOI 10.1038/ng0197-36; JOHNSTON MC, 1995, CRIT REV ORAL BIOL M, V6, P368, DOI 10.1177/10454411950060040601; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; LI Y, 1995, CELL, V80, P423, DOI 10.1016/0092-8674(95)90492-1; LUI VCH, 1995, BIOCHEM J, V311, P511, DOI 10.1042/bj3110511; Ma L, 1996, HUM MOL GENET, V5, P1915, DOI 10.1093/hmg/5.12.1915; MARSHALL D, 1958, AM J OPHTHALMOL, V45, P143, DOI 10.1016/0002-9394(58)90236-8; MAYNE R, 1993, J BIOL CHEM, V268, P9381; Muenke M, 1997, AM J HUM GENET, V60, P555; NIYIBIZI C, 1989, FEBS LETT, V242, P314, DOI 10.1016/0014-5793(89)80492-2; Oldridge M, 1997, HUM MOL GENET, V6, P137, DOI 10.1093/hmg/6.1.137; OXFORD JT, 1995, J BIOL CHEM, V270, P9478, DOI 10.1074/jbc.270.16.9478; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Richards AJ, 1996, HUM MOL GENET, V5, P1339, DOI 10.1093/hmg/5.9.1339; Schilling TF, 1997, BIOESSAYS, V19, P459, DOI 10.1002/bies.950190605; Shanske AL, 1997, AM J MED GENET, V70, P52, DOI 10.1002/(SICI)1096-8628(19970502)70:1<52::AID-AJMG11>3.0.CO;2-W; Sirko-Osadsa D. A., 1996, American Journal of Human Genetics, V59, pA17; SIRKOOSADSA DA, IN PRESS J PEDIAT; SNEAD MP, 1994, EYE, V8, P609, DOI 10.1038/eye.1994.153; SPERBER GH, 1994, CLEFT PALATE-CRAN J, V31, P91, DOI 10.1597/1545-1569(1994)031<0091:TEOC>2.3.CO;2; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; TAKAHARA K, 1995, GENOMICS, V29, P588, DOI 10.1006/geno.1995.9961; TILLER GE, 1995, AM J HUM GENET, V56, P388; TILSTRA DJ, 1994, ANNU REV MED, V45, P149, DOI 10.1146/annurev.med.45.1.149; Tsumaki N, 1996, J CELL BIOL, V134, P1573, DOI 10.1083/jcb.134.6.1573; VIKKULA M, 1995, CELL, V80, P431, DOI 10.1016/0092-8674(95)90493-X; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; YOSHIOKA H, 1990, J BIOL CHEM, V265, P6423; YOSHIOKA H, 1995, DEV DYNAM, V204, P41, DOI 10.1002/aja.1002040106; YOSHIOKA H, 1995, GENOMICS, V28, P337, DOI 10.1006/geno.1995.1151; ZHIDKOVA NI, 1995, J BIOL CHEM, V270, P9486, DOI 10.1074/jbc.270.16.9486	43	96	101	0	7	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1998	62	4					816	823		10.1086/301789	http://dx.doi.org/10.1086/301789			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZM197	9529347	Green Published, Bronze			2022-12-18	WOS:000073514400012
J	Suzuki, Y; Shirato, S; Taniguchi, F; Ohara, K; Nishimaki, K; Ohta, S				Suzuki, Y; Shirato, S; Taniguchi, F; Ohara, K; Nishimaki, K; Ohta, S			Mutations in the TIGR gene in familial primary open-angle glaucoma in Japan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									UNIV TOKYO,SCH MED,DEPT OPHTHALMOL,TOKYO 113,JAPAN; NIPPON MED COLL,INST GERONTOL,DEPT BIOCHEM & CELL BIOL,KANAGAWA,JAPAN	University of Tokyo; Nippon Medical School	Suzuki, Y (corresponding author), NIPPON MED COLL,DEPT OPHTHALMOL,BUNKYO KU,1-1-5 SENDAGI,TOKYO 113,JAPAN.							Kubota R, 1997, GENOMICS, V41, P360, DOI 10.1006/geno.1997.4682; NGUYEN TD, 1993, BASIC ASPECTS GLAUCO, V3, P331; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Raymond V, 1997, AM J HUM GENET, V60, P272; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668	6	96	104	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1202	1204		10.1086/301612	http://dx.doi.org/10.1086/301612			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345106	Green Published, Bronze			2022-12-18	WOS:A1997YH01700028
J	Philippe, C; Porter, DE; Emerton, ME; Wells, DE; Simpson, AHRW; Monaco, AP				Philippe, C; Porter, DE; Emerton, ME; Wells, DE; Simpson, AHRW; Monaco, AP			Mutation screening of the EXT1 and EXT2 genes in patients with hereditary multiple exostoses	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME-11; DNA; HETEROZYGOSITY; SPECTRUM; CLONING; MARKERS; CANCER	Hereditary multiple exostoses (HME), the most frequent of all skeletal dysplasias, is an autosomal dominant disorder characterized by the presence of multiple exostoses localized mainly at the end of long bones. HME is genetically heterogeneous, with at least three loci, on 8q24.1 (EXT1), 11p11-p13 (EXT2), and 19p (EXT3). Both the EXT1 and EXT2 genes have been cloned recently and define a new family of potential tumor suppressor genes. This is the first study in which mutation screening has been performed for both the EXT1 and EXT2 genes prior to any linkage analysis. We have screened 17 probands with the HME phenotype, for alterations in all translated exons and nanking intronic sequences, in the EXT1 and EXT2 genes, by conformation-sensitive gel electrophoresis. We found the disease-causing mutation in 12 families (70%), 7 (41%) of which have EXT1 mutations and 5 (29%) EXT2 mutations. Together with the previously described 1-bp deletion in exon 6, which is present in 2 of our families, we report five new mutations in EXT1, Two are missense mutations in exon 2 (G339D and R340C), and the other three alterations (a nonsense mutation, a frameshift, and a splicing mutation) are likely to result in truncated non-functional proteins. Four new mutations are described in EXT2. A missense mutation (D227N) was found in 2 different families; the other three alterations (two non-sense mutations and one frameshift mutation) lead directly or indirectly to premature stop codons. The mis-sense mutations in EXT1 and EXT2 may pinpoint crucial domains in both proteins and therefore give clues for the understanding of the pathophysiology of this skeletal disorder.	WELLCOME TRUST CTR HUMAN GENET, OXFORD OX3 7BN, ENGLAND; UNIV OXFORD, NUFFIELD DEPT ORTHOPAED SURG, OXFORD, ENGLAND; UNIV HOUSTON, DEPT BIOL, HOUSTON, TX 77204 USA; UNIV HOUSTON, INST MOL BIOL, HOUSTON, TX 77204 USA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Houston System; University of Houston; University of Houston System; University of Houston			Monaco, Anthony P/A-4495-2010; Simpson, Alasdair/F-1887-2013; /AAD-2181-2020	Monaco, Anthony P/0000-0001-7480-3197; Simpson, Alasdair/0000-0001-7793-642X; PHILIPPE, Christophe/0000-0001-7098-6520	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027981] Funding Source: NIH RePORTER; NICHD NIH HHS [HD27981] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; Bartsch O, 1996, AM J HUM GENET, V58, P734; BEAUDET AL, 1993, HUM MUTAT, V2, P245, DOI 10.1002/humu.1380020402; BOWTELL DDL, 1987, ANAL BIOCHEM, V162, P463, DOI 10.1016/0003-2697(87)90421-0; COOK A, 1993, AM J HUM GENET, V53, P71; DIETZ HC, 1993, SCIENCE, V259, P680, DOI 10.1126/science.8430317; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GIBSON RA, 1993, HUM MOL GENET, V2, P797, DOI 10.1093/hmg/2.6.797; HECHT JT, 1995, AM J HUM GENET, V56, P1125; Hecht JT, 1997, AM J HUM GENET, V60, P80; HENNEKAM RCM, 1991, J MED GENET, V28, P262, DOI 10.1136/jmg.28.4.262; Hogue Deborah A., 1996, American Journal of Human Genetics, V59, pA263; JEANPIERRE M, 1987, NUCLEIC ACIDS RES, V15, P9611, DOI 10.1093/nar/15.22.9611; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KRAWCZAK M, 1992, HUM GENET, V90, P41; LegeaiMallet L, 1997, HUM GENET, V99, P298, DOI 10.1007/s004390050361; LEMERRER M, 1994, HUM MOL GENET, V3, P717, DOI 10.1093/hmg/3.5.717; LOHMANN DR, 1994, HUM MOL GENET, V3, P2187, DOI 10.1093/hmg/3.12.2187; Ludecke HJ, 1997, GENOMICS, V40, P351, DOI 10.1006/geno.1996.4577; LUDECKE HJ, 1995, HUM MOL GENET, V4, P31, DOI 10.1093/hmg/4.1.31; Maquat LE, 1996, AM J HUM GENET, V59, P279; Mazoyer S, 1996, NAT GENET, V14, P253, DOI 10.1038/ng1196-253; MERTENS F, 1994, GENE CHROMOSOME CANC, V9, P8, DOI 10.1002/gcc.2870090103; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Raskind W. H., 1996, American Journal of Human Genetics, V59, pA280; RASKIND WH, 1995, AM J HUM GENET, V56, P1132; SCHMALE GA, 1994, J BONE JOINT SURG AM, V76A, P986, DOI 10.2106/00004623-199407000-00005; SOLOMON L, 1963, J BONE JOINT SURG BR, V45, P292, DOI 10.1302/0301-620X.45B2.292; Stickens D, 1996, NAT GENET, V14, P25, DOI 10.1038/ng0996-25; SUGIURA Y, 1976, JPN J HUM GENET, V21, P149; Wells DE, 1997, HUM GENET, V99, P612, DOI 10.1007/s004390050415; WICKLUND CL, 1995, AM J MED GENET, V55, P43, DOI 10.1002/ajmg.1320550113; Wise CA, 1997, GENOME RES, V7, P10, DOI 10.1101/gr.7.1.10; Wuyts W, 1996, HUM MOL GENET, V5, P1547, DOI 10.1093/hmg/5.10.1547; WUYTS W, 1995, AM J HUM GENET, V57, P382	36	96	105	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					520	528		10.1086/515505	http://dx.doi.org/10.1086/515505			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326317	Green Published, Bronze			2022-12-18	WOS:A1997XY52300009
J	Stevenson, RE; Schwartz, CE; Du, YZ; Adams, MJ				Stevenson, RE; Schwartz, CE; Du, YZ; Adams, MJ			Differences in methylenetetrahydrofolate reductase genotype frequencies, between whites and blacks	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							RISK FACTOR		CTR DIS CONTROL & PREVENT,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA	Stevenson, RE (corresponding author), JC SELF RES INST HUMAN GENET,1 GREGOR MENDEL CIRCLE,GREENWOOD,SC 29646, USA.							deFranchis R, 1995, LANCET, V346, P1703, DOI 10.1016/S0140-6736(95)92865-0; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Motulsky AG, 1996, AM J HUM GENET, V58, P17; Ou CY, 1996, AM J MED GENET, V63, P610, DOI 10.1002/(SICI)1096-8628(19960628)63:4<610::AID-AJMG15>3.3.CO;2-Y; VANDERPUT NMJ, 1995, LANCET, V346, P1070, DOI 10.1016/S0140-6736(95)91743-8; WHITEHEAD AS, 1995, QJM-MON J ASSOC PHYS, V88, P763	6	96	97	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					229	230						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981967				2022-12-18	WOS:A1997WA81800030
J	Tromp, G; Kuivaniemi, H; Raphael, S; AlaKokko, L; Christiano, A; Considine, E; Dhulipala, R; Hyland, J; Jokinen, A; Kivirikko, S; Korn, R; Madhatheri, S; McCarron, S; Pulkkinen, L; Punnett, H; Shimoya, K; Spotila, L; Tate, A; Williams, CJ				Tromp, G; Kuivaniemi, H; Raphael, S; AlaKokko, L; Christiano, A; Considine, E; Dhulipala, R; Hyland, J; Jokinen, A; Kivirikko, S; Korn, R; Madhatheri, S; McCarron, S; Pulkkinen, L; Punnett, H; Shimoya, K; Spotila, L; Tate, A; Williams, CJ			Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHEUMATOID-ARTHRITIS; INTERLEUKIN-4 RECEPTOR; CELL-ADHESION; LOD SCORE; PREVALENCE; SITE; MASSACHUSETTS; EPIDEMIOLOGY; AUTOIMMUNITY; SARCOIDOSIS	Blau syndrome (MIM 186580), first described in a large, three-generation kindred, is an autosomal, dominantly inherited disease characterized by multiorgan, tissue-specific inflammation. Its clinical phenotype includes granulomatous arthritis, skin rash, and uveitis and probably represents a subtype of a group of clinical entities referred to as ''familial granulomatosis,'' It is the sole human model with recognizably Mendelian inheritance for a variety of multisystem inflammatory diseases affecting a significant percentage of the population. A genomewide search for the Blau susceptibility locus was undertaken after karyotypic analysis revealed no abnormalities. Sixty-two of the 74-member pedigree were genotyped with dinucleotide-repeat markers. Linkage analysis was performed under a dominant model of inheritance with reduced penetrance. The marker D16S298 gave a maximum LOD score of 3.75 at theta = .04, with two-point analysis. LOD scores for flanking markers were consistent and placed the Blau susceptibility Locus within the 16p12-q21 interval.	THOMAS JEFFERSON UNIV, JEFFERSON INST MOL MED, DEPT BIOCHEM & MOL BIOL, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON INST MOL MED, DEPT DERMATOL, PHILADELPHIA, PA 19107 USA; ST CHRISTOPHERS HOSP CHILDREN, DEPT PEDIAT, PHILADELPHIA, PA 19133 USA; TEMPLE UNIV, SCH MED, PHILADELPHIA, PA 19122 USA	Jefferson University; Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University			Kuivaniemi, Helena/Q-8178-2019; Tromp, Gerard/B-2677-2017	Kuivaniemi, Helena/0000-0001-5753-8766; Tromp, Gerard/0000-0002-7761-0806				AHO K, 1989, RHEUMATOL INT, V9, P7, DOI 10.1007/BF00270283; BAARSMA GS, 1992, CURR EYE RES, V11, P1, DOI 10.3109/02713689208999505; BAZIL V, 1993, P NATL ACAD SCI USA, V90, P3792, DOI 10.1073/pnas.90.9.3792; BECKMANN MP, 1992, CHEM IMMUNOL, V51, P107; BLAU EB, 1985, J PEDIATR-US, V107, P689, DOI 10.1016/S0022-3476(85)80394-2; CHAN KWA, 1993, ARTHRITIS RHEUM-US, V36, P1691, DOI 10.1002/art.1780361207; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CORBI AL, 1988, J EXP MED, V167, P1597, DOI 10.1084/jem.167.5.1597; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DECHADAREVIAN JP, 1993, ARCH PATHOL LAB MED, V117, P1050; DWARKADAS S, 1994, HUM HERED, V44, P127, DOI 10.1159/000154205; FELSON DT, 1993, ARTHRITIS ALLIED CON, P17; GAO XJ, 1990, ARTHRITIS RHEUM, V33, P939, DOI 10.1002/art.1780330704; GREENBERG DA, 1993, AM J HUM GENET, V52, P135; HENKE CE, 1986, AM J EPIDEMIOL, V123, P840, DOI 10.1093/oxfordjournals.aje.a114313; JABS DA, 1985, AM J MED, V78, P801, DOI 10.1016/0002-9343(85)90286-4; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LANDER ES, 1989, GENETICS, V121, P185; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LAWRENCE RC, 1989, J RHEUMATOL, V16, P427; LAXER RM, 1986, ARTHRITIS RHEUM, V29, P439, DOI 10.1002/art.1780290322; LINOS A, 1980, AM J EPIDEMIOL, V111, P87, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A112878; MALONEY MD, 1994, J EXP MED, V180, P191, DOI 10.1084/jem.180.1.191; Maniatis T., 1982, MOL CLONING; NEPOM GT, 1991, ANNU REV IMMUNOL, V9, P493; NORTH AF, 1970, AM J MED, V48, P449, DOI 10.1016/0002-9343(70)90044-6; OSULLIVAN JB, 1972, ANN INTERN MED, V76, P573, DOI 10.7326/0003-4819-76-4-573; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; PASTORES GM, 1990, J PEDIATR-US, V117, P403, DOI 10.1016/S0022-3476(05)81080-7; PRITCHARD MA, 1991, GENOMICS, V10, P801, DOI 10.1016/0888-7543(91)90466-R; RAPHAEL SA, 1993, AM J DIS CHILD, V147, P842, DOI 10.1001/archpedi.1993.02160320044017; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1990, AM J HUM GENET S, V47, pA197; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Scharkoff T, 1987, Sarcoidosis, V4, P152; SHEN Y, 1994, GENOMICS, V22, P68, DOI 10.1006/geno.1994.1346; TERWILLIGER JD, 1994, HDB GENETIC LINKAGE; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEYAND CM, 1992, J CLIN INVEST, V90, P2355, DOI 10.1172/JCI116125; WEYAND CM, 1992, J CLIN INVEST, V89, P2033, DOI 10.1172/JCI115814	46	96	104	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1097	1107						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900239				2022-12-18	WOS:A1996VN90000018
J	TONIN, P; SEROVA, O; LENOIR, G; LYNCH, H; DUROCHER, F; SIMARD, J; MORGAN, K; NAROD, S				TONIN, P; SEROVA, O; LENOIR, G; LYNCH, H; DUROCHER, F; SIMARD, J; MORGAN, K; NAROD, S			BRCA1 MUTATIONS IN ASHKENAZI-JEWISH WOMEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									MCGILL UNIV,DEPT HUMAN GENET,MONTREAL,PQ,CANADA; INT AGCY RES CANC,F-69372 LYON,FRANCE; CREIGHTON UNIV,SCH MED,DEPT PREVENT & PUBL HLTH,OMAHA,NE; CHUL,RES CTR,MOLEC ENDOCRINOL LAB,QUEBEC CITY,PQ,CANADA	McGill University; World Health Organization; International Agency for Research on Cancer (IARC); Creighton University; Laval University	TONIN, P (corresponding author), MCGILL UNIV,DEPT MED,DIV MED GENET,MONTREAL,PQ,CANADA.		Narod, Steven A/AAA-6112-2022	Simard, Jacques/0000-0001-6906-3390; Durocher, Francine/0000-0001-8012-4641				MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; SHATTUCKEIDENS D, 1995, JAMA-J AM MED ASSOC, V273, P535, DOI 10.1001/jama.273.7.535; SIMARD J, 1994, NAT GENET, V8, P392, DOI 10.1038/ng1294-392; STRUEWING JP, 1995, AM J HUM GENET, V57, P1	4	96	98	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					189	189						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611288				2022-12-18	WOS:A1995RE62900023
J	CHILLON, M; DORK, T; CASALS, T; GIMENEZ, J; FONKNECHTEN, N; WILL, K; RAMOS, D; NUNES, V; ESTIVILL, X				CHILLON, M; DORK, T; CASALS, T; GIMENEZ, J; FONKNECHTEN, N; WILL, K; RAMOS, D; NUNES, V; ESTIVILL, X			A NOVEL DONOR SPLICE-SITE IN INTRON-11 OF THE CFTR GENE, CREATED BY MUTATION 1811+1.6KBA-]G, PRODUCES A NEW EXON - HIGH-FREQUENCY IN SPANISH CYSTIC-FIBROSIS CHROMOSOMES AND ASSOCIATION WITH SEVERE PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYSTIC-FIBROSIS MUTATIONS; IDENTIFICATION; POPULATION; SEQUENCE; ALLELES	mRNA analysis of the cystic fibrosis transmembrane regulator (CFTR) gene in tissues of cystic fibrosis (CF) patients has allowed us to detect a cryptic exon. The new exon involves 49 base pairs between exons 11 and 12 and is due to a point mutation (1811+1.6kbA-->G) that creates a new donor splice site in intron 11. Semiquantitative mRNA analysis showed that 1811+1.6kbA-->G-mRNA was 5-10-fold less abundant than Delta F508 mRNA. Mutation 1811+1.GkbA-->G was found in 21 Spanish and 1 German CF chromosomes, making it the fourth-most-frequent mutation (2%) in the Spanish population. Individuals with genotype Delta F508/1811+1.6kbA-->G have only 1%-3% of normal CFTR mRNA. This loss of 97% of normal CFTR mRNA must be responsible for the pancreatic insufficiency and for the severe CF phenotype in these patients.	HOSP DURAN & REYNALS,CANC RES INST,DEPT MOLEC GENET,E-08907 BARCELONA,SPAIN; HANNOVER MED SCH,HANNOVER,GERMANY; KLIN FORSCH GRP,HANNOVER,GERMANY; INST COCHIN GENET MOLEC,CNRS,UA 1147,INSERM,U129,F-75014 PARIS,FRANCE	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals; Hannover Medical School; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite			Nunes, Virginia/AAD-1014-2019; Estivill, Xavier/A-3125-2013; Dörk, Thilo/J-8620-2012; Chillon, Miguel/A-2466-2009	Nunes, Virginia/0000-0002-5747-9310; Estivill, Xavier/0000-0002-0723-2256; Dörk, Thilo/0000-0002-9458-0282; Chillon, Miguel/0000-0003-0840-2111				ABELIOVICH D, 1992, AM J HUM GENET, V51, P951; AKLI S, 1991, GENOMICS, V11, P124, DOI 10.1016/0888-7543(91)90109-R; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CHILLON M, 1994, HUM GENET, V93, P447; CHILLON M, 1993, HUM MOL GENET, V2, P1741, DOI 10.1093/hmg/2.10.1741; CHILLON M, 1994, HUM MUTAT, V3, P223, DOI 10.1002/humu.1380030308; CHOMCZYNSKI P, 1978, ANAL BIOCHEM, V162, P156; CLAUSTRES M, 1993, HUM MOL GENET, V2, P1209, DOI 10.1093/hmg/2.8.1209; CUPPENS H, 1993, GENOMICS, V18, P693, DOI 10.1016/S0888-7543(05)80376-3; DORK T, 1992, HUM GENET, V88, P417, DOI 10.1007/BF00215676; ESTES PA, 1992, J BIOL CHEM, V267, P14902; FEREC C, 1992, NAT GENET, V1, P188, DOI 10.1038/ng0692-188; FONKNECHTEN N, 1992, HUM GENET, V88, P508, DOI 10.1007/BF00219336; HAMOSH A, 1992, HUM MOL GENET, V1, P542, DOI 10.1093/hmg/1.7.542; HIGHSMITH WE, 1994, NEW ENGL J MED, V331, P974, DOI 10.1056/NEJM199410133311503; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KRAWCZAK M, 1992, HUM GENET, V90, P41; MORRAL N, 1993, HUM MOL GENET, V2, P677, DOI 10.1093/hmg/2.6.677; MORRAL N, 1993, HUM MOL GENET, V2, P1015, DOI 10.1093/hmg/2.7.1015; SCHWACHMAN H, 1958, AM J DIS CHILD, V96, P6; SENEPATHY P, 1990, METHOD ENZYMOL, V183, P252; TSUI LC, 1992, TRENDS GENET, V8, P392, DOI 10.1016/0168-9525(92)90301-J; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; WILL K, 1994, J CLIN INVEST, V93, P1852, DOI 10.1172/JCI117172; WILL K, 1993, HUM MOL GENET, V2, P231, DOI 10.1093/hmg/2.3.231; ZHANG ZX, 1994, HUM MOL GENET, V3, P139, DOI 10.1093/hmg/3.1.139; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7; ZIELENSKI J, 1993, AM J HUM GENET, V52, P609; 1993, NEW ENGL J MED, V329, P1308	30	96	99	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					623	629						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7534040				2022-12-18	WOS:A1995QK91800010
J	KNIGHT, SJL; VOELCKEL, MA; HIRST, MC; FLANNERY, AV; MONCLA, A; DAVIES, KE				KNIGHT, SJL; VOELCKEL, MA; HIRST, MC; FLANNERY, AV; MONCLA, A; DAVIES, KE			TRIPLET REPEAT EXPANSION AT THE FRAXE LOCUS AND X-LINKED MILD MENTAL HANDICAP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X; FMR-1 GENE; 2 FAMILIES; CPG ISLAND; RETARDATION; SITE; METHYLATION; DNA; IDENTIFICATION; AMPLIFICATION	We have recently shown that the expression of the FRAXE fragile site in Xq28 is associated with the expansion of a GCC trinucleotide repeat. In the families studied, FRAXE expression is also associated with mild mental handicap. Here we present data on families that previously had been diagnosed as having the fragile X syndrome but that later were found to be negative for trinucleotide repeat expansion at the FRAXA locus. In these families we demonstrate the presence of a GCC trinucleotide repeat expansion at the FRAXE locus. Studies of the FRAXE locus of normal individuals show that they have 6-25 copies of the repeat, whereas affected individuals have >200 copies. As in the fragile X syndrome, the amplified CpG residues are methylated in affected males.	JOHN RADCLIFFE HOSP,INST MOLEC MED,MOLEC GENET GRP,OXFORD OX3 9DU,ENGLAND; HOP ENFANTS LA TIMONE,CTR GENET MED,F-13385 MARSEILLE,FRANCE; HOP ENFANTS LA TIMONE,INSERM,U242,F-13385 MARSEILLE,FRANCE	University of Oxford; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille				Knight, Samantha/0000-0002-6047-3462	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CLARKE A, 1992, AM J MED GENET, V43, P299, DOI 10.1002/ajmg.1320430146; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DENNIS NR, 1992, AM J MED GENET, V43, P232, DOI 10.1002/ajmg.1320430137; FLYNN GA, 1993, J MED GENET, V30, P97, DOI 10.1136/jmg.30.2.97; FRYNS JP, 1989, FRAGILE X SYNDROME, P1; GEDEON AK, 1992, NAT GENET, V1, P341, DOI 10.1038/ng0892-341; HANSEN RS, 1992, HUM MOL GENET, V1, P571, DOI 10.1093/hmg/1.8.571; HANSEN RS, 1993, CELL, V73, P1403, DOI 10.1016/0092-8674(93)90365-W; HIRST MC, 1993, HUM MOL GENET, V2, P197, DOI 10.1093/hmg/2.2.197; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; NAKAHORI Y, 1991, NUCLEIC ACIDS RES, V19, P4355, DOI 10.1093/nar/19.16.4355; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; REYNIERS E, 1993, NAT GENET, V4, P143, DOI 10.1038/ng0693-143; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Sutherland Grant R., 1992, Human Molecular Genetics, V1, P111, DOI 10.1093/hmg/1.2.111; VERKERK AJM, 1991, CELL, V5, P905; VOELCKEL MA, 1989, HUM GENET, V81, P353, DOI 10.1007/BF00283690; WOHRLE D, 1992, AM J HUM GENET, V51, P299; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179	19	96	98	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1994	55	1					81	86						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	NW461	8023854				2022-12-18	WOS:A1994NW46100012
J	LEANACOX, J; JENKINS, L; PALMER, CG; PLATTNER, R; SHEPPARD, L; FLEJTER, WL; ZACKOWSKI, J; TSIEN, F; SCHWARTZ, S				LEANACOX, J; JENKINS, L; PALMER, CG; PLATTNER, R; SHEPPARD, L; FLEJTER, WL; ZACKOWSKI, J; TSIEN, F; SCHWARTZ, S			MOLECULAR CYTOGENETIC ANALYSIS OF INV DUP(15) CHROMOSOMES, USING PROBES SPECIFIC FAR THE PRADER-WILLI/ANGELMAN SYNDROME REGION - CLINICAL IMPLICATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BISATELLITED MARKER CHROMOSOMES; WILLI SYNDROME; DNA; IDENTIFICATION; ABNORMALITIES; HYBRIDIZATION	Twenty-seven cases of inverted duplications of chromosome 15 (inv dup[15]) were investigated by FISH with two DNA probes specific for the Prader-Willi syndrome/Angelman syndrome (PWS/AS) region on proximal 15q. Sixteen of the marker chromosomes displayed two copies of each probe, while in the remaining 11 markers no hybridization was observed. A significant association was found between the presence of this region and an abnormal phenotype (P <.01). This is the largest study to date of inv dup(15) chromosomes, that uses molecular cytogenetic methods and is the first to report a significant association between the presence of a specific chromosomal region in such markers and an abnormal phenotype.	CASE WESTERN RESERVE UNIV,CTR HUMAN GENET,CLEVELAND,OH 44106; UNIV MARYLAND,SCH MED,DEPT OBSTET & GYNECOL,DIV HUMAN GENET,BALTIMORE,MD 21201; UNIV MARYLAND,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21201; KAISER PERMANENTE MED GRP,DEPT GENET,SAN JOSE,CA; INDIANA UNIV,SCH MED,DEPT MED GENET,INDIANAPOLIS,IN 46202; PALO VERDE LAB INC,CHANDLER,AZ; UNIV MICHIGAN,CTR HUMAN GENET,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV FLORIDA,HLTH SCI CTR,DEPT PEDIAT,DIV GENET,GAINESVILLE,FL; TULANE UNIV,SCH MED,HUMAN GENET PROGRAM,NEW ORLEANS,LA 70112; CASE WESTERN RESERVE UNIV,DEPT GENET,CLEVELAND,OH 44106	Case Western Reserve University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Kaiser Permanente; Permanente Medical Groups; Indiana University System; Indiana University-Purdue University Indianapolis; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; Tulane University; Case Western Reserve University								BUCKTON KE, 1980, ANN HUM GENET, V43, P227, DOI 10.1111/j.1469-1809.1980.tb01556.x; BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; CALLEN DF, 1990, J MED GENET, V27, P155, DOI 10.1136/jmg.27.3.155; CHOO KH, 1990, GENOMICS, V7, P143, DOI 10.1016/0888-7543(90)90534-2; DAHOUNHADORN S, 1990, ANN GENET-PARIS, V33, P241; FUJITA H, 1980, HUM GENET, V55, P409, DOI 10.1007/BF00290227; KNIGHT LA, 1984, AM J MED GENET, V17, P649, DOI 10.1002/ajmg.1320170315; KUWANO A, 1991, CYTOGENET CELL GENET, V56, P212, DOI 10.1159/000133091; Kuwano Akira, 1992, Human Molecular Genetics, V1, P417, DOI 10.1093/hmg/1.6.417; LEDBETTER DH, 1982, AM J HUM GENET, V34, P278; MARASCHIO P, 1981, HUM GENET, V57, P345, DOI 10.1007/BF00281681; NICHOLLS RD, 1993, AM J MED GENET, V46, P16, DOI 10.1002/ajmg.1320460106; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PLATTNER R, 1991, HUM GENET, V87, P290; PLATTNER R, 1993, HUM GENET, V91, P589; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; SCHRECK RR, 1977, HUM GENET, V36, P1, DOI 10.1007/BF00390430; SCHWARTZ S, 1990, AM J HUM GENET S, V47, pA40; SCHWEIZER D, 1978, EXP CELL RES, V111, P327, DOI 10.1016/0014-4827(78)90177-5; SHIBUYA Y, 1991, CLIN GENET, V40, P233; STEINBACH P, 1983, HUM GENET, V65, P155, DOI 10.1007/BF00286654; STETTEN G, 1981, HUM GENET, V57, P357, DOI 10.1007/BF00281684; TANTRAVAHI U, 1989, AM J MED GENET, V33, P78, DOI 10.1002/ajmg.1320330110; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WISNIEWSKI L, 1979, HUM GENET, V50, P259, DOI 10.1007/BF00399391; WISNIEWSKI LP, 1980, CLIN GENET, V18, P42; WISNIEWSKI LP, 1985, HUM GENET, V69, P161, DOI 10.1007/BF00293289; [No title captured]; 1985, REPORT STANDING COMM	29	96	96	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					748	756						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178816				2022-12-18	WOS:A1994NH39400003
J	KLINE, AD; WHITE, ME; WAPNER, R; ROJAS, K; BIESECKER, LG; KAMHOLZ, J; ZACKAI, EH; MUENKE, M; SCOTT, CI; OVERHAUSER, J				KLINE, AD; WHITE, ME; WAPNER, R; ROJAS, K; BIESECKER, LG; KAMHOLZ, J; ZACKAI, EH; MUENKE, M; SCOTT, CI; OVERHAUSER, J			MOLECULAR ANALYSIS OF THE 18Q--SYNDROME - AND CORRELATION WITH PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BASIC-PROTEIN GENE; 18Q SYNDROME; PARENTAL ORIGIN; CHROMOSOME-15 DELETION; HIGH-RESOLUTION; SHORT ARM; ANGELMAN; HYBRIDS; LINKAGE; PATIENT	Seven individuals with deletions of the distal long arm of chromosome 18 were evaluated at the clinical, cytogenetic, and molecular levels. The patients had varying degrees of typical clinical findings associated with the 18q- syndrome. Cytogenetic analysis revealed deletions from 18q21.3 or 18q22.2 to qter. Somatic cell hybrids derived from the patients were molecularly characterized using ordered groups of probes isolated from a chromosome 18-specific library. In general, the size of the deletion could be correlated with the severity of the phenotype. Based on the clinical pictures of these seven patients, a preliminary phenotypic map for the clinical features associated with deletions of the distal portion of the long arm has been generated. Furthermore, genes previously localized to 18q21 were mapped relative to the chromosome breakpoints present in these patients.	THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,BLUEMLE LIFE SCI BLDG,ROOM 209,233 S 10TH ST,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,DIV MED GENET,PHILADELPHIA,PA 19107; UNIV MICHIGAN,DEPT PEDIAT,ANN ARBOR,MI 48109; UNIV PENN,SCH MED,DEPT GENET,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; ALFRED I DUPONT INST,WILMINGTON,DE 19899	Jefferson University; Jefferson University; University of Michigan System; University of Michigan; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Nemours Alfred I. duPont Hospital for Children			Biesecker, Leslie/AAG-2526-2021	Wapner, Ronald/0000-0003-0727-1244; Muenke, Maximilian/0000-0002-7719-6545	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007075] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG-00167] Funding Source: Medline; NICHD NIH HHS [5T32HD07075-15] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABUSREWIL SS, 1988, ARCH DIS CHILD, V63, P1090, DOI 10.1136/adc.63.9.1090; BOYLAN KB, 1990, GENOMICS, V6, P16, DOI 10.1016/0888-7543(90)90443-X; BUCHWALD M, 1984, CLIN BIOCHEM, V17, P143, DOI 10.1016/S0009-9120(84)80147-2; BUTLER MG, 1983, LANCET, V1, P1285; CIRULLO RE, 1983, SOMAT CELL GENET, V9, P215, DOI 10.1007/BF01543178; DANA S, 1982, MOL CELL BIOL, V2, P1220, DOI 10.1128/MCB.2.10.1220; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; FAED MJW, 1972, J MED GENET, V9, P102, DOI 10.1136/jmg.9.1.102; FAULKNER KW, 1983, J PEDIATR-US, V103, P600, DOI 10.1016/S0022-3476(83)80598-8; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FELDING I, 1987, CLIN GENET, V31, P206; FRACCARO M, 1971, ANN GENET-PARIS, V14, P275; FRYNS JP, 1979, EUR J PEDIATR, V130, P189, DOI 10.1007/BF00455265; HOO JJ, 1986, AM J MED GENET, V24, P533, DOI 10.1002/ajmg.1320240317; KAMHOLZ J, 1987, AM J HUM GENET, V40, P365; KLINE AD, 1992, GENOMICS, V13, P1, DOI 10.1016/0888-7543(92)90193-V; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; LAW EM, 1969, ANN GENET-PARIS, V12, P215; LEBACQVERHEYDEN AM, 1987, SOMAT CELL MOLEC GEN, V13, P81, DOI 10.1007/BF02422302; MILLER G, 1990, AM J MED GENET, V37, P128, DOI 10.1002/ajmg.1320370130; OVERHAUSER J, 1986, AM J HUM GENET, V39, P562; OVERHAUSER J, 1990, AM J MED GENET, V37, P83, DOI 10.1002/ajmg.1320370119; OVERHAUSER J, 1989, AM J HUM GENET, V45, P296; Sambrook J., 1989, MOL CLONING LAB MANU; SCHINZEL A, 1984, CATALOGUE UNBALANCED, P319; SILVERMAN GA, 1991, GENOMICS, V9, P219, DOI 10.1016/0888-7543(91)90245-A; STRAUB RE, IN PRESS GENOMICS; SUBRT I, 1970, HUMANGENETIK, V10, P181, DOI 10.1007/BF00295518; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; VANTUINEN P, 1988, AM J HUM GENET, V43, P587; VOGEL H, 1990, DEV MED CHILD NEUROL, V32, P725; WEISS BJ, 1991, ANN NEUROL, V30, P419, DOI 10.1002/ana.410300316; WERTELECKI W, 1971, J PEDIATR-US, V78, P44, DOI 10.1016/S0022-3476(71)80262-7; WILLIAMS CA, 1990, AM J MED GENET, V35, P350, DOI 10.1002/ajmg.1320350308; WILSON MG, 1979, AM J MED GENET, V3, P155, DOI 10.1002/ajmg.1320030207; Worton R G, 1979, Methods Enzymol, V58, P322; YE RD, 1989, J BIOL CHEM, V264, P5495; YUNIS JJ, 1976, SCIENCE, V191, P1268, DOI 10.1126/science.1257746	39	96	96	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1993	52	5					895	906						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LB889	8488839				2022-12-18	WOS:A1993LB88900006
J	SU, H; LAU, YFC				SU, H; LAU, YFC			IDENTIFICATION OF THE TRANSCRIPTIONAL UNIT, STRUCTURAL ORGANIZATION, AND PROMOTER SEQUENCE OF THE HUMAN SEX-DETERMINING REGION-Y (SRY) GENE, USING A REVERSE GENETIC APPROACH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TESTIS-DETERMINING FACTOR; CYSTIC-FIBROSIS GENE; DNA-BINDING MOTIF; EXPRESSED RETROPOSON; FUNCTIONAL-ANALYSIS; MAMMALIAN-CELLS; COSMID VECTORS; KINASE GENE; ENHANCER; PROTEIN	Using a simple strategy involving cosmid-mediated gene transfer, cDNA library construction, and molecular characterization techniques, we have determined the transcriptional unit, structural organization, and promoter sequence of the human sex-determining region Y (SRY) gene, the putative testis-determining factor (TDF) gene on the human Y chromosome. By this approach, a recombinant cosmid harboring the human SRY sequence was isolated and transfected to appropriate tissue-cultured cells. Recombinant cDNA clones were isolated from a cDNA library constructed from poly (A) + RNA of the transfected cells. Comparative studies between the respective cDNAs and the genomic cosmid have provided information regarding the organization of the SRY gene and its mRNAs. The results indicate that the human SRY gene is an intronless gene, produces transcripts of 1.1 kb, and possesses promoter activities in the transfected cells at approximately 310 bp of its upstream sequences.			SU, H (corresponding author), UNIV CALIF SAN FRANCISCO, VA MED CTR 111C5, DEPT MED, DIV CELL & DEV GENET, 4150 CLEMENT ST, SAN FRANCISCO, CA 94121 USA.		Lau, Yun-Fai C/E-4465-2014	Lau, Yun-Fai C/0000-0002-9119-7050	NICHD NIH HHS [HD27392, HD24384] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024384, R01HD027392] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ASHWORTH A, 1990, EMBO J, V9, P1529, DOI 10.1002/j.1460-2075.1990.tb08271.x; BACHVAROV D, 1991, NUCLEIC ACIDS RES, V19, P2331, DOI 10.1093/nar/19.9.2331; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BOER PH, 1987, MOL CELL BIOL, V7, P3107, DOI 10.1128/MCB.7.9.3107; CHOO KH, 1986, GENE, V46, P277, DOI 10.1016/0378-1119(86)90412-9; DEAN M, 1990, NUCLEIC ACIDS RES, V18, P345, DOI 10.1093/nar/18.2.345; DENNY P, 1992, NUCLEIC ACIDS RES, V20, P2887, DOI 10.1093/nar/20.11.2887; EBENSPERGER C, 1991, ANN GENET-PARIS, V34, P233; FINK GR, 1986, TRENDS GENET, V2, P118, DOI 10.1016/0168-9525(86)90200-3; FINNEGAN DJ, 1985, INT REV CYTOL, V93, P281, DOI 10.1016/S0074-7696(08)61376-5; Frankel AD, 1992, CURR OPIN GENET DEV, V2, P293, DOI 10.1016/S0959-437X(05)80287-4; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; HAWKINS JR, 1992, HUM GENET, V88, P471, DOI 10.1007/BF00215684; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; Johns EW, 1982, HMG CHROMOSOMAL PROT; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KUHN R, 1991, MOL CELL BIOL, V11, P4642, DOI 10.1128/MCB.11.9.4642; Lau Y F, 1987, Methods Enzymol, V151, P426, DOI 10.1016/S0076-6879(87)51034-5; LAU YF, 1984, P NATL ACAD SCI-BIOL, V81, P414, DOI 10.1073/pnas.81.2.414; LAU YF, 1983, P NATL ACAD SCI-BIOL, V80, P5225, DOI 10.1073/pnas.80.17.5225; LEE DK, 1991, CELL, V67, P1241, DOI 10.1016/0092-8674(91)90300-N; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LINDSAY S, 1987, NATURE, V327, P336, DOI 10.1038/327336a0; LOCK P, 1990, MOL CELL BIOL, V10, P4603, DOI 10.1128/MCB.10.9.4603; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MCCARREY JR, 1990, NUCLEIC ACIDS RES, V18, P949, DOI 10.1093/nar/18.4.949; MCELREAVEY KD, 1992, GENOMICS, V13, P838, DOI 10.1016/0888-7543(92)90164-N; MONACO AP, 1988, ADV HUM GENET, V17, P61; NASRIN N, 1991, NATURE, V354, P317, DOI 10.1038/354317a0; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PALMER MS, 1989, NATURE, V342, P937, DOI 10.1038/342937a0; PARISI MA, 1991, SCIENCE, V252, P965, DOI 10.1126/science.2035027; PRESTRIDGE DS, 1991, COMPUT APPL BIOSCI, V7, P203; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROSSITER BJF, 1991, FASEB J, V5, P21, DOI 10.1096/fasebj.5.1.1846832; Sambrook J., 1989, MOL CLONING; SEN R, 1986, CELL, V46, P705, DOI 10.1016/0092-8674(86)90346-6; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; STARR DB, 1991, CELL, V67, P1231, DOI 10.1016/0092-8674(91)90299-E; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; TSUDA KI, 1988, BIOCHEMISTRY-US, V27, P1197; van Holde KE., 1989, SPRINGER SERIES MOL; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; VILAIN E, 1992, AM J HUM GENET, V50, P1008; WEISSMAN JD, 1991, MOL CELL BIOL, V11, P4217, DOI 10.1128/MCB.11.8.4217; WEISSMAN JD, 1991, MOL CELL BIOL, V11, P4228, DOI 10.1128/MCB.11.8.4228; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; WU FK, 1988, EMBO J, V7, P2117, DOI 10.1002/j.1460-2075.1988.tb03051.x; ZHANG JS, IN PRESS HUM MOL GEN	58	96	113	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1993	52	1					24	38						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KK908	8434602				2022-12-18	WOS:A1993KK90800004
J	LUDWIG, EH; MCCARTHY, BJ				LUDWIG, EH; MCCARTHY, BJ			HAPLOTYPE ANALYSIS OF THE HUMAN APOLIPOPROTEIN-B MUTATION ASSOCIATED WITH FAMILIAL DEFECTIVE APOLIPOPROTEIN-B100	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,GLADSTONE FDN LABS CARDIOVASC DIS,POB 40608,SAN FRANCISCO,CA 94140	University of California System; University of California San Francisco; The J David Gladstone Institutes					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038781] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL38781] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANTONARAKIS SE, 1985, HUM GENET, V69, P1, DOI 10.1007/BF00295521; BOERWINKLE E, 1989, NUCLEIC ACIDS RES, V17, P4003, DOI 10.1093/nar/17.10.4003; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; DAIGER SP, 1989, AM J HUM GENET, V45, P310; FRIEDL W, 1990, J LIPID RES, V31, P659; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; HEGELE RA, 1986, NEW ENGL J MED, V315, P1509, DOI 10.1056/NEJM198612113152403; HIGGS DR, 1986, P NATL ACAD SCI USA, V83, P5165, DOI 10.1073/pnas.83.14.5165; HUANG LS, 1987, J BIOL CHEM, V262, P8952; HUANG SZ, 1986, HUM GENET, V74, P162, DOI 10.1007/BF00282081; INNERARITY TL, 1987, P NATL ACAD SCI USA, V84, P6919, DOI 10.1073/pnas.84.19.6919; INNERARITY TL, IN PRESS J LIPID RES; JARMAN AP, 1988, AM J HUM GENET, V43, P249; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; JENNER K, 1988, ATHEROSCLEROSIS, V69, P39, DOI 10.1016/0021-9150(88)90287-0; KOEBERL DD, 1989, AM J HUM GENET, V45, P448; LITT M, 1989, AM J HUM GENET, V44, P397; LUDWIG EH, 1987, DNA-J MOLEC CELL BIO, V6, P363, DOI 10.1089/dna.1987.6.363; LUDWIG EH, 1989, AM J HUM GENET, V45, P458; MARKERT ML, 1989, AM J HUM GENET, V45, P354; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; ORKIN SH, 1984, ANNU REV GENET, V18, P131; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; RAJPUTWILLIAMS J, 1988, LANCET, V2, P1442; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SORIA LF, 1989, P NATL ACAD SCI USA, V86, P587, DOI 10.1073/pnas.86.2.587; VEGA GL, 1986, J CLIN INVEST, V78, P1410, DOI 10.1172/JCI112729; WANG X, 1988, ARTERIOSCLEROSIS, V8, P429, DOI 10.1161/01.ATV.8.4.429; WEBER JL, 1989, AM J HUM GENET, V44, P388; YOUNG SG, 1989, J LIPID RES, V30, P443; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	33	96	96	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1990	47	4					712	720						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EB319	1977310				2022-12-18	WOS:A1990EB31900017
J	HARNDEN, DG				HARNDEN, DG			CYTOGENETIC STUDIES ON PATIENTS WITH VIRUS INFECTIONS + SUBJECTS VACCINATED AGAINST YELLOW FEVER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BUCKTON KE, 1962, LANCET, V2, P676; COOPER HL, 1963, J NATL CANCER I, V30, P1015; CURTOIS G, 1956, 30 WHO MON SER YELL, P105; HAMPAR B, 1961, NATURE, V192, P145, DOI 10.1038/192145a0; HAMPAR B, 1963, P NATL ACAD SCI USA, V49, P474, DOI 10.1073/pnas.49.4.474; KOPROWSKI H, 1962, J CELL COMPAR PHYSL, V59, P281, DOI 10.1002/jcp.1030590308; MACPHERSON I, 1963, J NATL CANCER I, V30, P795; MAZZONE HM, 1963, EXP CELL RES, V30, P591, DOI 10.1016/0014-4827(63)90336-7; MOORHEAD PS, 1963, J CELL COMPAR PHYSL, V62, P57, DOI 10.1002/jcp.1030620109; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; NICHOLS WW, 1962, HEREDITAS, V48, P367; SHEIN HM, 1962, P NATL ACAD SCI USA, V48, P1164, DOI 10.1073/pnas.48.7.1164	12	96	96	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1964	16	2					204	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2972A	14174801				2022-12-18	WOS:A19642972A00003
J	Tatton-Brown, K; Loveday, C; Yost, S; Clarke, M; Ramsay, E; Zachariou, A; Elliott, A; Wylie, H; Ardissone, A; Rittinger, O; Stewart, F; Temple, IK; Cole, T; Mahamdallie, S; Seal, S; Ruark, E; Rahman, N				Tatton-Brown, Katrina; Loveday, Chey; Yost, Shawn; Clarke, Matthew; Ramsay, Emma; Zachariou, Anna; Elliott, Anna; Wylie, Harriet; Ardissone, Anna; Rittinger, Olaf; Stewart, Fiona; Temple, I. Karen; Cole, Trevor; Mahamdallie, Shazia; Seal, Sheila; Ruark, Elise; Rahman, Nazneen		Childhood Overgrowth Collaboration	Mutations in Epigenetic Regulation Genes Are a Major Cause of Overgrowth with Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOTOS-SYNDROME; WEAVER SYNDROME; EZH2 MUTATIONS; DNMT3A; METHYLATION	To explore the genetic architecture of human overgrowth syndromes and human growth control, we performed experimental and bio-informatic analyses of 710 individuals with overgrowth (height and/or head circumference >=+2 SD) and intellectual disability (OGID). We identified a causal mutation in 1 of 14 genes in 50% (353/710). This includes HIST1H1E, encoding histone H1.4, which has not been associated with a developmental disorder previously. The pathogenic HIST1H1E mutations are predicted to result in a product that is less effective in neutralizing negatively charged linker DNA because it has a reduced net charge, and in DNA binding and protein-protein interactions because key residues are truncated. Functional network analyses demonstrated that epigenetic regulation is a prominent biological process dysregulated in individuals with OGID. Mutations in six epigenetic regulation genes-NSD1, EZH2, DNMT3A, CHD8, HIST1H1E, and EED-accounted for 44% of individuals (311/710). There was significant overlap between the 14 genes involved in OGID and 611 genes in regions identified in GWASs to be associated with height (p = 6.84 x 10(-8)), suggesting that a common variation impacting function of genes involved in OGID influences height at a population level. Increased cellular growth is a hallmark of cancer and there was striking overlap between the genes involved in OGID and 260 somatically mutated cancer driver genes (p = 1.75 x 10(-14)). However, the mutation spectra of genes involved in OGID and cancer differ, suggesting complex genotype-phenotype relationships. These data reveal insights into the genetic control of human growth and demonstrate that exome sequencing in OGID has a high diagnostic yield.	[Tatton-Brown, Katrina; Loveday, Chey; Yost, Shawn; Clarke, Matthew; Ramsay, Emma; Zachariou, Anna; Elliott, Anna; Wylie, Harriet; Mahamdallie, Shazia; Seal, Sheila; Ruark, Elise; Rahman, Nazneen; Childhood Overgrowth Collaboration] Inst Canc Res, Div Genet & Epidemiol, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England; [Tatton-Brown, Katrina] St Georges Univ Hosp NHS Fdn Trust, South West Thames Reg Genet Serv, London SW17 0QT, England; [Zachariou, Anna] Fdn IRCCS C Besta Neurol Inst, Child Neurol Unit, I-20133 Milan, Italy; [Rittinger, Olaf] Landeskrankenanstalten Salzburg, Kinderklin Dept Pediat, Klin Genet, A-5020 Salzburg, Austria; [Stewart, Fiona] Belfast City Hosp, Northern Ireland Reg Genet Serv, Belfast BT9 7AB, Antrim, North Ireland; [Temple, I. Karen] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton SO17 1BJ, Hants, England; [Temple, I. Karen] Univ Hosp Southampton NHS Trust, Wessex Clin Genet Serv, Southampton SO16 6YD, Hants, England; [Cole, Trevor] BirminghamWomens Hosp NHS Fdn Trust, West Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Cole, Trevor] Univ Birmingham, Birmingham Hlth Partners, Birmingham B15 2TG, W Midlands, England; [Rahman, Nazneen] Royal Marsden NHS Fdn Trust, Canc Genet Unit, London SW3 6JJ, England	University of London; Institute of Cancer Research - UK; Belfast City Hospital; University of Southampton; University of Birmingham; Royal Marsden NHS Foundation Trust	Rahman, N (corresponding author), Inst Canc Res, Div Genet & Epidemiol, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.; Rahman, N (corresponding author), Royal Marsden NHS Fdn Trust, Canc Genet Unit, London SW3 6JJ, England.	rahmanlab@icr.ac.uk	Ardissone, Anna/K-8495-2016	Ardissone, Anna/0000-0003-1969-0147; Temple, Isabel Karen/0000-0002-6045-1781	NIHR RM/ ICR Biomedical Research Centre; Wessex NIHR clinical research network; Child Growth Foundation [GR01/13]; Wellcome Trust [100210/Z/12/Z]; MRC [G0400188] Funding Source: UKRI; Medical Research Council [G0400188] Funding Source: researchfish	NIHR RM/ ICR Biomedical Research Centre; Wessex NIHR clinical research network; Child Growth Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the families for their participation and the clinicians that recruited them. The full list of collaborators is in the Supplemental Note. We are grateful to Margaret Warren-Perry for assistance in recruitment. We are grateful to Sandra Hanks, Silvana Powell, Imran Uddin, and Ann Strydom for technical and administrative support and Tara Mills for assistance with the GWAS analyses. We acknowledge support from the NIHR RM/ ICR Biomedical Research Centre and Wessex NIHR clinical research network. K.T.-B. is supported by funding from the Child Growth Foundation (GR01/13). This work was supported by Wellcome Trust Award 100210/Z/12/Z.	Barnard RA, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00477; Baynam G, 2015, AM J MED GENET A, V167, P1659, DOI 10.1002/ajmg.a.37070; Bodor C, 2013, BLOOD, V122, P3165, DOI 10.1182/blood-2013-04-496893; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen WY, 2015, EMBO REP, V16, P528, DOI 10.15252/embr.201439092; Cohen ASA, 2016, J HUM GENET, V61, P831, DOI 10.1038/jhg.2016.51; Cohen ASA, 2015, J HUM GENET, V60, P339, DOI 10.1038/jhg.2015.26; Cordeddu V, 2014, NAT GENET, V46, P815, DOI 10.1038/ng.3035; Cottereau E, 2013, AM J MED GENET C, V163C, P92, DOI 10.1002/ajmg.c.31360; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Douglas J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.031930; Edmondson AC, 2015, J PEDIATR GENET, V4, P136, DOI 10.1055/s-0035-1564440; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Field M, 2007, AM J HUM GENET, V81, P367, DOI 10.1086/520677; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Gilissen C, 2014, NATURE, V511, P344, DOI [10.1038/nature13394, 10.3389/fnhum.2013.00444]; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Kalashnikova AA, 2016, BBA-GENE REGUL MECH, V1859, P455, DOI 10.1016/j.bbagrm.2015.10.004; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Katanoda K, 2016, J EPIDEMIOL, V26, P163, DOI 10.2188/jea.JE20160038; Kurotaki N, 2005, HUM MOL GENET, V14, P535, DOI 10.1093/hmg/ddi050; Lapunzina P, 2005, AM J MED GENET C, V137C, P53, DOI 10.1002/ajmg.c.30064; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Loveday C, 2015, HUM MOL GENET, V24, P4775, DOI 10.1093/hmg/ddv182; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Malan V, 2010, AM J HUM GENET, V87, P189, DOI 10.1016/j.ajhg.2010.07.001; Maquat LE, 2001, RNA, V7, P445, DOI 10.1017/S1355838201002229; Martinez F, 2017, J MED GENET, V54, P87, DOI 10.1136/jmedgenet-2016-103964; Mirzaa G, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87623; Munz M, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0195-6; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Okosun J, 2014, NAT GENET, V46, P176, DOI 10.1038/ng.2856; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Rauch A, 2012, LANCET, V380, P1674, DOI 10.1016/S0140-6736(12)61480-9; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Ruark E, 2016, SCI REP-UK, V6, DOI 10.1038/srep31029; Ruark Elise, 2015, F1000Res, V4, P883, DOI 10.12688/f1000research.7049.1; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6; Saxena A, 2014, SEMIN CELL DEV BIOL, V36, P140, DOI 10.1016/j.semcdb.2014.09.018; Stocker H, 2000, CURR OPIN GENET DEV, V10, P529, DOI 10.1016/S0959-437X(00)00123-4; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; Tatton-Brown K, 2013, AM J MED GENET A, V161, P2972, DOI 10.1002/ajmg.a.36229; Tatton-Brown K, 2013, AM J MED GENET C, V163C, P71, DOI 10.1002/ajmg.c.31362; Tatton-Brown K, 2011, ONCOTARGET, V2, P1127, DOI 10.18632/oncotarget.385; Vissers LELM, 2016, NAT REV GENET, V17, P9, DOI 10.1038/nrg3999; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895	56	95	100	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 4	2017	100	5					725	736		10.1016/j.ajhg.2017.03.010	http://dx.doi.org/10.1016/j.ajhg.2017.03.010			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET8OV	28475857	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000400560000003
J	Gregor, A; Oti, M; Kouwenhoven, EN; Hoyer, J; Sticht, H; Ekici, AB; Kjaergaard, S; Rauch, A; Stunnenberg, HG; Uebe, S; Vasileiou, G; Reis, A; Zhou, HQ; Zweier, C				Gregor, Anne; Oti, Martin; Kouwenhoven, Evelyn N.; Hoyer, Juliane; Sticht, Heinrich; Ekici, Arif B.; Kjaergaard, Susanne; Rauch, Anita; Stunnenberg, Hendrik G.; Uebe, Steffen; Vasileiou, Georgia; Reis, Andre; Zhou, Huiqing; Zweier, Christiane			De Novo Mutations in the Genome Organizer CTCF Cause Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMATIN-REMODELING COMPLEX; COFFIN-SIRIS SYNDROME; IMPRINTING CENTER; CHROMOSOME 11P15; DNA; EXPRESSION; GENES; METHYLATION; ALIGNMENT; LEUKEMIA	An increasing number of genes involved in chromatin structure and epigenetic regulation has been implicated in a variety of developmental disorders, often including intellectual disability. By trio exome sequencing and subsequent mutational screening we now identified two de novo frameshift mutations and one de novo missense mutation in CTCF in individuals with intellectual disability, microcephaly, and growth retardation. Furthermore, an individual with a larger deletion including CTCF was identified. CTCF (CCCTC-binding factor) is one of the most important chromatin organizers in vertebrates and is involved in various chromatin regulation processes such as higher order of chromatin organization, enhancer function, and maintenance of three-dimensional chromatin structure. Transcriptome analyses in all three individuals with point mutations revealed deregulation of genes involved in signal transduction and emphasized the role of CTCF in enhancer-driven expression of genes. Our findings indicate that haploinsufficiency of CTCF affects genomic interaction of enhancers and their regulated gene promoters that drive developmental processes and cognition.	[Gregor, Anne; Hoyer, Juliane; Ekici, Arif B.; Uebe, Steffen; Vasileiou, Georgia; Reis, Andre; Zweier, Christiane] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Oti, Martin; Kouwenhoven, Evelyn N.; Zhou, Huiqing] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Kjaergaard, Susanne] Rigshosp, Univ Copenhagen Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Rauch, Anita] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Zhou, Huiqing] Radboud Univ Nijmegen, Fac Sci, Dept Mol Dev Biol, NL-6525 GA Nijmegen, Netherlands	University of Erlangen Nuremberg; Radboud University Nijmegen; University of Erlangen Nuremberg; Rigshospitalet; University of Copenhagen; University of Zurich; Radboud University Nijmegen; Radboud University Nijmegen	Zweier, C (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany.	christiane.zweier@uk-erlangen.de	Reis, André/D-2309-2009; Oti, Martin/D-9385-2015; Stunnenberg, Hendrik G./D-6875-2012; Rauch, Anita/C-5568-2014; Zhou, Huiqing/B-1721-2013; Zweier, Christiane/F-2202-2015; Ekici, Arif B/C-3971-2013	Reis, André/0000-0002-6301-6363; Oti, Martin/0000-0002-1005-5801; Stunnenberg, Hendrik G./0000-0002-0066-1576; Rauch, Anita/0000-0003-2930-3163; Zhou, Huiqing/0000-0002-2434-3986; Zweier, Christiane/0000-0001-8002-2020; Ekici, Arif B/0000-0001-6099-7066; Sticht, Heinrich/0000-0001-5644-045X; Vasileiou, Georgia/0000-0002-1993-1134	IZKF (Interdisziplinares Zentrum fur Klinische Forschung) Erlangen; Deutsche Forschungsmeinschaft [Zw184/1-1]; German Ministry of Education and Research [01GS08160]; BioRange program of the Netherlands Bioinformatics Centre (NBIC); Netherlands Genomics Initiative (NGI)	IZKF (Interdisziplinares Zentrum fur Klinische Forschung) Erlangen; Deutsche Forschungsmeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); BioRange program of the Netherlands Bioinformatics Centre (NBIC); Netherlands Genomics Initiative (NGI)	We thank the affected individuals and their parents for participation in this study. We thank Christine Zeck-Papp, Angelika Diem, Christian Gilissen, Nienka Wieskamp, Eva Janssen-Megens, and Kim Berentsen for excellent technical assistance. We thank Harald Rabe, Kinderzentrum St. Martin (Regensburg, Germany), and Maria Kibaek, Odense University Hospital (Denmark), for referring individuals. We thank Han Brunner for critical reading of the manuscript and helpful suggestions. C.Z. was supported by the IZKF (Interdisziplinares Zentrum fur Klinische Forschung) Erlangen and by a grant from the Deutsche Forschungsmeinschaft (Zw184/1-1). A. Reis was supported by a grant from the German Ministry of Education and Research (01GS08160). M.O. was supported by the BioRange program of the Netherlands Bioinformatics Centre (NBIC), which is supported by the Netherlands Genomics Initiative (NGI).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2001, GENOME RES, V11, P1425; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Day JJ, 2011, NEURON, V70, P813, DOI 10.1016/j.neuron.2011.05.019; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Herold M, 2012, DEVELOPMENT, V139, P1045, DOI 10.1242/dev.065268; Hirayama T, 2012, CELL REP, V2, P345, DOI 10.1016/j.celrep.2012.06.014; Hoyer J, 2012, AM J HUM GENET, V90, P565, DOI 10.1016/j.ajhg.2012.02.007; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larkin JD, 2012, MOL CELL BIOL, V32, P2738, DOI 10.1128/MCB.00179-12; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moore JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034915; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Ohlsson R, 2010, CHROMOSOMA, V119, P351, DOI 10.1007/s00412-010-0262-0; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Vaillend C, 2008, BEHAV BRAIN RES, V192, P88, DOI 10.1016/j.bbr.2008.01.009; van Bokhoven H, 2011, ANNU REV GENET, V45, P81, DOI 10.1146/annurev-genet-110410-132512; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Yu DH, 2013, MOL CELL BIOL, V33, P1845, DOI 10.1128/MCB.01124-12; Zentner GE, 2012, J BIOL CHEM, V287, P30888, DOI 10.1074/jbc.R111.296491	41	95	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					124	131		10.1016/j.ajhg.2013.05.007	http://dx.doi.org/10.1016/j.ajhg.2013.05.007			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23746550	Green Published, Bronze			2022-12-18	WOS:000321804500012
J	Srour, M; Schwartzentruber, J; Hamdan, FF; Ospina, LH; Patry, L; Labuda, D; Massicotte, C; Dobrzeniecka, S; Capo-Chichi, JM; Papillon-Cavanagh, S; Samuels, ME; Boycott, KM; Shevell, MI; Laframboise, R; Desilets, V; Maranda, B; Rouleau, GA; Majewski, J; Michaud, JL				Srour, Myriam; Schwartzentruber, Jeremy; Hamdan, Fadi F.; Ospina, Luis H.; Patry, Lysanne; Labuda, Damian; Massicotte, Christine; Dobrzeniecka, Sylvia; Capo-Chichi, Jose-Mario; Papillon-Cavanagh, Simon; Samuels, Mark E.; Boycott, Kym M.; Shevell, Michael I.; Laframboise, Rachel; Desilets, Valerie; Maranda, Bruno; Rouleau, Guy A.; Majewski, Jacek; Michaud, Jacques L.		FORGE Canada Consortium	Mutations in C5ORF42 Cause Joubert Syndrome in the French Canadian Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CENTROSOMAL PROTEIN; TRANSITION ZONE; SEQUENCING DATA; GENE; MECKEL; CILIOPATHIES; CILIOGENESIS; INDIVIDUALS; RETARDATION; VARIANTS	Joubert syndrome (JBTS) is an autosomal-recessive disorder characterized by a distinctive mid-hindbrain malformation, developmental delay with hypotonia, ocular-motor apraxia, and breathing abnormalities. Although JBTS was first described more than 40 years ago in French Canadian siblings, the causal mutations have not yet been identified in this family nor in most French Canadian individuals subsequently described. We ascertained a cluster of 16 JBTS-affected individuals from 11 families living in the Lower St. Lawrence region. SNP genotyping excluded the presence of a common homozygous mutation that would explain the clustering of these individuals. Exome sequencing performed on 15 subjects showed that nine affected individuals from seven families (including the original JBTS family) carried rare compound-heterozygous mutations in C5ORF42. Two missense variants (c.4006C>T [p.Arg1336Trp] and c.4690G>A [p.Ala1564Thr]) and a splicing mutation (c.7400+1G>A), which causes exon skipping, were found in multiple subjects that were not known to be related, whereas three other truncating mutations (c.6407del [p.Pro2136Hisfs*31], c.4804C>T [p.Arg1602*], and c.7477C>T [p.Arg2493*]) were identified in single individuals. None of the unaffected first-degree relatives were compound heterozygous for these mutations. Moreover, none of the six putative mutations were detected among 477 French Canadian controls. Our data suggest that mutations in C5ORF42 explain a large portion of French Canadian individuals with JBTS.	[Srour, Myriam; Hamdan, Fadi F.; Patry, Lysanne; Dobrzeniecka, Sylvia; Capo-Chichi, Jose-Mario; Michaud, Jacques L.] Univ Montreal, Ctr Excellence Neurosci, Montreal, PQ H3T 1C5, Canada; [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Ospina, Luis H.] Hop St Justine, Res Ctr, Dept Ophthalmol, Montreal, PQ H3T 1C5, Canada; [Boycott, Kym M.] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Shevell, Michael I.] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Div Pediat Neurol, Montreal, PQ H3H 1P3, Canada; [Laframboise, Rachel] CHU Laval, Dept Med Genet, Quebec City, PQ G1V 4G2, Canada; [Maranda, Bruno] CHU Sherbrooke, Div Genet, Sherbrooke, PQ J1H 5N4, Canada; [Rouleau, Guy A.] Univ Montreal, Ctr Hosp Univ Montreal, Res Ctr, Ctr Excellence Neurosci, Montreal, PQ H2L 2W5, Canada; [Rouleau, Guy A.] Dept Med, Montreal, PQ H2L 2W5, Canada; [Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A4, Canada	Universite de Montreal; Universite de Montreal; University of Ottawa; Children's Hospital of Eastern Ontario; McGill University; Laval University; University of Sherbrooke; Universite de Montreal; McGill University	Michaud, JL (corresponding author), Univ Montreal, Ctr Excellence Neurosci, Montreal, PQ H3T 1C5, Canada.	jacques.michaud@recherche-ste-justine.qc.ca	Scherer, Stephen W./B-3785-2013; Papillon-Cavanagh, Simon/AAS-8749-2020	Scherer, Stephen W./0000-0002-8326-1999; Papillon-Cavanagh, Simon/0000-0002-0372-2266; Schwartzentruber, Jeremy/0000-0002-6183-2092; Capo-Chichi, Jose-Mario/0000-0002-7440-3633	Government of Canada through Genome Canada; Canadian Institutes of Health Research (CIHR); Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; CIHR Institute of Genetics	Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; CIHR Institute of Genetics(Canadian Institutes of Health Research (CIHR))	Foremost, we thank the families who generously contributed their time and materials to this research study. This work was selected for study by the FORGE Canada Steering Committee, consisting of K. Boycott (University of Ottawa), J. Friedman (University of British Columbia), J. Michaud (Universite de Montreal), F. Bernier (University of Calgary), M. Brudno (University Toronto), B. Fernandez (Memorial University), B. Knoppers (McGill University), M. Samuels (Universite de Montreal), and S. Scherer (University of Toronto). We would like to thank Janet Marcadier (clinical coordinator) and Chandree Beaulieu (project manager) for their contribution to the infrastructure of the FORGE Canada Consortium. The authors also wish to acknowledge the contribution of the high-throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre (Montreal, Canada). This work was funded by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research (CIHR), and the Ontario Genomics Institute (OGI-049). Additional funding was provided by Genome Quebec and Genome British Columbia. K. Boycott is supported by a Clinical Investigatorship Award from the CIHR Institute of Genetics. J.L. Michaud is a National Scholar from the Fonds de la Recherche en Sante du Quebec (FRSQ). M. Srour holds a training award from the FRSQ.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andermann F, 1999, J CHILD NEUROL, V14, P565, DOI 10.1177/088307389901400903; Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Cantagrel V, 2008, AM J HUM GENET, V83, P170, DOI 10.1016/j.ajhg.2008.06.023; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; Dixon-Salazar T, 2004, AM J HUM GENET, V75, P979, DOI 10.1086/425985; Edvardson S, 2010, AM J HUM GENET, V86, P93, DOI 10.1016/j.ajhg.2009.12.007; Fortin J.C., 1999, BAS SAINT LAURENT; Ganesan AK, 2007, PROTEOMICS, V7, P2216, DOI 10.1002/pmic.200600971; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Gorden NT, 2008, AM J HUM GENET, V83, P559, DOI 10.1016/j.ajhg.2008.10.002; Hebert P.M., 1994, ACADIENS QUEBEC; Huang LJ, 2011, AM J HUM GENET, V89, P713, DOI 10.1016/j.ajhg.2011.11.005; Huang WN, 2011, MOL CELL BIOL, V31, P388, DOI 10.1128/MCB.00969-10; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee JE, 2012, NAT GENET, V44, P193, DOI 10.1038/ng.1078; Majewski J, 2011, HUM MUTAT, V32, P1114, DOI 10.1002/humu.21546; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mougou-Zerelli S, 2009, HUM MUTAT, V30, P1574, DOI 10.1002/humu.21116; Noor A, 2008, AM J HUM GENET, V82, P1011, DOI 10.1016/j.ajhg.2008.01.021; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Roddier K, 2005, NEUROLOGY, V64, P1762, DOI 10.1212/01.WNL.0000161849.29944.43; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Sattar S, 2011, DEV MED CHILD NEUROL, V53, P793, DOI 10.1111/j.1469-8749.2011.04021.x; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Yotova V, 2005, HUM GENET, V117, P177, DOI 10.1007/s00439-005-1298-8	37	95	104	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					693	700		10.1016/j.ajhg.2012.02.011	http://dx.doi.org/10.1016/j.ajhg.2012.02.011			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22425360	Green Published, Bronze			2022-12-18	WOS:000302833400012
J	Zalloua, PA; Platt, DE; El Sibai, M; Khalife, J; Makhoul, N; Haber, M; Xue, Y; Izaabel, H; Bosch, E; Adams, SM; Arroyo, E; Lopez-Parra, AM; Aler, M; Picornell, A; Ramon, M; Jobling, MA; Comas, D; Bertranpetit, J; Wells, RS; Tyler-Smith, C				Zalloua, Pierre A.; Platt, Daniel E.; El Sibai, Mirvat; Khalife, Jade; Makhoul, Nadine; Haber, Marc; Xue, Yali; Izaabel, Hassan; Bosch, Elena; Adams, Susan M.; Arroyo, Eduardo; Lopez-Parra, Ana Maria; Aler, Mercedes; Picornell, Antonia; Ramon, Misericordia; Jobling, Mark A.; Comas, David; Bertranpetit, Jaume; Wells, R. Spencer; Tyler-Smith, Chris		Genographic Consortium	Identifying Genetic Traces of Historical Expansions: Phoenician Footprints in the Mediterranean	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME; POPULATION; DIVERSITY; EUROPE; LEGACY; DIFFUSION; EVENTS; ORIGIN	Phoenicians were the dominant traders in the Mediterranean Sea two thousand to three thousand years ago and expanded from their homeland in the Levant to establish colonies and trading posts throughout the Mediterranean, but then they disappeared from history. We wished to identify their male genetic traces in modern populations. Therefore, we chose Phoenician-influenced sites oil the basis of well-documented historical records and collected new Y-chromosomal data from 1330 men from six such sites, as well as comparative data from the literature. We then developed an analytical strategy to distinguish between lineages specifically associated with the Phoenicians and those spread by geographically similar but historically distinct events, such as the Neolithic, Greek, and jewish expansions. This involved comparing historically documented Phoenician sites with neighboring non-Phoenician sites for the identification of weak but systematic signatures shared by the Phoenician sites that could not readily be explained by chance or fly other expansions. From these comparisons, we found that haplogroup J2, in general, and six Y-STR haplotypes, in particular, exhibited a Phoenician signature that contributed > 6% to the modern Phoenician-influenced populations examined. Our methodology can be applied to any historically documented expansion in which contact and noncontact sites can be identified.	[Xue, Yali; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Zalloua, Pierre A.; El Sibai, Mirvat; Khalife, Jade; Makhoul, Nadine; Haber, Marc] Lebanese Amer Univ, Beirut 11022801, Lebanon; [Zalloua, Pierre A.] Harvard Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Platt, Daniel E.] IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery, Yorktown Hts, NY 10598 USA; [Izaabel, Hassan] Univ Zohr, Lab Biol Cellulaire & Genet Mol, Agadir 8106, Morocco; [Bosch, Elena; Comas, David; Bertranpetit, Jaume] Univ Pompeu Fabra, Dept Ciences Expt & Salut, Consejo Super Invest Cient, Inst Evolutionary Biol, Barcelona 08003, Spain; [Adams, Susan M.; Jobling, Mark A.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Arroyo, Eduardo; Lopez-Parra, Ana Maria] Univ Complutense Madrid, Fac Med, E-28040 Madrid, Spain; [Aler, Mercedes] Univ Valencia, Fac Med, Sect Biol Forense, Unidad Docente Med Legal, Valencia 46010, Spain; [Picornell, Antonia] Univ Illes Balears, Dept Biol, Palma de Mallorca 07122, Spain; [Picornell, Antonia; Ramon, Misericordia] Univ Illes Balears, Inst Univ Invest Ciencias Salut, Genet Lab, Palma de Mallorca 07122, Spain; [Wells, R. Spencer] Natl Geog Soc, Genog Project, Washington, DC 20036 USA	Wellcome Trust Sanger Institute; Lebanese American University; Harvard University; Harvard T.H. Chan School of Public Health; International Business Machines (IBM); Ibn Zohr University of Agadir; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Leicester; Complutense University of Madrid; University of Valencia; Universitat de les Illes Balears; Universitat de les Illes Balears; National Geographic Society	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	cts@sanger.ac.uk	PARRA, ANA MARIA LOPEZ/L-1911-2014; Bertranpetit, Jaume/F-8550-2012; Santos, Fabrício Rodrigues/H-2370-2011; Pardo, Eduardo Arroyo/L-2240-2014; Lopez, Ana/T-7670-2019; Balanovsky, Oleg/G-1549-2014; RAMON, M MISERICORDIA/Y-2497-2018; Haber, Marc/Y-5090-2019; El-Sibai, Mirvat/C-7606-2019; Bosch, Elena/N-7603-2019; Bosch, Elena/D-8681-2014; Haber, Marc/D-2553-2012; Comas, David/D-5382-2014; Cooper, Alan/E-8171-2012; Picornell, Antonia/H-5072-2017	PARRA, ANA MARIA LOPEZ/0000-0001-8974-1005; Bertranpetit, Jaume/0000-0003-0100-0590; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Pardo, Eduardo Arroyo/0000-0003-1851-0589; Lopez, Ana/0000-0001-8974-1005; RAMON, M MISERICORDIA/0000-0003-1234-3337; Haber, Marc/0000-0003-1000-1448; El-Sibai, Mirvat/0000-0003-4084-6759; Bosch, Elena/0000-0003-2848-103X; Bosch, Elena/0000-0003-2848-103X; Haber, Marc/0000-0003-1000-1448; Comas, David/0000-0002-5075-0956; Cooper, Alan/0000-0002-7738-7851; Picornell, Antonia/0000-0003-4454-5304; Quintana-Murci, Lluis/0000-0003-2429-6320; Khalife, Jade/0000-0001-8765-0142; Royyuru, Ajay/0000-0003-4440-4755; zalloua, pierre/0000-0002-8494-5081; Matisoo-Smith, Elizabeth/0000-0002-3500-8307; Jobling, Mark/0000-0002-8061-1308	The Wellcome Trust; National Geographic Society, IBM; Waitt Family Foundation;  [057559]	The Wellcome Trust(Wellcome TrustEuropean Commission); National Geographic Society, IBM(National Geographic Society); Waitt Family Foundation; 	We thank the sample donors for taking part in this study, R. John Mitchell, Tad Schurr and other Genographic Project members for comments. We also thank Janet Ziegle and Applied Biosystems for genotyping support and Rabih Hosri for help with Figure 1. Y.X and C.T.S. were supported by The Wellcome Trust, and M.A.J. by a Wellcome Trust Senior Fellowship in Basic Biomedical Science (057559). The Genographic Project is supported by funding from the National Geographic Society, IBM and the Waitt Family Foundation.	Agrawal R., 1994, P 20 INT C VERY LARG, P487; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Aubet M.E., 2001, PHOENICIANS W POLITI; BARNAVI E, 1994, HIST ATLAS JEWISH PE; Behar DM, 2004, HUM GENET, V114, P354, DOI 10.1007/s00439-003-1073-7; Bowden GR, 2008, MOL BIOL EVOL, V25, P301, DOI 10.1093/molbev/msm255; DELAPERGOLA S, 2002, AM JEWISH YB 2002, P247; Firasat S, 2007, EUR J HUM GENET, V15, P121, DOI 10.1038/sj.ejhg.5201726; HANFORD JV, 2004, 2004 INT RELIG FREED; HARDEN D, 1971, PHOENICIANS; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Markoe G.E, 2000, PHOENICIANS; MARSTON E, 2002, PHOENICIANS; Mitchell RJ, 1997, AM J PHYS ANTHROPOL, V104, P167, DOI 10.1002/(SICI)1096-8644(199710)104:2<167::AID-AJPA3>3.0.CO;2-W; MOSCATI S, 1973, WORLD PHOENICIANS; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Schlecht J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000093; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Semino O, 1996, AM J HUM GENET, V59, P964; Sokal R. R., 1995, BIOMETRY PRINCIPLES; STIEGLITZ RR, 1990, B AM SCH ORIENTAL RE, P9, DOI 10.2307/1357204; TRIPOLITIS A, 2001, RELIG HELLENISTIC RO; Zalloua PA, 2008, AM J HUM GENET, V82, P873, DOI 10.1016/j.ajhg.2008.01.020; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	27	95	96	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					633	642		10.1016/j.ajhg.2008.10.012	http://dx.doi.org/10.1016/j.ajhg.2008.10.012			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	18976729	Green Published, hybrid			2022-12-18	WOS:000261006900010
J	Topaz, O; Indelman, M; Chefetz, I; Geiger, D; Metzker, A; Altschuler, Y; Choder, M; Bercovich, D; Uitto, J; Bergman, R; Richard, G; Sprecher, E				Topaz, Orit; Indelman, Margarita; Chefetz, Ilana; Geiger, Dan; Metzker, Aryeh; Altschuler, Yoram; Choder, Mordechai; Bercovich, Dani; Uitto, Jouni; Bergman, Reuven; Richard, Gabriele; Sprecher, Eli			A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSENSE MUTATION; GALNT3; FIBROBLAST-GROWTH-FACTOR-23; DISEASES; HYPERPHOSPHATEMIA; ATHEROSCLEROSIS; CALCIFICATION; GLYCOSYLATION; HYPEROSTOSIS; DEPOSITION	Familial tumoral calcinosis (FTC) is a rare autosomal recessive disorder characterized by the progressive deposition of calcified masses in cutaneous and subcutaneous tissues, which results in painful ulcerative lesions and severe skin and bone infections. Two major types of FTC have been recognized: hyperphosphatemic FTC (HFTC) and normophosphatemic FTC (NFTC). HFTC was recently shown to result from mutations in two different genes: GALNT3, which codes for a glycosyltransferase, and FGF23, which codes for a potent phosphaturic protein. To determine the molecular cause of NFTC, we performed homozygosity mapping in five affected families of Jewish Yemenite origin and mapped NFTC to 7q21-7q21.3. Mutation analysis revealed a homozygous mutation in the SAMD9 gene (K1495E), which was found to segregate with the disease in all families and to interfere with the protein expression. Our data suggest that SAMD9 is involved in the regulation of extraosseous calcification, a process of considerable importance in a wide range of diseases as common as atherosclerosis and autoimmune disorders.	Technion Israel Inst Technol, Dept Dermatol, Lab Mol Dermatol, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Haifa, Israel; Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; Technion Israel Inst Technol, Rappaport Inst Res Med Sci, Haifa, Israel; Souraski Med Ctr, Dept Dermatol, Tel Aviv, Israel; Hebrew Univ Jerusalem, Sch Pharm, Dept Pharmacol, IL-91120 Jerusalem, Israel; Migal Galilee Technol Ctr, Kiryat Shmona, Israel; Thomas Jefferson Univ, Dept Dermatol & Cutaneous Surg, Philadelphia, PA 19107 USA; GeneDx, Gaithersburg, MD USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Jefferson University	Sprecher, E (corresponding author), Technion Israel Inst Technol, Dept Dermatol, Lab Mol Dermatol, Rambam Hlth Care Campus, Haifa, Israel.	e_sprecher@rambam.health.gov.il	Chefetz, Ilana/K-7589-2019		NIAMS NIH HHS [R01 AR052627, R01 AR05267] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Araya K, 2005, J CLIN ENDOCR METAB, V90, P5523, DOI 10.1210/jc.2005-0301; Atzeni F, 2006, RHEUM DIS CLIN N AM, V32, P413, DOI 10.1016/j.rdc.2006.02.003; AVIGAD S, 1990, NATURE, V344, P168, DOI 10.1038/344168a0; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Boulman N, 2005, SEMIN ARTHRITIS RHEU, V34, P805, DOI 10.1016/j.semarthrit.2005.01.016; Campagnoli MF, 2006, J CLIN PATHOL, V59, P440, DOI 10.1136/jcp.2005.026369; Chefetz I, 2005, HUM GENET, V118, P261, DOI 10.1007/s00439-005-0026-8; Conlin PA, 2002, AM J DERMATOPATH, V24, P479, DOI 10.1097/00000372-200212000-00004; Frishberg Y, 2005, J MOL MED, V83, P240, DOI 10.1007/s00109-005-0654-4; Frishberg Y, 2005, J MOL MED, V83, P33, DOI 10.1007/s00109-004-0610-8; Ichikawa S, 2005, J CLIN ENDOCR METAB, V90, P2420, DOI 10.1210/jc.2004-2302; Jono S, 2006, J BONE MINER METAB, V24, P176, DOI 10.1007/s00774-005-0668-6; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Larsson T, 2005, J CLIN ENDOCR METAB, V90, P2424, DOI 10.1210/jc.2004-2238; METZKER A, 1988, EUR J PEDIATR, V147, P128, DOI 10.1007/BF00442209; Reuber BE, 1997, NAT GENET, V17, P445, DOI 10.1038/ng1297-445; Schultz J, 1997, PROTEIN SCI, V6, P249; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Silberstein M, 2006, AM J HUM GENET, V78, P922, DOI 10.1086/504158; Specktor P, 2006, J HUM GENET, V51, P487, DOI 10.1007/s10038-006-0377-6; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Touart DM, 1998, J AM ACAD DERMATOL, V39, P527, DOI 10.1016/S0190-9622(98)70001-5; White KE, 2006, ENDOCR REV, V27, P221, DOI 10.1210/er.2005-0019	24	95	98	1	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					759	764		10.1086/508069	http://dx.doi.org/10.1086/508069			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960814	Bronze, Green Published			2022-12-18	WOS:000240855900019
J	Khajavi, M; Inoue, K; Wiszniewski, W; Ohyama, T; Snipes, GJ; Lupski, JR				Khajavi, M; Inoue, K; Wiszniewski, W; Ohyama, T; Snipes, GJ; Lupski, JR			Curcumin treatment abrogates endoplasmic reticulum retention and aggregation-induced apoptosis associated with neuropathy-causing myelin protein zero-truncating mutants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEJERINE-SOTTAS; ALTERED TRAFFICKING; CYTOPLASMIC DOMAIN; P-0 MUTATIONS; PHENOTYPES; ADHESION; LOCALIZATION; DEGENERATION; DEFICIENT; INDUCTION	Mutations in MPZ, the gene encoding myelin protein zero (MPZ), the major protein constituent of peripheral myelin, can cause the adult-onset, inherited neuropathy Charcot-Marie-Tooth disease, as well as the more severe, childhood-onset Dejerine-Sottas neuropathy and congenital hypomyelinating neuropathy. Most MPZ-truncating mutations associated with severe forms of peripheral neuropathy result in premature termination codons within the terminal or penultimate exons that are not subject to nonsense-mediated decay and are stably translated into mutant proteins with potential dominant-negative activity. However, some truncating mutations at the 3' end of MPZ escape the nonsense-mediated decay pathway and cause a mild peripheral neuropathy phenotype. We examined the functional properties of MPZ-truncating proteins that escaped nonsense-mediated decay, and we found that frameshift mutations associated with severe disease cause an intracellular accumulation of mutant proteins, primarily within the endoplasmic reticulum (ER), which induces apoptosis. Curcumin, a chemical compound derived from the curry spice tumeric, releases the ER-retained MPZ mutants into the cytoplasm accompanied by a lower number of apoptotic cells. Our findings suggest that curcumin treatment is sufficient to relieve the toxic effect of mutant aggregation-induced apoptosis and may potentially have a therapeutic role in treating selected forms of inherited peripheral neuropathies.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Retardat & Birth Defect Res, Tokyo, Japan	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; National Center for Neurology & Psychiatry - Japan	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza,Room 604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu		Ohyama, Tomoko/0000-0003-1697-1138	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027042] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS27042, R01 NS027042] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		D'Urso D, 1998, J NEUROSCI, V18, P731; Deschenes SM, 1997, J NEUROSCI, V17, P9077; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; DING YG, 1994, J BIOL CHEM, V269, P10764; Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; HARATI Y, 1985, J NEUROL NEUROSUR PS, V48, P1269, DOI 10.1136/jnnp.48.12.1269; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Lamm GM, 1997, NUCLEIC ACIDS RES, V25, P4855, DOI 10.1093/nar/25.23.4855; LITTLE E, 1995, J BIOL CHEM, V270, P9526, DOI 10.1074/jbc.270.16.9526; LUPSKI JR, 1990, METABOLIC MOL BASIS, P5759; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MARTINI R, 1995, J NEUROSCI, V15, P4488; Matsuyama W, 2002, ACTA NEUROPATHOL, V103, P501, DOI 10.1007/s00401-001-0497-1; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Naef R, 1997, MOL CELL NEUROSCI, V9, P13, DOI 10.1006/mcne.1997.0604; Preobrazhensky S, 2001, CYTOMETRY, V43, P199, DOI 10.1002/1097-0320(20010301)43:3<199::AID-CYTO1050>3.0.CO;2-H; RAUTENSTRAUSS B, 1994, HUM MOL GENET, V3, P1701, DOI 10.1093/hmg/3.9.1701; Ryan MC, 2002, NEUROBIOL DIS, V10, P109, DOI 10.1006/nbdi.2002.0500; Saifi GM, 2003, J INVEST MED, V51, P261, DOI 10.1136/jim-51-05-14; Sarkar FH, 2004, MUTAT RES-FUND MOL M, V555, P53, DOI 10.1016/j.mrfmmm.2004.04.015; Shames I, 2003, J NEUROPATH EXP NEUR, V62, P751, DOI 10.1093/jnen/62.7.751; Shy ME, 2004, BRAIN, V127, P371, DOI 10.1093/brain/awh048; Song YL, 2004, J BIOL CHEM, V279, P40629, DOI 10.1074/jbc.M407308200; Sun XL, 2000, RNA, V6, P1, DOI 10.1017/S1355838200991660; SZIGETI K, IN PRESS PRINCIPLES; Teijido O, 2004, HUM MOL GENET, V13, P2581, DOI 10.1093/hmg/ddh291; Thomas PK, 2005, PERIPHERAL NEUROPATH, V2, P1623; TRAPP BD, 1979, P NATL ACAD SCI USA, V76, P3552, DOI 10.1073/pnas.76.7.3552; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; Wong MH, 1996, J CELL BIOL, V134, P1531, DOI 10.1083/jcb.134.6.1531; Xu WB, 2001, J CELL BIOL, V155, P439, DOI 10.1083/jcb.200107114; Yang FS, 2005, J BIOL CHEM, V280, P5892, DOI 10.1074/jbc.M404751200	37	95	96	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2005	77	5					841	850		10.1086/497541	http://dx.doi.org/10.1086/497541			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	974CT	16252242	Bronze, Green Published			2022-12-18	WOS:000232569600012
J	Ensenauer, R; Vockley, J; Willard, JM; Huey, JC; Sass, JO; Edland, SD; Burton, BK; Berry, SA; Santer, R; Grunert, S; Koch, HG; Marquardt, I; Rinaldo, P; Hahn, S; Matern, D				Ensenauer, R; Vockley, J; Willard, JM; Huey, JC; Sass, JO; Edland, SD; Burton, BK; Berry, SA; Santer, R; Grunert, S; Koch, HG; Marquardt, I; Rinaldo, P; Hahn, S; Matern, D			A common mutation is associated with a mild, potentially asymptomatic phenotype in patients with isovaleric acidemia diagnosed by newborn screening	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TANDEM MASS-SPECTROMETRY; ACYL-COA DEHYDROGENASE; DEFICIENCY; DISORDERS; METABOLISM; IDENTIFICATION; FIBROBLASTS; ISOLEUCINE; DEFECTS; GENE	Isovaleric acidemia (IVA) is an inborn error of leucine metabolism that can cause significant morbidity and mortality. Since the implementation, in many states and countries, of newborn screening (NBS) by tandem mass spectrometry, IVA can now be diagnosed presymptomatically. Molecular genetic analysis of the IVD gene for 19 subjects whose condition was detected through NBS led to the identification of one recurring mutation, 932C-->T (A282V), in 47% of mutant alleles. Surprisingly, family studies identified six healthy older siblings with identical genotype and biochemical evidence of IVA. Our findings indicate the frequent occurrence of a novel mild and potentially asymptomatic phenotype of IVA. This has significant consequences for patient management and counseling.	Mayo Clin & Mayo Fdn, Coll Med, Biochem Genet Lab, Dept Lab Med & Pathol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Med Genet, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Hlth Sci Res, Div Clin Epidemiol, Rochester, MN 55905 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Div Med Genet, Pittsburgh, PA USA; Univ Freiburg Klinikum, Zentrum Kinderheilkunde & Jugendmed, Freiburg, Germany; Childrens Mem Hosp, Chicago, IL 60614 USA; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Univ Childrens Hosp, Hamburg, Germany; Childrens Hosp, Braunschweig, Germany; Childrens Hosp, Oldenburg, Germany	Mayo Clinic; Mayo Clinic; Mayo Clinic; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Freiburg; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Minnesota System; University of Minnesota Twin Cities; University of Hamburg; University Medical Center Hamburg-Eppendorf	Ensenauer, R (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Biochem Genet Lab, Dept Lab Med & Pathol, Hilton 300,200 1st St SW, Rochester, MN 55905 USA.	regina.ensenauer@med.uni-muenchen.de	Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Grunert, Sarah Catharina/0000-0001-5986-0468; Berry, Susan/0000-0001-7970-688X	NIDDK NIH HHS [R01 DK045482, R01-DK45482] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045482] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abdenur JE, 1998, J INHERIT METAB DIS, V21, P624, DOI 10.1023/A:1005424331822; Andresen BS, 2000, AM J HUM GENET, V67, P1095, DOI 10.1086/303105; Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Chace DH, 2003, CLIN CHEM, V49, P1797, DOI 10.1373/clinchem.2003.022178; Ensenauer R., 2003, Journal of Inherited Metabolic Disease, V26, P38; FRERMAN FE, 1985, BIOCHEM MED METAB B, V33, P38, DOI 10.1016/0006-2944(85)90124-3; Gibson KM, 2000, PEDIATR RES, V47, P830, DOI 10.1203/00006450-200006000-00025; Koeberl DD, 2003, J INHERIT METAB DIS, V26, P25, DOI 10.1023/A:1024015227863; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matern D, 2003, PEDIATRICS, V112, P74, DOI 10.1542/peds.112.1.74; Mohsen AA, 1998, BIOCHEMISTRY-US, V37, P10325, DOI 10.1021/bi973096r; Nasser I, 2004, BBA-MOL BASIS DIS, V1690, P22, DOI 10.1016/j.bbadis.2004.04.008; PARIMOO B, 1993, GENOMICS, V15, P582, DOI 10.1006/geno.1993.1111; RINALDO P, IN PRESS TIETZ TXB C; Roe CR, 1999, MOL GENET METAB, V68, P243, DOI 10.1006/mgme.1999.2911; Schulze A, 2003, PEDIATRICS, V111, P1399, DOI 10.1542/peds.111.6.1399; Shen JJ, 2000, J INHERIT METAB DIS, V23, P27, DOI 10.1023/A:1005694712583; Sweetman L, 2001, METABOLIC MOL BASES, VII, P2125; Vockley J, 2000, AM J HUM GENET, V66, P356, DOI 10.1086/302751; Waisbren SE, 2003, JAMA-J AM MED ASSOC, V290, P2564, DOI 10.1001/jama.290.19.2564; Zytkovicz TH, 2001, CLIN CHEM, V47, P1945	21	95	103	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1136	1142		10.1086/426318	http://dx.doi.org/10.1086/426318			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15486829	Green Published, Bronze			2022-12-18	WOS:000224866400019
J	Warburton, D; Dallaire, L; Thangavelu, M; Ross, L; Levin, B; Kline, J				Warburton, D; Dallaire, L; Thangavelu, M; Ross, L; Levin, B; Kline, J			Trisomy recurrence: A reconsideration based on North American data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPONTANEOUS-ABORTION; DOWN-SYNDROME; FETAL LOSS; PREGNANCIES; RATES; RISK; AGE; NONDISJUNCTION; AMNIOCENTESIS; CHROMOSOME-21	Few reliable data exist concerning the recurrence risk for individual trisomies or the risk for recurrence of trisomy for a different chromosome. We collected records from two sources: (1) prenatal diagnoses performed at the Hopital Sainte-Justine in Montreal and (2) karyotype analyses performed at Genzyme. Using the standardized morbidity ratio (SMR), we compared the observed number of trisomies at prenatal diagnosis with the expected numbers, given maternal age-specific rates (by single year). SMRs were calculated both for recurrence of the same trisomy (homotrisomy) and of a different trisomy (heterotrisomy). After all cases with an index trisomy 21 were combined, the SMR for homotrisomy was 2.4 (90% CI 1.6-3.4; P=.0005). For women with both the index trisomy and subsequent prenatal diagnosis at age <30 years, the SMR was 8.0; it was 2.1 for women with both pregnancies at age >= 30 years. For the other index viable trisomies (13, 18, XXX, and XXY) combined, the SMR for homotrisomy was 2.5 (90% CI 0.7-8.0). For heterotrisomy, the SMR after an index trisomy 21 was 2.3 (90% CI 1.5-3.8, P=.0007); the SMR did not vary with maternal age at the first trisomy. When all cases with index viable trisomies were combined, the SMR for heterotrisomy was 1.6 (90% CI 1.1-2.4; P=.04). For prenatal diagnoses following a nonviable trisomy diagnosed in a spontaneous abortion (from Genzyme data only), the SMR for a viable trisomy was 1.8 (90% CI 1.1-3.0; P=.04). The significantly increased risk for heterotrisomy supports the hypothesis that some women have a risk for nondisjunction higher than do others of the same age.	Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; Columbia Univ, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Epidemiol Dev Brain Disorders Dept, New York, NY 10032 USA; Hop St Justine, Ctr Rech, Serv Genet Med, Montreal, PQ H3T 1C5, Canada; Genzyme Genet, Orange, CA USA	Columbia University; Columbia University; Columbia University; Columbia University; New York State Psychiatry Institute; Universite de Montreal; Sanofi-Aventis; Genzyme Corporation	Warburton, D (corresponding author), Columbia Univ, Med Ctr, Dept Genet & Dev, Room CHC-406,3959 Broadway, New York, NY 10032 USA.	cuh@cancercenter.columbia.edu			NATIONAL INSTITUTE ON AGING [R01AG015386] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG 15386, R01 AG015386] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arbuzova S, 2001, CLIN GENET, V60, P456, DOI 10.1034/j.1399-0004.2001.600609.x; Balicky EM, 2002, MOL BIOL CELL, V13, P3890, DOI 10.1091/mbc.E02-06-0332; Beever CL, 2003, AM J HUM GENET, V72, P399, DOI 10.1086/346119; Brown AS, 2000, HUM MOL GENET, V9, P515, DOI 10.1093/hmg/9.4.515; Bruyere H, 2000, AM J MED GENET, V94, P35, DOI 10.1002/1096-8628(20000904)94:1<35::AID-AJMG8>3.0.CO;2-9; Caron L, 1999, AM J MED GENET, V82, P149, DOI 10.1002/(SICI)1096-8628(19990115)82:2<149::AID-AJMG10>3.0.CO;2-L; Fleiss J. L., 2013, STAT METHODS RATES P; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hodges CA, 2002, HUM REPROD, V17, P1171, DOI 10.1093/humrep/17.5.1171; Hook E B, 1979, Birth Defects Orig Artic Ser, V15, P81; HOOK EB, 1992, PRENATAL DIAGNOSIS S; Hunt PA, 2003, CURR BIOL, V13, P546, DOI 10.1016/S0960-9822(03)00189-1; James RS, 1998, EUR J HUM GENET, V6, P207, DOI 10.1038/sj.ejhg.5200178; Kline J, 2000, AM J HUM GENET, V67, P395, DOI 10.1086/303009; Lynn A, 2002, SCIENCE, V296, P2222, DOI 10.1126/science.1071220; Morris JK, 1999, PRENATAL DIAG, V19, P142, DOI 10.1002/(SICI)1097-0223(199902)19:2<142::AID-PD486>3.3.CO;2-Z; PANGALOS CG, 1992, AM J HUM GENET, V51, P1015; SACHS ES, 1990, AM J MED GENET, P186; Schon E A, 2000, Hum Reprod, V15 Suppl 2, P160; SNIJDERS RJM, 1994, PRENATAL DIAG, V14, P543, DOI 10.1002/pd.1970140706; Snijders RJM, 1999, ULTRASOUND OBST GYN, V13, P167, DOI 10.1046/j.1469-0705.1999.13030167.x; Spencer K, 2001, PRENATAL DIAG, V21, P788, DOI 10.1002/pd.134; STENE J, 1984, PRENATAL DIAG, V4, P81, DOI 10.1002/pd.1970040707; UCHIDA IA, 1985, HUM GENET, V70, P246; WARBURTON D, 1987, AM J HUM GENET, V41, P465; Zwick ME, 1999, GENETICS, V152, P1605	26	95	102	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2004	75	3					376	385		10.1086/423331	http://dx.doi.org/10.1086/423331			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	845VA	15248154	Bronze, Green Published			2022-12-18	WOS:000223272200003
J	Rennert, H; Bercovich, D; Hubert, A; Abeliovich, D; Rozovsky, U; Bar-Shira, A; Soloviov, S; Schreiber, L; Matzkin, H; Rennert, G; Kadouri, L; Peretz, T; Yaron, Y; Orr-Urtreger, A				Rennert, H; Bercovich, D; Hubert, A; Abeliovich, D; Rozovsky, U; Bar-Shira, A; Soloviov, S; Schreiber, L; Matzkin, H; Rennert, G; Kadouri, L; Peretz, T; Yaron, Y; Orr-Urtreger, A			A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUSCEPTIBILITY LOCUS; CHROMOSOME; FREQUENCY	HPC1/RNASEL was recently identified as a candidate gene for hereditary prostate cancer. We identified a novel founder frameshift mutation in RNLASEL, 471delAAAG, in Ashkenazi Jews. The mutation frequency in the Ashkenazi population, estimated on the basis of the frequency in 150 healthy young women, was 4% (95% confidence interval [CI] 1.9%-8.4%). Among Ashkenazi Jews, the mutation frequency was higher in patients with prostate cancer (PRCA) than in elderly male control individuals (6.9% vs. 2.4%; odds ratio = 3.0; 95% Cl 0.6-15.3; P =.17). 471delAAAG was not detected in the 134 non-Ashkenazi patients with PRCA and control individuals tested. The median age at PRCA diagnosis did not differ significantly between the Ashkenazi carriers and noncarriers included in our study. However, carriers received diagnoses at a significantly earlier age, compared with patients with PRCA who were registered in the Israeli National Cancer Registry (65 vs. 74.4 years, respectively; P <.001). When we examined two brothers with PRCA, we found a heterozygous 471delAAAG mutation in one and a homozygous mutation in the other. Loss of heterozygosity was demonstrated in the tumor of the heterozygous sib. Taken together, these data suggest that the 471delAAAG null mutation is associated with PRCA in Ashkenazi men. However, additional studies are required to determine whether this mutation confers increased risk for PRCA in this population.	Tel Aviv Sourasky Med Ctr, Genet Inst, IL-64239 Tel Aviv, Israel; Tel Aviv Sourasky Med Ctr, Dept Pathol, IL-64239 Tel Aviv, Israel; Tel Aviv Sourasky Med Ctr, Dept Urol, IL-64239 Tel Aviv, Israel; Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; Hadassah Hebrew Univ Hosp, Sharett Inst Oncol, Jerusalem, Israel; Hadassah Hebrew Univ Hosp, Dept Human Genet, Jerusalem, Israel; Carmel Hosp, CHS Natl Canc Control Ctr, Haifa, Israel; Technion Israel Inst Technol, Fac Med, Haifa, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Orr-Urtreger, A (corresponding author), Tel Aviv Sourasky Med Ctr, Genet Inst, 6 Weizmann St, IL-64239 Tel Aviv, Israel.		Schreiber, Laura M./E-1902-2011	Schreiber, Laura M./0000-0002-8827-1838; Orr-Urtreger, Avi/0000-0001-9305-6203; Rennert, Gad/0000-0002-8512-068X				Berry R, 2000, AM J HUM GENET, V67, P82, DOI 10.1086/302994; Berthon P, 1998, AM J HUM GENET, V62, P1416, DOI 10.1086/301879; Carpten J, 2002, NAT GENET, V30, P181, DOI 10.1038/ng823; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Gavert Nancy, 2002, Hum Mutat, V19, P664, DOI 10.1002/humu.9037; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; Hubert A, 1999, AM J HUM GENET, V65, P921, DOI 10.1086/302525; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Ostrander EA, 2000, AM J HUM GENET, V67, P1367, DOI 10.1086/316916; Rokman A, 2002, AM J HUM GENET, V70, P1299, DOI 10.1086/340450; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Xu JF, 1998, NAT GENET, V20, P175, DOI 10.1038/2477; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	15	95	102	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2002	71	4					981	984		10.1086/342775	http://dx.doi.org/10.1086/342775			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	604HT	12145743	Green Published, Bronze			2022-12-18	WOS:000178613800027
J	Xiong, MM; Zhao, JY; Boerwinkle, E				Xiong, MM; Zhao, JY; Boerwinkle, E			Generalized T-2 test for genome association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX; TRAITS; MODELS	Recent progress in the development of single-nucleotide polymorphism (SNP) maps within genes and across the genome provides a valuable tool for fine-mapping and has led to the suggestion of genomewide association studies to search for susceptibility loci for complex traits. Test statistics for genome association studies that consider a single marker at a time, ignoring the linkage disequilibrium between markers, are inefficient. In this study, we present a generalized T-2 statistic for association studies of complex traits, which can utilize multiple SNP markers simultaneously and considers the effects of multiple disease-susceptibility loci. This generalized T-2 statistic is a corollary to that originally developed for multivariate analysis and has a close relationship to discriminant analysis and common measure of genetic distance. We evaluate the power of the generalized T-2 statistic and show that power to be greater than or equal to those of the traditional chi(2) test of association and a similar haplotype-test statistic. Finally, examples are given to evaluate the performance of the proposed T-2 statistic for association studies using simulated and real data.	Univ Texas Houston, Ctr Human Genet, Houston, TX 77225 USA	University of Texas System; University of Texas Health Science Center Houston	Xiong, MM (corresponding author), Univ Texas Houston, Ctr Human Genet, POB 20334, Houston, TX 77225 USA.	mxiong@sph.uth.tmc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056515] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 5448] Funding Source: Medline; NIGMS NIH HHS [GM56515] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almasy L, 2001, GENET EPIDEMIOL, V21, pS332, DOI 10.1002/gepi.2001.21.s1.s332; BALAKRISHNAN V, 1968, BIOMETRICS, V24, P859, DOI 10.2307/2528876; Bhat A, 1999, GENET EPIDEMIOL, V17, pS503; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Chapman NH, 1998, AM J HUM GENET, V63, P1872, DOI 10.1086/302139; Czika WA, 2001, GENET EPIDEMIOL, V21, pS435, DOI 10.1002/gepi.2001.21.s1.s435; Drysdale CM, 2000, P NATL ACAD SCI USA, V97, P10483, DOI 10.1073/pnas.97.19.10483; FAN R, IN PRESS ADV APPL ST; Gray IC, 2000, HUM MOL GENET, V9, P2403, DOI 10.1093/hmg/9.16.2403; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hotelling H, 1931, ANN MATH STAT, V2, P360, DOI 10.1214/aoms/1177732979; Huang QQ, 2001, GENET EPIDEMIOL, V21, pS620, DOI 10.1002/gepi.2001.21.s1.s620; Li X, 2001, GENET EPIDEMIOL, V21, pS516, DOI 10.1002/gepi.2001.21.s1.s516; Longmate JA, 2001, AM J HUM GENET, V68, P1229, DOI 10.1086/320106; MEDSGER TA, 1997, ARTHRITIS ALLIED CON, V14, P33; Motamed K, 1999, INT J BIOCHEM CELL B, V31, P1363, DOI 10.1016/S1357-2725(99)00090-4; NEUMAN RJ, 1992, GENET EPIDEMIOL, V9, P347, DOI 10.1002/gepi.1370090506; Ott J, 1999, ANAL HUMAN GENETIC L; PUDIL P, 1994, PATTERN RECOGN LETT, V15, P1119, DOI 10.1016/0167-8655(94)90127-9; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SCHORK NJ, 1993, AM J HUM GENET, V53, P1127; Sherriff A, 2001, ADV GENET, V42, P287, DOI 10.1016/S0065-2660(01)42029-3; TEMPLETON AR, 1987, GENETICS, V117, P343; Xiong MM, 2001, GENOME RES, V11, P1878, DOI 10.1101/gr.190001; Zhang HP, 2000, GENET EPIDEMIOL, V19, P323, DOI 10.1002/1098-2272(200012)19:4<323::AID-GEPI4>3.0.CO;2-5	26	95	102	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1257	1268		10.1086/340392	http://dx.doi.org/10.1086/340392			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11923914	Green Published, Bronze			2022-12-18	WOS:000175012400015
J	Jenne, DE; Tinschert, S; Reimann, H; Lasinger, W; Thiel, G; Hameister, H; Kehrer-Sawatzki, H				Jenne, DE; Tinschert, S; Reimann, H; Lasinger, W; Thiel, G; Hameister, H; Kehrer-Sawatzki, H			Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENTIRE NF1 GENE; GENOMIC DISORDERS; DELETION PATIENTS; GROSS DELETIONS; HNPP DELETION; RECOMBINATION; PHENOTYPE; CMT1A; REARRANGEMENTS; SEQUENCES	Homologous recombination between poorly characterized regions flanking the NF1 locus causes the constitutional loss of similar to1.5 Mb from 17q11.2 covering greater than or equal to 11 genes in 5%-20% of patients with neurofibromatosis type 1 (NF1). To elucidate the extent of microheterogeneity at the deletion boundaries, we used single-copy DNA fragments from the extreme ends of the deleted segment to perform FISH on metaphase chromosomes from eight patients with NF1 who had large deletions. In six patients, these probes were deleted, suggesting that breakage and fusions occurred within the adjacent highly homologous sequences. Reexamination of the deleted region revealed two novel functional genes FLJ12735 (AK022797) and KIAA0653-related (WI-12393 and AJ314647), the latter of which is located closest to the distal boundary and is partially duplicated. We defined the complete reading frames for these genes and two expressed-sequence tag (EST) clusters that were reported elsewhere and are associated with the markers SHGC-2390 and WI-9521. Hybrid cell lines carrying only the deleted chromosome 17 were generated from two patients and used to identify the fusion sequences by junction-specific PCRs. The proximal breakpoints were found between positions 125279 and 125479 in one patient and within 4 kb of position 143000 on BAC R-271K11 (AC005562) in three patients, and the distal breakpoints were found at the precise homologous position on R-640N20 (AC023278). The interstitial 17q11.2 microdeletion arises from unequal crossover between two highly homologous WI-12393-derived 60-kb duplicons separated by similar to1.5 Mb. Since patients with the NF1 large-deletion syndrome have a significantly increased risk of neurofibroma development and mental retardation, hemizygosity for genes from the deleted region around the neurofibromin locus (CYTOR4, FLJ12735, FLJ22729, HSA272195 (centaurin-alpha2), NF1, OMGP, EVI2A, EVI2B, WI-9521, HSA272196, HCA66, KIAA0160, and WI-12393) may contribute to the severe phenotype of these patients.	Univ Ulm, Dept Human Genet, D-89081 Ulm, Germany; Humboldt Univ, Charite, Inst Med Genet, Berlin, Germany; Max Planck Inst Neurobiol, Dept Neuroimmunol, Martinsried, Germany	Ulm University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society	Kehrer-Sawatzki, H (corresponding author), Univ Ulm, Dept Human Genet, Albert Einstein Allee 11, D-89081 Ulm, Germany.	hildegard.kehrer-sawatzki@medizin.uni-ulm.de	Jenne, Dieter Erich/AAP-1414-2020					Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Boerkoel CF, 1999, ANN NY ACAD SCI, V883, P22, DOI 10.1111/j.1749-6632.1999.tb08563.x; Cnossen MH, 1997, HUM MUTAT, V9, P458, DOI 10.1002/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; Correa CL, 1999, HUM MUTAT, V14, P387, DOI 10.1002/(SICI)1098-1004(199911)14:5<387::AID-HUMU4>3.0.CO;2-4; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; HAMERTON JL, 1975, BIRTH DEFECTS, P14; Huson S. M., 1994, P160; Jenne DE, 2000, GENOMICS, V66, P93, DOI 10.1006/geno.2000.6179; Ji YG, 2000, GENOME RES, V10, P597, DOI 10.1101/gr.10.5.597; KAYES LM, 1994, AM J HUM GENET, V54, P424; KAYES LM, 1992, J MED GENET, V29, P686, DOI 10.1136/jmg.29.10.686; KehrerSawatzki H, 1997, HUM GENET, V99, P237, DOI 10.1007/s004390050346; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lazaro C, 1996, HUM GENET, V98, P696, DOI 10.1007/s004390050287; Leppig KA, 1996, CYTOGENET CELL GENET, V72, P95, DOI 10.1159/000134171; Leppig KA, 1997, AM J MED GENET, V73, P197, DOI 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Lopes J, 1999, HUM MOL GENET, V8, P2285, DOI 10.1093/hmg/8.12.2285; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Rasmussen SA, 1998, J MED GENET, V35, P468, DOI 10.1136/jmg.35.6.468; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; Riva P, 1996, HUM GENET, V98, P646, DOI 10.1007/s004390050277; Riva P, 2000, AM J HUM GENET, V66, P100, DOI 10.1086/302709; SIDE LE, 1998, NEUROFIBROMATOSIS TY, P133; Tinschert S, 2000, EUR J HUM GENET, V8, P455, DOI 10.1038/sj.ejhg.5200493; Tonsgard JH, 1997, AM J MED GENET, V73, P80, DOI 10.1002/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N; Upadhyaya M, 1998, HUM GENET, V102, P591, DOI 10.1007/s004390050746; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; WU BL, 1995, AM J MED GENET, V59, P528, DOI 10.1002/ajmg.1320590427; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	38	95	101	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					516	527		10.1086/323043	http://dx.doi.org/10.1086/323043			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11468690	Green Published, Bronze			2022-12-18	WOS:000170271400005
J	Ophoff, RA; DeYoung, J; Service, SK; Joose, M; Caffo, NA; Sandkuijl, LA; Terwindt, GM; Haan, J; van den Maagdenberg, AMJM; Jen, J; Baloh, RW; Barilla-LaBarca, ML; Saccone, NL; Atkinson, JP; Ferrari, MD; Freimer, NB; Frants, RR				Ophoff, RA; DeYoung, J; Service, SK; Joose, M; Caffo, NA; Sandkuijl, LA; Terwindt, GM; Haan, J; van den Maagdenberg, AMJM; Jen, J; Baloh, RW; Barilla-LaBarca, ML; Saccone, NL; Atkinson, JP; Ferrari, MD; Freimer, NB; Frants, RR			Hereditary vascular retinopathy, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; BRAIN-TUMOR; RECOMBINATION; PREVALENCE; MIMICKING; MIGRAINE; REGION	We performed a genomewide search for linkage in an extended Dutch family with hereditary vascular retinopathy associated with migraine and Raynaud phenomenon. Patients with vascular retinopathy are characterized by microangiopathy of the retina, accompanied by microaneurysms and telangiectatic capillaries. The genome search, using a high throughput capillary sequencer, revealed significant evidence of linkage to chromosome 3p21.1-p21.3 (maximum pairwise LOD score 5.25, with D3S1578). Testing of two additional families that had a similar phenotype, cerebroretinal vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke, revealed linkage to the same chromosomal region (combined maximum LOD score 6.30, with D3S1588). Haplotype analysis of all three families defined a 3-cM candidate region between D3S1578 and D3S3564. Our study shows that three autosomal dominant vasculopathy syndromes with prominent cerebroretinal manifestations map to the same 3-cM interval on 3p21, suggesting a common locus.	Leiden Univ, Med Ctr, Dept Human & Clin Genet, NL-2333 AL Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2333 AL Leiden, Netherlands; Univ Calif San Francisco, Dept Psychiat, Neurogenet Lab, San Francisco, CA 94143 USA; Appl Biosyst Inc, Foster City, CA 94404 USA; Rijnland Hosp, Leiderdorp, Netherlands; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Francisco; Thermo Fisher Scientific; Applied Biosystems; Rijnland Hospital; University of California System; University of California Los Angeles; Washington University (WUSTL); Washington University (WUSTL)	Frants, RR (corresponding author), Leiden Univ, Med Ctr, Dept Human & Clin Genet, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.		Ferrari, Michel D./ABE-3758-2021; Barillla-LaBarca, Maria Louise/AAR-9207-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019	Ferrari, Michel D./0000-0001-9691-9449; Atkinson, John/0000-0002-2514-3441	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P60DC001404] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC00162, DC01404] Funding Source: Medline; NIMH NIH HHS [MH01375, K02 MH001375] Funding Source: Medline; NINDS NIH HHS [R01 NS037484, NS37484] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; David G, 1996, AM J HUM GENET, V59, P1328; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GRAND MG, 1988, OPHTHALMOLOGY, V95, P649, DOI 10.1016/s0161-6420(88)33131-3; GUTMANN DH, 1989, AM J MED GENET, V34, P217, DOI 10.1002/ajmg.1320340217; Hmani M, 1999, EUR J HUM GENET, V7, P363, DOI 10.1038/sj.ejhg.5200307; Jen J, 1997, NEUROLOGY, V49, P1322, DOI 10.1212/WNL.49.5.1322; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Maricq HR, 1997, J RHEUMATOL, V24, P879; Niedermayer I, 2000, NEUROLOGY, V54, P1878, DOI 10.1212/WNL.54.9.1878-a; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; RUSSELL MB, 1995, INT J EPIDEMIOL, V24, P612, DOI 10.1093/ije/24.3.612; Storimans C W, 1991, Eur J Ophthalmol, V1, P73; Terwindt GM, 1998, BRAIN, V121, P303, DOI 10.1093/brain/121.2.303; Weil S, 1999, NEUROLOGY, V53, P629, DOI 10.1212/WNL.53.3.629	15	95	104	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					447	453		10.1086/321975	http://dx.doi.org/10.1086/321975			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11438888	Bronze, Green Published			2022-12-18	WOS:000170108200020
J	van der Maarel, SM; Deidda, G; Lemmers, RJLF; van Overveld, PGM; van der Wielen, M; Hewitt, JE; Sandkuijl, L; Bakker, B; van Ommen, GJB; Padberg, GW; Frants, RR				van der Maarel, SM; Deidda, G; Lemmers, RJLF; van Overveld, PGM; van der Wielen, M; Hewitt, JE; Sandkuijl, L; Bakker, B; van Ommen, GJB; Padberg, GW; Frants, RR			De novo facioscapulohumeral muscular dystrophy: Frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERMLINE MOSAICISM; DNA REARRANGEMENTS; GENE CONVERSION; 4Q35; FSHD; MUTATIONS; ETIOLOGY; LOCUS; ANTICIPATION; INDICATE	Autosomal dominant facioscapulohumeral muscular dystrophy (FSHD) is caused by deletion of most copies of the 3.3-kb subtelomeric D4Z4 repeat array on chromosome 4q. The molecular mechanisms behind the deletion and the high proportion of new mutations have remained elusive. We surveyed 35 de novo FSHD families and found somatic mosaicism in 40% of cases, in either the patient or an asymptomatic parent. Mosaic males were typically affected; mosaic females were more often the unaffected parent of a nonmosaic de novo patient. A genotypic-severity score, composed of the residual repeat size and the degree of somatic mosaicism, yields a consistent relationship with severity and age at onset of disease. Mosaic females had a higher proportion of somatic mosaicism than did mosaic males. The repeat deletion is significantly enhanced by supernumerary homologous repeat arrays. In 10% of normal chromosomes, 4-type repeat arrays are present on chromosome 10. In mosaic individuals, 4-type repeats on chromosome 10 are almost five times more frequent. The reverse configuration, also 10% in normal chromosomes, was not found, indicating that mutations may arise from transchromosomal interaction, to which the increase in 4-type repeat clusters is a predisposing factor. The somatic mosaicism suggests a mainly mitotic origin; mitotic interchromosomal gene conversion or translocation between fully homologous 4-type repeat arrays may be a major mechanism for FSHD mutations.	Leiden Univ, Med Ctr, Ctr Med Genet, Dept Human & Clin Genet, NL-2333 AL Leiden, Netherlands; CNR, Inst Cell Biol, Rome, Italy; Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2RD, England; Univ Nijmegen Hosp, Dept Neurol, NL-6500 HB Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Consiglio Nazionale delle Ricerche (CNR); University of Nottingham; Radboud University Nijmegen	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, MGC Dept Human Genet, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.	S.M.Maarel@lumc.nl	van der Maarel, Silvere/X-3631-2018; Padberg, G.W.A.M./H-8079-2014; Bakker, Egbert/D-3525-2009	van der Maarel, Silvere/0000-0001-8103-711X; Bakker, Egbert/0000-0002-2843-7357; DEIDDA, GIANCARLO/0000-0002-0828-5800; van Overveld, Petra GM/0000-0003-0216-5004				BAKKER E, 1995, MUSCLE NERVE, pS39; BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; Bakker E, 1996, J MED GENET, V33, P29, DOI 10.1136/jmg.33.1.29; Becker J, 1996, AM J HUM GENET, V58, P657; Cacurri S, 1998, AM J HUM GENET, V63, P181, DOI 10.1086/301906; DEIDDA G, 1995, EUR J HUM GENET, V3, P155; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; Evans DGR, 1998, AM J HUM GENET, V63, P727, DOI 10.1086/512074; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; JEFFREYS AJ, 1994, NAT GENET, V6, P136, DOI 10.1038/ng0294-136; Kohler J, 1996, HUM GENET, V98, P485, DOI 10.1007/s004390050244; Lambert S, 1999, MUTAT RES-DNA REPAIR, V433, P159, DOI 10.1016/S0921-8777(99)00004-X; LEE JH, 1995, MUSCLE NERVE, pS6; Lemmers RJLF, 1998, HUM MOL GENET, V7, P1207, DOI 10.1093/hmg/7.8.1207; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Liao DQ, 1997, EMBO J, V16, P588, DOI 10.1093/emboj/16.3.588; Lunt P W, 1998, Neuromuscul Disord, V8, P126, DOI 10.1016/S0960-8966(98)00012-1; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; PADBERG GW, 1995, MUSCLE NERVE, pS81, DOI 10.1002/mus.880181315; Padberg GW, 1982, THESIS LEIDEN U LEID; PASSOSBUENO MR, 1992, AM J HUM GENET, V51, P1150; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P1997, DOI 10.1093/hmg/5.12.1997; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; ZATZ M, 1995, AM J HUM GENET, V56, P99; Zatz M, 1998, AM J MED GENET, V77, P155, DOI 10.1002/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.3.CO;2-G	30	95	99	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					26	35		10.1086/302730	http://dx.doi.org/10.1086/302730			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631134	Green Published, Bronze			2022-12-18	WOS:000085033600005
J	Vorechovsky, I; Webster, ADB; Plebani, A; Hammarstrom, L				Vorechovsky, I; Webster, ADB; Plebani, A; Hammarstrom, L			Genetic linkage of IgA deficiency to the major histocompatibility complex: Evidence for allele segregation distortion, parent-of-origin penetrance differences, and the role of anti-IgA antibodies in disease predisposition	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; IMMUNOGLOBULIN-A DEFICIENCY; DEPENDENT DIABETES-MELLITUS; CLASS-III GENES; T-CELLS; MITOCHONDRIAL-DNA; INSULIN GENE; HLA; FAMILY; SUSCEPTIBILITY	Immunoglobulin A (IgA) deficiency (IgAD) is characterized by a defect of terminal lymphocyte differentiation, leading to a lack of IgA in serum and mucosal secretions. Familial clustering, variable population prevalence in different ethnic groups, and a predominant inheritance pattern suggest a strong genetic predisposition to IgAD. The genetic susceptibility to IgAD is shared with a less prevalent, but more profound, defect called "common variable immunodeficiency" (CVID). Here we show an increased allele sharing at 6p21 in affected members of 83 multiplex IgAD/CVID pedigrees and demonstrate, using transmission/diseqilibrium tests, family-based associations indicating the presence of a predisposing locus, designated "IGAD1," in the proximal part of the major histocompatibility complex (MHC). The recurrence risk of IgAD was found to depend on the sex of parents transmitting the defect: affected mothers were more likely to produce offspring with IgAD than were affected fathers. Carrier mothers but not carrier fathers transmitted IGAD1 alleles more frequently to the affected offspring than would be expected under random segregation. The differential parent-of-origin penetrance is proposed to reflect a maternal effect mediated by the production of anti-IgA antibodies tentatively linked to IGAD1. This is supported by higher frequency of anti-IgA-positive females transmitting the disorder to children, in comparison with female IgAD nontransmitters, and by linkage data in the former group. Such pathogenic mechanisms may be shared by other MHC-linked complex traits associated with the production of specific autoantibodies, parental effects, and a particular MHC haplotype.	Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden; Royal Free Hosp, Sch Med, Dept Clin Immunol, MRC,Immunodeficiency Res Grp, London, England; Univ Genoa, Ist Giannina Gaslini, Genoa, Italy	Karolinska Institutet; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Genoa; IRCCS Istituto Giannina Gaslini	Vorechovsky, I (corresponding author), Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden.	igor.vorechovsky@cbt.ki.se	Plebani, Alessandro/C-8593-2011					AMBRUS M, 1977, CLIN IMMUNOL IMMUNOP, V7, P311, DOI 10.1016/0090-1229(77)90062-9; AMMANN AJ, 1971, MEDICINE, V50, P223, DOI 10.1097/00005792-197105000-00004; Ardlie KG, 1996, GENET RES, V67, P1, DOI 10.1017/S0016672300033425; AUKRUST P, 1995, BLOOD, V86, P1383, DOI 10.1182/blood.V86.4.1383.bloodjournal8641383; AWDEH ZL, 1983, P NATL ACAD SCI-BIOL, V80, P259, DOI 10.1073/pnas.80.1.259; Bach G L, 1971, Acta Rheumatol Scand, V17, P63; BARKA N, 1995, CLIN DIAGN LAB IMMUN, V2, P469, DOI 10.1128/CDLI.2.4.469-472.1995; BEERMANN B, 1974, SCAND J HAEMATOL, V12, P307; Buckley R H, 1975, Birth Defects Orig Artic Ser, V11, P134; Bui MM, 1996, J AUTOIMMUN, V9, P97, DOI 10.1006/jaut.1996.0012; Burrows PD, 1997, ADV IMMUNOL, V65, P245, DOI 10.1016/S0065-2776(08)60744-0; CLELAND LG, 1978, J RHEUMATOL, V5, P288; Cucca F, 1998, CLIN EXP IMMUNOL, V111, P76; Cucca F, 1998, NAT GENET, V19, P301, DOI 10.1038/995; CUCCIABELVEDERE M, 1989, TISSUE ANTIGENS, V34, P127, DOI 10.1111/j.1399-0039.1989.tb01725.x; CUNNINGHAMRUNDLES C, 1991, CLIN IMMUNOL IMMUNOP, V61, pS61, DOI 10.1016/S0090-1229(05)80039-X; Daniels SE, 1996, NATURE, V383, P247, DOI 10.1038/383247a0; deAsis MLB, 1996, ANN ALLERG ASTHMA IM, V76, P527, DOI 10.1016/S1081-1206(10)63272-3; DELAAT PCJ, 1991, CLIN IMMUNOL IMMUNOP, V58, P92, DOI 10.1016/0090-1229(91)90151-Y; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DOUGLAS SD, 1971, J PEDIATR-US, V78, P873, DOI 10.1016/S0022-3476(71)80367-0; DUNN LC, 1957, P NATL ACAD SCI USA, V43, P158, DOI 10.1073/pnas.43.1.158; EIBL MM, 1982, NEW ENGL J MED, V307, P803, DOI 10.1056/NEJM198209233071307; Espanol T, 1996, CLIN IMMUNOL IMMUNOP, V80, P333, DOI 10.1006/clin.1996.0132; GLEICHMANN H, 1981, CLIN IMMUNOL IMMUNOP, V18, P203, DOI 10.1016/0090-1229(81)90026-X; GONG YQ, 1994, J MED GENET, V31, P187, DOI 10.1136/jmg.31.3.187; GOSHEN E, 1989, J AUTOIMMUN, V2, P51, DOI 10.1016/0896-8411(89)90107-8; GUDMUNDSSON S, 1977, ACTA PATH MICRO IM C, V85, P87; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; HALL JG, 1990, AM J HUM GENET, V46, P857; HAMMARSTROM L, 1983, SCAND J IMMUNOL, V18, P509, DOI 10.1111/j.1365-3083.1983.tb00885.x; HILMAN BC, 1969, ANN ALLERGY, V27, P393; HOBBS JR, 1968, LANCET, V1, P110; Horowitz S, 1975, Birth Defects Orig Artic Ser, V11, P129; Huntley C C, 1968, N C Med J, V29, P325; ISHIZAKA A, 1989, EUR J PEDIATR, V149, P175, DOI 10.1007/BF01958274; Johnson ML, 1997, CLIN EXP IMMUNOL, V108, P477, DOI 10.1046/j.1365-2249.1997.3801278.x; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KIRKPATRICK CH, 1966, AM J MED, V41, P427, DOI 10.1016/0002-9343(66)90088-X; KLITZ W, 1987, HUM IMMUNOL, V18, P163, DOI 10.1016/0198-8859(87)90013-9; KLITZ W, 1995, AM J HUM GENET, V57, P1436; KOISTINEN J, 1976, VOX SANG, V30, P181, DOI 10.1111/j.1423-0410.1976.tb02811.x; KOISTINEN J, 1995, J CLIN IMMUNOL, V15, P194; Kondratenko I, 1997, CLIN EXP IMMUNOL, V108, P9, DOI 10.1046/j.1365-2249.1997.d01-993.x; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; KOSKINEN S, 1994, J CLIN IMMUNOL, V14, P116, DOI 10.1007/BF01541344; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LAKHANPAL S, 1988, MAYO CLIN PROC, V63, P461, DOI 10.1016/S0025-6196(12)65643-2; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LANGE K, 1986, ANN HUM GENET, V50, P283, DOI 10.1111/j.1469-1809.1986.tb01049.x; LAVEDAN C, 1993, LANCET, V341, P237, DOI 10.1016/0140-6736(93)90097-Z; LAWTON AR, 1972, J LAB CLIN MED, V80, P26; LEE KC, 1982, TRANSPLANTATION, V34, P150, DOI 10.1097/00007890-198209000-00008; LEVITT D, 1981, J PEDIATR-US, V98, P52, DOI 10.1016/S0022-3476(81)80532-X; LINDBLOM A, 1992, BREAST CANCER RES TR, V24, P159, DOI 10.1007/BF01961248; LOESCH DZ, 1995, AM J HUM GENET, V57, P1408; Macleod D, 1998, MOL CELL BIOL, V18, P4433, DOI 10.1128/MCB.18.8.4433; MARGARITTEJEANNIN P, 1995, AM J HUM GENET, V56, P1080; Martin MP, 1998, IMMUNOGENETICS, V47, P131; MCMAHON FJ, 1995, AM J HUM GENET, V56, P1277; Meyer JM, 1996, AM J HUM GENET, V58, P371; NATVIG JB, 1971, CLIN EXP IMMUNOL, V8, P229; NELL PA, 1972, PEDIATRICS, V49, P71; NICHOLLS RD, 1993, CURR OPIN GENET DEV, V3, P445, DOI 10.1016/0959-437X(93)90119-A; Noble JA, 1996, AM J HUM GENET, V59, P1134; ODONNELL CA, 1992, IMMUNOLOGY, V76, P604; OEN K, 1982, TISSUE ANTIGENS, V19, P174, DOI 10.1111/j.1399-0039.1982.tb01437.x; OLAH KSJ, 1993, PACE, V16, P1872, DOI 10.1111/j.1540-8159.1993.tb01822.x; OLERUP O, 1992, P NATL ACAD SCI USA, V89, P10653, DOI 10.1073/pnas.89.22.10653; OLERUP O, 1990, NATURE, V347, P289, DOI 10.1038/347289a0; OXELIUS VA, 1981, NEW ENGL J MED, V304, P1476, DOI 10.1056/NEJM198106113042408; Petronzelli F, 1997, ANN HUM GENET, V61, P307; PETTY RE, 1979, CLIN EXP IMMUNOL, V37, P83; PETTY RE, 1985, NEW ENGL J MED, V313, P1620, DOI 10.1056/NEJM198512263132602; Plebani A, 1993, Immunodeficiency, V4, P245; ROSNER F, 1978, NEW YORK STATE J MED, V78, P1459; SCHAFFER FM, 1989, P NATL ACAD SCI USA, V86, P8015, DOI 10.1073/pnas.86.20.8015; SCHAID DJ, 1994, AM J HUM GENET, V55, P402; SCHORK NJ, 1993, AM J HUM GENET, V53, P1320; Schroeder HW, 1998, MOL MED, V4, P72, DOI 10.1007/BF03401731; SCHUHMANN D, 1990, J IMMUNOL, V145, P2132; SCHWARTZ RH, 1969, J LAB CLIN MED, V74, P203; SELIGMANN M, 1991, CLIN EXP IMMUNOL, V84, P23; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Short S, 1996, EUR J IMMUNOL, V26, P3015, DOI 10.1002/eji.1830261229; SMITH CIE, 1985, PSEUDOALLERGIC REACT, V4, P138; Spickett GP, 1997, IMMUNOL TODAY, V18, P325, DOI 10.1016/S0167-5699(97)01086-4; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STOCKER F, 1968, ARCH DIS CHILD, V43, P585, DOI 10.1136/adc.43.231.585; THOMSEN M, 1994, EUR J IMMUNOGENET, V21, P33, DOI 10.1111/j.1744-313X.1994.tb00174.x; Thon V, 1997, CLIN EXP IMMUNOL, V108, P1, DOI 10.1046/j.1365-2249.1997.d01-989.x; TOMKIN GH, 1971, LANCET, V2, P124; TROTTIER Y, 1994, J MED GENET, V31, P377, DOI 10.1136/jmg.31.5.377; Truedsson L, 1995, APMIS, V103, P833, DOI 10.1111/j.1699-0463.1995.tb01442.x; VADHEIM CM, 1986, NEW ENGL J MED, V315, P1314, DOI 10.1056/NEJM198611203152103; VANLOGHE.E, 1974, EUR J IMMUNOL, V4, P57, DOI 10.1002/eji.1830040115; VASSALLO CL, 1970, AM REV RESPIR DIS, V101, P245; VOLANAKIS JE, 1992, J CLIN INVEST, V89, P1914, DOI 10.1172/JCI115797; VORECHOVSKY I, 1995, CLIN IMMUNOL IMMUNOP, V77, P185, DOI 10.1006/clin.1995.1142; WARRAM JH, 1984, NEW ENGL J MED, V311, P149, DOI 10.1056/NEJM198407193110304; WEEMAES C, 1982, CLIN IMMUNOL IMMUNOP, V23, P145, DOI 10.1016/0090-1229(82)90079-4; WILTON AN, 1985, IMMUNOGENETICS, V21, P333, DOI 10.1007/BF00430799; Wiltshire S, 1998, HUM MOL GENET, V7, P27, DOI 10.1093/hmg/7.1.27; ZHANG XY, 1990, NUCLEIC ACIDS RES, V18, P6253, DOI 10.1093/nar/18.21.6253; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175; ZOUROS E, 1992, NATURE, V359, P412, DOI 10.1038/359412a0	107	95	96	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1096	1109		10.1086/302326	http://dx.doi.org/10.1086/302326			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090895	Bronze, Green Published			2022-12-18	WOS:000079632900021
J	Tischfield, JA				Tischfield, JA			Loss of heterozygosity or: How I learned to stop worrying and love mitotic recombination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADENINE PHOSPHORIBOSYLTRANSFERASE; APRT LOCUS; CHROMOSOME-16; REPAIR; CANCER; CELLS; MICE		INDIANA UNIV,SCH MED,WALTHER ONCOL CTR,INDIANAPOLIS,IN 46202; WALTHER CANC INST,INDIANAPOLIS,IN	Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Walther Cancer Institute	Tischfield, JA (corresponding author), INDIANA UNIV,SCH MED,DEPT MED & MOL GENET,975 W WALNUT ST,IB 130,INDIANAPOLIS,IN 46202, USA.			Tischfield, Jay/0000-0003-3217-8287	NIDDK NIH HHS [DK38185] Funding Source: Medline; NIEHS NIH HHS [ES05652] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038185] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bezzubova O, 1997, CELL, V89, P185, DOI 10.1016/S0092-8674(00)80198-1; Cappione AJ, 1997, AM J HUM GENET, V60, P305; Ceci JD, 1996, MAMM GENOME, V6, pS151; deNooijvanDalen AG, 1997, MUTAT RES-FUND MOL M, V374, P51, DOI 10.1016/S0027-5107(96)00218-7; DESEPULVEDA P, 1995, MOL CELL BIOL, V15, P5898; Engle SJ, 1996, P NATL ACAD SCI USA, V93, P5307, DOI 10.1073/pnas.93.11.5307; Essers J, 1997, CELL, V89, P195, DOI 10.1016/S0092-8674(00)80199-3; FUJIMORI A, 1992, MUTAT RES, V269, P55, DOI 10.1016/0027-5107(92)90160-4; Gupta PK, 1997, CYTOGENET CELL GENET, V76, P214, DOI 10.1159/000134552; Gupta PK, 1997, CANCER RES, V57, P1188; JACKSON SP, 1995, TRENDS BIOCHEM SCI, V20, P412, DOI 10.1016/S0968-0004(00)89090-8; Jonkman MF, 1997, CELL, V88, P543, DOI 10.1016/S0092-8674(00)81894-2; KINZLER K, 1997, METABOLIC MOL BASES; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KNUDSON AG, 1993, P NATL ACAD SCI USA, V90, P10914, DOI 10.1073/pnas.90.23.10914; KUSHIRO J, 1992, MUTAT RES, V272, P17, DOI 10.1016/0165-1161(92)90005-7; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lloyd D.C., 1983, RAD INDUCED CHROMOSO, P23; LOEB LA, 1991, CANCER RES, V51, P3075; MORLEY AA, 1991, MUTAT RES, V250, P345, DOI 10.1016/0027-5107(91)90191-P; Moynahan ME, 1997, P NATL ACAD SCI USA, V94, P8988, DOI 10.1073/pnas.94.17.8988; Phear G, 1996, MOL CELL BIOL, V16, P6516; Qian F, 1997, AM J HUM GENET, V61, P1000, DOI 10.1086/301618; Sengstag C, 1997, MOL CARCINOGEN, V19, P147, DOI 10.1002/(SICI)1098-2744(199707)19:3&lt;147::AID-MC1&gt;3.0.CO;2-B; Shao C, 1996, CYTOGENET CELL GENET, V75, P216, DOI 10.1159/000134486; SHINOHARA A, 1995, TRENDS BIOCHEM SCI, V20, P387, DOI 10.1016/S0968-0004(00)89085-4; SIMMONDS HA, 1997, METABOLIC MOL BASES; SMITH LE, 1993, SOMAT CELL MOLEC GEN, V19, P515, DOI 10.1007/BF01233379; Stambrook PJ, 1996, ENVIRON MOL MUTAGEN, V28, P471; TISCHFIELD JA, 1974, P NATL ACAD SCI USA, V71, P45, DOI 10.1073/pnas.71.1.45	30	95	99	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					995	999		10.1086/301617	http://dx.doi.org/10.1086/301617			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345110	Green Published, Bronze			2022-12-18	WOS:A1997YH01700002
J	Tsou, HC; Teng, DHF; Ping, XL; Brancolini, V; Davis, T; Hu, R; Xie, XX; Gruener, AC; Schrager, CA; Christiano, AM; Eng, C; Steck, P; Ott, J; Tavtigian, SV; Peacocke, M				Tsou, HC; Teng, DHF; Ping, XL; Brancolini, V; Davis, T; Hu, R; Xie, XX; Gruener, AC; Schrager, CA; Christiano, AM; Eng, C; Steck, P; Ott, J; Tavtigian, SV; Peacocke, M			The role of MMAC1 mutations in early-onset breast cancer: Causative in association with Cowden syndrome and excluded in BRCA1-negative cases	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TUBEROUS SCLEROSIS; LINKAGE ANALYSIS; GENE; DISEASE; LOCALIZATION; MARKER; BRCA1	Cowden syndrome (CS) is an autosomal dominant disorder associated with the development of hamartomas and benign tumors in a variety of tissues, including the skin, thyroid, breast, endometrium, and brain. It has been suggested that women with CS are at increased risk for breast cancer. A locus for CS was recently defined on chromosome 10 in 12 families, resulting in the identification of the CS critical interval, between the markers D10S215 and D10S541. More recently, affected individuals in four families with CS have been shown to have germ-line mutations in a gene known as ''PTEN,'' or ''MMAC1,'' which is located in the CS critical interval on chromosome 10. In this study, we report three novel MMAC1 mutations in CS and demonstrate that MMAC1 mutations are associated with CS and breast cancer. Furthermore, we also show that certain families and individuals with CS do not have mutations in the coding sequence of MMAC1. Finally, we did not detect MMAC1 mutations in a subpopulation of individuals with early-onset breast cancer, suggesting that germ-line mutations in this gene do not appear to be common in this group.	COLUMBIA UNIV,COLL PHYS & SURG,DEPT DERMATOL,NEW YORK,NY; ROCKEFELLER UNIV,LAB STAT GENET,NEW YORK,NY 10021; MYRIAD GENET INC,SALT LAKE CITY,UT; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; UNIV TEXAS,MD ANDERSON CANCER CTR,DEPT NEUROONCOL & PATHOL,BRAIN TUMOR CTR,HOUSTON,TX 77030	Columbia University; Rockefeller University; Myriad Genetics, Inc; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center				Brancolini, Valeria/0000-0003-0871-537X; Eng, Charis/0000-0002-3693-5145	NATIONAL CANCER INSTITUTE [R01CA066693, R01CA070519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K04AG000694] Funding Source: NIH RePORTER; NCI NIH HHS [R0-1 CA-70519, R0-1 CA-66693] Funding Source: Medline; NIA NIH HHS [K-04 AG-00694] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALBRECHT S, 1992, CANCER-AM CANCER SOC, V70, P869, DOI 10.1002/1097-0142(19920815)70:4<869::AID-CNCR2820700424>3.0.CO;2-E; BROWNSTEIN MH, 1977, JAMA-J AM MED ASSOC, V238, P26; BROWNSTEIN MH, 1978, CANCER, V41, P2393, DOI 10.1002/1097-0142(197806)41:6<2393::AID-CNCR2820410644>3.0.CO;2-K; CLAUS EB, 1990, AM J EPIDEMIOL, V131, P961, DOI 10.1093/oxfordjournals.aje.a115616; FORD D, 1995, AM J HUM GENET, V57, P1457; FORNANDER T, 1989, LANCET, V1, P117; HAINES JL, 1991, AM J HUM GENET, V49, P764; KANDT RS, 1992, NAT GENET, V2, P37, DOI 10.1038/ng0992-37; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Li DM, 1997, CANCER RES, V57, P2124; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; LLOYD KM, 1963, ANN INTERN MED, V58, P136, DOI 10.7326/0003-4819-58-1-136; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; SCHRAGER CA, IN PRESS HUM PATHOL; SHATTUCKEIDENS D, IN PRESS JAMA; STARINK TM, 1986, CLIN GENET, V29, P222; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; WALTON BJ, 1986, SURGERY, V99, P82; WEARY PE, 1972, ARCH DERMATOL, V106, P682, DOI 10.1001/archderm.106.5.682; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	24	95	98	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1036	1043		10.1086/301607	http://dx.doi.org/10.1086/301607			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345101	Green Published, hybrid			2022-12-18	WOS:A1997YH01700007
J	Gatalica, B; Pulkkinen, L; Li, KH; Kuokkanen, K; Ryynanen, M; McGrath, JA; Uitto, J				Gatalica, B; Pulkkinen, L; Li, KH; Kuokkanen, K; Ryynanen, M; McGrath, JA; Uitto, J			Cloning of the human type XVII collagen gene (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COL7A1 UNDERLIE SEVERE; PEMPHIGOID ANTIGEN; STRUCTURAL ORGANIZATION; MOLECULAR-GENETICS; CYTOPLASMIC DOMAIN; TERMINATION CODON; ALPHA-1 CHAIN; AUTOANTIGEN; EXPRESSION; BETA-4	Generalized atrophic benign epidermolysis bullosa (GABEB) is a nonlethal variant of junctional epidermolysis bullosa (JEB). Previous findings have suggested that type XVII collagen is the candidate gene for mutations in this disease. We now have cloned the entire human type XVII collagen gene (COL17A1) and have elucidated its intron-exon organization. The gene comprises 56 distinct exons, which span similar to 52 kb of the genome, on the long arm of chromosome 10. It encodes a polypeptide, the alpha 1(XVII) chain, consisting of an intracellular globular domain, a transmembrane segment, and an extracellular domain that contains 15 separate collagenous subdomains, the largest consisting of 242 amino acids. We also have developed a strategy to identify mutations in COL17A1 by use of PCR amplification of genomic DNA, using primers placed on the flanking introns. The PCR products are scanned for sequence variants by heteroduplex analysis using conformation-sensitive gel electrophoresis and then are subjected to direct automated sequencing. We have identified several intragenic polymorphisms in COL17A1, as well as mutations, in both alleles, in two Finnish families with GABEB. The probands in both families showed negative immunofluorescence staining with an anti-type XVII collagen antibody. In one family, the proband was homozygous for a 5-bp deletion, 2944del5, which resulted in frameshift and a premature termination codon of translation. The proband in the other family was a compound heterozygote, with one allele containing the 2944del5 mutation and the other containing a nonsense mutation, Q1023X. These results expand the mutation database in different variants of JEB, and they attest to the functional importance of type XVII collagen as a transmembrane component of the hemidesmosomes at the dermal/epidermal junction.	THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT DERMATOL & CUTANEOUS BIOL,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT MOL PHARMACOL & BIOCHEM,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON INST MOL MED,MOL DERMATOL SECT,PHILADELPHIA,PA 19107; UNIV CENT TAMPERE HOSP,TAMPERE,FINLAND; KUOPIO UNIV HOSP,DEPT OBSTET & GYNECOL,DIV MED GENET,SF-70210 KUOPIO,FINLAND; UNITED MED & DENT SCH,ST JOHNS INST DERMATOL,LONDON SE1 9RT,ENGLAND	Jefferson University; Jefferson University; Jefferson University; Tampere University; Tampere University Hospital; Kuopio University Hospital; University of Eastern Finland; University of London; King's College London			McGrath, John/N-3529-2019; McGrath, John/D-6824-2012	McGrath, John/0000-0002-3708-9964	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923, T32AR007561] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR38923, T32-AR07561] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chavanas S, 1996, J CLIN INVEST, V98, P2196, DOI 10.1172/JCI119028; Christiano A M, 1996, Adv Dermatol, V11, P199; Christiano A M, 1996, Exp Dermatol, V5, P1, DOI 10.1111/j.1600-0625.1996.tb00086.x; Christiano AM, 1996, AM J HUM GENET, V58, P671; CHRISTIANO AM, 1994, GENOMICS, V21, P160, DOI 10.1006/geno.1994.1238; CHRISTIANO AM, 1994, GENOMICS, V21, P169, DOI 10.1006/geno.1994.1239; Darling T., 1996, Journal of Investigative Dermatology, V106, P842; DIAZ LA, 1990, J CLIN INVEST, V86, P1088, DOI 10.1172/JCI114812; EPSTEIN EH, 1992, SCIENCE, V256, P799, DOI 10.1126/science.1375393; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; FUCHS E, 1992, J INVEST DERMATOL, V99, P671, DOI 10.1111/1523-1747.ep12613737; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; GIUDICE GJ, 1991, J CLIN INVEST, V87, P734, DOI 10.1172/JCI115054; GIUDICE GJ, 1992, J INVEST DERMATOL, V99, P243, DOI 10.1111/1523-1747.ep12616580; HASHIMOTO I, 1976, DERMATOLOGICA, V152, P72, DOI 10.1159/000251166; HAYMAN AR, 1990, J BIOL CHEM, V265, P9864; HINTNER H, 1982, ARCH DERMATOL, V118, P375, DOI 10.1001/archderm.118.6.375; HOGERVORST F, 1990, EMBO J, V9, P765, DOI 10.1002/j.1460-2075.1990.tb08171.x; HOPKINSON SB, 1992, J INVEST DERMATOL, V99, P264, DOI 10.1111/1523-1747.ep12616615; JONKMAN MF, 1995, J CLIN INVEST, V95, P1345, DOI 10.1172/JCI117785; LI K, 1991, J BIOL CHEM, V266, P24064; LI KH, 1993, J BIOL CHEM, V268, P8825; Limardo Maria, 1996, Journal of Investigative Dermatology, V106, P860; McGrath JA, 1996, J INVEST DERMATOL, V106, P771, DOI 10.1111/1523-1747.ep12345821; MCGRATH JA, 1995, J INVEST DERMATOL, V104, P467, DOI 10.1111/1523-1747.ep12605904; McGrath JA, 1996, AM J PATHOL, V148, P1787; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; OWARIBE K, 1991, EXP CELL RES, V192, P622, DOI 10.1016/0014-4827(91)90084-8; Pulkkinen L, 1996, HUM MOL GENET, V5, P1539, DOI 10.1093/hmg/5.10.1539; Sambrook J, 1989, MOL CLONING LAB MANU; Schumann Hauke, 1996, Journal of Investigative Dermatology, V106, P821; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; SOININEN R, 1989, J BIOL CHEM, V264, P13565; TAMAI K, 1994, DERMATOLOGY, V189, P27, DOI 10.1159/000246924; TAMURA RN, 1990, J CELL BIOL, V111, P1593, DOI 10.1083/jcb.111.4.1593; TIKKA L, 1988, P NATL ACAD SCI USA, V85, P7491, DOI 10.1073/pnas.85.20.7491; Uitto J, 1996, MOL BIOL REP, V23, P35, DOI 10.1007/BF00357071; UITTO J, 1995, P ASSOC AM PHYSICIAN, V107, P245; UITTO J, 1992, J CLIN INVEST, V90, P687, DOI 10.1172/JCI115938; Uitto J, 1995, P 7 INT S BAS MEMBR, P257; VERRANDO P, 1991, LAB INVEST, V64, P85; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.bi.59.070190.004201; WICHE G, 1993, J CELL BIOL, V121, P607, DOI 10.1083/jcb.121.3.607; YAMADA Y, 1980, CELL, V22, P887, DOI 10.1016/0092-8674(80)90565-6	48	95	98	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					352	365						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012408				2022-12-18	WOS:A1997WE93100014
J	KODAIRA, M; SATOH, C; HIYAMA, K; TOYAMA, K				KODAIRA, M; SATOH, C; HIYAMA, K; TOYAMA, K			LACK OF EFFECTS OF ATOMIC-BOMB RADIATION ON GENETIC INSTABILITY OF TANDEM-REPETITIVE ELEMENTS IN HUMAN GERM-CELLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE CHAIN-REACTION; HUMAN DNA; HYPERVARIABLE MINISATELLITES; SURVIVORS; MUTATIONS; CHILDREN; JAPANESE; LOCI; DELETIONS	In a pilot study to detect the potential effects of atomic bomb radiation on germ-line instability, we screened 64 children from 50 exposed families and 60 from 50 control families for mutations at six minisatellite loci by using Southern blot analysis with Pc-1, lambda TM-18, ChdTC-15, p lambda g3, lambda MS-1, and CEB-1 probes. In the exposed families, one or both parents received a radiation dose >0.01 Sv. Among the 64 children, only one child had parents who were both exposed. Thus, of a total of 128 gametes that produced the 64 children, 65 gametes were derived from exposed parents and 63 were from unexposed parents, the latter being included in a group of 183 unexposed gametes used for calculating mutation rates. The average parental gonadal dose for the 65 gametes was 1.9 Sv. We detected a total of 28 mutations at the p lambda g3, lambda MS-1, and CEB-1 loci, but no mutations at the Pc-1, lambda TM-18, and ChdTC-15 loci. We detected 6 mutations in 390 alleles of the 65 exposed gametes and 22 mutations in 1098 alleles of the 183 gametes from the unexposed parents. The mean mutation rate per locus per gamete in these six minisatellite loci was 1.5% in the exposed parents and 2.0% in the unexposed parents. We observed no significant difference in mutation rates in the children of the exposed and the unexposed parents (P = .37, Fisher's exact probability test).	HIROSHIMA UNIV, SCH MED, DEPT INTERNAL MED 2, HIROSHIMA, JAPAN; RADIAT EFFECTS RES FDN, DEPT CLIN STUDIES, NAGASAKI, JAPAN	Hiroshima University; Radiation Effects Research Foundation - Japan	KODAIRA, M (corresponding author), RADIAT EFFECTS RES FDN, DEPT GENET, MINAMI KU, 5-2 HIJIYAMA PK, HIROSHIMA 732, JAPAN.							ARMOUR JAL, 1989, GENOMICS, V4, P328, DOI 10.1016/0888-7543(89)90338-8; ASAKAWA J, 1992, P NATL ACAD SCI USA, V89, P9126, DOI 10.1073/pnas.89.19.9126; AWA AA, 1987, CYTOGENETICS BASIC A, P166; DUBROVA YE, 1993, NAT GENET, V5, P92, DOI 10.1038/ng0993-92; FAN YJ, 1994, J RADIAT RES, V35, P285; HENKE J, 1993, INT J LEGAL MED, V105, P217, DOI 10.1007/BF01642797; HENKE L, 1991, EXPER SUPPL, V58, P144; HIYAMA K, 1990, MUTAT RES, V231, P219, DOI 10.1016/0027-5107(90)90028-3; HONMA M, 1992, HUM MOL GENET, V1, P555, DOI 10.1093/hmg/1.7.555; HONMA M, 1992, HUM MOL GENET, V1, P554; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; JEFFREYS AJ, 1988, NATURE, V332, P278, DOI 10.1038/332278a0; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; Kato H., 1966, AM J HUM GENET, V16, P214; KELLY R, 1989, GENOMICS, V5, P844, DOI 10.1016/0888-7543(89)90126-2; KODAIRA M, 1993, HUM GENET, V92, P237; LUNING KG, 1971, MUTAT RES, V12, P291, DOI 10.1016/0027-5107(71)90017-0; MITANI K, 1990, J BIOL CHEM, V265, P15203; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; NEEL JV, 1990, ANNU REV GENET, V24, P327; NEEL JV, 1988, AM J HUM GENET, V42, P663; NEEL JV, 1990, AM J HUM GENET, V46, P1053; NEEL JV, 1993, MUTAT RES, V291, P1, DOI 10.1016/0165-1161(93)90012-O; NEEL JV, 1956, PUB NATIONAL ACADEMY, V461; OTAKE M, 1990, RADIAT RES, V122, P1, DOI 10.2307/3577576; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SADAMOTO S, 1994, INT J RADIAT BIOL, V65, P549, DOI 10.1080/09553009414550641; SATOH C, 1990, PROG CLIN BIOL RES, V340, P197; SATOH C, 1993, AM J HUM GENET, V52, P167; SATOH C, 1991, J RADIAT RES, V32, P378, DOI 10.1269/jrr.32.SUPPLEMENT_378; SEARLE AG, 1974, ADV RADIAT BIOL, V4, P131; SUZUKI S, 1993, J BIOCHEM, V114, P292, DOI 10.1093/oxfordjournals.jbchem.a124169; TAKAHASHI N, 1990, MUTAT RES, V234, P61, DOI 10.1016/0165-1161(90)90032-J; VERGNAUD G, 1991, GENOMICS, V11, P135, DOI 10.1016/0888-7543(91)90110-Z; WONG FL, 1993, RADIAT RES, V135, P418, DOI 10.2307/3578884; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x; YOSHIMOTO Y, 1991, J RADIAT RES, V32, P327, DOI 10.1269/jrr.32.327; YOSHIMOTO Y, 1990, AM J HUM GENET, V46, P1041	38	95	101	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1275	1283						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533756				2022-12-18	WOS:A1995TE65500004
J	LEI, KJ; CHEN, YT; CHEN, HW; WONG, LJC; LIU, JL; MCCONKIEROSELL, A; VANHOVE, JLK; OU, HCY; YEH, NJ; PAN, LY; CHOU, JY				LEI, KJ; CHEN, YT; CHEN, HW; WONG, LJC; LIU, JL; MCCONKIEROSELL, A; VANHOVE, JLK; OU, HCY; YEH, NJ; PAN, LY; CHOU, JY			GENETIC-BASIS OF GLYCOGEN-STORAGE-DISEASE TYPE 1A - PREVALENT MUTATIONS AT THE GLUCOSE-6-PHOSPHATASE LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHISM ANALYSIS; METHYLATION; DNA	Diagnosis of glycogen storage disease (GSD) type 1a currently is established by demonstrating the lack of glucose-6-phosphatase (G6Pase) activity in the patient's biopsied liver specimen. Recent cloning of the G6Pase gene and identification of mutations within the gene that causes GSD type 1a allow for the development of a DNA-based diagnostic method. Using SSCP analysis and DNA sequencing, we characterized the G6Pase gene of 70 unrelated patients with enzymatically confirmed diagnosis of GSD type 1a and detected mutations in all except 17 alleles (88%). Sixteen mutations were uncovered that were shown by expression to abolish or greatly reduce G6Pase activity and that therefore are responsible for the GSD type 1a disorder. R83C and Q347X are the most prevalent mutations found in Caucasians, 130X and R83C are most prevalent in Hispanics, and R83H is most prevalent in Chinese. The Q347X mutation has thus far been identified only in Caucasian patients, and the 130X mutation has been identified only in Hispanic patients. Our results demonstrate that the DNA-based analysis can accurately, rapidly, and noninvasively detect the majority of mutations in GSD type 1a. This DNA-based diagnosis now permits prenatal diagnosis among at-risk patients and serves as a database in screening and counseling patients clinically suspected of having this disease.	NICHHD,HUMAN GENET BRANCH,BETHESDA,MD 20892; DUKE UNIV,MED CTR,DEPT PEDIAT,DURHAM,NC 27710; BAYLOR COLL MED,DEPT MOLEC & HUMAN GENET,HOUSTON,TX 77030	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Duke University; Baylor College of Medicine					NCRR NIH HHS [MO1-RR30] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ausubel FM, 1992, CURRENT PROTOCOLS MO; BEAUDET AL, 1991, HARRISONS PRINCIPLES, P1854; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; CHEN YT, 1988, NEW ENGL J MED, V318, P7, DOI 10.1056/NEJM198801073180102; CHEN YT, 1995, METABOLIC MOL BASES, P925; CLEVELAND D W, 1989, New Biologist, V1, P121; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DEMARCHI JM, 1994, HUM MUTAT, V4, P281, DOI 10.1002/humu.1380040409; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; LAI E, 1991, TRENDS BIOCHEM SCI, V16, P427, DOI 10.1016/0968-0004(91)90169-V; LEI KJ, 1994, J CLIN INVEST, V93, P1994, DOI 10.1172/JCI117192; LEI KJ, 1995, J CLIN INVEST, V95, P234, DOI 10.1172/JCI117645; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; MAGEWU AN, 1994, MOL CELL BIOL, V14, P4225, DOI 10.1128/MCB.14.6.4225; MICHAUD J, 1992, GENOMICS, V13, P389, DOI 10.1016/0888-7543(92)90258-T; NORDLIE RC, 1985, ENZYMES BIOL MEMBR, P349; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OTT J, 1986, HUMAN GENETIC DISEAS, P19; PELTZ S W, 1991, Critical Reviews in Eukaryotic Gene Expression, V1, P99; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; TASHEVA ES, 1993, SOMAT CELL MOLEC GEN, V19, P275, DOI 10.1007/BF01233075	22	95	108	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1995	57	4					766	771						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RV793	7573034				2022-12-18	WOS:A1995RV79300004
J	CURTIS, D; SHAM, PC				CURTIS, D; SHAM, PC			MODEL-FREE LINKAGE ANALYSIS USING LIKELIHOODS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LOD SCORE; HETEROGENEITY; VALUES	Misspecification of transmission model parameters can produce artifactually negative lod scores at small recombination fractions and in multipoint analysis. To avoid this problem, we have tried to devise a test that aims to detect a genetic effect at a particular locus, rather than attempting to estimate the map position of a locus with specified effect. Maximizing likelihoods over transmission model parameters, as well as linkage parameters, can produce seriously biased parameter estimates and so yield tests that lack power for the detection of linkage. However, constraining the transmission model parameters to produce the correct population prevalence largely avoids this problem. For computational convenience, we recommend that the likelihoods under linkage and non-linkage are independently maximized over a limited set of transmission models, ranging from Mendelian dominant to null effect and from null effect to Mendelian recessive. In order to test for a genetic effect at a given map position, the likelihood under linkage is maximized over admixture, the proportion of families linked. Application to simulated data for a wide range of transmission models in both affected sib pairs and pedigrees demonstrates that the new method is well behaved under the null hypothesis and provides a powerful test for linkage when it is present. This test requires no specification of transmission model parameters, apart from an approximate estimate of the population prevalence. It can be applied equally to sib pairs and pedigrees, and, since it does not diminish the lod score at test positions very close to a marker, it is suitable for application to multipoint data.	INST PSYCHIAT,DEPT BIOSTAT,LONDON SE5 8AF,ENGLAND	University of London; King's College London	CURTIS, D (corresponding author), INST PSYCHIAT,DEPT PSYCHOL MED,DE CRESPIGNY PK,LONDON SE5 8AF,ENGLAND.		Curtis, David/HGB-3921-2022	Curtis, David/0000-0002-4089-9183	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BABRON MC, 1993, GENET EPIDEMIOL, V10, P389, DOI 10.1002/gepi.1370100610; CHOTAI J, 1984, ANN HUM GENET, V48, P359, DOI 10.1111/j.1469-1809.1984.tb00849.x; CLERGETDARPOUX F, 1986, BIOMETRICS, V42, P393, DOI 10.2307/2531059; CURTIS D, 1994, ANN HUM GENET, V58, P151, DOI 10.1111/j.1469-1809.1994.tb01884.x; FARAWAY JJ, 1993, GENET EPIDEMIOL, V10, P75, DOI 10.1002/gepi.1370100108; GOLDIN LR, 1993, AM J HUM GENET, V53, P908; GREEN A, 1985, Genetic Epidemiology, V2, P1, DOI 10.1002/gepi.1370020102; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; HOLMANS P, 1993, AM J HUM GENET, V52, P362; KENDALL MG, 1979, ADV THEORY STATISTIC, V2; KONG A, 1992, AM J HUM GENET, V51, P1413; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; MACLEAN CJ, 1993, AM J HUM GENET, V53, P353; MORTON NE, 1955, AM J HUM GENET, V7, P277; Ott J., 1991, ANAL HUMAN GENETIC L; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; RISCH N, 1984, AM J HUM GENET, V36, P363; RISCH N, 1989, GENET EPIDEMIOL, V6, P473, DOI 10.1002/gepi.1370060402; RISCH N, 1991, AM J HUM GENET, V48, P1058; SANDKUIJL LA, 1989, MULTIPOINT MAPPING L, V6, P117; TERWILLIGER JD, 1992, CYTOGENET CELL GENET, V59, P142, DOI 10.1159/000133228; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; WEEKS DE, 1988, AM J HUM GENET, V42, P315; YU CE, 1994, AM J HUM GENET, V54, P631	24	95	95	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1995	57	3					703	716						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RR605	7668300				2022-12-18	WOS:A1995RR60500021
J	NIKALI, K; SUOMALAINEN, A; TERWILLIGER, J; KOSKINEN, T; WEISSENBACH, J; PELTONEN, L				NIKALI, K; SUOMALAINEN, A; TERWILLIGER, J; KOSKINEN, T; WEISSENBACH, J; PELTONEN, L			RANDOM SEARCH FOR SHARED CHROMOSOMAL REGIONS IN 4 AFFECTED INDIVIDUALS - THE ASSIGNMENT OF A NEW HEREDITARY ATAXIA LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; FRIEDREICH ATAXIA; GENE; LOCALIZATION; HYBRIDIZATION; D9S15; DNA	Infantile-onset spinocerebellar ataxia (IOSCA) is an autosomal recessively inherited progressive neurological disorder of unknown etiology. This ataxia, identified so far only in the genetically isolated Finnish population, does not share gene locus with any of the previously identified hereditary ataxias, and a random mapping approach was adopted to assign the IOSCA locus. Based on the assumption of one founder mutation, a primary screening of the genome was performed using samples from just four affected individuals in two consanguineous pedigrees. The identification of a shared chromosomal region in these four patients provided the first evidence that the IOSCA gene locus is on chromosome 10q23.3-q24.1, which was confirmed by conventional linkage analysis in the complete family material. Strong linkage disequilibrium observed between IOSCA and the linked markers was utilized to define accurately the critical chromosomal region. The results showed the power of linkage disequilibrium in the locus assignment of diseases with very limited family materials.	HELSINKI UNIV,CHILDRENS HOSP,DEPT CHILD NEUROL,HELSINKI,FINLAND; UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,OXFORD,ENGLAND; GENETHON,EVRY,FRANCE	University of Helsinki; University of Oxford; Wellcome Centre for Human Genetics	NIKALI, K (corresponding author), NATL PUBL HLTH INST,DEPT HUMAN MOLEC GENET,MANNERHEIMINTIE 166,SF-00300 HELSINKI,FINLAND.			Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BENHAMIDA C, 1993, NAT GENET, V5, P195; COCOZZA S, 1993, J NEUROL, V240, P254, DOI 10.1007/BF00818715; DELOUKAS P, 1993, GENOMICS, V17, P676, DOI 10.1006/geno.1993.1389; FAN YS, 1992, GENOMICS, V14, P1110, DOI 10.1016/S0888-7543(05)80140-5; GATTI RA, 1988, NATURE, V336, P577, DOI 10.1038/336577a0; GISPERT S, 1993, NAT GENET, V4, P295, DOI 10.1038/ng0793-295; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANAUER A, 1990, AM J HUM GENET, V46, P133; HARDING AE, 1983, LANCET, V5, P1151; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HELLSTEN E, 1993, GENOMICS, V16, P720, DOI 10.1006/geno.1993.1253; JODICE C, 1993, HUM MOL GENET, V2, P1383, DOI 10.1093/hmg/2.9.1383; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KOLBLE K, 1993, GENOMICS, V18, P702; KOSKINEN T, 1994, J NEUROL SCI, V121, P50, DOI 10.1016/0022-510X(94)90156-2; KOSKINEN T, 1994, MUSCLE NERVE, V17, P509, DOI 10.1002/mus.880170507; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MEEHAN RR, 1988, AM J HUM GENET, V42, P26; MOIR DT, 1994, GENOMICS, V22, P1, DOI 10.1006/geno.1994.1338; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NIKALI K, 1994, PEDIATR RES, V36, P607, DOI 10.1203/00006450-199411000-00012; Norio R., 1981, BIOCULTURAL ASPECTS, P359; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PANDOLFO M, 1990, AM J HUM GENET, V47, P228; RANUM LPW, 1991, AM J HUM GENET, V49, P31; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; ZHENG CJ, 1994, GENOMICS, V22, P55, DOI 10.1006/geno.1994.1345	30	95	95	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1995	56	5					1088	1095						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QU586	7726163				2022-12-18	WOS:A1995QU58600010
J	PAULI, RM; HORTON, VK; GLINSKI, LP; REISER, CA				PAULI, RM; HORTON, VK; GLINSKI, LP; REISER, CA			PROSPECTIVE ASSESSMENT OF RISKS FOR CERVICOMEDULLARY-JUNCTION COMPRESSION IN INFANTS WITH ACHONDROPLASIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HOMOZYGOUS ACHONDROPLASIA; CORD COMPRESSION; FORAMEN MAGNUM; UNEXPECTED DEATH; DECOMPRESSION; CHILDREN; APNEA	Achondroplasia, the most common heritable skeletal dysplasia, may result in abnormality at the craniocervical junction, which is a potentially lethal problem in a subset of young infants with this disorder. We evaluated and followed an unbiased and unselected consecutive series of infants with achondroplasia, to better document the occurrence, frequency, and clinical presentation of craniocervical abnormalities. Of 53 prospectively ascertained infants, 5 were judged to have sufficient craniocervical junction compression to require surgical decompression. Intraoperative observation always showed marked abnormality of the cervical spinal cord, and all operated-on children showed marked improvement of neurological function. The most frequent clinical abnormalities within this subset were those expected for high cervical myelopathy. The best predictors of need for suboccipital decompression included lower-limb hyperreflexia or clonus, on examination; central hypopnea demonstrated by polysomnography; and foramen magnum measures below the means for children with achondroplasia. Infants with achondroplasia are at risk for potentially lethal sequelae of craniocervical junction abnormalities; selective intervention can be life and health saving, but individuals at high risk will be identified only if all affected infants undergo comprehensive assessment in infancy.	UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53705	University of Wisconsin System; University of Wisconsin Madison	PAULI, RM (corresponding author), UNIV WISCONSIN,CLIN GENET CTR,DEPT PEDIAT,1500 HIGHLAND AVE,ROOM 353,MADISON,WI 53705, USA.							BLAND JD, 1982, DEV MED CHILD NEUROL, V24, P489; BLONDEAU M, 1983, ANN PEDIATR-PARIS, V30, P651; Carson B, 1988, Basic Life Sci, V48, P207; COLAMARIA V, 1991, BRAIN DEV-JPN, V13, P270, DOI 10.1016/S0387-7604(12)80062-3; FRANCOMANO CA, 1993, AM J HUM GENET S, V53, pA112; FRANKEL HL, 1975, LANCET, V2, P1183; FREMION AS, 1984, J PEDIATR-US, V104, P398, DOI 10.1016/S0022-3476(84)81103-8; HECHT JT, 1987, AM J HUM GENET, V41, P454; HECHT JT, 1984, EUR J PEDIATR, V143, P58, DOI 10.1007/BF00442750; HECHT JT, 1986, EUR J PEDIATR, V145, P545, DOI 10.1007/BF02429060; HECHT JT, 1989, AM J MED GENET, V32, P528, DOI 10.1002/ajmg.1320320421; HO KL, 1984, ACTA NEUROPATHOL, V63, P218, DOI 10.1007/BF00685248; Horton W A, 1977, Birth Defects Orig Artic Ser, V13, P101; MADOR MJ, 1990, CHEST, V97, P877, DOI 10.1378/chest.97.4.877; MOSKOWITZ N, 1989, J NEUROSURG, V70, P126, DOI 10.3171/jns.1989.70.1.0126; MUELLER SM, 1980, NEUROLOGY, V30, P769, DOI 10.1212/WNL.30.7.769; NELSON FW, 1988, ANN NEUROL, V24, P89, DOI 10.1002/ana.410240117; NELSON FW, 1984, NEUROLOGY, V34, P1053, DOI 10.1212/WNL.34.8.1053; OBERKLAID F, 1979, J MED GENET, V16, P140, DOI 10.1136/jmg.16.2.140; PAULI RM, 1986, J PEDIATR-US, V108, P579, DOI 10.1016/S0022-3476(86)80840-X; PAULI RM, 1983, AM J MED GENET, V16, P459, DOI 10.1002/ajmg.1320160404; PAULI RM, 1984, J PEDIATR-US, V104, P342, DOI 10.1016/S0022-3476(84)81092-6; PAULI RM, 1992, AM J HUM GENET, V51, pA112; PIERREKAHN A, 1980, CHILD BRAIN, V7, P205; REID CS, 1987, J PEDIATR-US, V110, P522, DOI 10.1016/S0022-3476(87)80542-5; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Spranger J, 1988, Basic Life Sci, V48, P103; STOKES DC, 1982, J PEDIATR, V102, P534; THOMAS IT, 1988, AM J DIS CHILD, V142, P989; TODOROV AB, 1981, AM J MED GENET, V9, P19, DOI 10.1002/ajmg.1320090105; WANG H, 1987, RADIOLOGY, V164, P515, DOI 10.1148/radiology.164.2.3602395; WASSMAN ER, 1988, J PEDIATR-US, V113, P411, DOI 10.1016/S0022-3476(88)80295-6; YAMADA H, 1981, J NEUROSURG, V54, P49, DOI 10.3171/jns.1981.54.1.0049; YANG SS, 1977, AM J CLIN PATHOL, V68, P68	34	95	97	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1995	56	3					732	744						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QK918	7887429				2022-12-18	WOS:A1995QK91800024
J	VERMEULEN, W; JAEKEN, J; JASPERS, NGJ; BOOTSMA, D; HOEIJMAKERS, JHJ				VERMEULEN, W; JAEKEN, J; JASPERS, NGJ; BOOTSMA, D; HOEIJMAKERS, JHJ			XERODERMA-PIGMENTOSUM COMPLEMENTATION GROUP-G ASSOCIATED WITH COCKAYNE-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTIONALLY ACTIVE DNA; GROUP-H; REPAIR; HETEROGENEITY; SENSITIVITY; FIBROBLASTS; DISEASE; DEFECT; FORM	Xeroderma pigmentosum (XP) and Cockayne syndrome (CS) are two rare inherited disorders with a clinical and cellular hypersensitivity to the UV component of the sunlight spectrum. Although the two traits are generally considered as clinically and genetically distinct entities, on the biochemical level a defect in the nucleotide excision-repair (NER) pathway is involved in both. Classical CS patients are primarily deficient in the preferential repair of DNA damage in actively transcribed genes, whereas in most XP patients the genetic defect affects both ''preferential'' and ''overall'' NER modalities. Here we report a genetic study of two unrelated, severely affected patients with the clinical characteristics of CS but with a biochemical defect typical of XP. By complementation analysis, using somatic cell fusion and nuclear microinjection of cloned repair genes, we assign these two patients to XP complementation group G, which previously was not associated with CS. This observation extends the earlier identification of two patients with a rare combined XP/CS phenotype within XP complementation groups B and D, respectively. It indicates that some mutations in at least three of the seven genes known to be involved in XP also can result in a picture of partial or even full-blown CS. We conclude that the syndromes XP and CS are biochemically closely related and may be part of a broader clinical disease spectrum. We suggest, as a possible molecular mechanism underlying this relation, that the XPGC repair gene has an additional vital function, as shown for some other NER genes.	ERASMUS UNIV ROTTERDAM, MGC, DEPT CELL BIOL & GENET, POB 1738, 3000 DR ROTTERDAM, NETHERLANDS; UNIV HOSP GASTHUISBERG, DIV METAB & NUTR, LOUVAIN, BELGIUM	Erasmus University Rotterdam; KU Leuven; University Hospital Leuven			Vermeulen, Wim/W-8708-2019; Hoeijmakers, Jan/AAX-6972-2021	Vermeulen, Wim/0000-0003-3616-734X; 				[Anonymous], 1985, DNA REPAIR; ARLETT CF, 1980, CARCINOGENESIS, V1, P745, DOI 10.1093/carcin/1.9.745; BOHR VA, 1991, CARCINOGENESIS, V12, P1983, DOI 10.1093/carcin/12.11.1983; CHEESBROUGH MJ, 1978, BRIT J DERMATOL, V99, P61, DOI 10.1111/j.1365-2133.1978.tb15252.x; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; Cleaver JE, 1989, METABOLIC BASIS INHE, V6th, P2949; FLETJER WL, 1992, P NATL ACAD SCI USA, V89, P261; GREENHAW GA, 1992, AM J HUM GENET, V50, P677; HANAWALT PC, 1991, MUTAT RES, V247, P203, DOI 10.1016/0027-5107(91)90016-H; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; ICHIHASHI M, 1985, J INVEST DERMATOL, V85, P284, DOI 10.1111/1523-1747.ep12276776; JAEKEN J, 1989, HUM GENET, V83, P339; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; JOHNSON RT, 1989, HUM GENET, V81, P203; JOHNSON RT, 1992, MUTAT RES, V273, P97, DOI 10.1016/0921-8777(92)90072-B; KEIJZER W, 1979, MUTAT RES, V62, P183, DOI 10.1016/0027-5107(79)90231-8; LAFFORET D, 1978, ARCH FR PEDIATR, V35, P65; LEHMANN AR, 1982, MUTAT RES, V106, P347, DOI 10.1016/0027-5107(82)90115-4; LEHMANN AR, 1992, MUTAT RES, V273, P1, DOI 10.1016/0921-8777(92)90046-6; MAYNE LV, 1982, CANCER RES, V42, P1473; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; NORRIS PG, 1987, BRIT J DERMATOL, V116, P861, DOI 10.1111/j.1365-2133.1987.tb04906.x; ROBBINS J H, 1988, Journal of the American Medical Association, V260, P384, DOI 10.1001/jama.260.3.384; ROBBINS JH, 1991, BRAIN, V114, P1335, DOI 10.1093/brain/114.3.1335; ROBBINS JH, 1974, ANN INTERN MED, V80, P221, DOI 10.7326/0003-4819-80-2-221; TANAKA K, 1981, SOMAT CELL GENET, V7, P445, DOI 10.1007/BF01542989; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; VANDUIN M, 1989, MUTAT RES, V217, P83, DOI 10.1016/0921-8777(89)90059-1; VENEMA J, 1990, NUCLEIC ACIDS RES, V18, P443, DOI 10.1093/nar/18.3.443; VENEMA J, 1990, P NATL ACAD SCI USA, V87, P4707, DOI 10.1073/pnas.87.12.4707; VERMEULEN W, 1986, MUTAT RES, V165, P199, DOI 10.1016/0167-8817(86)90055-6; VERMEULEN W, 1991, MUTAT RES, V255, P201, DOI 10.1016/0921-8777(91)90054-S; WEEDA G, 1990, CELL, V62, P777, DOI 10.1016/0092-8674(90)90122-U	33	95	95	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1993	53	1					185	192						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LJ385	8317483				2022-12-18	WOS:A1993LJ38500022
J	ANTONARAKIS, SE; BLOUIN, JL; MAHER, J; AVRAMOPOULOS, D; THOMAS, G; TALBOT, CC				ANTONARAKIS, SE; BLOUIN, JL; MAHER, J; AVRAMOPOULOS, D; THOMAS, G; TALBOT, CC			MATERNAL UNIPARENTAL DISOMY FOR HUMAN CHROMOSOME-14, DUE TO LOSS OF A CHROMOSOME-14 FROM SOMATIC-CELLS WITH T(13 14) TRISOMY-14	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; DNA POLYMORPHISMS; PATERNAL DISOMY; DOWN-SYNDROME; ISODISOMY; ORIGIN; HETERODISOMY; MOSAICISM; MARKERS	Uniparental disomy (UPD) for particular chromosomes is increasingly recognized as a cause of abnormal phenotypes in humans. We recently studied a 9-year-old female with a de novo Robertsonian translocation t(13;14), short stature, mild developmental delay, scoliosis, hyperextensible joints, hydrocephalus that resolved spontaneously during the first year of life, and hypercholesterolemia. To determine the parental origin of chromosomes 13 and 14 in the proband, we have studied the genotypes of DNA polymorphic markers due to (GT)n repeats in the patient and her parents' blood DNA. The genotypes of markers D14S43, D14S45, D14S49, and D14S54 indicated maternal UPD for chromosome 14. There was isodisomy for proximal markers and heterodisomy for distal markers, suggesting a recombination event on maternal chromosomes 14. In addition, DNA analysis first revealed-and subsequent cytogenetic analysis confirmed-that there was mosaic trisomy 14 in 5% of blood lymphocytes. There was normal (biparental) inheritance for chromosome 13, and there was no evidence of false paternity in genotypes of 11 highly polymorphic markers on human chromosome 21. Two cases of maternal UPD for chromosome 14 have previously been reported, one with a familial rob t(13;14) and the other with a t(14;14). There are several similarities among these patients, and a ''maternal UPD chromosome 14 syndrome'' is emerging; however, the contribution of the mosaic trisomy 14 to the phenotype cannot be evaluated. The study of de novo Robertsonian translocations of the type reported here should reveal both the extent of UPD in these events and the contribution of particular chromosomes involved in certain phenotypes.	JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT PEDIAT,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,CTR MED GENET,DEPT MED,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,KENNEDY KRIEGER INST,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute			Antonarakis, Stylianos E/N-8866-2014; Avramopoulos, Dimitrios/J-4392-2012	Antonarakis, Stylianos E/0000-0001-8907-5823; 	NICHD NIH HHS [HD24605, HD24061] Funding Source: Medline; NIGMS NIH HHS [T32 GM07471] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD024605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007471] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANTONARAKIS SE, 1992, GENOMICS, V14, P1126, DOI 10.1016/S0888-7543(05)80148-X; CASSIDY SB, 1992, AM J HUM GENET, V51, P701; DAVISSON MT, 1991, CYTOGENET CELL GENET, V58, P1152, DOI 10.1159/000133726; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; ENGEL E, 1991, AM J MED GENET, V40, P432, DOI 10.1002/ajmg.1320400411; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; FUJIMOTO A, 1992, AM J MED GENET, V44, P189, DOI 10.1002/ajmg.1320440214; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HALL JG, 1990, AM J HUM GENET, V46, P857; Henry I., 1993, European Journal of Human Genetics, V1, P19; HENRY I, 1991, NATURE, V351, P665, DOI 10.1038/351665a0; HENSON V, 1991, P NATL ACAD SCI USA, V88, P6486, DOI 10.1073/pnas.88.15.6486; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MARTIN AO, 1977, J MED GENET, V14, P214, DOI 10.1136/jmg.14.3.214; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; NIIKAWA N, 1984, AM J HUM GENET, V36, P123; PENTAO L, 1992, AM J HUM GENET, V50, P690; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; PETERSEN MB, 1991, AM J HUM GENET, V49, P529; PETERSEN MB, 1986, J MED GENET, V23, P86, DOI 10.1136/jmg.23.1.86; PETERSEN MB, 1992, GENOMICS, V13, P269, DOI 10.1016/0888-7543(92)90242-K; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; PURVISSMITH SG, 1992, AM J HUM GENET, V50, P1348; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROEDER GS, 1988, TRENDS GENET, V4, P263; SPENCE JE, 1988, AM J HUM GENET, V42, P217; TEMPLE IK, 1991, J MED GENET, V28, P511, DOI 10.1136/jmg.28.8.511; VOSS R, 1989, AM J HUM GENET, V45, P373; WANG JCC, 1991, AM J HUM GENET, V48, P1069; WANG ZY, 1992, GENOMICS, V13, P532, DOI 10.1016/0888-7543(92)90121-8; WEBER JL, 1989, AM J HUM GENET, V44, P388; WELCH TR, 1990, J CLIN INVEST, V86, P675, DOI 10.1172/JCI114760	33	95	98	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1145	1152						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503447				2022-12-18	WOS:A1993LG13300016
J	PUCK, JM; STEWART, CC; NUSSBAUM, RL				PUCK, JM; STEWART, CC; NUSSBAUM, RL			MAXIMUM-LIKELIHOOD ANALYSIS OF HUMAN T-CELL X-CHROMOSOME INACTIVATION PATTERNS - NORMAL WOMEN VERSUS CARRIERS OF X-LINKED SEVERE COMBINED IMMUNODEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WISKOTT-ALDRICH SYNDROME; GENE DEFECT; AGAMMAGLOBULINEMIA; DIAGNOSIS; LINKAGE; MALES	Lymphocytes of female carriers of X-linked severe combined immunodeficiency (XSCID; McKusick 300400; HGM genetic locus designation SCIDX1) exhibit nonrandom X chromosome inactivation. This phenomenon reflects a tissue-specific selective disadvantage for lymphocyte progenitors with an XSCID mutation on the active X chromosome and presumably is analogous to the process that inhibits T-cell development in affected boys with a single XSCID-bearing X chromosome. We investigated the specificity of T-cell X chromosome inactivation pattern as an indicator of immunodeficiency carrier status, as follows: X-inactivation ratios determined in a control group of noncarrier women exhibited a wide range, 20%-86% of T-cells with the paternal X active. Maximum-likelihood analysis of these data suggested that, in humans, mature T-cells are derived from a small pool of only about 10 randomly inactivated stem cells. Despite the wide variability in normal X-inactivation ratios, X inactivation in XSCID carriers appeared far more markedly skewed. Therefore a maximum-likelihood odds-ratio test was developed and proved to be successful in predicting the carrier status of women in XSCID pedigrees. This test has made it possible to identify XSCID carriers among mothers of boys with the heterogeneous syndrome of sporadic severe combined immunodeficiency.	UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT HUMAN GENET,PHILADELPHIA,PA 19104; HOWARD HUGHES MED INST,PHILADELPHIA,PA	University of Pennsylvania; University of Pennsylvania; Howard Hughes Medical Institute	PUCK, JM (corresponding author), CHILDRENS HOSP,JOSEPH STOKES JR RES INST,DIV INFECT DIS,CHILDRENS CTR,PHILADELPHIA,PA 19104, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD023679] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD23679] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BUCKLEY RH, 1986, J IMMUNOL, V136, P2398; CONLEY ME, 1988, J PEDIATR-US, V112, P688, DOI 10.1016/S0022-3476(88)80683-8; CONLEY ME, 1986, NEW ENGL J MED, V315, P564, DOI 10.1056/NEJM198608283150907; CONLEY ME, 1988, P NATL ACAD SCI USA, V85, P3090, DOI 10.1073/pnas.85.9.3090; CONLEY ME, 1990, J CLIN INVEST, V85, P1548, DOI 10.1172/JCI114603; FEARON ER, 1987, NEW ENGL J MED, V316, P427, DOI 10.1056/NEJM198702193160802; FEARON ER, 1988, BLOOD, V72, P1735; FIALKOW PJ, 1973, ANN HUM GENET, V37, P39, DOI 10.1111/j.1469-1809.1973.tb01813.x; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GITSCHIER J, 1989, LANCET, V1, P273; GREER WL, 1989, GENOMICS, V4, P60, DOI 10.1016/0888-7543(89)90315-7; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; LYON MARY F., 1966, ADVANCE TERATOLOGY, V1, P25; PRCHAL JT, 1980, BLOOD, V56, P1048; PUCK JM, 1987, J CLIN INVEST, V79, P1395, DOI 10.1172/JCI112967; PUCK JM, 1990, BLOOD, V75, P2369; PUCK JM, 1990, NEW ENGL J MED, V322, P1063, DOI 10.1056/NEJM199004123221508; PUCK JM, 1989, AM J HUM GENET, V44, P724; PUCK JM, 1991, CURR OPINION PEDIATR, V3, P855	20	95	95	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1992	50	4					742	748						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HL848	1550118				2022-12-18	WOS:A1992HL84800009
J	MURRAY, JC; NISHIMURA, DY; BUETOW, KH; ARDINGER, HH; SPENCE, MA; SPARKES, RS; FALK, RE; FALK, PM; GARDNER, RJM; HARKNESS, EM; GLINSKI, LP; PAULI, RM; NAKAMURA, Y; GREEN, PP; SCHINZEL, A				MURRAY, JC; NISHIMURA, DY; BUETOW, KH; ARDINGER, HH; SPENCE, MA; SPARKES, RS; FALK, RE; FALK, PM; GARDNER, RJM; HARKNESS, EM; GLINSKI, LP; PAULI, RM; NAKAMURA, Y; GREEN, PP; SCHINZEL, A			LINKAGE OF AN AUTOSOMAL DOMINANT CLEFTING SYNDROME (VANDERWOUDE) TO LOCI ON CHROMOSOME IQ	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV IOWA,DEPT PEDIAT,IOWA CITY,IA 52242; FOX CHASE CANC INST,PHILADELPHIA,PA 19111; UNIV CALIF LOS ANGELES,DEPT PSYCHIAT,LOS ANGELES,CA 90024; UNIV SO CALIF,CHILDRENS HOSP LOS ANGELES,LOS ANGELES,CA 90089; UNIV OTAGO,DEPT PAEDIAT,DUNEDIN,NEW ZEALAND; UNIV OTAGO,DEPT ORTHODONT,DUNEDIN,NEW ZEALAND; UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706; UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706; HOWARD HUGHES MED INST,SALT LAKE CITY,UT; COLLABORAT RES INC,WALTHAM,MA; UNIV ZURICH,INST MED GENET,CH-8006 ZURICH,SWITZERLAND	University of Iowa; Fox Chase Cancer Center; University of California System; University of California Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Otago; University of Otago; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Zurich					NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007091] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE08559] Funding Source: Medline; NIGMS NIH HHS [GM07091] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOCIAN M, 1987, AM J MED GENET, V26, P437, DOI 10.1002/ajmg.1320260223; BOCK SC, 1982, NUCLEIC ACIDS RES, V10, P8113, DOI 10.1093/nar/10.24.8113; BUETOW KH, 1989, CYTOGENET CELL GENET, V50, P972; BURDICK AB, 1985, J CRAN GENET DEV BIO, V5, P181; CARAS IW, 1987, NATURE, V325, P545, DOI 10.1038/325545a0; CARROLL MC, 1988, J EXP MED, V167, P1271, DOI 10.1084/jem.167.4.1271; CARTER CO, 1982, J MED GENET, V19, P246, DOI 10.1136/jmg.19.4.246; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COOK PJL, 1974, ANN HUM GENET, V37, P261, DOI 10.1111/j.1469-1809.1974.tb01834.x; CURTIS EJ, 1961, AM J DIS CHILD, V102, P853, DOI 10.1001/archpedi.1961.02080010855007; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EASTMAN JR, 1978, J MED GENET, V15, P217, DOI 10.1136/jmg.15.3.217; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FERGUSON MWJ, 1987, IRISH J MED SCI, V156, P309, DOI 10.1007/BF02951261; Fogh-Andersen, 1942, INHERITANCE HARELIP; HOFF M, 1988, NUCLEIC ACIDS RES, V16, P4741, DOI 10.1093/nar/16.10.4741; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUMLINWOLFF E, 1987, NUCLEIC ACIDS RES, V15, P9621, DOI 10.1093/nar/15.22.9621; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1985, AM J HUM GENET, V37, P482; MCGILL JR, 1987, CYTOGENET CELL GENET, V45, P55, DOI 10.1159/000132425; MOORE GE, 1987, NATURE, V326, P91, DOI 10.1038/326091a0; MORTON NE, 1955, AM J HUM GENET, V7, P277; MURRAY JC, 1986, NUCLEIC ACIDS RES, V14, P7136, DOI 10.1093/nar/14.17.7136; MURRAY JC, 1986, NUCLEIC ACIDS RES, V14, P5117, DOI 10.1093/nar/14.12.5117; MURRAY JC, 1987, NUCLEIC ACIDS RES, V15, P6763; NAKAI H, 1988, CYTOGENET CELL GENET, V47, P90, DOI 10.1159/000132515; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P9620, DOI 10.1093/nar/15.22.9620; NISHIMURA D, 1988, GENOMICS, V3, P393, DOI 10.1016/0888-7543(88)90134-6; PONCZ M, 1982, HEMOGLOBIN, V6, P27, DOI 10.3109/03630268208996930; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SCHINZEL A, 1986, J MED GENET, V23, P291, DOI 10.1136/jmg.23.4.291; SHERMAN S L, 1988, Cytogenetics and Cell Genetics, V49, P39, DOI 10.1159/000132646; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SMITH RF, 1987, NUCLEIC ACIDS RES, V15, P6764, DOI 10.1093/nar/15.16.6764; SPENCE MA, 1983, J CRAN GENET DEV BIO, V3, P207; WIENKER TF, 1987, J MED GENET, V24, P160, DOI 10.1136/jmg.24.3.160	39	95	97	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					486	491						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309700				2022-12-18	WOS:A1990CT66800011
J	BEAUDET, AL; FELDMAN, GL; FERNBACH, SD; BUFFONE, GJ; OBRIEN, WE				BEAUDET, AL; FELDMAN, GL; FERNBACH, SD; BUFFONE, GJ; OBRIEN, WE			LINKAGE DISEQUILIBRIUM, CYSTIC-FIBROSIS, AND GENETIC-COUNSELING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030	Baylor College of Medicine; Baylor College of Medicine	BEAUDET, AL (corresponding author), BAYLOR COLL MED,HOWARD HUGHES MED INST,HOUSTON,TX 77030, USA.				NIDDK NIH HHS [DK39617-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039617] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEAUDET AL, 1987, J PEDIATR-US, V111, P630, DOI 10.1016/S0022-3476(87)80137-3; BEAUDET AL, 1988, NEW ENGL J MED, V318, P50; BOUE A, 1986, HUM GENET, V74, P288; BROCK DJH, 1988, HUM GENET, V78, P271, DOI 10.1007/BF00291675; BUFFONE GJ, 1988, CLIN CHEM, V34, P933; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; ESTIVILL X, 1988, AM J HUM GENET, V43, P23; ESTIVILL X, 1987, NATURE, V326, P840, DOI 10.1038/326840a0; FARRALL M, 1988, AM J HUM GENET, V43, P471; KNOWLTON RG, 1985, NATURE, V318, P380, DOI 10.1038/318380a0; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1988, AM J HUM GENET, V42, P38; SPENCE JE, 1987, HUM GENET, V76, P5; TSUI LC, 1985, SCIENCE, V230, P1054, DOI 10.1126/science.2997931; WAINWRIGHT BJ, 1985, NATURE, V318, P384, DOI 10.1038/318384a0; WHITE R, 1985, NATURE, V318, P382, DOI 10.1038/318382a0	16	95	98	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1989	44	3					319	326						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	T3535	2916578				2022-12-18	WOS:A1989T353500003
J	KEPPEN, LD; LEPPERT, MF; OCONNELL, P; NAKAMURA, Y; STAUFFER, D; LATHROP, M; LALOUEL, JM; WHITE, R				KEPPEN, LD; LEPPERT, MF; OCONNELL, P; NAKAMURA, Y; STAUFFER, D; LATHROP, M; LALOUEL, JM; WHITE, R			ETIOLOGIC HETEROGENEITY IN X-LINKED SPASTIC PARAPLEGIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,603 WINTROBE BLDG,SALT LAKE CITY,UT 84132; UNIV UTAH,DEPT HUMAN GENET,SALT LAKE CITY,UT 84132; ARKANSAS CHILDRENS HOSP,DEPT PEDIAT,LITTLE ROCK,AR 72202	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Arkansas Children's Hospital								BARAITSER M, 1982, GENETICS NEUROLOGICA, P200; BARKER D, 1984, CELL, V36, P131, DOI 10.1016/0092-8674(84)90081-3; BARR HS, 1966, AM J MENT DEFIC, V71, P13; BEAUDET A, 1986, AM J HUM GENET, V39, P681; BLUMEL J, 1957, J PEDIATR-US, V50, P454, DOI 10.1016/S0022-3476(57)80255-8; CAVENEE W, 1984, AM J HUM GENET, V36, P10; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; DRAYNA D, 1985, SCIENCE, V230, P753, DOI 10.1126/science.4059909; HARDING AE, 1983, LANCET, V1, P1151; HARDING AE, 1981, J NEUROL NEUROSUR PS, V44, P871, DOI 10.1136/jnnp.44.10.871; HOLMES GL, 1977, J NEUROL NEUROSUR PS, V40, P1003, DOI 10.1136/jnnp.40.10.1003; JOHNSTON AW, 1962, AM J HUM GENET, V14, P83; KENWRICK S, 1986, HUM GENET, V73, P264, DOI 10.1007/BF00401241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; McKusick V. A., 1986, MENDELIAN INHERITANC; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; RAO CR, 1973, LINEAR STATISTICAL I; REED KC, 1985, NUCLEIC ACIDS RES, V13, P7207, DOI 10.1093/nar/13.20.7207; Seeligmuller A, 1876, DEUT MED WOCHENSCHR, V2, P185; Struampell A., 1880, ARCH PSYCHIAT NERVEN, V10, P676, DOI [10.1007/BF02224539, DOI 10.1007/BF02224539, 10.1007/bf02054821]; SUTHERLAND JM, 1975, HDB CLIN NEUROLOGY, V22, P421; Thurmon T F, 1971, Birth Defects Orig Artic Ser, V7, P219; ZATZ M, 1976, J MED GENET, V13, P217, DOI 10.1136/jmg.13.3.217	24	95	96	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1987	41	5					933	943						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K9361	3479019				2022-12-18	WOS:A1987K936100013
J	KRESSE, H; ROSTHOJ, S; QUENTIN, E; HOLLMANN, J; GLOSSL, J; OKADA, S; TONNESEN, T				KRESSE, H; ROSTHOJ, S; QUENTIN, E; HOLLMANN, J; GLOSSL, J; OKADA, S; TONNESEN, T			GLYCOSAMINOGLYCAN-FREE SMALL PROTEOGLYCAN CORE PROTEIN IS SECRETED BY FIBROBLASTS FROM A PATIENT WITH A SYNDROME RESEMBLING PROGEROID	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									AALBORG SYGEHUS, DEPT PEDIAT, AALBORG, DENMARK; JOHN F KENNEDY INST, GLOSTRUP, DENMARK	Aalborg University; Aalborg University Hospital	KRESSE, H (corresponding author), UNIV MUNSTER, INST PHYSIOL CHEM, WALDEYERSTR 15, D-4400 MUNSTER, GERMANY.		Glössl, Josef/H-8208-2013	Glössl, Josef/0000-0002-5042-8828				BOMMER W, 1961, Arch Kinderheilkd, V165, P172; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; Cantz M, 1972, METHOD ENZYMOL, V28, P884; CHEAH KSE, 1985, BIOCHEM J, V229, P287, DOI 10.1042/bj2290287; CHOPRA RK, 1985, BIOCHEM J, V232, P277, DOI 10.1042/bj2320277; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; DONNELLY PV, 1984, CONNECT TISSUE RES, V13, P89, DOI 10.3109/03008208409152146; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; GLOSSL J, 1986, J BIOL CHEM, V261, P1920; GLOSSL J, 1983, BIOCHEM J, V215, P295; GLOSSL J, 1984, J BIOL CHEM, V259, P4144; HARPER JR, 1985, EXTRACELLULAR MATRIX, P367; HASILIK A, 1980, J BIOL CHEM, V255, P4937; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P3705, DOI 10.1073/pnas.77.6.3705; HICKMAN S, 1984, J CELL BIOL, V98, P407, DOI 10.1083/jcb.98.2.407; HOPPE W, 1985, EUR J BIOCHEM, V152, P91, DOI 10.1111/j.1432-1033.1985.tb09167.x; KRUSIUS T, 1986, P NATL ACAD SCI USA, V83, P7683, DOI 10.1073/pnas.83.20.7683; KUNZE J, 1985, EUR J PEDIATR, V144, P348, DOI 10.1007/BF00441776; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MOURAO PAS, 1981, BIOCHEM BIOPH RES CO, V98, P388, DOI 10.1016/0006-291X(81)90852-4; NAKAZAWA K, 1984, J BIOL CHEM, V259, P3751; NIELSEN JB, 1986, EUR J PEDIATR, V145, P572, DOI 10.1007/BF02429071; OLSON CA, 1985, ANAL BIOCHEM, V146, P232, DOI 10.1016/0003-2697(85)90420-8; PINNELL SR, 1983, METABOLIC BASIS INHE, P1425; PROCKOP DJ, 1984, NEW ENGL J MED, V311, P376, DOI 10.1056/NEJM198408093110606; Roden L., 1980, BIOCH GLYCOPROTEINS, P267; SAITO H, 1968, J BIOL CHEM, V243, P1536; SCOTT JE, 1985, BIOSCIENCE REP, V5, P71, DOI 10.1007/BF01117443; SCOTT JE, 1981, BIOCHEM J, V197, P213, DOI 10.1042/bj1970213; STANESCU V, 1975, PEDIATR RES, V9, P779, DOI 10.1203/00006450-197510000-00006; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; VOLKER W, 1985, EUR J CELL BIOL, V36, P58; VOSS B, 1986, J HISTOCHEM CYTOCHEM, V34, P1013, DOI 10.1177/34.8.2426331; WIEDEMANN HR, 1969, Z KINDERHEILKD, V107, P91, DOI 10.1007/BF00440226; YAMASHINA I, 1983, MOL CELL BIOCHEM, V52, P107	35	95	98	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1987	41	3					436	453						18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	K0191	3631078				2022-12-18	WOS:A1987K019100009
J	DEMARTINVILLE, B; KUNKEL, LM; BRUNS, G; MORLE, F; KOENIG, M; MANDEL, JL; HORWICH, A; LATT, SA; GUSELLA, JF; HOUSMAN, D; FRANCKE, U				DEMARTINVILLE, B; KUNKEL, LM; BRUNS, G; MORLE, F; KOENIG, M; MANDEL, JL; HORWICH, A; LATT, SA; GUSELLA, JF; HOUSMAN, D; FRANCKE, U			LOCALIZATION OF DNA-SEQUENCES IN REGION XP21 OF THE HUMAN X-CHROMOSOME - SEARCH FOR MOLECULAR MARKERS CLOSE TO THE DUCHENNE MUSCULAR-DYSTROPHY LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									YALE UNIV, SCH MED, DEPT HUMAN GENET, 333 CEDAR ST, POB 3333, NEW HAVEN, CT 06510 USA; HARVARD UNIV, CHILDRENS HOSP, SCH MED, DEPT PEDIAT, DIV GENET, BOSTON, MA 02115 USA; UNIV STRASBOURG 1, CNRS, GENET MOLEC EUCARYOTES LAB, INSERM, U184, F-67085 STRASBOURG, FRANCE; HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; MASSACHUSETTS GEN HOSP, NEUROL SERV, BOSTON, MA 02114 USA; MIT, CANC RES CTR, BOSTON, MA USA	Yale University; Harvard University; Boston Children's Hospital; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)					NICHD NIH HHS [HD04807] Funding Source: Medline; NIGMS NIH HHS [GM-26105, GM-32156] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026105, P50GM032156] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; BHATTACHARYA SS, 1984, NATURE, V309, P253, DOI 10.1038/309253a0; BRUNS G, 1982, ADV EXP MED BIOL, V154, P60; CAMERINO G, 1984, CYTOGENET CELL GENET, V37, P431; CANKI N, 1979, ANN GENET-PARIS, V22, P35; DAVIES KE, 1981, NATURE, V293, P374, DOI 10.1038/293374a0; DAVIES KE, 1983, NUCLEIC ACIDS RES, V11, P2303, DOI 10.1093/nar/11.8.2303; DEMARTINVILLE B, 1984, AM J HUM GENET, V36, P1357; DRAYNA D, 1984, P NATL ACAD SCI-BIOL, V81, P2836, DOI 10.1073/pnas.81.9.2836; EMANUEL BS, 1983, J MED GENET, V20, P461, DOI 10.1136/jmg.20.6.461; FRANCES R, 1981, REV PSYCHOL APPL, V31, P25; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1976, SOMAT CELL GENET, V2, P27, DOI 10.1007/BF01539240; FRANCKE U, 1984, CYTOGENET CELL GENET, V38, P298, DOI 10.1159/000132078; FRANCKE U, 1978, HUM GENET, V45, P137, DOI 10.1007/BF00286957; FRANCKE U, 1977, CYTOGENET CELL GENET, V19, P197, DOI 10.1159/000130809; GREENSTEIN RM, 1980, CYTOGENET CELL GENET, V27, P268, DOI 10.1159/000131496; HARPER PS, 1983, J MED GENET, V20, P252, DOI 10.1136/jmg.20.4.252; HORWICH AL, 1984, SCIENCE, V224, P1068, DOI 10.1126/science.6372096; JACOBS PA, 1981, AM J HUM GENET, V33, P513; KAPUSCINSKI J, 1977, ANAL BIOCHEM, V83, P252, DOI 10.1016/0003-2697(77)90533-4; KHAN PM, 1971, ARCH BIOCHEM BIOPHYS, V145, P470, DOI 10.1016/S0003-9861(71)80007-3; KUNKEL LM, 1982, NUCLEIC ACIDS RES, V10, P1557, DOI 10.1093/nar/10.5.1557; KUNKEL LM, 1983, NUCLEIC ACIDS RES, V11, P7961, DOI 10.1093/nar/11.22.7961; LINDENBAUM RH, 1979, J MED GENET, V16, P389, DOI 10.1136/jmg.16.5.389; LINDGREN V, 1984, SCIENCE, V226, P698, DOI 10.1126/science.6494904; LITTLEFIELD JW, 1964, SCIENCE, V145, P709, DOI 10.1126/science.145.3633.709; McKusick V.A., 1983, MENDELIAN INHERITANC; MILLER OJ, 1984, CYTOGENET CELL GENET, V37, P176, DOI 10.1159/000132009; MOHANDAS T, 1979, CYTOGENET CELL GENET, V25, P187; MOSER H, 1984, HUM GENET, V66, P17, DOI 10.1007/BF00275183; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; NORWOOD TH, 1976, SOMAT CELL GENET, V2, P263, DOI 10.1007/BF01538964; OFARRELL P, 1981, FOCUS, V3, P1; PAGE D, 1982, P NATL ACAD SCI-BIOL, V79, P5352, DOI 10.1073/pnas.79.17.5352; PAI GS, 1980, P NATL ACAD SCI-BIOL, V77, P2810, DOI 10.1073/pnas.77.5.2810; PEARSON SJ, 1983, SOMAT CELL GENET, V9, P567, DOI 10.1007/BF01574259; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROZEN R, 1985, NATURE; VERELLENDUMOULIN C, 1984, HUM GENET, V67, P115, DOI 10.1007/BF00270570; WIEACKER P, 1983, HUM GENET, V64, P143, DOI 10.1007/BF00327111; WORTON RG, 1984, SCIENCE, V224, P1447, DOI 10.1126/science.6729462; ZATZ M, 1981, J MED GENET, V18, P442, DOI 10.1136/jmg.18.6.442	43	95	96	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					235	249						15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	2984924				2022-12-18	WOS:A1985AGY5900001
J	RISCH, N				RISCH, N			SEGREGATION ANALYSIS INCORPORATING LINKAGE MARKERS .1. SINGLE-LOCUS MODELS WITH AN APPLICATION TO TYPE-I DIABETES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,SCH PUBL HLTH,DIV BIOSTAT,NEW YORK,NY 10032	Columbia University; Columbia University	RISCH, N (corresponding author), NEW YORK STATE PSYCHIAT INST,DEPT MED GENET,NEW YORK,NY 10032, USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH030906, P30MH030906] Funding Source: NIH RePORTER; NICHD NIH HHS [K04-HD00477] Funding Source: Medline; NIMH NIH HHS [MH 30906-04] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARBOSA J, 1980, J CLIN INVEST, V65, P592, DOI 10.1172/JCI109704; BARBOSA J, 1977, J CLIN INVEST, V60, P989, DOI 10.1172/JCI108879; BARBOSA J, 1978, J CLIN INVEST, V62, P492, DOI 10.1172/JCI109151; BARRAI I, 1965, AM J HUM GENET, V17, P221; BERGER A, 1967, BIOMETRICS, V23, P356, DOI 10.2307/2528168; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CANNINGS C, 1977, CLIN GENET, V12, P208; CLERGETDARPOUX F, 1980, CLIN GENET, V18, P51; CONTU L, 1982, TISSUE ANTIGENS, V20, P123; CUDWORTH AG, 1978, DIABETOLOGIA, V14, P281, DOI 10.1007/BF01223018; DAY NE, 1976, TISSUE ANTIGENS, V8, P109; DUNSWORTH TS, 1982, CLIN GENET, V21, P233; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1973, HUM HERED, V23, P105, DOI 10.1159/000152561; ELSTON RC, 1979, AM J HUM GENET, V31, P62; ELSTON RC, 1980, CURRENT DEV ANTHR GE, V1, P327; EWENS WJ, 1982, AM J HUM GENET, V34, P853; GREEN A, 1982, TISSUE ANTIGENS, V19, P213, DOI 10.1111/j.1399-0039.1982.tb01442.x; GREEN JR, 1983, ANN HUM GENET, V47, P73, DOI 10.1111/j.1469-1809.1983.tb00972.x; GREENBERG DA, 1983, AM J MED GENET, V14, P487, DOI 10.1002/ajmg.1320140313; HASSTEDT SJ, 1979, AM J HUM GENET, V31, pA135; HODGE SE, 1981, AM J HUM GENET, V33, P396; HODGE SE, 1980, ANN HUM GENET, V43, P399, DOI 10.1111/j.1469-1809.1980.tb01573.x; KAPLAN EB, 1972, I STATISTICS MIMEO S, V823; KIDD KK, 1980, ETIOLOGY CLEFT LIP C, P407; KRAVITZ K, 1979, AM J HUM GENET, V31, P601; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LANGE K, 1975, HUM HERED, V25, P95, DOI 10.1159/000152714; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1983, AM J HUM GENET, V35, P201; MORTON NE, 1981, HUM HERED, V31, P3, DOI 10.1159/000153168; OTT J, 1974, AM J HUM GENET, V26, P588; RISCH N, 1983, AM J MED GENET, V16, P243, DOI 10.1002/ajmg.1320160214; RISCH N, 1983, ANN HUM GENET, V47, P245, DOI 10.1111/j.1469-1809.1983.tb00992.x; RUBINSTEIN P, 1981, AM J HUM GENET, V33, P865; SPIELMAN RS, 1980, ANN HUM GENET, V44, P135, DOI 10.1111/j.1469-1809.1980.tb00954.x; SPIELMAN RS, 1979, GENETIC ANAL COMMON, P567; SUAREZ B, 1982, AM J MED GENET, V12, P309, DOI 10.1002/ajmg.1320120309; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x; SUAREZ BK, 1981, DIABETOLOGIA, V20, P524, DOI 10.1007/BF00252759; THOMSON G, 1980, ANN HUM GENET, V43, P383, DOI 10.1111/j.1469-1809.1980.tb01572.x; Thomson G, 1977, HLA DISEASE, P84; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	46	95	95	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	2					363	386						24	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	SM324	6608876				2022-12-18	WOS:A1984SM32400012
J	MARTIN, RH; LIN, CC; BALKAN, W; BURNS, K				MARTIN, RH; LIN, CC; BALKAN, W; BURNS, K			DIRECT CHROMOSOMAL ANALYSIS OF HUMAN-SPERMATOZOA - PRELIMINARY-RESULTS FROM 18 NORMAL MEN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV CALGARY,DEPT PEDIAT,CALGARY T2N 1N4,ALBERTA,CANADA	University of Calgary	MARTIN, RH (corresponding author), ALBERTA CHILDRENS HOSP,MED GENET CLIN,CALGARY T2T 5C7,ALBERTA,CANADA.							BIGGERS J. D., 1971, Methods in mammalian embryology, P86; BOUE J, 1975, TERATOLOGY, V12, P11, DOI 10.1002/tera.1420120103; BOUE J, 1973, CHROMOSOMAL ERRORS R, P29; CREASY MR, 1976, HUM GENET, V31, P177, DOI 10.1007/BF00296145; EPSTEIN CJ, 1979, NATURE, V280, P144, DOI 10.1038/280144a0; Gropp A., 1973, P S I NATIONAL SANTE, P255; HASSOLD T, 1980, ANN HUM GENET, V44, P151, DOI 10.1111/j.1469-1809.1980.tb00955.x; HASSOLD TJ, 1978, ANN HUM GENET, V41, P443, DOI 10.1111/j.1469-1809.1978.tb00914.x; HECHT F, 1969, LANCET, V1, P1197; JACOBS PA, 1972, HUMANGENETIK, V16, P137, DOI 10.1007/BF00393999; JACOBS PA, 1971, P INT S GENETICS SPE, P346; KAJII T, 1973, AM J HUM GENET, V25, P539; Lauritsen J G, 1976, Acta Obstet Gynecol Scand Suppl, V52, P1; LEE S, 1970, AM J OBSTET GYNECOL, V108, P1294, DOI 10.1016/0002-9378(70)90111-0; MACLEOD J, 1979, FERTIL STERIL, V31, P103; MIKAMO K, 1970, AM J OBSTET GYNECOL, V106, P253; MOSTELLER F, 1961, BIOMETRIKA, V48, P433, DOI 10.1093/biomet/48.3-4.433; RACE RR, 1968, BLOOD GROUPS MAN, P557; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; Siegel S, 1956, NONPARAMETRIC STATIS; TARKOWSKI AK, 1966, CYTOGENETICS, V5, P394, DOI 10.1159/000129914; VANDESANDE JH, 1979, EXP CELL RES, V120, P439, DOI 10.1016/0014-4827(79)90409-9; WARBURTON D, 1980, LANCET, V1, P167	23	95	97	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	3					459	468						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NR133	7081223				2022-12-18	WOS:A1982NR13300011
J	MENDLEWICZ, J; RAINER, JD				MENDLEWICZ, J; RAINER, JD			MORBIDITY RISK AND GENETIC TRANSMISSION IN MANIC-DEPRESSIVE ILLNESS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK STATE PSYCHIAT INST,DEPT MED GENET,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT PSYCHIAT,722 W 168TH ST,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST,DEPT INTERN MED,NEW YORK,NY 10032	New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute								Angst J, 1968, Arch Psychiatr Nervenkr (1970), V210, P373, DOI 10.1007/BF00342013; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; KALLMANN FJ, 1954, DEPRESSION, P1; KIDD KK, 1973, SOC BIOL, V20, P254, DOI 10.1080/19485565.1973.9988051; LARSSON T, 1954, ACTA PSYCHIATRICA S, V89, P40; LEONHARD KARL, 1962, PSYCHIAT ET NEUROL, V143, P416; MENDLEWICZ J, 1972, J AMER MED ASSOC, V222, P1624, DOI 10.1001/jama.222.13.1624; MENDLEWICZ J, 1974, GENETICS PSYCHOPATHO; NEWCOMBE HB, 1964, 2 P INT C CONG MALF, P22; PERRIS C, 1971, BRIT J PSYCHIAT, V118, P207, DOI 10.1192/bjp.118.543.207; Perris C, 1966, ACTA PSYCHIAT SCAND, V194, P1; REICH T, 1969, AM J PSYCHIAT, V125, P1358, DOI 10.1176/ajp.125.10.1358; SLATER E, 1971, BRIT J PSYCHIAT, V118, P215, DOI 10.1192/bjp.118.543.215; SPITZER RL, 1967, COMPR PSYCHIAT, V8, P321, DOI 10.1016/S0010-440X(67)80061-0; Stenstedt A, 1952, ACTA PSYCH NEUROL SC, V79, P1; Stromgren E, 1935, Z GESAMTE NEUROL PSY, V153, P784, DOI 10.1007/BF02865780; WINOKUR G, 1969, DIS NERV SYST, V30, P89; WINOKUR G, 1967, RECENT ADV BIOLOGICA; Winokur G., 1969, MANIC DEPRESSIVE ILL; ZERBINRUDIN E, 1969, DAS DEPRESSIVE SYNDR, P35	22	95	95	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1974	26	6					692	701						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	V0911	4548308				2022-12-18	WOS:A1974V091100004
J	WILSON, MG; TOWNER, JW; FUJIMOTO, A				WILSON, MG; TOWNER, JW; FUJIMOTO, A			RETINOBLASTOMA AND D-CHROMOSOME DELETIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV SO CALIF,LOS ANGELES CTY HOSP,MED CTR,DEPT PEDIAT,LOS ANGELES,CA 90033	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California								ALLDERDICE PW, 1969, AM J HUM GENET, V21, P499; CAPOA AD, 1968, NATURE, V220, P264; COFFIN GS, 1970, AM J DIS CHILD, V119, P370, DOI 10.1001/archpedi.1970.02100050372020; DRETS ME, 1971, P NATL ACAD SCI USA, V68, P2073, DOI 10.1073/pnas.68.9.2073; GEY W, 1970, HUMANGENETIK, V10, P362, DOI 10.1007/BF00278776; GRACE E, 1971, J MED GENET, V8, P351, DOI 10.1136/jmg.8.3.351; LEHRKE R, 1971, LANCET, V2, P98; LELE KP, 1963, ANN HUM GENET, V27, P171, DOI 10.1111/j.1469-1809.1963.tb00209.x; MILLER OJ, 1966, CYTOGENETICS, V5, P137, DOI 10.1159/000129893; ORBELI DJ, 1971, HUMANGENETIK, V13, P296; ORYE E, 1971, LANCET, V2, P1376; SEABRIGH.M, 1971, LANCET, V2, P971; SEABRIGHT M, 1972, CHROMOSOMA, V36, P204; SPARKES RS, 1967, AM J HUM GENET, V19, P644; TAYLOR AI, 1970, HUMANGENETIK, V10, P209, DOI 10.1007/BF00295782; THOMPSON H, 1965, HUM CHROM NEWSL, V15, P21; VANKEMPEN C, 1966, MAANDSCHR KINDERGENE, V34, P92; WILSON M G, 1969, Journal of Medical Genetics, V6, P322, DOI 10.1136/jmg.6.3.322	18	95	96	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1973	25	1					57	61						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O5774	4119334				2022-12-18	WOS:A1973O577400007
J	CHUNG, CS; MORTON, NE				CHUNG, CS; MORTON, NE			SELECTION AT ABO LOCUS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ANDERSEN A, 1952, Acta Pathol Microbiol Scand, V31, P448; BENNETT JH, 1956, ANN HUM GENET, V20, P299; BENNETT JH, 1954, ANN EUGENIC, V18, P302; Boyd WC, 1941, ANN EUGENIC, V11, P1; Brues AM, 1954, AM J PHYS ANTHROP-NE, V12, P559, DOI 10.1002/ajpa.1330120408; CHEESEMAN EA, 1956, ANN HUM GENET, V21, P59, DOI 10.1111/j.1469-1809.1971.tb00265.x; CLARKE CA, 1960, BRIT MED J, V1, P21, DOI 10.1136/bmj.1.5165.21; COHEN BH, 1959, AM J HUM GENET, V11, P414; Cotterman CW, 1943, ANN EUGENIC, V12, P158, DOI 10.1111/j.1469-1809.1943.tb02319.x; CROW JF, 1958, AM ANTHROPOL, V60, P1; CROW JF, 1960, AM NAT, V94, P413, DOI 10.1086/282145; DAHR P, 1940, ZSCHR IMMUNFORSCH, V97, P168; Dahr P., 1940, ZSCHR RASSENPHYSIOL, V11, P78; DAHR PETER, 1938, ZEITSCHR RASSENPHYSIOL, V10, P49; EDWARDS J H, 1957, Br J Prev Soc Med, V11, P79; FILITTIWURMSER S, 1952, J CHIM PHYS PCB, V49, P550, DOI 10.1051/jcp/1952490550; GRUBB R., 1955, ANN HUMAN GENETICS, V19, P183, DOI 10.1111/j.1469-1809.1955.tb01343.x; HAGA H, 1959, JPN J HUM GENET, V4, P1; HAGUE M, 1954, ANN EUGEN, V18, P175; HIRAIZUMI Y, 1960, EVOLUTION, V14, P433, DOI 10.1111/j.1558-5646.1960.tb03111.x; HIRSZFELD L, 1927, Z IMMUN FORSCH, V54, P81; HIRSZFELD L, 1925, KLIN WOCHENSCHR, V4, P1152; HIRSZFELD L, 1938, SCHWEIZ ZSCHR AL PAT, V1, P23; Holford FE, 1938, J INFECT DIS, V63, P287, DOI 10.1093/infdis/63.3.287; Hyman HS, 1935, J IMMUNOL, V29, P223; JAMESON RJ, 1956, ANN HUM GENET, V20, P348; Johnstone JM, 1954, BRIT J PREV SOC MED, V8, P117; Kirk RL, 1955, BRIT J PREV SOC MED, V9, P104; Landsteiner K, 1928, J EXP MED, V48, P731, DOI 10.1084/jem.48.5.731; Landsteiner K, 1941, J EXP MED, V74, P309, DOI 10.1084/jem.74.4.309; LAWLER SD, 1957, ANN HUM GENET, V21, P410, DOI 10.1111/j.1469-1809.1972.tb00294.x; LEVINE P, 1959, J MED EDUC, V34, P418; LEVINE P, 1955, Rev Hematol, V10, P215; Levine P, 1943, J HERED, V34, P71, DOI 10.1093/oxfordjournals.jhered.a105249; LUDWIN I, 1952, AM J HUM GENET, V4, P182; Matson GA, 1936, J IMMUNOL, V30, P445; MATSUNAGA E, 1955, AM J HUM GENET, V7, P66; MATSUNAGA E, 1957, ANN HUM GENET, V22, P111, DOI 10.1111/j.1469-1809.1957.tb01926.x; MATTA D, 1937, EUFMP 11; MCARTHUR N, 1951, ANN EUGENIC, V15, P302; MCFARLANE M, 1946, ANN EUGENIC, V13, P15, DOI 10.1111/j.1469-1809.1946.tb02338.x; MCNEIL C, 1954, AM J CLIN PATHOL, V24, P767; Mohr J, 1954, STUDY LINKAGE MAN; MORTON NE, 1956, P NATL ACAD SCI USA, V42, P855, DOI 10.1073/pnas.42.11.855; MORTON NE, 1959, AM J HUM GENET, V11, P237; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1954, AM J HUM GENET, V6, P38; MUNKANDERSEN G, 1957, ACTA PATH MICROB SCA, V42, P43; MUSTAKALLIO E, 1937, ACTA SOC MED FENN  A, V20, P1; RACE RR, 1945, ANN EUGENIC, V12, P261; Race RR, 1943, ANN EUGENIC, V12, P206, DOI 10.1111/j.1469-1809.1943.tb02323.x; Race RR, 1941, ANN EUGENIC, V11, P385, DOI 10.1111/j.1469-1809.1941.tb02301.x; Race RR, 1941, ANN EUGENIC, V11, P365, DOI 10.1111/j.1469-1809.1941.tb02300.x; RACE RR, 1949, BRIT J EXP PATHOL, V30, P73; REED TE, 1956, AM J HUM GENET, V8, P257; REED TE, 1957, ANN HUM GENET, V22, P165, DOI 10.1111/j.1469-1809.1957.tb01932.x; REED TE, 1959, NATURE, V184, P611, DOI 10.1038/184611a0; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; ROBERTS J A F, 1957, Br J Prev Soc Med, V11, P107; ROSENFIELD RE, 1953, PROC AM ASS BLOOD BA; SANDLER L, 1957, AM NAT, V91, P105, DOI 10.1086/281969; SANGER R, 1948, HEREDITY, V2, P131, DOI 10.1038/hdy.1948.8; SCHIFF F, 1932, Z IMMUNITATSFORSCH, V77, P129; SHAW DH, 1958, TR 6 CONG EUROP SO H, P724; SHEPPARD PM, 1959, BRIT MED BULL, V15, P134, DOI 10.1093/oxfordjournals.bmb.a069737; SLATIS HM, 1958, AM J HUM GENET, V10, P446; STEVENSON A. C., 1955, ANN HUMAN GENETICS, V19, P165, DOI 10.1111/j.1469-1809.1955.tb01341.x; STRATTON F, 1945, ANN EUGENIC, V12, P250; Taylor GL, 1938, ANN EUGENIC, V8, P343, DOI 10.1111/j.1469-1809.1938.tb02186.x; WALTON JN, 1955, ANN HUM GENET, V20, P1, DOI 10.1111/j.1469-1809.1955.tb01274.x; Waterhouse JAH, 1947, BR J SOC MED, V1, P1; Wiener AS, 1944, J EXP MED, V79, P235, DOI 10.1084/jem.79.3.235; WIENER AS, 1949, AM J HUM GENET, V1, P127; WIENER AS, 1946, P SOC EXP BIOL MED, V61, P382; Wiener AS, 1943, GENETICS, V28, P157; Wiener AS, 1931, J IMMUNOL, V20, P371; WIENER AS, 1949, BLOOD, V4, P1014, DOI 10.1182/blood.V4.9.1014.1014; Wiener AS, 1936, ANN EUGENIC, V7, P141, DOI 10.1111/j.1469-1809.1936.tb02135.x; WIENER AS, 1943, BLOOD GROUPS TRANSFU; ZUELZER WW, 1954, AMA AM J DIS CHILD, V88, P319, DOI 10.1001/archpedi.1954.02050100321005	80	95	95	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1961	13	1					9	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2959A	13693519				2022-12-18	WOS:A19612959A00003
J	NEEL, JV; KODANI, M; BREWER, R; ANDERSON, RC				NEEL, JV; KODANI, M; BREWER, R; ANDERSON, RC			THE INCIDENCE OF CONSANGUINEOUS MATINGS IN JAPAN - WITH REMARKS ON THE ESTIMATION OF COMPARATIVE GENE FREQUENCIES AND THE EXPECTED RATE OF APPEARANCE OF INDUCED RECESSIVE MUTATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BARTELS ED, 1941, OP DOM BIOL HERED HU, V2, P384; Bell J, 1940, ANN EUGENIC, V10, P370; BELL J, 1926, TREAS HUM INHER, V2, P125; BOOK JA, 1948, HEREDITAS, V34, P252; BRENK H, 1931, ARCH KLAUS STIFT VER, V6, P1; COCKAYNE EA, 1933, INHERITED ABNORMALIT, P394; DAHLBERG G, 1948, MATH METHODS POPULAT, P175; DAHLBERG GUNNAR, 1938, PROC ROY SOC EDINBURGH, V58, P213; DERNOLLENBURG WA, 1932, Z KONST, V16, P707; DUNN LC, 1947, P NATL ACAD SCI USA, V33, P359, DOI 10.1073/pnas.33.12.359; EGENTER ARNOLD, 1934, ARCH JULIUS KLAUS STIFT, V9, P365; EVANS RD, 1949, SCIENCE, V109, P299, DOI 10.1126/science.109.2830.299; GATES RR, 1946, HUM GENET, P1518; GOTHLIN GF, 1924, ACTA OPHTHALMOL, V2, P15; Gothlin Gustaf F., 1941, ACTA OPHTHALMOL [COPENHAGEN], V19, P202; GROB WALTER, 1934, ARCH JULIUS KLAUS STIJT, V9, P237; Haldane JBS, 1939, ANN EUGENIC, V9, P232, DOI 10.1111/j.1469-1809.1939.tb02210.x; Haldane JBS, 1939, ANN EUGENIC, V9, P321, DOI 10.1111/j.1469-1809.1939.tb02217.x; HALDANE JBS, 1947, ANN EUGENIC, V14, P35, DOI 10.1111/j.1469-1809.1947.tb02377.x; HITOMI K, 1943, MINZOKU EISEI, V11, P427; HOGBEN L, 1946, INTRO MATH GENETICS, P260; KATSUNUMA, UNPUB; KIDA F, 1949, IDEN, V3, P135; KOMAI T, 1947, PEDIGREES HEREDITARY, P225; KOMAI T, 1934, PEDIGREES HEREDITARY, P51; KURASIMA M, 1937, NAGOYA J M SOC, V46, P33; Lenz Fritz, 1919, M NCHENER MEDIZINISC, V66, P1340; Macklin MT, 1936, ARCH DERMATOL SYPH, V34, P656, DOI 10.1001/archderm.1936.01470160103013; Orel Herbert, 1932, ARCHIV RASSENUND GES, V26, P249; PEARSON K, 1911, MONOGRAPH ALBINISM; PETER L, 1926, ARCH J KLAUS STIFT, V2, P143; Reutlinger Wilhelm., 1922, ARCHIV RASSENUND GES, V14, P301; Roberts JAF, 1932, NATURE, V130, P542, DOI 10.1038/130542a0; RUEPP G, 1935, ARCH J KLAUSSTIFTUNG, V10, P193; SIEMENS HW, 1925, Z INDUKT ABSTAMM VER, V38, P1; Sjogren T., 1931, HEREDITAS, V14, P197, DOI [10.1111/j.1601-5223.1931.tb02535.x, DOI 10.1111/J.1601-5223.1931.TB02535.X]; SJOGREN TORSTEN, 1948, ACTA PSYCHIAT ET NEUROL SUPPL, V52, P1; Slome D, 1933, J GENET, V27, P363, DOI 10.1007/BF02981749; SNYDER LH, 1947, YALE J BIOL MED, V19, P817; SPINDLER EA, 1922, ARCH RASSEN GES BIOL, V14, P9; Weinberg W, 1920, Z GESAMTE NEUROL PSY, V59, P39, DOI 10.1007/BF02901078; Wulz G., 1925, ARCHIV F R RASSENUND, V17, P82; YAMAMOTO H, 1939, OOSAKA IJI SHINSHI, V12, P1	43	95	96	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1949	1	2					156	178						23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XU076	17948392				2022-12-18	WOS:A1949XU07600004
J	Koczkowska, M; Chen, YJ; Callens, T; Gomes, A; Sharp, A; Johnson, S; Hsiao, MC; Chen, ZB; Balasubramanian, M; Barnett, CP; Becker, TA; Ben-Shachar, S; Bertola, DR; Blakeley, JO; Burkitt-Wright, EMM; Callaway, A; Crenshaw, M; Cunha, KS; Cunningham, M; D'Agostino, MD; Dahan, K; De Luca, A; Destree, A; Dhamija, R; Eoli, M; Evans, DGR; Galvin-Parton, P; George-Abraham, JK; Gripp, KW; Guevara-Campos, J; Hanchard, NA; Hernandez-Chico, C; Immken, L; Janssens, S; Jones, KJ; Keena, BA; Kochhar, A; Liebelt, J; Martir-Negron, A; Mahoney, MJ; Maystadt, I; McDougall, C; McEntagart, M; Mendelsohn, N; Miller, DT; Mortier, G; Morton, J; Pappas, J; Plotkin, SR; Pond, D; Rosenbaum, K; Rubin, K; Russell, L; Rutledge, LS; Saletti, V; Schonberg, R; Schreiber, A; Seidel, M; Siqveland, E; Stockton, DW; Trevisson, E; Ullrich, NJ; Upadhyaya, M; van Minkelen, R; Verhelst, H; Wallace, MR; Yap, YS; Zackai, E; Zonana, J; Zurcher, V; Claes, K; Martin, Y; Korf, BR; Legius, E; Messiaen, LM				Koczkowska, Magdalena; Chen, Yunjia; Callens, Tom; Gomes, Alicia; Sharp, Angela; Johnson, Sherrell; Hsiao, Meng-Chang; Chen, Zhenbin; Balasubramanian, Meena; Barnett, Christopher P.; Becker, Troy A.; Ben-Shachar, Shay; Bertola, Debora R.; Blakeley, Jaishri O.; Burkitt-Wright, Emma M. M.; Callaway, Alison; Crenshaw, Melissa; Cunha, Karin S.; Cunningham, Mitch; D'Agostino, Maria D.; Dahan, Karin; De Luca, Alessandro; Destree, Anne; Dhamija, Radhika; Eoli, Marica; Evans, D. Gareth R.; Galvin-Parton, Patricia; George-Abraham, Jaya K.; Gripp, Karen W.; Guevara-Campos, Jose; Hanchard, Neil A.; Hernandez-Chico, Concepcion; Immken, LaDonna; Janssens, Sandra; Jones, Kristi J.; Keena, Beth A.; Kochhar, Aaina; Liebelt, Jan; Martir-Negron, Arelis; Mahoney, Maurice J.; Maystadt, Isabelle; McDougall, Carey; McEntagart, Meriel; Mendelsohn, Nancy; Miller, David T.; Mortier, Geert; Morton, Jenny; Pappas, John; Plotkin, Scott R.; Pond, Dinel; Rosenbaum, Kenneth; Rubin, Karol; Russell, Laura; Rutledge, Lane S.; Saletti, Veronica; Schonberg, Rhonda; Schreiber, Allison; Seidel, Meredith; Siqveland, Elizabeth; Stockton, David W.; Trevisson, Eva; Ullrich, Nicole J.; Upadhyaya, Meena; van Minkelen, Rick; Verhelst, Helene; Wallace, Margaret R.; Yap, Yoon-Sim; Zackai, Elaine; Zonana, Jonathan; Zurcher, Vickie; Claes, Kathleen; Martin, Yolanda; Korf, Bruce R.; Legius, Eric; Messiaen, Ludwine M.			Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-I; OPTIC PATHWAY TUMORS; NERVE SHEATH TUMORS; SOUTH EAST WALES; VONRECKLINGHAUSEN NEUROFIBROMATOSIS; NOONAN-SYNDROME; TYPE-1 NEUROFIBROMATOSIS; SPINAL NEUROFIBROMATOSIS; PLEXIFORM NEUROFIBROMAS; NATURAL-HISTORY	Neurofibromatosis type 1 (NF1), a common genetic disorder with a birth incidence of 1: 2,000-3,000, is characterized by a highly variable clinical presentation. To date, only two clinically relevant intragenic genotype-phenotype correlations have been reported for NF1 missense mutations affecting p. Arg1809 and a single amino acid deletion p.Met922del. Both variants predispose to a distinct mild NF1 phenotype with neither externally visible cutaneous/plexiform neurofibromas nor other tumors. Here, we report 162 individuals (129 unrelated probands and 33 affected relatives) heterozygous for a constitutional missense mutation affecting one of five neighboring NF1 codons-Leu844, Cys845, Ala846, Leu847, and Gly848-located in the cysteine-serine-rich domain (CSRD). Collectively, these recurrent missense mutations affect similar to 0.8% of unrelated NF1 mutation-positive probands in the University of Alabama at Birmingham (UAB) cohort. Major superficial plexiform neurofibromas and symptomatic spinal neurofibromas were more prevalent in these individuals compared with classic NF1-affected cohorts (both p < 0.0001). Nearly half of the individuals had symptomatic or asymptomatic optic pathway gliomas and/or skeletal abnormalities. Additionally, variants in this region seem to confer a high predisposition to develop malignancies compared with the general NF1-affected population (p = 0.0061). Our results demonstrate that these NF1 missense mutations, although located outside the GAP-related domain, may be an important risk factor for a severe presentation. A genotype-phenotype correlation at the NF1 region 844-848 exists and will be valuable in the management and genetic counseling of a significant number of individuals.	[Koczkowska, Magdalena; Chen, Yunjia; Callens, Tom; Gomes, Alicia; Sharp, Angela; Johnson, Sherrell; Hsiao, Meng-Chang; Chen, Zhenbin; Korf, Bruce R.; Messiaen, Ludwine M.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Balasubramanian, Meena] Sheffield Childrens NHS Fdn Trust, Sheffield Clin Genet Serv, Sheffield S10 2TH, S Yorkshire, England; [Barnett, Christopher P.; Liebelt, Jan] Womens & Childrens Hosp SA Pathol, Adelaide, SA 5006, Australia; [Becker, Troy A.; Crenshaw, Melissa] John Hopkins All Childrens Hosp, Med Genet, St Petersburg, FL 33701 USA; [Ben-Shachar, Shay] Genet Inst Inc, Tel Aviv Sourasky Med Ctr, IL-6997801 Tel Aviv, Israel; [Ben-Shachar, Shay] Genet Inst Inc, Sackler Fac Med, IL-6997801 Tel Aviv, Israel; [Bertola, Debora R.] Univ Sao Paulo, Dept Pediat, BR-05403000 Sao Paulo, Brazil; [Blakeley, Jaishri O.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Burkitt-Wright, Emma M. M.; Evans, D. Gareth R.] Univ Manchester, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Div Evolut & Genom Sci,Gen Med, Manchester M13 9WL, Lancs, England; [Callaway, Alison] Salisbury NHS Fdn Trust, Wessex Reg Genet Lab, Salisbury SP2 8BJ, Wilts, England; [Cunha, Karin S.] Univ Fed Fluminense, Sch Med, Dept Pathol, BR-24220900 Niteroi, RJ, Brazil; [Cunningham, Mitch; Stockton, David W.] Childrens Hosp Michigan, Detroit Med Ctr, Div Genet Genom & Metab Disorders, Detroit, MI 48201 USA; [D'Agostino, Maria D.; Russell, Laura] McGill Univ, Hlth Ctr, Dept Med Genet, Montreal H4A 3J1, PQ, Canada; [Dahan, Karin; Destree, Anne; Maystadt, Isabelle] Inst Pathol & Genet, Ctr Human Genet, B-6041 Gosselies, Belgium; [De Luca, Alessandro] IRCCS, Casa Sollievo Sofferenza Hosp, Mol Genet Unit, I-71013 San Giovanni Rotondo, Italy; [Dhamija, Radhika] Mayo Clin, Dept Clin Genom & Neurol, Phoenix, AZ 85259 USA; [Eoli, Marica] IRCCS Fdn, Carlo Besta Neurol Inst, Unit Mol Neurooncol, I-20133 Milan, Italy; [Galvin-Parton, Patricia] Stony Brook Childrens, Dept Genet, Stony Brook, NY 11794 USA; [George-Abraham, Jaya K.; Immken, LaDonna] Dell Childrens Med Ctr Cent Texas, Austin, TX 78723 USA; [Gripp, Karen W.] DuPont Hosp Children, Div Med Genet, Wilmington, DE 19803 USA; [Guevara-Campos, Jose] Univ Oriente, Felipe Guevara Rojas Hosp, Pediat Serv, El Tigre Anzoategui 6034, Spain; [Hanchard, Neil A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Hernandez-Chico, Concepcion; Martin, Yolanda] Hosp Univ Ramon & Cayal, Dept Genet, Inst Hlth Res IRYCIS, Madrid 28034, Spain; [Hernandez-Chico, Concepcion; Martin, Yolanda] Hosp Univ Ramon & Cayal, Ctr Biomed Res Network Rare Dis CIBERER, Madrid 28034, Spain; [Janssens, Sandra; Claes, Kathleen] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Jones, Kristi J.] Childrens Hosp Westmead, Dept Clin Genet, Westmead, NSW 2145, Australia; [Keena, Beth A.; McDougall, Carey; Zackai, Elaine] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Kochhar, Aaina] Valley Childrens Healthcare, Dept Genet, Madera, CA 93636 USA; [Martir-Negron, Arelis] Miami Canc Inst, Ctr Genom Med, Div Clin Genet, Miami, FL 33176 USA; [Mahoney, Maurice J.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [McEntagart, Meriel] St Georges Univ Hosp NHS Fdn Trust, London SW17 0QT, England; [Mendelsohn, Nancy; Pond, Dinel; Siqveland, Elizabeth] Childrens Hosp Minnesota, Genom Med Program, Minneapolis, MN 55404 USA; [Miller, David T.] Boston Childrens Hosp, Multidisciplinary Neurofibromatosis Program, Boston, MA 02115 USA; [Mortier, Geert] Univ Antwerp, Dept Med Genet, B-2650 Antwerp, Belgium; [Mortier, Geert] Univ Antwerp Hosp, B-2650 Antwerp, Belgium; [Morton, Jenny] BirminghamWomens & Childrens NHS Fdn Trust, Birmingham B15 2TG, W Midlands, England; [Pappas, John] NYU, Sch Med, Clin Genet Serv, Dept Pediat, New York, NY 10016 USA; [Plotkin, Scott R.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Plotkin, Scott R.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Rosenbaum, Kenneth; Schonberg, Rhonda] Childrens Natl Hlth Syst, Div Genet & Metab, Washington, DC 20010 USA; [Rubin, Karol] Univ Minnesota Hlth, Minneapolis, MN 55404 USA; [Saletti, Veronica] IRCCS Fdn, Carlo Besta Neurol Inst, Dev Neurol Unit, I-20133 Milan, Italy; [Schreiber, Allison; Zurcher, Vickie] Cleveland Clin, Inst Med Genet, Cleveland, OH 44195 USA; [Trevisson, Eva] Univ Padua, Clin Genet Unit, Dept Womens & Childrens Hlth, I-35128 Padua, Italy; [Trevisson, Eva] Italy Ist Ric Pediatria, Citta Speranza, IRP, I-35128 Padua, Italy; [Ullrich, Nicole J.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Upadhyaya, Meena] Cardiff Univ, Div Canc & Genet, Cardiff CF14 4XN, S Glam, Wales; [van Minkelen, Rick] Erasmus MC, Dept Clin Genet, NL-3015 GE Rotterdam, Netherlands; [Verhelst, Helene] Ghent Univ Hosp, Div Paediat Neurol, Dept Paediat, B-9000 Ghent, Belgium; [Wallace, Margaret R.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; [Yap, Yoon-Sim] Natl Canc Ctr Singapore, Div Med Oncol, Singapore 169610, Singapore; [Yap, Yoon-Sim] Univ Adelaide, Sch Med, Fac Hlth Sci, Adelaide, SA 5000, Australia; [Zonana, Jonathan] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Legius, Eric] Univ Leuven, KU Leuven, Dept Human Genet, B-3000 Louvain, Belgium	University of Alabama System; University of Alabama Birmingham; Sheffield Children's NHS Foundation Trust; SA Pathology; Johns Hopkins University; Johns Hopkins Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Universidade de Sao Paulo; Johns Hopkins University; University of Manchester; Salisbury District Hospital; Universidade Federal Fluminense; Children's Hospital of Michigan; Detroit Medical Center; McGill University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); IRCCS Casa Sollievo Della Sofferenza; Mayo Clinic; Mayo Clinic Phoenix; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Nemours Alfred I. duPont Hospital for Children; Baylor College of Medicine; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Ghent University; Ghent University Hospital; University of Sydney; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yale University; Children's Hospitals & Clinics of Minnesota; Harvard University; Boston Children's Hospital; University of Antwerp; University of Antwerp; New York University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Children's National Health System; University of Minnesota System; University of Minnesota Twin Cities; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; Cleveland Clinic Foundation; University of Padua; Fondazione Citta della Speranza; Harvard University; Boston Children's Hospital; Cardiff University; Erasmus University Rotterdam; Erasmus MC; Ghent University; Ghent University Hospital; State University System of Florida; University of Florida; National Cancer Centre Singapore (NCCS); University of Adelaide; Oregon Health & Science University; KU Leuven	Messiaen, LM (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.	lmessiaen@uabmc.edu	D'Agostino, Maria Daniela/ABD-9131-2021; Wright, Emma Burkitt/X-6623-2019; Evans, D Gareth/AAB-4308-2022; Maystadt, Isabelle/AAH-1483-2021; Cunha, Karin SG/D-4519-2015; Cunha, K. S./J-9636-2012; Balasubramanian, Meena/AGB-4083-2022; Saletti, Veronica/K-3458-2018; Trevisson, Eva/K-8462-2016; Mortier, Geert/D-2542-2012; Hanchard, Neil/AAY-9075-2021; De Luca, Alessandro/B-2179-2017; Claes, Kathleen/AFR-6830-2022; Ullrich, Nicole/AAH-8720-2019; Eoli, Marica/K-7748-2016; Bertola, Débora/I-5120-2016; Pappas, John/Q-6683-2019	Evans, D Gareth/0000-0002-8482-5784; Cunha, Karin SG/0000-0002-5647-282X; Balasubramanian, Meena/0000-0003-1488-3695; Saletti, Veronica/0000-0003-4830-6204; Trevisson, Eva/0000-0002-5380-6265; Mortier, Geert/0000-0001-9871-4578; Hanchard, Neil/0000-0003-1925-2665; De Luca, Alessandro/0000-0002-4408-8062; Claes, Kathleen/0000-0003-0841-7372; Eoli, Marica/0000-0003-4744-9377; Bertola, Débora/0000-0002-4701-6777; Pappas, John/0000-0001-5625-2598; Plotkin, Scott/0000-0002-6109-6419; Cunningham, Mitchell/0000-0003-3321-5545; Yap, Yoon-Sim/0000-0002-0347-5066	Children's Tumor Foundation by the Isaac and Sadie Fuchs Genotype-Phenotype Study; Medical Genomics Laboratory at UAB; Manchester NIHR Biomedical Research Centre; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090255] Funding Source: NIH RePORTER	Children's Tumor Foundation by the Isaac and Sadie Fuchs Genotype-Phenotype Study; Medical Genomics Laboratory at UAB; Manchester NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank the individuals and their families for participating in this study. This work was supported by the Children's Tumor Foundation by the Isaac and Sadie Fuchs Genotype-Phenotype Study (to L.M.M.) and by internal funds from the Medical Genomics Laboratory at UAB. Parts of this work were presented during the 17th European Neurofibromatosis Meeting (September 8-11, 2016, Padova-Abano Terme, Italy) and the Children's Tumor Foundation NF Conference (June 10-13, 2017, Washington, DC, USA).; M.K. is also affiliated with the Department of Biology and Medical Genetics at the Medical University of Gdansk in Poland. D.G.R.E. is supported by the all Manchester NIHR Biomedical Research Centre as an NIHR Senior investigator. M.U. acknowledges Sheila Palmer-Smith and Ian Frayling for their support.	[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Bertola DR, 2005, AM J MED GENET A, V136A, P242, DOI 10.1002/ajmg.a.30813; Blanchard G, 2016, EUR J PAEDIATR NEURO, V20, P275, DOI 10.1016/j.ejpn.2015.12.002; Blazo MA, 2004, AM J MED GENET A, V127A, P224, DOI 10.1002/ajmg.a.20650; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Brems H, 2009, LANCET ONCOL, V10, P508, DOI 10.1016/S1470-2045(09)70033-6; Chang T, 2012, NEUROFIBROMATOSIS TY, V1, P469; Cnossen MH, 1998, ARCH DIS CHILD, V78, P408, DOI 10.1136/adc.78.5.408; Crucis A, 2015, PEDIATR BLOOD CANCER, V62, P1733, DOI 10.1002/pbc.25556; Cunha KS, 2016, GENES-BASEL, V7, DOI 10.3390/genes7120133; DeBella K, 2000, PEDIATRICS, V105, P608, DOI 10.1542/peds.105.3.608; DECLUE JE, 1991, P NATL ACAD SCI USA, V88, P9914, DOI 10.1073/pnas.88.22.9914; EASTON DF, 1993, AM J HUM GENET, V53, P305; Ekvall S, 2014, AM J MED GENET A, V164, P579, DOI 10.1002/ajmg.a.36313; Evans DG, 2010, AM J MED GENET A, V152A, P327, DOI 10.1002/ajmg.a.33139; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Friedman JM, 1997, AM J MED GENET, V70, P138, DOI 10.1002/(SICI)1096-8628(19970516)70:2<138::AID-AJMG7>3.0.CO;2-U; HUSON SM, 1989, J MED GENET, V26, P704, DOI 10.1136/jmg.26.11.704; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; HUSON SM, 1989, J MED GENET, V26, P712, DOI 10.1136/jmg.26.11.712; Jahraus CD, 2006, PEDIATR BLOOD CANCER, V46, P586, DOI 10.1002/pbc.20655; Kamat MA, 2016, HUM MUTAT, V37, P65, DOI 10.1002/humu.22917; Kehrer-Sawatzki H, 2017, HUM GENET, V136, P349, DOI 10.1007/s00439-017-1766-y; Khosrotehrani K, 2005, AM J MED GENET A, V132A, P49, DOI 10.1002/ajmg.a.30394; Kluwe L, 2003, J MED GENET, V40, P368, DOI 10.1136/jmg.40.5.368; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; Krab LC, 2008, JAMA-J AM MED ASSOC, V300, P287, DOI 10.1001/jama.300.3.287; Lammert M, 2005, ARCH DERMATOL, V141, P71, DOI 10.1001/archderm.141.1.71; Li KR, 2016, DIS MODEL MECH, V9, P759, DOI 10.1242/dmm.025783; Lin AE, 2000, AM J MED GENET, V95, P108, DOI 10.1002/1096-8628(20001113)95:2<108::AID-AJMG4>3.0.CO;2-0; LISTERNICK R, 1994, J PEDIATR-US, V125, P63, DOI 10.1016/S0022-3476(94)70122-9; Listernick R, 2007, ANN NEUROL, V61, P189, DOI 10.1002/ana.21107; Mangoura D, 2006, ONCOGENE, V25, P735, DOI 10.1038/sj.onc.1209113; Mautner VF, 2010, J MED GENET, V47, P623, DOI 10.1136/jmg.2009.075937; McCoughan A, 2007, J MED GENET, V44, P463, DOI 10.1136/jmg.2006.048140; McGaughran JM, 1999, J MED GENET, V36, P197; McPherson JR, 2015, CANCER MED-US, V4, P1871, DOI 10.1002/cam4.551; Messiaen L, 2003, J MED GENET, V40, P122, DOI 10.1136/jmg.40.2.122; Messiaen L., 2012, ADV NEUROFIBROMATOSI, P89; Messiaen L. M., 2008, V16, P63, DOI 10.1159/000126545; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Messiaen L, 2009, JAMA-J AM MED ASSOC, V302, P2111, DOI 10.1001/jama.2009.1663; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Nicolin G, 2009, PEDIATR BLOOD CANCER, V53, P1231, DOI 10.1002/pbc.22198; Nystrom AM, 2009, ACTA PAEDIATR, V98, P693, DOI 10.1111/j.1651-2227.2008.01170.x; Pascual-Castroviejo I, 2007, NEUROPEDIATRICS, V38, P105, DOI 10.1055/s-2007-985136; Pasmant E., 2012, NEUROFIBROMATOSIS TY, P269; Pasmant E, 2011, FASEB J, V25, P444, DOI 10.1096/fj.10-172452; Patil S, 2012, ONCOLOGIST, V17, P101, DOI 10.1634/theoncologist.2010-0181; Peltonen S., 2012, NEUROFIBROMATOSIS TY, P17; Pemov A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004575; Pinna V, 2015, EUR J HUM GENET, V23, P1068, DOI 10.1038/ejhg.2014.243; Plotkin SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035711; Prada CE, 2012, J PEDIATR-US, V160, P461, DOI 10.1016/j.jpeds.2011.08.051; PULST SM, 1991, NEUROLOGY, V41, P1923, DOI 10.1212/WNL.41.12.1923; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rojnueangnit K, 2015, HUM MUTAT, V36, P1052, DOI 10.1002/humu.22832; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruggieri M, 2015, CLIN GENET, V87, P401, DOI 10.1111/cge.12498; Sabbagh A, 2013, HUM MUTAT, V34, P1510, DOI 10.1002/humu.22392; Sabbagh A, 2009, HUM MOL GENET, V18, P2768, DOI 10.1093/hmg/ddp212; Santoro C, 2015, EUR J HUM GENET, V23, P1460, DOI 10.1038/ejhg.2015.93; Seminog OO, 2013, BRIT J CANCER, V108, P193, DOI 10.1038/bjc.2012.535; Stevenson DA, 2011, AM J MED GENET C, V157C, P90, DOI 10.1002/ajmg.c.30296; Sung L, 2004, J PEDIATR-US, V144, P666, DOI 10.1016/j.jpeds.2004.02.026; Szudek J, 2002, GENET EPIDEMIOL, V23, P150, DOI 10.1002/gepi.1129; Terry AR, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.03.029; Thakker SD, 1999, NEURORADIOLOGY, V41, P625, DOI 10.1007/s002340050814; Tonsgard JH, 1998, NEUROLOGY, V50, P1755, DOI 10.1212/WNL.50.6.1755; Toonen JA, 2016, HUM MOL GENET, V25, P1703, DOI 10.1093/hmg/ddw039; Duong TA, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-18; Tucker T, 2005, NEUROLOGY, V65, P205, DOI 10.1212/01.wnl.0000168830.79997.13; Upadhyaya M, 2007, AM J HUM GENET, V80, P140, DOI 10.1086/510781; Upadhyaya M, 2009, NEUROGENETICS, V10, P251, DOI 10.1007/s10048-009-0178-0; Uusitalo E, 2016, J CLIN ONCOL, V34, P1978, DOI 10.1200/JCO.2015.65.3576; Uusitalo E, 2015, J INVEST DERMATOL, V135, P904, DOI 10.1038/jid.2014.465; van Minkelen R, 2014, CLIN GENET, V85, P318, DOI 10.1111/cge.12187; VanEs S, 1996, PEDIATR RADIOL, V26, P478, DOI 10.1007/BF01377205; Vargiami E, 2004, J PEDIATR-US, V145, P859, DOI 10.1016/j.jpeds.2004.06.013; Waggoner DJ, 2000, AM J MED GENET, V92, P132, DOI 10.1002/(SICI)1096-8628(20000515)92:2<132::AID-AJMG10>3.0.CO;2-6; Williams VC, 2009, PEDIATRICS, V123, P124, DOI 10.1542/peds.2007-3204; Wright EMMB, 2013, J MED GENET, V50, P606, DOI 10.1136/jmedgenet-2013-101648; Xie J., 2012, NEUROFIBROMATOSIS TY, P151; Zhou X, 2016, NAT GENET, V48, P4, DOI 10.1038/ng.3466	89	94	104	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 4	2018	102	1					69	87		10.1016/j.ajhg.2017.12.001	http://dx.doi.org/10.1016/j.ajhg.2017.12.001			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FR8DU	29290338	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000419305500006
J	Shi, HWB; Mancuso, N; Spendlove, S; Pasaniuc, B				Shi, Huwenbo; Mancuso, Nicholas; Spendlove, Sarah; Pasaniuc, Bogdan			Local Genetic Correlation Gives Insights into the Shared Genetic Architecture of Complex Traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MENDELIAN RANDOMIZATION; CELL-TYPES; INFERENCE; DISEASES; VARIANTS; LINKAGE	Although genetic correlations between complex traits provide valuable insights into epidemiological and etiological studies, a precise quantification of which genomic regions disproportionately contribute to the genome-wide correlation is currently lacking. Here, we introduce r-HESS, a technique to quantify the correlation between pairs of traits due to genetic variation at a small region in the genome. Our approach requires GWAS summary data only and makes no distributional assumption on the causal variant effect sizes while accounting for linkage disequilibrium (LD) and overlapping GWAS samples. We analyzed large-scale GWAS summary data across 36 quantitative traits, and identified 25 genomic regions that contribute significantly to the genetic correlation among these traits. Notably, we find 6 genomic regions that contribute to the genetic correlation of 10 pairs of traits that show negligible genome-wide correlation, further showcasing the power of local genetic correlation analyses. Finally, we report the distribution of local genetic correlations across the genome for 55 pairs of traits that show putative causal relationships.	[Shi, Huwenbo; Pasaniuc, Bogdan] Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90024 USA; [Mancuso, Nicholas; Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90024 USA; [Pasaniuc, Bogdan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90024 USA; [Spendlove, Sarah] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Brigham Young University	Shi, HWB (corresponding author), Univ Calif Los Angeles, Bioinformat Interdept Program, Los Angeles, CA 90024 USA.	shihuwenbo@ucla.edu	Mancuso, Nicholas/GLQ-8627-2022	Pasaniuc, Bogdan/0000-0002-0227-2056	NIH (United States Public Health Service) [R01-HG009120, R01-GM053275, U01-CA194393]; NATIONAL CANCER INSTITUTE [U01CA194393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG009120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER	NIH (United States Public Health Service)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by NIH (United States Public Health Service) grants R01-HG009120, R01-GM053275, and U01-CA194393. We are grateful to Gleb Kichaev, Malika Kumar, Suraj Alva, and James Boocock for their helpful discussions that greatly improved the quality of this manuscript. We also thank Dr. Nicole Soranzo for kindly sharing summary data for the platelet traits.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; Baker DP, 2011, POPUL DEV REV, V37, P307, DOI 10.1111/j.1728-4457.2011.00412.x; Barban N, 2016, NAT GENET, V48, P1462, DOI 10.1038/ng.3698; Berisa T, 2016, BIOINFORMATICS, V32, P283, DOI 10.1093/bioinformatics/btv546; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; CAREY G, 1988, BEHAV GENET, V18, P329, DOI 10.1007/BF01260933; Davey Smith G, 2014, HUM MOL GENET, V23, pR89, DOI 10.1093/hmg/ddu328; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Efron B, 2012, ANN APPL STAT, V6, P1971, DOI 10.1214/12-AOAS571; Eppinga RN, 2016, NAT GENET, V48, P1557, DOI 10.1038/ng.3708; Getz GS, 2009, J LIPID RES, V50, pS156, DOI 10.1194/jlr.R800058-JLR200; Giambartolomei C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004383; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; HANSEN PC, 1987, BIT, V27, P534, DOI 10.1007/BF01937276; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HEGMANN JP, 1981, BEHAV GENET, V11, P103, DOI 10.1007/BF01065621; Horikoshi M, 2016, NATURE, V538, P248, DOI 10.1038/nature19806; Isserlis L, 1918, BIOMETRIKA, V12, P134, DOI 10.1093/biomet/12.1-2.134; Kottgen A, 2013, NAT GENET, V45, P145, DOI 10.1038/ng.2500; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Lu YC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10495; Mancuso N, 2017, AM J HUM GENET, V100, P473, DOI 10.1016/j.ajhg.2017.01.031; Mary A., 2009, ECON EDUC REV, V28, P122; Mefford J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003096; Neale M., 1992, METHODOLOGY GENETIC, V67; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Pallaud C, 2001, J LIPID RES, V42, P1879; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Pattaro C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10023; Perry JRB, 2014, NATURE, V514, P92, DOI 10.1038/nature13545; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Price AL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1684; Shayle R., 1971, SEARLE LINEAR MODELS, P65; Sheehan NA, 2008, PLOS MED, V5, P1205, DOI 10.1371/journal.pmed.0050177; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Teumer A, 2016, DIABETES, V65, P803, DOI 10.2337/db15-1313; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zheng HF, 2015, NATURE, V526, P112, DOI 10.1038/nature14878	55	94	94	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					737	751		10.1016/j.ajhg.2017.09.022	http://dx.doi.org/10.1016/j.ajhg.2017.09.022			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100087	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000414251600007
J	Garbes, L; Kim, K; Riess, A; Hoyer-Kuhn, H; Beleggia, F; Bevot, A; Kim, MJ; Huh, YH; Kweon, HS; Savarirayan, R; Amor, D; Kakadia, PM; Lindig, T; Kagan, KO; Becker, J; Boyadjiev, SA; Wollnik, B; Semler, O; Bohlander, SK; Kim, J; Netzer, C				Garbes, Lutz; Kim, Kyungho; Riess, Angelika; Hoyer-Kuhn, Heike; Beleggia, Filippo; Bevot, Andrea; Kim, Mi Jeong; Huh, Yang Hoon; Kweon, Hee-Seok; Savarirayan, Ravi; Amor, David; Kakadia, Purvi M.; Lindig, Tobias; Kagan, Karl Oliver; Becker, Jutta; Boyadjiev, Simeon A.; Wollnik, Bernd; Semler, Oliver; Bohlander, Stefan K.; Kim, Jinoh; Netzer, Christian			Mutations in SEC24D, Encoding a Component of the COPII Machinery, Cause a Syndromic Form of Osteogenesis Imperfecta	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL RECESSIVE SYNDROME; LENTICULO-SUTURAL DYSPLASIA; BONE; HYDROCEPHALUS; TRAFFICKING; PROCOLLAGEN; DISORDERS	As a result of a whole-exome sequencing study, we report three mutant alleles in SEC24D, a gene encoding a component of the COPII complex involved in protein export from the ER: the truncating mutation c.613C>T (p.Gln205*) and the missense mutations c.3044C>T (p.Ser1015Phe, located in a cargo-binding pocket) and c.2933A>C (p.Gln978Pro, located in the gelsolin-like domain). Three individuals from two families affected by a similar skeletal phenotype were each compound heterozygous for two of these mutant alleles, with c.3044C>T being embedded in a 14 Mb founder haplotype shared by all three. The affected individuals were a 7-year-old boy with a phenotype most closely resembling Cole-Carpenter syndrome and two fetuses initially suspected to have a severe type of osteogenesis imperfecta. All three displayed a severely disturbed ossification of the skull and multiple fractures with prenatal onset. The 7-year-old boy had short stature and craniofacial malformations including macrocephaly, midface hypoplasia, micrognathia, frontal bossing, and down-slanting palpebral fissures. Electron and immunofluorescence microscopy of skin fibroblasts of this individual revealed that ER export of procollagen was inefficient and that ER tubules were dilated, faithfully reproducing the cellular phenotype of individuals with cranio-lentico-sutural dysplasia (CLSD). CLSD is caused by SEC23A mutations and displays a largely overlapping craniofacial phenotype, but it is not characterized by generalized bone fragility and presented with cataracts in the original family described. The cellular and morphological phenotypes we report are in concordance with the phenotypes described for the Sec24d-deficient fish mutants vbi (medaka) and bulldog (zebrafish).	[Garbes, Lutz; Beleggia, Filippo; Becker, Jutta; Wollnik, Bernd; Netzer, Christian] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Garbes, Lutz; Beleggia, Filippo; Wollnik, Bernd] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Garbes, Lutz] Univ Cologne, Inst Genet, D-50931 Cologne, Germany; [Kim, Kyungho; Boyadjiev, Simeon A.; Kim, Jinoh] Univ Calif Davis, Med Ctr, Dept Pediat, Div Genom Med, Sacramento, CA 95817 USA; [Riess, Angelika] Univ Tubingen, Inst Med Genet & Appl Genom, D-72076 Tubingen, Germany; [Hoyer-Kuhn, Heike; Semler, Oliver] Univ Cologne, Childrens Hosp, D-50931 Cologne, Germany; [Beleggia, Filippo; Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Bevot, Andrea] Univ Childrens Hosp Tuebingen, Dept Paediat Neurol & Dev Med, D-72076 Tubingen, Germany; [Kim, Mi Jeong; Huh, Yang Hoon; Kweon, Hee-Seok] Korea Basic Sci Inst, Div Electron Microscopy Res, Taejon 305806, South Korea; [Savarirayan, Ravi; Amor, David] Murdoch Childrens Res Inst, Victorian Clin Genet Serv, Parkville, Vic 3052, Australia; [Savarirayan, Ravi; Amor, David] Univ Melbourne, Parkville, Vic 3052, Australia; [Kakadia, Purvi M.; Bohlander, Stefan K.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1142, New Zealand; [Lindig, Tobias] Univ Tubingen, Dept Diagnost & Intervent Neuroradiol, D-72076 Tubingen, Germany; [Kagan, Karl Oliver] Univ Tubingen, Dept Obstet & Gynaecol, D-72076 Tubingen, Germany	University of Cologne; University of Cologne; University of Cologne; University of California System; University of California Davis; Eberhard Karls University of Tubingen; University of Cologne; University of Cologne; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Korea Basic Science Institute (KBSI); Murdoch Children's Research Institute; University of Melbourne; University of Auckland; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kim, J (corresponding author), Univ Calif Davis, Med Ctr, Dept Pediat, Div Genom Med, Sacramento, CA 95817 USA.	jinoh.kim@ucdmc.ucdavis.edu; christian.netzer@uk-koeln.de	Kim, Jinoh/AAF-9178-2020; Wollnik, Bernd/GRY-6062-2022; Beleggia, Filippo/S-8481-2018; Amor, David J/A-6478-2018	Kim, Jinoh/0000-0003-2841-147X; Wollnik, Bernd/0000-0003-2589-0364; Amor, David J/0000-0001-7191-8511; Bohlander, Stefan/0000-0002-2202-9088; Beleggia, Filippo/0000-0003-0234-7094; Semler, Oliver/0000-0003-0029-7556	NHLBI [HL-102923, HL-102924, HL-102925, HL-102926, HL-103010]; National Institute of Dental and Craniofacial Research/NIH [R21 DE022419]; National Institute of General Medical Sciences/NIH [R01 GM110373]; German Federal Ministry of Education and Research (BMBF) [01GM1211A, 01GM1109C]; Korea Basic Science Institute [E34700]; Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science, ICT & Future Planning [2013M3A9A9050076]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE022419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110373] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental and Craniofacial Research/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of General Medical Sciences/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Korea Basic Science Institute; Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science, ICT & Future Planning; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to all family members that participated in this study and to Saskia Seland for excellent technical assistance. We would like to thank Philipp Greif and Nikola Konstandin (Department of Medicine III, University of Munich) as well as Stefan Krebs, Alexander Graf, and Helmut Blum (LaFuGA, Gene Center, University of Munich) for support in exome sequencing. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of groups contributing to ExAC can be found online. The authors would also like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies, which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010). This work was supported in part by grants to J.K. from the National Institute of Dental and Craniofacial Research/NIH (R21 DE022419) and the National Institute of General Medical Sciences/NIH (R01 GM110373), by grants to B.W. from the German Federal Ministry of Education and Research (BMBF), grant number 01GM1211A (E-RARE network CRANIRARE-2), and grant number 01GM1109C (national rare disease network FACE), and by grants to H.-S.K. from Korea Basic Science Institute (E34700) and the Bio & Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science, ICT & Future Planning (2013M3A9A9050076).	Amor DJ, 2000, AM J MED GENET, V92, P273, DOI 10.1002/(SICI)1096-8628(20000605)92:4<273::AID-AJMG10>3.0.CO;2-T; Baines AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061114; BEIGHTON P, 1985, CLIN GENET, V28, P69; Boyadjiev SA, 2011, CLIN GENET, V80, P169, DOI 10.1111/j.1399-0004.2010.01550.x; Boyadjiev SA, 2003, HUM GENET, V113, P1, DOI 10.1007/s00439-003-0932-6; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Byers PH, 2012, ANNU REV GENET, V46, P475, DOI 10.1146/annurev-genet-110711-155608; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; COLE DEC, 1987, J PEDIATR-US, V110, P76; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145; Kim SD, 2012, J BIOL CHEM, V287, P10134, DOI 10.1074/jbc.M111.283382; MACDERMOT KD, 1995, CLIN GENET, V48, P217; Mancias JD, 2008, EMBO J, V27, P2918, DOI 10.1038/emboj.2008.208; Marini JC, 2014, CURR OPIN PEDIATR, V26, P500, DOI 10.1097/MOP.0000000000000117; Marwaha R. K., 1993, Indian Journal of Pediatrics, V60, P305, DOI 10.1007/BF02822197; Miller EA, 2013, CURR OPIN CELL BIOL, V25, P420, DOI 10.1016/j.ceb.2013.04.005; NEUHAUSER G, 1976, CLIN GENET, V9, P324; Ohisa S, 2010, DEV BIOL, V342, P85, DOI 10.1016/j.ydbio.2010.03.016; Rauch F, 2004, LANCET, V363, P1377, DOI 10.1016/S0140-6736(04)16051-0; Sarmah S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010367; Schwarz K, 2009, NAT GENET, V41, P936, DOI 10.1038/ng.405; SHAPIRO R, 1972, AM J ROENTGENOL, V115, P569, DOI 10.2214/ajr.115.3.569; Stopfer J., 1992, American Journal of Human Genetics, V51, pA108; Van Dijk FS, 2014, AM J MED GENET A, V164, P1470, DOI 10.1002/ajmg.a.36545; Venditti R, 2014, TRENDS CELL BIOL, V24, P9, DOI 10.1016/j.tcb.2013.08.005; VILJOEN D, 1989, CLIN GENET, V36, P122; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Zanetti G, 2012, NAT CELL BIOL, V14, P20, DOI 10.1038/ncb2390	30	94	96	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					432	439		10.1016/j.ajhg.2015.01.002	http://dx.doi.org/10.1016/j.ajhg.2015.01.002			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25683121	Green Published, Bronze			2022-12-18	WOS:000350747800015
J	Knowles, MR; Ostrowski, LE; Loges, NT; Hurd, T; Leigh, MW; Huang, L; Wolf, WE; Carson, JL; Hazucha, MJ; Yin, WN; Davis, SD; Dell, SD; Ferkol, TW; Sagel, SD; Olivier, KN; Jahnke, C; Olbrich, H; Werner, C; Raidt, J; Wallmeier, J; Pennekamp, P; Dougherty, GW; Hjeij, R; Gee, HY; Otto, EA; Halbritter, J; Chaki, M; Diaz, KA; Braun, DA; Porath, JD; Schueler, M; Baktai, G; Griese, M; Turner, EH; Lewis, AP; Bamshad, MJ; Nickerson, DA; Hildebrandt, F; Shendure, J; Omran, H; Zariwala, MA				Knowles, Michael R.; Ostrowski, Lawrence E.; Loges, Niki T.; Hurd, Toby; Leigh, Margaret W.; Huang, Lu; Wolf, Whitney E.; Carson, Johnny L.; Hazucha, Milan J.; Yin, Weining; Davis, Stephanie D.; Dell, Sharon D.; Ferkol, Thomas W.; Sagel, Scott D.; Olivier, Kenneth N.; Jahnke, Charlotte; Olbrich, Heike; Werner, Claudius; Raidt, Johanna; Wallmeier, Julia; Pennekamp, Petra; Dougherty, Gerard W.; Hjeij, Rim; Gee, Heon Yung; Otto, Edgar A.; Halbritter, Jan; Chaki, Moumita; Diaz, Katrina A.; Braun, Daniela A.; Porath, Jonathan D.; Schueler, Markus; Baktai, Gyoergy; Griese, Matthias; Turner, Emily H.; Lewis, Alexandra P.; Bamshad, Michael J.; Nickerson, Deborah A.; Hildebrandt, Friedhelm; Shendure, Jay; Omran, Heymut; Zariwala, Maimoona A.			Mutations in SPAG1 Cause Primary Ciliary Dyskinesia Associated with Defective Outer and Inner Dynein Arms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; RETINITIS-PIGMENTOSA; TETRATRICOPEPTIDE REPEAT; CYSTIC KIDNEY; GENE; PROTEIN; DISEASE; CELLS; DNAH5; RPGR	Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal-recessive disorder, characterized by oto-sino-pulmonary disease and situs abnormalities. PCD-causing mutations have been identified in 20 genes, but collectively they account for only similar to 65% of all PCDs. To identify mutations in additional genes that cause PCD, we performed exome sequencing on three unrelated probands with ciliary outer and inner dynein arm (ODA+IDA) defects. Mutations in SPAG1 were identified in one family with three affected siblings. Further screening of SPAG1 in 98 unrelated affected individuals (62 with ODA+IDA defects, 35 with ODA defects, 1 without available ciliary ultrastructure) revealed biallelic loss-of-function mutations in 11 additional individuals (including one sib-pair). All 14 affected individuals with SPAG1 mutations had a characteristic PCD phenotype, including 8 with situs abnormalities. Additionally, all individuals with mutations who had defined ciliary ultrastructure had ODA+IDA defects. SPAG1 was present in human airway epithelial cell lysates but was not present in isolated axonemes, and immunofluorescence staining showed an absence of ODA and IDA proteins in cilia from an affected individual, thus indicating that SPAG1 probably plays a role in the cytoplasmic assembly and/or trafficking of the axonemal dynein arms. Zebrafish morpholino studies of spag1 produced cilia-related phenotypes previously reported for PCD-causing mutations in genes encoding cytoplasmic proteins. Together, these results demonstrate that mutations in SPAG1 cause PCD with ciliary ODA+IDA defects and that exome sequencing is useful to identify genetic causes of heterogeneous recessive disorders.	[Knowles, Michael R.; Ostrowski, Lawrence E.; Huang, Lu; Wolf, Whitney E.; Hazucha, Milan J.; Yin, Weining] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Loges, Niki T.; Jahnke, Charlotte; Olbrich, Heike; Werner, Claudius; Raidt, Johanna; Wallmeier, Julia; Pennekamp, Petra; Dougherty, Gerard W.; Hjeij, Rim] Univ Hosp Muenster, Dept Gen Pediat & Adolescent Med, D-48149 Munster, Germany; [Hurd, Toby; Gee, Heon Yung; Otto, Edgar A.; Chaki, Moumita; Diaz, Katrina A.; Braun, Daniela A.; Porath, Jonathan D.; Schueler, Markus; Hildebrandt, Friedhelm] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Leigh, Margaret W.; Carson, Johnny L.; Davis, Stephanie D.] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Dell, Sharon D.] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Sagel, Scott D.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Olivier, Kenneth N.] NIAID, NIH, Lab Clin Infect Dis, Bethesda, MD 20892 USA; [Baktai, Gyoergy] Pediat Inst Svabhegy, Dept Bronchol, H-1535 Budapest, Hungary; [Griese, Matthias] Univ Munich, Hauner Childrens Hosp, Member German Ctr Lung Res, D-80337 Munich, Germany; [Turner, Emily H.; Lewis, Alexandra P.; Bamshad, Michael J.; Nickerson, Deborah A.; Shendure, Jay] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Bamshad, Michael J.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Hildebrandt, Friedhelm] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Zariwala, Maimoona A.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Munster; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Munich; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Knowles, MR (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA.	knowles@med.unc.edu; zariwala@med.unc.edu	Gee, Heon Yung/K-7781-2019; Shendure, Jay/AAU-3684-2021; Huang, Lu/E-4250-2014; Schueler, Markus/AAF-6057-2021; Braun, Daniela A/R-2259-2017	Gee, Heon Yung/0000-0002-8741-6177; Braun, Daniela A/0000-0003-3146-1566; Dell, Sharon/0000-0003-2169-9407; Omran, Heymut/0000-0003-0282-6765; Turner, Emily/0000-0001-9040-9229; Raidt, Johanna/0000-0002-1571-2647; Muraglia, Katrina/0000-0002-4162-4667; Shendure, Jay/0000-0002-1516-1865; Wallmeier, Julia/0000-0002-3958-9065; Otto, Edgar/0000-0002-2387-9973; Hjeij, Rim/0000-0003-1464-7289	US NIH/ORDR/NHLBI [5U54HL096458-06]; NIH-NHLBI [5R01HL071798, 5R01HL094976, RC2 HL-102923]; NIH-NHGRI [5R21HG004749]; NIH-NIAID; RSG by NIH-NHLBI [HHSN268201100037C]; NIH-NCATS [UL1 TR000083, UL1 TR000154]; CF foundation [CFF R026-CR07]; DFG [Om6/4]; IZKF Muenster [Om2/009/12]; European Community; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082, UL1TR000083, UL1TR000154] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117836, R01HL094976, R01HL071798, RC2HL102923, U54HL096458] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER	US NIH/ORDR/NHLBI; NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH-NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); RSG by NIH-NHLBI; NIH-NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); CF foundation; DFG(German Research Foundation (DFG)); IZKF Muenster; European Community(European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding support for research was provided to M.R.K., M.W.L., J.L.C., M.J.H., S.D. Dell, S.D. Davis, T.W.F., S.D.S., K.N.O., and M.A.Z. by US NIH/ORDR/NHLBI grant 5U54HL096458-06; to M.R.K., L.E.O., and M.A.Z. by NIH-NHLBI grant 5R01HL071798; to J.S. and D.A.N. by NIH-NHLBI grant 5R01HL094976; to M.J.B. by NIH-NHLBI grant RC2 HL-102923; and to J.S. by NIH-NHGRI grant 5R21HG004749. K.N.O. is supported by the Intramural Research Program of NIH-NIAID. Resequencing was provided through RS&G by NIH-NHLBI contract # HHSN268201100037C. The work was supported by NIH-NCATS grants UL1 TR000083 to UNC-CH and UL1 TR000154 to Colorado CTSI and CF foundation grant CFF R026-CR07. H. Omran is supported by funding from DFG Om6/4, IZKF Muenster Om2/009/12, and BESTCILIA and SYSCILIA from the European Community. F.H. is an investigator of the Howard Hughes Medical Institute.	Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.3.CO;2-E; Bukowy-Bieryllo Z, 2013, PEDIATR PULM, V48, P352, DOI 10.1002/ppul.22632; Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Chakarova CF, 2007, AM J HUM GENET, V81, P1098, DOI 10.1086/521953; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Fliegauf M, 2005, AM J RESP CRIT CARE, V171, P1343, DOI 10.1164/rccm.200411-1583OC; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Kultgen PL, 2002, MOL BIOL CELL, V13, P4156, DOI 10.1091/mbc.E02-07-0391; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Moore A, 2006, J MED GENET, V43, P326, DOI 10.1136/jmg.2005.034868; Neesse A, 2007, ONCOGENE, V26, P1533, DOI 10.1038/sj.onc.1209961; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Ostrowski LE, 2010, AM J RESP CELL MOL, V43, P55, DOI 10.1165/rcmb.2009-0118OC; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Rashid S, 2006, MOL REPROD DEV, V73, P784, DOI 10.1002/mrd.20475; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Takaishi M, 1999, BIOCHEM BIOPH RES CO, V264, P81, DOI 10.1006/bbrc.1999.1477; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; van Rooijen E, 2008, J AM SOC NEPHROL, V19, P1128, DOI 10.1681/ASN.2007080917; Wirschell M, 2013, NAT GENET, V45, P262, DOI 10.1038/ng.2533; Zariwala M, 2001, AM J RESP CELL MOL, V25, P577, DOI 10.1165/ajrcmb.25.5.4619; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala MA, 2006, AM J RESP CRIT CARE, V174, P858, DOI 10.1164/rccm.200603-370OC; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007; Zito I, 2003, J MED GENET, V40, P609, DOI 10.1136/jmg.40.8.609	45	94	98	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 3	2013	93	4					711	720		10.1016/j.ajhg.2013.07.025	http://dx.doi.org/10.1016/j.ajhg.2013.07.025			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	243GT	24055112	Green Published, Bronze			2022-12-18	WOS:000326305600012
J	Gai, XW; Ghezzi, D; Johnson, MA; Biagosch, CA; Shamseldin, HE; Haack, TB; Reyes, A; Tsukikawa, M; Sheldon, CA; Srinivasan, S; Gorza, M; Kremer, LS; Wieland, T; Strom, TM; Polyak, E; Place, E; Consugar, M; Ostrovsky, J; Vidoni, S; Robinson, AJ; Wong, LJ; Sondheimer, N; Salih, MA; Al-Jishi, E; Raab, CP; Bean, C; Furlan, F; Parini, R; Lamperti, C; Mayr, JA; Konstantopoulou, V; Huemer, M; Pierce, EA; Meitinger, T; Freisinger, P; Sperl, W; Prokisch, H; Alkuraya, FS; Falk, MJ; Zeviani, M				Gai, Xiaowu; Ghezzi, Daniele; Johnson, Mark A.; Biagosch, Caroline A.; Shamseldin, Hanan E.; Haack, Tobias B.; Reyes, Aurelio; Tsukikawa, Mai; Sheldon, Claire A.; Srinivasan, Satish; Gorza, Matteo; Kremer, Laura S.; Wieland, Thomas; Strom, Tim M.; Polyak, Erzsebet; Place, Emily; Consugar, Mark; Ostrovsky, Julian; Vidoni, Sara; Robinson, Alan J.; Wong, Lee-Jun; Sondheimer, Neal; Salih, Mustafa A.; Al-Jishi, Emtethal; Raab, Christopher P.; Bean, Charles; Furlan, Francesca; Parini, Rossella; Lamperti, Costanza; Mayr, Johannes A.; Konstantopoulou, Vassiliki; Huemer, Martina; Pierce, Eric A.; Meitinger, Thomas; Freisinger, Peter; Sperl, Wolfgang; Prokisch, Holger; Alkuraya, Fowzan S.; Falk, Marni J.; Zeviani, Massimo			Mutations in FBXL4, Encoding a Mitochondrial Protein, Cause Early-Onset Mitochondrial Encephalomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UBIQUITIN LIGASES; DISEASE; SCF; REVEALS	Whole-exome sequencing and autozygosity mapping studies, independently performed in subjects with defective combined mitochondrial OXPHOS-enzyme deficiencies, identified a total of nine disease-segregating FBXL4 mutations in seven unrelated mitochondrial disease families, composed of six singletons and three siblings. All subjects manifested early-onset lactic acidemia, hypotonia, and developmental delay caused by severe encephalomyopathy consistently associated with progressive cerebral atrophy and variable involvement of the white matter, deep gray nuclei, and brainstem structures. A wide range of other multisystem features were variably seen, including dysmorphism, skeletal abnormalities, poor growth, gastrointestinal dysmotility, renal tubular acidosis, seizures, and episodic metabolic failure. Mitochondrial respiratory chain deficiency was present in muscle or fibroblasts of all tested individuals, together with markedly reduced oxygen consumption rate and hyperfragmentation of the mitochondrial network in cultured cells. In muscle and fibroblasts from several subjects, substantially decreased mtDNA content was observed. FBXL4 is a member of the F-box family of proteins, some of which are involved in phosphorylation-dependent ubiquitination and/or G protein receptor coupling. We also demonstrate that FBXL4 is targeted to mitochondria and localizes in the intermembrane space, where it participates in an approximately 400 kDa protein complex. These data strongly support a role for FBXL4 in controlling bioenergetic homeostasis and mtDNA maintenance. FBXL4 mutations are a recurrent cause of mitochondrial encephalomyopathy onset in early infancy.	[Gai, Xiaowu] Loyola Univ, Stritch Sch Med, Dept Mol Pharmacol & Therapeut, Maywood, IL 60153 USA; [Ghezzi, Daniele; Lamperti, Costanza; Zeviani, Massimo] Inst Neurol Besta, Dept Mol Neurogenet, I-23888 Milan, Italy; [Johnson, Mark A.; Reyes, Aurelio; Vidoni, Sara; Robinson, Alan J.; Zeviani, Massimo] MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Biagosch, Caroline A.; Haack, Tobias B.; Gorza, Matteo; Kremer, Laura S.; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Biagosch, Caroline A.; Haack, Tobias B.; Gorza, Matteo; Kremer, Laura S.; Wieland, Thomas; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Helmholtz Zentrum Munich, Inst Human Genet, D-81675 Munich, Germany; [Shamseldin, Hanan E.; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Tsukikawa, Mai; Sheldon, Claire A.; Polyak, Erzsebet; Place, Emily; Sondheimer, Neal; Falk, Marni J.] Childrens Hosp Philadelphia, Dept Pediat, Div Human Genet & Metab Dis, Philadelphia, PA 19104 USA; [Tsukikawa, Mai; Sheldon, Claire A.; Polyak, Erzsebet; Place, Emily; Sondheimer, Neal; Falk, Marni J.] Univ Penn, Perleman Sch Med, Philadelphia, PA 19104 USA; [Srinivasan, Satish; Ostrovsky, Julian] Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA; [Place, Emily; Pierce, Eric A.] Harvard Univ, Sch Med, MEEI, Ocular Genom Inst, Boston, MA 02114 USA; [Consugar, Mark; Wong, Lee-Jun] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Salih, Mustafa A.] King Khalid Univ Hosp, Dept Pediat, Riyadh 11461, Saudi Arabia; [Salih, Mustafa A.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Al-Jishi, Emtethal] Arabian Gulf Univ, Manama, Bahrain; [Raab, Christopher P.; Bean, Charles] Thomas Jefferson Univ, Nemours AI DuPont Hosp Children, Dept Pediat, Wilmington, DE 19803 USA; [Furlan, Francesca; Parini, Rossella] Fdn MBBM, San Gerardo Univ Hosp, Dept Pediat, Unit Metab Disorders, I-20900 Monza, Italy; [Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ Salzburg, Dept Paediat, A-5020 Salzburg, Austria; [Konstantopoulou, Vassiliki] Med Univ Vienna, Dept Pediat, A-1090 Vienna, Austria; [Huemer, Martina] LKH Bregenz, Dept Pediat, A-6900 Bregenz, Austria; [Pierce, Eric A.] Harvard Univ, Sch Med, Dept Ophthalmol, Berman Gund Lab Study Retinal Degenerat,MEEI, Boston, MA 02114 USA; [Freisinger, Peter] Klinikum Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany; [Alkuraya, Fowzan S.] Alfaisal Univ, Coll Med, Dept Anat & Cell Biol, Riyadh 11533, Saudi Arabia	Loyola University Chicago; IRCCS Istituto Neurologico Besta; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; King Faisal Specialist Hospital & Research Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Baylor College of Medicine; King Saud University; King Khalid University Hospital; King Saud University; Arabian Gulf University; Jefferson University; Nemours Alfred I. duPont Hospital for Children; Paracelsus Private Medical University; Medical University of Vienna; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Alfaisal University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa; mdz21@mrc-mbu.cam.ac.uk	Sondheimer, Neal/X-7846-2019; Ghezzi, Daniele/J-7873-2016; Zeviani, Massimo/K-2891-2014; Zeviani, Massimo/AAU-2632-2021; Falk, Marni/K-1997-2014; Salih, Mustafa/C-1222-2014; Parini, Rossella/J-9202-2018; lamperti, costanza/J-8801-2016; Meitinger, Thomas/O-1318-2015	Ghezzi, Daniele/0000-0002-6564-3766; Zeviani, Massimo/0000-0002-9067-5508; Salih, Mustafa/0000-0002-4379-2111; Parini, Rossella/0000-0003-4505-1306; lamperti, costanza/0000-0002-2280-2253; Prokisch, Holger/0000-0003-2379-6286; gai, Xiaowu/0000-0001-8679-9703; Kremer, Laura/0000-0002-1647-7538; Sondheimer, Neal/0000-0001-9982-5712; Huemer, Martina/0000-0002-0590-678X; Mayr, Johannes/0000-0001-6970-336X; Meitinger, Thomas/0000-0002-8838-8403; Pierce, Eric/0000-0002-2354-4102; Falk, Marni/0000-0002-1723-6728	Fondazione Telethon [GGP11011, GPP10005]; CARIPLO Foundation, Italy [2011/0526]; Italian Ministry of Health [GR2010-2316392]; Pierfranco and Luisa Mariani Foundation of Italy; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); German Federal Ministry of Education and Research (BMBF) [0315494A]; German Network for Mitochondrial Disorders [01GM0867, 01GM1113C]; E-rare grant GenoMit [JTC2011, 01GM1207, FWF I 920-B13]; EU FP7 Mitochondrial European Educational Training project (Meet); European Research Council [FP7-322424]; Medical Research Council (UK); Deanship of Scientific Research at King Saud University, Riyadh [301]; Penn Genome Frontiers Institute; National Institutes of Health [R03-DK082446, R01-EY012910, P30EY014104-MEEI, 1G20RR030939]; Foerderer Award for Excellence from the Children's Hospital of Philadelphia Research Institute; Telethon Italy [GTB12001]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, G20RR030939] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY014104, R01EY012910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK082521] Funding Source: NIH RePORTER; MRC [MC_U105674181, MC_UP_1002/1] Funding Source: UKRI; Austrian Science Fund (FWF) [I 920] Funding Source: researchfish; Medical Research Council [MC_UP_1002/1, MC_U105674181] Funding Source: researchfish	Fondazione Telethon(Fondazione TelethonEuropean Commission); CARIPLO Foundation, Italy(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy); Pierfranco and Luisa Mariani Foundation of Italy; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Network for Mitochondrial Disorders; E-rare grant GenoMit; EU FP7 Mitochondrial European Educational Training project (Meet); European Research Council(European Research Council (ERC)European Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deanship of Scientific Research at King Saud University, Riyadh; Penn Genome Frontiers Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foerderer Award for Excellence from the Children's Hospital of Philadelphia Research Institute; Telethon Italy(Fondazione Telethon); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study received financial support from Fondazione Telethon grants GGP11011 and GPP10005; the CARIPLO Foundation, Italy, grant 2011/0526; the Italian Ministry of Health (GR2010-2316392); the Pierfranco and Luisa Mariani Foundation of Italy, the Italian Association of Mitochondrial Disease Patients and Families (Mitocon); the German Federal Ministry of Education and Research (BMBF) funded Systems Biology of Metabotypes grant (SysMBo #0315494A); the German Network for Mitochondrial Disorders (mitoNET #01GM0867 and 01GM1113C); E-rare grant GenoMit (JTC2011, 01GM1207, and FWF I 920-B13); the EU FP7 Mitochondrial European Educational Training project (Meet); the European Research Council (grant "Mitcare" FP7-322424); the Medical Research Council (UK); the Deanship of Scientific Research at King Saud University, Riyadh, through the Research Group Project no 301 (M.A.S.); Penn Genome Frontiers Institute (E.A.P. and X.G.); the National Institutes of Health (R03-DK082446 to M.J.F., R01-EY012910 to E.A.P., P30EY014104-MEEI core support, and 1G20RR030939 to X.G.); the Foerderer Award for Excellence from the Children's Hospital of Philadelphia Research Institute (X.G. and M.J.F.); institutional support from Loyola University Stritch School of Medicine (X.G.); the Clinical and Translational Research Center at the Children's Hospital of Philadelphia (UL1-RR-024134); the Angelina Foundation Fund from the Division of Child Development and Metabolic Disease at the Children's Hospital of Philadelphia (M.J.F.); The Tristan Mullen Fund (M.J.F.); Canadian Institutes of Health Research (C.A.S.); DHFMR Collaborative Research Grant (F.S.A.); and the Center for Mitochondrial and Epigenomic Medicine (CMEM) at The Children's Hospital of Philadelphia. The cell lines and DNA bank of Paediatric Movement Disorders and Neurodegenerative Diseases, member of the Telethon Network of Genetic Biobanks (project no. GTB12001), funded by Telethon Italy, provided us with specimens. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The content of the article has not been influenced by the sponsors.	Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Calvo SE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003310; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004; Dimmock D, 2010, CLIN CHEM, V56, P1119, DOI 10.1373/clinchem.2009.141549; Dingley S, 2012, METHODS MOL BIOL, V837, P231, DOI 10.1007/978-1-61779-504-6_16; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Falk MJ, 2012, NAT GENET, V44, P1040, DOI 10.1038/ng.2361; Galan JM, 2001, MOL CELL BIOL, V21, P3105, DOI 10.1128/MCB.21.9.3105-3117.2001; Ghezzi D, 2009, HUM MOL GENET, V18, P1058, DOI 10.1093/hmg/ddn441; Haack TB, 2010, NAT GENET, V42, P1131, DOI 10.1038/ng.706; He LP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf067; HECKMATT JZ, 1984, ARCH DIS CHILD, V59, P528, DOI 10.1136/adc.59.6.528; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Horvath IT, 2012, TOP CURR CHEM, V308, P1, DOI 10.1007/978-3-642-25234-1; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; McCormick E, 2013, NEUROTHERAPEUTICS, V10, P251, DOI 10.1007/s13311-012-0174-1; Nakamura N, 2008, MOL BIOL CELL, V19, P1903, DOI 10.1091/mbc.E07-11-1103; Narendra DP, 2011, ANTIOXID REDOX SIGN, V14, P1929, DOI 10.1089/ars.2010.3799; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petruzzella V, 1998, GENOMICS, V54, P494, DOI 10.1006/geno.1998.5580; Reyes A, 2011, NUCLEIC ACIDS RES, V39, P5098, DOI 10.1093/nar/gkr052; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Shamseldin HE, 2012, J MED GENET, V49, P234, DOI 10.1136/jmedgenet-2012-100836; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Tiranti V, 1999, HUM MOL GENET, V8, P2533, DOI 10.1093/hmg/8.13.2533; Van Rechem C, 2011, J BIOL CHEM, V286, P30462, DOI 10.1074/jbc.M111.273508; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964	34	94	97	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 5	2013	93	3					482	495		10.1016/j.ajhg.2013.07.016	http://dx.doi.org/10.1016/j.ajhg.2013.07.016			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	297QB	23993194	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000330268900007
J	Campeau, PM; Lenk, GM; Lu, JT; Bae, YJ; Burrage, L; Turnpenny, P; Corona-Rivera, JR; Morandi, L; Mora, M; Reutter, H; Vulto-van Silfhout, AT; Faivre, L; Haan, E; Gibbs, RA; Meisler, MH; Lee, BH				Campeau, Philippe M.; Lenk, Guy M.; Lu, James T.; Bae, Yangjin; Burrage, Lindsay; Turnpenny, Peter; Roman Corona-Rivera, Jorge; Morandi, Lucia; Mora, Marina; Reutter, Heiko; Vulto-van Silfhout, Anneke T.; Faivre, Laurence; Haan, Eric; Gibbs, Richard A.; Meisler, Miriam H.; Lee, Brendan H.			Yunis-Varon Syndrome Is Caused by Mutations in FIG4, Encoding a Phosphoinositide Phosphatase	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLEIDOCRANIAL DYSPLASIA; NEURONAL EXPRESSION; LYSOSOMAL STORAGE; MOUSE; PI(3,5)P-2; YEAST; DELINEATION; AUTOPHAGY; THUMBS; GENE	Yunis-Varon syndrome (YVS) is an autosomal-recessive disorder with cleidocranial dysplasia, digital anomalies, and severe neurological involvement. Enlarged vacuoles are found in neurons, muscle, and cartilage. By whole-exome sequencing, we identified frameshift and missense mutations of FIG4 in affected individuals from three unrelated families. FIG4 encodes a phosphoinositide phosphatase required for regulation of PI(3,5)P-2 levels, and thus endosomal trafficking and autophagy. In a functional assay, both missense substitutions failed to correct the vacuolar phenotype of Fig4-null mouse fibroblasts. Homozygous Fig4-null mice exhibit features of YVS, including neurodegeneration and enlarged vacuoles in neurons. We demonstrate that Fig4-null mice also have small skeletons with reduced trabecular bone volume and cortical thickness and that cultured osteoblasts accumulate large vacuoles. Our findings demonstrate that homozygosity or compound heterozygosity for null mutations of FIG4 is responsible for YVS, the most severe known human phenotype caused by defective phosphoinositide metabolism. In contrast, in Charcot-Marie-Tooth disease type 4J (also caused by FIG4 mutations), one of the FIG4 alleles is hypomorphic and disease is limited to the peripheral nervous system. This genotypephenotype correlation demonstrates that absence of FIG4 activity leads to central nervous system dysfunction and extensive skeletal anomalies. Our results describe a role for PI(3,5)P-2 signaling in skeletal development and maintenance.	[Campeau, Philippe M.; Bae, Yangjin; Burrage, Lindsay; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lenk, Guy M.; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Lu, James T.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lu, James T.] Baylor Coll Med, Dept Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Turnpenny, Peter] Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX1 2ED, Devon, England; [Roman Corona-Rivera, Jorge] Dr Juan I Menchaca New Civil Hosp Guadalajara, Div Pediat, Genet Serv, Guadalajara 44340, Jalisco, Mexico; [Roman Corona-Rivera, Jorge] Univ Guadalajara, Dr Enrique Corona Rivera Ct Univ Ciencias Salud, Inst Human Genet, Guadalajara 44340, Jalisco, Mexico; [Morandi, Lucia; Mora, Marina] Fdn IRCCS Neurol Inst Carlo Besta, Neuromuscular Dis & Neuroimmunol Unit, I-20133 Milan, Italy; [Reutter, Heiko] Univ Bonn, Dept Neonatol, Childrens Hosp, D-58509 Bonn, Germany; [Reutter, Heiko] Univ Bonn, Inst Human Genet, Childrens Hosp, D-58509 Bonn, Germany; [Vulto-van Silfhout, Anneke T.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 Nijmegen, Netherlands; [Faivre, Laurence] Hop Enfants, Ctr Reference Malad Rares Anomalies Dev & Syndrom, Ctr Genet, F-21000 Dijon, France; [Faivre, Laurence] Univ Bourgogne, Equipe GAD EA4271, F-21078 Dijon, France; [Haan, Eric] Womens & Childrens Hosp, SA Pathol, South Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Haan, Eric] Univ Adelaide, Discipline Paediat, Adelaide, SA 5006, Australia; [Lee, Brendan H.] Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; University of Michigan System; University of Michigan; Baylor College of Medicine; Baylor College of Medicine; University of Exeter; Universidad de Guadalajara; IRCCS Istituto Neurologico Besta; University of Bonn; University of Bonn; Radboud University Nijmegen; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; SA Pathology; University of Adelaide; Howard Hughes Medical Institute	Meisler, MH (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.	meislerm@umich.edu; blee@bcm.edu	Campeau, Philippe/J-8614-2015; Lenk, Guy M./Q-1226-2016; Corona-Rivera, Jorge Román/F-3818-2018; Bae, Yangjin/AAO-1866-2021; AT, Vulto-van Silfhout/H-4199-2015; Mora, Marina/J-2883-2018	Campeau, Philippe/0000-0001-9713-7107; Lenk, Guy M./0000-0001-8092-1405; Bae, Yangjin/0000-0003-2397-0192; Mora, Marina/0000-0002-5765-2320; Corona-Rivera, Jorge/0000-0002-4626-148X; Faivre, Laurence/0000-0001-9770-444X	National Institutes of Health [PO1 HD22657, PO1 HD070394, R01 GM24872, UL1 TR000433, U54 HG003273-09]; Rolanette and Berdon Lawrence Bone Disease Program of Texas; CIHR; O'Malley Foundation; Ruth L. Kirschstein National Research Service Award [F30 MH098571-01]; EU [241995]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH098571] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rolanette and Berdon Lawrence Bone Disease Program of Texas; CIHR(Canadian Institutes of Health Research (CIHR)); O'Malley Foundation; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fondazione Telethon(Fondazione Telethon)	We thank Yuqing Chen for technical assistance, Alyssa Tran for clinical research support, and Shalini N. Jhangiani for exome sequencing coordination. We thank Brian Dawson and Megan Bagos for expert technical assistance with microCT analysis. Funding was provided by National Institutes of Health grants PO1 HD22657 and PO1 HD070394 (B.H.L.), R01 GM24872 (M.H.M.), UL1 TR000433 (G.M.L.), and U54 HG003273-09 (R.A.G.). Funding was also provided by The Rolanette and Berdon Lawrence Bone Disease Program of Texas (B.H.L.). P.M.C. is supported by a CIHR clinician-scientist training award and the O'Malley Foundation. G.M.L. is a fellow of the Postdoctoral Translational Scholars Program of the Michigan CTSA. J.T.L. is supported by Ruth L. Kirschstein National Research Service Award F30 MH098571-01. A.T.V.v.S. is supported by EU 7th FP under GA nr. 241995, project GENCODYS. The EuroBioBank and Telethon Network of Genetic Biobanks (GTB12001F to M.M.) are gratefully acknowledged for providing biological samples.	Abo-Dalo B, 2007, AM J MED GENET A, V143A, P2668, DOI 10.1002/ajmg.a.32034; ADES LC, 1993, J MED GENET, V30, P788, DOI 10.1136/jmg.30.9.788; Basel-Vanagaite L, 2008, AM J MED GENET A, V146A, P532, DOI 10.1002/ajmg.a.32135; Below JE, 2013, AM J HUM GENET, V92, P137, DOI 10.1016/j.ajhg.2012.11.011; Bhatia S, 2005, INDIAN PEDIATR, V42, P373; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Campeau PM, 2012, HUM MOL GENET, V21, P4904, DOI 10.1093/hmg/dds326; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Chow CY, 2009, AM J HUM GENET, V84, P85, DOI 10.1016/j.ajhg.2008.12.010; Christie J, 1999, J CLIN GASTROENTEROL, V29, P210, DOI 10.1097/00004836-199909000-00025; DWORZAK F, 1995, NEUROMUSCULAR DISORD, V5, P423, DOI 10.1016/0960-8966(94)00089-R; Elizondo-Duenaz R, 2012, GAC MED MEX, V148, P81; Ferguson CJ, 2012, HUM MOL GENET, V21, P3525, DOI 10.1093/hmg/dds179; Ferguson CJ, 2010, AUTOPHAGY, V6, P170, DOI 10.4161/auto.6.1.10626; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; GARRETT C, 1990, J MED GENET, V27, P114, DOI 10.1136/jmg.27.2.114; HENNEKAM RCM, 1989, J MED GENET, V26, P55, DOI 10.1136/jmg.26.1.55; Hnia K, 2012, TRENDS MOL MED, V18, P317, DOI 10.1016/j.molmed.2012.04.004; Huang LF, 1997, DEV DYNAM, V210, P33, DOI 10.1002/(SICI)1097-0177(199709)210:1<33::AID-AJA4>3.0.CO;2-2; Huber C, 2013, AM J HUM GENET, V92, P144, DOI 10.1016/j.ajhg.2012.11.015; HUGHES HE, 1983, AM J MED GENET, V14, P539, DOI 10.1002/ajmg.1320140318; Ikonomov OC, 2010, J BIOL CHEM, V285, P26760, DOI 10.1074/jbc.C110.154658; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Kulkarni M. L., 2006, Indian Journal of Pediatrics, V73, P353, DOI 10.1007/BF02825832; LAPEER GL, 1992, ORAL SURG ORAL MED O, V73, P456, DOI 10.1016/0030-4220(92)90324-J; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lenk GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002104; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Nagai T, 2001, Ryoikibetsu Shokogun Shirizu, P839; Nicholson G, 2011, BRAIN, V134, P1959, DOI 10.1093/brain/awr148; Nicot AS, 2008, TRAFFIC, V9, P1240, DOI 10.1111/j.1600-0854.2008.00754.x; Oyer CE, 1998, PEDIATR DEVEL PATHOL, V1, P314, DOI 10.1007/s100249900045; Partington M.W., 1988, P GREENWOOD GENETIC, V7, P224; PFEIFFER RA, 1988, ANN GENET-PARIS, V31, P241; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Rabe H, 1996, CLIN DYSMORPHOL, V5, P217; Reutter H, 2012, EUR J MED GENET, V55, P27, DOI 10.1016/j.ejmg.2011.09.002; Corona-Rivera JR, 2011, EUR J MED GENET, V54, P76, DOI 10.1016/j.ejmg.2010.09.013; Sumi M, 2004, AM J MED GENET A, V125A, P92, DOI 10.1002/ajmg.a.20414; Sunkin SM, 2013, NUCLEIC ACIDS RES, V41, pD996, DOI 10.1093/nar/gks1042; Tao JN, 2010, J BONE MINER RES, V25, P2175, DOI 10.1002/jbmr.115; Tsai CP, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.009; Verdiani S, 2013, AMYOTROPH LAT SCL FR, V14, P228, DOI 10.3109/21678421.2012.760605; Walch E, 2000, AM J MED GENET, V95, P157, DOI 10.1002/1096-8628(20001113)95:2<157::AID-AJMG12>3.0.CO;2-E; Weisman LS, 2003, ANNU REV GENET, V37, P435, DOI 10.1146/annurev.genet.37.050203.103207; Wen PJ, 2011, PROG LIPID RES, V50, P52, DOI 10.1016/j.plipres.2010.08.001; Winters JJ, 2011, J NEUROSCI, V31, P17736, DOI 10.1523/JNEUROSCI.1482-11.2011; YUNIS E, 1980, AM J DIS CHILD, V134, P649, DOI 10.1001/archpedi.1980.02130190017005	49	94	96	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 2	2013	92	5					781	791		10.1016/j.ajhg.2013.03.020	http://dx.doi.org/10.1016/j.ajhg.2013.03.020			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	139KY	23623387	Green Published, Bronze			2022-12-18	WOS:000318582800013
J	Bick, AG; Flannick, J; Ito, K; Cheng, S; Vasan, RS; Parfenov, MG; Herman, DS; DePalma, SR; Gupta, N; Gabriel, SB; Funke, BH; Rehm, HL; Benjamin, EJ; Aragam, J; Taylor, HA; Fox, ER; Newton-Cheh, C; Kathiresan, S; O'Donnell, CJ; Wilson, JG; Altshuler, DM; Hirschhorn, JN; Seidman, JG; Seidman, C				Bick, Alexander G.; Flannick, Jason; Ito, Kaoru; Cheng, Susan; Vasan, Ramachandran S.; Parfenov, Michael G.; Herman, Daniel S.; DePalma, Steven R.; Gupta, Namrata; Gabriel, Stacey B.; Funke, Birgit H.; Rehm, Heidi L.; Benjamin, Emelia J.; Aragam, Jayashri; Taylor, Herman A., Jr.; Fox, Ervin R.; Newton-Cheh, Christopher; Kathiresan, Sekar; O'Donnell, Christopher J.; Wilson, James G.; Altshuler, David M.; Hirschhorn, Joel N.; Seidman, J. G.; Seidman, Christine			Burden of Rare Sarcomere Gene Variants in the Framingham and Jackson Heart Study Cohorts	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEFT-VENTRICULAR HYPERTROPHY; RISK; MASS; CARDIOMYOPATHY; ASSOCIATION; DISEASE; PROFILE	Rare sarcomere protein variants cause dominant hypertrophic and dilated cardiomyopathies. To evaluate whether allelic variants in eight sarcomere genes are associated with cardiac morphology and function in the community, we sequenced 3,600 individuals from the Framingham Heart Study (FHS) and Jackson Heart Study (JHS) cohorts. Out of the total, 11.2% of individuals had one or more rare nonsynonymous sarcomere variants. The prevalence of likely pathogenic sarcomere variants was 0.6%, twice the previous estimates; however, only four of the 22 individuals had clinical manifestations of hypertrophic cardiomyopathy. Rare sarcomere variants were associated with an increased risk for adverse cardiovascular events (hazard ratio: 2.3) in the FHS cohort, suggesting that cardiovascular risk assessment in the general population can benefit from rare variant analysis.	[Bick, Alexander G.; Ito, Kaoru; Parfenov, Michael G.; Herman, Daniel S.; DePalma, Steven R.; Hirschhorn, Joel N.; Seidman, J. G.; Seidman, Christine] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Bick, Alexander G.; Flannick, Jason; Gupta, Namrata; Gabriel, Stacey B.; Altshuler, David M.; Hirschhorn, Joel N.] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA; [Flannick, Jason; Newton-Cheh, Christopher; Kathiresan, Sekar; Altshuler, David M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Cheng, Susan; Aragam, Jayashri; Seidman, Christine] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.; Newton-Cheh, Christopher; Kathiresan, Sekar; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Cardiol, Boston, MA 02118 USA; [Vasan, Ramachandran S.; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Prevent Med, Boston, MA 02118 USA; [Funke, Birgit H.; Rehm, Heidi L.] Partners Ctr Personalized Genet Med, Lab Mol Med, Cambridge, MA 02139 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; [Taylor, Herman A., Jr.; Fox, Ervin R.] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA; [Taylor, Herman A., Jr.] Jackson State Univ, Jackson, MS 39217 USA; [Newton-Cheh, Christopher; Kathiresan, Sekar] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [O'Donnell, Christopher J.] NHLBI, Div Intramural Res, Bethesda, MD 20892 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Funke, Birgit H.; Rehm, Heidi L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Taylor, Herman A., Jr.] Tougaloo Coll, Tougaloo, MS 39174 USA; [Seidman, Christine] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Boston University; Boston University; University of Mississippi; University of Mississippi Medical Center; Jackson State University; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Mississippi; University of Mississippi Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Tougaloo College; Howard Hughes Medical Institute	Seidman, C (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	cseidman@genetics.med.harvard.edu	Ramachandran, Vasan/Y-2527-2019; Ito, Kaoru/AAZ-3440-2021; Altshuler, David M/A-4476-2009; Benjamin, Emelia/E-7103-2011	Ramachandran, Vasan/0000-0001-7357-5970; Altshuler, David M/0000-0002-7250-4107; Bick, Alexander/0000-0001-5824-9595; Rehm, Heidi L./0000-0002-6025-0015; DePalma, Steven/0000-0002-0381-5016; Cheng, Susan/0000-0002-4977-036X; Benjamin, Emelia/0000-0003-4076-2336	National Human Genome Research Institute [U54 HG003067]; National Heart, Lung and Blood Institute [HL080494-05, N01-HC-95170, N01-HC-95171, N01-HC-95172, N01-HC-25195, 6R01-NS 17950]; Howard Hughes Medical Institute; NIH Medical Scientist Training Program fellowship [5T32GM007753-33]; Ellison Foundation; National Institute for Minority Health and Health Disparities; National Institute of Biomedical Imaging and Bioengineering; Affymetrix, Inc. [N02-HL-6-4278];  [K99HL107642]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006002, ZIAHL006173, ZIAHL006175] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH Medical Scientist Training Program fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); National Institute for Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Affymetrix, Inc.; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We gratefully acknowledge the contribution of Framingham and Jackson Heart Study cohort participants. This work was supported by grants from the National Human Genome Research Institute (Medical Sequencing Program grant U54 HG003067, to the Broad Institute PI, Lander), the National Heart, Lung and Blood Institute (HL080494-05 to C.E.S. and J.G.S.), and the Howard Hughes Medical Institute (to C.E.S). A.G.B. and D.S.H. are supported by NIH Medical Scientist Training Program fellowship 5T32GM007753-33. S.C. is supported in part by grant K99HL107642 and the Ellison Foundation. The Jackson Heart Study is supported by contracts N01-HC-95170, N01-HC-95171, and N01-HC-95172 from the National Heart, Lung, and Blood Institute, the National Institute for Minority Health and Health Disparities, and additional support from the National Institute of Biomedical Imaging and Bioengineering. The Framingham Heart Study was supported by contracts N01-HC-25195 and 6R01-NS 17950 from the National Heart, Lung and Blood Institute and genotyping services from Affymetrix, Inc. (contract No. N02-HL-6-4278 for the SNP Health Association Resource [SHARe] project).	Brown DW, 2000, AM HEART J, V140, P848, DOI 10.1067/mhj.2000.111112; CASALE PN, 1987, CIRCULATION, V75, P565, DOI 10.1161/01.CIR.75.3.565; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Simone G, 2002, J HYPERTENS, V20, P323, DOI 10.1097/00004872-200202000-00024; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DEVEREUX RB, 1987, HYPERTENSION, V9, P53; Georgakopoulos D, 1999, NAT MED, V5, P327, DOI 10.1038/6549; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Govindaraju DR, 2008, ADV GENET, V62, P33, DOI 10.1016/S0065-2660(08)00602-0; KANNEL WB, 1986, AM HEART J, V111, P391, DOI 10.1016/0002-8703(86)90156-0; Konno T, 2010, CURR OPIN CARDIOL, V25, P205, DOI 10.1097/HCO.0b013e3283375698; LAUER MS, 1991, JAMA-J AM MED ASSOC, V266, P231, DOI 10.1001/jama.266.2.231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieb W, 2009, CIRCULATION, V119, P3085, DOI 10.1161/CIRCULATIONAHA.108.824243; Lin TH, 2007, J AM GERIATR SOC, V55, P717, DOI 10.1111/j.1532-5415.2007.01134.x; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Maron BJ, 1999, J AM COLL CARDIOL, V33, P1590, DOI 10.1016/S0735-1097(99)00039-X; Morita H, 2006, CIRCULATION, V113, P2697, DOI 10.1161/CIRCULATIONAHA.105.593558; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Samdarshi TE, 2009, AM HEART J, V158, P209, DOI 10.1016/j.ahj.2009.05.020; Tani T, 2011, CARDIOVASC ULTRASOUN, V9, DOI 10.1186/1476-7120-9-34; Tsang TSM, 2006, J AM COLL CARDIOL, V47, P1018, DOI 10.1016/j.jacc.2005.08.077; Vasan RS, 1997, CIRCULATION, V96, P1863, DOI 10.1161/01.CIR.96.6.1863; Wilson JG, 2005, ETHNIC DIS, V15, pS30	27	94	96	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					513	519		10.1016/j.ajhg.2012.07.017	http://dx.doi.org/10.1016/j.ajhg.2012.07.017			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22958901	Green Published, Bronze			2022-12-18	WOS:000308683100011
J	Day-Williams, AG; Southam, L; Panoutsopoulou, K; Rayner, NW; Esko, T; Estrada, K; Helgadottir, HT; Hofman, A; Ingvarsson, T; Jonsson, H; Keis, A; Kerkhof, HJM; Thorleifsson, G; Arden, NK; Carr, A; Chapman, K; Deloukas, P; Loughlin, J; McCaskie, A; Ollier, WER; Ralston, SH; Spector, TD; Wallis, GA; Wilkinson, JM; Aslam, N; Birell, F; Carluke, I; Joseph, J; Rai, A; Reed, M; Walker, K; Doherty, SA; Jonsdottir, I; Maciewicz, RA; Muir, KR; Metspalu, A; Rivadeneira, F; Stefansson, K; Styrkarsdottir, U; Uitterlinden, AG; van Meurs, JBJ; Zhang, WY; Valdes, AM; Doherty, M; Zeggini, E				Day-Williams, Aaron G.; Southam, Lorraine; Panoutsopoulou, Kalliope; Rayner, Nigel W.; Esko, Tonu; Estrada, Karol; Helgadottir, Hafdis T.; Hofman, Albert; Ingvarsson, Throvaldur; Jonsson, Helgi; Keis, Aime; Kerkhof, Hanneke J. M.; Thorleifsson, Gudmar; Arden, Nigel K.; Carr, Andrew; Chapman, Kay; Deloukas, Panos; Loughlin, John; McCaskie, Andrew; Ollier, William E. R.; Ralston, Stuart H.; Spector, Timothy D.; Wallis, Gillian A.; Wilkinson, J. Mark; Aslam, Nadim; Birell, Fraser; Carluke, Ian; Joseph, John; Rai, Ashok; Reed, Mike; Walker, Kirsten; Doherty, Sally A.; Jonsdottir, Ingileif; Maciewicz, Rose A.; Muir, Kenneth R.; Metspalu, Andres; Rivadeneira, Fernando; Stefansson, Kari; Styrkarsdottir, Unnur; Uitterlinden, Andre G.; van Meurs, Joyce B. J.; Zhang, Weiya; Valdes, Ana M.; Doherty, Michael; Zeggini, Eleftheria		arcOGEN Consortium	A Variant in MCF2L Is Associated with Osteoarthritis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; KNEE; METAANALYSIS; IMPUTATION; GENOTYPES; PROJECT; GDF5; PAIN	Osteoarthritis (OA) is a prevalent, heritable degenerative joint disease with a substantial public health impact. We used a 1000-Genomes-Project-based imputation in a genome-wide association scan for osteoarthritis (3177 OA cases and 4894 controls) to detect a previously unidentified risk locus. We discovered a small disease-associated set of variants on chromosome 13. Through large-scale replication, we establish a robust association with SNPs in MCF2L (rs11842874, combined odds ratio [95% confidence interval] 1.17 [1.11-1.23], p = 2.1 x 10(-8)) across a total of 19,041 OA cases and 24,504 controls of European descent. This risk locus represents the third established signal for OA overall. MCF2L regulates a nerve growth factor (NGF), and treatment with a humanized monoclonal antibody against NGF is associated with reduction in pain and improvement in function for knee OA patients.	[Day-Williams, Aaron G.; Southam, Lorraine; Panoutsopoulou, Kalliope; Deloukas, Panos; Zeggini, Eleftheria] Wellcome Trust Sanger Inst, Hinxton CB10 1HH, Essex, England; [Southam, Lorraine; Rayner, Nigel W.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Estonian Bioctr, EE-51010 Tartu, Estonia; [Estrada, Karol; Kerkhof, Hanneke J. M.; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Meurs, Joyce B. J.] Erasmus MC, Dept Internal Med, NL-3000 DR Rotterdam, Netherlands; [Estrada, Karol; Kerkhof, Hanneke J. M.; Rivadeneira, Fernando; Uitterlinden, Andre G.; van Meurs, Joyce B. J.] Netherlands Consortium Healthy Aging, Netherlands Genom Initiat, NL-2300 RC Leiden, Netherlands; [Helgadottir, Hafdis T.; Thorleifsson, Gudmar; Jonsdottir, Ingileif; Stefansson, Kari; Styrkarsdottir, Unnur] deCODE Genet, IS-101 Reykjavik, Iceland; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Ingvarsson, Throvaldur] Univ Akureyri, Dept Hlth Sci, IS-600 Akureyri, Iceland; [Ingvarsson, Throvaldur; Jonsson, Helgi; Jonsdottir, Ingileif; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland; [Jonsson, Helgi] Landspitali Univ Hosp, Dept Med, IS-101 Reykjavik, Iceland; [Keis, Aime] Univ Tartu, Dept Publ Hlth, EE-51010 Tartu, Estonia; [Keis, Aime] Elva Hosp, EE-61501 Elva, Estonia; [Arden, Nigel K.] Univ Oxford, Natl Inst Hlth Res, Biomed Res Unit, Oxford OX3 7LD, England; [Arden, Nigel K.] Univ Southampton, Epidemiol Resource Ctr, MRC, Southampton SO16 7LB, Hants, England; [Carr, Andrew; Chapman, Kay] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Loughlin, John; McCaskie, Andrew; Birell, Fraser] Newcastle Univ, Musculoskeletal Res Grp, Inst Cellular Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [McCaskie, Andrew] Newcastle Upon Tyne Hosp NHS Trust Fdn, Freeman Hosp, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Ollier, William E. R.] Univ Manchester, Ctr Integrated Genom Med Res, Manchester M13 9PT, Lancs, England; [Ralston, Stuart H.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Spector, Timothy D.; Valdes, Ana M.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Wallis, Gillian A.] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Wilkinson, J. Mark] Univ Sheffield, Dept Human Metab, Acad Unit Bone Metab, Sheffield S5 7AU, S Yorkshire, England; [Wilkinson, J. Mark] No Gen Hosp, Ctr Biomed Res, Sheffield NIHR Bone Biomed Res Unit, Sheffield S5 7AU, S Yorkshire, England; [Aslam, Nadim] Worcestershire Acute Hosp NHS Trust, Dept Orthopaed, Worcester WR5 1DD, Worcs, England; [Birell, Fraser; Carluke, Ian; Reed, Mike; Walker, Kirsten] Northumbria Healthcare NHS Fdn Trust, Wansbeck Gen Hosp, Ashington NE63 9JJ, Northumberland, England; [Rai, Ashok] Worcestershire Acute Hosp NHS Trust, Dept Rheumatol, Worcester WR5 1DD, Worcs, England; [Doherty, Sally A.; Zhang, Weiya; Doherty, Michael] Univ Nottingham, Nottingham NG5 1PB, England; [Maciewicz, Rose A.] AstraZeneca, Charnwood R&D, Resp & Inflammat Res Area, Loughborough LE11 5RH, Leics, England; [Muir, Kenneth R.] Univ Warwick, Warwick Med Sch, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England	Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Tartu; University of Tartu; Estonian Biocentre; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Akureyri; University of Iceland; Landspitali National University Hospital; University of Tartu; University of Oxford; University of Southampton; University of Oxford; Newcastle University - UK; Newcastle Freeman Hospital; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Manchester; University of Edinburgh; University of London; King's College London; University of Manchester; University of Sheffield; Northern General Hospital; University of Sheffield; University of Nottingham; AstraZeneca; University of Warwick	Zeggini, E (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1HH, Essex, England.	eleftheria@sanger.ac.uk	Deloukas, Panos/B-2922-2013; Stefansson, Kari/AAE-7187-2019; Zhang, Weiya/X-9481-2019; Rivadeneira, Fernando/O-5385-2015	Deloukas, Panos/0000-0001-9251-070X; Zhang, Weiya/0000-0003-1142-1460; Rivadeneira, Fernando/0000-0001-9435-9441; Loughlin, John/0000-0003-2018-3361; van Meurs, Joyce/0000-0001-6245-2123; Panoutsopoulou, Kalliope/0000-0002-5460-8025; Doherty, Michael/0000-0002-5763-8326; Styrkarsdottir, Unnur/0000-0001-8146-8278; Jonsson, Helgi/0000-0003-0187-8985; Reed, Michael/0000-0002-6309-2710; Valdes, Ana M./0000-0003-1141-4471; Helgadottir, Hafdis/0000-0003-4352-152X; Zeggini, Eleftheria/0000-0003-4238-659X; McCaskie, Andrew/0000-0001-6476-0832; Esko, Tonu/0000-0003-1982-6569	Astra Zeneca UK; MRC [G0100594, MC_U122886349, G0901461] Funding Source: UKRI; Medical Research Council [G0901461, MC_U122886349, G0100594] Funding Source: researchfish	Astra Zeneca UK(AstraZeneca); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The collection of GOAL samples was funded by Astra Zeneca UK. The author affiliated with AstraZeneca is an employee of AstraZeneca, a global research-based biopharmaceutical company focused on discovering, developing and marketing medicines for some of the world's most serious illnesses, and owns stocks or stock options and has a pending patent application in the company. The authors that are affiliated with deCODE genetics are all employees of deCODE, a biotechnology company that provides genetic testing services, and some own stocks or stock options in the company. Additional acknowledgments are in the Supplemental Data.	ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; Evangelou E, 2009, ARTHRITIS RHEUM-US, V60, P1710, DOI 10.1002/art.24524; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Gouze JN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2082; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Liu ZM, 2009, J BIOL CHEM, V284, P15771, DOI 10.1074/jbc.M901853200; Magi R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-288; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Metspalu A, 2004, DEUT MED WOCHENSCHR, V129, pS25, DOI 10.1055/s-2004-824840; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Panoutsopoulou K, 2011, ANN RHEUM DIS, V70, P864, DOI 10.1136/ard.2010.141473; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Valdes AM, 2011, ANN RHEUM DIS, V70, P873, DOI 10.1136/ard.2010.134155; Valdes AM, 2011, NAT REV RHEUMATOL, V7, P23, DOI 10.1038/nrrheum.2010.191; Wood JN, 2010, NEW ENGL J MED, V363, P1572, DOI 10.1056/NEJMe1004416; Zhang W, 2008, ARTHRITIS RHEUM, V58, P137, DOI 10.1002/art.23237; Zhang W, 2010, PHARMACOGENOMICS, V11, P249, DOI [10.2217/pgs.09.173, 10.2217/PGS.09.173]	28	94	99	0	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 9	2011	89	3					446	450		10.1016/j.ajhg.2011.08.001	http://dx.doi.org/10.1016/j.ajhg.2011.08.001			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	820XQ	21871595	Green Published, hybrid			2022-12-18	WOS:000294939800010
J	Xu, SH; Jin, L				Xu, Shuhua; Jin, Li			A genome-wide analysis of admixture in Uyghurs and a high-density admixture map for disease-gene discovery	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPLE-SCLEROSIS SUSCEPTIBILITY; NUCLEOTIDE-POLYMORPHISM PANEL; MULTILOCUS GENOTYPE DATA; LINKAGE DISEQUILIBRIUM; ETHNIC-DIFFERENCES; AFRICAN-AMERICAN; ADMIXED POPULATIONS; CHINESE POPULATIONS; CARDIOVASCULAR RISK; ASIAN INDIANS	Following up on our previous study, we conducted a genome-wide analysis of admixture for two Uyghur population samples (HGDP-UG and PanAsia-UG), collected from the northern and southern regions of Xinjiang in China, respectively. Both HGDP-UG and PanAsia-UG showed a substantial admixture of East-Asian (EAS) and European (EUR) ancestries, with an empirical estimation of ancestry contribution of 53:47 (EAS:EUR) and 48:52 for HGDP-UG and PanAsia-UG, respectively. The effective admixture time under a model with a single pulse of admixture was estimated as 110 generations and 129 generations, or admixture events occurred about 2200 and 2580 years ago for HGDP-UG and PanAsia-UG, respectively, assuming an average of 20 yr per generation. Despite Uyghurs' earlier history compared to other admixture populations, admixture mapping, holds promise for this population, because of its large size and its mixture of ancestry from different continents. We screened multiple databases and identified a genome-wide single-nucleotide polymorphism panel that can distinguish EAS and FUR ancestry of chromosomal segments in Uyghurs. The panel contains 8150 ancestry-informative markers (AIMs) showing large frequency differences between EAS and FUR populations (F-ST > 0.25, mean F-ST = 0.43) but small frequency differences (7999 AIMs validated) within both populations (F-ST < 0.05, mean F-ST < 0.01). We evaluated the effectiveness of this admixture map for localizing disease genes in two Uyghur populations. To our knowledge, our map constitutes the first practical resource for admixture mapping in Uyghurs, and it will enable studies of diseases showing differences in genetic risk between FUR and EAS populations.	[Xu, Shuhua; Jin, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, Partner Inst Computat Biol, Max Planck Soc CAS MPG, Shanghai 200031, Peoples R China; [Jin, Li] Fudan Univ, MOE, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Jin, Li] Fudan Univ, Ctr Evolutionary Biol, Sch Life Sci, Shanghai 200433, Peoples R China; [Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Fudan University; Fudan University; Fudan University	Jin, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Partner Inst Computat Biol, Max Planck Soc CAS MPG, Shanghai 200031, Peoples R China.	lijin007@gmail.com	Xu, Shuhua/AAH-7620-2020; Jin, Li/M-5063-2019; Anthropology, MOE KeyLab Fudan/A-9454-2010; Jin, Li/C-1468-2009; XU, SHUHUA/D-5345-2009	Xu, Shuhua/0000-0002-1975-1002; Jin, Li/0000-0002-4546-2415; XU, SHUHUA/0000-0002-1975-1002	the Chinese High-Tech Program (863) [2002BA711A10]; the Basic Research Program of China (973) [2004CB518605, 2002CB512900]; the National Natural Science Foundation of China [NSFC30571060]; Shanghai Science and Technology Committee [04DZ14003]; Shanghai Leading Academic Discipline Project [B111]	the Chinese High-Tech Program (863)(National High Technology Research and Development Program of China); the Basic Research Program of China (973)(National Basic Research Program of China); the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	We are grateful to J. Tan, F. Zhang, and Z. Xu for their help in collecting Uyghur samples. We would like to express our appreciation to the PASNPI Consortium for its allowing us to use the genotype data. We thank N. Patternson, D. Reich, and A. Tandon for their helpful comments on ANCESTRYMAP analysis. This work was supported by grants from the Chinese High-Tech Program (863) (2002BA711A10), the Basic Research Program of China (973) (2004CB518605, 2002CB512900), the National Natural Science Foundation of China (NSFC30571060), and the Shanghai Science and Technology Committee (04DZ14003). This work was also supported by the Shanghai Leading Academic Discipline Project (No. B111).	Abate N, 2001, J DIABETES COMPLICAT, V15, P320, DOI 10.1016/S1056-8727(01)00161-1; Abate N, 2007, INDIAN J MED RES, V125, P251; AI Q, 1993, ACTA ANTHR SINICA, V12, P357; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barnett AH, 2006, DIABETOLOGIA, V49, P2234, DOI 10.1007/s00125-006-0325-1; Baskar V, 2006, DIABETES OBES METAB, V8, P214, DOI 10.1111/j.1463-1326.2005.00485.x; Brown DE, 2001, AM J HUM BIOL, V13, P486, DOI 10.1002/ajhb.1080; Budoff MJ, 2006, ATHEROSCLEROSIS, V187, P343, DOI 10.1016/j.atherosclerosis.2005.09.013; CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; Chambers John C, 2002, Semin Vasc Med, V2, P199, DOI 10.1055/s-2002-32043; Chaturvedi N, 2007, ATHEROSCLEROSIS, V193, P204, DOI 10.1016/j.atherosclerosis.2006.06.017; Collins-Schramm HE, 2002, AM J HUM GENET, V70, P737, DOI 10.1086/339368; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Darvasi A, 2005, NAT GENET, V37, P118, DOI 10.1038/ng0205-118; Du R, 1997, B BIOL FR BELG, V32, P9; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Falush D, 2003, GENETICS, V164, P1567; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goudet J., 2001, CLADISTICS; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; *HUGO PAN AS SNP C, 2008, SCIENCE; Jiang Wen-xi, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P523; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LING S, 2007, J MED RES, V36, P27; LONG JC, 1991, GENETICS, V127, P417; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2005, AM J HUM GENET, V76, P1, DOI 10.1086/426949; *NAT CAN I CAN, 2005, INT VAR CAN INC 1993; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pfaff CL, 2004, GENET EPIDEMIOL, V26, P305, DOI 10.1002/gepi.10319; Price AL, 2007, AM J HUM GENET, V80, P1024, DOI 10.1086/518313; Pritchard JK, 2000, GENETICS, V155, P945; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reich D, 2005, PHILOS T ROY SOC B, V360, P1605, DOI 10.1098/rstb.2005.1691; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Shriver MD, 1997, AM J HUM GENET, V60, P957; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Sundquist A, 2008, GENOME RES, V18, P676, DOI 10.1101/gr.072850.107; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; TILLIN T, 2007, INT J CARDIOL   1119; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; WUFUER M, 2005, BASIC CLIN MED, V25, P492; Xiao FX, 2002, HUM BIOL, V74, P555, DOI 10.1353/hub.2002.0050; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Xu SH, 2007, MOL BIOL EVOL, V24, P2049, DOI 10.1093/molbev/msm135; Yao YG, 2004, MOL BIOL EVOL, V21, P2265, DOI 10.1093/molbev/msh238; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; ZIMMET P, 1982, DIABETOLOGIA, V22, P399, DOI 10.1007/BF00282581	67	94	110	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP 12	2008	83	3					322	336		10.1016/j.ajhg.2008.08.001	http://dx.doi.org/10.1016/j.ajhg.2008.08.001			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	349TW	18760393	Bronze, Green Published			2022-12-18	WOS:000259307200004
J	Abu, A; Frydman, M; Marek, D; Pras, E; Nir, U; Reznik-Wolf, H; Pras, E				Abu, Almogit; Frydman, Moshe; Marek, Dina; Pras, Eran; Nir, Uri; Reznik-Wolf, Haike; Pras, Elon			Deleterious mutations in the zinc-finger 469 gene cause brittle cornea syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EHLERS-DANLOS-SYNDROME; AUTOSOMAL-DOMINANT KERATOCONUS; CONNECTIVE-TISSUE DISORDER; BLUE SCLERAE; RED HAIR; COLLAGEN; KERATOGLOBUS; DYSTROPHY; DISTINCT; COL8A2	Brittle cornea syndrome (BCS) is an autosomal-recessive disorder characterized by a thin cornea that tends to perforate, causing progressive visual loss and blindness. Additional systemic symptoms such as joint hypermotility, hyperlaxity of the skin, and kyphoscoliosis place BCS among the connective-tissue disorders. Previously, we assigned the disease gene to a 4.7 Mb interval on chromosome 16q24. In order to clone the BCS gene, we first narrowed the disease locus to a 2.8 Mb interval and systematically sequenced genes expressed in connective tissue in this chromosomal segment. We have identified two frameshift mutations in the Zinc-Finger 469 gene (ZNF469). In five unrelated patients of Tunisian Jewish ancestry, we found a 1 bp deletion at position 5943 (5943 de1A), and in an inbred Palestinian family we detected a single-nucleotide deletion at position 9527 (9527 de1G). The function of ZNF469 is unknown. However, a 30% homology to a number of collagens suggests that it could act as a transcription factor involved in the synthesis and/or organization of collagen fibers.	[Abu, Almogit; Frydman, Moshe; Marek, Dina; Reznik-Wolf, Haike; Pras, Elon] Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Israel; [Abu, Almogit; Nir, Uri] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-52900 Ramat Gan, Israel; [Pras, Eran] Assaf Harofeh Med Ctr, Dept Ophthalmol, IL-70300 Zerifin, Israel; [Frydman, Moshe; Marek, Dina; Pras, Eran; Pras, Elon] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel	Chaim Sheba Medical Center; Bar Ilan University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Pras, E (corresponding author), Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Israel.	epras@post.tau.ac.il						Abu A, 2006, INVEST OPHTH VIS SCI, V47, P5283, DOI 10.1167/iovs.06-0206; Al-Hussain H, 2004, AM J MED GENET A, V124A, P28, DOI 10.1002/ajmg.a.20326; ARKIN W, 1964, AM J OPHTHALMOL, V58, P678, DOI 10.1016/0002-9394(64)91389-3; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Brancati F, 2004, J MED GENET, V41, P188, DOI 10.1136/jmg.2003.012872; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; GREGORATOS ND, 1971, BRIT J OPHTHALMOL, V55, P424, DOI 10.1136/bjo.55.6.424; HYAMS SW, 1969, BRIT J OPHTHALMOL, V53, P53, DOI 10.1136/bjo.53.1.53; Ihanamaki T, 2004, PROG RETIN EYE RES, V23, P403, DOI 10.1016/j.preteyeres.2004.04.002; JUDISCH GF, 1976, ARCH OPHTHALMOL-CHIC, V94, P1489; Klintworth GK, 2003, FRONT BIOSCI-LANDMRK, V8, pD687, DOI 10.2741/1018; Martin Elizabeth, 2007, Curr Osteoporos Rep, V5, P91; ROYCE PM, 1990, EUR J PEDIATR, V149, P465, DOI 10.1007/BF01959396; Segev F, 2006, INVEST OPHTH VIS SCI, V47, P565, DOI 10.1167/iovs.05-0771; STEIN R, 1968, AM J OPHTHALMOL, V66, P67, DOI 10.1016/0002-9394(68)91789-3; Steinhorst U, 1988, Fortschr Ophthalmol, V85, P659; TICHO U, 1980, BRIT J OPHTHALMOL, V64, P175, DOI 10.1136/bjo.64.3.175; TUCKER DP, 1959, AM J OPHTHALMOL, V47, P345, DOI 10.1016/S0002-9394(14)76536-5; Tyynismaa H, 2002, INVEST OPHTH VIS SCI, V43, P3160; ZLOTOGORA J, 1990, AM J MED GENET, V36, P269, DOI 10.1002/ajmg.1320360303	21	94	96	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1217	1222		10.1016/j.ajhg.2008.04.001	http://dx.doi.org/10.1016/j.ajhg.2008.04.001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18452888	Bronze, Green Published			2022-12-18	WOS:000255923600023
J	Zalloua, PA; Xue, YL; Khalife, J; Makhoul, N; Debiane, L; Platt, DE; Royyuru, AK; Herrera, RJ; Hernanz, DFS; Blue-Smith, J; Wells, RS; Comas, D; Bertranpetit, J; Tyler-Smith, C				Zalloua, Pierre A.; Xue, Yali; Khalife, Jade; Makhoul, Nadine; Debiane, Labib; Platt, Daniel E.; Royyuru, Ajay K.; Herrera, Rene J.; Hernanz, David F. Soria; Blue-Smith, Jason; Wells, R. Spencer; Comas, David; Bertranpetit, Jaume; Tyler-Smith, Chris		Genographic Consortium	Y-chromosornal diversity in Lebanon is structured by recent historical events	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXIMUM-LIKELIHOOD-ESTIMATION; MIGRATION; DNA; MUSLIMS	Lebanon is an eastern Mediterranean country inhabited by approximately four million people with a wide variety of ethnicities and religions, including Muslim, Christian, and Druze. In the present study, 926 Lebanese men were typed with Y-chromosomal SNP and STR markers, and unusually, male genetic variation within Lebanon was found to be more strongly structured by religious affiliation than by geography. We therefore tested the hypothesis that migrations within historical times could have contributed to this situation. Y-haplogroupJ*(xJ2) was more frequent in the putative Muslim source region (the Arabian Peninsula) than in Lebanon, and it was also more frequent in Lebanese Muslims than in Lebanese non-Muslims. Conversely, haplogroup R1b was more frequent in the putative Christian source region (western Europe) than in Lebanon and was also more frequent in Lebanese Christians than in Lebanese non-Christians. The most common R1b STR-haplotype in Lebanese Christians was otherwise highly specific for western Europe and was unlikely to have reached its current frequency in Lebanese Christians without admixture. We therefore suggest that the Islamic expansion from the Arabian Peninsula beginning in the seventh century CE introduced lineages typical of this area into those who subsequently became Lebanese Muslims, whereas the Crusader activity in the 11(th)-13(th) centuries CE introduced western European lineages into Lebanese Christians.	[Xue, Yali; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Zalloua, Pierre A.; Khalife, Jade; Makhoul, Nadine; Debiane, Labib] Lebanese Amer Univ, Beirut 11022801, Lebanon; [Platt, Daniel E.; Royyuru, Ajay K.] IBM Corp, Div Res, TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Herrera, Rene J.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Hernanz, David F. Soria; Blue-Smith, Jason; Wells, R. Spencer] Natl Geog Soc, Genograp Project, Washington, DC 20036 USA; [Comas, David; Bertranpetit, Jaume] Univ Pompeu Fabra, Dept Ciencias Expt & Salut, Unitat Biol Evolut, Barcelona 08003, Catalonia, Spain	Wellcome Trust Sanger Institute; Lebanese American University; International Business Machines (IBM); State University System of Florida; Florida International University; National Geographic Society; Pompeu Fabra University	Tyler-Smith, C (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	cts@sanger.ac.uk	Bertranpetit, Jaume/F-8550-2012; Balanovsky, Oleg/G-1549-2014; Santos, Fabrício Rodrigues/H-2370-2011; Cooper, Alan/E-8171-2012; Comas, David/D-5382-2014	Bertranpetit, Jaume/0000-0003-0100-0590; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Cooper, Alan/0000-0002-7738-7851; Comas, David/0000-0002-5075-0956; Khalife, Jade/0000-0001-8765-0142; zalloua, pierre/0000-0002-8494-5081; Royyuru, Ajay/0000-0003-4440-4755; Quintana-Murci, Lluis/0000-0003-2429-6320	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agrawal S, 2005, CURR SCI INDIA, V88, P1977; Ayub Q, 2000, Nucleic Acids Res, V28, pe8, DOI 10.1093/nar/28.2.e8; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 1998, NATO ADV SCI I A-LIF, V306, P39; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Capelli C, 2007, MOL PHYLOGENET EVOL, V44, P228, DOI 10.1016/j.ympev.2006.11.030; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; EDWARDS IES, 1973, CAMBRIDGE ANCIENT HI, V2; EXCOFFIER L, 1992, GENETICS, V131, P479; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fisher R., 1930, GENETICAL THEORY NAT; *FREE SOFTW FDN, GSL GNU SCI LIB VER; Gusmao L, 2006, INT J LEGAL MED, V120, P191, DOI 10.1007/s00414-005-0026-1; Gutala R, 2006, HUM GENET, V120, P543, DOI 10.1007/s00439-006-0234-x; Haldane JBS, 1930, P CAMB PHILOS SOC, V26, P220; HARDEN D, 1971, PHOENICIANS; Heath I., 1978, ARMIES ENEMIES CRUSA; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hitti PK, 1957, LEBANON HIST EARLIES; Hourani A., 1946, SYRIA LEBANON; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; Kuhner MK, 2007, GENETICS, V175, P155, DOI 10.1534/genetics.106.056457; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; LAMB H, 1930, CRUSADES; LAPIDUS IM, 1999, CAMBRIDGE ILLUSTRATE; Luis JR, 2004, AM J HUM GENET, V74, P532, DOI 10.1086/382286; MANTEL N, 1967, CANCER RES, V27, P209; Nielsen R, 2001, GENETICS, V158, P885; Qamar R, 2002, AM J HUM GENET, V70, P1107, DOI 10.1086/339929; Ray N, 2001, INTERNET ARCHAEOLOGY, V11; RILEYSMITH J, 1991, ATLAS CRUSADES; RUNCIMAN S, 1964, HIST CRUSADES; Schneider S, 2000, ARELQUIN SOFTWARE PO; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Terreros MC, 2007, AM J PHYS ANTHROPOL, V133, P1004, DOI 10.1002/ajpa.20600; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thomas MG, 2002, AM J HUM GENET, V70, P1411, DOI 10.1086/340609; Willuweit S, 2007, FORENSIC SCI INT-GEN, V1, P83, DOI 10.1016/j.fsigen.2007.01.017; Wilson IJ, 2003, J R STAT SOC A STAT, V166, P155, DOI 10.1111/1467-985X.00264; Wright S, 1931, GENETICS, V16, P0097; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270	48	94	97	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2008	82	4					873	882		10.1016/j.ajhg.2008.01.020	http://dx.doi.org/10.1016/j.ajhg.2008.01.020			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	290DQ	18374297	Green Published, hybrid			2022-12-18	WOS:000255103900006
J	Luca, D; Ringquist, S; Klei, L; Lee, AB; Gieger, C; Wichmann, HE; Schreiber, S; Krawczak, M; Lu, Y; Styche, A; Devlin, B; Roeder, K; Trucco, M				Luca, Diana; Ringquist, Steven; Klei, Lambertus; Lee, Ann B.; Gieger, Christian; Wichmann, H-Erich; Schreiber, Stefan; Krawczak, Michael; Lu, Ying; Styche, Alexis; Devlin, Bernie; Roeder, Kathryn; Trucco, Massimo			On the use of general control samples for genome-wide association studies: Genetic matching highlights causal variants	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DQ BETA-CHAIN; POPULATION; STRATIFICATION; SUSCEPTIBILITY; STRATEGIES; DESIGNS; LOCI; ACID	Resources being amassed for genome-wide association (GWA) studies include "control databases" genotyped with a large-scale SNP array. How to use these databases effectively is an open question. We develop a method to match, by genetic ancestry, controls to affected individuals (cases). The impact of this method, especially for heterogeneous human populations, is to reduce the false-positive rate, inflate other spuriously small p values, and have little impact on the p values associated with true positive loci. Thus, it highlights true positives by downplaying false positives. We perform a GWA by matching Americans with type I diabetes (T1D) to controls from Germany. Despite the complex study design, these analyses identify numerous loci known to confer risk for T1D.	[Luca, Diana; Lee, Ann B.; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Ringquist, Steven; Lu, Ying; Styche, Alexis; Trucco, Massimo] Childrens Hosp Pittsburgh, Dept Pediat, Div Immunogenet, Pittsburgh, PA 15213 USA; [Klei, Lambertus; Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA; [Gieger, Christian; Wichmann, H-Erich] GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; [Gieger, Christian; Wichmann, H-Erich] Univ Munich, IBE, Chair Epidemiol, D-85764 Munich, Germany; [Schreiber, Stefan; Krawczak, Michael] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Schreiber, Stefan; Krawczak, Michael] Univ Kiel, PopGen Biobank, D-24105 Kiel, Germany	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Kiel; University of Kiel	Roeder, K (corresponding author), Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA.	roeder@stat.cmu.edu	Krawczak, Michael/A-8964-2010; Wichmann, Heinz Erich/AAA-5695-2022	Krawczak, Michael/0000-0003-2603-1502; Gieger, Christian/0000-0001-6986-9554; Roeder, Kathryn/0000-0002-8869-6254	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057881] Funding Source: NIH RePORTER; NIMH NIH HHS [MH057881, R37 MH057881, R01 MH057881] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; BALDING DJ, 1995, GENETICA, V96, P3, DOI 10.1007/BF01441146; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DORMAN JS, 1990, P NATL ACAD SCI USA, V87, P7370, DOI 10.1073/pnas.87.19.7370; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Everitt B., 1993, CLUSTER ANAL, V3rd; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hinds DA, 2004, AM J HUM GENET, V74, P317, DOI 10.1086/381716; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Johnstone IM, 2001, ANN STAT, V29, P295, DOI 10.1214/aos/1009210544; Jolliffe IT, 2002, PRINCIPAL COMPONENT, DOI 10.1007/b98835; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lee WC, 2004, GENET EPIDEMIOL, V27, P1, DOI 10.1002/gepi.20011; Lowel H, 2005, GESUNDHEITSWESEN, V67, pS13, DOI 10.1055/s-2005-858234; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; MOREL PA, 1988, P NATL ACAD SCI USA, V85, P8111, DOI 10.1073/pnas.85.21.8111; Mueller PW, 2006, J AM SOC NEPHROL, V17, P1782, DOI 10.1681/ASN.2005080822; Pasquali L, 2006, TRENDS BIOTECHNOL, V24, P516, DOI 10.1016/j.tibtech.2006.08.007; PATTERSON N, 2006, PLOS GENET, V2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; Ringquist Steven, 2007, V373, P115; Rosenbaum Paul R, 1995, OBSERVATIONAL STUDIE; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Skoll AD, 2007, GENET EPIDEMIOL, V31, P776, DOI 10.1002/gepi.20240; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1198/TECH.2003.S33, 10.1007/978-0-387-21706-2]; Wang HS, 2006, GENET EPIDEMIOL, V30, P356, DOI 10.1002/gepi.20150; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196	37	94	94	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					453	463		10.1016/j.ajhg.2007.11.003	http://dx.doi.org/10.1016/j.ajhg.2007.11.003			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252225	Green Published, Bronze			2022-12-18	WOS:000253223900017
J	Sapp, PC; Hosler, BA; McKenna-Yasek, D; Chin, W; Gann, A; Genise, H; Gorenstein, J; Huang, M; Sailer, W; Scheffler, M; Valesky, M; Haines, JL; Pericak-Vance, M; Siddique, T; Horvitz, HR; Brown, RH				Sapp, PC; Hosler, BA; McKenna-Yasek, D; Chin, W; Gann, A; Genise, H; Gorenstein, J; Huang, M; Sailer, W; Scheffler, M; Valesky, M; Haines, JL; Pericak-Vance, M; Siddique, T; Horvitz, HR; Brown, RH			Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; SUPEROXIDE-DISMUTASE GENE; MOTOR-NEURON DISEASE; DEGENERATION; MUTATIONS; MODEL; MICE; ALS	Amyotrophic lateral sclerosis (ALS) is a rapidly progressive, adult-onset motor neuron disease that arises as a dominantly inherited trait in similar to10% of ALS cases. Mutations in one gene, cytosolic Cu/Zn superoxide dismutase (SOD1), account for similar to25% of familial ALS (FALS) cases. We have performed a genetic linkage screen in 16 pedigrees with FALS with no evidence for mutations in the SOD1 gene and have identified novel ALS loci on chromosomes 16 and 20. The analysis of these genes will delineate pathways implicated as determinants of motor-neuron viability and provide insights into possible therapies for ALS.	Massachusetts Gen Hosp E, Cecil B Day Lab Neuromuscular Res, Charlestown, MA 02129 USA; MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Nashville, TN USA; Duke Univ, Ctr Human Genet, Durham, NC USA; Northwestern Univ, Feinberg Sch Med, Davee Dept Neurol & Clin Neurosci, Chicago, IL 60611 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Vanderbilt University; Duke University; Northwestern University; Feinberg School of Medicine	Brown, RH (corresponding author), Massachusetts Gen Hosp E, Cecil B Day Lab Neuromuscular Res, Charlestown Navy Yard,Bldg 114,Room 3125,114 13th, Charlestown, MA 02129 USA.		Haines, Jonathan/C-3374-2012; Siddique, Teepu/AAT-8166-2021	Haines, Jonathan/0000-0002-4351-4728; Siddique, Teepu/0000-0001-7293-9146	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS031248, R01NS037912] Funding Source: NIH RePORTER; NINDS NIH HHS [1PO1NS31248-02, R01NS37912] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1998, AM J HUM GENET A, V308; Sobel E, 1996, AM J HUM GENET, V58, P1323; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	17	94	99	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					397	403		10.1086/377158	http://dx.doi.org/10.1086/377158			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12858291	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000184223900016
J	Mirza, MM; Fisher, SA; King, K; Cuthbert, AP; Hampe, J; Sanderson, J; Mansfield, J; Donaldson, P; Macpherson, AJS; Forbes, A; Schreiber, S; Lewis, CM; Mathew, CG				Mirza, MM; Fisher, SA; King, K; Cuthbert, AP; Hampe, J; Sanderson, J; Mansfield, J; Donaldson, P; Macpherson, AJS; Forbes, A; Schreiber, S; Lewis, CM; Mathew, CG			Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCUS; NOD2 GENE; ASSOCIATION; TRANSMISSION; MUTATIONS	A common haplotype spanning 250 kb in the cytokine gene cluster on chromosome 5q31 has recently been reported to be strongly associated with Crohn disease ( CD) in Canadian families. We have replicated this finding by both the transmission-disequilibrium test (TDT) (P = .016) and in a case-control association study (P = .008) in a large European cohort of patients with CD, although the increase in disease risk was small ( odds ratio 1.49 for homozygotes, 95% CI 1.11-2.0). No association was detected in families or individuals with ulcerative colitis (UC). Stratification of offspring with CD in the TDT sample by mutation status in the CD susceptibility gene CARD15 showed that the association with the 5q31 risk haplotype was present only in offspring with at least one of the known CARD15 disease susceptibility alleles (P = .044). The 5q31 risk haplotype frequency was 53.1% in unrelated individuals with CD who had one or two CARD15 mutations versus 43.7% in control subjects (P = .0001) but was not significantly elevated in individuals with CD who had no CARD15 mutations (45.4%, p = .41). Kaplan-Meier survival analysis of age at disease onset showed a significantly earlier onset in homozygotes for the 5q31 risk haplotype (P = .0019). These findings suggest that genetic variants at the 5q31 ( IBD5) locus may hasten the onset of Crohn disease and cooperate with CARD15 in disease causation.	Guys Hosp, Univ London Kings Coll, GKT Sch Med, Div Med & Mol Genet, London SE1 9RT, England; St Thomas Hosp, Dept Gastroenterol, London, England; Univ Kiel, Dept Gen Internal Med, Kiel, Germany; Univ Newcastle Upon Tyne, Royal Victoria Infirm, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; St Marks Hosp, Harrow, Middx, England; Univ Spital Zurich, Inst Expt Immunol, Zurich, Switzerland	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of Kiel; Newcastle University - UK; Imperial College London; University of Zurich; University Zurich Hospital	Mathew, CG (corresponding author), Guys Hosp, Univ London Kings Coll, GKT Sch Med, Div Med & Mol Genet, 8th Floor Guys Tower, London SE1 9RT, England.		Mathew, Christopher G/G-3434-2015; Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010; Hampe, Jochen/A-2555-2010	Mathew, Christopher G/0000-0003-4178-1838; Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; Hampe, Jochen/0000-0002-2421-6127; Forbes, Alastair/0000-0001-7416-9843	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; Cookson WOC, 2002, CHEST, V121, p7S, DOI 10.1378/chest.121.3_suppl.7S-a; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Dahlman I, 2002, NAT GENET, V30, P149, DOI 10.1038/ng825; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; LIVAK KJ, 1995, NAT GENET, V9, P341, DOI 10.1038/ng0495-341; Miceli-Richard C, 2001, NAT GENET, V29, P19, DOI 10.1038/ng720; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Rioux JD, 2000, AM J HUM GENET, V66, P1863, DOI 10.1086/302913; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P21, DOI 10.1016/0016-5085(95)90004-7; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Vermeire S, 2002, AM J HUM GENET, V71, P74, DOI 10.1086/341124; Watts DA, 2002, GUT, V50, P31	19	94	97	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					1018	1022		10.1086/373880	http://dx.doi.org/10.1086/373880			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12618963	Green Published, Bronze			2022-12-18	WOS:000181972600022
J	Naz, S; Giguere, CM; Kohrman, DC; Mitchem, KL; Riazuddin, S; Morell, RJ; Ramesh, A; Srisailpathy, S; Deshmukh, D; Riazuddin, S; Griffith, AJ; Friedman, TB; Smith, RJH; Wilcox, ER				Naz, S; Giguere, CM; Kohrman, DC; Mitchem, KL; Riazuddin, S; Morell, RJ; Ramesh, A; Srisailpathy, S; Deshmukh, D; Riazuddin, S; Griffith, AJ; Friedman, TB; Smith, RJH; Wilcox, ER			Mutations in a novel gene, TMIE, are associated with hearing loss linked to the DFNB6 locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOSIN-VIIA GENE; USHER 1B SYNDROME; RECESSIVE DEAFNESS; DEFECTS; MAPS	We have identified five different homozygous recessive mutations in a novel gene, TMIE (transmembrane inner ear expressed gene), in affected members of consanguineous families segregating severe-to-profound prelingual deafness, consistent with linkage to DFNB6. The mutations include an insertion, a deletion, and three missense mutations, and they indicate that loss of function of TMIE causes hearing loss in humans. TMIE encodes a protein with 156 amino acids and exhibits no significant nucleotide or deduced amino acid sequence similarity to any other gene.	Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, NIH, Rockville, MD 20850 USA; Natl Inst Deafness & Other Commun Disorders, Sect Gene Struct & Funct, Genet Mol Lab, NIH, Rockville, MD 20850 USA; Univ Iowa, Dept Otolaryngol, Mol Otolaryngol Res Labs, Iowa City, IA USA; Univ Iowa, Interdepartmental Genet Program, Iowa City, IA USA; Univ Michigan, Sch Med, Dept Human Genet, Kresge Hearing Res Inst,Dept Otolaryngol, Ann Arbor, MI USA; Univ Madras, Dept Genet, Madras, Tamil Nadu, India; Rotary Deaf Sch, Ichalkaranji, India; Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); University of Iowa; University of Iowa; University of Michigan System; University of Michigan; University of Madras; University of Punjab	Wilcox, ER (corresponding author), Natl Inst Deafness & Other Commun Disorders, Sect Human Genet, NIH, 5 Res Court, Rockville, MD 20850 USA.		Naz, Sadaf/C-3911-2019; Morell, Robert James/Q-2042-2019; naz, sadaf/F-4406-2015	Naz, Sadaf/0000-0002-1912-0235; Smith, Richard/0000-0003-1201-6731; Morell, Robert/0000-0003-1537-7356	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000064, Z01DC000035, Z01DC000039, Z01DC000048] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DC000039, Z01 DC000064] Funding Source: Medline; NIDCD NIH HHS [1 Z01 DC 0039-04, 1 Z01 DC00035-04, 1 Z01 DC000064-01, R01-DC02842, R01-DC04410, R01 DC004410, T32 DC000035, R01 DC002842] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ahmed ZM, 2002, HUM GENET, V110, P527, DOI 10.1007/s00439-002-0732-4; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; FUKUSHIMA K, 1995, GENOME RES, V5, P305, DOI 10.1101/gr.5.3.305; Hmani M, 1999, EUR J HUM GENET, V7, P363, DOI 10.1038/sj.ejhg.5200307; Kozak M, 1996, MAMM GENOME, V7, P563, DOI 10.1007/s003359900171; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Mitchem KL, 2002, HUM MOL GENET, V11, P1887, DOI 10.1093/hmg/11.16.1887; Petit C, 2001, ANNU REV GENET, V35, P589, DOI 10.1146/annurev.genet.35.102401.091224; Steel KP, 1995, ANNU REV GENET, V29, P675; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; Young NM, 1996, AM J OTOL, V17, P30	15	94	99	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					632	636		10.1086/342193	http://dx.doi.org/10.1086/342193			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12145746	Green Published, Bronze			2022-12-18	WOS:000177489600017
J	Nath, SK; Kelly, JA; Namjou, B; Lam, T; Bruner, GR; Scofield, RH; Aston, CE; Harley, JB				Nath, SK; Kelly, JA; Namjou, B; Lam, T; Bruner, GR; Scofield, RH; Aston, CE; Harley, JB			Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SIB-PAIR FAMILIES; LINKAGE ANALYSIS; GENOME SCAN; PREVALENCE; DISORDERS; MODELS; BREAST	Both systemic lupus erythematosus (SLE) and vitiligo are autoimmune disorders that have strong evidence of complex genetic contributions to their etiology, but, to date, efforts using genetic linkage to find the susceptibility genes for either phenotype have met with limited success. Since autoimmune diseases are thought to share at least some of their genetic origins, and since only a small minority (16 of 92) of the European-American pedigrees multiplex for SLE in our collection have one or more affected members with vitiligo, we hypothesized that these pedigrees might be more genetically homogeneous at loci important to both SLE and vitiligo and, hence, have increased power for detection of linkage. We therefore evaluated genomewide microsatellite-marker-scan data for markers at an average marker density of similar to 11 cM in these 16 European-American pedigrees and identified a significant linkage at 17p13, where the maximum multipoint parametric LOD score was 3.64 (P<4.3x10(-5)) and the nonparametric linkage score was 4.02 (P<2.8x10(-5)), respectively. The segregation behavior of this linkage suggests a recessive mode of inheritance with a virtually homogeneous genetic effect in these 16 pedigrees. These results support the hypotheses that SLE and vitiligo may share important genetic effects and that sampling on the basis of clinical covariates dramatically improves power to identify genetic effects.	Oklahoma Med Res Fdn, Arthrit & Immunol Res Program, Oklahoma City, OK 73104 USA; Univ Oklahoma, Dept Med, Oklahoma City, OK USA; US Dept Vet Affairs Med Ctr, Oklahoma City, OK USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Nath, SK (corresponding author), Oklahoma Med Res Fdn, Arthrit & Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	swapan-nath@omrf.ouhsc.edu	Scofield, Robert Hal/AEJ-8314-2022	Kelly, Jennifer/0000-0002-3203-2467	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015577, P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024717, R01AI024717, R01AI031584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR045231, R01AR042460, N01AR012253] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR015577, P41 RR003655, RR03655, RR15577] Funding Source: Medline; NIAID NIH HHS [AI24717, AI31584, R01 AI031584, R37 AI024717, R01 AI024717] Funding Source: Medline; NIAMS NIH HHS [R01 AR042460, AR42460, AR-12253, AR45231] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chakravarti A, 1999, NAT GENET, V21, P56, DOI 10.1038/4482; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAS S K, 1985, Genetic Epidemiology, V2, P71; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; ELMOFTI AM, 1968, VITILIGO PSORALENS; Gaffney PM, 2000, AM J HUM GENET, V66, P547, DOI 10.1086/302767; Gaffney PM, 1998, P NATL ACAD SCI USA, V95, P14875, DOI 10.1073/pnas.95.25.14875; Gray-McGuire C, 2000, AM J HUM GENET, V67, P1460, DOI 10.1086/316891; Grimes PE, 1996, J AM ACAD DERMATOL, V35, P21, DOI 10.1016/S0190-9622(96)90490-9; HOCHBERG MC, 1997, DUBOIS LUPUS ERYTHEM, P49; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; James JA, 2001, ARTHRITIS RHEUM-US, V44, P1122, DOI 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LERNER AB, 1959, J INVEST DERMATOL, V32, P285, DOI 10.1038/jid.1959.49; Lindqvist AKB, 2000, J AUTOIMMUN, V14, P169, DOI 10.1006/jaut.1999.0357; Magnusson V, 2000, GENOMICS, V70, P307, DOI 10.1006/geno.2000.6374; MAJUMDER PP, 1993, ARCH DERMATOL, V129, P994, DOI 10.1001/archderm.129.8.994; MAJUMDER PP, 1988, AM J HUM GENET, V43, P119; MAJUMDER PP, 1992, J GENET, V71, P89, DOI 10.1007/BF02927890; MAJUMDER PP, 1993, HUMAN POPULATION GENETICS, P139; McKay JD, 2001, AM J HUM GENET, V69, P440, DOI 10.1086/321979; Meng W, 1996, Zhonghua Yu Fang Yi Xue Za Zhi, V30, P30; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; NATH SK, 1994, AM J HUM GENET, V55, P981; NATH SK, 1995, J GENET, V74, P41, DOI 10.1007/BF02924245; NORDLUND JJ, 1987, ARCH DERMATOL, V123, P1005, DOI 10.1001/archderm.123.8.1005; Ogg GS, 1998, J EXP MED, V188, P1203, DOI 10.1084/jem.188.6.1203; Olson JM, 1999, AM J HUM GENET, V64, P1464, DOI 10.1086/302360; Petri M, 1998, J Am Med Womens Assoc (1972), V53, P9; SIEMENS H W, 1953, Acta Genet Med Gemellol (Roma), V2, P118; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	39	94	98	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1401	1406		10.1086/324470	http://dx.doi.org/10.1086/324470			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11592035	Green Published, Bronze			2022-12-18	WOS:000172086900025
J	Nebel, A; Filon, D; Brinkmann, B; Majumder, PP; Faerman, M; Oppenheim, A				Nebel, A; Filon, D; Brinkmann, B; Majumder, PP; Faerman, M; Oppenheim, A			The y chromosome pool of Jews as part of the genetic landscape of the Middle East	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROSATELLITE LOCI; JEWISH POPULATIONS; LINEAGES; HAPLOTYPES; ORIGINS; DISTANCES; MTDNA; EUROPEANS; LANGUAGES; NETWORKS	A sample of 526 Y chromosomes representing six Middle Eastern populations (Ashkenazi, Sephardic, and Kurdish Jews from Israel; Muslim Kurds; Muslim Arabs from Israel and the Palestinian Authority Area; and Bedouin from the Negev) was analyzed for 13 binary polymorphisms and six microsatellite loci. The investigation of the genetic relationship among three Jewish communities revealed that Kurdish and Sephardic Jews were indistinguishable from one another, whereas both differed slightly, yet significantly, from Ashkenazi Jews. The differences among Ashkenazim may be a result of low-level gene flow from European populations and/or genetic drift during isolation. Admixture between Kurdish Jews and their former Muslim host population in Kurdistan appeared to be negligible. In comparison with data available from other relevant populations in the region, Jews were found to be more closely related to groups in the north of the Fertile Crescent (Kurds, Turks, and Armenians) than to their Arab neighbors. The two haplogroups Eu 9 and Eu 10 constitute a major part of the Y chromosome pool in the analyzed sample. Our data suggest that Eu 9 originated in the northern part, and Eu 10 in the southern part of the Fertile Crescent. Genetic dating yielded estimates of the expansion of both haplogroups that cover the Neolithic period in the region. Palestinian Arabs and Bedouin differed from the other Middle Eastern populations studied here, mainly in specific high-frequency Eu 10 haplotypes not found in the non-Arab groups. These chromosomes might have been introduced through migrations from the Arabian Peninsula during the last two millennia. The present study contributes to the elucidation of the complex demographic history that shaped the present-day genetic landscape in the region.	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91120 Jerusalem, Israel; Hadassah Univ Hosp, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Lab Biol Anthropol & Ancient DNA, Jerusalem, Israel; Univ Munster, Inst Rechtsmed, D-4400 Munster, Germany; Indian Stat Inst, Anthropol & Human Genet Unit, Kolkata 700035, W Bengal, India	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Munster; Indian Statistical Institute; Indian Statistical Institute Kolkata	Oppenheim, A (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Hematol, IL-91120 Jerusalem, Israel.	ariella@md.huji.ac.il	Nebel, Almut/E-4196-2010					BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BARYOSEF O, 1995, ARCHAEOLOGY SOC HOLY, P190; Ben-Sasson HH, 1976, HIST JEWISH PEOPLE; BENERECETTI ASS, 1993, ANN HUM GENET, V57, P55, DOI 10.1111/j.1469-1809.1993.tb00886.x; Bosch E, 1999, AM J HUM GENET, V65, P1623, DOI 10.1086/302676; Brauer Erich, 1993, JEWS KURDISTAN; Brinkmann C, 1999, INT J LEGAL MED, V112, P181, DOI 10.1007/s004140050228; CAVALLISFORZA I, 1994, HIST GEOGRAPHY HUMAN; Comas D, 2000, AM J PHYS ANTHROPOL, V112, P5, DOI 10.1002/(SICI)1096-8644(200005)112:1<5::AID-AJPA2>3.0.CO;2-Z; Dunlop D. M., 1954, HIST JEWISH KHAZARS; EXCOFFIER L, 1992, GENETICS, V131, P479; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; GOLDSTEIN DB, 1995, GENETICS, V139, P463; Hammer MF, 2000, P NATL ACAD SCI USA, V97, P6769, DOI 10.1073/pnas.100115997; Helgason A, 2000, AM J HUM GENET, V67, P697, DOI 10.1086/303046; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; KINNANE D, 1970, KURDS KURDISTAN; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; Levy T.E., 1995, ARCHAEOLOGY SOC HOLY, P226; LIVSHITS G, 1991, AM J HUM GENET, V49, P131; Michalakis Y, 1996, GENETICS, V142, P1061; Nebel A, 2001, EUR J HUM GENET, V9, P22, DOI 10.1038/sj.ejhg.5200577; Nebel A, 2000, HUM GENET, V107, P630, DOI 10.1007/s004390000426; Nei M., 1987, MOL EVOLUTIONARY GEN; PATRICH J, 1995, ARCHAEOLOGY SOC HOLY, P470; PELLETIERE S., 1984, KURDS UNSTABLE ELEME; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; ROTH C, 1972, ENCY JUDAICA, P1296; Salem AH, 1996, AM J HUM GENET, V59, P741; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; SLATKIN M, 1995, GENETICS, V139, P457; Sykes B, 2000, AM J HUM GENET, V66, P1417, DOI 10.1086/302850; Thomas MG, 1999, HUM GENET, V105, P577, DOI 10.1007/s004390051148; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Zerjal T, 1997, AM J HUM GENET, V60, P1174	45	94	96	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1095	1112		10.1086/324070	http://dx.doi.org/10.1086/324070			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11573163	Green Published, Bronze			2022-12-18	WOS:000171413400017
J	Feather, SA; Malcolm, S; Woolf, AS; Wright, V; Blaydon, D; Reid, CJD; Flinter, FA; Proesmans, W; Devriendt, K; Carter, J; Warwicker, P; Goodship, THJ; Goodship, JA				Feather, SA; Malcolm, S; Woolf, AS; Wright, V; Blaydon, D; Reid, CJD; Flinter, FA; Proesmans, W; Devriendt, K; Carter, J; Warwicker, P; Goodship, THJ; Goodship, JA			Primary, nonsyndromic vesicoureteric reflux and its nephropathy is genetically heterogeneous, with a locus on chromosome 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RAS-RELATED GENE; PAX2 GENE; CHILDREN; ANOMALIES; FAMILY; KIDNEY	Primary vesicoureteric reflux (VUR) affects 1%-2% of whites, and reflux nephropathy (RN) causes up to 15% of end-stage renal failure in children and adults. There is a 30-50-fold increased incidence of WR in first-degree relatives of probands, compared with the general population. We report the results of the first genomewide search of VUR and RN; we studied seven European families whose members exhibit apparently dominant inheritance. We initially typed 387 polymorphic markers spaced, on average, at 10 cM throughout the genome; we used the GENEHUNTER program to provide parametric and nonparametric linkage analyses of affected individuals. The most positive locus spanned 20 cM on 1p13 between GATA176C01 and D1S1653 and had a nonparametric LOD score (NPL) of 5.76 (P = .0002) and a parametric LOD score of 3.16. Saturation with markers at 1-cM intervals increased the NPL to 5.94 (P = .00009). Hence, WR maps to a locus on chromosome 1. There was evidence of genetic heterogeneity at the chromosome 1 locus, and 12 additional loci were identified genomewide, with P < .05. No significant linkage was found to Gp, where a renal and ureteric malformation locus has been reported, or to PAX2, mutations of which cause WR in renal-coloboma syndrome. Our results support the hypothesis that WR is a genetic disorder.	UCL, Inst Child Hlth, Clin & Mol Genet Unit, London WC1N 1EH, England; UCL, Inst Child Hlth, Nephrourol Unit, London WC1N 1EH, England; UCL, Div Med & Mol Genet & Nephrol, London WC1N 1EH, England; Ctr Human Genet, Louvain, Belgium; Univ Newcastle Upon Tyne, Dept Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Newcastle Upon Tyne, Dept Biochem & Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of London; University College London; University of London; University College London; University of London; University College London; Newcastle University - UK; Newcastle University - UK	Feather, SA (corresponding author), UCL, Inst Child Hlth, Clin & Mol Genet Unit, 30 Guilford St, London WC1N 1EH, England.	sfeather@ich.ucl.ac.uk	Woolf, Adrian S./AAZ-1075-2020	Woolf, Adrian S./0000-0001-5541-1358; Blaydon, Diana/0000-0002-9998-2563				Bailey RR, 1975, REFLUX PHROPATHY, P59; CHAPMAN CJ, 1985, AM J MED GENET, V20, P577, DOI 10.1002/ajmg.1320200403; Choi KL, 1998, J MED GENET, V35, P338, DOI 10.1136/jmg.35.4.338; de Vargas A, 1978, J Med Genet, V15, P85; Golka, 1997, Int J Occup Environ Health, V3, P105; Groenen PMA, 1998, GENOMICS, V49, P218, DOI 10.1006/geno.1998.5254; HINCHLIFFE SA, 1992, PEDIATR NEPHROL, V6, P439, DOI 10.1007/BF00874007; IZQUIERDO L, 1992, HUM GENET, V89, P557; KELALIS PP, 1971, MAYO CLIN PROC, V46, P807; Kincaid-Smith P S, 1984, Contrib Nephrol, V39, P94; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MACGREGOR ME, 1975, Q J MED, V44, P481; MACINTOSH M, 1989, TISSUE ANTIGENS, V34, P185; MADAULE P, 1985, CELL, V41, P31, DOI 10.1016/0092-8674(85)90058-3; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Nishimura H, 1999, MOL CELL, V3, P1, DOI 10.1016/S1097-2765(00)80169-0; NOE HN, 1992, J UROLOGY, V148, P1869, DOI 10.1016/S0022-5347(17)37053-2; NOE HN, 1992, J UROLOGY, V148, P1739, DOI 10.1016/S0022-5347(17)37017-9; PETERS PC, 1967, J UROLOGY, V97, P259, DOI 10.1016/S0022-5347(17)63025-8; PIZON V, 1988, ONCOGENE, V3, P201; RISDON RA, 1993, CLIN NEPHROL, V40, P308; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; SMELLIE JM, 1986, MICROBIAL DISEASES N, P243; TAMMINENMOBIUS T, 1992, J UROLOGY, V148, P1662, DOI 10.1016/S0022-5347(17)36997-5; Wada T, 1997, KIDNEY INT, V52, P934, DOI 10.1038/ki.1997.415; WINTER RM, 1998, LONDON DYSMORPHOLOGY; Woolf AS, 1998, J AM SOC NEPHROL, V9, P1114	29	94	98	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2000	66	4					1420	1425		10.1086/302864	http://dx.doi.org/10.1086/302864			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QP	10739767	Green Published, Bronze			2022-12-18	WOS:000088373400025
J	Bosch, E; Calafell, F; Santos, FR; Perez-Lezaun, A; Comas, D; Benchemsi, N; Tyler-Smith, C; Bertranpetit, J				Bosch, E; Calafell, F; Santos, FR; Perez-Lezaun, A; Comas, D; Benchemsi, N; Tyler-Smith, C; Bertranpetit, J			Variation in short tandem repeats is deeply structured by genetic background on the human Y chromosome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROSATELLITE LOCI; POPULATION-GENETICS; SEQUENCE VARIATION; HUMAN-EVOLUTION; DNA FRAGMENTS; HAPLOTYPES; POLYMORPHISMS; ORIGIN; AMERINDIANS; DIVERSITY	Eleven biallelic polymorphisms and seven short-tandem-repeat (STR) loci mapping on the nonrecombining portion of the human Y chromosome have been typed in men from northwestern Africa. Analysis of the biallelic markers, which represent probable unique events in human evolution, allowed us to characterize the stable backgrounds or haplogroups of Y chromosomes that prevail in this geographic region. Variation in the more rapidly mutating genetic markers (STRs) has been used both to estimate the time to the most recent common ancestor for STR variability within these stable backgrounds and to explore whether STR differentiation among haplogroups still retains information about their phylogeny. When analysis of molecular variance was used to study the apportionment of STR variation among both genetic backgrounds (i.e., those defined by haplogroups) and population backgrounds, we found STR variability to be clearly structured by haplogroups. More than 80% of the genetic variance was found among haplogroups, whereas only 3.72% of the genetic variation could be attributed to differences among populations-that is, genetic variability appears to be much more structured by lineage than by population. This was confirmed when two population samples from the Iberian Peninsula were added to the analysis. The deep structure of the genetic variation in old genealogical units (haplogroups) challenges a population-based perspective in the comprehension of human genome diversity. A population may be better understood as an association of lineages from a deep and population-independent gene genealogy, rather than as a complete evolutionary unit.	Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Barcelona 08003, Spain; Univ Oxford, Dept Biochem, Canc Res Campaign, Chromosome Mol Biol Grp, Oxford, England; Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; Ctr Natl Transfus Sanguine, Rabat, Morocco	Pompeu Fabra University; University of Oxford; Universidade Federal de Minas Gerais	Bertranpetit, J (corresponding author), Univ Pompeu Fabra, Fac Ciencies Salut & Vida, Unitat Biol Evolut, Doctor Aiguader 80, Barcelona 08003, Spain.		Bosch, Elena/D-8681-2014; Comas, David/D-5382-2014; Bosch, Elena/N-7603-2019; Calafell, Francesc/C-8595-2014; Santos, Fabrício Rodrigues/H-2370-2011; Bertranpetit, Jaume/F-8550-2012	Bosch, Elena/0000-0003-2848-103X; Comas, David/0000-0002-5075-0956; Bosch, Elena/0000-0003-2848-103X; Calafell, Francesc/0000-0002-1083-9438; Santos, Fabrício Rodrigues/0000-0001-9088-1750; Bertranpetit, Jaume/0000-0003-0100-0590				Altheide TK, 1997, AM J HUM GENET, V61, P462; BANCHS I, 1994, HUM MUTAT, V3, P365, DOI 10.1002/humu.1380030407; BERTRANPETIT J, 1995, ANN HUM GENET, V59, P63, DOI 10.1111/j.1469-1809.1995.tb01606.x; Bianchi NO, 1997, AM J PHYS ANTHROPOL, V102, P79; Bianchi NO, 1998, AM J HUM GENET, V63, P1862, DOI 10.1086/302141; Bouzekri N, 1998, HUM MOL GENET, V7, P655, DOI 10.1093/hmg/7.4.655; Brega A, 1987, Gene Geogr, V1, P201; Carvalho-Silva DR, 1999, J MOL EVOL, V49, P204, DOI 10.1007/PL00006543; CASANOVA M, 1985, SCIENCE, V230, P1403, DOI 10.1126/science.2999986; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; Deka R, 1996, GENOME RES, V6, P1177, DOI 10.1101/gr.6.12.1177; deKnijff P, 1997, INT J LEGAL MED, V110, P134, DOI 10.1007/s004140050052; Di Rienzo A, 1998, GENETICS, V148, P1269; ESTIVILL X, 1994, NAT GENET, V8, P216, DOI 10.1038/ng1194-216b; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Foster EA, 1998, NATURE, V396, P27, DOI 10.1038/23835; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GOLDSTEIN DB, 1995, GENETICS, V139, P463; GONCALVES J, 1994, AM J HUM GENET, V55, P583; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; GRIFFITHS RC, 1994, STAT SCI, V9, P307, DOI 10.1214/ss/1177010378; GUELLAEN G, 1984, NATURE, V307, P172, DOI 10.1038/307172a0; HAMMER MF, 1994, MOL BIOL EVOL, V11, P749; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; HAMMER MF, 1997, GENETICS, V145, P785; Hammer Michael F., 1996, Evolutionary Anthropology, V5, P116, DOI 10.1002/(SICI)1520-6505(1996)5:4<116::AID-EVAN2>3.0.CO;2-E; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Jazin E, 1998, NAT GENET, V18, P109, DOI 10.1038/ng0298-109; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Jobling MA, 1997, INT J LEGAL MED, V110, P118, DOI 10.1007/s004140050050; JOBLING MA, 1994, HUM MOL GENET, V3, P107, DOI 10.1093/hmg/3.1.107; Jobling MA, 1998, CURR BIOL, V8, P1391, DOI 10.1016/S0960-9822(98)00020-7; Jobling MA, 1998, HUM MOL GENET, V7, P643, DOI 10.1093/hmg/7.4.643; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Karafet T, 1997, AM J PHYS ANTHROPOL, V102, P301, DOI 10.1002/(SICI)1096-8644(199703)102:3<301::AID-AJPA1>3.0.CO;2-Y; Kayser M, 1997, INT J LEGAL MED, V110, P125, DOI 10.1007/s004140050051; Kwok C, 1996, J MED GENET, V33, P465, DOI 10.1136/jmg.33.6.465; LUCOTTE G, 1985, NUCLEIC ACIDS RES, V13, P8285, DOI 10.1093/nar/13.22.8285; Malaspina P, 1998, AM J HUM GENET, V63, P847, DOI 10.1086/301999; Mateu E, 1997, ANN HUM GENET, V61, P507, DOI 10.1017/S0003480097006544; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; Mitchell RJ, 1996, CURR OPIN GENET DEV, V6, P737, DOI 10.1016/S0959-437X(96)80029-3; MITCHELL RJ, 1993, HUM BIOL, V65, P387; Mitchell RJ, 1997, AM J PHYS ANTHROPOL, V104, P167, DOI 10.1002/(SICI)1096-8644(199710)104:2<167::AID-AJPA3>3.0.CO;2-W; PENA SDJ, 1995, NAT GENET, V11, P15, DOI 10.1038/ng0995-15; Perez-Lezaun A, 1999, AM J HUM GENET, V65, P208, DOI 10.1086/302451; PerezLezaun A, 1997, J MOL EVOL, V45, P265, DOI 10.1007/PL00006229; Pestoni C, 1998, INT J LEGAL MED, V112, P15, DOI 10.1007/s004140050191; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Rocha J, 1997, HUM GENET, V99, P194, DOI 10.1007/s004390050337; Roewer L, 1996, HUM MOL GENET, V5, P1029, DOI 10.1093/hmg/5.7.1029; Rolf B, 1998, EUR J HUM GENET, V6, P583, DOI 10.1038/sj.ejhg.5200223; Santos FR, 1996, AM J HUM GENET, V58, P1369; SANTOS FR, 1995, GENE, V165, P191, DOI 10.1016/0378-1119(95)00501-V; Santos FR, 1995, BRAZ J GENET, V18, P669; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; SANTOS FR, 1999, METHODS TOOLS BIOSCI, P133; Schneider S., 1997, ARLEQUIN VER 1 1 SOF; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; Semino O, 1996, AM J HUM GENET, V59, P964; SEMINO O, 1995, Y CHROMOSOME NEWSLET, V2, P5; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; Shriver MD, 1997, GENOME RES, V7, P586, DOI 10.1101/gr.7.6.586; SLATKIN M, 1995, GENETICS, V139, P457; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Thomas MG, 1998, NATURE, V394, P138, DOI 10.1038/28083; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; Underhill PA, 1996, P NATL ACAD SCI USA, V93, P196, DOI 10.1073/pnas.93.1.196; Vogt PH, 1997, CYTOGENET CELL GENET, V79, P2; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0; Zerjal T, 1997, AM J HUM GENET, V60, P1174	78	94	94	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1623	1638		10.1086/302676	http://dx.doi.org/10.1086/302676			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577916	Bronze, Green Published			2022-12-18	WOS:000084282500017
J	Cuisset, L; Drenth, JPH; Berthelot, JM; Meyrier, A; Vaudour, G; Watts, RA; Scott, DGI; Nicholls, A; Pavek, S; Vasseur, C; Beckmann, JS; Delpech, M; Grateau, G				Cuisset, L; Drenth, JPH; Berthelot, JM; Meyrier, A; Vaudour, G; Watts, RA; Scott, DGI; Nicholls, A; Pavek, S; Vasseur, C; Beckmann, JS; Delpech, M; Grateau, G			Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERIODIC FEVER; 12P13	The Muckle-Wells syndrome (MWS) is a hereditary inflammatory disorder characterized by acute febrile inflammatory episodes comprising abdominal pain, arthritis, and urticaria. Progressive nerve deafness develops subsequently, and, after several years, the disease is complicated by multiorgan AA-type amyloidosis (i.e., amyloidosis derived from the inflammatory serum amyloid-associated protein) (MIM 191900) with renal involvement and end-stage renal failure. The mode of inheritance is autosomal dominant, but some sporadic cases have also been described. No specific laboratory findings have been reported. The genetic basis of MWS is unknown. Using a genomewide search strategy in three families, we identified the locus responsible for MWS, at chromosome 1q44. Our results indicate that the gene is located within a 13.9-cM region between markers D1S2811 and D1S2882, with a maximum two-point LOD score of 4.66 (recombination fraction .00) at D1S2836 when full penetrance is assumed. Further identification of the specific gene that is responsible for MWS will therefore provide the first biological element for characterizing MWS, other than doing so on the basis of its variable clinical expression.	Inst Cochin Genet Mol, Lab Genet Mol Humaine, F-75014 Paris, France; Hop Cochin, F-75674 Paris, France; Hop Broussais, Serv Nephrol, Paris, France; Hop Broussais, INSERM, U430, Paris, France; Hop Hotel Dieu, Serv Med Interne, Paris, France; Univ Nijmegen St Radboud Hosp, Dept Med, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands; Hop Hotel Dieu, Serv Rhumatol, Nantes, France; Ctr Hosp Gen, Serv Pediat, St Quentin en Yvelines, France; Ipswich Hosp, Dept Rheumatol, Ipswich, Suffolk, England; Norfolk & Norwich Hosp, Dept Rheumatol, Norwich NR1 3SR, Norfolk, England; W Suffolk Hosp, Dept Rheumatol, Bury St Edmunds, Suffolk, England; Ctr Natl Genotypage, Evry, France; CNRS, Genethon Unite Rech Associee 1922, F-75700 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Radboud University Nijmegen; Nantes Universite; CHU de Nantes; Ipswich Hospital NHS Trust; Ipswich Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Delpech, M (corresponding author), Inst Cochin Genet Mol, Lab Genet Mol Humaine, 24 Rue Fg St Jacques, F-75014 Paris, France.	delpech@cochin.inserm.fr	Meyrier, Alain/GWQ-3527-2022; Drenth, J.P.H./H-8025-2014; Drenth, Joost/V-7436-2019; Beckmann, Jacques S/A-9772-2008	Beckmann, Jacques S/0000-0002-9741-1900				Aksentijevich I, 1997, CELL, V90, P797; Bernot A, 1997, NAT GENET, V17, P25; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DRENTH JPH, 1994, MEDICINE, V73, P133, DOI 10.1097/00005792-199405000-00002; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Gerbig AW, 1998, QJM-INT J MED, V91, P489, DOI 10.1093/qjmed/91.7.489; Grateau Gilles, 1999, Current Opinion in Rheumatology, V11, P75, DOI 10.1097/00002281-199901000-00013; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Kalatzis V, 1998, HUM MOL GENET, V7, P1589, DOI 10.1093/hmg/7.10.1589; LAGRUE G, 1972, NOUV PRESSE MED, V1, P2223; LINKE RP, 1983, LAB INVEST, V48, P698; McDermott EM, 1997, MAYO CLIN PROC, V72, P806, DOI 10.4065/72.9.806; McDermott MF, 1998, AM J HUM GENET, V62, P1446, DOI 10.1086/301886; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; MCDERMOTT MF, 1997, FAMILIAL MEDITERRANE, P189; MESSIER G, 1988, KIDNEY INT, V34, P566; MUCKLE TJ, 1979, BRIT J DERMATOL, V100, P87, DOI 10.1111/j.1365-2133.1979.tb03572.x; MUCKLE TJ, 1962, Q J MED, V31, P235; Mulley J, 1998, AM J HUM GENET, V62, P884, DOI 10.1086/301793; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; Prieur A M, 1987, Scand J Rheumatol Suppl, V66, P57; PROST A, 1976, REV RHUM, V43, P201; WATTS RA, 1994, BRIT J RHEUMATOL, V33, P1184	25	94	98	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1054	1059		10.1086/302589	http://dx.doi.org/10.1086/302589			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486324	Bronze, Green Published			2022-12-18	WOS:000082910000014
J	Mangion, J; Rahman, N; Edkins, S; Barfoot, R; Nguyen, T; Sigurdsson, A; Townend, JV; Fitzpatrick, DR; Flanagan, AM; Stratton, MR				Mangion, J; Rahman, N; Edkins, S; Barfoot, R; Nguyen, T; Sigurdsson, A; Townend, JV; Fitzpatrick, DR; Flanagan, AM; Stratton, MR			The gene for cherubism maps to chromosome 4p16.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GROWTH-FACTOR RECEPTOR-3; GIANT-CELL GRANULOMAS; MUTATION; ACHONDROPLASIA; DYSPLASIA; LESIONS; DOMAIN	Cherubism is a rare familial disease of childhood characterized by proliferative lesions within the mandible and maxilla that lead to prominence of the lower face and an appearance reminiscent of the cherubs portrayed in Renaissance art. Resolution of these bony abnormalities is often observed after puberty. Many cases are inherited in an autosomal dominant fashion, although several cases without a family history have been reported. Using two families with clinically, radiologically, and/or histologically proved cherubism, we have performed a genomewide linkage search and have localized the gene to chromosome 4p16.3, with a maximum multipoint LOD score of 5.64. Both families showed evidence of linkage to this locus. Critical meiotic recombinants place the gene in a 3-cM interval between D4S127 and 4p-telomere. Within this region a strong candidate is the gene for fibroblast growth factor receptor 3 (FGFR3); mutations in this gene have been implicated in a diverse set of disorders of bone development.	Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London W2 1PG, England; Inst Canc Res, Sect Canc Genet, Sutton, Surrey, England; St Richards Trust, Dept Maxillofacial Surg, Chichester, W Sussex, England; Western Gen Hosp Trust, Mol Med Ctr, Human & Clin Genet Unit, Edinburgh, Midlothian, Scotland	Imperial College London; University of London; Institute of Cancer Research - UK; University of Edinburgh	Flanagan, AM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, Norfolk Pl, London W2 1PG, England.		FitzPatrick, David R/C-7301-2013; FitzPatrick, David R/B-8311-2008; Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	Rahman, Nazneen/0000-0003-4376-0440; FitzPatrick, David R./0000-0003-4861-969X; Flanagan, Adrienne/0000-0002-2832-1303; Edkins, Sarah/0000-0003-0717-1972				ARNOTT DG, 1978, BRIT J ORAL SURG, V16, P38, DOI 10.1016/S0007-117X(78)80054-7; AYOUB AF, 1993, J ORAL MAXIL SURG, V51, P702, DOI 10.1016/S0278-2391(10)80276-9; BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357; BETTS NJ, 1993, ORAL SURG ORAL MED O, V76, P601, DOI 10.1016/0030-4220(93)90069-G; Cohen M.M., 1974, SYNDR IDENT, V2, P14; COHEN MM, 1991, AM J MED GENET, V40, P159, DOI 10.1002/ajmg.1320400208; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; DUNLAP C, 1989, ORAL SURG ORAL MED O, V67, P698, DOI 10.1016/0030-4220(89)90012-1; FLANAGAN AM, 1988, CANCER, V62, P1139, DOI 10.1002/1097-0142(19880915)62:6<1139::AID-CNCR2820620617>3.0.CO;2-8; Hawes M J, 1989, Ophthalmic Plast Reconstr Surg, V5, P133, DOI 10.1097/00002341-198906000-00010; HERRERA RC, 1998, MED ORAL, V3, P163; Hitomi G, 1996, ORAL SURG ORAL MED O, V81, P623, DOI 10.1016/S1079-2104(96)80060-6; Jones WA., 1933, AM J CANC, V17, P946, DOI [10.1158/ajc.1933.946, DOI 10.1158/AJC.1933.946]; Jones WA, 1938, BR J RADIO, V11, P227, DOI DOI 10.1259/0007-1285-11-124-227; KAUGARS GE, 1992, ORAL SURG ORAL MED O, V73, P369, DOI 10.1016/0030-4220(92)90137-F; KERLEY TR, 1981, ORAL SURG ORAL MED O, V51, P128, DOI 10.1016/0030-4220(81)90027-X; MARCK PA, 1992, J OTOLARYNGOL, V21, P84; MEYERS GA, 1995, NAT GENET, V11, P462, DOI 10.1038/ng1295-462; Muenke M, 1997, AM J HUM GENET, V60, P555; PENFOLD CN, 1993, INT J ORAL MAX SURG, V22, P158, DOI 10.1016/S0901-5027(05)80242-5; PETERS WJN, 1979, ORAL SURG ORAL MED O, V47, P307, DOI 10.1016/0030-4220(79)90251-2; PINANETO JM, 1986, AM J MED GENET, V25, P433, DOI 10.1002/ajmg.1320250305; QUAN F, 1995, HUM MOL GENET, V4, P1681, DOI 10.1093/hmg/4.9.1681; RAMON Y, 1967, ORAL SURG ORAL MED O, V24, P435, DOI 10.1016/0030-4220(67)90416-1; READE PC, 1984, BRIT J ORAL MAX SURG, V22, P189, DOI 10.1016/0266-4356(84)90096-2; RIEFKOHL R, 1985, ANN PLAS SURG, V14, P85, DOI 10.1097/00000637-198501000-00016; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Southgate J, 1998, J CLIN PATHOL, V51, P831, DOI 10.1136/jcp.51.11.831; TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321; VAILLANT JM, 1989, J CRANIO MAXILL SURG, V17, P345, DOI 10.1016/S1010-5182(89)80103-9; Valiathan A, 1997, ANGLE ORTHOD, V67, P237; Vastardis H, 1996, NAT GENET, V13, P417, DOI 10.1038/ng0896-417; Whitaker S B, 1995, Pract Periodontics Aesthet Dent, V7, P41; ZACHARIADES N, 1985, INT J ORAL MAXILLOF, V14, P138, DOI 10.1016/S0300-9785(85)80085-5; ZOHAR Y, 1989, J CRANIO MAXILL SURG, V17, P340, DOI 10.1016/S1010-5182(89)80102-7	38	94	97	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1999	65	1					151	157		10.1086/302454	http://dx.doi.org/10.1086/302454			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	212NZ	10364527	Green Published, Bronze			2022-12-18	WOS:000081224300019
J	Clark, KM; Taylor, RW; Johnson, MA; Chinnery, PF; Chrzanowska-Lightowlers, ZMA; Andrews, RM; Nelson, IP; Wood, NW; Lamont, PJ; Hanna, MG; Lightowlers, RN; Turnbull, DM				Clark, KM; Taylor, RW; Johnson, MA; Chinnery, PF; Chrzanowska-Lightowlers, ZMA; Andrews, RM; Nelson, IP; Wood, NW; Lamont, PJ; Hanna, MG; Lightowlers, RN; Turnbull, DM			An mtDNA mutation in the initiation codon of the cytochrome C oxidase subunit II gene results in lower levels of the protein and a mitochondrial encephalomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; HUMAN SKELETAL-MUSCLE; MYOCLONIC EPILEPSY; RNALYS MUTATION; HUMAN-CELLS; WILD-TYPE; DNA; DISEASE; FIBERS; MERRF	A novel heteroplasmic 7587T-->C mutation in the mitochondrial genome which changes the initiation codon of the gene encoding cytochrome c oxidase subunit II (COX II), was found in a family with mitochondrial disease. This T-->C transition is predicted to change the initiating methionine to threonine. The mutation load was present at 67% in muscle from the index case and at 91% in muscle from the patient's clinically affected son. Muscle biopsy samples revealed isolated COX deficiency and mitochondrial proliferation. Single-muscle-fiber analysis revealed that the 7587C copy was at much higher load in COX-negative fibers than in COX-positive fibers. After microphotometric enzyme analysis, the mutation was shown to cause a decrease in COX activity when the mutant load was >55%-65%. In fibroblasts from one family member, which contained >95% mutated mtDNA, there was no detectable synthesis or any steady-state level of COX II. This new mutation constitutes a new mechanism by which mtDNA mutations can cause disease-defective initiation of translation.	Univ Newcastle Upon Tyne, Sch Med, Dept Neurol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Sch Med, Dept Ophthalmol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ London, Dept Clin Neurol, Neurogenet Sect, London, England	Newcastle University - UK; Newcastle University - UK; University of London	Turnbull, DM (corresponding author), Univ Newcastle Upon Tyne, Sch Med, Dept Neurol, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Hanna, Michael G/B-1995-2009; Wood, Nicholas W/C-2505-2009	Wood, Nicholas W/0000-0002-9500-3348; Hanna, Michael/0000-0003-0825-4075; Chinnery, Patrick/0000-0002-7065-6617; nelson, isabelle/0000-0001-6390-622X; Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bentlage HACM, 1996, HUM MOL GENET, V5, P197, DOI 10.1093/hmg/5.2.197; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; BOULET L, 1992, AM J HUM GENET, V51, P1187; BROWN MD, 1992, GENETICS, V130, P163; Chalmers RM, 1997, NEUROLOGY, V49, P589, DOI 10.1212/WNL.49.2.589; Chinnery PF, 1997, J NEUROL NEUROSUR PS, V63, P559, DOI 10.1136/jnnp.63.5.559; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Clark KM, 1997, NAT GENET, V16, P222, DOI 10.1038/ng0797-222; DIMAURO S, 1993, ARCH NEUROL-CHICAGO, V50, P1197, DOI 10.1001/archneur.1993.00540110075008; ENGEL W, 1963, NEUROLOGY, V19, P919; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOWELL N, 1991, AM J HUM GENET, V48, P935; HOWELL N, 1991, AM J HUM GENET, V49, P939; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; JOHNS DR, 1995, NEW ENGL J MED, V333, P638, DOI 10.1056/NEJM199509073331007; JOHNSON MA, 1993, ANN NEUROL, V33, P28, DOI 10.1002/ana.410330106; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Schon EA, 1997, J BIOENERG BIOMEMBR, V29, P131, DOI 10.1023/A:1022685929755; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 1997, AM J HUM GENET, V60, P1107; Villani G, 1997, P NATL ACAD SCI USA, V94, P1166, DOI 10.1073/pnas.94.4.1166; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Weber K, 1997, AM J HUM GENET, V60, P373; WIELBURSKI A, 1982, BIOCHEM J, V204, P239, DOI 10.1042/bj2040239; WIELBURSKI A, 1983, BIOCHEM J, V212, P829, DOI 10.1042/bj2120829	31	94	95	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1330	1339		10.1086/302361	http://dx.doi.org/10.1086/302361			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205264	Bronze, Green Published			2022-12-18	WOS:000080093000011
J	Kohlhase, J; Taschner, PEM; Burfeind, P; Pasche, B; Newman, B; Blanck, C; Breuning, MH; ten Kate, LP; Maaswinkel-Mooy, P; Mitulla, B; Seidel, J; Kirkpatrick, SJ; Pauli, RM; Wargowski, DS; Devriendt, K; Proesmans, W; Gabrielli, O; Coppa, GV; Wesby-van Swaay, E; Trembath, RC; Schinzel, AA; Reardon, W; Seemanova, E; Engel, W				Kohlhase, J; Taschner, PEM; Burfeind, P; Pasche, B; Newman, B; Blanck, C; Breuning, MH; ten Kate, LP; Maaswinkel-Mooy, P; Mitulla, B; Seidel, J; Kirkpatrick, SJ; Pauli, RM; Wargowski, DS; Devriendt, K; Proesmans, W; Gabrielli, O; Coppa, GV; Wesby-van Swaay, E; Trembath, RC; Schinzel, AA; Reardon, W; Seemanova, E; Engel, W			Molecular analysis of SALL1 mutations in Townes-Brocks syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLI3; FAMILY; GENE; SPALT; DPP	Townes-Brocks syndrome (TBS) is an autosomal dominantly inherited malformation syndrome characterized by anal, renal limb, and ear anomalies. Recently, we showed that mutations in the putative zinc finger transcription factor gene SALL1 cause TBS. To determine the spectrum of SALL1 mutations and to investigate the genotype-phenotype correlations in TBS, we examined 23 additional families with TBS or similar phenotypes for SALL1 mutations. In 9 of these families mutations were identified. None of the mutations has previously been described. Two of these mutations are nonsense mutations, one of which occurred in three unrelated families. Five of the mutations are short deletions. All of the mutations are located 5' of the first double zinc finger (DZF) encoding region and are therefore predicted to result in putative prematurely terminated proteins lacking all DZF domains. This suggests that only SALL1 mutations that remove the DZF domains result in TBS. We also present evidence that in rare cases SALL1 mutations can lead to phenotypes similar to Goldenhar syndrome. However, phenotypic differences in TBS do not seem to depend on the site of mutation.	Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; Leiden Univ, Dept Human Genet, NL-2300 RA Leiden, Netherlands; Univ Gottingen, Med Ctr, Dept Pediat, D-37073 Gottingen, Germany; St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England; Vrije Univ Amsterdam, Acad Hosp, Dept Clin Genet, Amsterdam, Netherlands; Klinikum Suhl, Human Genet Beratungsstelle, Suhl, Germany; Univ Jena, Childrens Hosp, Dept Clin Genet, D-6900 Jena, Germany; Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI USA; Univ Wisconsin, Sch Med, Dept Med Genet, Madison, WI USA; Univ Louvain, Ctr Human Genet, Louvain, Belgium; Univ Louvain, Div Pediat Nephrol, Louvain, Belgium; Univ Ancona, Dept Pediat, Ancona, Italy; Erasmus Univ, Hosp Dijkzigt, Clin Genet Ctr, NL-3015 GD Rotterdam, Netherlands; Leicester Royal Infirm, Clin Genet Serv, Leicester, Leics, England; Univ Zurich, Inst Med Genet, Zurich, Switzerland; UCL, Sch Med, Inst Child Hlth, London W1N 8AA, England; Charles Univ Hosp, Dept Clin Genet, Prague, Czech Republic	University of Gottingen; Leiden University; Leiden University - Excl LUMC; University of Gottingen; University of Manchester; Vrije Universiteit Amsterdam; Friedrich Schiller University of Jena; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Marche Polytechnic University; Erasmus University Rotterdam; Erasmus MC; University of Leicester; University of Zurich; University of London; University College London; UCL Medical School; Charles University Prague; General University Hospital Prague	Kohlhase, J (corresponding author), Univ Gottingen, Inst Human Genet, Gosslerstr 12D, D-37073 Gottingen, Germany.	jkohlha@gwdg.de	Taschner, Peter/J-8853-2014; Breuning, Martijn H/E-3429-2010	Taschner, Peter/0000-0001-9621-465X; Reardon, Willie/0000-0001-7329-9179; Newman, William/0000-0002-6382-4678; Orazio, Gabrielli/0000-0003-1037-6899; Trembath, Richard/0000-0003-0550-3400				Antonarakis SE, 1998, HUM MUTAT, V11, P1; Barakat Amin Y, 1988, Dysmorphol Clin Genet, V2, P104; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; CAMERON TH, 1991, AM J MED GENET, V41, P1, DOI 10.1002/ajmg.1320410102; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DEPINANETO JM, 1984, AM J MED GENET, V18, P147, DOI 10.1002/ajmg.1320180118; DEVRIESVANDERWEERD MACS, 1988, CLIN GENET, V34, P195; Gabrielli O, 1993, Minerva Pediatr, V45, P459; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; Ishikiriyama S, 1996, AM J MED GENET, V61, P191, DOI 10.1002/ajmg.1320610203; Johnson JP, 1996, AM J MED GENET, V61, P134, DOI 10.1002/(SICI)1096-8628(19960111)61:2<134::AID-AJMG6>3.0.CO;2-X; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Kohlhase J, 1996, GENOMICS, V38, P291, DOI 10.1006/geno.1996.0631; Koster R, 1997, DEVELOPMENT, V124, P3147; KURNIT DM, 1978, J PEDIATR-US, V93, P270, DOI 10.1016/S0022-3476(78)80518-6; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; MOESCHLER J, 1982, AM J MED GENET, V12, P371, DOI 10.1002/ajmg.1320120403; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Newman WG, 1997, CLIN DYSMORPHOL, V6, P57; O'Callaghan M, 1995, CONGENITAL MALFORMAT, P326; OCALLAGHAN M, 1990, J MED GENET, V27, P457, DOI 10.1136/jmg.27.7.457; Radhakrishna U, 1997, NAT GENET, V17, P269, DOI 10.1038/ng1197-269; REID IS, 1976, J PEDIATR-US, V88, P992, DOI 10.1016/S0022-3476(76)81061-X; ROSSMILLER DR, 1994, OTOLARYNG HEAD NECK, V111, P175, DOI 10.1016/S0194-5998(94)70588-7; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; TOWNES PL, 1972, J PEDIATR-US, V81, P321, DOI 10.1016/S0022-3476(72)80302-0; WALPOLE IR, 1982, J PEDIATR-US, V100, P250, DOI 10.1016/S0022-3476(82)80649-5; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Wischermann A, 1997, MONATSSCHR KINDERH, V145, P382, DOI 10.1007/s001120050137	30	94	101	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					435	445		10.1086/302238	http://dx.doi.org/10.1086/302238			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973281	Bronze, Green Published			2022-12-18	WOS:000078740600013
J	Aita, VM; Liu, JJ; Knowles, JA; Terwilliger, JD; Baltazar, R; Grunn, A; Loth, JE; Kanyas, K; Lerer, B; Endicott, J; Wang, ZY; Penchaszadeh, G; Gilliam, TC; Baron, M				Aita, VM; Liu, JJ; Knowles, JA; Terwilliger, JD; Baltazar, R; Grunn, A; Loth, JE; Kanyas, K; Lerer, B; Endicott, J; Wang, ZY; Penchaszadeh, G; Gilliam, TC; Baron, M			A comprehensive linkage analysis of chromosome 21q22 supports prior evidence for a putative bipolar affective disorder locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE SEARCH; SYNDROME CRITICAL REGION; DOWN-SYNDROME; SUSCEPTIBILITY LOCUS; DIAGNOSTIC CRITERIA; MAP; IDENTIFICATION; RELIABILITY; STRATEGIES; PROGRESS	Previously, we demonstrated evidence of linkage to bipolar affective disorder (BP) in a single large, multigenerational family with a LOD score of 3.41 at the PFKL locus on chromosome 21q22.3. Additional families showed little support for linkage to PFKL under homogeneity or heterogeneity, in that study We I-rave expanded on that analysis, with 31 microsatellite markers at an average marker spacing of less than or equal to 2 cM, in the largest multigenerational BP pedigree series reported to date. A two-point heterogeneity (alpha=0.5) LOD score of 3.35 (P <.000156) was found at the D21S1260 locus, 5 cM proximal to PFKL. Polylocus analysis with a cluster of three neighboring markers was consistent with these results (PL-HetLOD = 3.25). In the design of this study, 373 individuals from 40 families (from a total set of 1,508 individuals in 57 families) were chosen, as a cost-effective approach to genotyping this large sample set. Linkage analyses were performed with an "affecteds-only" method. As such, our results are based solely on genetic information from affected individuals, without assumptions about the disease-locus genotypes of the unaffecteds. Furthermore, for ease of comparison, this study was performed with the same approach as a 10cM genome scan for BP loci, the results of which will be reported elsewhere.	Columbia Univ, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Columbia Genome Ctr, New York, NY 10032 USA; Hadassah Hebrew Univ, Med Ctr, Dept Psychiat, Jerusalem, Israel	Columbia University; Columbia University; Columbia University; Hebrew University of Jerusalem; Hadassah University Medical Center	Baron, M (corresponding author), Columbia Univ, Dept Psychiat, 1051 Riverside Dr,Unit 6, New York, NY 10032 USA.		Liu, Jianjun/AAK-4989-2020	Liu, Jianjun/0000-0002-3255-3019	NIMH NIH HHS [MH00176, MH43979, MH42535] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043979, R01MH042535] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS P, 1994, GENET EPIDEMIOL, V11, P87, DOI 10.1002/gepi.1370110109; Aita VM, 1997, AM J HUM GENET, V61, pA397; ANDREASEN NC, 1977, ARCH GEN PSYCHIAT, V34, P1229; Baron M, 1997, MOL PSYCHIATR, V2, P200, DOI 10.1038/sj.mp.4000211; BARON M, 1994, PSYCHIATR GENET, V4, P43, DOI 10.1097/00041444-199421000-00007; CRADDOCK N, 1994, J INTELL DISABIL RES, V38, P613; Dahmane N, 1998, GENOMICS, V48, P12, DOI 10.1006/geno.1997.5146; DeteraWadleigh SD, 1996, AM J HUM GENET, V58, P1279; DeteraWadleigh SD, 1997, AM J MED GENET, V74, P254, DOI 10.1002/(SICI)1096-8628(19970531)74:3<254::AID-AJMG4>3.0.CO;2-Q; DUFRESNEZACHARIA MC, 1994, GENOMICS, V19, P462, DOI 10.1006/geno.1994.1095; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Fuentes JJ, 1997, HUM GENET, V101, P346, DOI 10.1007/s004390050639; Ghosh S, 1997, GENOME RES, V7, P165, DOI 10.1101/gr.7.2.165; Goodwin FK, 1990, MANIC DEPRESSIVE ILL, P227; Gurling Hugh, 1998, Psychiatric Genetics, V8, P109, DOI 10.1097/00041444-199800820-00015; Holmans P, 1997, AM J HUM GENET, V60, P657; Kola I, 1997, HUM MOL GENET, V6, P1713, DOI 10.1093/hmg/6.10.1713; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; Lapenta V, 1998, GENOMICS, V49, P1, DOI 10.1006/geno.1997.5185; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Liu J, 1997, AM J MED GENET, V74, P590; Magnuson VL, 1996, BIOTECHNIQUES, V21, P700, DOI 10.2144/96214rr03; Ohira M, 1997, GENOME RES, V7, P47, DOI 10.1101/gr.7.1.47; Osoegawa K, 1996, GENOMICS, V32, P375, DOI 10.1006/geno.1996.0132; Ott J., 1991, ANAL HUMAN GENETIC L; PETERSON A, 1994, HUM MOL GENET, V3, P1735, DOI 10.1093/hmg/3.10.1735; RICE J, 1987, ARCH GEN PSYCHIAT, V44, P441; Sambrook J, 1989, MOL CLONING LAB MANU; Satsangi J, 1996, NAT GENET, V14, P199, DOI 10.1038/ng1096-199; SMITH CAB, 1961, 2ND P INT C HUM GEN, V1, P212; Smith DJ, 1997, HUM MOL GENET, V6, P1729, DOI 10.1093/hmg/6.10.1729; Smith DJ, 1997, NAT GENET, V16, P28, DOI 10.1038/ng0597-28; Smyth C, 1997, GENOMICS, V39, P271, DOI 10.1006/geno.1996.4486; SPENCE MA, 1995, AM J MED GENET, V60, P370, DOI 10.1002/ajmg.1320600505; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STRATENWERTH G, 1994, PSYCHIAT PRAX, V21, P3; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P477, DOI 10.1002/gepi.1370100625; TERWILLIGER JD, 1994, 4 WORKSH NORD GEN IN; Trembath RC, 1997, HUM MOL GENET, V6, P813, DOI 10.1093/hmg/6.5.813	40	94	97	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1999	64	1					210	217		10.1086/302185	http://dx.doi.org/10.1086/302185			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	164RM	9915960	Bronze, Green Published			2022-12-18	WOS:000078477400026
J	Bianchi, ME; Beltrame, M				Bianchi, ME; Beltrame, M			Flexing DNA: HMG-box proteins and their partners	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTIONAL ACTIVATION; CHROMOSOMAL-PROTEINS; GLIAL-CELLS; SRY; BINDING; GENE; EVOLUTION; INTERACTS; DOMAINS; COMPLEX		Univ Milan, Dipartimento Genet & Biol Microrganismi, I-20133 Milan, Italy; Ist Sci San Raffaele, I-20132 Milan, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bianchi, ME (corresponding author), Univ Milan, Dipartimento Genet & Biol Microrganismi, Via Celoria 26, I-20133 Milan, Italy.	marco.bianchi@unimi.it	Beltrame, Monica/D-8093-2017; Bianchi, Marco Emilio/K-3417-2018	Bianchi, Marco Emilio/0000-0002-5329-6445; Beltrame, Monica/0000-0001-5094-3494				Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; BIANCHI ME, 1995, DNA PROTEIN STRUCTUR, P177; Boonyaratanakornkit V, 1998, MOL CELL BIOL, V18, P4471, DOI 10.1128/MCB.18.8.4471; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Cantor C.R., 1980, BIOPHYS CHEM; Falciola L, 1997, J CELL BIOL, V137, P19, DOI 10.1083/jcb.137.1.19; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; LANDSMAN D, 1991, MOL CELL BIOL, V11, P4483, DOI 10.1128/MCB.11.9.4483; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; PIL PM, 1992, SCIENCE, V256, P234, DOI 10.1126/science.1566071; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Poulat F, 1997, J BIOL CHEM, V272, P7167, DOI 10.1074/jbc.272.11.7167; SUTRIASGRAU M, IN PRESS J BIOL CHEM; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; TUCKER PK, 1993, NATURE, V364, P715, DOI 10.1038/364715a0; Vaccari T, 1998, GENOMICS, V49, P247, DOI 10.1006/geno.1998.5214; WERNER MH, 1995, CELL, V81, P705, DOI 10.1016/0092-8674(95)90532-4; WHITFIELD LS, 1993, NATURE, V364, P713, DOI 10.1038/364713a0; Zappavigna V, 1996, EMBO J, V15, P4981, DOI 10.1002/j.1460-2075.1996.tb00878.x; ZWILLING S, 1995, EMBO J, V14, P1198, DOI 10.1002/j.1460-2075.1995.tb07103.x	25	94	96	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1573	1577		10.1086/302170	http://dx.doi.org/10.1086/302170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EL	9837808	Green Published, Bronze			2022-12-18	WOS:000077707700001
J	vanderSteege, G; Grootscholten, PM; Cobben, JM; Zappata, S; Scheffer, H; denDunnen, JT; vanOmmen, GJB; Brahe, C; Buys, CHCM				vanderSteege, G; Grootscholten, PM; Cobben, JM; Zappata, S; Scheffer, H; denDunnen, JT; vanOmmen, GJB; Brahe, C; Buys, CHCM			Apparent gene conversions involving the SMN gene in the region of the spinal muscular atrophy locus on chromosome 5	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERMANY WEST-THURINGEN; MOTOR-NEURON GENE; DELETIONS; DISEASE; 5Q13; ASSOCIATION; INDIVIDUALS; DIAGNOSIS; SEVERITY	The survival motor neuron (SMN) gene has been described as a determining gene for spinal muscular atrophy (SMA). SMN has a closely flanking, nearly identical copy ((C)BCD541). Gene and copy gene can be discriminated by sequence differences in exons 7 and 8. The large majority of SMA patients show homozygous deletions of at least exons 7 and 8 of the SMN gene. A minority of patients show absence of SMN exon 7 but retention of exon 8. This is explained by results of our present analysis of 13 such patients providing evidence for apparent gene-conversion events between SMN and the centromeric copy gene. Instead of applying a separate analysis for absence or presence of SMN exons 7 and 8, we used a contiguous PCR from intron 6 to exon 8. In every case we found a chimeric gene with a fusion of exon 7 of the copy gene and exon 8 of SMN and absence of a normal SMN gene. Similar events, including the fusion counterpart, were observed in a group of controls, although in the presence of a normal SMN gene. Chimeric genes as the result of fusions of parts of SMN and (C)BCD541 apparently are far from rare and may partly explain the frequently observed SMN deletions in SMA patients.	UNIV GRONINGEN,DEPT MED GENET,NL-9713 AW GRONINGEN,NETHERLANDS; CATHOLIC UNIV ROME,A GEMELLI SCH MED,INST MED GENET,ROME,ITALY; LEIDEN UNIV,DEPT HUMAN GENET,NL-2300 RA LEIDEN,NETHERLANDS	University of Groningen; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Leiden University; Leiden University - Excl LUMC			dunnen, johan den/ABH-4228-2020; Scheffer, Hans/E-4644-2012	dunnen, johan den/0000-0002-6304-1710; Scheffer, Hans/0000-0002-2986-0915	Telethon [517] Funding Source: Medline	Telethon(Fondazione Telethon)		BRAKENHOFF RH, 1991, NUCLEIC ACIDS RES, V19, P1949, DOI 10.1093/nar/19.8.1949; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; COBBEN JM, 1995, AM J HUM GENET, V57, P805; DIDONATO CJ, 1994, AM J HUM GENET, V55, P1218; EMERY AEH, 1971, J MED GENET, V8, P481, DOI 10.1136/jmg.8.4.481; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; HAHNEN E, 1995, HUM MOL GENET, V4, P1927, DOI 10.1093/hmg/4.10.1927; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; MUNSAT TL, 1992, NEUROMUSCULAR DISORD, V2, P423, DOI 10.1016/S0960-8966(06)80015-5; RODRIGUES NR, 1995, HUM MOL GENET, V4, P631, DOI 10.1093/hmg/4.4.631; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; THIEME A, 1994, HUM GENET, V93, P344, DOI 10.1007/BF00212036; THIEME A, 1993, HUM GENET, V91, P295; VANDERSTEEGE G, 1995, LANCET, V345, P985, DOI 10.1016/S0140-6736(95)90732-7; Velasco E, 1996, HUM MOL GENET, V5, P257, DOI 10.1093/hmg/5.2.257; WHITE PC, 1994, HUM MUTAT, V3, P373, DOI 10.1002/humu.1380030408; WIRTH B, 1995, HUM MOL GENET, V4, P1273, DOI 10.1093/hmg/4.8.1273; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415; [No title captured]	23	94	97	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					834	838						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808598				2022-12-18	WOS:A1996VL28300012
J	RAMSAY, M; COLMAN, MA; STEVENS, G; ZWANE, E; KROMBERG, J; FARRALL, M; JENKINS, T				RAMSAY, M; COLMAN, MA; STEVENS, G; ZWANE, E; KROMBERG, J; FARRALL, M; JENKINS, T			THE TYROSINASE-POSITIVE OCULOCUTANEOUS ALBINISM LOCUS MAPS TO CHROMOSOME 15Q11.2-Q12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; DINUCLEOTIDE REPEAT POLYMORPHISM; THROMBOSPONDIN GENE; MOUSE CHROMOSOME-7; ANGELMAN SYNDROMES; PARENTAL ORIGIN; HYPOPIGMENTATION; DELETION; REGION; ABNORMALITIES	Tyrosinase-positive oculocutaneous albinism (ty-pos OCA), an autosomal recessive disorder of the melanin biosynthetic pathway, is the most common type of albinism occurring worldwide. In southern African Bantu-speaking negroids it has an overall prevalence of about 1/3,900. Since the basic biochemical defect is unknown, a linkage study with candidate loci, candidate chromosomal regions, and random loci was undertaken. The ty-pos OCA locus was found to be linked to two arbitrary loci, D15S10 and D15S13, in the Prader-Willi/Angelman chromosomal region on chromosome 15q11.2-q12. The pink-eyed dilute locus, p, on mouse chromosome 7, maps close to a region of homology on human chromosome 15q, and we postulate that the ty-pos OCA and p loci are homologous.	S AFRICAN INST MED RES,SCH PATHOL,DEPT HUMAN GENET,MRC,HUMAN ECOGENET RES UNIT,JOHANNESBURG 2000,SOUTH AFRICA; UNIV WITWATERSRAND,JOHANNESBURG 2001,SOUTH AFRICA; NORTHWICK PK HOSP & CLIN RES CTR,CLIN RES CTR,DIV MOLEC MED,HARROW HA1 3UJ,MIDDX,ENGLAND	University of Witwatersrand; Imperial College London				Ramsay, Michele/0000-0002-4156-4801				BRILLIANT MH, 1991, SCIENCE, V252, P566, DOI 10.1126/science.1673574; BUTLER MG, 1989, AM J HUM GENET, V45, P140; CHAILLET JR, 1991, GENOMICS, V11, P773, DOI 10.1016/0888-7543(91)90090-2; CHINTAMANENI CD, 1991, P NATL ACAD SCI USA, V88, P5272, DOI 10.1073/pnas.88.12.5272; COLMAN MA, 1991, NUCLEIC ACIDS RES, V19, P5097, DOI 10.1093/nar/19.18.5097; COLMAN MA, IN PRESS HUM GENET; CREEL D, 1980, PHARMACOL BIOCHEM BE, V12, P969, DOI 10.1016/0091-3057(80)90461-X; CREEL DJ, 1986, NEW ENGL J MED, V314, P1606, DOI 10.1056/NEJM198606193142503; DONLON TA, 1986, P NATL ACAD SCI USA, V83, P4408, DOI 10.1073/pnas.83.12.4408; EDWARDS JH, 1987, J MED GENET, V24, P539, DOI 10.1136/jmg.24.9.539; FRYBURG JS, 1991, AM J MED GENET, V38, P58, DOI 10.1002/ajmg.1320380114; GIEBEL LB, 1991, J CLIN INVEST, V87, P1119, DOI 10.1172/JCI115075; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HAMABE J, 1991, AM J MED GENET, V41, P54, DOI 10.1002/ajmg.1320410116; HITTNER HM, 1982, AM J OPHTHALMOL, V94, P328, DOI 10.1016/0002-9394(82)90358-0; JAFFE E, 1990, GENOMICS, V7, P123, DOI 10.1016/0888-7543(90)90528-3; JENKINS T, 1990, OPHTHALMIC PAED GEN, V11, P251, DOI 10.3109/13816819009015710; KING RA, 1991, J CLIN INVEST, V87, P1046, DOI 10.1172/JCI115064; KNOLL JHM, 1991, AM J HUM GENET S, V49, pA87; KROMBERG JGR, 1982, S AFR MED J, V61, P383; KROMBERG JGR, 1989, CLIN GENET, V36, P43; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LINDEMAN R, 1991, NUCLEIC ACIDS RES, V19, P5449, DOI 10.1093/nar/19.19.5449-a; MAGENIS RE, 1990, AM J MED GENET, V35, P333, DOI 10.1002/ajmg.1320350307; NADEAU J, 1991, MOUSE GENOME, V89, P31; NAKATSU Y, 1992, MAMM GENOME, V2, P69, DOI 10.1007/BF00570442; NICHOLLS RD, 1989, AM J MED GENET, V33, P66, DOI 10.1002/ajmg.1320330109; NICHOLLS RD, 1991, AM J HUM GENET S, V49, pA334; OKORO AN, 1975, BRIT J DERMATOL, V92, P485; OTT J, 1985, ANAL HUMAN GENETIC L; PEMBREY M, 1989, J MED GENET, V26, P73, DOI 10.1136/jmg.26.2.73; PHELAN MC, 1988, P GREENWOOD GENET CT, V7, P27; POLYMEROPOULOS MH, 1990, NUCLEIC ACIDS RES, V18, P7467, DOI 10.1093/nar/18.24.7467; SEARLE AG, 1989, ANN HUM GENET, V53, P89, DOI 10.1111/j.1469-1809.1989.tb01777.x; Silvers WK., 1979, COAT COLORS MICE, DOI [10.1007/978-1-4612-6164-3, DOI 10.1007/978-1-4612-6164-3]; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TANTRAVAHI U, 1989, AM J MED GENET, V33, P78, DOI 10.1002/ajmg.1320330110; WAGSTAFF J, 1991, GENOMICS, V11, P1071, DOI 10.1016/0888-7543(91)90034-C; WALLIS CE, 1989, J MED GENET, V26, P337, DOI 10.1136/jmg.26.5.337; WALSH RJ, 1971, ANN HUM GENET, V34, P379, DOI 10.1111/j.1469-1809.1971.tb00250.x; WIESNER GL, 1987, AM J HUM GENET, V40, P431; [No title captured]	43	94	96	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1992	51	4					879	884						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JQ667	1415228				2022-12-18	WOS:A1992JQ66700022
J	KONTUSAARI, S; TROMP, G; KUIVANIEMI, H; LADDA, RL; PROCKOP, DJ				KONTUSAARI, S; TROMP, G; KUIVANIEMI, H; LADDA, RL; PROCKOP, DJ			INHERITANCE OF AN RNA SPLICING MUTATION (G+I-IVS20) IN THE TYPE-III PROCOLLAGEN GENE (COL3AI) IN A FAMILY HAVING AORTIC-ANEURYSMS AND EASY BRUISABILITY - PHENOTYPIC OVERLAP BETWEEN FAMILIAL ARTERIAL ANEURYSMS AND EHLERS-DANLOS SYNDROME TYPE-IV	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,JEFFERSON INST MOLEC MED,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; PENN STATE UNIV,MILTON S HERSHEY MED CTR,HERSHEY,PA 17033	Jefferson University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health			Kuivaniemi, Helena/Q-8178-2019; Tromp, Gerard/B-2677-2017	Kuivaniemi, Helena/0000-0001-5753-8766; Tromp, Gerard/0000-0002-7761-0806	NIAMS NIH HHS [AR-38188] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038188] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509; Beighton PH, 1970, EHLERS DANLOS SYNDRO; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; Bergqvist D, 1986, Lakartidningen, V83, P3010; BYERS PH, 1981, LAB INVEST, V44, P336; BYERS PH, 1982, AM ACADEMY ORTHOPAED, P76; BYERS PH, 1983, CLIN MED, P1; CHU ML, 1985, J BIOL CHEM, V260, P4357; COLLIN J, 1985, BRIT J SURG, V72, P851, DOI 10.1002/bjs.1800721102; COTTON RGH, 1989, BIOCHEM J, V263, P1; CRAWFORD ES, 1981, ANN SURG, V193, P699; DARLING RC, 1989, J VASC SURG, V10, P39, DOI 10.1067/mva.1989.vs0100039; GANGULY A, IN PRESS CLIN RES; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GRANDCHAMP B, 1989, P NATL ACAD SCI USA, V86, P661, DOI 10.1073/pnas.86.2.661; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HIGUCHI M, 1990, GENOMICS, V6, P65, DOI 10.1016/0888-7543(90)90448-4; JACOB M, 1989, NUCLEIC ACIDS RES, V17, P2159, DOI 10.1093/nar/17.6.2159; KONTUSAARI S, 1990, ANN NY ACAD SCI, V580, P556, DOI 10.1111/j.1749-6632.1990.tb17990.x; KUIVANIEMI H, IN PRESS J BIOL CHEM; Maniatis T., 1982, MOL CLONING; MCKUSICK VA, 1972, HERITABLE DISORDERS, P292; MEINKOTH J, 1984, ANAL BIOCHEM, V138, P267, DOI 10.1016/0003-2697(84)90808-X; MITCHELL PJ, 1986, MOL CELL BIOL, V6, P1926, DOI 10.1128/MCB.6.6.1926; POPE FM, 1975, P NATL ACAD SCI USA, V72, P1314, DOI 10.1073/pnas.72.4.1314; PROCKOP DJ, 1989, AM J MED GENET, V34, P60, DOI 10.1002/ajmg.1320340112; PYERITZ RE, 1984, AM J MED GENET, V19, P607, DOI 10.1002/ajmg.1320190328; RUTHERFORD RB, 1988, SEMIN VASC SURG, V1, P131; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAMBAN A, 1989, TXB PEDIATRIC DERMAT, P117; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; STOLLE CA, 1985, J BIOL CHEM, V260, P1937; STUDENCKI AB, 1984, DNA-J MOLEC CELL BIO, V3, P7, DOI 10.1089/dna.1.1984.3.7; SUPERTIFURGA A, 1989, HUM GENET, V82, P104, DOI 10.1007/BF00284038; SUPERTIFURGA A, 1988, J BIOL CHEM, V263, P6226; TRAYSTMAN MD, 1990, GENOMICS, V6, P293, DOI 10.1016/0888-7543(90)90569-G; TROMP G, 1989, J BIOL CHEM, V264, P19313; TROMPE G, 1989, J BIOL CHEM, V64, P1349; UITTO J, 1986, ANN INTERN MED, V105, P740, DOI 10.7326/0003-4819-105-5-740; UITTO J, 1982, AM ACADEMY ORTHOPAED, P82; WEIR B, 1987, ANEURYSMS AFFECTING; ZHAO M, 1990, ANN NY ACAD SCI, V580, P554, DOI 10.1111/j.1749-6632.1990.tb17989.x	43	94	97	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1990	47	1					112	120						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DK482	2349939				2022-12-18	WOS:A1990DK48200016
J	STALLINGS, RL; OLSON, E; STRAUSS, AW; THOMPSON, LH; BACHINSKI, LL; SICILIANO, MJ				STALLINGS, RL; OLSON, E; STRAUSS, AW; THOMPSON, LH; BACHINSKI, LL; SICILIANO, MJ			HUMAN CREATINE-KINASE GENES ON CHROMOSOME-15 AND CHROMOSOME-19, AND PROXIMITY OF THE GENE FOR THE MUSCLE FORM TO THE GENES FOR APOLIPOPROTEIN-C2 AND EXCISION REPAIR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT GENET,BOX 45,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT BIOCHEM,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT MOLEC BIOL,HOUSTON,TX 77030; WASHINGTON UNIV,SCH MED,DEPT BIOL CHEM,ST LOUIS,MO 63110; UNIV CALIF LAWRENCE LIVERMORE NATL LAB,DIV BIOMED SCI,LIVERMORE,CA 94550	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Washington University (WUSTL); United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System			Stallings, Raymond/A-7213-2008		NATIONAL CANCER INSTITUTE [P01CA034936, T32CA009299] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P60HL017646, P50HL017646] Funding Source: NIH RePORTER; NCI NIH HHS [CA09299, CA34936] Funding Source: Medline; NHLBI NIH HHS [HL17646] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARTLETT RJ, 1987, SCIENCE, V235, P1648, DOI 10.1126/science.3029876; BLIN N, 1976, NUCLEIC ACIDS RES, V3, P2303, DOI 10.1093/nar/3.9.2303; BOYD D, 1985, J BIOL CHEM, V260, P1755; BROOK JD, 1985, CYTOGENET CELL GENET, V40, P590; BROOK JD, 1986, CYTOGENET CELL GENET, V41, P30, DOI 10.1159/000132192; BUSKIN JN, 1985, J MOL EVOL, V22, P334, DOI 10.1007/BF02115689; CHERN CJ, 1980, CYTOGENET CELL GENET, V27, P232, DOI 10.1159/000131491; DAVIS MB, 1985, CYTOGENET CELL GENET, V40, P613; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; DONALD JA, 1985, HUM GENET, V69, P39, DOI 10.1007/BF00295527; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FIDDES JC, 1980, NATURE, V286, P684, DOI 10.1038/286684a0; FRIEDRICH U, 1987, HUM GENET, V75, P291, DOI 10.1007/BF00281077; FUJII D, 1986, SOMAT CELL MOLEC GEN, V12, P281, DOI 10.1007/BF01570787; GRACE AM, 1983, J BIOL CHEM, V258, P5346; HULSEBOS T, 1985, CYTOGENET CELL GENET, V40, P658; HULSEBOS T, 1986, CYTOGENET CELL GENET, V43, P47, DOI 10.1159/000132297; JACKSON CL, 1984, P NATL ACAD SCI-BIOL, V81, P2945, DOI 10.1073/pnas.81.10.2945; KANEDA Y, 1987, CHROMOSOMA, V95, P8, DOI 10.1007/BF00293835; LUSIS AJ, 1986, P NATL ACAD SCI USA, V83, P3929, DOI 10.1073/pnas.83.11.3929; MCMORRIS FA, 1973, SCIENCE, V179, P1129, DOI 10.1126/science.179.4078.1129; MEREDITH AL, 1985, CYTOGENET CELL GENET, V40, P698; NIGRO JM, 1987, AM J HUM GENET, V40, P115; PERICAKVANCE MA, 1986, NEUROLOGY, V36, P1418, DOI 10.1212/WNL.36.11.1418; PERRYMAN MB, 1983, BIOCHIM BIOPHYS ACTA, V747, P284, DOI 10.1016/0167-4838(83)90107-3; PERRYMAN MB, 1986, BIOCHEM BIOPH RES CO, V140, P981, DOI 10.1016/0006-291X(86)90732-1; PHILLIPS IR, 1985, P NATL ACAD SCI USA, V82, P983, DOI 10.1073/pnas.82.4.983; RENWICK JH, 1971, J MED GENET, V8, P407, DOI 10.1136/jmg.8.4.407; ROMAN D, 1985, P NATL ACAD SCI USA, V82, P8394, DOI 10.1073/pnas.82.24.8394; SHAW DJ, 1986, J MED GENET, V23, P2, DOI 10.1136/jmg.23.1.2; SHEPHARD EA, 1985, CYTOGENET CELL GENET, V40, P741; SICILIANO MJ, 1986, MUTAT RES, V174, P303, DOI 10.1016/0165-7992(86)90051-5; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRAUSS AW, 1986, CIRCULATION S2, V74, pA156; THOMPSON LH, 1985, SOMAT CELL MOLEC GEN, V11, P87, DOI 10.1007/BF01534738; THOMPSON LH, 1987, SOMAT CELL MOLEC GEN, V13, P539, DOI 10.1007/BF01534495; TZVETANOVA E, 1971, ENZYME, V12, P279, DOI 10.1159/000459547; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WESTERVELD A, 1984, NATURE, V310, P425, DOI 10.1038/310425a0; WORWOOD M, 1985, HUM GENET, V69, P371, DOI 10.1007/BF00291657; YAMAOKA LH, 1985, J NEUROGENET, V2, P403, DOI 10.3109/01677068509101426	41	94	96	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1988	43	2					144	151						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	P6084	3400641				2022-12-18	WOS:A1988P608400006
J	MUDD, SH; HAVLIK, R; LEVY, HL; MCKUSICK, VA; FEINLEIB, M				MUDD, SH; HAVLIK, R; LEVY, HL; MCKUSICK, VA; FEINLEIB, M			A STUDY OF CARDIOVASCULAR RISK IN HETEROZYGOTES FOR HOMOCYSTINURIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NHLBI,DIV HEART & VASC DIS,PROGRAM EPIDEMIOL & BIOMETRY PROGRAM,BETHESDA,MD 20205; JOHNS HOPKINS UNIV,SCH MED,DEPT MED,BALTIMORE,MD 21205; MASSACHUSETTS GEN HOSP,JOSEPH P KENNEDY JR LABS,NEUROL SERV,BOSTON,MA 02114; CHILDRENS HOSP MED CTR,HARVARD MED SCH,DEPT NEUROL,BOSTON,MA 02115	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School	MUDD, SH (corresponding author), NIMH,GEN & COMPARAT BIOCHEM LAB,BLDG 32,RM 101,9000 ROCKVILLE PIKE,BETHESDA,MD 20205, USA.							BAUMGARTNER B, 1980, J INHER METAB DIS, V3, P101; BYINGTON R, 1979, P C DECLINE CORONARY, P340; CUTLER S J, 1958, J Chronic Dis, V8, P699, DOI 10.1016/0021-9681(58)90126-7; DOLL R, 1964, BRIT MED J, V1, P1399, DOI 10.1136/bmj.1.5395.1399; DONAHUE S, 1974, AM J PATHOL, V77, P167; EDERER F, 1961, J AM STAT ASSOC, V56, P111, DOI 10.2307/2282336; GIBSON JB, 1964, J CLIN PATHOL, V17, P427, DOI 10.1136/jcp.17.4.427; GRUBERG ER, 1979, ATLANTIC MONTHLY MAY, P59; HARKER LA, 1976, J CLIN INVEST, V58, P731, DOI 10.1172/JCI108520; KANG SS, 1979, PEDIATR RES, V13, P1141, DOI 10.1203/00006450-197910000-00012; KANWAR YS, 1976, PEDIATR RES, V10, P598, DOI 10.1203/00006450-197606000-00008; MCCULLY KS, 1969, AM J PATHOL, V56, P111; MCCULLY KS, 1972, AM HEART J, V83, P571, DOI 10.1016/0002-8703(72)90051-8; MCCULLY KS, 1975, ATHEROSCLEROSIS, V22, P215, DOI 10.1016/0021-9150(75)90004-0; MCCULLY KS, 1970, AM J PATHOL, V61, P1; MUDD SH, 1974, HERITABLE DISORDERS, P429; MUDD SH, 1978, METABOLIC BASIS INHE, P458; ROTHMAN KJ, 1979, NIH791649 PUBL, P15; SARDHARWALLA IB, 1974, ARCH DIS CHILD, V49, P553, DOI 10.1136/adc.49.7.553; SORLIE P, 1977, NIH771247 PUBL, P83; WILCKEN DEL, 1976, J CLIN INVEST, V58, P1079	21	94	94	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	6					883	893						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV199	7325153				2022-12-18	WOS:A1981MV19900004
J	HOWARDPEEBLES, PN; STODDARD, GR; MIMS, MG				HOWARDPEEBLES, PN; STODDARD, GR; MIMS, MG			FAMILIAL X-LINKED MENTAL-RETARDATION, VERBAL DISABILITY, AND MARKER X CHROMOSOMES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ELLISVILLE STATE SCH,ELLISVILLE,MS 39437		HOWARDPEEBLES, PN (corresponding author), UNIV SO MISSISSIPPI,INST GENET,DEPT MICROBIOL,HATTIESBURG,MS 39401, USA.							Allan W, 1944, AM J MENT DEF, V48, P325; DEROOVER J, 1977, ANN GENET-PARIS, V20, P263; DUNN HG, 1962, AM J MENT DEFIC, V67, P827; GIRAUD F, 1976, HUM GENET, V34, P125, DOI 10.1007/BF00278880; HARVEY J, 1977, J MED GENET, V14, P46, DOI 10.1136/jmg.14.1.46; KENT DH, 1976, THESIS U SO MISS; LEHRKE RG, 1974, BIRTH DEFECTS OAS, V10; LUBS HA, 1969, AM J HUM GENET, V21, P231; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; RENPENNING H, 1962, CAN MED ASSOC J, V87, P954; Roe V, 1942, J SPEECH DISORD, V7, P37, DOI 10.1044/jshd.0701.37; SNYDER RD, 1969, CLIN PEDIATR, V8, P669, DOI 10.1177/000992286900801114; SUTHERLAND GR, 1977, SCIENCE, V197, P265, DOI 10.1126/science.877551; SUTHERLAND GR, 1977, NEW ENGL J MED, V296, P1415; Templin M.C., 1957, CERTAIN LANGUAGE SKI, DOI DOI 10.5749/J.CTTTV2ST; TURNER G, 1978, NEW ENGL J MED, V299, P1472; YARBROUGH KM, 1976, CLIN GENET, V9, P125	17	94	94	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1979	31	2					214	222						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	GZ386	453204				2022-12-18	WOS:A1979GZ38600011
J	BEUTLER, E; KUHL, W				BEUTLER, E; KUHL, W			BIOCHEMICAL AND ELECTROPHORETIC STUDIES OF ALPHA-GALACTOSIDASE IN NORMAL MAN, IN PATIENTS WITH FABRYS-DISEASE, AND IN EQUIDAE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BENSAUDE I, 1971, BIOCHEM BIOPH RES CO, V43, P913, DOI 10.1016/0006-291X(71)90704-2; BRADY RO, 1969, MED CLIN N AM, V53, P827, DOI 10.1016/S0025-7125(16)32735-3; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; DOFUKU R, 1971, NATURE-NEW BIOL, V232, P5, DOI 10.1038/newbio232005a0; HAKOMORI SI, 1971, J BIOL CHEM, V246, P2271; HANDA S, 1971, J BIOCHEM-TOKYO, V69, P625; KINT J A, 1970, Science (Washington D C), V167, P1268, DOI 10.1126/science.167.3922.1268; Krivit W, 1970, Trans Assoc Am Physicians, V83, P121; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAPES CA, 1970, SCIENCE, V169, P987, DOI 10.1126/science.169.3949.987; OHNO S, 1970, Clinical Genetics, V1, P121; OHNO S, 1971, Clinical Genetics, V2, P128; Ohno S., 1967, SEX CHROMOSOMES SEX; ROMEO G, 1970, SCIENCE, V170, P180, DOI 10.1126/science.170.3954.180; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SWEELEY CHARLES C., 1966, P618	16	94	95	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1972	24	3					237	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	M6948	5028964				2022-12-18	WOS:A1972M694800001
J	OKADA, S; VEATH, ML; LEROY, J; OBRIEN, JS				OKADA, S; VEATH, ML; LEROY, J; OBRIEN, JS			GANGLIOSIDE-GM2 STORAGE DISEASES - HEXOSAMINIDASE DEFICIENCIES IN CULTURED FIBROBLASTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		LEROY JG, 1967, SCIENCE, V157, P804, DOI 10.1126/science.157.3790.804; LOWRY OH, 1951, J BIOL CHEM, V193, P265; OBRIEN JS, 1970, NEW ENGL J MED, V283, P15, DOI 10.1056/NEJM197007022830104; OBRIEN JS, 1969, LANCET, V2, P805; OBRIEN JS, IN PRESS; OKADA S, 1969, SCIENCE, V165, P698, DOI 10.1126/science.165.3894.698; OKADA S, IN PRESS; SANDHOFF K, 1969, FEBS LETT, V4, P351, DOI 10.1016/0014-5793(69)80274-7	8	94	95	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1971	23	1					55	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	I6190	5581981				2022-12-18	WOS:A1971I619000006
J	WORKMAN, PL; COOPER, AJ; BLUMBERG, BS				WORKMAN, PL; COOPER, AJ; BLUMBERG, BS			SELECTION, GENE MIGRATION AND POLYMORPHIC STABILITY IN A U. S. WHITE AND NEGRO POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALLISON AC, 1958, NATURE, V181, P824, DOI 10.1038/181824a0; ALLISON AC, 1956, ANN HUM GENET, V21, P67, DOI 10.1111/j.1469-1809.1971.tb00266.x; ALLISON AC, TO BE PUBLISHED; ALLISON AC, 1962, U KANSAS SCI B; Bernstein P., 1931, COMITATO ITALIANO ST, P227; BEUTLER E, 1959, BLOOD, V14, P103, DOI 10.1182/blood.V14.2.103.103; BLUMBERG BS, 1961, NATURE, V189, P897, DOI 10.1038/189897a0; BLUMBERG BS, 1963, JAMA-J AM MED ASSOC, V184, P1021, DOI 10.1001/jama.1963.73700260004010b; BLUMBERG BS, 1961, ARCH ENVIRON HEALTH, V3, P612, DOI 10.1080/00039896.1961.10663084; BLUMBERG BS, PERSONAL COMMUNICATI; COOPER AJ, 1963, AM J HUM GENET, V15, P420; FAGE JC, 1959, HISTORY WEST AFRICA; FORD EB, 1960, EVOLUTION LIFE, V1; GERSHOWITZ H, 1959, AM J PHYS ANTHROPOL, V17, P195, DOI 10.1002/ajpa.1330170305; GIBLETT ER, 1960, AM J HUM GENET, V12, P160; GIBLETT ER, 1959, BRIT J HAEMATOL, V5, P319, DOI 10.1111/j.1365-2141.1959.tb04040.x; GLASS B, 1955, AM J HUM GENET, V7, P368; GLASS B, 1953, AM J HUM GENET, V5, P1; Herskovits MJ, 1941, MYTH NEGRO PAST; KIMURA M, 1956, S QUANT BIOL, V20, P33; KITCHIN FD, 1959, BMJ-BRIT MED J, V1, P1069, DOI 10.1136/bmj.1.5129.1069; LAYRISSE M, 1958, AM J PHYS ANTHROPOL, V16, P173, DOI 10.1002/ajpa.1330160203; MORAN PAP, 1962, STATISTICAL PROCESSE; MOTULSKY A, 1960, PROCESSES ONGOING HU; Mourant A., 1954, DISTRIBUTION HUMAN B; Mourant AE., 1958, ABO BLOOD GROUPS; PARKER WC, 1961, ANN HUM GENET, V25, P227; POLLITZER WS, 1958, AM J PHYS ANTHROPOL, V16, P241, DOI 10.1002/ajpa.1330160208; Race Robert Russell, 1958, BLOOD GROUPS MAN; ROBERTS DF, 1955, AM J HUM GENET, V7, P361; SALDANHA PH, 1957, AM J HUM GENET, V9, P299; SMITHIES O, 1962, AM J HUM GENET, V14, P14; STERN C, 1953, Acta Genet Stat Med, V4, P281; SUTTON H E, 1959, Ann Hum Genet, V23, P175	34	94	94	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	4					429	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2968A	14097237				2022-12-18	WOS:A19632968A00017
J	Gillies, CE; Putler, R; Menon, R; Otto, E; Yasutake, K; Nair, V; Hoover, P; Lieb, D; Li, SQ; Eddy, S; Fermin, D; McNulty, MT; Hacohen, N; Kiryluk, K; Kretzler, M; Wen, XQ; Sampson, MG				Gillies, Christopher E.; Putler, Rosemary; Menon, Rajasree; Otto, Edgar; Yasutake, Kalyn; Nair, Viji; Hoover, Paul; Lieb, David; Li, Shuqiang; Eddy, Sean; Fermin, Damian; McNulty, Michelle T.; Hacohen, Nir; Kiryluk, Krzysztof; Kretzler, Matthias; Wen, Xiaoquan; Sampson, Matthew G.		Nephrotic Syndrome Study Network	An eQTL Landscape of Kidney Tissue in Human Nephrotic Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE-EXPRESSION; RENAL DYSFUNCTION; RISK LOCI; ASSOCIATION; ARTHROGRYPOSIS; NEPHROPATHY; VARIANTS; GLOMERULOSCLEROSIS; SUSCEPTIBILITY; PHENOTYPE	Expression quantitative trait loci (eQTL) studies illuminate the genetics of gene expression and, in disease research, can be particularly illuminating when using the tissues directly impacted by the condition. In nephrology, there is a paucity of eQTL studies of human kidney. Here, we used whole-genome sequencing (WGS) and microdissected glomerular (GLOM) and tubulointerstitial (TI) transcriptomes from 187 individuals with nephrotic syndrome (NS) to describe the eQTL landscape in these functionally distinct kidney structures. Using MatrixEQTL, we performed cis-eQTL analysis on GLOM (n = 136) and TI (n = 166). We used the Bayesian "Deterministic Approximation of Posteriors'' (DAP) to fine-map these signals, eQTLBMA to discover GLOM- or TI-specific eQTLs, and single-cell RNA-seq data of control kidney tissue to identify the cell type specificity of significant eQTLs. We integrated eQTL data with an IgA Nephropathy (IgAN) GWAS to perform a transcriptome-wide association study (TWAS). We discovered 894 GLOM eQTLs and 1,767 TI eQTLs at FDR < 0.05. 14% and 19% of GLOM and TI eQTLs, respectively, had >1 independent signal associated with its expression. 12% and 26% of eQTLs were GLOM specific and TI specific, respectively. GLOM eQTLs were most significantly enriched in podocyte transcripts and TI eQTLs in proximal tubules. The IgAN TWAS identified significant GLOM and TI genes, primarily at the HLA region. In this study, we discovered GLOM and TI eQTLs, identified those that were tissue specific, deconvoluted them into cell-specific signals, and used them to characterize known GWAS alleles. These data are available for browsing and download via our eQTL browser, "nephQTL.''	[Gillies, Christopher E.; Putler, Rosemary; Yasutake, Kalyn; Fermin, Damian; McNulty, Michelle T.; Sampson, Matthew G.] Univ Michigan, Sch Med, Dept Pediat Nephrol, Ann Arbor, MI 48109 USA; [Menon, Rajasree; Kretzler, Matthias] Univ Michigan, Sch Med, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Otto, Edgar; Nair, Viji; Eddy, Sean; Kretzler, Matthias] Univ Michigan, Sch Med, Dept Med Nephrol, Ann Arbor, MI 48109 USA; [Hoover, Paul; Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Canc Ctr, Boston, MA 02114 USA; [Hoover, Paul; Lieb, David; Li, Shuqiang; Hacohen, Nir] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA; [Kiryluk, Krzysztof] Columbia Univ, Coll Phys & Surg, Dept Med, Div Nephrol, New York, NY USA; [Wen, Xiaoquan] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Columbia University; University of Michigan System; University of Michigan	Sampson, MG (corresponding author), Univ Michigan, Sch Med, Dept Pediat Nephrol, Ann Arbor, MI 48109 USA.	mgsamps@med.umich.edu		Wang, Chia-shi/0000-0001-6941-0057; Putler, Rosemary/0000-0001-7878-5491; Eddy, Sean/0000-0001-8578-3443; Menon, Rajasree/0000-0001-6280-9639; fornoni, Alessia/0000-0002-1313-7773; Urv, Tiina/0000-0002-2040-4972; McNulty, Michelle/0000-0002-2080-0940	Charles Woodson Clinical Research Fund; Ravitz Foundation; National Institutes of Health [RO1-DK108805, RO1-DK105124]; Office of Rare Diseases Research (ORDR), NCATS [U54-DK-083912]; National Institute of Diabetes, Digestive, and Kidney Diseases [U54-DK-083912]; University of Michigan; NephCure Kidney International; Halpin Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK083912, R01DK105124, R01DK108805] Funding Source: NIH RePORTER	Charles Woodson Clinical Research Fund; Ravitz Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Rare Diseases Research (ORDR), NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Diabetes, Digestive, and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Michigan(University of Michigan System); NephCure Kidney International; Halpin Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	M.G.S. is supported by the Charles Woodson Clinical Research Fund, the Ravitz Foundation, and National Institutes of Health RO1-DK108805. K.K. is supported by National Institutes of Health RO1-DK105124. The Nephrotic Syndrome Study Network Consortium (NEPTUNE), U54-DK-083912, is a part of the National Center for Advancing Translational Sciences (NCATS) Rare Disease Clinical Research Network (RDCRN), supported through a collaboration between the Office of Rare Diseases Research (ORDR), NCATS, and the National Institute of Diabetes, Digestive, and Kidney Diseases. RDCRN is an initiative of ORDR, NCATS. Additional funding and/or programmatic support for this project has also been provided by the University of Michigan, NephCure Kidney International, and the Halpin Foundation.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barbeira AN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03621-1; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Cevikbas F, 2008, MATRIX BIOL, V27, P42, DOI 10.1016/j.matbio.2007.07.003; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Flutre T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003486; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gadegbeku CA, 2013, KIDNEY INT, V83, P749, DOI 10.1038/ki.2012.428; Gagliardini E, 2006, CYTOKINE GROWTH F R, V17, P89, DOI 10.1016/j.cytogfr.2005.09.005; Gamazon ER, 2015, NAT GENET, V47, P1091, DOI 10.1038/ng.3367; Gbadegesin RA, 2015, J AM SOC NEPHROL, V26, P1701, DOI 10.1681/ASN.2014030247; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gharavi AG, 2011, NAT GENET, V43, P321, DOI 10.1038/ng.787; Gipson DS, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-30; Gissen P, 2005, HUM MOL GENET, V14, P1261, DOI 10.1093/hmg/ddi137; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Goldwich A, 2013, J AM SOC NEPHROL, V24, P906, DOI 10.1681/ASN.2012020133; Hingorani SR, 2002, PEDIATR NEPHROL, V17, P678, DOI 10.1007/s00467-002-0890-6; Holme A, 2013, CLIN KIDNEY J, V6, P183, DOI 10.1093/ckj/sfs182; Iyengar SK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005352; Ju WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7071; Jun G, 2015, GENOME RES, V25, P918, DOI 10.1101/gr.176552.114; Kerlin BA, 2009, J PEDIATR-US, V155, P105, DOI 10.1016/j.jpeds.2009.01.070; Kiryluk K, 2014, NAT GENET, V46, P1187, DOI 10.1038/ng.3118; Ko YA, 2017, AM J HUM GENET, V100, P940, DOI 10.1016/j.ajhg.2017.05.004; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Lin DY, 2009, GENET EPIDEMIOL, V33, P256, DOI 10.1002/gepi.20377; Lockstone HE, 2011, BRIEF BIOINFORM, V12, P634, DOI 10.1093/bib/bbq086; Lu YQ, 2017, KIDNEY INT, V92, P1119, DOI 10.1016/j.kint.2017.04.022; Muller YL, 2015, HUM MOL GENET, V24, P2985, DOI 10.1093/hmg/ddv040; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Okamoto K, 2011, NAT GENET, V43, P459, DOI 10.1038/ng.792; Olden M, 2014, J AM SOC NEPHROL, V25, P1869, DOI 10.1681/ASN.2013070781; Parts L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001276; Peters JE, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005908; Rao DA, 2018, BIORXIV275859, DOI [10.1101/275859, DOI 10.1101/275859]; Rogers NM, 2014, NAT REV NEPHROL, V10, P625, DOI 10.1038/nrneph.2014.170; Ruth EM, 2004, J PEDIATR-US, V145, P778, DOI 10.1016/j.jpeds.2004.08.022; Sajuthi SP, 2016, HUM GENET, V135, P869, DOI 10.1007/s00439-016-1680-8; Sampson MG, 2016, J AM SOC NEPHROL, V27, P1970, DOI 10.1681/ASN.2015050504; Sampson MG, 2016, J AM SOC NEPHROL, V27, P814, DOI 10.1681/ASN.2014111131; Sampson MG, 2015, SEMIN NEPHROL, V35, P212, DOI 10.1016/j.semnephrol.2015.04.002; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Toda N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42114; Trudu M, 2013, NAT MED, V19, P1655, DOI 10.1038/nm.3384; Vivante A, 2016, NAT REV NEPHROL, V12, P133, DOI 10.1038/nrneph.2015.205; Walsh AM, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0948-6; Wen XQ, 2016, ANN APPL STAT, V10, P1619, DOI 10.1214/16-AOAS952; Wen XQ, 2016, AM J HUM GENET, V98, P1114, DOI 10.1016/j.ajhg.2016.03.029; Wen XQ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005176; Weyand AC, 2016, PEDIATR BLOOD CANCER, V63, P561, DOI 10.1002/pbc.25814; Yu HY, 2016, J CLIN INVEST, V126, P1067, DOI 10.1172/JCI82592; Zhang JY, 2018, P NATL ACAD SCI USA, V115, P3446, DOI 10.1073/pnas.1716113115; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	66	93	93	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 2	2018	103	2					232	244		10.1016/j.ajhg.2018.07.004	http://dx.doi.org/10.1016/j.ajhg.2018.07.004			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GP1GR	30057032	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000440563700006
J	Strauss, KA; Jinks, RN; Puffenberger, EG; Venkatesh, S; Singh, K; Cheng, I; Mikita, N; Thilagavathi, J; Lee, J; Sarafianos, S; Benkert, A; Koehler, A; Zhu, AN; Trovillion, V; McGlincy, M; Morlet, T; Deardorff, M; Innes, AM; Prasad, C; Chudley, AE; Lee, INW; Suzuki, CK				Strauss, Kevin A.; Jinks, Robert N.; Puffenberger, Erik G.; Venkatesh, Sundararajan; Singh, Kamalendra; Cheng, Iteen; Mikita, Natalie; Thilagavathi, Jayapalraja; Lee, Jae; Sarafianos, Stefan; Benkert, Abigail; Koehler, Alanna; Zhu, Anni; Trovillion, Victoria; McGlincy, Madeleine; Morlet, Thierry; Deardorff, Matthew; Innes, A. Micheil; Prasad, Chitra; Chudley, Albert E.; Lee, Irene Nga Wing; Suzuki, Carolyn K.			CODAS Syndrome Is Associated with Mutations of LONP1, Encoding Mitochondrial AAA(+) Lon Protease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSCRIPTION FACTOR; SKELETAL ANOMALIES; ACTIVE-SITE; DNA-BINDING; PROTEINS; ACCUMULATION; DEGRADATION; SUBSTRATE; YEAST; DISEASE	CODAS syndrome is a multi-system developmental disorder characterized by cerebral, ocular, dental, auricular, and skeletal anomalies. Using whole-exome and Sanger sequencing, we identified four LONP1 mutations inherited as homozygous or compound-heterozygous combinations among ten individuals with CODAS syndrome. The individuals come from three different ancestral backgrounds (Amish-Swiss from United States, n = 8; Mennonite-German from Canada, n = 1; mixed European from Canada, n = 1). LONP1 encodes Lon protease, a homohexameric enzyme that mediates protein quality control, respiratory-complex assembly, gene expression, and stress responses in mitochondria. All four pathogenic amino acid substitutions cluster within the AAA(+) domain at residues near the ATP-binding pocket. In biochemical assays, pathogenic Lon proteins show substrate-specific defects in ATP-dependent proteolysis. When expressed recombinantly in cells, all altered Lon proteins localize to mitochondria. The Old Order Amish Lon variant (LONP1 c.2161C>G[p. Arg721Gly]) homo-oligomerizes poorly in vitro. Lymphoblastoid cell lines generated from affected children have (1) swollen mitochondria with electron-dense inclusions and abnormal inner-membrane morphology; (2) aggregated MT-CO2, the mtDNA-encoded subunit II of cytochrome c oxidase; and (3) reduced spare respiratory capacity, leading to impaired mitochondrial proteostasis and function. CODAS syndrome is a distinct, autosomal-recessive, developmental disorder associated with dysfunction of the mitochondrial Lon protease.	[Strauss, Kevin A.; Puffenberger, Erik G.; Benkert, Abigail] Clin Special Children, Strasburg, PA 17579 USA; [Strauss, Kevin A.] Lancaster Gen Hosp, Lancaster, PA 17602 USA; [Strauss, Kevin A.; Jinks, Robert N.; Puffenberger, Erik G.; Benkert, Abigail; Koehler, Alanna; Zhu, Anni; Trovillion, Victoria; McGlincy, Madeleine] Franklin & Marshall Coll, Dept Biol, Lancaster, PA 17603 USA; [Strauss, Kevin A.; Jinks, Robert N.; Puffenberger, Erik G.; Benkert, Abigail; Koehler, Alanna; Zhu, Anni; Trovillion, Victoria; McGlincy, Madeleine] Franklin & Marshall Coll, Biol Fdn Behav Program, Lancaster, PA 17603 USA; [Venkatesh, Sundararajan; Singh, Kamalendra; Thilagavathi, Jayapalraja; Lee, Jae; Suzuki, Carolyn K.] Rutgers State Univ, Dept Microbiol Biochem & Mol Genet, New Jersey Med Sch, Newark, NJ 07103 USA; [Cheng, Iteen; Mikita, Natalie; Lee, Irene Nga Wing] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Singh, Kamalendra; Sarafianos, Stefan] Univ Missouri, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65201 USA; [Morlet, Thierry] duPont Hosp Children, Auditory Physiol & Psychoacoust Res Lab, Wilmington, DE 19803 USA; [Deardorff, Matthew] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Deardorff, Matthew] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Innes, A. Micheil] Univ Calgary, Dept Med Genet, Calgary, AB T2N 1N4, Canada; [Innes, A. Micheil] Univ Calgary, Alberta Childrens Hosp Res Inst, Cumming Sch Med, Calgary, AB T2N 1N4, Canada; [Prasad, Chitra] Childrens Hlth Res Inst, Med Genet Program, Dept Pediat, London, ON N6C 2V5, Canada; [Prasad, Chitra] Univ Western Ontario, London, ON N6C 2V5, Canada; [Chudley, Albert E.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3A 1S1, Canada; [Chudley, Albert E.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3A 1S1, Canada	Franklin & Marshall College; Franklin & Marshall College; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Case Western Reserve University; University of Missouri System; University of Missouri Columbia; Nemours Alfred I. duPont Hospital for Children; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Calgary; University of Calgary; Western University (University of Western Ontario); University of Manitoba; University of Manitoba	Strauss, KA (corresponding author), Clin Special Children, Strasburg, PA 17579 USA.	kstrauss@clinicforspecialchildren.org	innes, allan micheil/A-9955-2017; Morlet, Thierry/AAL-8442-2021; Sundararajan, Venkatesh/H-3837-2014	Sundararajan, Venkatesh/0000-0003-4195-7776; Koehler, Alanna E./0000-0002-0148-7418; Puffenberger, Erik/0000-0002-6388-9148; Innes, Micheil/0000-0001-9881-5467; Sarafianos, Stefan G/0000-0002-5840-154X	Howard Hughes Medical Institute [52006294, 52007538]; Center for Research on Women and Newborn Health; ConnectCare3; National Science Foundation [CHE-1213175]; National Institutes of Health [R01GM084039, 1R21NS067668]; NJ Health Science Foundation; Direct For Mathematical & Physical Scien [1213175] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067668] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Center for Research on Women and Newborn Health; ConnectCare3; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NJ Health Science Foundation; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Kimberly Jacob, Prashant Patel, Ana Quiroz, and Jennie Silver for technical assistance and D. Streck from the Molecular Genetics Laboratory at the Rutgers New Jersey Medical School for next-generation mtDNA sequencing. R.N.J., E.G.P., and K.A.S. were supported by Howard Hughes Medical Institute undergraduate science education awards 52006294 and 52007538. R.N.J. was also supported by the Center for Research on Women and Newborn Health and by ConnectCare3. I.L. was supported by National Science Foundation grant CHE-1213175. C.K.S. was supported in part by National Institutes of Health grants R01GM084039 and 1R21NS067668 and also by the NJ Health Science Foundation. The Clinic for Special Children is supported by charitable donations from the communities it serves.	Barshop BA, 2004, MITOCHONDRION, V4, P521, DOI 10.1016/j.mito.2004.07.010; Bernstein SH, 2012, BLOOD, V119, P3321, DOI 10.1182/blood-2011-02-340075; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4; Botos I, 2004, J BIOL CHEM, V279, P8140, DOI 10.1074/jbc.M312243200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breuer ME, 2013, NEUROBIOL DIS, V51, P27, DOI 10.1016/j.nbd.2012.03.007; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Chen SH, 2008, NUCLEIC ACIDS RES, V36, P1273, DOI 10.1093/nar/gkm1140; DEALMEIDA JCC, 1995, AM J MED GENET, V55, P19, DOI 10.1002/ajmg.1320550107; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Di Fonzo A, 2009, AM J HUM GENET, V84, P594, DOI 10.1016/j.ajhg.2009.04.004; DiMauro S, 2013, NAT REV NEUROL, V9, P429, DOI 10.1038/nrneurol.2013.126; DISANTAGNESE PA, 1984, ULTRASTRUCT PATHOL, V6, P247, DOI 10.3109/01913128409018580; Duman RE, 2010, J MOL BIOL, V401, P653, DOI 10.1016/j.jmb.2010.06.030; Fishovitz J, 2011, ACS CHEM BIOL, V6, P781, DOI 10.1021/cb100408w; Fu GK, 1998, BIOCHEMISTRY-US, V37, P1905, DOI 10.1021/bi970928c; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Guha S, 2011, J MOL BIOL, V408, P222, DOI 10.1016/j.jmb.2011.02.044; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hirano M, 2004, NEUROLOGIST, V10, P8, DOI 10.1097/01.nrl.0000106919.06469.04; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Innes AM, 2001, AM J MED GENET, V102, P44, DOI 10.1002/1096-8628(20010722)102:1<44::AID-AJMG1410>3.0.CO;2-7; Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013; Jin SM, 2013, AUTOPHAGY, V9, P1750, DOI 10.4161/auto.26122; Koopman WJH, 2013, EMBO J, V32, P9, DOI 10.1038/emboj.2012.300; Lee I, 2001, ANAL BIOCHEM, V291, P74, DOI 10.1006/abio.2001.4988; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Lohr NJ, 2010, AM J HUM GENET, V86, P447, DOI 10.1016/j.ajhg.2010.01.028; Lu B, 2003, GENE, V306, P45, DOI 10.1016/S0378-1119(03)00403-7; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; Lu B, 2013, MOL CELL, V49, P121, DOI 10.1016/j.molcel.2012.10.023; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Marlin S, 2010, AM J MED GENET A, V152A, P1510, DOI 10.1002/ajmg.a.33242; Matsushima Y, 2010, P NATL ACAD SCI USA, V107, P18410, DOI 10.1073/pnas.1008924107; Neuwald AF, 1999, GENOME RES, V9, P27; Ngo JK, 2013, REDOX BIOL, V1, P258, DOI 10.1016/j.redox.2013.01.015; Ondrovicova G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; Puffenberger EG, 2007, BRAIN, V130, P1929, DOI 10.1093/brain/awm100; Puffenberger EG, 2012, HUM MUTAT, V33, P1639, DOI 10.1002/humu.22237; Puffenberger EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028936; Quiros PM, 2014, CELL REP, V8, P541, DOI 10.1016/j.celrep.2014.06.018; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Scorrano L, 2002, DEV CELL, V2, P55, DOI 10.1016/S1534-5807(01)00116-2; SHEBIB SM, 1991, AM J MED GENET, V40, P88, DOI 10.1002/ajmg.1320400118; Sherman EA, 2008, AM J HUM GENET, V83, P604, DOI 10.1016/j.ajhg.2008.09.018; Smakowska E, 2014, MITOCHONDRION, V19, P245, DOI 10.1016/j.mito.2014.03.005; Solheim C, 2012, PLANT PHYSIOL, V160, P1187, DOI 10.1104/pp.112.203711; Strauss KA, 2005, AM J MED GENET A, V138A, P262, DOI 10.1002/ajmg.a.30961; Strauss KA, 2008, CLIN IMMUNOL, V128, P31, DOI 10.1016/j.clim.2008.02.016; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; Teng HJ, 2013, P NATL ACAD SCI USA, V110, P12679, DOI 10.1073/pnas.1308487110; Thomas RE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004279; Thomas-Wohlever J, 2002, BIOCHEMISTRY-US, V41, P9418, DOI 10.1021/bi0255470; Tian Q, 2011, J BIOL CHEM, V286, P26424, DOI 10.1074/jbc.M110.215772; Truscott KN, 2010, BIOCHEM CELL BIOL, V88, P97, DOI [10.1139/O09-167, 10.1139/o09-167]; Um JW, 2009, MOL CELL NEUROSCI, V40, P421, DOI 10.1016/j.mcn.2008.12.010; VANDYCK L, 1994, J BIOL CHEM, V269, P238; Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003; Wilman HR, 2014, PROTEINS, V82, P1960, DOI 10.1002/prot.24550; Wohlever ML, 2014, MOL MICROBIOL, V91, P66, DOI 10.1111/mmi.12444; Wong TS, 2009, NUCLEIC ACIDS RES, V37, P6765, DOI 10.1093/nar/gkp750	68	93	95	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 8	2015	96	1					121	135		10.1016/j.ajhg.2014.12.003	http://dx.doi.org/10.1016/j.ajhg.2014.12.003			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AY6YE	25574826	Green Published, Bronze			2022-12-18	WOS:000347707800009
J	Auer, PL; Johnsen, JM; Johnson, AD; Logsdon, BA; Lange, LA; Nalls, MA; Zhang, GS; Franceschini, N; Fox, K; Lange, EM; Rich, SS; O'Donnell, CJ; Jackson, RD; Wallace, RB; Chen, Z; Graubert, TA; Wilson, JG; Tang, H; Lettre, G; Reiner, AP; Ganesh, SK; Li, Y				Auer, Paul L.; Johnsen, Jill M.; Johnson, Andrew D.; Logsdon, Benjamin A.; Lange, Leslie A.; Nalls, Michael A.; Zhang, Guosheng; Franceschini, Nora; Fox, Keolu; Lange, Ethan M.; Rich, Stephen S.; O'Donnell, Christopher J.; Jackson, Rebecca D.; Wallace, Robert B.; Chen, Zhao; Graubert, Timothy A.; Wilson, James G.; Tang, Hua; Lettre, Guillaume; Reiner, Alex P.; Ganesh, Santhi K.; Li, Yun		Natl Heart Lung Blood Inst	Imputation of Exome Sequence Variants into Population-Based Samples and Blood-Cell-Trait-Associated Loci in African Americans: NHLBI GO Exome Sequencing Project	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; GENOTYPE IMPUTATION; POSITIVE SELECTION; MUTATION; SNP; THROMBOPOIETIN; THROMBOCYTOSIS; METAANALYSIS; DEFICIENCY	Researchers have successfully applied exome sequencing to discover causal variants in selected individuals with familial, highly penetrant disorders. We demonstrate the utility of exome sequencing followed by imputation for discovering low-frequency variants associated with complex quantitative traits. We performed exome sequencing in a reference panel of 761 African Americans and then imputed newly discovered variants into a larger sample of more than 13,000 African Americans for association testing with the blood cell traits hemoglobin, hematocrit, white blood count, and platelet count. First, we illustrate the feasibility of our approach by demonstrating genome-wide-significant associations for variants that are not covered by conventional genotyping arrays; for example, one such association is that between higher platelet count and an MPL c.117G>T (p.Lys39Asn) variant encoding a p.Lys39Asn amino acid substitution of the thrombpoietin receptor gene (p = 1.5 x 10(-11)). Second, we identified an association between missense variants of LCT and higher white blood count (p = 4 x 10(-13)). Third, we identified low-frequency coding variants that might account for allelic heterogeneity at several known blood cell-associated loci: MPL c.754T>C (p.Tyr252His) was associated with higher platelet count; CD36 c.975T>G (p.Tyr325*) was associated with lower platelet count; and several missense variants at the alpha-globin gene locus were associated with lower hemoglobin. By identifying low-frequency missense variants associated with blood cell traits not previously reported by genome-wide association studies, we establish that exome sequencing followed by imputation is a powerful approach to dissecting complex, genetically heterogeneous traits in large population-based studies.	[Auer, Paul L.; Logsdon, Benjamin A.; Reiner, Alex P.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Johnsen, Jill M.] Puget Sound Blood Ctr, Res Inst, Seattle, WA 98109 USA; [Johnsen, Jill M.; Fox, Keolu] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Johnsen, Jill M.; Fox, Keolu] Univ Washington, Dept Epidemiol & Genome Sci, Seattle, WA 98195 USA; [Johnson, Andrew D.; O'Donnell, Christopher J.] NHLBI, Ctr Populat Studies, Framingham Heart Study, Framingham, MA 01702 USA; [Lange, Leslie A.; Zhang, Guosheng; Franceschini, Nora; Lange, Ethan M.; Li, Yun] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Lange, Leslie A.; Zhang, Guosheng; Franceschini, Nora; Lange, Ethan M.; Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Lange, Leslie A.; Zhang, Guosheng; Franceschini, Nora; Lange, Ethan M.; Li, Yun] Univ N Carolina, Dept Biostat Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Nalls, Michael A.; Reiner, Alex P.] NIA, Mol Genet Sect, Neurogenet Lab, Bethesda, MD 20892 USA; [Rich, Stephen S.] Univ Virginia, Dept Publ Hlth Sci, Ctr Publ Hlth Gen, Charlottesville, VA 22908 USA; [Jackson, Rebecca D.] Ohio State Univ, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Wallace, Robert B.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA; [Chen, Zhao] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Epidemiol & Biostat, Tucson, AZ 85724 USA; [Graubert, Timothy A.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Tang, Hua] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Tang, Hua] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Lettre, Guillaume] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Lettre, Guillaume] Univ Montreal, Dept Med, Montreal, PQ H1T 1C8, Canada; [Ganesh, Santhi K.] Univ Michigan, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI 48108 USA	Fred Hutchinson Cancer Center; Puget Sound Blood Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Virginia; University System of Ohio; Ohio State University; University of Iowa; University of Arizona; Washington University (WUSTL); University of Mississippi; University of Mississippi Medical Center; Stanford University; Stanford University; Universite de Montreal; Universite de Montreal; University of Michigan System; University of Michigan	Reiner, AP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA.	apreiner@u.washington.edu; yunli@med.unc.edu	Johnson, Andrew D/G-6520-2013; Auer, Paul/AAC-5060-2019	Johnson, Andrew D/0000-0001-6369-5178; Logsdon, Benjamin A/0000-0002-0572-2569; Rich, Stephen/0000-0003-3872-7793; Graubert, Timothy/0000-0002-7710-1171	National Heart, Lung, and Blood Institute (NHLBI); NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926, HHSN268200960009C]; National Human Genome Research Institute [R01HG006292, R01HG006703]; Intramural Research Program of the National Institutes of Health, National Institute on Aging [Z01-AG000932-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006170, RC2HL103010, ZIAHL006173, RC2HL102924, RC2HL102923, UC2HL102924, RC2HL102925, R01HL065226, RC2HL102926, ZIAHL006175, ZIAHL006002] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006703, R01HG006292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000932] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors wish to acknowledge the support of the National Heart, Lung, and Blood Institute (NHLBI) and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research. Funding for GO ESP was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (LungGO), and RC2 HL-102924 (WHISP). The exome sequencing was performed through NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). CARe was supported by a contract from NHLBI (HHSN268200960009C) to create a phenotype and genotype database for dissemination to the biomedical research community. Eight parent studies contributed phenotypic data and DNA samples through the Broad Institute (N01-HC-65226): the Atherosclerosis Risk in Communities study (ARIC), the Cleveland Family Study (CFS), the Coronary Artery Risk Development in Young Adults study (CARDIA), the Jackson Heart Study OHS), the Multi-Ethnic Study of Atherosclerosis (MESA) study, the Cardiovascular Health Study (CHS), the Framingham Heart Study (FHS), and the Sleep Heart Health Study (SHHS). Support for CARe also came from the individual research institutions, investigators, field staff, and study participants. This research was supported in part by grants from the National Human Genome Research Institute to Y.L. (R01HG006292 and R01HG006703). This research was also supported in part by the Intramural Research Program of the National Institutes of Health, National Institute on Aging (Z01-AG000932-04), and this study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health (see Web Resources).	ALBITAR M, 1992, BLOOD, V80, P1586; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Chen WM, 2010, J BIOL CHEM, V285, P26697, DOI 10.1074/jbc.M110.120956; Colantuoni C, 2011, NATURE, V478, P519, DOI 10.1038/nature10524; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Ding JM, 2009, BLOOD, V114, P3325, DOI 10.1182/blood-2008-04-149047; Ding J, 2010, AM J HUM GENET, V87, P779, DOI 10.1016/j.ajhg.2010.10.024; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; El-Harith EHA, 2009, BRIT J HAEMATOL, V144, P185, DOI 10.1111/j.1365-2141.2008.07430.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Evans D M, 1999, Twin Res, V2, P250, DOI 10.1375/136905299320565735; Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1; Flannick J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002604; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Fry AE, 2009, HUM MOL GENET, V18, P2683, DOI 10.1093/hmg/ddp192; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ghosh A, 2011, BLOOD, V117, P6355, DOI 10.1182/blood-2011-02-338582; Gieger C, 2011, NATURE, V480, P201, DOI 10.1038/nature10659; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Goh SH, 2005, BLOOD, V106, P1466, DOI 10.1182/blood-2005-03-0948; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Greenawalt DM, 2011, GENOME RES, V21, P1008, DOI 10.1101/gr.112821.110; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Heap GA, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-1; Heinzen EL, 2008, PLOS BIOL, V6, P2869, DOI 10.1371/journal.pbio.1000001; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Innocenti F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002078; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Kamatani Y, 2010, NAT GENET, V42, P210, DOI 10.1038/ng.531; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Kompass KS, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-6; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Lannutti BJ, 2009, BLOOD, V113, P1778, DOI 10.1182/blood-2007-11-124859; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y, 2011, GENOME RES, V21, P940, DOI 10.1101/gr.117259.110; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liu EY, 2012, GENET EPIDEMIOL, V36, P107, DOI 10.1002/gepi.21603; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Love-Gregory L, 2011, HUM MOL GENET, V20, P193, DOI 10.1093/hmg/ddq449; Maddatu TP, 2012, NUCLEIC ACIDS RES, V40, pD887, DOI 10.1093/nar/gkr1061; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Mathieson I, 2012, NAT GENET, V44, P243, DOI 10.1038/ng.1074; Meisinger C, 2009, AM J HUM GENET, V84, P66, DOI 10.1016/j.ajhg.2008.11.015; Moliterno AR, 2004, P NATL ACAD SCI USA, V101, P11444, DOI 10.1073/pnas.0404241101; Morel-Kopp MC, 2001, THROMB HAEMOSTASIS, V86, P1425; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879; Pasaniuc B, 2012, NAT GENET, V44, P631, DOI 10.1038/ng.2283; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Qayyum R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002491; Ramsuran V, 2011, CLIN INFECT DIS, V52, P1248, DOI 10.1093/cid/cir119; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Resing KA, 2004, ANAL CHEM, V76, P3556, DOI 10.1021/ac035229m; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Schroder A., 2011, PHARM J; Serbanovic-Canic J, 2011, BLOOD, V118, P4967, DOI 10.1182/blood-2011-02-337295; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Taylor Jr HA, 2005, ETHN DIS S6, V15, pS6; Tiedt R, 2009, BLOOD, V113, P1768, DOI 10.1182/blood-2008-03-146084; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Williams W.J, 1972, HEMATOLOGY, P10; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	83	93	95	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					794	808		10.1016/j.ajhg.2012.08.031	http://dx.doi.org/10.1016/j.ajhg.2012.08.031			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23103231	Green Published, Bronze			2022-12-18	WOS:000311011400003
J	Mendez, FL; Watkins, JC; Hammer, MF				Mendez, Fernando L.; Watkins, Joseph C.; Hammer, Michael F.			A Haplotype at STAT2 Introgressed from Neanderthals and Serves as a Candidate of Positive Selection in Papua New Guinea	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ARCHAIC ADMIXTURE; POLYMORPHISM; POPULATIONS; CHROMOSOME; RESOLUTION; DIVERSITY; SEQUENCE	Signals of archaic admixture have been identified through comparisons of the draft Neanderthal and Denisova genomes with those of living humans. Studies of individual loci contributing to these genome-wide average signals are required for characterization of the introgression process and investigation of whether archaic variants conferred an adaptive advantage to the ancestors of contemporary human populations. However, no definitive case of adaptive introgression has yet been described. Here we provide a DNA sequence analysis of the innate immune gene STAT2 and show that a haplotype carried by many Eurasians (but not sub-Saharan Africans) has a sequence that closely matches that of the Neanderthal STAT2. This haplotype, referred to as N, was discovered through a resequencing survey of the entire coding region of STAT2 in a global sample of 90 individuals. Analyses of publicly available complete genome sequence data show that haplotype N shares a recent common ancestor with the Neanderthal sequence (similar to 80 thousand years ago) and is found throughout Eurasia at an average frequency of similar to 5%. Interestingly, N is found in Melanesian populations at similar to 10-fold higher frequency (similar to 54%) than in Eurasian populations. A neutrality test that controls for demography rejects the hypothesis that a variant of N rose to high frequency in Melanesia by genetic drift alone. Although we are not able to pinpoint the precise target of positive selection, we identify nonsynonymous mutations in ERBB3, ESYT1, and STAT2-all of which are part of the same 250 kb introgressive haplotype-as good candidates.	[Mendez, Fernando L.; Hammer, Michael F.] Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA; [Mendez, Fernando L.; Hammer, Michael F.] Univ Arizona, Res Labs, Div Biotechnol, Tucson, AZ 85721 USA; [Watkins, Joseph C.] Univ Arizona, Dept Math, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; University of Arizona	Hammer, MF (corresponding author), Univ Arizona, Dept Ecol & Evolut Biol, Tucson, AZ 85721 USA.	mfh@u.arizona.edu		Mendez, Fernando/0000-0002-0879-3813	National Science Foundation HOMINID grant [BCS-0423670]	National Science Foundation HOMINID grant	We thank August Woerner and Krishna Veeramah for comments on the manuscript. This research was funded by a National Science Foundation HOMINID grant (BCS-0423670) to M.F.H.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Currat M, 2011, P NATL ACAD SCI USA, V108, P15129, DOI 10.1073/pnas.1107450108; Evans PD, 2006, P NATL ACAD SCI USA, V103, P18178, DOI 10.1073/pnas.0606966103; Garrigan D, 2005, MOL BIOL EVOL, V22, P189, DOI 10.1093/molbev/msi013; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hardy J, 2005, BIOCHEM SOC T, V33, P582, DOI 10.1042/BST0330582; Hawks J, 2008, TRENDS GENET, V24, P19, DOI 10.1016/j.tig.2007.10.003; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Lalioti V, 2009, P NATL ACAD SCI USA, V106, P4249, DOI 10.1073/pnas.0900218106; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li YH, 2009, SEMIN IMMUNOL, V21, P318, DOI 10.1016/j.smim.2009.04.002; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mendez FL, 2012, MOL BIOL EVOL, V29, P1513, DOI 10.1093/molbev/msr301; Mendez FL, 2011, HUM BIOL, V83, P39, DOI 10.3378/027.083.0103; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Reed DL, 2004, PLOS BIOL, V2, P1972, DOI 10.1371/journal.pbio.0020340; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reich NC, 2007, CYTOKINE GROWTH F R, V18, P511, DOI 10.1016/j.cytogfr.2007.06.021; Schuster SC, 2010, NATURE, V463, P943, DOI 10.1038/nature08795; TAJIMA F, 1989, GENETICS, V123, P585; TAKAHATA N, 1990, GENETICS, V124, P967; THOMSON G, 1991, BAILLIERE CLIN ENDOC, V5, P247, DOI 10.1016/S0950-351X(05)80126-0; Wall JD, 2008, GENOME RES, V18, P1354, DOI 10.1101/gr.075630.107; Wessel P., 1998, EOS T AM GEOPHYS UN, V79, P579, DOI [DOI 10.1029/98E000426, 10.1029/98EO00426]; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Xing JC, 2010, GENOMICS, V96, P199, DOI 10.1016/j.ygeno.2010.07.004; Yotova V, 2011, MOL BIOL EVOL, V28, P1957, DOI 10.1093/molbev/msr024; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142; Zietkiewicz E, 2003, AM J HUM GENET, V73, P994, DOI 10.1086/378777	36	93	94	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					265	274		10.1016/j.ajhg.2012.06.015	http://dx.doi.org/10.1016/j.ajhg.2012.06.015			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22883142	Green Published, Bronze			2022-12-18	WOS:000307608700005
J	Campeau, PM; Kim, JC; Lu, JT; Schwartzentruber, JA; Abdul-Rahman, OA; Schlaubitz, S; Murdock, DM; Jiang, MM; Lammer, EJ; Enns, GM; Rhead, WJ; Rowland, J; Robertson, SP; Cormier-Daire, V; Bainbridge, MN; Yang, XJ; Gingras, MC; Gibbs, RA; Rosenblatt, DS; Majewski, J; Lee, BH				Campeau, Philippe M.; Kim, Jaeseung C.; Lu, James T.; Schwartzentruber, Jeremy A.; Abdul-Rahman, Omar A.; Schlaubitz, Silke; Murdock, David M.; Jiang, Ming-Ming; Lammer, Edward J.; Enns, Gregory M.; Rhead, William J.; Rowland, Jon; Robertson, Stephen P.; Cormier-Daire, Valerie; Bainbridge, Matthew N.; Yang, Xiang-Jiao; Gingras, Marie-Claude; Gibbs, Richard A.; Rosenblatt, David S.; Majewski, Jacek; Lee, Brendan H.			Mutations in KAT6B, Encoding a Histone Acetyltransferase, Cause Genitopatellar Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ABSENT PATELLAE; STEM-CELLS; PHENOTYPE; PROTEIN; FEMALE; IDENTIFICATION; COACTIVATOR; ANOMALIES; TUMOR; LMX1B	Genitopatellar syndrome (GPS) is a skeletal dysplasia with cerebral and genital anomalies for which the molecular basis has not yet been determined. By exome sequencing, we found de novo heterozygous truncating mutations in KAT6B (lysine acetyltransferase 6B, formerly known as MYST4 and MORF) in three subjects; then by Sanger sequencing of KAT6B, we found similar mutations in three additional subjects. The mutant transcripts do not undergo nonsense-mediated decay in cells from subjects with GPS. In addition, human pathological analyses and mouse expression studies point to systemic roles of KAT6B in controlling organismal growth and development. Myst4 (the mouse orthologous gene) is expressed in mouse tissues corresponding to those affected by GPS. Phenotypic differences and similarities between GPS, the Say-Barber-Biesecker variant of Ohdo syndrome (caused by different mutations of KAT6B), and Rubinstein-Taybi syndrome (caused by mutations in other histone acetyltransferases) are discussed. Together, the data support an epigenetic dysregulation of the limb, brain, and genital developmental programs.	[Campeau, Philippe M.; Schlaubitz, Silke; Jiang, Ming-Ming; Gingras, Marie-Claude; Gibbs, Richard A.; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Kim, Jaeseung C.; Rosenblatt, David S.; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Lu, James T.; Murdock, David M.; Gingras, Marie-Claude; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lu, James T.; Bainbridge, Matthew N.] Baylor Coll Med, Dept Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Schwartzentruber, Jeremy A.; Majewski, Jacek] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Schwartzentruber, Jeremy A.; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Abdul-Rahman, Omar A.] Univ Mississippi, Med Ctr, Dept Pediat, Div Med Genet, Jackson, MS 39216 USA; [Lammer, Edward J.] Childrens Hosp & Res Ctr, Div Med Genet, Oakland, CA 94609 USA; [Enns, Gregory M.] Stanford Univ, Dept Pediat, Div Med Genet, Stanford, CA 94305 USA; [Rhead, William J.] Med Coll Wisconsin, Genet Sect, Dept Pediat, Milwaukee, WI 53226 USA; [Robertson, Stephen P.] Dunedin Sch Med, Dept Pediat, Dunedin 9054, New Zealand; [Cormier-Daire, Valerie] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, Unite Inst Natl Sante & Rech Med INSERM,U781, Paris 15, France; [Yang, Xiang-Jiao] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Yang, Xiang-Jiao; Rosenblatt, David S.] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ H3A 1A1, Canada; [Rosenblatt, David S.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Rosenblatt, David S.] McGill Univ, Dept Biol, Montreal, PQ H3A 2T5, Canada; [Lee, Brendan H.] Howard Hughes Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; McGill University; Baylor College of Medicine; Baylor College of Medicine; McGill University; University of Mississippi; University of Mississippi Medical Center; Stanford University; Medical College of Wisconsin; University of Otago; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; McGill University; McGill University; McGill University; Howard Hughes Medical Institute	Lee, BH (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	blee@bcm.edu	Campeau, Philippe/J-8614-2015; cormier-daire, valerie/H-6520-2017	Campeau, Philippe/0000-0001-9713-7107; Schwartzentruber, Jeremy/0000-0002-6183-2092; cormier-daire, valerie/0000-0002-2839-9856; Robertson, Stephen/0000-0002-5181-7809	Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH098571] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the families for participating in this study. We thank Alyssa Tran, Stephanie Dugan, and Andrea Kwan for help enrolling subjects; Kyu Sang Joeng, Yangjin Bae, Jianning Tao, and Terry Bertin for help and advice with the experiments; and the University Center for Fetal Medicine of the University of Mississippi for help collecting clinical information. Philippe Campeau is funded in part by the Clinician-Scientist Training award of the Canadian Institutes of Health Research.	Abdul-Rahman OA, 2006, AM J MED GENET A, V140A, P1567, DOI 10.1002/ajmg.a.31258; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Armstrong L, 2002, J MED GENET, V39, P933, DOI 10.1136/jmg.39.12.933; Bergmann C, 2011, ORAL MAXILLOFAC SURG, V15, P103, DOI 10.1007/s10006-009-0202-4; Brugha R, 2011, CLIN DYSMORPHOL, V20, P163, DOI 10.1097/MCD.0b013e328345a1dd; Champagne N, 1999, J BIOL CHEM, V274, P28528, DOI 10.1074/jbc.274.40.28528; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Cormier-Daire V, 2000, J MED GENET, V37, P520, DOI 10.1136/jmg.37.7.520; Das DK, 2009, DIAGN CYTOPATHOL, V37, P534, DOI 10.1002/dc.21081; Day R, 2008, CLIN GENET, V74, P434, DOI 10.1111/j.1399-0004.2008.01087.x; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Goldblatt J, 1988, DYSMORPHOL CLIN GENE, V2, P91; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Lammer EJ, 2002, AM J MED GENET, V111, P316, DOI 10.1002/ajmg.10582; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lifchez CA, 2003, AM J MED GENET A, V122A, P80, DOI 10.1002/ajmg.a.20268; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Oike Y, 1999, HUM MOL GENET, V8, P387, DOI 10.1093/hmg/8.3.387; Penttinen M, 2009, AM J MED GENET A, V149A, P451, DOI 10.1002/ajmg.a.32644; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Reardon W, 2002, AM J MED GENET, V111, P313, DOI 10.1002/ajmg.10590; Schlaubitz S, 2007, AM J MED GENET A, V143A, P1071, DOI 10.1002/ajmg.a.31685; Surapureddi S, 2002, P NATL ACAD SCI USA, V99, P11836, DOI 10.1073/pnas.182426699; Thomas T, 2000, DEVELOPMENT, V127, P2537; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Voss AK, 2009, BIOESSAYS, V31, P1050, DOI 10.1002/bies.200900051; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609	32	93	96	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					282	289		10.1016/j.ajhg.2011.11.023	http://dx.doi.org/10.1016/j.ajhg.2011.11.023			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	898KV	22265014	Bronze, Green Published			2022-12-18	WOS:000300742200008
J	Duff, RM; Tay, V; Hackman, P; Ravenscroft, G; McLean, C; Kennedy, P; Steinbach, A; Schoffler, W; van der Ven, PFM; Furst, DO; Song, J; Djinovic-Carugo, K; Penttila, S; Raheem, O; Reardon, K; Malandrini, A; Gambelli, S; Villanova, M; Nowak, KJ; Williams, DR; Landers, JE; Brown, RH; Udd, B; Laing, NG				Duff, Rachael M.; Tay, Valerie; Hackman, Peter; Ravenscroft, Gianina; McLean, Catriona; Kennedy, Paul; Steinbach, Alina; Schoeffler, Wiebke; van der Ven, Peter F. M.; Fuerst, Dieter O.; Song, Jaeguen; Djinovic-Carugo, Kristina; Penttila, Sini; Raheem, Olayinka; Reardon, Katrina; Malandrini, Alessandro; Gambelli, Simona; Villanova, Marcello; Nowak, Kristen J.; Williams, David R.; Landers, John E.; Brown, Robert H., Jr.; Udd, Bjarne; Laing, Nigel G.			Mutations in the N-terminal Actin-Binding Domain of Filamin C Cause a Distal Myopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MUSCULAR-DYSTROPHY; ANDROGEN RECEPTOR; ALPHA-ACTININ; KINASE GENE; Z-DISC; PROTEIN; IDENTIFICATION; HOMOLOGY; PROGRAM; COMPLEX	Linkage analysis of the dominant distal myopathy we previously identified in a large Australian family demonstrated one significant linkage region located on chromosome 7 and encompassing 18.6 Mbp and 151 genes. The strongest candidate gene was FLNC because filamin C, the encoded protein, is muscle-specific and associated with myofibrillar myopathy. Sequencing of FLNC cDNA identified a c.752T > C (p.Met251Thr) mutation in the N-terminal actin-binding domain (ABD); this mutation segregated with the disease and was absent in 200 controls. We identified an Italian family with the same phenotype and found a c.577G > A (p.Ala193Thr) filamin C ABD mutation that segregated with the disease. Filamin C ABD mutations have not been described, although filamin A and filamin B ABD mutations cause multiple musculoskeletal disorders. The distal myopathy phenotype and muscle pathology in the two families differ from myofibrillar myopathies caused by filamin C rod and dimerization domain mutations because of the distinct involvement of hand muscles and lack of pathological protein aggregation. Thus, like the position of FLNA and B mutations, the position of the FLNC mutation determines disease phenotype. The two filamin C ABD mutations increase actin-binding affinity in a manner similar to filamin A and filamin B ABD mutations. Cell-culture expression of the c.752T > C (p.Met251)Thr mutant filamin C ABD demonstrated reduced nuclear localization as did mutant filamin A and filamin B ABDs. Expression of both filamin C ABD mutants as full-length proteins induced increased aggregation of filamin. We conclude filamin C ABD mutations cause a recognizable distal myopathy, most likely through increased actin affinity, similar to the pathological mechanism of filamin A and filamin B ABD mutations.	[Duff, Rachael M.; Ravenscroft, Gianina; Nowak, Kristen J.; Laing, Nigel G.] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia; [Duff, Rachael M.; Ravenscroft, Gianina; Nowak, Kristen J.; Laing, Nigel G.] Western Australian Inst Med Res, Perth, WA 6009, Australia; [Duff, Rachael M.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Tay, Valerie; Reardon, Katrina] St Vincents Hosp, Ctr Clin Neurosci & Neurol Res, Melbourne, Vic 3065, Australia; [Hackman, Peter; Udd, Bjarne] Univ Helsinki, Haartman Inst, Dept Med Genet, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; [McLean, Catriona; Kennedy, Paul] Univ Melbourne, Dept Pathol, State Neuropathol Serv, Melbourne, Vic 3010, Australia; [Steinbach, Alina; Schoeffler, Wiebke; van der Ven, Peter F. M.; Fuerst, Dieter O.] Univ Bonn, Dept Mol Cell Biol, Inst Cell Biol, D-53121 Bonn, Germany; [Song, Jaeguen; Djinovic-Carugo, Kristina] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, A-1030 Vienna, Austria; [Penttila, Sini; Raheem, Olayinka; Udd, Bjarne] Univ Tampere, Tampere Univ Hosp, Dept Neurol, Neuromuscular Res Unit, Tampere 33520, Finland; [Malandrini, Alessandro; Gambelli, Simona] Univ Siena, Dept Neurol Neurosurg & Behav Sci, Unit Neurometabol Dis, I-53100 Siena, Italy; [Villanova, Marcello] Casa Cura Nigrisoli, I-40125 Bologna, Italy; [Williams, David R.] Monash Univ, Van Cleef Roet Ctr Nervous Dis, Melbourne, Vic 3800, Australia; [Landers, John E.; Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Djinovic-Carugo, Kristina] Univ Ljubljana, Dept Biochem, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Udd, Bjarne] Vasa Cent Hosp, Dept Neurol, Vaasa 65130, Finland	University of Western Australia; University of Western Australia; University of Western Australia; St Vincent's Hospital Melbourne; University of Helsinki; University of Melbourne; University of Bonn; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Tampere University; Tampere University Hospital; University of Siena; Monash University; University of Massachusetts System; University of Massachusetts Worcester; University of Ljubljana; Vaasa Central Hospital	Laing, NG (corresponding author), Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia.	nlaing@cyllene.uwa.edu.au	Fürst, Dieter O./H-8561-2013; Ravenscroft, Gina/H-5695-2014; Djinovic-Carugo, Kristina/AAW-1167-2021	Fürst, Dieter O./0000-0001-8805-6444; Ravenscroft, Gina/0000-0003-3634-211X; Djinovic-Carugo, Kristina/0000-0003-0252-2972; Song, Jae-Geun/0000-0002-0477-3903; McLean, Catriona/0000-0002-0302-5727; Landers, John/0000-0001-8084-5043; Laing, Nigel/0000-0001-5111-3732; Reardon, Katrina/0000-0002-6345-1859; van der Ven, Peter/0000-0002-9750-8913	Australian National Health and Medical Research Council (NHMRC) [403904, 403941]; German Research Foundation [FOR1228, FOR1352]; German Ministry of Education and Research (BMBF); Austrian Science Fund [W1221]; university, state, and commonwealth governments; Sigrid Juselius Foundation; Finnish Academy Foundation; Folkhalsan Research Foundation; Austrian Science Fund (FWF) [I 525] Funding Source: researchfish	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); German Research Foundation(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Austrian Science Fund(Austrian Science Fund (FWF)); university, state, and commonwealth governments; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Academy Foundation; Folkhalsan Research Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	N.G.L. was supported by an Australian National Health and Medical Research Council (NH&MRC) Fellowship (403904); K.J.N. and G.R. by NH&MRC Project Grant 403941. D.O.F. was supported by grants from the German Research Foundation (FOR1228 and FOR1352). D.O.F. and P.F.M.v.d.V. are members of the German muscular dystrophy network (MD-NET 2) funded by the German Ministry of Education and Research (BMBF). K.D.-C. acknowledges support from the Austrian Science Fund (Doctoral Program W1221 Structure and Interaction of Biological Macromolecules). The authors acknowledge the facilities and scientific and technical assistance of the Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy, Characterisation and Analysis, The University of Western Australia, a facility funded by the university, state, and commonwealth governments. B.U. was supported by the Sigrid Juselius Foundation, the Finnish Academy Foundation, and the Folkhalsan Research Foundation.	Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Berry FB, 2005, MOL CELL BIOL, V25, P1415, DOI 10.1128/MCB.25.4.1415-1424.2005; Bicknell LS, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.029967; Bolduc V, 2010, AM J HUM GENET, V86, P213, DOI 10.1016/j.ajhg.2009.12.013; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; Dalkilic I, 2006, MOL CELL BIOL, V26, P6522, DOI 10.1128/MCB.00243-06; Dudbridge F, 2004, BIOINFORMATICS, V20, P2327, DOI 10.1093/bioinformatics/bth231; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Faulkner G, 2000, J BIOL CHEM, V275, P41234, DOI 10.1074/jbc.M007493200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P614, DOI 10.1038/nsmb.1789; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Goetsch SC, 2005, STEM CELLS DEV, V14, P181, DOI 10.1089/scd.2005.14.181; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Griggs R, 2007, BRAIN, V130, P1477, DOI 10.1093/brain/awm006; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hackman P, 2002, AM J HUM GENET, V71, P492, DOI 10.1086/342380; HOCK RS, 1999, GUIDEBOOK CYTOSKELET, P94; Janmey PA, 1991, CURR OPIN CELL BIOL, V3, P4, DOI 10.1016/0955-0674(91)90159-V; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kayashima T, 2002, J HUM GENET, V47, P77, DOI 10.1007/s100380200004; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; KUHLMAN PA, 1992, FEBS LETT, V304, P201, DOI 10.1016/0014-5793(92)80619-R; Linnemann A, 2010, EUR J CELL BIOL, V89, P681, DOI 10.1016/j.ejcb.2010.04.004; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Lowe T, 2007, HUM MOL GENET, V16, P1351, DOI 10.1093/hmg/ddm085; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Luan XH, 2010, NEUROMUSCULAR DISORD, V20, P390, DOI 10.1016/j.nmd.2010.03.009; Mastaglia FL, 2005, CURR OPIN NEUROL, V18, P504, DOI 10.1097/01.wco.0000175936.23945.b6; Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Pacholsky D, 2004, J CELL SCI, V117, P5257, DOI 10.1242/jcs.01406; ROBERTS RG, 1994, HUM MUTAT, V4, P1, DOI 10.1002/humu.1380040102; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Schroder R, 2009, BRAIN PATHOL, V19, P483, DOI 10.1111/j.1750-3639.2009.00289.x; Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052; Senderek J, 2009, AM J HUM GENET, V84, P511, DOI 10.1016/j.ajhg.2009.03.006; Shatunov A, 2009, EUR J HUM GENET, V17, P656, DOI 10.1038/ejhg.2008.226; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Thompson TG, 2000, J CELL BIOL, V148, P115, DOI 10.1083/jcb.148.1.115; Udd B, 2009, Neuromuscul Disord, V19, P429, DOI 10.1016/j.nmd.2009.04.002; Udd B, 2007, BBA-MOL BASIS DIS, V1772, P145, DOI 10.1016/j.bbadis.2006.08.005; Uribe R, 2009, MOL BIOL REP, V36, P121, DOI 10.1007/s11033-007-9159-2; van der Ven PFM, 2000, CELL MOTIL CYTOSKEL, V45, P149, DOI 10.1002/(SICI)1097-0169(200002)45:2<149::AID-CM6>3.0.CO;2-G; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Wallgren-Pettersson C, 2007, BRAIN, V130, P1465, DOI 10.1093/brain/awm094; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; WEIHING RR, 1988, BIOCHEMISTRY-US, V27, P1865, DOI 10.1021/bi00406a011; WELANDER L, 1951, ACTA MED SCAND S265, V141, P7; Williams DR, 2005, NEUROLOGY, V64, P1245, DOI 10.1212/01.WNL.0000156524.95261.B9	58	93	94	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					729	740		10.1016/j.ajhg.2011.04.021	http://dx.doi.org/10.1016/j.ajhg.2011.04.021			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21620354	Green Published, Bronze			2022-12-18	WOS:000291768500005
J	Duffy, DL; Iles, MM; Glass, D; Zhu, G; Barrett, JH; Hoiom, V; Zhao, ZZ; Sturm, RA; Soranzo, N; Hammond, C; Kvaskoff, M; Whiteman, DC; Mangino, M; Hansson, J; Newton-Bishop, JA; Bataille, V; Hayward, NK; Martin, NG; Bishop, DT; Spector, TD; Montgomery, GW				Duffy, David L.; Iles, Mark M.; Glass, Dan; Zhu, Gu; Barrett, Jennifer H.; Hoiom, Veronica; Zhao, Zhen Z.; Sturm, Richard A.; Soranzo, Nicole; Hammond, Chris; Kvaskoff, Marina; Whiteman, David C.; Mangino, Massimo; Hansson, Johan; Newton-Bishop, Julia A.; Bataille, Veronique; Hayward, Nicholas K.; Martin, Nicholas G.; Bishop, D. Timothy; Spector, Timothy D.; Montgomery, Grant W.		GenoMEL	IRF4 Variants Have Age-Specific Effects on Nevus Count and Predispose to Melanoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CUTANEOUS MELANOMA; FAMILIAL AGGREGATION; POOLED ANALYSIS; SUN EXPOSURE; RISK-FACTORS; ADULT TWIN; PIGMENTATION; DENSITY; GENE	High melanocytic nevus count is a strong predictor of melanoma risk. A GWAS of nevus count in Australian adolescent twins identified an association of nevus count with the interferon regulatory factor 4 gene (IRF4 [p = 6 x 10(-9)]). There was a strong genotype-by-age interaction, which was replicated in independent UK samples of adolescents and adults. The rs12203592(star)T allele was associated with high nevus counts and high freckling scores in adolescents, but with low nevus counts and high freckling scores in adults. The rs12203592(star)T increased counts of flat (compound and junctional) nevi in Australian adolescent twins, but decreased counts of raised (intradermal) nevi. In combined analysis of melanoma case-control data from Australia, the UK, and Sweden, the rs12203592(star)C allele was associated with melanoma (odds ratio [OR] 1.15, p = 4 x 10(-3)), most significantly on the trunk (OR = 1.33, p = 2.5 x 10(-5)). The melanoma association was corroborated in a GWAS performed by the GenoMEL consortium for an adjacent SNP, rs872071 (rs872071(star)T: OR 1.14, p = 0.0035; excluding Australian, the UK, and Swedish samples typed at rs12203592: OR 1.08, p = 0.08).	[Duffy, David L.; Zhu, Gu; Zhao, Zhen Z.; Sturm, Richard A.; Kvaskoff, Marina; Whiteman, David C.; Hayward, Nicholas K.; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Iles, Mark M.; Barrett, Jennifer H.; Newton-Bishop, Julia A.; Bishop, D. Timothy] St James Univ Hosp, Sect Epidemiol & Biostat, Leeds Inst Mol Med, Canc Res UK Clin Ctr Leeds, Leeds LS9 7TF, W Yorkshire, England; [Glass, Dan; Soranzo, Nicole; Hammond, Chris; Mangino, Massimo; Bataille, Veronique; Spector, Timothy D.] UCL, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Sturm, Richard A.] Univ Queensland, Melanogenix Grp, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hoiom, Veronica; Hansson, Johan] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Kvaskoff, Marina] INSERM, ERI 20, EA 4045, F-75654 Paris 13, France; [Kvaskoff, Marina] Inst Gustave Roussy, F-94805 Villejuif, France	QIMR Berghofer Medical Research Institute; Cancer Research UK; Saint James's University Hospital; University of Leeds; University of London; University College London; University of Queensland; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Montgomery, GW (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	grant.montgomery@qimr.edu.au	Mangino, Massimo/F-5134-2011; hayward, nick/AAV-8802-2020; KVASKOFF, Marina/E-7981-2017; Kvaskoff, Marina/T-1018-2019; Montgomery, Grant W/B-7148-2008; Whiteman, David C/P-2728-2014; hayward, nicholas k/C-1367-2015; Höiom, Veronica/F-4153-2012; Duffy, David L/B-7392-2013; Sturm, Richard A/C-9943-2009	Mangino, Massimo/0000-0002-2167-7470; KVASKOFF, Marina/0000-0002-4557-3772; Montgomery, Grant W/0000-0002-4140-8139; Whiteman, David C/0000-0003-2563-9559; hayward, nicholas k/0000-0003-4760-1033; Duffy, David L/0000-0001-7227-632X; Sturm, Richard A/0000-0003-1301-0294; Barrett, Jenny/0000-0002-1720-7724; Iles, Mark/0000-0002-2603-6509; Bishop, Tim/0000-0002-8752-8785; Newton-Bishop, Julia/0000-0001-9147-6802; Martin, Nicholas/0000-0003-4069-8020; Soranzo, Nicole/0000-0003-1095-3852	National Institutes of Health (NIH)/National Cancer Institute [CA88363]; National Health and Medical Research Council of Australia (NHMRC); Cancer Council Queensland; Wellcome Trust; Department of Health via the National Institute for Health Research (NIHR); Biomedical Research Centre; EC [LSHC-CT-2006-018702]; CDRF; National Eye Institute via an NIH/CIDR; Cancer Research UK [C8216/A6129, C588/A4994, C588/A10721]; NIH [R01 CA83115, R01 ROI CA83115]; Ministere de l'Enseignement Superieur et de la Recherche; Institut National du Cancer (INCa); Karolinska Institutet; Magnus Bergvall Foundation; MRC [G0900339] Funding Source: UKRI; Cancer Research UK [10589] Funding Source: researchfish; Medical Research Council [G0900339] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA083115, R01CA088363] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland(Cancer Council Queensland); Wellcome Trust(Wellcome TrustEuropean Commission); Department of Health via the National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biomedical Research Centre; EC(European CommissionEuropean Commission Joint Research Centre); CDRF; National Eye Institute via an NIH/CIDR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cancer Research UK(Cancer Research UK); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Karolinska Institutet(Karolinska Institutet); Magnus Bergvall Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Australian studies were supported by the National Institutes of Health (NIH)/National Cancer Institute (CA88363), the National Health and Medical Research Council of Australia (NHMRC), and the Cancer Council Queensland. D.L.D., D.C.W., N.K.H., and G.W.M. are supported by the NHMRC Fellowships scheme. The TwinsUK study was supported by the Wellcome Trust, the Department of Health via the National Institute for Health Research (NIHR), a comprehensive Biomedical Research Centre award to Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, EC Framework 7 Health-2007-A ENGAGE project, and the CDRF. T.D.S. is an NIHR senior investigator, and D.G. is an MRC clinical research fellow. The authors acknowledge the funding and support of the National Eye Institute via an NIH/CIDR genotyping project (PI: Terri Young). The Leeds twin study and case-control studies were funded by Cancer Research UK (project grant C8216/A6129 and programme awards C588/A4994 and C588/A10721) and by the NIH (R01 CA83115). GenoMEL is also funded by the European Commission under the 6th Framework Programme, contract no. LSHC-CT-2006-018702, by a Cancer Research UK Programme Award (C588/A4994), and by NIH R01 ROI CA83115. Work at CNG was supported by the Ministere de l'Enseignement Superieur et de la Recherche and Institut National du Cancer (INCa). The Swedish Study was supported from Karolinska Institutet research funds and the Magnus Bergvall Foundation.	AITKEN JF, 1994, AM J EPIDEMIOL, V140, P961, DOI 10.1093/oxfordjournals.aje.a117203; Bataille V, 2000, JNCI-J NATL CANCER I, V92, P457, DOI 10.1093/jnci/92.6.457; Bataille V, 1998, BRIT J CANCER, V77, P505, DOI 10.1038/bjc.1998.81; Baxter AJ, 2008, TWIN RES HUM GENET, V11, P183, DOI 10.1375/twin.11.2.183; Begg CB, 2004, CANCER CAUSE CONTROL, V15, P957, DOI 10.1007/s10552-004-2474-1; Bishop DT, 2009, NAT GENET, V41, P920, DOI 10.1038/ng.411; BLISS JM, 1995, INT J CANCER, V62, P367, DOI 10.1002/ijc.2910620402; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang YM, 2009, INT J CANCER, V124, P420, DOI 10.1002/ijc.23869; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Cho EY, 2005, CANCER EPIDEM BIOMAR, V14, P1241, DOI 10.1158/1055-9965.EPI-04-0632; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Do KA, 2004, TWIN RES, V7, P98, DOI 10.1375/twin.7.1.98; DO TN, 2009, BIOCHIM BIOPHYS ACTA, V1802, P292; Duffy DL, 2010, J INVEST DERMATOL, V130, P520, DOI 10.1038/jid.2009.258; Falchi M, 2006, HUM MOL GENET, V15, P2975, DOI 10.1093/hmg/ddl227; Falchi M, 2009, NAT GENET, V41, P915, DOI 10.1038/ng.410; FRITSCHI L, 1994, BRIT J DERMATOL, V130, P599, DOI 10.1111/j.1365-2133.1994.tb13106.x; Gathany AH, 2009, CANCER CAUSE CONTROL, V20, P1291, DOI 10.1007/s10552-009-9348-5; Grossman A, 1996, GENOMICS, V37, P229, DOI 10.1006/geno.1996.0547; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Karin Meyer, 2007, Journal of Zhejiang University-Science B, V8, P815, DOI 10.1631/jzus.2007.B0815; Lange K, 2005, GENET EPIDEMIOL, V29, P36, DOI 10.1002/gepi.20073; MACKIE RM, 1985, BRIT J DERMATOL, V113, P167, DOI 10.1111/j.1365-2133.1985.tb02060.x; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Natkunam Y, 2001, MODERN PATHOL, V14, P686, DOI 10.1038/modpathol.3880373; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Olsen CM, 2009, INT J CANCER, V124, P937, DOI 10.1002/ijc.24011; Parra EJ, 2007, YEARB PHYS ANTHROPOL, V50, P85, DOI 10.1002/ajpa.20727; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Core Development Team, 2009, R LANG ENV STAT COMP; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Shaffer AL, 2009, CLIN CANCER RES, V15, P2954, DOI 10.1158/1078-0432.CCR-08-1845; Shekar SN, 2009, J INVEST DERMATOL, V129, P2211, DOI 10.1038/jid.2009.48; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Sundram U, 2003, MODERN PATHOL, V16, P802, DOI 10.1097/01.MP.0000081726.49886.CF; Tucker MA, 2009, HEMATOL ONCOL CLIN N, V23, P383, DOI 10.1016/j.hoc.2009.03.010; Wachsmuth RC, 2001, J INVEST DERMATOL, V117, P348, DOI 10.1046/j.0022-202x.2001.01415.x; Wang SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005360; Whiteman DC, 2003, J NATL CANCER I, V95, P806, DOI 10.1093/jnci/95.11.806; Zhao ZZ, 2006, MOL HUM REPROD, V12, P671, DOI 10.1093/molehr/gal078; Zhu G, 1999, AM J HUM GENET, V65, P483, DOI 10.1086/302494; Zhu G, 2007, EUR J HUM GENET, V15, P94, DOI 10.1038/sj.ejhg.5201729	46	93	93	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					6	16		10.1016/j.ajhg.2010.05.017	http://dx.doi.org/10.1016/j.ajhg.2010.05.017			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20602913	Green Published, Bronze			2022-12-18	WOS:000280029200001
J	Pereira, L; Freitas, F; Fernandes, V; Pereira, JB; Costa, MD; Costa, S; Maximo, V; Macaulay, V; Rocha, R; Samuels, DC				Pereira, Luisa; Freitas, Fernando; Fernandes, Veronica; Pereira, Joana B.; Costa, Marta D.; Costa, Stephanie; Maximo, Valdemar; Macaulay, Vincent; Rocha, Ricardo; Samuels, David C.			The Diversity Present in 5140 Human Mitochondrial Genomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER-RNA; PHYLOGENETIC NETWORK; ADAPTIVE SELECTION; DNA; SEQUENCE; MUTATIONS; DATABASE; LONGEVITY; EVOLUTION; VARIANTS	We analyzed the current status (as of the end of August 2008) of human mitochondrial genomes deposited in GenBank, amounting to 5140 complete or coding-region sequences, in order to present an overall picture of the diversity present in the mitochondrial DNA of the global human population. To perform this task, we developed mtDNA-GeneSyn, a computer tool that identifies and exhaustedly classifies the diversity present in large genetic data sets. The diversity observed in the 5140 human mitochondrial genomes was compared with all possible transitions and transversions from the standard human mitochondrial reference genome. This comparison showed that tRNA and rRNA secondary structures have a large effect in limiting the diversity of the human mitochondrial sequences, whereas for the protein-coding genes there is a bias toward less variation at the second codon positions. The analysis of the observed amino acid variations showed a tolerance of variations that convert between the amino acids V, 1, A, M, and T. This defines a group of amino acids with similar chemical properties that can interconvert by a single transition.	[Samuels, David C.] Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Pereira, Luisa; Freitas, Fernando; Fernandes, Veronica; Pereira, Joana B.; Costa, Marta D.; Costa, Stephanie; Maximo, Valdemar] Univ Porto IPATIMUP, Inst Patol & Imunol Mol, P-4200465 Oporto, Portugal; [Pereira, Luisa; Maximo, Valdemar] Univ Porto, Fac Med, P-4200465 Oporto, Portugal; [Macaulay, Vincent] Univ Glasgow, Dept Stat, Glasgow G12 8QQ, Lanark, Scotland; [Rocha, Ricardo] Univ Porto, Dept Ciencias Computadores, Fac Ciencias, P-4169007 Oporto, Portugal	Vanderbilt University; Universidade do Porto; Universidade do Porto; University of Glasgow; Universidade do Porto	Samuels, DC (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Dept Mol Physiol & Biophys, 221 Kirkland Hall, Nashville, TN 37232 USA.	david.samuels@chgr.mc.vanderbilt.edu	Fernandes, Vernonica/AAC-6824-2022; Rocha, Ricardo/B-2862-2012; Pereira, Luisa/H-3050-2011; INESC-TEC, CRACS/F-7527-2012; Samuels, David C/A-5393-2008; Pereira, Joana B./J-6026-2013; Costa, Marta Daniela/T-5148-2018; Samuels, David/C-1365-2012; Samuels, David/AHC-8381-2022; Maximo, Valdemar/E-7480-2011	Rocha, Ricardo/0000-0003-4502-8835; Pereira, Luisa/0000-0002-4271-1527; Samuels, David C/0000-0003-3529-7791; Pereira, Joana B./0000-0002-4409-514X; Costa, Marta Daniela/0000-0002-6247-0548; Samuels, David/0000-0003-3529-7791; Maximo, Valdemar/0000-0002-8631-8356; Macaulay, Vincent/0000-0001-9084-2700; fernandes, veronica/0000-0002-3873-2034	FCT (Fundacao para a Ciencia e a Tecnologia) [PTDC/AFR/71422/2006]; Programa Operacional Ciencia,Tecnologia e Inovacao (POCTI); Quadro Comunitario de Apoio III	FCT (Fundacao para a Ciencia e a Tecnologia)(Portuguese Foundation for Science and Technology); Programa Operacional Ciencia,Tecnologia e Inovacao (POCTI); Quadro Comunitario de Apoio III(European Commission)	This work was financed by a project (PTDC/AFR/71422/2006) funded by FCT (Fundacao para a Ciencia e a Tecnologia). IPATIMUP is supported by Programa Operacional Ciencia,Tecnologia e Inovacao (POCTI) e Quadro Comunitario de Apoio III. The authors state that they have no conflicts of interest.	ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; BANDELT HJ, 2006, MITOCHONDRIAL DNA EV, P47; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkt1030, 10.1093/nar/gkr1202, 10.1093/nar/gkq1079, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkn723, 10.1093/nar/gkx1094]; Bilal E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002421; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; BROWN MD, 1992, AM J HUM GENET, V51, P378; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; Elson JL, 2006, HUM GENET, V119, P241, DOI 10.1007/s00439-005-0123-8; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Hall T.A., 1999, NUCLC ACIDS S, V41, P95, DOI citeulike-article-id:691774; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Jin LJ, 2007, BIOCHEM BIOPH RES CO, V361, P133, DOI 10.1016/j.bbrc.2007.06.171; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; LANAVE C, 1986, BIOSYSTEMS, V19, P273, DOI 10.1016/0303-2647(86)90004-3; MARZUKI S, 1991, HUM GENET, V88, P139; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121; Pereira F, 2008, MOL BIOL EVOL, V25, P2759, DOI 10.1093/molbev/msn225; Pereira L, 2005, GENOME RES, V15, P19, DOI 10.1101/gr.3182305; Pereira L, 2007, MOL BIOL EVOL, V24, P868, DOI 10.1093/molbev/msm004; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Putz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Ruiz-Pesini E, 2006, HUM MUTAT, V27, P1072, DOI 10.1002/humu.20378; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	37	93	95	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					628	640		10.1016/j.ajhg.2009.04.013	http://dx.doi.org/10.1016/j.ajhg.2009.04.013			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19426953	Green Published, Bronze			2022-12-18	WOS:000266338800007
J	Wang, H; den Hollander, AI; Moayedi, Y; Abulimiti, A; Li, YM; Collin, RWJ; Hoyng, CB; Lopez, I; Bray, M; Lewis, RA; Lupski, JR; Mardon, G; Koenekoop, RK; Chen, R				Wang, Hui; den Hollander, Anneke I.; Moayedi, Yalda; Abulimiti, Abuduaini; Li, Yumei; Collin, Rob W. J.; Hoyng, Carel B.; Lopez, Irma; Bray, Molly; Lewis, Richard Alan; Lupski, James R.; Mardon, Graeme; Koenekoop, Robert K.; Chen, Rui			Mutations in SPATA7 Cause Leber Congenital Amaurosis and Juvenile Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE RETINAL DYSTROPHY; BARDET-BIEDL-SYNDROME; GENE-MUTATIONS; MESSENGER-RNA; PROTEIN; IDENTIFICATION; DISEASE; CEP290; CRX; TRUNCATION	Leber congenital amaurosis (LCA) and juvenile retinitis pigmentosa (RP) are the most common hereditary causes of visual impairment in infants and children. Using homozygosity mapping, we narrowed down the critical region of the LCA3 locus to 3.8 Mb between markers D14S1022 and D14S1005. By direct Sanger sequencing of all genes within this region, we found a homozygous nonsense mutation in the SPATA7 gene in Saudi Arabian family KKESH-060. Three other loss-of-function mutations were subsequently discovered in patients with LCA or juvenile RP from distinct populations. Furthermore, we determined that Spata7 is expressed in the mature mouse retina. Our findings reveal another human visual-disease gene that causes LCA and juvenile RP.	[Wang, Hui; Abulimiti, Abuduaini; Li, Yumei; Lewis, Richard Alan; Lupski, James R.; Mardon, Graeme; Chen, Rui] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lewis, Richard Alan; Mardon, Graeme] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Moayedi, Yalda; Mardon, Graeme] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mardon, Graeme] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Mardon, Graeme; Chen, Rui] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Wang, Hui; Li, Yumei; Chen, Rui] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Bray, Molly] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Lewis, Richard Alan; Lupski, James R.] Baylor Coll Med, Texas Childrens Hosp, Houston, TX 77030 USA; [den Hollander, Anneke I.; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [den Hollander, Anneke I.; Hoyng, Carel B.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, Nijmegen Ctr Mol Life Sci, NL-6500 HB Nijmegen, Netherlands; [Lopez, Irma] McGill Univ, Ctr Hlth, McGill Ocular Genet Ctr, Montreal, PQ H3H 1P3, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Radboud University Nijmegen; Radboud University Nijmegen; McGill University	Chen, R (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	ruichen@bcm.edu	Hoyng, C.B./H-8050-2014; Koenekoop, Robert/AAT-6676-2021; Moayedi, Yalda/AHA-7844-2022; Hollander, Anneke den/N-4911-2014; Collin, Rob/N-3575-2014	Moayedi, Yalda/0000-0002-0600-1253	Retinal Research Foundation; National Eye Institute; National Eye Institute [R01EY018571]; Foundation Fighting Blindness Canada; Fonds de la Recherche en Santee du Quebec (FRSQ); Netherlands Organisation for Scientific Research [916.56.160]; NATIONAL EYE INSTITUTE [R01EY018571] Funding Source: NIH RePORTER	Retinal Research Foundation; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Foundation Fighting Blindness Canada; Fonds de la Recherche en Santee du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank liuawei Xin for his help throughout this project and for his U.SCfLJI comments during the preparation of the manuscript. We are indebted to John Cavender, the Research Director of King Khalid Eye Specialist Hospital at the time of these studies, to the Research Council of KKF.Sti for its financial Support, and to tile staff of its Research Department for their diligent commitment to this program. In addition, we thank the families reported here for their willing cooperation with these studies. R.A.L. is a Senior Scientific Investigator of Research to Prevent Blindness, New York. We also thank Frans Cremers for his valuable discussions and Lara Bou-Khzam for her technical assistance. This work is supported by grants from the Retinal Research Foundation and the National Eye Institute (R01EY018571) to R.C. R.K.K. is supported by the Foundation Fighting Blindness Canada and the Fonds de la Recherche en Santee du Quebec (FRSQ). A.I.d.H. is supported by grants from the Netherlands Organisation for Scientific Research (916.56.160) and the Foundation Fighting Blindness USA (BR-GE-0606-0349-RAD).	Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; den Hollander AI, 2001, AM J HUM GENET, V69, P198; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2007, INVEST OPHTH VIS SCI, V48, P5690, DOI 10.1167/iovs.07-0610; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dharmaraj S R, 2000, Ophthalmic Genet, V21, P135; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Gerber S, 2001, EUR J HUM GENET, V9, P561, DOI 10.1038/sj.ejhg.5200689; Guo DC, 2003, BIOTECHNOL LETT, V25, P2079, DOI 10.1023/B:BILE.0000007075.24434.5e; Hagstrom SA, 1998, NAT GENET, V18, P174, DOI 10.1038/ng0298-174; Inoue K, 2004, NAT GENET, V36, P361, DOI 10.1038/ng1322; Jacobson SG, 1998, INVEST OPHTH VIS SCI, V39, P2417; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; Katsanis N, 2002, AM J HUM GENET, V71, P22, DOI 10.1086/341031; Keen TJ, 2003, EUR J HUM GENET, V11, P420, DOI 10.1038/sj.ejhg.5200981; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; LEBER T, 1869, A VONGRAEFES ARCH OP, V15, P1, DOI DOI 10.1007/BF02721213; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; LEWIS RA, 1988, JUVENILE HEREDITARY, P115; LEWIS RA, 2001, METABOLIC MOL BASES, P6077; LI Y, 2008, INVEST OPHTHALMOL VI; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; Perrault I, 1999, AM J HUM GENET, V64, P1225, DOI 10.1086/302335; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; Sohocki MM, 2000, NAT GENET, V24, P79, DOI 10.1038/71732; Sohocki MM, 2000, MOL GENET METAB, V70, P142, DOI 10.1006/mgme.2000.3001; Stockton DW, 1998, HUM GENET, V103, P328, DOI 10.1007/s004390050825; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Thompson DA, 2001, NAT GENET, V28, P123, DOI 10.1038/88828; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Zhang XD, 2003, J MOL MED-JMM, V81, P380, DOI 10.1007/s00109-003-0434-y	36	93	95	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 13	2009	84	3					380	387		10.1016/j.ajhg.2009.02.005	http://dx.doi.org/10.1016/j.ajhg.2009.02.005			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	420QL	19268277	Bronze, Green Published			2022-12-18	WOS:000264304200008
J	Achilli, A; Olivieri, A; Pala, M; Metspalu, E; Fornarino, S; Battaglia, V; Accetturo, M; Kutuev, I; Khusnutdinova, E; Pennarun, E; Cerutti, N; Di Gaetano, C; Crobu, F; Palli, D; Matullo, G; Santachiara-Benerecetti, AS; Cavalli-Sforza, LL; Semino, O; Villems, R; Bandelt, HJ; Piazza, A; Torroni, A				Achilli, Alessandro; Olivieri, Anna; Pala, Maria; Metspalu, Ene; Fornarino, Simona; Battaglia, Vincenza; Accetturo, Matteo; Kutuev, Ildus; Khusnutdinova, Elsa; Pennarun, Erwan; Cerutti, Nicoletta; Di Gaetano, Cornelia; Crobu, Francesca; Palli, Domenico; Matullo, Giuseppe; Santachiara-Benerecetti, A. Silvana; Cavalli-Sforza, L. Luca; Semino, Ornella; Villems, Richard; Bandelt, Hans-Juergen; Piazza, Alberto; Torroni, Antonio			Mitochondrial DNA variation of modern Tuscans supports the near eastern origin of Etruscans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHYLOGENY	The origin of the Etruscan people has been a source of major controversy for the past 2,500 years, and several hypotheses have been proposed to explain their language and sophisticated culture, including an Aegean/Anatolian origin. To address this issue, we analyzed the mitochondrial DNA (mtDNA) of 322 subjects from three well-defined areas of Tuscany and compared their sequence variation with that of 55 western Eurasian populations. Interpopulation comparisons reveal that the modern population of Murlo, a small town of Etruscan origin, is characterized by an unusually high frequency (17.5%) of Near Eastern mtDNA haplogroups. Each of these haplogroups is represented by different haplotypes, thus dismissing the possibility that the genetic allocation of the Murlo people is due to drift. Other Tuscan populations do not show the same striking feature; however, overall, similar to 5% of mtDNA haplotypes in Tuscany are shared exclusively between Tuscans and Near Easterners and occupy terminal positions in the phylogeny. These findings support a direct and rather recent genetic input from the Near East - a scenario in agreement with the Lydian origin of Etruscans. Such a genetic contribution has been extensively diluted by admixture, but it appears that there are still locations in Tuscany, such as Murlo, where traces of its arrival are easily detectable.	Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; Univ Tartu, Dept Evolut Biol, EE-50090 Tartu, Estonia; Estonian Bioctr, Tartu, Estonia; Russian Acad Sci, Inst Biochem & Genet, Ufa Sci Ctr, Ufa 450001, Russia; Univ Turin, Dipartimento Genet Biol & Biochim, I-10124 Turin, Italy; Inst Tuscany Reg, Ctr Study & Prevent Canc Sci Inst, Mol & Nutr Epidemiol Unit, Florence, Italy; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Univ Hamburg, Dept Math, D-2000 Hamburg, Germany	University of Pavia; University of Tartu; Estonian Biocentre; Institute of Biochemistry & Genetics of Ufa Science Centre of the RAS; Russian Academy of Sciences; University of Turin; Stanford University; University of Hamburg	Torroni, A (corresponding author), Univ Pavia, Dipartimento Genet & Microbiol, Via Ferrata 1, I-27100 Pavia, Italy.	torroni@ipvgen.unipv.it	Crobu, Francesca/AAC-2713-2019; Battaglia, Vincenza/F-6950-2017; Khusnutdinova, Elza Kamilevna/A-4810-2013; Pennarun, Erwan/AAW-7041-2020; Matullo, Giuseppe/K-6383-2016; OLIVIERI, ANNA/I-9235-2012; Torroni, Antonio/E-1557-2011; Achilli, Alessandro/I-9236-2012; Di Gaetano, Cornelia/AAA-5477-2019	Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; Pennarun, Erwan/0000-0002-8267-883X; Matullo, Giuseppe/0000-0003-0674-7757; OLIVIERI, ANNA/0000-0002-3941-8098; Torroni, Antonio/0000-0002-4163-4478; Achilli, Alessandro/0000-0001-6871-3451; Di Gaetano, Cornelia/0000-0001-8938-7093; Piazza, Alberto/0000-0002-2355-4183; SEMINO, Ornella/0000-0002-9675-9403; Pala, Maria/0000-0001-9202-8331; CROBU, FRANCESCA/0000-0001-7720-8158; tumino, rosario/0000-0003-2666-414X; PALLI, Domenico/0000-0002-5558-2437				Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2006, NUCL ACID M, V18, P117; Bandelt HJ, 2005, EUR J HUM GENET, V13, P1106, DOI 10.1038/sj.ejhg.5201476; Bandelt HJ, 2004, AM J HUM GENET, V75, P919, DOI 10.1086/425180; Barker G, 1998, ETRUSCANS; Beekes R.S.P., 2003, ORIGINS ETRUSCANS; Belle EMS, 2006, P NATL ACAD SCI USA, V103, P8012, DOI 10.1073/pnas.0509718103; Bonfante G., 2002, ETRUSCAN LANGUAGE IN; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Fadhlaoui-Zid K, 2004, ANN HUM GENET, V68, P222, DOI 10.1046/j.1529-8817.2004.00096.x; GUGLIELMINO CR, 1990, AM J PHYS ANTHROPOL, V83, P57, DOI 10.1002/ajpa.1330830107; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Malyarchuk BA, 2004, AM J HUM GENET, V75, P920, DOI 10.1086/425220; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; PELLECCHIA M, IN PRESS P BIOL SCI; PIAZZA A, 1988, ANN HUM GENET, V52, P203, DOI 10.1111/j.1469-1809.1988.tb01098.x; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; RASMUSSEN T, 2004, MEDITERRANEAN URBANI, P800; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2002, AM J HUM GENET, V71, P1168, DOI 10.1086/342930; Torroni A, 1996, GENETICS, V144, P1835; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Vernesi C, 2004, AM J HUM GENET, V74, P694, DOI 10.1086/383284	28	93	94	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					759	768		10.1086/512822	http://dx.doi.org/10.1086/512822			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357081	Bronze, Green Published			2022-12-18	WOS:000245465200016
J	Cath, D; Heutink, P; Grados, M; Singer, HS; Walkup, JT; Illmann, C; Scharf, JM; Santangelo, S; Stewart, SE; Platko, J; Pauls, DL; Cox, NJ; Robertson, MM; Service, S; Keen-Kim, D; Sabatti, C; Freimer, N; Rouleau, GA; Riviere, JB; Chouinard, S; Richer, F; Lesperance, P; Dion, Y; King, RA; Kidd, JR; Pakstis, AJ; Leckman, JF; Kidd, KK; Gericke, G; Kurlan, R; Como, P; Palumbo, D; Verkerk, A; Oostra, BA; McMahon, W; Leppert, M; Coon, H; Mathews, C; Sandor, P; Barr, CL; Betard, C; Zelenika, D				Cath, D.; Heutink, P.; Grados, M.; Singer, H. S.; Walkup, J. T.; Illmann, C.; Scharf, J. M.; Santangelo, S.; Stewart, S. E.; Platko, J.; Pauls, D. L.; Cox, N. J.; Robertson, M. M.; Service, S.; Keen-Kim, D.; Sabatti, C.; Freimer, N.; Rouleau, G. A.; Riviere, J. -B.; Chouinard, S.; Richer, F.; Lesperance, P.; Dion, Y.; King, R. A.; Kidd, J. R.; Pakstis, A. J.; Leckman, J. F.; Kidd, K. K.; Gericke, G.; Kurlan, R.; Como, P.; Palumbo, D.; Verkerk, A.; Oostra, B. A.; McMahon, W.; Leppert, M.; Coon, H.; Mathews, C.; Sandor, P.; Barr, C. L.; Betard, C.; Zelenika, D.		Tourette Syndrome Assoc Int Consor	Genome scan for Tourette disorder in affected-sibling-pair and multigenerational families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OBSESSIVE-COMPULSIVE DISORDER; AUTOSOMAL-DOMINANT TRANSMISSION; BILINEAL TRANSMISSION; SEGREGATION ANALYSIS; TIC DISORDERS; LINKAGE; ASSOCIATION; INHERITANCE; RELIABILITY; PEDIGREE	Tourette disorder (TD) is a neuropsychiatric disorder with a complex mode of inheritance and is characterized by multiple waxing and waning motor and phonic tics. This article reports the results of the largest genetic linkage study yet undertaken for TD. The sample analyzed includes 238 nuclear families yielding 304 "independent" sibling pairs and 18 separate multigenerational families, for a total of 2,040 individuals. A whole-genome screen with the use of 390 micro-satellite markers was completed. Analyses were completed using two diagnostic classifications: (1) only individuals with TD were included as affected and (2) individuals with either TD or chronic-tic (CT) disorder were included as affected. Strong evidence of linkage was observed for a region on chromosome 2p (-logP = 4.42, P = 3.8 x 10(-5)) in the analyses that included individuals with TD or CT disorder as affected. Results in several other regions also provide moderate evidence (-logP > 2.0) of additional susceptibility loci for TD.	Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Pauls, DL (corresponding author), Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Richard B Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	dpauls@pngu.mgh.harvard.edu	Sandor, Paul/I-7211-2016; Leckman, James/O-2426-2015; Mathews, Carol A A/M-8922-2017	Sandor, Paul/0000-0003-2397-0758; Mathews, Carol A A/0000-0003-2208-7058; Barr, Cathy/0000-0003-0361-0106; Verkerk, Annemieke JMH/0000-0002-7523-3656; Stewart, S. Evelyn/0000-0002-0994-6383; Grados, Marco/0000-0002-6189-6264	NINDS NIH HHS [NS 40024, U01 NS040024, R01 NS040024] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040024, U01NS040024] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; American Psychiatric Association, 2000, DIAGN STAT MAN; APTER A, 1993, ARCH GEN PSYCHIAT, V50, P734; Barr CL, 1999, AM J MED GENET, V88, P437, DOI 10.1002/(SICI)1096-8628(19990820)88:4<437::AID-AJMG24>3.0.CO;2-E; Conners CK, 1998, J ABNORM CHILD PSYCH, V26, P257, DOI 10.1023/A:1022602400621; Conners CK., 1999, CONNERS ADULT ADHD R, DOI DOI 10.1038/s41588-018-0269-7; EAPEN V, 1993, BRIT J PSYCHIAT, V162, P593, DOI 10.1192/bjp.162.5.593; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; HASSTEDT SJ, 1995, AM J HUM GENET, V57, P682; Hebebrand J, 1997, J PSYCHIAT RES, V31, P519, DOI 10.1016/S0022-3956(97)00028-9; HYDE TM, 1992, NEUROLOGY, V42, P652, DOI 10.1212/WNL.42.3.652; KAUFMAN J, 1995, KIDDIE SADS LIFETIME; KERNER B, 2006, AM J MED GENET B; KURLAN R, 1994, NEUROLOGY, V44, P2336, DOI 10.1212/WNL.44.12.2336; Lange K., 2001, AM J HUM GENET S, V69, pA1886; LECKMAN JF, 1994, AM J PSYCHIAT, V151, P675; LECKMAN JF, 1982, ARCH GEN PSYCHIAT, V39, P879; Leckman JF, 1997, AM J PSYCHIAT, V154, P911; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; LECKMAN JF, 1993, AM J PSYCHIAT, V150, P98; McMahon WM, 1996, J AM ACAD CHILD PSY, V35, P672, DOI 10.1097/00004583-199605000-00023; MCMAHON WM, 1992, ADV NEUROL, V58, P159; Merette C, 2000, AM J HUM GENET, V67, P1008, DOI 10.1086/303093; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 2002, PROGRAM BINOM VERSIO; Paschou P, 2004, AM J HUM GENET, V75, P545, DOI 10.1086/424389; Paula D, 1999, AM J HUM GENET, V65, P1428; PAULS DL, 1991, AM J HUM GENET, V48, P154; PAULS DL, 1995, AM J PSYCHIAT, V152, P76; PAULS DL, 1986, NEW ENGL J MED, V315, P993, DOI 10.1056/NEJM198610163151604; PAULS DL, 1991, PSYCHIAT GENET, V2, P28; PRICE RA, 1985, ARCH GEN PSYCHIAT, V42, P815; Robertson MM, 1999, NEUROLOGY, V53, P2108, DOI 10.1212/WNL.53.9.2108; Robertson MM, 1998, CURR OPIN NEUROL, V11, P373, DOI 10.1097/00019052-199808000-00014; Rosenfeld R., 1992, PSYCHOL ASSESSMENT, V4, P329, DOI [DOI 10.1037/1040-3590.4.3.329, https://doi.org/10.1037/1040-3590.4.3.329]; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; SCHARF JM, IN PRESS EMERY RIMOI; Seuchter SA, 2000, GENET EPIDEMIOL, V18, P33, DOI 10.1002/(SICI)1098-2272(200001)18:1<33::AID-GEPI3>3.0.CO;2-2; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Suarez BK, 2000, PROSTATE, V45, P106, DOI 10.1002/1097-0045(20001001)45:2<106::AID-PROS4>3.0.CO;2-H; SUAREZ BK, 1994, GENETIC APPROACHES M, P23; Verkerk AJMH, 2003, GENOMICS, V82, P1, DOI 10.1016/S0888-7543(03)00097-1; Walkup JT, 1996, AM J HUM GENET, V59, P684	49	93	95	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					265	272						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	129KX	17304708				2022-12-18	WOS:000243729500006
J	Ferdinandusse, S; Kostopoulos, P; Denis, S; Rusch, H; Overmars, H; Dillmann, U; Reith, W; Haas, D; Wanders, RJA; Duran, M; Marziniak, M				Ferdinandusse, S; Kostopoulos, P; Denis, S; Rusch, H; Overmars, H; Dillmann, U; Reith, W; Haas, D; Wanders, RJA; Duran, M; Marziniak, M			Mutations in the gene encoding peroxisomal sterol carrier protein X (SCPx) cause leukencephalopathy with dystonia and motor neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; D-BIFUNCTIONAL PROTEIN; BILE-ACID SYNTHESIS; PTS2 RECEPTOR; OXIDATION; IDENTIFICATION; DEFICIENCY; DISORDER; DISEASE; DEFECT	In this report, we describe the first known patient with a deficiency of sterol carrier protein X ( SCPx), a peroxisomal enzyme with thiolase activity, which is required for the breakdown of branched-chain fatty acids. The patient presented with torticollis and dystonic head tremor as well as slight cerebellar signs with intention tremor, nystagmus, hyposmia, and azoospermia. Magnetic resonance imaging showed leukencephalopathy and involvement of the thalamus and pons. Metabolite analyses of plasma revealed an accumulation of the branched-chain fatty acid pristanic acid, and abnormal bile alcohol glucuronides were excreted in urine. In cultured skin fibroblasts, the thiolytic activity of SCPx was deficient, and no SCPx protein could be detected by western blotting. Mutation analysis revealed a homozygous 1-nucleotide insertion, 545_546insA, leading to a frameshift and premature stop codon (I184fsX7).	Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; Univ Saarland, Dept Neurol, D-6650 Homburg, Germany; Univ Saarland, Dept Neuroradiol, D-6650 Homburg, Germany; Univ Heidelberg, Childrens Hosp, Ctr Metab Dis, D-6900 Heidelberg, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Saarland University; Saarland University; Ruprecht Karls University Heidelberg	Ferdinandusse, S (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	s.ferdinandusse@amc.uva.nl		Ferdinandusse, Sacha/0000-0002-7738-5709				Braverman N, 1997, NAT GENET, V15, P369, DOI 10.1038/ng0497-369; Clarke CE, 2004, NEUROLOGY, V63, P188, DOI 10.1212/01.WNL.0000132841.81250.B7; DUANE WC, 1988, J CLIN INVEST, V82, P82, DOI 10.1172/JCI113605; Ferdinandusse S, 2006, ANN NEUROL, V59, P92, DOI 10.1002/ana.20702; Ferdinandusse S, 2004, J LIPID RES, V45, P1104, DOI 10.1194/jlr.M300512-JLR200; Ferdinandusse S, 2000, J LIPID RES, V41, P336; Ferdinandusse S, 2002, AM J HUM GENET, V70, P1589, DOI 10.1086/340970; Ferdinandusse S, 2000, NAT GENET, V24, P188, DOI 10.1038/72861; HEYMANS HSA, 1985, NEW ENGL J MED, V313, P187; HOEFLER G, 1988, J PEDIATR-US, V112, P726, DOI 10.1016/S0022-3476(88)80689-9; Honda A, 2005, J LIPID RES, V46, P287, DOI 10.1194/jlr.M400256-JLR200; Kannenberg F, 1999, J BIOL CHEM, V274, P35455, DOI 10.1074/jbc.274.50.35455; McLean BN, 2002, J NEUROL NEUROSUR PS, V72, P396, DOI 10.1136/jnnp.72.3.396; Motley AM, 1997, NAT GENET, V15, P377, DOI 10.1038/ng0497-377; OHBA T, 1994, GENOMICS, V24, P370, DOI 10.1006/geno.1994.1630; OSSENDORP BC, 1991, EUR J BIOCHEM, V201, P233, DOI 10.1111/j.1432-1033.1991.tb16279.x; Seedorf U, 1998, GENE DEV, V12, P1189, DOI 10.1101/gad.12.8.1189; Wanders R.J., 2001, METABOLIC MOL BASES, P3219; Wierzbicki AS, 2002, J NEUROCHEM, V80, P727, DOI 10.1046/j.0022-3042.2002.00766.x; Wirtz KWA, 1997, BIOCHEM J, V324, P353, DOI 10.1042/bj3240353	20	93	100	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1046	1052		10.1086/503921	http://dx.doi.org/10.1086/503921			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685654	Green Published, Bronze			2022-12-18	WOS:000237553800013
J	Schule, B; Oviedo, A; Johnston, K; Pai, S; Francke, U				Schule, B; Oviedo, A; Johnston, K; Pai, S; Francke, U			Inactivating mutations in ESCO2 cause SC phocomelia and Roberts syndrome: No phenotype-genotype correlation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SISTER-CHROMATID COHESION; DE-LANGE-SYNDROME; SYNDROME CELLS; MESSENGER-RNA; HUMAN HOMOLOG; NIPPED-B; ACETYLTRANSFERASES; ESTABLISHMENT; PREDICTION; DROSOPHILA	The rare, autosomal recessive Roberts syndrome (RBS) is characterized by tetraphocomelia, profound growth deficiency of prenatal onset, craniofacial anomalies, microcephaly, and mental deficiency. SC phocomelia (SC) has a milder phenotype, with a lesser degree of limb reduction and with survival to adulthood. Since heterochromatin repulsion (HR) is characteristic for both disorders and is not complemented in somatic-cell hybrids, it has been hypothesized that the disorders are allelic. Recently, mutations in ESCO2 (establishment of cohesion 1 homolog 2) on 8p21.1 have been reported in RBS. To determine whether ESCO2 mutations are also responsible for SC, we studied three families with SC and two families in which variable degrees of limb and craniofacial abnormalities, detected by fetal ultrasound, led to pregnancy terminations. All cases were positive for HR. We identified seven novel mutations in exons 3-8 of ESCO2. In two families, affected individuals were homozygous-for a 5-nucleotide deletion in one family and a splice-site mutation in the other. In three nonconsanguineous families, probands were compound heterozygous for a single-nucleotide insertion or deletion, a nonsense mutation, or a splice-site mutation. Abnormal splice products were characterized at the RNA level. Since only protein-truncating mutations were identified, regardless of clinical severity, we conclude that genotype does not predict phenotype. Having established that RBS and SC are caused by mutations in the same gene, we delineated the clinical phenotype of the tetraphocomelia spectrum that is associated with HR and ESCO2 mutations and differentiated it from other types of phocomelia that are negative for HR.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; Kaiser Permanente, Dept Pathol, Oakland, CA USA; Kaiser Permanente, Dept Genet, San Francisco, CA USA; Med Univ S Carolina, Dept Pediat, Charleston, SC 29425 USA	Stanford University; Stanford University; Kaiser Permanente; Kaiser Permanente; Medical University of South Carolina	Francke, U (corresponding author), Stanford Univ, Sch Med, Dept Genet, 279 Campus Dr, Stanford, CA 94305 USA.	ufrancke@stanford.edu		Schuele, Birgitt/0000-0002-9952-5776				Bellows AM, 2003, NUCLEIC ACIDS RES, V31, P6334, DOI 10.1093/nar/gkg811; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; FEINGOLD M, 1992, AM J MED GENET, V43, P898, DOI 10.1002/ajmg.1320430532; FREEMAN MVR, 1974, CLIN GENET, V5, P1; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; HERRMANN J, 1969, Birth Defects Original Article Series, V5, P81; HERRMANN J, 1977, EUR J PEDIATR, V125, P117, DOI 10.1007/BF00489985; Hou FJ, 2005, MOL BIOL CELL, V16, P3908, DOI 10.1091/mbc.E04-12-1063; Hwang K, 2002, J CRANIOFAC SURG, V13, P390, DOI 10.1097/00001665-200205000-00005; JUDGE C, 1973, MED J AUSTRALIA, V2, P280, DOI 10.5694/j.1326-5377.1973.tb128828.x; Krantz ID, 2004, NAT GENET, V36, P631, DOI 10.1038/ng1364; KRASSIKOFF NE, 1986, AM J HUM GENET, V39, P618; McDaniel LD, 2000, AM J MED GENET, V93, P223, DOI 10.1002/1096-8628(20000731)93:3<223::AID-AJMG13>3.0.CO;2-J; McDaniel LD, 2005, AM J HUM GENET, V77, P132, DOI 10.1086/431328; PARRY DM, 1986, AM J MED GENET, V24, P653, DOI 10.1002/ajmg.1320240410; Roberts JB, 1919, ANN SURG, V70, P252; Strachan T, 2005, CURR OPIN GENET DEV, V15, P258, DOI 10.1016/j.gde.2005.04.005; TOMKINS D, 1979, AM J MED GENET, V4, P17, DOI 10.1002/ajmg.1320040104; TOMKINS DJ, 1984, AM J HUM GENET, V36, P1332; Tonkin ET, 2004, NAT GENET, V36, P636, DOI 10.1038/ng1363; Urban M, 1997, AM J MED GENET, V72, P307, DOI 10.1002/(SICI)1096-8628(19971031)72:3<307::AID-AJMG11>3.0.CO;2-X; VANDENBERG DJ, 1993, SOMAT CELL MOLEC GEN, V19, P377; VANDENBERG DJ, 1993, AM J MED GENET, V47, P1104, DOI 10.1002/ajmg.1320470735; Vega H, 2005, NAT GENET, V37, P468, DOI 10.1038/ng1548; WENGER SL, 1988, CANCER GENET CYTOGEN, V31, P285, DOI 10.1016/0165-4608(88)90230-0; Williams BC, 2003, CURR BIOL, V13, P2025, DOI 10.1016/j.cub.2003.11.018	26	93	100	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					1117	1128		10.1086/498695	http://dx.doi.org/10.1086/498695			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380922	Green Published, Bronze			2022-12-18	WOS:000233241200020
J	Spritz, RA; Gowan, K; Bennett, DC; Fain, PR				Spritz, RA; Gowan, K; Bennett, DC; Fain, PR			Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LINKAGE; EPIDEMIOLOGY; FAMILIES		Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA; Univ London St Georges Hosp, Sch Med, Dept Basic Med Sci, London SW17 0RE, England	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; St Georges University London	Spritz, RA (corresponding author), Univ Colorado, Hlth Sci Ctr, Human Med Genet Program, Box B161,4200 E 9th Ave, Denver, CO 80262 USA.	richard.spritz@uchsc.edu	Bennett, Dorothy C/C-2418-2008	Bennett, Dorothy C/0000-0002-3639-7527	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI046374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI046374, AI46374] Funding Source: Medline; NIAMS NIH HHS [AR45584, R01 AR045584] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alkhateeb A, 2003, PIGM CELL RES, V16, P208, DOI 10.1034/j.1600-0749.2003.00032.x; Alkhateeb A, 2002, HUM MOL GENET, V11, P661, DOI 10.1093/hmg/11.6.661; Arcos-Burgos M, 2002, HUM GENET, V110, P334, DOI 10.1007/s00439-002-0687-5; Betterle C, 2002, ENDOCR REV, V23, P327, DOI 10.1210/er.23.3.327; BOLOGNIA JL, 1998, PIGMENTARY SYSTEM, P513; CARNEVALE A, 1980, REV INVEST CLIN, V32, P37; DAS S K, 1985, Genetic Epidemiology, V2, P255, DOI 10.1002/gepi.1370020303; Fain PR, 2003, AM J HUM GENET, V72, P1560, DOI 10.1086/375451; GOUDIE BM, 1983, SCOT MED J, V28, P338, DOI 10.1177/003693308302800405; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HAFEZ M, 1983, ACTA DERM-VENEREOL, V63, P249; HANN SK, 2000, VITILIGO COMPREHENSI; HOWITZ J, 1977, ARCH DERMATOL, V113, P47, DOI 10.1001/archderm.113.1.47; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kovacs SO, 1998, J AM ACAD DERMATOL, V38, P647, DOI 10.1016/S0190-9622(98)70194-X; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MAJUMDER PP, 1993, ARCH DERMATOL, V129, P994, DOI 10.1001/archderm.129.8.994; MAJUMDER PP, 1988, AM J HUM GENET, V43, P119; MEHTA NR, 1973, INDIAN J MED RES, V61, P145; MORTON NE, 1956, AM J HUM GENET, V8, P80; NATH SK, 1994, AM J HUM GENET, V55, P981; Nath SK, 2001, AM J HUM GENET, V69, P1401, DOI 10.1086/324470; Nyholt DR, 2000, AM J HUM GENET, V67, P282, DOI 10.1086/303029; Ongenae K, 2003, PIGM CELL RES, V16, P90, DOI 10.1034/j.1600-0749.2003.00023.x; Ott J, 1999, ANAL HUMAN GENETIC L; Terwilliger J., 1994, HDB HUMAN GENETIC LI	26	93	98	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					188	191		10.1086/381134	http://dx.doi.org/10.1086/381134			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14691733	Green Published, Bronze			2022-12-18	WOS:000187723500019
J	Bi, WM; Park, SS; Shaw, CJ; Withers, MA; Patel, PI; Lupski, JR				Bi, WM; Park, SS; Shaw, CJ; Withers, MA; Patel, PI; Lupski, JR			Reciprocal crossovers and a positional preference for strand exchange in recombination events resulting in deletion or duplication of chromosome 17p11.2	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMITH-MAGENIS-SYNDROME; LOW-COPY REPEATS; AT-RICH PALINDROMES; GENOMIC DISORDERS; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; MEIOTIC RECOMBINATION; HOT-SPOT; HOTSPOT; DNA	Smith-Magenis syndrome (SMS) is caused by an similar to4-Mb heterozygous interstitial deletion on chromosome 17p11.2 in similar to80%-90% of affected patients. Three large (similar to200 kb), complex, and highly homologous (similar to98%) low-copy repeats (LCRs) are located inside or flanking the SMS common deletion. These repeats, also known as "SMS-REPs," are termed "distal," "middle," and "proximal." The directly oriented distal and proximal copies act as substrates for nonallelic homologous recombination resulting in both the deletion associated with SMS and the reciprocal duplication: dup(17)(p11.2p11.2). Using restriction enzyme cis-morphism analyses and direct sequencing, we mapped the regions of strand exchange in 16 somatic-cell hybrids that harbor only the recombinant SMS-REP. Our studies showed that the sites of crossovers were distributed throughout the region of homology between the distal and proximal SMS-REPs. However, despite similar to170 kb of high homology, 50% of the recombinant junctions occurred in a 12.0-kb region within the KER gene clusters. DNA sequencing of this hotspot (positional preference for strand exchange) in seven recombinant SMS-REPs narrowed the crossovers to an similar to8-kb interval. Four of them occurred in a 1,655-bp region rich in polymorphic nucleotides that could potentially reflect frequent gene conversion. For further evaluation of the strand exchange frequency in patients with SMS, novel junction fragments from the recombinant SMS-REPs were identified. As predicted by the reciprocal-recombination model, junction fragments were also identified from this hotspot region in patients with dup(17)(p11.2p11.2), documenting reciprocity of the positional preference for strand exchange. Several potential cis-acting recombination-promoting sequences were identified within the hotspot. It is interesting that we found 2.1-kb AT-rich inverted repeats flanking the proximal and middle KER gene clusters but not the distal one. The role of any or all of these in stimulating double-strand breaks around this positional recombination hotspot remains to be explored.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Room 604B,1 Baylor Plaza, Houston, TX 77030 USA.		Park, Sung Sup/J-2756-2012; Patel, Pragna/H-9129-2017	Park, Sung Sup/0000-0003-3754-4848; Patel, Pragna/0000-0003-3584-1072	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038420] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000188] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00188, M01 RR000188] Funding Source: Medline; NICHD NIH HHS [P01 HD38420, R01 HD038420, HD2406407] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Badge RM, 2000, HUM MOL GENET, V9, P1239, DOI 10.1093/hmg/9.8.1239; BARBOUTI A, IN PRESS AM J HUM GE; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Fioretos T, 1999, BLOOD, V94, P225, DOI 10.1182/blood.V94.1.225.413k24_225_232; Gao LI, 1997, NUCLEIC ACIDS RES, V25, P4740, DOI 10.1093/nar/25.23.4740; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; GORDENIN DA, 1993, MOL CELL BIOL, V13, P5315, DOI 10.1128/MCB.13.9.5315; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; GUZZETTA V, 1992, GENOMICS, V13, P551, DOI 10.1016/0888-7543(92)90124-B; Han LL, 2000, HUM MOL GENET, V9, P1881, DOI 10.1093/hmg/9.12.1881; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Inoue K, 2001, GENOME RES, V11, P1018, DOI 10.1101/gr.180401; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; Jenne DE, 2001, AM J HUM GENET, V69, P516, DOI 10.1086/323043; Juyal RC, 1996, AM J MED GENET, V66, P193, DOI 10.1002/(SICI)1096-8628(19961211)66:2<193::AID-AJMG13>3.3.CO;2-9; Juyal RC, 1996, AM J HUM GENET, V58, P998; Karran P, 2000, CURR OPIN GENET DEV, V10, P144, DOI 10.1016/S0959-437X(00)00069-1; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; Lobachev KS, 1998, GENETICS, V148, P1507; Lopes J, 1996, AM J HUM GENET, V58, P1223; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Lupski JR, 2003, AM J HUM GENET, V72, P246, DOI 10.1086/346217; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Potocki L, 2003, GENET MED, V5, P430, DOI 10.1097/01.GIM.0000095625.14160.AB; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; ROTH DB, 1985, MOL CELL BIOL, V5, P2599, DOI 10.1128/MCB.5.10.2599; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; SMITH G, 1997, BUS WEEK        0721, P49; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Timmerman V, 1997, J MED GENET, V34, P43, DOI 10.1136/jmg.34.1.43; Trask BJ, 1996, HUM GENET, V98, P710, DOI 10.1007/s004390050291; Valero MC, 2000, GENOMICS, V69, P1, DOI 10.1006/geno.2000.6312; VNENCAKJONES CL, 1990, SCIENCE, V250, P1745, DOI 10.1126/science.1980158; WAHLS WP, 1990, CELL, V60, P95, DOI 10.1016/0092-8674(90)90719-U; Waldman AS, 1999, GENETICS, V153, P1873; YAMAMOTO H, 1997, CURRENT TOPICS PHYTO, V1, P99; ZORI RT, 1993, AM J MED GENET, V47, P504, DOI 10.1002/ajmg.1320470414	53	93	96	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2003	73	6					1302	1315		10.1086/379979	http://dx.doi.org/10.1086/379979			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	756PW	14639526	Green Published, Bronze			2022-12-18	WOS:000187491100008
J	Verhoeven, K; De Jonghe, P; Van de Putte, T; Nelis, E; Zwijsen, A; Verpoorten, N; De Vriendt, E; Jacobs, A; Van Gerwen, V; Francis, A; Ceuterick, C; Huylebroeck, D; Timmerman, V				Verhoeven, K; De Jonghe, P; Van de Putte, T; Nelis, E; Zwijsen, A; Verpoorten, N; De Vriendt, E; Jacobs, A; Van Gerwen, V; Francis, A; Ceuterick, C; Huylebroeck, D; Timmerman, V			Slowed conduction and thin myelination of peripheral nerves associated with mutant Rho guanine-nucleotide exchange factor 10	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GTPASES; DOMAIN; GENE; PROTEINS; FAMILY	Slowed nerve-conduction velocities (NCVs) are a biological endophenotype in the majority of the hereditary motor and sensory neuropathies (HMSN). Here, we identified a family with autosomal dominant segregation of slowed NCVs without the clinical phenotype of HMSN. Peripheral-nerve biopsy showed predominantly thinly myelinated axons. We identified a locus at 8p23 and a Thr109Ile mutation in ARHGEF10, encoding a guanine-nucleotide exchange factor (GEF) for the Rho family of GTPase proteins (RhoGTPases). Rho GEFs are implicated in neural morphogenesis and connectivity and regulate the activity of small RhoGTPases by catalyzing the exchange of bound GDP by GTP. Expression analysis of ARHGEF10, by use of its mouse orthologue Gef10, showed that it is highly expressed in the peripheral nervous system. Our data support a role for ARHGEF10 in developmental myelination of peripheral nerves.	Univ Instelling Antwerp VIB, Dept Mol Genet, Peripheral Neuropathy Grp, B-2610 Antwerp, Belgium; Univ Instelling Antwerp, Born Bunge Fdn, Lab Neuropathol & Electronmicroscopy, B-2610 Antwerp, Belgium; Univ Antwerp Hosp, Div Neurol, Antwerp, Belgium; Univ Louvain VIB, Dept Dev Biol, Louvain, Belgium	Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; University of Antwerp; Flanders Institute for Biotechnology (VIB)	Timmerman, V (corresponding author), Univ Instelling Antwerp VIB, Dept Mol Genet, Peripheral Neuropathy Grp, Univ Pl 1, B-2610 Antwerp, Belgium.	vincent.timmerman@ua.ac.be	Timmerman, Vincent/O-7283-2019; Zwijsen, An/AAK-2897-2020	Timmerman, Vincent/0000-0002-2162-0933; Zwijsen, An/0000-0002-8583-1721; Huylebroeck, Danny/0000-0003-4862-1079				BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; De Jonghe P, 1999, ARCH NEUROL-CHICAGO, V56, P1283, DOI 10.1001/archneur.56.10.1283; DEWULF N, 1995, ENDOCRINOLOGY, V136, P2652, DOI 10.1210/en.136.6.2652; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; HART MJ, 1994, J BIOL CHEM, V269, P62; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; LATHROP GM, 1984, AM J HUM GENET, V36, P460; PASTERIS NG, 1994, CELL, V79, P669; Rumenapp U, 2002, BIOCHEM J, V366, P721, DOI 10.1042/BJ20020654; Wherlock M, 2002, J CELL SCI, V115, P239; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	17	93	96	0	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					926	932		10.1086/378159	http://dx.doi.org/10.1086/378159			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	14508709	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000185676100017
J	Risch, N; Tang, H; Katzenstein, H; Ekstein, J				Risch, N; Tang, H; Katzenstein, H; Ekstein, J			Geographic distribution of disease mutations in the Ashkenazi Jewish population supports genetic drift over selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TAY-SACHS-DISEASE; MUCOLIPIDOSIS TYPE-IV; FACTOR-XI DEFICIENCY; COMMON LITHUANIAN MUTATION; 185DELAG BRCA1 MUTATION; GAUCHER-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; PHENOTYPE ANALYSIS; COLORECTAL-CANCER; JEWS	The presence of four lysosomal storage diseases (LSDs) at increased frequency in the Ashkenazi Jewish population has suggested to many the operation of natural selection (carrier advantage) as the driving force. We compare LSDs and nonlysosomal storage diseases (NLSDs) in terms of the number of mutations, allele-frequency distributions, and estimated coalescence dates of mutations. We also provide new data on the European geographic distribution, in the Ashkenazi population, of seven LSD and seven NLSD mutations. No differences in any of the distributions were observed between LSDs and NLSDs. Furthermore, no regular pattern of geographic distribution was observed for LSD versus NLSD mutations-with some being more common in central Europe and others being more common in eastern Europe, within each group. The most striking disparate pattern was the geographic distribution of the two primary Tay-Sachs disease mutations, with the first being more common in central Europe (and likely older) and the second being exclusive to eastern Europe (primarily Lithuania and Russia) (and likely much younger). The latter demonstrates a pattern similar to two other recently arisen Lithuanian mutations, those for torsion dystonia and familial hypercholesterolemia. These observations provide compelling support for random genetic drift (chance founder effects, one similar to11 centuries ago that affected all Ashkenazim and another similar to5 centuries ago that affected Lithuanians), rather than selection, as the primary determinant of disease mutations in the Ashkenazi population.	Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; Stanford Univ, Dept Stat, Stanford, CA 94305 USA; Kaiser Permanente, Div Res, Oakland, CA USA; Dor Yeshorim, Brooklyn, NY USA	Stanford University; Stanford University; Kaiser Permanente	Risch, N (corresponding author), Stanford Univ, Dept Genet, Sch Med, M322, Stanford, CA 94305 USA.							Bar-Sade RB, 1997, EUR J HUM GENET, V5, P413, DOI 10.1159/000484800; Bar-Sade RB, 1998, HUM MOL GENET, V7, P801, DOI 10.1093/hmg/7.5.801; Bargal R, 2001, HUM MUTAT, V17, P397, DOI 10.1002/humu.1115; BEUTLER E, 1993, AM J HUM GENET, V52, P85; BLUMENFELD A, 1993, NAT GENET, V4, P160, DOI 10.1038/ng0693-160; Boas FE, 2000, BLOOD CELL MOL DIS, V26, P348, DOI 10.1006/bcmd.2000.0314; BROIDE E, 1993, AM J MED GENET, V47, P213, DOI 10.1002/ajmg.1320470214; CAGANNA M, 1994, AM J HUM GENET S, V55, pA147; Cavalli-Sforza Luigi., 1979, GENETIC DISEASES ASH, P93; CHAKRAVARTI A, 1978, AM J HUM GENET, V30, P256; CHASE GA, 1972, AM J HUM GENET, V24, P339; DIAMOND JM, 1994, NATURE, V368, P291, DOI 10.1038/368291a0; Diaz GA, 2000, AM J HUM GENET, V66, P1821, DOI 10.1086/302946; Dong JL, 2002, AM J MED GENET, V110, P253, DOI 10.1002/ajmg.10450; Dong JL, 2001, MOL GENET METAB, V73, P160, DOI 10.1006/mgme.2001.3182; Drucker L, 2000, CANCER-AM CANCER SOC, V88, P755, DOI 10.1002/(SICI)1097-0142(20000215)88:4<755::AID-CNCR4>3.0.CO;2-7; Durst R, 2001, AM J HUM GENET, V68, P1172, DOI 10.1086/320123; Edelmann L, 2002, AM J HUM GENET, V70, P1023, DOI 10.1086/339519; Ellis NA, 1998, AM J HUM GENET, V63, P1685, DOI 10.1086/302167; FRAIKOR AL, 1977, SOC BIOL, V24, P117, DOI 10.1080/19485565.1977.9988272; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; Goodman R. M., 1979, GENETIC DISORDERS JE; GOODMAN RM, 1979, GENETIC DIS ASHKENAZ; GOODMAN RM, 1979, GENETIC DIS JEWISH P; GREBNER EE, 1991, AM J HUM GENET, V48, P604; JORDE LB, 1992, GENETIC DIVERSITY AMONG JEWS, P305; KEREM E, 1995, HUM GENET, V96, P193, DOI 10.1007/BF00207378; KRONN D, 1995, AM J HUM GENET, V57, P1250; LACERDA L, 1994, CLIN GENET, V45, P298; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; MATALON R, 1995, PEDIATR RES, V37, pA150; MEINER V, 1991, AM J HUM GENET, V49, P443; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; MOTULSKY AG, 1979, GENETIC DIS ASHKENAZ, P301; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; Neuhausen SL, 1996, AM J HUM GENET, V58, P271; Neuhausen SL, 1998, AM J HUM GENET, V62, P1381, DOI 10.1086/301885; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; PAW BH, 1990, AM J HUM GENET, V47, P698; Peleg L, 2002, ISRAEL MED ASSOC J, V4, P95; PELEG L, 1994, BIOCHEM MED METAB B, V52, P22, DOI 10.1006/bmmb.1994.1029; Peretz H, 1997, BLOOD, V90, P2654, DOI 10.1182/blood.V90.7.2654.2654_2654_2659; PETERSEN GM, 1983, AM J HUM GENET, V35, P1258; PRAS E, 1995, AM J HUM GENET, V56, P1297; RAO DC, 1973, AM J HUM GENET, V25, P594; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; ROTTER JI, 1987, NATURE, V329, P289, DOI 10.1038/329289a0; Rozen P, 1999, GASTROENTEROLOGY, V116, P54, DOI 10.1016/S0016-5085(99)70228-3; Shahrabani-Gargir L, 1998, GENET TEST, V2, P293, DOI 10.1089/gte.1998.2.293; SHERMAN JB, 1994, AM J HUM GENET, V55, P305; SHPILBERG O, 1995, BLOOD, V85, P429, DOI 10.1182/blood.V85.2.429.bloodjournal852429; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; VERLANDER PC, 1995, BLOOD, V86, P4034, DOI 10.1182/blood.V86.11.4034.bloodjournal86114034; WAGENER D, 1978, AM J HUM GENET, V30, P262; Woodage T, 1998, NAT GENET, V20, P62, DOI 10.1038/1722; YOKOYAMA S, 1979, ANN HUM GENET, V43, P133, DOI 10.1111/j.1469-1809.1979.tb02005.x; ZLOTOGORA J, 1988, AM J HUM GENET, V42, P271	62	93	95	0	18	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					812	822		10.1086/373882	http://dx.doi.org/10.1086/373882			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12612865	Bronze, Green Published			2022-12-18	WOS:000181972600004
J	Sugimura, K; Taylor, KD; Lin, YC; Hang, T; Wang, D; Tang, YM; Fischel-Ghodsian, N; Targan, SR; Rotter, JI; Yang, HY				Sugimura, K; Taylor, KD; Lin, YC; Hang, T; Wang, D; Tang, YM; Fischel-Ghodsian, N; Targan, SR; Rotter, JI; Yang, HY			A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; LARGE EUROPEAN COHORT; SUSCEPTIBILITY LOCUS; SUPPORTS LINKAGE; GENETIC-ANALYSIS; IBD1 LOCUS; CHROMOSOME-16; NOD2; MUTATION; ASSOCIATION	Crohn disease (CD) exhibits a 2-4-fold increased frequency in Jews as compared with other ethnic/racial groups. Three coding variants of the NOD2/CARD15 have been reported as independent disease-predisposing mutations (DPMs), but these were found in only 30%-40% of patients with CD and could not account for all the linkage between CD and the IBD1 locus. The aim of the present study was to explore whether additional DPMs at the IBD1 locus exist in the high-risk Jewish group. Sixty-four Ashkenazi Jewish and 147 non-Jewish white families were studied. Six microsatellite markers spanning IBD1 were genotyped for linkage analysis in subgroups stratified on NOD2/CARD15 DPM status. SNPs in NOD2/CARD15 (R702W, G908R, 1007fs, and S268P) were then genotyped in family and independent case-control samples. On the basis of initial results, sequencing was done on NOD2/CARD15-translated regions in 12 Jewish individuals. Subsequently, a new NOD2/CARD15 variant was genotyped and analyzed. After excluding the influence of the three DPMs, significant linkage of IBD1 to CD in Jews remained with two peaks at D16S403 (mean allele sharing [MAS] = 0.70] and D16S411 (MAS = 0.59). Further, we observed an increased frequency of a haplotype carrying only the 268S variant in Jewish patients (OR = 3.13, P = .0023) but not in non-Jews, suggesting the existence of a Jewish-specific additional disease-predisposing factor on this haplotype. Sequencing of this haplotype revealed a new variant (IVS8+158; JW1). The 268S-JW1 combination exhibited a further increased risk (OR = 5.75, P = .0005) and the highest population-attributable risk (15.1%) for CD among reported DPMs in Jews. In Ashkenazi Jews, unrecognized population-specific predisposing factor(s) exist on the 268S-JW1 haplotype at the IBD1 locus. This factor may contribute to the higher risk for CD in Ashkenazi Jews as compared with non-Jews.	Cedars Sinai Med Ctr, Div Med Genet, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Inflammatory Bowel Dis Res Ctr, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Dept Med, Steven Spielberg Pediat Res Ctr, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Dept Pediat, Steven Spielberg Pediat Res Ctr, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Los Angeles, CA USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles	Yang, HY (corresponding author), Cedars Sinai Med Ctr, Ctr Med Genet Birth Defects, SSB 378, 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	Huiying.Yang@cshs.org			NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054967, P01DK046763] Funding Source: NIH RePORTER; NCRR NIH HHS [RR00425, P41 RR003655, M01 RR000425, 1 P42 RR03655] Funding Source: Medline; NIDDK NIH HHS [DK54967, P01 DK046763, DK46763] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu MT, 2002, GASTROENTEROLOGY, V123, P679, DOI 10.1053/gast.2002.35393; Ahmad T, 2002, GASTROENTEROLOGY, V122, P854, DOI 10.1053/gast.2002.32413; Akolkar PN, 2001, AM J GASTROENTEROL, V96, P1127; Annese V, 1999, EUR J HUM GENET, V7, P567, DOI 10.1038/sj.ejhg.5200328; Brant SR, 1998, GASTROENTEROLOGY, V115, P1056, DOI 10.1016/S0016-5085(98)70073-3; Cavanaugh J, 2001, AM J HUM GENET, V68, P1165, DOI 10.1086/320119; Cavanaugh JA, 1998, ANN HUM GENET, V62, P291, DOI 10.1046/j.1469-1809.1998.6240291.x; Cho JH, 1997, INFLAMM BOWEL DIS, V3, P186, DOI 10.1002/ibd.3780030303; Curran ME, 1998, GASTROENTEROLOGY, V115, P1066, DOI 10.1016/S0016-5085(98)70075-7; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Diamond J., 2002, GENETIC BASIS COMMON, P50; Hampe J, 2002, LANCET, V359, P1661, DOI 10.1016/S0140-6736(02)08590-2; Hampe J, 2002, P NATL ACAD SCI USA, V99, P321, DOI 10.1073/pnas.261567999; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lesage S, 2002, AM J HUM GENET, V70, P845, DOI 10.1086/339432; Moslehi R, 2000, AM J HUM GENET, V66, P1259, DOI 10.1086/302853; MOTULSKY AG, 1995, NAT GENET, V9, P99, DOI 10.1038/ng0295-99; MOTULSKY AG, 1979, GENETIC DIS ASHKENAZ, P301; Murillo L, 2002, IMMUNOGENETICS, V54, P59, DOI 10.1007/s00251-002-0440-1; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ohmen JD, 1996, HUM MOL GENET, V5, P1679, DOI 10.1093/hmg/5.10.1679; Parkes M, 1996, LANCET, V348, P1588, DOI 10.1016/S0140-6736(05)66204-6; ROTTER JI, 1992, GENETIC DIVERSITY AMONG JEWS, P395; SCHLESSELMAN JJ, 1982, CASE CONTROL STUDIES, P183; Sobel E, 1996, AM J HUM GENET, V58, P1323; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vermeire S, 2002, AM J HUM GENET, V71, P74, DOI 10.1086/341124; YANG H, 2000, INFLAMM BOWEL DIS, P250	36	93	97	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					509	518		10.1086/367848	http://dx.doi.org/10.1086/367848			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12577202	Green Published, Bronze			2022-12-18	WOS:000181152600001
J	Simonaro, CM; Desnick, RJ; McGovern, MM; Wasserstein, MP; Schuchman, EH				Simonaro, CM; Desnick, RJ; McGovern, MM; Wasserstein, MP; Schuchman, EH			The demographics and distribution of type B Niemann-Pick disease: Novel mutations lead to new genotype/phenotype correlations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID SPHINGOMYELINASE GENE; JEWISH TYPE-A; MISSENSE MUTATION; NUCLEOTIDE-SEQUENCE; IDENTIFICATION; EXPRESSION; DEFICIENCY; DELETION; PATIENT	We have collected demographic and/or mutation information on a worldwide sample of 394 patients with type B Niemann-Pick disease (NPD). The disorder is panethnic, with the highest incidence occurring in individuals of Turkish, Arabic, and North African descent. Only five of the 394 patients were Ashkenazi Jewish, revealing that, unlike the type A form of NPD, type B NPD does not occur frequently within this population. Mutation analysis of the acid sphingomyelinase (ASM) gene (designated "SMPD1") was performed on 228 patients (324 unique alleles), and several novel, "common" mutations were found. Among these were the L137P, fsP189, and L549P mutations, which accounted for similar to75% of the alleles in Turkish patients, the H421Y and K576N mutations, which accounted for similar to85% of the alleles in Saudi Arabian patients, the S379P, R441X, R474W, and F480L mutations, which accounted for similar to55% of the alleles in Portuguese/Brazilian patients, and the A196P mutation, which accounted for similar to42% of the alleles in Scottish/English patients. The previously reported DeltaR608 mutation occurred on similar to12% of the alleles studied. Overall, a total of 45 novel mutations were found, and several new genotype/phenotype correlations were identified. In particular, the L137P, A196P, and R474W mutations were consistent with a less severe form of type B NPD, whereas the H421Y and K576N mutations led to an early-onset, more severe form that was specific to Saudi Arabia. These data provide the first extensive demographic assessment of this disorder and describe several new mutations that can be used to predict phenotypic outcome and to gain new insights into the structure and function of ASM.	Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Schuchman, EH (corresponding author), Mt Sinai Sch Med, Dept Human Genet, 1425 Madison Ave,Room 14-20A, New York, NY 10029 USA.				NCRR NIH HHS [M01 RR000071, K23 RR16052-01, K23 RR016052, 5 M01 RR00071] Funding Source: Medline; NICHD NIH HHS [1 R01 HD28607, 1 P30 HD28822, R01 HD028607] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD028607, P30HD028822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000071, K23RR016052] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Brooks DA, 1997, BBA-MOL BASIS DIS, V1361, P203, DOI 10.1016/S0925-4439(97)00036-7; ELLEDER M, 1986, J INHERIT METAB DIS, V9, P357, DOI 10.1007/BF01800485; ELLEDER M, 1983, EUR J PEDIATR, V140, P323, DOI 10.1007/BF00442673; FERLINZ K, 1991, BIOCHEM BIOPH RES CO, V179, P1187, DOI 10.1016/0006-291X(91)91697-B; FRANCIS SH, 1994, J BIOL CHEM, V269, P22477; He XX, 1999, BBA-PROTEIN STRUCT M, V1432, P251, DOI 10.1016/S0167-4838(99)00069-2; IDA H, 1993, J BIOCHEM-TOKYO, V114, P15, DOI 10.1093/oxfordjournals.jbchem.a124131; LEVRAN O, 1991, P NATL ACAD SCI USA, V88, P3748, DOI 10.1073/pnas.88.9.3748; LEVRAN O, 1993, HUM MOL GENET, V2, P205, DOI 10.1093/hmg/2.2.205; LEVRAN O, 1993, HUM MUTAT, V2, P317, DOI 10.1002/humu.1380020414; LEVRAN O, 1991, J CLIN INVEST, V88, P806, DOI 10.1172/JCI115380; LEVRAN O, 1992, BLOOD, V80, P2081; Li L, 1997, AM J HUM GENET, V61, pA24; Lin XH, 1998, J BIOL CHEM, V273, P14374, DOI 10.1074/jbc.273.23.14374; Linke T, 2001, BIOL CHEM, V382, P283, DOI 10.1515/BC.2001.035; Schuchman E., 2001, METABOLIC MOL BASES; SCHUCHMAN EH, 1992, GENOMICS, V12, P197, DOI 10.1016/0888-7543(92)90366-Z; SCHUCHMAN EH, 1995, HUM MUTAT, V6, P352, DOI 10.1002/humu.1380060412; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; Schuchman EH, 1997, GENET TEST, V1, P13, DOI 10.1089/gte.1997.1.13; TAKAHASHI T, 1992, J BIOL CHEM, V267, P12552; Takahashi Tsutomu, 1992, Human Mutation, V1, P70, DOI 10.1002/humu.1380010111; VANIER MT, 1993, HUM GENET, V92, P325, DOI 10.1007/BF01247328; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300	24	93	102	2	7	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2002	71	6					1413	1419		10.1086/345074	http://dx.doi.org/10.1086/345074			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	621KD	12369017	Green Published, Bronze			2022-12-18	WOS:000179586800014
J	Rannala, B; Reeve, JP				Rannala, B; Reeve, JP			High-resolution multipoint linkage-disequilibrium mapping in the context of a human genome sequence	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIASTROPHIC DYSPLASIA; POSITIONAL CLONING; DISEASE GENES; POPULATIONS; INFERENCE; MUTATION; FINLAND; ALLELE; LOCI	A new method is presented for fine-scale linkage disequilibrium (LD) mapping of a disease mutation; it uses multiple linked single-nucleotide polymorphisms, restriction-fragment-length polymorphisms, or microsatellite markers and incorporates information from an annotated human genome sequence (HGS) and from a human mutation database. The method takes account of population demographic effects, using Markov chain Monte Carlo methods to integrate over the unknown gene genealogy and gene coalescence times. Information about the relative frequency of disease mutations in exons, introns, and other regions, from mutational databases, as well as assumptions about the completeness of the gene annotation, are used with an annotated HGS, to generate a prior probability that a mutation lies at any particular position in a specified region of the genome. This information is updated with information about mutation location, from LD at a set of linked markers in the region, to generate the posterior probability density of the mutation location. The performance of the method is evaluated by simulation and by analysis of a data set for diastrophic dysplasia (DTD) in Finland. The DTD disease gene has been positionally cloned, so the actual location of the mutation is known and can be compared with the position predicted by our method. For the DTD data, the addition of information from an HGS results in disease-gene localization at a resolution that is much higher than that which would be possible by LD mapping alone. In this case, the gene would be found by sequencing a region less than or equal to7 kb in size.	Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada	University of Alberta	Rannala, B (corresponding author), Univ Alberta, Dept Med Genet, 8-39 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	brannala@ualberta.ca	Rannala, Bruce/M-3188-2014	Rannala, Bruce/0000-0002-8355-9955	NHGRI NIH HHS [R01 HG001988] Funding Source: Medline	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Berger JO., 1985, STAT DECISION THEORY; BODMER WF, 1986, COLD SPRING HARB SYM, V51, P1; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; CLARK AG, 1990, MOL BIOL EVOL, V7, P111; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Gelman A., 1996, INFERENCE MONITORING; Graham J, 1998, AM J HUM GENET, V63, P1517, DOI 10.1086/302102; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hastbacka J, 1999, EUR J HUM GENET, V7, P664, DOI 10.1038/sj.ejhg.5200361; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HASTBACKA J, 1990, P NATL ACAD SCI USA, V87, P8056, DOI 10.1073/pnas.87.20.8056; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; Kingman J, 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; KUHNER MK, 1995, GENETICS, V140, P1421; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANDER ES, 1986, COLD SPRING HARB SYM, V51, P49, DOI 10.1101/SQB.1986.051.01.007; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Luria SE, 1943, GENETICS, V28, P491; McPeek MS, 1999, AM J HUM GENET, V65, P858, DOI 10.1086/302537; Medhi J, 1994, STOCHASTIC PROCESSES; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Morris AP, 2000, AM J HUM GENET, V67, P155, DOI 10.1086/302956; OTT J, 1999, ANAL HUM GENETIC LIN; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rannala B, 1998, AM J HUM GENET, V62, P459, DOI 10.1086/301709; Rannala B, 2000, GENET EPIDEMIOL, V19, pS71, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI11>3.0.CO;2-D; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Sobel E, 1996, AM J HUM GENET, V58, P1323; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; Yang ZH, 1997, MOL BIOL EVOL, V14, P717, DOI 10.1093/oxfordjournals.molbev.a025811	36	93	96	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					159	178		10.1086/321279	http://dx.doi.org/10.1086/321279			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11410841	Bronze, Green Published			2022-12-18	WOS:000170108100016
J	Cui, JS; Antoniou, AC; Dite, GS; Southey, MC; Venter, DJ; Easton, DF; Giles, GG; McCredie, MRE; Hopper, JL				Cui, JS; Antoniou, AC; Dite, GS; Southey, MC; Venter, DJ; Easton, DF; Giles, GG; McCredie, MRE; Hopper, JL			After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC EPIDEMIOLOGY; STEROID-HORMONE; RISK; HISTORY; ONSET; AGE; MUTATIONS; SAMPLE; HEALTH; WOMEN	Mutations in BRCA1 and BRCA2 that cause a dominantly inherited high risk of female breast cancer seem to explain only a small proportion of the aggregation of the disease. To study the possible additional genetic components, we conducted single-locus and two-locus segregation analyses, with and without a polygenic background, using three-generation families ascertained through 858 women with breast cancer diagnosed at age <40 years, ascertained through population cancer registries in Melbourne and Sydney, Australia. Extensive testing for deleterious mutations in BRCA1 and BRCA2, to date, has identified 34 carriers. Our analysis suggested that, after other possible unmeasured familial factors are adjusted for and the known BRCA1 and BRCA2 mutation carriers are excluded, there appears to be a residual dominantly inherited risk of female breast cancer in addition to that derived from mutations in BRCA1 and BRCA2. This study also suggests that there is a substantial recessively inherited risk of early-onset breast cancer. According to the best-fitting model, after excluding known carriers of mutations in BRCA1 and BRCA2, about 1/250 (95% confidence interval [CI] 1/500 to 1/125) women have a recessive risk of 86% (95% CI 69%-100%) by age 50 years and of almost 100% by age 60 years. Possible reasons that our study has implicated a novel strong recessive effect include our inclusion of data on lineal aunts and grandmothers, study of families ascertained through women with early-onset breast cancer, allowance for multiple familial factors in the analysis, and removal of families for whom the cause (i.e., BRCA1 or BRCA2) is known. Our findings may have implications for attempts to identify new breast cancer-susceptibility genes.	Univ Melbourne, Ctr Genet Epidemiol, Carlton, Vic 3053, Australia; Anticanc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic, Australia; Univ Cambridge, Inst Publ Hlth, CRC, Genet Epidemiol Unit, Cambridge, England; Peter MacCallum Canc Inst, Dept Pathol, Melbourne, Vic 3000, Australia; Peter MacCallum Canc Inst, Dept Res, Melbourne, Vic 3000, Australia; Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; New S Wales Canc Council, Canc Epidemiol Res Unit, Woolloomooloo, NSW, Australia; Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand	University of Melbourne; University of Cambridge; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Cancer Council New South Wales; University of Otago	Hopper, JL (corresponding author), Univ Melbourne, Ctr Genet Epidemiol, 200 Berkeley St, Carlton, Vic 3053, Australia.	j.hopper@unimelb.edu.au		Dite, Gillian/0000-0002-2448-2548; Southey, Melissa/0000-0002-6313-9005; Giles, Graham/0000-0003-4946-9099	NATIONAL CANCER INSTITUTE [U01CA069638] Funding Source: NIH RePORTER; NCI NIH HHS [CA69638, U01 CA069638] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANTONIOU AC, IN PRESS GENET EPIDE; *AUSTR I HLTH WELF, 1999, BREAST CANC AUSTR WO; Baffoe-Bonnie AB, 2000, GENET EPIDEMIOL, V18, P81, DOI 10.1002/(SICI)1098-2272(200001)18:1<81::AID-GEPI6>3.0.CO;2-H; BENICHOU J, 1997, ENCY BIOSTATISTICS, P11; BISHOP DT, 1980, BANBURY REPORT, V4, P389; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CHEN PL, 1995, GENET EPIDEMIOL, V12, P401, DOI 10.1002/gepi.1370120408; CLAUS EB, 1991, AM J HUM GENET, V48, P232; CLAUS EB, 1993, CANCER, V71, P147, DOI 10.1002/1097-0142(19930101)71:1<147::AID-CNCR2820710124>3.0.CO;2-V; CLAUS EB, 1990, AM J EPIDEMIOL, V131, P961, DOI 10.1093/oxfordjournals.aje.a115616; COLDITZ GA, 1993, JAMA-J AM MED ASSOC, V270, P338, DOI 10.1001/jama.270.3.338; Cui JS, 2000, CANCER EPIDEM BIOMAR, V9, P805; ECCLES D, 1994, J MED GENET, V31, P944, DOI 10.1136/jmg.31.12.944; ELANDTJOHNSON RC, 1971, PROBABILITY MODELS S; ESSIOUX L, 1995, ANN HUM GENET, V59, P271, DOI 10.1111/j.1469-1809.1995.tb00747.x; FERNANDO RL, 1994, THEOR APPL GENET, V88, P573, DOI 10.1007/BF01240920; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; GOLDSTEIN AM, 1990, JNCI-J NATL CANCER I, V82, P1911, DOI 10.1093/jnci/82.24.1911; GOLDSTEIN AM, 1987, JNCI-J NATL CANCER I, V78, P911; GREENWOOD M, 1926, 33 PUBL HLTH STAT SU; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hopper J L, 1999, J Natl Cancer Inst Monogr, P95; Hopper JL, 1999, CANCER EPIDEM BIOMAR, V8, P741; HOPPER JL, 1992, AM J EPIDEMIOL, V136, P1138, DOI 10.1093/oxfordjournals.aje.a116580; Hopper JL, 1994, BREAST, V3, P79; ISELIUS L, 1991, ANN HUM GENET, V55, P151, DOI 10.1111/j.1469-1809.1991.tb00408.x; Kainu T, 2000, P NATL ACAD SCI USA, V97, P9603, DOI 10.1073/pnas.97.17.9603; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; LANGE K, 1997, MATH STAT METHODS GE, P132; McCredie MRE, 1998, CANCER CAUSE CONTROL, V9, P189, DOI 10.1023/A:1008886328352; NEWMAN B, 1988, P NATL ACAD SCI USA, V85, P1; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; PETO J, 1980, BANBURY REPORT, V4, P203; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.0.CO;2-B; Puget N, 1999, AM J HUM GENET, V64, P300, DOI 10.1086/302211; SLATTERY ML, 1993, JAMA-J AM MED ASSOC, V270, P1563, DOI 10.1001/jama.270.13.1563; Southey MC, 1999, BRIT J CANCER, V79, P34, DOI 10.1038/sj.bjc.6690008; Spurdle AB, 2000, J NATL CANCER I, V92, P1674, DOI 10.1093/jnci/92.20.1674; *STATA, 1999, STATA REL 6; Tesoriero A, 1999, AM J HUM GENET, V65, P567, DOI 10.1086/302503	42	93	96	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2001	68	2					420	431		10.1086/318187	http://dx.doi.org/10.1086/318187			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	394LD	11133358	Bronze, Green Published			2022-12-18	WOS:000166524800012
J	Hannula, K; Lipsanen-Nyman, M; Kontiokari, T; Kere, J				Hannula, K; Lipsanen-Nyman, M; Kontiokari, T; Kere, J			A narrow segment of maternal uniparental disomy of chromosome 7q31-qter in Silver-Russell syndrome delimits a candidate gene region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; GROWTH-RETARDATION; PATERNAL ISODISOMY; SHORT STATURE; HETERODISOMY; MECHANISM; MOSAICISM; ETIOLOGY; PATIENT; GENOME	Maternal uniparental disomy of chromosome 7 (matUPD7), the inheritance of both chromosomes from only the mother, is observed in similar to 10% of patients with Silver-Russell syndrome (SRS). It has been suggested that at least one imprinted gene that regulates growth and development resides on human chromosome 7. To date, three imprinted genes-PEG1/MEST, gamma2-COP, and GRB10-have been identified on chromosome 7, but their role in the etiology of SRS remains uncertain. In a systematic screening with microsatellite markers, for matUPD7 cases among patients with SRS, we identified a patient who had a small segment of matUPD7 and biparental inheritance of the remainder of chromosome 7. Such a pattern may be explained by somatic recombination in the zygote. The matUPD7 segment at 7q31-qter extends for 35 Mb and includes the imprinted gene cluster of PEG1/MEST and gamma2-COP at 7q32. GRB10 at 7p11.2-p12 is located within a region of biparental inheritance. Although partial UPD has previously been reported for chromosomes 6, 11, 14, and 15, this is the first report of a patient with SRS who has segmental matUPD7. Our findings delimit a candidate imprinted region sufficient to cause SRS.	Univ Helsinki, Haartman Inst, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Hosp Children & Adolescents, FIN-00014 Helsinki, Finland; Univ Helsinki, Finnish Genome Ctr, FIN-00014 Helsinki, Finland; Univ Oulu, Dept Pediat, SF-90100 Oulu, Finland; Univ Turku, Dept Med Genet, Turku, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Oulu; University of Turku	Hannula, K (corresponding author), Univ Helsinki, Haartman Inst, Dept Med Genet, POB 21,Haartmaninkatu 3, FIN-00014 Helsinki, Finland.		Kere, Juha/A-9179-2008; Hannula-Jouppi, Katariina SE/F-4476-2011; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Hannula-Jouppi, Katariina/0000-0003-3864-2853				Bernstein BS, 1999, POW ENGN SER, V7, P87; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; Blagitko N, 1999, HUM MOL GENET, V8, P2387, DOI 10.1093/hmg/8.13.2387; CATTANACH BM, 1990, DEVELOPMENT, P63; Das S, 2000, AM J HUM GENET, V67, P1586, DOI 10.1086/316897; DUNCAN PA, 1990, AM J MED GENET, V35, P245, DOI 10.1002/ajmg.1320350220; EGGERDING FA, 1994, AM J HUM GENET, V55, P253; Eggermann T, 1997, HUM GENET, V100, P415, DOI 10.1007/s004390050526; ENGEL E, 1993, AM J MED GENET, V46, P670, DOI 10.1002/ajmg.1320460613; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; ESCOBAR V, 1978, CLIN GENET, V13, P278; GREGORY CA, 1991, HUM GENET, V88, P42, DOI 10.1007/BF00204927; HANNULA K, IN PRESS J MED GENET; Hayashida S, 2000, GENOMICS, V66, P221, DOI 10.1006/geno.2000.6206; Henry I., 1993, European Journal of Human Genetics, V1, P19; HOGLUND P, 1994, AM J HUM GENET, V55, P747; Joyce CA, 1999, HUM GENET, V105, P273, DOI 10.1007/s004390051101; Kipreos ET, 1996, CELL, V85, P829, DOI 10.1016/S0092-8674(00)81267-2; KOTZOT D, 1995, HUM MOL GENET, V4, P583, DOI 10.1093/hmg/4.4.583; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LANGLOIS S, 1995, J MED GENET, V32, P871, DOI 10.1136/jmg.32.11.871; Martin RA, 1999, J MED GENET, V36, P633; Miyoshi O, 1999, J MED GENET, V36, P326; Monk D, 2000, AM J HUM GENET, V66, P36, DOI 10.1086/302717; Nicholls RD, 1998, TRENDS GENET, V14, P194, DOI 10.1016/S0168-9525(98)01432-2; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; PARTINGTON MW, 1986, CLIN GENET, V29, P151; Preece MA, 1997, J MED GENET, V34, P6, DOI 10.1136/jmg.34.1.6; Price SM, 1999, J MED GENET, V36, P837; Reik W, 1997, TRENDS GENET, V13, P330, DOI 10.1016/S0168-9525(97)01200-6; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; RUSSELL A, 1954, P ROY SOC MED, V47, P1040; SILVER HK, 1953, PEDIATRICS, V12, P368; SPENCE JE, 1988, AM J HUM GENET, V42, P217; SPOTILA LD, 1992, AM J HUM GENET, V51, P1396; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Teebi A S, 1992, Clin Dysmorphol, V1, P151; VOSS R, 1989, AM J HUM GENET, V45, P373; Wakeling EL, 2000, J MED GENET, V37, P65, DOI 10.1136/jmg.37.1.65; WOLLMANN HA, 1995, EUR J PEDIATR, V154, P958, DOI 10.1007/BF01958638; YALLAMPALLI C, 1993, AM J OBSTET GYNECOL, V169, P1316, DOI 10.1016/0002-9378(93)90299-X; Yoshihashi H, 2000, AM J HUM GENET, V67, P476, DOI 10.1086/302997; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	43	93	96	0	0	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					247	253		10.1086/316937	http://dx.doi.org/10.1086/316937			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11112662	Bronze, Green Published			2022-12-18	WOS:000166399900026
J	Keightley, JA; Anitori, R; Burton, MD; Quan, F; Buist, NRM; Kennaway, NG				Keightley, JA; Anitori, R; Burton, MD; Quan, F; Buist, NRM; Kennaway, NG			Mitochondrial encephalomyopathy and complex III deficiency associated with a stop-codon mutation in the cytochrome b gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXERCISE INTOLERANCE; MISSENSE MUTATION; MTDNA MUTATION; POINT MUTATION; C REDUCTASE; PATIENT; MYOPATHY; MICRODELETION; ADVANTAGE; SUBUNITS	We have reinvestigated a young woman, originally reported by us in 1983, who presented with exercise intolerance and lactic acidosis associated with severe deficiency of complex III and who responded to therapy with menadione and ascorbate. Gradually, she developed symptoms of a mitochondrial encephalomyopathy. Immunocytochemistry of serial sections of muscle showed a mosaic of fibers that reacted poorly with antibodies to subunits of complex III but reacted normally with antibodies to subunits of complexes I, II, or IV, suggesting a mutation of mtDNA. These findings demonstrate the diagnostic value of immunocytochemistry in identifying specific respiratory-chain deficiencies and, potentially, distinguishing between nuclear- or mtDNA-encoded defects. Sequence analysis revealed a stop-codon mutation (G15242A) in the mtDNA-encoded cytochrome b gene, resulting in loss of the last 215 amino acids of cytochrome b. PCR-RFLP analysis indicated that the G15242A mutation was heteroplasmic and was present in a high percentage (87%) of affected tissue (skeletal muscle) and a low percentage (0.7%) of unaffected tissue (blood) but was not detected in controls. Analysis of microdissected muscle fibers showed a significant correlation between the immunoreactivity toward the Rieske protein of complex III and the percentage of mutant mtDNA: immunopositive fibers had a median value of 33% of the G15242A mutation, whereas immunonegative, ragged-red fibers had a median value of 89%, indicating that the stop-codon mutation was pathogenic in this patient. The G15242A mutation was also present in several other tissues, including hair roots, indicating that it must have arisen either very early in embryogenesis, before separation of the primary germ layers, or in the maternal germ line. The findings in this patient are contrasted with other recently described patients who have mutations in the cytochrome b gene.	Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Kennaway, NG (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, MP-350,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	kennaway@ohsu.edu	Quan, Fu-Shi/V-1826-2019					ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andreu AL, 1999, MOL GENET METAB, V67, P49, DOI 10.1006/mgme.1999.2843; Andreu AL, 2000, PEDIATR RES, V48, P311, DOI 10.1203/00006450-200009000-00008; Andreu AL, 1998, NEUROLOGY, V51, P1444, DOI 10.1212/WNL.51.5.1444; Andreu AL, 1999, ANN NEUROL, V45, P127, DOI 10.1002/1531-8249(199901)45:1<127::AID-ART20>3.0.CO;2-Y; Andreu AL, 1999, NEW ENGL J MED, V341, P1037, DOI 10.1056/NEJM199909303411404; ARGOV Z, 1986, ANN NEUROL, V19, P598, DOI 10.1002/ana.410190615; Bidooki SK, 1997, AM J HUM GENET, V60, P1430, DOI 10.1086/515460; BING DH, 1998, CURRENT PROTOCOLS HU, V2; Chinnery PF, 1999, J MED GENET, V36, P425; Chinnery PF, 1999, LANCET, V354, pSI17; Clark KM, 1999, AM J HUM GENET, V64, P1330, DOI 10.1086/302361; Comi GP, 1998, ANN NEUROL, V43, P110, DOI 10.1002/ana.410430119; DARLEYUSMAR VM, 1983, P NATL ACAD SCI-BIOL, V80, P5103, DOI 10.1073/pnas.80.16.5103; DARLEYUSMAR VM, 1986, CLIN CHIM ACTA, V158, P253, DOI 10.1016/0009-8981(86)90289-5; De Coo IFM, 1999, ANN NEUROL, V45, P130, DOI 10.1002/1531-8249(199901)45:1<130::AID-ART21>3.3.CO;2-Q; DiMauro S, 1998, BBA-BIOENERGETICS, V1366, P199, DOI 10.1016/S0005-2728(98)00113-3; DiMauro S, 1997, MOL GENETIC BASIS NE, P201; Dumoulin R, 1996, MOL CELL PROBE, V10, P389, DOI 10.1006/mcpr.1996.0053; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; ELEFF S, 1984, P NATL ACAD SCI-BIOL, V81, P3529, DOI 10.1073/pnas.81.11.3529; ELLIOT DL, 1989, MEDICINE, V68, P163, DOI 10.1097/00005792-198905000-00004; Fu K, 1996, HUM MOL GENET, V5, P1835, DOI 10.1093/hmg/5.11.1835; Griggs RC, 1999, NEW ENGL J MED, V341, P1077, DOI 10.1056/NEJM199909303411411; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; HAO HL, 1995, AM J HUM GENET, V56, P1017; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Keightley JA, 1996, NAT GENET, V12, P410, DOI 10.1038/ng0496-410; Kennaway N. G., 1998, MOL GENET METAB, V63, P49; KENNAWAY NG, 1984, PEDIATR RES, V18, P991; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; LEGROS F, 1999, CLIN MOL DIVERSITY R, P135; Mourmans J, 1997, J NEUROL SCI, V149, P111, DOI 10.1016/S0022-510X(97)05379-3; PULKES T, 1999, 4 EUR M MIT PATH CAM, P179; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SEN K, 1985, ARCH BIOCHEM BIOPHYS, V242, P393, DOI 10.1016/0003-9861(85)90223-1; Taanman JW, 1996, BBA-MOL BASIS DIS, V1315, P199, DOI 10.1016/0925-4439(95)00127-1; Valnot I, 1999, HUM GENET, V104, P460, DOI 10.1007/s004390050988; von Kleist-Retzow JC, 1998, AM J HUM GENET, V63, P428, DOI 10.1086/301957; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Weber K, 1997, AM J HUM GENET, V60, P373; Wong LJC, 1997, CLIN CHEM, V43, P1241; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	44	93	95	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1400	1410		10.1086/316900	http://dx.doi.org/10.1086/316900			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11047755	Green Published, Bronze			2022-12-18	WOS:000165607600005
J	Hoffman, HM; Wright, FA; Broide, DH; Wanderer, AA; Kolodner, RD				Hoffman, HM; Wright, FA; Broide, DH; Wanderer, AA; Kolodner, RD			Identification of a locus on chromosome 1q44 for familial cold urticaria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; MUCKLE-WELLS-SYNDROME	Familial cold urticaria (FCU) is a rare autosomal dominant inflammatory disorder characterized by intermittent episodes of rash with fever, arthralgias, conjunctivitis, and leukocytosis. These symptoms develop after generalized exposure to cold. Some individuals with FCU also develop late-onset reactive renal amyloidosis, which is consistent with Muckle-Wells syndrome. By analyzing individuals with FCU from five families, we identified linkage to chromosome 1q44. Two-point linkage analysis revealed a maximum LOD score (Z(max)) of 8.13 (recombination fraction 0) for marker D1S2836; multipoint linkage analysis identified a Z(max) of 10.32 in the same region; and haplotype analysis defined a 10.5-cM region between markers D1S423 and D1S2682. Muckle-Wells syndrome was recently linked to chromosome 1q44, which suggests that the two disorders may be linked to the same locus.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA; Ohio State Univ, Div Human Canc genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Canc, Columbus, OH 43210 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat & Allergy, Denver, CO USA	University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Hoffman, HM (corresponding author), Univ Calif San Diego, Div Rheumatol Allergy & Immunol, Mail Code 0635,9500 Gilman Dr, La Jolla, CA 92093 USA.			Broide, David/0000-0001-8405-9090	NIAID NIH HHS [K08 AI001508, 5K08AI01508] Funding Source: Medline; NIGMS NIH HHS [GM58934] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI001508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058934] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Castelain P Y, 1971, Bull Soc Fr Dermatol Syphiligr, V78, P525; COMMERFORD PJ, 1977, S AFR MED J, V51, P105; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; Cuisset L, 1999, AM J HUM GENET, V65, P1054, DOI 10.1086/302589; DERBES VJ, 1972, ANN ALLERGY, V30, P335; DOEGLAS HMG, 1974, ARCH DERMATOL, V110, P382, DOI 10.1001/archderm.110.3.382; DOEGLAS HMG, 1973, ARCH DERMATOL, V107, P136, DOI 10.1001/archderm.107.1.136; FORDYCE AM, 1993, BRIT DENT J, V175, P417, DOI 10.1038/sj.bdj.4808345; Gerbig AW, 1998, QJM-INT J MED, V91, P489, DOI 10.1093/qjmed/91.7.489; Grateau Gilles, 1999, Current Opinion in Rheumatology, V11, P75, DOI 10.1097/00002281-199901000-00013; IRWIN M, 1994, P NATL ACAD SCI USA, V91, P11684, DOI 10.1073/pnas.91.24.11684; Jung M., 1996, American Journal of Human Genetics, V59, pA223; KALOGEROMITROS D, 1995, ANN ALLERG ASTHMA IM, V74, P295; Kile RL., 1940, J AM MED ASS, V114, P1067, DOI [10.1001/jama.1940.62810120003010b, DOI 10.1001/JAMA.1940.62810120003010B]; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARTIN S, 1981, CUTIS, V27, P173; MUCKLE TJ, 1979, BRIT J DERMATOL, V100, P87, DOI 10.1111/j.1365-2133.1979.tb03572.x; ORMEROD AD, 1993, ARCH DERMATOL, V129, P343, DOI 10.1001/archderm.129.3.343; Ott J., 1991, ANAL HUMAN GENETIC L; RODIN H H, 1951, J Indiana State Med Assoc, V44, P846; ROUX H, 1982, REV RHUM, V49, P131; SHEPARD MK, 1971, 3 C CLIN DEL BIRT 12, V7, P352; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; TINDALL JP, 1969, ARCH INTERN MED, V124, P129, DOI 10.1001/archinte.124.2.129; TONNESAN MG, 1985, CLIN RES, V33, P690; TONNESEN MNG, 1985, ASP ALL C ASP JUL 26; Urano Y, 1998, BRIT J DERMATOL, V139, P504; Urback E, 1941, ARCH DERMATOL SYPH, V43, P366, DOI 10.1001/archderm.1941.01490200148014; VLAGOPOULOS T, 1975, ANN ALLERGY, V34, P366; WANDERER AA, 1979, HOSP PRACT, V14, P136, DOI 10.1080/21548331.1979.11707566; WITHERSPOON FG, 1948, ARCH DERMATOL SYPH, V58, P52, DOI 10.1001/archderm.1948.01520200055007; ZIP CM, 1993, CLIN EXP DERMATOL, V18, P338, DOI 10.1111/j.1365-2230.1993.tb02212.x	33	93	96	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1693	1698		10.1086/302874	http://dx.doi.org/10.1086/302874			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10741953	Bronze, Green Published			2022-12-18	WOS:000088373700024
J	Ramet, M; Haataja, R; Marttila, R; Floros, J; Hallman, M				Ramet, M; Haataja, R; Marttila, R; Floros, J; Hallman, M			Association between the surfactant protein A (SP-A) gene locus and respiratory-distress syndrome in the Finnish population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PULMONARY SURFACTANT; B GENE; RACIAL-DIFFERENCES; LUNG; EXPRESSION; DISEASE; INFANTS; PHOSPHATIDYLCHOLINE; CHROMOSOME-10; INHIBITION	Respiratory-distress syndrome (RDS) in the newborn is a major cause of neonatal mortality and morbidity. Although prematurity is the most-important risk factor for RDS, the syndrome does not develop in many premature infants. The main cause of RDS is a deficiency of pulmonary surfactant, which consists of phospholipids and specific proteins. The genes underlying susceptibility to RDS are insufficiently known. The candidate-gene approach was used to study the association between the surfactant protein A (SP-A) gene locus and RDS in the genetically homogeneous Finnish population. In the present study, 88 infants with RDS and 88 control infants that were matched for degree of prematurity, prenatal glucocorticoid therapy, and sex were analyzed for SP-A genotypes. We show that certain SP-A1 alleles (6A(2) and 6A(3)) and an SP-A1/SP-A2 haplotype (6A(2)/1A(0)) were associated with RDS. The 6A(2) allele was overrepresented and the 6A(3) allele was underrepresented in infants with RDS. These associations were particularly strong among small premature infants born at gestational age <32 wk. In infants protected from RDS (those that had no RDS, despite extreme prematurity and lack of glucocorticoid therapy), compared with infants that had RDS develop despite having received glucocorticoid therapy, the frequencies of 6A(2) (.22 vs. .71), 6A(3) (.72 vs. .17), 6A(2)/1A(0) (.17 vs. .68), 6A(3)/1A(1) (.39 vs. .10), and 6A(3)/1A(2) (.28 vs. .06) in the two groups, respectively, were strikingly different. According to the results of conditional logistic-regression analysis, diseases associated with premature birth did not explain the association between the odds of a particular homozygous SP-A1 genotype (6A(2)/6A(2) and 6A(3)/6A(3)) and RDS. In the population evaluated in the present study, SP-B intron 4 variant frequencies were low and had no detectable association with RDS. We conclude that the SP-A gene locus is an important determinant for predisposition to RDS in premature infants.	Oulu Univ, Dept Pediat, FIN-90014 Oulu, Finland; Oulu Univ, Bioctr Oulu, FIN-90014 Oulu, Finland; Cent Hosp So Ostrobotnia, Seinajoki, Finland; Penn State Univ, Coll Med, Dept Cellular & Mol Physiol & Pediat, Hershey, PA USA	University of Oulu; University of Oulu; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Hallman, M (corresponding author), Oulu Univ, Dept Pediat, POB 5000, FIN-90014 Oulu, Finland.		Hallman, Niilo/AHD-9810-2022	Saastamoinen, Ritva/0000-0002-8899-0381	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL034788] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37HL34788] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; BRUNS G, 1987, HUM GENET, V76, P58; COCKSHUTT AM, 1990, BIOCHEMISTRY-US, V29, P8424, DOI 10.1021/bi00488a032; Crouch EC, 1998, AM J RESP CELL MOL, V19, P177, DOI 10.1165/ajrcmb.19.2.140; CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; DEMELLO DE, 1993, AM J PATHOL, V142, P1631; DEMELLO DE, 1989, AM J PATHOL, V134, P1285; DiAngelo S, 1999, DIS MARKERS, V15, P269, DOI 10.1155/1999/961430; Eggleton P, 1999, CURR OPIN IMMUNOL, V11, P28, DOI 10.1016/S0952-7915(99)80006-5; FARRELL PM, 1976, PEDIATRICS, V58, P167; FISHER JH, 1987, AM J HUM GENET, V40, P503; FLOROS J, 1991, EXP LUNG RES, V17, P91, DOI 10.3109/01902149109063284; FLOROS J, 1995, BIOCHEM J, V305, P583, DOI 10.1042/bj3050583; Floros J, 1996, AM J RESP CELL MOL, V15, P489, DOI 10.1165/ajrcmb.15.4.8879183; Floros J, 1998, ANNU REV PHYSIOL, V60, P365, DOI 10.1146/annurev.physiol.60.1.365; Floros J, 1998, BBA-MOL BASIS DIS, V1408, P312, DOI 10.1016/S0925-4439(98)00077-5; GLUCK L, 1971, AM J OBSTET GYNECOL, V109, P440, DOI 10.1016/0002-9378(71)90342-5; GRAVEN SN, 1965, AM J DIS CHILD, V109, P489, DOI 10.1001/archpedi.1965.02090020491003; HAFEZ M, 1989, DIS MARKERS, V7, P201; HALLMAN M, 1988, AM J OBSTET GYNECOL, V158, P531, DOI 10.1016/0002-9378(88)90019-1; HALLMAN M, 1991, AM REV RESPIR DIS, V144, P1376, DOI 10.1164/ajrccm/144.6.1376; HALLMAN M, 1992, PULMONARY SURFACTANT, P425; HAWGOOD S, 1990, J CLIN INVEST, V86, P1, DOI 10.1172/JCI114670; Hoover RR, 1999, AM J PHYSIOL-LUNG C, V276, pL917, DOI 10.1152/ajplung.1999.276.6.L917; Ikegami M, 1998, AM J PHYSIOL-LUNG C, V275, pL247, DOI 10.1152/ajplung.1998.275.2.L247; JOBE AH, 1994, NEW THERAPIES NEONAT, P16; Kala P, 1998, PEDIATR RES, V43, P169, DOI 10.1203/00006450-199802000-00003; KARINCH AM, 1995, AM J RESP CELL MOL, V12, P77, DOI 10.1165/ajrcmb.12.1.7811473; Karinch AM, 1997, BIOCHEM J, V321, P39, DOI 10.1042/bj3210039; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; LANKENAU HM, 1976, EUR J PEDIATR, V123, P167, DOI 10.1007/BF00452094; Lin ZW, 1998, MOL GENET METAB, V64, P25, DOI 10.1006/mgme.1998.2702; MERRITT TA, 1993, J INTENSIVE CARE MED, V8, P205; MOYA FR, 1994, AM J RESP CRIT CARE, V150, P1672, DOI 10.1164/ajrccm.150.6.7952631; MYRIANTHOPOULOS NC, 1971, ACTA GENET MED GEMEL, V20, P199, DOI 10.1017/S1120962300011628; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; OLOWE SA, 1978, PEDIATRICS, V62, P38; Peltonen L, 1995, BIOL CHEM H-S, V376, P697; RICHARDSON DK, 1994, AM J OBSTET GYNECOL, V170, P1273; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; Veletza SV, 1996, EXP LUNG RES, V22, P489, DOI 10.3109/01902149609046037; VENKITARAMAN AR, 1990, CHEM PHYS LIPIDS, V56, P185, DOI 10.1016/0009-3084(90)90101-V; VOSS T, 1991, AM J RESP CELL MOL, V4, P88, DOI 10.1165/ajrcmb/4.1.88; WANG G, IN PRESS AM J PHYSL; YUKITAKE K, 1995, PEDIATR RES, V37, P21, DOI 10.1203/00006450-199501000-00005	46	93	100	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2000	66	5					1569	1579		10.1086/302906	http://dx.doi.org/10.1086/302906			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QT	10762543	Bronze, Green Published			2022-12-18	WOS:000088373700011
J	Chavanas, S; Garner, C; Bodemer, C; Ali, M; Hamel-Teillac, D; Wilkinson, J; Bonafe, JL; Paradisi, M; Kelsell, DP; Ansai, S; Mitsuhashi, Y; Larregue, M; Leigh, IM; Harper, JI; Taieb, A; de Prost, Y; Cardon, LR; Hovnanian, A				Chavanas, S; Garner, C; Bodemer, C; Ali, M; Hamel-Teillac, D; Wilkinson, J; Bonafe, JL; Paradisi, M; Kelsell, DP; Ansai, S; Mitsuhashi, Y; Larregue, M; Leigh, IM; Harper, JI; Taieb, A; de Prost, Y; Cardon, LR; Hovnanian, A			Localization of the Netherton syndrome gene to chromosome 5q32, by linkage analysis and homozygosity mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CASEIN KINASE-I; TOTAL SERUM IGE; SULFATE TRANSPORTER; ATOPIC-DERMATITIS; ALPHA-SUBUNIT; RECEPTOR; ASTHMA; ASSOCIATION; HYPERRESPONSIVENESS; POLYMORPHISMS	Netherton syndrome (NS [MIM 256500]) is a rare and severe autosomal recessive disorder characterized by congenital ichthyosis, a specific hair-shaft defect (trichorrhexis invaginata), and atopic manifestations. Infants with this syndrome often fail to thrive; life-threatening complications result in high postnatal mortality. We report the assignment of the NS gene to chromosome 5q32, by linkage analysis and homozygosity mapping in 20 families affected with NS. Significant evidence for linkage (maximum multipoint LOD score 10.11) between markers D5S2017 and D5S413 was obtained, with no evidence for locus heterogeneity. Analysis of critical recombinants mapped the NS locus between markers D5S463 and D5S2013, within an <3.5-cM. genetic interval. The NS locus is telomeric to the cytokine gene cluster in 5q31. The five known genes encoding casein kinase 1 alpha, the alpha subunit of retinal rod cGMP phosphodiesterase, the regulator of mitotic-spindle assembly, adrenergic receptor beta 2, and the diastrophic dysplasia sulfate-transporter gene, as well as the 38 expressed-sequence tags mapped within the critical region, are not obvious candidates. Our study is the first step toward the positional cloning of the NS gene. This finding promises a better understanding of the molecular mechanisms that control epidermal differentiation and immunity.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Hop Necker Enfants Malad, Dept Dermatol, Paris, France; Amersham Hosp, Dept Dermatol, Amersham, Netherlands; Hop Rangueil, Dept Dermatol, Toulouse, France; Immacolata Hosp, Dept Dermatol, Rome, Italy; St Bartholomews & Royal London Sch Med & Dent, Ctr Cutaneous Res, London, England; Great Ormond St Hosp Sick Children, Dept Paediat Dermatol, London, England; Dept Dermatol, Yamagata, Japan; La Miletrie Hosp, Dept Dermatol, Poitiers, France; St Andre Hosp, Dept Dermatol, Bordeaux, France	University of Oxford; Wellcome Centre for Human Genetics; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Toulouse; University of London; Queen Mary University London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; CHU Poitiers; Universite de Poitiers; CHU Bordeaux	Hovnanian, A (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	alain.hovnanian@well.ox.ac.uk	Hovnanian, Alain/I-4711-2017; Chavanas, stephane/K-1183-2014; Kelsell, David P/F-8767-2011; TAIEB, ALAIN/AAB-1085-2021	Hovnanian, Alain/0000-0003-3412-7512; Kelsell, David/0000-0002-9910-7144; chavanas, stephane/0000-0003-4323-2656; Ansai, Shin-ichi/0000-0001-7036-7084	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALTMAN J, 1969, ARCH DERMATOL, V100, P550, DOI 10.1001/archderm.100.5.550; BLEECKER ER, 1995, CLIN EXP ALLERGY, V25, P84, DOI 10.1111/j.1365-2222.1995.tb00430.x; Broide DH, 1999, AM J HUM GENET, V65, P302, DOI 10.1086/302520; CEGIELSKA A, 1993, MOL CELL BIOL, V13, P1202, DOI 10.1128/MCB.13.2.1202; Chruscinski AJ, 1999, J BIOL CHEM, V274, P16694, DOI 10.1074/jbc.274.24.16694; COMEL M, 1949, Dermatologica, V98, P133; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cox HE, 1998, BRIT J DERMATOL, V138, P182; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dixon J, 1996, NAT GENET, V12, P130; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Gross SD, 1997, J CELL SCI, V110, P3083; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hausser I, 1996, PEDIATR DERMATOL, V13, P183, DOI 10.1111/j.1442-200X.1996.tb02615.x; Hershey GKK, 1997, NEW ENGL J MED, V337, P1720, DOI 10.1056/NEJM199712113372403; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; JONES SK, 1986, BRIT J DERMATOL, V114, P741, DOI 10.1111/j.1365-2133.1986.tb04885.x; JUDGE MR, 1994, BRIT J DERMATOL, V131, P615, DOI 10.1111/j.1365-2133.1994.tb04971.x; KIM IG, 1994, J INVEST DERMATOL, V103, P137, DOI 10.1111/1523-1747.ep12392470; KRUGLYAK L, 1995, AM J HUM GENET, V56, P519; Large V, 1997, J CLIN INVEST, V100, P3005, DOI 10.1172/JCI119854; Mansur AH, 1998, CLIN EXP ALLERGY, V28, P141; MARSH DG, 1994, SCIENCE, V264, P1152, DOI 10.1126/science.8178175; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Montagutelli X, 1996, J INVEST DERMATOL, V107, P20, DOI 10.1111/1523-1747.ep12297438; NETHERTON EW, 1958, ARCH DERMATOL, V78, P483, DOI 10.1001/archderm.1958.01560100059009; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P688; POSTMA DS, 1995, NEW ENGL J MED, V333, P894, DOI 10.1056/NEJM199510053331402; Rudikoff D, 1998, LANCET, V351, P1715, DOI 10.1016/S0140-6736(97)12082-7; SMITH DL, 1995, J ALLERGY CLIN IMMUN, V95, P116, DOI 10.1016/S0091-6749(95)70159-1; Sobel E, 1996, AM J HUM GENET, V58, P1323; STEVANOVIC DV, 1969, BRIT J DERMATOL, V81, P851, DOI 10.1111/j.1365-2133.1969.tb15956.x; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; Tobin AB, 1997, J BIOL CHEM, V272, P20844, DOI 10.1074/jbc.272.33.20844; Traupe H., 1989, ICHTHYOSES GUIDE CLI, P168; TURKI J, 1995, J CLIN INVEST, V95, P1635, DOI 10.1172/JCI117838; Weeks DE., 1990, AM J HUM GENET, V47, pA203; YEO JP, 1994, NATURE, V367, P288, DOI 10.1038/367288a0	39	93	96	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					914	921		10.1086/302824	http://dx.doi.org/10.1086/302824			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712206	Bronze, Green Published			2022-12-18	WOS:000088373200014
J	Worth, PF; Giunti, P; Gardner-Thorpe, C; Dixon, PH; Davis, MB; Wood, NW				Worth, PF; Giunti, P; Gardner-Thorpe, C; Dixon, PH; Davis, MB; Wood, NW			Autosomal dominant cerebellar ataxia type III: Linkage in a large British family to a 7.6-cM region on chromosome 15q14-21.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINOCEREBELLAR ATAXIA; MOLECULAR-FEATURES; CLINICAL-FEATURES; REPEAT EXPANSION; HUMAN GENOME; CAG REPEAT; GENE; PHENOTYPE; GENOTYPE; CLONING	Autosomal dominant cerebellar ataxia type III (ADCA III) is a relatively benign, late-onset, slowly progressive neurological disorder characterized by an uncomplicated cerebellar syndrome. Three loci have been identified: a moderately expanded CAG trinucleotide repeat in the SCA 6 gene, the SCA 5 locus on chromosome 11, and a third locus on chromosome 22 (SCA 10). We have identified two British families in which affected individuals do not have the SCA 6 expansion and in which the disease is not linked to SCA 5 or SCA 10. Both families exhibit the typical phenotype of ADCA III. Using a genomewide searching strategy in one of these families, we have linked the disease phenotype to marker D15S1039. Construction of haplotypes has defined a 7.6-cM interval between the nanking markers D15S146 and D15S1016, thereby assigning another ADCA III locus to the proximal long-arm of chromosome 15 (SCA 11). We excluded linkage of the disease phenotype to this region in the second family. These results indicate the presence of two additional ADCA III loci and more clearly define the genetic heterogeneity of ADCA III.	Inst Neurol, Dept Clin Neurol, Neurogenet Sect, London WC1N 3BG, England; Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of London; University College London; University of Exeter	Wood, NW (corresponding author), Inst Neurol, Dept Clin Neurol, Neurogenet Sect, Queen Sq, London WC1N 3BG, England.	n.wood@ion.ucl.ac.uk	Wood, Nicholas W/C-2505-2009; Giunti, Paola/E-5526-2012	Wood, Nicholas W/0000-0002-9500-3348; Giunti, Paola/0000-0003-3508-4788; Dixon, Peter/0000-0002-0197-2632				COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Flanigan K, 1996, AM J HUM GENET, V59, P392; Geschwind DH, 1997, NEUROLOGY, V49, P1247, DOI 10.1212/WNL.49.5.1247; Giunti P, 1999, AM J HUM GENET, V64, P1594, DOI 10.1086/302406; Grewal RP, 1998, NEUROLOGY, V51, P1423, DOI 10.1212/WNL.51.5.1423; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Matsumura R, 1997, NEUROLOGY, V49, P1238, DOI 10.1212/WNL.49.5.1238; Matsuyama Z, 1997, HUM MOL GENET, V6, P1283, DOI 10.1093/hmg/6.8.1283; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; Robinson W, 1997, CYTOGENET CELL GENET, V76, P1, DOI 10.1159/000134500; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Schols L, 1998, J NEUROL NEUROSUR PS, V64, P67, DOI 10.1136/jnnp.64.1.67; Stevanin G, 1997, NEUROLOGY, V49, P1243, DOI 10.1212/WNL.49.5.1243; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402; YAGE I, 1998, J NEUROL SCI, V156, P89; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; Zu L, 1999, AM J HUM GENET, V64, P594, DOI 10.1086/302247	26	93	94	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1999	65	2					420	426		10.1086/302495	http://dx.doi.org/10.1086/302495			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	223JA	10417284	Green Published, Bronze			2022-12-18	WOS:000081836900017
J	Melton, T; Clifford, S; Martinson, E; Batzer, M; Stoneking, M				Melton, T; Clifford, S; Martinson, E; Batzer, M; Stoneking, M			Genetic evidence for the proto-Austronesian homeland in Asia: mtDNA and nuclear DNA variation in Taiwanese aboriginal tribes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; 9-BP DELETION; POPULATIONS; AFFINITIES; SEQUENCE; POLYMORPHISMS; REVEALS; ANCIENT; ORIGIN; REGION	Previous studies of mtDNA variation in indigenous Taiwanese populations have suggested that they held an ancestral position in the spread of mtDNAs throughout Southeast Asia and Oceania (Melton et al. 1995; Sykes et al. 1995), but the question of an absolute proto-Austronesian homeland remains. To search for Asian roots for indigenous Taiwanese populations, 28 mtDNAs representative of variation in four tribal groups (Ami, Atayal, Bunun, and Paiwan) were sequenced and were compared with each other and with mtDNAs from 25 other populations from Asia and Oceania. In addition, eight polymorphic Alu insertion loci were analyzed, to determine if the pattern of mtDNA variation is concordant with nuclear DNA variation. Tribal groups shared considerable mtDNA sequence identity (P > .90), where gene flow is believed to have been low, arguing for a common source or sources for the tribes. mtDNAs with a 9-bp deletion have considerable mainland-Asian diversity and have spread to Southeast Asia and Oceania through a Taiwanese bottleneck. Only four Taiwanese mtDNA haplotypes without the 9-bp deletion were shared with any other populations, but these shared types were widely dispersed geographically throughout mainland Asia. Phylogenetic and principal-component analyses of Alu loci were concordant with conclusions from the mtDNA analyses; overall, the results suggest that the Taiwanese have temporally deep roots, probably in central or south China, and have been isolated from other Asian populations in recent history.	Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Univ Oxford, Inst Mol Med, Oxford, England; Louisiana State Univ, Med Ctr, Dept Pathol, New Orleans, LA 70112 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Oxford; Louisiana State University System	Melton, T (corresponding author), Mitotyping Technol, 1981 Pine Hall Dr, State Coll, PA 16801 USA.	twm107@mitotyping.com		Martinson, Jeremy/0000-0003-4673-7238				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, GENETICS, V130, P139; BATZER MA, 1994, P NATL ACAD SCI USA, V91, P12288, DOI 10.1073/pnas.91.25.12288; BELLWOOD P, 1991, SCI AM, V265, P88, DOI 10.1038/scientificamerican0791-88; Bellwood P., 1995, AUSTRONESIANS HIST C, P96; Bellwood P., 1978, MANS CONQUEST PACIFI; Belwood P, 1985, PREHISTORY INDOMALAY; Benedict PK, 1942, AM ANTHROPOL, V44, P576, DOI 10.1525/aa.1942.44.4.02a00040; BLUST R, 1988, ASIAN PERSPECT, V26, P45; Chai C. K., 1967, TAIWAN ABORIGINES GE; Chang K. C., 1969, PUBLICATIONS ANTHR; CHANG KC, 1974, ASIAN PERSPECT, V17, P36; CHEN KH, 1985, AM J PHYS ANTHROPOL, V66, P327, DOI 10.1002/ajpa.1330660310; CHEN YS, 1995, AM J HUM GENET, V57, P133; CHOU PL, 1959, ZINXUIGAKU KENKYU, V6, P127; EXCOFFIER L, 1992, GENETICS, V131, P479; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; FERRELL R, 1969, MONOGRAPH I ETHNOLOG, V17; GODDARD WG, 1966, FORMOSA; GODDARD WG, 1963, MAKERS TAIWAN; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HARIHARA S, 1992, HUM BIOL, V64, P161; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; Horai S, 1996, AM J HUM GENET, V59, P579; HORAI S, 1993, MOL BIOL EVOL, V10, P23; HORAI S, 1990, AM J HUM GENET, V46, P828; HUANG MC, 1966, 11 PAC SCI C TOK; HUANG MC, 1964, JPN J LEGAL MED, V18, P135; IKEMOTO S, 1966, P JPN ACAD, V42, P173, DOI 10.2183/pjab1945.42.173; KAO T, 1958, TAIWAN HIST EVENTS; Kolman CJ, 1996, GENETICS, V142, P1321; Kumar S., 1993, MANUAL MEGA MOL EVOL; KUTSUNA M, 1939, J TAIWAN MED ASS, V38, P1153; Legendre P., 1991, R PACKAGE MULTIDIMEN; LUM JK, 1994, HUM BIOL, V66, P567; Melton T, 1996, J FORENSIC SCI, V41, P591; MELTON T, 1995, AM J HUM GENET, V57, P403; NAKAJIMA H, 1971, HUM HERED, V21, P362, DOI 10.1159/000152427; NAKAJIMA H, 1971, JPN J HUM GENET, V16, P57; NAKAJIMA HACHIRO, 1967, JAP J HUM GENET, V11, P244; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; OTA T, 1993, MANUAL DISPAN GENETI; PASSARINO G, 1993, AM J HUM GENET, V53, P609; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROSS MD, 1994, COMP AUSTRONESIAN DI; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SHERRY S, 1994, DOCUMENTATION IWAVE; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Soodyall H, 1996, AM J HUM GENET, V58, P595; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; STONEKING M, 1991, AM J HUM GENET, V48, P370; SYKES B, 1995, AM J HUM GENET, V57, P1463; TAJIMA F, 1989, GENETICS, V123, P585; TANG TK, 1995, HUM GENET, V95, P630; TORRONI A, 1993, AM J HUM GENET, V53, P591; TORRONI A, 1993, AM J HUM GENET, V53, P563; UMETSU K, 1994, HUM BIOL, V66, P339; UMETSU K, 1995, HUM HERED, V45, P181, DOI 10.1159/000154286; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; VIGILANT L, 1990, THESIS U CALIFORNIA; Weir BS, 1990, GENETIC DATA ANAL; WRISCHNIK LA, 1987, NUCLEIC ACIDS RES, V15, P529, DOI 10.1093/nar/15.2.529	65	93	94	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1998	63	6					1807	1823		10.1086/302131	http://dx.doi.org/10.1086/302131			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Genetics & Heredity	151EL	9837834	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000077707700027
J	Monteiro, J; Derom, C; Vlietinck, R; Kohn, N; Lesser, M; Gregersen, PK				Monteiro, J; Derom, C; Vlietinck, R; Kohn, N; Lesser, M; Gregersen, PK			Commitment to X inactivation precedes the twinning event in monochorionic MZ twins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; FEMALE MONOZYGOTIC TWINS; CHROMOSOME-INACTIVATION; MUSCULAR-DYSTROPHY; PATTERNS; STABILIZATION	To gain insight into the timing of twinning, we have examined a closely related event, X-chromosome inactivation, in female MZ twin pairs. X-inactivation patterns in peripheral blood and buccal mucosa were compared between monochorionic MZ (MC-MZ) and dichorionic MZ (DC-MZ) twins. Overall, the MC-MZ twins displayed highly similar X-inactivation patterns, whereas DC-MZ twins frequently differed in their X-inactivation patterns, when both tissues were tested. Previous experimental data suggest that commitment to X inactivation occurs when there are 10-20 cells in the embryo. Simulation of embryo splitting after commitment to X inactivation suggests that MC-MZ twinning occurs three or four rounds of replication after X inactivation, whereas a DC-MZ twinning event occurs earlier, before or around the time of X inactivation. Finally, the overall degree of skewing in the MZ twins was not significantly different from that observed in singletons. This indicates that X inactivation does not play a direct role in the twinning process, and it further suggests that extreme unequal splitting is not a common mechanism of twin formation.	NYU, Sch Med, N Shore Univ Hosp, Dept Med,Div Biol & Human Genet, Manhasset, NY 11030 USA; NYU, Sch Med, N Shore Univ Hosp, Dept Res,Div Biostat, Manhasset, NY 11030 USA; Katholieke Univ Leuven, Ctr Human Genet, B-3001 Leuven, Belgium	New York University; Northwell Health; North Shore University Hospital; New York University; Northwell Health; North Shore University Hospital; KU Leuven	Gregersen, PK (corresponding author), NYU, Sch Med, N Shore Univ Hosp, Dept Med,Div Biol & Human Genet, 350 Community Dr, Manhasset, NY 11030 USA.			Derom, Catherine/0000-0001-5574-796X				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Bamforth F, 1996, AM J MED GENET, V61, P209; Busque L, 1996, BLOOD, V88, P59; Derom R., 1995, MULTIPLE PREGNANCY E, P113; Goodship J, 1996, AM J MED GENET, V61, P205, DOI 10.1002/(SICI)1096-8628(19960122)61:3<205::AID-AJMG3>3.0.CO;2-T; HOGAN B, 1994, MANIPULATING MOUSE E, P20; Jarvik GP, 1997, AM J HUM GENET, V61, pA102; LUPSKI JR, 1991, AM J MED GENET, V40, P354, DOI 10.1002/ajmg.1320400323; MONTEIRO J, 1995, MOL MED, V1, P614, DOI 10.1007/BF03401602; NANCE WE, 1990, AM J HUM GENET, V46, P646; Naumova AK, 1996, AM J HUM GENET, V58, P1111; Panning B, 1998, CELL, V93, P305, DOI 10.1016/S0092-8674(00)81155-1; Panning B, 1997, CELL, V90, P907, DOI 10.1016/S0092-8674(00)80355-4; PUCK JM, 1992, AM J HUM GENET, V50, P742; PUCK JM, 1990, NEW ENGL J MED, V322, P1063, DOI 10.1056/NEJM199004123221508; RASTAN S, 1982, GENET RES, V40, P139, DOI 10.1017/S0016672300019017; RICHARDS CS, 1990, AM J HUM GENET, V46, P672; Sheardown SA, 1997, CELL, V91, P99, DOI 10.1016/S0092-8674(01)80012-X; TREJO V, 1994, MOL MED, V1, P62; WATKISS E, 1994, J MED GENET, V31, P754, DOI 10.1136/jmg.31.10.754	20	93	94	2	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					339	346		10.1086/301978	http://dx.doi.org/10.1086/301978			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110CB	9683609	hybrid, Green Published			2022-12-18	WOS:000075360800009
J	Yamamoto, S; Okada, M; Tsujikawa, M; Shimomura, Y; Nishida, K; Inoue, Y; Watanabe, H; Maeda, N; Kurahashi, H; Kinoshita, S; Nakamura, Y; Tano, Y				Yamamoto, S; Okada, M; Tsujikawa, M; Shimomura, Y; Nishida, K; Inoue, Y; Watanabe, H; Maeda, N; Kurahashi, H; Kinoshita, S; Nakamura, Y; Tano, Y			A kerato-epithelin (beta ig-h3) mutation in lattice corneal dystrophy type IIIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							GROWTH-FACTOR-BETA; PROTEIN		Osaka Univ, Sch Med, Dept Ophthalmol, Suita, Osaka 565, Japan; Osaka Univ, Sch Med, Dept Clin Genet, Suita, Osaka 565, Japan; Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan	Osaka University; Osaka University; Kyoto Prefectural University of Medicine	Yamamoto, S (corresponding author), Osaka Univ, Sch Med, Dept Ophthalmol, 2-2 Yamadaoka, Suita, Osaka 565, Japan.			Nishida, Kohji/0000-0001-9069-3610				GOREVIC PD, 1984, AM J OPHTHALMOL, V98, P216, DOI 10.1016/0002-9394(87)90357-6; HIDA T, 1987, AM J OPHTHALMOL, V104, P249, DOI 10.1016/0002-9394(87)90412-0; KLINTWOR.GK, 1967, AM J PATHOL, V50, P371; MERETOJA J, 1972, OPHTHALMOLOGICA, V165, P15, DOI 10.1159/000308469; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; STOCK EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P354, DOI 10.1001/archopht.1991.01080030056038; STONE EM, 1994, NAT GENET, V6, P47, DOI 10.1038/ng0194-47	10	93	99	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					719	722		10.1086/301765	http://dx.doi.org/10.1086/301765			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497262	Green Published, Bronze			2022-12-18	WOS:000072894400029
J	Suzuki, Y; Jiang, LL; Souri, M; Miyazawa, S; Fukuda, S; Zhang, ZY; Une, M; Shimozawa, N; Kondo, N; Orii, T; Hashimoto, T				Suzuki, Y; Jiang, LL; Souri, M; Miyazawa, S; Fukuda, S; Zhang, ZY; Une, M; Shimozawa, N; Kondo, N; Orii, T; Hashimoto, T			D-3-hydroxyacyl-CoA dehydratase D-3-hydroxyacyl-CoA dehydrogenase bifunctional protein deficiency: A newly identified peroxisomal disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACYL-COA OXIDASE; DETECTABLE ENZYME PROTEIN; BETA-OXIDATION; RAT-LIVER; COMPLEMENTATION ANALYSIS; PRISTANIC ACID; FATTY-ACIDS; CHAIN; MITOCHONDRIAL; PURIFICATION	Peroxisomal beta-oxidation proceeds from enoyl-CoA through D-3-hydroxyacyl-CoA to 3-ketoacyl-CoA by the D-3-hydroxyacyl-CoA dehydratase/D-3-hydroxy-acyl-CoA dehydrogenase bifunctional protein (D-bifunctional protein), and the oxidation of bile-acid precursors also has been suggested as being catalyzed by the D-bifunctional protein. Because of the important roles of this protein, we reinvestigated two Japanese patients previously diagnosed as having enoyl-CoA hydratase/L-3-hydroxyacyl-CoA dehydrogenase bifunctional protein (L-bifunctional protein) deficiency, in complementation studies. We found that both the protein and the enzyme activity of the D-bifunctional protein were hardly detectable in these patients but that the active L-bifunctional protein was present. The mRNA level in patient 1 was very low and, for patient 2, mRNA was of a smaller size. Sequencing analysis of the cDNA revealed a 52-bp deletion in patient 1 and a 237-bp deletion in patient 2. This seems to be the first report of D-bifunctional protein deficiency. Patients previously diagnosed as cases of L-bifunctional protein deficiency probably should be reexamined for a possible D-bifunctional protein deficiency.	SHINSHU UNIV,SCH MED,DEPT BIOCHEM,MATSUMOTO,NAGANO 390,JAPAN; HIROSHIMA UNIV,SCH MED,INST PHARMACEUT SCI,HIROSHIMA 734,JAPAN; CHUBU GAKUIN UNIV,FAC HUMAN WELF,DEPT HUMAN WELF,SEKI,JAPAN	Shinshu University; Hiroshima University	Suzuki, Y (corresponding author), GIFU UNIV,SCH MED,DEPT PEDIAT,TSUKASA MACHI 40,GIFU 500,JAPAN.			Shimozawa, Nobuyuki/0000-0003-3040-5458				ADAMSKI J, 1995, BIOCHEM J, V311, P437, DOI 10.1042/bj3110437; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLAYTON PT, 1988, J INHERIT METAB DIS, V11, P165, DOI 10.1007/BF01804226; FUKUDA S, IN PRESS J INHERIT M; FURUTA S, 1980, J BIOCHEM, V88, P1059, DOI 10.1093/oxfordjournals.jbchem.a133057; HASHIMOTO T, 1982, ANN NY ACAD SCI, V386, P5, DOI 10.1111/j.1749-6632.1982.tb21403.x; IIJIMA NS, 1985, P NATL ACAD SCI USA, V82, P6133; Jiang LL, 1996, J BIOCHEM, V120, P633; Jiang LL, 1997, J BIOCHEM-TOKYO, V121, P506; Jiang LL, 1996, J BIOCHEM-TOKYO, V120, P624; JIANG LL, 1997, J BIOCH, V121, P354; Kobayashi A, 1996, J BIOCHEM-TOKYO, V119, P775, DOI 10.1093/oxfordjournals.jbchem.a021307; Kunau WH, 1995, PROG LIPID RES, V34, P267, DOI 10.1016/0163-7827(95)00011-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MIYAZAWA S, 1980, EUR J BIOCHEM, V103, P589, DOI 10.1111/j.1432-1033.1980.tb05984.x; NAKADA Y, 1993, BRAIN DEV-JPN, V15, P453, DOI 10.1016/0387-7604(93)90087-O; Natowicz MR, 1996, AM J MED GENET, V63, P356; OSUMI T, 1980, J BIOCHEM, V87, P1735, DOI 10.1093/oxfordjournals.jbchem.a132918; PEDERSEN JI, 1993, BIOCHIMIE, V75, P159, DOI 10.1016/0300-9084(93)90073-2; POLLTHE BT, 1988, AM J HUM GENET, V42, P422; REDDY JK, 1994, ANNU REV NUTR, V14, P343, DOI 10.1146/annurev.nu.14.070194.002015; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHRAM AW, 1987, P NATL ACAD SCI USA, V84, P2494, DOI 10.1073/pnas.84.8.2494; SINGH H, 1990, J LIPID RES, V31, P217; SUZUKI Y, 1991, BIOCHEM PHARMACOL, V41, P453, DOI 10.1016/0006-2952(91)90544-F; SUZUKI Y, 1994, AM J HUM GENET, V54, P36; TENBRINK HJ, 1991, J INHERIT METAB DIS, V14, P345, DOI 10.1007/BF01811699; TENBRINK HJ, 1991, J INHERIT METAB DIS, V14, P681, DOI 10.1007/BF01799934; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VANVELDHOVEN PP, 1993, J INHERIT METAB DIS, V16, P381, DOI 10.1007/BF00710285; WANDERS RJA, 1990, J INHERIT METAB DIS, V13, P375, DOI 10.1007/BF01799399; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P385, DOI 10.1007/BF02435983; WATKINS PA, 1995, ANN NEUROL, V38, P472, DOI 10.1002/ana.410380322; WATKINS PA, 1989, J CLIN INVEST, V83, P771, DOI 10.1172/JCI113956; YAMAGUCHI S, 1988, J CLIN INVEST, V81, P813, DOI 10.1172/JCI113388	37	93	103	1	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1153	1162		10.1086/301599	http://dx.doi.org/10.1086/301599			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345094	Bronze, Green Published			2022-12-18	WOS:A1997YH01700022
J	Harrison, GA; Humphrey, KE; Jones, N; Badenhop, R; Guo, GG; Elakis, G; Kaye, JA; Turner, RJ; Grehan, M; Wilton, AN; Brennecke, SP; Cooper, DW				Harrison, GA; Humphrey, KE; Jones, N; Badenhop, R; Guo, GG; Elakis, G; Kaye, JA; Turner, RJ; Grehan, M; Wilton, AN; Brennecke, SP; Cooper, DW			A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PEDIGREE-MEMBER METHOD; SEVERE PRE-ECLAMPSIA; GENETIC-LINKAGE; CLOSE LINKAGE; LOD SCORES; ANGIOTENSINOGEN; HYPERTENSION; PREGNANCY; MAP; HUMAN-CHROMOSOME-4	Preeclampsia (PE) and eclampsia (E) are potentially life-threatening conditions that can occur during human pregnancy. Generally considered to be different degrees of severity of the same disease process, the PE/E syndrome is thought to be predominantly genetic in origin, although its exact etiology and genetics are not fully understood. Here we report results of a genomewide linkage search for the gene(s) responsible for susceptibility to PE/E, using 15 informative pedigrees and 90 polymorphic DNA markers from all autosomes. Because of uncertainties concerning inheritance and diagnosis, four different models that assume maternal gene expression have been used to carry out LOD-score analysis. The region between D4S450 and D4S610 (2.8 cM) on the long arm of chromosome 4 was identified as a strong candidate region for a PE/E-susceptibility locus. The maximum multipoint LOD score within this interval was 2.9. Analysis of markers in the region around D4S450 and D4S610 by the affected-pedigree-member method also supported the possibility of a susceptibility locus in this region. However, to verify or exclude definitively linkage to this region, other groups of PE/E pedigrees will be required.	MACQUARIE UNIV,SCH BIOL SCI,N RYDE,NSW 2109,AUSTRALIA; UNIV NEW S WALES,SCH BIOCHEM & MOL GENET,SYDNEY,NSW,AUSTRALIA; ROYAL HOSP WOMEN,DEPT PERINATAL MED,CARLTON,VIC,AUSTRALIA	Macquarie University; University of New South Wales Sydney			Wilton, Alan N/C-2430-2011; Brennecke, Shaun/AFV-3919-2022	Brennecke, Shaun/0000-0003-3070-6971; Grehan, Madonna/0000-0002-8754-593X				ADAMS EM, 1961, LANCET, V2, P1375; ARNGRIMSSON R, 1993, NAT GENET, V4, P114, DOI 10.1038/ng0693-114; ARNGRIMSSON R, 1990, BRIT J OBSTET GYNAEC, V97, P762, DOI 10.1111/j.1471-0528.1990.tb02569.x; ARNGRIMSSON R, 1995, HYPERTENS PREGNANCY, V14, P27, DOI 10.3109/10641959509058048; BRAVERMAN MS, 1985, COMPUT BIOMED RES, V18, P24, DOI 10.1016/0010-4809(85)90004-7; CHESLEY LC, 1986, BRIT J OBSTET GYNAEC, V93, P898, DOI 10.1111/j.1471-0528.1986.tb08006.x; CHESLEY LC, 1968, OBSTET GYNECOL, V32, P303; CHESLEY LC, 1961, PATHOL MICROBIOL, V24, P662, DOI 10.1159/000161178; COOPER DW, 1979, J MED GENET, V16, P409, DOI 10.1136/jmg.16.6.409; COOPER DW, 1993, HYPERTENS PREGNANCY, V12, P1, DOI 10.3109/10641959309031050; COOPER DW, 1988, BRIT J OBSTET GYNAEC, V95, P644, DOI 10.1111/j.1471-0528.1988.tb06524.x; COOPER DW, 1991, CYTOGENET CELL GENET, V58, P1851; DEGROOT CJM, 1993, ANN MED, V25, P243, DOI 10.3109/07853899309147870; *DEP HLTH, 1991, REP CONF ENQ MAT DEA, P17; FISHER KA, 1981, MEDICINE, V60, P267, DOI 10.1097/00005792-198107000-00002; GRAVES SW, 1993, NAT GENET, V4, P7, DOI 10.1038/ng0593-7; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Haldane JBS, 1919, J GENET, V8, P299; HARRISON GA, 1993, HUM MOL GENET, V2, P2200, DOI 10.1093/hmg/2.12.2200-a; HAYWARD C, 1992, AM J HUM GENET, V50, P749; Hughes EC., 1972, OBSTET GYNECOLOGIC T; HUMPHRIES JO, 1960, B JOHNS HOPKINS HOSP, V107, P271; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; KAUNITZ AM, 1985, OBSTET GYNECOL, V65, P605; KIDD KK, 1984, CYTOGENET CELL GENET, V37, P510; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MacGillivray I., 1983, PREECLAMPSIA HYPERTE, P1; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORGAN L, 1995, BRIT J OBSTET GYNAEC, V102, P489, DOI 10.1111/j.1471-0528.1995.tb11324.x; MYERS RM, 1994, CYTOGENET CELL GENET, V66, P218; *NHMRC, 1988, REP MAT DEATHS AUSTR; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1978, ANN HUM GENET, V42, P225; RIESS O, 1994, HUM GENET, V94, P1, DOI 10.1007/BF02272834; RISCH N, 1988, AM J HUM GENET, V42, P353; RISCH N, 1992, SCIENCE, V255, P803, DOI 10.1126/science.1536004; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; SCHROEDER M, 1994, GENET EPIDEMIOL, V11, P69, DOI 10.1002/gepi.1370110107; SUTHERLAND A, 1981, BRIT J OBSTET GYNAEC, V88, P785, DOI 10.1111/j.1471-0528.1981.tb01304.x; THOMPSON B, 1988, TWINNING TWINS, P253; THORNTON JG, 1991, BRIT MED J, V303, P1241, DOI 10.1136/bmj.303.6812.1241; Tishkoff SA, 1996, HUM GENET, V97, P759; WARD K, 1993, NAT GENET, V4, P59, DOI 10.1038/ng0593-59; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WILTON AN, 1991, TISSUE ANTIGENS, V38, P137, DOI 10.1111/j.1399-0039.1991.tb02027.x; WILTON AN, 1995, HYPERTENS PREGNANCY, V14, P251, DOI 10.3109/10641959509009586; WILTON AN, 1990, LANCET, V336, P653, DOI 10.1016/0140-6736(90)92149-C; ZEEMAN GG, 1992, CLIN OBSTET GYNECOL, V35, P317	53	93	96	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1158	1167						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150163				2022-12-18	WOS:A1997WX76000016
J	Richard, I; Brenguier, L; Dincer, P; Roudaut, C; Bady, B; Burgunder, JM; Chemaly, R; Garcia, CA; Halaby, G; Jackson, CE; Kurnit, DM; Lefranc, G; Legum, C; Loiselet, J; Merlini, L; NivelonChevallier, A; OllagnonRoman, E; Restagno, G; Topaloglu, H; Beckmann, JS				Richard, I; Brenguier, L; Dincer, P; Roudaut, C; Bady, B; Burgunder, JM; Chemaly, R; Garcia, CA; Halaby, G; Jackson, CE; Kurnit, DM; Lefranc, G; Legum, C; Loiselet, J; Merlini, L; NivelonChevallier, A; OllagnonRoman, E; Restagno, G; Topaloglu, H; Beckmann, JS			Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients from various geographical origins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-SARCOGLYCAN; LINKAGE ANALYSIS; GENE; MUTATIONS; REGION; MAPS; CHROMOSOME-15; GLYCOPROTEIN; DEFICIENCY; FAMILIES	Limb-girdle muscular dystrophies (LGMDs) are a group of neuromuscular diseases presenting great clinical heterogeneity. Mutations in CANP3, the gene encoding muscle-specific calpain, were used to identify this gene as the genetic site responsible for autosomal recessive LGMD type 2A (LGMD2A; MIM 253600). Analyses of the segregation of markers flanking the LGMD2A locus and a search for CANP3 mutations were performed for 21 LGMD2 pedigrees from various origins. In addition to the 16 mutations described previously, we report 19 novel mutations. These data indicate that muscular dystrophy caused by mutations in CANP3 are found in patients from all countries examined so far and further support the wide heterogeneity of molecular defects in this rare disease.	GENETHON, CNRS, URA 1922, F-91000 EVRY, FRANCE; HACETTEPE UNIV, DEPT MED BIOL, ANKARA, TURKEY; HOP NEUROL & NEUROCHIRURG P WERTHEIMER, LYON, FRANCE; NEUROL INSELSPITAL, NEUROMORPHOL LAB, BERN, SWITZERLAND; HOTEL DIEU FRANCE, BEIRUT, LEBANON; ST JOSEPHS UNIV, FAC MED, BEIRUT, LEBANON; LOUISIANA STATE UNIV, MED CTR, NEW ORLEANS, LA USA; HENRY FORD HOSP, DIV CLIN & MOL GENET, DETROIT, MI 48202 USA; UNIV MICHIGAN, MED CTR, HOWARD HUGHES MED INST, ANN ARBOR, MI 48109 USA; UNIV MONTPELLIER, INST MOL GENET,IMMUNOGENET MOL LAB,CNRS,UMR 9942, F-34059 MONTPELLIER, FRANCE; ICHILOV HOSP, ELIAS SOURASKI MED CTR, GENET INST, IL-64239 TEL AVIV, ISRAEL; IST ORTOPED RIZZOLI, NEUROMUSCULAR LAB, BOLOGNA, ITALY; CTR HOSP REG & UNIV DIJON, HOP ENFANTS, DIJON, FRANCE; AZIENDA OSPED SAN GIOVANNI BATTISTA, SERV UNIV CONVENZIONATO GENET MED, TURIN, ITALY	Centre National de la Recherche Scientifique (CNRS); Hacettepe University; CHU Lyon; University of Bern; University Hospital of Bern; Saint Joseph University Beirut; Louisiana State University System; Henry Ford Health System; Henry Ford Hospital; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Tel Aviv University; IRCCS Istituto Ortopedico Rizzoli; CHU Dijon Bourgogne; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette			Dincer, Pervin/AAL-6595-2021; Beckmann, Jacques S/A-9772-2008; Merlini, Luciano/N-6478-2019; Richard, isabelle/J-8298-2013; TOPALOGLU, HALUK AYDIN/I-9318-2013	Beckmann, Jacques S/0000-0002-9741-1900; Merlini, Luciano/0000-0002-1108-1198; 				ALLAMAND V, 1995, AM J HUM GENET, V56, P1417; AZIBI K, 1993, HUM MOL GENET, V2, P1423; BASHIR R, 1994, HUM MOL GENET, V3, P455, DOI 10.1093/hmg/3.3.455; BECKMANN JS, 1991, CR ACAD SCI III-VIE, V312, P141; BENOTHMANE K, 1992, NAT GENET, V2, P315, DOI 10.1038/ng1292-315; BONNEMANN CG, 1995, NAT GENET, V11, P266, DOI 10.1038/ng1195-266; BUSHBY KMD, 1995, NEUROMUSCULAR DISORD, V5, P337, DOI 10.1016/0960-8966(95)00005-8; CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DINCER P, IN PRESS ANN NEUROL; Fardeau M, 1996, BRAIN, V119, P295, DOI 10.1093/brain/119.1.295; FOUGEROUSSE F, 1994, HUM MOL GENET, V3, P285, DOI 10.1093/hmg/3.2.285; JACKSON CE, 1961, PEDIATRICS, V28, P77; KEEN J, 1991, TRENDS GENET, V7, P5; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LIM LE, 1995, NAT GENET, V11, P257, DOI 10.1038/ng1195-257; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MCNALLY EM, 1994, P NATL ACAD SCI USA, V91, P9690, DOI 10.1073/pnas.91.21.9690; Nigro V, 1996, HUM MOL GENET, V5, P1179, DOI 10.1093/hmg/5.8.1179; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; NOGUCHI S, 1995, SCIENCE, V270, P819, DOI 10.1126/science.270.5237.819; PassosBueno MR, 1996, HUM MOL GENET, V5, P815, DOI 10.1093/hmg/5.6.815; PASSOSBUENO MR, 1995, GENOMICS, V27, P192, DOI 10.1006/geno.1995.1024; PASSOSBUENO MR, 1993, J MED GENET, V30, P385, DOI 10.1136/jmg.30.5.385; PICCOLO F, 1995, NAT GENET, V10, P243, DOI 10.1038/ng0695-243; RICHARD I, 1995, NAT GENET, V10, P259, DOI 10.1038/ng0795-259; Richard I, 1996, MAMM GENOME, V7, P377, DOI 10.1007/s003359900108; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; ROBERDS SL, 1994, CELL, V78, P625, DOI 10.1016/0092-8674(94)90527-4; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; SORIMACHI H, 1992, BIOCHIM BIOPHYS ACTA, V1160, P55, DOI 10.1016/0167-4838(92)90037-E; WALTON JN, 1954, BRAIN, V77, P169, DOI 10.1093/brain/77.2.169	33	93	96	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1997	60	5					1128	1138						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WX760	9150160				2022-12-18	WOS:A1997WX76000013
J	Nobukuni, Y; Watanabe, A; Takeda, K; Skarka, H; Tachibana, M				Nobukuni, Y; Watanabe, A; Takeda, K; Skarka, H; Tachibana, M			Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HELIX-LOOP-HELIX; HUMAN TYROSINASE GENE; TRANSCRIPTION FACTOR; MICROPHTHALMIA GENE; MOLECULAR-BASIS; PAIRED DOMAIN; HUMAN HOMOLOG; DNA-BINDING; MOUSE; EXPRESSION	Waardenburg syndrome type 2 (WS2) is a dominantly inherited disorder characterized by a pigmentation anomaly and hearing impairment due to lack of melanocyte. Previous work has linked a subset of families with WS2 (WS2A) to the MITF gene that encodes a transcription factor with a basic-helix-loop-helix-leucine zipper (bHLH-Zip) motif and that is involved in melanocyte differentiation. Several splice-site and missense mutations have been reported in individuals affected with WS2A. In this report, we have identified two novel point mutations in the MITF gene in affected individuals from two different families with WS2A. The two mutations (C760-->T and C895-->T) create stop codons in exons 7 and 8, respectively. Corresponding mutant alleles predict the truncated proteins lacking HLH-Zip or Zip structure. To understand how these mutations cause WS2 in heterozygotes, we generated mutant MITF cDNAs and used them for DNA-binding and luciferase reporter assays. The mutated MITF proteins lose the DNA-binding activity and fail to trans-activate the promoter of tyrosinase, a melanocyte-specific enzyme. However, these mutated proteins do not appear to inter fere with the activity of wild-type MITF protein in these assays, indicating that they do not show a dominant-negative effect. These findings suggest that the pheno types of the two families with WS2A in the present study are caused by loss-of-function mutations in one of the two alleles of the MITF gene, resulting in haploinsufficiency of the MITF protein, the protein necessary for normal development of melanocytes.	NIDCD,MOL GENET LAB,NIH,ROCKVILLE,MD 20850; NIMH,CLIN NEUROGENET BRANCH,NIH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)			WATANABE, Atsushi/F-5687-2019	WATANABE, Atsushi/0000-0001-9143-3079				ARIAS S, 1971, Birth Defects Original Article Series, V7, P87; ASHER JH, 1990, J MED GENET, V27, P618, DOI 10.1136/jmg.27.10.618; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BENTLEY NJ, 1994, MOL CELL BIOL, V14, P7996, DOI 10.1128/MCB.14.12.7996; DANG CV, 1989, NATURE, V337, P664, DOI 10.1038/337664a0; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; FARRER LA, 1994, AM J HUM GENET, V55, P728; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FISHER DE, 1993, CELL, V72, P467, DOI 10.1016/0092-8674(93)90122-7; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; HAGEMAN MJ, 1977, AM J HUM GENET, V29, P468; Hayashi K, 1991, PCR Methods Appl, V1, P34; HEMESATH TJ, 1994, GENE DEV, V8, P2770, DOI 10.1101/gad.8.22.2770; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HOTH CF, 1993, AM J HUM GENET, V52, P455; Klein D, 1950, HELV PAEDIATR ACTA, V5, P38; LIU XZ, 1995, AM J MED GENET, V55, P95, DOI 10.1002/ajmg.1320550123; MIKI T, 1991, P NATL ACAD SCI USA, V88, P5167, DOI 10.1073/pnas.88.12.5167; NAKASHIMA S, 1992, LARYNGOSCOPE, V102, P563, DOI 10.1288/00005537-199205000-00016; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; ROMAN C, 1992, MOL CELL BIOL, V12, P817, DOI 10.1128/MCB.12.2.817; Sambrook J., 1989, MOL CLONING; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHAH KN, 1981, J PEDIATR-US, V99, P432, DOI 10.1016/S0022-3476(81)80339-3; SHIBATA K, 1992, J BIOL CHEM, V267, P20584; STEINGRIMSSON E, 1994, NAT GENET, V8, P256, DOI 10.1038/ng1194-256; TACHIBANA M, 1994, HUM MOL GENET, V3, P553, DOI 10.1093/hmg/3.4.553; TACHIBANA M, 1992, MOL CELL NEUROSCI, V3, P433, DOI 10.1016/1044-7431(92)90055-7; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1995, HUM MOL GENET, V4, P2131, DOI 10.1093/hmg/4.11.2131; WAARDENBURG PJ, 1951, AM J HUM GENET, V3, P195; WILKIE AOM, 1994, J MED GENET, V31, P89, DOI 10.1136/jmg.31.2.89; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	37	93	103	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					76	83						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659547				2022-12-18	WOS:A1996VL45500012
J	OVERHAUSER, J; MITCHELL, HF; ZACKAI, EH; TICK, DB; ROJAS, K; MUENKE, M				OVERHAUSER, J; MITCHELL, HF; ZACKAI, EH; TICK, DB; ROJAS, K; MUENKE, M			PHYSICAL MAPPING OF THE HOLOPROSENCEPHALY CRITICAL REGION IN 18P11.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERSPECTIVES; GENE	Holoprosencephaly (HPE) is a common developmental defect that results in a spectrum of craniofacial malformations. HPE is genetically heterogeneous, some cases being associated with deletions of the short arm of chromosome 18. In order to map the putative HPE gene located on 18p (HPE4) more precisely, six patients with various cytogenetic 18p deletions and clinical features of HPE have been characterized by using a combination of somatic cell hybrid analysis and FISH. By using a set of 27 chromosome 18p-specific markers, the deletion in each patient was characterized. The HPE minimal critical region on 18p was defined on a molecular level, localizing the HPE4 gene to 18p11.3.	CHILDRENS HOSP PHILADELPHIA,DIV HUMAN GENET & MOLEC BIOL,PHILADELPHIA,PA 19104; THOMAS JEFFERSON UNIV,DEPT BIOCHEM & MOLEC BIOL,PHILADELPHIA,PA 19107; UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104; MED COLL WISCONSIN,MILWAUKEE,WI 53226	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Jefferson University; University of Pennsylvania; University of Pennsylvania; Medical College of Wisconsin				Muenke, Maximilian/0000-0002-7719-6545	NHGRI NIH HHS [HG0167] Funding Source: Medline; NICHD NIH HHS [HD28732, HD29862] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD029862, R29HD028732] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AUGHTON DJ, 1991, J MED GENET, V28, P530, DOI 10.1136/jmg.28.8.530; COHEN MM, 1992, J CRAN GENET DEV BIO, V12, P196; COHEN MM, 1989, TERATOLOGY, V40, P211, DOI 10.1002/tera.1420400304; COHEN MM, 1989, AM J MED GENET, V34, P271, DOI 10.1002/ajmg.1320340232; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRANCKE U, 1994, CYTOGENET CELL GENET, V65, P206, DOI 10.1159/000133633; FREZAL J, 1991, CYTOGENET CELL GENET, V58, P986, DOI 10.1159/000133716; GURRIERI F, 1993, NAT GENET, V3, P247, DOI 10.1038/ng0393-247; HOSOYA M, 1992, BIOCHIM BIOPHYS ACTA, V1129, P199, DOI 10.1016/0167-4781(92)90488-L; KANEDA S, 1990, J BIOL CHEM, V265, P20277; KLINE AD, 1993, AM J HUM GENET, V52, P895; KLINE AD, 1992, GENOMICS, V13, P1, DOI 10.1016/0888-7543(92)90193-V; KRASSIKOFF N, 1989, AM J MED GENET, V34, P255, DOI 10.1002/ajmg.1320340227; MEWAR R, 1993, CYTOGENET CELL GENET, V64, P1, DOI 10.1159/000133547; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; MUENKE M, 1988, Human Genetics, V80, P219; MUENKE M, 1995, AM J HUM GENET, V57, P1074; MUENKE M, 1989, AM J MED GENET, V34, P237; Muenke Maximilian, 1994, Seminars in Developmental Biology, V5, P293, DOI 10.1006/sedb.1994.1038; OLSEN D, 1989, LAB INVEST, V60, P772; SCHELL U, 1944, AM J HUM GENET, V55, pA31; SCHINZEL A, 1984, CATALOGUE UNBALANCED, P604; SUKEGAWA J, 1987, MOL CELL BIOL, V7, P41, DOI 10.1128/MCB.7.1.41; VANKESSEL G, 1994, CYTOGENET CELL GENET, V65, P141	24	93	95	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1080	1085						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485158				2022-12-18	WOS:A1995TA44900014
J	WINNARD, AV; MENDELL, JR; PRIOR, TW; FLORENCE, J; BURGHES, AHM				WINNARD, AV; MENDELL, JR; PRIOR, TW; FLORENCE, J; BURGHES, AHM			FRAMESHIFT DELETIONS OF EXONS-3-7 AND REVERTANT FIBERS IN DUCHENNE MUSCULAR-DYSTROPHY - MECHANISMS OF DYSTROPHIN PRODUCTION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SOMATIC REVERSION SUPPRESSION; POLYMERASE CHAIN-REACTION; SKELETAL-MUSCLE; GENE DELETIONS; NONSENSE MUTATION; MOLECULAR-BASIS; DMD GENE; IDENTIFICATION; PROTEIN; PATIENT	Duchenne muscular dystrophy (DMD) patients with mutations that disrupt the translational reading frame produce little or no dystrophin. Two exceptions are the deletion of exons 3-7 and the occurrence of rare dystrophin-positive fibers (revertant fibers) in muscle of DMD patients. Antibodies directed against the amino-terminus and the 5' end of exon 8 did not detect dystrophin in muscle from patients who have a deletion of exons 3-7. However, in all cases, dystrophin was detected with an antibody directed against the 3' end of exon 8. The most likely method of dystrophin production in these cases is initiation at a new start codon in exon 8. We also studied two patients who have revertant fibers: one had an inherited duplication of exons 5-7, which, on immunostaining, showed two types of revertant fibers; and the second patient had a 2-bp nonsense mutation in exon 51, which creates a cryptic splice site. An in-frame mRNA that uses this splice site in exon 51 was detected. Immunostaining demonstrated the presence of the 3' end of exon 51, which is in agreement with the use of this mRNA in revertant fibers. The most likely method of dystrophin production in these fibers is a second mutation that restores the reading frame.	OHIO STATE UNIV, COLL MED, DEPT NEUROL, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, COLL MED, DEPT BIOCHEM MED, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, COLL MED, DEPT PATHOL, COLUMBUS, OH 43210 USA; OHIO STATE UNIV, COLL BIOL SCI, DEPT MOLEC GENET, COLUMBUS, OH 43210 USA; WASHINGTON UNIV, DEPT NEUROL, ST LOUIS, MO USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Washington University (WUSTL)				Burghes, Arthur/0000-0001-9031-1555	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR040015] Funding Source: NIH RePORTER; NIAMS NIH HHS [R29AR40015] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; BEGGS AH, 1990, HUM GENET, V86, P45; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BULMAN DE, 1991, AM J HUM GENET, V48, P295; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURROW K, 1991, NEUROLOGY, V41, P662; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; GANGOPADHYAY SB, 1992, AM J HUM GENET, V51, P562; GILLARD EF, 1989, AM J HUM GENET, V45, P507; HARLOW E, 1988, ANTIBODIES LABORATOR; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; Kaumaya Pravin T. P., 1993, Journal of Molecular Recognition, V6, P81, DOI 10.1002/jmr.300060206; Kaumaya PTP, 1994, PEPTIDES DESIGN SYNT, P133; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MATSUMURA K, 1993, AM J HUM GENET, V53, P409; MATSUMURA K, 1993, J CLIN INVEST, V92, P866, DOI 10.1172/JCI116661; MATSUMURA K, 1994, J CLIN INVEST, V93, P99, DOI 10.1172/JCI116989; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MONACO AP, 1988, ADV HUM GENET, V17, P61; NICHOLSON LVB, 1989, J NEUROL SCI, V94, P137, DOI 10.1016/0022-510X(89)90224-4; NICHOLSON LVB, 1992, J MED GENET, V29, P892, DOI 10.1136/jmg.29.12.892; PARTIDOS CD, 1990, J GEN VIROL, V71, P2099, DOI 10.1099/0022-1317-71-9-2099; PRINGLE JR, 1991, GUIDE YEAST GENETICS, P581; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; PRIOR TW, 1993, HUM MOL GENET, V2, P311, DOI 10.1093/hmg/2.3.311; PRIOR TW, 1990, CLIN CHEM, V36, P2113; PRIOR TW, 1993, HUM MUTAT, V2, P192, DOI 10.1002/humu.1380020307; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; ROBERTS RG, 1994, HUM MUTAT, V4, P1, DOI 10.1002/humu.1380040102; ROBERTS RG, 1993, GENOMICS, V16, P536, DOI 10.1006/geno.1993.1225; SHERRAT TG, 1993, AM J HUM GENET, V53, P1007; SHIMIZU T, 1988, P JPN ACAD B-PHYS, V64, P205, DOI 10.2183/pjab.64.205; THANH LT, 1993, AM J HUM GENET, V53, P131; WALLGRENPETTERSSON C, 1993, J NEUROL SCI, V118, P56, DOI 10.1016/0022-510X(93)90246-U; WINNARD AV, 1992, HUM MOL GENET, V1, P645, DOI 10.1093/hmg/1.8.645; WINNARD AV, 1993, HUM MOL GENET, V2, P737, DOI 10.1093/hmg/2.6.737; WORTON RG, 1988, INT REV NEUROBIOL, V29, P1, DOI 10.1016/S0074-7742(08)60083-5; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	47	93	99	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1995	56	1					158	166						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QC101	7825572				2022-12-18	WOS:A1995QC10100020
J	GABIZON, R; ROSENMANN, H; MEINER, Z; KAHANA, I; KAHANA, E; SHUGART, Y; OTT, J; PRUSINER, SB				GABIZON, R; ROSENMANN, H; MEINER, Z; KAHANA, I; KAHANA, E; SHUGART, Y; OTT, J; PRUSINER, SB			MUTATION AND POLYMORPHISM OF THE PRION PROTEIN GENE IN LIBYAN JEWS WITH CREUTZFELDT-JAKOB-DISEASE (CJD)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CODON-200; ISRAEL; FOCUS	The inherited prion diseases are neurodegenerative disorders which are not only genetic but also transmissible. More than a dozen mutations in the prion protein gene that result in nonconservative amino acid substitutions segregate with the inherited prion diseases including familial Creutzfeldt-Jakob disease (CJD). In Israel, the incidence of CJD is about 1 case/10(4) Libyan Jews. A Lys200 substitution segregates with CJD and is reported here to be genetically linked to CJD with a lod score of >4.8. Some healthy elderly LYS200 carriers >age 65 years were identified, suggesting the possibility of incomplete penetrance. In contrast, no linkage was found between the development of familial CJD and a polymorphism encoding either Met129 or Val129. All Libyan Jewish CJD patients with the Lys200 mutation encode a Met129 on the mutant allele. Homozygosity for Met129 did not correlate with age at disease onset or the duration of illness. The frequency of the Met129 allele was higher in the affected pedigrees than in a control population of Libyan Jews. The frequency of the Met129 and Val129 alleles in the control Libyan population was similar to that found in the general Caucasian population. The identification of three Libyan Jews homozygous for the LyS200 mutation suggests frequent intrafamilial marriages a custom documented by genealogical investigations.	BARZILAI GOVT HOSP,NEUROL UNIT,ASHQELON,ISRAEL; COLUMBIA UNIV,DEPT ORGAN CHEM,NEW YORK,NY 10027; UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	Ben Gurion University; Barzilai Medical Center; Columbia University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	GABIZON, R (corresponding author), HADASSAH UNIV HOSP,DEPT NEUROL,EIN KAREM,IL-91120 JERUSALEM,ISRAEL.			Kahana, Esther/0000-0002-3863-3271	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS014069, P01NS014069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00008] Funding Source: Medline; NIA NIH HHS [AG02132] Funding Source: Medline; NINDS NIH HHS [NS14069] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAKER HF, 1991, LANCET, V337, P1286, DOI 10.1016/0140-6736(91)92953-Y; BERTONI J M, 1992, Neurology, V42, P350; BOCKMAN JM, 1985, NEW ENGL J MED, V312, P73, DOI 10.1056/NEJM198501103120202; BOCKMAN JM, 1987, ANN NEUROL, V21, P589, DOI 10.1002/ana.410210611; BROWN P, 1986, ANN NEUROL, V20, P597, DOI 10.1002/ana.410200507; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; COLLINGE J, 1993, BRIT MED J, V306, P391; DOHURA K, 1991, NATURE, V353, P801, DOI 10.1038/353801b0; GIBBS CJ, 1969, SCIENCE, V165, P1023, DOI 10.1126/science.165.3897.1023; GIBBS CJ, 1968, SCIENCE, V161, P388, DOI 10.1126/science.161.3839.388; GOLDFARB LG, 1990, LANCET, V336, P514, DOI 10.1016/0140-6736(90)92073-Q; GOLDFARB LG, 1990, LANCET, V336, P637, DOI 10.1016/0140-6736(90)93443-S; GOLDFARB LG, 1991, EUR J EPIDEMIOL, V7, P477, DOI 10.1007/BF00143125; GOLDFARB LG, 1992, SCIENCE, V258, P806, DOI 10.1126/science.1439789; HSIAO K, 1991, NEW ENGL J MED, V324, P1091, DOI 10.1056/NEJM199104183241604; HSIAO KK, 1991, NEUROLOGY, V41, P681, DOI 10.1212/WNL.41.5.681; Jakob A, 1921, Z GESAMTE NEUROL PSY, V64, P147, DOI 10.1007/BF02870932; Jakob A, 1921, MED KLIN, V17, P372; KAHANA E, 1974, SCIENCE, V183, P90, DOI 10.1126/science.183.4120.90; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MEINER Z, 1992, NEUROLOGY, V42, P1355, DOI 10.1212/WNL.42.7.1355; NEUGUT RH, 1979, NEUROLOGY, V29, P225, DOI 10.1212/WNL.29.2.225; OWEN F, 1990, AM J HUM GENET, V46, P1215; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; ROOS R, 1973, BRAIN, V96, P1; SPARKES RS, 1986, P NATL ACAD SCI USA, V83, P7358, DOI 10.1073/pnas.83.19.7358; ZILBER N, 1991, NEUROLOGY, V41, P1385, DOI 10.1212/WNL.41.9.1385	31	93	94	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					828	835						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8105682				2022-12-18	WOS:A1993LY62700006
J	ROBINSON, WP; BERNASCONI, F; MUTIRANGURA, A; LEDBETTER, DH; LANGLOIS, S; MALCOLM, S; MORRIS, MA; SCHINZEL, AA				ROBINSON, WP; BERNASCONI, F; MUTIRANGURA, A; LEDBETTER, DH; LANGLOIS, S; MALCOLM, S; MORRIS, MA; SCHINZEL, AA			NONDISJUNCTION OF CHROMOSOME-15 - ORIGIN AND RECOMBINATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PRADER-WILLI SYNDROME; REDUCED RECOMBINATION; UNIPARENTAL DISOMY; FREQUENCIES; TRISOMY-21	Thirty-two cases of uniparental disomy (UPD), ascertained from Prader-Willi syndrome patients (N=27) and Angelman syndrome patients (N=5), are used to investigate the pattern of recombination associated with nondisjunction of chromosome 15. In addition, the meiotic stage of nondisjunction is inferred by using markers mapping near the centromere. Two basic approaches to the analysis of recombination are utilized. Standard methods of centromere mapping are employed to determine the level of recombination in specific pairwise intervals along the chromosome. This method shows a significant reduction in recombination for two of five intervals examined. Second, the observed frequency of each recombinant class (i.e., zero, one, two, three, or more observable crossovers) is compared with expected values. This is useful for testing whether the reduction in recombination can be attributed solely to a proportion of cases with no recombination at all (because of asynapsis), with the remaining groups showing normal recombination (or even excess recombination), or whether recombination is uniformly reduced. Analysis of maternal UPD(15) data shows a slight reduction in the multiple-recombinant classes, with a corresponding increase in both the zero- and one-recombinant classes over expected values. The majority, more than 82%, of the extra chromosomes in maternal UPD(15) cases are due to meiotic I nondisjunction events. In contrast, most paternal UPD(15) cases so far examined appear to have a postzygotic origin of the extra paternal chromosome.	BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA; UNIV BRITISH COLUMBIA, DEPT MED GENET, VANCOUVER V6T 1W5, BC, CANADA; UNIV LONDON, INST CHILD HLTH, LONDON, ENGLAND; UNIV GENEVA, DIV MED GENET, CH-1211 GENEVA 4, SWITZERLAND	Baylor College of Medicine; University of British Columbia; University of London; University College London; University of Geneva	ROBINSON, WP (corresponding author), UNIV ZURICH, INST MED GENET, RAMISTR 74, CH-8001 ZURICH, SWITZERLAND.		Robinson, Wendy P/I-9590-2014; Robinson, Wendy/AAB-6420-2020; Mutirangura, Apiwat/C-8197-2009	Robinson, Wendy P/0000-0002-2010-6174; Robinson, Wendy/0000-0002-2010-6174; 	NHGRI NIH HHS [HG00344, HG00024] Funding Source: Medline; NICHD NIH HHS [HD20619] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD020619] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000344] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ANTONARAKIS SE, 1986, COLD SPRING HARB SYM, V51, P185, DOI 10.1101/SQB.1986.051.01.022; ANTONARAKIS SE, 1993, NAT GENET, V3, P146, DOI 10.1038/ng0293-146; ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; ANTONARAKIS SE, 1992, GENOMICS, V14, P1126, DOI 10.1016/S0888-7543(05)80148-X; BOWCOCK AM, 1992, GENOMICS, V14, P833, DOI 10.1016/S0888-7543(05)80101-6; Bridges CB, 1916, GENETICS, V1, P107; CHAKRAVARTI A, 1987, Genomics, V1, P35, DOI 10.1016/0888-7543(87)90102-9; CHAKRAVARTI A, 1989, MOL CYTOGENETIC STUD, P45; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; HASSOLD TJ, 1991, J MED GENET, V28, P159, DOI 10.1136/jmg.28.3.159; Hong Hee-Kyung, 1992, American Journal of Human Genetics, V51, pA32; HULTEN MA, 1990, AM J MED GENET, P160; HULTEN MA, 1992, ANN HUM GENET, V56, P194; LORDASANCHEZ I, 1992, HUM GENET, V89, P524; MALCOLM S, 1991, LANCET, V337, P694, DOI 10.1016/0140-6736(91)90278-W; MARTIN RH, 1991, AM J MED GENET, V39, P321, DOI 10.1002/ajmg.1320390315; MASCARI MJ, 1992, NEW ENGL J MED, V326, P1599, DOI 10.1056/NEJM199206113262404; MERRIAM JR, 1964, GENETICS, V49, P109; MORTON NE, 1985, GENET RES, V45, P279, DOI 10.1017/S0016672300022266; MORTON NE, 1990, ANN HUM GENET, V54, P39, DOI 10.1111/j.1469-1809.1990.tb00359.x; MORTON NE, 1984, GENET RES, V44, P99, DOI 10.1017/S0016672300026276; MORTON NE, 1988, ANN HUM GENET, V52, P85, DOI 10.1111/j.1469-1809.1988.tb01083.x; MUTIRANGURA A, 1993, HUM MOL GENET, V2, P143, DOI 10.1093/hmg/2.2.143; NICHOLLS RD, 1992, ANN NEUROL, V32, P512, DOI 10.1002/ana.410320406; NICHOLLS RD, 1989, NATURE, V342, P281, DOI 10.1038/342281a0; RAO DC, 1977, HUM HERED, V27, P99, DOI 10.1159/000152856; ROBINSON WP, 1991, AM J HUM GENET, V49, P1219; ROBINSON WP, 1993, HUM GENET, V91, P181; ROBINSON WP, IN PRESS J MED GENET; ROEDER GS, 1990, TRENDS GENET, V6, P385, DOI 10.1016/0168-9525(90)90297-J; SHAHAR S, 1986, HUM GENET, V74, P215; SHERMAN SL, 1991, AM J HUM GENET, V49, P608; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519	33	93	93	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					740	751						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352279				2022-12-18	WOS:A1993LU55900018
J	COON, H; JENSEN, S; HOFF, M; HOLIK, J; PLAETKE, R; REIMHERR, F; WENDER, P; LEPPERT, M; BYERLEY, W				COON, H; JENSEN, S; HOFF, M; HOLIK, J; PLAETKE, R; REIMHERR, F; WENDER, P; LEPPERT, M; BYERLEY, W			A GENOME-WIDE SEARCH FOR GENES PREDISPOSING TO MANIC-DEPRESSION, ASSUMING AUTOSOMAL-DOMINANT INHERITANCE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONTINUOUS LINKAGE MAP; OLD ORDER AMISH; PSYCHIATRIC-DISORDERS; HUMAN CHROMOSOME-10; UTAH MORMONS; DNA MARKERS; LOCI FORM; SHORT ARM; LONG ARM; FAMILY	Manic-depressive illness (MDI), also known as ''bipolar affective disorder,'' is a common and devastating neuropsychiatric illness. Although pivotal biochemical alterations underlying the disease are unknown, results of family, twin, and adoption studies consistently implicate genetic transmission in the pathogenesis of MDI. In order to carry out linkage analysis, we ascertained eight moderately sized pedigrees containing multiple cases of the disease. For a four-allele marker mapping 5 cM from the disease gene, the pedigree sample has >97% power to detect a dominant allele under genetic homogeneity and has >73% power under 20% heterogeneity. To date, the eight pedigrees have been genotyped with 328 polymorphic DNA loci throughout the genome. When autosomal dominant inheritance was assumed, 273 DNA markers gave lod scores <-2.0 at recombination fraction (theta) = .0, 174 DNA loci produced lod scores <-2.0 at theta = .05, and 4 DNA marker loci yielded lod scores >1 (chromosome 5-D5S39, D5S43, and D5S62; chromosome 11-D11S85). Of the markers giving lod scores >1, only D5S62 continued to show evidence for linkage when the affected-pedigree-member method was used. The D5S62 locus maps to distal 5q, a region containing neurotransmitter-receptor genes for dopamine, norepinephrine, glutamate, and gamma-aminobutyric acid. Although additional work in this region may be warranted, our linkage results should be interpreted as preliminary data, as 68 unaffected individuals are not past the age of risk.	UNIV UTAH,MED CTR,DEPT PSYCHIAT,SALT LAKE CITY,UT 84132; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84132	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah					NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042643, P50MH044212] Funding Source: NIH RePORTER; NCRR NIH HHS [MO1-RR00064] Funding Source: Medline; NIMH NIH HHS [MH-44212, MH-42643] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BERRETTINI WH, 1991, PSYCHIATR GENET, V2, P192; BERTELSEN A, 1977, BRIT J PSYCHIAT, V130, P330, DOI 10.1192/bjp.130.4.330; BLANCHE H, 1991, GENOMICS, V9, P420, DOI 10.1016/0888-7543(91)90407-6; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOWCOCK AM, 1991, GENOMICS, V11, P517, DOI 10.1016/0888-7543(91)90058-M; BUCKLE VJ, 1989, NEURON, V3, P647, DOI 10.1016/0896-6273(89)90275-4; BUETOW KH, 1991, AM J HUM GENET, V48, P911; BYERLEY W, 1992, HUM HERED, V42, P259, DOI 10.1159/000154079; Byerley W., 1990, Psychiatric Genetics, V1, P55, DOI 10.1097/00041444-199021000-00006; DETERAWADLEIGH SD, 1992, NEUROPSYCHOPHARMACOL, V6, P219; DRACOPOLI NC, 1991, GENOMICS, V9, P686, DOI 10.1016/0888-7543(91)90362-I; DUMANSKI JP, 1991, GENOMICS, V11, P709, DOI 10.1016/0888-7543(91)90079-T; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GERSHON ES, 1982, ARCH GEN PSYCHIAT, V39, P1157; GOLDIN L R, 1984, Genetic Epidemiology, V1, P285, DOI 10.1002/gepi.1370010307; Goodwin F.K., 1990, MANIC DEPRESSIVE ILL; GRANDY DK, 1990, AM J HUM GENET, V47, P828; H/CEPH Collaborative Mapping Group, 1992, SCIENCE, V258, P67; HAINES JL, 1990, GENOMICS, V8, P1, DOI 10.1016/0888-7543(90)90218-J; JENSEN S, 1992, HUM HERED, V42, P269, DOI 10.1159/000154081; JORDE LB, 1989, ANN HUM GENET, V53, P339, DOI 10.1111/j.1469-1809.1989.tb01803.x; JULIER C, 1990, GENOMICS, V6, P419, DOI 10.1016/0888-7543(90)90471-6; JULIER C, 1990, GENOMICS, V7, P335, DOI 10.1016/0888-7543(90)90167-S; KELSOE JR, 1989, NATURE, V342, P238, DOI 10.1038/342238a0; LATHROP GM, 1989, GENOMICS, V5, P866, DOI 10.1016/0888-7543(89)90128-6; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1988, GENOMICS, V3, P361; LEACH R, 1986, P NATL ACAD SCI USA, V83, P3909, DOI 10.1073/pnas.83.11.3909; LEPPERT M, 1986, AM J HUM GENET, V39, P425; LITT M, 1989, AM J HUM GENET, V44, P397; MCLELLAN T, 1984, AM J HUM GENET, V36, P836; MCNAMARA JO, 1992, J NEUROSCI, V12, P2555; MELLON C, 1989, PSYCHIATR DEV, V2, P143; NAKAMURA Y, 1989, GENOMICS, V5, P945, DOI 10.1016/0888-7543(89)90139-0; NAKAMURA Y, 1988, GENOMICS, V3, P389, DOI 10.1016/0888-7543(88)90133-4; NAKAMURA Y, 1988, GENOMICS, V3, P342, DOI 10.1016/0888-7543(88)90125-5; NAKAMURA Y, 1989, GENOMICS, V4, P76, DOI 10.1016/0888-7543(89)90317-0; NAKAMURA Y, 1988, GENOMICS, V3, P72; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; O'CONNELL P, 1987, Genomics, V1, P93, DOI 10.1016/0888-7543(87)90110-8; OCONNELL P, 1989, GENOMICS, V5, P738, DOI 10.1016/0888-7543(89)90115-8; OCONNELL P, 1989, GENOMICS, V4, P12, DOI 10.1016/0888-7543(89)90308-X; OCONNELL P, 1988, GENOMICS, V3, P367, DOI 10.1016/0888-7543(88)90129-2; OTT J, 1990, AM J HUM GENET, V46, P219; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; PAKSTIS AJ, 1991, HUM GENET, V87, P475; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; RICE J, 1987, ARCH GEN PSYCHIAT, V44, P441; RISCH N, 1990, GENET EPIDEMIOL, V7, P3, DOI 10.1002/gepi.1370070103; RISCH N, 1991, AM J HUM GENET, V48, P1058; Sham Pak C., 1992, Psychiatric Genetics, V2, P175, DOI 10.1097/00041444-199203000-00002; SMITH M, 1989, American Journal of Human Genetics, V45, pA220; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; VIELAND VJ, 1992, GENET EPIDEMIOL, V9, P45, DOI 10.1002/gepi.1370090106; WARREN AC, 1989, GENOMICS, V4, P579, DOI 10.1016/0888-7543(89)90282-6; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEIFFENBACH B, 1991, GENOMICS, V10, P173, DOI 10.1016/0888-7543(91)90498-4; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEISSMAN MM, 1986, ARCH GEN PSYCHIAT, V43, P1104; WHITE RL, 1990, GENOMICS, V6, P393, DOI 10.1016/0888-7543(90)90469-B; YAMAKAWA K, 1991, GENOMICS, V11, P565, DOI 10.1016/0888-7543(91)90063-K; YANGFENG TL, 1990, P NATL ACAD SCI USA, V87, P1516, DOI 10.1073/pnas.87.4.1516; ZIMMERMAN M, 1988, ARCH GEN PSYCHIAT, V45, P320; [No title captured]; 1989, CYTOGENET CELL GENET, V51, P1	72	93	93	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1993	52	6					1234	1249						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LG133	8503452				2022-12-18	WOS:A1993LG13300025
J	BOWCOCK, AM; ANDERSON, LA; FRIEDMAN, LS; BLACK, DM; OSBORNELAWRENCE, S; ROWELL, SE; HALL, JM; SOLOMON, E; KING, MC				BOWCOCK, AM; ANDERSON, LA; FRIEDMAN, LS; BLACK, DM; OSBORNELAWRENCE, S; ROWELL, SE; HALL, JM; SOLOMON, E; KING, MC			THRA1 AND D17S183 FLANK AN INTERVAL OF LESS-THAN-4 CM FOR THE BREAST-OVARIAN CANCER GENE (BRCA1) ON CHROMOSOME-17Q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMORPHISM; LOCUS	In order to pinpoint the locale of the gene for early-onset familial breast and ovarian cancer (BRCA1), polymorphisms were developed within the locus for thyroid hormone receptor alpha (THRAI) and for several anonymous sequences at chromosome 17q12-q21. The THRA1 polymorphism is a dinucleotide repeat with 10 alleles and heterozygosity .79. Gene mapping in extended families with inherited, early-onset breast and ovarian cancer indicates that BRCA1 is distal to THRAI and proximal to D17S183 (SCG43), an interval of <4 cM. This locale excludes HER2, THRA1, WNT3, HOX2, NGFR, PHB, COLIA1, NME1, and NME2 as candidates for BRCA1 but does not exclude RARA or EDH17B. Resolving the remaining recombination events in these families by new polymorphisms in the THRA1-D17S183 interval will facilitate positional cloning of the breast-ovarian cancer gene on chromosome 17q12-q21.	UNIV CALIF BERKELEY,SCH PUBL HLTH,140 WARREN HALL,BERKELEY,CA 94720; UNIV TEXAS,SW MED CTR,DEPT PEDIAT,DALLAS,TX 75230; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND	University of California System; University of California Berkeley; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley; Cancer Research UK				Bowcock, Anne/0000-0001-8691-9090; King, Mary-Claire/0000-0001-9426-1743	NATIONAL CANCER INSTITUTE [R01CA027632] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA27632] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON LA, IN PRESS GENOMICS; BLACK DM, 1993, AM J HUM GENET, V52, P702; CHAMBERLAIN JS, 1993, AM J HUM GENET, V52, P792; COUCH FJ, 1991, NUCLEIC ACIDS RES, V19, P5093, DOI 10.1093/nar/19.18.5093; DEVILEE P, 1993, AM J HUM GENET, V52, P730; EASTON DF, 1993, AM J HUM GENET, V52, P678; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HALL JM, 1991, NUCLEIC ACIDS RES, V19, P2515, DOI 10.1093/nar/19.9.2515-a; JOHNSON TL, 1990, NUCLEIC ACIDS RES, V19, P4312; LAUDET V, 1991, NUCLEIC ACIDS RES, V19, P1105, DOI 10.1093/nar/19.5.1105; LEMONS RS, 1990, GENE CHROMOSOME CANC, V2, P79, DOI 10.1002/gcc.2870020202; NAROD SA, 1991, LANCET, V338, P82; PAPEWALIS J, 1991, NUCLEIC ACIDS RES, V19, P5452, DOI 10.1093/nar/19.19.5452-a; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4640, DOI 10.1093/nar/18.15.4640-a; WRIGHT DK, 1990, PCR PROTOCOLS GUIDE, P153	16	93	97	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1993	52	4					718	722						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KY059	8460637				2022-12-18	WOS:A1993KY05900008
J	GREGG, RG; WILFOND, BS; FARRELL, PM; LAXOVA, A; HASSEMER, D; MISCHLER, EH				GREGG, RG; WILFOND, BS; FARRELL, PM; LAXOVA, A; HASSEMER, D; MISCHLER, EH			APPLICATION OF DNA ANALYSIS IN A POPULATION-SCREENING PROGRAM FOR NEONATAL DIAGNOSIS OF CYSTIC-FIBROSIS (CF) - COMPARISON OF SCREENING PROTOCOLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPOT TRYPSIN ASSAY; IMMUNOREACTIVE TRYPSINOGEN; HETEROZYGOTE DETECTION; NEWBORN; MUTATION; EXPERIENCE; DISEASE; GENE	We compare two protocols for newborn screening for cystic fibrosis (CF). The first uses the immunoreactive trypsinogen (IRT) assay with a cutoff of greater-than-or-equal-to 180 ng/ml and a sweat test to identify CF patients. The second uses the IRT assay with a 100 ng/ml cutoff in conjunction with direct analysis for the DELTAF508 CF transmembrane conductance regulator (CFTR) mutation in a two-tiered (i.e., IRT/DNA) protocol, followed by a sweat test. We screened 220,865 newborns from Wisconsin for CF, using the IRT protocol identifying 369 infants with an elevated IRT, of whom 46 were found to have CF. Another 7 CF patients were identified who had a false-negative IRT level. The CF incidence in the white population was 1 in 3,431 (carrier incidence of 1 in 30). The IRT protocol had a sensitivity of 87% and a positive predictive value of 12.5%. We subsequently used the IRT/DNA protocol to screen 21,258 infants. Of 518 infants with an IRT level greater-than-or-equal-to 100 ng/ml, 24 carried at least one copy of the DELTAF508 CFTR mutation, and 4 of these infants were found to have CF, yielding a positive predictive value for this protocol of 16.7%. Direct comparison of the positive predictive value of the two protocols is not valid, because of the different populations screened. However, had the IRT protocol been used on the IRT/DNA cohort, 50 infants, including the 4 with CF, would have received sweat tests, yielding a positive predictive value of 8%. Because of the small sample size, this positive predictive value is not significantly different from that obtained for the IRT/DNA test. However, from a practical point of view the IRT/DNA approach does decrease considerably the number of sweat tests that must be undertaken. The number of false positives for the IRT protocol (46 in 21,258) is increased significantly compared with that for the IRT/DNA approach (20 in 21,258; P < .001). The incidence of DELTAF508 carriers detected in cohorts with an elevated IRT level was increased compared with the incidence in the general population. The direct costs for the IRT/DNA approach (100 ng/ml) were $11,374 per CF patient detected, compared with $10,187 per CF patient detected for the IRT protocol. Therefore, we conclude that the IRT/DNA approach to CF newborn screening decreases the number of false-positive subjects contacted, without a significant increase in cost.	UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706; STATE LAB HYG,MADISON,WI	University of Wisconsin System; University of Wisconsin Madison	GREGG, RG (corresponding author), UNIV WISCONSIN,WAISMAN CTR MENTAL RETARDAT & HUMAN DEV,ROOM 707,1500 HIGHLAND AVE,MADISON,WI 53706, USA.			Gregg, Ronald/0000-0001-5805-224X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034108, R56DK034108] Funding Source: NIH RePORTER; NCRR NIH HHS [RR03186] Funding Source: Medline; NIDDK NIH HHS [DK34108] Funding Source: Medline; PHS HHS [MCJ-009072] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ADRIAENSSENS K, 1981, LANCET, V1, P833; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; CROSSLEY JR, 1979, LANCET, V1, P472; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DANKERTROELSE JE, 1987, ACTA PAEDIATR SCAND, V76, P209, DOI 10.1111/j.1651-2227.1987.tb10449.x; Farrell PM, 1992, ADV PEDIATR, V39, P36; FOST N, 1989, CLIN RES, V37, P495; GIBSON LE, 1959, PEDIATRICS, V23, P545; HAMMOND KB, 1991, NEW ENGL J MED, V325, P769, DOI 10.1056/NEJM199109123251104; HAMMOND KB, 1986, GENETIC DISEASE SCRE, P81; HASSEMER DJ, 1987, ADV NEONATAL SCREENI, P393; HEELEY AF, 1982, ARCH DIS CHILD, V57, P18; HOLTZMAN NA, 1991, NEW ENGL J MED, V325, P802, DOI 10.1056/NEJM199109123251109; JINKS DC, 1989, HUM GENET, V81, P363, DOI 10.1007/BF00283692; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KULCZYCKI LL, 1974, AM J DIS CHILD, V127, P64, DOI 10.1001/archpedi.1974.02110200066009; LAROCHE D, 1991, LANCET, V337, P55, DOI 10.1016/0140-6736(91)93377-L; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; LYON ICT, 1983, NEW ZEAL MED J, V96, P673; MISCHLER EH, 1985, SEMIN RESPIR MED, V6, P271, DOI 10.1055/s-2007-1011506; RAMSEY BW, 1992, AM J CLIN NUTR, V55, P108, DOI 10.1093/ajcn/55.1.108; RANIERI E, 1991, BRIT MED J, V302, P1237, DOI 10.1136/bmj.302.6787.1237; ROBERTS G, 1988, ARCH DIS CHILD, V63, P1438, DOI 10.1136/adc.63.12.1438; ROCK MJ, 1990, PEDIATRICS, V85, P1001; ROMMENS J, 1990, AM J HUM GENET, V46, P395; RYLEY HC, 1988, J CLIN PATHOL, V41, P726, DOI 10.1136/jcp.41.7.726; TLUCZEK A, 1991, J DEV BEHAV PEDIATR, V13, P181; TUERCK JM, 1987, AM J PUBLIC HEALTH, V77, P1528, DOI 10.2105/AJPH.77.12.1528; WESLEY AW, 1989, AUST PAEDIATR J, V25, P151; WILCKEN B, 1985, LANCET, V2, P1319; WILCKEN B, 1983, J PEDIATR-US, V102, P383, DOI 10.1016/S0022-3476(83)80653-2; WILCKEN B, 1987, ADV NEONATAL SCREENI, P385; Wilfond B., 1991, PEDIATR PULM S, V6, P238; WILFOND BS, 1990, JAMA-J AM MED ASSOC, V263, P2777, DOI 10.1001/jama.263.20.2777	34	93	94	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1993	52	3					616	626						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KR720	7680526				2022-12-18	WOS:A1993KR72000019
J	BRENNER, DA; DIDIER, JM; FRASIER, F; CHRISTENSEN, SR; EVANS, GA; DAILEY, HA				BRENNER, DA; DIDIER, JM; FRASIER, F; CHRISTENSEN, SR; EVANS, GA; DAILEY, HA			A MOLECULAR DEFECT IN HUMAN PROTOPORPHYRIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ERYTHROPOIETIC PROTOPORPHYRIA; LIVER-FERROCHELATASE; SKIN FIBROBLASTS; EXPRESSION; PURIFICATION; GENE; SEQUENCE; VECTORS; DISEASE; CLONING	Protoporphyria is generally an autosomal dominant disease that is characterized clinically by photosensitivity and hepatobiliary disease and that is characterized biochemically by elevated protoporphyrin levels. The enzymatic activity of ferrochelatase, which catalyzes the last step in the heme biosynthetic pathway, is deficient in all tissues of patients with protoporphyria. In this study, sequencing of ferrochelatase cDNAs from a patient with protoporphyria revealed a single point mutation in the cDNAs, resulting in the conversion of a Phe(TTC) to a Ser(TCC) in the carboxy-terminal end of the protein, F417S. Further, the human ferrochelatase gene was mapped to chromosome 18q21.3 by chromosomal in situ suppression hybridization. Finally, expression of recombinant ferrochelatase in Escherichia coli demonstrated a marked deficiency in activity of the mutant ferrochelatase protein and of mouse-human mutant ferrochelatase chimeric proteins. Therefore, a point mutation in the coding region of the ferrochelatase gene is the genetic defect in some patients with protoporphyria.	UNIV CALIF SAN DIEGO,CTR MOLEC GENET,LA JOLLA,CA 92093; SALK INST BIOL STUDIES,LA JOLLA,CA 92037; UNIV GEORGIA,DEPT MICROBIOL,ATHENS,GA 30602; UNIV GEORGIA,CTR METALLOENZYME STUDIES,ATHENS,GA 30602	University of California System; University of California San Diego; Salk Institute; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	BRENNER, DA (corresponding author), UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093, USA.			Brenner, David/0000-0003-2573-525X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032303, R29DK039996, R01DK035898] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-32303, DK-35898, R56 DK032303, DK-39996] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; BLOOMER JR, 1976, LANCET, V2, P226; BLOOMER JR, 1975, AM J MED, V58, P869, DOI 10.1016/0002-9343(75)90644-0; BLOOMER JR, 1989, GASTROENTEROLOGY, V97, P188, DOI 10.1016/0016-5085(89)91434-0; BONKOWSKY HL, 1975, J CLIN INVEST, V56, P1139, DOI 10.1172/JCI108189; BOTTOMLEY SS, 1975, J LAB CLIN MED, V86, P126; BRENNER DA, 1991, P NATL ACAD SCI USA, V88, P849, DOI 10.1073/pnas.88.3.849; BRENNER DA, 1987, J BIOL CHEM, V262, P17690; CANEPA ET, 1988, BIOCHEM CELL BIOL, V66, P32, DOI 10.1139/o88-005; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAILEY HA, 1986, METHOD ENZYMOL, V123, P408; de Goeij A F, 1975, Eur J Clin Invest, V5, P397; EVANS GA, 1987, METHOD ENZYMOL, V152, P604; GRISSMER S, 1990, P NATL ACAD SCI USA, V87, P9411, DOI 10.1073/pnas.87.23.9411; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; HERBERT A, 1991, GASTROENTEROLOGY, V100, P1753, DOI 10.1016/0016-5085(91)90680-J; KARR SR, 1988, BIOCHEM J, V254, P799, DOI 10.1042/bj2540799; LABBEBOIS R, 1990, J BIOL CHEM, V265, P7278; LAMORIL J, 1991, BIOCHEM BIOPH RES CO, V181, P594, DOI 10.1016/0006-291X(91)91231-Z; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; NAKAHASHI Y, 1990, BIOCHIM BIOPHYS ACTA, V1037, P321, DOI 10.1016/0167-4838(90)90032-B; NAKAHASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P748, DOI 10.1016/S0006-291X(05)80099-3; NAYLOR EW, 1978, J MED GENET, V15, P157, DOI 10.1136/jmg.15.2.157; NORRIS PG, 1990, J INVEST DERMATOL, V95, P260, DOI 10.1111/1523-1747.ep12484876; RADEMAKERS LHPM, 1990, HEPATOLOGY, V11, P449; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; STRAKA JG, 1991, AM J HUM GENET, V48, P72; STRAKA JG, 1991, J BIOL CHEM, V266, P24637; TAKETANI S, 1982, EUR J BIOCHEM, V127, P443; TAKETANI S, 1990, J BIOL CHEM, V265, P19377; TAKETANI S, 1981, J BIOL CHEM, V256, P2748; WENT LN, 1984, ANN HUM GENET, V48, P105, DOI 10.1111/j.1469-1809.1984.tb01006.x; WHITCOMBE DM, 1991, GENOMICS, V11, P1152, DOI 10.1016/0888-7543(91)90044-F	34	93	94	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1992	50	6					1203	1210						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HY654	1376018				2022-12-18	WOS:A1992HY65400007
J	ROSATELLI, MC; DOZY, A; FAA, V; MELONI, A; SARDU, R; SABA, L; KAN, YW; CAO, A				ROSATELLI, MC; DOZY, A; FAA, V; MELONI, A; SARDU, R; SABA, L; KAN, YW; CAO, A			MOLECULAR CHARACTERIZATION OF BETA-THALASSEMIA IN THE SARDINIAN POPULATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; POLYMERASE CHAIN-REACTION; PRENATAL-DIAGNOSIS; DNA FRAGMENTS; GENOMIC DNA; MUTATIONS; AMPLIFICATION	This study reports the molecular characterization of beta-thalassemia in the Sardinian population. Three thousand beta-thalassemia chromosomes from prospective parents presenting at the genetic service were initially analyzed by dot blot analysis with oligonucleotide probes complementary to the most common beta-thalassemia mutations in the Mediterranean at-risk populations. The mutations which remained uncharacterized by this approach were defined by denaturing gradient gel electrophoresis (DGGE) followed by direct sequence analysis on amplified DNA. We reconfirmed that the predominant mutation in the Sardinian population is the codon 39 nonsense mutation, which accounts for 95.7% of the beta-thalassemia chromosomes. The other two relatively common mutations are frameshifts at codon 6 (2.1%) and at codon 76 (0.7%), relatively uncommon in other Mediterranean-origin populations. In this study we have detected a novel beta-thalassemia mutation, i.e., a frameshift at codon 1, in three beta-thalassemia chromosomes. The DGGE procedure followed by direct sequencing on amplified DNA is a powerful approach for the characterization of unknown mutations in this genetic system. The results herein presented allowed an expansion of the applicability of prenatal diagnosis by DNA analysis, to all couples at risk for beta-thalassemia in our population.	UNIV CAGLIARI,IST CLIN & BIOL ETA EVOLUT,VIA JENNER S-N,I-09100 CAGLIARI,ITALY; CNR,IST RIC TALASSEMIE & ANEMIE MEDITERRANEE,CAGLIARI,ITALY; UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	University of Cagliari; Consiglio Nazionale delle Ricerche (CNR); Howard Hughes Medical Institute; University of California System; University of California San Francisco				ROSATELLI, MARIA CRISTINA/0000-0001-6821-3190; Faa, Valeria/0000-0001-9783-7904; SABA, Luisella/0000-0002-3470-3279				CAI SP, 1990, J CLIN INVEST, V85, P550, DOI 10.1172/JCI114471; DIMARZO R, 1988, BRIT J HAEMATOL, V69, P393; FISCHER SG, 1983, P NATL ACAD SCI-BIOL, V80, P1579, DOI 10.1073/pnas.80.6.1579; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; LOSEKOOT M, 1990, BRIT J HAEMATOL, V76, P269, DOI 10.1111/j.1365-2141.1990.tb07883.x; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; RISTALDI MS, 1989, PRENATAL DIAG, V9, P629, DOI 10.1002/pd.1970090906; ROSATELLI C, 1987, J MED GENET, V24, P97, DOI 10.1136/jmg.24.2.97; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323	12	93	93	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1992	50	2					422	426						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HD001	1734721				2022-12-18	WOS:A1992HD00100019
J	OBER, C; ELIAS, S; KOSTYU, DD; HAUCK, WW				OBER, C; ELIAS, S; KOSTYU, DD; HAUCK, WW			DECREASED FECUNDABILITY IN HUTTERITE COUPLES SHARING HLA-DR	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECURRENT SPONTANEOUS-ABORTION; CLASS-II ANTIGENS; FERTILITY; ABSENCE; HUMANS	To study the effects of parental HLA sharing on pregnancy outcome, we initiated population-based studies in the Hutterites. We previously reported longer intervals from marriage to each birth among couples sharing HLA, particularly HLA-DR. In the present report, we present the results of a prospective, 5-year study of fecundability and fetal loss rates in this population. Between April 1986 and April 1991, 154 pregnancies were observed in 104 couples. The median number of months of unprotected intercourse to a positive pregnancy test was significantly longer among couples sharing HLA-DR who stopped nursing prior to the first menses as compared with couples not sharing HLA-DR who stopped nursing prior to the first menses (5.1 vs. 2.0 mo, respectively; P = .016). Fetal loss rates were increased among couples sharing HLA-B as compared with couples not sharing HLA-B (.23 vs. .12, respectively; P = .041, adjusted for age, gravidity, and kinship). These data suggest that our earlier observations of increased birth interval lengths among Hutterite couples sharing HLA were predominantly due to longer intervals until a clinical pregnancy among couples sharing HLA-DR and, to a lesser degree, were due to increased fetal loss rates among couples sharing HLA-B.	UNIV TENNESSEE,CTR HLTH SCI,COLL MED,DEPT OBSTET & GYNECOL,MEMPHIS,TN 38163; DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DURHAM,NC 27710; UNIV CALIF SAN FRANCISCO,DEPT EPIDEMIOL & BIOSTAT,SAN FRANCISCO,CA 94143	University of Tennessee System; University of Tennessee Health Science Center; Duke University; University of California System; University of California San Francisco	OBER, C (corresponding author), UNIV CHICAGO,DEPT OBSTET & GYNECOL,5841 MARYLAND AVE,CHICAGO,IL 60637, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21244] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSON S, 1980, STATISTICAL METHODS; BEER AE, 1980, FOLIA BIOL-PRAGUE, V26, P225; BEER AE, 1981, AM J OBSTET GYNECOL, V141, P987; BISHARA A, 1987, AM J REPROD IMMUNOL, V13, P97; BOLIS PF, 1984, BIOL RES PREG PERIN, V5, P135; BULMER JN, 1985, PLACENTA, V6, P127, DOI 10.1016/S0143-4004(85)80063-1; COULAM CB, 1987, AM J REPROD IMMUNOL, V14, P54; DAVAJAN V, 1986, INFERTILITY CONTRACE, P381; DESOYE G, 1988, J IMMUNOL, V140, P4157; FAULK WP, 1981, TRANSPLANTATION, V32, P1; GERENCER M, 1988, TISSUE ANTIGENS, V32, P130, DOI 10.1111/j.1399-0039.1988.tb01648.x; GILL TJ, 1983, TRANSPLANTATION, V35, P1; GILL TJ, 1979, AM J PATHOL, V95, P464; HAUCK WW, 1991, GENET EPIDEMIOL, V8, P187, DOI 10.1002/gepi.1370080305; HO HN, 1990, AM J OBSTET GYNECOL, V163, P164; Hostetler J, 1974, HUTTERITE SOC; JOHNSON PM, 1988, DIS MARKERS, V6, P163; KOMLOS L, 1977, CLIN IMMUNOL IMMUNOP, V7, P330, DOI 10.1016/0090-1229(77)90066-6; KOSTYU DD, 1989, AM J HUM GENET, V45, P261; KUHLMANN D, 1986, TISSUE ANTIGENS, V27, P179; Leridon H., 1977, HUMAN FERTILITY BASI; Malecot G., 1969, MATH HEREDITY; MANGE AP, 1964, HUM BIOL, V36, P104; MARGULIS SW, UNPUB REPRODUCTIVE C; MARTIN AO, 1980, BANBURY REPORT, V4, P235; MARTIN AO, 1979, AM J PHYS ANTHROPOL, V32, P351; MCINTYRE JA, 1986, OBSTET GYNECOL, V67, P169, DOI 10.1097/00006250-198602000-00003; MILLS JL, 1988, NEW ENGL J MED, V319, P1617, DOI 10.1056/NEJM198812223192501; OBER C, 1988, AM J REPROD IM MIC, V18, P111; OBER C, 1990, IMMUNOBIOLOBIOLOGY, P3; OBER CL, 1985, FERTIL STERIL, V44, P227; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; REZNIKOFFETIEVANT MF, 1984, TISSUE ANTIGENS, V24, P30; RISK JM, 1991, MOLECULAR AND CELLULAR IMMUNOBIOLOGY OF THE MATERNAL FETAL INTERFACE, P39; ROBERTS CJ, 1975, LANCET, V1, P498; ROBERTSON SA, 1991, MOLECULAR AND CELLULAR IMMUNOBIOLOGY OF THE MATERNAL FETAL INTERFACE, P191; SCHACTER B, 1979, LANCET, V1, P796; SHEPS MC, 1965, POP STUD-J DEMOG, V19, P65, DOI 10.2307/2173165; STEINBERG AG, 1967, 3RD P INT C HUM GEN, P267; UNANDER AM, 1983, AM J REPROD IMMUNOL, V4, P171, DOI 10.1111/j.1600-0897.1983.tb00273.x; WILCOX AJ, 1984, AM J EPIDEMIOL, V120, P727, DOI 10.1093/oxfordjournals.aje.a113940; [No title captured]	42	93	97	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					6	14						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1729895				2022-12-18	WOS:A1992HA04000002
J	YOSHIDA, K; OSHIMA, A; SHIMMOTO, M; FUKUHARA, Y; SAKURABA, H; YANAGISAWA, N; SUZUKI, Y				YOSHIDA, K; OSHIMA, A; SHIMMOTO, M; FUKUHARA, Y; SAKURABA, H; YANAGISAWA, N; SUZUKI, Y			HUMAN BETA-GALACTOSIDASE GENE-MUTATIONS IN GM1-GANGLIOSIDOSIS - A COMMON MUTATION AMONG JAPANESE ADULT CHRONIC CASES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECTAL BIOPSY; DEFICIENCY; FIBROBLASTS; EXPRESSION; JUVENILE; PROTEIN; DISEASE; ENZYME	Molecular analysis of the human beta-galactosidase gene revealed six different mutations in 10 of 11 Japanese G(M1)-gangliosidosis patients. They were the only abnormalities in each allele examined in this study. A 165-nucleotide duplication (positions 1103-1267) was found in two infantile patients, producing an abnormally large mRNA; one patient was probably a homozygote, and the other was a heterozygote of this mutation. The other two infantile patients had different mutations; a 123 Gly(GGG) --> Arg(AGG) mutation in one patient and a 316 Tyr(TAT) --> Cys(TGT) mutation in the other. A 201 Arg(CGC) --> Cys(TGC) mutation, eliminating a BspMI site, was detected in a late-infantile/juvenile patient; the restriction-site analysis of amplified genomic DNA confirmed his heterozygosity for this mutation. A 51 Ile(ATC) --> Thr(ACC) mutation was found in all five adult/chronic patients examined in this study. It created a Saul site, and restriction-site analysis confirmed that four patients were homozygous mutants. The other was a compound heterozygote for this mutation and another 457 Arg(CGA) --> Gln(CAA) mutation. These mutant genes expressed markedly decreased or completely deficient enzyme activities in beta-galactosidase-deficient human fibroblasts transformed by adenovirus-SV40 recombinants. We conclude that gene mutations are heterogeneous in G(M1)-gangliosidosis but that the 51 Ile(ATC) --> Thr(ACC) mutation is common among the Japanese adult/chronic cases. Genotype-phenotype correlations in G(M1)-gangliosidosis are briefly discussed.	SHINSHU UNIV,SCH MED,DEPT MED NEUROL,MATSUMOTO,NAGANO 390,JAPAN	Shinshu University	YOSHIDA, K (corresponding author), TOKYO METROPOLITAN INST MED SCI,DEPT CLIN GENET,3-18-22 HONKOMAGOME,BUNKYO KU,TOKYO 113,JAPAN.							ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; INUI K, 1990, J NEUROL, V237, P491, DOI 10.1007/BF00314770; KOIDE T, 1990, FEBS LETT, V259, P353, DOI 10.1016/0014-5793(90)80046-L; MIYAZAKI J, 1989, GENE, V79, P269; MORREAU H, 1989, J BIOL CHEM, V264, P20655; NAKANO T, 1985, NEUROLOGY, V35, P875, DOI 10.1212/WNL.35.6.875; NANBA E, 1988, BIOCHEM BIOPH RES CO, V152, P794, DOI 10.1016/S0006-291X(88)80108-6; O'Brien JS, 1989, METABOLIC BASIS INHE, P1797; OSHIMA A, 1988, BIOCHEM BIOPH RES CO, V157, P238, DOI 10.1016/S0006-291X(88)80038-X; OSHIMA A, 1990, HUM GENET, V85, P505; SAKURABA H, 1982, CLIN CHIM ACTA, V125, P275; SAKURABA H, 1990, AM J HUM GENET, V47, P784; Sambrook J., 1989, MOL CLONING LAB MANU; STEVENSON RE, 1978, CLIN GENET, V13, P305; SUZUKI Y, 1978, HUM GENET, V43, P127, DOI 10.1007/BF00293589; Suzuki Y, 1979, Brain Dev, V1, P83; SUZUKI Y, 1970, NEUROLOGY, V20, P848, DOI 10.1212/WNL.20.9.848; SUZUKI Y, 1977, HUM GENET, V36, P219, DOI 10.1007/BF00273261; USHIYAMA M, 1985, J NEUROL SCI, V71, P209, DOI 10.1016/0022-510X(85)90060-7; VANDOREN K, 1984, MOL CELL BIOL, V4, P163; WENGER DA, 1980, CLIN GENET, V17, P323	23	93	97	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					435	442						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1907800				2022-12-18	WOS:A1991GA86600022
J	GREENBERG, CR; EVANS, JA; MCKENDRYSMITH, S; REDEKOPP, S; HAWORTH, JC; MULIVOR, R; CHODIRKER, BN				GREENBERG, CR; EVANS, JA; MCKENDRYSMITH, S; REDEKOPP, S; HAWORTH, JC; MULIVOR, R; CHODIRKER, BN			INFANTILE HYPOPHOSPHATASIA - LOCALIZATION WITHIN CHROMOSOME REGION IP36.I-34 AND PRENATAL-DIAGNOSIS USING LINKED DNA MARKERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV MANITOBA,DEPT PEDIAT,WINNIPEG R3E 0W3,MANITOBA,CANADA; CORIELL INST MED RES,CAMDEN,NJ	University of Manitoba; Coriell Institute for Medical Research	GREENBERG, CR (corresponding author), UNIV MANITOBA,DEPT HUMAN GENET,250-770 BANNATYNE AVE,WINNIPEG R3E 0W3,MANITOBA,CANADA.							CHODIRKER B N, 1987, Genomics, V1, P280, DOI 10.1016/0888-7543(87)90056-5; CHODIRKER BN, 1990, AM J HUM GENET, V46; CHODIRKER BN, 1988, THESIS U MANITOBA WI; COGHLAN GE, 1988, 20 P C INT SOC BLOOD, P301; COTE GB, 1975, THESIS U BIRMINGHAM; EDWARDS JH, 1972, CLIN GENET, V3, P371; ESTIVILL X, 1987, Genomics, V1, P257, DOI 10.1016/0888-7543(87)90052-8; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRASER D, 1957, AM J MED, V22, P730, DOI 10.1016/0002-9343(57)90124-9; GREENBERG CR, 1987, AM J HUM GENET, V41, P128; Macpherson R I, 1972, J Can Assoc Radiol, V23, P16; MULIVOR RA, 1978, AM J HUM GENET, V30, P271; RASMUSSEN H, 1978, METABOLIC BASIS INHE, P1340; RATHBUN JC, 1948, AM J DIS CHILD, V75, P822, DOI 10.1001/archpedi.1948.02030020840003; RAY K, 1988, NUCLEIC ACIDS RES, V16, P2361, DOI 10.1093/nar/16.5.2361; SMITH M, 1988, Genomics, V2, P139, DOI 10.1016/0888-7543(88)90095-X; WARREN RC, 1985, LANCET, V2, P856; WEISS MJ, 1987, NUCLEIC ACIDS RES, V15, P860, DOI 10.1093/nar/15.2.860; WEISS MJ, 1989, AM J HUM GENET, V44, P686; WEISS MJ, 1986, P NATL ACAD SCI USA, V83, P7182, DOI 10.1073/pnas.83.19.7182; WEISS MJ, 1988, P NATL ACAD SCI USA, V85, P7666, DOI 10.1073/pnas.85.20.7666; WHYTE MP, 1986, J PEDIATR-US, V108, P82, DOI 10.1016/S0022-3476(86)80773-9	22	93	96	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1990	46	2					286	292						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CM938	1689104				2022-12-18	WOS:A1990CM93800009
J	BONNEY, GE; LATHROP, GM; LALOUEL, JM				BONNEY, GE; LATHROP, GM; LALOUEL, JM			COMBINED LINKAGE AND SEGREGATION ANALYSIS USING REGRESSIVE MODELS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,603 WINTROBE BLDG,SALT LAKE CITY,UT 84132; HOWARD UNIV,CTR CANC,DIV BIOSTAT,WASHINGTON,DC 20059	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Howard University					NCI NIH HHS [2P30CA14718] Funding Source: Medline; NIGMS NIH HHS [R29GM39573] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA014718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM039573] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BONNEY GE, 1984, AM J MED GENET, V18, P731, DOI 10.1002/ajmg.1320180420; BONNEY GE, IN PRESS GENET EPIDE; CANNINGS C, 1978, ADV APPL PROBAB, V10, P26, DOI 10.2307/1426718; CANNINGS C, 1977, CLIN GENET, V12, P208; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1979, AM J HUM GENET, V31, P62; ELSTON RC, 1978, ANNU REV BIOPHYS BIO, V7, P253, DOI 10.1146/annurev.bb.07.060178.001345; GOLDIN LR, 1980, AM J MED GENET, V6, P279, DOI 10.1002/ajmg.1320060405; Hasstedt SJ, 1981, 13 U UT DEP MED BIOP; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT MF, 1986, AM J HUM GENET, V39, P300; LEPPERT MF, IN PRESS J CLIN INVE; MORTON NE, 1974, AM J HUM GENET, V26, P489	15	93	93	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1988	43	1					29	37						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N9863	3163888				2022-12-18	WOS:A1988N986300005
J	FOLSTEIN, SE; CHASE, GA; WAHL, WE; MCDONNELL, AM; FOLSTEIN, MF				FOLSTEIN, SE; CHASE, GA; WAHL, WE; MCDONNELL, AM; FOLSTEIN, MF			HUNTINGTON DISEASE IN MARYLAND - CLINICAL ASPECTS OF RACIAL VARIATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											FOLSTEIN, SE (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,BALTIMORE,MD 21205, USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016375, P50NS016375] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-16375] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARNES FM, 1918, J MO MED ASS, V15, P324; BEAUBRUN MH, 1962, CARIBBEAN MED J, V24, P45; BIRD ED, 1974, ANN HUM GENET, V37, P255, DOI 10.1111/j.1469-1809.1974.tb01833.x; BOWER JL, 1890, J NERV MENT DIS, V15, P131; Bruyn G., 1968, HDB CLINICAL NEUROLO, V6, P298; BURR CW, 1921, ARCH NEUROL PSYCHIAT, V5, P767; DERCUM FX, 1891, INT CLIN, V3, P292; FARRER LA, 1985, AM J HUM GENET, V37, P350; FOLSTEIN SE, 1983, PSYCHOL MED, V13, P537, DOI 10.1017/S0033291700047966; FOLSTEIN SE, 1983, NEUROBEH TOXICOL TER, V5, P605; FOLSTEIN SE, 1986, NEUROLOGY, V36, P1279, DOI 10.1212/WNL.36.10.1279; FOLSTEIN SE, 1985, SCIENCE, V229, P776, DOI 10.1126/science.2992086; FOLSTEIN SE, 1983, PSYCHIATRIC DEV, V2, P193; Folstein SE, 1984, J NEUROGENET, V1, P175, DOI 10.3109/01677068409107083; GLASS J, 1979, S AFR MED J, V56, P685; Gordon H L, 1936, Proc R Soc Med, V29, P1469; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HADDOCK RDW, 1973, TROPICAL NEUROLOGY, P143; HAINES J, 1986, American Journal of Human Genetics, V39, pA156; HARRIES JR, 1973, TROPICAL NEUROLOGY, P207; HAYDEN MR, 1977, S AFR MED J, V52, P886; HAYDEN MR, 1982, J MED GENET, V19, P94, DOI 10.1136/jmg.19.2.94; HAYDEN MR, 1979, THESIS U S AFRICA; HEATHFIELD KW, 1967, BRAIN, V90, P203, DOI 10.1093/brain/90.1.203; HUTTON P W, 1956, East Afr Med J, V33, P209; JONES M B, 1970, Journal of Medical Genetics, V7, P20, DOI 10.1136/jmg.7.1.20; KLINTWORTH GORDON K., 1962, S AFRICAN MED JOUR, V36, P896; KOVEN S J, 1986, American Journal of Human Genetics, V39, pA96; LEIGH RJ, 1983, NEUROLOGY, V33, P1268, DOI 10.1212/WNL.33.10.1268; Mattsson B, 1974, Acta Psychiatr Scand Suppl, V255, P211; MERRITT AD, 1967, 2ND P INT C NEUR NEU, V1, P645; NEEL JV, 1954, HUMAN HEREDITY, P230; NEWCOMBE RG, 1981, ANN HUM GENET, V45, P387, DOI 10.1111/j.1469-1809.1981.tb00352.x; OSUNTOKUN BO, 1973, TROPICAL NEUROLOGY, P161; REED TE, 1958, AM J HUM GENET, V10, P201; ROBINS LN, 1984, ARCH GEN PSYCHIAT, V41, P949; Robins LN, 1981, NIMH DIAGNOSTIC INTE; SAFFER DS, 1974, S AFR MED J, V48, P2399; SAMUELS BL, 1978, S AFR MED J, V54, P648; Still C N, 1977, Neurol Neurocir Psiquiatr, V18, P193; STONE LL, 1939, J NERV MENT DIS, V89, P795; WALLACE DC, 1972, J NEUROL NEUROSUR PS, V35, P789, DOI 10.1136/jnnp.35.6.789; WALLACE DC, 1972, MED J AUSTRALIA, V1, P299, DOI 10.5694/j.1326-5377.1972.tb46796.x; WENT IN, 1983, ANN HUM GENET, V4, P205; WRIGHT HH, 1981, ARCH NEUROL-CHICAGO, V38, P412, DOI 10.1001/archneur.1981.00510070046005; YOUNGMAN S, 1985, American Journal of Human Genetics, V37, pA185; 1980, DIAGNOSTIC STATISTIC	47	93	94	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1987	41	2					168	179						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	J7575	2956881				2022-12-18	WOS:A1987J757500008
J	BONNETAMIR, B; JOHNSON, MJ; NATALI, A; WALLACE, DC; CAVALLISFORZA, LL				BONNETAMIR, B; JOHNSON, MJ; NATALI, A; WALLACE, DC; CAVALLISFORZA, LL			HUMAN MITOCHONDRIAL-DNA TYPES IN 2 ISRAELI POPULATIONS - A COMPARATIVE-STUDY AT THE DNA LEVEL	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									EMORY UNIV,SCH MED,DEPT BIOCHEM,ATLANTA,GA 30322	Emory University	BONNETAMIR, B (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305, USA.				NIGMS NIH HHS [GM-20467] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020467] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BONNETAMIR B, 1979, AM J HUM GENET, V31, P324; BONNETAMIR B, 1978, TISSUE ANTIGENS, V11, P235, DOI 10.1111/j.1399-0039.1978.tb01255.x; BROWN WM, 1980, P NATL ACAD SCI-BIOL, V77, P3605, DOI 10.1073/pnas.77.6.3605; BROWN WM, 1979, EXTRACHROMOSOMAL DNA, V15, P485; CANN RL, 1984, GENETICS, V106, P479; Cavalli-Sforza Luigi., 1979, GENETIC DISEASES ASH, P93; DENARO M, 1981, P NATL ACAD SCI-BIOL, V78, P5768, DOI 10.1073/pnas.78.9.5768; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; JOHNSON MJ, 1983, J MOL EVOL, V19, P255, DOI 10.1007/BF02099973; KAN YW, 1977, NEW ENGL J MED, V297, P1080; KARLIN S, 1979, AM J HUM GENET, V31, P341; LEVENE C, 1976, ACTA HAEMATOL-BASEL, V55, P300, DOI 10.1159/000208031; MORTON NE, 1982, CURR ANTHROPOL, V23, P157, DOI 10.1086/202800; Mourant AE, 1978, BLOOD GROUPS DIS; SANDLER SG, 1979, VOX SANG, V37, P41, DOI 10.1111/j.1423-0410.1979.tb02267.x	16	93	93	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1986	38	3					341	351						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A5781	3006483				2022-12-18	WOS:A1986A578100008
J	DUBOIS, G; HARZER, K; BAUMANN, N				DUBOIS, G; HARZER, K; BAUMANN, N			VERY LOW ARYLSULFATASE-A AND CEREBROSIDE SULFATASE ACTIVITIES IN LEUKOCYTES OF HEALTHY MEMBERS OF METACHROMATIC LEUKODYSTROPHY FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HOP SALPETRIERE,INSERM U134,NEUROCHIM LAB,CNRS,EQUIPE RECH 421,F-75634 PARIS 13,FRANCE; UNIV TUBINGEN,INST HIRNFORSCH,LAB GRP,D-7400 TUBINGEN 1,FED REP GER	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Eberhard Karls University of Tubingen								DREYFUS JC, 1975, NEW ENGL J MED, V292, P61, DOI 10.1056/NEJM197501092920201; DUBOIS G, 1975, NEW ENGL J MED, V293, P302; DUBOIS G, 1975, BIOMED EXPRESS, V23, P116; DUBOIS G, 1974, CR ACAD SCI D NAT, V278, P1401; JATZKEWITZ H, 1969, J NEUROCHEM, V16, P19, DOI 10.1111/j.1471-4159.1969.tb10339.x; NAVON R, 1973, AM J HUM GENET, V25, P287; PERCY AK, 1968, SCIENCE, V161, P594, DOI 10.1126/science.161.3841.594; VIDGOFF J, 1973, AM J HUM GENET, V25, P372	8	93	93	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1977	29	2					191	194						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DB507	15452				2022-12-18	WOS:A1977DB50700009
J	CAVALLISFORZA, LL; ZONTA, LA; NUZZO, F; BERNINI, L; DEJONG, WWW; KHAN, PM; RAY, AK; WENT, LN; SINISCALCO, M; NIJENHUIS, LE; VANLOGHE.E; MODIANO, G				CAVALLISFORZA, LL; ZONTA, LA; NUZZO, F; BERNINI, L; DEJONG, WWW; KHAN, PM; RAY, AK; WENT, LN; SINISCALCO, M; NIJENHUIS, LE; VANLOGHE.E; MODIANO, G			STUDIES ON AFRICAN PYGMIES .I. A PILOT INVESTIGATION OF BABINGA PYGMIES IN CENTRAL AFRICAN REPUBLIC (WITH AN ANALYSIS OF GENETIC DISTANCES)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		BAKER PT, 1966, BIOLOGY HUMAN ADAPTA; BERNINI L, 1966, ACCADEMIA NAZIO SFMN, V40, P280; BERNINI L, IN PRESS; Biasutti R., 1959, RAZZE POPOLI TERRA; BOYD WC, 1963, AM ANTHROPOL, V65, P243, DOI 10.1525/aa.1963.65.2.02a00010; BUETTNERJANUSCH J, 1966, ORIGINS MAN, P416; Cavalli-Sforza L L, 1966, Ala J Med Sci, V3, P376; CAVALLISFORZA LL, 1967, EVOLUTION, V21, P550, DOI 10.1111/j.1558-5646.1967.tb03411.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V9, P234; CAVALLISFORZA LL, 1969, 12 INT C GEN TOK; CONNELL GE, 1962, NATURE, V193, P505, DOI 10.1038/193505a0; Coon CS, 1965, LIVING RACES MAN; CRESTA M, 1964, RIC SCI, V4, P109; DEJONG WWW, 1968, NATURE, V219, P1360, DOI 10.1038/2191360a0; FRASER GR, 1966, AM J HUM GENET, V18, P546; GATES RR, 1958, ACTA GENET MED GEMEL, V8, P159; GIBLETT ER, 1966, AM J HUM GENET, V18, P553; Gusinde M, 1948, URWALDMENSCHEN ITURI; HOPKINSON DA, 1963, NATURE, V199, P969, DOI 10.1038/199969a0; IKIN EW, 1952, ROY ANTHROPOL I J, V82, P60; JENKINS T, 1966, AM J HUM GENET, V18, P399; JONES RT, 1966, CLIN RES, V14, P168; KIRK RL, 1965, DISTRIBUTION GENETIC; KRIEGER H, 1965, ANN HUM GENET, V29, P113, DOI 10.1111/j.1469-1809.1965.tb00507.x; LALOUEL J, 1949, B MEMOIRES SOCIETE A, P60; MANN GV, 1962, J CHRON DIS, V15, P341, DOI 10.1016/0021-9681(62)90082-6; MILETTO A, 1951, B I ET CENTRAFR, V2, P19; MODIANO G, 1967, ACTA GENET STAT MED, V17, P17; MOORHEAD PS, 1960, EXP CELL RES, V20, P613, DOI 10.1016/0014-4827(60)90138-5; MOTULSKY AG, 1966, AM J HUM GENET, V18, P514; Mourant A., 1954, DISTRIBUTION HUMAN B; NIJENHUIS LE, 1965, TROP GEOGR MED, V1, P69; Olivier G, 1947, ANTHROPOLOGIE, V51, P445; POULIK MD, 1957, NATURE, V180, P1477, DOI 10.1038/1801477a0; RACE RR, 1962, BLOOD GROUPS MAN; Ravisse, 1952, ANTHROPOLOGIE, V56, P491; SIMMONS RT, 1962, AM J PHYS ANTHROPOL, V20, P303, DOI 10.1002/ajpa.1330200314; SINGER R, 1963, SOUTHWEST J ANTHROP, V19, P168, DOI 10.1086/soutjanth.19.2.3629166; STEINBERG A, 1961, AM J HUM GENET, V13, P205; STEINBERG AG, 1960, NATURE, V188, P169, DOI 10.1038/188169a0; VALLOIS AV, 1940, AM J PHYS ANTHROPOL, V26, P449; VANLOGHE.E, 1967, VOX SANG, V13, P369; WEINER JS, 1966, CITED INDIRECTLY; Zoutendyk A, 1953, AM J PHYS ANTHROP-NE, V11, P361, DOI 10.1002/ajpa.1330110311; 1967, WHO366 TECHN REP; 1965, B WHO, V33, P721	46	93	93	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1969	21	3					252	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D4606	4978429				2022-12-18	WOS:A1969D460600004
J	SALZANO, FM; NEEL, JV; MAYBURYL.D				SALZANO, FM; NEEL, JV; MAYBURYL.D			FURTHER STUDIES ON XAVANTE INDIANS .I. DEMOGRAPHIC DATA ON 2 ADDITIONAL VILLAGES - GENETIC STRUCTURE OF TRIBE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article													Salzano, Francisco M/L-7916-2015					DEFREITAS AS, 1955, 1954 IND PROT SERV R; GREY G, 1941, J 2 EXPEDITIONS DISC, V2; GREY G, 1941, J 2 EXPEDITIONS DISC, V1; HOLMBERG AR, 1950, 10 I SOC ANTHR PUBL; KIMURA M, 1963, EVOLUTION, V17, P279, DOI 10.2307/2406157; MAYBURYLEWIS D, 1965, ANTHROPOS, V60, P340; MAYBURYLEWIS D, 1965, SAVAGE INNOCENT LOND; MAYBURYLEWIS DL, 1967, AKWESHAVANTE SOCIETY; METRAUX A, 143 SMITHS I BUR AM; METRAUX A, 1944, HANDBOOK SOUTH AMERI, V1, P445; NEEL JV, 1964, AM J HUM GENET, V16, P52; NEEL JV, 1958, AM ANTHROPOL, V60, P43; NEI M, 1966, GENET RES, V8, P257, DOI 10.1017/S0016672300010119; RANKE KE, 1898, DEUTSCH GES ANTHROPO, V29, P123; SALZANO FM, 1964, ACTA GENET MED GEMEL, V13, P278, DOI 10.1017/S1120962300015596; SALZANO FM, 1961, HUM BIOL, V33, P110; SHREFFLER DC, 1967, AM J HUM GENET, V19, P514; SIMOES HT, 1955, 1954 IND PROT SER ED; STEWARD JH, 1946, HANDBOOK SOUTH AM ED, V1; STEWARD JH, 143 SMITHS I BUR  ED; STEWARD JH, 1944, HANDBOOK SOUTH AM ED, V1, P445; Wright S, 1931, GENETICS, V16, P0097	22	93	94	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1967	19	4					463	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	98570	17948519				2022-12-18	WOS:A19679857000001
J	FIALKOW, PJ				FIALKOW, PJ			AUTOIMMUNITY AND CHROMOSOMAL ABERRATIONS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract																		ANDERSON JR, 1964, BMJ-BRIT MED J, V2, P1630; BACH F, 1964, SCIENCE, V143, P813, DOI 10.1126/science.143.3608.813; BARR ML, 1960, J MENT DEFIC RES, V4, P89; BENDA CE, 1949, JAMA-J AM MED ASSOC, V139, P979, DOI 10.1001/jama.1949.02900320009004; BENDA CE, 1946, MONGOLISM CRETINISM; BEUTNER EH, 1962, J IMMUNOL, V88, P462; BISHUN NP, 1964, LANCET, V1, P1452; BOYDEN SV, 1951, J EXP MED, V93, P107, DOI 10.1084/jem.93.2.107; BURGIO GR, 1965, LANCET, V1, P166; CARR DH, 1961, J CLIN ENDOCR METAB, V21, P491, DOI 10.1210/jcem-21-5-491; COPPEN A, 1960, BRIT MED J, V1, P1843, DOI 10.1136/bmj.1.5189.1843; DAVIS TE, 1963, NEW ENGL J MED, V268, P178, DOI 10.1056/NEJM196301242680404; DAY RW, 1964, LANCET, V1, P667; DONIACH D, 1965, ACTA PAEDIATR SCAND, V54, P260, DOI 10.1111/j.1651-2227.1965.tb06369.x; DONIACH D, 1964, SEMIN HEMATOL, V1, P313; DONIACH D, 1962, CLINICAL ASPECTS IMM, P630; EK J I, 1959, Acta Paediatr, V48, P33, DOI 10.1111/j.1651-2227.1959.tb16015.x; ENGEL E, 1961, LANCET, V2, P1004; FIALKOW PJ, 1965, LANCET, V2, P868; FIALKOW PJ, 1964, LANCET, V1, P474; FIALKOW PJ, 1965, J CLIN INVEST, V44, P1046; FIALKOW PJ, SUBMITTED PUBLICATIO; FIALKOW PJ, 1965, CLIN RES, V13, P124; FORBES AP, 1963, METABOLISM, V12, P428; FULTHORPE A, 1961, J CLIN PATHOL, V14, P654, DOI 10.1136/jcp.14.6.654; GRELL PGH, 1962, CLINICAL ASPECTS  ED, P630; GRUMBACH MM, 1964, J PEDIATR-US, V65, P1087, DOI 10.1016/S0022-3476(64)80078-0; HALL R, 1962, LANCET, V2, P1291; HALL R, 1960, LANCET, V2, P187; HARRIS H, 1965, NATURE, V205, P640, DOI 10.1038/205640a0; HILL OW, 1961, BRIT MED J, V1, P1793, DOI 10.1136/bmj.1.5242.1793; JACKSON JF, 1963, SCIENCE, V141, P424, DOI 10.1126/science.141.3579.424; LANDING BH, 1963, J CLIN ENDOCR METAB, V23, P119, DOI 10.1210/jcem-23-1-119; MASI AT, 1965, J CHRON DIS, V18, P1, DOI 10.1016/0021-9681(65)90050-0; MASI AT, 1965, J CHRON DIS, V18, P35, DOI 10.1016/0021-9681(65)90052-4; MELLON JP, 1963, J MENT DEFIC RES, V7, P31; MERTZ T, 1965, AUG ANN M AM SOC HUM; MOORE J M, 1963, Lancet, V2, P645; MYERS CR, 1938, P AMER ASSOC MENT DE, V62, P142; OHNO S, 1965, ISOANTIGENS CELL INT, P70; OWEN SG, 1958, LANCET, V2, P1034; PLUNKETT ER, 1964, J MENT DEFIC RES, V8, P25; ROBINSON A, 1965, SCIENCE, V148, P83, DOI 10.1126/science.148.3666.83; ROITT IM, 1956, LANCET, V2, P820; SAKSELA E, 1963, P NATL ACAD SCI USA, V50, P390, DOI 10.1073/pnas.50.2.390; SPARKES RS, 1963, LANCET, V1, P947; STOLLER A, 1965, Med J Aust, V1, P1; WILLIAMS ED, 1964, NEW ENGL J MED, V270, P805, DOI 10.1056/NEJM196404162701601; WITEBSKY E, 1956, J IMMUNOL, V76, P408; 1964, LANCET, V2, P511	50	93	93	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1966	18	1					93	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	72413	4221444				2022-12-18	WOS:A19667241300010
J	WEITKAMP, LR; RUCKNAGEL, DL; GERSHOWITZ, H				WEITKAMP, LR; RUCKNAGEL, DL; GERSHOWITZ, H			GENETIC LINKAGE BETWEEN STRUCTURAL LOCI FOR ALBUMIN AND GROUP SPECIFIC COMPONENT (GC)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ADAMS MORTON S., 1966, J MED GENET, V3, P198, DOI 10.1136/jmg.3.3.198; BOWMAN BH, 1965, P NATL ACAD SCI USA, V53, P722, DOI 10.1073/pnas.53.4.722; BOYER SH, 1963, AM J HUM GENET, V15, P438; BRAEND M, 1965, HEREDITAS-GENETISK A, V53, P137; Ceppellini R., 1959, CIBA F S BIOCHEMISTR, P133; CHALMERS JNM, 1953, ANN EUGENIC, V17, P267; COOKE KB, 1961, BIOCHEM J, V81, pP39; DRACHMANN O, 1965, Dan Med Bull, V12, P74; ELHEFNAWI H, 1965, ANN HUM GENET, V28, P273; GAHNE B, 1963, HEREDITAS, V50, P126; HALDANE JBS, 1947, ANN EUGENIC, V14, P10, DOI 10.1111/j.1469-1809.1947.tb02374.x; HIRSCHFELD J, 1962, PROG ALLERGY, V6, P155, DOI 10.1159/000313799; HIRSCHFELD J, 1959, ACTA PATHOL MIC SC, V46, P220; HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; HOSLI P, 1957, ACTA GENET BASEL, V7, P70; KNEDEL M, 1957, Blut, V3, P129, DOI 10.1007/BF01630687; MOHR J, 1951, ACTA PATHOL MIC SC, V28, P207; MOHR J, 1963, ACTA GENET STAT MED, V13, P328; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1955, AM J HUM GENET, V7, P277; NEEL JV, 1961, BLOOD, V18, P769, DOI 10.1182/blood.V18.6.769.769; NENNSTIEL HJ, 1957, KLIN WOCHENSCHR, V35, P689, DOI 10.1007/BF01481274; PEARSON HA, 1965, AM J HUM GENET, V17, P125; RACE RR, 1962, BLOOD GROUPS MAN, P411; RENWICK JH, 1955, ANN HUM GENET, V19, P312, DOI 10.1111/j.1469-1809.1955.tb01356.x; RENWICK JH, 1963, ANN HUM GENET, V27, P67, DOI 10.1111/j.1469-1809.1963.tb00782.x; SANDOR G, 1965, NATURE, V208, P1222, DOI 10.1038/2081222a0; SMITH CAB, 1959, AM J HUM GENET, V11, P289; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; SMITHIES O, 1959, BIOCHEM J, V71, P585, DOI 10.1042/bj0710585; SPENCER N, 1964, NATURE, V204, P742, DOI 10.1038/204742a0; UNGARI S, 1965, Minerva Pediatr, V17, P288; WOLSTENHOLME GEW, 1959, CIBA F S BIOCHEMI ED, P133	33	93	93	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1966	18	6					559	+						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	86655	5927876				2022-12-18	WOS:A19668665500006
J	Tiwari, V; Wilson, DM				Tiwari, Vinod; Wilson, David M., III			DNA Damage and Associated DNA Repair Defects in Disease and Premature Aging	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							NUCLEOTIDE EXCISION-REPAIR; STRAND-BREAK REPAIR; RNA-POLYMERASE-II; TRANSCRIPTION-COUPLED REPAIR; XERODERMA-PIGMENTOSUM; COCKAYNE-SYNDROME; MISMATCH-REPAIR; PROTEIN COMPLEX; INDUCED UBIQUITYLATION; ATAXIA-TELANGIECTASIA	Genetic information is constantly being attacked by intrinsic and extrinsic damaging agents, such as reactive oxygen species, atmospheric radiation, environmental chemicals, and chemotherapeutics. If DNA modifications persist, they can adversely affect the polymerization of DNA or RNA, leading to replication fork collapse or transcription arrest, or can serve as mutagenic templates during nucleic acid synthesis reactions. To combat the deleterious consequences of DNA damage, organisms have developed complex repair networks that remove chemical modifications or aberrant base arrangements and restore the genome to its original state. Not surprisingly, inherited or sporadic defects in DNA repair mechanisms can give rise to cellular outcomes that underlie disease and aging, such as transformation, apoptosis, and senescence. In the review here, we discuss several genetic disorders linked to DNA repair defects, attempting to draw correlations between the nature of the accumulating DNA damage and the pathological endpoints, namely cancer, neurological disease, and premature aging.	[Tiwari, Vinod; Wilson, David M., III] NIA, Lab Mol Gerontol, Intramural Res Program, NIH, 251 Bayview Blvd,Suite 100, Baltimore, MD 21224 USA; [Wilson, David M., III] Hasselt Univ, Biomed Res Inst, B-3590 Diepenbeek, Belgium	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Hasselt University	Tiwari, V; Wilson, DM (corresponding author), NIA, Lab Mol Gerontol, Intramural Res Program, NIH, 251 Bayview Blvd,Suite 100, Baltimore, MD 21224 USA.; Wilson, DM (corresponding author), Hasselt Univ, Biomed Res Inst, B-3590 Diepenbeek, Belgium.	vinod.tiwari@nih.gov; dmwilson3@outlook.com	Tiwari, Vinod/ABD-5836-2021; Wilson, David M/AAK-5409-2021	Tiwari, Vinod/0000-0003-2341-0953; Wilson, David M/0000-0002-8945-0395	Intramural Research Program of the NIH, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000751] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Drs. Beverly Baptiste and Anthony Moore (NIA) for their helpful comments on the article. This research was supported by the Intramural Research Program of the NIH, National Institute on Aging.	Abbotts R, 2017, FREE RADICAL BIO MED, V107, P228, DOI 10.1016/j.freeradbiomed.2016.11.039; Abedalthagafi Malak, 2018, Oncotarget, V9, P35458, DOI 10.18632/oncotarget.26249; Abeti R, 2019, BRIT J PHARMACOL, V176, P4293, DOI 10.1111/bph.14557; Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Alnajjar KS, 2017, BIOCHEMISTRY-US, V56, P5449, DOI 10.1021/acs.biochem.7b00713; Andres SN, 2015, ENVIRON MOL MUTAGEN, V56, P1, DOI 10.1002/em.21892; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Barbari SR, 2017, DNA REPAIR, V56, P16, DOI 10.1016/j.dnarep.2017.06.003; Barnes JL, 2018, BIOCHEM SOC T, V46, P1213, DOI 10.1042/BST20180519; Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; Beard WA, 2014, BIOCHEMISTRY-US, V53, P2768, DOI 10.1021/bi500139h; Bebenek A, 2018, CURR GENET, V64, P985, DOI 10.1007/s00294-018-0820-1; Bennett D, 2008, ADV EXP MED BIOL, V637, P57; Boetefuer EL, 2018, NUCLEIC ACIDS RES, V46, P7471, DOI 10.1093/nar/gky660; Brenerman BM, 2014, CARCINOGENESIS, V35, P2643, DOI 10.1093/carcin/bgu225; Brooks PJ, 2017, FREE RADICAL BIO MED, V107, P90, DOI 10.1016/j.freeradbiomed.2016.12.028; Bunting SF, 2013, NAT REV CANCER, V13, P443, DOI 10.1038/nrc3537; Cadet J, 2018, PHOTOCH PHOTOBIO SCI, V17, P1816, DOI 10.1039/c7pp00395a; Cadet J, 2017, FREE RADICAL BIO MED, V107, P13, DOI 10.1016/j.freeradbiomed.2016.12.049; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 2003, CELL, V112, P7, DOI 10.1016/S0092-8674(02)01247-3; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Catalano MJ, 2015, J AM CHEM SOC, V137, P3933, DOI 10.1021/jacs.5b00669; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chatterjee N, 2017, ENVIRON MOL MUTAGEN, V58, P235, DOI 10.1002/em.22087; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; Cheung-Ong K, 2013, CHEM BIOL, V20, P648, DOI 10.1016/j.chembiol.2013.04.007; Chiou YY, 2018, J BIOL CHEM, V293, P2476, DOI 10.1074/jbc.RA117.000971; Chistiakov DA, 2010, ADV EXP MED BIOL, V685, P175; CLEAVER JE, 1968, NATURE, V218, P652, DOI 10.1038/218652a0; Clouaire T, 2017, DNA REPAIR, V56, P84, DOI 10.1016/j.dnarep.2017.06.010; Coin F, 2006, MOL CELL, V21, P215, DOI 10.1016/j.molcel.2005.10.024; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Compe E, 2012, NAT REV MOL CELL BIO, V13, P343, DOI 10.1038/nrm3350; Cunningham JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04026; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Dehe PM, 2017, NAT REV MOL CELL BIO, V18, P315, DOI 10.1038/nrm.2016.177; Delgado JL, 2018, BIOCHEM J, V475, P373, DOI 10.1042/BCJ20160583; Difilippantonio MJ, 2000, NATURE, V404, P510, DOI 10.1038/35006670; DiGiovanna JJ, 2012, J INVEST DERMATOL, V132, P785, DOI 10.1038/jid.2011.426; Dizdaroglu M, 2017, MUTAT RES-REV MUTAT, V771, P99, DOI 10.1016/j.mrrev.2017.02.001; Dizdaroglu M, 2012, FREE RADICAL RES, V46, P382, DOI 10.3109/10715762.2011.653969; Dubaele S, 2003, MOL CELL, V11, P1635, DOI 10.1016/S1097-2765(03)00182-5; Dumitrache LC, 2017, MECH AGEING DEV, V161, P121, DOI 10.1016/j.mad.2016.04.009; Duraturo F, 2019, ONCOL LETT, V17, P3048, DOI 10.3892/ol.2019.9945; Eljack ND, 2014, METALLOMICS, V6, P2126, DOI 10.1039/c4mt00238e; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Ferri D, 2020, CLIN GENET, V97, P12, DOI 10.1111/cge.13545; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Fishel R, 2015, J BIOL CHEM, V290, P26395, DOI 10.1074/jbc.R115.660142; Fleming AM, 2017, DNA REPAIR, V56, P75, DOI 10.1016/j.dnarep.2017.06.009; Foray N, 2016, MUTAT RES-REV MUTAT, V770, P369, DOI 10.1016/j.mrrev.2016.09.001; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Goellner EM, 2014, MOL CELL, V55, P291, DOI 10.1016/j.molcel.2014.04.034; Gonzalo S, 2017, AGEING RES REV, V33, P18, DOI 10.1016/j.arr.2016.06.007; Harhouri K, 2018, NUCLEUS-PHILA, V9, P246, DOI 10.1080/19491034.2018.1460045; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; HUANG JC, 1994, P NATL ACAD SCI USA, V91, P12213, DOI 10.1073/pnas.91.25.12213; Illuzzi JL, 2017, ENVIRON MOL MUTAGEN, V58, P84, DOI 10.1002/em.22074; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Iyama T, 2015, NUCLEIC ACIDS RES, V43, P247, DOI 10.1093/nar/gku1279; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jaruga P, 2008, DNA REPAIR, V7, P1413, DOI 10.1016/j.dnarep.2008.06.005; Jasin M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012740; Jaul E, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00335; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Karikkineth AC, 2017, AGEING RES REV, V33, P3, DOI 10.1016/j.arr.2016.08.002; Katsuki Y, 2016, ENDOCR-RELAT CANCER, V23, pT19, DOI 10.1530/ERC-16-0221; Kaushal S, 2019, GENE CHROMOSOME CANC, V58, P270, DOI 10.1002/gcc.22721; Kim D, 2018, J MOL BIOL, V430, P4469, DOI 10.1016/j.jmb.2018.05.032; Kolesnikova O, 2019, ADV PROTEIN CHEM STR, V115, P21, DOI 10.1016/bs.apcsb.2019.01.003; Kozack R, 2000, MUTAT RES-FUND MOL M, V450, P41, DOI 10.1016/S0027-5107(00)00015-4; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; KRAEMER KH, 1984, CARCINOGENESIS, V5, P511, DOI 10.1093/carcin/5.4.511; Kresge N, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.O110.000232; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Laugel V, 2013, MECH AGEING DEV, V134, P161, DOI 10.1016/j.mad.2013.02.006; Lehmann J, 2018, ANTICANCER RES, V38, P1159, DOI 10.21873/anticanres.12335; Li MX, 2018, NUCLEIC ACIDS RES, V46, P5664, DOI 10.1093/nar/gky326; Li MX, 2014, ANTIOXID REDOX SIGN, V20, P678, DOI 10.1089/ars.2013.5492; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu DK, 2017, MUTAT RES-REV MUTAT, V773, P174, DOI 10.1016/j.mrrev.2017.07.001; Liu XJ, 2018, ADV EXP MED BIOL, V1044, P49, DOI 10.1007/978-981-13-0593-1_5; LOEB LA, 1986, ANNU REV GENET, V20, P201, DOI 10.1146/annurev.ge.20.120186.001221; Madireddy A, 2017, ADV EXP MED BIOL, V1042, P549, DOI 10.1007/978-981-10-6955-0_23; Marin M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010060; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; Mateos-Gomez PA, 2015, NATURE, V518, P254, DOI 10.1038/nature14157; Mathieu N, 2013, CURR BIOL, V23, P204, DOI 10.1016/j.cub.2012.12.032; Matsuura S, 1998, NAT GENET, V19, P179, DOI 10.1038/549; MCDOWELL ML, 1993, MUTAGENESIS, V8, P155, DOI 10.1093/mutage/8.2.155; McKinnon PJ, 2017, GENE DEV, V31, P1180, DOI 10.1101/gad.301325.117; Menon V, 2016, DNA REPAIR, V43, P57, DOI 10.1016/j.dnarep.2016.05.011; Moor NA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P411, DOI 10.1134/S0006297918040120; Mordukhovich I, 2010, ENVIRON HEALTH PERSP, V118, P511, DOI 10.1289/ehp.0901233; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Morio T, 2017, INT J HEMATOL, V106, P357, DOI 10.1007/s12185-017-2263-8; Moynahan ME, 1997, P NATL ACAD SCI USA, V94, P8988, DOI 10.1073/pnas.94.17.8988; Mu H, 2018, DNA REPAIR, V71, P33, DOI 10.1016/j.dnarep.2018.08.005; Mukherjee S, 2018, INT J MOL SCI, V19, P19; Mullenders LHF, 2018, PHOTOCH PHOTOBIO SCI, V17, P1842, DOI 10.1039/c8pp00182k; Murray JE, 2015, AM J HUM GENET, V96, P412, DOI 10.1016/j.ajhg.2015.01.013; Natale V, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0616-2; Natale V, 2011, AM J MED GENET A, V155A, P1081, DOI 10.1002/ajmg.a.33933; Neil AJ, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201700077; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Nilsen H, 2003, ONCOGENE, V22, P5381, DOI 10.1038/sj.onc.1206860; Niraj J, 2019, ANNU REV CANC BIOL, V3, P457, DOI 10.1146/annurev-cancerbio-030617-050422; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; O'Driscoll M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012773; Oshima J, 2017, AGEING RES REV, V33, P105, DOI 10.1016/j.arr.2016.03.002; Pannunzio NR, 2018, J BIOL CHEM, V293, P10512, DOI 10.1074/jbc.TM117.000374; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Patel DR, 2018, BIOCHEM SOC T, V46, P1643, DOI 10.1042/BST20180308; Pennington KP, 2014, CLIN CANCER RES, V20, P764, DOI 10.1158/1078-0432.CCR-13-2287; Phillips DH, 2012, INT J CANCER, V131, P2733, DOI 10.1002/ijc.27827; Ramus SJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv214; Ranish JA, 2004, NAT GENET, V36, P707, DOI 10.1038/ng1385; Ranjha L, 2018, CHROMOSOMA, V127, P187, DOI 10.1007/s00412-017-0658-1; Rapin I, 2013, HAND CLINIC, V113, P1637, DOI 10.1016/B978-0-444-59565-2.00032-0; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Reisz JA, 2014, ANTIOXID REDOX SIGN, V21, P260, DOI 10.1089/ars.2013.5489; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Richard P, 2017, J MOL BIOL, V429, P3168, DOI 10.1016/j.jmb.2016.08.031; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Rimel JK, 2018, PROTEIN SCI, V27, P1018, DOI 10.1002/pro.3424; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Rogozin IB, 2018, BRIEF BIOINFORM, V19, P1085, DOI 10.1093/bib/bbx049; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; Ryan E, 2017, CRIT REV ONCOL HEMAT, V116, P38, DOI 10.1016/j.critrevonc.2017.05.006; RYDBERG B, 1982, EMBO J, V1, P211, DOI 10.1002/j.1460-2075.1982.tb01149.x; Saada AA, 2018, DNA REPAIR, V71, P135, DOI 10.1016/j.dnarep.2018.08.017; Sallmyr A, 2018, J BIOL CHEM, V293, P10536, DOI 10.1074/jbc.TM117.000375; Santos-Pereira JM, 2015, NAT REV GENET, V16, P583, DOI 10.1038/nrg3961; Saxowsky TT, 2006, CHEM REV, V106, P474, DOI 10.1021/cr040466q; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Senejani AG, 2014, CELL REP, V6, P1, DOI 10.1016/j.celrep.2013.12.017; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Shibutani S, 2001, BIOCHEMISTRY-US, V40, P3717, DOI 10.1021/bi0027581; Shiloh Y, 2017, AGEING RES REV, V33, P76, DOI 10.1016/j.arr.2016.05.002; SHIVJI MKK, 1995, BIOCHEMISTRY-US, V34, P5011, DOI 10.1021/bi00015a012; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Smela ME, 2002, P NATL ACAD SCI USA, V99, P6655, DOI 10.1073/pnas.102167699; Song HL, 2015, J CLIN ONCOL, V33, P2901, DOI 10.1200/JCO.2015.61.2408; Spivak G, 2015, DNA REPAIR, V36, P13, DOI 10.1016/j.dnarep.2015.09.003; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; Sugasawa K, 2016, DNA REPAIR, V44, P110, DOI 10.1016/j.dnarep.2016.05.015; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tapias A, 2004, J BIOL CHEM, V279, P19074, DOI 10.1074/jbc.M312611200; Theil AF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003431; Tiwari V, 2017, FREE RADICAL BIO MED, V108, P564, DOI 10.1016/j.freeradbiomed.2017.04.029; Tran HT, 1999, MOL CELL BIOL, V19, P2000; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Van Wassenhove LD, 2016, MOL GENET METAB, V119, P28, DOI 10.1016/j.ymgme.2016.07.004; Velez-Cruz R, 2013, MECH AGEING DEV, V134, P234, DOI 10.1016/j.mad.2013.03.004; Vlahopoulos S, 2019, PHARMACOL THERAPEUT, V194, P59, DOI 10.1016/j.pharmthera.2018.09.004; Vo AT, 2005, EMBO REP, V6, P438, DOI 10.1038/sj.embor.7400392; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Wang W, 2018, P NATL ACAD SCI USA, V115, pE2538, DOI 10.1073/pnas.1722050115; Weren RDA, 2015, NAT GENET, V47, P668, DOI 10.1038/ng.3287; Williams GJ, 2014, DNA REPAIR, V17, P110, DOI 10.1016/j.dnarep.2014.02.009; Williams JS, 2016, NAT REV MOL CELL BIO, V17, P350, DOI 10.1038/nrm.2016.37; Wilson DM, 2008, MECH AGEING DEV, V129, P349, DOI 10.1016/j.mad.2008.02.013; Wilson MD, 2013, BBA-GENE REGUL MECH, V1829, P151, DOI 10.1016/j.bbagrm.2012.08.002; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Yamtich J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003052; Yokoi M, 2000, J BIOL CHEM, V275, P9870, DOI 10.1074/jbc.275.13.9870; Yoon Grace, 2018, Handb Clin Neurol, V155, P105, DOI 10.1016/B978-0-444-64189-2.00007-X; Zeinalian Mehrdad, 2018, Adv Biomed Res, V7, P28, DOI 10.4103/abr.abr_185_16; Zhang L, 2018, ANNU REV GENET, V52, P397, DOI 10.1146/annurev-genet-120417-031501; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011; Zhu QZ, 2017, PHOTOCHEM PHOTOBIOL, V93, P166, DOI 10.1111/php.12647	198	92	94	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2019	105	2					237	257		10.1016/j.ajhg.2019.06.005	http://dx.doi.org/10.1016/j.ajhg.2019.06.005			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IM5GK	31374202	Green Published, Bronze			2022-12-18	WOS:000478022200002
J	Martinelli, S; Krumbach, OHF; Pantaleoni, F; Coppola, S; Amin, E; Pannone, L; Nouri, K; Farina, L; Dvorsky, R; Lepri, F; Buchholzer, M; Konopatzki, R; Walsh, L; Payne, K; Pierpont, ME; Vergano, SS; Langley, KG; Larsen, D; Farwell, KD; Tang, S; Mroske, C; Gallotta, I; Di Schiavi, E; Della Monica, M; Lugli, L; Rossi, C; Seri, M; Cocchi, G; Henderson, L; Baskin, B; Alders, M; Mendoza-Londono, R; Dupuis, L; Nickerson, DA; Chong, JX; Meeks, N; Brown, K; Causey, T; Cho, MT; Demuth, S; Digilio, MC; Gelb, BD; Bamshad, MJ; Zenker, M; Ahmadian, MR; Hennekam, RC; Tartaglia, M; Mirzaa, GM				Martinelli, Simone; Krumbach, Oliver H. F.; Pantaleoni, Francesca; Coppola, Simona; Amin, Ehsan; Pannone, Luca; Nouri, Kazem; Farina, Luciapia; Dvorsky, Radovan; Lepri, Francesca; Buchholzer, Marcel; Konopatzki, Raphael; Walsh, Laurence; Payne, Katelyn; Pierpont, Mary Ella; Vergano, Samantha Schrier; Langley, Katherine G.; Larsen, Douglas; Farwell, Kelly D.; Tang, Sha; Mroske, Cameron; Gallotta, Ivan; Di Schiavi, Elia; Della Monica, Matteo; Lugli, Licia; Rossi, Cesare; Seri, Marco; Cocchi, Guido; Henderson, Lindsay; Baskin, Berivan; Alders, Marielle; Mendoza-Londono, Roberto; Dupuis, Lucie; Nickerson, Deborah A.; Chong, Jessica X.; Meeks, Naomi; Brown, Kathleen; Causey, Tahnee; Cho, Megan T.; Demuth, Stephanie; Digilio, Maria Cristina; Gelb, Bruce D.; Bamshad, Michael J.; Zenker, Martin; Ahmadian, Mohammad Reza; Hennekam, Raoul C.; Tartaglia, Marco; Mirzaa, Ghayda M.		Univ Washington Ctr Mendel	Functional Dysregulation of CDC42 Causes Diverse Developmental Phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISEASE GENE DISCOVERY; GTPASE-BINDING DOMAIN; NOONAN SYNDROME; INTELLECTUAL DISABILITY; KRAS MUTATIONS; RAC ACTIVATION; RHO-GTPASES; IN-VIVO; VARIANTS; DISORDERS	Exome sequencing has markedly enhanced the discovery of genes implicated in Mendelian disorders, particularly for individuals in whom a known clinical entity could not be assigned. This has led to the recognition that phenotypic heterogeneity resulting from allelic mutations occurs more commonly than previously appreciated. Here, we report that missense variants in CDC42, a gene encoding a small GTPase functioning as an intracellular signaling node, underlie a clinically heterogeneous group of phenotypes characterized by variable growth dysregulation, facial dysmorphism, and neurodevelopmental, immunological, and hematological anomalies, including a phenotype resembling Noonan syndrome, a developmental disorder caused by dysregulated RAS signaling. In silico, in vitro, and in vivo analyses demonstrate that mutations variably perturb CDC42 function by altering the switch between the active and inactive states of the GTPase and/or affecting CDC42 interaction with effectors, and differentially disturb cellular and developmental processes. These findings reveal the remarkably variable impact that dominantly acting CDC42 mutations have on cell function and development, creating challenges in syndrome definition, and exemplify the importance of functional profiling for syndrome recognition and delineation.	[Martinelli, Simone] Ist Super Sanita, Dept Oncol & Mol Med, I-00161 Rome, Italy; [Krumbach, Oliver H. F.; Amin, Ehsan; Nouri, Kazem; Dvorsky, Radovan; Buchholzer, Marcel; Konopatzki, Raphael; Ahmadian, Mohammad Reza] Heinrich Heine Univ, Inst Biochem & Mol Biol 2, Med Fac, D-40225 Dusseldorf, Germany; [Pantaleoni, Francesca; Pannone, Luca; Lepri, Francesca; Digilio, Maria Cristina; Tartaglia, Marco] Osped Pediat Bambino Gesu, IRCCS, Genet & Rare Dis Res Div, I-00146 Rome, Italy; [Coppola, Simona; Farina, Luciapia] Natl Ctr Rare Dis, Ist Super Sanita, I-00161 Rome, Italy; [Walsh, Laurence; Payne, Katelyn] Riley Hosp Children, Indianapolis, IN 46202 USA; [Pierpont, Mary Ella] Univ Minnesota, Dept Pediat, Minneapolis, MN 55454 USA; [Pierpont, Mary Ella] Childrens Hosp Minnesota, Minneapolis, MN 55454 USA; [Vergano, Samantha Schrier] Childrens Hosp Kings Daughters, Div Med Genet & Metab, Norfolk, VA 23507 USA; [Langley, Katherine G.; Henderson, Lindsay; Baskin, Berivan; Cho, Megan T.] GeneDX, Gaithersburg, MD 20877 USA; [Larsen, Douglas] Washington Univ, Dept Neurol, St Louis, MO 63130 USA; [Farwell, Kelly D.; Tang, Sha; Mroske, Cameron] Ambry Genet, Dept Clin Genom, Aliso Viejo, CA 92656 USA; [Gallotta, Ivan; Di Schiavi, Elia] CNR, Inst Biosci & Bioresources, I-80131 Naples, Italy; [Della Monica, Matteo] Azienda Osped Univ Meyer, Genet Med, I-50139 Florence, Italy; [Lugli, Licia] Policlin Modena, Struttura Complessa Neonatol, I-41124 Modena, Italy; [Rossi, Cesare] St Orsola Marcello Malpighi Hosp, Genet Med, I-40138 Bologna, Italy; [Seri, Marco; Cocchi, Guido] Univ Bologna, Dept Med & Surg Sci, I-40138 Bologna, Italy; [Alders, Marielle] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Mendoza-Londono, Roberto; Dupuis, Lucie] Hosp Sick Children, Div Clin & Metab Genet, Toronto, ON M5G 1X8, Canada; [Mendoza-Londono, Roberto] Hosp Sick Children, Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Mendoza-Londono, Roberto] Univ Toronto, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Nickerson, Deborah A.; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Chong, Jessica X.; Bamshad, Michael J.; Mirzaa, Ghayda M.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Meeks, Naomi; Brown, Kathleen] Childrens Hosp Colorado, Aurora, CO 80045 USA; [Causey, Tahnee] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Demuth, Stephanie] Praxis Humangenet Erfurt, D-99084 Erfurt, Germany; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Mindich Child Hlth & Dev Inst, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Genet, New York, NY 10029 USA; [Gelb, Bruce D.] Icahn Sch Med Mt Sinai, Dept Genom Sci, New York, NY 10029 USA; [Zenker, Martin] Univ Hosp Magdeburg, Inst Human Genet, D-39120 Magdeburg, Germany; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Mirzaa, Ghayda M.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Amin, Ehsan] Heinrich Heine Univ, Inst Neural & Sensory Physiol, Med Fac, Dusseldorf, Germany; [Nouri, Kazem] Queens Univ, Richardson Lab, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	Istituto Superiore di Sanita (ISS); Heinrich Heine University Dusseldorf; IRCCS Bambino Gesu; Istituto Superiore di Sanita (ISS); James Whitcomb Riley Hospital Children; University of Minnesota System; University of Minnesota Twin Cities; Children's Hospitals & Clinics of Minnesota; Washington University (WUSTL); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); University of Florence; Azienda Ospedaliera Universitaria (AOU) MEYER; Universita di Modena e Reggio Emilia; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Children's Hospital Colorado; Virginia Commonwealth University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University Hospital Magdeburg; University of Amsterdam; Academic Medical Center Amsterdam; Seattle Children's Hospital; Heinrich Heine University Dusseldorf; McMaster University; Queens University - Canada	Tartaglia, M (corresponding author), Osped Pediat Bambino Gesu, IRCCS, Genet & Rare Dis Res Div, I-00146 Rome, Italy.; Mirzaa, GM (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Mirzaa, GM (corresponding author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA.	marco.tartaglia@opbg.net; gmirzaa@u.washington.edu	Walsh, Laurence J/F-1210-2010; Lepri, Francesca Romana/AAA-6115-2020; Martinelli, Simone/J-9432-2018; Larsen, Douglas/M-4691-2019; Lugli, Licia/AAW-4289-2021; Gallotta, Ivan/ABB-4674-2020; Dvorsky, Radovan/ABE-3042-2020; Digilio, Maria Cristina/AAI-2434-2019; Coppola, Simona/A-6638-2015; Tartaglia, Marco/K-2955-2018; Chong, Jessica/GZH-1625-2022; PANNONE, LUCA/AAC-1528-2021; Walsh, Laurence/AAH-2876-2020; Farina, Luciapia/AAA-5340-2020; Rossi, Cesare/AAC-2083-2022; Amin, Ehsan/GPC-5382-2022; Di Schiavi, Elia/B-8046-2015; Hagman, Kelly/A-4707-2010	Walsh, Laurence J/0000-0001-5874-5687; Martinelli, Simone/0000-0002-5843-419X; Lugli, Licia/0000-0002-2149-0083; Coppola, Simona/0000-0001-7851-9409; Tartaglia, Marco/0000-0001-7736-9672; PANNONE, LUCA/0000-0001-7027-8196; Walsh, Laurence/0000-0001-5874-5687; Farina, Luciapia/0000-0002-8304-541X; Rossi, Cesare/0000-0003-1826-615X; Di Schiavi, Elia/0000-0002-8179-6666; Nouri, Kazem/0000-0001-7787-1304; Walsh, Laurence/0000-0003-4623-1317; Buchholzer, Marcel/0000-0001-7485-6918; Hagman, Kelly/0000-0003-1173-052X; Amin, Ehsan/0000-0003-2995-8864; Blue, Elizabeth/0000-0002-0633-0305; Della Monica, Matteo/0000-0001-8338-7949; Chong, Jessica/0000-0002-1616-2448	National Institute of Neurological Disorders and Stroke (NINDS) [K08NS092898]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG17583]; Fondazione Bambino Gesu; Italian Ministry of Health [RF-2011-02349938]; Italian Ministry of Health (Ricerca Corrente); E-Rare (NSEuroNet); International Research Training Group Intra- and Interorgan Communication of the Cardiovascular System [IRTG 1902, 1902]; Medical Faculty of the Heinrich-Heine University Duesseldorf [9772617]; National Human Genome Research Institute; National Heart, Lung, and Blood Institute grant [HG006493]; Pediatric Cardiac Genomics Consortium from the National Heart, Lung, and Blood Institute [U01HL131003, UM1HL098147, UM1HL098123, UM1HL128761, UM1HL128711, UM1HL098162]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL098147, U01HL131003, UM1HL128711, UM1HL128761, UM1HL098123, UM1HL098162] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006493, U54HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS092898] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Bambino Gesu; Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Health (Ricerca Corrente)(Ministry of Health, Italy); E-Rare (NSEuroNet); International Research Training Group Intra- and Interorgan Communication of the Cardiovascular System; Medical Faculty of the Heinrich-Heine University Duesseldorf; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pediatric Cardiac Genomics Consortium from the National Heart, Lung, and Blood Institute; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the families and referring physicians for their participation in this study. We thank Dr. David Wilson (Washington University, St. Louis) for providing clinical expertise and Dr. Serenella Venanzi (Istituto Superiore di Sanita, Rome) for technical assistance. This project was supported by the National Institute of Neurological Disorders and Stroke (NINDS) (K08NS092898 to G.M.M.), the Associazione Italiana per la Ricerca sul Cancro (AIRC) (IG17583 to M.T.), Fondazione Bambino Gesu (Vite Coraggiose to M.T.), Italian Ministry of Health (RF-2011-02349938 and Ricerca Corrente 2017 to M.T.), E-Rare (NSEuroNet to M.Z., M.R.A., and M.T.), International Research Training Group 1902 Intra- and Interorgan Communication of the Cardiovascular System (IRTG 1902 to E.A., M.B., and M.R.A.), and Medical Faculty of the Heinrich-Heine University Duesseldorf (9772617 to K.N., O.H. F.K., R.K., and M.R.A.). Exome sequencing was performed at the University of Washington Center for Mendelian Genomics (UW-CMG) and was funded by the National Human Genome Research Institute and the National Heart, Lung, and Blood Institute grant HG006493 (to D.A.N. and M.J.B.). This work was also supported by grants U01HL131003, UM1HL098147, UM1HL098123, UM1HL128761, UM1HL128711, and UM1HL098162 in support of the Pediatric Cardiac Genomics Consortium from the National Heart, Lung, and Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development. C. elegans strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We also thank WormBase, the contributors to MyGene2, and the University of Washington Center for Mendelian Genomics for use of data.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Aoki Y, 2013, AM J HUM GENET, V93, P173, DOI 10.1016/j.ajhg.2013.05.021; Arias-Romero LE, 2013, EXPERT OPIN THER TAR, V17, P1263, DOI 10.1517/14728222.2013.828037; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Beaty BT, 2014, EUR J CELL BIOL, V93, P438, DOI 10.1016/j.ejcb.2014.07.003; Chang MT, 2016, NAT BIOTECHNOL, V34, P155, DOI 10.1038/nbt.3391; Choi MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011885; Chong JX, 2016, GENET MED, V18, P788, DOI 10.1038/gim.2015.161; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cordeddu V, 2009, NAT GENET, V41, P1022, DOI 10.1038/ng.425; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Dvorsky R, 2004, EMBO REP, V5, P1130, DOI 10.1038/sj.embor.7400293; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Flex E, 2014, HUM MOL GENET, V23, P4315, DOI 10.1093/hmg/ddu148; Gizachew D, 2000, BIOCHEMISTRY-US, V39, P3963, DOI 10.1021/bi992646d; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gripp KW, 2010, AM J MED GENET A, V152A, P1161, DOI 10.1002/ajmg.a.33391; Hagman KDF, 2017, GENET MED, V19, P224, DOI 10.1038/gim.2016.95; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hemsath L, 2005, METHODS, V37, P173, DOI 10.1016/j.ymeth.2005.05.014; Hemsath L, 2005, MOL CELL, V20, P313, DOI 10.1016/j.molcel.2005.08.036; Holly SP, 2005, MOL BIOL CELL, V16, P2458, DOI 10.1091/mbc.E03-12-0917; Homsy J, 2015, SCIENCE, V350, P1262, DOI 10.1126/science.aac9396; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Janakiraman M, 2010, CANCER RES, V70, P5901, DOI 10.1158/0008-5472.CAN-10-0192; Kaduwal S, 2015, ONCOTARGET, V6, P33091, DOI 10.18632/oncotarget.5173; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kuhn S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8088; Lee CS, 2017, AM J HUM GENET, V101, P815, DOI 10.1016/j.ajhg.2017.09.019; Lohmer LL, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005786; Martinelli S, 2008, HUM MOL GENET, V17, P2018, DOI 10.1093/hmg/ddn099; Melendez J, 2013, GASTROENTEROLOGY, V145, P808, DOI 10.1053/j.gastro.2013.06.021; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Menke LA, 2016, AM J MED GENET A, V170, P2681, DOI 10.1002/ajmg.a.37800; Morreale A, 2000, NAT STRUCT BIOL, V7, P384; Niceta M, 2015, AM J HUM GENET, V96, P816, DOI 10.1016/j.ajhg.2015.03.001; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Pedersen E, 2012, EXP CELL RES, V318, P1779, DOI 10.1016/j.yexcr.2012.05.004; Philippakis AA, 2015, HUM MUTAT, V36, P915, DOI 10.1002/humu.22858; Pirone DM, 2001, TRENDS GENET, V17, P370, DOI 10.1016/S0168-9525(01)02311-3; Reijnders MRF, 2017, AM J HUM GENET, V101, P466, DOI 10.1016/j.ajhg.2017.08.007; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Roberts AE, 2013, LANCET, V381, P333, DOI 10.1016/S0140-6736(12)61023-X; Schmid T, 2015, CURR OPIN GENET DEV, V32, P1, DOI 10.1016/j.gde.2015.01.006; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Takenouchi T, 2016, AM J MED GENET A, V170, P852, DOI 10.1002/ajmg.a.37526; Takenouchi T, 2015, AM J MED GENET A, V167, P2822, DOI 10.1002/ajmg.a.37275; Tanaka AJ, 2015, AM J HUM GENET, V97, P457, DOI 10.1016/j.ajhg.2015.07.014; Tartaglia M, 2010, ANN NY ACAD SCI, V1214, P99, DOI 10.1111/j.1749-6632.2010.05790.x; Welchman DP, 2007, DEV BIOL, V305, P347, DOI 10.1016/j.ydbio.2007.02.022; Yamamoto GL, 2015, J MED GENET, V52, P413, DOI 10.1136/jmedgenet-2015-103018; Zegers Mirjam M, 2014, Small GTPases, V5, pe28997, DOI 10.4161/sgtp.28997	54	92	92	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 1	2018	102	2					309	320		10.1016/j.ajhg.2017.12.015	http://dx.doi.org/10.1016/j.ajhg.2017.12.015			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FV2OL	29394990	Green Published, Bronze			2022-12-18	WOS:000424407600009
J	Prudente, S; Jungtrakoon, P; Marucci, A; Ludovico, O; Buranasupkajorn, P; Mazza, T; Hastings, T; Milano, T; Morini, E; Mercuri, L; Bailetti, D; Mendonca, C; Alberico, F; Basile, G; Romani, M; Miccinilli, E; Pizzuti, A; Carella, M; Barbetti, F; Pascarella, S; Marchetti, P; Trischitta, V; Di Paola, R; Doria, A				Prudente, Sabrina; Jungtrakoon, Prapaporn; Marucci, Antonella; Ludovico, Ornella; Buranasupkajorn, Patinut; Mazza, Tommaso; Hastings, Timothy; Milano, Teresa; Morini, Eleonora; Mercuri, Luana; Bailetti, Diego; Mendonca, Christine; Alberico, Federica; Basile, Giorgio; Romani, Marta; Miccinilli, Elide; Pizzuti, Antonio; Carella, Massimo; Barbetti, Fabrizio; Pascarella, Stefano; Marchetti, Piero; Trischitta, Vincenzo; Di Paola, Rosa; Doria, Alessandro			Loss-of-Function Mutations in APPL1 in Familial Diabetes Mellitus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSULIN-SECRETION; ENDOPLASMIC-RETICULUM; GLUCOSE-HOMEOSTASIS; MEMBRANE CURVATURE; GENE; INHIBITION; GENERATION; DOMAINS; DISEASE; YOUNG	Diabetes mellitus is a highly heterogeneous disorder encompassing several distinct forms with different clinical manifestations including a wide spectrum of age at onset. Despite many advances, the causal genetic defect remains unknown for many subtypes of the disease, including some of those forms with an apparent Mendelian mode of inheritance. Here we report two loss-of-function mutations (c.1655T>A [p.Leu552*] and c.280G>A [p.Asp94Asnp]) in the gene for the Adaptor Protein, Phosphotyrosine Interaction, PH domain, and leucine zipper containing 1 (APPL1) that were identified by means of whole-exome sequencing in two large families with a high prevalence of diabetes not due to mutations in known genes involved in maturity onset diabetes of the young (MODY). APPL1 binds to AKT2, a key molecule in the insulin signaling pathway, thereby enhancing insulin-induced AKT2 activation and downstream signaling leading to insulin action and secretion. Both mutations cause APPL1 loss of function. The p.Leu552* alteration totally abolishes APPL1 protein expression in HepG2 transfected cells and the p.Asp94Asn alteration causes significant reduction in the enhancement of the insulin-stimulated AKT2 and GSK3 beta phosphorylation that is observed after wild-type APPL1 transfection. These findings-linking APPL1 mutations to familial forms of diabetes-reaffirm the critical role of APPL1 in glucose homeostasis.	[Prudente, Sabrina; Mazza, Tommaso; Mercuri, Luana; Bailetti, Diego; Alberico, Federica; Basile, Giorgio; Romani, Marta; Miccinilli, Elide; Pizzuti, Antonio; Trischitta, Vincenzo] IRCCS Casa Sollievo Sofferenza, Mendel Lab, I-71013 San Giovanni Rotondo, Italy; [Jungtrakoon, Prapaporn; Buranasupkajorn, Patinut; Hastings, Timothy; Mendonca, Christine; Doria, Alessandro] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Jungtrakoon, Prapaporn; Buranasupkajorn, Patinut; Doria, Alessandro] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Marucci, Antonella; Ludovico, Ornella; Morini, Eleonora; Trischitta, Vincenzo; Di Paola, Rosa] IRCCS Casa Sollievo Sofferenza, Res Unit Diabet & Endocrine Dis, I-71013 San Giovanni Rotondo, Italy; [Milano, Teresa; Pascarella, Stefano] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Bailetti, Diego; Basile, Giorgio; Pizzuti, Antonio; Trischitta, Vincenzo] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; [Carella, Massimo] IRCCS Casa Sollievo Sofferenza, Unit Med Genet, I-71013 San Giovanni Rotondo, Italy; [Barbetti, Fabrizio] Bambino Gesu Pediat Hosp, Lab Mendelian Diabet, I-00165 Rome, Italy; [Barbetti, Fabrizio] Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00133 Rome, Italy; [Marchetti, Piero] Univ Pisa, Dept Clin & Expt Med, I-56127 Pisa, Italy	IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome; Sapienza University Rome; IRCCS Casa Sollievo Della Sofferenza; IRCCS Bambino Gesu; University of Rome Tor Vergata; University of Pisa	Prudente, S (corresponding author), IRCCS Casa Sollievo Sofferenza, Mendel Lab, I-71013 San Giovanni Rotondo, Italy.	s.prudente@css-mendel.it; alessandro.doria@joslin.harvard.edu	Prudente, Sabrina/H-2886-2016; Alberico, Federica/AAI-8090-2021; Mazza, Tommaso/H-6414-2016; Mazza, Tommaso/I-4531-2019; marucci, antonella/B-8722-2017; Barbetti, Fabrizio/AAK-9106-2021; Alberico, Federica/AHC-7099-2022; Doria, Alessandro/H-9157-2018; BAILETTI, DIEGO/AHH-4403-2022; Marchetti, Piero/J-7439-2013; Barbetti, Fabrizio/I-7351-2018; Trischitta, Vincenzo/K-1487-2016; Di Paola, Rosa/G-7813-2011; Basile, Giorgio/AAD-2202-2022; Carella, Massimo/A-2804-2014	Prudente, Sabrina/0000-0001-9220-8981; Alberico, Federica/0000-0001-5287-2677; Mazza, Tommaso/0000-0003-0434-8533; Mazza, Tommaso/0000-0003-0434-8533; marucci, antonella/0000-0001-8131-8317; Barbetti, Fabrizio/0000-0003-4687-980X; Alberico, Federica/0000-0001-5287-2677; Doria, Alessandro/0000-0002-3830-4304; BAILETTI, DIEGO/0000-0001-7414-2448; Marchetti, Piero/0000-0003-4907-0635; Barbetti, Fabrizio/0000-0003-4687-980X; Trischitta, Vincenzo/0000-0003-1174-127X; Di Paola, Rosa/0000-0001-5837-9111; Basile, Giorgio/0000-0001-9900-4922; Jungtrakoon Thamtarana, Prapaporn/0000-0002-2637-6618; Carella, Massimo/0000-0002-6830-6829; PIZZUTI, Antonio/0000-0003-3245-1925	Italian Society of Diabetology (SID) [FO.RI.SID 2011]; NIH [R01DK55523, P30 DK036836]; Italian Ministry of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK055523] Funding Source: NIH RePORTER	Italian Society of Diabetology (SID); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian Ministry of Health(Ministry of Health, Italy); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We wish to thank the subjects and families involved in the study. This work was supported by the Italian Society of Diabetology (SID) (grant FO.RI.SID 2011 to S. Prudente), NIH (grant R01DK55523 to A.D. and P30 DK036836 to the Joslin Diabetes Research Center [Advanced Genomics and Genetics Core]), and the Italian Ministry of Health (Ricerca Corrente 2014 and 2015 to S. Prudente, R.D.P., and V.T.).	[Anonymous], 2014, EST DIAB ITS BURD US; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bonnefond A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037423; Castellana S, 2013, BRIEF BIOINFORM, V14, P684, DOI 10.1093/bib/bbs048; Castellana S, 2013, BRIEF BIOINFORM, V14, P448, DOI 10.1093/bib/bbt013; Cheng KKY, 2009, CELL METAB, V9, P417, DOI 10.1016/j.cmet.2009.03.013; Chial HJ, 2008, TRAFFIC, V9, P215, DOI 10.1111/j.1600-0854.2007.00680.x; Chial HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012471; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Deepa SS, 2009, AM J PHYSIOL-ENDOC M, V296, pE22, DOI 10.1152/ajpendo.90731.2008; Doria A, 1999, DIABETES CARE, V22, P253, DOI 10.2337/diacare.22.2.253; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Fajans SS, 2011, DIABETES CARE, V34, P1878, DOI 10.2337/dc11-0035; Han WP, 2012, P NATL ACAD SCI USA, V109, P8795, DOI 10.1073/pnas.1206730109; Kim SH, 2001, J CLIN ENDOCR METAB, V86, P2320, DOI 10.1210/jc.86.5.2320; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li J, 2007, STRUCTURE, V15, P525, DOI 10.1016/j.str.2007.03.011; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Masuda M, 2010, SEMIN CELL DEV BIOL, V21, P391, DOI 10.1016/j.semcdb.2010.01.010; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Mitsuuchi Y, 1999, ONCOGENE, V18, P4891, DOI 10.1038/sj.onc.1203080; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Prudente S, 2013, J CLIN ENDOCR METAB, V98, pE1143, DOI 10.1210/jc.2012-4282; Prudente S, 2012, ENDOCR REV, V33, P526, DOI 10.1210/er.2011-1042; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Ryu JY, 2014, CELL REP, V7, P1227, DOI 10.1016/j.celrep.2014.04.006; Saito T, 2007, J BIOL CHEM, V282, P32280, DOI 10.1074/jbc.M704150200; Schwitzgebel VM, 2014, J DIABETES INVEST, V5, P121, DOI 10.1111/jdi.12197; Suetsugu S, 2010, SEMIN CELL DEV BIOL, V21, P340, DOI 10.1016/j.semcdb.2009.12.002; Vaxillaire M, 2008, ENDOCR REV, V29, P254, DOI 10.1210/er.2007-0024; Wang C, 2013, DIABETOLOGIA, V56, P1999, DOI 10.1007/s00125-013-2971-4; Wu TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093060	35	92	100	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 2	2015	97	1					177	185		10.1016/j.ajhg.2015.05.011	http://dx.doi.org/10.1016/j.ajhg.2015.05.011			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CN1OO	26073777	Bronze, Green Published			2022-12-18	WOS:000358189500016
J	Foll, M; Gaggiotti, OE; Daub, JT; Vatsiou, A; Excoffier, L				Foll, Matthieu; Gaggiotti, Oscar E.; Daub, Josephine T.; Vatsiou, Alexandra; Excoffier, Laurent			Widespread Signals of Convergent Adaptation to High Altitude in Asia and America	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FALSE DISCOVERY RATE; POSITIVE SELECTION; GENOMIC DIFFERENTIATION; POPULATION-STRUCTURE; GENETIC ADAPTATION; TIBETAN; SIGNATURES; HYPOXIA; SCAN; LOCI	Living at high altitude is one of the most difficult challenges that humans had to cope with during their evolution. Whereas several genomic studies have revealed some of the genetic bases of adaptations in Tibetan, Andean, and Ethiopian populations, relatively little evidence of convergent evolution to altitude in different continents has accumulated. This lack of evidence can be due to truly different evolutionary responses, but it can also be due to the low power of former studies that have mainly focused on populations from a single geographical region or performed separate analyses on multiple pairs of populations to avoid problems linked to shared histories between some populations. We introduce here a hierarchical Bayesian method to detect local adaptation that can deal with complex demographic histories. Our method can identify selection occurring at different scales, as well as convergent adaptation in different regions. We apply our approach to the analysis of a large SNP data set from low- and high-altitude human populations from America and Asia. The simultaneous analysis of these two geographic areas allows us to identify several candidate genome regions for altitudinal selection, and we show that convergent evolution among continents has been quite common. In addition to identifying several genes and biological processes involved in high-altitude adaptation, we identify two specific biological pathways that could have evolved in both continents to counter toxic effects induced by hypoxia.	[Foll, Matthieu; Daub, Josephine T.; Excoffier, Laurent] Univ Bern, Inst Ecol & Evolut, CMPG, CH-3012 Bern, Switzerland; [Foll, Matthieu; Daub, Josephine T.; Excoffier, Laurent] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Gaggiotti, Oscar E.] Univ St Andrews, Scottish Oceans Inst, Sch Biol, St Andrews KY16 8LB, Fife, Scotland; [Gaggiotti, Oscar E.; Vatsiou, Alexandra] Univ Grenoble, CNRS, UMR 5553, Lab Ecol Alpine LECA, Grenoble, France	University of Bern; Swiss Institute of Bioinformatics; University of St Andrews; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Foll, M (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	matthieu.foll@epfl.ch	Excoffier, Laurent/D-3498-2013; Gaggiotti, Oscar E/G-2459-2010; Foll, Matthieu/A-8561-2014; Daub, Josephine/H-8488-2015	Excoffier, Laurent/0000-0002-7507-6494; Gaggiotti, Oscar E/0000-0003-1827-1493; Foll, Matthieu/0000-0001-9006-8436; Daub, Josephine/0000-0003-1424-6602	Swiss National Science Foundation [3100A0-126074, 31003A-143393, CRSII3_141940]; French ANR [09-GENM-017-001]; Marine Alliance for Science and Technology for Scotland (MASTS)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); French ANR(French National Research Agency (ANR)); Marine Alliance for Science and Technology for Scotland (MASTS)	We thank Abigail Bigham for making the genetic data analyzed here available. This work has been made possible by Swiss National Science Foundation grants No. 3100A0-126074, 31003A-143393, and CRSII3_141940 to L.E. O.E.G. was supported by French ANR grant No 09-GENM-017-001 and by the Marine Alliance for Science and Technology for Scotland (MASTS). The program BayeScan3 used to analyze the data is available from M.F. upon request.	Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; Alkorta-Aranburu G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003110; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banasiak KJ, 2000, PROG NEUROBIOL, V62, P215, DOI 10.1016/S0301-0082(00)00011-3; Beall CM, 2006, INTEGR COMP BIOL, V46, P18, DOI 10.1093/icb/icj004; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Begum F, 2012, NUCLEIC ACIDS RES, V40, P3777, DOI 10.1093/nar/gkr1255; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatnagar A, 2003, CIRC RES, V92, P821, DOI 10.1161/01.RES.0000071524.93731.34; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham AW, 2013, AM J HUM BIOL, V25, P190, DOI 10.1002/ajhb.22358; Bigham Abigail W., 2009, Human Genomics, V4, P79; Bradbury IR, 2010, P ROY SOC B-BIOL SCI, V277, P3725, DOI 10.1098/rspb.2010.0985; Campbell D, 2004, MOL BIOL EVOL, V21, P945, DOI 10.1093/molbev/msh101; Conte GL, 2012, P ROY SOC B-BIOL SCI, V279, P5039, DOI 10.1098/rspb.2012.2146; Crisci JL, 2012, J HERED, V103, P287, DOI 10.1093/jhered/esr128; Daub JT, 2013, MOL BIOL EVOL, V30, P1544, DOI 10.1093/molbev/mst080; Egan SP, 2008, EVOLUTION, V62, P1162, DOI 10.1111/j.1558-5646.2008.00352.x; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Fang XX, 2013, CELL MOL NEUROBIOL, V33, P241, DOI 10.1007/s10571-012-9891-6; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Fischer MC, 2011, MOL ECOL, V20, P1450, DOI 10.1111/j.1365-294X.2011.05015.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gaggiotti OE, 2010, MOL ECOL RESOUR, V10, P821, DOI 10.1111/j.1755-0998.2010.02873.x; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Hornbein T.F., 2001, HIGH ALTITUDE EXPLOR; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Huerta-Sanchez E, 2013, MOL BIOL EVOL, V30, P1877, DOI 10.1093/molbev/mst089; Jeong CW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4281; Ji LD, 2012, MOL BIOL EVOL, V29, P3359, DOI 10.1093/molbev/mss144; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Lachance J, 2013, ANNU REV ECOL EVOL S, V44, P123, DOI 10.1146/annurev-ecolsys-110512-135833; Li H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001881; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Liu XY, 2013, AM J HUM GENET, V92, P866, DOI 10.1016/j.ajhg.2013.04.021; Losos JB, 2011, EVOLUTION, V65, P1827, DOI 10.1111/j.1558-5646.2011.01289.x; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Mazzeo RS, 2001, J APPL PHYSIOL, V91, P2143; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Nosil P, 2009, MOL ECOL, V18, P375, DOI 10.1111/j.1365-294X.2008.03946.x; Pagani L, 2012, HUM GENET, V131, P423, DOI 10.1007/s00439-011-1084-8; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Rannala B, 1996, GENET RES, V67, P147, DOI 10.1017/S0016672300033607; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roesti M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-94; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Scheinfeldt LB, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-1-r1; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Scherag A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000916; Simonson TS, 2012, HUM GENET, V131, P527, DOI 10.1007/s00439-011-1109-3; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Tennessen JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002127; Tintle Nathan L, 2009, BMC Proc, V3 Suppl 7, pS96; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wanders RJA, 2011, FEBS J, V278, P182, DOI 10.1111/j.1742-4658.2010.07947.x; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	73	92	92	1	101	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 2	2014	95	4					394	407		10.1016/j.ajhg.2014.09.002	http://dx.doi.org/10.1016/j.ajhg.2014.09.002			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AQ2XW	25262650	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000342654300005
J	Yu, JH; Harrell, TM; Jamal, SM; Tabor, HK; Bamshad, MJ				Yu, Joon-Ho; Harrell, Tanya M.; Jamal, Seema M.; Tabor, Holly K.; Bamshad, Michael J.			Attitudes of Genetics Professionals Toward the Return of Incidental Results from Exome and Whole-Genome Sequencing	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACMG RECOMMENDATIONS; CLINICAL GENOMICS; PERSPECTIVES; VARIANTS; GENES	Professional recommendations for the return of results from exome and whole-genome sequencing (ES/WGS) have been controversial. The lack of clear guidance about whether and, if so, how to return ES/WGS incidental results limits the extent to which individuals and families might benefit from ES/WGS. The perspectives of genetics professionals, particularly those at the forefront of using ES/WGS in clinics, are largely unknown. Data on stakeholder perspectives could help clarify how to weigh expert positions and recommendations. We conducted an online survey of 9,857 genetics professionals to learn their attitudes on the return of incidental results from ES/WGS and the recent American College of Medical Genetic and Genomics Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing. Of the 847 respondents, 760 completed the survey. The overwhelming majority of respondents thought that incidental ES/WGS results should be offered to adult patients (85%), healthy adults (75%), and the parents of a child with a medical condition (74%). The majority thought that incidental results about adult-onset conditions (62%) and carrier status (62%) should be offered to the parents of a child with a medical condition. About half thought that offered results should not be limited to those deemed clinically actionable. The vast majority (81%) thought that individual preferences should guide return. Genetics professionals' perspectives on the return of ES/WGS results differed substantially from current recommendations, underscoring the need to establish clear purpose for recommendations on the return of incidental ES/WGS results as professional societies grapple with developing and updating recommendations.	[Yu, Joon-Ho; Harrell, Tanya M.; Jamal, Seema M.; Tabor, Holly K.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Tabor, Holly K.] Seattle Childrens Res Inst, Treuman Katz Ctr Pediat Bioeth, Seattle, WA 98101 USA; [Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Yu, JH (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.	joonhoyu@u.washington.edu			NIH National Human Genome Research Institute [U54HG006493, RC2HG005608, R01HG006618]; Life Sciences Discovery Fund [2065508, 0905001]; Washington Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005608, UM1HG006493, U54HG006493, R01HG006618] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Life Sciences Discovery Fund; Washington Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the genetics professionals who graciously completed our survey. Our work was supported in part by grants from the NIH National Human Genome Research Institute (award numbers U54HG006493 to M.J.B., Debbie Nickerson, and Jay Shendure; RC2HG005608 to M.J.B.; and R01HG006618 to H.K.T. and M.J.B.), the Life Sciences Discovery Fund (2065508 and 0905001), and the Washington Research Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Allyse M, 2013, TRENDS BIOTECHNOL, V31, P439, DOI 10.1016/j.tibtech.2013.04.006; American College of Medical Genetics and Genomics, 2012, POL STAT POINTS CONS; American College of Medical Genetics and Genomics, 2014, ACMG UPD REC OPT OUT; Berg JS, 2013, GENET MED, V15, P860, DOI 10.1038/gim.2013.133; Biesecker LG, 2013, AM J HUM GENET, V92, P648, DOI 10.1016/j.ajhg.2013.04.001; Burke W, 2013, GENET MED, V15, P854, DOI 10.1038/gim.2013.113; Burke W, 2013, HASTINGS LAW J, V64, P1649; Christenhusz GM, 2013, EUR J HUM GENET, V21, P248, DOI 10.1038/ejhg.2012.130; Cooksey JA, 2005, GENET MED, V7, P439, DOI 10.1097/01.GIM.0000172416.35285.9F; Costain G, 2013, AM J BIOETHICS, V13, P58, DOI 10.1080/15265161.2012.754063; Daack-Hirsch S, 2013, CLIN GENET, V84, P11, DOI 10.1111/cge.12167; Downing NR, 2013, PATIENT EDUC COUNS, V90, P133, DOI 10.1016/j.pec.2012.09.010; Evans JP, 2012, GENET MED, V14, P358, DOI 10.1038/gim.2012.8; GARVER KL, 1990, AM J HUM GENET, V47, P345; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Grove M.E., 2013, J GENET COUNS; Holm I.A., 2014, GENET MED; Holtzman NA, 2013, GENET MED, V15, P750, DOI 10.1038/gim.2013.96; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Lemke AA, 2013, CLIN GENET, V84, P230, DOI 10.1111/cge.12060; Levenseller B.L., 2013, J GENET COUNS; Lohn Z, 2013, AM J MED GENET A, V161A, P542, DOI 10.1002/ajmg.a.35794; McGuire AL, 2013, SCIENCE, V340, P1047, DOI 10.1126/science.1240156; Meilleur KG, 2009, AM J MED GENET A, V149A, P819, DOI 10.1002/ajmg.a.32723; Mills Rachel A, 2012, Virtual Mentor, V14, P604, DOI 10.1001/virtualmentor.2012.14.8.ecas1-1208; National Society of Genetic Counselors, 2012, 2012 PROF STAT SURV; Parker LS, 2012, MINN J L SCI TECH, V13, P449; Presidential Commission for the Study of Bioethical Issues, 2013, ANT COMM ETH MAN INC; Ross LF, 2013, PERS MED, V10, P523, DOI 10.2217/pme.13.51; Tabor HK, 2011, AM J MED GENET A, V155A, P2916, DOI 10.1002/ajmg.a.34357; Townsend A, 2013, GENET MED, V15, P751, DOI 10.1038/gim.2013.105; Turbitt E., 2014, EUR J HUM GENET; Watson M, 2013, GENET MED, V15, P664, DOI 10.1038/gim.2013.82; Wolf SM, 2013, ANNU REV GENOM HUM G, V14, P557, DOI 10.1146/annurev-genom-091212-153506; Wolf SM, 2013, SCIENCE, V340, P1049, DOI 10.1126/science.1239119; Yu JH, 2013, GENET MED, V15, P684, DOI 10.1038/gim.2013.35	36	92	92	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2014	95	1					77	84		10.1016/j.ajhg.2014.06.004	http://dx.doi.org/10.1016/j.ajhg.2014.06.004			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AL1RP	24975944	Green Published, Bronze			2022-12-18	WOS:000338904100006
J	Thomas, S; Legendre, M; Saunier, S; Bessieres, B; Alby, C; Bonniere, M; Toutain, A; Loeuillet, L; Szymanska, K; Jossic, F; Gaillard, D; Yacoubi, MT; Mougou-Zerelli, S; David, A; Barthez, MA; Ville, Y; Bole-Feysot, C; Nitschke, P; Lyonnet, S; Munnich, A; Johnson, CA; Encha-Razavi, F; Cormier-Daire, V; Thauvin-Robinet, C; Vekemans, M; Attie-Bitach, T				Thomas, Sophie; Legendre, Marine; Saunier, Sophie; Bessieres, Bettina; Alby, Caroline; Bonniere, Maryse; Toutain, Annick; Loeuillet, Laurence; Szymanska, Katarzyna; Jossic, Frederique; Gaillard, Dominique; Yacoubi, Mohamed Tahar; Mougou-Zerelli, Soumaya; David, Albert; Barthez, Marie-Anne; Ville, Yves; Bole-Feysot, Christine; Nitschke, Patrick; Lyonnet, Stanislas; Munnich, Arnold; Johnson, Colin A.; Encha-Razavi, Ferechte; Cormier-Daire, Valerie; Thauvin-Robinet, Christel; Vekemans, Michel; Attie-Bitach, Tania			TCTN3 Mutations Cause Mohr-Majewski Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JOUBERT-SYNDROME; RETINAL DEGENERATION; MECKEL; GENE; RPGRIP1L; MODIFIER; REVEALS; OFD1; AHI1	Orofaciodigital syndromes (OFDSs) consist of a group of heterogeneous disorders characterized by abnormalities in the oral cavity, face, and digits and associated phenotypic abnormalities that lead to the delineation of 13 OFDS subtypes. Here, by a combined approach of homozygozity mapping and exome ciliary sequencing, we identified truncating TCTN3 mutations as the cause of an extreme form of OFD associated with bone dysplasia, tibial defect, cystic kidneys, and brain anomalies (OFD IV, Mohr-Majewski syndrome). Analysis of 184 individuals with various ciliopathies (OFD, Meckel, Joubert, and short rib polydactyly syndromes) led us to identify four additional truncating TCTN3 mutations in unrelated fetal cases with overlapping Meckel and OFD IV syndromes and one homozygous missense mutation in a family with Joubert syndrome. By exploring roles of TCTN3 in human ciliary related functions, we found that TCTN3 is necessary for transduction of the sonic hedgehog (SHH) signaling pathway, as revealed by abnormal processing of GLI3 in patient cells. These results are consistent with the suggested role of its murine ortholog, which forms a complex at the ciliary transition zone with TCTN1 and TCTN2, both of which are also implicated in the transduction of SHH signaling. Overall, our data show the involvement of the transition zone protein TCTN3 in the regulation of the key SHH signaling pathway and that its disruption causes a severe form of ciliopathy, combining features of Meckel and OFD IV syndromes.	[Thomas, Sophie; Legendre, Marine; Lyonnet, Stanislas; Munnich, Arnold; Encha-Razavi, Ferechte; Cormier-Daire, Valerie; Vekemans, Michel; Attie-Bitach, Tania] Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; [Thomas, Sophie; Saunier, Sophie; Alby, Caroline; Ville, Yves; Lyonnet, Stanislas; Munnich, Arnold; Encha-Razavi, Ferechte; Cormier-Daire, Valerie; Vekemans, Michel; Attie-Bitach, Tania] Univ Paris 05, F-75006 Paris, France; [Saunier, Sophie] Hop Necker Enfants Malad, INSERM, U983, F-75015 Paris, France; [Bessieres, Bettina; Bonniere, Maryse; Lyonnet, Stanislas; Munnich, Arnold; Encha-Razavi, Ferechte; Cormier-Daire, Valerie; Vekemans, Michel; Attie-Bitach, Tania] Hop Necker Enfants Malad, AP HP, Dept Genet, F-75015 Paris, France; [Alby, Caroline; Ville, Yves] Hop Necker Enfants Malad, AP HP, Serv Gynecol Obstet, F-75015 Paris, France; [Toutain, Annick] CHRU, Hop Bretonneau, Serv genet, F-37044 Tours, France; [Loeuillet, Laurence] CHI Poissy, Serv Anat & Cytol Pathol, F-78100 St Germain En Laye, France; [Szymanska, Katarzyna; Johnson, Colin A.] St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; [Jossic, Frederique] CHU Nantes, Serv Anat Pathol, F-44093 Nantes, France; [Gaillard, Dominique] CHU Reims, Serv Genet & Biol Reprod, F-51092 Reims, France; [Yacoubi, Mohamed Tahar] CHU Farhat Hached, Serv Anat & Cytol Pathol, Sousse 4001, Tunisia; [Mougou-Zerelli, Soumaya] CHU Farhat Hached, Serv Cytogenet Genet Mol & Biol Reprod, Sousse 4001, Tunisia; [David, Albert] CHU Nantes, Hop Hotel Dieu, Serv Genet Clin, F-44093 Nantes, France; [Barthez, Marie-Anne] Hop Clocheville, CHRU Tours, Serv Neuropediat, F-37044 Tours, France; [Bole-Feysot, Christine] Hop Necker Enfants Malad, Fdn IMAGINE, F-75015 Paris, France; [Nitschke, Patrick] Univ Paris 05, F-75015 Paris, France; [Thauvin-Robinet, Christel] CHU Dijon, Hop Enfants, Ctr Genet, F-21079 Dijon, France; [Thauvin-Robinet, Christel] Univ Bourgogne, IFR Sante STIC, EA GAD, F-21070 Dijon, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Hospital Chi of Poissy Saint Germain; Saint James's University Hospital; University of Leeds; Nantes Universite; CHU de Nantes; CHU de Reims; Universite de Reims Champagne-Ardenne; Universite de Sousse; Hopital Farhat Hached; Universite de Sousse; Hopital Farhat Hached; Nantes Universite; CHU de Nantes; CHU Tours; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Dijon Bourgogne; Universite de Bourgogne	Attie-Bitach, T (corresponding author), Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France.	tania.attie@inserm.fr	Lyonnet, Stanislas/H-5483-2017; thomas, sophie/GVS-1279-2022; Saunier, Sophie/G-6044-2015; THOMAS, Sophie/F-4492-2017; ATTIE-BITACH, Tania/K-1453-2017; cormier-daire, valerie/H-6520-2017	Lyonnet, Stanislas/0000-0001-5426-9417; Saunier, Sophie/0000-0002-1069-0047; THOMAS, Sophie/0000-0002-8569-3277; ATTIE-BITACH, Tania/0000-0002-1155-3626; Toutain, Annick/0000-0002-5999-5300; cormier-daire, valerie/0000-0002-2839-9856; Johnson, Colin/0000-0002-2979-8234	ANR [BLAN 1122 01]; Fondation pour la Recherche Medicale (FRM) [DEQ20071210558]; The Sir Jules Thorn Charitable Trust [09JTA] Funding Source: researchfish	ANR(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); The Sir Jules Thorn Charitable Trust	We thank the families for their participation. We also thank Leila Hakkakian, Judite De Oliveira, Celine Huber, and Nadege Gigot for technical assistance and Stephane Romano and Pascale de Lonlay for patient referral, and we are grateful to the French Society of Fetal Pathology (SOFFOET) for participating in the study. This work was supported by grants from ANR (2010 FOETOCILPATH No BLAN 1122 01 to T.A.B.) and Fondation pour la Recherche Medicale (FRM No DEQ20071210558 to S.S).	ADES LC, 1994, AM J MED GENET, V49, P211, DOI 10.1002/ajmg.1320490211; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; BARAITSER M, 1986, J MED GENET, V23, P116, DOI 10.1136/jmg.23.2.116; BARAITSER M, 1983, J MED GENET, V20, P65, DOI 10.1136/jmg.20.1.65; BURN J, 1984, J MED GENET, V21, P189, DOI 10.1136/jmg.21.3.189; Dafinger C, 2011, J CLIN INVEST, V121, P2662, DOI 10.1172/JCI43639; Davis EE, 2011, NAT GENET, V43, P189, DOI 10.1038/ng.756; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; DIGILIO MC, 1995, CLIN GENET, V48, P156; Garcia-Gonzalo FR, 2011, NAT GENET, V43, P776, DOI 10.1038/ng.891; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Khaddour Rana, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9489; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; McKusick V.A., 1978, BIRTH DEFECTS ORIG A, V14, P1; Mougou-Zerelli S, 2009, HUM MUTAT, V30, P1574, DOI 10.1002/humu.21116; Putoux A, 2011, NAT GENET, V43, P601, DOI 10.1038/ng.826; Reiter JF, 2006, GENE DEV, V20, P22, DOI 10.1101/gad.1363606; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Shaheen R, 2011, HUM MUTAT, V32, P573, DOI 10.1002/humu.21507; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Temtamy S A, 1978, Birth Defects Orig Artic Ser, V14, pi; Toriello HV, 1997, AM J MED GENET, V69, P250, DOI 10.1002/(SICI)1096-8628(19970331)69:3<250::AID-AJMG8>3.0.CO;2-P; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Valente EM, 2008, EUR J MED GENET, V51, P1, DOI 10.1016/j.ejmg.2007.11.003; Valente EM, 2010, NAT GENET, V42, P619, DOI 10.1038/ng.594	28	92	94	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 10	2012	91	2					372	378		10.1016/j.ajhg.2012.06.017	http://dx.doi.org/10.1016/j.ajhg.2012.06.017			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	990CN	22883145	Bronze, Green Published			2022-12-18	WOS:000307608700017
J	Mill, P; Lockhart, PJ; Fitzpatrick, E; Mountford, HS; Hall, EA; Reijns, MAM; Keighren, M; Bahlo, M; Bromhead, CJ; Budd, P; Aftimos, S; Delatycki, MB; Savarirayan, R; Jackson, IJ; Amor, DJ				Mill, Pleasantine; Lockhart, Paul J.; Fitzpatrick, Elizabeth; Mountford, Hayley S.; Hall, Emma A.; Reijns, Martin A. M.; Keighren, Margaret; Bahlo, Melanie; Bromhead, Catherine J.; Budd, Peter; Aftimos, Salim; Delatycki, Martin B.; Savarirayan, Ravi; Jackson, Ian J.; Amor, David J.			Human and Mouse Mutations in WDR35 Cause Short-Rib Polydactyly Syndromes Due to Abnormal Ciliogenesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASPHYXIATING THORACIC DYSTROPHY; INTRAFLAGELLAR TRANSPORT PROTEIN; CRANIOECTODERMAL DYSPLASIA; SENSENBRENNER-SYNDROME; REPRESSOR FUNCTIONS; CYTOPLASMIC DYNEIN; CILIA; CHLAMYDOMONAS; NEK1; LOCALIZATION	Defects in cilia formation and function result in a range of human skeletal and visceral abnormalities. Mutations in several genes have been identified to cause a proportion of these disorders, some of which display genetic (locus) heterogeneity. Mouse models are valuable for dissecting the function of these genes, as well as for more detailed analysis of the underlying developmental defects. The short-rib polydactyly (SRP) group of disorders are among the most severe human phenotypes caused by cilia dysfunction. We mapped the disease locus from two siblings affected by a severe form of SRP to 2p24, where we identified an in-frame homozygous deletion of exon 5 in WDR35. We subsequently found compound heterozygous missense and nonsense mutations in WDR35 in an independent second case with a similar, severe SRP phenotype. In a mouse mutation screen for developmental phenotypes, we identified a mutation in Wdr35 as the cause of midgestation lethality, with abnormalities characteristic of defects in the Hedgehog signaling pathway. We show that endogenous WDR35 localizes to cilia and centrosomes throughout the developing embryo and that human and mouse fibroblasts lacking the protein fail to produce cilia. Through structural modeling, we show that WDR35 has strong homology to the COPI coatamers involved in vesicular trafficking and that human SRP mutations affect key structural elements in WDR35. Our report expands, and sheds new light on, the pathogenesis of the SRP spectrum of ciliopathies.	[Mill, Pleasantine; Hall, Emma A.; Reijns, Martin A. M.; Keighren, Margaret; Budd, Peter; Jackson, Ian J.] Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Lockhart, Paul J.; Fitzpatrick, Elizabeth; Mountford, Hayley S.; Delatycki, Martin B.] Murdoch Childrens Res Inst, Bruce Lefroy Ctr Genet Hlth Res, Parkville, Vic 3052, Australia; [Lockhart, Paul J.; Delatycki, Martin B.; Savarirayan, Ravi; Amor, David J.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Bahlo, Melanie; Bromhead, Catherine J.] Walter & Eliza Hall Inst Med Res, Bionformat Div, Parkville, Vic 3052, Australia; [Aftimos, Salim] Auckland Hosp, No Reg Genet Serv, Auckland 1148, New Zealand; [Delatycki, Martin B.] Austin Hlth, Clin Genet, Heidelberg, Vic 3081, Australia; [Savarirayan, Ravi; Amor, David J.] Murdoch Childrens Res Inst, Victoria Clin Genet Serv, Parkville, Vic 3052, Australia	University of Edinburgh; Murdoch Children's Research Institute; University of Melbourne; Walter & Eliza Hall Institute; Auckland City Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Murdoch Children's Research Institute	Mill, P (corresponding author), Western Gen Hosp, Inst Genet & Mol Med, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	pleasantine.mill@hgu.mrc.ac.uk; paul.lockhart@mcri.edu.au	Amor, David J/A-6478-2018; Mill, Pleasantine/AAE-4718-2019; Delatycki, Martin B/A-5409-2013; Reijns, Martin/L-4355-2013; Lockhart, Paul J/E-7753-2011	Amor, David J/0000-0001-7191-8511; Reijns, Martin/0000-0002-5048-2752; Lockhart, Paul J/0000-0003-2531-8413; Hall, Emma/0000-0002-6944-6719; Mill, Pleasantine/0000-0001-5218-134X; Mountford, Hayley/0000-0002-7663-6326; Jackson, Ian/0000-0001-6526-0688; Bahlo, Melanie/0000-0001-5132-0774	Medical Research Council (UK); National Health and Medical Research Council Australia [490037, 334346]; National Sciences and Engineering Research Council of Canada; Caledonian Research Foundation; Medical Research Council [MC_U127561112, MC_PC_U127561112] Funding Source: researchfish; MRC [MC_U127561112, MC_PC_U127561112] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Caledonian Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank K. Pope (Clinical Research Coordinator, MCRI) and the families involved in this research. We thank I. Algianis, E. Maher, and C. Patel for sharing clinical samples for WDR35 screening. We are grateful to P. Perry and M. Pearson for imaging assistance. We thank D. FitzPatrick, A. Jackson, and T. Kunath for critical comments on the manuscript. This work was funded by the Medical Research Council (UK) and the National Health and Medical Research Council Australia (program grant 490037). Support to P.M. was provided by fellowships from the National Sciences and Engineering Research Council of Canada and the Caledonian Research Foundation. P.J.L. was supported by a National Health and Medical Research Council Australia RD Wright Fellowship (334346).	Amar MJA, 1997, AM J MED GENET, V70, P349, DOI 10.1002/(SICI)1096-8628(19970627)70:4<349::AID-AJMG3>3.0.CO;2-O; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Baker K, 2009, AM J MED GENET C, V151C, P281, DOI 10.1002/ajmg.c.30231; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Blacque OE, 2006, MOL BIOL CELL, V17, P5053, DOI 10.1091/mbc.E06-06-0571; Cole DG, 2003, TRAFFIC, V4, P435, DOI 10.1034/j.1600-0854.2003.t01-1-00103.x; Cortellino S, 2009, DEV BIOL, V325, P225, DOI 10.1016/j.ydbio.2008.10.020; Dagoneau N, 2009, AM J HUM GENET, V84, P706, DOI 10.1016/j.ajhg.2009.04.016; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Ho NC, 2000, AM J MED GENET, V90, P310, DOI 10.1002/(SICI)1096-8628(20000214)90:4<310::AID-AJMG9>3.0.CO;2-N; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Kannu P, 2007, AM J MED GENET A, V143A, P2607, DOI 10.1002/ajmg.a.31989; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Merrill AE, 2009, AM J HUM GENET, V84, P542, DOI 10.1016/j.ajhg.2009.03.015; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Qin JA, 2011, P NATL ACAD SCI USA, V108, P1456, DOI 10.1073/pnas.1011410108; Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; Thiel C, 2011, AM J HUM GENET, V88, P106, DOI 10.1016/j.ajhg.2010.12.004; Upadhya P, 2000, P NATL ACAD SCI USA, V97, P217, DOI 10.1073/pnas.97.1.217; Walczak-Sztulpa J, 2010, AM J HUM GENET, V86, P949, DOI 10.1016/j.ajhg.2010.04.012; White MC, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-29	29	92	97	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					508	515		10.1016/j.ajhg.2011.03.015	http://dx.doi.org/10.1016/j.ajhg.2011.03.015			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21473986	Green Submitted, Green Published, hybrid			2022-12-18	WOS:000289664300012
J	Vermeer, S; Hoischen, A; Meijer, RPP; Gilissen, C; Neveling, K; Wieskamp, N; de Brouwer, A; Koenig, M; Anheim, M; Assoum, M; Drouot, N; Todorovic, S; Milic-Rasic, V; Lochmuller, H; Stevanin, G; Goizet, C; David, A; Durr, A; Brice, A; Kremer, B; van de Warrenburg, BPC; Schijvenaars, MMVAP; Heister, A; Kwint, M; Arts, P; van der Wijst, J; Veltman, J; Kamsteeg, EJ; Scheffer, H; Knoers, N				Vermeer, Sascha; Hoischen, Alexander; Meijer, Rowdy P. P.; Gilissen, Christian; Neveling, Kornelia; Wieskamp, Nienke; de Brouwer, Arjan; Koenig, Michel; Anheim, Mathieu; Assoum, Mirna; Drouot, Nathalie; Todorovic, Slobodanka; Milic-Rasic, Vedrana; Lochmueller, Hanns; Stevanin, Giovanni; Goizet, Cyril; David, Albert; Durr, Alexandra; Brice, Alexis; Kremer, Berry; van de Warrenburg, Bart P. C.; Schijvenaars, Mascha M. V. A. P.; Heister, Angelien; Kwint, Michael; Arts, Peer; van der Wijst, Jenny; Veltman, Joris; Kamsteeg, Erik-Jan; Scheffer, Hans; Knoers, Nine			Targeted Next-Generation Sequencing of a 12.5 Mb Homozygous Region Reveals ANO10 Mutations in Patients with Autosomal-Recessive Cerebellar Ataxia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMEMBRANE PROTEIN; CHLORIDE CHANNEL; GENE; DOMINANT; TMEM16A; MEMBERS; FAMILY	Autosomal-recessive cerebellar ataxias comprise a clinically and genetically heterogeneous group of neurodegenerative disorders. In contrast to their dominant counterparts, unraveling the molecular background of these ataxias has proven to be more complicated and the currently known mutations provide incomplete coverage for genotyping of patients. By combining SNP array-based linkage analysis and targeted resequencing of relevant sequences in the linkage interval with the use of next-generation sequencing technology, we identified a mutation in a gene and have shown its association with autosomal-recessive cerebellar ataxia. In a Dutch consanguineous family with three affected siblings a homozygous 12.5 Mb region on chromosome 3 was targeted by array-based sequence capture. Prioritization of all detected sequence variants led to four candidate genes, one of which contained a variant with a high base pair conservation score (phyloP score: 5.26). This variant was a leucine-to-arginine substitution in the DUF 590 domain of a 16K transmembrane protein, a putative calcium-activated chloride channel encoded by anoctamin 10 (ANO10). The analysis of ANO10 by Sanger sequencing revealed three additional mutations: a homozygous mutation (c.1150_1151del [p.Leu384fs]) in a Serbian family and a compound-heterozygous splice-site mutation (c.1476+1G>T) and a frameshift mutation (c.1604del [p.Leu535X]) in a French family. This illustrates the power of using initial homozygosity mapping with next-generation sequencing technology to identify genes involved in autosomal-recessive diseases. Moreover, identifying a putative calcium-dependent chloride channel involved in cerebellar ataxia adds another pathway to the list of pathophysiological mechanisms that may cause cerebellar ataxia.	[Vermeer, Sascha; Hoischen, Alexander; Meijer, Rowdy P. P.; Gilissen, Christian; Neveling, Kornelia; Wieskamp, Nienke; de Brouwer, Arjan; Schijvenaars, Mascha M. V. A. P.; Heister, Angelien; Kwint, Michael; Arts, Peer; Veltman, Joris; Kamsteeg, Erik-Jan; Scheffer, Hans; Knoers, Nine] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [van der Wijst, Jenny] Radboud Univ Nijmegen, Med Ctr, Dept Physiol, NL-6500 HB Nijmegen, Netherlands; [van de Warrenburg, Bart P. C.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [Kremer, Berry] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 GZ Groningen, Netherlands; [Koenig, Michel; Assoum, Mirna; Drouot, Nathalie] Univ Strasbourg, CNRS UMR7104, INSERM U964, IGBMC, F-67404 Illkirch Graffenstaden, France; [Koenig, Michel] Nouvel Hop Civil, Lab Diagnost Genet, F-67091 Strasbourg, France; [Anheim, Mathieu; Durr, Alexandra; Brice, Alexis] Hop La Pitie Salpetriere, Ctr Reference Malad Neurogenet Enfant & Adulte, F-75013 Paris, France; [Anheim, Mathieu; Stevanin, Giovanni; Durr, Alexandra; Brice, Alexis] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, F-75005 Paris, France; [Anheim, Mathieu; Stevanin, Giovanni; Durr, Alexandra; Brice, Alexis] INSERM, U975, F-75013 Paris, France; [Anheim, Mathieu; Stevanin, Giovanni; Durr, Alexandra; Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Dept Genet & Cytogenet, F-75013 Paris, France; [Todorovic, Slobodanka; Milic-Rasic, Vedrana] Univ Belgrade, Fac Med, Clin Pediat & Adolescent Neurol & Psychiat, Belgrade 11000, Serbia; [Lochmueller, Hanns] Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Stevanin, Giovanni; Durr, Alexandra; Brice, Alexis] CNRS, UMR 7225, F-75013 Paris, France; [Goizet, Cyril] Univ Bordeaux 2, Lab Genet Humaine, F-33076 Bordeaux, France; [Goizet, Cyril] CHU Pellegrin, Serv Genet Med, F-33076 Bordeaux, France; [David, Albert] CHU Nantes, Serv Genet Med, F-44093 Nantes, France	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Belgrade; Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Nantes Universite; CHU de Nantes	Vermeer, S (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	s.vermeer@antrg.umcn.nl; n.knoers@antrg.umcn.nl	van der Wijst, Jenny/T-1620-2019; Brice, Alexis/A-2170-2009; Stevanin, Giovanni/E-5038-2016; Schijvenaars, Mascha/P-8712-2015; GOIZET, Cyril/M-4576-2014; Neveling, K./L-4544-2015; Kwint, Michael/AAC-9062-2019; brice, alexis/AAE-8275-2019; van de Warrenburg, Bart PC/D-1935-2010; van der Wijst, Jenny/D-9726-2016; Heister, Angelien/ABC-3651-2020; Scheffer, Hans/E-4644-2012; Veltman, Joris A/F-5128-2010; Gilissen, Christian/E-5246-2012; de Brouwer, Arjan PM/P-5949-2015; Kamsteeg, Erik-Jan/L-4421-2015; Hoischen, Alexander/AGF-7293-2022; Hoischen, Alexander/D-1282-2013; Arts, Peer/Q-4139-2019	van der Wijst, Jenny/0000-0002-1547-516X; Stevanin, Giovanni/0000-0001-9368-8657; GOIZET, Cyril/0000-0002-1913-889X; brice, alexis/0000-0002-0941-3990; van de Warrenburg, Bart PC/0000-0003-4412-1616; van der Wijst, Jenny/0000-0002-1547-516X; Scheffer, Hans/0000-0002-2986-0915; Veltman, Joris A/0000-0002-3218-8250; Gilissen, Christian/0000-0003-1693-9699; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; Arts, Peer/0000-0002-6742-6239; Lochmuller, Hanns/0000-0003-2324-8001; Vermeer, Sascha/0000-0001-7625-1912; Anheim, Mathieu/0000-0001-8121-0605	Netherlands Organization of Health Research and Development [ZonMW RM000085, 917-66-36, 911-08-025]; European Community [FP7/2007-2013, 223143]; Verum Foundation; French National Agency for Research; Agence Nationale pour la Recherche-Maladies Neurologiques et Psychiatriques [ANR-09-MNPS-001-01]; MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: researchfish	Netherlands Organization of Health Research and Development(Netherlands Organization for Health Research and Development); European Community(European Commission); Verum Foundation; French National Agency for Research(French National Research Agency (ANR)); Agence Nationale pour la Recherche-Maladies Neurologiques et Psychiatriques(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to the patients for their participation, to the referring clinicians, and especially to C. Haaxma, E. Kamping, E. Mundwiller, and the DNA and Cell Bank of the CR-ICM for their clinical and technical support. This work was supported by a grant from the Netherlands Organization of Health Research and Development (ZonMW RM000085 to N.K.). The next-generation sequencing platforms have been funded in part by the Netherlands Organization for Health Research and Development (ZonMW grants 917-66-36 and 911-08-025 to J.V.). Targeted sequence-capture experiments were performed in part by funding to H.S. from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement number 223143 (project acronym: TECHGENE). Furthermore, we would like to thank the Verum Foundation (support to A.B.), the French National Agency for Research (support to A.D., M.K., and G.S.), and Agence Nationale pour la Recherche-Maladies Neurologiques et Psychiatriques (ANR-09-MNPS-001-01; support to M.K., A.D., and A.B.).	Anheim M, 2010, NEUROGENETICS, V11, P1, DOI 10.1007/s10048-009-0196-y; [Anonymous], INTEGRATIVE GENOMICS; [Anonymous], ONLINE MENDELIAN INH; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bolduc V, 2010, AM J HUM GENET, V86, P213, DOI 10.1016/j.ajhg.2009.12.013; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Carlson KM, 2009, CURR OPIN GENET DEV, V19, P247, DOI 10.1016/j.gde.2009.02.009; Galindo BE, 2005, INT J MOL MED, V16, P919; Gritli-Linde A, 2009, GENE EXPR PATTERNS, V9, P178, DOI 10.1016/j.gep.2008.11.002; HARDING AE, 1983, LANCET, V1, P1151; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Hartzell HC, 2009, J PHYSIOL-LONDON, V587, P2127, DOI 10.1113/jphysiol.2008.163709; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Kasumu A, 2012, CEREBELLUM, V11, P630, DOI 10.1007/s12311-010-0182-9; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Saegusa H, 2007, MOL CELL NEUROSCI, V34, P261, DOI 10.1016/j.mcn.2006.11.006; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Trudeau MM, 2006, J MED GENET, V43, P527, DOI 10.1136/jmg.2005.035667; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; van de Leemput J, 2007, PLOS GENET, V3, P1076, DOI 10.1371/journal.pgen.0030108; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62; REFSEQ; DBSNP BUILD 130; EASYLINKAGE	33	92	98	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC 10	2010	87	6					813	819		10.1016/j.ajhg.2010.10.015	http://dx.doi.org/10.1016/j.ajhg.2010.10.015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	698AT	21092923	Green Published, Bronze			2022-12-18	WOS:000285564600007
J	Tyynismaa, H; Ylikallio, E; Patel, M; Molnar, MJ; Haller, RG; Suomalainen, A				Tyynismaa, Henna; Ylikallio, Emil; Patel, Mehul; Molnar, Maria J.; Haller, Ronald G.; Suomalainen, Anu			A Heterozygous Truncating Mutation in RRM2B Causes Autosomal-Dominant Progressive External Ophthalmoplegia with Multiple mtDNA Deletions	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA DEPLETION; ADENINE-NUCLEOTIDE TRANSLOCATOR; RIBONUCLEOTIDE REDUCTASE GENE; IN-VITRO; TWINKLE MUTATIONS; P53R2 PROTEIN; RESTING CELLS; DNTP POOLS; DAMAGE; ATAXIA	Autosomal-dominant progressive external ophthalmoplegia (adPEO) is a mitochondrial disorder that is characterized by accumulation of multiple mitochondrial DNA (mtDNA) deletions in postmitotic tissues. The disorder is heterogeneous, with five known nuclear disease genes that encode the proteins ANTI, Twinkle, POLG, POLG2, and OPA1. Defects in these proteins affect mtDNA maintenance, probably leading to stalled replication forks, consequent mtDNA deletion formation, and progressive respiratory chain deficiency. Here we present a large adPEO family with Multiple mtDNA deletions, whose disease was not explained by mutations in any of the known adPEO loci. We mapped the disease locus in this family to chromosome 8q22.1-q23.3. The critical linkage region contained the RRM2B gene, which encodes the small subunit of the ribonucleotide reductase p53R2, which has previously been shown to be essential for the maintenance of mtDNA copy number. Mutation screening of RRM2B revealed a heterozygous nonsense mutation in exon 9 (c.979C -> T [p.R327X]) in all affected individuals that was absent in 380 control chromosomes. The same mutation was found to segregate in another adPEO family. The mutant mRNA escaped nonsense-mediated decay and resulted in a protein with truncation of 25 highly conserved C-terminal amino acids essential for the interaction with the ribonucleotide reductase subunit R1. We conclude that dominant-negative or gain-of-function mutations in RRM2B are a cause of multiple mtDNA deletions and adPEO.	[Tyynismaa, Henna; Ylikallio, Emil; Suomalainen, Anu] Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland; [Patel, Mehul; Haller, Ronald G.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA; [Molnar, Maria J.] Semmelweis Univ, Clin & Res Ctr Mol Neurol, H-1083 Budapest, Hungary; [Haller, Ronald G.] Dallas VA Med Ctr, Dallas, TX 75231 USA; [Haller, Ronald G.] Inst Exercise & Environm Med, Neuromuscular Ctr, Dallas, TX 75231 USA; [Suomalainen, Anu] Univ Helsinki, Cent Hosp, Dept Neurol, FIN-00290 Helsinki, Finland	University of Helsinki; University of Texas System; University of Texas Southwestern Medical Center Dallas; Semmelweis University; University of Helsinki; Helsinki University Central Hospital	Tyynismaa, H (corresponding author), Univ Helsinki, Biomedicum Helsinki, Res Program Mol Neurol, FIN-00290 Helsinki, Finland.	henna.tyynisma@helsinki.fi	Tyynismaa, Henna/F-1428-2011; Ylikallio, Emil/S-9434-2019	Ylikallio, Emil/0000-0001-5178-0703; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195; Molnar, Maria Judit/0000-0001-9350-1864; Patel, Mehul/0000-0002-4654-5933; Tyynismaa, Henna/0000-0002-2493-2422	Academy of Finland; Sigrid Juselius Foundation; University of Helsinki; VA Merit Review grant	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki; VA Merit Review grant(US Department of Veterans Affairs)	The authors would like to thank families I and 2 for participation in the study; the Finnish Genome Center for performing the SNP chip protocol; and K. Ayyad, N. Romaine, and A. Harju for laboratory assistance. V. Bianchi and R Reichard are acknowledged for valuable comments. This study was supported by the Academy of Finland (H.T. and A.S.), the Sigrid Juselius Foundation (A.S.), University of Helsinki (A.S.), and a VA Merit Review grant (R.G.H.).	Bornstein B, 2008, NEUROMUSCULAR DISORD, V18, P453, DOI 10.1016/j.nmd.2008.04.006; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Byun DS, 2002, INT J CANCER, V98, P718, DOI 10.1002/ijc.10253; Chang LF, 2008, P NATL ACAD SCI USA, V105, P18519, DOI 10.1073/pnas.0803313105; Deng ZL, 2005, WORLD J GASTROENTERO, V11, P5169; FISHER A, 1993, J MED CHEM, V36, P3859, DOI 10.1021/jm00076a015; Goffart S, 2009, HUM MOL GENET, V18, P328, DOI 10.1093/hmg/ddn359; Guittet O, 2001, J BIOL CHEM, V276, P40647, DOI 10.1074/jbc.M106088200; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hakonen AH, 2008, HUM MOL GENET, V17, P3822, DOI 10.1093/hmg/ddn280; Hakonen AH, 2007, BRAIN, V130, P3032, DOI 10.1093/brain/awm242; Hudson G, 2008, BRAIN, V131, P329, DOI 10.1093/brain/awm272; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Longley MJ, 2006, AM J HUM GENET, V78, P1026, DOI 10.1086/504303; Luoma P, 2004, LANCET, V364, P875, DOI 10.1016/S0140-6736(04)16983-3; Luoma PT, 2005, HUM MOL GENET, V14, P1907, DOI 10.1093/hmg/ddi196; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Melberg A, 1996, MUSCLE NERVE, V19, P751; Nakano K, 2000, ONCOGENE, V19, P4283, DOI 10.1038/sj.onc.1203774; Nishino I, 1999, SCIENCE, V283, P689, DOI 10.1126/science.283.5402.689; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Palmieri L, 2005, HUM MOL GENET, V14, P3079, DOI 10.1093/hmg/ddi341; Pontarin G, 2007, J BIOL CHEM, V282, P16820, DOI 10.1074/jbc.M701310200; Pontarin G, 2008, P NATL ACAD SCI USA, V105, P17801, DOI 10.1073/pnas.0808198105; Sarzi E, 2007, ANN NEUROL, V62, P579, DOI 10.1002/ana.21207; SERVIDEI S, 1991, NEUROLOGY, V41, P1053, DOI 10.1212/WNL.41.7.1053; Shao JM, 2004, CANCER RES, V64, P1, DOI 10.1158/0008-5472.CAN-03-3048; Smeds J, 2002, CARCINOGENESIS, V23, P645, DOI 10.1093/carcin/23.4.645; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Goethem G, 2004, NEUROLOGY, V63, P1251, DOI 10.1212/01.WNL.0000140494.58732.83; Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	39	92	96	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 14	2009	85	2					290	295		10.1016/j.ajhg.2009.07.009	http://dx.doi.org/10.1016/j.ajhg.2009.07.009			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	488EV	19664747	Green Published, Bronze			2022-12-18	WOS:000269332900018
J	Gurnett, CA; Alaee, F; Kruse, LM; Desruisseau, DM; Hecht, JT; Wise, CA; Bowcock, AM; Dobbs, MB				Gurnett, Christina A.; Alaee, Farhang; Kruse, Lisa M.; Desruisseau, David M.; Hecht, Jacqueline T.; Wise, Carol A.; Bowcock, Anne M.; Dobbs, Matthew B.			Asymmetric Lower-Limb Malformations in Individuals with Homeobox PITX1 Gene Mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SMALL PATELLA SYNDROME; RIEGER-SYNDROME; TALIPES EQUINOVARUS; PELVIC REDUCTION; HOMEODOMAIN PROTEIN; LINKAGE ANALYSES; CLUB FOOT; HINDLIMB; MORPHOGENESIS; FAMILIES	Clubfoot is one of the most common severe musculoskeletal birth defects, with a worldwide incidence of 1 in 1000 live births. In the present study, we describe a five-generation family with asymmetric right-sided predominant idiopathic clubfoot segregating as an autosomal-dominant condition with incomplete penetrance. Other lower-limb malformations, including patellar hypoplasia, oblique talus, tibial hemimelia, developmental hip dysplasia, and preaxial polydactyly, were also present in some family members. Genome-wide linkage analysis with Affymetrix GeneChip Mapping 10K mapping data from 13 members of this family revealed a multipoint LODmax of 3.31 on chromosome 5q31. A single missense mutation (c.388G -> A) was identified in PITX1, a bicoid-related homeodomain transcription factor critical for hindlimb development, and segregated with disease in this family. The PITX1 E130K mutation is located in the highly conserved homeodomain and reduces the ability of PITX1 to transactivate it luciferase reporter. The PITX1 E130K mutation also suppresses wild-type PITX I activity in a dose-dependent manner, Suggesting dominant-negative effects on transcription. The propensity for right-sided involvement in tibial hemimelia and clubfoot suggests that PITX1, or pathways involving PITX1, may be involved in their etiology. Implication of a gene involved in early limb development in clubfoot pathogenesis also Suggests additional pathways for future investigations of idiopathic Clubfoot etiology in humans.	[Gurnett, Christina A.; Alaee, Farhang; Kruse, Lisa M.; Desruisseau, David M.; Dobbs, Matthew B.] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO 63119 USA; [Gurnett, Christina A.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63119 USA; [Gurnett, Christina A.] Washington Univ, Sch Med, Div Genom Med, Dept Pediat, St Louis, MO 63119 USA; [Bowcock, Anne M.] Washington Univ, Sch Med, Div Human Genet, Dept Genet, St Louis, MO 63119 USA; [Hecht, Jacqueline T.] Univ Texas Houston, Hlth Sci Ctr, Houston, TX 77030 USA; [Wise, Carol A.] Texas Scottish Rite Hosp Children, Seay Ctr Musculoskeletal Res, Dallas, TX 75219 USA; [Dobbs, Matthew B.] St Louis Shriners Hosp Children, St Louis, MO 63131 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Texas System; University of Texas Health Science Center Houston; Texas Scottish Rite Hospital for Children	Gurnett, CA (corresponding author), Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO 63119 USA.	gurnettc@neuro.wustl.edu		Bowcock, Anne/0000-0001-8691-9090; Wise, Carol/0000-0002-6790-2194	National Institutes of Health [K12 HD001459]; The Children's Discovery Institute; March of Dimes Basil O'Connor Starter Scholar Research Award; St Louis Children's Hospital Foundation; Pediatric Orthopaedic Society of North America; Shriners Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Children's Discovery Institute; March of Dimes Basil O'Connor Starter Scholar Research Award(March of Dimes); St Louis Children's Hospital Foundation; Pediatric Orthopaedic Society of North America; Shriners Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We kindly thank Dr. Andrew Russo for use of the TK-Bic luciferase reporter plasmid and the National Institutes of Health Neuroscience Microarray Consortium for performing the Affymetrix microarray analyses. The PITX1 sequence annotation used here corresponds to NM_002653.4 coding sequence only. This work was Supported by grants from the National Institutes of Health (K12 HD001459), The Children's Discovery Institute, and March of Dimes Basil O'Connor Starter Scholar Research Award, St Louis Children's Hospital Foundation, Pediatric Orthopaedic Society of North America, and Shriners Hospital. The authors have no conflict of interest to disclose.	Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; BEALS RK, 1978, NEW ZEAL MED J, V88, P144; Bongers EMHF, 2004, AM J HUM GENET, V74, P1239, DOI 10.1086/421331; Bongers EMHF, 2001, J MED GENET, V38, P209, DOI 10.1136/jmg.38.3.209; Chaney BA, 2005, BIOCHEMISTRY-US, V44, P7497, DOI 10.1021/bi0473253; CHUNG CS, 1969, HUM HERED, V19, P321, DOI 10.1159/000152236; CLARK MW, 1975, J BONE JOINT SURG AM, VA 57, P262, DOI 10.2106/00004623-197557020-00022; Coyle SM, 2007, J HERED, V98, P581, DOI 10.1093/jhered/esm066; GibsonBrown JJ, 1996, MECH DEVELOP, V56, P93, DOI 10.1016/0925-4773(96)00514-X; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; KALAMCHI A, 1985, J BONE JOINT SURG BR, V67, P581, DOI 10.1302/0301-620X.67B4.4030854; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Lanctot C, 1997, DEVELOPMENT, V124, P2807; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Lochmiller C, 1998, AM J MED GENET, V79, P90, DOI 10.1002/(SICI)1096-8628(19980901)79:2<90::AID-AJMG3>3.3.CO;2-M; Logan M, 1999, SCIENCE, V283, P1736, DOI 10.1126/science.283.5408.1736; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Marcil A, 2003, DEVELOPMENT, V130, P45, DOI 10.1242/dev.00192; NUNES ME, 1995, HUM MOL GENET, V4, P2165, DOI 10.1093/hmg/4.11.2165; Piedra ME, 1998, CELL, V94, P319, DOI 10.1016/S0092-8674(00)81475-0; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Saadi I, 2003, MOL CELL BIOL, V23, P1968, DOI 10.1128/MCB.23.6.1968-1982.2003; Saadi I, 2001, J BIOL CHEM, V276, P23034, DOI 10.1074/jbc.M008592200; SCHREINER CM, 1993, DEV BIOL, V158, P560, DOI 10.1006/dbio.1993.1214; SEARLE AG, 1964, GENET RES, V5, P171, DOI 10.1017/S0016672300001166; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Szeto DP, 1996, P NATL ACAD SCI USA, V93, P7706, DOI 10.1073/pnas.93.15.7706; Szeto DP, 1999, GENE DEV, V13, P484, DOI 10.1101/gad.13.4.484; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Tickle C, 2003, DEV CELL, V4, P449, DOI 10.1016/S1534-5807(03)00095-9; WIEDEMANN HR, 1983, AM J MED GENET, V14, P467, DOI 10.1002/ajmg.1320140310; WYNNEDAVIES R, 1964, J BONE JOINT SURG BR, V46, P445, DOI 10.1302/0301-620X.46B3.445; WYNNEDAVIES R, 1972, CLIN ORTHOP RELAT R, P9; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Zelzer E, 2003, NATURE, V423, P343, DOI 10.1038/nature01659; Zguricas J, 1999, J MED GENET, V36, P32	43	92	94	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2008	83	5					616	622		10.1016/j.ajhg.2008.10.004	http://dx.doi.org/10.1016/j.ajhg.2008.10.004			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	373XN	18950742	Green Published, Bronze			2022-12-18	WOS:000261006900008
J	Kayser, M; Lao, O; Saar, K; Brauer, S; Wang, XY; Nurnberg, P; Trent, RJ; Stoneking, M				Kayser, Manfred; Lao, Oscar; Saar, Kathrin; Brauer, Silke; Wang, Xingyu; Nuernberg, Peter; Trent, Ronald J.; Stoneking, Mark			Genorne-wide analysis indicates more Asian than melanesian ancestry of polynesians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ADMIXTURE PROPORTIONS; Y-CHROMOSOME; POPULATION; ORIGINS; MTDNA; DIVERSITY; LINEAGES	Analyses of mitochondrial DNA (mtDNA) and nonrecombining Y chromosome (NRY) variation in the same populations are sometimes concordant but sometimes discordant. Perhaps the most dramatic example known of the latter concerns Polynesians, in which about 94% of Polynesian mtDNAs are of East Asian origin, while about 66% of Polynesian Y chromosomes are of Melanesian origin. Here we analyze on a genome-wide scale, to our knowledge for the first time, the origins of the autosomal gene pool of Polynesians by screening 377 autosomal short tandem repeat (STR) loci in 47 Pacific Islanders and compare the results with those obtained from 44 Chinese and 24 individuals from Papua New Guinea. Our data indicate that on average about 79% of the Polynesian autosomal gene pool is of East Asian origin and 21% is of Melanesian origin. The genetic data thus suggest a dual origin of Polynesians with a high East Asian but also considerable Melanesian component, reflecting sex-biased admixture in Polynesian history in agreement with the Slow Boat model. More generally, these results also demonstrate that conclusions based solely on uniparental markers, which are frequently used in population history studies, may not accurately reflect the history of the autosomal gene pool of a population.	[Kayser, Manfred; Lao, Oscar; Brauer, Silke] Erasmus Univ, Med Ctr Rotterdam, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands; [Saar, Kathrin] Max Delbruck Ctr Mol Med, Gene Mapping Ctr, D-13092 Berlin, Germany; [Brauer, Silke] Netherlands Forens Inst, Dept Biol, NL-2490 AA The Hague, Netherlands; [Wang, Xingyu] Fu Wai Hosp, Beijing Hypertens League Inst, Beijing 100037, Peoples R China; [Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Trent, Ronald J.] Royal Prince Alfred Hosp, Dept Mol & Clin Genet, Camperdown, NSW 2050, Australia; [Trent, Ronald J.] Univ Sydney, Cent Clin Sch, Camperdown, NSW 2050, Australia; [Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany	Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Hypertension League; University of Cologne; University of Sydney; University of Sydney; Max Planck Society	Kayser, M (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Forens Mol Biol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.kayser@erasmusmc.nl	; Lao, Oscar/N-9930-2017	Saar, Kathrin/0000-0002-4483-1557; Lao, Oscar/0000-0002-8525-9649				Beaumont MA, 2002, GENETICS, V162, P2025; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Choisy M, 2004, MOL ECOL, V13, P955, DOI 10.1111/j.1365-294X.2004.02107.x; DIAMOND JM, 1988, NATURE, V336, P307, DOI 10.1038/336307a0; Excoffier L, 2005, GENETICS, V169, P1727, DOI 10.1534/genetics.104.036236; Friedlaender JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000248; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; GREEN RC, 1991, INDOPACIFIC PREHIST, V11, P295; Hage P, 1998, J POLYNESIAN SOC, V107, P365; Hage P, 2003, CURR ANTHROPOL, V44, pS121, DOI 10.1086/379272; Hamilton G, 2005, P NATL ACAD SCI USA, V102, P7476, DOI 10.1073/pnas.0409253102; Hurles ME, 2002, GENETICS, V160, P289; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; Kayser M, 2000, CURR BIOL, V10, P1237, DOI 10.1016/S0960-9822(00)00734-X; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Kayser M, 2001, AM J HUM GENET, V68, P173, DOI 10.1086/316949; Kayser M, 2006, MOL BIOL EVOL, V23, P2234, DOI 10.1093/molbev/msl093; KIRCH PV, 1997, LAPITA PEOPLES ANCES; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; MELTON T, 1995, AM J HUM GENET, V57, P403; Oppenheimer SJ, 2001, NATURE, V410, P166, DOI 10.1038/35065520; Pierson MJ, 2006, MOL BIOL EVOL, V23, P1966, DOI 10.1093/molbev/msl063; Pritchard JK, 2000, GENETICS, V155, P945; Saar K, 2003, PEDIATRICS, V111, P321, DOI 10.1542/peds.111.2.321; Scheinfeldt L, 2006, MOL BIOL EVOL, V23, P1628, DOI 10.1093/molbev/msl028; TERRELL J, 1988, ANTIQUITY, V62, P642, DOI 10.1017/S0003598X00075049; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; Wang JL, 2003, GENETICS, V164, P747; Zeitoun Elizabeth, 1999, SELECTED PAPERS 8 IN, P31	30	92	92	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2008	82	1					194	198		10.1016/j.ajhg.2007.09.010	http://dx.doi.org/10.1016/j.ajhg.2007.09.010			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NM	18179899	Green Published, Bronze			2022-12-18	WOS:000253223800021
J	Friedman, JS; Chang, B; Kannabiran, C; Chakarova, C; Singh, HP; Jalali, S; Hawes, NL; Branham, K; Othman, M; Filippova, E; Thompson, DA; Webster, AR; Andreasson, S; Jacobson, SG; Bhattacharya, SS; Heckenlively, JR; Swaroop, A				Friedman, James S.; Chang, Bo; Kannabiran, Chitra; Chakarova, Christina; Singh, Hardeep P.; Jalali, Subhadra; Hawes, Norman L.; Branham, Kari; Othman, Mohammad; Filippova, Elena; Thompson, Debra A.; Webster, Andrew R.; Andreasson, Sten; Jacobson, Samuel G.; Bhattacharya, Shomi S.; Heckenlively, John R.; Swaroop, Anand			Premature truncation of a novel protein, RD3, exhibiting subnuclear localization is associated with retinal degeneration	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOMINANT RETINITIS-PIGMENTOSA; BETA-SUBUNIT; GENE; MUTATIONS; IDENTIFICATION; MOUSE; NRL; MODEL; PHOSPHODIESTERASE; EXPRESSION	The rd3 mouse is one of the oldest identified models of early-onset retinal degeneration. Using the positional candidate approach, we have identified a C -> T substitution in a novel gene, Rd3, that encodes an evolutionarily conserved protein of 195 amino acids. The rd3 mutation results in a predicted stop codon after residue 106. This change is observed in four rd3 lines derived from the original collected mice but not in the nine wild-type mouse strains that were examined. Rd3 is preferentially expressed in the retina and exhibits increasing expression through early postnatal development. In transiently transfected COS-1 cells, the RD3-fusion protein shows subnuclear localization adjacent to promyelocytic leukemia-gene-product bodies. The truncated mutant RD3 protein is detectable in COS-1 cells but appears to get degraded rapidly. To explore potential association of the human RD3 gene at chromosome 1q32 with retinopathies, we performed a mutation screen of 881 probands from North America, India, and Europe. In addition to several alterations of uncertain significance, we identified a homozygous alteration in the invariant G nucleotide of the RD3 exon 2 donor splice site in two siblings with Leber congenital amaurosis. This mutation is predicted to result in premature truncation of the RD3 protein, segregates with the disease, and is not detected in 121 ethnically matched control individuals. We suggest that the retinopathy-associated RD3 protein is part of subnuclear protein complexes involved in diverse processes, such as transcription and splicing.	Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Kellogg Eye Ctr, Dept Human Genet, Ann Arbor, MI 48105 USA; LV Prasad Eye Inst, Kannuri SAnthamma Retina Vitreous Serv, Hyderabad, Andhra Pradesh, India; LV Prasad Eye Inst, Kallam Anji Reddy Mol Genet Lab, Hyderabad, Andhra Pradesh, India; Jackson Lab, Bar Harbor, ME 04609 USA; UCL, Inst Ophthalmol, Dept Mol Genet, London WC1E 6BT, England; Moorfields Eye Hosp, London, England; Univ Lund Hosp, Dept Ophthalmol, S-22185 Lund, Sweden; Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Jackson Laboratory; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; Lund University; Skane University Hospital; University of Pennsylvania; Pennsylvania Medicine	Swaroop, A (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St, Ann Arbor, MI 48105 USA.	swaroop@umich.edu	Chakarova, Christina/C-9479-2013; Branham, Kari/AAA-8336-2022; Bhattacharya, Shom/N-2926-2016; Kannabiran, Chitra/S-9361-2019	Bhattacharya, Shom/0000-0002-1601-6344; Kannabiran, Chitra/0000-0001-8435-0320; Jacobson, Samuel/0000-0003-2122-169X; Singh, Hardeep/0000-0002-9586-8544; Chang, Bo/0000-0001-8259-7290; Thompson, Debra/0000-0003-3485-0794; Swaroop, Anand/0000-0002-1975-1141; Branham, Kari/0000-0002-2492-254X	NEI NIH HHS [P30 EY007003, F31 EY007003, R01 EY011115, EY007003, EY007758, R01 EY007758, EY011115] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011115, R01EY007758] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551; Akhtar A, 2006, NAT CELL BIOL, V8, P3, DOI 10.1038/ncb0106-3; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Allikmets Rando, 2004, Ophthalmic Genet, V25, P67, DOI 10.1080/13816810490514261; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Banerjee P, 1998, NAT GENET, V18, P177, DOI 10.1038/ng0298-177; Bessant DAR, 1999, NAT GENET, V21, P355, DOI 10.1038/7678; Blackshaw S, 2001, CELL, V107, P579, DOI 10.1016/S0092-8674(01)00574-8; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; CHANDLER D, 1993, BIOCONTROL SCI TECHN, V3, P161, DOI 10.1080/09583159309355272; Chang B, 2005, VISUAL NEUROSCI, V22, P587, DOI 10.1017/S0952523805225075; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cioce M, 2005, ANNU REV CELL DEV BI, V21, P105, DOI 10.1146/annurev.cellbio.20.010403.103738; Daiger Stephen P, 2004, Novartis Found Symp, V255, P17; Danciger JS, 1999, MAMM GENOME, V10, P657, DOI 10.1007/s003359901067; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Fain GL, 2006, BIOESSAYS, V28, P344, DOI 10.1002/bies.20382; Friedman JS, 2004, J BIOL CHEM, V279, P47233, DOI 10.1074/jbc.M408298200; Friedman JS, 2000, INVEST OPHTH VIS SCI, V41, P2059; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; HECKENLIVELY JR, 1993, RETINAL DEGENERATION, P273; Janecke AR, 2004, NAT GENET, V36, P850, DOI 10.1038/ng1394; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; Keen TJ, 2002, EUR J HUM GENET, V10, P245, DOI 10.1038/sj.ejhg.5200797; Kennan A, 2005, TRENDS GENET, V21, P103, DOI 10.1016/j.tig.2004.12.001; Koenekoop RK, 2004, SURV OPHTHALMOL, V49, P379, DOI 10.1016/j.survophthal.2004.04.003; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lavorgna G, 2003, BIOCHEM BIOPH RES CO, V308, P414, DOI 10.1016/S0006-291X(03)01410-4; Linberg KA, 2005, VISUAL NEUROSCI, V22, P721, DOI 10.1017/S0952523805226044; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; NAKAI K, 1994, GENE, V141, P171, DOI 10.1016/0378-1119(94)90567-3; Pang JJ, 2005, MOL VIS, V11, P152; PiekeDahl S, 1997, HEARING RES, V112, P1, DOI 10.1016/S0378-5955(97)00087-7; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Rakoczy PE, 2006, EXP EYE RES, V82, P741, DOI 10.1016/j.exer.2005.10.012; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Rivolta C, 2002, HUM MOL GENET, V11, P1219, DOI 10.1093/hmg/11.10.1219; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Strudwick S, 2002, LEUKEMIA, V16, P1906, DOI 10.1038/sj.leu.2402724; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Weleber Richard G, 2005, Retina, V25, pS4, DOI 10.1097/00006982-200512001-00002; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	54	92	97	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1059	1070		10.1086/510021	http://dx.doi.org/10.1086/510021			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186464	Green Published, Bronze			2022-12-18	WOS:000242131600007
J	Morgan, NV; Brueton, LA; Cox, P; Greally, MT; Tolmie, J; Pasha, S; Aligianis, IA; van Bokhoven, H; Marton, T; Al-Gazali, L; Morton, JEV; Oley, C; Johnson, CA; Trembath, RC; Brunner, HG; Maher, ER				Morgan, Neil V.; Brueton, Louise A.; Cox, Phillip; Greally, Marie T.; Tolmie, John; Pasha, Shanaz; Aligianis, Irene A.; van Bokhoven, Hans; Marton, Tamas; Al-Gazali, Lihadh; Morton, Jenny E. V.; Oley, Christine; Johnson, Colin A.; Trembath, Richard C.; Brunner, Han G.; Maher, Eamonn R.			Mutations in the embryonal subunit of the acetylcholine receptor (CHRNG) cause lethal and escobar variants of multiple pterygium syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYASTHENIA-GRAVIS; FETAL; MUSCLE	Multiple pterygium syndromes (MPSs) comprise a group of multiple-congenital- anomaly disorders characterized by webbing (pterygia) of the neck, elbows, and/or knees and joint contractures (arthrogryposis). In addition, a variety of developmental defects (e.g., vertebral anomalies) may occur. MPSs are phenotypically and genetically heterogeneous but are traditionally divided into prenatally lethal and nonlethal (Escobar) types. To elucidate the pathogenesis of MPS, we undertook a genomewide linkage scan of a large consanguineous family and mapped a locus to 2q36-37. We then identified germline-inactivating mutations in the embryonal acetylcholine receptor g subunit (CHRNG) in families with both lethal and nonlethal MPSs. These findings extend the role of acetylcholine receptor dysfunction in human disease and provide new insights into the pathogenesis and management of fetal akinesia syndromes.	Univ Birmingham, Sect Med & Mol Genet, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Div Reprod & Child Hlth, WellChild Paediat Res Ctr, Birmingham B15 2TT, W Midlands, England; Birmingham Womens Hosp, Clin Genet Unit, Birmingham, W Midlands, England; Birmingham Womens Hosp, Dept Pathol, Birmingham, W Midlands, England; Saad Specialist Hosp, Al Khobar, Saudi Arabia; Royal Hosp Sick Children, Dept Clin Genet, Glasgow G3 8SJ, Lanark, Scotland; Univ Nijmegen, Med Ctr, Dept Human Genet, Nijmegen, Netherlands; United Arab Emirates Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; Kings Coll London, Sch Med, Div Genet & Mol Med, London WC2R 2LS, England	University of Birmingham; University of Birmingham; Birmingham Women's Hospital; Birmingham Women's Hospital; Saad Specialist Hospital; University of Glasgow; Radboud University Nijmegen; United Arab Emirates University; University of London; King's College London	Maher, ER (corresponding author), Univ Birmingham, Sect Med & Mol Genet, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England.	E.R.Maher@bham.ac.uk	Morgan, Neil/A-5475-2009; van Bokhoven, J.H.L.M. (Hans)/H-8015-2014; MAHER, EAMONN/A-9507-2008	Morgan, Neil/0000-0001-6433-5692; Marton, Tamas/0000-0001-5585-2276; van Bokhoven, J.H.L.M. (Hans)/0000-0002-2153-9254; Cox, Phillip/0000-0002-4636-5668; MAHER, EAMONN/0000-0002-6226-6918; Trembath, Richard/0000-0003-0550-3400	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Beeson David, 2005, Neuromuscul Disord, V15, P498, DOI 10.1016/j.nmd.2005.05.001; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Brownlow S, 2001, J CLIN INVEST, V108, P125, DOI 10.1172/JCI12935; Burke G, 2003, NEUROLOGY, V61, P826, DOI 10.1212/01.WNL.0000085865.55513.AE; Cox PM, 2003, PEDIATR DEVEL PATHOL, V6, P59, DOI 10.1007/s10024-002-0042-9; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Engel AG, 2003, ANN NY ACAD SCI, V998, P138, DOI 10.1196/annals.1254.016; ESCOBAR V, 1978, AM J DIS CHILD, V132, P609, DOI 10.1001/archpedi.1978.02120310073016; Froster UG, 1997, AM J MED GENET, V68, P82, DOI 10.1002/(SICI)1096-8628(19970110)68:1<82::AID-AJMG16>3.0.CO;2-K; HALL JG, 1984, AM J MED GENET, V17, P803, DOI 10.1002/ajmg.1320170410; HALL JG, 1982, AM J MED GENET, V12, P377, DOI 10.1002/ajmg.1320120404; HESSELMANS LFGM, 1993, ANAT REC, V236, P553, DOI 10.1002/ar.1092360315; Jurkat-Rott K, 2005, J CLIN INVEST, V115, P2000, DOI 10.1172/JCI25525; KUES WA, 1995, EUR J NEUROSCI, V7, P1376, DOI 10.1111/j.1460-9568.1995.tb01129.x; MISHINA M, 1986, NATURE, V321, P406, DOI 10.1038/321406a0; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Polizzi A, 2000, TERATOLOGY, V62, P332, DOI 10.1002/1096-9926(200011)62:5<332::AID-TERA7>3.3.CO;2-5; Rajab A, 2005, AM J MED GENET A, V134A, P151, DOI 10.1002/ajmg.a.30583; Takahashi M, 2002, EMBO REP, V3, P674, DOI 10.1093/embo-reports/kvf128; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; VERNETDERGARABEDIAN B, 1994, J CLIN INVEST, V94, P555, DOI 10.1172/JCI117369; VINCENT A, 1995, LANCET, V346, P24, DOI 10.1016/S0140-6736(95)92652-6	22	92	102	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					390	395		10.1086/506256	http://dx.doi.org/10.1086/506256			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826531	Bronze, Green Published			2022-12-18	WOS:000239040400022
J	Oates, NA; van Vliet, J; Duffy, DL; Kroes, HY; Martin, NG; Boomsma, DI; Campbell, M; Coulthard, MG; Whitelaw, E; Chong, S				Oates, N. A.; van Vliet, J.; Duffy, D. L.; Kroes, H. Y.; Martin, N. G.; Boomsma, D. I.; Campbell, M.; Coulthard, M. G.; Whitelaw, E.; Chong, S.			Increased DNA methylation at the AXIN1 gene in a monozygotic twin from a pair discordant for a caudal duplication anomaly	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EPIGENETIC DIFFERENCES; CPG ISLANDS; PHENOTYPE; IDENTIFY; SITES; WIDE	The AXIN1 gene has been implicated in caudal duplication anomalies. Its coding region was sequenced in both members of a monozygotic ( MZ) twin pair discordant for a caudal duplication anomaly, but no mutation was found. Using bisulfite sequencing, we examined methylation at the promoter region of the AXIN1 gene in these twins and in twin and age-matched singleton controls. Methylation of the promoter region in peripheral blood mononucleated cells was variable among individuals, including MZ pairs. In the MZ pair discordant for the caudal duplication, this region of the affected twin was significantly more methylated than that of the unaffected twin (), which was significantly more P < .0001 methylated than those of the controls (). We have confirmed that this CpG island does function as a promoter P = .02 in vitro and that its activity is inversely proportional to the extent of methylation. This finding raises the possibility that hypermethylation of the AXIN1 promoter, by mechanisms as yet undetermined, is associated with the malformation. This case may be paradigmatic for some cases of MZ discordance.	Queensland Inst Med Res, Brisbane, Qld 4006, Australia; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Royal Childrens Hosp, Dept Paediat & Child Hlth, Brisbane, Qld 4029, Australia; Univ Utrecht, Med Ctr, Dept Med Genet, Utrecht, Netherlands; Free Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands	QIMR Berghofer Medical Research Institute; University of Sydney; Royal Children's Hospital Brisbane; Utrecht University; Vrije Universiteit Amsterdam	Whitelaw, E (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	emma.whitelaw@qimr.edu.au	Coulthard, Mark G/AAT-7735-2021; Duffy, David L/B-7392-2013; Chong, Suyinn/B-6715-2012; Boomsma, Dorret I/AAX-4470-2020; Coulthard, Mark Graeme/E-9444-2010	Coulthard, Mark G/0000-0001-7400-5582; Duffy, David L/0000-0001-7227-632X; Chong, Suyinn/0000-0001-8062-7281; Coulthard, Mark Graeme/0000-0001-7400-5582; Campbell, Megan/0000-0002-6056-6140; Martin, Nicholas/0000-0003-4069-8020				ALLEN RC, 1992, AM J HUM GENET, V51, P1229; BATES D, 2005, IME4 LINEAR MIXED EF; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cooney CA, 2002, J NUTR, V132, p2393S; Daniels RJ, 2001, HUM MOL GENET, V10, P339, DOI 10.1093/hmg/10.4.339; DOMINGUEZ R, 1993, AM J DIS CHILD, V147, P1048, DOI 10.1001/archpedi.1993.02160340034009; Flint J, 1997, NAT GENET, V15, P252, DOI 10.1038/ng0397-252; FLODERUS B, 1988, INT J EPIDEMIOL, V17, P332, DOI 10.1093/ije/17.2.332; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Kroes HY, 2002, AM J MED GENET, V112, P390, DOI 10.1002/ajmg.10594; Ling JH, 2002, J VIROL, V76, P2410, DOI 10.1128/JVI.76.5.2410-2423.2002; Machin GA, 1996, AM J MED GENET, V61, P216, DOI 10.1002/(SICI)1096-8628(19960122)61:3<216::AID-AJMG5>3.0.CO;2-S; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Monteiro J, 1998, AM J HUM GENET, V63, P339, DOI 10.1086/301978; Petronis A, 2003, SCHIZOPHRENIA BULL, V29, P169, DOI 10.1093/oxfordjournals.schbul.a006988; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Torrey E. F., 1994, SCHIZOPHRENIA MANIC; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vasicek TJ, 1997, GENETICS, V147, P777; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; WOLFF GL, 1978, GENETICS, V88, P529; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhu G, 2004, TWIN RES, V7, P197, DOI 10.1375/136905204323016186	31	92	131	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2006	79	1					155	162		10.1086/505031	http://dx.doi.org/10.1086/505031			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	053YD	16773576	Green Published, Bronze			2022-12-18	WOS:000238341200017
J	Luo, XG; Kranzler, HR; Zuo, LJ; Wang, S; Schork, NJ; Gelernter, J				Luo, Xingguang; Kranzler, Henry R.; Zuo, Lingjun; Wang, Shuang; Schork, Nicholas J.; Gelernter, Joel			Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: Multiple significant associations with alcohol dependence	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAPLOTYPE RECONSTRUCTION; DEHYDROGENASE ISOENZYMES; ADH2-ASTERISK-2 ALLELE; METABOLISM GENES; DRUG-DEPENDENCE; LOCI; LINKAGE; RISK; POLYMORPHISM; GENOTYPES	The set of alcohol-metabolizing enzymes has considerable genetic and functional complexity. The relationships between some alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) genes and alcohol dependence (AD) have long been studied in many populations, but not comprehensively. In the present study, we genotyped 16 markers within the ADH gene cluster (including the ADH1A, ADH1B, ADH1C, ADH5, ADH6, and ADH7 genes), 4 markers within the ALDH2 gene, and 38 unlinked ancestry-informative markers in a case-control sample of 801 individuals. Associations between markers and disease were analyzed by a Hardy-Weinberg equilibrium (HWE) test, a conventional case-control comparison, a structured association analysis, and a novel diplotype trend regression (DTR) analysis. Finally, the disease alleles were fine mapped by a Hardy-Weinberg disequilibrium (HWD) measure (J). All markers were found to be in HWE in controls, but some markers showed HWD in cases. Genotypes of many markers were associated with AD. DTR analysis showed that ADH5 genotypes and diplotypes of ADH1A, ADH1B, ADH7, and ALDH2 were associated with AD in European Americans and/or African Americans. The risk-influencing alleles were fine mapped from among the markers studied and were found to coincide with some well-known functional variants. We demonstrated that DTR was more powerful than many other conventional association methods. We also found that several ADH genes and the ALDH2 gene were susceptibility loci for AD, and the associations were best explained by several independent risk genes.	Yale Univ, Sch Med, Dept Psychiat, West Haven, CT 06516 USA; VA Connecticut Healthcare Syst, West Haven, CT USA; Univ Connecticut, Sch Med, Dept Psychiat, Alcohol Res Ctr, Farmington, CT USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Connecticut; Columbia University; University of California System; University of California San Diego	Gelernter, J (corresponding author), Yale Univ, Sch Med, Dept Psychiat, VA Psychiat 116A2,950 Campbell Ave, West Haven, CT 06516 USA.	joel.gelernter@yale.edu	kranzler, henry/AAS-1113-2020	kranzler, henry/0000-0002-1018-0450; Schork, Nicholas/0000-0003-0920-5013; Gelernter, Joel/0000-0002-4067-1859	NCRR NIH HHS [M01 RR006192, M01-RR06192] Funding Source: Medline; NIAAA NIH HHS [K08-AA13732, K24-AA13736, R01 AA011330, K24 AA013736, P50-AA12870, P50 AA012870, K08 AA013732, R01-AA11330] Funding Source: Medline; NIDA NIH HHS [R01-DA12690, R01 DA012690, R01-DA12849, K24-DA15105, R01 DA012849, K24 DA015105] Funding Source: Medline; NIMH NIH HHS [K02-MH01387] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR006192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA013732, R01AA011330, K24AA013736, P50AA012870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012849, K24DA015105, R01DA012690] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Borras E, 2000, HEPATOLOGY, V31, P984, DOI 10.1053/he.2000.5978; Ccok NR, 2004, STAT MED, V23, P1439, DOI 10.1002/sim.1749; Chao You-Chen, 1994, Proceedings of the National Science Council Republic of China Part B Life Sciences, V18, P101; Chen CC, 1999, AM J HUM GENET, V65, P795, DOI 10.1086/302540; Chen WJ, 1996, BRIT J PSYCHIAT, V168, P762, DOI 10.1192/bjp.168.6.762; Chiano MN, 1998, ANN HUM GENET, V62, P55, DOI 10.1046/j.1469-1809.1998.6210055.x; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Dong CH, 2003, AM J HUM GENET, V72, P115, DOI 10.1086/345648; EAVES L J, 1984, Genetic Epidemiology, V1, P215, DOI 10.1002/gepi.1370010302; Edenberg HJ, 2000, PROG NUCLEIC ACID RE, V64, P295, DOI 10.1016/S0079-6603(00)64008-4; EDMAN K, 1992, HUM GENET, V90, P395; Ehlers CL, 2004, AM J MED GENET B, V129B, P110, DOI 10.1002/ajmg.b.30057; Ehlers CL, 2001, ALCOHOL CLIN EXP RES, V25, P1773; Fallin D, 2000, AM J HUM GENET, V67, P947, DOI 10.1086/303069; Falush D, 2003, GENETICS, V164, P1567; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Foroud T, 2003, AM J HUM GENET, V73, P521; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauderman WJ, 1997, AM J HUM GENET, V61, P1189, DOI 10.1086/301597; Guindalini C, 2005, AM J PSYCHIAT, V162, P1005, DOI 10.1176/appi.ajp.162.5.1005; Haan C.T., 2002, STAT METHODS HYDROLO; Hao K, 2004, GENET EPIDEMIOL, V26, P22, DOI 10.1002/gepi.10293; Hara K, 2000, LIFE SCI, V67, P1163, DOI 10.1016/S0024-3205(00)00707-4; Hasin D, 2002, AM J PSYCHIAT, V159, P1432, DOI 10.1176/appi.ajp.159.8.1432; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001; IWAHASHI K, 1995, ALCOHOL CLIN EXP RES, V19, P564, DOI 10.1111/j.1530-0277.1995.tb01549.x; Jiang R, 2001, ANN HUM GENET, V65, P207, DOI 10.1017/S0003480001008570; Kaufman J, 2004, P NATL ACAD SCI USA, V101, P17316, DOI 10.1073/pnas.0404376101; Konishi T, 2003, EXP MOL PATHOL, V74, P183, DOI 10.1016/S0014-4800(03)00006-6; Lee WC, 2003, AM J EPIDEMIOL, V158, P397, DOI 10.1093/aje/kwg150; LI TK, 1977, P NATL ACAD SCI USA, V74, P4378, DOI 10.1073/pnas.74.10.4378; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; LUO X, 2005, ADH4 GENE VARIATION; Luo XG, 2005, PHARMACOGENET GENOM, V15, P755, DOI 10.1097/01.fpc.0000180141.77036.dc; Luo XG, 2005, HUM MOL GENET, V14, P2421, DOI 10.1093/hmg/ddi244; Luo XG, 2004, BIOL PSYCHIAT, V55, P112, DOI 10.1016/S0006-3223(03)00588-2; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McCarthy DM, 2000, EXP CLIN PSYCHOPHARM, V8, P168, DOI 10.1037/1064-1297.8.2.168; Mulligan CJ, 2003, HUM GENET, V113, P325, DOI 10.1007/s00439-003-0971-z; Nakamura K, 1995, Arukoru Kenkyuto Yakubutsu Ison, V30, P33; Nakamura K, 1996, ALCOHOL CLIN EXP RES, V20, P52, DOI 10.1111/j.1530-0277.1996.tb01043.x; Neumark YD, 1998, J STUD ALCOHOL, V59, P133, DOI 10.15288/jsa.1998.59.133; Nielsen DM, 1998, AM J HUM GENET, V63, P1531, DOI 10.1086/302114; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Osier M, 1999, AM J HUM GENET, V64, P1147, DOI 10.1086/302317; Osier MV, 2004, AM J MED GENET B, V126B, P19, DOI 10.1002/ajmg.b.20136; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Peterson RJ, 1999, HUM GENET, V104, P177, DOI 10.1007/s004390050932; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Saccone NL, 2000, AM J MED GENET, V96, P632, DOI 10.1002/1096-8628(20001009)96:5<632::AID-AJMG8>3.0.CO;2-#; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; SELF SG, 1991, BIOMETRICS, V47, P53, DOI 10.2307/2532495; Shea P., 2001, ONLINE ED, P31, DOI 10.24059/olj.v4i3.1897; Shen YC, 1997, ALCOHOL CLIN EXP RES, V21, P1272, DOI 10.1111/j.1530-0277.1997.tb04448.x; Shi MM, 1999, J CLIN PATHOL-MOL PA, V52, P295, DOI 10.1136/mp.52.5.295; SMITH M, 1973, ANN HUM GENET, V36, P401, DOI 10.1111/j.1469-1809.1973.tb00604.x; SMITH M, 1972, ANN HUM GENET, V35, P243, DOI 10.1111/j.1469-1809.1957.tb01398.x; Stein MB, 2004, BIOL PSYCHIAT, V56, P217, DOI 10.1016/j.biopsych.2004.05.020; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tanaka F, 1996, HEPATOLOGY, V23, P234, DOI 10.1002/hep.510230206; THOMASSON HR, 1994, ALCOHOL CLIN EXP RES, V18, P640, DOI 10.1111/j.1530-0277.1994.tb00923.x; TIRET L, 1993, GENET EPIDEMIOL, V10, P581, DOI 10.1002/gepi.1370100642; Valdes AM, 1997, AM J HUM GENET, V60, P703; Wang S, 2003, AM J EPIDEMIOL, V158, P899, DOI 10.1093/aje/kwg233; Williams JT, 1999, AM J HUM GENET, V65, P1148, DOI 10.1086/302571; Wittke-Thompson JK, 2005, AM J HUM GENET, V76, P967, DOI 10.1086/430507; Yang BZ, 2005, GENET EPIDEMIOL, V28, P302, DOI 10.1002/gepi.20070; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; ZGOMBICKNIGHT M, 1995, J BIOL CHEM, V270, P4305, DOI 10.1074/jbc.270.9.4305; Zinn-Justin A, 1999, GENET EPIDEMIOL, V17, pS421	82	92	96	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					973	987		10.1086/504113	http://dx.doi.org/10.1086/504113			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685648	Bronze, Green Published			2022-12-18	WOS:000237553800007
J	Li, MY; Boehnke, M; Abecasis, GR				Li, MY; Boehnke, M; Abecasis, GR			Joint modeling of linkage and association: Identifying SNPs responsible for a linkage signal	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; QUANTITATIVE TRAIT LOCI; TRANSMISSION-DISEQUILIBRIUM; ASYMPTOTIC PROPERTIES; DIABETES-MELLITUS; GENETIC-VARIATION; CROHNS-DISEASE; PEDIGREES; TESTS; SUSCEPTIBILITY	Once genetic linkage has been identified for a complex disease, the next step is often association analysis, in which single-nucleotide polymorphisms (SNPs) within the linkage region are genotyped and tested for association with the disease. If a SNP shows evidence of association, it is useful to know whether the linkage result can be explained, in part or in full, by the candidate SNP. We propose a novel approach that quantifies the degree of linkage disequilibrium (LD) between the candidate SNP and the putative disease locus through joint modeling of linkage and association. We describe a simple likelihood of the marker data conditional on the trait data for a sample of affected sib pairs, with disease penetrances and disease-SNP haplotype frequencies as parameters. We estimate model parameters by maximum likelihood and propose two likelihood-ratio tests to characterize the relationship of the candidate SNP and the disease locus. The first test assesses whether the candidate SNP and the disease locus are in linkage equilibrium so that the SNP plays no causal role in the linkage signal. The second test assesses whether the candidate SNP and the disease locus are in complete LD so that the SNP or a marker in complete LD with it may account fully for the linkage signal. Our method also yields a genetic model that includes parameter estimates for disease-SNP haplotype frequencies and the degree of disease-SNP LD. Our method provides a new tool for detecting linkage and association and can be extended to study designs that include unaffected family members.	Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Stat Genet, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Li, MY (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Biostat, 1420 Washington Heights, Ann Arbor, MI 48109 USA.	myli@umich.edu	Abecasis, Goncalo R/B-7840-2010	Abecasis, Goncalo/0000-0003-1509-1825	NHGRI NIH HHS [R01 HG002651, HG00376, HG02651, R01 HG000376] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002651, R29HG000376, R01HG000376] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Allison DB, 1997, AM J HUM GENET, V60, P676; Baum LE, 1972, INEQUALITIES, V3, P1; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Cantor RM, 2005, AM J HUM GENET, V76, P538, DOI 10.1086/428628; Cardon LR, 2000, BEHAV GENET, V30, P235, DOI 10.1023/A:1001970425822; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fulker DW, 1999, AM J HUM GENET, V64, P259, DOI 10.1086/302193; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Haldane JBS, 1919, J GENET, V8, P299; HOLMANS P, 1993, AM J HUM GENET, V52, P362; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Li C, 2004, AM J HUM GENET, V74, P418, DOI 10.1086/381712; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Olivier M, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf052; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; RISCH N, 1990, AM J HUM GENET, V46, P229; RISCH N, 1987, AM J HUM GENET, V40, P1; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Sun L, 2002, AM J HUM GENET, V70, P399, DOI 10.1086/338660; Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535; THOMPSON EA, 1975, ANN HUM GENET, V39, P173, DOI 10.1111/j.1469-1809.1975.tb00120.x	34	92	94	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					934	949		10.1086/430277	http://dx.doi.org/10.1086/430277			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15877278	Green Published, Bronze			2022-12-18	WOS:000229047900003
J	Souto, JC; Blanco-Vaca, F; Soria, JM; Buil, A; Almasy, L; Ordonez-Llanos, J; Martin-Campos, JM; Lathrop, M; Stone, W; Blangero, J; Fontcuberta, J				Souto, JC; Blanco-Vaca, F; Soria, JM; Buil, A; Almasy, L; Ordonez-Llanos, J; Martin-Campos, JM; Lathrop, M; Stone, W; Blangero, J; Fontcuberta, J			A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: Results from the GAIT project	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; RISK-FACTOR; HYPERHOMOCYSTEINEMIA; THROMBOSIS; DISEASE; SUSCEPTIBILITY; PEDIGREE; DEMENTIA; LOCUS	Homocysteine (Hcy) plasma level is an independent risk marker for venous thrombosis, myocardial infarction, stroke, congestive heart failure, osteoporotic fractures, and Alzheimer disease. Hcy levels are determined by the interaction of genetic and environmental factors. The genetic basis is still poorly understood, since only the MTHFR 677 C -> T polymorphism has been consistently associated with plasma Hcy levels. We conducted a genomewide linkage scan for genes affecting variation in plasma Hcy levels in 398 subjects from 21 extended Spanish families. A variance-components linkage method was used to analyze the data. The strongest linkage signal (LOD score of 3.01; genomewide P = .035) was found on chromosome 11q23, near marker D11S908, where a candidate gene involved in the metabolism of Hcy (the nicotinamide N-methyltransferase gene [NNMT]) is mapped. Haplotype analyses of 10 single-nucleotide polymorphisms within this gene found one haplotype associated with plasma Hcy levels ( P = .0003). Our results, to our knowledge, represent the first genomic scan for quantitative variation in Hcy plasma levels. They strongly suggest that the NNMT gene could be a major genetic determinant of plasma Hcy levels in Spanish families. Since this gene encodes an enzyme involved in Hcy synthesis, this finding would be consistent with known biochemical pathways. These data could be relevant in determining the relationships between Hcy level, cardiovascular disease, osteoporosis, and Alzheimer disease.	Hosp Santa Creu & Sant Pau, Unitat Trombosi & Hemostasia, E-08025 Barcelona, Spain; Hosp Santa Creu & Sant Pau, Dept Hematol, Barcelona, Spain; Hosp Santa Creu & Sant Pau, Serv Bioquim, Barcelona, Spain; SW Fdn Biomed Res, Dept Genet, San Antonio, TX USA; Ctr Natl Genotypage, Evry, France	Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Texas Biomedical Research Institute; CEA; UDICE-French Research Universities; Universite Paris Saclay	Souto, JC (corresponding author), Hosp Santa Creu & Sant Pau, Unitat Trombosi & Hemostasia, Sant Antoni Ma Claret 167, E-08025 Barcelona, Spain.	jsouto@hsp.santpau.es	Blangero, John/ABA-7175-2021; Almasy, Laura/V-3156-2019; Martín-Campos, Jesús M./AAQ-5478-2021; Ordonez-Llanos, Jordi/B-4961-2011; Soria Fernández, José Manuel/AAD-6761-2019; Blanco-Vaca, Francisco/AAC-2600-2022; Martín-Campos, Jesús Maria/AGJ-2586-2022; Ordonez-Llanos, Jorge/AAE-3088-2020; Ordonez-Llanos, Jorge/A-9335-2010; Ordonez-Llanos, Jorge/N-1126-2019	Ordonez-Llanos, Jordi/0000-0003-4896-5832; Soria Fernández, José Manuel/0000-0002-6226-4293; Martín-Campos, Jesús Maria/0000-0003-0414-037X; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Ordonez-Llanos, Jorge/0000-0003-4896-5832; Blanco-Vaca, Francisco/0000-0001-7380-5385; Buil, Alfonso/0000-0002-3097-1014	NHLBI NIH HHS [R01 HL070751, HL70751] Funding Source: Medline; NIMH NIH HHS [R01 MH059490, R37 MH059490, MH59490] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490, R37MH059490] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; AKSOY S, 1994, J BIOL CHEM, V269, P14835; Almasy L, 2004, BEHAV GENET, V34, P173, DOI 10.1023/B:BEGE.0000013731.03827.69; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Blanco-Vaca F, 2000, CLIN CHEM LAB MED, V38, P327, DOI 10.1515/CCLM.2000.047; Blangero J, 2000, GENET EPIDEMIOL, V19, pS8, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI2>3.0.CO;2-Y; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; BRATTSTROM L, 1994, J INTERN MED, V236, P633, DOI 10.1111/j.1365-2796.1994.tb00856.x; Cattaneo M, 1999, THROMB HAEMOSTASIS, V81, P165; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Hasstedt SJ, 2004, J THROMB HAEMOST, V2, P868, DOI 10.1111/j.1538-7836.2004.00663.x; Husemoen LLN, 2003, GENET EPIDEMIOL, V24, P322, DOI 10.1002/gepi.10239; Jee SH, 2002, HUM GENET, V111, P128, DOI 10.1007/s00439-002-0757-8; Kluijtmans LAJ, 2003, BLOOD, V101, P2483, DOI 10.1182/blood.V101.7.2483; McIlroy SP, 2002, STROKE, V33, P2351, DOI 10.1161/01.STR.0000032550.90046.38; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Morris MS, 2003, LANCET NEUROL, V2, P425, DOI 10.1016/S1474-4422(03)00438-1; Morris MS, 2001, AM J CLIN NUTR, V73, P927; Noga AA, 2003, J BIOL CHEM, V278, P5952, DOI 10.1074/jbc.M212194200; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Smith ML, 1998, BBA-GENE STRUCT EXPR, V1442, P238, DOI 10.1016/S0167-4781(98)00177-8; Sobel E, 1996, AM J HUM GENET, V58, P1323; Soria JM, 2003, BLOOD, V101, P163, DOI 10.1182/blood-2002-06-1792; Soria JM, 2002, AM J HUM GENET, V70, P567, DOI 10.1086/339259; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Vasan RS, 2003, JAMA-J AM MED ASSOC, V289, P1251, DOI 10.1001/jama.289.10.1251; Wald DS, 2002, BMJ-BRIT MED J, V325, P1202, DOI 10.1136/bmj.325.7374.1202; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570; Yan L, 1999, PHARMACOGENETICS, V9, P307, DOI 10.1097/00008571-199906000-00005	34	92	95	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2005	76	6					925	933		10.1086/430409	http://dx.doi.org/10.1086/430409			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	925IX	15849667	Green Published, Bronze			2022-12-18	WOS:000229047900002
J	Hoffjan, S; Nicolae, D; Ostrovnaya, I; Roberg, K; Evans, M; Mirel, DB; Steiner, L; Walker, K; Shult, P; Gangnon, RE; Gern, JE; Martinez, FD; Lemanske, RF; Ober, C				Hoffjan, S; Nicolae, D; Ostrovnaya, I; Roberg, K; Evans, M; Mirel, DB; Steiner, L; Walker, K; Shult, P; Gangnon, RE; Gern, JE; Martinez, FD; Lemanske, RF; Ober, C			Gene-environment interaction effects on the development of immune responses in the 1st year of life	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTERFERON-GAMMA PRODUCTION; DAY-CARE ATTENDANCE; BLOOD MONONUCLEAR-CELLS; HIGH-RISK; HYGIENE HYPOTHESIS; IFN-GAMMA; T-CELLS; ASTHMA; ATOPY; AGE	Asthma is a common disease that results from both genetic and environmental risk factors. Children attending day care in the 1st year of life have lower risks for developing asthma, although the mechanism for this "day care" effect is largely unknown. We investigated the interactions between day care exposure in the 1st 6 mo of life and genotypes for 72 polymorphisms at 45 candidate loci and their effects on cytokine response profiles and on the development of atopic phenotypes in the 1st year of life in the Childhood Onset of Asthma ( COAST) cohort of children. Six interactions ( at four polymorphisms in three loci) with "day care" that had an effect on early-life immune phenotypes were significant at P < .001. The estimated false-discovery rate was 33%, indicating that an estimated four P values correspond to true associations. Moreover, the " day care" effect at some loci was accounted for by the increased number of viral infections among COAST children attending day care, whereas interactions at other loci were independent of the number of viral infections, indicating the presence of additional risk factors associated with day care environment. This study identified significant gene-environment interactions influencing the early patterning of the immune system and the subsequent development of asthma and highlights the importance of considering environmental risk factors in genetic analyses.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA; Univ Wisconsin, Dept Pediat, Madison, WI USA; Univ Wisconsin, Dept Med, Madison, WI USA; Univ Wisconsin, Dept Biostat & Med Bioinformat, Madison, WI USA; Univ Wisconsin, Wisconsin State Lab Hyg, Madison, WI 53706 USA; Roche Mol Syst, Alameda, CA USA; Univ Arizona, Tucson Resp Ctr, Tucson, AZ USA	University of Chicago; University of Chicago; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Roche Holding; University of Arizona	Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 507C, Chicago, IL 60637 USA.	c-ober@genetics.uchicago.edu		Evans, Michael/0000-0001-7449-3993; Nicolae, Dan/0000-0002-0918-4630; Ober, Carole/0000-0003-4626-9809	NCRR NIH HHS [M01 RR03186, M01 RR003186] Funding Source: Medline; NHLBI NIH HHS [P01 HL70831, R01 HL61879, P01 HL070831] Funding Source: Medline; NICHD NIH HHS [R01 HD061879] Funding Source: Medline; NIDDK NIH HHS [R01 DK055889, R01 DK55889] Funding Source: Medline; NIMH NIH HHS [R01 MH061879] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR003186] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831, R01HL061879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055889] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Barr CS, 2004, ARCH GEN PSYCHIAT, V61, P1146, DOI 10.1001/archpsyc.61.11.1146; Beasley R, 2002, J ALLERGY CLIN IMMUN, V109, pS482, DOI 10.1067/mai.2002.122716; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman DM, 2004, CANCER RES, V64, P6820, DOI 10.1158/0008-5472.CAN-04-1916; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Braun-Fahrlander C, 2001, CLIN EXP ALLERGY, V31, P1799, DOI 10.1046/j.1365-2222.2001.01269.x; BURR M L, 1989, Archives of Disease in Childhood, V64, P1452, DOI 10.1136/adc.64.10.1452; Celedon JC, 1999, PEDIATRICS, V104, P495, DOI 10.1542/peds.104.3.495; Celedon JC, 2003, AM J RESP CRIT CARE, V167, P1239, DOI 10.1164/rccm.200209-1063OC; Colilla S, 2003, J ALLERGY CLIN IMMUN, V111, P840, DOI 10.1067/mai.2003.170; Copenhaver CC, 2004, AM J RESP CRIT CARE, V170, P175, DOI 10.1164/rccm.200312-1647OC; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; Dilda CL, 2002, GENETICS, V162, P1655; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gern JE, 2004, J ALLERGY CLIN IMMUN, V113, P307, DOI 10.1016/j.jaci.2003.11.017; Haby MM, 2000, PEDIATR PULM, V30, P377, DOI 10.1002/1099-0496(200011)30:5<377::AID-PPUL3>3.3.CO;2-V; Hoffjan S, 2004, J ALLERGY CLIN IMMUN, V113, P511, DOI 10.1016/j.jaci.2003.10.044; Hoffjan S, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-14; HOLT PG, 1992, CLIN EXP ALLERGY, V22, P1093, DOI 10.1111/j.1365-2222.1992.tb00135.x; Kondo N, 1998, CLIN EXP ALLERGY, V28, P1340; Koppelman GH, 2003, CLIN EXP ALLERGY, V33, P170, DOI 10.1046/j.1365-2222.2003.01591.x; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Lemanske RF, 2002, PEDIAT ALLERG IMM-UK, V13, P38, DOI 10.1034/j.1399-3038.13.s.15.8.x; Leng SG, 2004, CANCER EPIDEM BIOMAR, V13, P1631; Liao SY, 1996, CLIN EXP ALLERGY, V26, P397, DOI 10.1111/j.1365-2222.1996.tb00555.x; Liu AH, 2003, J ALLERGY CLIN IMMUN, V111, P471, DOI 10.1067/mai.2003.172; Martin LJ, 2002, GENET EPIDEMIOL, V22, P105, DOI 10.1002/gepi.0135; MARTINEZ FD, 1995, J ALLERGY CLIN IMMUN, V96, P652, DOI 10.1016/S0091-6749(95)70264-4; Martinez FD, 2001, RESPIR RES, V2, P129, DOI 10.1186/rr48; McIntire JJ, 2004, SPRINGER SEMIN IMMUN, V25, P335, DOI 10.1007/s00281-003-0141-3; Merikangas KR, 2003, SCIENCE, V302, P599, DOI 10.1126/science.1091468; Mirel DB, 2002, DIABETES, V51, P3336, DOI 10.2337/diabetes.51.11.3336; Neaville WA, 2003, J ALLERGY CLIN IMMUN, V112, P740, DOI 10.1016/S0091-6749(03)01868-2; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Padyukov L, 2004, ARTHRITIS RHEUM, V50, P3085, DOI 10.1002/art.20553; Pohl D, 1997, ALLERGY, V52, P732, DOI 10.1111/j.1398-9995.1997.tb01230.x; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; Rinas U, 1993, Pediatr Allergy Immunol, V4, P60, DOI 10.1111/j.1399-3038.1993.tb00068.x; Rowe J, 2004, J ALLERGY CLIN IMMUN, V113, P710, DOI 10.1016/j.jaci.2003.12.585; Sheikh A, 2003, J ALLERGY CLIN IMMUN, V111, P131, DOI 10.1067/mai.2003.8; Smart JM, 2002, CLIN EXP ALLERGY, V32, P796, DOI 10.1046/j.1365-2222.2002.01391.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; TANG M, 1993, CLIN EXP IMMUNOL, V92, P120; TANG MLK, 1994, LANCET, V344, P983, DOI 10.1016/S0140-6736(94)91641-1; Umetsu DT, 2003, J ALLERGY CLIN IMMUN, V112, P480, DOI 10.1067/mai.2003.1717; Ungerer MC, 2003, GENETICS, V165, P353; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230; VONMUTIUS E, 1994, BRIT MED J, V308, P692, DOI 10.1136/bmj.308.6930.692; WARNER JA, 1994, CLIN EXP ALLERGY, V24, P423, DOI 10.1111/j.1365-2222.1994.tb00930.x; Weiss LA, 2005, AM J HUM GENET, V76, P33, DOI 10.1086/426697; Weiss ST, 2002, NEW ENGL J MED, V347, P930, DOI 10.1056/NEJMe020092; Werner M, 2003, J ALLERGY CLIN IMMUN, V112, P323, DOI 10.1067/mai.2003.1648; Wickens KL, 1999, EPIDEMIOLOGY, V10, P699, DOI 10.1097/00001648-199911000-00009	57	92	95	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					696	704		10.1086/429418	http://dx.doi.org/10.1086/429418			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15726497	Green Published, Bronze			2022-12-18	WOS:000227516000016
J	Painter, JN; Tapanainen, H; Somer, M; Tukiainen, P; Aittomaki, K				Painter, JN; Tapanainen, H; Somer, M; Tukiainen, P; Aittomaki, K			A 4-bp deletion in the Birt-Hogg-Dube gene (FLCN) causes dominantly inherited spontaneous pneumothorax	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL SPONTANEOUS PNEUMOTHORAX; RENAL-CELL CARCINOMA; BHD GENE; PULMONARY-DISEASE; MUTATION; CANCER; TUMORS; RISK	Primary spontaneous pneumothorax (PSP), a condition in which air enters the pleural space and causes secondary lung collapse, is mostly sporadic but also occurs in families. The precise etiology of PSP remains unknown, although it is associated with emphysemalike changes ( bullae) in the lungs of almost all patients. We describe the results of a genetic study of a large Finnish family with a dominantly inherited tendency to PSP. A genomewide scan suggested linkage to chromosome 17p11. Screening of the best candidate gene, FLCN, revealed a 4-bp deletion in the first coding exon, which causes a frameshift that predicts a protein truncation 50 missense amino acids downstream. All carriers of the deletion had bullous lung lesions. Mutations in FLCN are also responsible for Birt-Hogg- Dube (BHD) syndrome ( a dominantly inherited disease characterized by benign skin tumors, PSP, and diverse types of renal cancer) and, rarely, are detected in sporadic renal and colorectal tumors. Unlike other FLCN mutations, the exon 4 deletion seems to be associated with bullous lung changes only with 100% penetrance. These results suggest that changes in FLCN may have an important role in the development of PSP and, more importantly, of emphysema, a chronic pulmonary disease that often leads to formation of bullous lesions and lowered pulmonary function. Additionally, given the strong association of PSP and BHD, the connection between these conditions needs to be investigated further, particularly in patients with familial PSP, who may be at a greater risk of developing renal cancer.	Univ Helsinki, Biomedicum helsinki, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland; Family Federat Finland, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Pulm Med, Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Clin Genet, Helsinki, Finland	University of Helsinki; Family Federation of Finland; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital	Painter, JN (corresponding author), Univ Helsinki, Biomedicum helsinki, Folkhalsan Inst Genet, POB 63, FIN-00014 Helsinki, Finland.	jodie.painter@helsinki.fi	Painter, Jodie N/AAC-6332-2019	Painter, Jodie N/0000-0002-4992-2458				ABOLNIK IZ, 1991, AM J MED GENET, V40, P155, DOI 10.1002/ajmg.1320400207; Bagchi I, 2002, ARCH DIS CHILD-FETAL, V87, pF70, DOI 10.1136/fn.87.1.F70; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; BENSE L, 1987, EUR J RESPIR DIS, V71, P181; BENSE L, 1987, CHEST, V92, P1009, DOI 10.1378/chest.92.6.1009; BIRT AR, 1977, ARCH DERMATOL, V113, P1674, DOI 10.1001/archderm.113.12.1674; Choyke PL, 2003, RADIOLOGY, V226, P33, DOI 10.1148/radiol.2261011296; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; da Silva NF, 2003, J MED GENET, V40, P820; Daniel R, 2000, Respir Care, V45, P327; Dowton SB, 1996, CLIN GENET, V50, P510; DWYER EM, 1965, ANN INTERN MED, V62, P1285, DOI 10.7326/0003-4819-62-6-1285; Fukuda Y, 1994, AM J RESP CRIT CARE, V149, pA1022; Kahnoski K, 2003, J MED GENET, V40, P511, DOI 10.1136/jmg.40.7.511; Khoo SK, 2003, CANCER RES, V63, P4583; Khoo SK, 2002, J MED GENET, V39, P906, DOI 10.1136/jmg.39.12.906; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Koivisto PA, 2001, CHEST, V119, P1610, DOI 10.1378/chest.119.5.1610; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; MELTON LJ, 1979, AM REV RESPIR DIS, V120, P1379; Morrison PJ, 1998, THORAX, V53, P151, DOI 10.1136/thx.53.2.151; Nagy A, 2004, INT J CANCER, V109, P472, DOI 10.1002/ijc.11694; Nickerson ML, 2002, CANCER CELL, V2, P157, DOI 10.1016/S1535-6108(02)00104-6; Okimoto K, 2004, P NATL ACAD SCI USA, V101, P2023, DOI 10.1073/pnas.0308071100; PRIMROSE WR, 1984, SCOT MED J, V29, P15, DOI 10.1177/003693308402900105; Sahn SA, 2000, NEW ENGL J MED, V342, P868, DOI 10.1056/NEJM200003233421207; Schramel FMNH, 2001, CHEST, V119, P1976, DOI 10.1378/chest.119.6.1976-a; Schramel FMNH, 1997, EUR RESPIR J, V10, P1372, DOI 10.1183/09031936.97.10061372; SHARPE IK, 1980, CHEST, V78, P264, DOI 10.1378/chest.78.2.264; Shin JH, 2003, J MED GENET, V40, P364, DOI 10.1136/jmg.40.5.364; Suki B, 2003, AM J RESP CRIT CARE, V168, P516, DOI 10.1164/rccm.200208-908PP; Vincent A, 2003, J AM ACAD DERMATOL, V49, P698, DOI 10.1067/S0190-9622(03)01582-2; Warren MB, 2004, MODERN PATHOL, V17, P998, DOI 10.1038/modpathol.3800152; Yamada Akitoshi, 2003, Jpn J Thorac Cardiovasc Surg, V51, P456, DOI 10.1007/BF02719603; Zbar B, 2002, CANCER EPIDEM BIOMAR, V11, P393	36	92	98	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2005	76	3					522	527		10.1086/428455	http://dx.doi.org/10.1086/428455			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	895HO	15657874	Green Published, Bronze			2022-12-18	WOS:000226851900015
J	Begovich, AB; Caillier, SJ; Alexander, HC; Penko, JM; Hauser, SL; Barcellos, LF; Oksenberg, JR				Begovich, AB; Caillier, SJ; Alexander, HC; Penko, JM; Hauser, SL; Barcellos, LF; Oksenberg, JR			The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							AUTOIMMUNE-DISEASE; GENERAL PEDIGREES; KINASE P50(CSK); T-CELLS; SUSCEPTIBILITY; COMPLEX; PEP; LINKAGE; IDENTIFICATION; HETEROGENEITY		Celera Diagnost, Alameda, CA 94502 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley	Begovich, AB (corresponding author), Celera Diagnost, 1401 Harbor Bay Pkwy, Alameda, CA 94502 USA.	Ann.Begovich@celeradiagnostics.com	Hauser, Stephen L/J-2978-2016		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046297] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS046297, NS 46297] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baranzini SE, 1999, J IMMUNOL, V163, P5133; Barcellos LF, 2002, BRAIN, V125, P150; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Gjorloff-Wingren A, 1999, EUR J IMMUNOL, V29, P3845, DOI 10.1002/(SICI)1521-4141(199912)29:12<3845::AID-IMMU3845>3.0.CO;2-U; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hasegawa K, 2004, SCIENCE, V303, P685, DOI 10.1126/science.1092138; Hauser SL, 2001, HARRISONS PRINC INT, V2, P2452; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; LEE AT, IN PRESS GENES IMMUN; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Marrack P, 2001, NAT MED, V7, P899, DOI 10.1038/90935; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Martin ER, 2003, GENET EPIDEMIOL, V25, P203, DOI 10.1002/gepi.10258; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rubio JP, 2002, AM J HUM GENET, V70, P1125, DOI 10.1086/339932; Sawcer S, 1996, NAT GENET, V13, P464, DOI 10.1038/ng0896-464; Wandstrat A, 2001, NAT IMMUNOL, V2, P802, DOI 10.1038/ni0901-802	27	92	95	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					184	187		10.1086/427244	http://dx.doi.org/10.1086/427244			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15580548	Green Published, Bronze			2022-12-18	WOS:000225643600019
J	Song, YQ; Niu, TH; Manson, JAE; Kwiatkowski, DJ; Liu, SM				Song, YQ; Niu, TH; Manson, JAE; Kwiatkowski, DJ; Liu, SM			Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; HUMAN FAT-CELLS; CALPAIN-10 GENE; INSULIN-RESISTANCE; NONDIABETIC SUBJECTS; HAPLOTYPE STRUCTURE; GLUCOSE LEVELS; MELLITUS; SUSCEPTIBILITY; JAPANESE	The calpain-10 gene (CAPN10) on chromosome 2q37.3 was the first candidate gene for type 2 diabetes (T2D) identified through a genomewide screen and positional cloning. One polymorphism (UCSNP-43: G-->A) and a specific haplotype combination defined by three polymorphisms (UCSNP-43, -19, and -63) were linked to an increased risk of T2D in several populations. To quantitatively assess the collective evidence for the effects of CAPN10 on risk of T2D, we conducted a meta-analysis of both population-based and family-based association studies. We retrieved data from the MEDLINE, PubMed, and Online Mendelian Inheritance in Man databases, as well as from other relevant reports and abstracts published up to July 2003. From a total of 26 studies with primary data (21 population-based studies: 5,013 cases and 5,876 controls; 5 family-based studies: 487 parent-offspring trios), we developed a summary database that contains variables of study design, study population/ethnicity, specific polymorphisms and haplotype combinations in CAPN10, and diabetes-related metabolic phenotypes. For population-based studies, we used both fixed-effects and random-effects models to calculate the pooled odds ratio (OR) and 95% confidence interval (CI) for the associations of CAPN10 genotypes with the risk of T2D. We also calculated weighted mean differences for the associations between CAPN10 and diabetes-related quantitative traits. Under either an additive or a dominant effect model, we found no statistically significant relation between CAPN10 genotypes in the UCSNP-43 locus and T2D risk. However, under a recessive model, individuals homozygous for the common G allele had a statistically significant 19% higher risk of T2D than carriers of the A allele (OR 1.19; 95% CI 1.07-1.33). The association between the 112/121 haplotype combination and T2D risk appeared to be overestimated by several initial small studies with positive findings (OR 1.38; 95% CI 1.04-1.84). After we removed these initial studies, this association became nonsignificant (OR 1.11; 95% CI 0.91-1.35). Moreover, we found no evidence for the associations between the UCSNP-43 G/G genotype and the 112/121 haplotype combination and metabolic phenotypes. Our meta-analysis of family-based studies showed only an overtransmission of the rare allele C in UCSNP-44 from heterozygous parents to their affected offspring with T2D. Our analysis indicates that inadequate statistical power, racial/ethnic differences in frequencies of alleles, haplotypes and haplotype combinations, potential gene-gene or gene-environment interactions, publication bias, and multiple hypothesis testing may contribute to the significant heterogeneity in previous studies of CAPN10 and T2D. Our findings also suggest that both large-scale, well-designed association studies and functional studies are warranted to either reliably confirm or conclusively refute the initial hypothesis regarding the role of CAPN10 in T2D risk.	Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Channing Lab, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Liu, SM (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	siminliu@hsph.harvard.edu	Liu, Simin/GSN-4159-2022; Liu, Simin/I-3689-2014	Liu, Simin/0000-0003-2098-3844	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062290, R01DK062290] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK62290, R01 DK062290, R56 DK062290] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler D, 2000, NAT GENET, V26, P135, DOI 10.1038/79839; Ardlie KG, 2002, AM J HUM GENET, V71, P304, DOI 10.1086/341719; Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; Cardon LR, 2001, NAT REV GENET, V2, P91, DOI 10.1038/35052543; Cassell PG, 2002, DIABETES, V51, P1622, DOI 10.2337/diabetes.51.5.1622; Cox Nancy J, 2002, Curr Diab Rep, V2, P186, DOI 10.1007/s11892-002-0079-1; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Cox NJ, 2001, HUM MOL GENET, V10, P2301, DOI 10.1093/hmg/10.20.2301; Daimon M, 2002, DIABETES RES CLIN PR, V56, P147, DOI 10.1016/S0168-8227(01)00372-2; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 2001, SYSTEMATIC REV HLTH; Elbein SC, 2002, J CLIN ENDOCR METAB, V87, P650, DOI 10.1210/jc.87.2.650; Engelman C, 2003, DIABETES, V52, pA510; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Fingerlin TE, 2002, DIABETES, V51, P1644, DOI 10.2337/diabetes.51.5.1644; Florez JC, 2003, ANNU REV GENOM HUM G, V4, P257, DOI 10.1146/annurev.genom.4.070802.110436; Fullerton SM, 2002, AM J HUM GENET, V70, P1096, DOI 10.1086/339930; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garant MJ, 2002, DIABETES, V51, P231, DOI 10.2337/diabetes.51.1.231; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GREENLAND S, 1998, MODERN EPIDEMIOLOGY, P00281; Hegele RA, 2001, DIABETES CARE, V24, P1498, DOI 10.2337/diacare.24.8.1498-a; Hoffstedt J, 2002, DIABETOLOGIA, V45, P276, DOI 10.1007/s00125-001-0732-2; Hoffstedt J, 2002, J CLIN ENDOCR METAB, V87, P3362, DOI 10.1210/jc.87.7.3362; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Horikawa Y, 2003, J CLIN ENDOCR METAB, V88, P244, DOI 10.1210/jc.2002-020847; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Iwasaki N, 2003, DIABETES, V52, pA511; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; KAHN CR, 1994, DIABETES, V43, P1066, DOI 10.2337/diab.43.8.1066; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lynn S, 2002, DIABETES, V51, P247, DOI 10.2337/diabetes.51.1.247; Malecki MT, 2002, EUR J ENDOCRINOL, V146, P695, DOI 10.1530/eje.0.1460695; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; Ng MCY, 2001, DIABETES, V50, pA234; Normand SLT, 1999, STAT MED, V18, P321, DOI 10.1002/(SICI)1097-0258(19990215)18:3<321::AID-SIM28>3.0.CO;2-P; Orho-Melander M, 2002, DIABETES, V51, P2658, DOI 10.2337/diabetes.51.8.2658; Pankow JS, 2002, AM J HUM GENET, V71, P1478, DOI 10.1086/344582; Rasmussen SK, 2002, DIABETES, V51, P3561, DOI 10.2337/diabetes.51.12.3561; Schwarz P, 2003, DIABETES, V52, pA255; Schwarz PEH, 2001, DIABETES, V50, pA232; Shore AC, 2002, DIABETOLOGIA, V45, P899, DOI 10.1007/s00125-002-0847-0; Stumvoll M, 2002, DIABETOLOGIA, V45, P651, DOI 10.1007/s00125-002-0793-x; Stumvoll M, 2001, DIABETES, V50, P2161, DOI 10.2337/diabetes.50.9.2161; Sun HX, 2002, BIOMED ENVIRON SCI, V15, P75; Tsai HJ, 2001, AM J HUM GENET, V69, P1236, DOI 10.1086/324646; Wacholder S, 2000, J NATL CANCER I, V92, P1151, DOI 10.1093/jnci/92.14.1151; Xiang K, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P426; Xiang KS, 2001, DIABETES, V50, pA232	51	92	95	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					208	222		10.1086/381400	http://dx.doi.org/10.1086/381400			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14730479	Green Published, Bronze			2022-12-18	WOS:000188860000002
J	Burdon, KP; McKay, JD; Sale, MM; Russell-Eggitt, IM; Mackey, DA; Wirth, MG; Elder, JE; Nicoll, E; Clarke, MP; FitzGerald, LM; Stankovich, JM; Shaw, MA; Sharma, S; Gajovic, S; Gruss, P; Ross, S; Thomas, P; Voss, AK; Thomas, T; Gecz, J; Craig, JE				Burdon, KP; McKay, JD; Sale, MM; Russell-Eggitt, IM; Mackey, DA; Wirth, MG; Elder, JE; Nicoll, E; Clarke, MP; FitzGerald, LM; Stankovich, JM; Shaw, MA; Sharma, S; Gajovic, S; Gruss, P; Ross, S; Thomas, P; Voss, AK; Thomas, T; Gecz, J; Craig, JE			Mutations in a novel gene, NHS, cause the pleiotropic effects of Nance-Horan syndrome, including severe congenital cataract, dental anomalies, and mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							X-LINKED CATARACT; LINKAGE ANALYSIS; 4 FAMILIES; LOCALIZATION; MOUSE; LOCUS; IDENTIFICATION; CHROMOSOME; ASSIGNMENT; UNDERLIE	Nance-Horan syndrome (NHS) is an X-linked disorder characterized by congenital cataracts, dental anomalies, dysmorphic features, and, in some cases, mental retardation. NHS has been mapped to a 1.3-Mb interval on Xp22.13. We have confirmed the same localization in the original, extended Australian family with NHS and have identified protein-truncating mutations in a novel gene, which we have called "NHS," in five families. The NHS gene encompasses similar to650 kb of genomic DNA, coding for a 1,630-amino acid putative nuclear protein. NHS orthologs were found in other vertebrates, but no sequence similarity to known genes was identified. The murine developmental expression profile of the NHS gene was studied using in situ hybridization and a mouse line containing a lacZ reporter-gene insertion in the Nhs locus. We found a complex pattern of temporally and spatially regulated expression, which, together with the pleiotropic features of NHS, suggests that this gene has key functions in the regulation of eye, tooth, brain, and craniofacial development.	Univ Tasmania, Menzies Ctr Populat Hlth Res, Hobart, Tas, Australia; Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27109 USA; Wake Forest Univ, Sch Med, Dept Biochem, Winston Salem, NC 27109 USA; Wake Forest Univ, Sch Med, Dept Internal Med, Winston Salem, NC 27109 USA; Great Ormond St Hosp Children, London WC1N 3JH, England; Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; Royal Childrens Hosp, Dept Ophthalmol, Melbourne, Vic, Australia; Murdoch Childrens Res Inst, Melbourne, Vic, Australia; Univ Zurich, Dept Ophthalmol, Zurich, Switzerland; Univ Newcastle Upon Tyne, Dept Ophthalmol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Adelaide, Dept Pediat, Adelaide, SA, Australia; Womens & Childrens Hosp, Dept Cytogenet & Mol Genet, Adelaide, SA, Australia; Flinders Univ S Australia, Dept Ophthalmol, Bedford Pk, SA 5042, Australia; Univ Zagreb, Sch Med, Croat Inst Brain Res, Zagreb 41001, Croatia; Max Planck Inst Biophys, Dept Mol Cell Biol, Gottingen, Germany; Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	University of Tasmania; Wake Forest University; Wake Forest University; Wake Forest University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Zurich; Newcastle University - UK; University of Adelaide; Womens & Childrens Hospital Australia; Flinders University South Australia; University of Zagreb; Max Planck Society; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Craig, JE (corresponding author), Flinders Univ S Australia, Med Ctr, Dept Ophthalmol, Bedford Pk, SA 5042, Australia.		Thomas, Paul Q/K-4497-2012; Elder, James/O-5839-2019; Clarke, Michael W/H-8997-2014; Burdon, Kathryn/A-5026-2009; Mackey, David A/H-5340-2014; Voss, Anne K/F-5110-2013; Gecz, Jozef/X-3469-2019; Gajovic, Srecko/Z-1720-2018	Elder, James/0000-0003-0214-2304; Clarke, Michael W/0000-0002-9639-5670; Burdon, Kathryn/0000-0001-8217-1249; Mackey, David A/0000-0001-7914-4709; Voss, Anne K/0000-0002-3853-9381; Gecz, Jozef/0000-0002-7884-6861; Gajovic, Srecko/0000-0001-8668-5239; Thomas, Tim/0000-0002-7623-8344; Craig, Jamie/0000-0001-9955-9696; Sharma, Shiwani/0000-0002-0828-025X; FitzGerald, Liesel/0000-0002-6882-2698; Stankovich, Jim/0000-0001-9344-7749				Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Chelly J, 2001, NAT REV GENET, V2, P669, DOI 10.1038/35088558; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; FAVOR J, 1990, GENET RES, V56, P157, DOI 10.1017/S0016672300035242; Francis PJ, 2002, J MED GENET, V39, P105, DOI 10.1136/jmg.39.2.105; Hanson I, 1999, HUM MOL GENET, V8, P165, DOI 10.1093/hmg/8.2.165; HORAN MB, 1974, AUST PAEDIATR J, V10, P98; Jamieson RV, 2002, HUM MOL GENET, V11, P33, DOI 10.1093/hmg/11.1.33; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LEWIS RA, 1990, OPHTHALMOLOGY, V97, P110; LEWIS RA, 1990, OPHTHALMOLOGY, V97, P120; Litt M, 1997, HUM MOL GENET, V6, P665, DOI 10.1093/hmg/6.5.665; NANCE W E, 1974, Birth Defects Original Article Series, V10, P285; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; STAMBOLIAN D, 1995, NAT GENET, V10, P307, DOI 10.1038/ng0795-307; STAMBOLIAN D, 1990, AM J HUM GENET, V47, P13; Thomas T, 2000, DEVELOPMENT, V127, P2537; Toutain A, 1997, HUM GENET, V99, P256, DOI 10.1007/s004390050349; Toutain A, 1997, AM J MED GENET, V71, P305, DOI 10.1002/(SICI)1096-8628(19970822)71:3<305::AID-AJMG11>3.0.CO;2-O; Toutain A, 2002, EUR J HUM GENET, V10, P516, DOI 10.1038/sj.ejhg.5200846; Voss AK, 1998, DEV DYNAM, V212, P171, DOI 10.1002/(SICI)1097-0177(199806)212:2<171::AID-AJA3>3.0.CO;2-E; WALPOLE IR, 1990, J MED GENET, V27, P632, DOI 10.1136/jmg.27.10.632; ZHU D, 1990, HUM GENET, V86, P54	28	92	95	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2003	73	5					1120	1130		10.1086/379381	http://dx.doi.org/10.1086/379381			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	742AR	14564667	Bronze, Green Published			2022-12-18	WOS:000186493400013
J	Freed, LA; Acierno, JS; Dai, D; Leyne, M; Marshall, JE; Nesta, F; Levine, RA; Slaugenhaupt, SA				Freed, LA; Acierno, JS; Dai, D; Leyne, M; Marshall, JE; Nesta, F; Levine, RA; Slaugenhaupt, SA			A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MULTILOCUS LINKAGE ANALYSIS; GENERAL-POPULATION; PSEUDOXANTHOMA ELASTICUM; MOLECULAR-GENETICS; CONNECTIVE-TISSUE; CLINICAL-FEATURES; MARFAN-SYNDROME; COLLAGEN GENES; FOLLOW-UP	Mitral valve prolapse (MVP) is a common cardiovascular abnormality in the United States, occurring in similar to2.4% of the general population. Clinically, patients with MVP exhibit fibromyxomatous changes in one or both of the mitral leaflets that result in superior displacement of the leaflets into the left atrium. Although often clinically benign, MVP can be associated with important accompanying sequelae, including mitral regurgitation, bacterial endocarditis, congestive heart failure, atrial fibrillation, and even sudden death. MVP is genetically heterogeneous and is inherited as an autosomal dominant trait that exhibits both sex- and age-dependant penetrance. In this report, we describe the results of a genome scan and show that a locus for MVP maps to chromosome 11p15.4. Multipoint parametric analysis performed by use of GENEHUNTER gave a maximum LOD score of 3.12 for the chromosomal region immediately surrounding the four-marker haplotype D11S4124-D11S2349-D11S1338-D11S1323, and multipoint nonparametric analysis (NPL) confirms this finding (NPL = 38.59; P = .000397). Haplotype analysis across this region defines a 4.3-cM region between the markers D11S1923 and D11S1331 as the location of a new MVP locus, MMVP2, and confirms the genetic heterogeneity of this disorder. The discovery of genes involved in the pathogenesis of this common disease is crucial to understanding the marked variability in disease expression and mortality seen in MVP.	Massachusetts Gen Hosp, Dept Med, Div Cardiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Harvard Inst Human Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Mol Neurogenet Unit, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Slaugenhaupt, SA (corresponding author), Harvard Inst Med, Room 422,77 Ave Louis Pasteur, Boston, MA 02115 USA.			Acierno, James/0000-0002-5301-4970	NHLBI NIH HHS [K24 HL67434, R01 HL038176, R01 HL38176, K24 HL067434] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038176, K24HL067434] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON MA, 1984, IN VITRO CELL DEV B, V20, P856; Avierinos JF, 2002, CIRCULATION, V106, P1355, DOI 10.1161/01.CIR.0000028933.34260.09; BARLOW JB, 1966, AM HEART J, V71, P166, DOI 10.1016/0002-8703(66)90179-7; Benjamin EJ, 2001, AM J MED, V111, P726, DOI 10.1016/S0002-9343(01)01055-5; BRAUNWALD E, 1992, HEART DIS TXB CARDIO, P1029; BRYHN M, 1984, ACTA MED SCAND, V215, P157; CHANDRARATNA PAN, 1984, AM J CARDIOL, V54, P1283; COLE WG, 1984, BIOCHEM J, V219, P451, DOI 10.1042/bj2190451; Coonar AS, 1997, ADV GENET, V35, P285, DOI 10.1016/S0065-2660(08)60453-8; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DEVEREUX RB, 1989, ANN INTERN MED, V111, P305, DOI 10.7326/0003-4819-111-4-305; DEVEREUX RB, 1987, AM HEART J, V113, P1265, DOI 10.1016/0002-8703(87)90955-0; DEVEREUX RB, 1982, ANN INTERN MED, V97, P826, DOI 10.7326/0003-4819-97-6-826; Disse S, 1999, AM J HUM GENET, V65, P1242, DOI 10.1086/302624; FORTUIN NJ, 1977, CLIN RES, V25, pS470; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Freed LA, 2002, J AM COLL CARDIOL, V40, P1298, DOI 10.1016/S0735-1097(02)02161-7; Freed LA, 2002, AM J CARDIOL, V89, P1326, DOI 10.1016/S0002-9149(02)02340-8; Gilon D, 1999, NEW ENGL J MED, V341, P8, DOI 10.1056/NEJM199907013410102; GLESBY MJ, 1989, JAMA-J AM MED ASSOC, V262, P523, DOI 10.1001/jama.262.4.523; HENNEY AM, 1989, BRIT HEART J, V61, P292; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kyndt F, 1998, AM J HUM GENET, V62, P627, DOI 10.1086/301747; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1986, GENET EPIDEMIOL, V3, P39, DOI 10.1002/gepi.1370030105; LEVINE RA, 1989, CIRCULATION, V80, P589, DOI 10.1161/01.CIR.80.3.589; LEVINE RA, 1988, J AM COLL CARDIOL, V11, P1010, DOI 10.1016/S0735-1097(98)90059-6; LEVINE RA, 1987, CIRCULATION, V75, P756, DOI 10.1161/01.CIR.75.4.756; LEVY D, 1987, AM HEART J, V113, P1281, DOI 10.1016/0002-8703(87)90956-2; MALCOLM AD, 1985, BRIT HEART J, V53, P353; MARKIEWICZ W, 1976, CIRCULATION, V53, P464, DOI 10.1161/01.CIR.53.3.464; MARKS AR, 1989, NEW ENGL J MED, V320, P1031, DOI 10.1056/NEJM198904203201602; Maron BJ, 1998, CIRCULATION, V98, P1460, DOI 10.1161/01.CIR.98.14.1460; Milewicz DM, 1998, CURR OPIN CARDIOL, V13, P198; NIDORF SM, 1993, J AM SOC ECHOCARDIOG, V6, pS8; NISHIMURA RA, 1985, NEW ENGL J MED, V313, P1305, DOI 10.1056/NEJM198511213132101; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; PERLOFF JK, 1987, AM HEART J, V113, P1324, DOI 10.1016/0002-8703(87)90961-6; PERLOFF JK, 1989, CIRCULATION, V80, P710, DOI 10.1161/01.CIR.80.3.710; PROCACCI PM, 1976, NEW ENGL J MED, V294, P1086, DOI 10.1056/NEJM197605132942004; Rubegni P, 2000, AM J CARDIOL, V85, P1268, DOI 10.1016/S0002-9149(00)00745-1; SAVAGE DD, 1983, AM HEART J, V106, P571, DOI 10.1016/0002-8703(83)90704-4; SAVAGE DD, 1983, AM HEART J, V106, P577, DOI 10.1016/0002-8703(83)90705-6; Scordo K A, 1998, Dimens Crit Care Nurs, V17, P177; Seidman CE, 1998, BASIC RES CARDIOL, V93, P13; Shah P M, 1994, J Am Soc Echocardiogr, V7, P286; SHORES J, 1994, NEW ENGL J MED, V330, P1335, DOI 10.1056/NEJM199405123301902; SOLOMON SD, 1990, J CLIN INVEST, V86, P993, DOI 10.1172/JCI114802; STRAHAN NV, 1983, AM J MED, V74, P967, DOI 10.1016/0002-9343(83)90791-X; Struk B, 1997, HUM MOL GENET, V6, P1823, DOI 10.1093/hmg/6.11.1823; TAMURA K, 1995, AM HEART J, V129, P1149, DOI 10.1016/0002-8703(95)90397-6; Tesson F, 1998, HUM MUTAT, V12, P385, DOI 10.1002/(SICI)1098-1004(1998)12:6<385::AID-HUMU4>3.0.CO;2-E; VIVALDI MT, 1994, CIRCULATION, V90, P222; WALLER BF, 1982, AM HEART J, V104, P276, DOI 10.1016/0002-8703(82)90204-6; WARTH DC, 1985, J AM COLL CARDIOL, V5, P1173, DOI 10.1016/S0735-1097(85)80021-8; Weeks DE., 1990, AM J HUM GENET, V47, pA203; WEISS AN, 1975, CIRCULATION, V52, P1091, DOI 10.1161/01.CIR.52.6.1091; Weissman MM, 2000, AM J MED GENET, V96, P24, DOI 10.1002/(SICI)1096-8628(20000207)96:1<24::AID-AJMG7>3.0.CO;2-E; WEISSMAN NJ, 1994, AM J CARDIOL, V73, P1080, DOI 10.1016/0002-9149(94)90287-9; WORDSWORTH P, 1989, BRIT HEART J, V61, P300; Zuppiroli A, 1998, AM J CARDIOL, V82, P823, DOI 10.1016/S0002-9149(98)00454-8	63	92	102	1	11	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1551	1559		10.1086/375452	http://dx.doi.org/10.1086/375452			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12707861	Green Published, Bronze			2022-12-18	WOS:000183275500018
J	Gallagher, RC; Pils, B; Albalwi, M; Francke, U				Gallagher, RC; Pils, B; Albalwi, M; Francke, U			Evidence for the role of PWCR1/HBII-85 C/D box small nucleolar RNAs in Prader-Willi syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSLOCATION BREAKPOINT; SYNDROME PATIENT; SYNDROME REGION; MOUSE MODEL; SNRPN GENE; DELETION; IDENTIFICATION; ORGANIZATION; HYPOTONIA; MUTATIONS	Prior work has suggested that loss of expression of one or more of the many C/D box small nucleolar RNAs (snoRNAs) encoded within the complex, paternally expressed SNRPN (small nuclear ribonuclear protein N) locus may result in the phenotype of Prader-Willi syndrome (PWS). We suggest that the minimal critical region for PWS is similar to121 kb within the >460-kb SNRPN locus, bordered by a breakpoint cluster region identified in three individuals with PWS who have balanced reciprocal translocations and by the proximal deletion breakpoint of a familial deletion found in an unaffected mother, her three children with Angelman syndrome, and her father. The subset of SNRPN-encoded snoRNAs within this region comprises the PWCR1/HBII-85 cluster of snoRNAs and the single HBII-438A snoRNA. These are the only known genes within this region, which suggests that loss of their expression may be responsible for much or all of the phenotype of PWS. This hypothesis is challenged by findings in two individuals with PWS who have balanced translocations with breakpoints upstream of the proposed minimal critical region but whose cells were reported to express transcripts within it, adjacent to these snoRNAs. By use of real-time quantitative reverse-transcriptase polymerase chain reaction, we reassessed expression of these transcripts and of the snoRNAs themselves in fibroblasts of one of these patients. We find that the transcripts reported to be expressed in lymphoblast-somatic cell hybrids are not expressed in fibroblasts, and we suggest that the original results were misinterpreted. Most important, we show that the PWCR1/HBII-85 snoRNAs are not expressed in fibroblasts of this individual. These results are consistent with the hypothesis that loss of expression of the snoRNAs in the proposed minimal critical region confers much or all of the phenotype of PWS.	Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Francke, U (corresponding author), Stanford Univ, Sch Med, Beckman Ctr Mol & Genet Med, Dept Genet, 279 Campus Dr, Stanford, CA 94305 USA.			Al Balwi, Mohammed/0000-0003-2910-0390	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD083284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008748] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD83284] Funding Source: Medline; NIGMS NIH HHS [T32 GM008748, T32-GM08748] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CATTANACH BM, 1992, NAT GENET, V2, P270, DOI 10.1038/ng1292-270; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397; Conroy JM, 1997, AM J HUM GENET, V61, P388, DOI 10.1086/514852; de los Santos T, 2000, AM J HUM GENET, V67, P1067, DOI 10.1086/303106; Dupont JM, 1999, J MED GENET, V36, P652; Gillessen-Kaesbach G, 1999, EUR J HUM GENET, V7, P638, DOI 10.1038/sj.ejhg.5200362; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gray TA, 1999, P NATL ACAD SCI USA, V96, P5616, DOI 10.1073/pnas.96.10.5616; GREGER V, 1993, HUM MOL GENET, V2, P921, DOI 10.1093/hmg/2.7.921; Gunay-Aygun M, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e92; HAMABE J, 1991, AM J MED GENET, V41, P64, DOI 10.1002/ajmg.1320410117; HOLM VA, 1993, PEDIATRICS, V91, P398; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Jady BE, 2000, NUCLEIC ACIDS RES, V28, P1348, DOI 10.1093/nar/28.6.1348; JOHNSON DK, 1995, GENETICS, V141, P1563; Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3; Kuslich CD, 1999, AM J HUM GENET, V64, P70, DOI 10.1086/302177; Meguro M, 2001, HUM MOL GENET, V10, P383, DOI 10.1093/hmg/10.4.383; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Samarsky DA, 1998, EMBO J, V17, P3747, DOI 10.1093/emboj/17.13.3747; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Wevrick R, 1997, HUM MOL GENET, V6, P325, DOI 10.1093/hmg/6.2.325; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; Wirth J, 2001, HUM MOL GENET, V10, P201, DOI 10.1093/hmg/10.3.201; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25	30	92	99	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2002	71	3					669	678		10.1086/342408	http://dx.doi.org/10.1086/342408			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	584VN	12154412	Green Published, Bronze			2022-12-18	WOS:000177489600023
J	Moore, RC; Xiang, FQ; Monaghan, J; Han, D; Zhang, ZP; Edstrom, L; Anvret, M; Prusiner, SB				Moore, RC; Xiang, FQ; Monaghan, J; Han, D; Zhang, ZP; Edstrom, L; Anvret, M; Prusiner, SB			Huntington disease phenocopy is a familial prion disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PAIR GENE INSERTION; PROTEIN GENE; PRNP GENE; MUTATION; FEATURES; MICE; SEQUENCE; ILLNESS; REPEATS; PRP	Huntington disease (HD) is a common autosomal dominant neurodegenerative disease with early adult-onset motor abnormalities and dementia. Many studies of HD show that huntingtin (CAG) n repeat-expansion length is a sensitive and specific marker for HD. However, there are a significant number of examples of HD in the absence of a huntingtin (CAG) n expansion, suggesting that mutations in other genes can provoke HD-like disorders. The identification of genes responsible for these "phenocopies" may greatly improve the reliability of genetic screens for HD and may provide further insight into neurodegenerative disease. We have examined an HD phenocopy pedigree with linkage to chromosome 20p12 for mutations in the prion protein (PrP) gene (PRNP). This reveals that affected individuals are heterozygous for a 192-nucleotide (nt) insertion within the PrP coding region, which encodes an expanded PrP with eight extra octapeptide repeats. This reveals that this HD phenocopy is, in fact, a familial prion disease and that PrP repeat-expansion mutations can provoke an HD "genocopy." PrP repeat expansions are well characterized and provoke early-onset, slowly progressive atypical prion diseases with an autosomal dominant pattern of inheritance and a remarkable range of clinical features, many of which overlap with those of HD. This observation raises the possibility that an unknown number of HD phenocopies are, in fact, familial prion diseases and argues that clinicians should consider screening for PrP mutations in individuals with HD-like diseases in which the characteristic HD (CAG) n repeat expansions are absent.	Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Karolinska Inst Hosp, Div Neurol, Dept Clin Neurosci, Stockholm, Sweden	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Karolinska Institutet; Karolinska University Hospital	Prusiner, SB (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, HSE-774,Box 0518, San Francisco, CA 94143 USA.							ANDREW SE, 1994, AM J HUM GENET, V54, P852; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Chiesa R, 2000, P NATL ACAD SCI USA, V97, P5574, DOI 10.1073/pnas.97.10.5574; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; COLLINGE J, 1992, BRAIN, V115, P687, DOI 10.1093/brain/115.3.687; DUCHEN LW, 1993, BRAIN, V116, P555, DOI 10.1093/brain/116.3.555; Gambetti P, 1999, COLD SPRING HARBOR M, V38, P509; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; KRASEMANN S, 1995, MOL BRAIN RES, V34, P173, DOI 10.1016/0169-328X(95)00175-R; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; KRETZSCHMAR HA, 1986, DNA-J MOLEC CELL BIO, V5, P315, DOI 10.1089/dna.1986.5.315; Laplanche JL, 1999, BRAIN, V122, P2375, DOI 10.1093/brain/122.12.2375; Lee IY, 1998, GENOME RES, V8, P1022, DOI 10.1101/gr.8.10.1022; Lesperance MM, 2000, AM J HUM GENET, V67, P262, DOI 10.1086/302975; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; OWEN F, 1992, MOL BRAIN RES, V13, P155, DOI 10.1016/0169-328X(92)90056-H; Palmer MS, 1996, HUM MUTAT, V7, P280, DOI 10.1002/(SICI)1098-1004(1996)7:3<280::AID-HUMU17>3.0.CO;2-Z; POULTER M, 1992, BRAIN, V115, P675, DOI 10.1093/brain/115.3.675; PUCKETT C, 1991, AM J HUM GENET, V49, P320; Xiang FQ, 1998, AM J HUM GENET, V63, P1431, DOI 10.1086/302093	20	92	99	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2001	69	6					1385	1388		10.1086/324414	http://dx.doi.org/10.1086/324414			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	491AY	11593450	Bronze, Green Published			2022-12-18	WOS:000172086900022
J	Kuwahara, M; Iwai, K; Ooeda, T; Igarashi, T; Ogawa, E; Katsushima, Y; Shinbo, I; Uchida, S; Terada, Y; Arthus, MF; Lonergan, M; Fujiwara, TM; Bichet, DG; Marumo, F; Sasaki, S				Kuwahara, M; Iwai, K; Ooeda, T; Igarashi, T; Ogawa, E; Katsushima, Y; Shinbo, I; Uchida, S; Terada, Y; Arthus, MF; Lonergan, M; Fujiwara, TM; Bichet, DG; Marumo, F; Sasaki, S			Three families with autosomal dominant nephrogenic diabetes insipidus caused by aquaporin-2 mutations in the C-terminus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KIDNEY COLLECTING DUCT; WATER CHANNEL; PLASMA-MEMBRANE; XENOPUS OOCYTES; MIP FAMILY; PROTEIN; PERMEABILITY; EXPRESSION; CLONING; OCCURS	The vasopressin-regulated water channel aquaporin-2 (AQP2) is known to tetramerize in the apical membrane of the renal tubular cells and contributes to urine concentration. We identified three novel mutations, each in a single allele of exon 4 of the AQP2 gene, in three families showing autosomal dominant nephrogenic diabetes insipidus (NDI). These mutations were found in the C-terminus of AQP2: a deletion of G at nucleotide 721 (721 delG), a deletion of 10 nucleotides starting at nucleotide 763 (763-772del), and a deletion of 7 nucleotides starting at nucleotide 812 (812-818del). The wild-type AQP2 is predicted to be a 271-amino acid protein, whereas these mutant genes are predicted to encode proteins that are 330-333 amino acids in length, because of the frameshift mutations. Interestingly, these three mutant AQP2s shared the same C-terminal tail of 61 amino acids. In Xenopus oocytes injected with mutant AQP2 cRNAs, the osmotic water permeability (Pf) was much smaller than that of oocytes with the AQP2 wild-type (14%-17%). Immunoblot analysis of the lysates of the oocytes expressing the mutant AQP2s detected a band at 34 kD, whereas the immunoblot of the plasma-membrane fractions of the oocytes and immunocytochemistry failed to show a significant surface expression, suggesting a defect in trafficking of these mutant proteins. Furthermore, coinjection of wild-type cRNAs with mutant cRNAs markedly decreased the oocyte Pf in parallel with the surface expression of the wild-type AQP2. Immunoprecipitation with antibodies against wild-type and mutant AQP2 indicated the formation of mixed oligomers composed of wild-type and mutant AQP2 monomers. Our results suggest that the trafficking of mutant AQP2 is impaired because of elongation of the C-terminal tail, and the dominant-negative effect is attributed to oligomerization of the wild-type and mutant AQP2s. Segregation of the mutations in the C-terminus of AQP2 with dominant-type NDI underlies the importance of this domain in the intracellular trafficking of AQP2.	Tokyo Med & Dent Univ, Grad Sch, Dept Homeostasis Med & Nephrol, Tokyo 1138519, Japan; Univ Tokyo, Dept Pediat, Tokyo, Japan; Fukui Prefectural Hosp, Fukui, Japan; Chiba Univ, Dept Med 2, Chiba, Japan; Tohoku Univ, Dept Pediat, Sendai, Miyagi 980, Japan; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Hop Sacre Coeur, Res Ctr, Montreal, PQ H4J 1C5, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada	Tokyo Medical & Dental University (TMDU); University of Tokyo; Chiba University; Tohoku University; Universite de Montreal; Universite de Montreal; McGill University; McGill University	Kuwahara, M (corresponding author), Tokyo Med & Dent Univ, Grad Sch, Dept Homeostasis Med & Nephrol, Tokyo 1138519, Japan.		Uchida, Shinichi/D-1111-2013	BICHET, DANIEL-G/0000-0003-2856-6850				Amara J F, 1992, Trends Cell Biol, V2, P145, DOI 10.1016/0962-8924(92)90101-R; Arthus MF, 2000, J AM SOC NEPHROL, V11, P1044, DOI 10.1681/ASN.V1161044; Cheng AC, 1997, NATURE, V387, P627, DOI 10.1038/42517; DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Goji K, 1998, J CLIN ENDOCR METAB, V83, P3205, DOI 10.1210/jc.83.9.3205; HALBAN PA, 1994, BIOCHEM J, V299, P1; Ishibashi K, 1998, NEWS PHYSIOL SCI, V13, P137; JASCUR T, 1991, BIOCHEMISTRY-US, V30, P1908, DOI 10.1021/bi00221a025; JUNG JS, 1994, J BIOL CHEM, V269, P14648; Kamsteeg EJ, 1999, EMBO J, V18, P2394, DOI 10.1093/emboj/18.9.2394; Kuwahara M, 1999, BIOCHEMISTRY-US, V38, P16340, DOI 10.1021/bi9916776; KUWAHARA M, 1995, J BIOL CHEM, V270, P10384, DOI 10.1074/jbc.270.18.10384; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mandon B, 1996, J CLIN INVEST, V98, P906, DOI 10.1172/JCI118873; Marples D, 1998, AM J PHYSIOL-RENAL, V274, pF384, DOI 10.1152/ajprenal.1998.274.2.F384; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Mulders SM, 1998, J CLIN INVEST, V102, P57, DOI 10.1172/JCI2605; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; NIELSEN S, 1995, J CLIN INVEST, V96, P1834, DOI 10.1172/JCI118229; NIELSEN S, 1995, P NATL ACAD SCI USA, V92, P1013, DOI 10.1073/pnas.92.4.1013; OHZEKI T, 1984, J PEDIATR-US, V104, P593, DOI 10.1016/S0022-3476(84)80556-9; PAN Y, 1992, NAT GENET, V2, P103, DOI 10.1038/ng1092-103; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PRESTON GM, 1993, J BIOL CHEM, V268, P17; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Ramjeesingh M, 1997, BIOCHEM J, V327, P17, DOI 10.1042/bj3270017; SASAKI S, 1994, J CLIN INVEST, V93, P1250, DOI 10.1172/JCI117079; SHEPHERD FH, 1995, ANAL BIOCHEM, V224, P21, DOI 10.1006/abio.1995.1003; Shinbo I, 1999, AM J PHYSIOL-RENAL, V277, pF734, DOI 10.1152/ajprenal.1999.277.5.F734; WALL DA, 1989, J MEMBRANE BIOL, V107, P189, DOI 10.1007/BF01871724; Walz T, 1997, NATURE, V387, P624, DOI 10.1038/42512; YAMAMOTO N, 1995, AM J PHYSIOL, V268, pC1546	35	92	97	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2001	69	4					738	748		10.1086/323643	http://dx.doi.org/10.1086/323643			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	472WP	11536078	Green Published, Bronze			2022-12-18	WOS:000171008200007
J	Perola, M; Ohman, M; Hiekkalinna, T; Leppavuori, J; Pajukanta, P; Wessman, M; Koskenvuo, M; Palotie, A; Lange, K; Kaprio, J; Peltonen, L				Perola, M; Ohman, M; Hiekkalinna, T; Leppavuori, J; Pajukanta, P; Wessman, M; Koskenvuo, M; Palotie, A; Lange, K; Kaprio, J; Peltonen, L			Quantitative-trait-locus analysis of body-mass index and of stature, by combined analysis of genome scans of five Finnish study groups	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL COMBINED HYPERLIPIDEMIA; HUMAN OBESITY GENES; LINKAGE ANALYSIS; WIDE SCAN; PREDISPOSING LOCI; MAPS; REVEALS; MARKERS; REGION; HEIGHT	In recent years, many genomewide screens have been performed, to identify novel loci predisposing to various complex diseases. Often, only a portion of the collected clinical data from the study subjects is used in the actual analysis of the trait, and much of the phenotypic data is ignored. With proper consent, these data could subsequently be used in studies of common quantitative traits influencing human biology, and such a reanalysis method would be further justified by the nonbiased ascertainment of study individuals. To make our point, we report here a quantitative-trait-locus (QTL) analysis of body-mass index (BMI) and stature (i.e., height), with genotypic data from genome scans of five Finnish study groups. The combined study group was composed of 614 individuals from 247 families. Five study groups were originally ascertained in genetic studies on hypertension, obesity, osteoarthritis, migraine, and familial combined hyperlipidemia. Most of the families are from the Finnish Twin Cohort, which represents a population-wide sample. In each of the five genome scans, similar to 350 evenly spaced markers were genotyped on 22 autosomes. In analyzing the genotype data by a variance-component method, we found, on chromosome 7pter (maximum multipoint LOD score of 2.91), evidence for QTLs affecting stature, and a second locus, with suggestive evidence for linkage to stature, was detected on chromosome 9q (maximum multipoint LOD score of 2.61). Encouragingly, the locus on chromosome 7 is supported by the data reported by Hirschhorn et al. (in this issue), who used a similar method. We found no evidence for QTLs affecting BMI.	Univ Calif Los Angeles, Dept Human Genet, Gonda Neurosci & Genet Res Ctr, Los Angeles, CA 90095 USA; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland; Univ Helsinki, Dept Biosci, Div Genet, SF-00100 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, SF-00100 Helsinki, Finland; Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Turku, Dept Publ Hlth, Turku, Finland; Univ Oulu, Dept Publ Hlth & Gen Practice, Oulu, Finland	University of California System; University of California Los Angeles; Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; University of California System; University of California Los Angeles; University of Turku; University of Oulu	Peltonen, L (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Gonda Neurosci & Genet Res Ctr, Room 6506,695 Charles E Young Dr S,Box 708822, Los Angeles, CA 90095 USA.		Öhman, Miina K/U-9609-2018; Kaprio, Jaakko/A-1820-2008	Öhman, Miina K/0000-0002-3966-7780; Kaprio, Jaakko/0000-0002-3716-2455; Palotie, Aarno/0000-0002-2527-5874; Hiekkalinna, Tero/0000-0002-3345-2981	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053275] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053275, GM53275] Funding Source: Medline; NIMH NIH HHS [MH59498] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DB, 1996, INT J OBESITY, V20, P990; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Goring HHH, 2000, AM J HUM GENET, V66, P1298, DOI 10.1086/302846; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hanson RL, 1998, AM J HUM GENET, V63, P1130, DOI 10.1086/302061; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; KAPRIO J, 1994, ANN MED, V26, P135, DOI 10.3109/07853899409147880; Kittles RA, 1998, AM J HUM GENET, V62, P1171, DOI 10.1086/301831; KORKEILA M, 1991, INT J OBESITY, V15, P647; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Lee JH, 1997, INT J OBESITY, V21, P935, DOI 10.1038/sj.ijo.0800498; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; Leppavuori J, 1999, AM J HUM GENET, V65, P1060, DOI 10.1086/302569; Mitchell BD, 1999, DIABETES, V48, P1863, DOI 10.2337/diabetes.48.9.1863; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ohman M, 2000, J CLIN ENDOCR METAB, V85, P3183, DOI 10.1210/jc.85.9.3183; Pajukanta P, 1997, ARTERIOSCL THROM VAS, V17, P841, DOI 10.1161/01.ATV.17.5.841; Pajukanta P, 1999, AM J HUM GENET, V64, P1453, DOI 10.1086/302365; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; Porkka KVK, 1997, ATHEROSCLEROSIS, V133, P245, DOI 10.1016/S0021-9150(97)00134-2; Preece MA, 1996, HORM RES, V45, P56, DOI 10.1159/000184849; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; SOLOMON PJ, 1983, ANN HUM BIOL, V10, P247, DOI 10.1080/03014468300006411; Terwilliger JD, 2000, HUM BIOL, V72, P63; THOMPSON DB, 1995, AM J MED GENET, V59, P495, DOI 10.1002/ajmg.1320590417; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; WESSMAN M, 1998, AM J HUM GENET S, V63, pA314	31	92	93	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2001	69	1					117	123		10.1086/321286	http://dx.doi.org/10.1086/321286			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XM	11410840	Green Published, Bronze			2022-12-18	WOS:000170108100012
J	Alam, NA; Bevan, S; Churchman, M; Barclay, E; Barker, K; Jaeger, EEM; Nelson, HM; Healy, E; Pembroke, AC; Friedmann, PS; Dalziel, K; Calonje, E; Anderson, J; August, PJ; Davies, MG; Felix, R; Munro, CS; Murdoch, M; Rendall, J; Kennedy, S; Leigh, IM; Kelsell, DP; Tomlinson, IPM; Houlston, RS				Alam, NA; Bevan, S; Churchman, M; Barclay, E; Barker, K; Jaeger, EEM; Nelson, HM; Healy, E; Pembroke, AC; Friedmann, PS; Dalziel, K; Calonje, E; Anderson, J; August, PJ; Davies, MG; Felix, R; Munro, CS; Murdoch, M; Rendall, J; Kennedy, S; Leigh, IM; Kelsell, DP; Tomlinson, IPM; Houlston, RS			Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTILOCUS LINKAGE ANALYSIS; DELETION; 7Q; EXPRESSION; TWIN	Dominant transmission of multiple uterine and cutaneous smooth-muscle tumors is seen in the disorder multiple leiomyomatosis (ML). We undertook a genomewide screen of 11 families segregating ML and found evidence for linkage to chromosome 1q42.3-q43 (maximum multipoint LOD score 5.40). Haplotype construction and analysis of recombinations permitted the minimal interval containing the locus, which we have designated "MCUL1," to be refined to an similar to 14-cM region flanked by markers D1S517 and D1S2842. Allelic-loss studies of tumors indicated that MCUL1 may act as a tumor suppressor. Identification of MCUL1 should have wide interest, since this gene may harbor low-penetrance variants predisposing to the common form of uterine fibroids and/or may undergo somatic mutation in sporadic leiomyomata.	Royal London Hosp, Imperial Canc Res Fund, Mol & Populat Genet Lab, London E1 1BB, England; Royal London Hosp, Imperial Canc Res Fund, Skin Tumour Lab, London E1 1BB, England; St Thomas Hosp, St Johns Inst Dermatol, Dept Dermatopathol, London, England; Inst Canc Res, Haddow Labs, Sect Canc Genet, Sutton, Surrey, England; John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England; Queens Hosp, Dept Dermatol, Burton Upon Trent, England; Univ Southampton, Dept Dermatopharmacol, Southampton, Hants, England; Orpington Hosp, Dept Dermatol, Orpington, England; Queens Med Ctr, Dept Dermatol, Nottingham NG7 2UH, England; Queen Elizabeth Hosp, Dept Dermatol, Peterborough, Cambs, England; Leighton Hosp, Dept Dermatol, Crewe, England; Summerleas, Yelverton, England; Frimley Pk Hosp, Dept Dermatol, Frimley, England; So Gen Hosp, Dept Dermatol, Glasgow G51 4TF, Lanark, Scotland; Watford Dist Gen Hosp, Dept Dermatol, Watford, England; Cty Hosp, Dept Dermatol, Hereford HR1 2ER, England	Barts Health NHS Trust; Royal London Hospital; Cancer Research UK; Barts Health NHS Trust; Royal London Hospital; Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; Institute of Cancer Research - UK; University of Oxford; University of Southampton; University of Nottingham; University of Glasgow; Watford General Hospital	Tomlinson, IPM (corresponding author), Imperial Canc Res Fund, Mol Populat Genet Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	i.tomlinson@icrf.icnet.uk; r.houlston@icr.ac.uk	Kennedy, Stephen/B-8950-2009; Kelsell, David P/F-8767-2011	Bevan, Steve/0000-0003-0490-6830; Kelsell, David/0000-0002-9910-7144; Healy, Eugene/0000-0001-5591-6970; Houlston, Richard/0000-0002-5268-0242				COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; ENGELKE H, 1979, ACTA DERM-VENEREOL, V59, P51; FRYNS JP, 1985, HUM GENET, V70, P284, DOI 10.1007/BF00273459; GUILLET G, 1987, SEM HOP PARIS, V63, P65; Henneberg SCM, 1996, PARTY POLIT, V2, P277, DOI 10.1177/1354068896002002007; Ishwad CS, 1997, GENE CHROMOSOME CANC, V19, P156, DOI 10.1002/(SICI)1098-2264(199707)19:3<156::AID-GCC4>3.0.CO;2-X; ISHWAD CS, 1995, GENE CHROMOSOME CANC, V14, P51, DOI 10.1002/gcc.2870140109; Klotzbucher M, 1999, AM J PATHOL, V155, P1535, DOI 10.1016/S0002-9440(10)65469-7; KOORBANOVA MK, 1989, GENETIKA+, V25, P1896; KOORBANOVA MK, 1989, GENETIKA+, V25, P1122; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Luoto R, 2000, MATURITAS, V37, P15, DOI 10.1016/S0378-5122(00)00160-2; Mezzadra G, 1965, Minerva Dermatol, V40, P388; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Polito P, 1999, CANCER GENET CYTOGEN, V108, P107, DOI 10.1016/S0165-4608(98)00128-9; REED WB, 1973, ACTA DERM-VENEREOL, V53, P409; RUDNER EJ, 1972, ARCH DERMATOL, V104, P81; Sell SM, 1998, CANCER GENET CYTOGEN, V100, P165, DOI 10.1016/S0165-4608(97)00032-0; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; Sourla A, 1996, CANCER RES, V56, P3123; van der Heijden O, 1998, MOL CARCINOGEN, V23, P243, DOI 10.1002/(SICI)1098-2744(199812)23:4<243::AID-MC7>3.0.CO;2-E; Vanni R, 1999, CANCER GENET CYTOGEN, V113, P183, DOI 10.1016/S0165-4608(99)00025-4; VIKHLYAEVA EM, 1995, INT J GYNECOL OBSTET, V51, P127, DOI 10.1016/0020-7292(95)02533-I; Zeng WR, 1997, ONCOGENE, V14, P2355, DOI 10.1038/sj.onc.1201076	24	92	94	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2001	68	5					1264	1269		10.1086/320124	http://dx.doi.org/10.1086/320124			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	423HZ	11283798	Green Published, Bronze			2022-12-18	WOS:000168171200019
J	Joenje, H; Levitus, M; Waisfisz, Q; D'Andrea, A; Garcia-Higuera, I; Pearson, T; van Berkel, CGM; Rooimans, MA; Morgan, N; Mathew, CG; Arwert, F				Joenje, H; Levitus, M; Waisfisz, Q; D'Andrea, A; Garcia-Higuera, I; Pearson, T; van Berkel, CGM; Rooimans, MA; Morgan, N; Mathew, CG; Arwert, F			Complementation analysis in Fanconi anemia: Assignment of the reference FA-H patient to group A	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYMPHOBLASTOID CELL-LINES; GENE; FANCG/XRCC9; MOSAICISM; COMPLEX; PATHWAY; MAPS	Fanconi anemia (FA) is an autosomal recessive disorder with diverse clinical symptoms and extensive genetic heterogeneity. Of eight FA genes that have been implicated on the basis of complementation studies, four have been identified and two have been mapped to different loci; the status of the genes supposed to be defective in groups B and H is uncertain. Here we present evidence indicating that the patient who has been the sole representative of the eighth complementation group (FA-H) in fact belongs to group FA-A. Previous exclusion from group A was apparently based on phenotypic reversion to wild-type rather than on genuine complementation in fusion hybrids. To avoid the pitfall of reversion, future assignment of patients with FA to new complementation groups should conform with more-stringent criteria. A new group should be based on at least two patients with FA whose cell lines are excluded from all known groups and that fail to complement each other in fusion hybrids, or, if only one such cell line were available, on a new complementing gene that carries pathogenic mutations in this cell line. On the basis of these criteria, the current number of complementation groups in FA is seven.	Free Univ Amsterdam, Dept Clin Genet & Human Genet, Med Ctr, NL-1081 BT Amsterdam, Netherlands; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA USA; Univ Orange Free State, Dept Neurol, Div Human Genet, Bloemfontein, South Africa; Guys Hosp, GKT Sch Med, Div Med & Mol Genet, London SE1 9RT, England	Vrije Universiteit Amsterdam; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of the Free State; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Joenje, H (corresponding author), Free Univ Amsterdam, Dept Clin Genet & Human Genet, Med Ctr, Van der Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.		Morgan, Neil V/A-5475-2009; Garcia-Higuera, Irene/L-5004-2014; Mathew, Christopher G/G-3434-2015	Morgan, Neil V/0000-0001-6433-5692; Garcia-Higuera, Irene/0000-0001-6331-075X; Mathew, Christopher G/0000-0003-4178-1838; Waisfisz, Quinten/0000-0002-7384-9182				Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; AUERBACH AD, 1998, GENETIC BASIS HUMAN, P317; Carreau M, 1999, MUTAT RES-DNA REPAIR, V435, P103, DOI 10.1016/S0921-8777(99)00041-5; de Winter JP, 2000, NAT GENET, V24, P15, DOI 10.1038/71626; de Winter JP, 1998, NAT GENET, V20, P281, DOI 10.1038/3093; DUCKWORTHRYSIECKI G, 1985, SOMAT CELL MOLEC GEN, V11, P35, DOI 10.1007/BF01534732; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; JOENJE H, 1995, BLOOD, V86, P2156, DOI 10.1182/blood.V86.6.2156.bloodjournal8662156; Joenje H, 1997, AM J HUM GENET, V61, P940, DOI 10.1086/514881; Kruyt FAE, 1996, BLOOD, V87, P938, DOI 10.1182/blood.V87.3.938.bloodjournal873938; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; LoTenFoe JR, 1997, EUR J HUM GENET, V5, P137, DOI 10.1159/000484749; Pulsipher M, 1998, MOL MED, V4, P468, DOI 10.1007/BF03401752; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; van de Vrugt HJ, 2000, MAMM GENOME, V11, P326, DOI 10.1007/s003350010060; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Waisfisz Q, 1999, AM J HUM GENET, V64, P1400, DOI 10.1086/302385; Waisfisz Q, 1999, NAT GENET, V22, P379, DOI 10.1038/11956; WHITNEY M, 1995, NAT GENET, V11, P341, DOI 10.1038/ng1195-341; Yamashita T, 1998, P NATL ACAD SCI USA, V95, P13085, DOI 10.1073/pnas.95.22.13085	20	92	94	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					759	762		10.1086/303067	http://dx.doi.org/10.1086/303067			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10936108	Green Published, Bronze			2022-12-18	WOS:000089002300023
J	Warburton, PE; Dolled, M; Mahmood, R; Alonso, A; Li, SL; Naritomi, K; Tohma, T; Nagai, T; Hasegawa, T; Ohashi, H; Govaerts, LCP; Eussen, BHJ; Van Hemel, JO; Lozzio, C; Schwartz, S; Dowhanick-Morrissette, JJ; Spinner, NB; Rivera, H; Crolla, JA; Yu, CY; Warburton, D				Warburton, PE; Dolled, M; Mahmood, R; Alonso, A; Li, SL; Naritomi, K; Tohma, T; Nagai, T; Hasegawa, T; Ohashi, H; Govaerts, LCP; Eussen, BHJ; Van Hemel, JO; Lozzio, C; Schwartz, S; Dowhanick-Morrissette, JJ; Spinner, NB; Rivera, H; Crolla, JA; Yu, CY; Warburton, D			Molecular cytogenetic analysis of eight inversion duplications of human chromosome 13q that each contain a neocentromere	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DETECTABLE ALPHA-SATELLITE; ACENTRIC MARKER CHROMOSOME; MAMMALIAN ARTIFICIAL CHROMOSOMES; INNER KINETOCHORE PLATE; CENP-A; FUNCTIONAL CENTROMERE; INVERTED DUPLICATION; Y-CHROMOSOME; DNA; IDENTIFICATION	Neocentromeres are fully functional centromeres that have arisen in previously noncentromeric chromosomal locations on rearranged chromosomes, The formation of neocentromeres results in the mitotic stability of chromosomal fragments that do not contain endogenous centromeres and that would normally be lost, Here we describe a unique collection of eight independent patient-derived cell lines, each of which contains a neocentromere on a supernumerary inversion duplication of a portion of human chromosome 13q, Findings in these patients reveal insight into the clinical manifestations associated with polysomy for portions of chromosome 13q. The results of FISH and immunofluorescent analysis of the neocentromeres in these chromosomes confirm the lack of alpha-satellite DNA and the presence of CENtromere proteins (CENP)-C, -E, and hMAD2, The positions of the inversion break-points in these chromosomes have been placed onto the physical map of chromosome 13, by means of FISH mapping with cosmid probes. These cell lines define, within chromosome 13q, at least three distinct locations where neocentromeres have formed, with five independent neocentromeres in band 13q32, two in band 13q21, and one in band 13q31. The results of examination of the set of 40 neocentromere-containing chromosomes that have thus far been described, including the 8 neocentromere-containing chromosomes from chromosome 13q that are described in the present study, suggest that chromosome 13q has an increased propensity for neocentromere formation, relative to some other human chromosomes, These neocentromeres will provide the means for testing hypotheses about sequence requirements for human centromere formation.	CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Columbia Univ, Dept Genet & Dev, New York, NY USA; Univ Ryukyus, Sch Med, Dept Med Genet, Okinawa, Japan; Univ Ryukyus, Sch Med, Dept Pediat, Okinawa, Japan; Dokkyo Univ, Sch Med, Koshigaya Hosp, Dept Pediat, Mibu, Tochigi, Japan; Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; Erasmus Univ, Hosp Dijkzigt, Dept Clin Genet, NL-3015 GD Rotterdam, Netherlands; Univ Tennessee, Med Ctr, Dev Genet Ctr, Knoxville, TN USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Case Western Reserve Univ, Ctr Human Genet, Dept Genet, Cleveland, OH 44106 USA; Childrens Hosp Philadelphia, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Inst Mexicano Seguro Social, Div Genet, Guadalajara, Jalisco, Mexico; Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury, Wilts, England	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Columbia University; University of the Ryukyus; University of the Ryukyus; Dokkyo Medical University; Keio University; Erasmus University Rotterdam; Erasmus MC; University of Tennessee System; University of Tennessee Health Science Center; University Hospitals of Cleveland; Case Western Reserve University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Instituto Mexicano del Seguro Social; Salisbury District Hospital	Warburton, D (corresponding author), CUNY Mt Sinai Sch Med, Dept Human Genet, Box 1498, New York, NY 10029 USA.		Hasegawa, Tomonobu/L-3331-2013; RIVERA, HORACIO/N-9557-2013		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007413] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM61150-01] Funding Source: Medline; NINDS NIH HHS [5T32NS07413] Funding Source: Medline; NCHHSTP CDC HHS [PSO-HL62177-01] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCHHSTP CDC HHS		Aagaard L, 2000, J CELL SCI, V113, P817; Abeliovich D, 1996, CANCER GENET CYTOGEN, V89, P1, DOI 10.1016/0165-4608(95)00300-2; ALONSO A, IN PRESS CHROMOSOME; Barbi G, 2000, AM J MED GENET, V91, P116, DOI 10.1002/(SICI)1096-8628(20000313)91:2<116::AID-AJMG7>3.0.CO;2-Q; Barry AE, 1999, HUM MOL GENET, V8, P217, DOI 10.1093/hmg/8.2.217; BLENNOW E, 1994, AM J HUM GENET, V54, P877; Bukvic N, 1996, HUM GENET, V97, P453; Cayanis E, 1998, GENOMICS, V47, P26, DOI 10.1006/geno.1997.5087; Choo KHA, 1997, AM J HUM GENET, V61, P1225, DOI 10.1086/301657; CHU TW, 1994, AM J MED GENET, V52, P92, DOI 10.1002/ajmg.1320520118; COCKWELL AE, IN PRESS AM J MED GE; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; DOWHANICK JJ, 1998, AM J HUM GENET, V63, pA740; DUMANOIR S, 1993, HUM GENET, V90, P590, DOI 10.1007/BF00202476; duSart D, 1997, NAT GENET, V16, P144; Govaerts LP, 1999, AM J HUM GENET S, V65, pA893; Grimbacher B, 1999, GENET MED, V1, P213; Harrington JJ, 1997, NAT GENET, V15, P345, DOI 10.1038/ng0497-345; He DC, 1998, CHROMOSOMA, V107, P189, DOI 10.1007/s004120050296; Henning KA, 1999, P NATL ACAD SCI USA, V96, P592, DOI 10.1073/pnas.96.2.592; Huang B, 1998, AM J MED GENET, V80, P368, DOI 10.1002/(SICI)1096-8628(19981204)80:4<368::AID-AJMG12>3.3.CO;2-2; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; KAISERROGERS KA, 1995, AM J HUM GENET S, V57, pA658; Koch J, 2000, HUM MOL GENET, V9, P149, DOI 10.1093/hmg/9.2.149; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; LIU P, 1993, CANCER GENET CYTOGEN, V65, P93, DOI 10.1016/0165-4608(93)90213-6; LOZZIO C, 1997, AM J HUM GENET, V61, P751; Maraschio P, 1996, HUM GENET, V97, P382; Murphy TD, 1998, CELL, V93, P317, DOI 10.1016/S0092-8674(00)81158-7; OHASHI H, 1994, AM J HUM GENET, V55, P1202; Petit P, 1997, GENET COUNSEL, V8, P341; Portnoi MF, 1999, J MED GENET, V36, P246; RAVNAN JB, 1999, AM J HUM GENET S, V65, pA2012; Rivera H, 1996, ANN GENET-PARIS, V39, P236; Rivera H, 1999, AM J MED GENET, V85, P385, DOI 10.1002/(SICI)1096-8628(19990806)85:4<385::AID-AJMG15>3.0.CO;2-P; Sacchi N, 1996, CYTOGENET CELL GENET, V73, P123, DOI 10.1159/000134322; Saffery R, 2000, HUM MOL GENET, V9, P175, DOI 10.1093/hmg/9.2.175; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Slater HR, 1999, J MED GENET, V36, P914; Sugata N, 1999, J BIOL CHEM, V274, P27343, DOI 10.1074/jbc.274.39.27343; SULCOVA V, 1999, AM J HUM GENET S, V65, pA2026; SULLIVAN BA, 1995, HUM MOL GENET, V4, P2189, DOI 10.1093/hmg/4.12.2189; TESHIMA I, 1998, AM J HUM GENET S, V63, pA859; Tohma T., 1998, AM J HUM GENET, V63, pA862; Tyler-Smith C, 1999, AM J HUM GENET, V64, P1440, DOI 10.1086/302380; Vafa O, 1997, CURR BIOL, V7, P897, DOI 10.1016/S0960-9822(06)00381-2; Vance GH, 1997, AM J MED GENET, V71, P436, DOI 10.1002/(SICI)1096-8628(19970905)71:4<436::AID-AJMG13>3.0.CO;2-H; VandenEnden A, 1996, AM J MED GENET, V63, P482, DOI 10.1002/(SICI)1096-8628(19960614)63:3<482::AID-AJMG13>3.0.CO;2-I; Voullaire L, 1999, AM J MED GENET, V85, P403, DOI 10.1002/(SICI)1096-8628(19990806)85:4<403::AID-AJMG18>3.3.CO;2-I; VOULLAIRE LE, 1993, AM J HUM GENET, V52, P1153; Wandall A, 1998, CHROMOSOMA, V107, P359, DOI 10.1007/s004120050319; Warburton PE, 1999, MOL GENET METAB, V68, P152, DOI 10.1006/mgme.1999.2908; Warburton PE, 1997, CURR BIOL, V7, P901, DOI 10.1016/S0960-9822(06)00382-4; Wiens GR, 1998, CELL, V93, P313, DOI 10.1016/S0092-8674(00)81157-5; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30	55	92	97	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2000	66	6					1794	1806		10.1086/302924	http://dx.doi.org/10.1086/302924			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QU	10777715	Green Published, Bronze			2022-12-18	WOS:000088373800008
J	Leppavuori, J; Kujala, U; Kinnunen, J; Kaprio, J; Nissila, M; Heliovaara, M; Klinger, N; Partanen, J; Terwilliger, JD; Peltonen, L				Leppavuori, J; Kujala, U; Kinnunen, J; Kaprio, J; Nissila, M; Heliovaara, M; Klinger, N; Partanen, J; Terwilliger, JD; Peltonen, L			Genome scan for predisposing loci for distal interphalangeal joint osteoarthritis: Evidence for a locus on 2q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; RADIOGRAPHIC OSTEOARTHRITIS; MULTIPLE-SCLEROSIS; OSTEO-ARTHRITIS; MODEL-FREE; ASSOCIATION; GENE; WOMEN; HLA; DISEQUILIBRIUM	The genetic contribution to common forms of osteoarthritis (OA) is well established but poorly understood. We performed a genome scan, using 302 markers for loci predisposing to distal interphalangeal joint (DIP) OA. To minimize genetic heterogeneity in our study sample, we identified siblings with a severe, radiologically defined phenotype from the nationwide registers of Finland. In the initial genome scan, linkage analysis in 27 sibships gave a pairwise LOD score (Z) >1.00 with nine of the screening markers. In the second stage, additional markers and family members were genotyped in these chromosomal regions. On 2q12-q13, IL1R1 resulted in Z= 2.34 at recombination fraction (theta) 0, allowing a dominant mode of inheritance. Association analysis of markers D2S2264, IL1R1, D2S373, and D2S1789 jointly provided some evidence for a shared haplotype among the affected individuals (P value of .012). Also, multipoint nonparametric linkage analysis yielded a P value of .0001 near the locus IL1R1 and P =.0007 similar to 20 cM telomeric near marker D2S1399, which, in two-point analysis, gave Z = 1.48 (theta =.02). This chromosomal region on 2q harbors the interleukin 1 gene cluster and, thus, represents a good candidate region for inflammatory and autoimmune disorders. Three additional chromosomal regions-4q26-q27, 7p15-p21, and Xcen-also provided some evidence for linkage, and further analyses would be justified to clarify their potential involvement in the genetic predisposition to DIP OA.	Natl Publ Hlth Inst, Dept Human Mol Genet, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Helsinki, Inst Biomed, Unit Sports & Exercise Med, Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Radiol, Helsinki, Finland; Natl Publ Hlth Inst, Dept Hlth & Funct Capac, Helsinki, Finland; Finnish Red Cross & Blood Transfus Serv, Tissue Typing Lab, SF-00310 Helsinki, Finland; Rheumatism Fdn Hosp, SF-18120 Heinola, Finland; Columbia Univ, Dept Psychiat, New York, NY USA; Columbia Univ, Columbia Genome Ctr, New York, NY USA	Finland National Institute for Health & Welfare; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; Rheumatism Foundation Hospital; Columbia University; Columbia University	Peltonen, L (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Human Genet, 33-257 CHS,Box 851737, Los Angeles, CA 90095 USA.		Partanen, Jukka/B-7207-2014; Kujala, Urho/AAP-2547-2020; Kaprio, Jaakko/A-1820-2008	Partanen, Jukka/0000-0001-6681-4734; Kaprio, Jaakko/0000-0002-3716-2455; Kujala, Urho/0000-0002-9262-1992				BALDWIN CT, 1995, AM J HUM GENET, V56, P692; BENAVIDES G, 1985, CLIN RHEUMATOL, V4, P97, DOI 10.1007/BF02032327; Chapman K, 1999, AM J HUM GENET, V65, P167, DOI 10.1086/302465; Cooper C, 1996, J RHEUMATOL, V23, P1938; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Cox A, 1998, AM J HUM GENET, V62, P1180, DOI 10.1086/301817; CURTIS D, 1995, AM J HUM GENET, V57, P703; ERCILLA MG, 1977, J RHEUMATOL, V4, P89; FELSON DT, 1988, EPIDEMIOL REV, V10, P1; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1064, DOI 10.1002/1529-0131(199806)41:6<1064::AID-ART13>3.0.CO;2-K; GORING H, 1999, AM J HUM GENET, V65; HART D, 1994, ANN RHEUM DIS, V53, P220, DOI 10.1136/ard.53.4.220; Hirsch R, 1998, ARTHRITIS RHEUM, V41, P1227, DOI 10.1002/1529-0131(199807)41:7<1227::AID-ART13>3.0.CO;2-N; Kaprio J, 1996, BRIT MED J, V313, P232, DOI 10.1136/bmj.313.7051.232; KARKKAINEN A, 1985, PUBLICATIONS SOCIAL, V52, P1; Kellgren J, 1963, EPIDEMIOL CHRON, P1; KNOWLTON RG, 1990, P NATL ACAD SCI USA, V87, P6565; Kruglyak L, 1997, AM J HUM GENET, V61, P254; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KUJALA UM, IN PRESS TWIN RES; Kuokkanen S, 1996, NAT GENET, V13, P477, DOI 10.1038/ng0896-477; Kuokkanen S, 1997, AM J HUM GENET, V61, P1379, DOI 10.1086/301637; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Lin L, 1997, TISSUE ANTIGENS, V50, P507, DOI 10.1111/j.1399-0039.1997.tb02907.x; Mahtani MM, 1996, NAT GENET, V14, P90, DOI 10.1038/ng0996-90; MCDOWELL TL, 1995, ARTHRITIS RHEUM, V38, P221, DOI 10.1002/art.1780380210; Meulenbelt I, 1997, ARTHRITIS RHEUM, V40, P1760, DOI 10.1002/art.1780401006; Ott J., 1991, ANAL HUMAN GENETIC L; PATTRICK M, 1989, ANN RHEUM DIS, V48, P470, DOI 10.1136/ard.48.6.470; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; Sobel E, 1996, AM J HUM GENET, V58, P1323; Spector TD, 1996, BRIT MED J, V312, P940; Stecher RM, 1941, AM J MED SCI, V201, P801, DOI 10.1097/00000441-194106000-00004; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P477, DOI 10.1002/gepi.1370100625; Uitterlinden AG, 1997, J CLIN INVEST, V100, P259, DOI 10.1172/JCI119530; VIKKULA M, 1993, ANN RHEUM DIS, V52, P762, DOI 10.1136/ard.52.10.762; Vikkula M, 1996, ANN MED, V28, P301, DOI 10.3109/07853899608999084; Wright GD, 1996, ANN RHEUM DIS, V55, P317, DOI 10.1136/ard.55.5.317	40	92	96	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					1060	1067		10.1086/302569	http://dx.doi.org/10.1086/302569			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486325	Bronze, Green Published			2022-12-18	WOS:000082910000015
J	Gregersen, PK; Kowalsky, E; Kohn, N; Marvin, EW				Gregersen, PK; Kowalsky, E; Kohn, N; Marvin, EW			Absolute pitch: Prevalence, ethnic variation, and estimation of the genetic component	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							IDENTIFICATION		N Shore Univ Hosp, Div Biol & Human Genet, Manhasset, NY 11030 USA; N Shore Univ Hosp, Div Biostat, Manhasset, NY USA; Univ Rochester, Eastman Sch Mus, Dept Mus Theory, Rochester, NY 14627 USA	Northwell Health; North Shore University Hospital; Northwell Health; North Shore University Hospital; University of Rochester	Gregersen, PK (corresponding author), N Shore Univ Hosp, Div Biol & Human Genet, Manhasset, NY 11030 USA.							Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Gregersen PK, 1998, AM J HUM GENET, V62, P221, DOI 10.1086/301734; KUMAR S, 1996, AM J HUM GENET S, V59, pA179; MIYAZAKI K, 1988, PERCEPT PSYCHOPHYS, V44, P501, DOI 10.3758/BF03207484; PROFITA J, 1988, AM J MED GENET, V29, P763, DOI 10.1002/ajmg.1320290405; TAKEUCHI AH, 1991, MUSIC PERCEPT, V9, P27	7	92	93	0	15	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					911	913		10.1086/302541	http://dx.doi.org/10.1086/302541			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441595	Green Published, Bronze			2022-12-18	WOS:000082426400034
J	Camp, NJ				Camp, NJ			Genomewide transmission/disequilibrium testing - Consideration of the genotypic relative risks at disease loci	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; REGION; SUSCEPTIBILITY	Genomewide association studies are set to become the tool of the future for detection of small-effect genes in complex diseases. It will therefore be necessary to calculate sufficient sample sizes with which to perform them. In this paper I illustrate how to calculate the required number of families for general genotypic relative risks (GRRs). I show the superior sensitivity of the genomewide association study over the standard genomewide affected-sib-pair linkage analysis, for a range of different underlying GRR patterns. I also illustrate the extent of change in the sample sizes that is necessary for a genomewide association analysis depending on the pattern of the GRRs at the disease locus. In many cases, the comparative numbers of families required under different genetic mechanisms vary by several orders of magnitude. These sometimes dramatic differences have important implications for the determination of the size of the collection of samples prior to analysis and for the types of effects that are likely-and unlikely-to be detected by such an analysis.	Univ Sheffield, Royal Hallamshire Hosp, Sect Mol Med, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Camp, NJ (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Sect Mol Med, M Floor, Sheffield S10 2JF, S Yorkshire, England.	njc@mendel.shef.ac.uk						BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; FIELD LL, 1986, GENET EPIDEMIOL, P323; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; MullerMyhsok B, 1997, SCIENCE, V275, P1328; Risch N, 1997, SCIENCE, V275, P1329; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1978, ANN HUM GENET, V42, P87, DOI 10.1111/j.1469-1809.1978.tb00933.x	11	92	93	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	1997	61	6					1424	1430		10.1086/301648	http://dx.doi.org/10.1086/301648			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YT019	9399906	Bronze, Green Published			2022-12-18	WOS:000071555900027
J	Schanen, NC; Dahle, EJR; Capozzoli, F; Holm, VA; Zoghbi, HY; Francke, U				Schanen, NC; Dahle, EJR; Capozzoli, F; Holm, VA; Zoghbi, HY; Francke, U			A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							UNIPARENTAL DISOMY; LINKAGE MAP; INACTIVATION; MUTATIONS; GIRLS; MARKERS; TWINS; PROBE	Although familial recurrences of Rett syndrome (RTT) comprise only similar to 1% of the reported cases, it is these cases that hold the key for the understanding of the genetic basis of the disorder. Families in which RTT occurs in mother and daughter, aunt and niece, and half sisters are consistent with dominant inheritance and variable expressivity of the phenotype. Recurrence of RTT in sisters is likely due to germ-line mosaicism in one of the parents, rather than to recessive inheritance. The exclusive occurrence of classic RTT in females led to the hypothesis that it is X-linked and may be lethal in males. In an X-linked dominant disorder, unaffected obligate-carrier females would be expected to show nonrandom or skewed inactivation of the X chromosome bearing the mutant allele, We investigated the X chromosome inactivation (XCI) patterns in the female members of a newly identified family with recurrence of RTT in a maternal aunt and a niece. Skewing of XCI is present in the obligate carrier in this family, supporting the hypothesis that RTT is an X-linked disorder. However, evaluation of the XCI pattern in the mother of affected half sisters shows random XCI, suggesting germ-line mosaicism as the cause of repeated transmission in this family. To determine which regions of the X chromosome were inherited concordantly/discordantly by the probands, we genotyped the individuals in the aunt-niece family and two previously reported pairs of half sisters. These combined exclusion-mapping data allow us to exclude the RTT locus from the interval between DXS1053 in Xp22.2 and DXS1222 in Xq22.3. This represents an extension of the previous exclusion map.	STANFORD UNIV, SCH MED, DEPT GENET, STANFORD, CA 94305 USA; BAYLOR COLL MED, DEPT PEDIAT, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT HUMAN MOL GENET, HOUSTON, TX 77030 USA; BAYLOR COLL MED, HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA; UNIV WASHINGTON, DEPT PEDIAT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, CTR HUMAN DEV & DISABIL, SEATTLE, WA 98195 USA	Stanford University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Schanen, NC (corresponding author), STANFORD UNIV, SCH MED, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA.			Zoghbi, Huda/0000-0002-0700-3349	NICHD NIH HHS [HD01103, HD24234] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALLEN RC, 1992, AM J HUM GENET, V51, P1229; ANVRET M, 1990, AM J MED GENET, V37, P31, DOI 10.1002/ajmg.1320370109; ANVRET M, 1994, CLIN GENET, V45, P274; ARCHIDIACONO N, 1991, HUM GENET, V86, P604; BARKER DF, 1989, CYTOGENET CELL GENET, V51, P958; BRUCK I, 1991, AM J MED GENET, V39, P415, DOI 10.1002/ajmg.1320390411; BUHLER EM, 1990, AM J MED GENET, V36, P126, DOI 10.1002/ajmg.1320360125; CAMUS P, 1994, AM J MED GENET, V50, P307, DOI 10.1002/ajmg.1320500321; Camus P, 1996, HUM GENET, V97, P247, DOI 10.1007/BF02265275; COLEMAN M, 1987, BRAIN DEV-JPN, V9, P475, DOI 10.1016/S0387-7604(87)80067-0; COMINGS DE, 1986, AM J MED GENET, V24, P383; CURTIS ARJ, 1993, HUM GENET, V90, P551; ELLISON KA, 1992, AM J HUM GENET, V50, P278; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HAGBERG B, 1985, ACTA PAEDIATR SCAND, V74, P405, DOI 10.1111/j.1651-2227.1985.tb10993.x; HUNTER A, 1992, AM J MED GENET, V42, P213, DOI 10.1002/ajmg.1320420215; KORMANNBORTOLOTTO MH, 1992, CLIN GENET, V42, P296; KORMANNBORTOLOTTO MH, 1995, J INTELL DISABIL RES, V39, P91, DOI 10.1111/j.1365-2788.1995.tb00476.x; MIGEON BR, 1995, AM J HUM GENET, V56, P647; Naumova AK, 1996, AM J HUM GENET, V58, P1111; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P308; PEGORARO E, 1994, AM J HUM GENET, V54, P989; Rett A, 1966, Wien Med Wochenschr, V116, P723; RICCARDI VM, 1986, AM J MED GENET, V24, P389; RIVKIN MJ, 1992, BRAIN DEV-JPN, V14, P273, DOI 10.1016/S0387-7604(12)80247-6; RUCH A, 1989, PEDIATR NEUROL, V5, P320, DOI 10.1016/0887-8994(89)90027-1; SIMMLER MC, 1987, EMBO J, V6, P963, DOI 10.1002/j.1460-2075.1987.tb04846.x; Thomas GH, 1996, AM J HUM GENET, V58, P1364; TREVATHAN E, 1988, ANN NEUROL, V23, P425; WEBB T, 1993, CLIN GENET, V44, P236; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WITTENGERSTROM I, 1992, DEV MED CHILD NEUROL, V34, P1022; ZOGHBI H, 1988, J CHILD NEUROL, V3, pS76, DOI 10.1177/0883073888003001S15; ZOGHBI HY, 1990, BRAIN DEV-JPN, V12, P131, DOI 10.1016/S0387-7604(12)80194-X	34	92	92	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					634	641		10.1086/515525	http://dx.doi.org/10.1086/515525			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326329	Green Published, Bronze			2022-12-18	WOS:A1997XY52300021
J	Peral, B; Gamble, V; Strong, C; Ong, ACM; SloaneStanley, J; Zerres, K; Winearls, CG; Harris, PC				Peral, B; Gamble, V; Strong, C; Ong, ACM; SloaneStanley, J; Zerres, K; Winearls, CG; Harris, PC			Identification of mutations in the duplicated region of the polycystic kidney disease 1 gene (PKD1) by a novel approach	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RENAL-DISEASE; LOCUS; HETEROGENEITY; AMPLIFICATION; MISMATCHES; DELETION; SEQUENCE; LINKAGE; PROTEIN; FAMILY	Mutation screening of the major autosomal dominant polycystic kidney disease gene (PKD1) has been complicated by the large transcript size (>14 kb) and by reiteration of the genomic area encoding 75% of the protein on the same chromosome (the HG loci). The sequence similarity between the PKD1 and HG regions has precluded specific analysis of the duplicated region of PKD1, and consequently all previously described mutations map to the unique 3' region of PKD1. We have now developed a novel anchored reverse-transcription-PCR (RT-PCR) approach to specifically amplify duplicated regions of PKD1, employing one primer situated within the single-copy region and one within the reiterated area. This strategy has been incorporated in a mutation screen of 100 patients for more than half of the PKD1 exons (exons 22-46; 37% of the coding region), including 11 (exons 22-32) within the duplicated gene region, by use of the protein-truncation test (PTT). Sixty of these patients also were screened for missense changes, by use of the nonisotopic RNase cleavage assay (NIRCA), in exons 23-36, Eleven mutations have been identified, six within the duplicated region, and these consist of three stop mutations, three frameshifting deletions of a single nucleotide, two splicing defects, and three possible missense changes. Each mutation was detected in just one family (although one has been described elsewhere); no mutation hot spot was identified. The nature and distribution of mutations, plus the lack of a clear phenotype/genotype correlation, suggest that they may inactivate the molecule. RT-PCR/PTT proved to be a rapid and efficient method to detect PKD1 mutations (differentiating pathogenic changes from polymorphisms), and we recommend this procedure as a first-pass mutation screen in this disorder.	JOHN RADCLIFFE HOSP,INST MOL MED,MRC,MOL HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND; CHURCHILL HOSP,RENAL UNIT,OXFORD OX3 7LJ,ENGLAND; UNIV BONN,INST HUMAN GENET,D-5300 BONN,GERMANY	University of Oxford; University of Oxford; University of Bonn			Ong, Albert/AAN-9430-2021; Peral, Belén/F-4562-2015	Ong, Albert/0000-0002-7211-5400; Peral, Belén/0000-0003-4984-4020	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKSENTIJEVICH I, 1993, AM J HUM GENET, V53, P451; BOGDANOVA N, 1995, HUM GENET, V95, P645; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; BURN TC, 1995, HUM MOL GENET, V4, P575, DOI 10.1093/hmg/4.4.575; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAOUST MC, 1995, GENOMICS, V25, P733, DOI 10.1016/0888-7543(95)80020-M; DEALMEIDA S, 1995, HUM GENET, V96, P83, DOI 10.1007/BF00214191; DEISSEROTH A, 1979, P NATL ACAD SCI USA, V76, P2185, DOI 10.1073/pnas.76.5.2185; DODE C, 1990, BRIT J HAEMATOL, V76, P275, DOI 10.1111/j.1365-2141.1990.tb07884.x; *EUR POL KIDN DIS, 1994, CELL, V77, P881; GABOW PA, 1990, AM J KIDNEY DIS, V16, P403, DOI 10.1016/S0272-6386(12)80051-5; GABOW PA, 1992, KIDNEY INT, V41, P1311, DOI 10.1038/ki.1992.195; HARRIS PC, 1995, J AM SOC NEPHROL, V6, P1125; HARRIS PC, 1991, LANCET, V338, P1484, DOI 10.1016/0140-6736(91)92300-Q; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; *INT POL KIDN DIS, 1995, CELL, V81, P289; KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999; LOHRING C, IN PRESS MAMM GEONOM; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moy GW, 1996, J CELL BIOL, V133, P809, DOI 10.1083/jcb.133.4.809; MYERS RM, 1985, SCIENCE, V230, P1242, DOI 10.1126/science.4071043; Neophytou P, 1996, HUM GENET, V98, P437, DOI 10.1007/s004390050235; PERAL B, 1995, HUM MOL GENET, V4, P569, DOI 10.1093/hmg/4.4.569; Peters D. J. M., 1996, Journal of the American Society of Nephrology, V7, P1603; PETERS DJM, 1992, CONTRIB NEPHROL, V97, P128; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; RAVINE D, 1992, LANCET, V340, P1330, DOI 10.1016/0140-6736(92)92503-8; ROEST PAM, 1993, HUM MOL GENET, V2, P1719, DOI 10.1093/hmg/2.10.1719; Rossetti S, 1996, AM J MED GENET, V65, P155, DOI 10.1002/(SICI)1096-8628(19961016)65:2<155::AID-AJMG15>3.0.CO;2-P; SNAREY A, 1994, AM J HUM GENET, V55, P365; TORRA R, IN PRESS HUM MUTAT; TURCO AE, 1995, HUM MOL GENET, V4, P1331, DOI 10.1093/hmg/4.8.1331; WHITE PC, 1994, HUM MUTAT, V3, P373, DOI 10.1002/humu.1380030408; WIERINGA B, 1984, CELL, V37, P915, DOI 10.1016/0092-8674(84)90426-4; WINTER E, 1985, P NATL ACAD SCI USA, V82, P7575, DOI 10.1073/pnas.82.22.7575	36	92	101	0	5	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1399	1410		10.1086/515467	http://dx.doi.org/10.1086/515467			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199561	Green Published, Bronze			2022-12-18	WOS:A1997XE29400018
J	Saar, K; Chrzanowska, KH; Stumm, M; Jung, M; Nurnberg, G; Wienker, TF; Seemanova, E; Wegner, RD; Reis, A; Sperling, K				Saar, K; Chrzanowska, KH; Stumm, M; Jung, M; Nurnberg, G; Wienker, TF; Seemanova, E; Wegner, RD; Reis, A; Sperling, K			The gene for the ataxia-telangiectasia variant, Nijmegen breakage syndrome, maps to a 1-cM interval on chromosome 8q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENTATION ANALYSIS; NORMAL INTELLIGENCE; IMMUNODEFICIENCY; INSTABILITY; RISK; ABERRATIONS; DISORDER	Nijmegen breakage syndrome (NBS; Seemanova II syndrome) and Berlin breakage syndrome (BBS), also known as ataxia-telangiectasia variants, are two clinically indistinguishable autosomal recessive familial cancer syndromes that share with ataxia-telangiectasia similar cellular, immunological, and chromosomal but not clinical findings. Classification in NBS and BBS was based on complementation of their hypersensitivity to ionizing radiation in cell-fusion experiments. Recent investigations have questioned the former classification into two different disease entities, suggesting that NBS/ BBS is caused by mutations in a single radiosensitivity gene. We now have performed a whole-genome screen in 14 NBS/BBS families and have localized the gene for NBS/BBS to a 1-cM interval on chromosome 8q21, between markers D8S271 and D8S270, with a peak LOD score of 6.86 at D8S1811. This marker also shows strong allelic association to both Slavic NBS and German BBS patients, suggesting the existence of one major mutation of Slavic origin. Since the same allele is seen in both former complementation groups, genetic homogeneity of NBS/BBS can be considered as proved.	HUMBOLDT UNIV BERLIN,VIRCHOW KLINIKUM,INST HUMANGENET,D-13353 BERLIN,GERMANY; CHILDRENS MEM HLTH INST,DEPT MED GENET,WARSAW,POLAND; MAX DELBRUCK CTR MOL MED,MIKROSATELLITEZENTRUMZEN,BERLIN,GERMANY; CHARLES UNIV,DEPT MED GENET,PRAGUE,CZECH REPUBLIC	Humboldt University of Berlin; Children's Memorial Health Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Charles University Prague			Reis, André/D-2309-2009	Reis, André/0000-0002-6301-6363; Chrzanowska, Krystyna/0000-0003-3888-0624; Saar, Kathrin/0000-0002-4483-1557				Bourne Y, 1996, CELL, V84, P863, DOI 10.1016/S0092-8674(00)81065-X; BrayWard P, 1996, GENOMICS, V32, P1, DOI 10.1006/geno.1996.0070; CHEN P, 1984, MUTAT RES, V129, P165, DOI 10.1016/0027-5107(84)90149-0; CHEN P, 1993, CYTOGENET CELL GENET, V64, P9, DOI 10.1159/000133549; CHRZANOWSKA KH, 1995, AM J MED GENET, V57, P462, DOI 10.1002/ajmg.1320570321; Demetrick DJ, 1996, CYTOGENET CELL GENET, V73, P250, DOI 10.1159/000134349; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; HUDSON TJ, 1995, SCIENCE, V270, P1945, DOI 10.1126/science.270.5244.1945; JASPERS NGJ, 1988, AM J HUM GENET, V42, P66; JASPERS NGJ, 1988, CYTOGENET CELL GENET, V49, P259, DOI 10.1159/000132673; JASPERS NGJ, 1982, P NATL ACAD SCI-BIOL, V79, P2641, DOI 10.1073/pnas.79.8.2641; Komatsu K, 1996, AM J HUM GENET, V58, P885; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; SEEMANOVA E, 1990, MUTAT RES, V238, P321, DOI 10.1016/0165-1110(90)90024-6; SEEMANOVA E, 1985, AM J MED GENET, V20, P639, DOI 10.1002/ajmg.1320200410; STUMM M, 1995, AM J HUM GENET, V57, P960; TAALMAN RDFM, 1989, AM J MED GENET, V32, P425, DOI 10.1002/ajmg.1320320332; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; vanderBurgt I, 1996, J MED GENET, V33, P153, DOI 10.1136/jmg.33.2.153; WEGNER RD, 1988, CLIN GENET, V33, P20; WEGNER RD, 1994, CHROMOSOMAL ALTERATI, P269	21	92	96	0	10	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					605	610						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042920				2022-12-18	WOS:A1997WK40300017
J	Schuffenecker, I; Ginet, N; Goldgar, D; Eng, C; Chambe, B; Boneu, A; Houdent, C; Pallo, D; Schlumberger, M; Thivolet, C; Lenoir, GM				Schuffenecker, I; Ginet, N; Goldgar, D; Eng, C; Chambe, B; Boneu, A; Houdent, C; Pallo, D; Schlumberger, M; Thivolet, C; Lenoir, GM			Prevalence and parental origin of de novo RET mutations in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							TYROSINE KINASE DOMAIN; MEN 2A; POINT MUTATION; PROTOONCOGENE; FMTC; 2B; PATIENT; LOCUS		UNIV LYON 1,FAC MED,CNRS UMR 5641,F-69365 LYON,FRANCE; HOP EDOUARD HERRIOT,SERV ENDOCRINOL,LYON,FRANCE; CTR RECH CANC,UNITE EPIDEMIOL GENET,LYON,FRANCE; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV CANC EPIDEMIOL & CONTROL,BOSTON,MA 02115; CTR CLAUDIUS REGAUD,NUCL MED SERV,TOULOUSE,FRANCE; CHU GRENOBLE,SERV ENDOCRINOL,F-38043 GRENOBLE,FRANCE; INST GUSTAVE ROUSSY,NUCL MED SERV,PARIS,FRANCE; HOP BOIS GUILLAUME,SERV ENDOCRINOL,ROUEN,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; UNICANCER; Institut Claudius Regaud; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UNICANCER; Gustave Roussy; CHU de Rouen	Schuffenecker, I (corresponding author), HOP EDOUARD HERRIOT,GENET LAB,1 PL ARSONVAL,F-69437 LYON 03,FRANCE.			Eng, Charis/0000-0002-3693-5145				BOLINO A, 1995, ONCOGENE, V10, P2415; CARLSON KM, 1994, AM J HUM GENET, V55, P1076; CARLSON KM, 1994, P NATL ACAD SCI USA, V91, P1579, DOI 10.1073/pnas.91.4.1579; ENG C, 1995, CLIN ENDOCRINOL, V43, P123, DOI 10.1111/j.1365-2265.1995.tb01903.x; ENG C, 1994, HUM MOL GENET, V3, P237, DOI 10.1093/hmg/3.2.237; ENG C, 1995, ONCOGENE, V10, P509; ENG C, IN PRESS JAMA; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; KITAMURA Y, 1995, HUM MOL GENET, V4, P1987, DOI 10.1093/hmg/4.10.1987; LAIRMORE TC, 1993, P NATL ACAD SCI USA, V90, P492, DOI 10.1073/pnas.90.2.492; LOVE DR, 1993, HUM MOL GENET, V2, P491, DOI 10.1093/hmg/2.4.491-a; MODIGLIANI E, 1995, J INTERN MED, V238, P363, DOI 10.1111/j.1365-2796.1995.tb01211.x; MULLIGAN LM, 1993, NATURE, V363, P458, DOI 10.1038/363458a0; MULLIGAN LM, 1994, HUM MOL GENET, V3, P1007, DOI 10.1093/hmg/3.6.1007; MULLIGAN LM, 1994, NAT GENET, V6, P70, DOI 10.1038/ng0194-70; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P10073, DOI 10.1093/nar/15.23.10073; PASINI B, 1995, ONCOGENE, V11, P1737; Ponder BAJ, 1995, CANCER SURV, V25, P195; ROSSEL M, 1995, HUM GENET, V95, P403; SAPIENZA C, 1994, AM J HUM GENET, V55, P1073; SAPIENZA C, 1994, METABOLIC BASIS INHE; SCHUFFENECKER I, 1994, HUM MOL GENET, V3, P1939, DOI 10.1093/hmg/3.11.1939; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; Wohllk N, 1996, J CLIN ENDOCR METAB, V81, P3740, DOI 10.1210/jc.81.10.3740	25	92	98	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					233	237						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981969				2022-12-18	WOS:A1997WA81800032
J	Colman, SD; Rasmussen, SA; Ho, VT; Abernathy, CR; Wallace, MR				Colman, SD; Rasmussen, SA; Ho, VT; Abernathy, CR; Wallace, MR			Somatic mosaicism in a patient with neurofibromatosis type 1	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VONRECKLINGHAUSEN NEUROFIBROMATOSIS; GENE; MUTATIONS; DELETIONS; SEQUENCE; ORIGIN; BLOOD; DNA	Using loss of heterozygosity analysis, a method designed to detect moderate to large gene deletions, we have identified a new-mutation neurofibromatosis type 1 (NF1) patient who is somatically mosaic for a large maternally derived deletion in the NF1 gene region. The deletion extends at least from exon 4 near the 5' end of the gene to intron 39 near the 3' end. The gene-coding region is, therefore, mostly or entirely deleted, encompassing a loss of greater than or equal to 100 kb. We hypothesize that the deletion occurred at a relatively early developmental timepoint, since signs of NF1 in this patient are not confined to a specific body region, as seen in ''segmental'' NF, and since both mesodermally and ectodermally derived cells are affected. This report provides the first molecular evidence of somatic mosaicism in NF1 and, taken together with a recent report of germ-line mosaicism in NF1, adds credence to the concept that mosaicism plays an important role in phenotypic and genetic aspects of NF1 and may even be a relatively common phenomenon.	UNIV FLORIDA,COLL MED,CTR MAMMALIAN GENET,DEPT PEDIAT,DIV GENET,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,DEPT BIOCHEM & MOLEC BIOL,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,DEPT LAB MED & PATHOL,GAINESVILLE,FL 32610	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida					NATIONAL CANCER INSTITUTE [T32CA009126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS031550] Funding Source: NIH RePORTER; NCI NIH HHS [T32 CA09126] Funding Source: Medline; NINDS NIH HHS [R29 NS31550] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERNATHY C, 1994, CLIN GENET, V45, P313; BAKKER E, 1989, J MED GENET, V26, P553, DOI 10.1136/jmg.26.9.553; BERNARDS A, 1994, NEW ENGL J MED, V331, P1447, DOI 10.1056/NEJM199411243312110; BOLTSHAUSER E, 1989, Neurofibromatosis, V2, P244; BOURN D, 1994, AM J HUM GENET, V55, P69; Byers PH., 1995, METABOLIC MOL BASES, V7th ed, P4029; COLMAN SD, 1995, NAT GENET, V11, P90, DOI 10.1038/ng0995-90; FISHLER K, 1991, AM J MENT RETARD, V96, P345; HALL JG, 1988, AM J HUM GENET, V43, P355; HIRSCHHORN R, 1994, AM J HUM GENET, V55, P59; HOFF M, 1988, NUCLEIC ACIDS RES, V16, P781, DOI 10.1093/nar/16.2.781; HOFFMEYER S, 1994, HUM GENET, V93, P481; HUSON SM, 1994, NEUROFIBROMATOSES PA, P204; JADAYEL D, 1990, NATURE, V343, P558, DOI 10.1038/343558a0; JORDE LB, 1993, AM J HUM GENET, V53, P1038; KAYES LM, 1994, AM J HUM GENET, V54, P424; KONTUSAARI S, 1992, AM J HUM GENET, V51, P497; LAZARO C, 1994, HUM GENET, V93, P351, DOI 10.1007/BF00212039; LAZARO C, 1994, NEW ENGL J MED, V331, P1403, DOI 10.1056/NEJM199411243312102; MADISEN L, 1987, AM J MED GENET, V27, P379, DOI 10.1002/ajmg.1320270216; MARCHUK DA, 1991, GENOMICS, V11, P931, DOI 10.1016/0888-7543(91)90017-9; Martin-Gallardo A, 1992, DNA Seq, V3, P237, DOI 10.3109/10425179209034023; REYNIERS E, 1993, HUM GENET, V92, P631, DOI 10.1007/BF00420953; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; RICCARDI VM, 1988, AM J HUM GENET, V42, P284; Rubenstein AE, 1983, NEUROLOGY S2, V33, P76; SAITO K, 1995, AM J MED GENET, V56, P80, DOI 10.1002/ajmg.1320560118; Sambrook J., 1989, MOL CLONING LAB MANU; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SHANNON KM, 1994, NEW ENGL J MED, V330, P597, DOI 10.1056/NEJM199403033300903; Soltan H., 1995, American Journal of Human Genetics, V57, pA228; STEPHENS K, 1992, HUM GENET, V88, P279; VANESSEN AJ, 1992, HUM GENET, V88, P249, DOI 10.1007/BF00197255; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; WALLIS GA, 1990, AM J HUM GENET, V46, P1034; XU W, 1991, NUCLEIC ACIDS RES, V19, P3764; ZLOTOGORA J, 1993, AM J MED GENET, V46, P182, DOI 10.1002/ajmg.1320460217	37	92	95	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1996	58	3					484	490						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TV564	8644707				2022-12-18	WOS:A1996TV56400006
J	STEINMANN, B; EYRE, DR; SHAO, P				STEINMANN, B; EYRE, DR; SHAO, P			URINARY PYRIDINOLINE CROSS-LINKS IN EHLERS-DANLOS-SYNDROME TYPE-VI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LYSYL HYDROXYLASE; I COLLAGEN; 2 SIBLINGS; RESORPTION; RESIDUES; MARKERS; GENE		UNIV WASHINGTON,SCH MED,DEPT ORTHOPAED,SEATTLE,WA	University of Washington; University of Washington Seattle	STEINMANN, B (corresponding author), UNIV ZURICH,CHILDRENS HOSP,DEPT PEDIAT,DIV METAB & MOLEC DIS,STEINWIESTR 75,CH-8032 ZURICH,SWITZERLAND.				NIAMS NIH HHS [R01 AR036794, R37 AR037318] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR037318, R01AR036794] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BEARDSWORTH LJ, 1990, J BONE MINER RES, V5, P671; BOLLEN AM, 1994, BONE, V15, P31, DOI 10.1016/8756-3282(94)90888-5; EYRE D, 1987, METHOD ENZYMOL, V144, P115; GARNERO P, 1994, J CLIN ENDOCR METAB, V79, P1693, DOI 10.1210/jc.79.6.1693; GERRIETS JE, 1993, J BIOL CHEM, V268, P25553; HANSON DA, 1992, J BONE MINER RES, V7, P1251; HAUTALA T, 1993, GENOMICS, V15, P399, DOI 10.1006/geno.1993.1074; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; PASQUALI M, 1994, NEW ENGL J MED, V331, P132, DOI 10.1056/NEJM199407143310217; ROBINS SP, 1991, EUR J CLIN INVEST, V21, P310, DOI 10.1111/j.1365-2362.1991.tb01375.x; ROYCE PM, 1985, BIOCHEM J, V230, P475, DOI 10.1042/bj2300475; Steinmann Beat, 1993, P351	12	92	92	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1505	1508						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533783				2022-12-18	WOS:A1995TE65500031
J	PRIOR, TW; BARTOLO, C; PEARL, DK; PAPP, AC; SNYDER, PJ; SEDRA, MS; BURGHES, AHM; MENDELL, JR				PRIOR, TW; BARTOLO, C; PEARL, DK; PAPP, AC; SNYDER, PJ; SEDRA, MS; BURGHES, AHM; MENDELL, JR			SPECTRUM OF SMALL MUTATIONS IN THE DYSTROPHIN CODING REGION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE-MUSCULAR-DYSTROPHY; POLYMERASE CHAIN-REACTION; NONSENSE MUTATION; MESSENGER-RNA; POINT MUTATIONS; INTRAGENIC RECOMBINATION; GENOMIC ORGANIZATION; GLYCOPROTEIN COMPLEX; TERMINAL DOMAINS; CYSTEINE-RICH	Duchenne and Becker muscular dystrophies (DMD and BMD) are caused by defects in the dystrophin gene. About two-thirds of the affected patients have large deletions or duplications, which occur in the 5' and central portion of the gene. The nondeletion/duplication cases are most likely the result of smaller mutations that cannot be identified by current diagnostic screening strategies. We screened similar to 80% of the dystrophin coding sequence for small mutations in 158 patients without deletions or duplications and identified 23 mutations. The study indicates that many of the DMD and the majority of the BMD small mutations lie in noncoding regions of the gene. All of the mutations identified were unique to single patients, and most of the mutations resulted in protein truncation. We did not find a clustering of small mutations similar to the deletion distribution but found >40% of the small mutations 3' of exon 55. The extent of protein truncation caused by the 3' mutations did not determine the phenotype, since even the exon 76 nonsense mutation resulted in the severe DMD phenotype. Our study confirms that the dystrophin gene is subject to a high rate of mutation in CpG sequences. As a consequence of not finding any hotspots or prevalent small mutations, we conclude that it is presently not possible to perform direct carrier and prenatal diagnostics for many families without deletions or duplications.	OHIO STATE UNIV,DEPT MOLEC GENET,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT STAT,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT NEUROL,COLUMBUS,OH 43210	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	PRIOR, TW (corresponding author), OHIO STATE UNIV,DEPT PATHOL,121 HAMILTON HALL,1645 NEIL AVE,COLUMBUS,OH 43210, USA.		Pearl, Dennis/AAO-5314-2020	Pearl, Dennis/0000-0003-1981-1826; Burghes, Arthur/0000-0001-9031-1555				ABBS S, 1990, GENOMICS, V7, P602, DOI 10.1016/0888-7543(90)90205-9; AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; AKALIN N, 1994, HUM MOL GENET, V3, P1425, DOI 10.1093/hmg/3.8.1425; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; BASERGA SJ, 1992, P NATL ACAD SCI USA, V89, P2935, DOI 10.1073/pnas.89.7.2935; BEBCHUK KG, 1993, HUM MOL GENET, V2, P593, DOI 10.1093/hmg/2.5.593; BEGGS AH, 1990, HUM GENET, V86, P45; BEGGS AH, 1990, NUCLEIC ACIDS RES, V18, P1931, DOI 10.1093/nar/18.7.1931; BEGGS AH, 1994, CURRENT PROTOCOLS HU; BELGRADER P, 1993, P NATL ACAD SCI USA, V90, P482, DOI 10.1073/pnas.90.2.482; BIES RD, 1992, J CLIN INVEST, V90, P666, DOI 10.1172/JCI115909; BULMAN DE, 1991, GENOMICS, V10, P457, DOI 10.1016/0888-7543(91)90332-9; BULMAN DE, 1991, AM J HUM GENET, V48, P295; BURROW K, 1991, NEUROLOGY, V41, P662; CAMPBELL KP, 1989, NATURE, V338, P259, DOI 10.1038/338259a0; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CLEMENS PR, 1991, AM J HUM GENET, V49, P951; DARRAS BT, 1988, AM J HUM GENET, V43, P620; DENNIS JA, 1989, P NATL ACAD SCI USA, V86, P7947, DOI 10.1073/pnas.86.20.7947; Emery A, 1988, DUCHENNE MUSCULAR DY; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FEENER CA, 1990, AM J HUM GENET, V48, P621; FORREST S M, 1988, Genomics, V2, P109, DOI 10.1016/0888-7543(88)90091-2; GILLARD EF, 1989, AM J HUM GENET, V45, P507; GRIMM T, 1994, J MED GENET, V31, P183, DOI 10.1136/jmg.31.3.183; HAGIWAR Y, 1994, AM J HUM GENET, V54, P53; HAMOSH A, 1991, J CLIN INVEST, V88, P1880, DOI 10.1172/JCI115510; HARPER PS, 1989, METABOLIC BASIS INHE, P2869; HELLIWELL TR, 1992, AM J HUM GENET, V50, P508; HOFFMAN EP, 1991, ANN NEUROL, V30, P605, DOI 10.1002/ana.410300414; HU XY, 1990, AM J HUM GENET, V46, P682; KILIMANN MW, 1992, HUM GENET, V89, P253; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; KNEPPERS ALJ, 1993, AM J HUM GENET, V53, P1493; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LENK U, 1993, HUM MOL GENET, V2, P1877, DOI 10.1093/hmg/2.11.1877; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; MASHIMA Y, 1992, AM J HUM GENET, V51, P81; MATSUO M, 1990, BIOCHEM BIOPH RES CO, V170, P963, DOI 10.1016/0006-291X(90)92185-3; MCCABE ERB, 1989, J CLIN INVEST, V83, P95, DOI 10.1172/JCI113890; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; NIGRO V, 1994, HUM MOL GENET, V3, P1907, DOI 10.1093/hmg/3.10.1907; NIGRO V, 1992, HUM MOL GENET, V1, P517, DOI 10.1093/hmg/1.7.517; OUDET C, 1990, HUM GENET, V84, P283; OUDET C, 1991, AM J HUM GENET, V49, P311; POWEL JF, 1990, NUCLEIC ACIDS RES, V19, P1159; PRIOR TW, 1994, AM J MED GENET, V50, P68, DOI 10.1002/ajmg.1320500115; PRIOR TW, 1993, NAT GENET, V4, P357, DOI 10.1038/ng0893-357; PRIOR TW, 1994, HUM MOL GENET, V3, P1173; PRIOR TW, 1993, HUM MOL GENET, V2, P311, DOI 10.1093/hmg/2.3.311; PRIOR TW, 1993, HUM MUTAT, V2, P192, DOI 10.1002/humu.1380020307; PRIOR TW, IN PRESS HUM MUTAT; RAFAEL JA, 1994, HUM MOL GENET, V3, P1725, DOI 10.1093/hmg/3.10.1725; RECAN D, 1992, J CLIN INVEST, V89, P712, DOI 10.1172/JCI115640; ROBERTS RG, 1994, HUM MUTAT, V4, P1, DOI 10.1002/humu.1380040102; ROBERTS RG, 1993, HUM MOL GENET, V2, P75, DOI 10.1093/hmg/2.1.75; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; ROBERTS RG, 1902, P NATLA CAD SCI US, V89, P2331; SAAD FA, 1993, HUM MUTAT, V2, P314, DOI 10.1002/humu.1380020413; SAAD FA, 1993, HUM MOL GENET, V2, P2199, DOI 10.1093/hmg/2.12.2199; Saad Fawzy, 1992, Human Molecular Genetics, V1, P345, DOI 10.1093/hmg/1.5.345; Soto D, 1992, PCR Methods Appl, V2, P96; SUZUKI A, 1995, J CELL BIOL, V128, P373, DOI 10.1083/jcb.128.3.373; TSUKAMOTO H, 1994, HUM MOL GENET, V3, P995, DOI 10.1093/hmg/3.6.995; URLAUB G, 1989, MOL CELL BIOL, V9, P2868, DOI 10.1128/MCB.9.7.2868; WHITE MB, 1992, GENOMICS, V12, P301, DOI 10.1016/0888-7543(92)90377-5; WILTON SD, 1994, HUM MUTAT, V3, P133, DOI 10.1002/humu.1380030208; WINNARD AV, 1992, HUM MOL GENET, V1, P645, DOI 10.1093/hmg/1.8.645; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276	72	92	95	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1995	57	1					22	33						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RE629	7611292				2022-12-18	WOS:A1995RE62900003
J	DENG, GY; MUIR, A; MACLAREN, NK; SHE, JX				DENG, GY; MUIR, A; MACLAREN, NK; SHE, JX			ASSOCIATION OF LMP2 AND LMP7 GENES WITHIN THE MAJOR HISTOCOMPATIBILITY COMPLEX WITH INSULIN-DEPENDENT DIABETES-MELLITUS - POPULATION AND FAMILY STUDIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-II REGION; MHC-LINKED LMP; PROTEASOME SUBUNITS; TRANSPORTERS; RESISTANCE; MOLECULES; SEQUENCES; FRAGMENTS	LMP2 and LMP7, two subunits of the proteasomes encoded in the major histocompatibility complex, are speculated to play a role in the generation of endogenous peptides for presentation by class I molecules to cytotoxic T cells. Their possible role in the pathogenesis of insulin-dependent diabetes mellitus (IDDM) has not been documented. In this study of Caucasian subjects, we have analyzed the polymorphisms of four genes within the HLA class II region (LMP2, LMP7, and HLA-DRB1 and -DQB1) in 198 unrelated IDDM patients and 192 normal controls ascertained from the southeastern United States. A genomic polymorphism of LMP7 was found strongly associated with IDDM, and the Arg/His-60 polymorphism in LMP2 was found associated with IDDM only in subjects containing an HLA DR4-DOB1*0302 haplotype. To determine whether the apparent associations between LMP genes and IDDM resulted from the strong linkage disequilibria observed between LMP and HLA-DR/DQ genes, we compared LMP gene frequencies in extended LMP-HLA haplotypes derived from control and diabetic families. Our results suggest that LMP genes have independent effects on TT)DM susceptibility.	UNIV FLORIDA,COLL MED,DEPT PATHOL,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,DEPT PATHOL & LAB MED,GAINESVILLE,FL 32610; UNIV FLORIDA,COLL MED,CTR MAMMALIAN GENET,GAINESVILLE,FL 32610	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida					NICHD NIH HHS [HD19469] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD019469] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ARNOLD D, 1992, NATURE, V360, P171, DOI 10.1038/360171a0; BECK S, 1992, J MOL BIOL, V228, P433, DOI 10.1016/0022-2836(92)90832-5; BROWN MG, 1991, NATURE, V353, P355, DOI 10.1038/353355a0; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; CAILLATZUCMAN S, 1993, EUR J IMMUNOL, V23, P1784, DOI 10.1002/eji.1830230808; COHENHAGUENAUER O, 1985, P NATL ACAD SCI USA, V82, P3335, DOI 10.1073/pnas.82.10.3335; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; DICK LR, 1994, J IMMUNOL, V152, P3884; DRISCOLL J, 1993, NATURE, V365, P262, DOI 10.1038/365262a0; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; FESTENSTEIN H, 1986, NATURE, V322, P64, DOI 10.1038/322064a0; FRUH K, 1992, J BIOL CHEM, V267, P22131; GACZYNSKA M, 1993, NATURE, V365, P264, DOI 10.1038/365264a0; KELLY A, 1991, NATURE, V353, P667, DOI 10.1038/353667a0; MAITY SN, 1992, J BIOL CHEM, V267, P16574; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; MONACO JJ, 1982, P NATL ACAD SCI-BIOL, V79, P3001, DOI 10.1073/pnas.79.9.3001; MONACO JJ, 1984, NATURE, V309, P797, DOI 10.1038/309797a0; NEPOM BS, 1986, J EXP MED, V164, P345, DOI 10.1084/jem.164.1.345; ORITZNAVARRETE V, 1991, NATURE, V353, P662; OWERBACH D, 1983, NATURE, V303, P815, DOI 10.1038/303815a0; SHE JX, 1994, AUTOIMMUNITY, V18, P195, DOI 10.3109/08916939409007996; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; Svejgaard A, 1975, Monogr Hum Genet, V7, P1; THORSBY E, 1992, ANN MED, V24, P523, DOI 10.3109/07853899209167006; THORSBY E, 1993, DIABETOLOGIA, V36, P371, DOI 10.1007/BF00402270; TIWARI JL, 1985, HLA DISEASE ASS, P185; Tiwari JL, 1985, HLA DISEASE ASS, P18; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; VANENDERT PM, 1992, P NATL ACAD SCI USA, V89, P11594, DOI 10.1073/pnas.89.23.11594; VANENDERT PM, 1994, DIABETES, V43, P110, DOI 10.2337/diabetes.43.1.110; YEWDELL J, 1994, J IMMUNOL, V152, P1163; 1979, DIABETES, V28, P1039	33	92	104	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1995	56	2					528	534						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QF423	7847389				2022-12-18	WOS:A1995QF42300022
J	FELLEYBOSCO, E; WESTON, A; CAWLEY, HM; BENNETT, WP; HARRIS, CC				FELLEYBOSCO, E; WESTON, A; CAWLEY, HM; BENNETT, WP; HARRIS, CC			FUNCTIONAL-STUDIES OF A GERM-LINE POLYMORPHISM AT CODON-47 WITHIN THE P53 GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILD-TYPE P53; CELLULAR TUMOR-ANTIGEN; HUMAN LUNG-CANCER; ACTIVATING MUTATIONS; SUPPRESSOR GENE; CELLS; TRANSFORMATION; PROTEIN; GROWTH; EXPRESSION	A rare germ-line polymorphism in codon 47 of the p53 gene replaces the wild-type proline (CCG) with a serine (TCG). Restriction analysis of 101 human samples revealed the frequency of the rare allele to be 0% (n = 69) in Caucasians and 4.7% (3/64, n = 32) among African-Americans. To investigate the consequence of this amino acid substitution, a cDNA construct (p53 mut47ser) containing the mutation was introduced into a lung adenocarcinoma cell line (Calu-6) that does not express p53. A growth suppression similar to that obtained after introduction of a wild-type p53 cDNA construct was observed, in contrast to the result obtained by introduction of p53 mut143ala. Furthermore, expression of neither p53 mut47ser nor wild-type p53 was tolerated by growing cells. In transient expression assays, both mut47ser and wild-type p53 activated the expression of a reporter gene linked to a p53 binding sequence (PG13-CAT) and inhibited the expression of the luciferase gene under the control of the Rous sarcoma virus promoter (RSVluc). In the same assay, mut143ala did not activate the expression of PG13-CAT and produced only a slight inhibitory effect on RSVluc. These findings indicate that the p53 variant with a serine at codon 47 should be considered as a rare germ-line polymorphism that does not alter the growth-suppression activity of p53.	NCI,HUMAN CARCINOGENESIS LAB,BLDG 37,ROOM 2C09,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Felley-Bosco, Emanuela/E-7484-2017	Felley-Bosco, Emanuela/0000-0002-3408-0294				AGOFF SN, 1993, SCIENCE, V259, P84, DOI 10.1126/science.8418500; AHUJA HG, 1990, ONCOGENE, V5, P1409; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; CAAMANO J, 1991, AM J PATHOL, V139, P839; CARBONE D, 1991, ONCOGENE, V6, P1691; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DELACALLEMARTIN O, 1990, NUCLEIC ACIDS RES, V18, P4963, DOI 10.1093/nar/18.16.4963; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; ELIYAHU D, 1984, NATURE, V312, P646, DOI 10.1038/312646a0; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FREBOURG T, 1992, CANCER RES, V52, P6976; FREBOURG T, 1992, P NATL ACAD SCI USA, V89, P6413, DOI 10.1073/pnas.89.14.6413; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; GERWIN BI, 1992, P NATL ACAD SCI USA, V89, P2759, DOI 10.1073/pnas.89.7.2759; GINSBERG D, 1991, P NATL ACAD SCI USA, V88, P9979, DOI 10.1073/pnas.88.22.9979; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; JENKINS JR, 1984, NATURE, V312, P651, DOI 10.1038/312651a0; JOHNSON P, 1991, MOL CELL BIOL, V11, P1; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; LEHMAN TA, 1991, CANCER RES, V51, P4090; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MALKIN D, 1992, NEW ENGL J MED, V326, P1309, DOI 10.1056/NEJM199205143262002; MATLASHEWSKI GJ, 1987, MOL CELL BIOL, V7, P961, DOI 10.1128/MCB.7.2.961; PARADA LF, 1984, NATURE, V312, P649, DOI 10.1038/312649a0; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; SUBLER MA, 1992, J VIROL, V66, P4757, DOI 10.1128/JVI.66.8.4757-4762.1992; TAKAHASHI T, 1992, CANCER RES, V52, P2340; TOGUCHIDA J, 1992, NEW ENGL J MED, V326, P1301, DOI 10.1056/NEJM199205143262001; WESTON A, 1992, CANCER EPIDEM BIOMAR, V1, P481; ZAKUTHOURI R, 1985, EMBO J, V4, P1251, DOI 10.1002/j.1460-2075.1985.tb03768.x	30	92	93	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1993	53	3					752	759						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LU559	8352280				2022-12-18	WOS:A1993LU55900019
J	BULMAN, DE; MURPHY, EG; ZUBRZYCKAGAARN, EE; WORTON, RG; RAY, PN				BULMAN, DE; MURPHY, EG; ZUBRZYCKAGAARN, EE; WORTON, RG; RAY, PN			DIFFERENTIATION OF DUCHENNE AND BECKER MUSCULAR-DYSTROPHY PHENOTYPES WITH AMINO-TERMINAL AND CARBOXY-TERMINAL ANTISERA SPECIFIC FOR DYSTROPHIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SKELETAL-MUSCLE; DMD GENE; MOLECULAR-BASIS; PROTEIN; DELETIONS; SURFACE; ABNORMALITIES; FRACTIONATION; DEFICIENCY; DIAGNOSIS	Antibodies directed against the amino- and carboxy-terminal regions of dystrophin have been used to characterize 25 Duchenne muscular dystrophy (DMD), two intermediate, and two Becker muscular dystrophy (BMD) patients. Western blot analysis revealed an altered-size (truncated) immunoreactive dystrophin band in 11 of the 25 DMD patients, on one of the two intermediate patients, and in both BMD patients, when immunostained with antiserum raised against the amino terminus of dystophin. None of the DMD or intermediate patients demonstrated an immunoreactive dystrophin band when immunostained with an antiserum specific for the carboxy terminus of the protein. In contrast, dystrophin was detected in both BMD patients by the antiserum specific for the carboxy terminus. Quantitative studies indicated that the relative abundance of dystrophin in patients with a severe (DMD), intermediate, or mild (BMD) phenotype may overlap, therefore suggesting that differential diagnosis of disease severity based entirely on dystrophin quantitation may be unsatisfactory. Our results suggest that a differential diagnosis between DMD and BMD would benefit from examination of both the N terminus and C terminus of the protein, in addition to measurements of the relative abundance of the protein.	HOSP SICK CHILDREN,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,RES INST,TORONTO M5G 1X8,ONTARIO,CANADA; HOSP SICK CHILDREN,DIV NEUROL,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET & MED BIOPHYS,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto								ARAHATA K, 1989, P NATL ACAD SCI USA, V86, P7154, DOI 10.1073/pnas.86.18.7154; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; BULMAN D E, 1989, American Journal of Human Genetics, V45, pA179; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; CARPENTER S, 1990, MUSCLE NERVE, V13, P376, DOI 10.1002/mus.880130503; CULLEN MJ, 1990, PROC R SOC SER B-BIO, V240, P197, DOI 10.1098/rspb.1990.0034; DAVISON MD, 1988, CELL, V52, P159, DOI 10.1016/0092-8674(88)90503-X; DENDUNNEN JT, 1987, NATURE, V329, P640, DOI 10.1038/329640a0; EMERY AEH, 1987, OXFORD MONOGRAPHS ME; FEENER CA, 1989, NATURE, V338, P509, DOI 10.1038/338509a0; FORREST SM, 1987, NATURE, V329, P638, DOI 10.1038/329638a0; GILLARD EF, 1989, AM J HUM GENET, V45, P507; HAMMONDS RG, 1987, CELL, V51, P1, DOI 10.1016/0092-8674(87)90002-X; HOFFMAN EP, 1989, NEUROLOGY, V39, P1011, DOI 10.1212/WNL.39.8.1011; HOFFMAN EP, 1989, NEURON, V2, P1019, DOI 10.1016/0896-6273(89)90226-2; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; HOFFMAN EP, 1987, CELL, V51, P928; HU XY, 1990, AM J HUM GENET, V46, P682; HUMPHRIES RK, 1984, BLOOD, V64, P23; JACOBS HK, 1989, CURRENT TRENDS INFAN, P361; KARPATI G, 1990, J NEUROPATH EXP NEUR, V49, P96, DOI 10.1097/00005072-199003000-00002; KLAMUT HJ, 1989, BRIT MED BULL, V45, P681, DOI 10.1093/oxfordjournals.bmb.a072352; KNUDSON CM, 1988, J BIOL CHEM, V263, P8480; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; NICHOLSON LVB, 1989, J NEUROL SCI, V94, P137, DOI 10.1016/0022-510X(89)90224-4; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; PATEL K, 1989, LANCET, V1, P47; PATEL K, 1988, J NEUROL SCI, V87, P315, DOI 10.1016/0022-510X(88)90256-0; ROWLAND LP, 1980, MUSCLE NERVE, V3, P3, DOI 10.1002/mus.880030103; SALVIATI G, 1989, BIOCHEM J, V258, P837, DOI 10.1042/bj2580837; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; SUGITA H, 1988, P JPN ACAD, V64, P1; TAKESHITA K, 1984, BLOOD, V64, P13; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; ZUBRZYCKAGAARN EE, IN PRESS EXP CELL RE; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	48	92	93	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1991	48	2					295	304						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV744	1990838				2022-12-18	WOS:A1991EV74400014
J	WALLIS, GA; STARMAN, BJ; ZINN, AB; BYERS, PH				WALLIS, GA; STARMAN, BJ; ZINN, AB; BYERS, PH			VARIABLE EXPRESSION OF OSTEOGENESIS IMPERFECTA IN A NUCLEAR FAMILY IS EXPLAINED BY SOMATIC MOSAICISM FOR A LETHAL POINT MUTATION IN THE ALPHA-I(I) GENE (COLIAI) OF TYPE-I COLLAGEN IN A PARENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WASHINGTON,DEPT PATHOL,SM-30,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT INHERITED DIS,SEATTLE,WA 98195; CASE WESTERN RESERVE UNIV,DEPT PEDIAT,CLEVELAND,OH 44106	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Case Western Reserve University				Byers, Peter H./0000-0001-7786-7030	NIAMS NIH HHS [AR 21557] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR021557] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BATEMAN JF, 1988, J BIOL CHEM, V263, P11627; BATEMAN JF, 1987, J BIOL CHEM, V262, P7021; BENSON S A, 1984, Biotechniques, V2, P66; BENYA PD, 1981, COLLAGEN REL RES, V1, P17; BONADIO J, 1985, J BIOL CHEM, V260, P1734; Byers P H, 1988, Ann N Y Acad Sci, V543, P117, DOI 10.1111/j.1749-6632.1988.tb55324.x; BYERS PH, 1988, AM J HUM GENET, V42, P237; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; Chromczynski P, 1987, ANAL BIOCHEM, V162, P156; COHN DH, 1990, AM J HUM GENET, V46; COLE WG, 1981, BIOCHEM J, V197, P377, DOI 10.1042/bj1970377; CONSTANTINOU CD, 1989, J CLIN INVEST, V83, P574, DOI 10.1172/JCI113920; GREENBERG ME, 1987, CURRENT PROTOCOLS MO, V1, P2; HALL JG, 1988, AM J HUM GENET, V43, P355; MANIATIS T, 1982, MOL CLONING, P213; MESSING J, 1981, NUCLEIC ACIDS RES, V9, P309, DOI 10.1093/nar/9.2.309; PRUCHNO CJ, UNPUB OSTEOGENESIS I; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Smith R., 1983, BRITTLE BONE SYNDROM; STACEY A, 1988, NATURE, V332, P131, DOI 10.1038/332131a0; STARMAN BJ, 1989, J CLIN INVEST, V84, P1206, DOI 10.1172/JCI114286; WALLIS GA, UNPUB SUBSTITUTION A; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424	25	92	94	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1034	1040						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2339700				2022-12-18	WOS:A1990DF20200004
J	KHOURY, MJ; ADAMS, MJ; FLANDERS, WD				KHOURY, MJ; ADAMS, MJ; FLANDERS, WD			AN EPIDEMIOLOGIC APPROACH TO ECOGENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CTR DIS CONTROL,CTR ENVIRONM HLTH & INJURY CONTROL,DIV CHRON DIS CONTROL,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA	KHOURY, MJ (corresponding author), CTR DIS CONTROL,CTR ENVIRONM HLTH & INJURY CONTROL,ATLANTA,GA 30333, USA.							AYESH R, 1984, NATURE, V312, P169, DOI 10.1038/312169a0; BARBEAU A, 1985, LANCET, V2, P1213; BIAS WB, 1981, BIOCULTURAL ASPECTS, P95; CALABRESE EJ, 1984, ECOGENETICS GENETIC; CARTWRIGHT RA, 1982, LANCET, V2, P842; EVANS DAP, 1984, J MED GENET, V21, P243, DOI 10.1136/jmg.21.4.243; EVANS DAP, 1983, PRINCIPLES PRACTICE, V2, P1389; FRANK AL, 1986, PUBLIC HLTH PREVENTI, P714; GOEDDE HW, 1978, FORTSCHR MED, V97, P165; GOEDDE HW, 1978, FORTSCHR MED, V97, P127; Haldane J. B. S., 1946, ANN EUGENICS LOND, V13, P197; KAHN HA, 1983, INTRO EPIDEMIOLOGIC; Kalow Werner, 1963, PHARMACOGENETICS HER; KHOURY MJ, 1987, AM J EPIDEMIOL, V126, P561, DOI 10.1093/oxfordjournals.aje.a114695; LUZZATTO L, 1970, LANCET, V1, P319; MOTULSKY AG, 1978, HUM GENET S, V1, P1; MULVIHILL JJ, 1984, GENES CANCER, P19; Rothman K, 1986, MODERN EPIDEMIOLOGY; Sing C F, 1985, Prog Clin Biol Res, V194, P39; TOCKMAN MS, 1985, CHRONIC OBSTRUCTIVE, V28, P43; VESELL ES, 1973, PROG MED GENET, V9, P291; Ward R H, 1985, Prog Clin Biol Res, V194, P147; [No title captured]	23	92	95	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1988	42	1					89	95						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	L8697	3337114				2022-12-18	WOS:A1988L869700013
J	LAI, EC; KAO, FT; LAW, ML; WOO, SLC				LAI, EC; KAO, FT; LAW, ML; WOO, SLC			ASSIGNMENT OF THE ALPHA-1-ANTITRYPSIN GENE AND A SEQUENCE-RELATED GENE TO HUMAN CHROMOSOME-14 BY MOLECULAR HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									ELEANOR ROOSEVELT INST CANC RES,DENVER,CO 80262; BAYLOR COLL MED,HOWARD HUGHES MED INST LAB,HOUSTON,TX 77030	Baylor College of Medicine	LAI, EC (corresponding author), BAYLOR COLL MED,DEPT CELL BIOL,HOUSTON,TX 77030, USA.				NHLBI NIH HHS [HL-27509] Funding Source: Medline; NIGMS NIH HHS [GM-26631] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL027509] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEATTY K, 1980, J BIOL CHEM, V255, P3931; BRISCOE WA, 1966, AM REV RESPIR DIS, V94, P529; COX DW, 1982, NATURE, V297, P428, DOI 10.1038/297428a0; CROCE CM, 1979, P NATL ACAD SCI USA, V76, P3416, DOI 10.1073/pnas.76.7.3416; DARLINGTON GJ, 1982, P NATL ACAD SCI-BIOL, V79, P870, DOI 10.1073/pnas.79.3.870; GEDDEDAHL T, 1975, ANN HUM GENET, V39, P43; GEDDEDAHL T, 1972, ANN HUM GENET, V35, P393; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; HEIMBURGER N, 1971, P INT RES C PROTEINA, P1; HOBART MJ, 1981, ANN HUM GENET, V45, P331, DOI 10.1111/j.1469-1809.1981.tb00346.x; JANOFF A, 1972, AM REV RESPIR DIS, V105, P121; JONES C, 1978, HUM GENET, V45, P1, DOI 10.1007/BF00277567; Kao F T, 1974, Methods Cell Biol, V8, P23, DOI 10.1016/S0091-679X(08)60441-0; KAO FT, 1982, P NATL ACAD SCI-BIOL, V79, P865, DOI 10.1073/pnas.79.3.865; KAO FT, 1970, NATURE, V228, P329, DOI 10.1038/228329a0; KAO FT, 1968, P NATL ACAD SCI USA, V60, P1275, DOI 10.1073/pnas.60.4.1275; KAO FT, 1973, P NATL ACAD SCI USA, V70, P2893, DOI 10.1073/pnas.70.10.2893; KUEPPERS F, 1973, AM J HUM GENET, V25, P677; LAI EC, 1979, CELL, V16, P210; LAURELL CB, 1963, SCAND J CLIN LAB INV, V15, P132, DOI 10.3109/00365516309051324; LEICHT M, 1982, NATURE, V297, P655, DOI 10.1038/297655a0; MCREYNOLDS LA, 1977, GENE, V2, P217, DOI 10.1016/0378-1119(77)90002-6; OHLSSON K, 1973, EUR J BIOCHEM, V36, P473, DOI 10.1111/j.1432-1033.1973.tb02932.x; OLSEN GN, 1975, J CLIN INVEST, V55, P427, DOI 10.1172/JCI107947; SHARP HL, 1969, J LAB CLIN MED, V73, P934; SMITH M, 1981, EUR J IMMUNOL, V11, P852, DOI 10.1002/eji.1830111021; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; TUTTLE WC, 1975, AM J CLIN PATHOL, V64, P477; YOSHIDA A, 1976, P NATL ACAD SCI USA, V73, P1324, DOI 10.1073/pnas.73.4.1324	29	92	96	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1983	35	3					385	392						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	QS160	6602546				2022-12-18	WOS:A1983QS16000004
J	KUEPPERS, F; CHRISTOPHERSON, MJ				KUEPPERS, F; CHRISTOPHERSON, MJ			ALPHA1-ANTITRYPSIN - FURTHER GENETIC-HETEROGENEITY REVEALED BY ISOELECTRIC-FOCUSING	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MAYO CLIN & MAYO FDN,ROCHESTER,MN 55901	Mayo Clinic	KUEPPERS, F (corresponding author), TEMPLE UNIV,SCH MED,PHILADELPHIA,PA 19140, USA.							CONSTANS J, 1975, CR ACAD SCI D NAT, V281, P1361; COX DW, 1974, CAN J GENET CYTOL, V16, P297, DOI 10.1139/g74-033; FAGERHOL MK, 1970, PROG MED GENET, V7, P96; FAGERHOL MK, 1972, 4TH P INT C HUM GEN, P277; FRANTS RR, 1976, HUM HERED, V26, P435, DOI 10.1159/000152838; GENZ T, 1977, HUM GENET, V38, P325, DOI 10.1007/BF00402159; KELLERMA.G, 1970, HUMANGENETIK, V10, P145, DOI 10.1007/BF00295513; KLASEN EC, 1977, HUM GENET, V37, P303, DOI 10.1007/BF00393613; KUEPPERS F, 1976, J LAB CLIN MED, V88, P151; KUEPPERS F, 1967, HUMANGENETIK, V5, P54, DOI 10.1007/BF00286211; KUEPPERS F, 1976, AM J HUM GENET, V28, P370; LAURELL CB, 1965, ANAL BIOCHEM, V10, P358, DOI 10.1016/0003-2697(65)90278-2; LIEBERMAN J, 1976, AM REV RESPIR DIS, V114, P1194; Mancini G, 1965, Immunochemistry, V2, P235, DOI 10.1016/0019-2791(65)90004-2; PIERCE JA, 1975, JAMA-J AM MED ASSOC, V231, P609, DOI 10.1001/jama.231.6.609; VANDENBROEK WGM, 1976, HUM GENET, V34, P17, DOI 10.1007/BF00284429; VANDEVILLE D, 1974, HUMANGENETIK, V21, P33, DOI 10.1007/BF00278562	17	92	92	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	4					359	365						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP353	309724				2022-12-18	WOS:A1978FP35300004
J	Amendola, LM; Jarvik, GP; Leo, MC; McLaughlin, HM; Akkari, Y; Amaral, MD; Berg, JS; Biswas, S; Bowling, KM; Conlin, LK; Cooper, GM; Dorschner, MO; Dulik, MC; Ghazani, AA; Ghosh, R; Green, RC; Hart, R; Horton, C; Johnston, JJ; Lebo, MS; Milosavljevic, A; Ou, J; Pak, CM; Patel, RY; Punj, S; Richards, CS; Salama, J; Strande, NT; Yang, YP; Plon, SE; Biesecker, LG; Rehm, HL				Amendola, Laura M.; Jarvik, Gail P.; Leo, Michael C.; McLaughlin, Heather M.; Akkari, Yassmine; Amaral, Michelle D.; Berg, Jonathan S.; Biswas, Sawona; Bowling, Kevin M.; Conlin, Laura K.; Cooper, Greg M.; Dorschner, Michael O.; Dulik, Matthew C.; Ghazani, Arezou A.; Ghosh, Rajarshi; Green, Robert C.; Hart, Ragan; Horton, Carrie; Johnston, Jennifer J.; Lebo, Matthew S.; Milosavljevic, Aleksandar; Ou, Jeffrey; Pak, Christine M.; Patel, Ronak Y.; Punj, Sumit; Richards, Carolyn Sue; Salama, Joseph; Strande, Natasha T.; Yang, Yaping; Plon, Sharon E.; Biesecker, Leslie G.; Rehm, Heidi L.			Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium (vol 98, pg 1067, 2016)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Correction												pair@u.washington.edu; hrehm@partners.org	Biesecker, Leslie/AAG-2526-2021; Strande, Natasha T./H-9894-2019; Ghazani, Arezou A./AAS-6871-2021; Cooper, Gregory/D-6914-2011	Strande, Natasha T./0000-0001-5148-9772; Lebo, Matthew/0000-0002-9733-5207; Hart, Ragan/0000-0003-3758-8082; Cooper, Gregory/0000-0001-5509-9923; Rehm, Heidi L./0000-0002-6025-0015	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U41HG006834, U01HG006485, R21HG006596, P50HG007257, UM1HG007301, U01HG006546, R01HG006600, U01HG006507] Funding Source: NIH RePORTER; NHGRI NIH HHS [R21 HG006596, P50 HG007257, R01 HG006600, U01 HG006546, UM1 HG007301, U01 HG006485, U01 HG006507, U41 HG006834] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Amendola LM, 2016, AM J HUM GENET, V98, P1067, DOI 10.1016/j.ajhg.2016.03.024	1	91	96	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					247	247		10.1016/j.ajhg.2016.06.001	http://dx.doi.org/10.1016/j.ajhg.2016.06.001			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27392081	Green Published, Bronze			2022-12-18	WOS:000381616600024
J	Bolar, NA; Golzio, C; Zivna, M; Hayot, G; Van Hemelrijk, C; Schepers, D; Vandeweyer, G; Hoischen, A; Huyghe, JR; Raes, A; Matthys, E; Sys, E; Azou, M; Gubler, MC; Praet, M; Van Camp, G; McFadden, K; Pediaditakis, I; Pristoupilova, A; Hodanova, K; Vylet'al, P; Hartmannova, H; Stranecky, V; Hulkova, H; Baresova, V; Jedlickova, I; Sovova, J; Hnizda, A; Kidd, K; Bleyer, AJ; Spong, RS; Vande Walle, J; Mortier, G; Brunner, H; Van Laer, L; Kmoch, S; Katsanis, N; Loeys, BL				Bolar, Nikhita Ajit; Golzio, Christelle; Zivna, Martina; Hayot, Gaelle; Van Hemelrijk, Christine; Schepers, Dorien; Vandeweyer, Geert; Hoischen, Alexander; Huyghe, Jeroen R.; Raes, Ann; Matthys, Erve; Sys, Emiel; Azou, Myriam; Gubler, Marie-Claire; Praet, Marleen; Van Camp, Guy; McFadden, Kelsey; Pediaditakis, Igor; Pristoupilova, Anna; Hodanova, Katerina; Vylet'al, Petr; Hartmannova, Hana; Stranecky, Viktor; Hulkova, Helena; Baresova, Veronika; Jedlickova, Ivana; Sovova, Jana; Hnizda, Ales; Kidd, Kendrah; Bleyer, Anthony J.; Spong, Richard S.; Vande Walle, Johan; Mortier, Geert; Brunner, Han; Van Laer, Lut; Kmoch, Stanislav; Katsanis, Nicholas; Loeys, Bart L.			Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSLOCATION; NEPHROPATHY; GENOME; PRONEPHROS; PREDICTION; FRAMEWORK; LOCUS	Autosomal-dominant tubulo-interstitial kidney disease (ADTKD) encompasses a group of disorders characterized by renal tubular and interstitial abnormalities, leading to slow progressive loss of kidney function requiring dialysis and kidney transplantation. Mutations in UMOD, MUC1, and REN are responsible for many, but not all, cases of ADTKD. We report on two families with ADTKD and congenital anemia accompanied by either intrauterine growth retardation or neutropenia. Ultrasound and kidney biopsy revealed small dysplastic kidneys with cysts and tubular atrophy with secondary glomerular sclerosis, respectively. Exclusion of known ADTKD genes coupled with linkage analysis, whole-exome sequencing, and targeted re-sequencing identified heterozygous missense variants in SEC61A1-c.553A>G (p.Thr185Ala) and c.200T > G (p.Val67Gly)-both affecting functionally important and conserved residues in SEC61. Both transiently expressed SEC6A1A variants are delocalized to the Golgi, a finding confirmed in a renal biopsy from an affected individual. Suppression or CRISPR-mediated deletions of sec61al2 in zebrafish embryos induced convolution defects of the pronephric tubules but not the pronephric ducts, consistent with the tubular atrophy observed in the affected individuals. Human mRNA encoding either of the two pathogenic alleles failed to rescue this phenotype as opposed to a complete rescue by human wild-type mRNA. Taken together, these findings provide a mechanism by which mutations in SEC61A1 lead to an autosomal-dominant syndromic form of progressive chronic kidney disease. We highlight protein translocation defects across the endoplasmic reticulum membrane, the principal role of the SEC61 complex, as a contributory pathogenic mechanism for ADTKD.	[Bolar, Nikhita Ajit; Schepers, Dorien; Vandeweyer, Geert; Huyghe, Jeroen R.; Van Camp, Guy; Mortier, Geert; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp, Fac Med & Hlth Sci, Ctr Med Genet, B-2650 Antwerp, Belgium; [Bolar, Nikhita Ajit; Schepers, Dorien; Vandeweyer, Geert; Huyghe, Jeroen R.; Van Camp, Guy; Mortier, Geert; Van Laer, Lut; Loeys, Bart L.] Univ Antwerp Hosp, B-2650 Antwerp, Belgium; [Golzio, Christelle; Hayot, Gaelle; McFadden, Kelsey; Pediaditakis, Igor; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Golzio, Christelle; Hayot, Gaelle; McFadden, Kelsey; Pediaditakis, Igor; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Golzio, Christelle; Hayot, Gaelle; McFadden, Kelsey; Pediaditakis, Igor; Katsanis, Nicholas] Duke Univ, Dept Psychiat, Durham, NC 27710 USA; [Zivna, Martina; Pristoupilova, Anna; Hodanova, Katerina; Vylet'al, Petr; Hartmannova, Hana; Stranecky, Viktor; Hulkova, Helena; Baresova, Veronika; Jedlickova, Ivana; Sovova, Jana; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12000, Czech Republic; [Van Hemelrijk, Christine; Raes, Ann; Vande Walle, Johan] Univ Hosp Ghent, Dept Pediat Nephrol, B-9000 Ghent, Belgium; [Hoischen, Alexander; Brunner, Han; Loeys, Bart L.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Matthys, Erve] Sint Jan Hosp, Dept Nephrol, B-8000 Brugge, Belgium; [Sys, Emiel; Azou, Myriam] Sint Lucas Hosp, Dept Nephrol, B-8310 Brugge, Belgium; [Gubler, Marie-Claire] INSERM, U983, Paris 15, France; [Praet, Marleen] Univ Hosp Ghent, Dept Pathol, B-9000 Ghent, Belgium; [Hnizda, Ales] Acad Sci Czech Republ, Inst Organ Chem & Biochem, Flemingovo Nam 2, CR-16610 Prague, Czech Republic; [Kidd, Kendrah; Bleyer, Anthony J.] Wake Forest Sch Med, Nephrol Sect, Med Ctr Blvd, Winston Salem, NC 27157 USA; [Spong, Richard S.] Univ Minnesota, Dept Med, Div Renal Dis & Hypertens, Minneapolis, MN 55455 USA; [Huyghe, Jeroen R.] Univ Michigan, Ctr Stat Genet, Dept Biostat, Ann Arbor, MI 48109 USA	University of Antwerp; University of Antwerp; Duke University; Duke University; Duke University; Charles University Prague; Ghent University; Ghent University Hospital; Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); Ghent University; Ghent University Hospital; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Wake Forest University; University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan	Loeys, BL (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Ctr Med Genet, B-2650 Antwerp, Belgium.; Loeys, BL (corresponding author), Univ Antwerp Hosp, B-2650 Antwerp, Belgium.; Loeys, BL (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	bart.loeys@uantwerpen.be	Loeys, Bart/B-3236-2017; Stranecky, Viktor/I-8524-2017; Hnizda, Ales/AAG-5962-2021; Pristoupilova, Anna/F-4990-2017; raes, ann/AAA-1051-2020; Hůlková, Helena/O-2268-2017; Van Camp, Guy/F-3386-2013; Vyleťal, Petr/AAC-3468-2021; Mortier, Geert/D-2542-2012; raes, ann/ABD-1809-2020; Hnizda, Ales/H-9433-2014; Jedlickova, Ivana/K-7480-2017; Hartmannova, Hana/H-4735-2017; Vyleťal, Petr/F-4771-2017; Vande Walle, Johan Gustaaf Jules/AAG-3858-2020; Vyleťal, Petr/AHE-7903-2022; Baresova, Veronika/H-4931-2017; Hoischen, Alexander/D-1282-2013; Hodaňová, Kateřina/I-4727-2017; Kmoch, Stanislav/C-1575-2010; Hoischen, Alexander/AGF-7293-2022	Loeys, Bart/0000-0003-3703-9518; Stranecky, Viktor/0000-0002-2599-6479; Hnizda, Ales/0000-0002-1521-4453; Pristoupilova, Anna/0000-0003-0047-9405; Hůlková, Helena/0000-0002-7441-6610; Van Camp, Guy/0000-0001-5105-9000; Mortier, Geert/0000-0001-9871-4578; raes, ann/0000-0001-7809-2505; Hnizda, Ales/0000-0002-1521-4453; Jedlickova, Ivana/0000-0002-3362-0834; Hartmannova, Hana/0000-0001-7787-832X; Vyleťal, Petr/0000-0002-9357-1237; Vande Walle, Johan Gustaaf Jules/0000-0001-9700-5358; Baresova, Veronika/0000-0001-8989-6090; Hoischen, Alexander/0000-0002-8072-4476; Hodaňová, Kateřina/0000-0001-9172-9945; Kmoch, Stanislav/0000-0002-6239-707X; Hoischen, Alexander/0000-0002-8072-4476; Hayot, Gaelle/0000-0001-8113-7399; Golzio, Christelle/0000-0002-4420-3921; Gubler, Marie-Claire/0000-0002-3526-5661	Fund for Scientific Research, Flanders (FWO, Belgium) [G.0458.09, G.0221.12]; Fondation Leducq [MIBAVA 12CVD03]; European Research Council [ERC-StG-2012-30972-BRAVE]; University of Antwerp (Lanceringsproject); Charles University [PRVOUK-P24/LF1/3, UNCE 204011, SVV2016/260148]; Ministry of Education of the Czech Republic [LQ1604 NPU II, LH12015]; Ministry of Education [NT13116-4/2012]; Ministry of Health of the Czech Republic; GA UK [1402213]; program "NPU I" [LO1304]; Netherlands Organization for Health Research and Development [ZonMW 916-12-095]; US NIH [1R21DK106584-01];  [P50DK096415];  [P30DK096493]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK096493, R21DK106584, P50DK096415] Funding Source: NIH RePORTER	Fund for Scientific Research, Flanders (FWO, Belgium)(FWO); Fondation Leducq(Leducq Foundation); European Research Council(European Research Council (ERC)European Commission); University of Antwerp (Lanceringsproject); Charles University; Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Education; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); GA UK; program "NPU I"; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	B.L.L. is senior clinical investigator of the Fund for Scientific Research, Flanders (FWO, Belgium). This research was supported by funding from the Fund for Scientific Research, Flanders (FWO, Belgium) [G.0458.09; G.0221.12], the Fondation Leducq (MIBAVA 12CVD03), Starting grant (to B.L.L.) of the European Research Council (ERC-StG-2012-30972-BRAVE), and the University of Antwerp (Lanceringsproject). N.K. is a Distinguished Brumley Professor. This work was supported by grants P50DK096415 and P30DK096493 (to N.K.). S.K., A.P., K.H., and V.S. are funded by Charles University institutional programs PRVOUK-P24/LF1/3, UNCE 204011, and SVV2016/260148 and by the project LQ1604 NPU II from the Ministry of Education of the Czech Republic. This work was specifically supported by grants LH12015 from the Ministry of Education of the Czech Republic and NT13116-4/2012 from the Ministry of Education and Ministry of Health of the Czech Republic. A.P. was supported by GA UK No. 1402213. A. Hnizda was supported by the project LO1304 (program "NPU I"). A. Hoischen was supported by the Netherlands Organization for Health Research and Development (ZonMW 916-12-095). A.J.B. is supported by the US NIH grant 1R21DK106584-01.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Adam J, 2012, AM J KIDNEY DIS, V59, P117, DOI 10.1053/j.ajkd.2011.08.014; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Beck LH, 2012, AM J KIDNEY DIS, V59, P174, DOI 10.1053/j.ajkd.2011.09.009; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bingham C, 2003, KIDNEY INT, V63, P1645, DOI 10.1046/j.1523-1755.2003.00903.x; Bleyer AJ, 2010, CLIN NEPHROL, V74, P411; Bleyer AJ, 2014, KIDNEY INT, V86, P459, DOI 10.1038/ki.2014.125; Bleyer AJ, 2014, CLIN J AM SOC NEPHRO, V9, P527, DOI 10.2215/CJN.06380613; Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019; CAROTHERS AD, 1990, AM J HUM GENET, V47, P165; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Eckardt KU, 2015, KIDNEY INT, V88, P676, DOI 10.1038/ki.2015.28; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; GRAY TM, 1984, J MOL BIOL, V175, P75, DOI 10.1016/0022-2836(84)90446-7; Hassdenteufel S, 2014, BIOCHEM CELL BIOL, V92, P499, DOI 10.1139/bcb-2014-0043; Hodanova K, 2005, KIDNEY INT, V68, P1472, DOI 10.1111/j.1523-1755.2005.00560.x; Hoischen A, 2011, NAT GENET, V43, P729, DOI 10.1038/ng.868; Hoischen A, 2010, HUM MUTAT, V31, P492, DOI 10.1002/humu.21221; Hotamisligil GS, 2008, INT J OBESITY, V32, pS52, DOI 10.1038/ijo.2008.238; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Junne T, 2007, J BIOL CHEM, V282, P33201, DOI 10.1074/jbc.M707219200; Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; Kamhi-Nesher S, 2001, MOL BIOL CELL, V12, P1711, DOI 10.1091/mbc.12.6.1711; Lang S, 2011, CHANNELS, V5, P228, DOI 10.4161/chan.5.3.15314; Li DH, 2005, INT J DEV BIOL, V49, P401, DOI 10.1387/ijdb.052005dl; Lindstrand A, 2014, AM J HUM GENET, V94, P745, DOI 10.1016/j.ajhg.2014.03.017; Lloyd DJ, 2010, DIABETES, V59, P460, DOI 10.2337/db08-1362; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Paila U, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003153; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Stiburkova B, 2003, EUR J HUM GENET, V11, P145, DOI 10.1038/sj.ejhg.5200937; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Vissers LELM, 2011, AM J MED GENET A, V155A, P2609, DOI 10.1002/ajmg.a.34325; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Voorhees RM, 2016, SCIENCE, V351, P88, DOI 10.1126/science.aad4992; Vylet'al P, 2006, KIDNEY INT, V70, P1155, DOI 10.1038/sj.ki.5001728; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE, P385; Xiao CT, 2011, DIABETES, V60, P918, DOI 10.2337/db10-1433; Zivna M, 2009, AM J HUM GENET, V85, P204, DOI 10.1016/j.ajhg.2009.07.010; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	52	91	93	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 7	2016	99	1					174	187		10.1016/j.ajhg.2016.05.028	http://dx.doi.org/10.1016/j.ajhg.2016.05.028			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT6TI	27392076	Green Published, hybrid			2022-12-18	WOS:000381616600014
J	Takahashi, Y; Fukuda, Y; Yoshimura, J; Toyoda, A; Kurppa, K; Moritoyo, H; Belzil, VV; Dion, PA; Higasa, K; Doi, K; Ishiura, H; Mitsui, J; Date, H; Ahsan, B; Matsukawa, T; Ichikawa, Y; Moritoyo, T; Ikoma, M; Hashimoto, T; Kimura, F; Murayama, S; Onodera, O; Nishizawa, M; Yoshida, M; Atsuta, N; Sobue, G; Fifita, JA; Williams, KL; Blair, IP; Nicholson, GA; Gonzalez-Perez, P; Brown, RH; Nomoto, M; Elenius, K; Rouleau, GA; Fujiyama, A; Morishita, S; Goto, J; Tsuji, S				Takahashi, Yuji; Fukuda, Yoko; Yoshimura, Jun; Toyoda, Atsushi; Kurppa, Kari; Moritoyo, Hiroyoko; Belzil, Veronique V.; Dion, Patrick A.; Higasa, Koichiro; Doi, Koichiro; Ishiura, Hiroyuki; Mitsui, Jun; Date, Hidetoshi; Ahsan, Budrul; Matsukawa, Takashi; Ichikawa, Yaeko; Moritoyo, Takashi; Ikoma, Mayumi; Hashimoto, Tsukasa; Kimura, Fumiharu; Murayama, Shigeo; Onodera, Osamu; Nishizawa, Masatoyo; Yoshida, Mari; Atsuta, Naoki; Sobue, Gen; Fifita, Jennifer A.; Williams, Kelly L.; Blair, Ian P.; Nicholson, Garth A.; Gonzalez-Perez, Paloma; Brown, Robert H., Jr.; Nomoto, Masahiro; Elenius, Klaus; Rouleau, Guy A.; Fujiyama, Asao; Morishita, Shinichi; Goto, Jun; Tsuji, Shoji		JaCALS	ERBB4 Mutations that Disrupt the Neuregulin-ErbB4 Pathway Cause Amyotrophic Lateral Sclerosis Type 19	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; GENETICS; RECEPTOR; DOMAIN; SYSTEM	Amyotrophic lateral sclerosis (ALS) is a devastating neurological disorder characterized by the degeneration of motor neurons and typically results in death within 3-5 years from onset. Familial ALS (PALS) comprises 5%-10% of ALS cases, and the identification of genes associated with FALS is indispensable to elucidating the molecular pathogenesis. We identified a Japanese family affected by late-onset, autosomal-dominant ALS in which mutations in genes known to be associated with FALS were excluded. A whole- genome sequencing and parametric linkage analysis under the assumption of an autosomal-dominant mode of inheritance with incomplete penetrance revealed the mutation c.2780G>A (p. Arg927Gln) in ERBB4. An extensive mutational analysis revealed the same mutation in a Canadian individual with familial ALS and a de novo mutation, c.3823C>T (p. Arg1275Trp), in a Japanese simplex case. These amino acid substitutions involve amino acids highly conserved among species, are predicted as probably damaging, and are located within a tyrosine kinase domain (p. Arg927Gln) or a C-terminal domain (p. Arg1275Trp), both of which mediate essential functions of ErbB4 as a receptor tyrosine kinase. Functional analysis revealed that these mutations led to a reduced autophosphorylation of ErbB4 upon neuregulin-1 (NRG-1) stimulation. Clinical presentations of the individuals with mutations were characterized by the involvement of both upper and lower motor neurons, a lack of obvious cognitive dysfunction, and relatively slow progression. This study indicates that disruption of the neuregulin-ErbB4 pathway is involved in the pathogenesis of ALS and potentially paves the way for the development of innovative therapeutic strategies such using NRGs or their agonists to upregulate ErbB4 functions.	[Takahashi, Yuji; Fukuda, Yoko; Ishiura, Hiroyuki; Mitsui, Jun; Date, Hidetoshi; Ahsan, Budrul; Matsukawa, Takashi; Ichikawa, Yaeko; Goto, Jun; Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1138655, Japan; [Yoshimura, Jun; Higasa, Koichiro; Doi, Koichiro; Morishita, Shinichi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Chiba 2778561, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Comparat Genom Lab, Shizuoka 4118540, Japan; [Kurppa, Kari; Elenius, Klaus] Univ Turku, Dept Med Biochem & Genet, Turku 20014, Finland; [Kurppa, Kari] Turku Doctoral Programme Biomed Sci, Turku 20520, Finland; [Moritoyo, Hiroyoko; Moritoyo, Takashi; Nomoto, Masahiro] Ehime Univ Hosp, Dept Neurol & Clin Pharmacol, Toon, Ehime 7910295, Japan; [Belzil, Veronique V.; Dion, Patrick A.; Rouleau, Guy A.] Univ Montreal, Ctr Hosp Univ St Justine, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Dion, Patrick A.] Univ Montreal, Dept Pathol & Cellular Biol, Montreal, PQ H3T 1C5, Canada; [Ikoma, Mayumi; Hashimoto, Tsukasa] Ehime Natl Hosp, Natl Hosp Org, Dept Neurol, Toon, Ehime 7910281, Japan; [Kimura, Fumiharu] Osaka Med Coll, Dept Internal Med 1, Div Neurol, Osaka 5698686, Japan; [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Dept Neurol & Neuropathol, Tokyo 1730015, Japan; [Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Brain Bank Aging Res, Tokyo 1730015, Japan; [Murayama, Shigeo] Inst Gerontol, Tokyo 1730015, Japan; [Onodera, Osamu; Nishizawa, Masatoyo] Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 9518520, Japan; [Yoshida, Mari] Aichi Med Univ, Inst Med Sci Aging, Dept Neuropathol, Nagakute 4801195, Aichi, Japan; [Atsuta, Naoki; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668560, Japan; [JaCALS] Japanese Consortium Amyotroph Lateral Sclerosis R, Nagoya, Aichi, Japan; [Fifita, Jennifer A.; Williams, Kelly L.; Blair, Ian P.; Nicholson, Garth A.] ANZAC Res Inst, Northcott Neurosci Lab, Sydney, NSW 2139, Australia; [Fifita, Jennifer A.; Williams, Kelly L.; Blair, Ian P.; Nicholson, Garth A.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Fifita, Jennifer A.; Williams, Kelly L.; Blair, Ian P.] Macquarie Univ, Austrian Sch Med, Sydney, NSW 2109, Australia; [Gonzalez-Perez, Paloma; Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; [Elenius, Klaus] Turku Univ Hosp, Dept Oncol, Turku 20521, Finland; [Rouleau, Guy A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; [Rouleau, Guy A.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Tsuji, Shoji] Univ Tokyo, Tokyo Univ Hosp, Med Genome Ctr, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Turku; Ehime University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Osaka Medical College; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Niigata University; Aichi Medical University; Nagoya University; University of Sydney; ANZAC Research Institute; University of Sydney; Macquarie University; University of Massachusetts System; University of Massachusetts Worcester; University of Turku; McGill University; McGill University; University of Tokyo	Tsuji, S (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1138655, Japan.	tsuji@m.u-tokyo.ac.jp	Research Institute, ANZAC/CAE-9030-2022; Atsuta, naoki/I-7412-2014; Williams, Kelly L/A-5545-2010; Belzil, Veronique/J-9361-2012; Elenius, Klaus/AAI-7594-2021; Onodera, Osamu/K-7327-2013	Williams, Kelly L/0000-0001-6319-9473; Elenius, Klaus/0000-0001-5700-0827; Onodera, Osamu/0000-0003-3354-5472; Kurppa, Kari/0000-0001-8286-2429; Blair, Ian/0000-0003-3083-0075; Fukuda-Yuzawa, Yoko/0000-0002-9887-9820; Nicholson, Garth/0000-0001-9694-066X; Fifita, Jennifer/0000-0002-0814-0118; Yoshimura, Jun/0000-0003-2988-1123; Morishita, Shinichi/0000-0002-6201-8885	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22129001, 22129002]; Ministry of Health, Labour, and Welfare, Japan [H23-Jitsuyoka [Nanbyo]-Ippan-004]; ALS Therapy Alliance; Project ALS; P2ALS; Angel Fund; Pierre L. de Bourgknecht ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [1R01NS050557]; MND Research Institute of Australia; Alfonso Martin Escudero Foundation (Madrid); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050557] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); ALS Therapy Alliance; Project ALS; P2ALS; Angel Fund; Pierre L. de Bourgknecht ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MND Research Institute of Australia; Alfonso Martin Escudero Foundation (Madrid); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank all the family members for participating in this study. This study was supported in part by KAKENHI (Grants-in-Aid for Scientific Research on Innovative Areas [22129001 and 22129002]) to S.T.; the Global COE Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and a grant-in-aid (H23-Jitsuyoka [Nanbyo]-Ippan-004) from the Ministry of Health, Labour, and Welfare, Japan to S.T. We acknowledge support to R.H.B. from ALS Therapy Alliance, Project ALS, P2ALS, the Angel Fund, the Pierre L. de Bourgknecht ALS Research Foundation, the Al-Athel ALS Research Foundation, the ALS Family Charitable Foundation, and grant 1R01NS050557 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health and support to G.A.N. from the MND Research Institute of Australia. P.G.-P. was supported by the Alfonso Martin Escudero Foundation (Madrid).	Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3; Fukuda Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-121; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Pearson RJ, 2004, J HISTOCHEM CYTOCHEM, V52, P1299, DOI 10.1369/jhc.3A6208.2004; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Song F, 2012, J NEUROPATH EXP NEUR, V71, P104, DOI 10.1097/NEN.0b013e3182423c43; Sundvall M, 2012, J BIOL CHEM, V287, P23216, DOI 10.1074/jbc.M111.335927; Takahashi Y, 2008, ARCH NEUROL-CHICAGO, V65, P1326, DOI 10.1001/archneur.65.10.1326; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	21	91	96	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					900	905		10.1016/j.ajhg.2013.09.008	http://dx.doi.org/10.1016/j.ajhg.2013.09.008			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24119685	Green Published, Bronze			2022-12-18	WOS:000326996600010
J	Ronchi, D; Di Fonzo, A; Lin, WQ; Bordoni, A; Liu, CW; Fassone, E; Pagliarani, S; Rizzuti, M; Zheng, L; Filosto, M; Ferro, MT; Ranieri, M; Magri, F; Peverelli, L; Li, HZ; Yuan, YC; Corti, S; Sciacco, M; Moggio, M; Bresolin, N; Shen, BH; Comi, GP				Ronchi, Dario; Di Fonzo, Alessio; Lin, Weiqiang; Bordoni, Andreina; Liu, Changwei; Fassone, Elisa; Pagliarani, Serena; Rizzuti, Mafalda; Zheng, Li; Filosto, Massimiliano; Ferro, Maria Teresa; Ranieri, Michela; Magri, Francesca; Peverelli, Lorenzo; Li, Hongzhi; Yuan, Yate-Ching; Corti, Stefania; Sciacco, Monica; Moggio, Maurizio; Bresolin, Nereo; Shen, Binghui; Comi, Giacomo Pietro			Mutations in DNA2 Link Progressive Myopathy to Mitochondrial DNA Instability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENZYMATIC-PROPERTIES; REPLICATION; DISEASE; REPAIR; DELETIONS; PROTEIN; TWINKLE; FLAP	Syndromes associated with multiple mtDNA deletions are due to different molecular defects that can result in a wide spectrum of predominantly adult-onset clinical presentations, ranging from progressive external ophthalmoplegia (PRO) to multisystemic disorders of variable severity. The autosomal-dominant form of PEO is genetically heterogeneous. Recently, causative mutations have been reported in several nuclear genes that encode proteins of the mtDNA replisome machinery (POLG, POLG2, and C10orf2) or that are involved in pathways for the synthesis of deoxyribonuclotides (ANTI and RRM2B). Despite these findings, putative mutations remain unknown in half of the subjects with PEO. We report the identification, by exome sequencing, of mutations in DNA2 in adult-onset individuals with a form of mitochondrial myopathy featuring instability of muscle mtDNA. DNA2 encodes a helicase/nuclease family member that is most likely involved in mtDNA replication, as well as in the long-patch base-excision repair (LP-BER) pathway. In vitro biochemical analysis of purified mutant proteins revealed a severe impairment of nuclease, helicase, and ATPase activities. These results implicate human DNA2 and the LP-BER pathway in the pathogenesis of adult-onset disorders of mtDNA maintenance.	[Ronchi, Dario; Di Fonzo, Alessio; Bordoni, Andreina; Pagliarani, Serena; Rizzuti, Mafalda; Ranieri, Michela; Magri, Francesca; Corti, Stefania; Bresolin, Nereo; Comi, Giacomo Pietro] Univ Milan, Ist Ricovero & Cura,Neurol Unit, Carattere Sci Fdn Ca Granda Osped Maggiore Policl, Dino Ferrari Ctr,Neurosci Sect,Dept Pathophysiol, I-20122 Milan, Italy; [Lin, Weiqiang; Liu, Changwei; Zheng, Li; Shen, Binghui] Beckman Res Inst City Hope, Dept Radiat Biol, Duarte, CA 91010 USA; [Fassone, Elisa] UCL, Inst Child Hlth, Mitochondrial Res Grp, London WC1N 3BG, England; [Filosto, Massimiliano] Spedali Civil Brescia, Univ Hosp, Sect Neuromuscular Dis & Neuropathies, I-25123 Brescia, Italy; [Ferro, Maria Teresa] Osped Maggiore Crema, Neurol Unit, I-26013 Crema, Italy; [Corti, Stefania; Bresolin, Nereo; Comi, Giacomo Pietro] Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20122 Milan, Italy; [Peverelli, Lorenzo; Sciacco, Monica; Moggio, Maurizio] Univ Milan, Carattere Sci Fdn Ca Granda Osped Maggiore Policl, Ist Ricovero & Cura, Neuromuscular Unit,Dino Ferrari Ctr, I-20122 Milan, Italy; [Li, Hongzhi; Yuan, Yate-Ching] City Hope Comprehens Canc Ctr, Beckman Res Inst, Bioinformat Core, Duarte, CA 91010 USA; [Bresolin, Nereo] Ist Ricovero & Cura Carattere Sci Eugenio Medea, I-23842 Bosisio Parini, Lecco, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; City of Hope; Beckman Research Institute of City of Hope; University of London; University College London; Hospital Spedali Civili Brescia; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; City of Hope; Beckman Research Institute of City of Hope; IRCCS Eugenio Medea	Shen, BH (corresponding author), Beckman Res Inst City Hope, Dept Radiat Biol, Duarte, CA 91010 USA.	bshen@coh.org; giacomo.comi@unimi.it	Pagliarani, Serena/K-8035-2016; Magri, Francesca/K-5739-2016; Sciacco, Monica/AAC-6500-2022; Rizzuti, Mafalda/AAC-2407-2022; Filosto, Massimiliano/S-9446-2019; Ronchi, Dario/O-4138-2019; Di Fonzo, Alessio/A-5702-2013; Corti, Stefania/K-6034-2016; Comi, Giacomo P/K-5702-2016; Ronchi, Dario/K-8011-2016	Pagliarani, Serena/0000-0002-7145-1998; Magri, Francesca/0000-0001-8974-9453; Sciacco, Monica/0000-0003-4593-4977; Filosto, Massimiliano/0000-0002-2852-7512; Ronchi, Dario/0000-0002-6093-9816; Di Fonzo, Alessio/0000-0001-6478-026X; Corti, Stefania/0000-0001-5425-969X; Comi, Giacomo P/0000-0002-1383-5248; Ronchi, Dario/0000-0002-6093-9816; Rizzuti, Mafalda/0000-0001-5734-7476; Peverelli, Lorenzo/0000-0001-6175-025X; Bresolin, Nereo/0000-0001-6694-3595; Shen, Binghui/0000-0002-4408-407X; Lin, Weiqiang/0000-0002-2171-8009	Telethon [GTB07001ER, GUP09004]; Eurobiobank project [QLTR-2001-02769]; National Institutes of Health [R01CA085344]; Associazione Amici del Centro Dino Ferrari, University of Milan; NATIONAL CANCER INSTITUTE [R01CA085344] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); Eurobiobank project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Amici del Centro Dino Ferrari, University of Milan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We wish to thank the patients and their families for their support and collaboration. This work was supported by the following grants: Telethon project GTB07001ER, Eurobiobank project QLTR-2001-02769, Telethon grant GUP09004 to G.P.C., and National Institutes of Health grant R01CA085344 to B.S. The financial support of Associazione Amici del Centro Dino Ferrari, University of Milan is gratefully acknowledged.	Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Budd ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004267; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Copeland WC, 2012, CRIT REV BIOCHEM MOL, V47, P64, DOI 10.3109/10409238.2011.632763; Copeland WC, 2008, MOL CELL, V32, P457, DOI 10.1016/j.molcel.2008.11.007; Duxin JP, 2009, MOL CELL BIOL, V29, P4274, DOI 10.1128/MCB.01834-08; Fratter C, 2011, NEUROLOGY, V76, P2032, DOI 10.1212/WNL.0b013e31821e558b; Gilissen C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-228; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Liu Y, 2004, MOL CELL BIOL, V24, P4049, DOI 10.1128/MCB.24.9.4049-4064.2004; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Sen D, 2012, J BIOL CHEM, V287, P14545, DOI 10.1074/jbc.M111.309468; Stumpf JD, 2011, CELL MOL LIFE SCI, V68, P219, DOI 10.1007/s00018-010-0530-4; Virgilio R, 2008, J NEUROL, V255, P1384, DOI 10.1007/s00415-008-0926-3; Wanrooij S, 2010, BBA-BIOENERGETICS, V1797, P1378, DOI 10.1016/j.bbabio.2010.04.015; Ylikallio E, 2010, HUM MOL GENET, V19, P2695, DOI 10.1093/hmg/ddq163; ZEVIANI M, 1990, ANN NEUROL, V28, P94, DOI 10.1002/ana.410280118; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	19	91	92	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					293	300		10.1016/j.ajhg.2012.12.014	http://dx.doi.org/10.1016/j.ajhg.2012.12.014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23352259	hybrid, Green Published			2022-12-18	WOS:000315179600015
J	Knowles, MR; Leigh, MW; Ostrowski, LE; Huang, L; Carson, JL; Hazucha, MJ; Yin, WN; Berg, JS; Davis, SD; Dell, SD; Ferkol, TW; Rosenfeld, M; Sagel, SD; Milla, CE; Olivier, KN; Turner, EH; Lewis, AP; Bamshad, MJ; Nickerson, DA; Shendure, J; Zariwala, MA				Knowles, Michael R.; Leigh, Margaret W.; Ostrowski, Lawrence E.; Huang, Lu; Carson, Johnny L.; Hazucha, Milan J.; Yin, Weining; Berg, Jonathan S.; Davis, Stephanie D.; Dell, Sharon D.; Ferkol, Thomas W.; Rosenfeld, Margaret; Sagel, Scott D.; Milla, Carlos E.; Olivier, Kenneth N.; Turner, Emily H.; Lewis, Alexandra P.; Bamshad, Michael J.; Nickerson, Deborah A.; Shendure, Jay; Zariwala, Maimoona A.		Genetic Disorders Mucociliary	Exome Sequencing Identifies Mutations in CCDC114 as a Cause of Primary Ciliary Dyskinesia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEFECTS; DISEASE; SPECTRUM; COMPLEX	Primary ciliary dyskinesia (PCD) is a genetically heterogeneous, autosomal-recessive disorder, characterized by oto-sino-pulmonary disease and situs abnormalities. PCD-causing mutations have been identified in 14 genes, but they collectively account for only -60% of all PCD. To identify mutations that cause PCD, we performed exome sequencing on six unrelated probands with ciliary outer dynein arm (ODA) defects. Mutations in CCDC114, an ortholog of the Chlamydomonas reinhardtii motility gene DCC2, were identified in a family with two affected siblings. Sanger sequencing of 67 additional individuals with PCD with ODA defects from 58 families revealed CCDC114 mutations in 4 individuals in 3 families. All 6 individuals with CCDC114 mutations had characteristic oto-sino-pulmonary disease, but none had situs abnormalities. In the remaining 5 individuals with PCD who underwent exome sequencing, we identified mutations in two genes (DNAI2, DNAH5) known to cause PCD, including an Ashkenazi Jewish founder mutation in DNAI2. These results revealed that mutations in CCDC114 are a cause of ciliary dysmotility and PCD and further demonstrate the utility of exome sequencing to identify genetic causes in heterogeneous recessive disorders.	[Knowles, Michael R.; Ostrowski, Lawrence E.; Huang, Lu; Hazucha, Milan J.; Yin, Weining; Berg, Jonathan S.] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA; [Leigh, Margaret W.; Carson, Johnny L.; Davis, Stephanie D.] Univ N Carolina, Sch Med, Dept Pediat, Chapel Hill, NC 27599 USA; [Berg, Jonathan S.] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Dell, Sharon D.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Ferkol, Thomas W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Rosenfeld, Margaret] Childrens Hosp, Seattle, WA 98105 USA; [Rosenfeld, Margaret] Univ Washington, Seattle, WA 98105 USA; [Sagel, Scott D.] Univ Colorado, Sch Med, Dept Pediat, Aurora, CO 80045 USA; [Milla, Carlos E.] Stanford Univ, Dept Pediat, Stanford, CA 94304 USA; [Olivier, Kenneth N.] NIAID, Lab Clin Infect Dis, Bethesda, MD 20892 USA; [Turner, Emily H.; Lewis, Alexandra P.; Bamshad, Michael J.; Nickerson, Deborah A.; Shendure, Jay] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Bamshad, Michael J.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Zariwala, Maimoona A.] Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Washington University (WUSTL); Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Knowles, MR (corresponding author), Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27599 USA.	knowles@med.unc.edu; zariwala@med.unc.edu	Shendure, Jay/AAU-3684-2021; Huang, Lu/E-4250-2014	Shendure, Jay/0000-0002-1516-1865; Rosenfeld, Margaret/0000-0002-8105-614X; Berg, Jonathan/0000-0003-2360-2664; Dell, Sharon/0000-0003-2169-9407; Turner, Emily/0000-0001-9040-9229; Milla, Carlos/0000-0001-5515-3053	US NIH/ORDR/NHLBI [5U54 HL096458-06]; NIH-NHLBI [5R01HL071798, 5R01HL094976, RC2 HL-102923]; NIH/NHGRI [5R21HG004749]; NIH/NCATS [UL1 TR000083, UL1 TR000154, CFF R026-CR07]; ORDR; NHLBI; NHGRI; NCATS; NIH; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000083, UL1TR000154] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102923, R01HL071798, R01HL094976, U54HL096458] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004749] Funding Source: NIH RePORTER	US NIH/ORDR/NHLBI; NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); ORDR; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to PCD patients and families for their participation. We thank Michele Manion and the US POD Foundation, all investigators and the coordinators of the Genetic Disorders of Mucociliary Clearance Consortium (GDMCC) that is part of the Rare Disease Clinical Research Network, including Andrea Henkel (NIAID/NIH, MD), Jeffrey Atkinson and Jane Quante (Washington University, MO), Shelley Mann (The Children's Hospital, CO), Sharon McNamara (Children's Hospital, WA), Jacquelyn Zirbes (Stanford University Medical Center, CA), Melody Miki (The Hospital for Sick Children, Toronto, ON, Canada), and Susan Minnix and Caroline O'Connor (UNC-Chapel Hill). We thank Kimberly Burns, Whitney Wolf, Rhonda Pace, and Andrew Cutting for technical assistance; Elizabeth Godwin for administrative support; and Syanne Olson for editorial assistance. We acknowledge Lucy Morgan (Concord Hospital, Australia), Robbert de Iongh (University of Melbourne, Australia), and Ugo Pradal (Cystic Fibrosis Center, Verona, Italy) for providing DNA. Funding support for research was provided to M.R.K., M.W.L., J.L.C., M.J.H., S.D. Davis, S.D. Dell, T.W.F., K.N.O., S.D.S., M.R., C.E.M., and M.A.Z. by US NIH/ORDR/NHLBI grant 5U54 HL096458-06, to M.R.K., L.E.O., and M.A.Z. by NIH-NHLBI grant 5R01HL071798, to J.S. and D.A.N. by NIH-NHLBI grant 5R01HL094976, to M.J.B. by NIH-NHLBI grant RC2 HL-102923, and to J.S. by NIH/NHGRI grant 5R21HG004749 and NIH/NCATS grants UL1 TR000083, UL1 TR000154, and CFF R026-CR07. In addition, this publication was made possible by grants from the ORDR, NHLBI, NHGRI, and NCATS, components of NIH. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.	Becker-Heck A, 2011, NAT GENET, V43, P79, DOI 10.1038/ng.727; Blanchon S, 2012, J MED GENET, V49, P410, DOI 10.1136/jmedgenet-2012-100867; Bush A, 2007, ARCH DIS CHILD, V92, P1136, DOI 10.1136/adc.2006.096958; Carlen B, 2005, ULTRASTRUCT PATHOL, V29, P217, DOI 10.1080/01913120590951220; Chilvers MA, 2003, J ALLERGY CLIN IMMUN, V112, P518, DOI 10.1067/mai.2003.1701; Day A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r112; Day A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008491; Escudier E, 2002, AM J RESP CRIT CARE, V166, P1257, DOI 10.1164/rccm.2111070; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Hornef N, 2006, AM J RESP CRIT CARE, V174, P120, DOI 10.1164/rccm.200601-084OC; Jorissen M, 2000, Acta Otorhinolaryngol Belg, V54, P343; Kennedy MP, 2007, CIRCULATION, V115, P2814, DOI 10.1161/CIRCULATIONAHA.106.649038; Leigh Margaret W, 2011, Proc Am Thorac Soc, V8, P434, DOI 10.1513/pats.201103-028SD; Leigh MW, 2009, GENET MED, V11, P473, DOI 10.1097/GIM.0b013e3181a53562; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Narang I, 2002, THORAX, V57, P586, DOI 10.1136/thorax.57.7.586; Noone PG, 2004, AM J RESP CRIT CARE, V169, P459, DOI 10.1164/rccm.200303-365OC; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Olin JT, 2011, PEDIATR PULM, V46, P483, DOI 10.1002/ppul.21402; Ostrowski LE, 2011, AM J RESP CRIT CARE, V183; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Takada S, 2002, MOL BIOL CELL, V13, P1015, DOI 10.1091/mbc.01-04-0201; Zariwala M, 2001, AM J RESP CELL MOL, V25, P577, DOI 10.1165/ajrcmb.25.5.4619; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zariwala MA, 2006, AM J RESP CRIT CARE, V174, P858, DOI 10.1164/rccm.200603-370OC; Zhou HB, 2009, INHAL TOXICOL, V21, P875, DOI 10.1080/08958370802555898	31	91	94	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 10	2013	92	1					99	106		10.1016/j.ajhg.2012.11.003	http://dx.doi.org/10.1016/j.ajhg.2012.11.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	073RA	23261302	Green Published, Bronze			2022-12-18	WOS:000313759000010
J	Ng, BG; Hackmann, K; Jones, MA; Eroshkin, AM; He, P; Wiliams, R; Bhide, S; Cantagrel, V; Gleeson, JG; Paller, AS; Schnur, RE; Tinschert, S; Zunich, J; Hegde, MR; Freeze, HH				Ng, Bobby G.; Hackmann, Karl; Jones, Melanie A.; Eroshkin, Alexey M.; He, Ping; Wiliams, Roy; Bhide, Shruti; Cantagrel, Vincent; Gleeson, Joseph G.; Paller, Amy S.; Schnur, Rhonda E.; Tinschert, Sigrid; Zunich, Janice; Hegde, Madhuri R.; Freeze, Hudson H.			Mutations in the Glycosylphosphatidylinositol Gene PIGL Cause CHIME Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GPI ANCHOR; DEFICIENCY	CHIME syndrome is characterized by colobomas, heart defects, ichthyosiform dermatosis, mental retardation (intellectual disability), and ear anomalies, including conductive hearing loss. Whole-exome sequencing on five previously reported cases identified PIGL, the de-N-acetylase required for glycosylphosphatidylinositol (GPI) anchor formation, as a strong candidate. Furthermore, cell lines derived from these cases had significantly reduced levels of the two GPI anchor markers, CD59 and a GPI-binding toxin, aerolysin (FLAER), confirming the pathogenicity of the mutations.	[Ng, Bobby G.; Eroshkin, Alexey M.; He, Ping; Wiliams, Roy; Freeze, Hudson H.] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, Genet Dis Program, La Jolla, CA 92037 USA; [Hackmann, Karl; Tinschert, Sigrid] Tech Univ Dresden, Med Fak Carl Gustav Carus, Inst Klin Genet, D-01307 Dresden, Germany; [Jones, Melanie A.; Bhide, Shruti; Hegde, Madhuri R.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Cantagrel, Vincent; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci & Pediat, Neurogenet Lab,Inst Genom Med, La Jolla, CA 92093 USA; [Paller, Amy S.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA; [Schnur, Rhonda E.] Rowan Univ, Cooper Med Sch, Dept Pediat, Div Genet, Camden, NJ 08103 USA; [Zunich, Janice] Indiana Univ Sch Med NW, Genet Ctr, Gary, IN 46408 USA	Sanford Burnham Prebys Medical Discovery Institute; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Emory University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Northwestern University; Feinberg School of Medicine; Rowan University; Cooper Medical School of Rowan University; Indiana University System; Indiana University Northwest	Freeze, HH (corresponding author), Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, Genet Dis Program, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org	Vincent, Cantagrel/H-8698-2017	Vincent, Cantagrel/0000-0002-5180-4848; Freeze, Hudson/0000-0001-6316-0501; Paller, Amy/0000-0001-6187-6549	Rocket Fund; Sanford Professorship; Bundesministerium fur Bildung und Forschung network [01GS08166];  [R01 DK55615]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	Rocket Fund; Sanford Professorship; Bundesministerium fur Bildung und Forschung network; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by The Rocket Fund, a Sanford Professorship (H.H.F.) and R01 DK55615. K.H. was supported by the Bundesministerium fur Bildung und Forschung network grant MR-NET 01GS08166.	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Cantagrel V, 2010, CELL, V142, P203, DOI 10.1016/j.cell.2010.06.001; Ferguson MAJ, 2009, ESSENTIALS GLYCOBIOL, V2nd, P143; Freeze H.H., 2011, CSH PERSPECT BIOL, P35; Godfrey C, 2011, CURR OPIN GENET DEV, V21, P278, DOI 10.1016/j.gde.2011.02.001; Hara-Chikuma M, 2004, J INVEST DERMATOL, V123, P464, DOI 10.1111/j.0022-202X.2004.23227.x; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Schnur RE, 1997, AM J MED GENET, V72, P24, DOI 10.1002/(SICI)1096-8628(19971003)72:1<24::AID-AJMG5>3.3.CO;2-P; SHASHI V, 1995, J MED GENET, V32, P465, DOI 10.1136/jmg.32.6.465; Sidbury R, 2001, PEDIATR DERMATOL, V18, P252, DOI 10.1046/j.1525-1470.2001.018003252.x; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Tinschert S, 1996, PEDIATR DERMATOL, V13, P363, DOI 10.1111/j.1525-1470.1996.tb00702.x; Watanabe R, 1999, BIOCHEM J, V339, P185, DOI 10.1042/0264-6021:3390185; Zunich J., 2008, CHIME SYNDROME ZUNIC, P949	15	91	96	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 6	2012	90	4					685	688		10.1016/j.ajhg.2012.02.010	http://dx.doi.org/10.1016/j.ajhg.2012.02.010			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	926LV	22444671	Green Published, Bronze			2022-12-18	WOS:000302833400010
J	Bae, GU; Domene, S; Roessler, E; Schachter, K; Kang, JS; Muenke, M; Krauss, RS				Bae, Gyu-Un; Domene, Sabina; Roessler, Erich; Schachter, Karen; Kang, Jong-Sun; Muenke, Maximilian; Krauss, Robert S.			Mutations in CDON, Encoding a Hedgehog Receptor, Result in Holoprosencephaly and Defective Interactions with Other Hedgehog Receptors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							IG SUPERFAMILY MEMBER; SONIC HEDGEHOG; MYOGENIC DIFFERENTIATION; BINDING; PROTEINS; PATHWAY; GAS1; BOC; MICE; ACTIVATION	Holoprosencephaly (HPE), a common human congenital anomaly defined by a failure to delineate the midline of the forebrain and/or midface, is associated with diminished Sonic hedgehog (SHH)-pathway activity in development of these structures. SHH signaling is regulated by a network of ligand-binding factors, including the primary receptor PTCH1 and the putative coreceptors, CDON (also called CDO), BOG, and GAS1. Although binding of SHH to these receptors promotes pathway activity, it is not known whether interactions between these receptors are important. We report here identification of missense CDON mutations in human HPE. These mutations diminish CDON's ability to support SHH-dependent gene expression in cell-based signaling assays. The mutations occur outside the SHH-binding domain of CDON, and the encoded variant CDON proteins do not display defects in binding to SHH. In contrast, wild-type CDON associates with PTCH1 and GAS1, but the variants do so inefficiently, in a manner that parallels their activity in cell-based assays. Our findings argue that CDON must associate with both ligand and other hedgehog-receptor components, particularly PTCH1, for signaling to occur and that disruption of the latter interactions is a mechanism of HPE.	[Bae, Gyu-Un; Kang, Jong-Sun] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea; [Bae, Gyu-Un; Schachter, Karen; Krauss, Robert S.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Domene, Sabina; Roessler, Erich; Muenke, Maximilian] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	Sungkyunkwan University (SKKU); Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Kang, JS (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon 440746, South Korea.	kangj01@skku.edu; mamuenke@mail.nih.gov		Muenke, Maximilian/0000-0002-7719-6545	March of Dimes; Ministry for Health, Welfare and Family Affairs, Republic of Korea [A090176]; Korea government (MEST) [2011-0017315]; Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000209, ZIEHG200354] Funding Source: NIH RePORTER	March of Dimes(March of Dimes); Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to M. Lu for help with data analysis, B. Allen and F. Charron for helpful discussions, R. Toftgard and A. McMahon for reagents, and P. Wassarman and B. Gelb for critical reading of the manuscript. This work was supported by a grant from the March of Dimes (R.S.K.); by grants from the Korea Healthcare Technology R and D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea (A090176); and the National Research Foundation of Korea (NRF) funded by the Korea government (MEST; 2011-0017315) (J.-S.K.); and by the Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health, Department of Health and Human Services (MM.).	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Bae GU, 2009, MOL CELL BIOL, V29, P4130, DOI 10.1128/MCB.00199-09; Beachy PA, 2010, GENE DEV, V24, P2001, DOI 10.1101/gad.1951710; Brown L, 2005, HUM MOL GENET, V14, P411, DOI 10.1093/hmg/ddi037; Brown LY, 2001, HUM MOL GENET, V10, P791, DOI 10.1093/hmg/10.8.791; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; Cole F, 2003, CURR BIOL, V13, P411, DOI 10.1016/S0960-9822(03)00088-5; Izzi L, 2011, DEV CELL, V20, P788, DOI 10.1016/j.devcel.2011.04.017; Jehee FS, 2006, CLEFT PALATE-CRAN J, V43, P148, DOI 10.1597/04-206.1; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kang JS, 1997, J CELL BIOL, V138, P203, DOI 10.1083/jcb.138.1.203; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Kogerman P, 2002, ONCOGENE, V21, P6007, DOI 10.1038/sj.onc.1205865; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; MUENKE M, 2001, METABOLIC MOL BASES, P6203; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Pineda-Alvarez DE, 2010, AM J MED GENET C, V154C, P93, DOI 10.1002/ajmg.c.30253; Roessler E, 2010, AM J MED GENET C, V154C, P52, DOI 10.1002/ajmg.c.30236; Schachter KA, 2008, CURR TOP DEV BIOL, V84, P139, DOI 10.1016/S0070-2153(08)00603-0; Schimmenti LA, 2003, AM J MED GENET A, V116A, P215, DOI 10.1002/ajmg.a.10884; Sun Hong, 2007, V383, P303, DOI 10.1007/978-1-59745-335-6_19; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs; Yamada S, 2004, BIRTH DEFECTS RES A, V70, P495, DOI 10.1002/bdra.20048; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005; Zhang W, 2011, DIS MODEL MECH, V4, P368, DOI 10.1242/dmm.005744	34	91	97	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 12	2011	89	2					231	240		10.1016/j.ajhg.2011.07.001	http://dx.doi.org/10.1016/j.ajhg.2011.07.001			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	810TA	21802063	Green Published, Bronze			2022-12-18	WOS:000294148800003
J	Mitsuhashi, S; Ohkuma, A; Talim, B; Karahashi, M; Koumura, T; Aoyama, C; Kurihara, M; Quinlivan, R; Sewry, C; Mitsuhashi, H; Goto, K; Koksal, B; Kale, G; Ikeda, K; Taguchi, R; Noguchi, S; Hayashi, YK; Nonaka, I; Sher, RB; Sugimoto, H; Nakagawa, Y; Cox, GA; Topaloglu, H; Nishino, I				Mitsuhashi, Satomi; Ohkuma, Aya; Talim, Beril; Karahashi, Minako; Koumura, Tomoko; Aoyama, Chieko; Kurihara, Mana; Quinlivan, Ros; Sewry, Caroline; Mitsuhashi, Hiroaki; Goto, Kanako; Koksal, Burcu; Kale, Gulsev; Ikeda, Kazutaka; Taguchi, Ryo; Noguchi, Satoru; Hayashi, Yukiko K.; Nonaka, Ikuya; Sher, Roger B.; Sugimoto, Hiroyuki; Nakagawa, Yasuhito; Cox, Gregory A.; Topaloglu, Haluk; Nishino, Ichizo			A Congenital Muscular Dystrophy with Mitochondrial Structural Abnormalities Caused by Defective De Novo Phosphatidylcholine Biosynthesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHOLINE KINASE ISOFORMS; ALPHA; BETA; MOUSE; EXPRESSION; DELETION; CELLS; MICE	Congenital muscular dystrophy is a heterogeneous group of inherited muscle diseases characterized clinically by muscle weakness and hypotonia in early infancy. A number of genes harboring causative mutations have been identified, but several cases of congenital muscular dystrophy remain molecularly unresolved. We examined 15 individuals with a congenital muscular dystrophy characterized by early-onset muscle wasting, mental retardation, and peculiar enlarged mitochondria that are prevalent toward the periphery of the fibers but are sparse in the center on muscle biopsy, and we have identified homozygous or compound heterozygous mutations in the gene encoding choline kinase beta (CHKB). This is the first enzymatic step in a biosynthetic pathway for phosphatidylcholine, the most abundant phospholipid in eukaryotes. In muscle of three affected individuals with nonsense mutations, choline kinase activities were undetectable, and phosphatidylcholine levels were decreased. We identified the human disease caused by disruption of a phospholipid de novo biosynthetic pathway, demonstrating the pivotal role of phosphatidylcholine in muscle and brain.	[Mitsuhashi, Satomi; Ohkuma, Aya; Mitsuhashi, Hiroaki; Goto, Kanako; Noguchi, Satoru; Hayashi, Yukiko K.; Nonaka, Ikuya] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan; [Talim, Beril; Koksal, Burcu; Kale, Gulsev] Hacettepe Childrens Hosp Med Ctr, Dept Pediat, Pathol Unit, TR-06100 Ankara, Turkey; [Karahashi, Minako; Koumura, Tomoko; Nakagawa, Yasuhito] Kitasato Univ, Sch Pharmaceut Sci, Tokyo 1088641, Japan; [Aoyama, Chieko; Sugimoto, Hiroyuki] Dokkyo Med Univ, Sch Med, Dept Biochem, Mibu, Tochigi 3210293, Japan; [Kurihara, Mana] Kanagawa Rehabil Ctr, Dept Pediat, Kanagawa 2430121, Japan; [Quinlivan, Ros; Sewry, Caroline] Great Ormond St Hosp Sick Children, Dubowitz Neuromuscular Ctr, London WC1N 3JH, England; [Quinlivan, Ros] Natl Hosp Neurol & Neurosurg, MRC Ctr Neuromuscular Disorders, London WC1N 3BG, England; [Sewry, Caroline] RJAH Orthopaed Hosp, Oswestry SY107AG, Shrops, England; [Ikeda, Kazutaka; Taguchi, Ryo] Univ Tokyo, Grad Sch Med, Dept Metabolome, Tokyo 1130033, Japan; [Sher, Roger B.; Cox, Gregory A.] Jackson Lab, Bar Harbor, ME 04609 USA; [Topaloglu, Haluk] Hacettepe Childrens Hosp Med Ctr, Dept Pediat, Child Neurol Unit, TR-06100 Ankara, Turkey	National Center for Neurology & Psychiatry - Japan; Hacettepe University; Kitasato University; Dokkyo Medical University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Tokyo; Jackson Laboratory; Hacettepe University	Nishino, I (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Neuromuscular Res, Tokyo 1878502, Japan.	nishino@ncnp.go.jp	TOPALOGLU, HALUK AYDIN/I-9318-2013; Mitsuhashi, Hiroaki/AAA-6205-2019; Nishino, Ichizo/G-2676-2010; Koksal, Burcu Tahire/AAF-2109-2021	Mitsuhashi, Hiroaki/0000-0001-7789-8611; Nishino, Ichizo/0000-0001-9452-112X; Koksal, Burcu Tahire/0000-0001-9580-7656; Quinlivan, Rosaline/0000-0002-2306-4782	Research on Psychiatric and Neurological Diseases and Mental Health of Health and Labour Sciences research grants; Research on Intractable Diseases of Health and Labor Sciences research grants; Ministry of Health, Labour and Welfare [20B-12, 20B-13]; NCNP [23-4, 23-5]; KAKENHI [20390250, 22791019]; Research on Publicly Essential Drugs and Medical Devices of Health and Labor Sciences research grants; National Institute of Biomedical Innovation (NIBIO); Japan Foundation for Neuroscience and Mental Health; National Institutes of Health [AR-49043]; Grants-in-Aid for Scientific Research [21591104] Funding Source: KAKEN; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049043, R01AR054170] Funding Source: NIH RePORTER	Research on Psychiatric and Neurological Diseases and Mental Health of Health and Labour Sciences research grants; Research on Intractable Diseases of Health and Labor Sciences research grants; Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); NCNP; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Research on Publicly Essential Drugs and Medical Devices of Health and Labor Sciences research grants; National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to the patients and their family for their participation, to Megumu Ogawa, Etsuko Keduka, Yuriko Kure, Mieko Ohnishi, Kaoru Tatezawa, and Kazu lwasawa (National Center of Neurology and Psychiatry) for their technical assistance, to Naoki Kondou and Hiroyuki Taguchi (Kao Corporation) for their kind support on mass analysis, to Osamu Fujino and Kiyoshi Takahashi (Department of Pediatrics, Nippon Medical School) for providing patient information, and to Ken Inoue (National Center of Neurology and Psychiatry) for thoughtful comments on genetics. This study was supported partly by the Research on Psychiatric and Neurological Diseases and Mental Health of Health and Labour Sciences research grants; partly by Research on Intractable Diseases of Health and Labor Sciences research grants; partly by a Research Grant for Nervous and Mental Disorders (20B-12, 20B-13) from the Ministry of Health, Labour and Welfare; partly by an Intramural Research Grant (23-4, 23-5) for Neurological and Psychiatric Disorders from NCNP; partly by KAKENHI (20390250, 22791019); partly by Research on Publicly Essential Drugs and Medical Devices of Health and Labor Sciences research grants; partly by the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); and partly by a grant from the Japan Foundation for Neuroscience and Mental Health. G.A.C. and R.B S. were supported in part by a National Institutes of Health grant (AR-49043 to G.A.C.).	Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 2000, J LIPID RES, V41, P452; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Ikeda K, 2011, CANCER SCI, V102, P79, DOI 10.1111/j.1349-7006.2010.01754.x; ISHIDATE K, 1992, METHOD ENZYMOL, V209, P121; Liao HN, 2006, BBA-MOL CELL BIOL L, V1761, P111, DOI 10.1016/j.bbalip.2006.01.005; Matsumoto H, 2005, NEUROMUSCULAR DISORD, V15, P342, DOI 10.1016/j.nmd.2005.01.009; Mitsuhashi H, 2008, J NEUROCHEM, V105, P101, DOI 10.1111/j.1471-4159.2007.05121.x; Miyagawa T, 2008, NAT GENET, V40, P1324, DOI 10.1038/ng.231; Nakanishi H, 2010, J BIOCHEM, V147, P245, DOI 10.1093/jb/mvp171; Nishino I, 1998, MUSCLE NERVE, V21, P40, DOI 10.1002/(SICI)1097-4598(199801)21:1<40::AID-MUS6>3.0.CO;2-G; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Taguchi R, 2005, J CHROMATOGR B, V823, P26, DOI 10.1016/j.jchromb.2005.06.005; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Wu GS, 2010, BBA-MOL CELL BIOL L, V1801, P446, DOI 10.1016/j.bbalip.2009.12.003; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Zweigner J, 2004, J EXP MED, V200, P99, DOI 10.1084/jem.20032100	20	91	95	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					845	851		10.1016/j.ajhg.2011.05.010	http://dx.doi.org/10.1016/j.ajhg.2011.05.010			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21665002	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000291768500017
J	Whibley, AC; Plagnol, V; Tarpey, PS; Abidi, F; Fullston, T; Choma, MK; Boucher, CA; Shepherd, L; Willatt, L; Parkin, G; Smith, R; Futreal, PA; Shaw, M; Boyle, J; Licata, A; Skinner, C; Stevenson, RE; Turner, G; Field, M; Hackett, A; Schwartz, CE; Gecz, J; Stratton, MR; Raymond, FL				Whibley, Annabel C.; Plagnol, Vincent; Tarpey, Patrick S.; Abidi, Fatima; Fullston, Tod; Choma, Maja K.; Boucher, Catherine A.; Shepherd, Lorraine; Willatt, Lionel; Parkin, Georgina; Smith, Raffaella; Futreal, P. Andrew; Shaw, Marie; Boyle, Jackie; Licata, Andrea; Skinner, Cindy; Stevenson, Roger E.; Turner, Gillian; Field, Michael; Hackett, Anna; Schwartz, Charles E.; Gecz, Jozef; Stratton, Michael R.; Raymond, F. Lucy			Fine-Scale Survey of X Chromosome Copy Number Variants and Indels Underlying Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKED MENTAL-RETARDATION; ACID AMIDE HYDROLASE; STRUCTURAL VARIATION; GENOMIC ARCHITECTURE; IL1RAPL1 GENE; ARRAY-CGH; DUPLICATIONS; REARRANGEMENTS; MUTATIONS; IDENTIFICATION	Copy number variants and indels in 251 families with evidence of X-linked intellectual disability (XLID) were investigated by array comparative genomic hybridization on a high-density oligonucleotide X chromosome array platform. We identified pathogenic copy number variants in 10% of families, with mutations ranging from 2 kb to 11 Mb in size. The challenge of assessing causality was facilitated by prior knowledge of XLID-associated genes and the ability to test for cosegregation of variants with disease through extended pedigrees. Fine-scale analysis of rare variants in XLID families leads us to propose four additional genes, PTCHD1, WDR13, FAAH2, and GSPT2, as candidates for XLID causation and the identification of further deletions and duplications affecting X chromosome genes but without apparent disease consequences. Breakpoints of pathogenic variants were characterized to provide insight into the underlying mutational mechanisms and indicated a predominance of mitotic rather than meiotic events. By effectively bridging the gap between karyotype-level investigations and X chromosome exon resequencing, this study informs discussion of alternative mutational mechanisms, such as non-coding variants and non-X-linked disease, which might explain the shortfall of mutation yield in the well-characterized International Genetics of Learning Disability (IGOLD) cohort, where currently disease remains unexplained in two-thirds of families.	[Whibley, Annabel C.; Plagnol, Vincent; Choma, Maja K.; Boucher, Catherine A.; Shepherd, Lorraine; Raymond, F. Lucy] Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Plagnol, Vincent] UCL, Genet Inst, London WC1E 6BT, England; [Tarpey, Patrick S.; Smith, Raffaella; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Abidi, Fatima; Licata, Andrea; Skinner, Cindy; Stevenson, Roger E.; Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; [Fullston, Tod; Gecz, Jozef] Womens & Childrens Hosp, SA Pathol, Adelaide, SA 5006, Australia; [Fullston, Tod; Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5000, Australia; [Willatt, Lionel; Parkin, Georgina] Addenbrookes Hosp NHS Trust, Dept Med Genet, Cambridge CB2 0QQ, England; [Shaw, Marie; Gecz, Jozef] Womens & Childrens Hlth Res Inst, Adelaide, SA 5006, Australia; [Boyle, Jackie; Turner, Gillian; Field, Michael; Hackett, Anna] GOLD Serv, Waratah, NSW 2298, Australia	University of Cambridge; University of London; University College London; Wellcome Trust Sanger Institute; Greenwood Genetic Center; SA Pathology; Womens & Childrens Hospital Australia; University of Adelaide; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Womens & Childrens Hospital Australia	Raymond, FL (corresponding author), Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England.	flr24@cam.ac.uk	Gecz, Jozef/X-3469-2019; Whibley, Annabel/P-2509-2017; Plagnol, Vincent/A-5667-2011; Whibley, Annabel/G-2836-2011	Gecz, Jozef/0000-0002-7884-6861; Whibley, Annabel/0000-0003-1878-7705; Plagnol, Vincent/0000-0002-5597-9215	Wellcome Trust; Action Medical Research; Baily Thomas Charitable Trust; NIHR; Evelyn Trust; Australian NHMRC [400121]; State of NSW Health Department through their support of the NSW GOLD Service; NICHD [HD26202]; South Carolina Department of Disabilities and Special Needs (SCDDSN)	Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research; Baily Thomas Charitable Trust; NIHR(National Institute for Health Research (NIHR)); Evelyn Trust; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); State of NSW Health Department through their support of the NSW GOLD Service; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); South Carolina Department of Disabilities and Special Needs (SCDDSN)	We would like to thank both the families and referring clinicians for their long-term cooperation. This work was supported by grants from the Wellcome Trust, Action Medical Research, Baily Thomas Charitable Trust, NIHR, The Evelyn Trust, Australian NH&MRC Program Grant #400121, the State of NSW Health Department through their support of the NSW GOLD Service, a NICHD grant (HD26202), and a grant from the South Carolina Department of Disabilities and Special Needs (SCDDSN). We wish to acknowledge Jenny Moon, Josep Parnau, and Richard Francis for their technical expertise in the early stages of the project and Guy Froyen for sharing unpublished data.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Alexander SPH, 2007, BRIT J PHARMACOL, V152, P602, DOI 10.1038/sj.bjp.0707456; American Psychiatric Association, DIAGN STAT MAN MENT; Bauters M, 2008, GENOME RES, V18, P847, DOI 10.1101/gr.075903.107; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; Clayton-Smith J, 2009, EUR J HUM GENET, V17, P434, DOI 10.1038/ejhg.2008.192; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; de Smith AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003104; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Emerson JJ, 2008, SCIENCE, V320, P1629, DOI 10.1126/science.1158078; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Friesema ECH, 2004, LANCET, V364, P1435, DOI 10.1016/S0140-6736(04)17226-7; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; Froyen G, 2008, AM J HUM GENET, V82, P432, DOI 10.1016/j.ajhg.2007.11.002; Froyen G, 2007, HUM MUTAT, V28, P1034, DOI 10.1002/humu.20564; Gecz J, 1997, HUM MOL GENET, V6, P435, DOI 10.1093/hmg/6.3.435; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Girirajan S, 2010, NAT GENET, V42, P203, DOI 10.1038/ng.534; Guilmatre A, 2009, ARCH GEN PSYCHIAT, V66, P947, DOI 10.1001/archgenpsychiatry.2009.80; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Horn C, 2007, NAT GENET, V39, P933, DOI 10.1038/ng0807-933; Hoshino S, 1998, J BIOL CHEM, V273, P22254, DOI 10.1074/jbc.273.35.22254; Jin H, 2000, EUR J HUM GENET, V8, P87, DOI 10.1038/sj.ejhg.5200415; Kerzendorfer C, 2010, HUM MOL GENET, V19, P1324, DOI 10.1093/hmg/ddq008; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Koolen DA, 2008, EUR J HUM GENET, V16, P395, DOI 10.1038/sj.ejhg.5201975; Koolen DA, 2009, HUM MUTAT, V30, P283, DOI 10.1002/humu.20883; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; Le Goff C, 2002, GENES CELLS, V7, P1043, DOI 10.1046/j.1365-2443.2002.00585.x; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Madrigal I, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-443; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Merikangas AK, 2009, TRENDS GENET, V25, P536, DOI 10.1016/j.tig.2009.10.006; Nawara M, 2008, AM J MED GENET A, V146A, P3167, DOI 10.1002/ajmg.a.32613; NOOR A, 2010, SCI TRANSLA IN PRESS; Plenge RM, 1997, NAT GENET, V17, P353, DOI 10.1038/ng1197-353; Price M, 2003, MOL BRAIN RES, V117, P58, DOI 10.1016/S0169-328X(03)00285-7; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Raymond FL, 2006, HUM MOL GENET, V15, pR110, DOI 10.1093/hmg/ddl189; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reymond A, 2007, CURR OPIN GENET DEV, V17, P381, DOI 10.1016/j.gde.2007.08.009; Ropers HH, 2008, CURR OPIN GENET DEV, V18, P241, DOI 10.1016/j.gde.2008.07.008; Royland JE, 2008, TOXICOL APPL PHARM, V231, P179, DOI 10.1016/j.taap.2008.04.023; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; SCHREPPERS-TIJDINK G A J, 1988, Journal de Genetique Humaine, V36, P425; Seierstad M, 2008, J MED CHEM, V51, P7327, DOI 10.1021/jm800311k; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2007, HUM MOL GENET, V16, P2770, DOI 10.1093/hmg/ddm234; Singh BN, 2003, GENOMICS, V81, P315, DOI 10.1016/S0888-7543(02)00036-8; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Stankiewicz P, 2007, CURR OPIN GENET DEV, V17, P182, DOI 10.1016/j.gde.2007.04.009; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tabolacci E, 2006, AM J MED GENET A, V140A, P482, DOI 10.1002/ajmg.a.31107; Tarpey PS, 2007, NAT GENET, V39, P1127, DOI 10.1038/ng2100; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Turkish AR, 2005, J BIOL CHEM, V280, P14755, DOI 10.1074/jbc.M500025200; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Vissers LELM, 2009, HUM MOL GENET, V18, P3579, DOI 10.1093/hmg/ddp306; Wei BQQ, 2006, J BIOL CHEM, V281, P36569, DOI 10.1074/jbc.M606646200; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; WHIBLEY A, 2010, EUR J HUM G IN PRESS; Willatt L, 2005, AM J HUM GENET, V77, P154, DOI 10.1086/431653; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; World Health Organization, ICD 10 CLASS MENT BE; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005; Zhouravleva G, 2006, IUBMB LIFE, V58, P199, DOI 10.1080/15216540600686862	81	91	93	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 13	2010	87	2					173	188		10.1016/j.ajhg.2010.06.017	http://dx.doi.org/10.1016/j.ajhg.2010.06.017			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	641EG	20655035	Green Published, Bronze			2022-12-18	WOS:000281107000002
J	Hoefs, SJG; Dieteren, CEJ; Distelmaier, F; Janssen, RJRJ; Epplen, A; Swarts, HGP; Forkink, M; Rodenburg, RJ; Nijtmans, LG; Willems, PH; Smeitink, JAM; van den Heuvel, LP				Hoefs, Saskia J. G.; Dieteren, Cindy E. J.; Distelmaier, Felix; Janssen, Rolf J. R. J.; Epplen, Andrea; Swarts, Herman G. P.; Forkink, Marleen; Rodenburg, Richard J.; Nijtmans, Leo G.; Willems, Peter H.; Smeitink, Jan A. M.; van den Heuvel, Lambert P.			NDUFA2 complex I mutation leads to Leigh disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BOVINE HEART-MITOCHONDRIA; UBIQUINONE OXIDOREDUCTASE; SUBUNIT COMPOSITION; RESPIRATORY-CHAIN; HUMAN NADH; DEFICIENCY; GENE; PATHOLOGY; ENCEPHALOMYOPATHY; CARDIOMYOPATHY	Mitochondrial isolated complex I deficiency is the most frequently encountered OXPHOS defect. We report a patient with an isolated complex I deficiency expressed in skin fibroblasts as well as muscle tissue. Because the parents were consanguineous, we performed homozygosity mapping to identify homozygous regions containing candidate genes such as NDUFA2 on chromosome 5. Screening of this gene on genomic DNA revealed a mutation that interferes with correct splicing and results in the skipping of exon 2. Exon skipping was confirmed on the mRNA level. The mutation in this accessory subunit causes reduced activity and disturbed assembly of complex I. Furthermore, the mutation is associated with a mitochondrial depolarization. The expression and activity of complex I and the depolarization was (partially) rescued with a baculovirus system expressing the NDUFA2 gene.	[Hoefs, Saskia J. G.; Dieteren, Cindy E. J.; Distelmaier, Felix; Janssen, Rolf J. R. J.; Forkink, Marleen; Rodenburg, Richard J.; Nijtmans, Leo G.; Smeitink, Jan A. M.; van den Heuvel, Lambert P.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; [Dieteren, Cindy E. J.; Distelmaier, Felix; Swarts, Herman G. P.; Willems, Peter H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Membrane Biochem, NL-6500 HB Nijmegen, Netherlands; [Distelmaier, Felix] Univ Dusseldorf, Dept Gen Pediat, D-40225 Dusseldorf, Germany; [Epplen, Andrea] Ruhr Univ Bochum, Dept Human Genet, D-44801 Bochum, Germany	Radboud University Nijmegen; Radboud University Nijmegen; Heinrich Heine University Dusseldorf; Ruhr University Bochum	van den Heuvel, LP (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mitochondrial Disorders, Dept Pediat, NL-6500 HB Nijmegen, Netherlands.	b.vandenheuvel@cukz.umcn.nl	Willems, P.H.G.M./L-4759-2015; Dieteren, Cindy E.J./D-6042-2011; van den Heuvel, Lambertus/AAM-1772-2021; van den Heuvel, L.P.W.J./H-8044-2014; Smeitink, Jan A.M./D-6064-2011; Nijtmans, L.G.J./L-4549-2015; Smeitink, Jan/C-1351-2013; Rodenburg, Richard/N-3579-2014	Willems, P.H.G.M./0000-0002-0915-1599; van den Heuvel, Lambertus/0000-0003-3917-6727; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Rodenburg, Richard/0000-0001-5227-3527				Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Benit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225; Benit P, 2001, AM J HUM GENET, V68, P1344, DOI 10.1086/320603; Berger I, 2008, ANN NEUROL, V63, P405, DOI 10.1002/ana.21332; Brockmann C, 2004, STRUCTURE, V12, P1645, DOI 10.1016/j.str.2004.06.021; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; Dunning CJR, 2007, EMBO J, V26, P3227, DOI 10.1038/sj.emboj.7601748; El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Fernandez-Moreira D, 2007, ANN NEUROL, V61, P73, DOI 10.1002/ana.21036; Gabaldon T, 2005, J MOL BIOL, V348, P857, DOI 10.1016/j.jmb.2005.02.067; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Janssen AJM, 2006, CLIN CHEM, V52, P860, DOI 10.1373/clinchem.2005.062414; Janssen AJM, 2003, ANN CLIN BIOCHEM, V40, P3, DOI 10.1258/000456303321016114; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; Janssen RJRJ, 2006, J INHERIT METAB DIS, V29, P499, DOI 10.1007/s10545-006-0362-4; Kirby DM, 2004, J CLIN INVEST, V114, P837, DOI 10.1172/JCI200420683; Komen JC, 2007, CELL MOL LIFE SCI, V64, P3271, DOI 10.1007/s00018-007-7357-7; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Loeffen J, 2001, ANN NEUROL, V49, P195, DOI 10.1002/1531-8249(20010201)49:2<195::AID-ANA39>3.0.CO;2-M; Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154; Loeffen JLCM, 2000, HUM MUTAT, V15, P123, DOI 10.1002/(SICI)1098-1004(200002)15:2<123::AID-HUMU1>3.0.CO;2-P; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Nijtmans LGJ, 2002, METHODS, V26, P327, DOI 10.1016/S1046-2023(02)00038-5; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Pitkanen S, 1996, J INHERIT METAB DIS, V19, P675, DOI 10.1007/BF01799845; Saada A, 2008, AM J HUM GENET, V82, P32, DOI 10.1016/j.ajhg.2007.08.003; Schuelke M, 1999, NAT GENET, V21, P260, DOI 10.1038/6772; Smeitink J, 2001, NAT REV GENET, V2, P342, DOI 10.1038/35072063; Smeitink J, 2001, J BIOENERG BIOMEMBR, V33, P259, DOI 10.1023/A:1010743321800; Triepels RH, 1999, ANN NEUROL, V45, P787, DOI 10.1002/1531-8249(199906)45:6<787::AID-ANA13>3.0.CO;2-6; van den Heuvel L, 1998, AM J HUM GENET, V62, P262, DOI 10.1086/301716; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200	36	91	94	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2008	82	6					1306	1315		10.1016/j.ajhg.2008.05.007	http://dx.doi.org/10.1016/j.ajhg.2008.05.007			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	312CP	18513682	Bronze, Green Published			2022-12-18	WOS:000256647000008
J	Song, YQ; Cheung, KMC; Ho, DWH; Poon, SCS; Chiba, K; Kawaguchi, Y; Hirose, Y; Alini, M; Grad, S; Yee, AFY; Leong, JCY; Luk, KDK; Yip, SP; Karppinen, J; Cheah, KSE; Sham, P; Ikegawa, S; Chan, D				Song, You-Qiang; Cheung, Kenneth M. C.; Ho, Daniel W. H.; Poon, Sandy C. S.; Chiba, Kazuhiro; Kawaguchi, Yoshiharu; Hirose, Yuichiro; Alini, Mauro; Grad, Sibylle; Yee, Anita F. Y.; Leong, John C. Y.; Luk, Keith D. K.; Yip, Shea-Ping; Karppinen, Jaro; Cheah, Kathryn S. E.; Sham, Pak; Ikegawa, Shiro; Chan, Danny			Association of the asporin D14 allele with lumbar-disc degeneration in Asians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RISK-FACTOR; SUSCEPTIBILITY; REPEAT; IDENTIFICATION; POLYMORPHISM; PROTEIN; COL9A2; ASPN	Lumbar-disc degeneration (LDD) is a polygenic disease. Susceptibility genes reported so far are mainly extracellular matrix proteins. D14 allele of asporin (ASPN) is associated with osteoarthritis (OA). Candidate-gene association studies showed that the D14 allele is also significantly associated with LDD in Chinese and Japanese individuals. Meta-analysis showed that individuals harboring a D14 allele had higher risk with a summary odds ratio of 1.70 (p = 0.000013). ASPN expression in vertebral discs increased with age and degeneration. Our results indicate ASPN is a LDD gene in Asians, and common risk factors may be considered for OA and LDD.	[Song, You-Qiang; Ho, Daniel W. H.; Poon, Sandy C. S.; Cheah, Kathryn S. E.; Chan, Danny] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Cheung, Kenneth M. C.; Yee, Anita F. Y.; Luk, Keith D. K.] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Song, You-Qiang; Sham, Pak] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Chiba, Kazuhiro; Kawaguchi, Yoshiharu] Keio Univ, Dept Orthopaed Surg, Tokyo 1608582, Japan; [Kawaguchi, Yoshiharu] Toyama Univ, Dept Orthopaed Surg, Toyama 9300194, Japan; [Alini, Mauro; Grad, Sibylle] AO Fdn, Davos, Switzerland; [Leong, John C. Y.] Open Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Yip, Shea-Ping] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China; [Karppinen, Jaro] Finnish Inst Occupat Hlth, Oulu 90220, Finland; [Hirose, Yuichiro; Ikegawa, Shiro] RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Tokyo 1088639, Japan	University of Hong Kong; University of Hong Kong; University of Hong Kong; Keio University; University of Toyama; Hong Kong Metropolitan University; Hong Kong Polytechnic University; Finnish Institute of Occupational Health; RIKEN	Chan, D (corresponding author), Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China.	chand@hkusua.hku.hk	Sham, Pak Chung/C-4388-2009; Yip, Shea Ping/A-1185-2016; Song, You-qiang/C-4401-2009; Alini, Mauro/AAG-7961-2020; Ho, Daniel Wai Hung WH/O-1194-2016; Ikegawa, Shiro/N-6895-2015; Song, You-Qiang/E-5207-2011; Chan, Danny/C-4203-2009	Yip, Shea Ping/0000-0002-2170-8185; Ho, Daniel Wai Hung WH/0000-0003-3884-296X; Ikegawa, Shiro/0000-0003-0316-2147; Cheung, Kenneth/0000-0001-8304-0419; Song, You-Qiang/0000-0001-9407-2256; Chan, Danny/0000-0003-3824-5778				Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Annunen S, 1999, SCIENCE, V285, P409, DOI 10.1126/science.285.5426.409; Battie MC, 1995, SPINE, V20, P2601, DOI 10.1097/00007632-199512150-00001; Bax Leon, 2006, BMC Med Res Methodol, V6, P50, DOI 10.1186/1471-2288-6-50; Chan D, 2006, EUR SPINE J, V15, pS317, DOI 10.1007/s00586-006-0171-3; Jim JJT, 2005, SPINE, V30, P2735, DOI 10.1097/01.brs.0000190828.85331.ef; Kawaguchi Y, 1999, SPINE, V24, P2456, DOI 10.1097/00007632-199912010-00006; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Matsui H, 1998, SPINE, V23, P1029, DOI 10.1097/00007632-199805010-00013; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Nakamura T, 2007, HUM MOL GENET, V16, P1676, DOI 10.1093/hmg/ddm115; Paassilta P, 2001, JAMA-J AM MED ASSOC, V285, P1843, DOI 10.1001/jama.285.14.1843; SAMBROOK PN, 1999, ARTHRITIS RHEUM, V72, P66; SCHNEIDERMAN G, 1987, SPINE, V12, P276, DOI 10.1097/00007632-198704000-00016; Seki S, 2005, NAT GENET, V37, P607, DOI 10.1038/ng1557; Valdes AM, 2007, ARTHRITIS RHEUM-US, V56, P137, DOI 10.1002/art.22301; Virtanen M, 2007, J MED GENET, V44, P285, DOI 10.1136/jmg.2006.047076	18	91	94	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2008	82	3					744	747		10.1016/j.ajhg.2007.12.017	http://dx.doi.org/10.1016/j.ajhg.2007.12.017			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	275JN	18304494	Green Published, Bronze			2022-12-18	WOS:000254067800018
J	Freathy, RM; Weedon, MN; Bennett, A; Hypponen, E; Relton, CL; Knight, B; Shields, B; Parnell, KS; Groves, CJ; Ring, SM; Pembrey, ME; Ben-Shlomo, Y; Strachan, DP; Power, C; Jarvelin, MR; McCarthy, MI; Smith, GD; Hattersley, AT; Frayling, TM				Freathy, Rachel M.; Weedon, Michael N.; Bennett, Amanda; Hypponen, Elina; Relton, Caroline L.; Knight, Beatrice; Shields, Beverley; Parnell, Kirstie S.; Groves, Christopher J.; Ring, Susan M.; Pembrey, Marcus E.; Ben-Shlomo, Yoav; Strachan, David P.; Power, Chris; Jarvelin, Marjo-Riitta; McCarthy, Mark I.; Smith, George Davey; Hattersley, Andrew T.; Frayling, Timothy M.			Type 2 diabetes TCF7L2 risk genotypes alter birth weight: A study of 24,053 individuals	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE VARIABLE-NUMBER; GROWTH-FACTOR-I; GLUCOSE-TOLERANCE; FETAL-GROWTH; ACTIVATING MUTATIONS; COMMON POLYMORPHISM; INSULIN-SECRETION; GLUCOKINASE GENE; FASTING GLUCOSE; INS-VNTR	The role of genes in normal birth-weight variation is poorly understood, and it has been suggested that the genetic component of fetal growth is small. Type 2 diabetes genes may influence birth weight through maternal genotype, by increasing maternal glycemia in pregnancy, or through fetal genotype, by altering fetal insulin secretion. We aimed to assess the role of the recently described type 2 diabetes gene TCF7L2 in birth weight. We genotyped the polymorphism rs7903146 in 15,709 individuals whose birth weight was available from six studies and in 8,344 mothers from three studies. Each fetal copy of the predisposing allele was associated with an 18-g (95% confidence interval [CI] 7-29 g) increase in birth weight (P = .001) and each maternal copy with a 30-g (95% CI 15-45 g) increase in offspring birth weight (P = 2.8 x 10(-5)). Stratification by fetal genotype suggested that the association was driven by maternal genotype (31-g [ 95% CI 9-48 g] increase per allele; corrected P = .003). Analysis of diabetes- related traits in 10,314 nondiabetic individuals suggested the most likely mechanism is that the risk allele reduces maternal insulin secretion ( disposition index reduced by similar to 0.15 standard deviation; P =1 x 10(-4)), which results in increased maternal glycemia in pregnancy and hence increased offspring birth weight. We combined information with the other common variant known to alter fetal growth, the - 30G -> A polymorphism of glucokinase (rs1799884). The 4% of offspring born to mothers carrying three or four risk alleles were 119 g (95% CI 62-172 g) heavier than were the 32% born to mothers with none (for overall trend, P = 2 x 10(-7)), comparable to the impact of maternal smoking during pregnancy. In conclusion, we have identified the first type 2 diabetes - susceptibility allele to be reproducibly associated with birth weight. Common gene variants can substantially influence normal birth-weight variation.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; Univ London St Georges Hosp, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth, Div Community Hlth Sci, London, England; Imperial Coll London, Dept Epidemiol & Publ Hlth, London, England; Newcastle Univ, Sch Clin Med Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Bristol, Avon Longitudinal Study Parents & Children, Bristol, Avon, England; Univ Bristol, Dept Social Med, Bristol, Avon, England; Univ Oulu, Dept Publ Hlth & Gen Practice, Oulu, Finland	University of Exeter; University of Oxford; St Georges University London; University of London; University College London; Imperial College London; Newcastle University - UK; University of Bristol; University of Bristol; University of Oulu	Frayling, TM (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Magdalen Rd, Exeter EX1 2LU, Devon, England.	tim.frayling@pms.ac.uk	Davey Smith, George/A-7407-2013; Hypponen, Elina/B-2596-2014; Relton, Caroline/AAC-5904-2019; Ben-Shlomo, Yoav/ABD-2004-2021; McCarthy, Mark/M-3763-2015	Davey Smith, George/0000-0002-1407-8314; Hypponen, Elina/0000-0003-3670-9399; Ben-Shlomo, Yoav/0000-0001-6648-3007; bennett, amanda/0000-0003-2140-8710; Freathy, Rachel/0000-0003-4152-2238; Frayling, Timothy/0000-0001-8362-2603; Hattersley, Andrew/0000-0001-5620-473X; Weedon, Michael/0000-0002-6174-6135; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Relton, Caroline/0000-0003-2052-4840; Venkatasubramanian, Siddharth/0000-0002-5860-0768; s, hema/0000-0002-3440-9475; McCarthy, Mark/0000-0002-4393-0510	Medical Research Council [G0400546B] Funding Source: researchfish; National Institute for Health Research [PHCS/C4/4/016] Funding Source: researchfish; MRC [G0400546, G0500070, G0000934] Funding Source: UKRI; Medical Research Council [G9815508, G0000934, G0500070, G0400546] Funding Source: Medline; Wellcome Trust [068545/z/02, gr069224ma] Funding Source: Medline; Department of Health [PHCS/C4/4/016] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Department of Health		Arya R, 2006, HUM MOL GENET, V15, P1569, DOI 10.1093/hmg/ddl076; Baird J, 2001, DIABETOLOGIA, V44, P33, DOI 10.1007/s001250051577; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Bennett A, 2005, DIABETOLOGIA, V48, P886, DOI 10.1007/s00125-005-1737-z; Bennett AJ, 2004, DIABETES, V53, P2126, DOI 10.2337/diabetes.53.8.2126; Bernstein IM, 2005, OBSTET GYNECOL, V106, P986, DOI 10.1097/01.AOG.0000182580.78402.d2; BRESCHI MC, 1993, DIABETOLOGIA, V36, P1315, DOI 10.1007/BF00400812; Cauchi S, 2006, DIABETES, V55, P2903, DOI 10.2337/db06-0474; Chandak GR, 2007, DIABETOLOGIA, V50, P63, DOI 10.1007/s00125-006-0502-2; Chase DS, 1998, J MED GENET, V35, P413, DOI 10.1136/jmg.35.5.413; Clausson B, 2000, BRIT J OBSTET GYNAEC, V107, P375, DOI 10.1111/j.1471-0528.2000.tb13234.x; Damcott CM, 2006, DIABETES, V55, P2654, DOI 10.2337/db06-0338; Day INM, 2002, LANCET, V360, P945, DOI 10.1016/S0140-6736(02)11044-0; Dunger DB, 1998, NAT GENET, V19, P98, DOI 10.1038/ng0598-98; Edghill EL, 2006, DIABETIC MED, V23, P1301, DOI 10.1111/j.1464-5491.2006.01999.x; FARMER G, 1988, DIABETOLOGIA, V31, P134, DOI 10.1007/BF00276845; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Fradin D, 2006, J CLIN ENDOCR METAB, V91, P4164, DOI 10.1210/jc.2006-0529; Frayling TM, 2002, DIABETES, V51, P2313, DOI 10.2337/diabetes.51.7.2313; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hansen SK, 2004, DIABETOLOGIA, V47, P1079, DOI 10.1007/s00125-004-1418-3; Hattersley AT, 1998, NAT GENET, V19, P268, DOI 10.1038/953; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hypponen E, 2003, BMJ-BRIT MED J, V326, P19, DOI 10.1136/bmj.326.7379.19; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Jarvelin MR, 1997, PAEDIATR PERINAT EP, V11, P298, DOI 10.1111/j.1365-3016.1997.tb00007.x; Kieffer EC, 2006, AM J PUBLIC HEALTH, V96, P2201, DOI 10.2105/AJPH.2005.065953; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; Le Stunff C, 2000, NAT GENET, V26, P444, DOI 10.1038/82579; Lindley AA, 2000, AM J PUBLIC HEALTH, V90, P420, DOI 10.2105/AJPH.90.3.420; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; Lindsay RS, 2003, DIABETES, V52, P187, DOI 10.2337/diabetes.52.1.187; Lindsay RS, 2002, HUM GENET, V110, P503, DOI 10.1007/s00439-002-0718-2; Magnus P, 2001, J EPIDEMIOL COMMUN H, V55, P873, DOI 10.1136/jech.55.12.873; Mitchell SMS, 2004, J CLIN ENDOCR METAB, V89, P310, DOI 10.1210/jc.2003-030605; Munoz J, 2006, DIABETES, V55, P3630, DOI 10.2337/db06-0574; Ong KK, 2004, DIABETES, V53, P1128, DOI 10.2337/diabetes.53.4.1128; Ong KKL, 1999, NAT GENET, V21, P262, DOI 10.1038/6775; Pearson ER, 2007, PLOS MED, V4, P760, DOI 10.1371/journal.pmed.0040118; Petry CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-22; Pfab T, 2006, OBESITY, V14, P1880, DOI 10.1038/oby.2006.218; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x; Rasmussen SK, 2000, J CLIN ENDOCR METAB, V85, P2951, DOI 10.1210/jc.85.8.2951; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Scott LJ, 2006, DIABETES, V55, P2649, DOI 10.2337/db06-0341; Slingerland AS, 2006, J CLIN ENDOCR METAB, V91, P2782, DOI 10.1210/jc.2006-0201; Smith GD, 2004, J EPIDEMIOL COMMUN H, V58, P126, DOI 10.1136/jech.58.2.126; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Vaessen N, 2002, LANCET, V359, P1036, DOI 10.1016/S0140-6736(02)08067-4; Vaessen N, 2001, DIABETES, V50, P637, DOI 10.2337/diabetes.50.3.637; van Baal C G, 1998, Twin Res, V1, P123, DOI 10.1375/136905298320566258; van Vliet-Ostaptchouk JV, 2007, DIABETOLOGIA, V50, P59, DOI 10.1007/s00125-006-0477-z; Wannamethee SG, 2004, DIABETOLOGIA, V47, P12, DOI 10.1007/s00125-003-1270-x; Wareham N J, 1995, Diabet Med, V12, P931; Weedon MN, 2006, AM J HUM GENET, V79, P991, DOI 10.1086/509517; Weedon MN, 2005, DIABETES, V54, P576, DOI 10.2337/diabetes.54.2.576; Weedon MN, 2003, DIABETOLOGIA, V46, P1021, DOI 10.1007/s00125-003-1135-3; WRIGHT NM, 1993, AM J DIS CHILD, V147, P607; Zhang CL, 2006, DIABETES, V55, P2645, DOI 10.2337/db06-0643	66	91	92	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2007	80	6					1150	1161		10.1086/518517	http://dx.doi.org/10.1086/518517			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	168WD	17503332	Bronze, Green Published			2022-12-18	WOS:000246553800013
J	Kalb, R; Neveling, K; Hoehn, H; Schneider, H; Linka, Y; Batish, SD; Hunt, C; Berwick, M; Callen, E; Surralles, J; Casado, JA; Bueren, J; Dasi, A; Soulier, J; Gluckman, E; Zwaan, CM; van Spaendonk, R; Pals, G; de Winter, JP; Joenje, H; Grompe, M; Auerbach, AD; Hanenberg, H; Schindler, D				Kalb, Reinhard; Neveling, Kornelia; Hoehn, Holger; Schneider, Hildegard; Linka, Yvonne; Batish, Sat Dev; Hunt, Curtis; Berwick, Marianne; Callen, Elsa; Surralles, Jordi; Casado, Jose A.; Bueren, Juan; Dasi, Angeles; Soulier, Jean; Gluckman, Eliane; Zwaan, C. Michel; van Spaendonk, Rosalina; Pals, Gerard; de Winter, Johan P.; Joenje, Hans; Grompe, Markus; Auerbach, Arleen D.; Hanenberg, Helmut; Schindler, Detlev			Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENTATION GROUP; DNA-REPAIR; RETROVIRAL VECTORS; PATHWAY; LINK; MONOUBIQUITINATION; RECOMBINATION; ORTHOLOG; GENOME; CELLS	FANCD2 is an evolutionarily conserved Fanconi anemia ( FA) gene that plays a key role in DNA double-strand-type damage responses. Using complementation assays and immunoblotting, a consortium of American and European groups assigned 29 patients with FA from 23 families and 4 additional unrelated patients to complementation group FA-D2. This amounts to 3% - 6% of FA-affected patients registered in various data sets. Malformations are frequent in FA-D2 patients, and hematological manifestations appear earlier and progress more rapidly when compared with all other patients combined ( FA - non-D2) in the International Fanconi Anemia Registry. FANCD2 is flanked by two pseudogenes. Mutation analysis revealed the expected total of 66 mutated alleles, 34 of which result in aberrant splicing patterns. Many mutations are recurrent and have ethnic associations and shared allelic haplotypes. There were no biallelic null mutations; residual FANCD2 protein of both isotypes was observed in all available patient cell lines. These analyses suggest that, unlike the knockout mouse model, total absence of FANCD2 does not exist in FA-D2 patients, because of constraints on viable combinations of FANCD2 mutations. Although hypomorphic mutations arie involved, clinically, these patients have a relatively severe form of FA.	Univ Wurzburg, Dept Human Genet, Biozentrum, D-97074 Wurzburg, Germany; Univ Dusseldorf, Dept Pediat Oncol Hematol & Immunol, D-4000 Dusseldorf, Germany; Rockefeller Univ, Lab Human Genet & Hematol, New York, NY 10021 USA; Univ New Mexico, Div Epidemiol, Albuquerque, NM 87131 USA; Univ Autonoma Barcelona, Dept Genet & Microbiol, E-08193 Barcelona, Spain; Ctr Biomed Res Rare Dis, Bellaterra, Spain; Ctr Invest Energet Medioambientales & Tecnol, Hematopoiesis & Gene Therapy Div, Madrid, Spain; Hosp La Fe, Unit Pediat Hematol, E-46009 Valencia, Spain; Hop St Louis, Inst Univ Hematol, Paris, France; Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat HematolOncol, Rotterdam, Netherlands; Dutch Childhood Oncol Grp, Rotterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet & Human Genet, Amsterdam, Netherlands; Oregon Hlth & Sci Univ, Dept Med & Mol Genet, Portland, OR 97201 USA; Indiana Univ, Sch Med, Dept Pediat, Indianapolis, IN 46204 USA	University of Wurzburg; Heinrich Heine University Dusseldorf; Rockefeller University; University of New Mexico; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro de Investigaciones Energeticas, Medioambientales Tecnologicas; Hospital Universitari i Politecnic La Fe; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Dutch Childhood Oncology Group; Vrije Universiteit Amsterdam; Oregon Health & Science University; Indiana University System; Indiana University-Purdue University Indianapolis	Schindler, D (corresponding author), Univ Wurzburg, Dept Human Genet, Biozentrum, Hubland, D-97074 Wurzburg, Germany.	schindler@biozentrum.uni-wuerzburg.de	eliane, Gluckman/AAA-5024-2021; Casado, José Antonio/H-5077-2015; Berwick, Marianne/E-9608-2010; Surrallés, Jordi/AAE-7667-2020; Pals, Gerard/A-5198-2011; Bueren, Juan/L-6112-2014; Kalb, Reinhard/AAR-3249-2021	Casado, José Antonio/0000-0003-2479-1508; Bueren, Juan/0000-0002-3228-7013; Kalb, Reinhard/0000-0003-3906-6907; Grompe, Markus/0000-0002-6616-4345; Auerbach, Arleen/0000-0002-6911-8379; Berwick, Marianne/0000-0001-5062-2180; Vervenne, Resie/0000-0002-6077-8725; Pals, Gerard/0000-0003-4091-7115; Surralles, Jordi/0000-0002-4041-7519	NCI NIH HHS [R01 CA82678, R01 CA082678] Funding Source: Medline; NHLBI NIH HHS [R37 HL032987, R37 HL32987] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082678] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032987] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Auerbach AD, 2003, CURRENT PROTOCOLS HU, V8, P1; Auerbach AD, 2001, FANCONI ANEMIA, V1, P753; BERGER R, 1993, CANCER GENET CYTOGEN, V69, P13, DOI 10.1016/0165-4608(93)90104-T; Blom E, 2002, ACTA HAEMATOL-BASEL, V108, P231, DOI 10.1159/000065659; Borriello A, 2007, LEUKEMIA, V21, P72, DOI 10.1038/sj.leu.2404468; Callen E, 2005, BLOOD, V105, P1946, DOI 10.1182/blood-2004-07-2588; Carreau M, 2004, BLOOD, V103, P2430, DOI 10.1182/blood-2003-11-3946; Carter Anthony B., 2004, Human Genomics, V1, P167; CASADO JA, 2006, J MED GENET; Chandra S, 2005, MOL THER, V12, P976, DOI 10.1016/j.ymthe.2005.04.021; Dequen F, 2005, COMP BIOCHEM PHYS B, V141, P453, DOI 10.1016/j.cbpc.2005.05.010; Digweed M, 2002, CARCINOGENESIS, V23, P1121, DOI 10.1093/carcin/23.7.1121; Faivre L, 2000, BLOOD, V96, P4064; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Garcia-Cabeza I, 2001, BMC PSYCHIATRY, V1, DOI 10.1186/1471-244X-1-7; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hanenberg H, 1997, HUM GENE THER, V8, P2193, DOI 10.1089/hum.1997.8.18-2193; Hanenberg H, 2002, EXP HEMATOL, V30, P410, DOI 10.1016/S0301-472X(02)00782-8; Heinrich MC, 1998, BLOOD, V91, P275, DOI 10.1182/blood.V91.1.275.275_275_287; Hildinger M, 1999, J VIROL, V73, P4083, DOI 10.1128/JVI.73.5.4083-4089.1999; Ho GPH, 2006, MOL CELL BIOL, V26, P7005, DOI 10.1128/MCB.02018-05; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Hozel M, 2003, J PATHOL, V201, P198, DOI 10.1002/path.1450; HURET JL, 2002, ATLAS GENET CYTOGENE; Joenje H, 2001, NAT REV GENET, V2, P446, DOI 10.1038/35076590; JOENJE H, 1997, FANCONI ANEMIA CYTOG; Kennedy RD, 2005, GENE DEV, V19, P2925, DOI 10.1101/gad.1370505; Kutler David I, 2004, Fam Cancer, V3, P241, DOI 10.1007/s10689-004-9565-8; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Levitus M, 2004, BLOOD, V103, P2498, DOI 10.1182/blood-2003-08-2915; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levitus M, 2006, CELL ONCOL, V28, P3; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Liu H, 2003, EDUC ASIA-PACIFIC, V2, P53; Mansfield SG, 2004, TRENDS MOL MED, V10, P263, DOI 10.1016/j.molmed.2004.04.007; Marek LR, 2006, DNA REPAIR, V5, P1317, DOI 10.1016/j.dnarep.2006.05.044; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Mirchandani KD, 2006, EXP CELL RES, V312, P2647, DOI 10.1016/j.yexcr.2006.06.014; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Pace P, 2002, EMBO J, V21, P3414, DOI 10.1093/emboj/cdf355; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Roy-Engel AM, 2001, GENETICS, V159, P279; SCHINDLER D, 1988, AM J HUM GENET, V43, P429; SEYSCHAB H, 1995, BLOOD, V85, P2233, DOI 10.1182/blood.V85.8.2233.bloodjournal8582233; Shimamura A, 2002, BLOOD, V100, P4649, DOI 10.1182/blood-2002-05-1399; Soulier J, 2005, BLOOD, V105, P1329, DOI 10.1182/blood-2004-05-1852; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; TENFOE JRL, 1997, EUR J HUM GENET, V5, P137; Thompson LH, 2005, ENVIRON MOL MUTAGEN, V45, P128, DOI 10.1002/em.20109; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Tischkowitz M, 2004, BRIT J HAEMATOL, V126, P176, DOI 10.1111/j.1365-2141.2004.05023.x; Wang Y, 2004, BIOINFORMATICS, V20, P1170, DOI 10.1093/bioinformatics/bth059; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005	60	91	92	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					895	910		10.1086/517616	http://dx.doi.org/10.1086/517616			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436244	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000245973200008
J	Wang, LY; Hauser, ER; Shah, SH; Pericak-Vance, MA; Haynes, C; Crosslin, D; Harris, M; Nelson, S; Hale, AB; Granger, CB; Haines, JL; Jones, CJH; Crossman, D; Seo, D; Gregory, SG; Kraus, WE; Goldschmidt-Clermont, PJ; Vance, JM				Wang, Liyong; Hauser, Elizabeth R.; Shah, Svati H.; Pericak-Vance, Margaret A.; Haynes, Carol; Crosslin, David; Harris, Marco, II; Nelson, Sarah; Hale, A. Brent; Granger, Christopher B.; Haines, Jonathan L.; Jones, Christopher J. H.; Crossman, David; Seo, David; Gregory, Simon G.; Kraus, William E.; Goldschmidt-Clermont, Pascal J.; Vance, Jeffery M.			Peakwide mapping on chromosome 3q13 identifies the kalirin gene as a novel candidate gene for coronary artery disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NUCLEOTIDE EXCHANGE FACTOR; HEART-DISEASE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; NITRIC-OXIDE; SUSCEPTIBILITY LOCUS; FAMILIAL OCCURRENCE; METABOLIC SYNDROME; LINKAGE ANALYSIS; BINDING-PROTEIN	A susceptibility locus for coronary artery disease (CAD) has been mapped to chromosome 3q13-21 in a linkage study of early-onset CAD. We completed an association-mapping study across the 1-LOD-unit-down supporting interval, using two independent white case-control data sets (CATHGEN, initial and validation) to evaluate association under the peak. Single-nucleotide polymorphisms (SNPs) evenly spaced at 100-kb intervals were screened in the initial data set (N = 468). Promising SNPs (P < .1) were then examined in the validation data set (N = 514). Significant findings (P < .05) in the combined initial and validation data sets were further evaluated in multiple independent data sets, including a family-based data set (P < .1), an African American case-control data set (N = 190), and an additional white control data set (N = 225). The association between genotype and aortic atherosclerosis was examined in 145 human aortas. The peakwide survey found evidence of association in SNPs from multiple genes. The strongest associations were found in three SNPs from the kalirin (KALRN) gene, especially in patients with early-onset CAD (P = .00001-00028 in the combined CATHGEN data sets). In-depth investigation of the gene found that an intronic SNP, rs9289231, was associated with early- onset CAD in all white data sets examined (P < .05). In the joint analysis of all white early- onset CAD cases P (N = 332) and controls (N = 546), rs9289231 was highly significant (P = .00008), with an odds-ratio estimate of 2.1. Furthermore, the risk allele of this SNP was associated with atherosclerosis burden (P = .03) in 145 human aortas. KALRN is a protein with many functions, including the inhibition of inducible nitric oxide synthase and guanine-exchange-factor activity. KALRN and two other associated genes identified in this study (CDGAP and MYLK) belong to the Rho GTPase-signaling pathway. Our data suggest the importance of the KALRN gene and the Rho GTPase-signaling pathway in the pathogenesis of CAD.	Duke Univ, Ctr Med, Ctr Human Genet, Durham, NC 27706 USA; Duke Univ, Ctr Med, Div Cardiol, Durham, NC 27706 USA; Duke Univ, Ctr Med, Dept Med, Durham, NC 27706 USA; Vanderbilt Univ, Nashville, TN 37232 USA; Cardiff Univ, Coll Med, Cardiff CF1 3NS, S Glam, Wales; Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England; Univ Miami, Miller Sch Med, Miami, FL 33101 USA	Duke University; Duke University; Duke University; Vanderbilt University; Cardiff University; University of Sheffield; University of Miami	Vance, JM (corresponding author), Univ Miami, Miami Inst Human Genom, POB 019132,M-860, Miami, FL 33101 USA.	JVance@med.miami.edu	Granger, Christopher B/D-3458-2014; Haines, Jonathan/C-3374-2012; Nelson, Sarah Catherine/AAN-9814-2020	Granger, Christopher B/0000-0002-0045-3291; Haines, Jonathan/0000-0002-4351-4728; Nelson, Sarah Catherine/0000-0002-2109-6465; Hauser, Elizabeth/0000-0003-0367-9189; Gregory, Simon/0000-0002-7805-1743; Kraus, William E/0000-0003-1930-9684; Vance, Jeffery/0000-0003-3815-8199	NHLBI NIH HHS [R01 HL073389, P01 HL073042, R01 HL073389-01, P01 HL73042] Funding Source: Medline; NIA NIH HHS [R01 AG019757, R01 AG021547] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073389, P01HL073042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019757, R01AG021547] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Alam MR, 1997, J BIOL CHEM, V272, P12667, DOI 10.1074/jbc.272.19.12667; [Anonymous], 1993, Arterioscler Thromb, V13, P1291; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bowden DW, 2006, DIABETES, V55, P1985, DOI 10.2337/db06-0003; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Colomer V, 1997, HUM MOL GENET, V6, P1519, DOI 10.1093/hmg/6.9.1519; Connelly JJ, 2006, PLOS GENET, V2, P1265, DOI 10.1371/journal.pgen.0020139; Cooke JP, 2002, CIRCULATION, V105, P2133, DOI 10.1161/01.CIR.0000014928.45119.73; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Farrall M, 2006, PLOS GENET, V2, P755, DOI 10.1371/journal.pgen.0020072; Felker GM, 2002, J AM COLL CARDIOL, V39, P210, DOI 10.1016/S0735-1097(01)01738-7; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Fujita A, 2000, J CELL SCI, V113, P103; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Hauser ER, 2004, AM J HUM GENET, V75, P436, DOI 10.1086/423900; Hauser ER, 2003, AM HEART J, V145, P602, DOI 10.1067/mhj.2003.13; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Knaus UG, 2000, IMMUNOL RES, V21, P103, DOI 10.1385/IR:21:2-3:103; Li MY, 2005, AM J HUM GENET, V76, P934, DOI 10.1086/430277; Martin ER, 2003, AM J HUM GENET, V73, P1016, DOI 10.1086/378779; McPherson CE, 2004, J MOL NEUROSCI, V22, P51, DOI 10.1385/JMN:22:1-2:51; McPherson CE, 2002, GENE, V284, P41, DOI 10.1016/S0378-1119(02)00386-4; Murabito JM, 2005, JAMA-J AM MED ASSOC, V294, P3117, DOI 10.1001/jama.294.24.3117; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Oliveira SA, 2005, AM J HUM GENET, V77, P252, DOI 10.1086/432588; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; Penzes P, 2000, J BIOL CHEM, V275, P6395, DOI 10.1074/jbc.275.9.6395; Rabiner CA, 2005, NEUROSCIENTIST, V11, P148, DOI 10.1177/1073858404271250; Ratovitski EA, 1999, J BIOL CHEM, V274, P30250, DOI 10.1074/jbc.274.42.30250; Ren J, 2005, ACTA PHARMACOL SIN, V26, P279, DOI 10.1111/j.1745-7254.2005.00059.x; RISSANEN AM, 1979, AM J CARDIOL, V44, P60, DOI 10.1016/0002-9149(79)90251-0; Samani NJ, 2005, AM J HUM GENET, V77, P1011; Schwartz M, 2004, J CELL SCI, V117, P5457, DOI 10.1242/jcs.01582; Seo D, 2004, ARTERIOSCL THROM VAS, V24, P1922, DOI 10.1161/01.ATV.0000141358.65242.1f; Shah SH, 2006, ANN HUM GENET, V70, P738, DOI 10.1111/j.1469-1809.2006.00288.x; SHEA S, 1984, J AM COLL CARDIOL, V4, P793, DOI 10.1016/S0735-1097(84)80408-8; Shephard N, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S66; Shiffman D, 2006, ARTERIOSCL THROM VAS, V26, P1613, DOI 10.1161/01.ATV.0000226543.77214.e4; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; SMITH LR, 1991, CIRCULATION, V84, P245; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; TENKATE LP, 1982, AM J CARDIOL, V50, P945, DOI 10.1016/0002-9149(82)90400-3; THOMAS CB, 1955, ANN INTERN MED, V42, P90, DOI 10.7326/0003-4819-42-1-90; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Watanabe G, 1996, SCIENCE, V271, P645, DOI 10.1126/science.271.5249.645; Wherlock M, 2002, J CELL SCI, V115, P239; Xu H, 2005, BIOINFORMATICS, V21, P4181, DOI 10.1093/bioinformatics/bti682	58	91	99	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2007	80	4					650	663		10.1086/512981	http://dx.doi.org/10.1086/512981			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	153VV	17357071	Bronze, Green Published			2022-12-18	WOS:000245465200006
J	Toydemir, RM; Brassington, AE; Bayrak-Toydemir, P; Krakowiak, PA; Jorde, LB; Whitby, FG; Longo, N; Viskochil, DH; Carey, JC; Bamshad, MJ				Toydemir, Reha M.; Brassington, Anna E.; Bayrak-Toydemir, Pinar; Krakowiak, Patrycja A.; Jorde, Lynn B.; Whitby, Frank G.; Longo, Nicola; Viskochil, David H.; Carey, John C.; Bamshad, Michael J.			A novel mutation in FGFR3 causes camptodactyly, tall stature, and hearing loss (CATSHL) syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FIBROBLAST-GROWTH-FACTOR; HUMAN INSULIN-RECEPTOR; TYROSINE KINASE; HEREDITARY CHONDRODYSPLASIA; SKELETAL DYSPLASIA; DOMAIN; ACTIVATION; GENE; MICE	Activating mutations of FGFR3, a negative regulator of bone growth, are well known to cause a variety of short-limbed bone dysplasias and craniosynostosis syndromes. We mapped the locus causing a novel disorder characterized by camptodactyly, tall stature, scoliosis, and hearing loss (CATSHL syndrome) to chromosome 4p. Because this syndrome recapitulated the phenotype of the Fgfr3 knockout mouse, we screened FGFR3 and subsequently identified a heterozygous missense mutation that is predicted to cause a p.R621H substitution in the tyrosine kinase domain and partial loss of FGFR3 function. These findings indicate that abnormal FGFR3 signaling can cause human anomalies by promoting as well as inhibiting endochondral bone growth.	Univ Washington, Sch Med, Div Genet & Dev Med, Dept Pediat, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Childrens Hosp & Reg Med Ctr, Seattle, WA USA; Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT USA; Univ Utah, Dept Pathol, Salt Lake City, UT USA; Univ Utah, Dept Biochem, Salt Lake City, UT USA; Univ Utah, Dept Pediat, Salt Lake City, UT USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Bamshad, MJ (corresponding author), Univ Washington, Sch Med, Div Genet & Dev Med, Dept Pediat, 1959 NE Pacific St,HSB RR349, Seattle, WA 98195 USA.	mbamshad@u.washington.edu	Toydemir, Reha/U-9739-2019	Toydemir, Reha M./0000-0002-0797-1999	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048895] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-00064, M01 RR000064] Funding Source: Medline; NICHD NIH HHS [HD-048895, R01 HD048895] Funding Source: Medline; PHS HHS [U50/CCU822097-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ablooglu AJ, 2001, J BIOL CHEM, V276, P46933, DOI 10.1074/jbc.M107236200; Beever JE, 2006, ANIM GENET, V37, P66, DOI 10.1111/j.1365-2052.2005.01398.x; Bellus GA, 2000, AM J HUM GENET, V67, P1411, DOI 10.1086/316892; CHANG PY, 1994, J BIOL CHEM, V269, P16034; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Muenke M, 1997, AM J HUM GENET, V60, P555; PIRVOLA U, 1995, P NATL ACAD SCI USA, V92, P9269, DOI 10.1073/pnas.92.20.9269; Rau H, 2000, DIABETES, V49, P1264, DOI 10.2337/diabetes.49.7.1264; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Tavormina PL, 1999, AM J HUM GENET, V64, P722, DOI 10.1086/302275; VANEK JA, 1989, J AM VET MED ASSOC, V194, P244; Wilkie AOM, 2002, AM J MED GENET, V112, P266, DOI 10.1002/ajmg.10775; Williams DM, 2000, J BIOL CHEM, V275, P38127, DOI 10.1074/jbc.C000606200; Wright TJ, 1997, HUM MOL GENET, V6, P317, DOI 10.1093/hmg/6.2.317	16	91	99	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					935	941		10.1086/508433	http://dx.doi.org/10.1086/508433			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033969	Green Published, Bronze			2022-12-18	WOS:000241667400014
J	Gelernter, J; Panhuysen, C; Wilcox, M; Hesselbrock, V; Rounsaville, B; Poling, J; Weiss, R; Sonne, S; Zhao, HY; Farrer, L; Kranzler, HR				Gelernter, J; Panhuysen, C; Wilcox, M; Hesselbrock, V; Rounsaville, B; Poling, J; Weiss, R; Sonne, S; Zhao, HY; Farrer, L; Kranzler, HR			Genomewide linkage scan for opioid dependence and related traits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALCOHOL DEPENDENCE; DRUG-DEPENDENCE; RECEPTOR GENE; HEROIN DEPENDENCE; COMPLEX TRAITS; RISK-FACTORS; CHRM2 GENE; LOD SCORES; ASSOCIATION; LOCI	Risk of opioid dependence is genetically influenced. We recruited a sample of 393 small nuclear families (including 250 full-sib and 46 half-sib pairs), each with at least one individual with opioid dependence. Subjects underwent a detailed evaluation of substance dependence-related traits. As planned a priori to reduce heterogeneity, we used cluster analytic methods to identify opioid dependence-related symptom clusters, which were shown to be heritable. We then completed a genomewide linkage scan (with 409 markers) for the opioid-dependence diagnosis and for the two cluster-defined phenotypes represented by > 250 families: the heavy-opioid-use cluster and the non-opioid-use cluster. Further exploratory analyses were completed for the other cluster-defined phenotypes. The statistically strongest results were seen with the cluster-defined traits. For the heavy-opioid-use cluster, we observed a LOD score of 3.06 on chromosome 17 (empirical pointwise P = .0002) for European American (EA) and African American (AA) subjects combined, and, for the non-opioid-use cluster, we observed a LOD score of 3.46 elsewhere on chromosome 17 (empirical pointwise, uncorrected for multiple traits studied) for EA subjects only. P = .00002 We also identified a possible linkage (LOD score 2.43) of opioid dependence with chromosome 2 markers for the AA subjects. These results are an initial step in identifying genes for opioid dependence on the basis of a genomewide investigation (i.e., a study not conditioned on prior physiological candidate-gene hypotheses).	Yale Univ, Sch Med, Dept Psychiat, Div Human Genet, West Haven, CT 06516 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, West Haven, CT 06516 USA; Yale Univ, Sch Med, Dept Genet, West Haven, CT 06516 USA; VA Connecticut Healthcare Ctr, West Haven, CT USA; Boston Univ, Sch Med, Genet Program, Dept Med, Boston, MA 02118 USA; Boston Univ, Sch Med, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; Univ Connecticut, Sch Med, Dept Psychiat, Farmington, CT USA; McLean Hosp, Alcohol & Drug Abuse Treatment Program, Belmont, MA 02178 USA; Med Univ S Carolina, Dept Psychiat, Charleston, SC 29425 USA	Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Boston University; Boston University; Harvard University; Harvard Medical School; University of Connecticut; Harvard University; McLean Hospital; Medical University of South Carolina	Gelernter, J (corresponding author), Yale Univ, Sch Med, Dept Psychiat, Div Human Genet, VA CT 116A2,950 Campbell Ave, West Haven, CT 06516 USA.	joel.gelernter@yale.edu	Farrer, Lindsay/AAS-1035-2020; kranzler, henry/AAS-1113-2020	kranzler, henry/0000-0002-1018-0450; Farrer, Lindsay/0000-0001-5533-4225; Poling, James/0000-0002-0133-3136; Gelernter, Joel/0000-0002-4067-1859	NIDA NIH HHS [R01 DA012690, R01 DA12849, R01 DA12690, R01 DA012849] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012690, R01DA012849] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Bart G, 2004, MOL PSYCHIATR, V9, P547, DOI 10.1038/sj.mp.4001504; Basu D, 2004, DRUG ALCOHOL DEPEN, V73, P289, DOI 10.1016/j.drugalcdep.2003.11.004; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Covault J, 2004, AM J MED GENET B, V129B, P104, DOI 10.1002/ajmg.b.30091; CURTIS D, 1995, AM J HUM GENET, V57, P703; Edenberg HJ, 2004, AM J HUM GENET, V74, P705, DOI 10.1086/383283; Ellickson PL, 1999, J ADOLESCENT HEALTH, V25, P382, DOI 10.1016/S1054-139X(98)00144-X; Evans DM, 2004, AM J HUM GENET, V75, P687, DOI 10.1086/424696; Gelernter J, 2005, AM J MED GENET B, V136B, P45, DOI 10.1002/ajmg.b.30189; Gelernter J, 2004, AM J MED GENET B, V128B, P94, DOI 10.1002/ajmg.b.30019; GREENACRE MJ, 1984, THEORY APPL CORRESPE; Karkowski LM, 2000, AM J MED GENET, V96, P665, DOI 10.1002/1096-8628(20001009)96:5<665::AID-AJMG13>3.0.CO;2-O; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lappalainen J, 2005, ALCOHOL CLIN EXP RES, V29, P493, DOI 10.1097/01.ALC.0000158938.97464.90; Lebart L., 1984, MULTIVARIATE DESCRIP; Long JC, 1998, AM J MED GENET, V81, P216, DOI 10.1002/(SICI)1096-8628(19980508)81:3<216::AID-AJMG2>3.0.CO;2-U; LUO X, 2005, NEUROPSYCHOPHARMACOL; Luo XG, 2005, HUM MOL GENET, V14, P2421, DOI 10.1093/hmg/ddi244; Luo XG, 2003, AM J MED GENET B, V120B, P97, DOI 10.1002/ajmg.b.20034; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; National Institute on Drug Abuse, 2003, DRUG US AM RAC ETHN; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Pierucci-Lagha A, 2005, DRUG ALCOHOL DEPEN, V80, P303, DOI 10.1016/j.drugalcdep.2005.04.005; Pritchard JK, 2000, GENETICS, V155, P945; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; RISCH N, 1990, AM J HUM GENET, V46, P229; *SAS I, 2001, SAS REL 8 02 CAR; Sawcer SJ, 2004, HUM MOL GENET, V13, P1943, DOI 10.1093/hmg/ddh202; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schaid DJ, 2004, AM J HUM GENET, V75, P948, DOI 10.1086/425870; Stallings MC, 2005, ARCH GEN PSYCHIAT, V62, P1042, DOI 10.1001/archpsyc.62.9.1042; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Tan EC, 2003, NEUROREPORT, V14, P569, DOI 10.1097/00001756-200303240-00008; Tsuang MT, 1996, AM J MED GENET, V67, P473, DOI 10.1002/(SICI)1096-8628(19960920)67:5<473::AID-AJMG6>3.3.CO;2-D; Turner RJ, 2003, ADDICTION, V98, P305, DOI 10.1046/j.1360-0443.2003.00312.x; Uhl GR, 2001, AM J HUM GENET, V69, P1290, DOI 10.1086/324467; VEGA WA, 1993, AM J PUBLIC HEALTH, V83, P185, DOI 10.2105/AJPH.83.2.185; Wang JC, 2004, HUM MOL GENET, V13, P1903, DOI 10.1093/hmg/ddh194; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEEKS DE, 2001, SLINK GEN SIMULATION; Xu K, 2004, ARCH GEN PSYCHIAT, V61, P597, DOI 10.1001/archpsyc.61.6.597; Zhang HP, 2006, HUM MOL GENET, V15, P807, DOI 10.1093/hmg/ddl024; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510	52	91	92	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2006	78	5					759	769		10.1086/503631	http://dx.doi.org/10.1086/503631			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EH	16642432	Green Published, Bronze			2022-12-18	WOS:000236756200003
J	Wang, XS; Ishimori, N; Korstanje, R; Rollins, J; Paigen, B				Wang, XS; Ishimori, N; Korstanje, R; Rollins, J; Paigen, B			Identifying novel genes for atherosclerosis through mouse-human comparative genetics	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							CORONARY-ARTERY-DISEASE; QUANTITATIVE TRAIT LOCUS; APOLIPOPROTEIN E-DEFICIENT; GENOMEWIDE LINKAGE ANALYSIS; E-KNOCKOUT MOUSE; MYOCARDIAL-INFARCTION; HIGH-RESOLUTION; HEART-DISEASE; STRAINS C57BL/6J; CANDIDATE GENES	Susceptibility to atherosclerosis is determined by both environmental and genetic factors. Its genetic determinants have been studied by use of quantitative- trait - locus ( QTL) analysis. So far, 21 atherosclerosis QTLs have been identified in the mouse: 7 in a high- fat - diet model only, 9 in a sensitized model ( apolipoprotein E - or LDL [ low-density lipoprotein] receptor - deficient mice) only, and 5 in both models, suggesting that different gene sets operate in each model and that a subset operates in both. Among the 27 human atherosclerosis QTLs reported, 17 ( 63%) are located in regions homologous ( concordant) to mouse QTLs, suggesting that these mouse and human atherosclerosis QTLs have the same underlying genes. Therefore, genes regulating human atherosclerosis will be found most efficiently by first finding their orthologs in concordant mouse QTLs. Novel mouse QTL genes will be found most efficiently by using a combination of the following strategies: identifying QTLs in new crosses performed with previously unused parental strains; inducing mutations in large- scale, high- throughput mutagenesis screens; and using new genomic and bioinformatics tools. Once QTL genes are identified in mice, they can be tested in human association studies for their relevance in human atherosclerotic disease.	Jackson Lab, Bar Harbor, ME 04509 USA; Hokkaido Univ, Grad Sch Med, Dept Cardiovasc Med, Sapporo, Hokkaido, Japan; Univ Groningen, Dept Pathol & Lab Med, Med Biol Sect, Ctr Med, Groningen, Netherlands	Jackson Laboratory; Hokkaido University; University of Groningen	Wang, XS (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04509 USA.	xw@jax.org	Ishimori, Naoki/AAP-2349-2020; Ishimori, Naoki/A-8015-2012; Rollins, Jarod/B-4076-2009	Rollins, Jarod/0000-0002-6279-7831	NHLBI NIH HHS [R37 HL077796, HL66611, HL70486, U01 HL066611, R01 HL077796, HL77796] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077796, U01HL066611, R37HL077796] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Agah Ramtin, 2002, Expert Rev Mol Diagn, V2, P448, DOI 10.1586/14737159.2.5.448; Allayee H, 2003, ARTERIOSCL THROM VAS, V23, P1501, DOI 10.1161/01.ATV.0000090886.40027.DC; Balling R, 2001, ANNU REV GENOM HUM G, V2, P463, DOI 10.1146/annurev.genom.2.1.463; Ben-Asher E, 2004, ISRAEL MED ASSOC J, V6, P318; Bhagavatula MRK, 2004, HUM MOL GENET, V13, P3181, DOI 10.1093/hmg/ddh329; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Brewer HB, 2004, ARTERIOSCL THROM VAS, V24, P387, DOI 10.1161/01.ATV.0000121505.88326.d2; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Calara F, 2001, J PATHOL, V195, P257, DOI 10.1002/path.915; Caligiuri G, 1999, P NATL ACAD SCI USA, V96, P6920, DOI 10.1073/pnas.96.12.6920; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Choudhury RP, 2002, ATHEROSCLEROSIS, V162, P315, DOI 10.1016/S0021-9150(01)00730-4; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Dansky HM, 2002, GENETICS, V160, P1599; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; Fayad ZA, 1998, CIRCULATION, V98, P1541, DOI 10.1161/01.CIR.98.15.1541; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Fox CS, 2004, AM J HUM GENET, V74, P253, DOI 10.1086/381559; Francke S, 2001, HUM MOL GENET, V10, P2751, DOI 10.1093/hmg/10.24.2751; Geng Y J, 2001, Curr Atheroscler Rep, V3, P234, DOI 10.1007/s11883-001-0066-z; Gharani N, 2004, MOL PSYCHIATR, V9, P474, DOI 10.1038/sj.mp.4001498; Gotto AM, 2004, J AM COLL CARDIOL, V43, P717, DOI 10.1016/j.jacc.2003.08.061; Hansson GK, 2002, CIRC RES, V91, P281, DOI 10.1161/01.RES.0000029784.15893.10; Harrap SB, 2002, ARTERIOSCL THROM VAS, V22, P874, DOI 10.1161/01.ATV.0000016258.40568.F1; Hauser ER, 2004, AM J HUM GENET, V75, P436, DOI 10.1086/423900; Helgadottir A, 2004, NAT GENET, V36, P233, DOI 10.1038/ng1311; Hitzemann R, 2002, GENES BRAIN BEHAV, V1, P214, DOI 10.1034/j.1601-183X.2002.10403.x; Hixson JE, 1999, J CLIN ENDOCR METAB, V84, P3187, DOI 10.1210/jc.84.9.3187; Hockings PD, 2002, CIRCULATION, V106, P1716, DOI 10.1161/01.CIR.0000030188.50326.8D; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Humphries SE, 2004, LANCET NEUROL, V3, P227, DOI 10.1016/S1474-4422(04)00708-2; Iakoubova OA, 2001, GENOMICS, V74, P89, DOI 10.1006/geno.2000.6497; Ishimori N, 2004, ARTERIOSCL THROM VAS, V24, P161, DOI 10.1161/01.ATV.0000104027.52895.D7; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jawien J, 2004, J PHYSIOL PHARMACOL, V55, P503; Johnson J, 2005, CIRCULATION, V111, P1422, DOI 10.1161/01.CIR.0000158435.98035.8D; Johnson JL, 2001, ATHEROSCLEROSIS, V154, P399, DOI 10.1016/S0021-9150(00)00515-3; Kelmenson PM, 2005, GENETICS, V169, P833, DOI 10.1534/genetics.104.035063; Korstanje R, 2004, ATHEROSCLEROSIS, V177, P443, DOI 10.1016/j.atherosclerosis.2004.08.006; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; LANDER ES, 1989, GENETICS, V121, P185; Lohmussaar E, 2005, STROKE, V36, P731, DOI 10.1161/01.STR.0000157587.59821.87; Lusis MJ, 2004, ANNU REV GENOM HUM G, V5, P189, DOI [10.1146/annurev.genom.5.061903.175930, 10.1016/j.tig.2012.03.001]; Manenti G, 2004, ONCOGENE, V23, P4495, DOI 10.1038/sj.onc.1207584; Manolio TA, 2004, ARTERIOSCL THROM VAS, V24, P1567, DOI 10.1161/01.ATV.0000138789.11433.c1; McAteer MA, 2004, ARTERIOSCL THROM VAS, V24, P2384, DOI 10.1161/01.ATV.0000146811.19029.fb; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; Mehrabian M, 2002, CIRC RES, V91, P120, DOI 10.1161/01.RES.0000028008.99774.7F; Mehrabian M, 2001, CIRC RES, V89, P125, DOI 10.1161/hh1401.093458; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Mu JL, 1999, J LIPID RES, V40, P1328; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; PAIGEN B, 1987, BIOCHEM GENET, V25, P501, DOI 10.1007/BF00554352; PAIGEN B, 1987, P NATL ACAD SCI USA, V84, P3763, DOI 10.1073/pnas.84.11.3763; PAIGEN B, 1995, AM J CLIN NUTR, V62, p458S, DOI 10.1093/ajcn/62.2.458S; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Pajukanta P, 2000, AM J HUM GENET, V67, P1481, DOI 10.1086/316902; PALINSKI W, 1994, ARTERIOSCLER THROMB, V14, P605, DOI 10.1161/01.ATV.14.4.605; Park YG, 2003, GENOME RES, V13, P118, DOI 10.1101/gr.786403; Phelan SA, 2002, MAMM GENOME, V13, P548, DOI 10.1007/s00335-002-2196-1; Pollanen PJ, 2001, ARTERIOSCL THROM VAS, V21, P1446, DOI 10.1161/hq0901.095545; Purcell MK, 2001, MAMM GENOME, V12, P495, DOI 10.1007/s00335001-0006-9; Reardon CA, 2003, ARTERIOSCL THROM VAS, V23, P1449, DOI 10.1161/01.ATV.0000079793.58054.2E; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Schneider JE, 2004, J MAGN RESON IMAGING, V20, P981, DOI 10.1002/jmri.20211; Seidelmann SB, 2005, ARTERIOSCL THROM VAS, V25, P204, DOI 10.1161/01.ATV.0000149146.32385.1b; Shifman S, 2005, GENETICS, V169, P849, DOI 10.1534/genetics.104.032474; Smith J, 2003, CURR OPIN LIPIDOL, V14, P499, DOI 10.1097/00041433-200310000-00011; Steinberg D, 2002, CIRCULATION, V105, P2107, DOI 10.1161/01.CIR.0000014762.06201.06; STEWARTPHILLIPS JL, 1989, CLIN INVEST MED, V12, P121; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; Sugiyama F, 2001, GENOMICS, V71, P70, DOI 10.1006/geno.2000.6401; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; TEUPSER D, 2004, 5 ANN C ART THROMB V; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wang D, 2005, STROKE, V36, P540, DOI 10.1161/01.STR.0000155746.65185.4e; Wang LJ, 2003, SCIENCE, V302, P1578, DOI 10.1126/science.1088477; Wang Q, 2004, AM J HUM GENET, V74, P262, DOI 10.1086/381560; Wang S, 2003, CIRCULATION, V108, P177; Wang XS, 2005, CURR OPIN LIPIDOL, V16, P127, DOI 10.1097/01.mol.0000162317.09054.9d; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Wang XS, 2005, CIRC RES, V96, P27, DOI 10.1161/01.RES.0000151332.39871.13; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; Welch CL, 2001, P NATL ACAD SCI USA, V98, P7946, DOI 10.1073/pnas.141239098; Wheeler JG, 2004, LANCET, V363, P689, DOI 10.1016/S0140-6736(04)15642-0; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; Zhang BP, 1999, CIRCULATION, V99, P1788, DOI 10.1161/01.CIR.99.14.1788	94	91	94	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2005	77	1					1	15		10.1086/431656	http://dx.doi.org/10.1086/431656			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	935PP	15931593	Green Published, Bronze			2022-12-18	WOS:000229794500001
J	Ohashi, J; Naka, I; Patarapotikul, J; Hananantachai, H; Brittenham, G; Looareesuwan, S; Clark, AG; Tokunaga, K				Ohashi, J; Naka, I; Patarapotikul, J; Hananantachai, H; Brittenham, G; Looareesuwan, S; Clark, AG; Tokunaga, K			Extended linkage disequilibrium surrounding the hemoglobin E variant due to malarial selection	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLOBIN GENE-CLUSTER; CLASS-II REGION; PLASMODIUM-FALCIPARUM; HUMAN GENOME; MEIOTIC RECOMBINATION; HAPLOTYPE STRUCTURE; SOUTHEAST-ASIA; RECENT ORIGIN; E TRAIT; POPULATION	The hemoglobin E variant (HbE; (beta)26Glu-->Lys) is concentrated in parts of Southeast Asia where malaria is endemic, and HbE carrier status has been shown to confer some protection against Plasmodium falciparum malaria. To examine the effect of natural selection on the pattern of linkage disequilibrium (LD) and to infer the evolutionary history of the HbE variant, we analyzed biallelic markers surrounding the HbE variant in a Thai population. Pairwise LD analysis of HbE and 43 surrounding biallelic markers revealed LD of HbE extending beyond 100 kb, whereas no LD was observed between non-HbE variants and the same markers. The inferred haplotype network suggests a single origin of the HbE variant in the Thai population. Forward-in-time computer simulations under a variety of selection models indicate that the HbE variant arose 1,240-4,440 years ago. These results support the conjecture that the HbE mutation occurred recently, and the allele frequency has increased rapidly. Our study provides another clear demonstration that a high-resolution LD map across the human genome can detect recent variants that have been subjected to positive selection.	Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; Mahidol Univ, Fac Trop Med, Dept Microimmunol & Clin Trop Med, Bangkok, Thailand; Columbia Univ, Coll Phys & Surg, Dept Pediat & Med, New York, NY USA	University of Tokyo; Mahidol University; Columbia University	Ohashi, J (corresponding author), Care of Clark AG, Cornell Univ, Dept Mol Biol & Genet, 227 Biotechnol Bldg, Ithaca, NY 14853 USA.	juno-tky@umin.ac.jp	NAKA, IZUMI/G-5495-2015; OHASHI, JUN/G-5907-2015	Clark, Andrew/0000-0001-7159-8511	FIC NIH HHS [D43TW00620] Funding Source: Medline	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; ANTONARAKIS SE, 1982, P NATL ACAD SCI-BIOL, V79, P6608, DOI 10.1073/pnas.79.21.6608; BUNYARATVEJ A, 1986, ACTA HAEMATOL-BASEL, V76, P155, DOI 10.1159/000206041; CHAKRAVARTI A, 1984, AM J HUM GENET, V36, P1239; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Cullen M, 2002, AM J HUM GENET, V71, P759, DOI 10.1086/342973; Currat M, 2002, AM J HUM GENET, V70, P207, DOI 10.1086/338304; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; FRIEDMAN MJ, 1978, P NATL ACAD SCI USA, V75, P1994, DOI 10.1073/pnas.75.4.1994; FUCHAROEN G, 1990, BIOCHEM BIOPH RES CO, V170, P698, DOI 10.1016/0006-291X(90)92147-R; FUCHAROEN S, 1987, HEMOGLOBIN, V11, P65, DOI 10.3109/03630268709036587; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goldstein DB, 2001, NAT GENET, V29, P109, DOI 10.1038/ng1001-109; Haldane J.B.S., 1949, HEREDITAS, V35, P267; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; Hutagalung R, 1999, J INFECT DIS, V179, P283, DOI 10.1086/314561; Hutagalung R, 2000, J INFECT DIS, V181, P1513, DOI 10.1086/315373; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Kauppi L, 2003, HUM MOL GENET, V12, P33, DOI 10.1093/hmg/ddg008; LEWONTIN RC, 1988, GENETICS, V120, P849; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; Ohashi J, 2000, GENETICS, V155, P921; Ohashi J, 2002, J INFECT DIS, V186, P578, DOI 10.1086/341779; Ohashi J, 2000, HEREDITAS, V133, P25, DOI 10.1111/j.1601-5223.2000.00025.x; Omi K, 2003, AM J HUM GENET, V72, P364, DOI 10.1086/346091; PASVOL G, 1978, NATURE, V274, P701, DOI 10.1038/274701a0; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; Roessli D, 2000, ARLEQUIN VERSION 2 0; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saunders MA, 2002, GENETICS, V162, P1849; Schneider JA, 2002, HUM MOL GENET, V11, P207, DOI 10.1093/hmg/11.3.207; Smith RA, 1998, BLOOD, V92, P4415, DOI 10.1182/blood.V92.11.4415.423a07_4415_4421; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tishkoff SA, 2003, CURR OPIN GENET DEV, V13, P569, DOI 10.1016/j.gde.2003.10.010; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; VERNES AJM, 1986, T ROY SOC TROP MED H, V80, P642, DOI 10.1016/0035-9203(86)90163-X; Wall JD, 2003, AM J HUM GENET, V73, P502, DOI 10.1086/378099; WALL JD, 1933, AM J HUM GENET, V73, P1330	41	91	95	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2004	74	6					1198	1208		10.1086/421330	http://dx.doi.org/10.1086/421330			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	823ZB	15114532	Green Published, Bronze			2022-12-18	WOS:000221651900012
J	Bachinski, LL; Udd, B; Meola, G; Sansone, V; Bassez, G; Eymard, B; Thornton, CA; Moxley, RT; Harper, PS; Rogers, MT; Jurkat-Rott, K; Lehmann-Horn, F; Wieser, T; Gamez, J; Navarro, C; Bottani, A; Kohler, A; Shriver, MD; Sallinen, R; Wessman, M; Zhang, SX; Wright, FA; Krahe, R				Bachinski, LL; Udd, B; Meola, G; Sansone, V; Bassez, G; Eymard, B; Thornton, CA; Moxley, RT; Harper, PS; Rogers, MT; Jurkat-Rott, K; Lehmann-Horn, F; Wieser, T; Gamez, J; Navarro, C; Bottani, A; Kohler, A; Shriver, MD; Sallinen, R; Wessman, M; Zhang, SX; Wright, FA; Krahe, R			Confirmation of the type 2 myotonic dystrophy (CCTG)(n) expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: A single shared haplotype indicates an ancestral founder effect	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; DELETION POLYMORPHISM; MYOPATHY SYNDROME; CTG REPEATS; FAMILY; PROMM; PHENOTYPE; HETEROGENEITY; INSTABILITY; DISORDER	Myotonic dystrophy (DM), the most common form of muscular dystrophy in adults, is a clinically and genetically heterogeneous neuromuscular disorder. DM is characterized by autosomal dominant inheritance, muscular dystrophy, myotonia, and multisystem involvement. Type 1 DM (DM1) is caused by a (CTG)(n) expansion in the 3' untranslated region of DMPK in 19q13.3. Multiple families, predominantly of German descent and with clinically variable presentation that included proximal myotonic myopathy (PROMM) and type 2 DM (DM2) but without the DM1 mutation, showed linkage to the 3q21 region and were recently shown to segregate a (CCTG)(n) expansion mutation in intron 1 of ZNF9. Here, we present linkage to 3q21 and mutational confirmation in 17 kindreds of European origin with PROMM and proximal myotonic dystrophy, from geographically distinct populations. All patients have the DM2 (CCTG)(n) expansion. To study the evolution of this mutation, we constructed a comprehensive physical map of the DM2 region around ZNF9. High-resolution haplotype analysis of disease chromosomes with five microsatellite and 22 single-nucleotide polymorphism markers around the DM2 mutation identified extensive linkage disequilibrium and a single shared haplotype of at least 132 kb among patients from the different populations. With the exception of the (CCTG)(n) expansion, the available markers indicate that the DM2 haplotype is identical to the most common haplotype in normal individuals. This situation is reminiscent of that seen in DM1. Taken together, these data suggest a single founding mutation in DM2 patients of European origin. We estimate the age of the founding haplotype and of the DM2 (CCTG) expansion mutation to be similar to200-540 generations.	Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet,Unit 11, Houston, TX 77030 USA; Vaasa Cent Hosp, Dept Neurol, Vaasa, Finland; Tampere Univ Hosp, Dept Neurol, Tampere, Finland; San Donato Hosp, Dept Neurol, Milan, Italy; Henri Mondor Univ Hosp, Dept Pathol, Creteil, France; Salpetriere Hosp, Myol Inst, Paris, France; Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; Univ Wales Hosp, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales; Univ Ulm, Dept Appl Physiol, Ulm, Germany; Univ Halle Wittenberg, Dept Neurol, Halle An Der Saale, Germany; Gen Hosp Vall Hebron Univ, Dept Neurol, Barcelona, Spain; Meixoeiro Hosp, Dept Anat Pathol, Vigo, Spain; Univ Hosp Geneva, Div Med Genet, Geneva, Switzerland; Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland; Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland; Univ Helsinki, Folkhalsan Inst Genet, Helsinki, Finland; Biomedicum Helsinki, Res Program Mol Med, Helsinki, Finland; Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA	University of Texas System; UTMD Anderson Cancer Center; Vaasa Central Hospital; Tampere University; Tampere University Hospital; IRCCS Policlinico San Donato; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Rochester; Cardiff University; Ulm University; Martin Luther University Halle Wittenberg; Hospital Universitari Vall d'Hebron; Complexo Hospitalario Universitario de Vigo; University of Geneva; University of Geneva; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Helsinki; University of Helsinki; University of Helsinki; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill	Krahe, R (corresponding author), Univ Texas, MD Anderson Canc Ctr, Dept Mol Genet, Sect Canc Genet,Unit 11, Room Y7-6032,1515 Holcombe Blvd, Houston, TX 77030 USA.	RalfKrahe@mdanderson.org	Navarro, Carmen/A-9210-2012; Meola, Giovanni/K-4775-2016; Bassez, Guillaume/AAD-3033-2022	Meola, Giovanni/0000-0001-6396-717X; Bassez, Guillaume/0000-0002-2044-1052; Shriver, Mark/0000-0003-0006-0479; Sallinen, Riitta/0000-0003-4252-0197; Gamez, Josep/0000-0003-3127-7486	NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048171] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016058, P30 CA16058] Funding Source: Medline; NIAMS NIH HHS [R01 AR48171, R01 AR048171] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbruzzese C, 1996, J NEUROL, V243, P715, DOI 10.1007/BF00873977; ASHIZAWA T, 1991, LANCET, V338, P642, DOI 10.1016/0140-6736(91)90659-D; Bassez G, 2001, REV NEUROL-FRANCE, V157, P209; Borrego S, 2003, AM J HUM GENET, V72, P88, DOI 10.1086/345466; Brock GJR, 1999, HUM MOL GENET, V8, P1061, DOI 10.1093/hmg/8.6.1061; BROOK, 1992, CELL, V69, P385; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Cheng R, 2003, GENETICS, V164, P1175; Cleary JD, 2002, NAT GENET, V31, P37, DOI 10.1038/ng870; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Day JW, 2003, NEUROLOGY, V60, P657, DOI 10.1212/01.WNL.0000054481.84978.F9; Day JW, 1999, NEUROMUSCULAR DISORD, V9, P19, DOI 10.1016/S0960-8966(98)00094-7; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Gonzalez I, 2000, NEUROLOGY, V54, P1218; Gourdon G, 1997, NAT GENET, V15, P190, DOI 10.1038/ng0297-190; Harper PS, 2001, MYOTONIC DYSTROPHY; HEISKANEN M, 1994, BIOTECHNIQUES, V17, P928; IMBERT G, 1993, NAT GENET, V4, P72, DOI 10.1038/ng0593-72; IRWIN M, 1994, P NATL ACAD SCI USA, V91, P11684, DOI 10.1073/pnas.91.24.11684; Kohler A, 2000, EUR NEUROL, V43, P50, DOI 10.1159/000008129; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; KRAHE R, 1995, AM J HUM GENET, V56, P1067; Kress W, 2000, NEUROMUSCULAR DISORD, V10, P478, DOI 10.1016/S0960-8966(00)00129-2; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; MAHADEVAN MS, 1993, GENOMICS, V15, P446, DOI 10.1006/geno.1993.1087; Mankodi A, 2002, CURR OPIN NEUROL, V15, P545, DOI 10.1097/00019052-200210000-00005; Matsuura T, 2002, ANN NEUROL, V51, P271, DOI 10.1002/ana.10049; Meola G, 1996, NEUROMUSCULAR DISORD, V6, P143, DOI 10.1016/0960-8966(95)00040-2; Monckton DG, 1997, NAT GENET, V15, P193, DOI 10.1038/ng0297-193; Moxley RT, 1998, NEUROMUSCULAR DISORD, V8, P508, DOI 10.1016/S0960-8966(98)00068-6; NEVILLE CE, 1994, HUM MOL GENET, V3, P45; Newman B, 1999, NEUROMUSCULAR DISORD, V9, P144, DOI 10.1016/S0960-8966(98)00118-7; Pandya S, 2001, NEUROMUSCULAR DISORD, V11, P630; Phillips MF, 1998, NEUROMUSCULAR DISORD, V8, P439, DOI 10.1016/S0960-8966(98)00054-6; Ranum LPW, 1998, NAT GENET, V19, P196, DOI 10.1038/570; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; Richards RI, 1996, ANN HUM GENET, V60, P391, DOI 10.1111/j.1469-1809.1996.tb00437.x; Ricker K, 1999, NEUROLOGY, V52, P170, DOI 10.1212/WNL.52.1.170; RICKER K, 1994, NEUROLOGY, V44, P1448, DOI 10.1212/WNL.44.8.1448; RICKER K, 1995, ARCH NEUROL-CHICAGO, V52, P25, DOI 10.1001/archneur.1995.00540250029009; Sallinen R, 2001, MAMM GENOME, V12, P340, DOI 10.1007/s003350010271; Schaffer AA, 1996, HUM HERED, V46, P226, DOI 10.1159/000154358; Sermon K, 2001, MOL CELL ENDOCRINOL, V183, pS77, DOI 10.1016/S0303-7207(01)00572-X; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; THORNTON CA, 1994, ANN NEUROL, V35, P269, DOI 10.1002/ana.410350305; Udd B, 1997, NEUROMUSCULAR DISORD, V7, P217, DOI 10.1016/S0960-8966(97)00041-2; Warner JP, 1996, J MED GENET, V33, P1022, DOI 10.1136/jmg.33.12.1022; Wieser HG, 2000, EPILEPTIC DISORD, V2, P141; Yamagata H, 1996, HUM GENET, V97, P145, DOI 10.1007/BF02265255; Yamagata H, 1998, J HUM GENET, V43, P246, DOI 10.1007/s100380050082; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659	53	91	97	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2003	73	4					835	848		10.1086/378566	http://dx.doi.org/10.1086/378566			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	727TL	12970845	Green Published, Bronze			2022-12-18	WOS:000185676100011
J	Pastore, Y; Jedlickova, K; Guan, YL; Liu, EL; Fahner, J; Hasle, H; Prchal, JF; Prchal, JT				Pastore, Y; Jedlickova, K; Guan, YL; Liu, EL; Fahner, J; Hasle, H; Prchal, JF; Prchal, JT			Mutations of von Hippel-Lindau tumor-suppressor gene and congenital polycythemia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIF-ALPHA; DISEASE; COMPLEX; DEFINE; CANCER	The von Hippel-Lindau (pVHL) protein plays an important role in hypoxia sensing. It binds to the hydroxylated hypoxia-inducible factor 1alpha (HIF-1alpha) and serves as a recognition component of an E3-ubiquitin ligase complex. In hypoxia or secondary to a mutated VHL gene, the nondegraded HIF-1alpha forms a heterodimer with HIF-beta and leads to increased transcription of hypoxia-inducible genes, including erythropoietin (EPO). The autosomal dominant cancer-predisposition von Hippel-Lindau (VHL) syndrome is due to inheritance of a single mutated allele of VHL. In contrast, we recently showed that homozygous germline 598C-->T VHL mutation leads to Chuvash polycythemia (CP). We subsequently found VHL mutations in three unrelated individuals unaffected with CP, one of whom was compound heterozygous for the 598C-->T mutation and another VHL mutation. We now report seven additional polycythemic patients with VHL mutations in both alleles. Two Danish siblings and another American boy were homozygous for the VHL 598C-->T mutation. Three unrelated white Americans were compound heterozygotes for 598C-->T and another VHL mutation, 562C-->G in two and 574C-->T in the third. Additionally, a Croatian boy was homozygous for a 571C-->G VHL mutation, the first example of homozygous VHL germline mutation causing polycythemia, other than the VHL 598C-->T mutation. We have not observed VHL syndrome - associated tumors in polycythemic subjects or their heterozygous relatives; however, this will need to be evaluated by longitudinal studies. Over all, we found that up to half of the consecutive patients with apparent congenital polycythemia and increased serum Epo we have examined have mutations of both VHL alleles. Those findings, along with reports of CP, underscore that VHL mutations are the most frequent cause of congenital polycythemia and define a new class of polycythemic disorder, polycythemias due to augmented hypoxia sensing.	Baylor Coll Med, Houston, TX 77030 USA; Texas Childrens Canc Ctr & Hematol Serv, Houston, TX USA; Vet Adm Hosp, Houston, TX USA; DeVos Childrens Hosp, Grand Rapids, MI USA; Viborg Hosp, Dept Pediat, Viborg, Denmark; McGill Univ, Dept Hematol Oncol, Montreal, PQ, Canada	Baylor College of Medicine; Texas Children's Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Aarhus University; McGill University	Prchal, JT (corresponding author), Baylor Coll Med, 1 Baylor Plaza,Suite 802E, Houston, TX 77030 USA.	jprchal@bcm.tmc.edu	Pastore, Yves Dominique/AAE-2427-2019	Hasle, Henrik/0000-0003-3976-9231	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066333] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL5007-08, R01 HL066333, R01HL66333-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adryan B, 2000, ONCOGENE, V19, P2803, DOI 10.1038/sj.onc.1203611; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; Ang SO, 2002, BLOOD CELL MOL DIS, V28, P57, DOI 10.1006/bcmd.2002.0488; Bender BU, 2001, J MED GENET, V38, P508, DOI 10.1136/jmg.38.8.508; Bruning T, 1997, ARCH TOXICOL, V71, P332, DOI 10.1007/s002040050394; CHOYKE PL, 1995, RADIOLOGY, V194, P629, DOI 10.1148/radiology.194.3.7862955; Clifford SC, 2001, HUM MOL GENET, V10, P1029, DOI 10.1093/hmg/10.10.1029; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Friedrich CA, 2001, HUM MOL GENET, V10, P763, DOI 10.1093/hmg/10.7.763; GAO JZ, 1995, CANCER RES, V55, P743; Gordeuk VR, 2001, BLOOD, V98, p224A; Hoffman MA, 2001, HUM MOL GENET, V10, P1019, DOI 10.1093/hmg/10.10.1019; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KNUDSON AG, 1975, P NATL ACAD SCI USA, V72, P5116, DOI 10.1073/pnas.72.12.5116; Kralovics R, 2001, AM J HEMATOL, V68, P115, DOI 10.1002/ajh.1162; MANKAD VN, 1987, J PEDIATR-US, V111, P743, DOI 10.1016/S0022-3476(87)80259-7; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Ohh M, 1999, J CLIN INVEST, V104, P1583, DOI 10.1172/JCI8161; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pastore YD, 2003, BLOOD, V101, P1591, DOI 10.1182/blood-2002-06-1843; Percy MJ, 2002, BLOOD, V100, p660A; PRCHAL JT, IN PRESS MED CLIN N; Richards FM, 1998, J INTERN MED, V243, P527; Ritter MM, 1996, J CLIN ENDOCR METAB, V81, P1035, DOI 10.1210/jc.81.3.1035; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Sergeyeva A, 1997, BLOOD, V89, P2148, DOI 10.1182/blood.V89.6.2148; Webster AR, 1998, AM J HUM GENET, V63, P1025, DOI 10.1086/302037	28	91	94	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					412	419		10.1086/377108	http://dx.doi.org/10.1086/377108			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12844285	Green Published, Bronze			2022-12-18	WOS:000184223900018
J	Richards, M; Rengo, C; Cruciani, F; Gratrix, F; Wilson, JF; Scozzari, R; Macaulay, V; Torroni, A				Richards, M; Rengo, C; Cruciani, F; Gratrix, F; Wilson, JF; Scozzari, R; Macaulay, V; Torroni, A			Extensive female-mediated gene flow from sub-Saharan Africa into near eastern Arab populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME VARIATION; MITOCHONDRIAL-DNA ANALYSIS; HOMO-SAPIENS-SAPIENS; SEQUENCE VARIATION; MTDNA VARIATION; POLYMORPHISMS; TREE; HAPLOTYPES; DIVERSITY; HAPLOGROUPS	We have analyzed and compared mitochondrial DNA variation of populations from the Near East and Africa and found a very high frequency of African lineages present in the Yemen Hadramawt: more than a third were of clear sub-Saharan origin. Other Arab populations carried similar to10% lineages of sub-Saharan origin, whereas non-Arab Near Eastern populations, by contrast, carried few or no such lineages, suggesting that gene flow has been preferentially into Arab populations. Several lines of evidence suggest that most of this gene flow probably occurred within the past similar to2,500 years. In contrast, there is little evidence for male-mediated gene flow from sub-Saharan Africa in Y-chromosome haplotypes in Arab populations, including the Hadramawt. Taken together, these results are consistent with substantial migration from eastern Africa into Arabia, at least in part as a result of the Arab slave trade, and mainly female assimilation into the Arabian population as a result of miscegenation and manumission.	Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ Cattolica Sacro Cuore, Ist Med Legale, I-00168 Rome, Italy; Univ London Imperial Coll Sci Technol & Med, Dept Sci Biol, London, England; UCL, Dept Biol, London, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy	University of Huddersfield; Sapienza University Rome; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Imperial College London; University of London; University College London; University of Oxford; University of Pavia	Richards, M (corresponding author), Univ Huddersfield, Dept Chem & Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England.	m.b.richards@hud.ac.uk	Wilson, James F/A-5704-2009; Cruciani, Fulvio/G-6105-2012; Torroni, Antonio/E-1557-2011	Wilson, James F/0000-0001-5751-9178; Torroni, Antonio/0000-0002-4163-4478; Cruciani, Fulvio/0000-0002-6900-024X; RICHARDS, MARTIN/0000-0003-3118-0967				Alves-Silva J, 2000, AM J HUM GENET, V67, P444, DOI 10.1086/303004; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Chen YS, 2000, AM J HUM GENET, V66, P1362, DOI 10.1086/302848; CHEN YS, 1995, AM J HUM GENET, V57, P133; CorteReal HBSM, 1996, ANN HUM GENET, V60, P331, DOI 10.1111/j.1469-1809.1996.tb01196.x; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; Ellis N, 2002, GENOME RES, V12, P339; Fattovich R, 1997, ENCY PRECOLONIAL AFR, P479; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 2001, MOL BIOL EVOL, V18, P1189, DOI 10.1093/oxfordjournals.molbev.a003906; Kivisild T, 1999, GENOMIC DIVERSITY, P135; Krings M, 1999, AM J HUM GENET, V64, P1166, DOI 10.1086/302314; Lewis B., 1992, RACE SLAVERY MIDDLE; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Mateu E, 1997, ANN HUM GENET, V61, P507, DOI 10.1017/S0003480097006544; Mourant AE, 1978, BLOOD GROUPS DIS; Nebel A, 2001, AM J HUM GENET, V69, P1095, DOI 10.1086/324070; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; PHILLIPSON JW, 1993, AFRICAN ARCHAEOLOGY; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rando JC, 1998, ANN HUM GENET, V62, P531, DOI 10.1046/j.1469-1809.1998.6260531.x; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; RICHARDS M, 2000, ARCHAEOGENETICS DNA, P139; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Scozzari R, 2001, HUM IMMUNOL, V62, P871, DOI 10.1016/S0198-8859(01)00286-5; Scozzari R, 1999, AM J HUM GENET, V65, P829, DOI 10.1086/302538; Segal Ronald, 2002, ISLAMS BLACK SLAVES; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; SEMINO O, 1989, ANN HUM GENET, V53, P193, DOI 10.1111/j.1469-1809.1989.tb01784.x; Thomas MG, 2000, AM J HUM GENET, V66, P674, DOI 10.1086/302749; Thomas MG, 2002, AM J HUM GENET, V70, P1411, DOI 10.1086/340609; TORRONI A, 1994, AM J PHYS ANTHROPOL, V93, P189, DOI 10.1002/ajpa.1330930204; Torroni A, 1996, GENETICS, V144, P1835; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Watson E, 1997, AM J HUM GENET, V61, P691, DOI 10.1086/515503; Weale ME, 2001, HUM GENET, V109, P659, DOI 10.1007/s00439-001-0627-9; Wilson JF, 2001, P NATL ACAD SCI USA, V98, P5078, DOI 10.1073/pnas.071036898	46	91	91	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					1058	1064		10.1086/374384	http://dx.doi.org/10.1086/374384			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12629598	Green Published, Bronze			2022-12-18	WOS:000181972600029
J	Kurahashi, H; Shaikh, T; Takata, M; Toda, T; Emanuel, BS				Kurahashi, H; Shaikh, T; Takata, M; Toda, T; Emanuel, BS			The constitutional t(17;22): another translocation mediated by palindromic AT-rich repeats	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUROFIBROMATOSIS TYPE-1; INSTABILITY; BREAKPOINT; T(11-22); 22Q11; HUMAN-CHROMOSOME-22; RECOMBINATION; LOCALIZATION; SEQUENCE; REGIONS	We have demonstrated that the breakpoints of the constitutional t(11; 22) are located at palindromic AT-rich repeats (PATRRs) on 11q23 and 22q11. As a mechanism for this recurrent translocation, we proposed that the PATRR forms a cruciform structure that induces the genomic instability leading to the rearrangement. A patient with neurofibromatosis type 1 (NF1) had previously been found to have a constitutional t( 17; 22) disrupting the NF1 gene on 17q11. We have localized the breakpoint on 22q11 within the 22q11-specific low-copy repeat where the breakpoints of the constitutional t( 11; 22) s reside, implying a similar palindrome-mediated mechanism for generation of the t( 17; 22). The NF1 gene contains a 195-bp PATRR within intron 31. We have isolated the junction fragments from both the der(17) and the der( 22). The breakpoint on 17q11 is close to the center of the PATRR. A published breakpoint of an additional NF1-afflicted patient with a constitutional t( 17; 22) is also located close to the center of the same PATRR. Our data lend additional support to the hypothesis that PATRR-mediated genomic instability can lead to a variety of translocations.	Childrens Hosp Philadelphia, Abramson Res Ctr 1002, Div Human Genet & Mol Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Osaka Univ, Grad Sch Med, Div Funct Genom, Dept Postgenom Dis, Osaka, Japan	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Osaka University	Emanuel, BS (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr 1002, Div Human Genet & Mol Biol, 3516 Civ Ctr Blvd, Philadelphia, PA 19104 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD026979] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA039926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002027] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA039926, CA39926] Funding Source: Medline; NICHD NIH HHS [HD26979, P30 HD026979] Funding Source: Medline; NIDCD NIH HHS [P01 DC002027, DC02027] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Budarf ML, 1996, GENOMICS, V35, P275, DOI 10.1006/geno.1996.0358; Collick A, 1996, EMBO J, V15, P1163, DOI 10.1002/j.1460-2075.1996.tb00455.x; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Funke B, 1999, AM J HUM GENET, V64, P747, DOI 10.1086/302284; KehrerSawatzki H, 1997, HUM GENET, V99, P237, DOI 10.1007/s004390050346; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; LEACH DRF, 1994, BIOESSAYS, V16, P893, DOI 10.1002/bies.950161207; LEDBETTER DH, 1989, AM J HUM GENET, V44, P20; Lewis SM, 1999, NUCLEIC ACIDS RES, V27, P2521, DOI 10.1093/nar/27.12.2521; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; OCONNELL P, 1989, AM J HUM GENET, V44, P51; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Shaikh TH, 1999, AM J HUM GENET, V65, P1595, DOI 10.1086/302666; Tapia-Paez I, 2001, HUM GENET, V109, P167; VISKOCHIL D, 1990, CELL, V62, P187, DOI 10.1016/0092-8674(90)90252-A; [No title captured]	21	91	93	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2003	72	3					733	738		10.1086/368062	http://dx.doi.org/10.1086/368062			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	648LJ	12557125	Bronze, Green Published			2022-12-18	WOS:000181152600024
J	Soria, JM; Almasy, L; Souto, JC; Bacq, D; Buil, A; Faure, A; Martinez-Marchan, E; Mateo, J; Borrell, M; Stone, W; Lathrop, M; Fontcuberta, J; Blangero, J				Soria, JM; Almasy, L; Souto, JC; Bacq, D; Buil, A; Faure, A; Martinez-Marchan, E; Mateo, J; Borrell, M; Stone, W; Lathrop, M; Fontcuberta, J; Blangero, J			A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DEEP-VEIN THROMBOSIS; LINKAGE ANALYSIS; RISK-FACTORS; THROMBOEMBOLISM; POPULATION; DEFICIENCY; PEDIGREES; REGION; MODELS	One approach to the identification of genetic loci that influence complex diseases is through the study of quantitative risk factors correlated with disease susceptibility. Factor XII (FXII) plasma levels, a related phenotype correlated with thrombosis, is such a risk factor. We conducted the first genomewide linkage screen to localize genes that influence variation in FXII levels. Two loci were detected: one on chromosome 5 and another on chromosome 10 (LOD scores 4.73 and 3.53, respectively). On chromosome 5, the peak LOD score occurred in the 5q33-5ter region, near the FXII gene. Addition of a 46C/T mutation in the FXII gene increased the multipoint LOD score to 10.21 (P = 3.6 x 10(-12)). A bivariate linkage analysis of FXII activity and thrombosis further improved the linkage signal (LOD p 11.73) and provided strong evidence that this quantitative- trait locus (QTL) has a pleiotropic effect on the risk of thrombosis (P = .004). Linkage analysis conditional on 46C/T indicated that this mutation alone cannot explain the chromosome 5 signal, implying that other functional sites must exist. These results represent the first direct genetic evidence that a QTL in or near the FXII gene influences both FXII activity and susceptibility to thrombosis and suggest the presence of one or more still unknown functional variants in FXII.	Hosp Santa Cruz & San Pablo, Unitat Hemostasia & Trombosi, Dept Hematol, E-08025 Barcelona, Spain; SW Fdn Biomed Res, San Antonio, TX 78284 USA; Ctr Natl Genotypage, Evry, France	Texas Biomedical Research Institute; CEA; UDICE-French Research Universities; Universite Paris Saclay	Soria, JM (corresponding author), Hosp Santa Cruz & San Pablo, Unitat Hemostasia & Trombosi, Dept Hematol, C Sant Antoni M Claret 167, E-08025 Barcelona, Spain.		Soria Fernández, José Manuel/AAD-6761-2019; Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021	Soria Fernández, José Manuel/0000-0002-6226-4293; Buil, Alfonso/0000-0002-3097-1014; Mateo, Jose/0000-0002-4227-3256	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59490, R37 MH059490, R01 MH059490] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DB, 1999, AM J HUM GENET, V65, P531, DOI 10.1086/302487; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1994, AM J HUM GENET, V54, P535; ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Blangero J, 2000, GENET EPIDEMIOL, V19, pS8, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI2>3.0.CO;2-Y; Boehnke M, 1984, Prog Clin Biol Res, V147, P173; COOL DE, 1987, J BIOL CHEM, V262, P13662; COON WW, 1973, CIRCULATION, V48, P839, DOI 10.1161/01.CIR.48.4.839; DYKE B, 1995, 2 PGL DEP GEN SW FDN; FEINGOLD E, 1993, AM J HUM GENET, V53, P234; HALBMAYER WM, 1992, THROMB HAEMOSTASIS, V68, P285; Helft G, 2000, AM J HEMATOL, V64, P322, DOI 10.1002/1096-8652(200008)64:4<322::AID-AJH18>3.0.CO;2-B; HOPPER JL, 1982, ANN HUM GENET, V46, P373, DOI 10.1111/j.1469-1809.1982.tb01588.x; Ishii K, 2000, BLOOD COAGUL FIBRIN, V11, P277; Kanaji T, 1998, BLOOD, V91, P2010, DOI 10.1182/blood.V91.6.2010.2010_2010_2014; KAPLAN AP, 1987, BLOOD, V70, P1; KLUFT C, 1987, SEMIN THROMB HEMOST, V13, P50, DOI 10.1055/s-2007-1003475; Lane DA, 1996, THROMB HAEMOSTASIS, V76, P651; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; NORDSTROM M, 1992, J INTERN MED, V232, P155, DOI 10.1111/j.1365-2796.1992.tb00565.x; ROYLE NJ, 1988, SOMAT CELL MOLEC GEN, V14, P217, DOI 10.1007/BF01534407; Soria JM, 2000, BLOOD, V95, P2780, DOI 10.1182/blood.V95.9.2780.009k36_2780_2785; Souto JC, 2000, CIRCULATION, V101, P1546, DOI 10.1161/01.CIR.101.13.1546; Souto JC, 2000, AM J HUM GENET, V67, P1452, DOI 10.1086/316903; Williams JT, 1999, AM J HUM GENET, V65, P1134, DOI 10.1086/302570	25	91	99	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2002	70	3					567	574		10.1086/339259	http://dx.doi.org/10.1086/339259			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	522DG	11805911	Green Published, Bronze			2022-12-18	WOS:000173880000001
J	Sham, PC; Purcell, S				Sham, PC; Purcell, S			Equivalence between Haseman-Elston and variance-components linkage analyses for sib pairs	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							QUANTITATIVE TRAIT	The Haseman-Elston regression method offers a simpler alternative to variance-components (VC) models, for the linkage analysis of quantitative traits. However, even the "revisited" method, which uses the cross-product-rather than the squared difference-in sib trait values, is, in general, less powerful than VC models. In this report, we clarify the relative efficiencies of existing Haseman-Elston methods and show how a new Haseman-Elston method can be constructed to have power equivalent to that of VC models. This method uses as the dependent variable a linear combination of squared sums and squared differences, in which the weights are determined by the overall trait correlation between sibs in a population. We show how this method can be used for both the selection of maximally informative sib pairs for genotyping and the subsequent analysis of such selected samples.	Inst Psychiat, Social Genet & Dev Res Ctr, London SE5 8AF, England	University of London; King's College London	Sham, PC (corresponding author), Inst Psychiat, Social Genet & Dev Res Ctr, London SE5 8AF, England.	p.sham@iop.kcl.ac.uk			NEI NIH HHS [EY12562, R01 EY012562] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012562] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Drigalenko E, 1998, AM J HUM GENET, V63, P1242; Elston RC, 2000, GENET EPIDEMIOL, V19, P1, DOI 10.1002/1098-2272(200007)19:1<1::AID-GEPI1>3.0.CO;2-E; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; Mood A. M., 1974, INTRO THEORY STAT; Purcell S, 2001, HUM HERED, V52, P1, DOI 10.1159/000053350; Rijsdijk FV, 2001, EUR J HUM GENET, V9, P335, DOI 10.1038/sj.ejhg.5200634; Sham PC, 2000, GENET EPIDEMIOL, V19, pS22, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI4>3.0.CO;2-S; Wright FA, 1997, AM J HUM GENET, V60, P740; Xu X, 2000, AM J HUM GENET, V67, P1025, DOI 10.1086/303081	9	91	92	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1527	1532		10.1086/320593	http://dx.doi.org/10.1086/320593			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11353401	Green Published, Bronze			2022-12-18	WOS:000169094600025
J	Allikmets, R				Allikmets, R			Simple and complex ABCR: Genetic predisposition to retinal disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							RECESSIVE RETINITIS-PIGMENTOSA; CASSETTE TRANSPORTER GENE; AGE-RELATED MACULOPATHY; STARGARDT-DISEASE; MACULAR DEGENERATION; RIM PROTEIN; CYSTIC-FIBROSIS; MUTATIONS; ASSOCIATION; DYSTROPHY		Columbia Univ, Dept Ophthalmol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Allikmets, R (corresponding author), Columbia Univ, Dept Ophthalmol, Room 715,630 W 168th St, New York, NY 10032 USA.		Dean, Michael C/G-8172-2012; Allikmets, Rando/ABD-4533-2021	Dean, Michael C/0000-0003-2234-0631; 				Allikmets R, 1999, EUR J OPHTHALMOL, V9, P255, DOI 10.1177/112067219900900401; Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; ANDERSON KL, 1995, AM J HUM GENET, V57, P1351; Azarian SM, 1997, FEBS LETT, V409, P247, DOI 10.1016/S0014-5793(97)00517-6; Cremers FPM, 1998, HUM MOL GENET, V7, P355, DOI 10.1093/hmg/7.3.355; De La Paz MA, 1999, OPHTHALMOLOGY, V106, P1531, DOI 10.1016/S0161-6420(99)90449-9; Fishman GA, 1999, ARCH OPHTHALMOL-CHIC, V117, P504, DOI 10.1001/archopht.117.4.504; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; KAPLAN J, 1993, NAT GENET, V5, P308, DOI 10.1038/ng1193-308; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Kuroiwa S, 1999, BRIT J OPHTHALMOL, V83, P613, DOI 10.1136/bjo.83.5.613; Lewis RA, 1999, AM J HUM GENET, V64, P422, DOI 10.1086/302251; Long AD, 1999, GENOME RES, V9, P720; Lotery AJ, 2000, INVEST OPHTH VIS SCI, V41, pS143; Martinez-Mir A, 1998, NAT GENET, V18, P11, DOI 10.1038/ng0198-11; Mata NL, 2000, INVEST OPHTH VIS SCI, V41, pS144; Maugeri A, 2000, AM J HUM GENET, V67, P960, DOI 10.1086/303079; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; McNeill RJ, 2000, INVEST OPHTH VIS SCI, V41, pS144; MEHTA C, 1995, STATXACT3 WINDOWS US; Morton NE, 1998, P NATL ACAD SCI USA, V95, P11389, DOI 10.1073/pnas.95.19.11389; O'Donovan MC, 1999, AM J HUM GENET, V65, P587, DOI 10.1086/302560; PAPERMASTER DS, 1976, EXP EYE RES, V23, P105, DOI 10.1016/0014-4835(76)90194-9; PAPERMASTER DS, 1978, J CELL BIOL, V78, P415, DOI 10.1083/jcb.78.2.415; RIORDAN JR, 1989, SCIENCE, V245, P1066; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Rivera A, 2000, AM J HUM GENET, V67, P800, DOI 10.1086/303090; Rozet JM, 1999, J MED GENET, V36, P447; Rozet JM, 1998, EUR J HUM GENET, V6, P291, DOI 10.1038/sj.ejhg.5200221; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Shroyer NF, 1999, VISION RES, V39, P2537, DOI 10.1016/S0042-6989(99)00037-1; Simonelli F, 2000, INVEST OPHTH VIS SCI, V41, P892; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Stone EM, 1998, NAT GENET, V20, P328, DOI 10.1038/3798; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; SUN H, 2000, IN PRESS NAT GENET; van Driel MA, 1998, OPHTHALMIC GENET, V19, P117, DOI 10.1076/opge.19.3.117.2187; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Weeks DE, 2000, HUM MOL GENET, V9, P1329, DOI 10.1093/hmg/9.9.1329; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	44	91	101	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4					793	799		10.1086/303100	http://dx.doi.org/10.1086/303100			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	360DL	10970771	Green Published, Bronze			2022-12-18	WOS:000089651100003
J	Lien, S; Szyda, J; Schechinger, B; Rappold, G; Arnheim, N				Lien, S; Szyda, J; Schechinger, B; Rappold, G; Arnheim, N			Evidence for heterogeneity in recombination in the human pseudoautosomal region: High resolution analysis by sperm typing and radiation-hybrid mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ESCAPES X-INACTIVATION; HUMAN SEX-CHROMOSOMES; GENETIC-LINKAGE MAP; ADP ATP TRANSLOCASE; PHYSICAL MAP; Y-CHROMOSOME; HUMAN GENOME; HUMAN MALES; MOUSE; SITES	Accurate genetic and physical maps for the human pseudoautosomal region were constructed by use of sperm typing and high-resolution radiation-hybrid mapping. PCR analysis of 1,912 sperm was done with a manual, single-sperm isolation method. Data on four donors show highly significant linkage heterogeneity among individuals. The most significant difference was observed in a marker interval located in the middle of the Xp/Yp pseudoautosomal region, where one donor showed a particularly high recombination fraction. Longitudinal models were fitted to the data to test whether linkage heterogeneity among donors was significant for multiple intervals across the region. The results indicated that increased recombination in particular individuals and regions is compensated for by reduced recombination in neighboring intervals. To investigate correspondence between physical and genetic distances within the region, we constructed a high-resolution radiation-hybrid map containing 29 markers. The recombination fraction per unit of physical distance varies between regions ranging from 13- to 70-fold greater than the genome-average rate.	Univ So Calif, Program Mol Biol, Los Angeles, CA 90089 USA; Agr Univ Norway, Dept Anim Sci, Aas, Norway; Wroclaw Agr Univ, Dept Genet, Wroclaw, Poland; Univ Heidelberg, Inst Human Genet, Heidelberg, Germany	University of Southern California; Norwegian University of Life Sciences; Wroclaw University of Environmental & Life Sciences; Ruprecht Karls University Heidelberg	Arnheim, N (corresponding author), Univ So Calif, Program Mol Biol, 835 W 37th St, Los Angeles, CA 90089 USA.		Szyda, Joanna/S-7668-2016	Szyda, Joanna/0000-0001-9688-0193; Arnheim, Norman/0000-0003-1247-1347	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036745] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM036745, R37-GM36745] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BABRON MC, 1990, ANN HUM GENET, V54, P107, DOI 10.1111/j.1469-1809.1990.tb00366.x; BAIRD DM, 1995, EMBO J, V14, P5433, DOI 10.1002/j.1460-2075.1995.tb00227.x; BEASLEY EM, 1997, GENOME MAPPING SEQUE; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Brooks LD., 1988, EVOLUTION SEX, P87; BROWN WRA, 1988, EMBO J, V7, P2377, DOI 10.1002/j.1460-2075.1988.tb03082.x; BRYDA EC, 1992, MAMM GENOME, V2, P123, DOI 10.1007/BF00353860; BUETOW KH, 1991, AM J HUM GENET, V48, P911; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CHONG SS, 1993, HUM MOL GENET, V2, P1187, DOI 10.1093/hmg/2.8.1187; CHURCHILL GA, 1994, GENETICS, V138, P963; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; FERRERO GB, 1995, HUM MOL GENET, V4, P1821, DOI 10.1093/hmg/4.10.1821; FISHER EMC, 1990, GENOMICS, V7, P625, DOI 10.1016/0888-7543(90)90209-D; GEDDEDAHL T, 1972, ANN HUM GENET, V35, P393; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; HUBERT R, 1994, NAT GENET, V7, P420, DOI 10.1038/ng0794-420; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Klungland H, 1997, MAMM GENOME, V8, P573, DOI 10.1007/s003359900506; LANGE K, 1995, GENOME RES, V5, P136, DOI 10.1101/gr.5.2.136; LAURIE DA, 1985, ANN HUM GENET, V49, P189, DOI 10.1111/j.1469-1809.1985.tb01693.x; LAZZERONI LC, 1994, AM J HUM GENET, V55, P431; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; Lien S, 1999, ANIM GENET, V30, P42, DOI 10.1046/j.1365-2052.1999.00430.x; LIEN S, 1993, GENOMICS, V16, P41, DOI 10.1006/geno.1993.1137; MACDONALD ME, 1989, NEURON, V3, P183, DOI 10.1016/0896-6273(89)90031-7; Mohrenweiser HW, 1998, GENOMICS, V47, P153, DOI 10.1006/geno.1997.5097; MORTON NE, 1956, AM J HUM GENET, V8, P80; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; Nachman MW, 1996, GENETICS, V142, P537; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; PARK C, 1995, GENOMICS, V27, P113, DOI 10.1006/geno.1995.1012; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; Rao E, 1997, HUM GENET, V100, P236, DOI 10.1007/s004390050497; RAPPOLD G, 1992, GENOMICS, V14, P455, DOI 10.1016/S0888-7543(05)80241-1; RAPPOLD GA, 1994, HUM MOL GENET, V3, P1337, DOI 10.1093/hmg/3.8.1337; RAPPOLD GA, 1988, NUCLEIC ACIDS RES, V16, P5361, DOI 10.1093/nar/16.12.5361; REEVES RH, 1990, GENOMICS, V8, P141, DOI 10.1016/0888-7543(90)90236-N; Ried K, 1998, HUM MOL GENET, V7, P1771, DOI 10.1093/hmg/7.11.1771; RIED K, 1995, GENOMICS, V29, P787, DOI 10.1006/geno.1995.9933; Robinson WP, 1996, AM J HUM GENET, V59, P1175; RODERICK TH, 1990, MOUSE NEWS LETT, V85, P87; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; Schaaff F, 1996, HUM GENET, V98, P158, DOI 10.1007/s004390050180; SCHIEBEL K, 1993, NAT GENET, V3, P82, DOI 10.1038/ng0193-82; SCHMITT K, 1994, AM J HUM GENET, V55, P423; SCHMITT K, 1993, HUM MOL GENET, V2, P1978, DOI 10.1093/hmg/2.11.1978; SHIROISHI T, 1995, ADV BIOPHYS, V31, P119, DOI 10.1016/0065-227X(95)99387-5; Simianer H, 1997, MAMM GENOME, V8, P830, DOI 10.1007/s003359900587; SLIM R, 1993, GENOMICS, V16, P26, DOI 10.1006/geno.1993.1135; SLIM R, 1993, GENOMICS, V16, P691, DOI 10.1006/geno.1993.1249; SMITH MJ, 1993, HUM MOL GENET, V2, P417, DOI 10.1093/hmg/2.4.417; WEITKAMP LR, 1978, CYTOGENET CELL GENET, V22, P647, DOI 10.1159/000131044; Yu J, 1996, AM J HUM GENET, V59, P1186	58	91	94	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					557	566		10.1086/302754	http://dx.doi.org/10.1086/302754			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677316	Green Published, Bronze			2022-12-18	WOS:000088373100023
J	Ying, LH; Katz, Y; Schlesinger, M; Carmi, R; Shalev, H; Haider, N; Beck, G; Sheffield, VC; Landau, D				Ying, LH; Katz, Y; Schlesinger, M; Carmi, R; Shalev, H; Haider, N; Beck, G; Sheffield, VC; Landau, D			Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GLOMERULAR DEPOSITS; DEFICIENCY; HYPOCOMPLEMENTEMIA; ACID; GLOMERULONEPHRITIS; LINKAGE; FAMILY; C3B	Atypical hemolytic uremic syndrome (HUS) presents with the clinical features of hypertension, microangiopathic hemolytic anemia, and acute renal failure. Both dominant and recessive modes of inheritance have been reported. This study describes the genetic and functional analysis of a large Bedouin kindred with autosomal recessive HUS. The kindred consists of several related nuclear families in which all parent unions of affected children are consanguineous. A previous report demonstrated that a dominant form of HUS maps to chromosome Iq and that complement factor H (CFH), a regulatory component of the complement system, lies within the region and is involved in the dominant disorder. Early-onset and persistent hypocomplementemia in this Bedouin kindred prompted us to evaluate the CFH gene. Linkage analysis was performed, demonstrating linkage between the disorder and the markers near the CFH gene. Mutation analysis of the CFH coding region revealed a single missense mutation. Functional analyses demonstrate that the mutant CFH is properly expressed and synthesized but that it is not transported normally from the cell. This is the first study reporting that a recessive, atypical, early-onset, and relapsing HUS is associated with the CFH protein and that a CFH mutation affects intracellular trafficking and secretion.	Univ Iowa, Dept Pediat, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Tel Aviv Univ, Assaf Harofeh Med Ctr, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Ben Gurion Univ Negev, Soroka Med Ctr, Dept Pediat, Beer Sheva, Israel; Ben Gurion Univ Negev, Barzilai Med Ctr, Dept Pediat, Beer Sheva, Israel	Howard Hughes Medical Institute; University of Iowa; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Barzilai Medical Center	Sheffield, VC (corresponding author), Univ Iowa, Dept Pediat, Howard Hughes Med Inst, 440 John W Eckstein Med Res Bldg, Iowa City, IA 52242 USA.			Sheffield, Val/0000-0002-6282-0835				ADAMSON D, 1995, AM J HUM GENET, V57, P619; Ault BH, 1997, J BIOL CHEM, V272, P25168, DOI 10.1074/jbc.272.40.25168; BARRE P, 1977, ARCH PATHOL LAB MED, V101, P357; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bogdanovic R, 1997, NEPHRON, V76, P481, DOI 10.1159/000190232; BOGDANOVIC R, 1988, PEDIATR NEPHROL, V2, P236, DOI 10.1007/BF00862598; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FARR MJ, 1975, Q J MED, V44, P161; Fijen CAP, 1996, CLIN EXP IMMUNOL, V105, P511, DOI 10.1046/j.1365-2249.1996.d01-777.x; GONZALO A, 1981, CLIN NEPHROL, V16, P193; JANSEN JH, 1995, VET REC, V137, P240, DOI 10.1136/vr.137.10.240; KAPLAN BS, 1987, SEMIN HEMATOL, V24, P148; KAPLAN BS, 1977, CLIN NEPHROL, V8, P495; KAPLAN BS, 1975, NEW ENGL J MED, V292, P1090, DOI 10.1056/NEJM197505222922102; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; MATTOO TK, 1989, J PEDIATR-US, V114, P814; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Ohali M, 1998, PEDIATR NEPHROL, V12, P619, DOI 10.1007/s004670050515; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PICHETTE V, 1994, AM J KIDNEY DIS, V24, P936, DOI 10.1016/S0272-6386(12)81065-1; RIPOCHE J, 1988, BIOCHEM J, V249, P593, DOI 10.1042/bj2490593; Segal Nurit, 1995, Harefuah, V128, P677; Sharma AK, 1996, P NATL ACAD SCI USA, V93, P10996, DOI 10.1073/pnas.93.20.10996; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Sim R B, 1993, Int Rev Immunol, V10, P65, DOI 10.3109/08830189309051172; SKERKA C, 1995, IMMUNOGENETICS, V42, P268; VICRA GD, 1990, BIOTECHNIQUES, V8, P370; VOGT BA, 1995, PEDIATR NEPHROL, V9, P11, DOI 10.1007/BF00858956; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; WELLER JM, 1976, P NATL ACAD SCI USA, V73, P3268; West CD, 1998, PEDIATR NEPHROL, V12, P471, DOI 10.1007/s004670050490	32	91	95	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1999	65	6					1538	1546		10.1086/302673	http://dx.doi.org/10.1086/302673			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	266CF	10577907	Bronze, Green Published			2022-12-18	WOS:000084282500008
J	Redd, AJ; Stoneking, M				Redd, AJ; Stoneking, M			Peopling of Sahul: mtDNA variation in Aboriginal Australian and Papua New Guinean populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN MITOCHONDRIAL-DNA; CONTROL-REGION SEQUENCE; HUMAN OCCUPATION SITE; GENETIC AFFINITIES; NUCLEOTIDE SUBSTITUTIONS; PHYLOGENETIC TREES; HAPLOTYPE ANALYSIS; DIVERSITY; EVOLUTION; DELETION	We examined genetic affinities of Aboriginal Australian and New Guinean populations by using nucleotide variation in the two hypervariable segments of the mtDNA control region (CR). A total of 318 individuals from highland Papua New Guinea (PNG), coastal PNG, and Aboriginal Australian populations were typed with a panel of 29 sequence-specific oligonucleotide (SSO) probes. The SSO-probe panel included five new probes that were used to type an additional 1,037 individuals from several Asian populations. The SSO-type data guided the selection of 78 individuals from Australia and east Indonesia for CR sequencing. A gene tree of these CR sequences, combined with published sequences from worldwide populations, contains two previously identified highland PNG clusters that do not include any Aboriginal Australians; the highland PNG clusters have coalescent time estimates of similar to 80,000 and 122,000 years ago, suggesting ancient isolation and genetic drift. 880-type data indicate that 84% of the sample of PNG highlander mtDNA belong to these two clusters. In contrast, the Aboriginal Australian sequences are intermingled throughout the tree and cluster with sequences from multiple populations. Phylogenetic and multidimensional-scaling analyses of CR sequences and SSO types split PNG highland and Aboriginal Australian populations and link Aboriginal Australian populations with populations from the subcontinent of India. These mtDNA results do not support a close relationship between Aboriginal Australian and PNG populations-but instead suggest multiple migrations in the peopling of Sahul.	Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; Max Planck Inst Evolut Anthropol, Leipzig, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Max Planck Society	Redd, AJ (corresponding author), Univ Arizona, Lab Mol Systemat & Evolut, Dept Ecol & Evolutionary Biol, Biol Sci W 239, Tucson, AZ 85721 USA.							ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; [Anonymous], 1993, MEGA MOL EVOLUTIONAR; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Bellwood P.S., 1989, COLONIZATION PACIFIC, P1; Betty DJ, 1996, AM J HUM GENET, V58, P428; Birdsell, 1967, ARCH PHYS ANTHR OCEA, V2, P102; BIRDSELL JB, 1957, COLD SPRING HARB SYM, V22, P47, DOI 10.1101/SQB.1957.022.01.008; BIRDSELL JB, 1996, MICROEVOLUTIONARY PA, P22; Bonatto SL, 1997, AM J HUM GENET, V61, P1413, DOI 10.1086/301629; BROWN P, 1997, HIST PHYSICAL ANTHR, V1, P138; CAVALLISFORZA LL, 1994, HIST GEOGRAPHY HUMAN, P77; CHEN LZ, 1992, HUM BIOL, V64, P1; CORBETT L, 1995, DINGO AUSTR ASIA, P9; DIXON RMW, 1980, LANGUAGES AUSTR, V1, P19; DIXON RMW, 1980, LANGUAGES AUSTR, V1, P234; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FORAN DR, 1988, NUCLEIC ACIDS RES, V16, P5841, DOI 10.1093/nar/16.13.5841; GAO X, 1991, HUM IMMUNOL, V32, P269, DOI 10.1016/0198-8859(91)90090-V; Glover I. C, 1985, RECENT ADV INDOPACIF, P185; Gollan K, 1985, RECENT ADV INDOPACIF, P439; GRAVEN L, 1995, MOL BIOL EVOL, V12, P334; GROUBE L, 1986, NATURE, V324, P453, DOI 10.1038/324453a0; Hanihara T, 1996, AM J PHYS ANTHROPOL, V99, P389, DOI 10.1002/(SICI)1096-8644(199603)99:3<389::AID-AJPA3>3.0.CO;2-S; HARPENDING H, 1996, MOL BIOL HUMAN DIVER, P283; HARPENDING HC, 1994, HUM BIOL, V66, P591; HARPER TJ, 1993, GLASS TECHNOL, V34, P96; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; HORAI S, 1995, P NATL ACAD SCI USA, V92, P532, DOI 10.1073/pnas.92.2.532; HOWELLS WW, 1989, SKULL SHAPES MAP CRA, P37; Johnson BJ, 1999, SCIENCE, V284, P1150, DOI 10.1126/science.284.5417.1150; JONES R, 1995, ANNU REV ANTHROPOL, V24, P423; KEATS B, 1977, J HUM EVOL, V6, P319, DOI 10.1016/S0047-2484(77)80002-X; KIRK RL, 1976, HUMANITIES, P277; KIRK RL, 1989, COLONIZATION PACIFIC, P60; KOCHER TD, 1991, EVOLUTION OF LIFE, P391; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; MANTEL N, 1967, CANCER RES, V27, P209; MELTON T, 1995, AM J HUM GENET, V57, P403; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; MOUTAIN JL, 1997, ANN J HUM GENET, V61, P705; NEI M, 1993, MOL BIOL EVOL, V10, P927; NEI M, 1989, MOL BIOL EVOL, V6, P290; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols Johanna, 1994, Evolutionary Anthropology, V3, P206, DOI 10.1002/evan.1360030607; O'Connell JF, 1998, EVOL ANTHROPOL, V6, P132, DOI 10.1002/(SICI)1520-6505(1998)6:4<132::AID-EVAN3>3.0.CO;2-F; Pellekaan SMV, 1998, AM J HUM GENET, V62, P435, DOI 10.1086/301710; Pellekaan SV, 1997, ELECTROPHORESIS, V18, P1538, DOI 10.1002/elps.1150180909; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; Pietrusewsky M., 1994, OCEAN LINGUIST, V33, P407; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Roberts RG, 1994, AUSTR ABORIGINAL STU, V2, P2; RobertsThomson JM, 1996, AM J HUM GENET, V58, P1017; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; ROHLF FJ, 1981, SYST ZOOL, V30, P459, DOI 10.2307/2413054; ROYCHOUDHURY AK, 1984, HUM HERED, V34, P314, DOI 10.1159/000153487; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; RZHETSKY A, 1993, MOL BIOL EVOL, V10, P1073; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SERJEANTSON SW, 1989, COLONIZATION PACIFIC, P120; SERJEANTSON SW, 1985, OUT ASIA PEOPLING AM, P133; SLATKIN M, 1995, GENETICS, V139, P457; STONEKING M, 1992, PHILOS T ROY SOC B, V337, P167, DOI 10.1098/rstb.1992.0094; Stoneking M, 1997, GENOME RES, V7, P1061, DOI 10.1101/gr.7.11.1061; STONEKING M, 1990, GENETICS, V124, P717; STONEKING M, 1991, AM J HUM GENET, V48, P370; STONEKING M, 1989, COLONIZATION PACIFIC, P215; SYKES B, 1995, AM J HUM GENET, V57, P1463; TAJIMA F, 1994, MOL BIOL EVOL, V11, P278; TAJIMA F, 1989, GENETICS, V123, P585; TAKEZAKI N, 1995, MOL BIOL EVOL, V12, P823; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thorne A, 1999, J HUM EVOL, V36, P591, DOI 10.1006/jhev.1999.0305; TSINTSOF AS, 1990, AM J HUM GENET, V46, P138; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Wakeley J, 1996, THEOR POPUL BIOL, V49, P369, DOI 10.1006/tpbi.1996.0018; WAKELEY J, 1993, J MOL EVOL, V37, P613; WHITE JP, 1982, PREHISTORY AUSTR NEW, P76; WURM SA, 1982, PAPUAN LANGUAGES OCE, P1; YENCHITSOMANUS PT, 1986, AUST J EXP BIOL MED, V64, P297, DOI 10.1038/icb.1986.31; YENCHITSOMANUS PT, 1985, AM J HUM GENET, V37, P778; YOSHIDA M, 1995, AM J PHYS ANTHROPOL, V96, P177, DOI 10.1002/ajpa.1330960206; [No title captured]	88	91	92	2	17	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					808	828		10.1086/302533	http://dx.doi.org/10.1086/302533			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441589	Bronze, Green Published			2022-12-18	WOS:000082426400027
J	Almasy, L; Hixson, JE; Rainwater, DL; Cole, S; Williams, JT; Mahaney, MC; VandeBerg, JL; Stern, MP; MacCluer, JW; Blangero, J				Almasy, L; Hixson, JE; Rainwater, DL; Cole, S; Williams, JT; Mahaney, MC; VandeBerg, JL; Stern, MP; MacCluer, JW; Blangero, J			Human pedigree-based quantitative-trait-locus mapping: Localization of two genes influencing HDL-cholesterol metabolism	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-DENSITY-LIPOPROTEIN; CORONARY HEART-DISEASE; APOLIPOPROTEIN-A-I; ESTER TRANSFER PROTEIN; LINKAGE ANALYSIS; PLASMA-LIPIDS; ENVIRONMENTAL-INFLUENCES; CARDIOVASCULAR-DISEASE; DNA POLYMORPHISMS; HEPATIC LIPASE	Common disorders with genetic susceptibilities involve the action of multiple genes interacting with each other and with environmental factors, making it difficult to localize the specific genetic loci responsible. An important route to the disentangling-of this complex inheritance is through the study of normal physiological variation in quantitative risk factors that may underlie liability to disease. We present an analysis of HDL-cholesterol (HDL-C), which is inversely correlated with risk of heart disease. A variety of HDL subphenotypes were analyzed, including HDL particle-size classes and the concentrations and:proportions of esterified and unesterified HDL-C. Results of a complete genomic screen in large, randomly ascertained pedigrees implicated two loci, one on chromosome 8 and the other on chromo-some 15, that influence a component of HDL-C-namely, unesterified HDL2a-C. Multivariate analyses of multiple HDL phenotypes and simultaneous multilocus analysis of the quantitative-trait loci identified permit further characterization of the genetic effects on HDL-C. These analyses suggest that the action of the chromosome 8 locus is specific to unesterified cholesterol levels, whereas the chromosome 15 locus appears to influence both HDL-C concentration and distribution of cholesterol among HDL particle sizes.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; Univ Texas, Hlth Sci Ctr, San Antonio, TX USA	Texas Biomedical Research Institute; University of Texas System; University of Texas Health San Antonio	Almasy, L (corresponding author), SW Fdn Biomed Res, Dept Genet, 7620 NW Loop 410,POB 760549, San Antonio, TX 78245 USA.		Blangero, John/ABA-7175-2021; Almasy, Laura/V-3156-2019	Hixson, James/0000-0002-0849-9315	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM018897, R01GM031575] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL45522] Funding Source: Medline; NIGMS NIH HHS [GM18897, GM31575] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; AMOS CI, 1987, GENET EPIDEMIOL, V4, P115, DOI 10.1002/gepi.1370040206; AUSTIN MA, 1987, AM J EPIDEMIOL, V125, P308, DOI 10.1093/oxfordjournals.aje.a114531; Barbagallo CM, 1998, GERONTOLOGY, V44, P106, DOI 10.1159/000021992; BLANCHE PJ, 1981, BIOCHIM BIOPHYS ACTA, V665, P408, DOI 10.1016/0005-2760(81)90253-8; Blangero J, 1997, GENET EPIDEMIOL, V14, P959, DOI 10.1002/(SICI)1098-2272(1997)14:6<959::AID-GEPI66>3.0.CO;2-K; Bruce C, 1998, J LIPID RES, V39, P1071; BUCHER KD, 1988, GENET EPIDEMIOL, V5, P17, DOI 10.1002/gepi.1370050103; COHEN JC, 1994, J CLIN INVEST, V94, P2377, DOI 10.1172/JCI117603; Devlin CM, 1998, HUM GENET, V102, P273, DOI 10.1007/s004390050691; Duggirala R, 1997, GENET EPIDEMIOL, V14, P987, DOI 10.1002/(SICI)1098-2272(1997)14:6<987::AID-GEPI71>3.0.CO;2-G; DupuyGorce AM, 1996, CLIN GENET, V50, P191; FRIEDLANDER Y, 1986, GENET EPIDEMIOL, V3, P285, DOI 10.1002/gepi.1370030502; GERDES C, 1995, CIRCULATION, V92, P1765, DOI 10.1161/01.CIR.92.7.1765; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Guerra R, 1997, P NATL ACAD SCI USA, V94, P4532, DOI 10.1073/pnas.94.9.4532; HAMSTEN A, 1986, ATHEROSCLEROSIS, V60, P199, DOI 10.1016/0021-9150(86)90166-8; HASSTEDT SJ, 1986, AM J MED GENET, V24, P57, DOI 10.1002/ajmg.1320240108; HELLER DA, 1993, NEW ENGL J MED, V328, P1150, DOI 10.1056/NEJM199304223281603; HUNT SC, 1989, AM J EPIDEMIOL, V129, P625, DOI 10.1093/oxfordjournals.aje.a115175; JEMAA R, 1995, J LIPID RES, V36, P2141; JIANG D, 1995, CHUNG HUA NEI KO TSA, V34, P298; Kamboh MI, 1996, ATHEROSCLEROSIS, V127, P255, DOI 10.1016/S0021-9150(96)05966-7; Kastelein JJP, 1998, CLIN GENET, V53, P27, DOI 10.1034/j.1399-0004.1998.531530106.x; Knoblauch H, 1997, ARTERIOSCL THROM VAS, V17, P2054, DOI 10.1161/01.ATV.17.10.2054; LANGE K, 1983, AM J MED GENET, V14, P513, DOI 10.1002/ajmg.1320140315; LEFEVRE M, 1988, J LIPID RES, V29, P815; MAHANEY MC, 1995, ARTERIOSCL THROM VAS, V15, P1730, DOI 10.1161/01.ATV.15.10.1730; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; MATTU RK, 1995, CIRCULATION, V91, P270, DOI 10.1161/01.CIR.91.2.270; McPherson R, 1996, J LIPID RES, V37, P1743; MILLER GJ, 1975, LANCET, V1, P16; MINNICH A, 1995, ARTERIOSCL THROM VAS, V15, P1740, DOI 10.1161/01.ATV.15.10.1740; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Mowat BF, 1997, ATHEROSCLEROSIS, V131, P161, DOI 10.1016/S0021-9150(97)06097-8; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; OCONNELL DL, 1988, GENET EPIDEMIOL, V5, P323, DOI 10.1002/gepi.1370050504; Rainwater DL, 1995, ATHEROSCLEROSIS, V118, P307, DOI 10.1016/0021-9150(95)05623-8; RAINWATER DL, 1992, J LIPID RES, V33, P1876; RAO DC, 1982, AM J HUM GENET, V34, P888; RHOADS GG, 1976, NEW ENGL J MED, V294, P293, DOI 10.1056/NEJM197602052940601; RICE T, 1991, HUM HERED, V41, P107, DOI 10.1159/000153987; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; SILVERMAN DI, 1993, AM J MED, V94, P636, DOI 10.1016/0002-9343(93)90217-D; SWEETNAM PM, 1994, CIRCULATION, V90, P769, DOI 10.1161/01.CIR.90.2.769; TURNER PR, 1995, ATHEROSCLEROSIS, V116, P221, DOI 10.1016/0021-9150(94)05550-3; VERDERY RB, 1989, J LIPID RES, V30, P1085; WHITFIELD JB, 1983, ATHEROSCLEROSIS, V48, P265, DOI 10.1016/0021-9150(83)90044-8; Wijsman EM, 1997, GENET EPIDEMIOL, V14, P719, DOI 10.1002/(SICI)1098-2272(1997)14:6<719::AID-GEPI28>3.0.CO;2-S; WILSON PWF, 1995, CLIN CHEM, V41, P165	52	91	92	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1686	1693		10.1086/302425	http://dx.doi.org/10.1086/302425			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330356	Green Published, Bronze			2022-12-18	WOS:000080696200021
J	Balemans, W; Van Den Ende, J; Paes-Alves, AF; Dikkers, FG; Willems, PJ; Vanhoenacker, F; de Almeida-Melo, N; Alves, CF; Stratakis, CA; Hill, SC; Van Hul, W				Balemans, W; Van Den Ende, J; Paes-Alves, AF; Dikkers, FG; Willems, PJ; Vanhoenacker, F; de Almeida-Melo, N; Alves, CF; Stratakis, CA; Hill, SC; Van Hul, W			Localization of the gene for sclerosteosis to the van Buchem Disease-gene region on chromosome 17q12-q21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HYPEROSTOSIS CORTICALIS GENERALISATA; AUTOSOMAL DOMINANT OSTEOSCLEROSIS; FEATURES	Sclerosteosis is an uncommon, autosomal recessive, progressive, sclerosing, bone dysplasia characterized by generalized osteosclerosis and hyperostosis of the skeleton, affecting mainly the skull and mandible. In most patients this causes facial paralysis and hearing loss. Other features are gigantism and hand abnormalities. In the present study, linkage analysis in two consanguineous families with sclerosteosis resulted in the assignment of the sclerosteosis gene to chromosome 17q12-q21. This region was analyzed because of the recent assignment to this chromosomal region of the gene causing van Buchem disease, a fare autosomal recessive condition with a hyperostosis similar to sclerosteosis. Because of the clinical similarities between sclerosteosis and van Buchem disease, it has previously been suggested that both conditions might be caused by mutations in the same gene. Our study now provides genetic evidence for this hypothesis.	Univ Antwerp, Dept Med Genet, B-2610 Antwerp, Belgium; Univ Antwerp, Dept Biochem Physiol & Genet, B-2020 Antwerp, Belgium; Univ Antwerp, Dept Radiol, B-2020 Antwerp, Belgium; Univ Fed Bahia, Dept Ginecol Obstet & Reprod, Salvador, BA, Brazil; Univ Groningen Hosp, Dept Otorhinolaryngol, Groningen, Netherlands; Escola Bahiana Med, Salvador, BA, Brazil; NICHHD, Unit Genet Endocrinol, Dev Endocrinol Branch, Bethesda, MD 20892 USA; NIH, Dept Radiol, Ctr Clin, Bethesda, MD 20892 USA	University of Antwerp; University of Antwerp; University of Antwerp; Universidade Federal da Bahia; University of Groningen; Escola Bahiana de Medicina e Saude Publica; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Van Hul, W (corresponding author), Univ Antwerp, Dept Med Genet, Univ Plein 1, B-2610 Antwerp, Belgium.	vhul@uia.ac.be	Dikkers, Frederik G/ABA-5218-2020; Dikkers, Frederik/M-1212-2013; Stratakis, Constantine A./AAP-4745-2020	Dikkers, Frederik G/0000-0001-5265-3722; Van Hul, Wim/0000-0002-5065-7858	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000642, ZIAHD000642] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEIGHTON P, 1976, ANN INTERN MED, V84, P393, DOI 10.7326/0003-4819-84-4-393; BEIGHTON P, 1988, J MED GENET, V25, P200, DOI 10.1136/jmg.25.3.200; BEIGHTON P, 1984, CLIN GENET, V25, P175; BETTINI R, 1991, Recenti Progressi in Medicina, V82, P24; BUENO M, 1994, J MED GENET, V31, P976, DOI 10.1136/jmg.31.12.976; COOK JV, 1989, BRIT J RADIOL, V62, P74, DOI 10.1259/0007-1285-62-733-74; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DIXON JM, 1982, J NEUROL NEUROSUR PS, V45, P913, DOI 10.1136/jnnp.45.10.913; Dyson D P, 1972, Br J Oral Surg, V9, P237; Fransen E, 1997, HUM MOL GENET, V6, P1625, DOI 10.1093/hmg/6.10.1625; FRYNS JP, 1988, EUR J PEDIATR, V147, P99, DOI 10.1007/BF00442624; GELMAN MI, 1977, RADIOLOGY, V125, P289, DOI 10.1148/125.2.289; GORLIN RJ, 1977, RADIOLOGY, V125, P547, DOI 10.1148/125.2.547; Hansen HG, 1967, HDB KINDERHEILKUNDE, P351; Higinbotham N., 1941, AM J SURG, V53, P444; HUGHES AE, 1993, GENOMICS, V15, P433, DOI 10.1006/geno.1993.1083; KELLEY CH, 1946, RADIOLOGY, V47, P507, DOI 10.1148/47.5.507; LAPRESLE J, 1976, NOUV PRESSE MED, V5, P2703; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LOPEZ AG, 1985, REV CLIN ESP, V177, P293; MAROTEAUX P, 1971, ARCH FR PEDIATR, V28, P685; MIGUEZ AM, 1986, MED CLIN-BARCELONA, V87, P719; NAGER GT, 1983, AM J OTOLARYNG, V4, P1, DOI 10.1016/S0196-0709(83)80002-7; OWEN RH, 1976, BRIT J RADIOL, V49, P126, DOI 10.1259/0007-1285-49-578-126; PEREZVICENTE JA, 1987, CLIN GENET, V31, P161; PIETRUSCHKA G, 1958, Klin Monbl Augenheilkd Augenarztl Fortbild, V132, P509; RODRIGUEZ NG, 1995, ANN MED INTERN MED, V12, P229; RUCKERT EW, 1985, J ORAL MAXIL SURG, V43, P801, DOI 10.1016/0278-2391(85)90339-8; SCHENDEL SA, 1988, ANN PLAS SURG, V20, P462, DOI 10.1097/00000637-198805000-00011; STEIN SA, 1983, NEUROLOGY, V33, P267, DOI 10.1212/WNL.33.3.267; SUGIURA Y, 1975, J BONE JOINT SURG AM, VA 57, P273, DOI 10.2106/00004623-197557020-00026; Tacconi P, 1998, CLIN GENET, V53, P497; TEMEERMAN GJ, 1995, CLIN EXP ALLERGY, V25, P97; Van Buchem FSPP, 1976, HYPEROSTOSIS CORTICA; Van Hul W, 1998, AM J HUM GENET, V62, P391, DOI 10.1086/301721; VAYSSAIRAT M, 1976, J RADIOL ELEC MED N, V57, P719; Worth H M, 1966, J Can Assoc Radiol, V17, P67; [No title captured]; [No title captured]; [No title captured]	40	91	117	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	1999	64	6					1661	1669		10.1086/302416	http://dx.doi.org/10.1086/302416			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	203FA	10330353	Bronze, Green Published			2022-12-18	WOS:000080696200018
J	Evans, DGR; Wallace, AJ; Wu, CL; Trueman, L; Ramsden, RT; Strachan, T				Evans, DGR; Wallace, AJ; Wu, CL; Trueman, L; Ramsden, RT; Strachan, T			Somatic mosaicism: A common cause of classic disease in tumor-prone syndromes? Lessons from type 2 neurofibromatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GERM-LINE MUTATIONS; NF2 GENE; INDIVIDUALS; PHENOTYPES; SEVERITY	Blood samples from 125 families with classic type 2 neurofibromatosis with bilateral vestibular schwannomas were analyzed for mutations in the NF2 gene. Causative mutations were identified in 52 families. In five families, the first affected individual in the family (the index case) was a mosaic for a disease-causing mutation. Only one of nine children from the three mosaic cases with children are affected. Four of these nine children inherited the allele associated with the disease-causing mutation yet did not inherit the mutation. NF2 mutations were identified in only 27/79 (34%) of sporadic cases, compared with 25/46 (54%) of familiar cases (P < .05). In 48 families in which a mutation has not been identified, the index cases have had 125 children, of whom only 29 are affected with NF2 and of whom only a further 21 cases would be predicted to be affected by use of life curves. The 50/125 (40%) of cases is significantly less than the 50% expected eventually to develop NF2 (P < .05). Somatic mosaicism is likely to be a common cause of classic NF2 and may well account for a low detection rate for mutations in sporadic cases. Degrees of gonosomal mosaicism mean that recurrence risks may well be < 50% in the index case when a mutation is not identified in lymphocyte DNA.	St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Manchester Royal Infirm, Dept Otolaryngol, Manchester M13 9WL, Lancs, England; Newcastle Univ, Dept Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Manchester; University of Manchester; Newcastle University - UK	Evans, DGR (corresponding author), St Marys Hosp, Dept Med Genet, Hathersage Rd, Manchester M13 0JH, Lancs, England.	Gevans@central.cmht.nwest.nhs.uk	Evans, D Gareth/AAB-4308-2022	Evans, D Gareth/0000-0002-8482-5784				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; BILJSMA EK, 1997, J MED GENET, V34, P934; BOURN D, 1994, AM J HUM GENET, V55, P69; BOURN D, 1995, HUM GENET, V95, P712; BUNYAN DJ, 1995, HUM GENET, V95, P43; EVANS DGR, 1992, J MED GENET, V29, P847, DOI 10.1136/jmg.29.12.847; Evans DGR, 1998, J MED GENET, V35, P450, DOI 10.1136/jmg.35.6.450; EVANS DGR, 1992, Q J MED, V84, P603; HALL JG, 1988, AM J HUM GENET, V43, P355; Huson S. M., 1994, P160; KANTER WR, 1980, NEUROLOGY, V30, P851, DOI 10.1212/WNL.30.8.851; Kluwe L, 1996, HUM GENET, V98, P534, DOI 10.1007/s004390050255; KOMMINOTH P, 1995, CANCER, V76, P479; KOVAR H, 1992, ONCOGENE, V7, P2169; MACCOLLIN M, 1994, AM J HUM GENET, V55, P314; MEREL P, 1995, GENE CHROMOSOME CANC, V12, P117, DOI 10.1002/gcc.2870120206; MOSS C, 1994, BRIT J DERMATOL, V130, P106, DOI 10.1111/j.1365-2133.1994.tb06893.x; PARRY DM, 1994, AM J MED GENET, V52, P450, DOI 10.1002/ajmg.1320520411; Parry DM, 1996, AM J HUM GENET, V59, P529; Ruttledge MH, 1996, AM J HUM GENET, V59, P331; SAITO K, 1995, AM J MED GENET, V56, P80, DOI 10.1002/ajmg.1320560118; Sampson JR, 1997, AM J HUM GENET, V61, P843, DOI 10.1086/514888; Thonney F., 1996, American Journal of Human Genetics, V59, pA84; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	24	91	93	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					727	736		10.1086/512074	http://dx.doi.org/10.1086/512074			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718334	Green Published, Bronze			2022-12-18	WOS:000075919000010
J	Eeles, RA; Durocher, F; Edwards, S; Teare, D; Badzioch, M; Hamoudi, R; Gill, S; Biggs, P; Dearnaley, D; Ardern-Jones, A; Dowe, A; Shearer, R; McLennan, DL; Norman, RL; Ghadirian, P; Aprikian, A; Ford, D; Amos, C; King, TM; Labrie, F; Simard, J; Narod, SA; Easton, D; Foulkes, WD; Foulkes, WD				Eeles, RA; Durocher, F; Edwards, S; Teare, D; Badzioch, M; Hamoudi, R; Gill, S; Biggs, P; Dearnaley, D; Ardern-Jones, A; Dowe, A; Shearer, R; McLennan, DL; Norman, RL; Ghadirian, P; Aprikian, A; Ford, D; Amos, C; King, TM; Labrie, F; Simard, J; Narod, SA; Easton, D; Foulkes, WD; Foulkes, WD		Cancer Res Campaign	Linkage analysis of chromosome 1q markers in 136 prostate cancer families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RISK; HISTORY	Prostate cancer shows evidence of familial aggregation, particularly at young ages at diagnosis, but the inherited basis of familial prostate cancer is poorly understood. Smith et al. recently found evidence of linkage to markers on Iq, at a locus designated "HPC1," in 91 families with multiple cases of early-onset prostate cancer. Using both parametric and nonparametric methods, we attempted to confirm this finding, in 60 affected related pairs and in 76 families with three or more cases of prostate cancer, but we found no significant evidence of linkage. The estimated proportion of linked families, under a standard autosomal dominant model, was 4%, with an upper 95% confidence limit of 31%. We conclude that the HPC1 locus is responsible for only a minority of familial prostate cancer cases and that it is likely to be most important in families with at least four cases of the disease.	Inst Canc Res, Canc Genet Team, Epidemiol Sect, Sutton SM2 5PT, Surrey, England; Canc Res Campaign Mol Carcinogenesis, Sutton, Surrey, England; Bob Champion Unit, Sutton, Surrey, England; Royal Marsden NHS Trust, Sutton, Surrey, England; CHUL, Res Ctr, MRC, Grp Mol Endocrinol,Lab Hereditary Canc, Quebec City, PQ, Canada; Inst Publ Hlth, CRC, Genet Epidemiol Unit, Cambridge, England; MD Anderson Cancer Ctr, Houston, TX USA; Dalhousie Univ, Nova Scotia Prostate Clin, Queen Elizabeth II Sci Ctr, Halifax, NS, Canada; Univ Montreal, Hotel Dieu, Ctr Rech, Montreal, PQ, Canada; McGill Univ, Dept Urol, Montreal, PQ, Canada; McGill Univ, Dept Med & Human Genet, Montreal, PQ, Canada; Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; Univ Toronto, Womens Coll Hosp, Dept Med, Toronto, ON, Canada	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Laval University; University of Cambridge; University of Texas System; UTMD Anderson Cancer Center; Dalhousie University; Queen Elizabeth II Health Sciences Centre; Laval University; Universite de Montreal; McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital	Eeles, RA (corresponding author), Inst Canc Res, Canc Genet Team, Epidemiol Sect, Downs Rd, Sutton SM2 5PT, Surrey, England.		Narod, Steven A/AAA-6112-2022; Dearnaley, David P/J-2318-2014; Biggs, Patrick Jon/H-3355-2014; Foulkes, William D./AAR-9586-2021	Dearnaley, David P/0000-0002-3954-2806; Biggs, Patrick Jon/0000-0002-0285-4101; Foulkes, William D./0000-0001-7427-4651; Simard, Jacques/0000-0001-6906-3390; Durocher, Francine/0000-0001-8012-4641; Teare, Marion Dawn/0000-0003-3994-0051; Eeles, Rosalind/0000-0002-3698-6241; Hamoudi, Rifat/0000-0002-1402-0868	NATIONAL CANCER INSTITUTE [R03CA067942] Funding Source: NIH RePORTER; NCI NIH HHS [R03CA67942] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cannon L., 1982, CANCER SURV, V1, P47; CANNONALBRIGHT L, 1995, NAT GENET, V9, P336, DOI 10.1038/ng0495-336; CARTER BS, 1992, P NATL ACAD SCI USA, V89, P3367, DOI 10.1073/pnas.89.8.3367; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; Eeles RA, 1997, BRIT J UROL, V79, P8, DOI 10.1111/j.1464-410X.1997.tb00795.x; EELES RA, 1996, GENETIC PREDISPOSITI; GOLDGAR DE, 1994, J NATL CANCER I, V86, P1600, DOI 10.1093/jnci/86.21.1600; Gronberg H, 1996, CANCER, V77, P138, DOI 10.1002/(SICI)1097-0142(19960101)77:1<138::AID-CNCR23>3.0.CO;2-5; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; McIndoe RA, 1997, AM J HUM GENET, V61, P347, DOI 10.1086/514853; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; *OFF NAT STAT, 1991, OFF NAT STAT SER; Office for National Statistics, 1998, OFF NAT STAT SER; Smith JR, 1996, SCIENCE, V274, P1371, DOI 10.1126/science.274.5291.1371; STEELE R, 1971, J CHRON DIS, V24, P29, DOI 10.1016/0021-9681(71)90056-7; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; vonEschenbach A, 1997, CANCER, V80, P1805, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1805::AID-CNCR17>3.3.CO;2-8; WOOLF CM, 1960, CANCER, V13, P739, DOI 10.1002/1097-0142(196007/08)13:4<739::AID-CNCR2820130414>3.0.CO;2-E	20	91	93	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					653	658		10.1086/301745	http://dx.doi.org/10.1086/301745			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497242	Green Published, Bronze			2022-12-18	WOS:000072894400019
J	Annabi, B; Hiraiwa, H; Mansfield, BC; Lei, KJ; Ubagai, T; Polymeropoulos, MH; Moses, SW; Parvari, R; Hershkovitz, E; Mandel, H; Fryman, M; Chou, JY				Annabi, B; Hiraiwa, H; Mansfield, BC; Lei, KJ; Ubagai, T; Polymeropoulos, MH; Moses, SW; Parvari, R; Hershkovitz, E; Mandel, H; Fryman, M; Chou, JY			The gene for glycogen-storage disease type 1b maps to chromosome 11q23	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MICROSOMAL GLUCOSE-6-PHOSPHATASE SYSTEM; TRANSPORT-SYSTEM; IB; MUTATIONS; DEFECT; HUMANS; 1A	Glycogen-storage disease type 1 (GSD-1), also known as "von Gierke disease," is caused by a deficiency in microsomal glucose-6-phosphatase (G6Pase) activity. There are four distinct subgroups of this autosomal recessive disorder: 1a, 1b, 1c, and 1d. All share the same clinical manifestations, which are caused by abnormalities in the metabolism of glucose-6-phosphate (G6P). However, only GSD-1b patients suffer infectious complications, which are due to both the heritable neutropenia and the functional deficiencies of neutrophils and monocytes. Whereas G6Pase deficiency in GSD-1a patients arises from mutations in the G6Pase gene, this gene is normal in GSD-1b patients, indicating a separate locus for the disorder in the 1b subgroup. We now report the linkage of the GSD-1b locus to genetic markers spanning a 3-cM region on chromosome 11q23. Eventual molecular characterization of this disease will provide new insights into the genetic bases of G6P metabolism and neutrophil-monocyte dysfunction.	NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA; Natl Human Genome Res Inst, Lab Genet Dis Res, NIH, Bethesda, MD 20892 USA; Georgetown Univ, Med Ctr, Dept Pediat, Washington, DC 20007 USA; Ben Gurion Univ Negev, Div Pediat, IL-84105 Beer Sheva, Israel; Rambam Med Ctr, Dept Pediat, Haifa, Israel; Sackler Sch Med, Chaim Sheba Med Ctr, Tel Aviv, Israel	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Georgetown University; Ben Gurion University; Rambam Health Care Campus; Technion Israel Institute of Technology; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Chou, JY (corresponding author), NICHHD, Heritable Disorders Branch, NIH, Bldg 10,Room 9S241, Bethesda, MD 20892 USA.		Herskowitz, eli/F-1922-2012	Herskowitz, eli/0000-0003-1624-1960; Mansfield, Brian/0000-0002-8533-2789				Anderson DC, 1995, METABOLIC MOL BASES, P3955; ARION WJ, 1980, J BIOL CHEM, V255, P396; BEAUDET AL, 1980, J PEDIATR-US, V97, P906, DOI 10.1016/S0022-3476(80)80418-5; BENEDETTI A, 1988, J BIOL CHEM, V263, P3466; Chen Y-T, 1995, METABOLIC MOL BASES, P935; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; DRACOPOLI NC, 1995, CURRENT PROTOCOLS HU; FERNANDES J, 1988, EUR J PEDIATR, V147, P226, DOI 10.1007/BF00442683; Foster JD, 1997, P SOC EXP BIOL MED, V215, P314; GALLIN JI, 1992, INFLAMMATION BASIC P, P859; GITZELMANN R, 1993, EUR J PEDIATR, V152, pS33; GOLDE DW, 1992, INFLAMMATION BASIC P, P291; GU Y, 1992, CELL, V71, P701, DOI 10.1016/0092-8674(92)90603-A; IGARASHI Y, 1984, BIOCHEM BIOPH RES CO, V119, P593, DOI 10.1016/S0006-291X(84)80290-9; KILPATRICK L, 1990, J CLIN INVEST, V86, P196, DOI 10.1172/JCI114684; LACHAUX A, 1993, J PEDIATR-US, V123, P1005, DOI 10.1016/S0022-3476(05)80403-2; LANGE AJ, 1980, J BIOL CHEM, V255, P8381; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEI KJ, 1994, J CLIN INVEST, V93, P1994, DOI 10.1172/JCI117192; LEI KJ, 1995, J CLIN INVEST, V95, P234, DOI 10.1172/JCI117645; LEI KJ, 1993, SCIENCE, V262, P580, DOI 10.1126/science.8211187; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; MOSES SW, 1990, J PEDIAT GASTROENTER, V11, P156; NARISAWA K, 1978, BIOCHEM BIOPH RES CO, V83, P1360, DOI 10.1016/0006-291X(78)91371-2; NORDLIE RC, 1983, J BIOL CHEM, V258, P9739; ROE TF, 1992, NEW ENGL J MED, V326, P1666, DOI 10.1056/NEJM199206183262504; Spiekermann K, 1997, LEUKEMIA, V11, P466, DOI 10.1038/sj.leu.2400607; WADDELL ID, 1991, BIOCHEM J, V275, P133, DOI 10.1042/bj2750133; WENDEL U, 1993, EUR J PEDIATR, V152, pS49	29	91	96	0	3	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1998	62	2					400	405		10.1086/301727	http://dx.doi.org/10.1086/301727			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZA927	9463334	hybrid, Green Published			2022-12-18	WOS:000072416000024
J	Weston, MD; Kelley, PM; Overbeck, LD; Wagenaar, M; Orten, DJ; Hasson, T; Chen, ZY; Corey, D; Mooseker, M; Sumegi, J; Cremers, C; Moller, C; Jacobson, SG; Gorin, MB; Kimberling, WJ				Weston, MD; Kelley, PM; Overbeck, LD; Wagenaar, M; Orten, DJ; Hasson, T; Chen, ZY; Corey, D; Mooseker, M; Sumegi, J; Cremers, C; Moller, C; Jacobson, SG; Gorin, MB; Kimberling, WJ			Myosin VIIA mutation screening in 189 Usher syndrome type 1 patients	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-I; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE; CHROMOSOME-11; DEAFNESS; MUSCLE	Usher syndrome type 1b (USH1B) is an autosomal recessive disorder characterized by congenital profound hearing loss, vestibular abnormalities, and retinitis pigmentosa, The disorder has recently been shown to be caused by mutations in the myosin VIIa gene (MYO7A) located on 11q14, In the current study, a panel of 189 genetically independent Usher I cases were screened for the presence of mutations in the N-terminal coding portion of the motor domain of MYO7A by heteroduplex analysis of 14 exons, Twenty-three mutations were found segregating with the disease in 20 families, Of the 23 mutations, 13 were unique, and 2 of the 13 unique mutations (Arg212His and Arg212Cys) accounted for the greatest percentage of observed mutant alleles (8/23, 31%), Six of the 13 mutations caused premature stop codons, 6 caused changes in the amino acid sequence of the myosin VIIa protein, and 1 resulted in a splicing defect, Three patients were homozygotes or compound heterozygotes for mutant alleles; these three cases were Tyr333Stop/Tyr333Stop, Arg212His-Arg302His/Arg212His-Arg302His, and IVS13nt-8c-->g/Glu450Gln. All the other USH1B mutations observed were simple heterozygotes, and it is presumed that the mutation on the other allele is present in the unscreened regions of the gene, None of the mutations reported here were observed in 96 unrelated control samples, although several polymorphisms were detected, These results add three patients to single case reported previously where mutations have been found in both alleles and raises the total number of unique mutations in MYO7A to 16.	BOYS TOWN NATL RES HOSP, CTR HEREDITARY COMMUN DISORDERS, DEPT GENET, OMAHA, NE 68131 USA; UNIV NEBRASKA, MED CTR, DEPT PATHOL & MICROBIOL, OMAHA, NE USA; UNIV NIJMEGEN HOSP, DEPT OTORHINOLARYNGOL, NL-6500 HB NIJMEGEN, NETHERLANDS; YALE UNIV, DEPT BIOL, NEW HAVEN, CT USA; YALE UNIV, DEPT PATHOL, NEW HAVEN, CT USA; YALE UNIV, DEPT CELL BIOL, NEW HAVEN, CT USA; MASSACHUSETTS GEN HOSP, HOWARD HUGHES MED INST, BOSTON, MA 02114 USA; HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA; LINKOPING UNIV, DEPT OTOLARYNGOL, LINKOPING, SWEDEN; UNIV PENN, SCHEIE EYE INST, PHILADELPHIA, PA 19104 USA; UNIV PITTSBURGH, DEPT OPHTHALMOL, PITTSBURGH, PA 15260 USA; UNIV PITTSBURGH, DEPT HUMAN GENET, PITTSBURGH, PA USA	Boys Town National Research Hospital; University of Nebraska System; University of Nebraska Medical Center; Radboud University Nijmegen; Yale University; Yale University; Yale University; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Linkoping University; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh			Cremers, C.W.R.J./L-4254-2015	Corey, David/0000-0003-4497-6016; HASSON, TAMA/0000-0002-5405-662X; Jacobson, Samuel/0000-0003-2122-169X	NATIONAL EYE INSTITUTE [R01EY005627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK038979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC001813] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY05627] Funding Source: Medline; NIDCD NIH HHS [P01 DC01813-01] Funding Source: Medline; NIDDK NIH HHS [P01 DK38979] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GUILFORD P, 1994, HUM MOL GENET, V3, P989, DOI 10.1093/hmg/3.6.989; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; KEEN J, 1991, TRENDS GENET, V7, P5; Kimberling W J, 1995, J Am Acad Audiol, V6, P63; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; KRAWCZAK M, 1992, HUM GENET, V90, P41; Mooseker MS, 1995, ANNU REV CELL DEV BI, V11, P633, DOI 10.1146/annurev.cellbio.11.1.633; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; SAVOV A, 1995, HUM MOL GENET, V4, P1169, DOI 10.1093/hmg/4.7.1169; SEBILLON P, 1995, NUCLEIC ACIDS RES, V23, P3419, DOI 10.1093/nar/23.17.3419; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; TAYLOR EW, 1993, SCIENCE, V261, P35, DOI 10.1126/science.8316856; Vikstrom KL, 1996, CURR OPIN CELL BIOL, V8, P97, DOI 10.1016/S0955-0674(96)80053-6; WATKINS H, 1995, HUM MOL GENET, V4, P1721, DOI 10.1093/hmg/4.suppl_1.1721; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	22	91	93	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					1074	1083						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900236				2022-12-18	WOS:A1996VN90000015
J	LITT, M; KRAMER, P; BROWNE, D; GANCHER, S; BRUNT, ERP; ROOT, D; PHROMCHOTIKUL, T; DUBAY, CJ; NUTT, J				LITT, M; KRAMER, P; BROWNE, D; GANCHER, S; BRUNT, ERP; ROOT, D; PHROMCHOTIKUL, T; DUBAY, CJ; NUTT, J			A GENE FOR EPISODIC ATAXIA/MYOKYMIA MAPS TO CHROMOSOME 12P13	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY PAROXYSMAL ATAXIA; POTASSIUM CHANNEL GENE; PERIODIC ATAXIA; LOCALIZATION; ACETAZOLAMIDE; MYOKYMIA; KINDREDS; CLONING; LOCUS	Episodic ataxia (EA) is a rare, familial disorder producing attacks of generalized ataxia, with normal or near-normal neurological function between attacks. Families with autosomal dominant EA represent at least two distinct clinical syndromes. One clinical type of EA (MIM 160120) includes individuals who have episodes of ataxia and dysarthria lasting seconds to minutes. In addition, myokymia (rippling of muscles, diagnosable by electromyography) is evident during and between attacks. Since Kf channel genes are candidate genes for EA, we tested markers near known Kf channel genes for linkage. Using a group of Genethon markers from one such region-chromosome 12p-we found evidence of linkage in four EA/myokymia families. A maximum combined lod score of 13.6 was obtained at theta = 0, with the marker D12S99. A human Ca++ channel gene, CACNL1A1, and three human K+ channel genes-KCNA5, KCNA6, and KCNAl-map close to D12S99, but the Ca++ channel gene is unlikely to be the site of the defect, because crossovers have been observed to occur between the disease gene and a CA-repeat marker located close to this gene. Studies of a large Ed family with a different clinical phenotype (MIM 108500), which lacks myokymia but is associated with nystagmus, have excluded the gene causing that disease from the chromosome 12p locus.	OREGON HLTH SCI UNIV,DEPT BIOCHEM & MOLEC BIOL,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT MOLEC & MED GENET,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201; UNIV GRONINGEN HOSP,DEPT NEUROL,GRONINGEN,NETHERLANDS	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of Groningen					NHGRI NIH HHS [HG00022] Funding Source: Medline; NINDS NIH HHS [NS25370] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025370] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALBRECHT B, 1993, RECEPTOR CHANNEL, V1, P99; BELL GI, 1981, P NATL ACAD SCI-BIOL, V78, P5759, DOI 10.1073/pnas.78.9.5759; BROWNE DL, 1994, HUM MOL GENET, V3, P842; BRUNT ERP, 1990, BRAIN, V113, P1361, DOI 10.1093/brain/113.5.1361; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CURRAN ME, 1992, GENOMICS, V12, P729, DOI 10.1016/0888-7543(92)90302-9; DONAT JR, 1979, ARCH NEUROL-CHICAGO, V36, P568, DOI 10.1001/archneur.1979.00500450062011; FARMER TW, 1963, ARCH NEUROL-CHICAGO, V8, P471, DOI 10.1001/archneur.1963.00460050021002; FRIEDMAN JH, 1986, NEUROLOGY, V36, P276; Gancher S T, 1986, Mov Disord, V1, P239, DOI 10.1002/mds.870010404; GRANDY D, 1992, AM J HUM GENET S, V51, pA396; GRIGGS RC, 1978, NEUROLOGY, V28, P1259, DOI 10.1212/WNL.28.12.1259; GRISSMER S, 1992, J BIOL CHEM, V267, P20971; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HANSON PA, 1977, ANN NEUROL, V1, P120, DOI 10.1002/ana.410010203; KLOCKE R, 1993, GENOMICS, V18, P568, DOI 10.1016/S0888-7543(05)80358-1; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LITT M, 1993, BIOTECHNIQUES, V15, P280; MARGOLIN D, 1982, T AM NEUROL ASSOC, V106, P1; MCPHERSON JD, 1991, CYTOGENET CELL GENET, V58, P1979; PARKER HL, 1946, MAYO CLIN P, V38, P642; PHROMCHOTIKUL T, 1993, HUM MOL GENET, V2, P1512, DOI 10.1093/hmg/2.9.1512-a; RAMASWAMI M, 1990, Molecular and Cellular Neuroscience, V1, P214, DOI 10.1016/1044-7431(90)90004-N; RANUM LPW, 1991, AM J HUM GENET, V49, P31; RUDY B, 1991, Molecular and Cellular Neuroscience, V2, P89, DOI 10.1016/1044-7431(91)90001-5; SCHAFFER AA, IN PRESS HUM HEREDIT; SCHULTZ D, 1993, P NATL ACAD SCI USA, V90, P6228, DOI 10.1073/pnas.90.13.6228; VANDYKE DH, 1975, J NEUROL SCI, V25, P109, DOI 10.1016/0022-510X(75)90191-4; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WHITE JC, 1969, ARCH NEUROL-CHICAGO, V20, P276, DOI 10.1001/archneur.1969.00480090064010; ZASORIN NL, 1983, NEUROLOGY, V33, P1212, DOI 10.1212/WNL.33.9.1212; ZOGHBI HY, 1991, AM J HUM GENET, V49, P23	32	91	92	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					702	709						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942848				2022-12-18	WOS:A1994PJ02700013
J	ANDREW, SE; GOLDBERG, YP; KREMER, B; SQUITIERI, F; THEILMANN, J; ZEISLER, J; TELENIUS, H; ADAM, S; ALMQUIST, E; ANVRET, M; LUCOTTE, G; STOESS, AJ; CAMPANELLA, G; HAYDEN, MR				ANDREW, SE; GOLDBERG, YP; KREMER, B; SQUITIERI, F; THEILMANN, J; ZEISLER, J; TELENIUS, H; ADAM, S; ALMQUIST, E; ANVRET, M; LUCOTTE, G; STOESS, AJ; CAMPANELLA, G; HAYDEN, MR			HUNTINGTON DISEASE WITHOUT CAG EXPANSION - PHENOCOPIES OR ERRORS IN ASSIGNMENT	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA; RECOMBINATION; ATROPHY; FAMILY	Huntington disease (HD) has been shown to be associated with an expanded CAG repeat within a novel gene on 4p16.3 (IT15). A total of 30 of 1,022 affected persons (2.9% of our cohort) did not have an expanded CAG in the disease range. The reasons for not observing expansion in affected individuals are important for determining the sensitivity of using repeat length both for diagnosis of affected patients and for predictive testing programs and may have biological relevance for the understanding of the molecular mechanism underlying HD. Here we show that the majority (18) of the individuals with normal sized alleles represent misdiagnosis, sample mix-up, or clerical error. The remaining 12 patients represent possible phenocopies for HD. In at least four cases, family studies of these phenocopies excluded 4p16.3 as the region responsible for the phenotype. Mutations in the HD gene that are other than CAG expansion have not been excluded for the remaining eight cases; however, in as many as seven of these persons, retrospective review of these patients' clinical features identified characteristics not typical for HD. This study shows that on rare occasions mutations in other, as-yet-undefined genes can present with a clinical phenotype very similar to that of HD.	UNIV BRITISH COLUMBIA,DEPT MED GENET,VANCOUVER V6T 1Z4,BC,CANADA; KAROLINSKA INST,DEPT GERIATR MED,S-10401 STOCKHOLM,SWEDEN; KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM,SWEDEN; HOP ROBERT DEBRE,CTR REG NEUROGENET,REIMS,FRANCE; UNIV HOSP LONDON,DEPT CLIN NEUROL SCI,LONDON,ENGLAND; UNIV NAPLES,NEUROL CLIN 2,NAPLES,ITALY	University of British Columbia; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; CHU de Reims; University of Naples Federico II			Hayden, Michael R/D-8581-2011; Stoessl, A Jon/J-9661-2015; Squitieri, Ferdinando/N-1852-2019	Hayden, Michael R/0000-0001-5159-1419; Stoessl, A Jon/0000-0002-9778-7246; Squitieri, Ferdinando/0000-0002-7397-1727; Adam, Shelin/0000-0002-4401-6157				ANDREW S, 1992, GENOMICS, V13, P301, DOI 10.1016/0888-7543(92)90246-O; ANDREW SE, 1994, HUM MOL GENET, V3, P65, DOI 10.1093/hmg/3.1.65; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; GOLDBERG YP, 1993, HUM MOL GENET, V2, P635, DOI 10.1093/hmg/2.6.635; Harper PS, 1991, HUNTINGTONS DISEASE; HAYDEN MR, 1986, NEUROLOGY, V36, P888, DOI 10.1212/WNL.36.7.888; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; IIZUKA R, 1984, J NEUROL NEUROSUR PS, V47, P1288, DOI 10.1136/jnnp.47.12.1288; IIZUKA R, 1986, HDB CLIN NEUROLOGY, V5, P437; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; KREMER B, UNPUB WORLDWIDE DIST; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; NAGAFUCHI S, 1994, NAT GENET, V6, P14, DOI 10.1038/ng0194-14; NAITO H, 1982, NEUROLOGY, V32, P798, DOI 10.1212/WNL.32.8.798; NORREMOLLE A, 1993, HUM MOL GENET, V2, P1475, DOI 10.1093/hmg/2.9.1475; PRITCHARD C, 1992, AM J HUM GENET, V50, P1218; RIESS O, 1993, HUM MOL GENET, V2, P637, DOI 10.1093/hmg/2.6.637; ROBBINS C, 1989, AM J HUM GENET, V44, P422; RUBENSZTEIN DC, 1993, HUM MOL GENET, V2, P1713; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Taylor S. A. M., 1992, Human Molecular Genetics, V1, P142, DOI 10.1093/hmg/1.2.142-a; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; TELENIUS H, IN PRESS NATURE GENE; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0; WEBER B, 1992, NAT GENET, V2, P216, DOI 10.1038/ng1192-216; WEBER B, 1992, HUM MOL GENET, V2, P827; ZUHLKE C, 1993, HUM MOL GENET, V2, P1467; 1993, CELL, V72, P971	30	91	92	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1994	54	5					852	863						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NH394	8178825				2022-12-18	WOS:A1994NH39400015
J	WEBER, JL; WANG, ZY; HANSEN, K; STEPHENSON, M; KAPPEL, C; SALZMAN, S; WILKIE, PJ; KEATS, B; DRACOPOLI, NC; BRANDRIFF, BF; OLSEN, AS				WEBER, JL; WANG, ZY; HANSEN, K; STEPHENSON, M; KAPPEL, C; SALZMAN, S; WILKIE, PJ; KEATS, B; DRACOPOLI, NC; BRANDRIFF, BF; OLSEN, AS			EVIDENCE FOR HUMAN MEIOTIC RECOMBINATION INTERFERENCE OBTAINED THROUGH CONSTRUCTION OF A SHORT TANDEM REPEAT-POLYMORPHISM LINKAGE MAP OF CHROMOSOME-19	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HIGH-RESOLUTION; DNA POLYMORPHISMS; GENE CONVERSIONS; COSMID CONTIGS; RYR1 LOCUS; CEA-GENE; MOUSE; LOCALIZATION; REGION; EXCLUSION	An improved linkage map for human chromosome 19 containing 35 short tandem repeat polymorphisms (STRPs) and one VNTR (D19S20) was constructed. The map included 12 new (GATA)n tetranucleotide STRPs. Although total lengths of the male (114 cM) and female (128 cM) maps were similar, at both ends of the chromosome male recombination exceeded female recombination, while in the interior portion of the map female recombination was in excess. Cosmid clones containing the STRP sequences were identified and were positioned along the chromosome by fluorescent in situ hybridization. Four rounds of careful checking and removal of genotyping errors allowed biologically relevant conclusions to be made concerning the numbers and distributions of recombination events on chromosome 19. The average numbers of recombinations per chromosome matched closely the lengths of the genetic maps computed by using the program CRIMAP. Significant numbers of chromosomes with zero, one, two, or three recombinations were detected as products of both female and male meioses. On the basis of the total number of observed pairs of recombination events in which only a single informative marker was situated between the two recombinations, a maximal estimate for the rate of meiotic STRP ''gene'' conversion without recombination was calculated as 3 X 10(-4)/meiosis. For distances up to 30 cM between recombinations, many fewer chromosomes which had undergone exactly two recombinations were observed than were expected on the basis of the assumption of independent recombination locations. This strong new evidence for human meiotic interference will help to improve the accuracy of interpretation of clinical DNA test results involving polymorphisms flanking a genetic abnormality.	LOUISIANA STATE UNIV, MED CTR, DEPT BIOMETRY & GENET, NEW ORLEANS, LA 70112 USA; MIT, CTR GENOME RES, DEPT BIOL, CAMBRIDGE, MA 02139 USA; LAWRENCE LIVERMORE NATL LAB, CTR HUMAN GENOME, BIOL & BIOTECHNOL RES PROGRAM, LIVERMORE, CA 94550 USA	Louisiana State University System; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Livermore National Laboratory	WEBER, JL (corresponding author), MARSHFIELD MED RES FDN, CTR MED GENET, 1000 N OAK AVE, MARSHFIELD, WI 54449 USA.			Dracopoli, Nicholas/0000-0003-3962-4059	NHGRI NIH HHS [HG00248, HG00835, HG00395] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000835, R01HG000395, R01HG000248] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BLANK RD, 1988, GENETICS, V120, P1073; BUETOW KH, 1991, AM J HUM GENET, V49, P985; CALLEN DF, 1993, AM J HUM GENET, V52, P922; CARRANO AV, 1989, GENOMICS, V4, P129, DOI 10.1016/0888-7543(89)90291-7; CARTER TC, 1951, J GENET, V50, P307, DOI 10.1007/BF02996226; CECI JD, 1989, GENOMICS, V5, P699, DOI 10.1016/0888-7543(89)90111-0; Chen H., 1992, American Journal of Human Genetics, V51, pA191; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; COUCH FJ, 1991, NUCLEIC ACIDS RES, V19, P5094, DOI 10.1093/nar/19.18.5094; DALLAS JF, 1992, MAMM GENOME, V3, P452, DOI 10.1007/BF00356155; DEJONG PJ, 1989, CYTOGENET CELL GENET, V51, P985; GOLDGAR DE, 1989, GENOMICS, V5, P283, DOI 10.1016/0888-7543(89)90059-1; GUYER M, 1992, SCIENCE, V258, P67; HAINES JL, 1992, GENOMICS, V14, P517, DOI 10.1016/S0888-7543(05)80257-5; HASTBACKA J, 1992, GENETICS, V2, P204; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; HOFMANN SL, 1991, GENOMICS, V9, P656, DOI 10.1016/0888-7543(91)90359-M; HOGG RV, 1978, INTRO MATH STATISTIC; HUDSON TJ, 1992, GENOMICS, V13, P622, DOI 10.1016/0888-7543(92)90133-D; HULTEN M, 1974, HEREDITAS, V76, P55; HULTEN M, 1990, AM J MED GENET, P148; ILES DE, 1992, GENOMICS, V14, P749, DOI 10.1016/S0888-7543(05)80179-X; ILES DE, 1992, NUCLEIC ACIDS RES, V20, P1170; KEIRNAN EC, 1991, NUCLEIC ACIDS RES, V19, P3160, DOI 10.1093/nar/19.11.3160-a; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; KOURI RE, 1990, AM J HUM GENET S, V47, pA186; KWIATKOWSKI DJ, 1992, GENOMICS, V12, P229, DOI 10.1016/0888-7543(92)90370-8; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Levitt R. C., 1992, Human Molecular Genetics, V1, P139, DOI 10.1093/hmg/1.2.139; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MOORE LA, 1992, J MOL BIOL, V223, P383, DOI 10.1016/0022-2836(92)90741-2; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; NAKAMURA Y, 1988, Genomics, V3, P67, DOI 10.1016/0888-7543(88)90161-9; Ott J., 1991, ANAL HUMAN GENETIC L; Petes T. D., 1991, MOL CELLULAR BIOL YE, P407; PETRUKHIN KE, 1993, GENOMICS, V15, P76, DOI 10.1006/geno.1993.1012; RICHARDS RI, 1991, GENOMICS, V11, P77, DOI 10.1016/0888-7543(91)90103-L; ROPERS HH, 1991, CYTOGENET CELL GENET, V58, P751, DOI 10.1159/000133179; ROYLE NJ, 1993, GENOMICS, V15, P119, DOI 10.1006/geno.1993.1019; ROYLE NJ, 1992, NUCLEIC ACIDS RES, V20, P1163, DOI 10.1093/nar/20.5.1163-a; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; SLIGHTOM JL, 1987, J BIOL CHEM, V262, P7472; SPEED TP, 1992, P NATL ACAD SCI USA, V89, P3103, DOI 10.1073/pnas.89.7.3103; Todd John A., 1992, Human Molecular Genetics, V1, P663, DOI 10.1093/hmg/1.9.663; TOMFOHRDE J, 1992, GENOMICS, V14, P144, DOI 10.1016/S0888-7543(05)80297-6; TRASK B, 1993, GENOMICS, V15, P133, DOI 10.1006/geno.1993.1021; TRASK B, 1992, GENOMICS, V14, P162, DOI 10.1016/S0888-7543(05)80299-X; TYNAN K, 1992, NUCLEIC ACIDS RES, V20, P1629, DOI 10.1093/nar/20.7.1629; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4639, DOI 10.1093/nar/18.15.4639-a; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P1927, DOI 10.1093/nar/18.7.1927; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1991, GENOMICS, V11, P695, DOI 10.1016/0888-7543(91)90077-R; WEBER JL, 1990, GENOME ANAL, V1, P159; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2835; WEBER JL, IN PRESS HUM MOL GEN; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Whitehouse H. L. K., 1982, GENETIC RECOMBINATIO; ZIEGLE JS, 1992, GENOMICS, V14, P1026, DOI 10.1016/S0888-7543(05)80126-0	60	91	95	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1079	1095						17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213834				2022-12-18	WOS:A1993MC33300012
J	MOHANDAS, TK; SPEED, RM; PASSAGE, MB; YEN, PH; CHANDLEY, AC; SHAPIRO, LJ				MOHANDAS, TK; SPEED, RM; PASSAGE, MB; YEN, PH; CHANDLEY, AC; SHAPIRO, LJ			ROLE OF THE PSEUDOAUTOSOMAL REGION IN SEX-CHROMOSOME PAIRING DURING MALE MEIOSIS - MEIOTIC STUDIES IN A MAN WITH A DELETION OF DISTAL XP	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							Y-CHROMOSOME; SYNAPTONEMAL COMPLEX; HUMAN SPERMATOCYTES; INFERTILE MEN; SHORT ARM; SEQUENCES; PROPHASE; MINISATELLITES; DISSOCIATION; STERILITY	Meiotic studies were undertaken in a 24-year-old male patient with short stature, chondrodysplasia punctata, ichthyosis, steroid sulfatase deficiency, and mild mental retardation with an inherited cytologically visible deletion of distal Xp. Molecular investigations showed that the pseudoautosomal region as well as the steroid sulfatase gene were deleted, but telomeric sequences were present at the pter on the deleted X chromosome. A complete failure of sex-chromosome pairing was observed in the primary spermatocytes of the patient. Telomeric approaches between the sex chromosomes were made at zygotene in some cells, but no XY synaptonemal complex was formed. The sex chromosomes were present as univalents at metaphase I, and germ-cell development was arrested between metaphase I and metaphase II in the vast majority of cells, consistent with the azoospermia observed in the patient. The failure of XY pairing in this individual indicates that the pseudoautosomal sequences play an important role in initiating XY pairing and formation of synaptonemal complex at meiosis.	WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; UNIV CALIF SAN FRANCISCO,DEPT PEDIAT,SAN FRANCISCO,CA 94143	University of Edinburgh; University of California System; University of California San Francisco	MOHANDAS, TK (corresponding author), UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DIV MED GENET,TORRANCE,CA 90509, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012178, R01HD015193] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-12178, HD-15193] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BEECHEY CV, 1973, CYTOGENET CELL GENET, V12, P60, DOI 10.1159/000130439; BUCKLE V, 1985, NATURE, V317, P739, DOI 10.1038/317739a0; CHANDLEY A C, 1987, P71; CHANDLEY AC, 1989, J MED GENET, V26, P546, DOI 10.1136/jmg.26.9.546; CHANDLEY AC, 1973, HEREDITY, V30, P262; CHANDLEY AC, 1971, CYTOGENETICS, V10, P295, DOI 10.1159/000130149; CHANDLEY AC, 1984, CYTOGENET CELL GENET, V38, P241, DOI 10.1159/000132070; CHANDLEY AC, 1981, ANN GENET-PARIS, V24, P5; CHANDLEY AC, 1986, HUM GENET, V72, P50, DOI 10.1007/BF00278817; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; COOKE HJ, 1986, COLD SPRING HARB SYM, V51, P213, DOI 10.1101/SQB.1986.051.01.026; CURRY CJR, 1984, NEW ENGL J MED, V311, P1010, DOI 10.1056/NEJM198410183111603; DAVIES KE, 1990, CYTOGENET CELL GENET, V55, P254, DOI 10.1159/000133019; ELLIS N, 1989, TRENDS GENET, V5, P406, DOI 10.1016/0168-9525(89)90199-6; EVANS EP, 1964, CYTOGENETICS, V3, P289, DOI 10.1159/000129818; GABRIELROBEZ O, 1990, CYTOGENET CELL GENET, V54, P38, DOI 10.1159/000132951; GILLIES CB, 1984, CRC CR REV PLANT SCI, V2, P81, DOI 10.1080/07352688409382191; JOHANNISSON R, 1987, CYTOGENET CELL GENET, V45, P220; LI XM, 1990, NUCLEIC ACIDS RES, V18, P2783, DOI 10.1093/nar/18.9.2783; MATSUDA Y, 1991, P NATL ACAD SCI USA, V88, P4850, DOI 10.1073/pnas.88.11.4850; MIKLOS GLG, 1974, CYTOGENET CELL GENET, V13, P558, DOI 10.1159/000130307; MOHANDAS T, 1986, SOMAT CELL MOLEC GEN, V12, P89, DOI 10.1007/BF01560731; MORIN GB, 1991, NATURE, V353, P454, DOI 10.1038/353454a0; MOSES MJ, 1977, CHROMOSOMES TODAY, V6, P71; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; ROUYER F, 1990, EMBO J, V9, P505, DOI 10.1002/j.1460-2075.1990.tb08137.x; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; Sambrook J., 1989, MOL CLONING LAB MANU; SIMMLER MC, 1985, NATURE, V317, P692, DOI 10.1038/317692a0; SIMMLER MC, 1987, EMBO J, V6, P963, DOI 10.1002/j.1460-2075.1987.tb04846.x; SOLARI AJ, 1980, CHROMOSOMA, V81, P315, DOI 10.1007/BF00368145; SPEED RM, 1990, HUM GENET, V84, P547; SPEED RM, 1991, HUM GENET, V87, P416; VONWETTSTEIN D, 1984, ANNU REV GENET, V18, P331, DOI 10.1146/annurev.ge.18.120184.001555; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; YEN PH, 1984, SOMAT CELL MOLEC GEN, V10, P561, DOI 10.1007/BF01535221	36	91	94	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1992	51	3					526	533						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JJ828	1496984				2022-12-18	WOS:A1992JJ82800009
J	HARLEY, HG; BROOK, JD; FLOYD, J; RUNDLE, SA; CROW, S; WALSH, KV; THIBAULT, MC; HARPER, PS; SHAW, DJ				HARLEY, HG; BROOK, JD; FLOYD, J; RUNDLE, SA; CROW, S; WALSH, KV; THIBAULT, MC; HARPER, PS; SHAW, DJ			DETECTION OF LINKAGE DISEQUILIBRIUM BETWEEN THE MYOTONIC-DYSTROPHY LOCUS AND A NEW POLYMORPHIC DNA MARKER	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RANGE RESTRICTION MAP; HUMAN CHROMOSOME-19; GENETIC-MARKERS; REGION; APOLIPOPROTEIN-C2; LOCALIZATION; FRAGMENTS; QUEBEC; CLONE; 19Q	We have examined the linkage of two new polymorphic DNA markers (D19S62 and D19S63) and a previously unreported polymorphism with an existing DNA marker (ERCC1) to the myotonic dystrophy (DM) locus. In addition, we have used pulsed-field gel electrophoresis to obtain a fine-structure map of this region. The detection of linkage disequilibrium between DM and one of these markers (D19S63) is the first demonstration of this phenomenon in a heterogeneous DM population. The results suggest that at least 58% of DM patients in the British population, as well as those in a French-Canadian subpopulation, are descended from the same ancestral DM mutation. We discuss the implications of this finding in terms of strategies for cloning the DM gene, for a possible role in modification of risk for prenatal and presymptomatic testing, and we speculate on the origin and number of existing mutations which may result in a DM phenotype.			HARLEY, HG (corresponding author), UNIV COLL CARDIFF,INST MED GENET,HEATH PK,CARDIFF CF4 4XN,S GLAM,WALES.			Brook, John David/0000-0002-5946-6740	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BROOK J D, 1987, Genomics, V1, P320, DOI 10.1016/0888-7543(87)90031-0; BROOK JD, 1990, NUCLEIC ACIDS RES, V18, P1086, DOI 10.1093/nar/18.4.1086-a; BROOK JD, 1990, NUCLEIC ACIDS RES, V18, P1085; BROOK JD, 1984, HUM GENET, V68, P282, DOI 10.1007/BF00292584; BROOK JD, 1986, CYTOGENET CELL GENET, V41, P30, DOI 10.1159/000132192; BROOK JD, 1991, J MED GENET, V28, P84, DOI 10.1136/jmg.28.2.84; BROOK JD, IN PRESS HUM GENET; BRUNNER HG, 1989, GENOMICS, V5, P589, DOI 10.1016/0888-7543(89)90027-X; CHU G, 1986, SCIENCE, V234, P1582, DOI 10.1126/science.3538420; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HARLEY HG, 1988, GENOMICS, V3, P380, DOI 10.1016/0888-7543(88)90131-0; HARLEY HG, IN PRESS HUM GENET; Harper P.S., 1989, MYOTONIC DYSTROPHY; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; HULSEBOS T, 1986, CYTOGENET CELL GENET, V43, P47, DOI 10.1159/000132297; JOHNSON K, 1990, AM J HUM GENET, V46, P1073; JOHNSON K, 1989, GENOMICS, V5, P746, DOI 10.1016/0888-7543(89)90116-X; KORNELUK RG, 1989, GENOMICS, V5, P596, DOI 10.1016/0888-7543(89)90028-1; LABERGE C, 1985, CYTOGENET CELL GENET, V40, P675; LABERGE C, 1989, CAN J NEUROL SCI, V16, P123, DOI 10.1017/S0317167100028663; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEBEAU MM, 1989, CYTOGENET CELL GENET, V51, P338, DOI 10.1159/000132798; MACKENZIE AE, 1989, AM J HUM GENET, V44, P140; Maniatis T., 1982, MOL CLONING; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SHAW DJ, 1989, HUM GENET, V83, P71, DOI 10.1007/BF00274152; SMEETS H, 1990, AM J HUM GENET, V46, P492; STALLINGS RL, 1988, AM J HUM GENET, V43, P144; WALSH KV, 1990, HUM GENET, V85, P305	30	91	94	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	1991	49	1					68	75						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FW511	2063878				2022-12-18	WOS:A1991FW51100009
J	GUTTENBACH, M; SCHMID, M				GUTTENBACH, M; SCHMID, M			DETERMINATION OF Y-CHROMOSOME ANEUPLOIDY IN HUMAN SPERM NUCLEI BY NONRADIOACTIVE INSITU HYBRIDIZATION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV WURZBURG, DEPT HUMAN GENET, KOELLIKERSTR 2, W-8700 WURZBURG, GERMANY	University of Wurzburg								BARLOW P, 1970, NATURE, V226, P961, DOI 10.1038/226961a0; BRANDRIFF B, 1984, HUM GENET, V66, P193, DOI 10.1007/BF00286600; BRANDRIFF BF, 1988, CYTOGENET CELL GENET, V47, P29, DOI 10.1159/000132500; CASPERSSON T, 1970, CHROMOSOMA, V30, P215; COOKE HJ, 1982, CHROMOSOMA, V87, P491, DOI 10.1007/BF00333470; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; JOSEPH AM, 1984, HUM GENET, V66, P234, DOI 10.1007/BF00286608; KLASEN M, 1981, HUM GENET, V58, P156, DOI 10.1007/BF00278701; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; MARTIN RH, 1987, AM J HUM GENET, V41, P484; MARTIN RH, 1987, HUM GENET, V77, P108, DOI 10.1007/BF00272374; MARTIN RH, 1983, HUM GENET, V63, P305, DOI 10.1007/BF00274750; MARTIN RH, 1982, AM J HUM GENET, V34, P459; PAWLOWITZKI IH, 1972, HUMANGENETIK, V16, P119, DOI 10.1007/BF00393995; PEARSON PL, 1970, NATURE, V226, P78, DOI 10.1038/226078a0; Pfeiffer R.A., 1974, METHODS HUMAN CYTOGE, P1; ROBERTS AM, 1976, NATURE, V262, P493, DOI 10.1038/262493a0; RUDAK E, 1978, NATURE, V274, P911, DOI 10.1038/274911a0; SCHMID M, IN PRESS GENOMICS; SCHMIDTKE J, 1980, HUM GENET, V55, P255, DOI 10.1007/BF00291774; SCHWEIZER D, 1978, EXP CELL RES, V111, P327, DOI 10.1016/0014-4827(78)90177-5; SCHWINGER E, 1976, HUM GENET, V34, P265, DOI 10.1007/BF00295289; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; SUMNER AT, 1971, NATURE-NEW BIOL, V229, P231, DOI 10.1038/newbio229231a0; SZABO P, 1979, CYTOGENET CELL GENET, V25, P212; TISHLER PV, 1974, HUMANGENETIK, V22, P275, DOI 10.1007/BF00295487	28	91	91	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1990	46	3					553	558						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CT668	2309704				2022-12-18	WOS:A1990CT66800019
J	DEVITA, G; ALCALAY, M; SAMPIETRO, M; CAPPELINI, MD; FIORELLI, G; TONIOLO, D				DEVITA, G; ALCALAY, M; SAMPIETRO, M; CAPPELINI, MD; FIORELLI, G; TONIOLO, D			2 POINT MUTATIONS ARE RESPONSIBLE FOR G6PD-POLYMORPHISM IN SARDINIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CNR, IST GENET BIOCHIM & EVOLUT, VIA ABBIATEGRASSO 207, I-27100 PAVIA, ITALY; CNR, IST INT GENET BIOFIS, NAPLES, ITALY; UNIV MILAN, IST SCI BIOMED S GERADO, I-20122 MILAN, ITALY; UNIV MILAN, IST MED INTERNA, I-20122 MILAN, ITALY	Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); University of Milan; University of Milan			Alcalay, Myriam/AAB-4300-2019; Toniolo, Daniela/AAE-2969-2019; Alcalay, Myriam/B-3182-2016; De Vita, Gabriella/H-4422-2011; CAPPELLINI, MARIA DOMENICA/B-4475-2017	Alcalay, Myriam/0000-0002-5558-4272; Toniolo, Daniela/0000-0001-9545-6032; Alcalay, Myriam/0000-0002-5558-4272; De Vita, Gabriella/0000-0002-7302-1174; CAPPELLINI, MARIA DOMENICA/0000-0001-8676-6864				BEUTLER E, 1977, BRIT J HAEMATOL, V35, P331, DOI 10.1111/j.1365-2141.1977.tb00589.x; BEUTLER E, 1976, J LAB CLIN MED, V88, P328; BEUTLER E, 1978, HAEMOLYTIC ANAEMIA D; Beutler E, 1983, METABOLIC BASIS INHE, P1629; CAMARDELLA L, 1981, BIOCHEM BIOPH RES CO, V103, P1384, DOI 10.1016/0006-291X(81)90276-X; FENU MP, 1982, ANN HUM GENET, V46, P105, DOI 10.1111/j.1469-1809.1982.tb00701.x; FOUTS D, 1988, GENE, V63, P261, DOI 10.1016/0378-1119(88)90530-6; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; JEFFREY J, 1985, BIOCHEMISTRY-US, V4, P666; LENZERINI L, 1969, AM J HUM GENET, V21, P142; LUZZATTO L, 1965, BIOCHEM BIOPH RES CO, V21, P547, DOI 10.1016/0006-291X(65)90520-6; LUZZATTO L, 1985, ADV HUM GENET, V14, P217; Luzzatto L, 1978, Curr Top Hematol, V1, P1; LUZZATTO L, 1983, CIBA F SYMP, V94, P159; Maniatis T., 1982, MOL CLONING; MARTINI G, 1986, EMBO J, V5, P1849, DOI 10.1002/j.1460-2075.1986.tb04436.x; MORELLI A, 1984, SCAND J HAEMATOL, V33, P145; NICHOLLS RD, 1985, NUCLEIC ACIDS RES, V13, P7569, DOI 10.1093/nar/13.21.7569; PERSICO M, 1982, ADV RED BLOOD CELL B, P309; PERSICO MG, 1986, NUCLEIC ACIDS RES, V14, P2511, DOI 10.1093/nar/14.6.2511; RATTAZZI MC, 1969, AM J HUM GENET, V21, P154; RATTAZZI MC, 1969, BIOCHIM BIOPHYS ACTA, V181, P1, DOI 10.1016/0005-2795(69)90221-9; SINISCALCO M, 1966, B WORLD HEALTH ORGAN, V34, P379; TAKIZAWA T, 1987, Genomics, V1, P228, DOI 10.1016/0888-7543(87)90048-6; TAKIZAWA T, 1986, P NATL ACAD SCI USA, V83, P4157, DOI 10.1073/pnas.83.12.4157; TESTA U, 1980, HUM GENET, V56, P99; TONIOLO D, 1984, EMBO J, V3, P1987, DOI 10.1002/j.1460-2075.1984.tb02080.x; TONIOLO D, 1988, P NATL ACAD SCI USA, V85, P1851; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; 1967, WHO TECH REP SER, V366	30	91	92	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1989	44	2					233	240						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	R9705	2912069				2022-12-18	WOS:A1989R970500008
J	FISHER, JH; KAO, FT; JONES, C; WHITE, RT; BENSON, BJ; MASON, RJ				FISHER, JH; KAO, FT; JONES, C; WHITE, RT; BENSON, BJ; MASON, RJ			THE CODING SEQUENCE FOR THE 32,000-DALTON PULMONARY SURFACTANT-ASSOCIATED PROTEIN-A IS LOCATED ON CHROMOSOME-10 AND IDENTIFIES 2 SEPARATE RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & GENET,DENVER,CO 80262; ELEANOR ROOSEVELT INST CANC RES,DENVER,CO 80206; CALIF BIOTECHNOL INC,MT VIEW,CA 94043; NATL JEWISH CTR IMMUNOL & RESP MED,DEPT INTERNAL MED,DENVER,CO 80206	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Jewish Health	FISHER, JH (corresponding author), UNIV COLORADO,HLTH SCI CTR,DIV PULM SCI,DEPT INTERNAL MED,4200 E 9TH AVE,DENVER,CO 80262, USA.				NHLBI NIH HHS [HL-27353] Funding Source: Medline; NICHD NIH HHS [HD-02080] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD002080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL027353] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BORGAONKAR DS, 1984, CHROMOSOMAL VARIATIO; CHEUNG P, 1984, P NATL ACAD SCI-BIOL, V81, P508, DOI 10.1073/pnas.81.2.508; CLEMENTS JA, 1965, HDB PHYSL, V31, P1565; FISHER JH, 1984, SOMAT CELL MOLEC GEN, V10, P455, DOI 10.1007/BF01534850; FLOROS J, 1986, J BIOL CHEM, V261, P9029; FLOROS J, 1985, J BIOL CHEM, V260, P495; GROUCHY J, 1977, CLIN ATLAS HUMAN CHR, P126; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; HALLMAN M, 1982, J CLIN INVEST, V70, P673, DOI 10.1172/JCI110662; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; INUI K, 1985, HUM GENET, V69, P197, DOI 10.1007/BF00293023; JONES C, 1975, SOMAT CELL GENET, V1, P345, DOI 10.1007/BF01538666; JONES C, 1985, SCIENCE, V228, P83, DOI 10.1126/science.3919444; KAO FT, 1984, HUM GENET, V67, P34, DOI 10.1007/BF00270555; KAO FT, 1982, P NATL ACAD SCI-BIOL, V79, P865, DOI 10.1073/pnas.79.3.865; KATYAL SL, 1984, BIOCHIM BIOPHYS ACTA, V794, P411, DOI 10.1016/0005-2760(84)90007-9; KATYAL SL, 1984, PROG RESPIR RES, V18, P106; KING RJ, 1975, J APPL PHYSIOL, V39, P735, DOI 10.1152/jappl.1975.39.5.735; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LINLEE YC, 1985, BIOCHEMISTRY-US, V24, P3751, DOI 10.1021/bi00335a050; MORSE HG, 1982, MAMM CHROMOSOME NEWS, V23, P127; NAKAMICHI NN, IN PRESS SOMATIC CEL; NATT E, 1986, HUM GENET, V72, P225, DOI 10.1007/BF00291882; NG VL, 1983, BIOCHIM BIOPHYS ACTA, V754, P218, DOI 10.1016/0005-2760(83)90164-9; PHELPS DS, 1985, COMP BIOCHEM PHYS B, V82, P441, DOI 10.1016/0305-0491(85)90006-9; PHELPS DS, 1984, BIOCHIM BIOPHYS ACTA, V791, P226, DOI 10.1016/0167-4838(84)90013-X; PHELPS DS, 1986, BIOCHEM J, V237, P373, DOI 10.1042/bj2370373; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SUEISHI K, 1981, BIOCHIM BIOPHYS ACTA, V665, P442, DOI 10.1016/0005-2760(81)90257-5; WAHL GM, 1979, P NATL ACAD SCI USA, V76, P3683, DOI 10.1073/pnas.76.8.3683; WHITE RT, 1985, NATURE, V317, P361, DOI 10.1038/317361a0; WHITSETT JA, 1985, PEDIATR RES, V19, P501, DOI 10.1203/00006450-198505000-00018; WILLIAMS MC, 1981, J HISTOCHEM CYTOCHEM, V29, P291, DOI 10.1177/29.2.7019304; 1985, CYTOGENET CELL GENET, V40, P1	34	91	91	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1987	40	6					503	511						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	H9693	2884868				2022-12-18	WOS:A1987H969300003
J	DEMENAIS, F; LATHROP, M; LALOUEL, JM				DEMENAIS, F; LATHROP, M; LALOUEL, JM			ROBUSTNESS AND POWER OF THE UNIFIED MODEL IN THE ANALYSIS OF QUANTITATIVE MEASUREMENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV PARIS 07,ANTHROPOL BIOL LAB,F-75251 PARIS 05,FRANCE	UDICE-French Research Universities; Universite Paris Cite	DEMENAIS, F (corresponding author), INSERM,UNITE RECH GENET EPIDEMIOL,U155,CHATEAU LONGCHAMP,BOIS BOULOGNE,F-75016 PARIS,FRANCE.		Demenais, Florence/G-3298-2013	Demenais, Florence/0000-0001-8361-0936				COX DR, 1964, J R STAT SOC B, V26, P211; EAVES LJ, 1983, AM J HUM GENET, V35, P1179; Elston R C, 1981, Adv Hum Genet, V11, P63; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1975, ANN HUM GENET, V39, P67, DOI 10.1111/j.1469-1809.1975.tb00109.x; GO RCP, 1978, AM J HUM GENET, V30, P28; Lalouel J. M., 1980, COMPUTER PROGRAM COM; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1981, GENETIQUE MED ACQUIS, P161; MACLEAN CJ, 1975, AM J HUM GENET, V27, P365; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MORTON NE, 1974, AM J HUM GENET, V26, P489; OTT J, 1979, HUM GENET, V51, P79, DOI 10.1007/BF00278296	13	91	92	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1986	38	2					228	234						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	A3111	3946424				2022-12-18	WOS:A1986A311100010
J	JOHNSTON, AW; MCKUSICK, VA				JOHNSTON, AW; MCKUSICK, VA			A SEX-LINKED RECESSIVE FORM OF SPASTIC PARAPLEGIA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		Allan W, 1939, ARCH INTERN MED, V63, P1123, DOI 10.1001/archinte.1939.00180230108008; BELL J, 1939, TREASURY HUMAN INH 3, V5; Bell Julia, 1935, TREASURY HUMAN INH 2, VIV; BRUINS J W, 1957, Acta Genet Stat Med, V7, P329; CHUNG CS, 1959, ANN HUM GENET, V23, P357, DOI 10.1111/j.1469-1809.1959.tb01479.x; Ferguson FR, 1928, J NEUROL PSYCHOPATHO, V9, P120; Ferguson FR, 1929, BRAIN, V52, P203, DOI 10.1093/brain/52.2.203; FORD FR, 1937, DIS NERVOUS SYSTEM I, P306; FUNK F J Jr, 1957, South Med J, V50, P1065; Greenfield JG, 1954, SPINOCEREBELLAR DEGE; GRUMBACH MM, 1958, PROGR HORMONE RES, V14, P255; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; Haldane JBS, 1941, J GENET, V41, P141, DOI 10.1007/BF02983017; HOHMANN H, 1957, Nervenarzt, V28, P323; JOHNSTON AW, 1961, BRIT MED J; KRAFTEBBING R, 1900, DTSCH Z NERVENHEILK, V17, P87; LANDAU WM, 1951, AMA ARCH NEUROL PSY, V66, P346, DOI 10.1001/archneurpsyc.1951.02320090095008; MORTON NE, 1957, AM J HUM GENET, V9, P55; REFSUM S, 1954, NEUROLOGY, V4, P40, DOI 10.1212/WNL.4.1.40; REFSUM SB, PERSONAL COMMUNICATI; SCHUT JW, 1954, GENETICS INHERITANCE; STEINBERG AG, 1959, AM J HUM GENET, V11, P315; STEWART JSS, 1959, LANCET, V2, P592; Turner EV, 1938, J NERV MENT DIS, V87, P74, DOI 10.1097/00005053-193801000-00005; VAN BOGAERT L, 1952, J Genet Hum, V1, P6; VANBOGAERT L, PERSONAL COMMUNICATI; VANLEEUWEN AM, 1949, BRAIN, V72, P340	27	91	91	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	1					83	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2966A	14452137				2022-12-18	WOS:A19622966A00008
J	Benner, C; Havulinna, AS; Jarvelin, MR; Salomaa, V; Ripatti, S; Pirinen, M				Benner, Christian; Havulinna, Aki S.; Jarvelin, Marjo-Riitta; Salomaa, Veikko; Ripatti, Samuli; Pirinen, Matti			Prospects of Fine-Mapping Trait-Associated Genomic Regions by Using Summary Statistics from Genome-wide Association Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENETIC ARCHITECTURE; CAUSAL VARIANTS; BAYESIAN FRAMEWORK; DIRECT IMPUTATION; COMPLEX TRAITS; RISK; METAANALYSIS; INSIGHTS; LOCI; PLINK	During the past few years, various novel statistical methods have been developed for fine-mapping with the use of summary statistics from genome-wide association studies (GWASs). Although these approaches require information about the linkage disequilibrium (LD) between variants, there has not been a comprehensive evaluation of how estimation of the LD structure from reference genotype panels performs in comparison with that from the original individual-level GWAS data. Using population genotype data from Finland and the UK Biobank, we show here that a reference panel of 1,000 individuals from the target population is adequate for a GWAS cohort of up to 10,000 individuals, whereas smaller panels, such as those from the 1000 Genomes Project, should be avoided. We also show, both theoretically and empirically, that the size of the reference panel needs to scale with the GWAS sample size; this has important consequences for the application of these methods in ongoing GWAS meta-analyses and large biobank studies. We conclude by providing software tools and by recommending practices for sharing LD information to more efficiently exploit summary statistics in genetics research.	[Benner, Christian; Havulinna, Aki S.; Ripatti, Samuli; Pirinen, Matti] Univ Helsinki, Inst Mol Med Finland, FIN-00014 Helsinki, Finland; [Benner, Christian; Ripatti, Samuli; Pirinen, Matti] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Havulinna, Aki S.; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki 00271, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Ctr Life Course Hlth Res, Oulu 90014, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Northern Finland Cohort Ctr, Oulu 90014, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Oulu 90014, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu 90220, Finland; [Jarvelin, Marjo-Riitta] Imperial Coll London, Fac Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London W2 1PG, England; [Ripatti, Samuli] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Pirinen, Matti] Univ Helsinki, Helsinki Inst Informat Technol, FIN-00014 Helsinki, Finland; [Pirinen, Matti] Univ Helsinki, Dept Math & Stat, FIN-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; University of Oulu; Imperial College London; Wellcome Trust Sanger Institute; University of Helsinki; University of Helsinki	Benner, C; Pirinen, M (corresponding author), Univ Helsinki, Inst Mol Med Finland, FIN-00014 Helsinki, Finland.; Benner, C; Pirinen, M (corresponding author), Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland.; Pirinen, M (corresponding author), Univ Helsinki, Helsinki Inst Informat Technol, FIN-00014 Helsinki, Finland.; Pirinen, M (corresponding author), Univ Helsinki, Dept Math & Stat, FIN-00014 Helsinki, Finland.	christian.benner@helsinki.fi; matti.pirinen@helsinki.fi	Havulinna, Aki/AAM-4769-2021	Pirinen, Matti/0000-0002-1664-1350	National Institute for Health and Welfare; Academy of Finland [139635, 257654, 288509, 294050]; Finnish Foundation for Cardiovascular Research; University of Oulu [NFBC1966, 65354]; Oulu University Hospital [2/97, 8/97]; Ministry of Health and Social Affairs [23/251/97, 160/97, 190/97]; National Institute for Health and Welfare [54121]; Regional Institute of Occupational Health [50621, 54231]; Doctoral Programme in Population Health; EU [201413, 261433]; Biocentrum Helsinki; Sigrid Juselius Foundation; Academy of Finland Center of Excellence for Complex Disease Genetics; Medical Research Council [MC_qA137853] Funding Source: researchfish	National Institute for Health and Welfare; Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; University of Oulu; Oulu University Hospital; Ministry of Health and Social Affairs; National Institute for Health and Welfare; Regional Institute of Occupational Health; Doctoral Programme in Population Health; EU(European Commission); Biocentrum Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland Center of Excellence for Complex Disease Genetics(Academy of Finland); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the participants of the FINRISK cohort and its funders: the National Institute for Health and Welfare, the Academy of Finland (139635 to V.S.), and the Finnish Foundation for Cardiovascular Research. This study made use of NFBC1966 data. We thank the late Prof. Paula Rantakallio (who launched NFBC1966), the participants in the 31 year study, and the Northern Finland Birth Cohort project center. NFBC1966 received financial support from University of Oulu grant no. 65354, Oulu University Hospital grant nos. 2/97 and 8/97, Ministry of Health and Social Affairs grant nos. 23/251/97, 160/97, and 190/97, National Institute for Health and Welfare grant no. 54121, and Regional Institute of Occupational Health grant nos. 50621 and 54231.This research was conducted with the UK Biobank Resource under application no. 22627. We acknowledge the Finnish CSC - IT Centre for Science for computational resources. This work was financially supported by the Doctoral Programme in Population Health (C.B.) and the Academy of Finland (257654, 288509, and 294050 to M.P.; 251217 and 255847 to S.R.). S.R. was further supported by the Academy of Finland Center of Excellence for Complex Disease Genetics, EU FP7 project ENGAGE (201413), BioSHaRE (261433), the Finnish Foundation for Cardiovascular Research, Biocentrum Helsinki, and the Sigrid Juselius Foundation.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Benner C, 2016, BIOINFORMATICS, V32, P1493, DOI 10.1093/bioinformatics/btw018; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; Brown BC, 2016, AM J HUM GENET, V99, P76, DOI 10.1016/j.ajhg.2016.05.001; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen WA, 2016, GENETICS, V204, P933, DOI 10.1534/genetics.116.188953; Chen W, 2015, GENETICS, V200, P719, DOI 10.1534/genetics.115.176107; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Feng S, 2014, BIOINFORMATICS, V30, P2828, DOI 10.1093/bioinformatics/btu367; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gormley P, 2016, NAT GENET, V48, P856, DOI 10.1038/ng.3598; Guo MH, 2017, P NATL ACAD SCI USA, V114, pE327, DOI 10.1073/pnas.1619052114; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Iotchkova V, 2016, NAT GENET, V48, P1303, DOI 10.1038/ng.3668; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kichaev G, 2015, AM J HUM GENET, V97, P260, DOI 10.1016/j.ajhg.2015.06.007; Kichaev G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004722; Klos K, 2008, HUM MOL GENET, V17, P2039, DOI 10.1093/hmg/ddn101; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Lee D, 2015, BIOINFORMATICS, V31, P1176, DOI 10.1093/bioinformatics/btu816; Lee D, 2013, BIOINFORMATICS, V29, P2925, DOI 10.1093/bioinformatics/btt500; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li Y, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw627; Liu J, 2016, BIOINFORMATICS, V32, P1856, DOI 10.1093/bioinformatics/btw081; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Newcombe PJ, 2016, GENET EPIDEMIOL, V40, P188, DOI 10.1002/gepi.21953; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Pasaniuc B, 2014, BIOINFORMATICS, V30, P2906, DOI 10.1093/bioinformatics/btu416; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RANTAKALLIO P, 1969, ACTA PAEDIAT SC S193, V0193; Rantakallio P., 1969, ACTA PAEDIATRIC S193, V193, p[1, 193]; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Sanna S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002198; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Shi H, 2016, AM J HUM GENET, V99, P139, DOI 10.1016/j.ajhg.2016.05.013; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Spain SL, 2015, HUM MOL GENET, V24, pR111, DOI 10.1093/hmg/ddv260; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Surakka I, 2015, NAT GENET, V47, P589, DOI 10.1038/ng.3300; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wen XQ, 2010, ANN APPL STAT, V4, P1158, DOI 10.1214/10-AOAS338; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Xu Z, 2015, BIOINFORMATICS, V31, P2434, DOI 10.1093/bioinformatics/btv168; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zhu X, 2017, ANN APPL STAT, V11, P1561, DOI 10.1214/17-AOAS1046	54	90	90	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT 5	2017	101	4					539	551		10.1016/j.ajhg.2017.08.012	http://dx.doi.org/10.1016/j.ajhg.2017.08.012			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FI8UJ	28942963	Green Published, Bronze			2022-12-18	WOS:000412277300005
J	Lloyd-Jones, LR; Holloway, A; McRae, A; Yang, J; Small, K; Zhao, J; Zeng, B; Bakshi, A; Metspalu, A; Dermitzakis, M; Gibson, G; Spector, T; Montgomery, G; Esko, T; Visscher, PM; Powell, JE				Lloyd-Jones, Luke R.; Holloway, Alexander; McRae, Allan; Yang, Jian; Small, Kerrin; Zhao, Jing; Zeng, Biao; Bakshi, Andrew; Metspalu, Andres; Dermitzakis, Manolis; Gibson, Greg; Spector, Tim; Montgomery, Grant; Esko, Tonu; Visscher, Peter M.; Powell, Joseph E.			The Genetic Architecture of Gene Expression in Peripheral Blood	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MIXED-MODEL ANALYSIS; MISSING HERITABILITY; COMPLEX TRAITS; TRANS-EQTLS; VARIANTS; DISEASE; POWER	We analyzed the mRNA levels for 36,778 transcript expression traits (probes) from 2,765 individuals to comprehensively investigate the genetic architecture and degree of missing heritability for gene expression in peripheral blood. We identified 11,204 cis and 3,791 trans independent expression quantitative trait loci (eQTL) by using linear mixed models to perform genome-wide association analyses. Furthermore, using information on both closely and distantly related individuals, heritability was estimated for all expression traits. Of the set of expressed probes (15,966), 10,580 (66%) had an estimated narrow-sense heritability (h(2)) greater than zero with a mean (median) value of 0.192 (0.142). Across these probes, on average the proportion of genetic variance explained by all eQTL (h(COlO)(2)) was 31% (0.060/0.192), meaning that 69% is missing, with the sentinel SNP of the largest eQTL explaining 87 A, (0.052/0.060) of the variance attributed to all identified cis- and trans-eQTL. For the same set of probes, the genetic variance attributed to genome-wide common (MAF > 0.01) HapMap 3 SNPs (h(q)(2)) accounted for on average 48% (0.093/0.192) of h(2). Taken together, the evidence suggests that approximately half the genetic variance for gene expression is not tagged by common SNPs, and of the variance that is tagged by common SNPs, a large proportion can be attributed to identifiable eQTL of large effect, typically in cis. Finally, we present evidence that, compared with a meta-analysis, using individual-level data results in an increase of approximately 50% in power to detect eQTL.	[Lloyd-Jones, Luke R.; McRae, Allan; Yang, Jian; Montgomery, Grant; Visscher, Peter M.; Powell, Joseph E.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Lloyd-Jones, Luke R.; Holloway, Alexander; Yang, Jian; Bakshi, Andrew; Visscher, Peter M.; Powell, Joseph E.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Small, Kerrin; Spector, Tim] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Zhao, Jing; Zeng, Biao; Gibson, Greg] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Zhao, Jing; Zeng, Biao; Gibson, Greg] Georgia Inst Technol, Ctr Integrat Genom, Atlanta, GA 30332 USA; [Metspalu, Andres; Esko, Tonu] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Dermitzakis, Manolis] Univ Geneva, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland	University of Queensland; University of Queensland; University of London; King's College London; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University of Tartu; University of Geneva	Lloyd-Jones, LR; Powell, JE (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.; Lloyd-Jones, LR; Powell, JE (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	l.lloydjones@uq.edu.au; joseph.powell@uq.edu.au	Yang, Jian/A-5852-2010; Lloyd-Jones, Luke R/F-1237-2013; Montgomery, Grant W/B-7148-2008; Visscher, Peter/ABB-6151-2020; McRae, Allan/J-2644-2014	Yang, Jian/0000-0003-2001-2474; Lloyd-Jones, Luke R/0000-0002-0229-0625; Montgomery, Grant W/0000-0002-4140-8139; Visscher, Peter/0000-0002-2143-8760; Bakshi, Andrew/0000-0001-5650-7036; McRae, Allan/0000-0001-5286-5485; Powell, Joseph/0000-0002-5070-4124; Small, Kerrin/0000-0003-4566-0005	Australian National Health and Medical Research Council (NHMRC) [1046880, 1083405, 1107599, 1083656, 1078037, 1078399]; Sylvia and Charles Viertel Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Australian National Health and Medical Research Council (NHMRC) grants (1046880, 1083405, 1107599, 1083656, 1078037, 1078399, 1107599) and the Sylvia and Charles Viertel Charitable Foundation.	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Blom G., 1958, STAT ESTIMATES TRANS, V1st; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen CY, 2013, BIOINFORMATICS, V29, P1399, DOI 10.1093/bioinformatics/btt144; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Gaffney DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003501; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Idaghdour Y, 2010, NAT GENET, V42, P62, DOI 10.1038/ng.495; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kim J, 2014, GENOME MED, V6, DOI 10.1186/gm560; Kirsten H, 2015, HUM MOL GENET, V24, P4746, DOI 10.1093/hmg/ddv194; Leitsalu L, 2015, INT J EPIDEMIOL, V44, P1137, DOI 10.1093/ije/dyt268; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lynch M., 1998, GENETICS ANAL QUANTI, V1; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Panagiotou OA, 2013, ANNU REV GENOM HUM G, V14, P441, DOI 10.1146/annurev-genom-091212-153520; Powell JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003502; Powell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035430; Powell JE, 2012, GENOME RES, V22, P456, DOI 10.1101/gr.126540.111; Preininger M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003362; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001317; R Foundation for Statistical Computing, 2021, R LANG ENV STAT COMP; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Schweiger R, 2016, AM J HUM GENET, V98, P1181, DOI 10.1016/j.ajhg.2016.04.016; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Witte JS, 2014, NAT REV GENET, V15, P765, DOI 10.1038/nrg3786; Wright FA, 2014, NAT GENET, V46, P430, DOI 10.1038/ng.2951; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390; Yang J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003355; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zhao J, 2016, AM J HUM GENET, V98, P299, DOI 10.1016/j.ajhg.2015.12.023; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310	46	90	90	1	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 2	2017	100	2					228	237		10.1016/j.ajhg.2016.12.008	http://dx.doi.org/10.1016/j.ajhg.2016.12.008			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EJ6TP	28065468	Green Published, Bronze			2022-12-18	WOS:000393352000005
J	Browning, BL; Browning, SR				Browning, Brian L.; Browning, Sharon R.			Detecting Identity by Descent and Estimating Genotype Error Rates in Sequence Data	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Existing methods for identity by descent (IBD) segment detection were designed for SNP array data, not sequence data. Sequence data have a much higher density of genetic variants and a different allele frequency distribution, and can have higher genotype error rates. Consequently, best practices for IBD detection in SNP array data do not necessarily carry over to sequence data. We present a method, IBDseq, for detecting IBD segments in sequence data and a method, SEQERR, for estimating genotype error rates at low-frequency variants by using detected IBD. The IBDseq method estimates probabilities of genotypes observed with error for each pair of individuals under IBD and non-IBD models. The ratio of estimated probabilities under the two models gives a LOD score for IBD. We evaluate several IBD detection methods that are fast enough for application to sequence data (IBDseq, Beagle Refined IBD, PLINK, and GERMLINE) under multiple parameter settings, and we show that IBDseq achieves high power and accuracy for IBD detection in sequence data. The SEQERR method estimates genotype error rates by comparing observed and expected rates of pairs of homozygote and heterozygote genotypes at low-frequency variants in IBD segments. We demonstrate the accuracy of SEQERR in simulated data, and we apply the method to estimate genotype error rates in sequence data from the UK10K and 1000 Genomes projects.	[Browning, Brian L.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Browning, Sharon R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Browning, BL (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	browning@uw.edu; sguy@uw.edu	Browning, Sharon/B-1530-2008; Browning, Brian L/A-1178-2010	Browning, Sharon/0000-0001-7251-9715; Browning, Brian L/0000-0001-6454-6633	Wellcome Trust [076113, 085475, WT091310]; National Institutes of Health, USA [HG004960, HG005701, GM099568, GM075091]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004960, R01HG005701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568, R01GM075091] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of the WTCCC investigators who contributed to the generation of the data is available online. Funding for the project was provided by the Wellcome Trust under awards 076113 and 085475. This study makes use of data generated by the UK10K Consortium, derived from samples from UK10K_COHORTS_TWINSUK and UK10K_COHORT_ALSPAC cohorts. A full list of the UK10K investigators who contributed to the generation of the data is available online. Funding for UK10K was provided by the Wellcome Trust under award WT091310. This study was supported by research grants HG004960, HG005701, GM099568, and GM075091 from the National Institutes of Health, USA.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bentley J., 1984, Communications of the ACM, V27, P865, DOI 10.1145/358234.381162; Browning BL, 2013, GENETICS, V194, P459, DOI 10.1534/genetics.113.150029; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning SR, 2012, ANNU REV GENET, V46, P617, DOI 10.1146/annurev-genet-110711-155534; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Su SY, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-121; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Zhuang Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047618	15	90	94	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 7	2013	93	5					840	851		10.1016/j.ajhg.2013.09.014	http://dx.doi.org/10.1016/j.ajhg.2013.09.014			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252HU	24207118	Green Published, Bronze			2022-12-18	WOS:000326996600005
J	Coram, MA; Duan, Q; Hoffmann, TJ; Thornton, T; Knowles, JW; Johnson, NA; Ochs-Balcom, HM; Donlon, TA; Martin, LW; Eaton, CB; Robinson, JG; Risch, NJ; Zhu, XF; Kooperberg, C; Li, Y; Reiner, AP; Tang, H				Coram, Marc A.; Duan, Qing; Hoffmann, Thomas J.; Thornton, Timothy; Knowles, Joshua W.; Johnson, Nicholas A.; Ochs-Balcom, Heather M.; Donlon, Timothy A.; Martin, Lisa W.; Eaton, Charles B.; Robinson, Jennifer G.; Risch, Neil J.; Zhu, Xiaofeng; Kooperberg, Charles; Li, Yun; Reiner, Alex P.; Tang, Hua			Genome-wide Characterization of Shared and Distinct Genetic Components that Influence Blood Lipid Levels in Ethnically Diverse Human Populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CASSETTE TRANSPORTERS G1; AFRICAN-AMERICANS; METABOLIC SYNDROME; ASSOCIATION; DISEASE; RISK; GENOTYPE; HEALTH; HERITABILITY	Blood lipid concentrations are heritable risk factors associated with atherosclerosis and cardiovascular diseases. Lipid traits exhibit considerable variation among populations of distinct ancestral origin as well as between individuals within a population. We performed association analyses to identify genetic loci influencing lipid concentrations in African American and Hispanic American women in the Women's Health Initiative SNP Health Association Resource. We validated one African-specific high-density lipoprotein cholesterol locus at CD36 as well as 14 known lipid loci that have been previously implicated in studies of European populations. Moreover, we demonstrate striking similarities in genetic architecture (loci influencing the trait, direction and magnitude of genetic effects, and proportions of phenotypic variation explained) of lipid traits across populations. In particular, we found that a disproportionate fraction of lipid variation in African Americans and Hispanic Americans can be attributed to genomic loci exhibiting statistical evidence of association in Europeans, even though the precise genes and variants remain unknown. At the same time, we found substantial allelic heterogeneity within shared loci, characterized both by population-specific rare variants and variants shared among multiple populations that occur at disparate frequencies. The allelic heterogeneity emphasizes the importance of including diverse populations in future genetic association studies of complex traits such as lipids; furthermore, the overlap in lipid loci across populations of diverse ancestral origin argues that additional knowledge can be gleaned from multiple populations.	[Coram, Marc A.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Duan, Qing; Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hoffmann, Thomas J.; Risch, Neil J.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; [Hoffmann, Thomas J.; Risch, Neil J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Thornton, Timothy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Knowles, Joshua W.] Stanford Univ, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Knowles, Joshua W.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Johnson, Nicholas A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Ochs-Balcom, Heather M.] SUNY Buffalo, Dept Social & Prevent Med, Buffalo, NY 14214 USA; [Donlon, Timothy A.] Kuakini Med Ctr, Honolulu, HI 96817 USA; [Donlon, Timothy A.] Univ Hawaii, John A Bums Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96813 USA; [Donlon, Timothy A.] Univ Hawaii, John A Bums Sch Med, Dept Pathol, Honolulu, HI 96813 USA; [Martin, Lisa W.] George Washington Univ, Div Cardiol, Sch Med & Hlth Sci, Washington, DC 20037 USA; [Eaton, Charles B.] Brown Univ, Alpert Med Sch, Dept Family Med, Pawtucket, RI 02860 USA; [Eaton, Charles B.] Brown Univ, Program Publ Hlth, Dept Epidemiol, Pawtucket, RI 02860 USA; [Robinson, Jennifer G.] Univ Iowa, Dept Epidemiol & Med, Iowa City, IA 52242 USA; [Risch, Neil J.] Kaiser Permanente, Div Res, Oakland, CA 94612 USA; [Zhu, Xiaofeng] Case Western Reserve Univ, Dept Epidemiol & Biostat, Sch Med, Cleveland, OH 44106 USA; [Kooperberg, Charles] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98109 USA; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA; [Reiner, Alex P.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Tang, Hua] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Stanford University; Stanford University; Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Hawaii System; University of Hawaii System; George Washington University; Brown University; Brown University; University of Iowa; Kaiser Permanente; Case Western Reserve University; Fred Hutchinson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Stanford University	Reiner, AP (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	apreiner@u.washington.edu; huatang@stanford.edu	Zhu, Xiaofeng/O-6874-2019; Ochs-Balcom, Heather M/F-3500-2012; , Jennifer/AAD-8336-2019	Eaton, Charles/0000-0002-7723-9461; Coram, Marc/0000-0002-8877-2501; Martin, Lisa Warsinger/0000-0003-4352-0914; Zhu, Xiaofeng/0000-0003-0037-411X	National Institutes of Health [GM073059, K01 CA148958, R25 CA112355]; National Heart, Lung, and Blood Institute, National Institutes of Health; United States Department of Health and Human Services [HHSN268201100046C, HHSN2682011 00001C, HHSN268201100002C, HHSN268201100003C, HHSN2 68201100004C, HHSN271201100004C]; NATIONAL CANCER INSTITUTE [K01CA148958, K07CA136969, R25CA112355] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099568, R01GM073059] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the National Institutes of Health grants GM073059 (to H.T.), K01 CA148958 (to T.T.), and R25 CA112355 (to T.J.H.). The Women's Health Initiative (WHI) program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, and the United States Department of Health and Human Services through contracts HHSN268201100046C, HHSN2682011 00001C, HHSN268201100002C, HHSN268201100003C, HHSN2 68201100004C, and HHSN271201100004C. The authors thank the WHI investigators and staff for their dedication and the study participants for making the program possible. A listing of WHI investigators can be found at https://cleo.whi.org/researchers/Documents%20%20Write%20a%20Paper/WHI%20Investigator%20Long%20List.pdf. We thank two anonymous reviewers for their helpful comments.	Basu A, 2009, HUM MOL GENET, V18, P2091, DOI 10.1093/hmg/ddp122; Beekman M, 2002, TWIN RES, V5, P87, DOI 10.1375/twin.5.2.87; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Carty CL, 2012, HUM MOL GENET, V21, P711, DOI 10.1093/hmg/ddr489; Charlesworth B, 1997, GENET RES, V70, P155, DOI 10.1017/S0016672397002954; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Deo RC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000342; Dumitrescu L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002138; Elbers CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050198; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Furuhashi M, 2003, DIABETES CARE, V26, P471, DOI 10.2337/diacare.26.2.471; GARTSIDE PS, 1984, AM HEART J, V108, P641, DOI 10.1016/0002-8703(84)90649-5; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Hays J, 2003, ANN EPIDEMIOL, V13, pS18, DOI 10.1016/S1047-2797(03)00042-5; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Huang CC, 2009, CIRC-CARDIOVASC GENE, V2, P354, DOI 10.1161/CIRCGENETICS.108.828467; Huang WD, 2011, NATURE, V470, P414, DOI 10.1038/nature09703; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; LaRosa JC, 2005, AM J MED, V118, P1314, DOI 10.1016/j.amjmed.2005.04.041; Lettre G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001300; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Love-Gregory L, 2011, HUM MOL GENET, V20, P193, DOI 10.1093/hmg/ddq449; Luo BF, 2010, J MED GENET, V47, P415, DOI 10.1136/jmg.2009.068932; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mensah GA, 2005, CIRCULATION, V111, P1233, DOI 10.1161/01.CIR.0000158136.76824.04; Metcalf PA, 1998, AM J EPIDEMIOL, V148, P750; Morris AP, 2011, GENET EPIDEMIOL, V35, P809, DOI 10.1002/gepi.20630; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000519; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2012, AM J HUM GENET, V91, P502, DOI 10.1016/j.ajhg.2012.07.023; Reiner AP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002108; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tang H, 2006, AM J HUM GENET, V79, P1, DOI 10.1086/504302; Tang H, 2010, GENET EPIDEMIOL, V34, P783, DOI 10.1002/gepi.20520; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Thornton T, 2010, AM J HUM GENET, V86, P172, DOI 10.1016/j.ajhg.2010.01.001; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com; Wei M, 1996, AM J EPIDEMIOL, V144, P1058, DOI 10.1093/oxfordjournals.aje.a008878; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003379; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	58	90	94	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					904	916		10.1016/j.ajhg.2013.04.025	http://dx.doi.org/10.1016/j.ajhg.2013.04.025			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23726366	Green Published, Bronze			2022-12-18	WOS:000320415300007
J	Zhu, MF; Need, AC; Han, YJ; Ge, DL; Maia, JM; Zhu, QQ; Heinzen, EL; Cirulli, ET; Pelak, K; He, M; Ruzzo, EK; Gumbs, C; Singh, A; Feng, S; Shianna, KV; Goldstein, DB				Zhu, Mingfu; Need, Anna C.; Han, Yujun; Ge, Dongliang; Maia, Jessica M.; Zhu, Qianqian; Heinzen, Erin L.; Cirulli, Elizabeth T.; Pelak, Kimberly; He, Min; Ruzzo, Elizabeth K.; Gumbs, Curtis; Singh, Abanish; Feng, Sheng; Shianna, Kevin V.; Goldstein, David B.			Using ERDS to Infer Copy-Number Variants in High-Coverage Genomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RARE CHROMOSOMAL DELETIONS; STRUCTURAL VARIATION; RECURRENT MICRODELETIONS; 16P13.11 PREDISPOSE; POLYMORPHISM; ALGORITHM; SPECTRUM; FORMAT; MAP	Although there are many methods available for inferring copy-number variants (CNVs) from next-generation sequence data, there remains a need for a system that is computationally efficient but that retains good sensitivity and specificity across all types of CNVs. Here, we introduce a new method, estimation by read depth with single-nucleotide variants (ERDS), and use various approaches to compare its performance to other methods. We found that for common CNVs and high-coverage genomes, ERDS performs as well as the best method currently available (Genome STRiP), whereas for rare CNVs and high-coverage genomes, ERDS performs better than any available method. Importantly, ERDS accommodates both unique and highly amplified regions of the genome and does so without requiring separate alignments for calling CNVs and other variants. These comparisons show that for genomes sequenced at high coverage, ERDS provides a computationally convenient method that calls CNVs as well as or better than any currently available method.	[Zhu, Mingfu; Need, Anna C.; Han, Yujun; Ge, Dongliang; Maia, Jessica M.; Zhu, Qianqian; Heinzen, Erin L.; Cirulli, Elizabeth T.; Pelak, Kimberly; He, Min; Ruzzo, Elizabeth K.; Gumbs, Curtis; Singh, Abanish; Shianna, Kevin V.; Goldstein, David B.] Duke Univ, Ctr Human Genome Variat, Durham, NC 27708 USA; [Ge, Dongliang; Feng, Sheng] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27708 USA	Duke University; Duke University	Zhu, MF (corresponding author), Duke Univ, Ctr Human Genome Variat, Durham, NC 27708 USA.	mingfu.zhu@duke.edu; d.goldstein@duke.edu	Zhu, Mingfu/F-3217-2011; Goldstein, David/AAY-8125-2020	Zhu, Mingfu/0000-0003-0296-712X; Cirulli Rogers, Liz/0000-0001-7808-2809; Need, Anna/0000-0003-3955-8207	Center for HIV/AIDS Vaccine Immunology ("CHAVI") from the National Institute of Allergy and Infectious Diseases, National Institutes of Health [UO1AIO67854]; American Recovery and Reinvestment Act (ARRA) National Institute of Mental Health (NIMH) Grand Opportunities [1RC2MH089915-01]; National Institute of Neurological Disorders and Stroke [1RC2NS070344-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC2NS070344] Funding Source: NIH RePORTER	Center for HIV/AIDS Vaccine Immunology ("CHAVI") from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; American Recovery and Reinvestment Act (ARRA) National Institute of Mental Health (NIMH) Grand Opportunities; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research has been funded in whole or part with federal funds from the Center for HIV/AIDS Vaccine Immunology ("CHAVI") under a grant from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, grant number UO1AIO67854, American Recovery and Reinvestment Act (ARRA) National Institute of Mental Health (NIMH) Grand Opportunities grant 1RC2MH089915-01, and National Institute of Neurological Disorders and Stroke-funded ARRA Grand Opportunities grant 1RC2NS070344-01. We thank Evan Eichler and Can Alkan in particular for helping us to establish an appropriate framework for handling SD regions within ERDS. We thank Evan Eichler, Can Alkan, Aylwyn Scally, and Thomas Urban for their help during software development and Donald Conrad, Ryan Mills and Jacques Fellay for their help during manuscript preparation. We thank Robert Handsaker and Steven McCarroll for assistance with setting up Genome STRiP, Alexej Abyzov for assistance with setting up CNVnator, and Paul Medvedev for assistance with setting up CNVer.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; LANDER E S, 1988, Genomics, V2, P231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Medvedev P, 2010, GENOME RES, V20, P1613, DOI 10.1101/gr.106344.110; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stewart C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002236; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/NMETH.1628, 10.1038/nmeth.1628]; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	40	90	91	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 7	2012	91	3					408	421		10.1016/j.ajhg.2012.07.004	http://dx.doi.org/10.1016/j.ajhg.2012.07.004			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	004LL	22939633	Green Published, Bronze			2022-12-18	WOS:000308683100002
J	Zelinger, L; Banin, E; Obolensky, A; Mizrahi-Meissonnier, L; Beryozkin, A; Bandah-Rozenfeld, D; Frenkel, S; Ben-Yosef, T; Merin, S; Schwartz, SB; Cideciyan, AV; Jacobson, SG; Sharon, D				Zelinger, Lina; Banin, Eyal; Obolensky, Alexey; Mizrahi-Meissonnier, Liliana; Beryozkin, Avigail; Bandah-Rozenfeld, Dikla; Frenkel, Shahar; Ben-Yosef, Tamar; Merin, Saul; Schwartz, Sharon B.; Cideciyan, Artur V.; Jacobson, Samuel G.; Sharon, Dror			A Missense Mutation in DHDDS, Encoding Dehydrodolichyl Diphosphate Synthase, Is Associated with Autosomal-Recessive Retinitis Pigmentosa in Ashkenazi Jews	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							N-GLYCOSYLATION; DOLICHOL; GENE; METABOLISM; RHODOPSIN; BRAIN; IDENTIFICATION; BIOSYNTHESIS; CARBOHYDRATE; ACCUMULATION	Retinitis pigmentosa (RP) is a heterogeneous group of inherited retinal degenerations caused by mutations in at least 50 genes. Using homozygosity mapping in Ashkenazi Jewish (AJ) patients with autosomal-recessive RP (arRP), we identified a shared 1.7 Mb homozygous region on chromosome 1p36.11. Sequence analysis revealed a founder homozygous missense mutation, c.124A>G (p.Lys42Glu), in the dehydrodolichyl diphosphate synthase gene (DHDDS) in 20 AJ patients with RP of 15 unrelated families. The mutation was not identified in an additional set of 109 AJ patients with RP, in 20 AJ patients with other inherited retinal diseases, or in 70 patients with retinal degeneration of other ethnic origins. The mutation was found heterozygously in 1 out of 322 ethnically matched normal control individuals. RT-PCR analysis in 21 human tissues revealed ubiquitous expression of DHDDS. Immunohistochemical analysis of the human retina with anti-DHDDS antibodies revealed intense labeling of the cone and rod photoreceptor inner segments. Clinical manifestations of patients who are homozygous for the c.124A>G mutation were within the spectrum associated with arRP. Most patients had symptoms of night and peripheral vision loss, nondetectable electroretinographic responses, constriction of visual fields, and funduscopic hallmarks of retinal degeneration. DHDDS is a key enzyme in the pathway of dolichol, which plays an important role in N-glycosylation of many glycoproteins, including rhodopsin. Our results support a pivotal role of DHDDS in retinal function and may allow for new therapeutic interventions for RP.	[Schwartz, Sharon B.; Cideciyan, Artur V.; Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA; [Zelinger, Lina; Banin, Eyal; Obolensky, Alexey; Mizrahi-Meissonnier, Liliana; Beryozkin, Avigail; Bandah-Rozenfeld, Dikla; Frenkel, Shahar; Merin, Saul; Sharon, Dror] Hadassah Hebrew Univ, Dept Ophthalmol, Med Ctr, IL-91120 Jerusalem, Israel; [Ben-Yosef, Tamar] Technion Israel Inst Technol, Dept Genet, Rappaport Fac Med, IL-31096 Haifa, Israel	University of Pennsylvania; Pennsylvania Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Jacobson, SG (corresponding author), Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA.	jacobsos@mail.med.upenn.edu; dror.sharon1@gmail.com	Frenkel, Shahar/AAQ-1909-2020; Zelinger, Lina/L-3272-2019; Sharon, Dror/P-4539-2015; Cideciyan, Artur V/A-1075-2007	Frenkel, Shahar/0000-0002-3688-8676; Sharon, Dror/0000-0002-1789-5811; Cideciyan, Artur V/0000-0002-2018-0905; Zelinger, Lina/0000-0003-3028-7172; Jacobson, Samuel/0000-0003-2122-169X	Foundation Fighting Blindness USA [BR-GE-0510-0490-HUJ, C-CL-07-0411,0412]; Israeli Science Foundation [612/09]; Hope for Vision; Yedidut 1 research grant	Foundation Fighting Blindness USA; Israeli Science Foundation(Israel Science Foundation); Hope for Vision; Yedidut 1 research grant	This study was financially supported by the Foundation Fighting Blindness USA (BR-GE-0510-0490-HUJ to D.S.; C-CL-07-0411,0412 to A.V.C. and S.G.J.), by the Legacy Heritage Biomedical Program of the Israeli Science Foundation (grant 612/09 to T.B.-Y. and D.S.), Hope for Vision (to A.V.C. and S.G.J.), and the Yedidut 1 research grant (to E.B.). We thank the patients and their families for their participation in the study. The authors thank Michal Ben-Hur, Rob W. Collin, Sandro Banfi, Robert K. Koenekoop, Israel Barzel, Alejandro Roman, Malgorzata Swider, Alexander Sumaroka, Yelena Piontek, and Michael Kogan for excellent and generous assistance. The authors would also like to thank Steven J. Fliesler for helpful discussions.	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; ARDAIL D, 1990, BIOCHIM BIOPHYS ACTA, V1024, P131, DOI 10.1016/0005-2736(90)90216-B; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Behar DM, 2003, AM J HUM GENET, V73, P768, DOI 10.1086/378506; Beit-Ya'acov A, 2007, INVEST OPHTH VIS SCI, V48, P4308, DOI 10.1167/iovs.07-0244; Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; BUNDEY S, 1984, J MED GENET, V21, P421, DOI 10.1136/jmg.21.6.421; BUNKER CH, 1984, AM J OPHTHALMOL, V97, P357, DOI 10.1016/0002-9394(84)90636-6; CARROLL KK, 1992, BIOCHEM CELL BIOL, V70, P382, DOI 10.1139/o92-059; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Cideciyan AV, 2007, HUM MUTAT, V28, P1074, DOI 10.1002/humu.20565; Cohen T, 2004, ANN HUM BIOL, V31, P38, DOI 10.1080/0301446032000159255; DUFFIN KL, 1993, GLYCOBIOLOGY, V3, P365, DOI 10.1093/glycob/3.4.365; EDLUND C, 1992, BIOCHEM CELL BIOL, V70, P422, DOI 10.1139/o92-065; EGGENS I, 1983, BIOCHIM BIOPHYS ACTA, V751, P355, DOI 10.1016/0005-2760(83)90294-1; ELBEIN AD, 1984, CRC CR REV BIOCH MOL, V16, P21, DOI 10.3109/10409238409102805; Endo S, 2003, BBA-GENE STRUCT EXPR, V1625, P291, DOI 10.1016/S0167-4781(02)00628-0; FLIESLER SJ, 1985, J CELL BIOL, V100, P574, DOI 10.1083/jcb.100.2.574; FLIESLER SJ, 1984, EXP EYE RES, V39, P153, DOI 10.1016/0014-4835(84)90005-8; FLIESLER SJ, 1984, NATURE, V311, P575, DOI 10.1038/311575a0; FLIESLER SJ, 1988, GLYCOCONJUGATES MED, P316; FUJITA S, 1994, GLYCOBIOLOGY, V4, P633, DOI 10.1093/glycob/4.5.633; FUKUDA MN, 1979, J BIOL CHEM, V254, P8201; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hiller M, 2004, NAT GENET, V36, P1255, DOI 10.1038/ng1469; Hooff GP, 2010, BBA-MOL CELL BIOL L, V1801, P896, DOI 10.1016/j.bbalip.2010.03.014; HUANG SH, 1995, NAT GENET, V11, P468, DOI 10.1038/ng1295-468; Jacobson SG, 2008, HUM MOL GENET, V17, P2405, DOI 10.1093/hmg/ddn140; Kean EL, 1999, BBA-GEN SUBJECTS, V1473, P272, DOI 10.1016/S0304-4165(99)00198-1; KELLER RK, 1988, J BIOL CHEM, V263, P2250; Kukuruzinska MA, 1998, CRIT REV ORAL BIOL M, V9, P415, DOI 10.1177/10454411980090040301; LIANG CJ, 1979, J BIOL CHEM, V254, P6414; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Murray AR, 2009, OPHTHALMIC GENET, V30, P109, DOI 10.1080/13816810902962405; Nebel A, 2001, AM J HUM GENET, V69, P1095, DOI 10.1086/324070; PULLARKAT RK, 1982, J BIOL CHEM, V257, P5991; Rebl A, 2009, COMP BIOCHEM PHYS B, V152, P260, DOI 10.1016/j.cbpb.2008.12.003; RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6; Rosenberg T, 2003, DEV OPHTHALMOL, V37, P16; Rozen S, 2000, Methods Mol Biol, V132, P365; SODERBERG M, 1992, J NEUROCHEM, V59, P1646; Wang H, 2009, AM J HUM GENET, V84, P380, DOI 10.1016/j.ajhg.2009.02.005; WEST CM, 1986, MOL CELL BIOCHEM, V72, P3; WOLFE LS, 1982, LANCET, V2, P99; WOLFE LS, 1983, NEUROLOGY, V33, P103, DOI 10.1212/WNL.33.1.103; Zlotogora J, 2000, MOL GENET METAB, V69, P169, DOI 10.1006/mgme.2000.2969	49	90	92	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 11	2011	88	2					207	215		10.1016/j.ajhg.2011.01.002	http://dx.doi.org/10.1016/j.ajhg.2011.01.002			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	725YZ	21295282	Green Published, Bronze			2022-12-18	WOS:000287684100009
J	Rodriguez-Santiago, B; Malats, N; Rothman, N; Armengol, L; Garcia-Closas, M; Kogevinas, M; Villa, O; Hutchinson, A; Earl, J; Marenne, G; Jacobs, K; Rico, D; Tardon, A; Carrato, A; Thomas, G; Valencia, A; Silverman, D; Real, FX; Chanock, SJ; Perez-Jurado, LA				Rodriguez-Santiago, Benjamin; Malats, Nuria; Rothman, Nathaniel; Armengol, Lluis; Garcia-Closas, Montse; Kogevinas, Manolis; Villa, Olaya; Hutchinson, Amy; Earl, Julie; Marenne, Gaelle; Jacobs, Kevin; Rico, Daniel; Tardon, Adonina; Carrato, Alfredo; Thomas, Gilles; Valencia, Alfonso; Silverman, Debra; Real, Francisco X.; Chanock, Stephen J.; Perez-Jurado, Luis A.			Mosaic Uniparental Disomies and Aneuploidies as Large Structural Variants of the Human Genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER-VARIATION; LOW-LEVEL MOSAICISM; CHROMOSOMAL MOSAICISM; SOMATIC MOSAICISM; SEGMENTAL DUPLICATIONS; INSTABILITY; MECHANISMS; MUTATION; CANCER; REGION	Mosaicism is defined as the coexistence of cells with different genetic composition within an individual, caused by postzygotic somatic mutation. Although somatic mosaicism for chromosomal abnormalities is a well-established cause of developmental and somatic disorders and has also been detected in different tissues, its frequency and extent in the adult normal population are still unknown. We provide here a genome-wide survey of mosaic genomic variation obtained by analyzing Illumina 1M SNP array data from blood or buccal DNA samples of 1991 adult individuals from the Spanish Bladder Cancer/EPICURO genome-wide association study. We found mosaic abnormalities in autosomes in 1.7% of samples, including 23 segmental uniparental disomies, 8 complete trisomies, and 11 large (1.5-37 Mb) copy-number variants. Alterations were observed across the different autosomes with recurrent events in chromosomes 9 and 20. No case-control differences were found in the frequency of events or the percentage of cells affected, thus indicating that most rearrangements found are not central to the development of bladder cancer. However, five out of six events tested were detected in both blood and bladder tissue from the same individual, indicating an early developmental origin. The high cellular frequency of the anomalies detected and their presence in normal adult individuals suggest that this type of mosaicism is a widespread phenomenon in the human genome. Somatic mosaicism should be considered in the expanding repertoire of inter- and intraindividual genetic variation, some of which may cause somatic human diseases but also contribute to modifying inherited disorders and/or late-onset multifactorial traits.	[Rodriguez-Santiago, Benjamin; Villa, Olaya; Real, Francisco X.; Perez-Jurado, Luis A.] Univ Pompeu Fabra, Dept Ciencias Expt Salut, E-08003 Barcelona, Spain; [Rodriguez-Santiago, Benjamin; Villa, Olaya; Perez-Jurado, Luis A.] CIBERER, E-08003 Barcelona, Spain; [Malats, Nuria; Earl, Julie; Marenne, Gaelle; Rico, Daniel; Valencia, Alfonso; Real, Francisco X.] Ctr Nacl Invest Oncol, E-28029 Madrid, Spain; [Rothman, Nathaniel; Garcia-Closas, Montse; Silverman, Debra; Chanock, Stephen J.] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; [Armengol, Lluis] qGenomics, Quantitat Genom Med Lab, E-08003 Barcelona, Spain; [Kogevinas, Manolis] Hosp del Mar, IMIM, Municipal Inst Med Res, E-08003 Barcelona, Spain; [Kogevinas, Manolis; Tardon, Adonina] Ctr Res Environm Epidemiol CREAL, E-08003 Barcelona, Spain; [Kogevinas, Manolis] CIBERESP, E-08003 Barcelona, Spain; [Kogevinas, Manolis] Natl Sch Publ Hlth, G-11521 Athens, Greece; [Jacobs, Kevin; Thomas, Gilles; Chanock, Stephen J.] SAIC Frederick, Core Genotyping Facil, Frederick, MD 21702 USA; [Tardon, Adonina] Univ Oviedo, Dept Epidemiol & Med Prevent, E-33003 Oviedo, Spain; [Carrato, Alfredo] Hosp Gen Univ Elche, Mol Oncol Grp, E-03203 Elche, Spain; [Perez-Jurado, Luis A.] Hosp Univ Vall Hebron, Programa Med Mol & Genet, E-08035 Barcelona, Spain; [Perez-Jurado, Luis A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Science Applications International Corporation (SAIC); SAIC-Frederick; University of Oviedo; Hospital Universitari Vall d'Hebron; University of Washington; University of Washington Seattle	Perez-Jurado, LA (corresponding author), Univ Pompeu Fabra, Dept Ciencias Expt Salut, E-08003 Barcelona, Spain.	luis.perez@upf.edu	Garcia-Closas, Montserrat/F-3871-2015; Kogevinas, Manolis/C-3918-2017; Marenne, Gaelle/AAU-8338-2020; Pérez Jurado, Luis Alberto/M-7706-2015; Malats, Nuria/H-7041-2015; TARDON, ADONINA/B-6563-2014; Arribas, Francisco X Real/H-5275-2015; Valencia, Alfonso/I-3127-2015; Rico, Daniel/I-2049-2013	Garcia-Closas, Montserrat/0000-0003-1033-2650; Kogevinas, Manolis/0000-0002-9605-0461; Marenne, Gaelle/0000-0002-4363-7170; Malats, Nuria/0000-0003-2538-3784; TARDON, ADONINA/0000-0001-5150-1209; Arribas, Francisco X Real/0000-0001-9501-498X; Valencia, Alfonso/0000-0002-8937-6789; Earl, Julie/0000-0001-9360-4716; CARRATO, ALFREDO/0000-0001-7749-8140; Rico, Daniel/0000-0002-6561-2310; Rodriguez-Santiago, Benjamin/0000-0003-1167-3852	NCI Division of Cancer Epidemiology and Genetics; Asociacion Espanola Contra el Cancer; EU [LSHG-CT-2006-037627, HEALTH-STREP-2006-037739-DropTop, 201663-UROMOL, 201333-DEC-anBIO]; Fondo de Investigacion Sanitaria [PI076832, PI061614]; Consolider ONCOBIO; National Institutes of Health [R01 CA089715-06A2]; Red Tematica de Investigacion Cooperativa en Cancer; Fundacio La Marato de TV3; Fondo Investigacion Sanitaria [FIS CD06/00019, FI09/00205]; NATIONAL CANCER INSTITUTE [R01CA089715] Funding Source: NIH RePORTER	NCI Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Asociacion Espanola Contra el Cancer; EU(European Commission); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Consolider ONCOBIO; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Red Tematica de Investigacion Cooperativa en Cancer; Fundacio La Marato de TV3; Fondo Investigacion Sanitaria(Instituto de Salud Carlos III); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank D. Pastor, A. Alfaro, M. Marquez, T. Lobato, F. Fernandez, M. Tora, J. Lloreta, C. Guerrero, C. Ampurdanes, A. Itsara, K. Wang, and M. Salido for technical assistance, as well as D.G. Pisano, E. Andres, R. Diaz-Uriarte, G. Gomez, A. Gonzalez-Neira, G. Pita, and I. Cusco for critical comments. This work was supported by the Intramural Research Program of the NCI Division of Cancer Epidemiology and Genetics (to N.R., D.S., and S.J.C.), the Asociacion Espanola Contra el Cancer (to F.X.R., N.M., and L.A.P.-J.), EU-6FP grants LSHG-CT-2006-037627 (to L.A.P.-J.) and HEALTH-STREP-2006-037739-DropTop (to N.M. and F.X.R.), Fondo de Investigacion Sanitaria grants PI076832 (to L.A.P.-J.) and PI061614 (to F.X.R.), Consolider ONCOBIO (to F.X.R.), National Institutes of Health grant R01 CA089715-06A2 (to N.M. and F.X.R.), Red Tematica de Investigacion Cooperativa en Cancer (to N.M. and A.C.), Fundacio La Marato de TV3 (to N.M.), and EU-7FP grant agreements #201663-UROMOL (to N.M. and F.X.R.) and #201333-DEC-anBIO (to N.M.). B.R.-S. and G.M. were supported by a postdoctoral fellowship (FIS CD06/00019) and a predoctoral fellowship (FI09/00205) of the Fondo Investigacion Sanitaria, respectively.	Amiel A, 2001, J HUM GENET, V46, P245, DOI 10.1007/s100380170073; Balliff BC, 2006, AM J MED GENET A, V140A, P2757, DOI 10.1002/ajmg.a.31539; Bench AJ, 2000, ONCOGENE, V19, P3902, DOI 10.1038/sj.onc.1203728; Bruder CEG, 2008, AM J HUM GENET, V82, P763, DOI 10.1016/j.ajhg.2007.12.011; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Cheung SW, 2007, AM J MED GENET A, V143A, P1679, DOI 10.1002/ajmg.a.31740; Conlin LK, 2010, HUM MOL GENET, V19, P1263, DOI 10.1093/hmg/ddq003; Cusco I, 2008, GENOME RES, V18, P683, DOI 10.1101/gr.073197.107; Engel E, 2006, EUR J HUM GENET, V14, P1158, DOI 10.1038/sj.ejhg.5201619; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; Frank SA, 2010, P NATL ACAD SCI USA, V107, P1725, DOI 10.1073/pnas.0909343106; Guey LT, 2010, EUR UROL, V57, P283, DOI 10.1016/j.eururo.2009.08.001; GUTTENBACH M, 1995, AM J HUM GENET, V57, P1143; HALL JG, 1988, AM J HUM GENET, V43, P355; HSU LYF, 1992, PRENATAL DIAG, V12, P555, DOI 10.1002/pd.1970120702; Hsu LYF, 1996, PRENATAL DIAG, V16, P1, DOI 10.1002/(SICI)1097-0223(199601)16:1<1::AID-PD816>3.0.CO;2-W; Iourov IY, 2008, MOL CYTOGENET, V1, DOI 10.1186/1755-8166-1-26; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kotzot D, 2008, J MED GENET, V45, P545, DOI 10.1136/jmg.2008.058016; Lee S, 2007, P NATL ACAD SCI USA, V104, P13732, DOI 10.1073/pnas.0701771104; Lerner M, 2009, EXP CELL RES, V315, P2941, DOI 10.1016/j.yexcr.2009.07.001; Liang Q, 2008, P NATL ACAD SCI USA, V105, P17453, DOI 10.1073/pnas.0805638105; Lu XY, 2008, PEDIATRICS, V122, P1310, DOI 10.1542/peds.2008-0297; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Migliazza A, 2001, BLOOD, V97, P2098, DOI 10.1182/blood.V97.7.2098; Mkrtchyan H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009591; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Notini AJ, 2008, CYTOGENET GENOME RES, V123, P270, DOI 10.1159/000184717; Piotrowski A, 2008, HUM MUTAT, V29, P1118, DOI 10.1002/humu.20815; Rehen SK, 2005, J NEUROSCI, V25, P2176, DOI 10.1523/JNEUROSCI.4560-04.2005; Samanic C, 2006, CANCER EPIDEM BIOMAR, V15, P1348, DOI 10.1158/1055-9965.EPI-06-0021; Scott SA, 2010, GENET MED, V12, P85, DOI 10.1097/GIM.0b013e3181cc75d0; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; WHITE NJ, 1994, BLOOD, V83, P2809, DOI 10.1182/blood.V83.10.2809.2809; Youssoufian H, 2002, NAT REV GENET, V3, P748, DOI 10.1038/nrg906; Yurov YB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000558	39	90	91	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 9	2010	87	1					129	138		10.1016/j.ajhg.2010.06.002	http://dx.doi.org/10.1016/j.ajhg.2010.06.002			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	627HD	20598279	Green Published, Bronze			2022-12-18	WOS:000280029200014
J	Oeffner, F; Fischer, G; Happle, R; Konig, A; Betz, RC; Bornholdt, D; Neidel, U; Boente, MD; Redler, S; Romero-Gomez, J; Salhi, A; Vera-Casano, A; Weirich, C; Grzeschik, KH				Oeffner, Frank; Fischer, Gayle; Happle, Rudolf; Koenig, Arne; Betz, Regina C.; Bornholdt, Dorothea; Neidel, Ulrike; Boente, Maria del Carmen; Redler, Silke; Romero-Gomez, Javier; Salhi, Aicha; Vera-Casano, Angel; Weirich, Christian; Grzeschik, Karl-Heinz			IFAP Syndrome Is Caused by Deficiency in MBTPS2, an Intramembrane Zinc Metalloprotease Essential for Cholesterol Homeostasis and ER Stress Response	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STEROL REGULATORY ELEMENT; ICHTHYOSIS-FOLLICULARIS; PHOTOPHOBIA; ALOPECIA; CLEAVAGE; ATRICHIA; GENE; PROTEIN; IDENTIFICATION; MUTATIONS	Ichthyosis follicularis with atrichia and photophobia (IFAP syndrome) is a rare X-linked, oculocutaneous human disorder. Here, we assign the IFAP locus to the 5.4 Mb region between DXS989 and DXS8019 on Xp22.11-p22.13 and provide evidence that missense mutations exchanging highly conserved amino acids of membrane-bound transcription factor protease, site 2 (MBTPS2) are associated with this phenotype. MBTPS2, a membrane-embedded zinc metalloprotease, activates signaling proteins involved in sterol control of transcription and ER stress response. Wild-type MBTPS2 was able to complement the protease deficiency in Chinese hamster M19 cells as shown by induction of an SRE-regulated reporter gene in transient transfection experiments and by growth of stably transfected cells in media devoid of cholesterol and lipids. These functions were impaired in five mutations as detected in unrelated patients. The degree of diminished activity correlated with clinical severity as noted in male patients. Our findings indicate that the phenotypic expression of IFAP syndrome is quantitatively related to a reduced function of a key cellular regulatory system affecting cholesterol homeostasis and ability to cope with ER stress.	[Oeffner, Frank; Bornholdt, Dorothea; Neidel, Ulrike; Weirich, Christian; Grzeschik, Karl-Heinz] Univ Marburg, Dept Human Genet, D-35037 Marburg, Germany; [Fischer, Gayle] Univ Sydney, No Clin Sch, St Leonards, NSW 2065, Australia; [Happle, Rudolf; Koenig, Arne] Univ Marburg, Dept Dermatol, D-35037 Marburg, Germany; [Betz, Regina C.; Redler, Silke] Univ Bonn, Dept Human Genet, D-53111 Bonn, Germany; [Salhi, Aicha] Univ Algiers, Dept Dermatol, Algiers 16030, Algeria; [Boente, Maria del Carmen] Hosp Nino Jesus, Dept Dermatol, RA-4000 San Miguel De Tucuman, Tucuman, Argentina; [Vera-Casano, Angel] Hosp Carlos Haya, Dept Dermatol, Malaga 29010, Spain	Philipps University Marburg; University of Sydney; Philipps University Marburg; University of Bonn; Hospital Carlos Haya	Grzeschik, KH (corresponding author), Univ Marburg, Dept Human Genet, D-35037 Marburg, Germany.	grzeschi@staff.uni-marburg.de	Betz, Regina C/E-8591-2011	Betz, Regina C/0000-0001-5024-3623	BMBF (Netzwerk fur Ichthyosen und verwandte Verhornungsstorungen, NIRK); EU (Coordination Action Geneskin); German Research Foundation (DFG)	BMBF (Netzwerk fur Ichthyosen und verwandte Verhornungsstorungen, NIRK)(Federal Ministry of Education & Research (BMBF)); EU (Coordination Action Geneskin)(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	We are grateful to the patients and their families for their cooperation, and we thank Howard Cann, CEPH, Paris, for a control DNA sample, M. Soufi, Department of Internal Medicine, Philipp University, Marburg, for a supply of delipidated FCS, Dr. J.L. Goldstein, UT Southwestern Medical School, Dallas, Texas, for advice on where to trace research materials, T.Y. Chang, Dartmouth Medical School, Hanover, N.H., for providing CHO-K1-M19 cells, and S. Wiemann, DKFZ, Heidelberg, for the plasmid pdEYFP-Clamp. This research was supported by BMBF (Netzwerk fur Ichthyosen und verwandte Verhornungsstorungen, NIRK) and EU (Coordination Action Geneskin). R.C.B. is a recipient of an Emmy Noether grant from the German Research Foundation (DFG).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Boente MD, 2000, EUR J DERMATOL, V10, P98; Braverman N, 1999, NAT GENET, V22, P291, DOI 10.1038/10357; BRIGGS MR, 1993, J BIOL CHEM, V268, P14490; Cambiaghi S, 2002, J AM ACAD DERMATOL, V46, pS156, DOI 10.1067/mjd.2002.112930; Cursiefen C, 1999, ARCH OPHTHALMOL-CHIC, V117, P681; Elias PM, 2008, J LIPID RES, V49, P697, DOI 10.1194/jlr.R800002-JLR200; Elias PM, 2004, J INVEST DERMATOL, V122, P314, DOI 10.1046/j.1523-1747.2003.22258.x; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; Happle R, 2004, AM J MED GENET A, V124A, P328, DOI 10.1002/ajmg.a.20353; HASAN MT, 1994, SOMAT CELL MOLEC GEN, V20, P183, DOI 10.1007/BF02254759; Keyvani K, 1998, AM J MED GENET, V78, P371, DOI 10.1002/(SICI)1096-8628(19980724)78:4<371::AID-AJMG13>3.0.CO;2-F; Khandpur S, 2005, J EUR ACAD DERMATOL, V19, P759, DOI 10.1111/j.1468-3083.2005.01318.x; Konig A, 1999, AM J MED GENET, V85, P365, DOI 10.1002/(SICI)1096-8628(19990806)85:4<365::AID-AJMG12>3.0.CO;2-#; Konig A, 2000, AM J MED GENET, V90, P339; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lisch W, 2000, AM J OPHTHALMOL, V130, P461, DOI 10.1016/S0002-9394(00)00494-3; Macleod JMH, 1909, BRIT J DERMATOL, V21, P165; Megarbane H, 2004, AM J MED GENET A, V124A, P323, DOI 10.1002/ajmg.a.20352; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Rawson RB, 1997, MOL CELL, V1, P47, DOI 10.1016/S1097-2765(00)80006-4; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Sato-Matsumura KC, 2000, BRIT J DERMATOL, V142, P157, DOI 10.1046/j.1365-2133.2000.03260.x; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Stirling J, 2006, MOL BIOL CELL, V17, P413, DOI 10.1091/mbc.E05-06-0500; Traboulsi Elias, 2004, Ophthalmic Genet, V25, P153, DOI 10.1080/13816810490514405; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Zelenski NG, 1999, J BIOL CHEM, V274, P21973, DOI 10.1074/jbc.274.31.21973	28	90	95	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 10	2009	84	4					459	467		10.1016/j.ajhg.2009.03.014	http://dx.doi.org/10.1016/j.ajhg.2009.03.014			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	433VB	19361614	Green Published, Bronze			2022-12-18	WOS:000265232800004
J	Ahram, D; Sato, TS; Kohilan, A; Tayeh, M; Chen, S; Leal, S; Al-Salem, M; El-Shanti, H				Ahram, Dina; Sato, T. Shawn; Kohilan, Abdulghani; Tayeh, Marwan; Chen, Shan; Leal, Suzanne; Al-Salem, Mahmoud; El-Shanti, Hatem			A Homozygous Mutation in ADAMTSL4 Causes Autosomal-Recessive Isolated Ectopia Lentis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LENS SUBLUXATION; GENETIC-LINKAGE; MARFAN-SYNDROME; ALLEGRO; FAMILY; MYOPIA	Ectopia lentis is a genetically heterogeneous condition that is characterized by the subluxation of the lens resulting from the disruption of the zonular fibers. Patients with ectopia lentis commonly present with a marked loss in visual acuity in addition to a number of possibly accompanying ocular complications including cataract, myopia, and retinal detachment. We here describe an isolated form of ectopia lentis in a large inbred family that shows autosomal-recessive inheritance. We map the ectopia lentis locus in this family to the pericentromeric region on chromosome 1 (1p13.2-q21.1). The linkage region contains well more than 60 genes. Mutation screening of four candidate genes revealed a homozygous nonsense mutation in exon 11 of ADAMTSL4 (p.Y595X; c.1785T -> G) in all affected individuals that is absent in 380 control chromosomes. The mutation would result in a truncated protein of half the original length, if the mRNA escapes nonsense-mediated decay. We conclude that mutations in ADAMTSL4 are responsible for autosomal-recessive simple ectopia lentis and that ADAMTS-like4 plays a role in the development and/or integrity of the zonular fibers.	[Ahram, Dina; Kohilan, Abdulghani; El-Shanti, Hatem] Shafallah Med Genet Ctr, Doha, Qatar; [Sato, T. Shawn] Univ Iowa, Carver Coll Med, Iowa City, IA 52246 USA; [Chen, Shan; El-Shanti, Hatem] Univ Iowa, Dept Pediat, Iowa City, IA 52246 USA; [Tayeh, Marwan] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Leal, Suzanne] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Al-Salem, Mahmoud] Ibn Al Hytham Hosp, Dept Ophthalmol, Amman, Jordan	Al Shafallah Center; University of Iowa; University of Iowa; Emory University; Baylor College of Medicine	El-Shanti, H (corresponding author), Shafallah Med Genet Ctr, Doha, Qatar.	eishantih@smgc.org.qa	El-Shanti, Hatem/O-5990-2014; EL-SHANTI, HATEM/Q-4932-2016	El-Shanti, Hatem/0000-0001-6230-8316; EL-SHANTI, HATEM/0000-0001-6230-8316; Sato, T Shawn/0000-0002-3082-3070	The Shafallah Center for Children; "Chaire Internationale de Recherche, Blaise Pascal, de l'etat et de la Region d'Ilede-France,"; "Fondation de l'Ecole Normate Superieure,"	The Shafallah Center for Children; "Chaire Internationale de Recherche, Blaise Pascal, de l'etat et de la Region d'Ilede-France,"; "Fondation de l'Ecole Normate Superieure,"	The authors wish to thank the family members for their gracious participation in this study. This study was supported by generous funds from The Shafallah Center for Children with Special Needs and its sibling the Shafallah Medical Genetics Center, Doha, Qatar (D.A., A.K., H.E.-S.). H.E.-S. was supported by the "Chaire Internationale de Recherche, Blaise Pascal, de l'etat et de la Region d'Ilede-France," which is managed with further support by the "Fondation de l'Ecole Normate Superieure," as well as start-up funds from the University of Iowa during the initial linkage studies.	ALSALEM M, 1990, OPHTHALMIC PAED GEN, V11, P123, DOI 10.3109/13816819009012957; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BJERRUM K, 1991, ACTA OPHTHALMOL, V69, P630; Buchner DA, 2003, GENE, V307, P23, DOI 10.1016/S0378-1119(03)00423-2; CASPER D S, 1985, Journal of Pediatric Ophthalmology and Strabismus, V22, P227; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRUYSBERG JRM, 1995, BRIT J OPHTHALMOL, V79, P135, DOI 10.1136/bjo.79.2.135; Dagi LR, 2006, J AAPOS, V10, P345, DOI 10.1016/j.jaapos.2006.01.218; Dagoneau N, 2004, AM J HUM GENET, V75, P801, DOI 10.1086/425231; Faivre L, 2003, AM J MED GENET A, V123A, P204, DOI 10.1002/ajmg.a.20289; Faivre L, 2003, J MED GENET, V40, P34, DOI 10.1136/jmg.40.1.34; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hanssen E, 2001, MATRIX BIOL, V20, P77, DOI 10.1016/S0945-053X(01)00122-6; HAYASAKA S, 1984, ACTA OPHTHALMOL, V62, P425; JAUREGUY BM, 1979, CLIN GENET, V15, P97; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Krupin T, 1999, J GLAUCOMA, V8, P396; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; NOBLE KG, 1993, DOC OPHTHALMOL, V83, P97, DOI 10.1007/BF01206207; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; RUIZ C, 1986, OPHTHALMIC PAED GEN, V7, P81, DOI 10.3109/13816818609076113; Sachdev NH, 2004, ARCH OPHTHALMOL-CHIC, V122, P111, DOI 10.1001/archopht.122.1.111; STREETEN BW, 1983, INVEST OPHTH VIS SCI, V24, P667; TSIPOURAS P, 1992, NEW ENGL J MED, V326, P905, DOI 10.1056/NEJM199204023261401; Vanita V, 2007, MOL VIS, V13, P2035	26	90	93	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 13	2009	84	2					274	278		10.1016/j.ajhg.2009.01.007	http://dx.doi.org/10.1016/j.ajhg.2009.01.007			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	413NL	19200529	Green Published, Bronze			2022-12-18	WOS:000263799700017
J	Tompson, SW; Merriman, B; Funari, VA; Fresquet, M; Lachman, RS; Rimoin, DL; Nelson, SF; Briggs, MD; Cohn, DH; Krakow, D				Tompson, Stuart W.; Merriman, Barry; Funari, Vincent A.; Fresquet, Maryline; Lachman, Ralph S.; Rimoin, David L.; Nelson, Stanley F.; Briggs, Michael D.; Cohn, Daniel H.; Krakow, Deborah			A Recessive Skeletal Dysplasia, SEMD Aggrecan Type, Results from a Missense Mutation Affecting the C-Type Lectin Domain of Aggrecan	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENE; GENOME; CARTILAGE; SULFATE	Analysis of a nuclear family with three affected offspring identified an autosomal-recessive form of spondyloepimetaphyseal dysplasia characterized by severe short stature and a unique constellation of radiographic findings. Homozygosity for a haplotype that was identical by descent between two of the affected individuals identified a locus for the disease gene within a 17.4 Mb interval on chromosome 15, a region containing 296 genes. These genes were assessed and ranked by cartilage selectivity with whole-genome microarray data, revealing only two genes, encoding aggrecan and chondroitin sulfate proteoglycan 4, that were selectively expressed in cartilage. Sequence analysis of aggrecan complementary DNA from an affected individual revealed homozygosity for a missense mutation (c.6799G -> A) that predicts a p.D2267N amino acid substitution in the C-type lectin domain within the G3 domain of aggrecan. The D2267 residue is predicted to coordinate binding of a calcium ion, which influences the conformational binding loops of the C-type lectin domain that mediate interactions with tenascins and other extracellular-matrix proteins. Expression of the normal and mutant G3 domains in mammalian cells showed that the mutation created a functional N-glycosylation site but did not adversely affect protein trafficking and secretion. Surface-plasmon-resonance studies showed that the mutation influenced the binding and kinetics of the interactions between the aggrecan G3 domain and tenascin-C. These findings identify an autosomal-recessive skeletal dysplasia and a significant role for the aggrecan C-type lectin domain in regulating endochondral ossification and, thereby, height.	[Tompson, Stuart W.; Funari, Vincent A.; Lachman, Ralph S.; Rimoin, David L.; Cohn, Daniel H.; Krakow, Deborah] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Merriman, Barry; Rimoin, David L.; Nelson, Stanley F.; Cohn, Daniel H.; Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Funari, Vincent A.; Lachman, Ralph S.; Rimoin, David L.; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Rimoin, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Lachman, Ralph S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Krakow, Deborah] Univ Calif Los Angeles, David Geffen Sch Med, Dept Orthoped Surg, Los Angeles, CA 90095 USA; [Fresquet, Maryline; Briggs, Michael D.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cellmatrix Res, Manchester M13 9PT, Lancs, England	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Manchester	Cohn, DH (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, 7 Spielberg Bldg,8723 Alden Dr, Los Angeles, CA 90048 USA.	dan.cohn@cshs.org	Krakow, Deborah/B-5778-2009; Nelson, Stanley F/D-4771-2009	Krakow, Deborah/0000-0001-9906-4968; Nelson, Stanley F/0000-0002-2082-3114; Tompson, Stuart/0000-0001-9788-6730; Fresquet, Maryline/0000-0001-9530-6392	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [HD22657]; Joseph Drown Foundation; Cedars-Sinai Medical Center; Wellcome Trust [071161/Z/03/Z]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Joseph Drown Foundation; Cedars-Sinai Medical Center; Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grant HD22657 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health. D.K. is supported by a grant from the Joseph Drown Foundation and a Winnick Family Clinical Scholar award from Cedars-Sinai Medical Center. We thank Arleen Hernandez for assistance with coordinating the clinical studies and Marc Firestein for assistance with the metacarpophalangeal profiles. M.D.B. is the recipient of a Wellcome Trust Senior Research Fellowship in Basic Biomedical Science (Grant 071161/Z/03/Z). BIAcore anaylsis was undertaken in the Biornolecular Analysis Core Facility in the Faculty of Life Sciences at the University of Manchester. The aggrecan cDNA constructs were a kind gift from Tim Hardingham.	Bengtsson E, 2000, J BIOL CHEM, V275, P40695, DOI 10.1074/jbc.M007917200; Cavanagh JAL, 2007, MAMM GENOME, V18, P808, DOI 10.1007/s00335-007-9066-9; Day JM, 2004, J BIOL CHEM, V279, P12511, DOI 10.1074/jbc.M400242200; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; DELACHAPELLE A, 1972, ARCH FR PEDIATR, V29, P759; Funari VA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-165; Gleghorn L, 2005, AM J HUM GENET, V77, P484, DOI 10.1086/444401; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; LANDAUER W, 1965, J HERED, V56, P131, DOI 10.1093/oxfordjournals.jhered.a107392; Lundell A, 2004, STRUCTURE, V12, P1495, DOI 10.1016/j.str.2004.05.021; Superti-Furga A, 2007, AM J MED GENET A, V143A, P1, DOI 10.1002/ajmg.a.31483; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121	13	90	98	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 9	2009	84	1					72	79		10.1016/j.ajhg.2008.12.001	http://dx.doi.org/10.1016/j.ajhg.2008.12.001			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	397RJ	19110214	Bronze, Green Published			2022-12-18	WOS:000262679500009
J	Marshall, CR; Young, EJ; Pani, AM; Freckmann, ML; Lacassie, Y; Howald, C; Fitzgerald, KK; Peippo, M; Morris, CA; Shane, K; Priolo, M; Morimoto, M; Kondo, I; Manguoglu, E; Berker-Karauzum, S; Edery, P; Hobart, HH; Mervis, CB; Zuffardi, O; Reymond, A; Kaplan, P; Tassabehji, M; Gregg, RG; Scherer, SW; Osborne, LR				Marshall, Christian R.; Young, Edwin J.; Pani, Ariel M.; Freckmann, Mary-Louise; Lacassie, Yves; Howald, Cedric; Fitzgerald, Kristi K.; Peippo, Maarit; Morris, Colleen A.; Shane, Kate; Priolo, Manuela; Morimoto, Masafumi; Kondo, Ikuko; Manguoglu, Esra; Berker-Karauzum, Sibel; Edery, Patrick; Hobart, Holly H.; Mervis, Carolyn B.; Zuffardi, Orsetta; Reymond, Alexandre; Kaplan, Paige; Tassabehji, May; Gregg, Ronald G.; Scherer, Stephen W.; Osborne, Lucy R.			Infantile spasms is associated with deletion of the MAGI2 gene on chromosome 7q11.23-q21.11	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WILLIAMS-BEUREN-SYNDROME; SYNAPTIC-SCAFFOLDING-MOLECULE; D-ASPARTATE RECEPTORS; INTERSTITIAL DELETION; PATIENT; EPIDEMIOLOGY; STARGAZIN; MUTATIONS; SEIZURES; SPECTRUM	Infantile spasms (IS) is the most severe and common form of epilepsy occurring in the first year of life. At least half of IS cases are idiopathic in origin, with others presumed to arise because of brain insult or malformation. Here, we identify a locus for IS by high-resolution mapping of 7q11.23-q21.1 interstitial deletions in patients. The breakpoints delineate a 500 kb interval within the MAGI2 gene (1.4 Mb in size) that is hemizygously disrupted in 15 of 16 participants with IS or childhood epilepsy, but remains intact in 11 of 12 participants with no seizure history. MAGI2 encodes the synaptic scaffolding protein membrane-associated guanylate kinase inverted-2 that interacts with Stargazin, a protein also associated with epilepsy in the stargazer mouse.	[Marshall, Christian R.; Young, Edwin J.; Scherer, Stephen W.; Osborne, Lucy R.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Marshall, Christian R.; Young, Edwin J.; Scherer, Stephen W.] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Marshall, Christian R.; Young, Edwin J.; Scherer, Stephen W.] Hosp Sick Children, Ctr Appl Gen, Toronto, ON M5G 1L7, Canada; [Young, Edwin J.; Osborne, Lucy R.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Osborne, Lucy R.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Pani, Ariel M.; Gregg, Ronald G.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [Mervis, Carolyn B.] Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; [Freckmann, Mary-Louise] Sydney Childrens Hosp, Dept Clin Genet, Randwick, NSW 2031, Australia; [Lacassie, Yves] Louisiana State Univ, Div Genet, Dept Pediat, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Lacassie, Yves] Childrens Hosp, New Orleans, LA 70118 USA; [Howald, Cedric] Univ Lausanne, Ctr Integrat Gen, CH-1015 Lausanne, Switzerland; [Fitzgerald, Kristi K.] Childrens Hosp Philadelphia, Sect Metab Dis, Philadelphia, PA 19104 USA; [Fitzgerald, Kristi K.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Peippo, Maarit] Dept Med Genet, Helsinki 00101, Finland; [Morris, Colleen A.; Hobart, Holly H.] Univ Nevada, Dept Pediat, Sch Med, Las Vegas, NV 89102 USA; [Shane, Kate] Nationwide Childrens Hosp, Dept Pediat, Columbus, OH 43205 USA; [Priolo, Manuela] Hosp Reggio Calabria Az Ospedaliera Bianchi Melac, Operat Unit Med Genet, I-89100 Reggio Di Calabria, Italy; [Morimoto, Masafumi] Kyoto Prefectural Univ Med, Dept Pediat, Kyoto 6028566, Japan; [Kondo, Ikuko] Ibaraki Prefectural Handicapped Childrens Ctr, Dept Pediat, Ibaraki 3100845, Japan; [Manguoglu, Esra; Berker-Karauzum, Sibel] Akdeniz Univ, Dept Med Biol & Genet, Sch Med, TR-07070 Antalya, Turkey; [Edery, Patrick] Ctr Biol & Pathol, Serv Cytogenet Constitutionnelle, F-69677 Bron, France; [Zuffardi, Orsetta] Univ Pavia, I-27100 Pavia, Italy; [Zuffardi, Orsetta] IRCCS Policlin, I-27100 Pavia, Italy; [Tassabehji, May] Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Louisville; University of Louisville; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Children's Hospital of New Orleans; University of Lausanne; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Kyoto Prefectural University of Medicine; Akdeniz University; University of Pavia; University of Manchester	Osborne, LR (corresponding author), Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	lucy.osborne@utoronto.ca	Karauzum, Sibel/C-4848-2016; Edery, Patrick/B-6407-2012; Scherer, Stephen W./B-3785-2013; Shane-Carson, Kate/GRY-7595-2022; manguoglu, esra/C-2408-2016	Scherer, Stephen W./0000-0002-8326-1999; zuffardi, orsetta/0000-0002-1466-4559; Reymond, Alexandre/0000-0003-1030-8327; Gregg, Ronald/0000-0001-5805-224X; Young, Ted (Edwin)/0000-0003-4882-6752	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035102] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35102, R01 NS035102] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Annegers JF, 1996, MAYO CLIN PROC, V71, P570, DOI 10.4065/71.6.570; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Berg AT, 2001, EPILEPSIA, V42, P1553, DOI 10.1046/j.1528-1157.2001.21101.x; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Courtens W, 2005, AM J MED GENET A, V134A, P12, DOI 10.1002/ajmg.a.30106; Cowan LD, 2002, MENT RETARD DEV D R, V8, P171, DOI 10.1002/mrdd.10035; Curatolo P, 1996, CHILD NERV SYST, V12, P515; DeBerardinis RJ, 2003, AM J MED GENET A, V121A, P31, DOI 10.1002/ajmg.a.20162; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; Ferland RJ, 2006, AM J MED GENET A, V140A, P1305, DOI 10.1002/ajmg.a.31259; Gibbs F, 1952, EPILEPSY, V2; Hayashi M, 2000, NEUROPATHOLOGY, V20, P297, DOI 10.1046/j.1440-1789.2000.00353.x; Hirao K, 2000, J BIOL CHEM, V275, P2966, DOI 10.1074/jbc.275.4.2966; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Hongou K, 1998, PEDIATR NEUROL, V18, P354, DOI 10.1016/S0887-8994(97)00206-3; Hrachovy RA, 2002, ADV EXP MED BIOL, V497, P33; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Iida J, 2007, MOL CELL BIOL, V27, P4388, DOI 10.1128/MCB.01901-06; KORF BR, 1993, EPILEPSIA, V34, P616, DOI 10.1111/j.1528-1157.1993.tb00437.x; Manguoglu E, 2005, GENET COUNSEL, V16, P155; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; MCELVEEN C, 1995, AM J MED GENET, V56, P1, DOI 10.1002/ajmg.1320560102; Mizugishi K, 1998, J HUM GENET, V43, P178, DOI 10.1007/s100380050064; Morimoto M, 2003, EPILEPSIA, V44, P1459, DOI 10.1046/j.1528-1157.2003.34703.x; Morris C. A., 2006, WILLIAMS BEUREN SYND, P3; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; PALMINI A, 1991, NEUROLOGY, V41, P1656, DOI 10.1212/WNL.41.10.1656; Riikonen R, 2004, J CHILD NEUROL, V19, P401, DOI 10.1177/088307380401900601; Riikonen R, 2001, BRAIN DEV-JPN, V23, P683, DOI 10.1016/S0387-7604(01)00307-2; Saltik S, 2003, J CHILD NEUROL, V18, P241, DOI 10.1177/08830738030180041201; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Sillanpaa M, 1998, NEW ENGL J MED, V338, P1715, DOI 10.1056/NEJM199806113382402; Stock AD, 2003, AM J MED GENET A, V120A, P320, DOI 10.1002/ajmg.a.20055; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Tercero MFB, 2005, AM J MED GENET A, V133A, P213, DOI 10.1002/ajmg.a.30486; Turnbull J, 2005, HUM MOL GENET, V14, P2491, DOI 10.1093/hmg/ddi250; Tzschach A, 2007, AM J MED GENET A, V143A, P333, DOI 10.1002/ajmg.a.31601; Weaving LS, 2004, AM J HUM GENET, V75, P1079, DOI 10.1086/426462; Wu YQ, 1999, J MED GENET, V36, P928	40	90	91	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					106	111		10.1016/j.ajhg.2008.06.001	http://dx.doi.org/10.1016/j.ajhg.2008.06.001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18565486	Bronze, Green Published			2022-12-18	WOS:000257784000013
J	Lehmann, K; Seemann, P; Silan, F; Goecke, TO; Irgang, S; Kjaer, KW; Kjaergaard, S; Mahoney, MJ; Morlot, S; Reissner, C; Kerr, B; Wilkie, AOM; Mundlos, S				Lehmann, K.; Seemann, P.; Silan, F.; Goecke, T. O.; Irgang, S.; Kjaer, K. W.; Kjaergaard, S.; Mahoney, M. J.; Morlot, S.; Reissner, C.; Kerr, B.; Wilkie, A. O. M.; Mundlos, S.			A new subtype of brachydactyly type B caused by point mutations in the bone morphogenetic protein antagonist NOGGIN	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SERINE/THREONINE KINASE RECEPTORS; GENE-ENCODING NOGGIN; TYROSINE KINASE; ROBINOW-SYNDROME; JOINT FORMATION; ROR2; EXPRESSION; BINDING; BMPR1B; GDF5	(B) under bar rachy (d) under bar actyly type B (BDB) is characterized by terminal deficiency of fingers and toes, which is caused by heterozygous truncating mutations in the receptor tyrosine kinase-like orphan receptor 2 (ROR2) in the ma ority of patients n a subset of ROR2-negative patients with BDB, clinically defined by the additional occurrence of proximal symphalangism and carpal synostosis, we identified six different point mutations (P35A, P35S, A36p, E48K, R167G, and P187S) in the bone morphogenetic protein (BMP) antagonist NOGGIN (NOG). In contrast to previously described loss-of-function mutations in NOG, which are known to cause a range of conditions associated with abnormal joint formation but without BD13, the newly identified BDB mutations do not indicate a major loss of function, as suggested by calculation of free-binding energy of the modeled NOG-GDF5 complex and functional analysis of the micromass culture system. Rather, they presumably alter NOG's ability to bind to BMPs and growth-differentiation factors (GDFs) in a subtle way, thus disturbing the intricate balance of BMP signaling. The combined features observed in this phenotypic subtype of BDB argue for a functional connection between BMP and ROR2 signaling and support previous findings of a modulating effect of ROR2 on the BMP-receptor pathway through the formation of a heteromeric complex of the receptors at the cell surface.	Univ Med Berlin, Charite, Inst Med Genet, D-13353 Berlin, Germany; Max Planck Inst Mol Genet, Berlin, Germany; Duzce Univ, Duzce Sch Med, Dept Med Genet, Duzce, Turkey; Univ Dusseldorf, Inst Human Genet & Anthropol, D-4000 Dusseldorf, Germany; Univ Copenhagen, Inst Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-1168 Copenhagen, Denmark; John F Kennedy Inst, Dept Med Genet, DK-2600 Glostrup, Denmark; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06520 USA; Arxtliche Partnerschaft Wagner Stibbe Hannover, Hannover, Germany; Univ Magdeburg, Inst Mol Mol Neurobiol, D-39106 Magdeburg, Germany; Royal Manchester Childrens Hosp, Reg Genet Serv, Manchester, Lancs, England; Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DU, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Duzce University; Heinrich Heine University Dusseldorf; University of Copenhagen; Yale University; Otto von Guericke University; Royal Manchester Children's Hospital; University of Oxford	Lehmann, K (corresponding author), Univ Med Berlin, Charite, Inst Med Genet, Augustenburger Pl 1, D-13353 Berlin, Germany.	katarina.lehmann@charite.de	Wilkie, Andrew/AAC-3820-2020; Mundlos, Stefan/ABH-9585-2020; Seemann, Petra/G-3606-2011	Wilkie, Andrew/0000-0002-2972-5481; Seemann, Petra/0000-0002-6056-6669; Mundlos, Stefan/0000-0002-9788-3166; Dathe, Katarina/0000-0002-8674-5817	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Afzal AR, 2003, HUM MUTAT, V22, P1, DOI 10.1002/humu.10233; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Bell J., 1951, TREASURY HUMAN INHER, VVol 1, P1; Brown DJ, 2002, AM J HUM GENET, V71, P618, DOI 10.1086/342067; Brunet LJ, 1998, SCIENCE, V280, P1455, DOI 10.1126/science.280.5368.1455; Dawson K, 2006, AM J HUM GENET, V78, P708, DOI 10.1086/503204; Debeer P, 2005, AM J MED GENET A, V134A, P318, DOI 10.1002/ajmg.a.30645; Demirhan O, 2005, J MED GENET, V42, P314, DOI 10.1136/jmg.2004.023564; Dixon ME, 2001, GENET MED, V3, P349, DOI 10.1097/00125817-200109000-00004; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Francis-West PH, 1999, CELL TISSUE RES, V296, P111, DOI 10.1007/s004410051272; Gao Y, 2004, J MOL MODEL, V10, P44, DOI 10.1007/s00894-003-0168-3; Gilboa L, 2000, MOL BIOL CELL, V11, P1023, DOI 10.1091/mbc.11.3.1023; Gong YQ, 1999, NAT GENET, V21, P302, DOI 10.1038/6821; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Herrmann J, 1974, Birth Defects Orig Artic Ser, V10, P23; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kosaki K, 2004, FERTIL STERIL, V81, P1137, DOI 10.1016/j.fertnstert.2003.08.054; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Lehmann K, 2006, EUR J HUM GENET, V14, P1248, DOI 10.1038/sj.ejhg.5201708; Mangino M, 2002, Hum Mutat, V19, P308, DOI 10.1002/humu.9016.abs; Marcelino J, 2001, P NATL ACAD SCI USA, V98, P11353, DOI 10.1073/pnas.201367598; MAROTEAUX P, 1972, NOUV PRESSE MED, V1, P3041; Massague J, 2000, GENE DEV, V14, P627; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Nifuji A, 1999, J BONE MINER RES, V14, P2057, DOI 10.1359/jbmr.1999.14.12.2057; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Oldridge M, 1999, AM J HUM GENET, V64, P578, DOI 10.1086/302255; Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x; Schreuder H, 2005, BIOCHEM BIOPH RES CO, V329, P1076, DOI 10.1016/j.bbrc.2005.02.078; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Schwabe GC, 2004, AM J MED GENET A, V124A, P356, DOI 10.1002/ajmg.a.20349; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; Stricker S, 2006, DEV DYNAM, V235, P3456, DOI 10.1002/dvdy.20993; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	40	90	95	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2007	81	2					388	396		10.1086/519697	http://dx.doi.org/10.1086/519697			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	197FQ	17668388	Green Published, Bronze			2022-12-18	WOS:000248540400018
J	Balciuniene, J; Feng, NP; Iyadurai, K; Hirsch, B; Charnas, L; Bill, BR; Easterday, MC; Staaf, J; Oseth, L; Czapansky-Beilman, D; Avramopoulos, D; Thomas, GH; Borg, A; Valle, D; Schimmenti, LA; Selleck, SB				Balciuniene, Jorune; Feng, Ningping; Iyadurai, Kelly; Hirsch, Betsy; Charnas, Lawrence; Bill, Brent R.; Easterday, Mathew C.; Staaf, Johan; Oseth, LeAnn; Czapansky-Beilman, Desiree; Avramopoulos, Dimitri; Thomas, George H.; Borg, Ake; Valle, David; Schimmenti, Lisa A.; Selleck, Scott B.			Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEGMENTAL DUPLICATIONS; PTEN MUTATION; STRUCTURAL VARIATION; COWDEN-SYNDROME; SCHIZOPHRENIA; DISEASE; GENE; REARRANGEMENTS; NEUREGULIN-1; POLYMORPHISM	Low-copy repeats (LCRs) are genomic features that affect chromosome stability and can produce disease-associated rearrangements. We describe members of three families with deletions in 10q22.3-q23.31, a region harboring a complex set of LCRs, and demonstrate that rearrangements in this region are associated with behavioral and neurodevelopmental abnormalities, including cognitive impairment, autism, hyperactivity, and possibly psychiatric disease. Fine mapping of the deletions in members of all three families by use of a custom 10q oligonucleotide array-based comparative genomic hybridization (NimbleGen) and polymerase chain reaction - based methods demonstrated a different deletion in each family. In one proband, the deletion breakpoints are associated with DNA fragments containing noncontiguous sequences of chromosome 10, whereas, in the other two families, the breakpoints are within paralogous LCRs, removing similar to 7.2 Mb and 32 genes. Our data provide evidence that the 10q22-q23 genomic region harbors one or more genes important for cognitive and behavioral development and that recurrent deletions affecting this interval define a novel genomic disorder.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Ophthalmol, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Univ Minnesota, Ctr Dev Biol, Minneapolis, MN 55455 USA; Univ Minnesota, Univ Minnesota Canc Ctr, Minneapolis, MN 55455 USA; Johns Hopkins Univ, Sch Med, McKusickNathans Inst Genet Med, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21218 USA; Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21218 USA; Kennedy Krieger Inst, Baltimore, MD USA; Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Lund University; Skane University Hospital	Selleck, SB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, 6-160 Jackson,321 Church St SE, Minneapolis, MN 55455 USA.	selle011@umn.edu	Avramopoulos, Dimitrios/J-4392-2012	Schimmenti, Lisa/0000-0003-3154-4249; Bill, Brent/0000-0002-3436-1969	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NCI NIH HHS [P30CA077598, P30 CA077598] Funding Source: Medline; NICHD NIH HHS [P30 HD024061, HD024061] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arch EM, 1997, AM J MED GENET, V71, P489, DOI 10.1002/(SICI)1096-8628(19970905)71:4<489::AID-AJMG24>3.0.CO;2-B; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bayley N., 2006, BAYLEY SCALES INFANT, VThird; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Delnatte C, 2006, AM J HUM GENET, V78, P1066, DOI 10.1086/504301; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Fallin MD, 2005, AM J HUM GENET, V77, P918, DOI 10.1086/497703; Fallin MD, 2003, AM J HUM GENET, V73, P601, DOI 10.1086/378158; FARRELL SA, 1993, J MED GENET, V30, P248, DOI 10.1136/jmg.30.3.248; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacoby RF, 1997, AM J MED GENET, V70, P361, DOI 10.1002/(SICI)1096-8628(19970627)70:4<361::AID-AJMG6>3.0.CO;2-W; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Longy M, 1998, J MED GENET, V35, P886, DOI 10.1136/jmg.35.11.886; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; MORI MA, 1988, J MED GENET, V25, P209, DOI 10.1136/jmg.25.3.209; Nelen MR, 1999, EUR J HUM GENET, V7, P267, DOI 10.1038/sj.ejhg.5200289; Nelen MR, 1997, HUM MOL GENET, V6, P1383, DOI 10.1093/hmg/6.8.1383; *PSYCH CORP, 2002, WPPSI 3 TECHN INT MA; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; SHAPIRO SD, 1985, AM J MED GENET, V20, P181, DOI 10.1002/ajmg.1320200122; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2003, MOL PSYCHIATR, V8, P639, DOI 10.1038/sj.mp.4001384; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103; Wechsler D., 1997, WECHSLER INTELLIGENC; Zhang LQ, 2005, MOL BIOL EVOL, V22, P135, DOI 10.1093/molbev/msh262; ZIMMERMANN I, 1992, PRESCHOOL LANGUAGE S; Zori RT, 1998, AM J MED GENET, V80, P399, DOI 10.1002/(SICI)1096-8628(19981204)80:4<399::AID-AJMG18>3.0.CO;2-O	38	90	93	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2007	80	5					938	947		10.1086/513607	http://dx.doi.org/10.1086/513607			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160WM	17436248	Green Published, Bronze			2022-12-18	WOS:000245973200012
J	Martinez-Mir, A; Zlotogorski, A; Gordon, D; Petukhova, L; Mo, J; Gilliam, TC; Londono, D; Haynes, C; Ott, J; Hordinsky, M; Nanova, K; Norris, D; Price, V; Duvic, M; Christiano, AM				Martinez-Mir, Amalia; Zlotogorski, Abraham; Gordon, Derek; Petukhova, Lynn; Mo, Jianhong; Gilliam, T. Conrad; Londono, Douglas; Haynes, Chad; Ott, Jurg; Hordinsky, Maria; Nanova, Krassimira; Norris, David; Price, Vera; Duvic, Madeleine; Christiano, Angela M.			Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEMENT FACTOR-H; MACULAR DEGENERATION; LOD SCORES; RECEPTOR ANTAGONIST; ATOPIC-DERMATITIS; CROHNS-DISEASE; HAIR FOLLICLE; AUTOIMMUNE-DISEASE; CANDIDATE REGIONS; GENETIC-LINKAGE	Alopecia areata (AA) is a genetically determined, immune-mediated disorder of the hair follicle that affects 1%-2% of the U. S. population. It is defined by a spectrum of severity that ranges from patchy localized hair loss on the scalp to the complete absence of hair everywhere on the body. In an effort to define the genetic basis of AA, we performed a genomewide search for linkage in 20 families with AA consisting of 102 affected and 118 unaffected individuals from the United States and Israel. Our analysis revealed evidence of at least four susceptibility loci on chromosomes 6, 10, 16 and 18, by use of several different statistical approaches. Fine-mapping analysis with additional families yielded a maximum multipoint LOD score of 3.93 on chromosome 18, a two-point affected sib pair (ASP) LOD score of 3.11 on chromosome 16, several ASP LOD scores > 2.00 on chromosome 6q, and a haplotype-based relative risk LOD of > 2.00 on chromosome 6p (in the major histocompatibility complex locus). Our findings confirm previous studies of association of the human leukocyte antigen locus with human AA, as well as the C3H-HeJ mouse model for AA. Interestingly, the major loci on chromosomes 16 and 18 coincide with loci for psoriasis reported elsewhere. These results suggest that these regions may harbor gene(s) involved in a number of different skin and hair disorders.	Columbia Univ, Dept Dermatol, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Rockefeller Univ, Lab Stat Genet, New York, NY 10021 USA; Hadassah Hebrew Univ Jerusalem, Med Ctr, Dept Dermatol, Jerusalem, Israel; Rutgers State Univ, Dept Genet, Piscataway, NJ USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Case Western Reserve Univ, Dept Epidemiol & Biostat, Div Mol & Genet Epidemiol, Cleveland, OH 44106 USA; Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA; Univ Colorado Denver & Hlth Sci Ctr, Dept Dermatol, Denver, CO USA; Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; Univ Texas, MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA	Columbia University; Columbia University; Rockefeller University; Hebrew University of Jerusalem; Hadassah University Medical Center; Rutgers State University New Brunswick; University of Chicago; Case Western Reserve University; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center	Christiano, AM (corresponding author), Columbia Univ, Dept Dermatol, Coll Phys & Surg, 630 W 168th St,VC-15204A, New York, NY 10032 USA.	amc65@columbia.edu	Lauschner, Flavia H/P-2457-2018; IBIS, NEUROGENETICA/P-2947-2015; Martinez-Mir, Amalia/K-7715-2018; Petukhova, Lynn/W-6858-2019; Gordon, Derek/AAU-2281-2020; Londono, Douglas/H-9109-2012	Martinez-Mir, Amalia/0000-0002-1628-8972; Gordon, Derek/0000-0003-2945-1748; 	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR002249, R03AR050158, R01AR052579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH044292] Funding Source: NIH RePORTER; NIAMS NIH HHS [R03 AR050158, R01 AR052579, R01AR52579, N01AR02249, R03AR050158] Funding Source: Medline; NIMH NIH HHS [R01 MH044292, R01MH44292] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; ADAMS P, 1994, GENET EPIDEMIOL, V11, P87, DOI 10.1002/gepi.1370110109; Aita VM, 1999, AM J HUM GENET, V64, P210, DOI 10.1086/302185; Altmuller J, 2001, AM J HUM GENET, V69, P936, DOI 10.1086/324069; Asumalahti K, 2003, J INVEST DERMATOL, V121, P735, DOI 10.1046/j.1523-1747.2003.12483.x; Bahmer FA, 2002, HAUTARZT, V53, P492, DOI 10.1007/s00105-002-0375-3; Barahamani N, 2002, J INVEST DERMATOL, V118, P335, DOI 10.1046/j.0022-202x.2001.01676.x; Barahmani N, 2006, J INVEST DERMATOL, V126, P74, DOI 10.1038/sj.jid.5700009; Barlag K, 1995, Dtsch Med Wochenschr, V120, P158; Bartlett CW, 2005, AM J HUM GENET, V76, P688, DOI 10.1086/429345; Baumer A, 2000, EUR J HUM GENET, V8, P443, DOI 10.1038/sj.ejhg.5200506; Betterle C, 1998, J CLIN ENDOCR METAB, V83, P1049, DOI 10.1210/jc.83.4.1049; Bhalerao J, 1998, HUM MOL GENET, V7, P1537, DOI 10.1093/hmg/7.10.1537; BLACKWELDER W C, 1985, Genetic Epidemiology, V2, P85, DOI 10.1002/gepi.1370020109; Bradley M, 2002, HUM MOL GENET, V11, P1539, DOI 10.1093/hmg/11.13.1539; Brant SR, 2004, INFLAMM BOWEL DIS, V10, P300, DOI 10.1097/00054725-200405000-00019; Brzustowicz LM, 2000, SCIENCE, V288, P678, DOI 10.1126/science.288.5466.678; Cash TF, 2001, CLIN DERMATOL, V19, P161, DOI 10.1016/S0738-081X(00)00127-9; de Andrade M, 1999, J INVEST DERM SYMP P, V4, P220, DOI 10.1038/sj.jidsp.5640215; DUVIVIER A, 1975, BMJ-BRIT MED J, V1, P191, DOI 10.1136/bmj.1.5951.191; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; ELSTON RC, 1989, AM J MED GENET, V34, P487, DOI 10.1002/ajmg.1320340407; Ewens WJ, 2005, HUM HERED, V60, P206, DOI 10.1159/000090544; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Finch SJ, 2001, GENET EPIDEMIOL, V21, P315, DOI 10.1002/gepi.1037; FJALLDAL JB, 2001, P INT JOINT C NEUR N, pA1; Gilhar A, 1999, J INVEST DERM SYMP P, V4, P207, DOI 10.1038/sj.jidsp.5640212; Gilhar A, 2006, AUTOIMMUN REV, V5, P64, DOI 10.1016/j.autrev.2005.07.001; Gilhar A, 1998, J CLIN INVEST, V101, P62, DOI 10.1172/JCI551; GOLDENHERSH MA, 1992, AM J DERMATOPATH, V14, P367, DOI 10.1097/00000372-199208000-00013; Gordon D, 2000, GENOMICS, V66, P87, DOI 10.1006/geno.2000.6190; Gordon D, 2001, GENET EPIDEMIOL, V21, pS396, DOI 10.1002/gepi.2001.21.s1.s396; Gordon D, 2006, HUM HERED, V61, P97, DOI 10.1159/000093303; Green J, 2000, Australas J Dermatol, V41, P213, DOI 10.1046/j.1440-0960.2000.00439.x; Gulec AT, 2004, INT J DERMATOL, V43, P352, DOI 10.1111/j.1365-4632.2004.02028.x; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Helms C, 2005, HUM GENET, V118, P466, DOI 10.1007/s00439-005-0048-2; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 1997, AM J HUM GENET, V60, P217; Hodge SE, 2001, AM J MED GENET, V105, P62, DOI 10.1002/1096-8628(20010108)105:1<62::AID-AJMG1063>3.0.CO;2-C; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Hugot JP, 1996, NATURE, V379, P821, DOI 10.1038/379821a0; Jackow C, 1998, J AM ACAD DERMATOL, V38, P418, DOI 10.1016/S0190-9622(98)70499-2; Kemp EH, 2006, HUM IMMUNOL, V67, P535, DOI 10.1016/j.humimm.2006.04.006; KHOURY EL, 1988, J INVEST DERMATOL, V90, P193, DOI 10.1111/1523-1747.ep12462213; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Leal SM, 2000, AM J HUM GENET, V66, P567, DOI 10.1086/302748; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Liu JJ, 2002, AM J HUM GENET, V70, P51, DOI 10.1086/338453; Liu JJ, 2001, AM J HUM GENET, V69, P327, DOI 10.1086/321980; MAFFEI C, 1994, ARCH DERMATOL, V130, P868, DOI 10.1001/archderm.130.7.868; Magnuson VL, 1996, BIOTECHNIQUES, V21, P700, DOI 10.2144/96214rr03; Martinez-Mir A, 2003, J INVEST DERM SYMP P, V8, P199, DOI 10.1046/j.1087-0024.2003.00809.x; McDonagh AJG, 2002, CLIN EXP DERMATOL, V27, P409, DOI 10.1046/j.1365-2230.2002.01077.x; Mikelsaar RV, 2002, AM J MED GENET, V108, P252, DOI 10.1002/ajmg.10259; MORLING N, 1991, DIS MARKERS, V9, P35; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Nair RP, 1997, HUM MOL GENET, V6, P1349, DOI 10.1093/hmg/6.8.1349; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ostrer H, 2001, NAT REV GENET, V2, P891, DOI 10.1038/35098506; OTT J, 1999, ANAL HUMAN GENETIC L, P225; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Palsson B, 1999, GENOME RES, V9, P1002, DOI 10.1101/gr.9.10.1002; Plinck E P, 1993, Ned Tijdschr Geneeskd, V137, P1207; Sawaya M E, 1992, Adv Dermatol, V7, P211; Schwartz RA, 1997, CUTIS, V59, P238; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Soderhall C, 2001, HUM GENET, V109, P129, DOI 10.1007/s004390100556; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; SUAREZ BK, 1984, AM J MED GENET, V18, P135, DOI 10.1002/ajmg.1320180117; Sundberg JP, 2004, J INVEST DERMATOL, V123, P294, DOI 10.1111/j.0022-202X.2004.23222.x; SUNDBERG JP, 1995, J INVEST DERMATOL, V104, P577; TARLOW JK, 1994, J INVEST DERMATOL, V103, P387, DOI 10.1111/1523-1747.ep12395398; Tazi-Ahnini R, 2002, EUR J IMMUNOGENET, V29, P25, DOI 10.1046/j.1365-2370.2002.00271.x; Tazi-Ahnini R, 2000, HUM GENET, V106, P639, DOI 10.1007/s004390050037; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI, P227; Tobin DJ, 1997, J INVEST DERMATOL, V109, P329, DOI 10.1111/1523-1747.ep12335848; Tobin DJ, 1997, ARCH DERMATOL, V133, P57, DOI 10.1001/archderm.133.1.57; VANDERSTEEN P, 1992, ACTA DERM-VENEREOL, V72, P373; Veal CD, 2001, J MED GENET, V38, P7, DOI 10.1136/jmg.38.1.7; WELSH EA, 1994, J INVEST DERMATOL, V103, P758, DOI 10.1111/1523-1747.ep12412584; Wiggs JL, 2006, ARCH OPHTHALMOL-CHIC, V124, P577, DOI 10.1001/archopht.124.4.577; Wise LH, 1999, GENET EPIDEMIOL, V17, pS767; ZLOTOGORSKI A, 1990, TISSUE ANTIGENS, V36, P40, DOI 10.1111/j.1399-0039.1990.tb01797.x; DOCUMENTATION ANALYZ	91	90	94	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					316	328		10.1086/511442	http://dx.doi.org/10.1086/511442			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236136	Green Published, Bronze			2022-12-18	WOS:000243729500011
J	Wang, T; Elston, RC				Wang, Tao; Elston, Robert C.			Improved power by use of a weighted score test for linkage disequilibrium mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; ASSOCIATION	Association studies offer an exciting approach to finding underlying genetic variants of complex human diseases. However, identification of genetic variants still includes difficult challenges, and it is important to develop powerful new statistical methods. Currently, association methods may depend on single-locus analysis-that is, analysis of the association of one locus, which is typically a single-nucleotide polymorphism (SNP), at a time-or on multilocus analysis, in which multiple SNPs are used to allow extraction of maximum information about linkage disequilibrium (LD). It has been shown that single-locus analysis may have low power because a single SNP often has limited LD information. Multilocus analysis, which is more informative, can be performed on the basis of either haplotypes or genotypes. It may lose power because of the often large number of degrees of freedom involved. The ideal method must make full use of important information from multiple loci but avoid increasing the degrees of freedom. Therefore, we propose a method to capture information from multiple SNPs but with the use of fewer degrees of freedom. When a set of SNPs in a block are correlated because of LD, we might expect that the genotype variation among the different phenotypic groups would extend across all the SNPs, and this information could be compressed into the low-frequency components of a Fourier transform. Therefore, we develop a test based on weighted Fourier transformation coefficients, with more weight given to the low-frequency components. Our simulation results demonstrate the validity and substantially higher power of the proposed method compared with other common methods. This method provides an additional tool to existing methods for identification of causative genetic variants underlying complex diseases.	Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	Case Western Reserve University	Elston, RC (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	rce@darwin.case.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR003655, RR03655] Funding Source: Medline; NIGMS NIH HHS [R37 GM028356, R01 GM028356, GM28356] Funding Source: Medline; PHS HHS [P30CAD43703] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Conti DV, 2003, AM J HUM GENET, V72, P351, DOI 10.1086/346117; Cordell HJ, 1999, GENET EPIDEMIOL, V17, P237, DOI 10.1002/(SICI)1098-2272(199911)17:4<237::AID-GEPI1>3.0.CO;2-P; Crawford DC, 2004, AM J HUM GENET, V74, P610, DOI 10.1086/382227; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Lazzeroni LC, 1998, AM J HUM GENET, V62, P159, DOI 10.1086/301678; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Roeder K, 2005, GENET EPIDEMIOL, V28, P207, DOI 10.1002/gepi.20050; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Tzeng JY, 2003, AM J HUM GENET, V72, P891, DOI 10.1086/373881; Xiong MM, 2002, AM J HUM GENET, V70, P1257, DOI 10.1086/340392; Zhang LF, 2003, ADV ATMOS SCI, V20, P29, DOI 10.1007/BF03342047	15	90	97	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					353	360		10.1086/511312	http://dx.doi.org/10.1086/511312			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236140	Bronze, Green Published			2022-12-18	WOS:000243729500015
J	Zabetian, CP; Hutter, CM; Yearout, D; Lopez, AN; Factor, SA; Griffith, A; Leis, BC; Bird, TD; Nutt, JG; Higgins, DS; Roberts, JW; Kay, DM; Edwards, KL; Samii, A; Payami, H				Zabetian, Cyrus P.; Hutter, Carolyn M.; Yearout, Dora; Lopez, Alexis N.; Factor, Stewart A.; Griffith, Alida; Leis, Berta C.; Bird, Thomas D.; Nutt, John G.; Higgins, Donald S.; Roberts, John W.; Kay, Denise M.; Edwards, Karen L.; Samii, Ali; Payami, Haydeh			LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: Evidence of two distinct founding events beginning two millennia ago	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; COMMON FOUNDER; ASHKENAZI JEWS; GENETIC DRIFT; MUTATION; POPULATIONS; FREQUENT	The leucine-rich repeat kinase 2 (LRRK2) G2019S mutation is the most common genetic determinant of Parkinson disease (PD) identified to date. It accounts for 1%-7% of PD in patients of European origin and 20%-40% in Ashkenazi Jews and North African Arabs with PD. Previous studies concluded that patients from these populations all shared a common Middle Eastern founder who lived in the 13th century. We tested this hypothesis by genotyping 25 microsatellite and single-nucleotide-polymorphism markers in 22 families with G2019S and observed two distinct haplotypes. Haplotype 1 was present in 19 families of Ashkenazi Jewish and European ancestry, whereas haplotype 2 occurred in three European American families. Using a maximum-likelihood method, we estimated that the families with haplotype 1 shared a common ancestor 2,250 (95% confidence interval 1,650 - 3,120) years ago, whereas those with haplotype 2 appeared to share a more recent founder. Our data suggest two separate founding events for G2019S in these populations, beginning at a time that coincides with the Jewish Diasporas.	Univ Washington, Sch Med, Vet Affairs Puget Sound Hlth Care Syst, Ctr Geriatr Res Educ & Clin,Dept Neurol, Seattle, WA 98108 USA; Univ Washington, Sch Med, Vet Affairs Puget Sound Hlth Care Syst, Dept Neurol,Parkinsons Dis Res Educ & Clin Ctr, Seattle, WA 98108 USA; Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA; Virginia Mason Med Ctr, Seattle, WA 98101 USA; Albany Med Ctr, Parkinsons Dis & Movement Disorder Clin, Albany, NY USA; New York State Dept Hlth, Wadsworth Ctr, Genom Inst, Albany, NY USA; Evergreen Hosp, Med Ctr, Booth Gardner Parkinsons Care Ctr, Kirkland, WA USA; Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA	Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Virginia Mason Medical Center; Albany Medical College; State University of New York (SUNY) System; Wadsworth Center; Oregon Health & Science University	Zabetian, CP (corresponding author), Univ Washington, Sch Med, Vet Affairs Puget Sound Hlth Care Syst, Ctr Geriatr Res Educ & Clin,Dept Neurol, S-182,1660 S Columbian Way, Seattle, WA 98108 USA.	zabetian@u.washington.edu	Higgins, Donald/AAJ-1261-2020; Higgins, Donald S/B-5071-2010; Payami, Haydeh/ABE-1944-2020	Kay, Denise/0000-0002-9928-2698; Zabetian, Cyrus/0000-0002-7739-4306	NATIONAL CANCER INSTITUTE [R01CA149051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS044138, R01NS036960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008017] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA149051] Funding Source: Medline; NIA NIH HHS [P30 AG008017] Funding Source: Medline; NINDS NIH HHS [K08 NS044138-04, R01 NS036960, K08 NS044138] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BONIFATI V, 1995, CAN J NEUROL SCI, V22, P272, DOI 10.1017/S0317167100039469; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Colombo R, 2000, AM J HUM GENET, V66, P692, DOI 10.1086/302757; Di Fonzo A, 2005, LANCET, V365, P412; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kay DM, 2006, MOVEMENT DISORD, V21, P519, DOI 10.1002/mds.20751; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kong X, 2005, BIOINFORMATICS, V21, P557, DOI 10.1093/bioinformatics/bti024; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Lesage S, 2005, AM J HUM GENET, V77, P330, DOI 10.1086/432422; Nichols WC, 2005, LANCET, V365, P410, DOI 10.1016/S0140-6736(05)17828-3; Niell BL, 2003, AM J HUM GENET, V73, P1250, DOI 10.1086/379926; Nishimura AL, 2005, HUM GENET, V118, P499, DOI 10.1007/s00439-005-0031-y; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; ZABETIAN CP, 2006, IDENTIFICATION HAPLO; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	30	90	91	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					752	758		10.1086/508025	http://dx.doi.org/10.1086/508025			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960813	Bronze, Green Published			2022-12-18	WOS:000240855900018
J	Morgan, NV; Pasha, S; Johnson, CA; Ainsworth, JR; Eady, RAJ; Dawood, B; McKeown, C; Trembath, RC; Wilde, J; Watson, SP; Maher, ER				Morgan, NV; Pasha, S; Johnson, CA; Ainsworth, JR; Eady, RAJ; Dawood, B; McKeown, C; Trembath, RC; Wilde, J; Watson, SP; Maher, ER			A germline mutation in BLOC1S3/reduced pigmentation causes a novel variant of Hermansky-Pudlak syndrome (HPS8)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYSOSOME-RELATED ORGANELLES; PULMONARY-FIBROSIS; PROTEINS; PIGMENTATION; MELANOSOMES; BIOGENESIS; ALBINISM; COLITIS; COMPLEX; MODELS	Hermansky-Pudlak syndrome (HPS) is genetically heterogeneous, and mutations in seven genes have been reported to cause HPS. Autozygosity mapping studies were undertaken in a large consanguineous family with HPS. Affected individuals displayed features of incomplete oculocutaneous albinism and platelet dysfunction. Skin biopsy demonstrated abnormal aggregates of melanosomes within basal epidermal keratinocytes. A homozygous germline frameshift mutation in BLOC1S3 ( p. Gln150ArgfsX75) was identified in all affected individuals. BLOC1S3 mutations have not been previously described in patients with HPS, but BLOC1S3 encodes a subunit of the biogenesis of lysosome-related organelles complex 1 ( BLOC-1). Mutations in other BLOC-1 subunits have been associated with an HPS phenotype in humans and/or mouse, and a nonsense mutation in the murine orthologue of BLOC1S3 causes the reduced pigmentation (rp) model of HPS. Interestingly, eye pigment formation is reported to be normal in rp, but we found visual defects ( nystagmus, iris transilluminancy, foveal hypoplasia, reduced visual acuity, and evidence of optic pathway misrouting) in affected individuals. These findings define a novel form of human HPS (HPS8) and extend genotype-phenotype correlations in HPS.	Univ Birmingham, Sect Med & Mol Genet, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Ctr Cardiovasc Sci, Inst Biomed Res, Div Med Sci, Birmingham B15 2TT, W Midlands, England; Birmingham Midland Eye Hosp, Birmingham, W Midlands, England; Childrens Hosp, Birmingham B16 8ET, W Midlands, England; Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham, W Midlands, England; Univ Hosp Birmingham, W Midlands Adult Haemophilia Ctr, Birmingham, W Midlands, England; St Thomas Hosp, Genet Skin Dis Grp, St Johns Inst Dermatol, London, England; Univ Leicester, Div Med Genet, Dept Med, Leicester, Leics, England; Univ Leicester, Div Med Genet, Dept Genet, Leicester, Leics, England	University of Birmingham; University of Birmingham; Birmingham Women's Hospital; University of Birmingham; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Leicester; University of Leicester	Maher, ER (corresponding author), Univ Birmingham, Sect Med & Mol Genet, Inst Biomed Res, Birmingham B15 2TT, W Midlands, England.	E.R.Maher@bham.ac.uk	MAHER, EAMONN R/A-9507-2008; Morgan, Neil V/A-5475-2009; Watson, Stephen P/Q-6292-2016	MAHER, EAMONN R/0000-0002-6226-6918; Morgan, Neil V/0000-0001-6433-5692; Watson, Stephen P/0000-0002-7846-7423; Trembath, Richard/0000-0003-0550-3400; Johnson, Colin/0000-0002-2979-8234	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anderson PD, 2003, HUM GENET, V113, P10, DOI 10.1007/s00439-003-0933-5; Atkinson BT, 2001, EUR J BIOCHEM, V268, P5242, DOI 10.1046/j.0014-2956.2001.02448.x; Auger JM, 2005, FASEB J, V19, P825, DOI 10.1096/fj.04-1940fje; DAVIES BH, 1976, Q J MED, V45, P219; Dell'Angelica EC, 2004, CURR OPIN CELL BIOL, V16, P458, DOI 10.1016/j.ceb.2004.05.001; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; EADY RAJ, 1985, METHODS SKIN RES; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; HERMANSKY F, 1959, BLOOD, V14, P162, DOI 10.1182/blood.V14.2.162.162; Hermos CR, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9097; Horikawa T, 2000, BRIT J DERMATOL, V143, P635, DOI 10.1046/j.1365-2133.2000.03725.x; Kuijpers MJE, 2003, FASEB J, V17, P685, DOI 10.1096/fj.02-0381fje; Li W, 2004, BIOESSAYS, V26, P616, DOI 10.1002/bies.20042; Nguyen T, 2002, J INVEST DERMATOL, V119, P1156, DOI 10.1046/j.1523-1747.2002.19535.x; Sandberg-Gertzen H, 1999, SCAND J GASTROENTERO, V34, P1055; SCHINELLA RA, 1980, ANN INTERN MED, V92, P20, DOI 10.7326/0003-4819-92-1-20; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Stark P, 2001, POPTRONICS, V2, P3; Swank RT, 1998, PIGM CELL RES, V11, P60, DOI 10.1111/j.1600-0749.1998.tb00713.x; Witkop C J, 1990, Bol Asoc Med P R, V82, P333	21	90	93	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					160	166		10.1086/499338	http://dx.doi.org/10.1086/499338			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385460	Green Published, Bronze			2022-12-18	WOS:000233930400017
J	Wang, NJ; Liu, DH; Parokonny, AS; Schanen, NC				Wang, NJ; Liu, DH; Parokonny, AS; Schanen, NC			High-resolution molecular characterization of 15q11-q13 rearrangements by array comparative genomic hybridization (array CGH) with detection of gene dosage	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPERNUMERARY MARKER CHROMOSOMES; PRADER-WILLI-SYNDROME; INV DUP(15); INTERSTITIAL DUPLICATIONS; COMMON BREAKPOINT; ANGELMAN-SYNDROME; PROXIMAL 15Q; DELETION; REGION; MICROARRAY	Maternally derived duplication of the imprinted region of chromosome 15q11-q14 leads to a complex neurobehavioral phenotype that often includes autism, cognitive deficits, and seizures. Multiple repeat elements within the region mediate a variety of rearrangements, including interstitial duplications, interstitial triplications, and supernumerary isodicentric marker chromosomes, as well as the deletions that cause Prader-Willi and Angelman syndromes. To elucidate the molecular structure of these duplication chromosomes, we designed a high-resolution array comparative genomic hybridization (array CGH) platform. The array contains 79 clones that form a gapped contig across the critical region on chromosome 15q11-q14 and 21 control clones from other autosomes and the sex chromosomes. We used this array to examine a set of 48 samples from patients with segmental aneuploidy of chromosome 15q. Using the array, we were able to determine accurately the dosage, which ranged from 1 to 6 copies, and also to detect atypical and asymmetric rearrangements. In addition, the increased resolution of the array allowed us to position two previously reported breakpoints within the contig. These results indicate that array CGH is a powerful technique to study rearrangements of proximal chromosome 15q.	Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Alfred I Dupont Hosp Children, Nemours Childrens Clin, Nemours Biomed Res, Wilmington, DE USA	University of California System; University of California Los Angeles; Nemours Alfred I. duPont Hospital for Children	Schanen, NC (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	schanen@medsci.udel.edu			NICHD NIH HHS [U19-HD-35470, U19 HD035470] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U19HD035470] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Browne CE, 1997, AM J HUM GENET, V61, P1342, DOI 10.1086/301624; Bruder CEG, 2001, HUM MOL GENET, V10, P271, DOI 10.1093/hmg/10.3.271; Buckley PG, 2002, HUM MOL GENET, V11, P3221, DOI 10.1093/hmg/11.25.3221; Butler MG, 2004, PEDIATRICS, V113, P565, DOI 10.1542/peds.113.3.565; Chai JH, 2003, AM J HUM GENET, V73, P898, DOI 10.1086/378816; CHRISTIAN SI, 1995, AM J HUM GENET, V57, P40; Christian SL, 1999, HUM MOL GENET, V8, P1025, DOI 10.1093/hmg/8.6.1025; Cook EH, 1997, AM J HUM GENET, V60, P928; CROLLA JA, 1995, HUM GENET, V95, P161; Dawson AJ, 2002, AM J MED GENET, V107, P334, DOI 10.1002/ajmg.10170; Eggermann K, 2002, CLIN GENET, V62, P89, DOI 10.1034/j.1399-0004.2002.620113.x; Hodgson G, 2001, NAT GENET, V29, P459, DOI 10.1038/ng771; Huang B, 1997, HUM GENET, V99, P11; KNOLL JHM, 1990, AM J HUM GENET, V47, P149; KNOLL JHM, 1989, AM J MED GENET, V32, P285, DOI 10.1002/ajmg.1320320235; Kubota T, 1996, J MED GENET, V33, P1011, DOI 10.1136/jmg.33.12.1011; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; Maggouta F, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.7.e84; MANN SM, IN PRESS HUM GENET; Mignon C, 1996, EUR J HUM GENET, V4, P88; Nietzel A, 2003, J Med Genet, V40, pe28, DOI 10.1136/jmg.40.3.e28; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; Pujana MA, 2002, EUR J HUM GENET, V10, P26, DOI 10.1038/sj.ejhg.5200760; Qumsiyeh MB, 2003, AM J MED GENET A, V116A, P356, DOI 10.1002/ajmg.a.10050; Repetto GR, 1998, AM J MED GENET, V79, P82, DOI 10.1002/(SICI)1096-8628(19980901)79:2<82::AID-AJMG2>3.0.CO;2-P; Ritchie RJ, 1998, HUM MOL GENET, V7, P1253, DOI 10.1093/hmg/7.8.1253; Roberts SE, 2003, AM J HUM GENET, V73, P1061, DOI 10.1086/379155; Robinson WP, 1998, J MED GENET, V35, P130, DOI 10.1136/jmg.35.2.130; Ungaro P, 2001, J MED GENET, V38, P26, DOI 10.1136/jmg.38.1.26; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Wandstrat AE, 2000, CHROMOSOMA, V109, P498, DOI 10.1007/s004120000103; Wandstrat AE, 1998, AM J HUM GENET, V62, P925, DOI 10.1086/301777; WEBB T, 1994, J MED GENET, V31, P585, DOI 10.1136/jmg.31.8.585; Yu W, 2003, HUM MOL GENET, V12, P2145, DOI 10.1093/hmg/ddg230	36	90	96	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2004	75	2					267	281		10.1086/422854	http://dx.doi.org/10.1086/422854			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	838GR	15197683	Green Published, Bronze			2022-12-18	WOS:000222702000011
J	Wen, G; Mahata, SK; Cadman, P; Mahata, M; Ghosh, S; Mahapatra, NR; Rao, FW; Stridsberg, M; Smith, DW; Mahboubi, P; Schork, NJ; O'Connor, DT; Hamilton, BA				Wen, G; Mahata, SK; Cadman, P; Mahata, M; Ghosh, S; Mahapatra, NR; Rao, FW; Stridsberg, M; Smith, DW; Mahboubi, P; Schork, NJ; O'Connor, DT; Hamilton, BA			Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INHIBITORY PEPTIDE CATESTATIN; CHROMOGRANIN-A FRAGMENT; ESSENTIAL-HYPERTENSION; PROTEOLYTIC CLEAVAGE; STATISTICAL-METHOD; GENE-EXPRESSION; RELEASE; REGION; IDENTIFICATION; EVOLUTION	The chromogranin/secretogranin proteins are costored and coreleased with catecholamines from secretory vesicles in chromaffin cells and noradrenergic neurons. Chromogranin A (CHGA) regulates catecholamine storage and release through intracellular (vesiculogenic) and extracellular (catecholamine release-inhibitory) mechanisms. CHGA is a candidate gene for autonomic dysfunction syndromes, including intermediate phenotypes that contribute to human hypertension. Here, we show a surprising pattern of CHGA variants that alter the expression and function of this gene, both in vivo and in vitro. Functional variants include both common alleles that quantitatively alter gene expression and rare alleles that qualitatively change the encoded product to alter the signaling potency of CHGA-derived catecholamine release-inhibitory catestatin peptides.	Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Div Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, John & Rebecca Moores Canc Ctr, La Jolla, CA 92093 USA; VA San Diego Healthcare Syst, San Diego, CA USA; Univ Hosp, Dept Med Sci, Uppsala, Sweden	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Uppsala University; Uppsala University Hospital	Hamilton, BA (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, 9500 Gilman Dr,Cellular & Mol Med W, La Jolla, CA 92093 USA.	bah@ucsd.edu	Mahapatra, Nitish R/D-4123-2014; Mahata, Sushil/AAF-8781-2021	Mahapatra, Nitish R/0000-0002-0695-3510; Schork, Nicholas/0000-0003-0920-5013; Hamilton, Bruce/0000-0001-5599-9139	NHLBI NIH HHS [HL58120, P01 HL058120] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058120] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Bamshad MJ, 2002, P NATL ACAD SCI USA, V99, P10539, DOI 10.1073/pnas.162046399; BARBOSA JA, 1991, ENDOCRINOLOGY, V128, P174, DOI 10.1210/endo-128-1-174; Cadman PE, 2002, ANN NY ACAD SCI, V971, P528, DOI 10.1111/j.1749-6632.2002.tb04518.x; Eskeland NL, 1996, J CLIN INVEST, V98, P148, DOI 10.1172/JCI118760; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fay JC, 2000, GENETICS, V155, P1405; Fu YX, 1996, GENETICS, V143, P557; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Herrmann V, 2000, AM J HYPERTENS, V13, P1021, DOI 10.1016/S0895-7061(00)01188-2; HUDSON RR, 1987, GENETICS, V116, P153; Jiang QJ, 2001, J BIOL CHEM, V276, P25022, DOI 10.1074/jbc.M101545200; Kennedy BP, 1998, PEPTIDES, V19, P1241, DOI 10.1016/S0196-9781(98)00086-2; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Loots GG, 2002, GENOME RES, V12, P832, DOI 10.1101/gr.225502; Mahata M, 1998, HYPERTENSION, V32, P907, DOI 10.1161/01.HYP.32.5.907; Mahata SK, 2000, MOL ENDOCRINOL, V14, P1525, DOI 10.1210/me.14.10.1525; Mahata SK, 1999, J BIOL CHEM, V274, P2920, DOI 10.1074/jbc.274.5.2920; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; MIALL WE, 1963, BRIT MED J, P75; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; O'Connor D T, 2000, Curr Hypertens Rep, V2, P16, DOI 10.1007/s11906-000-0053-8; O'Connor DT, 1999, BLOOD PRESSURE, V8, P285, DOI 10.1080/080370599439508; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; ROZANSKY DJ, 1994, J CLIN INVEST, V94, P2357, DOI 10.1172/JCI117601; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Rozen S, 2000, Methods Mol Biol, V132, P365; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; SCHOBER M, 1989, HYPERTENSION, V13, P469, DOI 10.1161/01.HYP.13.5.469; Schug J., 1997, TESS TRANSCRIPTION E; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Stridsberg M, 2000, J ENDOCRINOL, V165, P703, DOI 10.1677/joe.0.1650703; Stridsberg M, 2000, ADV EXP MED BIOL, V482, P319; STRIDSBERG M, 1995, J ENDOCRINOL, V144, P49, DOI 10.1677/joe.0.1440049; TAJIMA F, 1989, GENETICS, V123, P585; TAKIYYUDDIN MA, 1995, HYPERTENSION, V26, P213, DOI 10.1161/01.HYP.26.1.213; TAKIYYUDDIN MA, 1993, HYPERTENSION, V21, P674, DOI 10.1161/01.HYP.21.5.674; Tasiemski A, 2002, BLOOD, V100, P553, DOI 10.1182/blood.V100.2.553; Taupenot L, 2000, REGUL PEPTIDES, V95, P9, DOI 10.1016/S0167-0115(00)00135-X; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Taupenot L, 2002, ANN NY ACAD SCI, V971, P262, DOI 10.1111/j.1749-6632.2002.tb04473.x; Taylor CV, 2000, J BIOL CHEM, V275, P22905, DOI 10.1074/jbc.M001232200; Timberlake DS, 2001, CURR OPIN NEPHROL HY, V10, P71, DOI 10.1097/00041552-200101000-00012; Tsigelny I, 1998, REGUL PEPTIDES, V77, P43, DOI 10.1016/S0167-0115(98)00040-8; VIDEEN JS, 1992, J BIOL CHEM, V267, P3066; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WU HJ, 1994, J CLIN INVEST, V94, P118, DOI 10.1172/JCI117297; Yoo SH, 2002, ANN NY ACAD SCI, V971, P300, DOI 10.1111/j.1749-6632.2002.tb04484.x	56	90	97	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2004	74	2					197	207		10.1086/381399	http://dx.doi.org/10.1086/381399			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	772UM	14740315	Green Published, Bronze			2022-12-18	WOS:000188860000001
J	Howell, N; Oostra, RJ; Bolhuis, PA; Spruijt, L; Clarke, LA; Mackey, DA; Preston, G; Herrnstadt, C				Howell, N; Oostra, RJ; Bolhuis, PA; Spruijt, L; Clarke, LA; Mackey, DA; Preston, G; Herrnstadt, C			Sequence analysis of the mitochondrial genomes from Dutch pedigrees with Leber hereditary optic neuropathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PATHOGENIC MTDNA MUTATIONS; CONTROL REGION; COMPLEX-I; ND6 GENE; DEGENERATION; POPULATION; QUEBEC; NERVE; DNA; DYSFUNCTION	The complete mitochondrial DNA (mtDNA) sequences for 63 Dutch pedigrees with Leber hereditary optic neuropathy (LHON) were determined, 56 of which carried one of the classic LHON mutations at nucleotide (nt) 3460, 11778, or 14484. Analysis of these sequences indicated that there were several instances in which the mtDNAs were either identical or related by descent. The most striking example was a haplogroup J mtDNA that carried the 14484 LHON mutation. Four different but related mitochondrial genotypes were identified in seven of the Dutch pedigrees with LHON, including six of those described by van Senus. The control region of the founder sequence for these Dutch pedigrees with LHON matches the control-region sequence that Macmillan and colleagues identified in the founder mtDNA of French Canadian pedigrees with LHON. In addition, we obtained a perfect match between the Dutch 14484 founder sequence and the complete mtDNA sequences of two Canadian pedigrees with LHON. Those results indicate that these Dutch and French Canadian 14484 pedigrees with LHON share a common ancestor, that the single origin of the 14484 mutation in this megalineage occurred before the year 1600, and that there is a 14484/haplogroup J founder effect. We estimate that this lineage-including the 14484 LHON mutation-arose 900-1,800 years ago. Overall, the phylogenetic analyses of these mtDNA sequences conservatively indicate that a LHON mutation has arisen at least 42 times in the Dutch population. Finally, analysis of the mtDNA sequences from those pedigrees that did not carry classic LHON mutations suggested candidate pathogenic mutations at nts 9804, 13051, and 14325.	MitoKor, San Diego, CA 92121 USA; Univ Texas, Med Branch, Dept Radiat Oncol, Galveston, TX 77550 USA; Univ Amsterdam, Acad Med Ctr, Dept Anat & Embryol, NL-1105 AZ Amsterdam, Netherlands; Netherlands Ophthalm Res Inst, Dept Ophthalmogenet, NL-1100 AC Amsterdam, Netherlands; Hlth Council Netherlands, The Hague, Netherlands; Acad Hosp Maastricht, Dept Clin Genet, Maastricht, Netherlands; Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada; Royal Victoria Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia	University of Texas System; University of Texas Medical Branch Galveston; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Maastricht University; Maastricht University Medical Centre (MUMC); University of British Columbia; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital	Howell, N (corresponding author), MitoKor, 11494 Sorrento Valley Rd, San Diego, CA 92121 USA.		Mackey, David A/H-5340-2014	Mackey, David A/0000-0001-7914-4709; Clarke, Lorne/0000-0003-0512-7281; Oostra, Roelof-Jan/0000-0002-2452-8307				Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Brown MD, 1997, AM J HUM GENET, V60, P381; BROWN MD, 1995, HUM MUTAT, V6, P311, DOI 10.1002/humu.1380060405; Carelli V, 2002, NEUROCHEM INT, V40, P573, DOI 10.1016/S0197-0186(01)00129-2; Chinnery PF, 2001, BRAIN, V124, P209, DOI 10.1093/brain/124.1.209; Corona P, 2001, ANN NEUROL, V49, P106, DOI 10.1002/1531-8249(200101)49:1<106::AID-ANA16>3.0.CO;2-T; DEBRAEKELEER M, 1994, HUM BIOL, V66, P205; DeVries DD, 1996, AM J HUM GENET, V58, P703; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Heyer E, 1997, HUM BIOL, V69, P209; HEYER E, 1995, AM J HUM GENET, V56, P970; Heyer E, 2001, AM J HUM GENET, V69, P1113, DOI 10.1086/324024; Howell N, 1998, VISION RES, V38, P1495, DOI 10.1016/S0042-6989(97)00444-6; Howell N, 2000, AM J HUM GENET, V66, P1589, DOI 10.1086/302910; Howell N, 1996, AM J HUM GENET, V59, P501; Howell N, 1997, VISION RES, V37, P3495, DOI 10.1016/S0042-6989(96)00167-8; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Howell N, 2002, J NEURO-OPHTHALMOL, V22, P262, DOI 10.1097/00041327-200212000-00002; HOWELL N, 1994, AM J HUM GENET, V55, P219; HOWELL N, IN PRESS AM J MED GE; JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321; JOHNS DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P495, DOI 10.1001/archopht.1993.01090040087038; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Liolitsa D, 2003, ANN NEUROL, V53, P128, DOI 10.1002/ana.10435; Mackey DA, 1996, AM J HUM GENET, V59, P481; Macmillan C, 2000, AM J HUM GENET, V66, P332, DOI 10.1086/302716; Oostra RJ, 1996, HUM GENET, V97, P500; OOSTRA RJ, 1994, J MED GENET, V31, P280, DOI 10.1136/jmg.31.4.280; OOSTRA RJ, 1994, HUM GENET, V94, P265, DOI 10.1007/BF00208281; Torroni A, 1997, AM J HUM GENET, V60, P1107; Valentino ML, 2002, ANN NEUROL, V51, P774, DOI 10.1002/ana.10193; VAN SENUS A. H. C., 1963, DOC OPHTHALMOL, V17, P1; Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431	34	90	92	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2003	72	6					1460	1469		10.1086/375537	http://dx.doi.org/10.1086/375537			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	685QV	12736867	Green Published, Bronze			2022-12-18	WOS:000183275500009
J	Eberle, MA; Pfutzer, R; Pogue-Geile, KL; Bronner, MP; Crispin, D; Kimmey, MB; Duerr, RH; Kruglyak, L; Whitcomb, DC; Brentnall, TA				Eberle, MA; Pfutzer, R; Pogue-Geile, KL; Bronner, MP; Crispin, D; Kimmey, MB; Duerr, RH; Kruglyak, L; Whitcomb, DC; Brentnall, TA			A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY PANCREATITIS; LINKAGE ANALYSIS; RISK-FACTORS; RETINOBLASTOMA; FAMILIES; MUTATION; HISTORY	Pancreatic cancer is the fifth leading cause of cancer death in the United States. Nearly every person diagnosed with pancreatic cancer will die from it, usually in <6 mo. Familial clustering of pancreatic cancers is commonly recognized, with an autosomal dominant inheritance pattern in &SIM;10% of all cases. However, the late age at disease onset and rapid demise of affected individuals markedly hamper collection of biological samples. We report a genetic linkage scan of family X with an autosomal dominant pancreatic cancer with early onset and high penetrance. For the study of this family, we have developed an endoscopic surveillance program that allows the early detection of cancer and its precursor, before family members have died of the disease. In a genomewide screening of 373 microsatellite markers, we found significant linkage (maximum LOD score 4.56 in two-point analysis and 5.36 in three-point analysis) on chromosome 4q32-34, providing evidence for a major locus for pancreatic cancer.	Univ Washington, Med Ctr, Dept Med, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98104 USA; Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98104 USA; Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Pittsburgh, Dept Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Ctr Genom Sci, Pittsburgh, PA 15261 USA; Vet Adm Pittsburgh Hlth Care Syst, Pittsburgh, PA USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Whitcomb, DC (corresponding author), Univ Washington, Med Ctr, Dept Med, Box 356424,1959 NE Pacific, Seattle, WA 98195 USA.		Duerr, Richard H/B-4188-2009	Duerr, Richard H/0000-0001-6586-3905; Eberle, Michael/0000-0001-8965-1253	NIDDK NIH HHS [DK 54709, R01 DK054709] Funding Source: Medline; NIMH NIH HHS [R01 MH059520, R37 MH059520, MH 59520] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059520, R37MH059520] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Banke MG, 2000, MED CLIN N AM, V84, P677, DOI 10.1016/S0025-7125(05)70250-9; Brentnall TA, 1999, ANN INTERN MED, V131, P247, DOI 10.7326/0003-4819-131-4-199908170-00003; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Efthimiou E, 2001, GUT, V48, P143, DOI 10.1136/gut.48.2.143; Hruban RH, 2001, DIGEST DIS, V19, P76, DOI 10.1159/000050656; Kern S, 2001, CANCER RES, V61, P4923; Kernan GJ, 1999, AM J IND MED, V36, P260, DOI 10.1002/(SICI)1097-0274(199908)36:2<260::AID-AJIM5>3.3.CO;2-G; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Lowenfels AB, 1997, J NATL CANCER I, V89, P442, DOI 10.1093/jnci/89.6.442; LYNCH HT, 1990, AM J GASTROENTEROL, V85, P54; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; Meckler KA, 2001, AM J SURG PATHOL, V25, P1047, DOI 10.1097/00000478-200108000-00009; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ponder BAJ, 2001, NATURE, V411, P336, DOI 10.1038/35077207; Rulyak SJ, 2001, PANCREATOLOGY, V1, P477, DOI 10.1159/000055851; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Schnall SF, 1996, SEMIN ONCOL, V23, P220; Silverman DT, 1999, BRIT J CANCER, V80, P1830, DOI 10.1038/sj.bjc.6690607; Tersmette AC, 2001, CLIN CANCER RES, V7, P738; Whitcomb DC, 1999, GUT, V45, P317, DOI 10.1136/gut.45.3.317; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Whitcomb DC, 2000, MED CLIN N AM, V84, P531, DOI 10.1016/S0025-7125(05)70238-8; Whitcomb DC, 2001, PANCREATOLOGY, V1, P423, DOI 10.1159/000055842	24	90	93	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1044	1048		10.1086/339692	http://dx.doi.org/10.1086/339692			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11870593	Green Published, Bronze			2022-12-18	WOS:000174252100024
J	Akey, JM; Zhang, K; Xiong, MM; Doris, P; Jin, L				Akey, JM; Zhang, K; Xiong, MM; Doris, P; Jin, L			The effect that genotyping errors have on the robustness of common linkage-disequilibrium measures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; GAMETIC DISEQUILIBRIUM; ISOLATED POPULATIONS; CD4 LOCUS; GENOME; PATTERNS; REGIONS; SYSTEM; GENES	The rapid development of a dense single-nucleotide-polymorphism marker map has stimulated numerous studies attempting to characterize the magnitude and distribution of background linkage disequilibrium (LD) within and between human populations. Although genotyping errors are an inherent problem in all LD studies, there have been few systematic investigations documenting their consequences on estimates of background LD. Therefore, we derived simple deterministic formulas to investigate the effect that genotyping errors have on four commonly used LD measures-D', r, Q, and d-in studies of background LD. We have found that genotyping error rates as small as 3% can have serious affects on these LD measures, depending on the allele frequencies and the assumed error model. Furthermore, we compared the robustness of D', r, Q, and d, in the presence of genotyping errors. In general, Q and d are more robust than D' and r, although exceptions do exist. Finally, through stochastic simulations, we illustrate how genotyping errors can lead to erroneous inferences when measures of LD between two samples are compared.	Univ Texas, Ctr Human Genet, Sch Publ Hlth, Houston, TX USA; Univ Texas, Inst Mol Med, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System	Akey, JM (corresponding author), Univ Texas, Grad Sch Publ Hlth, 1200 Herman Pressler, Houston, TX 77030 USA.	jakey@gsbs3.gs.uth.tmc.edu	Jin, Li/M-5063-2019; Zhang, Kun/ABE-6349-2020; Jin, Li/C-1468-2009	Zhang, Kun/0000-0002-7596-5224; Jin, Li/0000-0002-4546-2415; Akey, Joshua/0000-0002-4411-1330	NIDDK NIH HHS [R01 DK069632] Funding Source: Medline; NIGMS NIH HHS [GM56515] Funding Source: Medline; PHS HHS [E509912] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056515] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Akey J, 2001, EUR J HUM GENET, V9, P291, DOI 10.1038/sj.ejhg.5200619; Akey JM, 2001, BIOTECHNIQUES, V30, P358, DOI 10.2144/01302tt05; BUETOW KH, 1991, AM J HUM GENET, V49, P985; Cho RJ, 1999, NAT GENET, V23, P203, DOI 10.1038/13833; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Eaves IA, 2000, NAT GENET, V25, P320; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Gordon D, 2000, GENOMICS, V66, P87, DOI 10.1006/geno.2000.6190; Gordon D, 2001, Pac Symp Biocomput, P18; Gordon D, 1999, GENET EPIDEMIOL, V17, pS587; Goring HHH, 2000, AM J HUM GENET, V66, P1107, DOI 10.1086/302798; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; Halushka MK, 1999, NAT GENET, V22, P239, DOI 10.1038/10297; HEDRICK PW, 1987, GENETICS, V117, P331; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Jorde LB, 2000, HUM HERED, V50, P57, DOI 10.1159/000022891; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; LEWONTIN RC, 1988, GENETICS, V120, P849; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; LEWONTIN RC, 1964, GENETICS, V49, P49; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Moffatt MF, 2000, HUM MOL GENET, V9, P1011, DOI 10.1093/hmg/9.7.1011; NEI M, 1980, GENET RES, V35, P65, DOI 10.1017/S001667230001394X; Pastinen T, 2000, GENOME RES, V10, P1031, DOI 10.1101/gr.10.7.1031; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; Prince JA, 2001, GENOME RES, V11, P152, DOI 10.1101/gr.150201; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SHIELDS DC, 1991, P NATL ACAD SCI USA, V88, P6501, DOI 10.1073/pnas.88.15.6501; Taillon-Miller P, 2000, NAT GENET, V25, P324, DOI 10.1038/77100; Terwilliger JD, 1990, AM J HUM GENET S, V47, pA201; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wu YY, 2000, CLIN CHIM ACTA, V293, P213, DOI 10.1016/S0009-8981(99)00237-5; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; Yule GU, 1900, PHILOS T R SOC LOND, V194, P257, DOI 10.1098/rsta.1900.0019; Zavattari P, 2000, HUM MOL GENET, V9, P2947, DOI 10.1093/hmg/9.20.2947	41	90	95	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2001	68	6					1447	1456		10.1086/320607	http://dx.doi.org/10.1086/320607			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	439DB	11359212	Green Published, Bronze			2022-12-18	WOS:000169094600015
J	Elson, JL; Andrews, RM; Chinnery, PF; Lightowlers, RN; Turnbull, DM; Howell, N				Elson, JL; Andrews, RM; Chinnery, PF; Lightowlers, RN; Turnbull, DM; Howell, N			Analysis of European mtDNAs for recombination	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA RECOMBINATION; LINKAGE DISEQUILIBRIUM MEASURES; SUBSTITUTION RATE; HUMAN-POPULATION; CONTROL-REGION; SEQUENCE; SITES; GENE; INHERITANCE; HUMANS	The standard paradigm postulates that the human mitochondrial genome (mtDNA) is strictly maternally inherited and that, consequently, mtDNA lineages are clonal. As a result of mtDNA clonality, phylogenetic and population genetic analyses should therefore be free of the complexities imposed by biparental recombination. The use of mtDNA in analyses of human molecular evolution is contingent, in fact, on clonality, which is also a condition that is critical both for forensic studies and for understanding the transmission of pathogenic mtDNA mutations within families. This paradigm, however, has been challenged recently by Eyre-Walker and colleagues. Using two different tests, they have concluded that recombination has contributed to the distribution of mtDNA polymorphisms within the human population. We have assembled a database that comprises the complete sequences of 64 European and 2 African mtDNAs. When this set of sequences was analyzed using any of three measures of linkage disequilibrium, one of the tests of Eyre-Walker and colleagues, there was no evidence for mtDNA recombination. When their test for excess homoplasies was applied to our set of sequences, only a slight excess of homoplasies was observed. We discuss possible reasons that our results differ from those of Eyre-Walker and colleagues. When we take the various results together, our conclusion is that mtDNA recombination has not been sufficiently frequent during human evolution to overturn the standard paradigm.	Univ Texas, Med Branch, Dept Radiat Oncol, Biol Div 0656, Galveston, TX 77555 USA; Newcastle Univ, Dept Neurol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Newcastle Univ, Sch Med, Dept Ophthalmol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Newcastle Univ, MRC, Dev Ctr Clin Brain Ageing, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Texas, Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; University of Texas System; University of Texas Medical Branch Galveston	Howell, N (corresponding author), Univ Texas, Med Branch, Dept Radiat Oncol, Biol Div 0656, Galveston, TX 77555 USA.	nhowell@utmb.edu		/0000-0002-3551-5624; Chinnery, Patrick/0000-0002-7065-6617	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; AWADALLA P, 2000, SCIENCE, V288, P1931; Berg OG, 2000, MOL BIOL EVOL, V17, P951, DOI 10.1093/oxfordjournals.molbev.a026376; Berg OG, 1999, J MOL EVOL, V48, P398, DOI 10.1007/PL00006484; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; Danan C, 1999, AM J HUM GENET, V65, P463, DOI 10.1086/302484; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Enriquez JA, 2000, J BIOL CHEM, V275, P11207, DOI 10.1074/jbc.275.15.11207; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P2041, DOI 10.1098/rspb.1999.0884; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Guo SW, 1997, HUM HERED, V47, P301, DOI 10.1159/000154430; Gurven M, 2000, HUM BIOL, V72, P455; Hagelberg E, 2000, P ROY SOC B-BIOL SCI, V267, P1595, DOI 10.1098/rspb.2000.1183; Hagelberg E, 1999, P ROY SOC B-BIOL SCI, V266, P485, DOI 10.1098/rspb.1999.0663; Hey J, 2000, TRENDS ECOL EVOL, V15, P181, DOI 10.1016/S0169-5347(00)01856-5; Howell N, 1997, AM J HUM GENET, V61, P19, DOI 10.1086/513910; Howell N, 1996, AM J HUM GENET, V59, P501; Howell N, 1999, INT REV CYTOL, V186, P49; HOWELL N, 1992, AM J HUM GENET, V50, P1333; Huelsenbeck JP, 1999, SYST BIOL, V48, P317, DOI 10.1080/106351599260319; Jacobs HT, 2000, BIOESSAYS, V22, P564, DOI 10.1002/(SICI)1521-1878(200006)22:6<564::AID-BIES9>3.0.CO;2-4; Jorde L B, 2000, Science, V288, P1931; Kivisild T, 2000, Science, V288, P1931; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Macaulay V, 1999, P ROY SOC B-BIOL SCI, V266, P2037, DOI 10.1098/rspb.1999.0883; Merriweather DA, 1999, SCIENCE, V285, P837; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; Richards M, 1996, AM J HUM GENET, V59, P185; Schierup MH, 2000, GENETICS, V156, P879; Sharma A, 2000, SCIENCE, V288, P977; Siguroardottir S, 2000, AM J HUM GENET, V66, P1599, DOI 10.1086/302902; SLATKIN M, 1994, GENETICS, V137, P331; Smith JM, 1999, GENETICS, V153, P1021; Stoneking M, 2000, AM J HUM GENET, V67, P1029, DOI 10.1086/303092; Strauss E, 1999, SCIENCE, V286, P2436; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; Torroni A, 1996, GENETICS, V144, P1835; WEIR BS, 1986, AM J HUM GENET, V38, P776; Wise CA, 1998, GENETICS, V148, P409; Xiong MM, 1997, AM J HUM GENET, V60, P1513, DOI 10.1086/515475; YANG ZH, 1995, GENETICS, V139, P993	46	90	95	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2001	68	1					145	153		10.1086/316938	http://dx.doi.org/10.1086/316938			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	392FG	11115380	Green Published, Bronze			2022-12-18	WOS:000166399900013
J	Scott, WK; Grubber, JM; Conneally, PM; Small, GW; Hulette, CM; Rosenberg, CK; Saunders, AM; Roses, AD; Haines, JL; Pericak-Vance, MA				Scott, WK; Grubber, JM; Conneally, PM; Small, GW; Hulette, CM; Rosenberg, CK; Saunders, AM; Roses, AD; Haines, JL; Pericak-Vance, MA			Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: Potential genetic and phenotypic heterogeneity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NONPARAMETRIC LINKAGE ANALYSIS; APOLIPOPROTEIN-E; PROTEIN GENE; CLINICAL-DIAGNOSIS; MISSENSE MUTATIONS; NEURAL NETWORKS; TYPE-4 ALLELE; ASSOCIATION; RECEPTOR; ALPHA-2-MACROGLOBULIN	Apolipoprotein E (APOE) is the only confirmed susceptibility gene for late-onset Alzheimer disease (AD). In a recent genomic screen of 54 families with late-onset AD, we detected significant evidence for a second late-onset AD locus located on chromosome 12 between D12S373 and D12S390. Linkage to this region was strongest in 27 large families with at least one affected individual without an APOE-4 allele, suggesting that APOE and the chromosome 12 locus might have independent effects. We have since genotyped several additional markers across the region, to refine the linkage results. In analyzing these additional data, we have addressed the issue of heterogeneity in the data set by weighting results by clinical and neuropathologic features, sibship size, and APOE genotype. When considering all possible affected sib pairs (ASPs) per nuclear family, we obtained a peak maximum LOD score between D12S1057 and D12S1042. The magnitude and location of the maximum LOD score changed when different weighting schemes were used to control for the number of ASPs contributed by each nuclear family. Using the affected-relative-pair method implemented in GENEHUNTER-PLUS, we obtained a maximum LOD score between D12S398 and D12S1632, 25 cM from the original maximum LOD score. These results indicate that family size influences the location estimate for the chromosome 12 AD gene. The results of conditional linkage analysis by use of GENEHUNTER-PLUS indicated that evidence for linkage to chromosome 12 was stronger in families with affected individuals lacking an APOE-4 allele; much of this evidence came from families with affected individuals with neuropathologic diagnosis of dementia with Lewy bodies (DLB). Taken together, these results indicate that the chromosome 12 locus acts independently of APOE to increase the risk of late-onset familial AD and that it may be associated with the DLB variant of AD.	Duke Univ, Med Ctr, Ctr Human Genet, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Indiana Univ, Med Ctr, Dept Med & Mol Genet, Indianapolis, IN USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA USA; Vanderbilt Univ, Med Ctr, Program Human Genet, Nashville, TN USA; Glaxo Wellcome Res & Dev Ltd, Genet Directorate, Res Triangle Pk, NC USA	Duke University; Duke University; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Los Angeles; Vanderbilt University; GlaxoSmithKline	Pericak-Vance, MA (corresponding author), Duke Univ, Med Ctr, Ctr Human Genet, Dept Med, Box 3445, Durham, NC 27710 USA.		Scott, William/A-7593-2009; Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728; Scott, William/0000-0001-9336-6404	NCRR NIH HHS [M01 RR000865] Funding Source: Medline; NIA NIH HHS [U24 AG021886, R01 AG013308, P60 AG011268, AG05128, P30 AG010123, AG11268, P50 AG005128] Funding Source: Medline; NIMH NIH HHS [R01 MH052453] Funding Source: Medline; NINDS NIH HHS [R01 NS031153, NS31153] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U24AG021886, R01AG013308, P50AG005128, P30AG010123, P60AG011268] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Blacker D, 1998, NAT GENET, V19, P357, DOI 10.1038/1243; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Clatworthy AE, 1997, ARCH NEUROL-CHICAGO, V54, P1289, DOI 10.1001/archneur.1997.00550220087019; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Dow DJ, 1999, NAT GENET, V22, P16, DOI 10.1038/8724; Falk CT, 1998, AM J HUM GENET, V62, P941, DOI 10.1086/301780; Fallin D, 1997, NEUROSCI LETT, V233, P145, DOI 10.1016/S0304-3940(97)00634-4; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Feakes R, 1999, GENET EPIDEMIOL, V17, P51, DOI 10.1002/(SICI)1098-2272(1999)17:1<51::AID-GEPI4>3.0.CO;2-V; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guttman R, 1999, ARCH FAM MED, V8, P347, DOI 10.1001/archfami.8.4.347; HAINES JL, 1993, ALZHEIMERS DIS ADV C, P221; HINDS D, 1998, ASPEX PACKAGE AFFECT; Hollenbach E, 1998, NEUROLOGY, V50, P1905, DOI 10.1212/WNL.50.6.1905; HULETTE C, 1995, NEUROLOGY, V45, P1991, DOI 10.1212/WNL.45.11.1991; Hyman BT, 1997, J NEUROPATH EXP NEUR, V56, P1095, DOI 10.1097/00005072-199710000-00002; Kamboh MI, 1998, NEUROSCI LETT, V244, P65, DOI 10.1016/S0304-3940(98)00141-4; Kang DE, 1997, NEUROLOGY, V49, P56, DOI 10.1212/WNL.49.1.56; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Lendon CL, 1997, NEUROSCI LETT, V222, P187, DOI 10.1016/S0304-3940(97)13381-X; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lucek P, 1998, HUM HERED, V48, P275, DOI 10.1159/000022816; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Ott J, 1999, ANAL HUMAN GENETIC L; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237; RIMMLER J, 1998, AM J HUM GENET S, V63, pA240; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614; Rogaeva EA, 1999, NAT GENET, V22, P19, DOI 10.1038/8729; Rudrasingham V, 1999, NAT GENET, V22, P17, DOI 10.1038/8726; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scott WK, 1998, NEUROGENETICS, V1, P179, DOI 10.1007/s100480050026; Scott WK, 1999, JAMA-J AM MED ASSOC, V281, P513, DOI 10.1001/jama.281.6.513; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Vance Jeffery M., 1998, P213; WavrantDeVrieze F, 1997, NEUROSCI LETT, V227, P68, DOI 10.1016/S0304-3940(97)00304-2; WISNIEWSKI T, 1993, BIOCHEM BIOPH RES CO, V192, P359, DOI 10.1006/bbrc.1993.1423; Wu WS, 1998, JAMA-J AM MED ASSOC, V280, P619, DOI 10.1001/jama.280.7.619	47	90	95	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	2000	66	3					922	932		10.1086/302828	http://dx.doi.org/10.1086/302828			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QM	10712207	Green Published, Bronze			2022-12-18	WOS:000088373200015
J	Ota, M; Mizuki, N; Katsuyama, Y; Tamiya, G; Shiina, T; Oka, A; Ando, H; Kimura, M; Goto, K; Ohno, S; Inoko, H				Ota, M; Mizuki, N; Katsuyama, Y; Tamiya, G; Shiina, T; Oka, A; Ando, H; Kimura, M; Goto, K; Ohno, S; Inoko, H			The critical region for Behcet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CLASS-I REGION; REPEAT POLYMORPHISM; MICA GENE; POPULATION; JAPANESE	The HLA-B51 allele is known to be associated with Behcet disease. Recently, we found a higher risk for Behcet disease in the MICA gene, 46 kb centromeric of HLA-B, by investigation of GCT repetitive polymorphism within exon 5 of MICA. The pathogenic gene causing Behcet disease, however, has remained uncertain. Here, eight polymorphic microsatellite markers, distributed over a 300-kb region surrounding the HLA-B locus, were subjected to association analysis for Behcet disease. Statistical studies of associated alleles detected on each microsatellite locus showed that the pathogenic gene for Behcet disease is most likely found within a 46-kb segment between the MICA and HLA-B genes. The results of this mapping study, and the results of an earlier study of ours, suggest that MICA is a strong candidate gene for the development-of Behcet disease.	Tokai Univ, Sch Med, Dept Genet Informat, Div Mol Life Sci, Kanagawa 2591193, Japan; Japanese Red Cross Saitama Blood Ctr, Shonan Blood Ctr, Kanagawa, Japan; Yokohama City Univ, Sch Med, Dept Ophthalmol, Yokohama, Kanagawa 232, Japan; Shinshu Univ, Sch Med, Dept Legal Med, Matsumoto, Nagano 390, Japan; Shinshu Univ, Sch Med, Dept Pharm, Matsumoto, Nagano 390, Japan	Tokai University; Yokohama City University; Shinshu University; Shinshu University	Inoko, H (corresponding author), Tokai Univ, Sch Med, Dept Genet Informat, Div Mol Life Sci, Kanagawa 2591193, Japan.		zhang, jun/D-7782-2015	Tamiya, Gen/0000-0002-0597-415X; Shiina, Takashi/0000-0002-2067-6708				Grimaldi MC, 1996, HUM IMMUNOL, V51, P89, DOI 10.1016/S0198-8859(96)00228-5; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Mizuki N, 1997, GENOMICS, V42, P55, DOI 10.1006/geno.1997.4708; Mizuki N, 1997, P NATL ACAD SCI USA, V94, P1298, DOI 10.1073/pnas.94.4.1298; Mizuki N, 1996, HUM IMMUNOL, V50, P47, DOI 10.1016/0198-8859(96)00122-X; MIZUKI N, 1995, HUM IMMUNOL, V43, P129, DOI 10.1016/0198-8859(94)00159-N; OHNO S, 1982, ARCH OPHTHALMOL-CHIC, V100, P1455; Ota M, 1997, TISSUE ANTIGENS, V49, P448, DOI 10.1111/j.1399-0039.1997.tb02778.x; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Shiina T, 1998, GENOMICS, V47, P372, DOI 10.1006/geno.1997.5114; Tamiya G, 1998, TISSUE ANTIGENS, V51, P337	14	90	93	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1999	64	5					1406	1410		10.1086/302364	http://dx.doi.org/10.1086/302364			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	192RP	10205273	Green Published, Bronze			2022-12-18	WOS:000080093000020
J	Perrault, I; Rozet, JM; Ghazi, I; Leowski, C; Bonnemaison, M; Gerber, S; Ducroq, D; Cabot, A; Souied, E; Dufier, JL; Munnich, A; Kaplan, J				Perrault, I; Rozet, JM; Ghazi, I; Leowski, C; Bonnemaison, M; Gerber, S; Ducroq, D; Cabot, A; Souied, E; Dufier, JL; Munnich, A; Kaplan, J			Different functional outcome of RetGC1 and RPE65 gene mutations in Leber congenital amaurosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							SEVERE RETINAL DYSTROPHY; RETINITIS-PIGMENTOSA; HETEROGENEITY		Hop Necker Enfants Malad, Dept Genet, INSERM, U393,Unite Rech Handicaps Genet Enfant, F-75015 Paris, France; Hop Necker Enfants Malad, Serv Ophtalmol, Paris, France; Inst Natl Jeunes Aveugles, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Kaplan, J (corresponding author), Hop Necker Enfants Malad, Dept Genet, INSERM, U393,Unite Rech Handicaps Genet Enfant, F-75015 Paris, France.		ROZET, Jean-Michel/E-5737-2016; perrault, isabelle/H-3047-2017	ROZET, Jean-Michel/0000-0001-7951-7886; GERBER, Sylvie/0000-0002-6827-1769; perrault, isabelle/0000-0002-8560-1379				Camuzat A, 1996, HUM GENET, V97, P798; CAMUZAT A, 1995, HUM MOL GENET, V4, P1447, DOI 10.1093/hmg/4.8.1447; FOXMAN SG, 1985, ARCH OPHTHALMOL-CHIC, V103, P1502; FRANCESCHETTI A, 1954, Confin Neurol, V14, P184; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Hamel CP, 1998, M S-MED SCI, V14, P754, DOI 10.4267/10608/1132; KAPLAN J, 1990, HUM GENET, V85, P635; Leber T., 1869, GRAEFES ARCH KLIN EX, V15, P13, DOI 10.1007/BF0272121318; Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139; MERIN S, 1991, INHERITED EYE DIS DI, P251; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Perrault I, 1996, NAT GENET, V14, P461, DOI 10.1038/ng1296-461; TRABOULSI EI, 1995, OPHTHALMIC GENET, V16, P27, DOI 10.3109/13816819509057851; WAARDENBURG PJ, 1963, ACTA OPHTHALMOL, V41, P317	14	90	92	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1999	64	4					1225	1228		10.1086/302335	http://dx.doi.org/10.1086/302335			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184UV	10090910	Bronze, Green Published			2022-12-18	WOS:000079632900036
J	Broman, KW; Weber, JL				Broman, KW; Weber, JL			Estimation of pairwise relationships in the presence of genotyping errors	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter									Marshfield Med Res Fdn, Ctr Med Genet, Marshfield, WI 54449 USA		Broman, KW (corresponding author), Marshfield Med Res Fdn, Ctr Med Genet, 1000 N Oak Ave, Marshfield, WI 54449 USA.			Broman, Karl/0000-0002-4914-6671				Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Yuan B, 1997, AM J HUM GENET, V60, P459	3	90	91	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1563	1564		10.1086/302112	http://dx.doi.org/10.1086/302112			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792888	Bronze, Green Published			2022-12-18	WOS:000076985200037
J	Brown, CJ; Carrel, L; Willard, HF				Brown, CJ; Carrel, L; Willard, HF			Expression of genes from the human active and inactive X chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; DNA-POLYMERASE-ALPHA; YAC-CONTIG; ADRENOLEUKODYSTROPHY GENE; GENOMIC ORGANIZATION; E1-ALPHA SUBUNIT; PHYSICAL LINKAGE; BINDING-PROTEIN; TURNER SYNDROME; MESSENGER-RNA	X-chromosome inactivation results in the cis-limited inactivation of many, but not all, of the genes on one of the pair of X chromosomes in mammalian females. In addition to the genes from the pseudoautosomal region, which have long been anticipated to escape inactivation, genes from several other regions of the human X chromosome have now been shown to escape inactivation and to be expressed from both the active and inactive X chromosomes. The growing number of genes escaping inactivation emphasizes the need for a reliable system for assessing the inactivation status of X-linked genes. Since many features of the active or inactive X chromosome, including transcriptional activity, are maintained in rodent/human somatic-cell hybrids, such hybrids have been used to study the inactivation process and to determine the inactivation status of human X-linked genes. In order to assess the fidelity of inactivation status in such hybrids, we have examined the expression of 33 X-linked genes in eight mouse/human somatic-cell hybrids that contain either the human active (three hybrids) or inactive X (five hybrids) chromosome. Inactivation of nine of these genes had previously been demonstrated biochemically in human cells, and the expression of these genes only in hybrids retaining an active X, but not in those retaining an inactive X, confirms that expression in-hybrids reflects expression in human cells. Although the majority of genes tested showed consistent patterns of expression among the active X hybrids or inactive X hybrids, surprisingly, 5 of the 33 genes showed heterogeneous expression among the hybrids, demonstrating a significantly higher rate of variability than previously reported for other genes in either human somatic cells or mouse/human somatic-cell hybrids. These data suggest that at least some X-linked genes may be under additional levels of epigenetic regulation not previously recognized and that somatic-cell hybrids may provide a useful approach for studying these chromosomal phenomena.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT GENET,CTR HUMAN GENET,CLEVELAND,OH 44106; UNIV HOSP CLEVELAND,CLEVELAND,OH 44106	Case Western Reserve University; University Hospitals of Cleveland			Brown, Carolyn J/A-5159-2014	Brown, Carolyn J/0000-0002-8959-0101	NIGMS NIH HHS [GM45441] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045441] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; [Anonymous], ADV DEV BIO; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; BROWN CJ, 1989, AM J HUM GENET, V45, P592; BROWN CJ, 1995, HUM MOL GENET, V4, P251, DOI 10.1093/hmg/4.2.251; BROWN CJ, 1990, NUCLEIC ACIDS RES, V18, P4191, DOI 10.1093/nar/18.14.4191; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BROWN RM, 1989, GENOMICS, V4, P174, DOI 10.1016/0888-7543(89)90297-8; CAPOBIANCHI MR, 1976, EXPERIENTIA, V32, P459, DOI 10.1007/BF01920795; Carrel L, 1996, HUM MOL GENET, V5, P391, DOI 10.1093/hmg/5.3.391; Carrel L, 1996, AM J MED GENET, V64, P27, DOI 10.1002/(SICI)1096-8628(19960712)64:1<27::AID-AJMG3>3.0.CO;2-O; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; COLEMAN MP, 1994, GENOMICS, V21, P337, DOI 10.1006/geno.1994.1274; DAHL HHM, 1987, J BIOL CHEM, V262, P7398; DARLING SM, 1986, COLD SPRING HARB SYM, V51, P205, DOI 10.1101/SQB.1986.051.01.025; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; DERRY JMJ, 1992, GENOMICS, V12, P632, DOI 10.1016/0888-7543(92)90286-2; DISTECHE CM, 1995, TRENDS GENET, V11, P17, DOI 10.1016/S0168-9525(00)88981-7; DONG BH, 1993, NUCLEIC ACIDS RES, V21, P4085, DOI 10.1093/nar/21.17.4085; ELLISON J, 1992, SOMAT CELL MOLEC GEN, V18, P259, DOI 10.1007/BF01233862; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FRANCO B, 1995, CELL, V81, P15, DOI 10.1016/0092-8674(95)90367-4; GARDNER RJ, 1995, AM J HUM GENET, V57, P311; GARTLER SM, 1994, DEV GENET, V15, P504, DOI 10.1002/dvg.1020150609; GARTLER SM, 1972, NATURE-NEW BIOL, V236, P149, DOI 10.1038/newbio236149a0; GEERKENS C, 1995, HUM GENET, V96, P44, DOI 10.1007/BF00214185; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; GRAVES JAM, 1991, CHROMOSOMA, V101, P63, DOI 10.1007/BF00357055; GRAVES JAM, 1986, SOMAT CELL MOLEC GEN, V12, P275, DOI 10.1007/BF01570786; GREIG GM, 1993, HUM MOL GENET, V2, P1611; HELLKUHL B, 1978, CYTOGENET CELL GENET, V22, P527, DOI 10.1159/000131016; HOULDSWORTH J, 1988, P NATL ACAD SCI USA, V85, P377, DOI 10.1073/pnas.85.2.377; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; JOLLY DJ, 1983, P NATL ACAD SCI-BIOL, V80, P477, DOI 10.1073/pnas.80.2.477; Jones MH, 1996, HUM MOL GENET, V5, P1695, DOI 10.1093/hmg/5.11.1695; KAHAN B, 1975, P NATL ACAD SCI USA, V72, P1510, DOI 10.1073/pnas.72.4.1510; KAHAN B, 1980, SOMAT CELL GENET, V6, P309, DOI 10.1007/BF01542785; KIRCHGESSNER CU, 1995, J MED GENET, V32, P925, DOI 10.1136/jmg.32.12.925; LAFRENIERE RG, 1993, HUM MOL GENET, V2, P1105, DOI 10.1093/hmg/2.8.1105; LAFRENIERE RG, 1994, HUM MOL GENET, V3, P1133, DOI 10.1093/hmg/3.7.1133; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MARK GE, 1986, P NATL ACAD SCI USA, V83, P6312, DOI 10.1073/pnas.83.17.6312; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MEYER WJ, 1975, P NATL ACAD SCI USA, V72, P1469, DOI 10.1073/pnas.72.4.1469; MICHELSON AM, 1985, P NATL ACAD SCI USA, V82, P6965, DOI 10.1073/pnas.82.20.6965; MIGEON BR, 1982, NATURE, V299, P838, DOI 10.1038/299838a0; MIGEON BR, 1974, P NATL ACAD SCI USA, V71, P937, DOI 10.1073/pnas.71.3.937; MIGEON BR, 1972, NATURE, V239, P87, DOI 10.1038/239087a0; MIGEON BR, 1971, AM J HUM GENET, V23, P199; MIGEON BR, 1975, AM J HUM GENET, V27, P233; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; MIGEON BR, 1988, NATURE, V335, P93, DOI 10.1038/335093a0; MIGEON BR, 1977, AM J HUM GENET, V29, P595; MILLER AP, 1995, HUM MOL GENET, V4, P731, DOI 10.1093/hmg/4.4.731; MOHANDAS T, 1984, AM J HUM GENET, V36, P916; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P308; PAPAYANNOPOULOU T, 1964, LANCET, V2, P1215; PERISCO MG, 1986, NUCLEIC ACIDS RES, V14, P2511; PETERSEN JA, 1972, P NATL ACAD SCI USA, V69, P571, DOI 10.1073/pnas.69.3.571; RACE RR, 1975, BLOOD GROUPS MAN, P579; RAO VN, 1989, SCIENCE, V244, P66, DOI 10.1126/science.2539641; ROESSLER BJ, 1989, NUCLEIC ACIDS RES, V18, P193; ROSENBLOOM FM, 1967, LANCET, V2, P305; SARDE CO, 1994, GENOMICS, V22, P13, DOI 10.1006/geno.1994.1339; SCHEIBEL K, 1993, NAT GENET, V3, P82; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; SEKIGUCHI T, 1991, MOL CELL BIOL, V11, P3317, DOI 10.1128/MCB.11.6.3317; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SLIM R, 1993, GENOMICS, V16, P26, DOI 10.1006/geno.1993.1135; SMITH MJ, 1993, HUM MOL GENET, V2, P417, DOI 10.1093/hmg/2.4.417; TILLEY WD, 1989, P NATL ACAD SCI USA, V86, P327, DOI 10.1073/pnas.86.1.327; Vermeesch JR, 1997, HUM MOL GENET, V6, P1, DOI 10.1093/hmg/6.1.1; WANG JC, 1992, SOMAT CELL MOLEC GEN, V18, P195, DOI 10.1007/BF01233165; WANG TSF, 1985, P NATL ACAD SCI USA, V82, P5270, DOI 10.1073/pnas.82.16.5270; WILES MV, 1987, SOMAT CELL MOLEC GEN, V14, P31; Willard H, 1995, METABOLIC MOL BASES, P719; WILLARD HF, 1993, COLD SPRING HARB SYM, V58, P315, DOI 10.1101/SQB.1993.058.01.037; WILSON PJ, 1990, P NATL ACAD SCI USA, V87, P8531, DOI 10.1073/pnas.87.21.8531; WONG SW, 1988, EMBO J, V7, P37, DOI 10.1002/j.1460-2075.1988.tb02781.x; WU JS, 1994, HUM MOL GENET, V3, P153, DOI 10.1093/hmg/3.1.153; ZINN AR, 1993, TRENDS GENET, V9, P90, DOI 10.1016/0168-9525(93)90230-F	85	90	97	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1997	60	6					1333	1343		10.1086/515488	http://dx.doi.org/10.1086/515488			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XE294	9199554	Bronze, Green Published			2022-12-18	WOS:A1997XE29400011
J	Menke, DB; Mutter, GL; Page, DC				Menke, DB; Mutter, GL; Page, DC			Expression of DAZ, an Azoospermia factor candidate, in human spermatogonia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							CHROMOSOME LONG ARM; HUMAN Y-CHROMOSOME; MOUSE TESTIS; GENE; SPERMATOGENESIS; LOCUS; LOCALIZATION; PROTEIN; RNA; RAT		WHITEHEAD INST BIOMED RES,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02142; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital			Mutter, George L/C-5819-2009	Menke, Douglas/0000-0002-7109-1451				CASTRILLON DH, 1993, GENETICS, V135, P489; Cooke HJ, 1996, HUM MOL GENET, V5, P513, DOI 10.1093/hmg/5.4.513; DISTEL RJ, 1984, SCIENCE, V224, P68, DOI 10.1126/science.6701535; DRABENT B, 1991, GENE, V103, P263, DOI 10.1016/0378-1119(91)90284-I; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; ELLIS RE, 1994, CIBA F SYMP, V182, P179; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; HECHT NB, 1995, DEV GENET, V16, P95, DOI 10.1002/dvg.1020160202; HULL MGR, 1985, BRIT MED J, V291, P1693, DOI 10.1136/bmj.291.6510.1693; KETTERLING RP, 1993, AM J HUM GENET, V52, P152; KOBAYASHI K, 1994, HUM MOL GENET, V3, P1965, DOI 10.1093/hmg/3.11.1965; KOJI T, 1988, HISTOCHEM J, V20, P551, DOI 10.1007/BF01002609; KURATA S, 1993, EUR J BIOCHEM, V217, P633, DOI 10.1111/j.1432-1033.1993.tb18286.x; MA K, 1992, HUM MOL GENET, V1, P29, DOI 10.1093/hmg/1.1.29; MANOVA K, 1990, DEVELOPMENT, V110, P1057; MARKKULA M, 1995, ENDOCRINOLOGY, V136, P4769, DOI 10.1210/en.136.11.4769; MEINHARDT A, 1995, BIOL REPROD, V52, P798, DOI 10.1095/biolreprod52.4.798; MUTTER GL, 1993, AM J HUM GENET, V53, P1096; Najmabadi H, 1996, J CLIN ENDOCR METAB, V81, P1347, DOI 10.1210/jc.81.4.1347; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Reijo R, 1996, LANCET, V347, P1290, DOI 10.1016/S0140-6736(96)90938-1; Reijo R, 1996, GENOMICS, V35, P346, DOI 10.1006/geno.1996.0366; SALEHIASHTIANI K, 1993, MOL REPROD DEV, V35, P1, DOI 10.1002/mrd.1080350102; Saxena R, 1996, NAT GENET, V14, P292, DOI 10.1038/ng1196-292; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; TAKAHASHI K, 1995, CANCER RES, V55, P3478; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; VANZYL JA, 1975, INT J FERTIL, V20, P129; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; WYKES SM, 1995, DNA CELL BIOL, V14, P155, DOI 10.1089/dna.1995.14.155	30	90	92	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					237	241						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981970				2022-12-18	WOS:A1997WA81800033
J	Verpy, E; Biasotto, M; Brai, M; Misiano, G; Meo, T; Tosi, M				Verpy, E; Biasotto, M; Brai, M; Misiano, G; Meo, T; Tosi, M			Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angioedema	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEREDITARY ANGIONEUROTIC-EDEMA; FACTOR-IX PROMOTER; C1 INHIBITOR; C1-INHIBITOR GENE; HEMOPHILIA-B; DNA; CLEAVAGE; SP1; SEQUENCE; REGION	A complete mutational scan of the gene coding for the serpin C1 inhibitor, comprising all eight exons and adjacent intron sequences and 550 bp preceding the transcription start site, was rapidly accomplished in 36 unrelated angioedema patients by using fluorescence-assisted mismatch analysis (FAMA). Mutations accounting for C1 inhibitor deficiency were identified in every one of 34 patients, with two failures turning out to be spurious cases. Two new substitution dimorphisms were also detected in introns. Changes affecting the C1 inhibitor protein, distributed throughout the seven coding exons, provide new insights into the molecular pathology of serpins. Six different splice-site and two promoter mutations were also found. Among the latter, a C-->T transition within one of two putative CAAT boxes of this TATA-less promoter, the sole idiomorphic nucleotide change in this kindred, was found homozygous in the proband, at variance with the dominant mode of transmission observed for structural mutations. FAMA, in the chemical probes configuration used in this study, is a rapid and robust mutation-scanning procedure, applicable to large DNA segments or transcripts and proved capable of 100% detection. Moreover, it provides accurate positional information-and hence recognition of multiple substitutions, precise relationship with those already known, and often immediate identification of the nucleotide change.	INST PASTEUR, INSERM, U276, F-75724 PARIS, FRANCE; IST PATOL GEN, PALERMO, ITALY; INST PASTEUR, UNITE IMMUNOGENET, F-75724 PARIS 15, FRANCE	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris								ALSENZ J, 1987, NEW ENGL J MED, V312, P534; Biasotto M, 1996, LABORATORY PROTOCOLS FOR MUTATION DETECTION, P54; BOCK SC, 1986, BIOCHEMISTRY-US, V25, P4292, DOI 10.1021/bi00363a018; CARTER PE, 1991, EUR J BIOCHEM, V197, P301, DOI 10.1111/j.1432-1033.1991.tb15911.x; COTTON RGH, 1989, NUCLEIC ACIDS RES, V17, P4223, DOI 10.1093/nar/17.11.4223; COTTON RGH, 1993, MUTAT RES, V285, P125, DOI 10.1016/0027-5107(93)90060-S; COUTINHO M, 1994, J IMMUNOL, V153, P3648; CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0; CROSSLEY M, 1992, SCIENCE, V257, P377, DOI 10.1126/science.1631558; CURIEL DT, 1990, MOL CELL BIOL, V10, P47, DOI 10.1128/MCB.10.1.47; DAVIS AE, 1988, ANNU REV IMMUNOL, V6, P595, DOI 10.1146/annurev.iy.06.040188.003115; DAVIS AE, 1992, NAT GENET, V1, P354, DOI 10.1038/ng0892-354; DAVIS TL, 1989, P NATL ACAD SCI USA, V86, P9682, DOI 10.1073/pnas.86.24.9682; ELDERING E, 1995, J BIOL CHEM, V270, P2579, DOI 10.1074/jbc.270.6.2579; FRANGI D, 1991, J CLIN INVEST, V88, P755, DOI 10.1172/JCI115373; GRAHAM A, 1989, HUM GENET, V84, P55, DOI 10.1007/BF00210671; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; GROMPE M, 1993, NAT GENET, V5, P11; HARIS II, 1994, PCR METH APPL, V3, P268; JACKSON J, 1986, NATURE, V323, P722, DOI 10.1038/323722a0; JANSON M, 1991, P NATL ACAD SCI USA, V88, P10609, DOI 10.1073/pnas.88.23.10609; KOIVISTO UM, 1994, P NATL ACAD SCI USA, V91, P10526, DOI 10.1073/pnas.91.22.10526; KWOK PY, 1994, GENOMICS, V23, P138, DOI 10.1006/geno.1994.1469; La Rocca E, 1986, G Ital Dermatol Venereol, V121, P203; LANE DA, 1992, J CLIN INVEST, V90, P2422, DOI 10.1172/JCI116133; MASHAL RD, 1995, NAT GENET, V9, P177, DOI 10.1038/ng0295-177; MILLAR DS, 1994, HUM GENET, V94, P509; NEWBURGER PE, 1994, J CLIN INVEST, V94, P1205, DOI 10.1172/JCI117437; Perry DJ, 1996, HUM MUTAT, V7, P7, DOI 10.1002/(SICI)1098-1004(1996)7:1<7::AID-HUMU2>3.3.CO;2-A; PHELPS RS, 1995, BIOTECHNIQUES, V19, P984; RONCHI A, 1989, NUCLEIC ACIDS RES, V17, P10231, DOI 10.1093/nar/17.24.10231; ROSEN FS, 1965, SCIENCE, V148, P957, DOI 10.1126/science.148.3672.957; Rowley G, 1995, GENOMICS, V30, P574, DOI 10.1006/geno.1995.1279; SAKAI T, 1991, NATURE, V353, P83, DOI 10.1038/353083a0; SENAPATHY P, 1990, METHOD ENZYMOL, V183, P252; SIDDIQUE Z, 1992, HUM HERED, V42, P231, DOI 10.1159/000154075; SIDDIQUE Z, 1991, HUM GENET, V88, P231; SIDDIQUE Z, 1993, HUM HERED, V43, P155, DOI 10.1159/000154171; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; STOPPALYONNET D, 1991, AM J HUM GENET, V49, P1055; STOPPALYONNET D, 1987, NEW ENGL J MED, V317, P1, DOI 10.1056/NEJM198707023170101; SYKES K, 1990, MOL CELL BIOL, V10, P95, DOI 10.1128/MCB.10.1.95; VERPY E, 1995, J CLIN INVEST, V95, P350, DOI 10.1172/JCI117663; VERPY E, 1994, P NATL ACAD SCI USA, V91, P1873, DOI 10.1073/pnas.91.5.1873; YOUIL R, 1995, P NATL ACAD SCI USA, V92, P87, DOI 10.1073/pnas.92.1.87; ZAHEDI K, 1994, J BIOL CHEM, V269, P9669	46	90	93	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	1996	59	2					308	319						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VM288	8755917				2022-12-18	WOS:A1996VM28800006
J	Ushikubo, S; Aoyama, T; Kamijo, T; Wanders, RJA; Rinaldo, P; Vockley, J; Hashimoto, T				Ushikubo, S; Aoyama, T; Kamijo, T; Wanders, RJA; Rinaldo, P; Vockley, J; Hashimoto, T			Molecular characterization of mitochondrial trifunctional protein deficiency: Formation of the enzyme complex is important for stabilization of both alpha- and beta-subunits	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE; RAT-LIVER MITOCHONDRIA; FATTY-ACID OXIDATION; MULTIENZYME COMPLEX; PURIFICATION; RECONSTITUTION; SEQUENCE; MEMBRANE; THIOLASE; SYSTEM	Mitochondrial trifunctional protein (TP) is an enzyme complex with three activities: enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacyl-CoA thiolase. Studies on defects in this enzyme in patients with TP deficiency suggest that there are two types of defect. Patients in group 1 have normal amount of crossreacting material by immunoblot and lack only long-chain 3-hydroxyacyl-CoA dehydrogenase activity. Patients in group 2 have a trace amount of cross-reacting material, with all three activities being low. We identified three patients in group 2, and analysis was made at the cDNA level. In patient 2, there was a heterozygous 71-bp deletion at position 110-180 in the alpha-subunit. In patients 1 and 3, there was an abnormal beta-subunit; patient 1 had an A-788-to-G substitution, and patient 3 had G-182-to-A and G-740-to-A substitutions in each of separate alleles. This is the first demonstration of disease-causing mutations in the beta-subunit. cDNA-expression experiments in patients' fibroblasts, using a vaccinia virus system, and gel filtration analysis, using patients' fibroblasts, revealed that the existence of both normal alpha- and beta-subunits, and possibly their association, are important for stabilizing TP and that A-788-to-G substitution on the beta-subunit in patient 1 seems to interfere with the association, the result being a rapid decomposition of TP.	SHINSHU UNIV,SCH MED,DEPT BIOCHEM,MATSUMOTO,NAGANO 390,JAPAN; SHINSHU UNIV,SCH MED,DEPT PEDIAT,MATSUMOTO,NAGANO 390,JAPAN; UNIV HOSP AMSTERDAM,DEPT CLIN BIOCHEM,AMSTERDAM,NETHERLANDS; YALE UNIV,SCH MED,DEPT GENET,NEW HAVEN,CT 06510; MAYO CLIN,DEPT MED GENET,ROCHESTER,MN	Shinshu University; Shinshu University; University of Amsterdam; Academic Medical Center Amsterdam; Yale University; Mayo Clinic			Vockley, Jerry/AAF-8523-2020; Vockley, Jerry/B-5210-2016	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457				AOYAMA T, 1989, J BIOL CHEM, V264, P10388; AOYAMA T, 1994, J BIOL CHEM, V269, P19088; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; AOYAMA T, 1995, AM J HUM GENET, V57, P273; AOYAMA T, 1994, BIOCHEM BIOPH RES CO, V201, P1541, DOI 10.1006/bbrc.1994.1879; AOYAMA T, 1990, P NATL ACAD SCI USA, V87, P5425, DOI 10.1073/pnas.87.14.5425; AOYAMA T, 1994, BIOCHEM BIOPH RES CO, V198, P1113, DOI 10.1006/bbrc.1994.1158; AOYAMA T, 1995, ANAL BIOCHEM, V227, P85, DOI 10.1006/abio.1995.1256; BRACKETT JC, 1995, J CLIN INVEST, V95, P2076, DOI 10.1172/JCI117894; CARPENTER K, 1992, BIOCHEM BIOPH RES CO, V183, P443, DOI 10.1016/0006-291X(92)90501-B; CARPENTER K, 1991, J INHERIT METAB DIS, V14, P321, DOI 10.1007/BF01811693; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; FURUTA S, 1980, J BIOCHEM, V88, P1059, DOI 10.1093/oxfordjournals.jbchem.a133057; IJLST L, 1995, J INHERIT METAB DIS, V18, P241, DOI 10.1007/BF00711778; IJLST L, 1994, BBA-LIPID LIPID MET, V1215, P347, DOI 10.1016/0005-2760(94)90064-7; IMAMURA S, 1990, J BIOCHEM, V107, P184, DOI 10.1093/oxfordjournals.jbchem.a123023; IZAI K, 1992, J BIOL CHEM, V267, P1027; JACKSON S, 1992, J CLIN INVEST, V90, P1219, DOI 10.1172/JCI115983; JACKSON S, 1995, BIOCHEM BIOPH RES CO, V214, P247, DOI 10.1006/bbrc.1995.2281; JACKSON S, 1991, PEDIATR RES, V29, P406, DOI 10.1203/00006450-199104000-00016; KAMIJO T, 1994, J CLIN INVEST, V93, P1740, DOI 10.1172/JCI117158; KAMIJO T, 1993, J BIOL CHEM, V268, P26452; KAMIJO T, 1994, BIOCHEM BIOPH RES CO, V199, P818, DOI 10.1006/bbrc.1994.1302; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNEN F, 1953, BIOCHEM Z, V330, P269; MANTAMADIOTIS T, 1993, BIOCHIM BIOPHYS ACTA, V1170, P211, DOI 10.1016/0005-2760(93)90073-I; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MIYAZAWA S, 1980, EUR J BIOCHEM, V103, P589, DOI 10.1111/j.1432-1033.1980.tb05984.x; OSUMI T, 1980, ARCH BIOCHEM BIOPHYS, V203, P372, DOI 10.1016/0003-9861(80)90189-7; OSUMI T, 1979, BIOCHIM BIOPHYS ACTA, V574, P258; SAIJO T, 1994, J BIOL CHEM, V269, P4401; SIMS HF, 1995, P NATL ACAD SCI USA, V92, P841, DOI 10.1073/pnas.92.3.841; Steinman H M, 1975, Methods Enzymol, V35, P136, DOI 10.1016/0076-6879(75)35149-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UCHIDA Y, 1992, J BIOL CHEM, V267, P1034; WANDERS RJA, 1989, LANCET, V2, P52, DOI 10.1016/S0140-6736(89)90300-0; WANDERS RJA, 1992, BIOCHEM BIOPH RES CO, V188, P1139, DOI 10.1016/0006-291X(92)91350-Y; WIELAND T, 1953, ANGEW CHEM-GER EDIT, V65, P186, DOI 10.1002/ange.19530650706; ZHANG QX, 1994, BBA-GENE STRUCT EXPR, V1219, P567, DOI 10.1016/0167-4781(94)90091-4	41	90	97	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					979	988						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651282				2022-12-18	WOS:A1996UH19200010
J	MUENKE, M; BONE, LJ; MITCHELL, HF; HART, I; WALTON, K; HALLJOHNSON, K; IPPEL, EF; DIETZBAND, J; KVALOY, K; FAN, CM; TESSIERLAVIGNE, M; PATTERSON, D				MUENKE, M; BONE, LJ; MITCHELL, HF; HART, I; WALTON, K; HALLJOHNSON, K; IPPEL, EF; DIETZBAND, J; KVALOY, K; FAN, CM; TESSIERLAVIGNE, M; PATTERSON, D			PHYSICAL MAPPING OF THE HOLOPROSENCEPHALY CRITICAL REGION IN 21Q22.3, EXCLUSION OF SIM2 AS A CANDIDATE GENE FOR HOLOPROSENCEPHALY, AND MAPPING OF SIM2 TO A REGION OF CHROMOSOME-21 IMPORTANT FOR DOWN-SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-MINDED GENE; CNS MIDLINE DEVELOPMENT; DROSOPHILA; PERSPECTIVES; PROTEIN; HYBRIDS; DELETION; ENCODES; INFANT; MAP	We set out to define the holoprosencephaly (HPE) critical region on chromosome 21 and also to determine whether there were human homologues of the Drosophila single-minded (sim) gene that might be involved in HPE. Analysis of somatic cell hybrid clones that contained rearranged chromosomes 21 from HPE patients defined the HPE minimal critical region in 21q22.3 as D21S113 to qter. We used established somatic cell hybrid mapping panels to map SIM2 to chromosome 21 within subbands q22.2-q22.3. Analysis of the HPE patient-derived somatic cell hybrids showed that SIM2 is not deleted in two of three patients and thus is not a likely candidate for HPE1, the HPE gene on chromosome 21. However, SIM2 does map within the Down syndrome critical region and thus is a candidate gene that might contribute to the Down syndrome phenotype.	UNIV PENN,DEPT PEDIAT,PHILADELPHIA,PA 19104; UNIV PENN,DEPT GENET,PHILADELPHIA,PA 19104; ELEANOR ROOSEVELT INST,DENVER,CO; CLIN GENET CTR,3501 CA UTRECHT,NETHERLANDS; ONCOR INC,GAITHERSBURG,MD; UNIV OXFORD,DEPT BIOCHEM,OXFORD OX1 3QU,ENGLAND; UNIV CALIF SAN FRANCISCO,DEPT ANAT,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	University of Pennsylvania; University of Pennsylvania; University of Oxford; Howard Hughes Medical Institute; University of California System; University of California San Francisco	MUENKE, M (corresponding author), CHILDRENS HOSP PHILADELPHIA,DIV HUMAN GENET & MOLEC BIOL,34TH & CIVIC CTR BLVD,PHILADELPHIA,PA 19104, USA.			Muenke, Maximilian/0000-0002-7719-6545	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD028732, P01HD017449] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000716] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00716] Funding Source: Medline; NICHD NIH HHS [HD28732, HD17449] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANTONARAKIS SE, IN PRESS CYTOGENET C; ARONSON DC, 1987, CLIN GENET, V31, P48; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; CHUMAKOV IM, 1992, NAT GENET, V1, P222, DOI 10.1038/ng0692-222; COHEN MM, 1992, J CRAN GENET DEV BIO, V12, P196; COHEN MM, 1989, TERATOLOGY, V40, P211, DOI 10.1002/tera.1420400304; COHEN MM, 1989, AM J MED GENET, V34, P271, DOI 10.1002/ajmg.1320340232; COLLINS FS, 1995, NAT GENET, V9, P347, DOI 10.1038/ng0495-347; CREWS S, 1992, J EXP ZOOL, V261, P234, DOI 10.1002/jez.1402610303; CREWS ST, 1988, CELL, V52, P143, DOI 10.1016/0092-8674(88)90538-7; DELABAR JM, 1993, GENOMICS, V18, P735, DOI 10.1016/S0888-7543(05)80390-8; ESTABROOKS LL, 1990, AM J MED GENET, V36, P306, DOI 10.1002/ajmg.1320360312; FREZAL J, 1991, CYTOGENET CELL GENET, V58, P986, DOI 10.1159/000133716; GARDINER K, 1988, SOMAT CELL MOLEC GEN, V14, P623, DOI 10.1007/BF01535316; GLASER T, 1989, SOMAT CELL MOLEC GEN, V15, P477, DOI 10.1007/BF01534910; GRAW S, 1988, SOMAT CELL MOLEC GEN, V14, P233, DOI 10.1007/BF01534584; GURRIERI F, 1993, NAT GENET, V3, P247, DOI 10.1038/ng0393-247; IPPEL PF, 1991, 2ORD ANN MARCH DIM C; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; LANGER JA, 1990, SOMAT CELL MOLEC GEN, V16, P231, DOI 10.1007/BF01233359; MUENKE M, 1994, P NATL ACAD SCI USA, V91, P8102, DOI 10.1073/pnas.91.17.8102; MUENKE M, 1989, AM J MED GENET, V34, P237; Muenke Maximilian, 1994, Seminars in Developmental Biology, V5, P293, DOI 10.1006/sedb.1994.1038; NAMBU JR, 1991, CELL, V67, P1157, DOI 10.1016/0092-8674(91)90292-7; NAMBU JR, 1990, CELL, V63, P63, DOI 10.1016/0092-8674(90)90288-P; NIEDERMEYE RKK, 1994, AM J HUM GENET S, V55, P494; OVERHAUSER J, 1995, AM J HUM GENET, V57, P1080; PETTERSON A, 1994, HUM MOL GENET, V3, P1735; SHECHTER I, 1994, GENOMICS, V20, P116, DOI 10.1006/geno.1994.1135; SHIMIZU N, 1995, CYTOGENET CELL GENET, V70, P147; VANKEUREN ML, 1986, AM J HUM GENET, V38, P793	31	90	91	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1995	57	5					1074	1079						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TA449	7485157				2022-12-18	WOS:A1995TA44900013
J	BOEHNKE, M				BOEHNKE, M			LIMITS OF RESOLUTION OF GENETIC-LINKAGE STUDIES - IMPLICATIONS FOR THE POSITIONAL CLONING OF HUMAN-DISEASE GENES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROPOSED LINKAGE; HUMAN GENOME; POWER	Positional cloning studies to identify disease genes are being carried out for many human genetic diseases. Such studies often include a genome-scan linkage analysis to identify the rough chromosomal location of a disease gene, fine structure genetic mapping to define and narrow the chromosomal interval in which the disease gene may be located, and physical mapping and gene identification in the genetically defined interval to clone the disease gene. During the planning of a positional cloning study, it is important to know that, if linkage is found, the genetic interval identified is likely to be sufficiently narrow to be dissected efficiently by methods of physical mapping and gene identification. Thus, we wish to know the limits of resolution of a genetic linkage study. In this paper, I determine for Mendelian diseases the distributions and moments of three measures of linkage resolution: (1) in a set of N chromosomes, the distance between the nearest crossovers that flank a disease locus, (2) the distance between the nearest genetic markers that flank the pair of flanking crossovers after a genome scan, and (3) the distance between the nearest flanking markers after additional randomly placed markers are generated and typed in an identified interval. These results provide explicit sample-size guidelines for future positional cloning studies of Mendelian diseases and make possible a more objective evaluation of whether a proposed positional cloning study is likely to be successful. I also briefly discuss the more difficult problem of linkage resolution for complex genetic diseases.			BOEHNKE, M (corresponding author), UNIV MICHIGAN,SCH PUBL HLTH,DEPT BIOSTAT,1420 WASHINGTON HTS,ANN ARBOR,MI 48109, USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000376, R29HG000376] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00376] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		BICKMORE WA, 1989, TRENDS GENET, V5, P144, DOI 10.1016/0168-9525(89)90055-3; BOEHNKE M, 1986, AM J HUM GENET, V39, P513; CHAR BW, 1991, MAPLE LANGUAGE REFER; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; EDWARDS JH, 1971, ANN HUM GENET, V34, P229, DOI 10.1111/j.1469-1809.1971.tb00237.x; ELSTON RC, 1992, 16TH P INT BIOM C HA, P39; LANGE K, 1985, AM J HUM GENET, V37, P853; MORTON NE, 1991, P NATL ACAD SCI USA, V88, P7474, DOI 10.1073/pnas.88.17.7474; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1991, ANAL HUMAN GENETIC L; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; RISCH N, 1993, AM J HUM GENET, V53, P185; SACCONE S, 1992, P NATL ACAD SCI USA, V89, P4913, DOI 10.1073/pnas.89.11.4913; Taylor HM., 1984, INTRO STOCHASTIC MOD, V3	14	90	94	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1994	55	2					379	390						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	NZ336	8037215				2022-12-18	WOS:A1994NZ33600021
J	HOROWITZ, M; TZURI, G; EYAL, N; BEREBI, A; KOLODNY, EH; BRADY, RO; BARTON, NW; ABRAHAMOV, A; ZIMRAN, A				HOROWITZ, M; TZURI, G; EYAL, N; BEREBI, A; KOLODNY, EH; BRADY, RO; BARTON, NW; ABRAHAMOV, A; ZIMRAN, A			PREVALENCE OF 9 MUTATIONS AMONG JEWISH AND NON-JEWISH GAUCHER DISEASE PATIENTS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACID BETA-GLUCOSIDASE; HUMAN GLUCOCEREBROSIDASE GENE; ACTIVATOR PROTEIN; ASSIGNMENT; IDENTIFICATION; HETEROGENEITY; CHROMOSOME-1; SEQUENCE; CLONING; ALLELES	The frequency of nine different mutated alleles known to occur in the glucocerebrosidase gene was determined in 247 Gaucher patients, of whom 176 were of Jewish extraction, 2 were Jewish with one converted parent, and 69 were of non-jewish origin. DNA was prepared from peripheral blood, active glucocerebrosidase sequences were amplified by using the PCR technique, and the mutations were identified by using the allele-specific oligonucleotide hybridization method. The N37OS mutation appeared in 69.77% of the mutated alleles in Jewish patients and in 22.86% of the mutated alleles in non-jews. The 84GG mutation, which has not been found so far among non-jewish patients, existed in 10.17% of the disease alleles among Jewish patients. The IVS2+1. mutation constituted 2.26% of the disease alleles among Jewish patients and 1.43% among the non-Jewish patients. RecTL, a complex allele containing four. single-base-pair changes, occurred in 2.26% of the alleles in Jewish patients and was found in two (1.43%) of the patients of non-jewish extraction. Another complex allele, designated ''RecNciI'' and containing three single-point mutations, appeared in 7.8% of alleles of non-jewish patients and in only two (0.56%) of the Jewish families. The prevalence of the L444P mutation among non-jewish Gaucher patients was 31.43%, while its prevalence among Jewish patients was only 4.24%. The prevalence of two other point mutations-D409H and R463C-was 5.00% and 3.57%, respectively, among non-jewish patients and was not found among the Jewish Gaucher patient population. The prevalence of the R496H mutation, found so far only among Jewish patients, was 1.13%. The results presented demonstrate that seven mutations identify 90.40% of the mutations among Jewish patients and that these seven mutations allow diagnosis of only 73.52% of the non-jewish patients. Identification of additional mutant alleles will enhance the accuracy of carrier detection.	KAPLAN HOSP,DEPT HAEMATOL,IL-76100 REHOVOT,ISRAEL; NYU,SCH MED,DEPT NEUROL,NEW YORK,NY 10003; NIH,BETHESDA,MD 20892; SHAARE ZEDEK MED CTR,IL-91000 JERUSALEM,ISRAEL	Hebrew University of Jerusalem; Kaplan Medical Center; New York University; National Institutes of Health (NIH) - USA; Hebrew University of Jerusalem; Shaare Zedek Medical Center	HOROWITZ, M (corresponding author), TEL AVIV UNIV,DEPT CELL RES & IMMUNOL,IL-69978 TEL AVIV,ISRAEL.							BARNEVELD RA, 1983, HUM GENET, V64, P227, DOI 10.1007/BF00279398; Barranger J. A., 1989, METABOLIC BASIS INHE, P1677; BEUTLER E, 1992, BLOOD, V79, P1662; BEUTLER E, 1991, NEW ENGL J MED, V325, P1354; BEUTLER E, 1991, P NATL ACAD SCI USA, V88, P10544, DOI 10.1073/pnas.88.23.10544; BEUTLER E, 1993, GENOMICS, V15, P203, DOI 10.1006/geno.1993.1035; BRADY RO, 1993, METABOLIC BASIS INHE, P842; EYAL N, 1990, GENE, V96, P277, DOI 10.1016/0378-1119(90)90264-R; FIRON N, 1990, AM J HUM GENET, V46, P527; Gatt S, 1981, Methods Enzymol, V72, P351; GRABOWSKI GA, 1990, CRIT REV BIOCHEM MOL, V25, P385, DOI 10.3109/10409239009090616; GRAVES PN, 1988, DNA-J MOLEC CELL BIO, V7, P521, DOI 10.1089/dna.1.1988.7.521; GROSSTSUR V, 1989, PEDIATR NEUROL, V5, P128, DOI 10.1016/0887-8994(89)90042-8; HE GS, 1992, AM J HUM GENET, V51, P810; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; HONG CM, 1990, DNA CELL BIOL, V9, P233, DOI 10.1089/dna.1990.9.233; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; KLEINSCHMIDT T, 1987, BIOL CHEM H-S, V368, P1571, DOI 10.1515/bchm3.1987.368.2.1571; KOLODNY EH, 1990, AM J MED GENET, V36, P467, DOI 10.1002/ajmg.1320360419; LATHAM T, 1990, AM J HUM GENET, V47, P79; MORIMOTO S, 1989, P NATL ACAD SCI USA, V86, P3389, DOI 10.1073/pnas.86.9.3389; OCKERMAN PA, 1968, BIOCHIM BIOPHYS ACTA, V165, P59, DOI 10.1016/0304-4165(68)90187-6; OHASHI T, 1989, American Journal of Human Genetics, V45, pA211; SCHNABEL D, 1991, FEBS LETT, V284, P57, DOI 10.1016/0014-5793(91)80760-Z; SHAFITZAGARDO B, 1981, AM J HUM GENET, V33, P564; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; WIGDERSON M, 1989, AM J HUM GENET, V44, P365; ZIMRAN A, 1989, LANCET, V2, P349; ZIMRAN A, 1990, AM J HUM GENET, V46, P902; ZIMRAN A, 1990, J CLIN INVEST, V85, P219, DOI 10.1172/JCI114415	33	90	90	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1993	53	4					921	930						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LY627	8213821				2022-12-18	WOS:A1993LY62700017
J	BLENNOW, E; ANNEREN, G; BUI, TH; BERGGREN, E; ASADI, E; NORDENSKJOLD, M				BLENNOW, E; ANNEREN, G; BUI, TH; BERGGREN, E; ASADI, E; NORDENSKJOLD, M			CHARACTERIZATION OF SUPERNUMERARY RING MARKER CHROMOSOMES BY FLUORESCENCE IN-SITU HYBRIDIZATION (FISH)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUPPRESSION HYBRIDIZATION; CLINICAL CYTOGENETICS; INV DUP(15); DIAGNOSIS; ORIGIN; ISOCHROMOSOME-18P; REARRANGEMENTS; AMNIOCENTESIS; SPECIFICITY	Five cases with small supernumerary ring chromosomes are characterized at the molecular level. Routine chromosome banding analysis was insufficient for identification of the ring chromosomes, and none of them was DA/DAPI positive. Fluorescence in situ hybridization utilizing repetitive centromeric probes for all chromosomes has determined that one of these five ring chromosomes originates in each of chromosomes 4, 7, 8, 9, and 20. Chromosome painting with chromosome-specific libraries has confirmed this and excluded the involvement of additional chromosomes in the rearrangements.	SACHSSKA CHILDRENS HOSP,DEPT PEDIAT,STOCKHOLM,SWEDEN; REG HOSP OREBRO,DEPT PEDIAT,S-70185 OREBRO,SWEDEN; UNIV UPPSALA HOSP,DEPT CLIN GENET,S-75014 UPPSALA,SWEDEN	Uppsala University; Uppsala University Hospital	BLENNOW, E (corresponding author), KAROLINSKA HOSP,DEPT CLIN GENET,S-10401 STOCKHOLM 60,SWEDEN.			Nordenskjold, Magnus/0000-0002-4974-425X				BLENNOW E, 1991, CLIN GENET, V39, P429; BLENNOW E, 1992, HUM GENET, V90, P371, DOI 10.1007/BF00220461; BUCKTON KE, 1985, HUM GENET, V69, P353, DOI 10.1007/BF00291656; CALLEN DF, 1990, J MED GENET, V27, P155, DOI 10.1136/jmg.27.3.155; CALLEN DF, 1991, AM J HUM GENET, V48, P769; CALLEN DF, 1992, AM J MED GENET, V43, P709, DOI 10.1002/ajmg.1320430412; CALLEN DF, 1990, AM J HUM GENET, V47, P493; CHEUNG SW, 1990, PRENATAL DIAG, V10, P717, DOI 10.1002/pd.1970101105; CROLLA JA, 1992, J MED GENET, V29, P699, DOI 10.1136/jmg.29.10.699; FRIEDRICH U, 1974, CLIN GENET, V29, P23; HOOK EB, 1987, AM J HUM GENET, V40, P83; HULTEN MA, 1991, J MED GENET, V28, P577, DOI 10.1136/jmg.28.9.577; JAUCH A, 1990, HUM GENET, V85, P145; KIRKILIONIS AJ, 1987, CLIN GENET, V31, P425; LIN MS, 1990, CLIN GENET, V37, P74; MCDERMID HE, 1986, SCIENCE, V232, P646, DOI 10.1126/science.3961499; NIELSEN J, 1975, HEREDITAS, V81, P221; PEREZCASTILLO A, 1987, CYTOGENET CELL GENET, V45, P62, DOI 10.1159/000132427; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; RAUCH A, 1992, CLIN GENET, V42, P84; SACHS ES, 1987, PRENATAL DIAG, V7, P81, DOI 10.1002/pd.1970070204; SCHINZEL A, 1991, J MED GENET, V28, P122, DOI 10.1136/jmg.28.2.122; SOUDEK D, 1977, CLIN GENET, V12, P285; STEINBACH P, 1983, HUM GENET, V65, P155, DOI 10.1007/BF00286654; STETTEN G, 1981, HUM GENET, V57, P357, DOI 10.1007/BF00281684; TRASK BJ, 1991, TRENDS GENET, V7, P149, DOI 10.1016/0168-9525(91)90378-4; WALTZER S, 1969, J PEDIATR, V74, P438; WARBURTON D, 1984, PRENATAL DIAG, V4, P69, DOI 10.1002/pd.1970040706; WARBURTON D, 1991, AM J HUM GENET, V49, P995; WISNIEWSKI L, 1979, HUM GENET, V50, P259, DOI 10.1007/BF00399391	30	90	91	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1993	53	2					433	442						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LN820	8328459				2022-12-18	WOS:A1993LN82000015
J	WILKIE, AOM; ZEITLIN, HC; LINDENBAUM, RH; BUCKLE, VJ; FISCHELGHODSIAN, N; CHUI, DHK; GARDNERMEDWIN, D; MACGILLIVRAY, MH; WEATHERALL, DJ; HIGGS, DR				WILKIE, AOM; ZEITLIN, HC; LINDENBAUM, RH; BUCKLE, VJ; FISCHELGHODSIAN, N; CHUI, DHK; GARDNERMEDWIN, D; MACGILLIVRAY, MH; WEATHERALL, DJ; HIGGS, DR			CLINICAL-FEATURES AND MOLECULAR ANALYSIS OF THE ALPHA-THALASSEMIA MENTAL-RETARDATION SYNDROMES .2. CASES WITHOUT DETECTABLE ABNORMALITY OF THE ALPHA-GLOBIN COMPLEX	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									JOHN RADCLIFFE HOSP,INST MOLEC MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND; CHURCHILL HOSP,DEPT MED GENET,OXFORD OX3 7LJ,ENGLAND; CEDARS SINAI MED CTR,LOS ANGELES,CA 90048; MCMASTER UNIV,DEPT PATHOL,HAMILTON L8S 4L8,ONTARIO,CANADA; CHILDRENS HOSP,DIV ENDOCRINOL,BUFFALO,NY 14222; NEWCASTLE GEN HOSP,DEPT CHILDRENS,NEWCASTLE TYNE NE4 6BE,TYNE & WEAR,ENGLAND	University of Oxford; University of Oxford; Cedars Sinai Medical Center; McMaster University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Newcastle General Hospital			Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481				ABEL T, 1989, NATURE, V341, P24, DOI 10.1038/341024a0; BIALER MG, 1987, AM J MED GENET, V28, P723, DOI 10.1002/ajmg.1320280320; BIANCHI DW, 1986, J PEDIATR-US, V108, P716, DOI 10.1016/S0022-3476(86)81049-6; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; DEGROUCHY J, 1985, ANN GENET-PARIS, V28, P154; DEISSEROTH A, 1978, CELL, V15, P55, DOI 10.1016/0092-8674(78)90082-X; FISCHELGHODSIAN N, 1987, NATURE, V329, P397, DOI 10.1038/329397b0; FISCHELGHODSIAN N, 1987, NUCLEIC ACIDS RES, V15, P6197, DOI 10.1093/nar/15.15.6197; FISCHELGHODSIAN N, 1988, BRIT J HAEMATOL, V70, P233, DOI 10.1111/j.1365-2141.1988.tb02469.x; GALANELLO R, 1984, ACTA HAEMATOL-BASEL, V72, P34, DOI 10.1159/000206353; GERMINO GG, 1990, AM J HUM GENET, V46, P925; HARRIS PC, IN PRESS GENOMICS; HIGGS DR, 1983, NATURE, V306, P398, DOI 10.1038/306398a0; HIGGS DR, 1983, AM J MED, V75, P181, DOI 10.1016/0002-9343(83)91189-0; HIGGS DR, 1989, BLOOD, V73, P1081; JARMAN AP, 1988, AM J HUM GENET, V43, P249; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; LAMB J, 1989, LANCET, V2, P819; LAUER J, 1980, CELL, V20, P119, DOI 10.1016/0092-8674(80)90240-8; LIEBHABER SA, 1987, J CLIN INVEST, V80, P154, DOI 10.1172/JCI113041; MOI P, 1987, J CLIN INVEST, V80, P1416, DOI 10.1172/JCI113220; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P3122, DOI 10.1093/nar/16.7.3122; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; ORKIN SH, 1981, P NATL ACAD SCI-BIOL, V78, P5041, DOI 10.1073/pnas.78.8.5041; ORKIN SH, 1981, CELL, V24, P345, DOI 10.1016/0092-8674(81)90324-X; PIRASTU M, 1984, J BIOL CHEM, V259, P2315; PROUDFOOT NJ, 1982, CELL, V31, P553, DOI 10.1016/0092-8674(82)90311-7; REITH W, 1988, CELL, V53, P897, DOI 10.1016/S0092-8674(88)90389-3; Rudolph A., 1977, PEDIATRICS, P1109; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; SJOLIN S, 1964, ACTA HAEMATOL-BASEL, V32, P239, DOI 10.1159/000209592; TURLEAU C, 1984, CLIN GENET, V26, P356; WEATHERALL DJ, 1981, NEW ENGL J MED, V305, P607, DOI 10.1056/NEJM198109103051103; Weatherall DJ, 1981, THALASSEMIA SYNDROME; WILKIE AOM, 1990, AM J HUM GENET, V46; WOLFF E, 1988, NUCLEIC ACIDS RES, V16, P9885, DOI 10.1093/nar/16.20.9885; Zeitlin H C, 1983, Mol Biol Med, V1, P489; ZERIAL M, 1986, EUR J BIOCHEM, V160, P479, DOI 10.1111/j.1432-1033.1986.tb10064.x	38	90	91	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1990	46	6					1127	1140						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DF202	2339705				2022-12-18	WOS:A1990DF20200013
J	VANKEUREN, ML; WATKINS, PC; DRABKIN, HA; JABS, EW; GUSELLA, JF; PATTERSON, D				VANKEUREN, ML; WATKINS, PC; DRABKIN, HA; JABS, EW; GUSELLA, JF; PATTERSON, D			REGIONAL LOCALIZATION OF DNA-SEQUENCES ON CHROMOSOME-21 USING SOMATIC-CELL HYBRIDS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INTEGRATED GENET INC,FRAMINGHAM,MA 01701; UNIV COLORADO,HLTH SCI CTR,DEPT ONCOL,DENVER,CO 80262; JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT GENET,NEUROGENET LAB,BOSTON,MA 02114; UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM BIOPHYS & CHEM,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	VANKEUREN, ML (corresponding author), ELEANOR ROOSEVELT INST CANC RES,BOX B129,4200 E 9TH AVE,DENVER,CO 80262, USA.			Jabs, Ethylin/0000-0001-8983-5466	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD006470, P01HD017449] Funding Source: NIH RePORTER; NICHD NIH HHS [F32 HD06470, HD17441, HD17449] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ADAMS MM, 1981, JAMA-J AM MED ASSOC, V246, P758, DOI 10.1001/jama.246.7.758; ALHADEFF B, 1977, CYTOGENET CELL GENET, V19, P236, DOI 10.1159/000130814; BARTLEY JA, 1980, BIOCHEM BIOPH RES CO, V93, P1286, DOI 10.1016/0006-291X(80)90629-4; CERVENKA J, 1977, CLIN GENET, V11, P119; CHADEFAUX B, 1984, HUM GENET, V66, P190, DOI 10.1007/BF00286599; CHADEFAUX B, 1985, BIOCHEM BIOPH RES CO, V128, P40, DOI 10.1016/0006-291X(85)91641-9; DAVIDSON J, 1984, ADV GENE TECHNOLOGY, P148; DAVIES KE, 1984, HUM GENET, V66, P54, DOI 10.1007/BF00275186; DEVINE EA, 1985, AM J HUM GENET, V37, P114; DEVINE EA, 1984, BIOCHEM BIOPH RES CO, V121, P380, DOI 10.1016/0006-291X(84)90733-2; DRABKIN HA, 1985, P NATL ACAD SCI USA, V82, P464, DOI 10.1073/pnas.82.2.464; ELLIS WG, 1974, NEUROLOGY, V24, P101, DOI 10.1212/WNL.24.2.101; EPSTEIN CJ, 1982, BIOCHEM BIOPH RES CO, V107, P1060, DOI 10.1016/0006-291X(82)90629-5; ERICKSON JM, 1981, GENE, V16, P1, DOI 10.1016/0378-1119(81)90055-X; FEASTER WW, 1977, AM J HUM GENET, V29, P563; FRIEND KK, 1976, SOMAT CELL GENET, V2, P183, DOI 10.1007/BF01542631; GRAHAM GJ, 1984, AM J HUM GENET, V36, P25; GUSELLA J, 1979, P NATL ACAD SCI USA, V76, P5239, DOI 10.1073/pnas.76.10.5239; HABEDANK M, 1982, HUM GENET, V60, P74, DOI 10.1007/BF00281269; HAGEMEIJER A, 1977, HUM GENET, V38, P15, DOI 10.1007/BF00295803; JABS EW, 1984, P NATL ACAD SCI-BIOL, V81, P4884, DOI 10.1073/pnas.81.15.4884; Kao F T, 1974, Methods Cell Biol, V8, P23, DOI 10.1016/S0091-679X(08)60441-0; KAZAZIAN HH, 1985, ANN NY ACAD SCI, V450, P33, DOI 10.1111/j.1749-6632.1985.tb21481.x; KITSIOUTZELI S, 1984, AM J MED GENET, V18, P725, DOI 10.1002/ajmg.1320180419; KOZAK CA, 1977, EXP CELL RES, V105, P109, DOI 10.1016/0014-4827(77)90156-2; KRUMLAUF R, 1982, P NATL ACAD SCI-BIOL, V79, P2971, DOI 10.1073/pnas.79.9.2971; LIEMANHURWITZ J, 1982, P NATL ACAD SCI-BIOL, V79, P2808, DOI 10.1073/pnas.79.9.2808; Martin G M, 1978, Birth Defects Orig Artic Ser, V14, P5; MATTEI JF, 1981, HUM GENET, V56, P409, DOI 10.1007/BF00274703; MILLER YE, 1986, TRISOMY, V21; MOORE EE, 1977, AM J HUM GENET, V29, P389; NEIBUHR E, 1974, HUMANGENETIK, V21, P99; OATES DC, 1977, SOMAT CELL GENET, V3, P561, DOI 10.1007/BF01539066; OLSON MI, 1969, BRAIN, V92, P147, DOI 10.1093/brain/92.1.147; PATTERSON D, 1983, SOMAT CELL GENET, V9, P359, DOI 10.1007/BF01539144; PATTERSON D, 1981, P NATL ACAD SCI-BIOL, V78, P405, DOI 10.1073/pnas.78.1.405; PFEIFFER RA, 1977, CLIN GENET, V11, P207; POISSONNIER M, 1976, ANN GENET-PARIS, V19, P69; QUAXJEUKEN Y, 1985, P NATL ACAD SCI USA, V82, P5819, DOI 10.1073/pnas.82.17.5819; RAZIUDDIN A, 1984, P NATL ACAD SCI-BIOL, V81, P5504, DOI 10.1073/pnas.81.17.5504; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; ROWE RD, 1961, AM J MED, V31, P726, DOI 10.1016/0002-9343(61)90157-7; ROWLEY JD, 1981, LANCET, V2, P1020; SCHITIU S, 1974, HUMANGENETIK, V23, P65; SCHMICKEL RD, 1975, PEDIATR RES, V11, P929; SCHOLL T, 1982, DEV MED CHILD NEUROL, V24, P817; SCOGGIN CH, 1980, CLIN RES, V28, pA31; SEABRIGH.M, 1971, LANCET, V2, P971; SINET PM, 1976, EXP CELL RES, V97, P47, DOI 10.1016/0014-4827(76)90653-4; SKOVBY F, 1984, HUM GENET, V65, P291, DOI 10.1007/BF00286520; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STETTEN G, 1984, HUM GENET, V68, P310, DOI 10.1007/BF00292590; STEWART GD, 1984, CYTOGENET CELL GENET, V37, P593; SYLVESTER JE, 1985, AM J HUM GENET, V36, pS154; TAN YH, 1973, J EXP MED, V137, P317, DOI 10.1084/jem.137.2.317; TANDON R, 1973, CIRCULATION, V47, P1349, DOI 10.1161/01.CIR.47.6.1349; TANZI R, UNPUB GENETIC LINKAG; TAYSI K, 1982, J MED GENET, V19, P144, DOI 10.1136/jmg.19.2.144; VORA S, 1981, P NATL ACAD SCI-BIOL, V78, P3738, DOI 10.1073/pnas.78.6.3738; WATKINS P, 1984, CYTOGENET CELL GENET, V37, P602; WATKINS PC, 1985, NUCLEIC ACIDS RES, V13, P6075, DOI 10.1093/nar/13.17.6075; WATKINS PC, 1985, CYTOGENET CELL GENET, V40, P773; WATSON DK, 1986, P NATL ACAD SCI US; WILLIAMS JD, 1975, AM J HUM GENET, V27, P478	64	90	90	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1986	38	6					793	804						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	D3922	3014865				2022-12-18	WOS:A1986D392200001
J	AFZELIUS, BA				AFZELIUS, BA			GENETIC AND ULTRASTRUCTURAL ASPECTS OF THE IMMOTILE-CILIA SYNDROME	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article											AFZELIUS, BA (corresponding author), UNIV STOCKHOLM, WENNER GREN INST, S-11345 STOCKHOLM, SWEDEN.							AFZELIUS B A, 1976, Science (Washington D C), V193, P317; Afzelius B A, 1979, Int Rev Exp Pathol, V19, P1; AFZELIUS BA, 1979, J ULTRA MOL STRUCT R, V69, P43, DOI 10.1016/S0022-5320(79)80041-6; AFZELIUS BA, 1975, J CELL BIOL, V66, P225, DOI 10.1083/jcb.66.2.225; AFZELIUS BA, 1978, FERTIL STERIL, V29, P72; AFZELIUS BA, 1981, CELL BIOL 1980 1981, P440; ALBEGGER KW, 1978, LARYNG RHINOL OTOL V, V57, P395; ARGE E, 1960, LANCET, V1, P412; BARONDESS JA, 1979, ANN INTERN MED, V90, P412, DOI 10.7326/0003-4819-90-3-412; BRYAN JHD, 1977, CELL TISSUE RES, V180, P187, DOI 10.1007/BF00231951; BURDICK AB, 1977, HUM HERED, V27, P366, DOI 10.1159/000152892; CHIPPS BE, 1978, CHEST, V73, P519, DOI 10.1378/chest.73.4.519; CHURCHILL ED, 1949, J THORAC SURG, V18, P279; CONWAY DJ, 1951, ARCH DIS CHILD, V26, P253, DOI 10.1136/adc.26.127.253; COOK CD, 1962, AM J HUM GENET, V14, P290; CORNILLIE F, 1980, PEDIATR RES, V14, P168, DOI 10.1203/00006450-198002000-00042; COX DW, 1979, PEDIATR CLIN N AM, V26, P467; Dochez C, 1975, Tijdschr Gastroenterol, V18, P263; EDDY CA, 1978, AM J OBSTET GYNECOL, V132, P814, DOI 10.1016/S0002-9378(78)80016-7; ELIASSON R, 1977, NEW ENGL J MED, V297, P1, DOI 10.1056/NEJM197707072970101; ELVERLAND HH, 1979, ACTA OTO-LARYNGOL, P129; FINKLER E, 1956, Schweiz Med Wochenschr, V86, P631; FINNSTROM O, 1980, INT J PEDIATR OTORHI, V2, P33, DOI 10.1016/0165-5876(80)90026-9; FORNATTO E J, 1956, Laryngoscope, V66, P1202; GIBNEY RTN, 1980, IRISH MED J, V73, P87; GOLDMAN AS, 1980, J PEDIATR-US, V96, P244, DOI 10.1016/S0022-3476(80)80812-2; GORHAM GW, 1959, B JOHNS HOPKINS HOSP, V104, P11; GRIMFELD A, 1979, THORAX, V34, P709; GUERRANT JL, 1978, NEW ENGL J MED, V298, P282; HARTLINE JV, 1971, AM J DIS CHILD, V121, P349, DOI 10.1001/archpedi.1971.02100150123020; HERZON FS, 1980, ANN OTO RHINOL LARYN, V89, P81, DOI 10.1177/000348948008900120; HOLMES LB, 1968, AM J MED SCI, V255, P13; HOLMES LB, 1979, BIRTH DEFECT COMPEND, P284; HOWELL JT, 1980, ARCH PATHOL LAB MED, V104, P52; HUANG B, 1979, J BIOL CHEM, V254, P3091; JAHRSDOERFER R, 1979, LARYNGOSCOPE, V89, P769; JEAN Y, 1979, FERTIL STERIL, V31, P349; JEWETT MAS, 1980, J UROLOGY, V124, P292, DOI 10.1016/S0022-5347(17)55413-0; Kartagener M., 1933, BEITR KLIN ERFORSCH, V83, P489, DOI DOI 10.1007/BF02141468; KARTAGENER M, 1935, ERG INN MED KINDERHK, V49, P378; KNOX G, 1960, ANN HUM GENET, V24, P137; KOMADOVA V, 1976, FOLIA MORPHOL PRAHA, V24, P296; LAFITTE JJ, 1979, PRESSE MED, V8, P4114; Layton W M Jr, 1978, Birth Defects Orig Artic Ser, V14, P277; LAYTON WM, 1976, J HERED, V67, P336, DOI 10.1093/oxfordjournals.jhered.a108749; LOGAN WD, 1965, DIS CHEST, V48, P613, DOI 10.1378/chest.48.6.613; LUPIN AJ, 1978, J OTOLARYNGOL, V7, P95; MCKUSICK VA, 1963, ARCH ENVIRON HEALTH, V6, P25, DOI 10.1080/00039896.1963.10663355; MCMANUS C, 1978, THESIS U CAMBRIDGE; MCTAGGART D, 1979, MED J AUSTRALIA, V2, P704, DOI 10.5694/j.1326-5377.1979.tb104311.x; MILLER RD, 1972, CHEST, V62, P130, DOI 10.1378/chest.62.2.130; MORGAN MJ, 1978, BEHAV BRAIN SCI, V1, P270, DOI 10.1017/S0140525X00074483; MOSSBERG B, 1978, SCAND J RESPIR DIS, V59, P55; NEFFEN H, 1980, RESPIRATION, V40, P161, DOI 10.1159/000194266; NEUSTEIN HB, 1979, JAMA-J AM MED ASSOC, V241, P2423, DOI 10.1001/jama.241.22.2423; NORWOOD JT, 1980, BIOL REPROD, V23, P788, DOI 10.1095/biolreprod23.4.788; PEDERSEN H, 1976, NATURE, V262, P494, DOI 10.1038/262494a0; PEDERSEN M, 1980, BRIT J DIS CHEST, V74, P239, DOI 10.1016/0007-0971(80)90049-2; RICHER CL, 1977, CAN J GENET CYTOL, V19, P565, DOI 10.1139/g77-061; ROOKLIN AR, 1980, PEDIATRICS, V66, P526; ROSSMAN CM, 1980, AM REV RESPIR DIS, V121, P1011; ROSSMAN CM, 1980, CHEST, V78, P580, DOI 10.1378/chest.78.4.580; ROTT HD, 1979, HUM GENET, V46, P249, DOI 10.1007/BF00273308; ROTT HD, 1978, HUM GENET, V43, P1, DOI 10.1007/BF00396472; RUTLAND J, 1980, LANCET, V2, P564; SCHNEEBERGER EE, 1980, J ULTRA MOL STRUCT R, V73, P34, DOI 10.1016/0022-5320(80)90114-8; SHARMA OP, 1972, NEW YORK STATE J MED, V72, P1057; Siewert A.K., 1904, BERLIN KLIN WOCHEN S, V41, P139; STAUFFER U. G., 1967, BEITR KLIN ERFORSCH TUBERK LUNGENKR, V135, P15, DOI 10.1007/BF02091039; STURGESS JM, 1979, NEW ENGL J MED, V300, P53, DOI 10.1056/NEJM197901113000201; STURGESS JM, 1980, NEW ENGL J MED, V303, P318, DOI 10.1056/NEJM198008073030606; TAKASAKA T, 1980, ANN OTO RHINOL LARYN, V89, P37, DOI 10.1177/000348948008900110; TORGERSEN J, 1949, ARCH PATHOL, V47, P566; TORGERSEN J, 1952, SCHWEIZ MED WSCHR, V82, P770; Twitty VC, 1928, J EXP ZOOL, V50, P319, DOI 10.1002/jez.1400500302; VARANO N R, 1960, J Int Coll Surg, V33, P131; VEERMAN AJP, 1980, PEDIATRICS, V65, P698; WAKEFIELD SJ, 1980, AM REV RESPIR DIS, V121, P1003	78	90	92	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1981	33	6					852	864						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MV199	7034533				2022-12-18	WOS:A1981MV19900002
J	WEINSHILBOUM, RM; SCHROTT, HG; RAYMOND, FA; WEIDMAN, WH; ELVEBACK, LR				WEINSHILBOUM, RM; SCHROTT, HG; RAYMOND, FA; WEIDMAN, WH; ELVEBACK, LR			INHERITANCE OF VERY LOW SERUM DOPAMINE-BETA-HYDROXYLASE ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PLASMA; RELEASE; NORADRENALINE; LOCALIZATION; ELEVATION; TISSUES; ASSAY		MAYO FDN, DEPT PHARMACOL, ROCHESTER, MN 55901 USA; MAYO FDN, DEPT MED GENET, ROCHESTER, MN 55901 USA; MAYO FDN, DEPT PEDIAT, ROCHESTER, MN 55901 USA; MAYO FDN, DEPT MED STATISTICS & EPIDEMIOL, ROCHESTER, MN 55901 USA; MAYO FDN, DEPT INTERN MED, ROCHESTER, MN 55901 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic								CAVALLISTORZA LL, 1971, GENETICS HUMAN POPUL; DEPOTTER WP, 1969, J PHYSIOL-LONDON, V204, pP102; EDWARDS JH, 1969, BRIT MED BULL, V25, P58, DOI 10.1093/oxfordjournals.bmb.a070672; FREEDMAN LS, 1972, NATURE, V236, P310, DOI 10.1038/236310a0; GEFFEN LB, 1969, J PHYSIOL-LONDON, V204, pP58; GEFFEN LB, 1969, J PHYSIOL-LONDON, V204, P593, DOI 10.1113/jphysiol.1969.sp008934; GOLDSTEIN M, 1972, NEW ENGL J MED, V286, P1123, DOI 10.1056/NEJM197205252862102; GOLDSTEIN M, 1971, EXPERIENTIA, V27, P632, DOI 10.1007/BF02136929; HORWITZ D, 1973, CIRC RES, V32, P594, DOI 10.1161/01.RES.32.5.594; KAUFMAN S, 1965, PHARMACOL REV, V17, P71; LI CC, 1961, HUMAN GENETICS; LIEBERMAN AN, 1972, LANCET, V1, P153; Lindgren B. W., 1959, INTRO PROBABILITY ST; MOLINOFF PB, 1971, J PHARMACOL EXP THER, V178, P425; MOSS AJ, 1963, AM J DIS CHILD, V106, P364, DOI 10.1001/archpedi.1963.02080050366004; OKA M., 1967, LIFE SCI, V6, P461, DOI 10.1016/0024-3205(67)90048-3; PLANZ G, 1973, EUR J CLIN PHARMACOL, V5, P255, DOI 10.1007/BF00567014; ROSS SB, 1972, MOL PHARMACOL, V8, P50; ROSS SB, 1973, LIFE SCI, V12, P529, DOI 10.1016/0024-3205(73)90056-8; RUSH RA, 1972, CIRC RES, V31, P444, DOI 10.1161/01.RES.31.3.444; SCHANBERG SM, 1974, SCIENCE, V183, P523, DOI 10.1126/science.183.4124.523; STJARNE L, 1967, BIOCHEM PHARMACOL, V16, P1719, DOI 10.1016/0006-2952(67)90247-X; VIVEROS OH, 1968, LIFE SCI PT 1 PHYSI, V7, P609, DOI 10.1016/0024-3205(68)90186-0; WEINSHIL.R, 1970, PHARMACOLOGIST, V12, P214; WEINSHILBOUM R, 1971, CIRC RES, V28, P307, DOI 10.1161/01.RES.28.3.307; WEINSHILBOUM R, 1971, SCIENCE, V173, P931, DOI 10.1126/science.173.4000.931; WEINSHILBOUM RM, 1971, NATURE-NEW BIOL, V230, P287, DOI 10.1038/newbio230287a0; WEINSHILBOUM RM, 1971, SCIENCE, V174, P1349, DOI 10.1126/science.174.4016.1349; WEINSHILBOUM RM, 1973, SCIENCE, V181, P943, DOI 10.1126/science.181.4103.943; WEINSHILBOUM RM, 1971, NEW ENGL J MED, V285, P938, DOI 10.1056/NEJM197110212851703; WETTERBERG L, 1972, CLIN GENET, V3, P152; WOOTEN GF, 1973, ARCH NEUROL-CHICAGO, V28, P103, DOI 10.1001/archneur.1973.00490200051006; WOOTEN GF, 1973, NEW ENGL J MED, V288, P284, DOI 10.1056/NEJM197302082880604; 1970, GENERAL POPULATION C	34	90	92	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1975	27	5					573	585						13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AR239	1163533				2022-12-18	WOS:A1975AR23900001
J	COHEN, ME; BADAL, DW; KILPATRICK, A; REED, EW; WHITE, PD				COHEN, ME; BADAL, DW; KILPATRICK, A; REED, EW; WHITE, PD			THE HIGH FAMILIAL PREVALENCE OF NEUROCIRCULATORY ASTHENIA (ANXIETY NEUROSIS, EFFORT SYNDROME)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARCHARD HJ, 1934, MED REC, V139, P639; BAACH M, 1940, DEUT MILITARARZT, V10, P405; BALLET G, 1909, NEURASTHENIA; Beard George M., 1880, PRACTICAL TREATISE N; Beard George Miller, 1869, BOSTON MED SURG J, V80, P217, DOI [DOI 10.1056/NEJM186904290801301, 10.1056/nejm186904290801301]; Brown F W, 1942, Proc R Soc Med, V35, P785; CHAPMAN WP, 1946, J CLIN INVEST, V25, P890, DOI 10.1172/JCI101777; Cobb I. G., 1915, PRACTITIONER LOND, V95, P224; COHEN ME, 1948, ARCH INTERN MED, V81, P260, DOI 10.1001/archinte.1948.00220210014002; COHEN ME, 1947, J CLIN INVEST, V26, P339, DOI 10.1172/JCI101814; COHEN ME, 1947, J CLIN INVEST, V26, P520, DOI 10.1172/JCI101836; COHEN ME, 1946, OEMCMR157 OFF SCI RE, P135; Craig HR, 1934, ARCH INTERN MED, V53, P633, DOI 10.1001/archinte.1934.00160110002001; CRILE GW, 1940, MIL SURG, V87, P509; Da Costa JM., 1871, AM J MED SCI, V61, P17; Deutsch H., 1930, PSYCHOANALYSE NEUROS; DRAPER G, 1944, HUMAN CONSTITUTION C; Dunn WH, 1942, PSYCHOSOM MED, V4, P333, DOI 10.1097/00006842-194210000-00001; Fenichel O., 1934, OUTLINE CLIN PSYCHOA; FLINT A, 1884, TREATISE PRINCIPLES, P778; Fraser Roberts JA, 1940, INTRO MED GENETICS; Freud S., 1920, SELECTED PAPERS HYST, V3rd; FREUD S, 1895, NEUROL CENTRALBL, V14, P50; Freud Sigmund, 1935, AUTOBIOGRAPHY; Gates R. R., 1946, HUMAN GENETICS, VII; GATES RR, 1946, HUMAN GENETICS, V1; Greene R, 1944, LANCET, V2, P307; GROSS WM, 1948, EUGEN REV, V40, P140; GUNTHER H, 1929, WURZBURG ABH, V26, P155; Haldane J.S., 1935, RESPIRATION; HARTENBERG P, 1902, NEVROSE ANGOISSE ETU; Hartshorne H., 1864, AM J MED SCI, V48, P89; Heckel F., 1917, NEVROSE ANGOISSE ETA; HILL AB, 1948, PRINCIPLES MED STATI; Hogben L, 1932, J GENET, V26, P75, DOI 10.1007/BF02991444; Hogben L, 1932, J GENET, V25, P211, DOI 10.1007/BF02983255; HOGBEN L, 1934, CHANCES MORBID INHER; Hogben LT, 1946, INTRO MATH GENETICS; Irvine-Jones E, 1933, AM J DIS CHILD, V45, P1184; JOHNSON O, 1936, N ENGLAND J M, V215, P438; Levit SG, 1936, J GENET, V33, P411, DOI 10.1007/BF02982897; Lewis T., 1940, SOLDIERS HEART EFFOR; LEWIS T, 1917, 8 MED RES COMM SPEC; Lewis Thomas, 1918, SOLDIERS HEART EFFOR; Maclean W C, 1867, Br Med J, V1, P161; Marshall W, 1938, J NERV MENT DIS, V88, P36, DOI 10.1097/00005053-193807000-00004; Moschcowitz E, 1944, AM HEART J, V28, P177, DOI 10.1016/S0002-8703(44)90281-4; Myerson A., 1925, INHERITANCE MENTAL D; Oppenheimer BS, 1918, J AMER MED ASSOC, V70, P1919, DOI 10.1001/jama.1918.26010250005006a; OPPENHEIMER BS, 1918, MIL SURG, V42, P409; Parkinson J, 1941, BRIT MED J, V1941, P545, DOI 10.1136/bmj.1.4188.545; Pearl R, 1940, INTRO MED BIOMETRY S; PEARL R, 1933, CONSTITUTION HLTH; PEARSON K, 1914, HANDICAPPING 1ST BOR; Reich W, 1926, INT Z PSYCHOANAL, V12, P25; Robey WH, 1918, J AMER MED ASSOC, V71, P525, DOI 10.1001/jama.1918.02600330023009; Roth WF, 1943, AM J PSYCHIAT, V99, P662, DOI 10.1176/ajp.99.5.662; SAVILL T, 1907, CLIN LECTURES NEURAS; SAVILL TD, 1899, CLIN LECTURES NEURAS; Sheldon W. H., 1940, VARIETIES HUMAN PHYS; Slater E, 1943, J NEUROL PSYCHIATRY, V6, P1, DOI 10.1136/jnnp.6.1-2.1; Soley MH, 1938, AM J MED SCI, V196, P840, DOI 10.1097/00000441-193812000-00010; Starr I, 1942, AM J MED SCI, V204, P573, DOI 10.1097/00000441-194220440-00017; Strandskov HH, 1942, AM NAT, V76, P156, DOI 10.1086/281028; STRONG GF, 1946, CAN MED ASSOC J, V55, P344; THAMES E, 1935, J MED ASSOC ALABAMA, V5, P54; WERTHEIMER FI, 1926, MED MONOGRAPHS, V10; WHEELER EO, 1948, J CLIN INVEST, V27, P562; WHEELER EO, 1947, P N E HEART ASS, P65; WHITE PD, 1944, T ASS AM PHYSCNS, V58, P129; Wood P, 1941, BRIT MED J, V1941, P805; Wood P, 1941, BRIT MED J, V1941, P767; Wood P, 1941, BMJ-BRIT MED J, V1941, P845, DOI 10.1136/bmj.1.4196.845; WORCESTER JL, COMMUNICATION; 1947, 10A78 VET ADM TECHN	75	90	90	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1951	3	2					126	158						33	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XS393	14902758				2022-12-18	WOS:A1951XS39300003
J	Liu, YW; Chen, SX; Li, ZL; Morrison, AC; Boerwinkle, E; Lin, XH				Liu, Yaowu; Chen, Sixing; Li, Zilin; Morrison, Alanna C.; Boerwinkle, Eric; Lin, Xihong			ACAT: A Fast and Powerful p Value Combination Method for Rare-Variant Analysis in Sequencing Studies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSING HERITABILITY; HIGHER CRITICISM; ASSOCIATION; GENOME; TESTS; LIPOPROTEIN	Set-based analysis that jointly tests the association of variants in a group has emerged as a popular tool for analyzing rare and low-frequency variants in sequencing studies. The existing set-based tests can suffer significant power loss when only a small proportion of variants are causal, and their powers can be sensitive to the number, effect sizes, and effect directions of the causal variants and the choices of weights. Here we propose an aggregated Cauchy association test (ACAT), a general, powerful, and computationally efficient p value combination method for boosting power in sequencing studies. First, by combining variant-level p values, we use ACAT to construct a set-based test (ACAT-V) that is particularly powerful in the presence of only a small number of causal variants in a variant set. Second, by combining different variant-set-level p values, we use ACAT to construct an omnibus test (ACAT-O) that combines the strength of multiple complimentary set-based tests, including the burden test, sequence kernel association test (SKAT), and ACAT-V. Through analysis of extensively simulated data and the whole-genome sequencing data from the Atherosclerosis Risk in Communities (ARIC) study, we demonstrate that ACAT-V complements the SKAT and the burden test, and that ACAT-O has a substantially more robust and higher power than those of the alternative tests.	[Liu, Yaowu; Chen, Sixing; Li, Zilin; Lin, Xihong] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Morrison, Alanna C.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Human Genet Ctr, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine	Lin, XH (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	xlin@hsph.harvard.edu	Li, Zilin/AAB-1216-2019; Li, Zilin/AAG-8038-2021	Li, Zilin/0000-0003-1521-8945	National Heart, Lung, and Blood Institute [R35 CA197449, P01-CA134294, U01-HG009088, U19-CA203654, R01-HL113338]; National Human Genome Research Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C];  [U54 HG003273];  [UM1 HG008898]; NATIONAL CANCER INSTITUTE [R35CA197449, U19CA203654, P01CA134294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113338] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG009088, UM1HG008898] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grants R35 CA197449, P01-CA134294, U01-HG009088, U19-CA203654, and R01-HL113338 (to X.L.). The ARIC study is carried out as a collaborative study supported by the National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C). The authors thank the staff and participants of the ARIC study for their important contributions. Sequencing was carried out at the Baylor College of Medicine Human Genome Sequencing Center and was also supported by National Human Genome Research Institute grants U54 HG003273 and UM1 HG008898.	Barnett I, 2017, J AM STAT ASSOC, V112, P64, DOI 10.1080/01621459.2016.1192039; Blom G., 1958, STAT ESTIMATES TRANS, V1st; Chen H, 2016, AM J HUM GENET, V98, P653, DOI 10.1016/j.ajhg.2016.02.012; Chen LS, 2012, AM J HUM GENET, V91, P977, DOI 10.1016/j.ajhg.2012.09.017; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Derkach A, 2013, GENET EPIDEMIOL, V37, P110, DOI 10.1002/gepi.21689; Dey R, 2017, AM J HUM GENET, V101, P37, DOI 10.1016/j.ajhg.2017.05.014; Donoho D, 2004, ANN STAT, V32, P962, DOI 10.1214/009053604000000265; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fisher R.A., 1992, BREAKTHROUGHS STAT, P66, DOI [10.1007/978-1-4612-4380-9_6, DOI 10.1007/978-1-4612-4380-9_6]; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Li J, 2015, J HUM GENET, V60, P755, DOI 10.1038/jhg.2015.107; Liu Y., 2018, J AM STAT ASS; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Marouli E, 2017, NATURE, V542, P186, DOI 10.1038/nature21039; Morrison AC, 2017, AM J HUM GENET, V100, P205, DOI 10.1016/j.ajhg.2016.12.009; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Ronald J, 2011, STROKE, V42, P2, DOI 10.1161/STROKEAHA.110.591230; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zhu X, 2017, ANN APPL STAT, V11, P1561, DOI 10.1214/17-AOAS1046; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	30	89	89	2	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 7	2019	104	3					410	421		10.1016/j.ajhg.2019.01.002	http://dx.doi.org/10.1016/j.ajhg.2019.01.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HN9SY	30849328	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000460541200008
J	Pedersen, BS; Quinlan, AR				Pedersen, Brent S.; Quinlan, Aaron R.			Who's Who? Detecting and Resolving Sample Anomalies in Human DNA Sequencing Studies with Peddy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ASSOCIATION; FORMAT	The potential for genetic discovery in human DNA sequencing studies is greatly diminished if DNA samples from a cohort are mislabeled, swapped, or contaminated or if they include unintended individuals. Unfortunately, the potential for such errors is significant since DNA samples are often manipulated by several protocols, labs, or scientists in the process-of-sequencing. We have developed a software package, peddy, to identify and facilitate the remediation of such errors via interactive visualizations and reports comparing the stated sex, relatedness, and ancestry to what is inferred from the individual genotypes derived from whole-genome (WGS) or whole-exome (WES) sequencing. Peddy predicts a sample's ancestry using a machine learning model trained on individuals of diverse ancestries from the 1000 Genomes Project reference panel. Peddy facilitates both automated and interactive, visual detection of sample swaps, poor sequencing quality, and other indicators of sample problems that, if left undetected, would inhibit discovery.	[Pedersen, Brent S.; Quinlan, Aaron R.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84105 USA; [Pedersen, Brent S.; Quinlan, Aaron R.] Univ Utah, Dept Biomed Informat, Salt Lake City, UT 84105 USA; [Pedersen, Brent S.; Quinlan, Aaron R.] Univ Utah, USTAR Ctr Genet Discovery, Salt Lake City, UT 84105 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Quinlan, AR (corresponding author), Univ Utah, Dept Human Genet, Salt Lake City, UT 84105 USA.; Quinlan, AR (corresponding author), Univ Utah, Dept Biomed Informat, Salt Lake City, UT 84105 USA.; Quinlan, AR (corresponding author), Univ Utah, USTAR Ctr Genet Discovery, Salt Lake City, UT 84105 USA.	aquinlan@genetics.utah.edu		Quinlan, Aaron/0000-0003-1756-0859	US National Human Genome Research Institute [NIH R01HG006693]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006693] Funding Source: NIH RePORTER	US National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Barry Moore provided valuable feedback on early versions of the software and suggested the idea of predicting an individual's ancestry. Daniel McGoldrick and Jessica Chong provided helpful feedback and QC on the software. This research was supported by a US National Human Genome Research Institute award to A.R.Q. (NIH R01HG006693).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Blue Elizabeth M, 2016, BMC Proc, V10, P357; Boada R, 2009, DEV DISABIL RES REV, V15, P284, DOI 10.1002/ddrr.83; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Eberle M. A., 2016, BIORXIV; Halko N., 2009, FINDING STRUCTURE RA; Heinrich V, 2017, BIOINFORMATICS, V33, P72, DOI 10.1093/bioinformatics/btw550; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Miller CA, 2014, NAT METHODS, V11, P1189, DOI 10.1038/nmeth.3174; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Staples J, 2016, BIOINFORMATICS, V32, P596, DOI 10.1093/bioinformatics/btv618	13	89	89	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 2	2017	100	3					406	413		10.1016/j.ajhg.2017.01.017	http://dx.doi.org/10.1016/j.ajhg.2017.01.017			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EN2PH	28190455	hybrid, Green Submitted, Green Published			2022-12-18	WOS:000395851900008
J	Paff, T; Loges, NT; Aprea, I; Wu, K; Bakey, Z; Haarman, EG; Daniels, JMA; Sistermans, EA; Bogunovic, N; Dougherty, GW; Hoeben, IM; Grosse-Onnebrink, J; Matter, A; Olbrich, H; Werner, C; Pals, G; Schmidts, M; Omran, H; Micha, D				Paff, Tamara; Loges, Niki T.; Aprea, Isabella; Wu, Kaman; Bakey, Zeineb; Haarman, Eric G.; Daniels, Johannes M. A.; Sistermans, Erik A.; Bogunovic, Natalija; Dougherty, Gerard W.; Hoeben, Inga M.; Grosse-Onnebrink, Jorg; Matter, Anja; Olbrich, Heike; Werner, Claudius; Pals, Gerard; Schmidts, Miriam; Omran, Heymut; Micha, Dimitra			Mutations in PIH1 D3 Cause X-Linked Primary Ciliary Dyskinesia with Outer and Inner Dynein Arm Defects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							OF-FUNCTION MUTATIONS; AXONEMAL DYNEIN; RESPIRATORY CILIA; BODY ASYMMETRY; DOCKING; RANDOMIZATION; DISEASE; SCREEN; DYSFUNCTION; COMPLEXES	Defects in motile cilia and sperm flagella cause primary ciliary dyskinesia (PCD), characterized by chronic airway disease, infertility, and left-right body axis disturbance. Here we report maternally inherited and de novo mutations in PIH1D3 in four men affected with PCD. PIN1D3 is located on the X chromosome and is involved in the preassembly of both outer (ODA) and inner (IDA) dynein arms of cilia and sperm flagella. Loss-of-function mutations in PIH1D3 lead to absent ODA5 and reduced to absent IDAs, causing ciliary and flagellar immotility. Further, PIH1D3 interacts and co-precipitates with cytoplasmic ODA/IDA assembly factors DNAAF2 and DNAAF4. This result has clinical and genetic counseling implications for genetically unsolved male case subjects with a classic PCD phenotype that lack additional phenotypes such as intellectual disability or retinitis pigmentosa.	[Paff, Tamara; Daniels, Johannes M. A.] Vrije Univ Amsterdam, Med Ctr, Dept Pulm Dis, NL-1007 MB Amsterdam, Netherlands; [Paff, Tamara; Haarman, Eric G.] Vrije Univ Amsterdam, Med Ctr, Dept Paediat Pulmonol, NL-1007 MB Amsterdam, Netherlands; [Paff, Tamara; Sistermans, Erik A.; Pals, Gerard; Micha, Dimitra] Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1007 MB Amsterdam, Netherlands; [Loges, Niki T.; Aprea, Isabella; Dougherty, Gerard W.; Hoeben, Inga M.; Grosse-Onnebrink, Jorg; Matter, Anja; Olbrich, Heike; Werner, Claudius; Omran, Heymut] Univ Childrens Hosp Muenster, Dept Gen Pediat, D-48149 Munster, Germany; [Wu, Kaman; Bakey, Zeineb; Schmidts, Miriam] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Bogunovic, Natalija] Vrije Univ Amsterdam, Med Ctr, Amsterdam Cardiovasc Sci, Dept Surg & Physiol, NL-1007 MB Amsterdam, Netherlands; [Schmidts, Miriam] Univ Hosp Freiburg, Ctr Pediat & Adolescent Med, Pediat Genet Div, D-79110 Freiburg, Germany	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Munster; Radboud University Nijmegen; Vrije Universiteit Amsterdam; University of Freiburg	Micha, D (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Clin Genet, NL-1007 MB Amsterdam, Netherlands.	d.micha@vumc.nl	Sistermans, Erik/B-1109-2009; Micha, Dimitra/U-4979-2019; Daniels, Johannes/N-9525-2016; Schmidts, Miriam/A-3777-2012	Sistermans, Erik/0000-0001-7187-4563; Micha, Dimitra/0000-0001-7890-4411; Pals, Gerard/0000-0003-4091-7115; Daniels, Johannes/0000-0001-8976-9120; Omran, Heymut/0000-0003-0282-6765; Schmidts, Miriam/0000-0002-1714-6749; Hoben, Inga Marlena/0000-0002-1133-6496; Bogunovic, Natalija/0000-0002-1688-5152	Fonds NutsOhra [1103-054]; Deutsche Forschungsgemeinschaft [OM 6/4, OM 6/7, OM 6/8]; IZKF Muenster [Om2/009/12, Om/015/16]; European Commission [262055]; European Union seventh FP under GA [241955]; project SYSCILIA; project BESTCILIA; Radboudumc Hypatia Tenure track fellowship; Radboud University Excellence Fellowship; ERC starting grant TREATCilia [716344]; German Research Foundation [CRC-1140];  [305404]	Fonds NutsOhra; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); IZKF Muenster; European Commission(European CommissionEuropean Commission Joint Research Centre); European Union seventh FP under GA; project SYSCILIA; project BESTCILIA; Radboudumc Hypatia Tenure track fellowship; Radboud University Excellence Fellowship; ERC starting grant TREATCilia; German Research Foundation(German Research Foundation (DFG)); 	This work was supported by Fonds NutsOhra (1103-054 to G.P.), the Deutsche Forschungsgemeinschaft grants OM 6/4, OM 6/7, OM 6/8 (H. Omran), the IZKF Muenster to H. Omran (Om2/009/12 and Om/015/16), by the European Commission (FP7/2007-2013) grant agreement (GA) Nr. 262055 (H. Omran) as a Transnational Access project of the European Sequencing and Genotyping Infrastructure (ESGI), and by the European Union seventh FP under GA Nr. 241955, project SYSCILIA (H. Omran), and GA Nr. 305404, project BESTCILIA (H. Omran). M.S. is funded by a Radboudumc Hypatia Tenure track fellowship, a Radboud University Excellence Fellowship, and ERC starting grant TREATCilia (grant agreement 716344) and acknowledges funding from the German Research Foundation (CRC-1140, KIDGEM).	Austin-Tse C, 2013, AM J HUM GENET, V93, P672, DOI 10.1016/j.ajhg.2013.08.015; Bartoloni L, 2002, P NATL ACAD SCI USA, V99, P10282, DOI 10.1073/pnas.152337699; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; Bukowy-Bieryllo Z, 2013, PEDIATR PULM, V48, P352, DOI 10.1002/ppul.22632; Dong FL, 2014, J CELL BIOL, V204, P203, DOI 10.1083/jcb.201304076; Dougherty GW, 2016, AM J RESP CELL MOL, V55, P213, DOI 10.1165/rcmb.2015-0353OC; Duquesnoy P, 2009, AM J HUM GENET, V85, P890, DOI 10.1016/j.ajhg.2009.11.008; Duriez B, 2007, P NATL ACAD SCI USA, V104, P3336, DOI 10.1073/pnas.0611405104; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337, DOI 10.1091/mbc.9.9.2337; Harrison MJ, 2016, PAEDIATR RESPIR REV, V18, P25, DOI 10.1016/j.prrv.2015.09.003; Hjeij R, 2014, AM J HUM GENET, V95, P257, DOI 10.1016/j.ajhg.2014.08.005; Hjeij R, 2013, AM J HUM GENET, V93, P357, DOI 10.1016/j.ajhg.2013.06.009; Horani A, 2016, PAEDIATR RESPIR REV, V18, P18, DOI 10.1016/j.prrv.2015.09.001; Horani A, 2012, AM J HUM GENET, V91, P685, DOI 10.1016/j.ajhg.2012.08.022; Ibanez-Tallon I, 2004, HUM MOL GENET, V13, P2133, DOI 10.1093/hmg/ddh219; Knowles MR, 2013, AM J RESP CRIT CARE, V188, P913, DOI 10.1164/rccm.201301-0059CI; Knowles MR, 2013, AM J HUM GENET, V93, P711, DOI 10.1016/j.ajhg.2013.07.025; Knowles MR, 2013, AM J HUM GENET, V92, P99, DOI 10.1016/j.ajhg.2012.11.003; Knowles MR, 2012, THORAX, V67, P433, DOI 10.1136/thoraxjnl-2011-200301; Kott E, 2012, AM J HUM GENET, V91, P958, DOI 10.1016/j.ajhg.2012.10.003; Loges NT, 2008, AM J HUM GENET, V83, P547, DOI 10.1016/j.ajhg.2008.10.001; Loges NT, 2009, AM J HUM GENET, V85, P883, DOI 10.1016/j.ajhg.2009.10.018; Mazor M, 2011, AM J HUM GENET, V88, P599, DOI 10.1016/j.ajhg.2011.03.018; Mitchison HM, 2012, NAT GENET, V44, P381, DOI 10.1038/ng.1106; Moore A, 2006, J MED GENET, V43, P326, DOI 10.1136/jmg.2005.034868; Moore DJ, 2013, AM J HUM GENET, V93, P346, DOI 10.1016/j.ajhg.2013.07.009; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Omran H, 2009, METHOD CELL BIOL, V91, P123, DOI 10.1016/S0091-679X(08)91007-4; Onoufriadis A, 2013, AM J HUM GENET, V92, P88, DOI 10.1016/j.ajhg.2012.11.002; Panizzi JR, 2012, NAT GENET, V44, P714, DOI 10.1038/ng.2277; Pennarun G, 1999, AM J HUM GENET, V65, P1508, DOI 10.1086/302683; SATIR P, 1968, J CELL BIOL, V39, P77, DOI 10.1083/jcb.39.1.77; Satir P, 2014, BIOSCIENCE, V64, P1073, DOI 10.1093/biosci/biu180; Schwabe GC, 2008, HUM MUTAT, V29, P289, DOI 10.1002/humu.20656; SUMMERS KE, 1971, P NATL ACAD SCI USA, V68, P3092, DOI 10.1073/pnas.68.12.3092; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Viswanadha R, 2014, CYTOSKELETON, V71, P573, DOI 10.1002/cm.21192; Wallmeier J, 2016, AM J HUM GENET, V99, P460, DOI 10.1016/j.ajhg.2016.06.014; Werner Claudius, 2015, Cilia, V4, P2, DOI 10.1186/s13630-014-0011-8; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Wilson KS, 2015, CYTOSKELETON, V72, P477, DOI 10.1002/cm.21252; Yamamoto R, 2010, J CELL BIOL, V190, P65, DOI 10.1083/jcb.201002081; Zariwala MA, 2013, AM J HUM GENET, V93, P336, DOI 10.1016/j.ajhg.2013.06.007	46	89	94	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN 5	2017	100	1					160	168		10.1016/j.ajhg.2016.11.019	http://dx.doi.org/10.1016/j.ajhg.2016.11.019			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EH6UX	28041644	Green Published, hybrid			2022-12-18	WOS:000391910500014
J	Cheng, CX; Zhou, Y; Li, HY; Xiong, T; Li, SC; Bi, YH; Kong, PZ; Wang, F; Cui, HY; Li, YP; Fang, XD; Yan, T; Li, YK; Wang, J; Yang, B; Zhang, L; Jia, ZW; Song, B; Hu, XL; Yang, J; Qiu, HL; Zhang, GH; Liu, J; Xu, EW; Shi, RY; Zhang, YY; Liu, HY; He, CT; Zhao, ZX; Qian, Y; Rong, RZ; Han, ZW; Zhang, YL; Luo, W; Wang, JQ; Peng, SL; Yang, XK; Li, XC; Li, L; Fang, H; Liu, XM; Ma, L; Chen, YQ; Guo, SP; Chen, X; Xi, YF; Li, GD; Liang, JF; Yang, XF; Guo, JS; Jia, JM; Li, QS; Cheng, XL; Zhan, QM; Cui, YP				Cheng, Caixia; Zhou, Yong; Li, Hongyi; Xiong, Teng; Li, Shuaicheng; Bi, Yanghui; Kong, Pengzhou; Wang, Fang; Cui, Heyang; Li, Yaoping; Fang, Xiaodong; Yan, Ting; Li, Yike; Wang, Juan; Yang, Bin; Zhang, Ling; Jia, Zhiwu; Song, Bin; Hu, Xiaoling; Yang, Jie; Qiu, Haile; Zhang, Gehong; Liu, Jing; Xu, Enwei; Shi, Ruyi; Zhang, Yanyan; Liu, Haiyan; He, Chanting; Zhao, Zhenxiang; Qian, Yu; Rong, Ruizhou; Han, Zhiwei; Zhang, Yanlin; Luo, Wen; Wang, Jiaqian; Peng, Shaoliang; Yang, Xukui; Li, Xiangchun; Li, Lin; Fang, Hu; Liu, Xingmin; Ma, Li; Chen, Yunqing; Guo, Shiping; Chen, Xing; Xi, Yanfeng; Li, Guodong; Liang, Jianfang; Yang, Xiaofeng; Guo, Jiansheng; Jia, JunMei; Li, Qingshan; Cheng, Xiaolong; Zhan, Qimin; Cui, Yongping			Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY-NUMBER; HUMAN CANCER; MESENCHYMAL TRANSITION; COMPLEX REARRANGEMENTS; MUTATIONAL PROCESSES; PANCREATIC-CANCER; BINDING PROTEIN; GASTRIC-CANCER; MECHANISMS; GENE	Comprehensive identification of somatic structural variations (SVs) and understanding their mutational mechanisms in cancer might contribute to understanding biological differences and help to identify new therapeutic targets. Unfortunately, characterization of complex SVs across the whole genome and the mutational mechanisms underlying esophageal squamous cell carcinoma (ESCC) is largely unclear. To define a comprehensive catalog of somatic SVs, affected target genes, and their underlying mechanisms in ESCC, we reanalyzed whole-genome sequencing (WGS) data from 31 ESCCs using Meerkat algorithm to predict somatic SVs and Patchwork to determine copy-number changes. We found deletions and translocations with NHEJ and alt-EJ signature as the dominant SV types, and 16% of deletions were complex deletions. SVs frequently led to disruption of cancer-associated genes (e.g., CDKN2A and NOTCH1) with different mutational mechanisms. Moreover, chromothripsis, kataegis, and breakage-fusion-bridge (BFB) were identified as contributing to locally mis-arranged chromosomes that occurred in 55% of ESCCs. These genomic catastrophes led to amplification of oncogene through chromothripsis-derived double-minute chromosome formation (e.g., FGFR1 and LETM2) or BFB-affected chromosomes (e.g., CCND1, EGFR, ERBB2, MMPs, and MYC), with approximately 30% of ESCCs harboring BFB-derived CCND1 amplification. Furthermore, analyses of copy-number alterations reveal high frequency of whole-genome duplication (WGD) and recurrent focal amplification of CDCA7 that might act as a potential oncogene in ESCC. Our findings reveal molecular defects such as chromothripsis and BFB in malignant transformation of ESCCs and demonstrate diverse models of SVs-derived target genes in ESCCs. These genome-wide SV profiles and their underlying mechanisms provide preventive, diagnostic, and therapeutic implications for ESCCs.	[Cheng, Caixia; Li, Hongyi; Bi, Yanghui; Kong, Pengzhou; Wang, Fang; Cui, Heyang; Li, Yaoping; Yan, Ting; Li, Yike; Wang, Juan; Yang, Bin; Zhang, Ling; Jia, Zhiwu; Song, Bin; Hu, Xiaoling; Yang, Jie; Liu, Jing; Shi, Ruyi; Zhang, Yanyan; Liu, Haiyan; He, Chanting; Zhao, Zhenxiang; Qian, Yu; Rong, Ruizhou; Han, Zhiwei; Cheng, Xiaolong; Cui, Yongping] Shanxi Med Univ, Translat Med Res Ctr, Taiyuan 030001, Shanxi, Peoples R China; [Cheng, Caixia; Li, Hongyi; Bi, Yanghui; Kong, Pengzhou; Wang, Fang; Cui, Heyang; Yan, Ting; Li, Yike; Wang, Juan; Yang, Bin; Zhang, Ling; Jia, Zhiwu; Song, Bin; Hu, Xiaoling; Yang, Jie; Shi, Ruyi; Liu, Haiyan; He, Chanting; Zhao, Zhenxiang; Qian, Yu; Rong, Ruizhou; Han, Zhiwei; Cheng, Xiaolong; Cui, Yongping] Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China; [Cheng, Caixia; Liang, Jianfang] Shanxi Med Univ, Hosp 1, Dept Pathol, Taiyuan 030001, Shanxi, Peoples R China; [Zhou, Yong; Xiong, Teng; Cui, Heyang; Fang, Xiaodong; Luo, Wen; Wang, Jiaqian; Yang, Xukui; Li, Xiangchun; Li, Lin; Fang, Hu; Liu, Xingmin] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Li, Shuaicheng; Zhang, Yanlin] City Univ Hong Kong, Dept Comp Sci, Hong Kong 518057, Hong Kong, Peoples R China; [Li, Yaoping; Yang, Bin; Ma, Li; Chen, Yunqing; Guo, Shiping] Shanxi Canc Hosp, Dept Tumor Surg, Taiyuan 030001, Shanxi, Peoples R China; [Li, Yike; Liu, Jing; Zhang, Yanyan; Rong, Ruizhou; Han, Zhiwei; Guo, Jiansheng] Shanxi Med Univ, Hosp 1, Dept Gen Surg, Taiyuan 030001, Shanxi, Peoples R China; [Song, Bin; Qiu, Haile; Zhang, Gehong; Jia, JunMei] Shanxi Med Univ, Hosp 1, Dept Oncol, Taiyuan 030001, Shanxi, Peoples R China; [Xu, Enwei; Xi, Yanfeng; Li, Guodong] Shanxi Canc Hosp, Dept Pathol, Taiyuan 030001, Shanxi, Peoples R China; [Peng, Shaoliang] Natl Univ Def Technol, Sch Comp Sci, Changsha 410073, Hunan, Peoples R China; [Peng, Shaoliang] Natl Univ Def Technol, State Key Lab High Performance Comp, Changsha 410073, Hunan, Peoples R China; [Chen, Xing] Shanxi Prov Peoples Hosp, Dept Endoscopy, Taiyuan 030001, Shanxi, Peoples R China; [Yang, Xiaofeng] Shanxi Med Univ, Hosp 1, Dept Urol, Taiyuan 030001, Shanxi, Peoples R China; [Li, Qingshan] Shanxi Med Univ, Sch Pharmaceut Sci, Taiyuan 030001, Shanxi, Peoples R China; [Zhan, Qimin] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Zhan, Qimin] Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China; [Zhan, Qimin] Peking Union Med Coll, Beijing 100021, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University; Beijing Genomics Institute (BGI); City University of Hong Kong; Shanxi Medical University; Shanxi Medical University; National University of Defense Technology - China; National University of Defense Technology - China; Shanxi People's Hospital; Shanxi Medical University; Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cui, YP (corresponding author), Shanxi Med Univ, Translat Med Res Ctr, Taiyuan 030001, Shanxi, Peoples R China.; Cui, YP (corresponding author), Shanxi Med Univ, Minist Educ, Key Lab Cellular Physiol, Taiyuan 030001, Shanxi, Peoples R China.; Zhan, QM (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.; Zhan, QM (corresponding author), Chinese Acad Med Sci, Canc Hosp, Beijing 100021, Peoples R China.; Zhan, QM (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	zhanqimin@pumc.edu.cn; cuiy0922@yahoo.com	Wang, Jiaqian/AHA-3427-2022; Fang, Xiaodong/K-6743-2018	Fang, Xiaodong/0000-0001-7061-3337; LI, Shuaicheng/0000-0001-6246-6349; ZHOU, Yong/0000-0002-4197-7809; Qian, Yu/0000-0003-4759-4697; Peng, Shaoliang/0000-0002-4647-2615	National Natural Science Foundation of China [81330063, 81272189, 81230047, 81272694, 81201956, 81402342, 81502135]; Key Project of Chinese Ministry of Education [NO213005A]; Specialized Research Fund for the Doctoral Program of Higher Education [20121417110001]; Shanxi Scholarship Council of China [2013-053, 2015-key3]; Innovative Team in Science & Technology of Shanxi [2013-23]; Program for the Outstanding Innovative Teams of Higher Learning Institutions of Shanxi [2015-313]; 973 National Fundamental Research Program of China [2015CB553904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Chinese Ministry of Education(Ministry of Education, China); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Shanxi Scholarship Council of China; Innovative Team in Science & Technology of Shanxi; Program for the Outstanding Innovative Teams of Higher Learning Institutions of Shanxi; 973 National Fundamental Research Program of China(National Basic Research Program of China)	This work was supported by funding from the National Natural Science Foundation of China (81330063 and 81272189 to Y.C., 81230047 to Q.Z., 81272694 to X.C., 81201956 to J.L., 81402342 to L.Z., and 81502135 to P.K.), the Key Project of Chinese Ministry of Education (NO213005A to Y.C.), the Specialized Research Fund for the Doctoral Program of Higher Education (20121417110001 to Y.C.), a research project supported by Shanxi Scholarship Council of China (2013-053 and 2015-key3 to Y.C.), the Innovative Team in Science & Technology of Shanxi (2013-23 to Y.C.), the Program for the Outstanding Innovative Teams of Higher Learning Institutions of Shanxi (2015-313 to Y.C.), and the 973 National Fundamental Research Program of China (2015CB553904 to Q.Z.).	Abo RP, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1211; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bandla S, 2012, ANN THORAC SURG, V93, P1101, DOI 10.1016/j.athoracsur.2012.01.064; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Colnaghi R, 2011, SEMIN CELL DEV BIOL, V22, P875, DOI 10.1016/j.semcdb.2011.07.010; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Fungtammasan A, 2012, GENOME RES, V22, P993, DOI 10.1101/gr.134395.111; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gillis LD, 2013, ONCOGENE, V32, P3598, DOI 10.1038/onc.2012.371; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hermetz KE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004139; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hu WH, 2005, J BIOL CHEM, V280, P29233, DOI 10.1074/jbc.M501670200; Inaki K, 2012, TRENDS GENET, V28, P550, DOI 10.1016/j.tig.2012.07.002; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee PS, 2014, BREAST CANCER-BASIC, V8, P135, DOI 10.4137/BCBCR.S17766; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Liu PF, 2011, CELL, V146, P888, DOI 10.1016/j.cell.2011.07.042; Malhotra A, 2013, GENOME RES, V23, P762, DOI 10.1101/gr.143677.112; Marek L, 2009, MOL PHARMACOL, V75, P196, DOI 10.1124/mol.108.049544; Matsui Atsuka, 2013, Biomol Concepts, V4, P567, DOI 10.1515/bmc-2013-0026; Mayrhofer M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r24; Mehine M, 2013, NEW ENGL J MED, V369, P43, DOI 10.1056/NEJMoa1302736; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Nones K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6224; Osthus RC, 2005, CANCER RES, V65, P5620, DOI 10.1158/0008-5472.CAN-05-0536; Ozery-Flato M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r61; Parikh RA, 2007, GENE CHROMOSOME CANC, V46, P761, DOI 10.1002/gcc.20462; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Reid BJ, 2015, GASTROENTEROLOGY, V149, P1142, DOI 10.1053/j.gastro.2015.07.010; Sakofsky CJ, 2014, CELL REP, V7, P1640, DOI 10.1016/j.celrep.2014.04.053; Sato F, 2015, CANCER BIOL THER, V16, P933, DOI 10.1080/15384047.2015.1040959; Schou Kenneth B, 2014, Cilia, V3, P6, DOI 10.1186/2046-2530-3-6; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Stahl P, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0231-4; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Yang LX, 2013, CELL, V153, P919, DOI 10.1016/j.cell.2013.04.010; Ying JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039797; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; Zhang L, 2015, AM J HUM GENET, V96, P597, DOI 10.1016/j.ajhg.2015.02.017; Zhao S, 2008, DNA CELL BIOL, V27, P159, DOI 10.1089/dna.2007.0634	54	89	95	1	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					256	274		10.1016/j.ajhg.2015.12.013	http://dx.doi.org/10.1016/j.ajhg.2015.12.013			19	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26833333	hybrid, Green Published			2022-12-18	WOS:000370502300003
J	Kopajtich, R; Nicholls, TJ; Rorbach, J; Metodiev, MD; Freisinger, P; Mandel, H; Vanlander, A; Ghezzi, D; Carrozzo, R; Taylor, RW; Marquard, K; Murayama, K; Wieland, T; Schwarzmayr, T; Mayr, JA; Pearce, SF; Powell, CA; Saada, A; Ohtake, A; Invemizzi, F; Lamantea, E; Sommerville, EW; Pyle, A; Chinnery, PF; Crushell, E; Okazaki, Y; Kohda, M; Kishita, Y; Tokuzawa, Y; Assouline, Z; Rio, M; Feillet, F; de Camaret, BM; Chretien, D; Munnich, A; Menten, B; Sante, T; Smet, J; Regal, L; Lorber, A; Khoury, A; Zeviani, M; Strom, TM; Meitinger, T; Bertini, ES; Van Coster, R; Klopstock, T; Rotig, A; Haack, TB; Minczuk, M; Prokisch, H				Kopajtich, Robert; Nicholls, Thomas J.; Rorbach, Joanna; Metodiev, Metodi D.; Freisinger, Peter; Mandel, Hanna; Vanlander, Arnaud; Ghezzi, Daniele; Carrozzo, Rosalba; Taylor, Robert W.; Marquard, Klaus; Murayama, Kei; Wieland, Thomas; Schwarzmayr, Thomas; Mayr, Johannes A.; Pearce, Sarah F.; Powell, Christopher A.; Saada, Ann; Ohtake, Akira; Invemizzi, Federica; Lamantea, Eleonora; Sommerville, Ewen W.; Pyle, Angela; Chinnery, Patrick F.; Crushell, Ellen; Okazaki, Yasushi; Kohda, Masakazu; Kishita, Yoshihito; Tokuzawa, Yoshimi; Assouline, Zahra; Rio, Marlene; Feillet, Francois; de Camaret, Benedict Mousson; Chretien, Dominique; Munnich, Arnold; Menten, Bjoern; Sante, Tom; Smet, Joel; Regal, Luc; Lorber, Abraham; Khoury, Asaad; Zeviani, Massimo; Strom, Tim M.; Meitinger, Thomas; Bertini, Enrico S.; Van Coster, Rudy; Klopstock, Thomas; Roetig, Agnes; Haack, Tobias B.; Minczuk, Michal; Prokisch, Holger			Mutations in GTPBP3 Cause a Mitochondria! Translation Defect Associated with Hypertrophic Cardiomyopathy, Lactic Acidosis, and Encephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSFER-RNA; OXIDATIVE DEFECTS; GALACTOSE MEDIUM; SCREENING-TEST; MYOPATHY; CELLS	Respiratory chain deficiencies exhibit a wide variety of clinical phenotypes resulting from defective mitochondrial energy production through oxidative phosphorylation. These defects can be caused by either mutations in the mtDNA or mutations in nuclear genes coding for mitochondrial proteins. The underlying pathomechanisms can affect numerous pathways involved in mitochondrial physiology. By whole-exome and candidate gene sequencing, we identified 11 individuals from 9 families carrying compound heterozygous or homozygous mutations in GTPBP3, encoding the mitochondrial GTP-binding protein 3. Affected individuals from eight out of nine families presented with combined respiratory chain complex deficiencies in skeletal muscle. Mutations in GTPBP3 are associated with a severe mitochondrial translation defect, consistent with the predicted function of the protein in catalyzing the formation of 5-taurinomethyluridine (tau m(5)U) in the anticodon wobble position of five mitochondrial tRNAs. All case subjects presented with lactic acidosis and nine developed hypertrophic cardiomyopathy. In contrast to individuals with mutations in MTO1, the protein product of which is predicted to participate in the generation of the same modification, most individuals with GTPBP3 mutations developed neurological symptoms and MRI involvement of thalamus, putamen, and brainstem resembling Leigh syndrome. Our study of a mitochondrial translation disorder points toward the importance of posttranscriptional modification of mitochondrial tRNAs for proper mitochondrial function.	[Kopajtich, Robert; Wieland, Thomas; Schwarzmayr, Thomas; Strom, Tim M.; Meitinger, Thomas; Haack, Tobias B.; Prokisch, Holger] Helmholtz Zentrum Munchen, Inst Human Genet, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany; [Nicholls, Thomas J.; Rorbach, Joanna; Pearce, Sarah F.; Powell, Christopher A.; Zeviani, Massimo; Minczuk, Michal] MRC Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Metodiev, Metodi D.; Chretien, Dominique; Munnich, Arnold; Roetig, Agnes] Univ Paris 05, Sorbonne Paris Cite, INSERM, U1163,Inst Imagine, F-75015 Paris, France; [Freisinger, Peter] Klinikum Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany; [Mandel, Hanna] Childrens Hosp, Metab Unit, IL-31096 Haifa, Israel; [Vanlander, Arnaud; Smet, Joel; Van Coster, Rudy] Univ Hosp Ghent, Dept Pediat Neurol & Metab, B-9000 Ghent, Belgium; [Ghezzi, Daniele; Invemizzi, Federica; Lamantea, Eleonora; Zeviani, Massimo] Fdn IRCCS Ist Ricovero & Cura CarattereSci, Ist Neurol Carlo Besta, Unit Mol Neurogenet, I-20126 Milan, Italy; [Carrozzo, Rosalba; Bertini, Enrico S.] IRCCS Osped Pediat Bambino Gesu, Lab Med Mol, Dipartimento Neurosci, Unita Malattie Neuromuscolari & Neurodegenerat, I-00165 Rome, Italy; [Taylor, Robert W.; Sommerville, Ewen W.] Newcastle Univ, Inst Neurosci, Wellcome Trust Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Marquard, Klaus] Klinikum Stuttgart, Dept Neuropediat, D-70176 Stuttgart, Germany; [Murayama, Kei] Chiba Childrens Hosp, Dept Metab, Chiba 2660007, Japan; [Wieland, Thomas; Schwarzmayr, Thomas; Strom, Tim M.; Meitinger, Thomas; Haack, Tobias B.; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Mayr, Johannes A.] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria; [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Monique & Jacques Roboh Dept Genet Res, IL-91120 Jerusalem, Israel; [Saada, Ann] Hadassah Hebrew Univ, Med Ctr, Dept Genet & Metab Dis, IL-91120 Jerusalem, Israel; [Ohtake, Akira] Saitama Med Univ, Dept Pediat, Fac Med, Saitama 3500495, Japan; [Pyle, Angela; Chinnery, Patrick F.] Newcastle Univ, Wellcome Trust Ctr Mitochondrial Res, Inst Med Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Crushell, Ellen] Temple St Childrens Univ Hosp, Natl Ctr Inherited Metab Disorders, Dublin 12, Ireland; [Okazaki, Yasushi; Kohda, Masakazu] Saitama Med Univ, Res Ctr Genom Med, Dept Translat Res, Saitama 3501241, Japan; [Okazaki, Yasushi; Kishita, Yoshihito; Tokuzawa, Yoshimi] Saitama Med Univ, Res Ctr Genom Med, Dept Funct Genom & Syst Med, Saitama 3501241, Japan; [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Pediat, F-75015 Paris, France; [Assouline, Zahra; Rio, Marlene; Munnich, Arnold] Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Feillet, Francois] CHU Nancy, Serv Med Infantile, Hop Enfants Brabois, F-54511 Vandoeuvre Les Nancy, France; [de Camaret, Benedict Mousson] CHU Lyon, Serv Malad Hereditaires Metab, F-69677 Bron, France; [Menten, Bjoern; Sante, Tom] Univ Ghent, Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Regal, Luc] Univ Hosp Leuven, Dept Pediat, Metab Ctr, B-3000 Leuven, Belgium; [Lorber, Abraham; Khoury, Asaad] Rambam Med Ctr, Dept Pediat Cardiol, IL-31096 Haifa, Israel; [Meitinger, Thomas] DZHK German Ctr Cardiovasc Res, D-81675 Munich, Germany; [Meitinger, Thomas] Munich Heart Alliance, D-80802 Munich, Germany; [Meitinger, Thomas; Klopstock, Thomas] Munich Cluster Syst Neurol SyNergy, D-80336 Munich, Germany; [Klopstock, Thomas] German Res Ctr Neurodegenerat Dis DZNE, D-80336 Munich, Germany; [Klopstock, Thomas] Univ Munich, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ghent University; Ghent University Hospital; IRCCS Istituto Neurologico Besta; IRCCS Bambino Gesu; Newcastle University - UK; Klinikum Stuttgart; Chiba Children's Hospital; Technical University of Munich; Paracelsus Private Medical University; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Saitama Medical University; Newcastle University - UK; Childrens University Hospital - Temple Street; Saitama Medical University; Saitama Medical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Nancy; CHU Lyon; Ghent University; Ghent University Hospital; KU Leuven; University Hospital Leuven; Rambam Health Care Campus; Technion Israel Institute of Technology; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Munich; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Minczuk, M (corresponding author), MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.	michal.minczuk@mrc-mbu.cam.ac.uk; prokisch@helmholtz-muenchen.de	Metodiev, Metodi/C-4780-2015; Saada, Ann/J-6864-2017; rorbach, Joanna/AAM-5683-2021; Feillet, Francois/A-3648-2017; Menten, Björn/B-3072-2013; Zeviani, Massimo/AAU-2632-2021; Bertini, Enrico/A-2284-2014; Lamantea, Eleonora/J-8339-2016; Rötig, Agnès/G-9592-2017; Meitinger, Thomas/O-1318-2015; Feillet, Francois/A-2871-2015; Pearce, Sarah/AAE-7196-2019; Arnaud, Vanlander/ABB-5978-2021; Ghezzi, Daniele/J-7873-2016; Bertini, Enrico/ABG-1278-2020; Carrozzo, Rosalba/A-2808-2014; Invernizzi, Federica/J-9849-2016; Minczuk, Michal/G-1638-2014	Metodiev, Metodi/0000-0002-9596-2434; Saada, Ann/0000-0003-2951-0656; rorbach, Joanna/0000-0002-2891-2840; Feillet, Francois/0000-0002-8717-469X; Zeviani, Massimo/0000-0002-9067-5508; Bertini, Enrico/0000-0001-9276-4590; Lamantea, Eleonora/0000-0001-5090-6028; Rötig, Agnès/0000-0003-0589-0703; Ghezzi, Daniele/0000-0002-6564-3766; Carrozzo, Rosalba/0000-0002-3327-4054; Ohtake, Akira/0000-0003-1147-3113; Mayr, Johannes/0000-0001-6970-336X; Prokisch, Holger/0000-0003-2379-6286; Chinnery, Patrick/0000-0002-7065-6617; Invernizzi, Federica/0000-0001-8072-0152; Meitinger, Thomas/0000-0002-8838-8403; Rio, Marlene/0000-0003-2049-5058; Powell, Christopher/0000-0001-7501-0586; Okazaki, Yasushi/0000-0003-3241-5502; KOHDA, Masakazu/0000-0001-5970-2224; Kishita, Yoshihito/0000-0003-4978-1680; Nicholls, Thomas/0000-0002-3034-4109; Regal, Luc/0000-0001-8231-5767; Minczuk, Michal/0000-0001-8242-1420	Deutsche Forschungsgemeinschaft [EXC 1010]; German Bundesministerium fur Bildung und Forschung (BMBF) through E-Rare project GENOMIT [01GM1207, 2011-RARE-005-03, J41J11000420001, FWF I 920-B13]; German Network for Mitochondrial Disorders [mito-NET 01GM1113C, 01GM1113A]; German Center for Heart Research [Z76010017300, Z56010015300]; European Commission [N261123]; Medical Research Council, UK [MC_U105697135]; Wellcome Trust [096919/Z/11/Z]; MRC Centre for Neuromuscular Diseases [G0601943]; UK NHS; Fund for Scientific Research Belgium (FWO) [G.0200.10]; Fondazione Telethon [GGP11011, GPP10005]; Italian Ministry of Health [GR2010-2316392]; CARIPLO [2011/0526]; Pierfranco and Luisa Mariani Foundation; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation); Promotion and Mutual Aid Corporation for Private Schools of Japan from MEXT; Ministry of Health, Labour and Welfare of Japan; Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Association Francaise contre les Myopathies (AFM); AFM [16615]; Austrian Science Fund (FWF) [I 920] Funding Source: researchfish; Medical Research Council [1594369, MC_UP_1002/1, MC_U105697135, G0601943] Funding Source: researchfish; Wellcome Trust [101876/B/13/Z] Funding Source: researchfish; MRC [MC_UP_1002/1, MC_U105697135, G0601943] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Bundesministerium fur Bildung und Forschung (BMBF) through E-Rare project GENOMIT(Federal Ministry of Education & Research (BMBF)); German Network for Mitochondrial Disorders; German Center for Heart Research; European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Neuromuscular Diseases(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK NHS; Fund for Scientific Research Belgium (FWO)(FWO); Fondazione Telethon(Fondazione TelethonEuropean Commission); Italian Ministry of Health(Ministry of Health, Italy); CARIPLO(Fondazione Cariplo); Pierfranco and Luisa Mariani Foundation; Italian Association of Mitochondrial Disease Patients and Families (Mitocon); Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation); Promotion and Mutual Aid Corporation for Private Schools of Japan from MEXT; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); AFM(Association Francaise contre les Myopathies); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Terrile, M. Borzes, and C. Fischer for technical support and F. Miyake and T. Wada for referral of sample materials. This work was supported by the Deutsche Forschungsgemeinschaft within the framework of the Munich Cluster for Systems Neurology (EXC 1010 SyNergy), the German Bundesministerium fur Bildung und Forschung (BMBF) through funding of the E-Rare project GENOMIT (01GM1207 for T.M. and H.P., 2011-RARE-005-03 for A.R. and M.D.M., J41J11000420001 for M.Z., and FWF I 920-B13 for J.A.M.), German Network for Mitochondrial Disorders (mito-NET 01GM1113C for T.M., H.P., and P.F. and 01GM1113A for T.K.), the German Center for Heart Research (Z76010017300 and Z56010015300 for T.M.), European Commission 7th Framework Program (Project N261123 GEUVADIS), Medical Research Council, UK (MC_U105697135 for T.J.N., J.R., S.F.P., C.A.P., and M.M.), Wellcome Trust Strategic Award (096919/Z/11/Z for R.W.T. and P.F.C.), MRC Centre for Neuromuscular Diseases (G0601943), UK NHS Highly Specialised "Rare Mitochondrial Disorders of Adults and Children" Service for R.W.T. and P.F.C., Fund for Scientific Research Belgium (FWO, contract number G.0200.10 for A.V., J.S., and R.V.C.), Fondazione Telethon (GGP11011 and GPP10005), Italian Ministry of Health (GR2010-2316392), CARIPLO (2011/0526), Pierfranco and Luisa Mariani Foundation, and Italian Association of Mitochondrial Disease Patients and Families (Mitocon) to D.G., F.I., E.L., and M.Z., Research Program of Innovative Cell Biology by Innovative Technology (Cell Innovation), Grant-in-Aid for the Development of New Technology from The Promotion and Mutual Aid Corporation for Private Schools of Japan from MEXT for Y.O., Grants-in-Aid for the Research on Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan for A.O., Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics for K. Murayama, Association Francaise contre les Myopathies (AFM) for A.R. and M.D.M., and Fellowship from the AFM (16615 for M.D.M.).	Baruffini E, 2013, HUM MUTAT, V34, P1501, DOI 10.1002/humu.22393; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Boczonadi V, 2014, INT J BIOCHEM CELL B, V48, P77, DOI 10.1016/j.biocel.2013.12.011; Bykhovskaya Y, 2004, AM J HUM GENET, V74, P1303, DOI 10.1086/421530; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004; Elstner M, 2009, METHOD ENZYMOL, V457, P3, DOI 10.1016/S0076-6879(09)05001-0; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Haack TB, 2013, AM J HUM GENET, V93, P211, DOI 10.1016/j.ajhg.2013.06.006; Invernizzi F, 2012, MITOCHONDRION, V12, P328, DOI 10.1016/j.mito.2012.01.001; Kornblum C, 2013, NAT GENET, V45, P214, DOI 10.1038/ng.2501; Li XM, 2002, MOL CELL BIOL, V22, P7701, DOI 10.1128/MCB.22.21.7701-7711.2002; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Osawa S., 1995, EVOLUTION GENETIC CO; PETROVABENEDICT R, 1992, J INHERIT METAB DIS, V15, P943, DOI 10.1007/BF01800243; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Taylor RW, 2014, JAMA-J AM MED ASSOC, V312, P68, DOI 10.1001/jama.2014.7184; Villarroya M, 2008, MOL CELL BIOL, V28, P7514, DOI 10.1128/MCB.00946-08; Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002; Yarham JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004424; Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004	30	89	93	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 4	2014	95	6					708	720		10.1016/j.ajhg.2014.10.017	http://dx.doi.org/10.1016/j.ajhg.2014.10.017			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AX0DH	25434004	Green Published, hybrid			2022-12-18	WOS:000346623100007
J	Thevenon, J; Milh, M; Feillet, F; St-Onge, J; Duffourd, Y; Juge, C; Roubertie, A; Heron, D; Mignot, C; Raffo, E; Isidor, B; Wahlen, S; Sanlaville, D; Villeneuve, N; Darmency-Stambou, V; Toutain, A; Lefebvre, M; Chouchane, M; Huet, F; Lafon, A; de Saint Martin, A; Lesca, G; El Chehadeh, S; Thauvin-Robinet, C; Masurel-Paulet, A; Odent, S; Villard, L; Philippe, C; Faivre, L; Riviere, JB				Thevenon, Julien; Milh, Mathieu; Feillet, Francois; St-Onge, Judith; Duffourd, Yannis; Juge, Clara; Roubertie, Agathe; Heron, Delphine; Mignot, Cyril; Raffo, Emmanuel; Isidor, Bertrand; Wahlen, Sandra; Sanlaville, Damien; Villeneuve, Nathalie; Darmency-Stambou, Veronique; Toutain, Annick; Lefebvre, Mathilde; Chouchane, Mondher; Huet, Frederic; Lafon, Arnaud; de Saint Martin, Anne; Lesca, Gaetan; El Chehadeh, Salima; Thauvin-Robinet, Christel; Masurel-Paulet, Alice; Odent, Sylvie; Villard, Laurent; Philippe, Christophe; Faivre, Laurence; Riviere, Jean-Baptiste			Mutations in SLC13A5 Cause Autosomal-Recessive Epileptic Encephalopathy with Seizure Onset in the First Days of Life	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DE-NOVO MUTATIONS; NA+/DICARBOXYLATE COTRANSPORTER; FUNCTIONAL FEATURES; TRANSPORTER; ACID; DICARBOXYLATE; ORGANIZATION; EPILEPSIES; SUBSTRATE; FRAMEWORK	Epileptic encephalopathy (EE) refers to a clinically and genetically heterogeneous group of severe disorders characterized by seizures, abnormal interictal electro-encephalogram, psychomotor delay, and/or cognitive deterioration. We ascertained two multiplex families (including one consanguineous family) consistent with an autosomal-recessive inheritance pattern of EE. All seven affected individuals developed subclinical seizures as early as the first day of life, severe epileptic disease, and profound developmental delay with no facial dysmorphism. Given the similarity in clinical presentation in the two families, we hypothesized that the observed phenotype was due to mutations in the same gene, and we performed exome sequencing in three affected individuals. Analysis of rare variants in genes consistent with an autosomal-recessive mode of inheritance led to identification of mutations in SLC13A5, which encodes the cytoplasmic sodium-dependent citrate carrier, notably expressed in neurons. Disease association was confirmed by cosegregation analysis in additional family members. Screening of 68 additional unrelated individuals with early-onset epileptic encephalopathy for SLC13A5 mutations led to identification of one additional subject with compound heterozygous mutations of SLC13A5 and a similar clinical presentation as the index subjects. Mutations affected key residues for sodium binding, which is critical for citrate transport. These findings underline the value of careful clinical characterization for genetic investigations in highly heterogeneous conditions such as EE and further highlight the role of citrate metabolism in epilepsy.	[Thevenon, Julien; St-Onge, Judith; Duffourd, Yannis; Lefebvre, Mathilde; El Chehadeh, Salima; Thauvin-Robinet, Christel; Masurel-Paulet, Alice; Faivre, Laurence; Riviere, Jean-Baptiste] Ctr Hosp Univ Dijon, Federat Hosp Univ Med Translat & Anomalies Dev TR, F-21079 Dijon, France; [Thevenon, Julien; Lefebvre, Mathilde; El Chehadeh, Salima; Thauvin-Robinet, Christel; Masurel-Paulet, Alice; Faivre, Laurence] Ctr Hosp Univ Dijon, Ctr Genet, F-21079 Dijon, France; [Thevenon, Julien; Lefebvre, Mathilde; El Chehadeh, Salima; Thauvin-Robinet, Christel; Masurel-Paulet, Alice; Faivre, Laurence] Ctr Hosp Univ Dijon, Ctr Reference Anomalies Dev & Syndromes Malformat, F-21079 Dijon, France; [Thevenon, Julien; St-Onge, Judith; Duffourd, Yannis; Juge, Clara; Thauvin-Robinet, Christel; Faivre, Laurence; Riviere, Jean-Baptiste] Univ Bourgogne, Equipe Accueil 4271, F-21079 Dijon, France; [Milh, Mathieu; Villeneuve, Nathalie] Hop La Timone, Assistance Publ Hopitaux Marseille, Serv Neurol Pediat, F-13005 Marseille, France; [Milh, Mathieu; Villard, Laurent] Aix Marseille Univ, Unite Mixte Rech 910, Inst Natl Sante & Rech Med, F-13005 Marseille, France; [Feillet, Francois] Ctr Hosp Univ Brabois Enfants, Ctr Reference Malad Hereditaires Metabolisme, Serv Medecine Infantile 1, F-54511 Vandoeuvre Les Nancy, France; [St-Onge, Judith; Riviere, Jean-Baptiste] Ctr Hosp Univ Dijon, Lab Genet Mol Plateau Tech Biol, F-21079 Dijon, France; [Roubertie, Agathe] Hop Gui de Chauliac, Dept Neurol Pediat, F-34295 Montpellier, France; [Roubertie, Agathe] Inst Neurosci Montpellier, Inst Natl Sante & Rech Med Unite 1051, F-34172 Montpellier, France; [Heron, Delphine; Mignot, Cyril; Wahlen, Sandra] AP HP, Genet & Cytogenet Dept, Ctr Reference Deficiences Intellectuelles Causes, F-75013 Paris, France; [Raffo, Emmanuel] Ctr Hosp Univ Nancy, Unite Neurol Pediat, F-54000 Nancy, France; [Isidor, Bertrand] CHU Nantes, Serv Genet Med, F-44000 Nantes, France; [Sanlaville, Damien; Lesca, Gaetan] Lyon Univ Hosp, Dept Genet, F-69000 Lyon, France; [Sanlaville, Damien; Lesca, Gaetan] CNRS, Unite Mixte Rech 5292, F-69000 Lyon, France; [Villeneuve, Nathalie] Hop Henri Gastaut, Ctr Invest Neurol Adulte & Pediat Soins Epileptol, Ctr St Paul, F-13009 Marseille, France; [Darmency-Stambou, Veronique] Ctr Hosp Univ Dijon, Ctr Referent Troubles Langage & Apprentissages, Hop Enfants, F-21079 Dijon, France; [Toutain, Annick] Ctr Hospitalier Univ Tours, Serv Genet, F-37000 Tours, France; [Chouchane, Mondher; Huet, Frederic] Ctr Hosp Univ Dijon, Serv Pediat 1, F-21079 Dijon, France; [Lafon, Arnaud] Ctr Hosp Univ Dijon, Serv Odontol Stomatol, F-21079 Dijon, France; [de Saint Martin, Anne] Hop Hautepierre, CHU Strasbourg, Serv Pediat 1, F-67098 Strasbourg, France; [Odent, Sylvie] Ctr Hosp Univ Rennes, Serv Genet Clin, F-35200 Rennes, France; [Philippe, Christophe] Ctr Hosp Univ Nancy, Med Genet Lab, F-54511 Vandoeuvre Les Nancy, France	CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU de Nancy; CHU Dijon Bourgogne; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Assistance Publique Hopitaux Paris (APHP); CHU de Nancy; Nantes Universite; CHU de Nantes; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; CHU Dijon Bourgogne; CHU Tours; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Rennes; Universite de Rennes 1; CHU de Nancy	Thevenon, J (corresponding author), Ctr Hosp Univ Dijon, Federat Hosp Univ Med Translat & Anomalies Dev TR, F-21079 Dijon, France.	julien.thevenon@chu-dijon.fr; jean-baptiste.riviere@u-bourgogne.fr	Isidor, Bertrand/L-2435-2015; Feillet, Francois/A-3648-2017; lefebvre, mathilde/AAD-3299-2021; Sanlaville, Damien/M-4716-2014; Villard, Laurent/E-3941-2016; Feillet, Francois/A-2871-2015; Lesca, Gaetan/C-6111-2019; Isidor, Bertrand/AAJ-3456-2021	Isidor, Bertrand/0000-0001-6480-126X; Feillet, Francois/0000-0002-8717-469X; lefebvre, mathilde/0000-0002-9102-6884; Sanlaville, Damien/0000-0001-9939-2849; Villard, Laurent/0000-0001-6657-5008; Isidor, Bertrand/0000-0001-6480-126X; Faivre, Laurence/0000-0001-9770-444X; PHILIPPE, Christophe/0000-0001-7098-6520; Toutain, Annick/0000-0002-5999-5300; Lesca, Gaetan/0000-0001-7691-9492; DE SAINT-MARTIN, ANNE/0000-0003-4666-5369; Frederic, HUET/0000-0002-4510-7093	Regional Council of Burgundy; Dijon University Hospital; NHLBI GO: Lung GO Sequencing Project [HL-102923]; NHLBI GO: WHI Sequencing Project [HL-102924]; NHLBI GO: Broad GO Sequencing Project [HL-102925]; NHLBI GO: Seattle GO Sequencing Project [HL-102926]; NHLBI GO: Heart GO Sequencing Project [HL-103010]	Regional Council of Burgundy(Region Bourgogne-Franche-Comte); Dijon University Hospital; NHLBI GO: Lung GO Sequencing Project; NHLBI GO: WHI Sequencing Project; NHLBI GO: Broad GO Sequencing Project; NHLBI GO: Seattle GO Sequencing Project; NHLBI GO: Heart GO Sequencing Project	We wish to thank the subjects and families involved in the study, C.T. Gordon for kind advice, Integragen for the exome sequencing experiments, and the University of Burgundy Centre de Calcul (CCuB) for technical support and management of the informatics platform. This work was supported by the Regional Council of Burgundy and Dijon University Hospital. We also thank the NHLBI GO Exome Sequencing Project and its ongoing studies that produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926), and the Heart GO Sequencing Project (HL-103010).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Allen AS, 2013, NATURE, V501, P217, DOI 10.1038/nature12439; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Berg AT, 2013, PEDIATRICS, V132, P124, DOI 10.1542/peds.2012-3998; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bergeron MJ, 2013, MOL ASPECTS MED, V34, P299, DOI 10.1016/j.mam.2012.12.001; Birkenfeld AL, 2011, CELL METAB, V14, P184, DOI 10.1016/j.cmet.2011.06.009; Borges K, 2012, EPILEPSY RES, V100, P239, DOI 10.1016/j.eplepsyres.2011.05.023; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Covanis A, 2012, EPILEPSIA, V53, P114, DOI 10.1111/j.1528-1167.2012.03621.x; Dulac O, 2001, EPILEPSIA, V42, P23, DOI 10.1046/j.1528-1157.2001.042suppl.3023.x; GIRARDI E, 1985, NEUROCHEM INT, V7, P683, DOI 10.1016/0197-0186(85)90066-X; Gopal E, 2007, AM J PHYSIOL-GASTR L, V292, pG402, DOI 10.1152/ajpgi.00371.2006; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Griffith DA, 1999, BIOCHEMISTRY-US, V38, P7524, DOI 10.1021/bi990076b; Helbig I, 2013, CURR OPIN NEUROL, V26, P179, DOI 10.1097/WCO.0b013e32835ee6ff; Inoue K, 2004, BIOCHEM J, V378, P949, DOI 10.1042/BJ20031261; Kahn ES, 1999, BIOCHEMISTRY-US, V38, P6151, DOI 10.1021/bi9827722; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kovac S, 2013, NEUROPHARMACOLOGY, V69, P96, DOI 10.1016/j.neuropharm.2012.05.012; Mancusso R, 2012, NATURE, V491, P622, DOI 10.1038/nature11542; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Milh M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-80; Milh M, 2011, EPILEPSIA, V52, P1828, DOI 10.1111/j.1528-1167.2011.03181.x; Molinari F, 2005, AM J HUM GENET, V76, P334, DOI 10.1086/427564; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Nota B, 2013, AM J HUM GENET, V92, P627, DOI 10.1016/j.ajhg.2013.03.009; Pajor AM, 2001, J BIOL CHEM, V276, P29961, DOI 10.1074/jbc.M011387200; Pajor AM, 2014, PFLUG ARCH EUR J PHY, V466, P119, DOI 10.1007/s00424-013-1369-y; Saitsu H, 2008, NAT GENET, V40, P782, DOI 10.1038/ng.150; Weckhuysen S, 2013, NEUROLOGY, V81, P1697, DOI 10.1212/01.wnl.0000435296.72400.a1	32	89	90	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 13	2014	95	1					113	120		10.1016/j.ajhg.2014.06.006	http://dx.doi.org/10.1016/j.ajhg.2014.06.006			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AL1RP	24995870	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000338904100010
J	Haack, TB; Kopajtich, R; Freisinger, P; Wieland, T; Rorbach, J; Nicholls, TJ; Baruffini, E; Walther, A; Danhauser, K; Zimmermann, FA; Husain, RA; Schum, J; Mundy, H; Ferrero, I; Strom, TM; Meitinger, T; Taylor, RW; Minczuk, M; Mayr, JA; Prokisch, H				Haack, Tobias B.; Kopajtich, Robert; Freisinger, Peter; Wieland, Thomas; Rorbach, Joanna; Nicholls, Thomas J.; Baruffini, Enrico; Walther, Anett; Danhauser, Katharina; Zimmermann, Franz A.; Husain, Ralf A.; Schum, Jessica; Mundy, Helen; Ferrero, Ileana; Strom, Tim M.; Meitinger, Thomas; Taylor, Robert W.; Minczuk, Michal; Mayr, Johannes A.; Prokisch, Holger			ELAC2 Mutations Cause a Mitochondrial RNA Processing Defect Associated with Hypertrophic Cardiomyopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX I DEFICIENCY; SUSCEPTIBILITY GENE ELAC2; MISSENSE MUTATIONS; LACTIC-ACIDOSIS; PRODUCT; DISEASE; DNA; TRANSLATION; METABOLISM; VARIANTS	The human mitochondrial genome encodes RNA components of its own translational machinery to produce the 13 mitochondrial-encoded subunits of the respiratory chain. Nuclear-encoded gene products are essential for all processes within the organelle, including RNA processing. Transcription of the mitochondrial genome generates large polycistronic transcripts punctuated by the 22 mitochondrial (mt) tRNAs that are conventionally cleaved by the RNase P-complex and the RNase Z activity of ELAC2 at 5' and 3' ends, respectively. We report the identification of mutations in ELAC2 in five individuals with infantile hypertrophic cardiomyopathy and complex I deficiency. We observed accumulated mtRNA precursors in affected individuals muscle and fibroblasts. Although mature mt-tRNA, mt-mRNA, and mt-rRNA levels were not decreased in fibroblasts, the processing defect was associated with impaired mitochondrial translation. Complementation experiments in mutant cell lines restored RNA processing and a yeast model provided additional evidence for the disease-causal role of defective ELAC2, thereby linking mtRNA processing to human disease.	[Haack, Tobias B.; Wieland, Thomas; Walther, Anett; Danhauser, Katharina; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Haack, Tobias B.; Kopajtich, Robert; Wieland, Thomas; Walther, Anett; Schum, Jessica; Strom, Tim M.; Meitinger, Thomas; Prokisch, Holger] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Freisinger, Peter] Klinikum Reutlingen, Dept Pediat, D-72764 Reutlingen, Germany; [Rorbach, Joanna; Nicholls, Thomas J.; Minczuk, Michal] MRC, Mitochondrial Biol Unit, Cambridge CB2 OXY, England; [Baruffini, Enrico; Ferrero, Ileana] Univ Parma, Dept Life Sci, I-43124 Parma, Italy; [Zimmermann, Franz A.; Mayr, Johannes A.] Paracelsus Med Univ Salzburg, Dept Pediat, A-5020 Salzburg, Austria; [Husain, Ralf A.] Jena Univ Hosp, Dept Neuropediatr, D-07740 Jena, Germany; [Mundy, Helen] Evelina Childrens Hosp, Guys & St Thomas NHS Fdn Trust, Ctr Inherited Metab Dis, London SE1 7EH, England; [Meitinger, Thomas] German Ctr Cardiovasc Res, DZHK, D-81675 Munich, Germany; [Meitinger, Thomas] Munich Heart Alliance, D-80802 Munich, Germany; [Taylor, Robert W.] Newcastle Univ, Sch Med, Wellcome Trust Ctr Mitochondrial Res, Inst Ageing & Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Parma; Paracelsus Private Medical University; Friedrich Schiller University of Jena; Guy's & St Thomas' NHS Foundation Trust; German Centre for Cardiovascular Research; Munich Heart Alliance; Newcastle University - UK	Minczuk, M (corresponding author), MRC, Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 OXY, England.	michal.minczuk@mrc-mbu.cam.ac.uk; prokisch@helmholtz-muenchen.de	Baruffini, Enrico/AAL-2608-2020; Meitinger, Thomas/O-1318-2015; Husain, Ralf A./AAO-7658-2020; Baruffini, Enrico/C-1057-2015; rorbach, Joanna/AAM-5683-2021; Prokisch, Holger/N-8964-2013; Minczuk, Michal/G-1638-2014	Baruffini, Enrico/0000-0002-8280-7849; Husain, Ralf A./0000-0003-0798-6346; Baruffini, Enrico/0000-0002-8280-7849; rorbach, Joanna/0000-0002-2891-2840; Minczuk, Michal/0000-0001-8242-1420; Nicholls, Thomas/0000-0002-3034-4109; Mayr, Johannes/0000-0001-6970-336X; Prokisch, Holger/0000-0003-2379-6286; Meitinger, Thomas/0000-0002-8838-8403	UK Medical Research Council; German Bundesministerium fur Bildung und Forschung (BMBF) [SysMBo 0315494A]; E-Rare project GENOMIT [01GM1207, FWF I 920-B13]; German Network for mitochondrial disorders (mitoNET) [mitoNET 01GM1113C]; Wellcome Trust [096919/Z/11/Z]; Fondazione Telethon [GGP11011]; MRC [MC_U105697135, MR/K000608/1] Funding Source: UKRI; Austrian Science Fund (FWF) [I 920] Funding Source: researchfish; Medical Research Council [MR/K000608/1, MC_U105697135] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); E-Rare project GENOMIT; German Network for mitochondrial disorders (mitoNET); Wellcome Trust(Wellcome TrustEuropean Commission); Fondazione Telethon(Fondazione TelethonEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank E. Botz, R. Hellinger, and C. Fischer for technical support and V. Tiranti for providing the ELAC2 plasmid. This work was supported by the UK Medical Research Council (T.J.N, J.R., and M.M.), the German Bundesministerium fur Bildung und Forschung (BMBF) through funding of the Systems Biology of Metabotypes grant (SysMBo 0315494A), the E-Rare project GENOMIT (01GM1207 for T.M. and H.P. and FWF I 920-B13 for J.A.M), the German Network for mitochondrial disorders (mitoNET), including to T.M., H.P., and P.F. (mitoNET 01GM1113C), a Wellcome Trust Strategic Award (096919/Z/11/Z) to R.W.T., and Fondazione Telethon grant GGP11011 for E.B. and I.F.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Baruffini E, 2010, METHODS, V51, P426, DOI 10.1016/j.ymeth.2010.02.023; BINDOFF LA, 1993, J BIOL CHEM, V268, P19559; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Christian BE, 2010, J BIOL CHEM, V285, P28379, DOI 10.1074/jbc.M110.149054; Danhauser K, 2011, MOL GENET METAB, V103, P161, DOI 10.1016/j.ymgme.2011.03.004; Elstner M, 2008, MOL BIOTECHNOL, V40, P306, DOI 10.1007/s12033-008-9100-5; Feichtinger RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-149; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Haack TB, 2012, J MED GENET, V49, P277, DOI 10.1136/jmedgenet-2012-100846; Haack TB, 2012, J MED GENET, V49, P83, DOI 10.1136/jmedgenet-2011-100577; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945; Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884; Levinger L, 2012, RNA BIOL, V9, P283, DOI 10.4161/rna.19025; Minagawa A, 2005, CANCER LETT, V222, P211, DOI 10.1016/j.canlet.2004.09.013; Mineri R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005713; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pearce S, 2013, MOL CELL NEUROSCI, V55, P1, DOI 10.1016/j.mcn.2012.08.013; Rorbach J, 2012, NUCLEIC ACIDS RES, V40, P4097, DOI 10.1093/nar/gkr1282; Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470; Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4; Rossmanith W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019152; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smith MM, 2004, DEV BIOL, V266, P151, DOI 10.1016/j.ydbio.2003.10.016; Tomari Y, 2003, J BIOL CHEM, V278, P16828, DOI 10.1074/jbc.M213216200; Xu B, 2010, PROSTATE CANCER P D, V13, P270, DOI 10.1038/pcan.2010.6	29	89	93	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2013	93	2					211	223		10.1016/j.ajhg.2013.06.006	http://dx.doi.org/10.1016/j.ajhg.2013.06.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	202AP	23849775	Green Published, hybrid			2022-12-18	WOS:000323186200002
J	Malfait, F; Kariminejad, A; Van Damme, T; Gauche, C; Syx, D; Merhi-Soussi, F; Gulberti, S; Symoens, S; Vanhauwaert, S; Willaert, A; Bozorgmehr, B; Kariminejad, MH; Ebrahimiadib, N; Hausser, I; Huysseune, A; Fournel-Gigleux, S; De Paepe, A				Malfait, Fransiska; Kariminejad, Ariana; Van Damme, Tim; Gauche, Caroline; Syx, Delfien; Merhi-Soussi, Faten; Gulberti, Sandrine; Symoens, Sofie; Vanhauwaert, Suzanne; Willaert, Andy; Bozorgmehr, Bita; Kariminejad, Mohamad Hasan; Ebrahimiadib, Nazanin; Hausser, Ingrid; Huysseune, Ann; Fournel-Gigleux, Sylvie; De Paepe, Anne			Defective Initiation of Glycosaminoglycan Synthesis due to B3GALT6 Mutations Causes a Pleiotropic Ehlers-Danlos-Syndrome-like Connective Tissue Disorder	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							THUMB-CLUBFOOT SYNDROME; PROTEIN LINKAGE REGION; TENASCIN-X DEFICIENCY; OF-FUNCTION MUTATIONS; COLLAGEN TYPE-VI; HEPARAN-SULFATE; GALACTOSYLTRANSFERASE-II; PROGRESSIVE KYPHOSCOLIOSIS; MOLECULAR-CLONING; JOINT LAXITY	Proteoglycans are important components of cell plasma membranes and extracellular matrices of connective tissues. They consist of glycosaminoglycan chains attached to a core protein via a tetrasaccharide linkage, whereby the addition of the third residue is catalyzed by galactosyltransferase II (beta 3GalT6), encoded by B3GALT6. Homozygosity mapping and candidate gene sequence analysis in three independent families, presenting a severe autosomal-recessive connective tissue disorder characterized by skin fragility, delayed wound healing, joint hyperlaxity and contractures, muscle hypotonia, intellectual disability, and a spondyloepimetaphyseal dysplasia with bone fragility and severe kyphoscoliosis, identified biallelic B3GALT6 mutation's, including homozygous missense mutations in family 1 (c.619G>C [p.Asp207His]) and family 3 (c.649G>A [p.Gly217Ser]) and compound heterozygous mutations in family 2 (c.323_344del [p.Ala108Glyfs*163], c.619G>C [p.Asp207His]). The phenotype overlaps with several recessive Ehlers-Danlos variants and spondyloepimetaphyseal dysplasia with joint hyperlaxity. Affected individuals' fibroblasts exhibited a large decrease in ability to prime glycosaminoglycan synthesis together with impaired glycanation of the small chondroitin/dermatan sulfate proteoglycan decorin, confirming beta 3GalT6 loss of function. Dermal electron microcopy disclosed abnormalities in collagen fibril organization, in line with the important regulatory role of decorin in this process. A strong reduction in heparan sulfate level was also observed, indicating that beta 3GalT6 deficiency alters synthesis of both main types of glycosaminoglycans. In vitro wound healing assay revealed a significant delay in fibroblasts from two index individuals, pointing to a role for glycosaminoglycan defect in impaired wound repair in vivo. Our study emphasizes a crucial role for beta 3GalT6 in multiple major developmental and pathophysiological processes.	[Malfait, Fransiska; Van Damme, Tim; Syx, Delfien; Symoens, Sofie; Vanhauwaert, Suzanne; Willaert, Andy; De Paepe, Anne] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Kariminejad, Ariana; Bozorgmehr, Bita; Kariminejad, Mohamad Hasan] Kariminejad Najmabadi Pathol & Genet Ctr, Tehran 14656, Iran; [Gauche, Caroline; Merhi-Soussi, Faten; Gulberti, Sandrine; Fournel-Gigleux, Sylvie] Univ Lorraine, CNRS, UMR 7365, IMoPA,MolCelTEG Team,Biopole UL,Fac Med, F-54505 Vandoeuvre Les Nancy, France; [Ebrahimiadib, Nazanin] Univ Tehran Med Sci, Farabi Eye Hosp, Eye Res Ctr, Tehran 14656, Iran; [Hausser, Ingrid] Heidelberg Univ, Dept Dermatol, D-69120 Heidelberg, Germany; [Huysseune, Ann] Univ Ghent, Dept Biol, B-9000 Ghent, Belgium	Ghent University; Ghent University Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; Tehran University of Medical Sciences; Ruprecht Karls University Heidelberg; Ghent University	Malfait, F (corresponding author), Ghent Univ Hosp, Ctr Med Genet, De Pintelaan 185, B-9000 Ghent, Belgium.	fransiska.malfait@ugent.be	Willaert, Andy/AAZ-9111-2020; Ebrahimiadib, Nazanin/B-1543-2019; Malfait, Fransiska/K-7897-2014	Ebrahimiadib, Nazanin/0000-0002-2058-9225; Vanhauwaert, Suzanne/0000-0002-7768-4549; Malfait, Fransiska/0000-0002-5010-0304; Willaert, Andy/0000-0002-9543-1932; Van Damme, Tim/0000-0002-6424-4421; GULBERTI, Sandrine/0000-0002-9378-4697; Kariminejad, Ariana/0000-0002-8467-4728	Ghent University [08/01M01108]; Fund for Scientific Research (FWO), Flanders, Belgium [G.0171.05]; Agence Nationale de la Recherche (ANR GAG-Network) [ANR-08-PCVI-0023]; SED66 patient association; Region Lorraine; Universite de Lorraine	Ghent University(Ghent University); Fund for Scientific Research (FWO), Flanders, Belgium(FWO); Agence Nationale de la Recherche (ANR GAG-Network)(French National Research Agency (ANR)); SED66 patient association; Region Lorraine(Region Grand-Est); Universite de Lorraine	We wish to thank the families for participating in this work. F.M. and D.S. are fellows of the Fund for Scientific Research (FWO), Flanders, Belgium. This work was supported by a Methusalem Grant 08/01M01108 from the Ghent University and Grant G.0171.05 from the Fund for Scientific Research (FWO), Flanders, Belgium, both to A.D.P. This work (C.G., F.M.-S., S.G., S.F.-G.) was funded by Agence Nationale de la Recherche (ANR GAG-Network ANR-08-PCVI-0023), SED66 patient association, Region Lorraine and Universite de Lorraine. C.G. is a recipient for a French Ministerial PhD Fellowship. S.F.-G. gratefully acknowledges Mrs. Valerie Gisclard from SED66 for her kind support.	Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Baasanjav S, 2011, AM J HUM GENET, V89, P15, DOI 10.1016/j.ajhg.2011.05.021; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; BEIGHTON P, 1983, S AFR MED J, V64, P772; BEIGHTON P, 1980, SKELETAL RADIOL, V5, P205, DOI 10.1007/BF00580591; BIDANSET DJ, 1992, J BIOL CHEM, V267, P5250; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; BONALDO P, 1990, BIOCHEMISTRY-US, V29, P1245, DOI 10.1021/bi00457a021; Bui C, 2010, FEBS LETT, V584, P3962, DOI 10.1016/j.febslet.2010.08.001; Bui C, 2010, FASEB J, V24, P436, DOI 10.1096/fj.09-136291; Cole SE, 2001, MAMM GENOME, V12, P177, DOI 10.1007/s003350010241; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dundar M, 2009, AM J HUM GENET, V85, P873, DOI 10.1016/j.ajhg.2009.11.010; Duncan G, 2001, J CLIN INVEST, V108, P511, DOI 10.1172/JCI13737; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Hermanns P, 2008, AM J HUM GENET, V82, P1368, DOI 10.1016/j.ajhg.2008.05.006; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Li Y, 2010, AM J HUM GENET, V87, P757, DOI 10.1016/j.ajhg.2010.10.003; Maeda N, 2011, NEUROCHEM RES, V36, P1228, DOI 10.1007/s11064-010-0324-y; Malfait F, 2010, HUM MUTAT, V31, P1233, DOI 10.1002/humu.21355; Mao JR, 2002, NAT GENET, V30, P421, DOI 10.1038/ng850; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Prydz K, 2000, J CELL SCI, V113, P193; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; Schalkwijk J, 2001, NEW ENGL J MED, V345, P1167, DOI 10.1056/NEJMoa002939; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Stepp MA, 2002, J CELL SCI, V115, P4517, DOI 10.1242/jcs.00128; Symoens S, 2011, BIOCHEM J, V433, P371, DOI 10.1042/BJ20101061; Talhaoui I, 2010, J BIOL CHEM, V285, P37342, DOI 10.1074/jbc.M110.151951; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Turnbull JE, 2010, BIOCHEM SOC T, V38, P1356, DOI 10.1042/BST0381356; Ueyama M, 2008, J BIOL CHEM, V283, P6076, DOI 10.1074/jbc.M709189200; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; Voermans NC, 2007, AM J MED GENET A, V143A, P2215, DOI 10.1002/ajmg.a.31899; Wiberg C, 2001, J BIOL CHEM, V276, P18947, DOI 10.1074/jbc.M100625200; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	44	89	91	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					935	945		10.1016/j.ajhg.2013.04.016	http://dx.doi.org/10.1016/j.ajhg.2013.04.016			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23664118	Green Published, Bronze			2022-12-18	WOS:000320415300010
J	Fernandes, V; Alshamali, F; Alves, M; Costa, MD; Pereira, JB; Silva, NM; Cherni, L; Harich, N; Cerny, V; Soares, P; Richards, MB; Pereira, L				Fernandes, Veronica; Alshamali, Farida; Alves, Marco; Costa, Marta D.; Pereira, Joana B.; Silva, Nuno M.; Cherni, Lotfi; Harich, Nourdin; Cerny, Viktor; Soares, Pedro; Richards, Martin B.; Pereira, Luisa			The Arabian Cradle: Mitochondrial Relicts of the First Steps along the Southern Route out of Africa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BAYESIAN COALESCENT INFERENCE; ANATOMICALLY MODERN HUMANS; HUMAN-POPULATIONS; GENETIC-STRUCTURE; EUROPEAN FARMERS; Y-CHROMOSOME; SUB-SAHARAN; DNA; HAPLOGROUP; SETTLEMENT	A major unanswered question regarding the dispersal of modem humans around the world concerns the geographical site of the first human steps outside of Africa. The "southern coastal route" model predicts that: the early stages of the dispersal took place when people crossed the Red Sea to southern Arabia, but genetic evidence has hitherto been tenuous. We have addressed this question by analyzing the three minor west-Eurasian haplogroups, N1, N2, and X. These lineages branch directly from the first non-African founder node, the root of haplogroup N, and coalesce to the time of the first successful movement of modern humans out of Africa, similar to 60 thousand years (ka) ago. We sequenced complete mtDNA genomes from 85 Southwest Asian samples carrying these haplogroups and compared them with a database of 300 European examples. The results show that these minor haplogroups have a relict distribution that suggests an ancient ancestry within the Arabian Peninsula, and they most likely spread from the Gulf Oasis region toward the Near East and Europe during the pluvial period 55-24 ka ago. This pattern suggests that Arabia was indeed the first staging post in the spread of modern humans around the world.	[Fernandes, Veronica; Alves, Marco; Costa, Marta D.; Pereira, Joana B.; Silva, Nuno M.; Soares, Pedro; Pereira, Luisa] Univ Porto, Inst Patol & Imunol Mol, P-4200465 Oporto, Portugal; [Fernandes, Veronica; Costa, Marta D.; Pereira, Joana B.; Richards, Martin B.] Univ Leeds, Inst Integrat & Comparat Biol, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Alshamali, Farida] Dubai Police Gen Headquarters, Gen Dept Forens Sci & Criminol, Dubai 1493, U Arab Emirates; [Cherni, Lotfi] Fac Sci Tunis, Lab Genet Immunol & Human Pathol, Tunis 2092, Tunisia; [Cherni, Lotfi] Higher Inst Biotechnol Monastir, Monastir 5000, Tunisia; [Harich, Nourdin] Univ Chouaib Doukkali, Dept Biol, Lab Anthropogenet, El Jadida 24000, Morocco; [Cerny, Viktor] Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague 12843, Czech Republic; [Cerny, Viktor] Inst Adv Study, F-75648 Paris, France; [Richards, Martin B.] Univ Huddersfield, Sch Appl Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Pereira, Luisa] Univ Porto, Fac Med, P-4200319 Oporto, Portugal	Universidade do Porto; University of Leeds; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite de Monastir; Chouaib Doukkali University of El Jadida; Charles University Prague; University of Huddersfield; Universidade do Porto	Pereira, L (corresponding author), Univ Porto, Inst Patol & Imunol Mol, P-4200465 Oporto, Portugal.	lpereira@ipatimup.pt	Cerny, Viktor/G-7842-2014; L, CHERNI C_L22/J-2849-2013; Soares, Pedro A/G-9422-2011; Fernandes, Vernonica/AAC-6824-2022; LOTFI, CHERNI/AAN-5639-2021; Alshamali, Farida/N-1119-2013; Pereira, Luisa/H-3050-2011; Pereira, Joana B./J-6026-2013; Costa, Marta Daniela/T-5148-2018	Soares, Pedro A/0000-0002-2807-690X; LOTFI, CHERNI/0000-0002-7050-6539; Pereira, Luisa/0000-0002-4271-1527; Pereira, Joana B./0000-0002-4409-514X; Costa, Marta Daniela/0000-0002-6247-0548; fernandes, veronica/0000-0002-3873-2034; RICHARDS, MARTIN/0000-0003-3118-0967; Alshamali, Farida/0000-0002-0736-5147	Portuguese Foundation for Science and Technology [PTDC/CS-ANT/113832/2009, SFRH/BD/61342/2009, SFRH/BD/69119/2010, SFRH/BD/45657/2008, SFRH/BD/48372/2008, SFRH/BPD/64233/2009]; Leverhulme Trust [10 105/D]; De Laszlo Foundation; FCT; Fundação para a Ciência e a Tecnologia [PTDC/CS-ANT/113832/2009] Funding Source: FCT	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Leverhulme Trust(Leverhulme Trust); De Laszlo Foundation; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	We thank Sergei and Oksana Rychkov, Mukaddes Golge, Jiri Hatina, Ariella Oppenheim, Dimitar Dimitrov, Mark Thomas, and the donors themselves for generously providing DNA samples. FCT, the Portuguese Foundation for Science and Technology, supported this work through the research project PTDC/CS-ANT/113832/2009 and the personal grants to V.F. (SFRH/BD/61342/2009), N.M.S. (SFRH/BD/69119/2010), J.B.P. (SFRH/BD/45657/2008), M.D.C. (SFRH/BD/48372/2008), and P.S. (SFRH/BPD/64233/2009). We also thank the Leverhulme Trust (research project grant 10 105/D) and the De Laszlo Foundation for financial support to P.S. The Instituto de Patologia e Imunologia Molecular da Universidade do Porto is an Associate Laboratory of the Portuguese Ministry of Science, Technology, and Higher Education and is partially supported by FCT.	Alshamali F, 2009, HUM HERED, V68, P45, DOI 10.1159/000210448; Alshamali F, 2008, FORENSIC SCI INT-GEN, V2, pE9, DOI 10.1016/j.fsigen.2007.08.005; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Ashrafian-Bonab M, 2007, HEREDITY, V98, P151, DOI 10.1038/sj.hdy.6800918; Atkinson QD, 2009, P ROY SOC B-BIOL SCI, V276, P367, DOI 10.1098/rspb.2008.0785; BANDELT HJ, 1995, GENETICS, V141, P743; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Cerny V, 2008, AM J PHYS ANTHROPOL, V136, P128, DOI 10.1002/ajpa.20784; Cerny V, 2011, MOL BIOL EVOL, V28, P2491, DOI 10.1093/molbev/msr067; Cerny V, 2009, AM J PHYS ANTHROPOL, V138, P439, DOI 10.1002/ajpa.20960; Cherni L, 2009, AM J PHYS ANTHROPOL, V139, P253, DOI 10.1002/ajpa.20979; Derbeneva O. A., 2002, Genetika, V38, P1554; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Forster P, 1996, AM J HUM GENET, V59, P935; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; Harich N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-138; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Kashani BH, 2012, AM J PHYS ANTHROPOL, V147, P35, DOI 10.1002/ajpa.21614; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Maher LA, 2009, VERTEBR PALEOBIOL PA, P187, DOI 10.1007/978-90-481-2719-1_14; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Musilova E, 2011, AM J PHYS ANTHROPOL, V145, P592, DOI 10.1002/ajpa.21522; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Oppenheimer S., 2003, OUT EDEN PEOPLING WO; Palanichamy MG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-304; Perego UA, 2009, CURR BIOL, V19, P1, DOI 10.1016/j.cub.2008.11.058; Pereira L, 2007, MOL BIOL EVOL, V24, P868, DOI 10.1093/molbev/msm004; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards M, 2003, AM J HUM GENET, V72, P1058, DOI 10.1086/374384; Richards M., 2006, MITOCHONDRIAL DNA EV, P225; Rose JI, 2010, CURR ANTHROPOL, V51, P849, DOI 10.1086/657397; Shea JJ, 2008, QUATERNARY SCI REV, V27, P2253, DOI 10.1016/j.quascirev.2008.08.015; Shlush LI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002105; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Thangaraj K, 2005, SCIENCE, V308, P996, DOI 10.1126/science.1109987; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Uerpmann HP, 2009, VERTEBR PALEOBIOL PA, P205, DOI 10.1007/978-90-481-2719-1_15; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VanAndel TH, 1996, QUATERNARY SCI REV, V15, P481, DOI 10.1016/0277-3791(96)00028-5	52	89	91	2	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB 10	2012	90	2					347	355		10.1016/j.ajhg.2011.12.010	http://dx.doi.org/10.1016/j.ajhg.2011.12.010			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	898KV	22284828	Green Published, Bronze			2022-12-18	WOS:000300742200017
J	Knight, HM; Pickard, BS; Maclean, A; Malloy, MP; Soares, DC; Mcrae, AF; Condie, A; White, A; Hawkins, W; McGhee, K; van Beck, M; MacIntyre, DJ; Starr, JM; Deary, IJ; Visscher, PM; Porteous, DJ; Cannon, RE; St Clair, D; Muir, WJ; Blackwood, DHR				Knight, Helen M.; Pickard, Benjamin S.; Maclean, Alan; Malloy, Mary P.; Soares, Dinesh C.; McRae, Allan F.; Condie, Alison; White, Angela; Hawkins, William; McGhee, Kevin; van Beck, Margaret; MacIntyre, Donald J.; Starr, John M.; Deary, Ian J.; Visscher, Peter M.; Porteous, David J.; Cannon, Ronald E.; St Clair, David; Muir, Walter J.; Blackwood, Douglas H. R.			A Cytogenetic Abnormality and Rare Coding Variants Identify ABCA13 as a Candidate Gene in Schizophrenia, Bipolar Disorder, and Depression	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POSTMORTEM ORBITOFRONTAL CORTEX; GLUTAMATE-RECEPTOR GENE; FATTY-ACIDS; ATP HYDROLYSIS; PROTEIN; TRANSPORTER; TRANSLOCATION; DISRUPTION; PREDICTION	Schizophrenia and bipolar disorder are leading causes of morbidity across all Populations, with heritability estimates of similar to 80% indicating a substantial genetic component. Population genetics and genome-wide association studies Suggest an overlap of genetic risk factors between these illnesses but it is unclear how this genetic component is divided between common gene polymorphisms, rare genomic copy number variants, and rare gene sequence mutations. We report evidence that the lipid transporter gene ABCA13 is a susceptibility factor for both schizophrenia and bipolar disorder. After the initial discovery of its disruption by a chromosome abnormality in a person with schizophrenia, we resequenced ABCA13 exons in 100 cases with schizophrenia and 100 controls. Multiple rare coding variants were identified including one nonsense and nine missense mutations and compound heterozygosity/homozygosity in six cases. Variants were genotyped in additional schizophrenia, bipolar, depression (n > 1600), and control (n > 950) cohorts and the frequency of all rare variants combined was greater than controls in schizophrenia (OR = 1.93, p = 0.0057) and bipolar disorder (OR = 2.71, p = 0.00007). The population attributable risk of these mutations was 2.2% for schizophrenia and 4.0% for bipolar disorder. In a Study of 21 families of mutation carriers, we genotyped affected and unaffected relatives and found significant linkage (LOD = 4.3) of rare variants with a phenotype including schizophrenia, bipolar disorder, and major depression. These data identify a candidate gene, highlight the genetic overlap between schizophrenia, bipolar disorder, and depression, and suggest that rare coding variants may contribute significantly to risk of these disorders.	[Knight, Helen M.; Maclean, Alan; Malloy, Mary P.; McGhee, Kevin; van Beck, Margaret; MacIntyre, Donald J.; Muir, Walter J.; Blackwood, Douglas H. R.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; [McRae, Allan F.; Visscher, Peter M.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Condie, Alison; White, Angela; Hawkins, William] Western Gen Hosp, Wellcome Trust Clin Res Facil, Edinburgh EH4 2XU, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Geriatr Med Unit, Royal Victoria Hosp, Edinburgh EH4 2DN, Midlothian, Scotland; [Knight, Helen M.; Pickard, Benjamin S.; Maclean, Alan; Malloy, Mary P.; Soares, Dinesh C.; McGhee, Kevin; Porteous, David J.; Muir, Walter J.; Blackwood, Douglas H. R.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Mol Med Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Cannon, Ronald E.] NIEHS, Canc Biol Grp, Natl Ctr Toxicogen, Res Triangle Pk, NC 27709 USA; [St Clair, David] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; QIMR Berghofer Medical Research Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Aberdeen	Pickard, BS (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, John Arbuthnott Bldg,27 Taylor St, Glasgow G4 0NR, Lanark, Scotland.	benjamin.pickard@strath.ac.uk	Soares, Dinesh C/A-4425-2012; Starr, John/C-8951-2011; St Clair, David/AAN-2412-2021; Porteous, David/AAA-3446-2021; McRae, Allan F/J-2644-2014; Visscher, Peter/ABB-6151-2020; blackwood, douglas/AIB-8874-2022; Pickard, Benjamin S/K-3923-2014; Porteous, David J/C-7289-2013; Deary, Ian J/C-6297-2009	Soares, Dinesh C/0000-0001-7557-0495; Porteous, David/0000-0003-1249-6106; McRae, Allan F/0000-0001-5286-5485; Visscher, Peter/0000-0002-2143-8760; Pickard, Benjamin S/0000-0002-2374-6329; Porteous, David J/0000-0003-1249-6106; Deary, Ian J/0000-0002-1733-263X; MacIntyre, Donald J/0000-0001-6963-1335; Knight, Helen Miranda/0000-0003-3267-9591	MRC [G0900627, G0100266] Funding Source: UKRI; Medical Research Council [G0700704B, G9900991B] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council [G0900627, G0100266] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Chief Scientist Office [CZB/4/498] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Albrecht C, 2007, PFLUG ARCH EUR J PHY, V453, P581, DOI 10.1007/s00424-006-0047-8; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barros SA, 2003, GENE, V307, P191, DOI 10.1016/S0378-1119(03)00465-7; Bergen AAB, 2007, PFLUG ARCH EUR J PHY, V453, P685, DOI 10.1007/s00424-005-0039-0; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; D'Angelo G, 2008, CURR OPIN CELL BIOL, V20, P360, DOI 10.1016/j.ceb.2008.03.013; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Doris AB, 1998, SCHIZOPHR RES, V31, P185, DOI 10.1016/S0920-9964(98)00016-4; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Fishman GA, 1999, ARCH OPHTHALMOL-CHIC, V117, P504, DOI 10.1001/archopht.117.4.504; Fitzgerald ML, 2004, J BIOL CHEM, V279, P48477, DOI 10.1074/jbc.M409848200; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Georgieva L, 2006, P NATL ACAD SCI USA, V103, P12469, DOI 10.1073/pnas.0603029103; GLEN AIM, 1994, SCHIZOPHR RES, V12, P53, DOI 10.1016/0920-9964(94)90084-1; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kaminski WE, 2006, BBA-MOL BASIS DIS, V1762, P510, DOI 10.1016/j.bbadis.2006.01.011; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; Kieseppa T, 2004, AM J PSYCHIAT, V161, P1814, DOI 10.1176/appi.ajp.161.10.1814; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kitiratschky VBD, 2008, EUR J HUM GENET, V16, P812, DOI 10.1038/ejhg.2008.23; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; MAIER W, 1993, ARCH GEN PSYCHIAT, V50, P871; Makinen VP, 2005, EUR J HUM GENET, V13, P987, DOI 10.1038/sj.ejhg.5201430; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; McNamara RK, 2008, PSYCHIAT RES, V160, P285, DOI 10.1016/j.psychres.2007.08.021; McNamara RK, 2007, SCHIZOPHR RES, V91, P37, DOI 10.1016/j.schres.2006.11.027; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Narayan S, 2009, J NEUROSCI RES, V87, P278, DOI 10.1002/jnr.21822; Nikaido K, 1999, J BIOL CHEM, V274, P26727, DOI 10.1074/jbc.274.38.26727; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; PEET M, 1995, J PSYCHIAT RES, V29, P227, DOI 10.1016/0022-3956(95)00001-L; Pei JM, 2006, NUCLEIC ACIDS RES, V34, P4364, DOI 10.1093/nar/gkl514; Pickard BS, 2006, MOL PSYCHIATR, V11, P847, DOI 10.1038/sj.mp.4001867; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Pickard BS, 2008, P NATL ACAD SCI USA, V105, P14940, DOI 10.1073/pnas.0800643105; Pickard BS, 2007, PSYCHIAT GENET, V17, P129, DOI 10.1097/YPG.0b013e328014492b; Pickard BS, 2005, AM J MED GENET B, V136B, P26, DOI 10.1002/ajmg.b.30204; Prades C, 2002, CYTOGENET GENOME RES, V98, P160, DOI 10.1159/000069852; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheffel F, 2005, FEBS LETT, V579, P2953, DOI 10.1016/j.febslet.2005.04.017; Schmitt A, 2004, BIOL PSYCHIAT, V56, P41, DOI 10.1016/j.biopsych.2004.03.019; Segal D, 2007, INT J NEUROPSYCHOPH, V10, P503, DOI 10.1017/S146114570600722X; Sims R, 2009, NEUROSCI LETT, V461, P54, DOI 10.1016/j.neulet.2009.05.051; Slatter TL, 2008, CLIN GENET, V73, P179, DOI 10.1111/j.1399-0004.2007.00940.x; Sokolov BP, 2007, INT J NEUROPSYCHOPH, V10, P547, DOI 10.1017/S1461145706007322; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Sunyaev S, 2000, TRENDS GENET, V16, P198, DOI 10.1016/S0168-9525(00)01988-0; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tkachev D, 2007, INT J NEUROPSYCHOPH, V10, P557, DOI 10.1017/S1461145706007334; Uitto J, 2005, TRENDS MOL MED, V11, P341, DOI 10.1016/j.molmed.2005.06.004; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; World Health Organization, 2001, WORLD HLTH REP; YAO JK, 1994, SCHIZOPHR RES, V13, P227, DOI 10.1016/0920-9964(94)90046-9; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657	81	89	108	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 11	2009	85	6					833	846		10.1016/j.ajhg.2009.11.003	http://dx.doi.org/10.1016/j.ajhg.2009.11.003			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	533BN	19944402	Green Published, Bronze			2022-12-18	WOS:000272797100007
J	Hoffmann, S; Cepok, S; Grummel, V; Lehmann-Horn, K; Hackermueller, J; Stadler, PE; Hartung, HP; Berthele, A; Deisenhammer, F; Wasmuth, R; Hemmer, B				Hoffmann, Steve; Cepok, Sabine; Grummel, Verena; Lehmann-Horn, Klaus; Hackermueller, Joerg; Stadler, Peter E.; Hartung, Hans-Peter; Berthele, Achim; Deisenhammer, Florian; Wasmuth, Ralf; Hemmer, Bernhard			HLA-DRBI*0401 and HLA-DRBI*0408 are strongly associated with the development of antibodies against interferon-beta therapy in multiple sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							NEUTRALIZING ANTIBODIES; IMMUNOGENICITY; PROTEINS; ALLELES; SUSCEPTIBILITY; HAPLOTYPES; INSULIN; SARS	The formation of antibodies to interferon-beta (IFN-beta), a protein-based disease-modifying agent for multiple sclerosis (MS), is a problem in clinical practice. These antibodies may neutralize the biological effects of the protein drug, potentially decreasing its therapeutic effects. By high-resolution HLA class I and II typing we identified two HLA class II alleles associated with the development of antibodies to IFN-beta. In two independent continuous and binary-trait association studies, HLA-DRB1*0401 and HLA-DRB1*0408 (odds ratio: 5.15)-but not other HLA alleles-were strongly associated with the development of binding and neutralizing antibodies to IFN-beta. The associated HLA-DRB1*04 alleles differ from nonassociated HLA-DRB1*04 alleles by a glycine-to-valine substitution in position 86 of the epitope-binding alpha-helix of the HLA class II molecule. The peptide-binding motif of HLA-DRB1*0401 and *0408 might promote binding and presentation of an immunogenic peptide, which may eventually break T cell tolerance and facilitate antibody development to IFN-beta. In summary, we identified genetic factors determining the immunogenicity of IFN-beta, a protein-based disease-modifying agent for the treatment of MS.	[Hoffmann, Steve; Stadler, Peter E.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany; [Hoffmann, Steve; Stadler, Peter E.] Univ Leipzig, Dept Bioinformat, D-04107 Leipzig, Germany; [Cepok, Sabine; Grummel, Verena; Berthele, Achim; Hemmer, Bernhard] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, D-81675 Munich, Germany; [Hackermueller, Joerg] Fraunhofer Inst Cell Therapy & Immunol, D-04103 Leipzig, Germany; [Stadler, Peter E.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Hartung, Hans-Peter] Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; [Deisenhammer, Florian] Innsbruck Med Univ, Dept Neurol, A-6020 Innsbruck, Austria; [Wasmuth, Ralf] Univ Klinikum Carl Gustav Carus, Med Klin & Poliklin 1, D-01307 Dresden, Germany; [Wasmuth, Ralf] DKMS Life Sci Lab, D-01307 Dresden, Germany	Leipzig University; Leipzig University; Technical University of Munich; Fraunhofer Gesellschaft; The Santa Fe Institute; Heinrich Heine University Dusseldorf; Medical University of Innsbruck; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Hemmer, B (corresponding author), Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany.	hemmer@lrz.tu-muenchen.de	Hackermüller, Jörg/F-2494-2016; Hoffmann, Steve/E-1438-2013; Hemmer, Bernhard/AAT-8388-2021; Stadler, Peter F. F/L-7857-2015; Hemmer, Bernhard/GPX-8451-2022	Hackermüller, Jörg/0000-0003-4920-7072; Stadler, Peter F. F/0000-0002-5016-5191; Hemmer, Bernhard/0000-0001-5985-6784	European Union (NABinMS); Deutsche Forschungsgerneinschaft [He2386/7-1]; BiogenIdec	European Union (NABinMS)(European Commission); Deutsche Forschungsgerneinschaft(German Research Foundation (DFG)); BiogenIdec(Biogen)	This study was supported by the European Union (NABinMS), Deutsche Forschungsgerneinschaft (He2386/7-1), and BiogenIdec.	BEIN G, 1992, TISSUE ANTIGENS, V39, P68, DOI 10.1111/j.1399-0039.1992.tb01909.x; Bertolotto A, 2004, J NEUROL, V251, P15, DOI 10.1007/s00415-004-1204-7; Cinatl J, 2003, LANCET, V362, P293, DOI 10.1016/S0140-6736(03)13973-6; CLELAND JL, 1993, CRIT REV THER DRUG, V10, P307; Congia M, 1998, P NATL ACAD SCI USA, V95, P3833, DOI 10.1073/pnas.95.7.3833; DeLuca GC, 2007, P NATL ACAD SCI USA, V104, P20896, DOI 10.1073/pnas.0707731105; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Fogdell-Hahn A, 2000, TISSUE ANTIGENS, V55, P140, DOI 10.1034/j.1399-0039.2000.550205.x; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hemmer B, 2005, LANCET NEUROL, V4, P403, DOI 10.1016/S1474-4422(05)70117-4; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; KOBAYASHI Y, 1993, HEPATOLOGY, V18, P1319, DOI 10.1002/hep.1840180606; LUDVIGSSON J, 1984, DIABETOLOGIA, V26, P138; Oksenberg JR, 2001, J NEUROIMMUNOL, V113, P171, DOI 10.1016/S0165-5728(00)00444-6; OLERUP O, 1991, TISSUE ANTIGENS, V38, P1, DOI 10.1111/j.1399-0039.1991.tb02029.x; Pachner Andrew, 2003, Mol Diagn, V7, P17, DOI 10.2165/00066982-200307010-00004; Pachner AR, 2003, NEUROLOGY, V61, P1444, DOI 10.1212/01.WNL.0000094198.37489.11; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Reveille JD, 2006, AUTOIMMUN REV, V5, P389, DOI 10.1016/j.autrev.2005.10.012; Sainz B, 2004, VIROLOGY, V329, P11, DOI 10.1016/j.virol.2004.08.011; Sawcer S, 1997, TRENDS GENET, V13, P234, DOI 10.1016/S0168-9525(97)01140-2; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Schellekens H, 2005, NEPHROL DIAL TRANSPL, V20, P3, DOI 10.1093/ndt/gfh1092; Schellekens H, 2004, TRENDS BIOTECHNOL, V22, P406, DOI 10.1016/j.tibtech.2004.06.003; Schellekens H, 2002, NAT REV DRUG DISCOV, V1, P457, DOI 10.1038/nrd818; Sharma B, 2007, BIOTECHNOL ADV, V25, P325, DOI 10.1016/j.biotechadv.2007.01.007; Sorensen PS, 2003, LANCET, V362, P1184, DOI 10.1016/S0140-6736(03)14541-2; Sundberg EJ, 2007, SEMIN IMMUNOL, V19, P262, DOI 10.1016/j.smim.2007.04.006; Tsuji K, 2008, EUR J PHARM BIOPHARM, V68, P496, DOI 10.1016/j.ejpb.2007.07.013; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Zhao Jing Hua, 2006, Hum Genomics, V2, P258	33	89	90	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 8	2008	83	2					219	227		10.1016/j.ajhg.2008.07.006	http://dx.doi.org/10.1016/j.ajhg.2008.07.006			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337EL	18656179	Bronze, Green Published			2022-12-18	WOS:000258418200007
J	Zhu, XF; Li, SC; Cooper, RS; Elston, RC				Zhu, Xiaofeng; Li, Shengchao; Cooper, Richard S.; Elston, Robert C.			A unified association analysis approach for family and unrelated samples correcting for stratification	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; QUANTITATIVE TRAITS; POPULATION STRATIFICATION; TRANSMISSION/DISEQUILIBRIUM TESTS; GENETIC ASSOCIATIONS; SEMIPARAMETRIC TEST; DIABETES-MELLITUS; BLOOD-PRESSURE; LINKAGE; MARKERS	There are two common designs for association mapping of complex diseases: case-control and family-based designs. A case-control sample is more powerful to detect genetic effects than a family-based sample that contains the same numbers of affected and unaffected persons, although additional markers may be required to control for spurious association. When family and unrelated samples are available, statistical analyses are often performed in the family and unrelated samples separately, conditioning on parental information for the former, thus resulting in reduced power. In this report, we propose a unified approach that can incorporate both family and casecontrol samples and, provided the additional markers are available, at the same time corrects for population stratification. We apply the principal components of a marker matrix to adjust for the effect of population stratification. This unified approach makes it unnecessary to perform a conditional analysis of the family data and is more powerful than the separate analyses of unrelated and family samples, or a meta-analysis performed by combining the results of the usual separate analyses. This property is demonstrated in both a variety of simulation models and empirical data. The proposed approach can be equally applied to the analysis of both qualitative and quantitative traits.	[Zhu, Xiaofeng; Elston, Robert C.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Li, Shengchao] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Cooper, Richard S.] Loyola Univ, Stritch Sch Med, Dept Epidemiol & Prevent Med, Maywood, IL 60153 USA	Case Western Reserve University; Cleveland Clinic Foundation; Loyola University Chicago	Zhu, XF (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	xzhu1@darwin.case.edu	Zhu, Xiaofeng/O-6874-2019	Zhu, Xiaofeng/0000-0003-0037-411X	NHGRI NIH HHS [HG003054, R01 HG003054] Funding Source: Medline; NHLBI NIH HHS [R01 HL074166, HL074166] Funding Source: Medline; NIGMS NIH HHS [R37 GM028356, R01 GM028356, GM28356] Funding Source: Medline; PHS HHS [P30CAD43703] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074166] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allison DB, 1997, AM J HUM GENET, V60, P676; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Bouzekri N, 2004, EUR J HUM GENET, V12, P460, DOI 10.1038/sj.ejhg.5201166; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Chen HS, 2003, ANN HUM GENET, V67, P250, DOI 10.1046/j.1469-1809.2003.00036.x; Cooper RS, 2002, HYPERTENSION, V40, P629, DOI 10.1161/01.HYP.0000035708.02789.39; Cox R, 2002, HUM MOL GENET, V11, P2969, DOI 10.1093/hmg/11.23.2969; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELSTON RC, 1992, HUM HERED, V42, P16, DOI 10.1159/000154043; Epstein MP, 2007, AM J HUM GENET, V80, P921, DOI 10.1086/516842; Epstein MP, 2005, AM J HUM GENET, V76, P592, DOI 10.1086/429225; Falush D, 2003, GENETICS, V164, P1567; Fisher RA, 1925, STAT METHODS RES WOR; George V, 1999, AM J HUM GENET, V65, P236, DOI 10.1086/302444; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P193, DOI 10.1002/gepi.1370040304; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.2307/2333639; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hoggart CJ, 2003, AM J HUM GENET, V72, P1492, DOI 10.1086/375613; KNOWLER WC, 1988, AM J HUM GENET, V43, P520; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Nagelkerke NJD, 2004, EUR J HUM GENET, V12, P964, DOI 10.1038/sj.ejhg.5201255; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Satten GA, 2001, AM J HUM GENET, V68, P466, DOI 10.1086/318195; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Xiong MM, 1998, ANN HUM GENET, V62, P431, DOI 10.1046/j.1469-1809.1998.6250431.x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang SL, 2003, GENET EPIDEMIOL, V24, P44, DOI 10.1002/gepi.10196; Zhao HY, 2000, AM J HUM GENET, V67, P936, DOI 10.1086/303073; Zhu XF, 2000, AM J HUM GENET, V67, P1144; Zhu XF, 2002, DIABETES, V51, P541, DOI 10.2337/diabetes.51.2.541; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104; Zhu XF, 2001, HUM HERED, V51, P183, DOI 10.1159/000053341; Zhu XF, 2001, GENET EPIDEMIOL, V20, P57, DOI 10.1002/1098-2272(200101)20:1<57::AID-GEPI6>3.0.CO;2-5; Zhu XF, 2006, HUM GENET, V120, P431, DOI 10.1007/s00439-006-0224-z	48	89	91	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2008	82	2					352	365		10.1016/j.ajhg.2007.10.009	http://dx.doi.org/10.1016/j.ajhg.2007.10.009			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	263NN	18252216	Bronze, Green Published			2022-12-18	WOS:000253223900008
J	Milet, J; Dehais, V; Bourgain, C; Jouanolle, AM; Mosser, A; Perrin, M; Morcet, J; Brissot, P; David, V; Deugnier, Y; Mosser, J				Milet, Jacqueline; Dehais, Valrie; Bourgain, Catherine; Jouanolle, Anne Marie; Mosser, Annick; Perrin, Michele; Morcet, Jeff; Brissot, Pierre; David, Veronique; Deugnier, Yves; Mosser, Jean			Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHENOTYPIC-EXPRESSION; HEREDITARY HEMOCHROMATOSIS; LINKAGE-DISEQUILIBRIUM; C282Y MUTATION; GENOTYPE DATA; POPULATION; ASSOCIATION; FRENCH; POLYMORPHISMS; HAPLOTYPES	Most cases of genetic hemochromatosis (GH) are associated with the HFE C282Y/C282Y (p. Cys282Tyr/p. Cys282Tyr) genotype in white populations. The symptoms expressed by C282Y homozygotes are extremely variable. Only a few suffer from an overt disease. Several studies have suggested that, in addition to environmental factors, a genetic component could explain a substantial part of this phenotypic variation, although very few genetic factors have been identified so far. In the present study, we tested the association between common variants in candidate genes and hemochromatosis penetrance, in a large sample of C282Y homozygotes, using pretherapeutic serum ferritin level as marker of hemochromatosis penetrance. We focused on two biologically relevant gene categories: genes involved in non-HFE GH (TFR2, HAMP, and SLC40A1) and genes involved in the regulation of hepcidin expression, including genes from the bone morphogenetic protein (BMP) regulatory pathway (BMP2, BMP4, HJV, SMAD1, SMAD4, and SMAD5) and the IL6 gene from the inflammation- mediated regulation pathway. A significant association was detected between serum ferritin level and rs235756, a common single- nucleotide polymorphism (SNP) in the BMP2 genic region (P = 4.42 x 10(-5)). Mean ferritin level, adjusted for age and sex, is 655 ng/ml among TT genotypes, 516 ng/ml in TC genotypes, and 349 ng/ml in CC genotypes. Our results further suggest an interactive effect on serum ferritin level of rs235756 in BMP2 and a SNP in HJV, with a small additive effect of a SNP in BMP4. This first reported association between common variants in the BMP pathway and iron burden suggests that full expression of HFE hemochromatosis is linked to abnormal liver expression of hepcidin, not only through impairment in the HFE function but also through functional modulation in the BMP pathway. Our results also highlight the BMP regulation pathway as a good candidate for identification of new modifier genes.	Univ Rennes 1, IFR GFAS 140, Fac Med, CNRS UMR Genet & Dev 6061, F-35043 Rennes, France; INSERM, U535, Villejuif, France; Univ Paris Sud, IFR69, UMR S535, Villejuif, France; Ctr Clin Invest CIC INSERM 0203, Rennes, France; Serv Malad Foie, Rennes, France; CHU, Pontchaillou Hosp, Med Genom Unit, Rennes, France	Universite de Rennes 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Rennes	Mosser, J (corresponding author), Univ Rennes 1, IFR GFAS 140, Fac Med, CNRS UMR Genet & Dev 6061, 2 Ave Pr Leon Bernard,CS 34317, F-35043 Rennes, France.	jean.mosser@univ-rennes1.fr	Girelli, Domenico/B-1183-2008; Bourgain, Catherine/L-1505-2017	Girelli, Domenico/0000-0001-9684-1899; MILET, Jacqueline/0000-0003-2710-1517; Bourgain, Catherine/0000-0002-6761-0140				Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bensaid M, 2004, GASTROENTEROLOGY, V126, P1400, DOI 10.1053/j.gastro.2004.01.021; Beutler E, 2004, BLOOD CELL MOL DIS, V33, P344, DOI 10.1016/j.bcmd.2004.06.006; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Brissot P, 1999, J HEPATOL, V30, P588, DOI 10.1016/S0168-8278(99)80188-3; BRISSOT P, 2006, CURRENT APPROACHES M, P36; Bulaj ZJ, 2000, NEW ENGL J MED, V343, P1529, DOI 10.1056/NEJM200011233432104; Burt MJ, 1998, GUT, V43, P830, DOI 10.1136/gut.43.6.830; Clayton D, 2004, GENET EPIDEMIOL, V27, P415, DOI 10.1002/gepi.20032; Coppin H, 2003, BRIT MED J, V327, P132, DOI 10.1136/bmj.327.7407.132; CUSTER EM, 1995, J LAB CLIN MED, V126, P88; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Deugnier Y, 2002, BRIT J HAEMATOL, V118, P1170, DOI 10.1046/j.1365-2141.2002.03718.x; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Jacolot S, 2004, BLOOD, V103, P2835, DOI 10.1182/blood-2003-10-3366; Jouanolle AM, 1998, ANN GENET-PARIS, V41, P195; Le Gac G, 2004, HUM MOL GENET, V13, P1913, DOI 10.1093/hmg/ddh206; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Livesey KJ, 2004, J MED GENET, V41, P6, DOI 10.1136/jmg.2003.008805; Loreal O, 2005, CURR PROTEIN PEPT SC, V6, P279, DOI 10.2174/1389203054065392; Merryweather-Clarke AT, 2003, HUM MOL GENET, V12, P2241, DOI 10.1093/hmg/ddg225; Merryweather-Clarke AT, 1999, HUM MUTAT, V13, P154, DOI 10.1002/(SICI)1098-1004(1999)13:2<154::AID-HUMU8>3.0.CO;2-E; Moirand R, 1999, GASTROENTEROLOGY, V116, P372, DOI 10.1016/S0016-5085(99)70134-4; Morris AP, 2004, AM J HUM GENET, V74, P945, DOI 10.1086/420773; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Olynyk JK, 1999, NEW ENGL J MED, V341, P718, DOI 10.1056/NEJM199909023411002; Pietrangelo A, 2005, SEMIN LIVER DIS, V25, P450, DOI 10.1055/s-2005-923316; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Team RDC, 2005, R LANG ENV STAT COMP; Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103; Whitfield JB, 2000, AM J HUM GENET, V66, P1246, DOI 10.1086/302862; Whiting PW, 2002, J HEPATOL, V37, P309, DOI 10.1016/S0168-8278(02)00216-7; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631	36	89	95	1	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2007	81	4					799	807		10.1086/520001	http://dx.doi.org/10.1086/520001			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	208GK	17847004	Green Published, Bronze			2022-12-18	WOS:000249307600020
J	Gurley, KA; Reimer, RJ; Kingsley, DM				Gurley, Kyle A.; Reimer, Richard J.; Kingsley, David M.			Biochemical and genetic analysis of ANK in arthritis and bone disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DIHYDRATE CRYSTAL DEPOSITION; NUCLEOSIDE TRIPHOSPHATE PYROPHOSPHATASE; PROGRESSIVE ANKYLOSIS GENE; INORGANIC PYROPHOSPHATE; CRANIOMETAPHYSEAL DYSPLASIA; PATHOLOGICAL CALCIFICATION; EXTRACELLULAR PPI; PROTEIN; TRANSPORT; CARTILAGE	Mutations in the progressive ankylosis gene (Ank/ANKH) cause surprisingly different skeletal phenotypes in mice and humans. In mice, recessive loss-of-function mutations cause arthritis, ectopic crystal formation, and joint fusion throughout the body. In humans, some dominant mutations cause chondrocalcinosis, an adult-onset disease characterized by the deposition of ectopic joint crystals. Other dominant mutations cause craniometaphyseal dysplasia, a childhood disease characterized by sclerosis of the skull and abnormal modeling of the long bones, with little or no joint pathology. Ank encodes a multiple-pass transmembrane protein that regulates pyrophosphate levels inside and outside tissue culture cells in vitro, but its mechanism of action is not yet clear, and conflicting models have been proposed to explain the effects of the human mutations. Here, we test wild-type and mutant forms of ANK for radiolabeled pyrophosphate-transport activity in frog oocytes. We also reconstruct two human mutations in a bacterial artificial chromosome and test them in transgenic mice for rescue of the Ank null phenotype and for induction of new skeletal phenotypes. Wildtype ANK stimulates saturable transport of pyrophosphate ions across the plasma membrane, with half maximal rates attained at physiological levels of pyrophosphate. Chondrocalcinosis mutations retain apparently wild-type transport activity and can rescue the joint-fusion phenotype of Ank null mice. Craniometaphyseal dysplasia mutations do not transport pyrophosphate and cannot rescue the defects of Ank null mice. Furthermore, microcomputed tomography revealed previously unappreciated phenotypes in Ank null mice that are reminiscent of craniometaphyseal dysplasia. The combination of biochemical and genetic analyses presented here provides insight into how mutations in ANKH cause human skeletal disease.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Kingsley, DM (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol, 279 Campus Dr, Stanford, CA 94305 USA.	kingsley@cmgm.stanford.edu			NIAMS NIH HHS [AR42236, R37 AR042236, R01 AR042236] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR042236, R01AR042236] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bedell MA, 1997, GENE DEV, V11, P11, DOI 10.1101/gad.11.1.11; BEIGHTON P, 1995, J MED GENET, V32, P370, DOI 10.1136/jmg.32.5.370; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Cass CE, 1998, BIOCHEM CELL BIOL, V76, P761, DOI 10.1139/bcb-76-5-761; CASWELL AM, 1991, CRIT REV CL LAB SCI, V28, P175, DOI 10.3109/10408369109106862; Chaudhry FA, 1999, CELL, V99, P769, DOI 10.1016/S0092-8674(00)81674-8; Corbel S, 1996, FEBS LETT, V391, P279, DOI 10.1016/0014-5793(96)00741-7; Costello JC, 2004, CURR OPIN RHEUMATOL, V16, P268, DOI 10.1097/00002281-200405000-00017; DERFUS BA, 1992, ARTHRITIS RHEUM, V35, P231, DOI 10.1002/art.1780350218; Derfus BA, 2002, J RHEUMATOL, V29, P570; Doherty M, 1996, ANN RHEUM DIS, V55, P432, DOI 10.1136/ard.55.7.432; DOHERTY M, 1991, BRIT J RHEUMATOL, V30, P10; FLEISCH H, 1962, NATURE, V195, P911, DOI 10.1038/195911a0; FLEISCH H, 1962, AM J PHYSIOL, V203, P671, DOI 10.1152/ajplegacy.1962.203.4.671; FLEISH H, 1961, AM J PHYSIOL, V200, P1296, DOI 10.1152/ajplegacy.1961.200.6.1296; GORLIN RJ, 1969, BIRTH DEFECTS OAS, V4, P79; Gurley KA, 2006, J BONE MINER RES, V21, P1238, DOI 10.1359/JBMR.060515; HAKIM FT, 1984, ARTHRITIS RHEUM, V27, P1411, DOI 10.1002/art.1780271212; HAMILTON E, 1991, BRIT J RHEUMATOL, V30, P260; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hirose J, 2002, ARTHRITIS RHEUM-US, V46, P3218, DOI 10.1002/art.10632; Ho AM, 2000, SCIENCE, V289, P265, DOI 10.1126/science.289.5477.265; Hosoda Y, 1981, Ryumachi, V21 Suppl, P157; Johnson K, 2005, FRONT BIOSCI-LANDMRK, V10, P988, DOI 10.2741/1593; Johnson K, 2004, OSTEOARTHR CARTILAGE, V12, P321, DOI 10.1016/j.joca.2003.12.004; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Jonker JW, 2004, J PHARMACOL EXP THER, V308, P2, DOI 10.1124/jpet.103.053298; Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lejeune E, 1966, Rev Rhum Mal Osteoartic, V33, P714; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Malkin I, 2005, BONE, V36, P365, DOI 10.1016/j.bone.2004.09.002; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MANDEL GS, 1990, SCANNING MICROSCOPY, V4, P175; MANDEL NS, 1984, ARTHRITIS RHEUM, V27, P789, DOI 10.1002/art.1780270710; MANDEL NS, 1984, SCANNING ELECTRON MI, V4, P1779; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Murshed M, 2005, GENE DEV, V19, P1093, DOI 10.1101/gad.1276205; Narisawa S, 1997, DEV DYNAM, V208, P432, DOI 10.1002/(SICI)1097-0177(199703)208:3<432::AID-AJA13>3.0.CO;2-1; Neuhoff S, 2005, EUR J PHARM SCI, V25, P211, DOI 10.1016/j.ejps.2005.02.009; Nurnberg P, 2001, NAT GENET, V28, P37, DOI 10.1038/88236; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; PATTRICK M, 1991, ANN RHEUM DIS, V50, P214, DOI 10.1136/ard.50.4.214; Pendleton A, 2002, AM J HUM GENET, V71, P933, DOI 10.1086/343054; PISONI RL, 1987, J BIOL CHEM, V262, P15011; PISONI RL, 1987, J BIOL CHEM, V262, P6010; Reichenberger E, 2001, AM J HUM GENET, V68, P1321, DOI 10.1086/320612; RIMOIN DL, 1969, BIRTH DEFECTS, V4, P96; RYAN LM, 1992, ARTHRITIS RHEUM, V35, P1520, DOI 10.1002/art.1780351216; RYAN LM, 1979, ARTHRITIS RHEUM, V22, P886, DOI 10.1002/art.1780220812; SAMPSON HW, 1988, AM J ANAT, V182, P257, DOI 10.1002/aja.1001820307; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI200317202; Speer MY, 2002, J EXP MED, V196, P1047, DOI 10.1084/jem.20020911; Steitz SA, 2002, AM J PATHOL, V161, P2035, DOI 10.1016/S0002-9440(10)64482-3; STOOL SE, 1973, ARCH OTOLARYNGOL, V97, P410; SWEET HO, 1981, J HERED, V72, P87, DOI 10.1093/oxfordjournals.jhered.a109459; TAYLOR D B, 1989, Australasian Radiology, V33, P84, DOI 10.1111/j.1440-1673.1989.tb03242.x; Timms AE, 2003, ARTHRITIS RHEUM, V48, P2898, DOI 10.1002/art.11258; Tsui FWL, 2003, ARTHRITIS RHEUM-US, V48, P791, DOI 10.1002/art.10844; Tsui HW, 2005, ARTHRITIS RES THER, V7, pR513, DOI 10.1186/ar1701; Wang W, 2005, MOL CELL BIOL, V25, P312, DOI 10.1128/MCB.25.1.312-323.2005; WAYMIRE KG, 1995, NAT GENET, V11, P45, DOI 10.1038/ng0995-45; Williams CJ, 2003, ARTHRITIS RHEUM, V48, P2627, DOI 10.1002/art.11133; Williams CJ, 2003, CURR OPIN RHEUMATOL, V15, P326, DOI 10.1097/00002281-200305000-00023; Williams CJ, 2002, AM J HUM GENET, V71, P985, DOI 10.1086/343053; Zhang XX, 2005, AM J HUM GENET, V76, P312, DOI 10.1086/427762; Zhang Y, 2005, ARTHRITIS RHEUM-US, V52, P1110, DOI 10.1002/art.20978	70	89	93	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2006	79	6					1017	1029		10.1086/509881	http://dx.doi.org/10.1086/509881			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	106WB	17186460	Green Published, Bronze			2022-12-18	WOS:000242131600003
J	Lee-Kirsch, MA; Gong, ML; Schulz, H; Ruschendorf, F; Stein, A; Pfeiffer, C; Ballarini, A; Gahr, M; Hubner, N; Linne, M				Lee-Kirsch, Min Ae; Gong, Maolian; Schulz, Herbert; Rueschendorf, Franz; Stein, Annette; Pfeiffer, Christiane; Ballarini, Annalisa; Gahr, Manfred; Hubner, Norbert; Linne, Maja			Familial chilblain lupus, a monogenic form of cutaneous lupus erythematosus, maps to chromosome 3p	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AICARDI-GOUTIERES-SYNDROME; BASAL GANGLIA; T-CELLS; DEFICIENCY; GENE; ENCEPHALOPATHY; CALCIFICATIONS; COMPLEMENT; ANTIBODIES; RECEPTORS	Systemic lupus erythematosus is a prototypic autoimmune disease. Apart from rare monogenic deficiencies of complement factors, where lupuslike disease may occur in association with other autoimmune diseases or high susceptibility to bacterial infections, its etiology is multifactorial in nature. Cutaneous findings are a hallmark of the disease and manifest either alone or in association with internal-organ disease. We describe a novel genodermatosis characterized by painful bluish-red inflammatory papular or nodular lesions in acral locations such as fingers, toes, nose, cheeks, and ears. The lesions sometimes appear plaquelike and tend to ulcerate. Manifestation usually begins in early childhood and is precipitated by cold and wet exposure. Apart from arthralgias, there is no evidence for internal-organ disease or an increased susceptibility to infection. Histological findings include a deep inflammatory infiltrate with perivascular distribution and granular deposits of immunoglobulins and complement along the basement membrane. Some affected individuals show antinuclear antibodies or immune complex formation, whereas cryoglobulins or cold agglutinins are absent. Thus, the findings are consistent with chilblain lupus, a rare form of cutaneous lupus erythematosus. Investigation of a large German kindred with 18 affected members suggests a highly penetrant trait with autosomal dominant inheritance. By single-nucleotide-polymorphism-based genomewide linkage analysis, the locus was mapped to chromosome 3p. Haplotype analysis defined the locus to a 13.8-cM interval with a LOD score of 5.04. This is the first description of a monogenic form of cutaneous lupus erythematosus. Identification of the gene responsible for familial chilblain lupus may shed light on the pathogenesis of common forms of connective-tissue disease such as systemic lupus erythematosus.	Tech Univ Dresden, Klin Kinder & Jugendmedizin, D-01307 Dresden, Germany; Tech Univ Dresden, Dermatol Klin, D-01307 Dresden, Germany; Tech Univ Dresden, Inst Klin Genet, D-01307 Dresden, Germany; Max Delbruck Ctr Mol Med, Berlin, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Lee-Kirsch, MA (corresponding author), Tech Univ Dresden, Klin Kinder & Jugendmedizin, Fetscherstasse 74, D-01307 Dresden, Germany.	minae.lee-kirsch@uniklinikum-dresden.de	Lee-Kirsch, Min Ae/C-5769-2018					Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Aicardi J, 2000, NEUROPEDIATRICS, V31, P113, DOI 10.1055/s-2000-7533; Alarcon-Riquelme ME, 2005, J AUTOIMMUN, V25, P46, DOI 10.1016/j.jaut.2005.09.012; Ali M, 2006, J MED GENET, V43, P444, DOI 10.1136/jmg.2005.031880; ALPER CA, 1973, NEW ENGL J MED, V288, P601, DOI 10.1056/NEJM197303222881204; Amoura Z, 2003, ARTHRITIS RHEUM-US, V48, P3487, DOI 10.1002/art.11350; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; Crow YJ, 2003, J MED GENET, V40, P183, DOI 10.1136/jmg.40.3.183; Dale RC, 2000, NEUROPEDIATRICS, V31, P155, DOI 10.1055/s-2000-7492; De Laet C, 2005, NEUROPEDIATRICS, V36, P399, DOI 10.1055/s-2005-873058; Dragon-Durey MA, 2001, J IMMUNOL, V166, P7612, DOI 10.4049/jimmunol.166.12.7612; Eriksson C, 2003, LUPUS, V12, P766, DOI 10.1191/0961203303lu467oa; Franceschini F, 1999, LUPUS, V8, P215, DOI 10.1191/096120399678847632; Goutieres F, 1998, ANN NEUROL, V44, P900, DOI 10.1002/ana.410440608; Graham DSC, 2004, CLIN EXP IMMUNOL, V137, P1, DOI 10.1111/j.1365-2249.2004.02525.x; HANNEMA AJ, 1984, CLIN EXP IMMUNOL, V55, P106; Hutchinson J, 1888, Br Med J, V1, P113; Kurasawa K, 2000, ARTHRITIS RHEUM-US, V43, P2455, DOI 10.1002/1529-0131(200011)43:11<2455::AID-ANR12>3.0.CO;2-K; LEE SL, 1978, ARTHRITIS RHEUM, V21, P958, DOI 10.1002/art.1780210813; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; MILLARD LG, 1978, BRIT J DERMATOL, V98, P497, DOI 10.1111/j.1365-2133.1978.tb01935.x; MILLS JA, 1994, NEW ENGL J MED, V330, P1871, DOI 10.1056/NEJM199406303302608; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Ng MW, 2005, RHEUMATOLOGY, V44, P1456, DOI 10.1093/rheumatology/kei120; PROVOST TT, 1983, ARTHRITIS RHEUM, V26, P1279, DOI 10.1002/art.1780261017; Rasmussen M, 2005, NEUROPEDIATRICS, V36, P40, DOI 10.1055/s-2004-830532; SNYDERMAN R, 1979, AM J MED, V67, P638, DOI 10.1016/0002-9343(79)90247-X; Sontheimer RD, 1997, LUPUS, V6, P84, DOI 10.1177/096120339700600203; TOLMIE JL, 1995, J MED GENET, V32, P881, DOI 10.1136/jmg.32.11.881; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Walport MJ, 2000, NAT GENET, V25, P135, DOI 10.1038/75963; Weston WL, 2000, PEDIATR DERMATOL, V17, P97, DOI 10.1046/j.1525-1470.2000.01722.x; Wilber A, 2003, CLIN EXP IMMUNOL, V134, P46, DOI 10.1046/j.1365-2249.2003.02267.x	35	89	90	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2006	79	4					731	737		10.1086/507848	http://dx.doi.org/10.1086/507848			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	089BV	16960810	Green Published, Bronze			2022-12-18	WOS:000240855900015
J	Perng, MD; Su, M; Wen, SF; Li, R; Gibbon, T; Prescott, AR; Brenner, M; Quinlan, RA				Perng, Ming Der; Su, Mu; Wen, Shu Fang; Li, Rong; Gibbon, Terry; Prescott, Alan R.; Brenner, Michael; Quinlan, Roy A.			The Alexander disease-causing glial fibrillary acidic protein mutant, R416W, accumulates into Rosenthal fibers by a pathway that involves filament aggregation and the association of alpha B-crystallin and HSP27	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEAT-SHOCK-PROTEIN; KERATIN INTERMEDIATE-FILAMENTS; GENOTYPE-PHENOTYPE CORRELATION; NONHELICAL TAIL DOMAIN; CENTRAL-NERVOUS-SYSTEM; MECHANICAL-PROPERTIES; IN-VITRO; VIMENTIN; MUTATIONS; GFAP	Here, we describe the early events in the disease pathogenesis of Alexander disease. This is a rare and usually fatal neurodegenerative disorder whose pathological hallmark is the abundance of protein aggregates in astrocytes. These aggregates, termed "Rosenthal fibers," contain the protein chaperones alpha B-crystallin and HSP27 as well as glial fibrillary acidic protein (GFAP), an intermediate filament (IF) protein found almost exclusively in astrocytes. Heterozygous, missense GFAP mutations that usually arise spontaneously during spermatogenesis have recently been found in the majority of patients with Alexander disease. In this study, we show that one of the more frequently observed mutations, R416W, significantly perturbs in vitro filament assembly. The filamentous structures formed resemble assembly intermediates but aggregate more strongly. Consistent with the heterozygosity of the mutation, this effect is dominant over wild-type GFAP in coassembly experiments. Transient transfection studies demonstrate that R416W GFAP induces the formation of GFAP containing cytoplasmic aggregates in a wide range of different cell types, including astrocytes. The aggregates have several important features in common with Rosenthal fibers, including the association of alpha B-crystallin and HSP27. This association occurs simultaneously with the formation of protein aggregates containing R416W GFAP and is also specific, since HSP70 does not partition with them. Monoclonal antibodies specific for R416W GFAP reveal, for the first time for any IF-based disease, the presence of the mutant protein in the characteristic histopathological feature of the disease, namely Rosenthal fibers. Collectively, these data confirm that the effects of the R416W GFAP are dominant, changing the assembly process in a way that encourages aberrant filament-filament interactions that then lead to protein aggregation and chaperone sequestration as early events in Alexander disease.	Univ Durham, Sch Biol & Biomed Sci, Durham, England; Univ Alabama, Dept Neurobiol, Birmingham, AL USA; Univ Alabama, Civitan Int Res Ctr, Birmingham, AL USA; Univ Dundee, Sch Life Sci, Ctr High Resolut Imaging & Proc Cell & Mol Biol, Dundee, Scotland	Durham University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Dundee	Quinlan, RA (corresponding author), Dept Biol Sci, S Rd, Durham DH1 3LE, England.	r.a.quinlan@durham.ac.uk	Quinlan, Roy/A-1348-2012; Prescott, Alan/Y-5956-2018	Quinlan, Roy/0000-0003-0644-4123; Prescott, Alan/0000-0002-0747-7317	NINDS NIH HHS [P01NS42803, P01 NS042803, P01 NS042803-010004] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042803] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER WS, 1949, BRAIN, V72, P373, DOI 10.1093/brain/72.3.373; Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102; Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Bernot KM, 2005, J CELL BIOL, V168, P965, DOI 10.1083/jcb.200408116; Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; BRENNER M, 1990, MOL BRAIN RES, V7, P277, DOI 10.1016/0169-328X(90)90078-R; CHEN WJ, 1994, J CELL SCI, V107, P2299; CHEN WJ, 1994, J CELL BIOL, V127, P813, DOI 10.1083/jcb.127.3.813; Deprez M, 1999, ACTA NEUROL SCAND, V99, P158, DOI 10.1111/j.1600-0404.1999.tb07338.x; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Gu LH, 2005, MOL BIOL CELL, V16, P1427, DOI 10.1091/mbc.E04-06-0498; HAZAN R, 1986, LAB INVEST, V54, P543; HEAD MW, 1993, AM J PATHOL, V143, P1743; HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5; Herrmann H, 2003, INT REV CYTOL, V223, P83; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; IWAKI A, 1992, NEUROSCI LETT, V140, P89, DOI 10.1016/0304-3940(92)90689-5; IWAKI T, 1993, AM J PATHOL, V143, P487; IWAKI T, 1992, AM J PATHOL, V140, P345; JOHNSON AB, 1989, AM J ANAT, V185, P335, DOI 10.1002/aja.1001850228; Kamradt MC, 2002, J BIOL CHEM, V277, P38731, DOI 10.1074/jbc.M201770200; KOUKLIS PD, 1991, J CELL BIOL, V114, P773, DOI 10.1083/jcb.114.4.773; Koyama Y, 1999, AM J PATHOL, V154, P1563, DOI 10.1016/S0002-9440(10)65409-0; Ku NO, 2005, GASTROENTEROLOGY, V129, P885, DOI 10.1053/j.gastro.2005.06.065; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANE EB, 1992, NATURE, V356, P244, DOI 10.1038/356244a0; Li R, 2006, HUM GENET, V119, P137, DOI 10.1007/s00439-005-0116-7; Li R, 2005, ANN NEUROL, V57, P310, DOI 10.1002/ana.20406; Mairesse N, 1996, CELL BIOL INT, V20, P205, DOI 10.1006/cbir.1996.0025; MANN E, 1991, FEBS LETT, V294, P133, DOI 10.1016/0014-5793(91)81359-G; MCCORMICK MB, 1993, J CELL BIOL, V122, P395, DOI 10.1083/jcb.122.2.395; McLean WHI, 2005, J INVEST DERM SYMP P, V10, P31, DOI 10.1111/j.1087-0024.2005.10205.x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; NEAL JW, 1992, ACTA NEUROPATHOL, V84, P322; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Perng MD, 1999, J CELL SCI, V112, P2099; POLLARD TD, 1982, METHOD ENZYMOL, V85, P211; RALTON JE, 1994, J CELL SCI, V107, P1935; Reichard EAP, 1996, PEDIATR PATHOL LAB M, V16, P327, DOI 10.1080/107710496175804; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rodriguez D, 2001, AM J HUM GENET, V69, P1134, DOI 10.1086/323799; RUSSO LS, 1976, NEUROLOGY, V26, P607, DOI 10.1212/WNL.26.7.607; SANDILANDS A, 1995, J CELL SCI, V108, P1397; Schweitzer SC, 2001, J CELL SCI, V114, P1079; Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246; TOMOKANE N, 1991, AM J PATHOL, V138, P875; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539; Wyttenbach A, 2002, HUM MOL GENET, V11, P1137, DOI 10.1093/hmg/11.9.1137; Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1; Yamada S, 2002, MOL BIOL CELL, V13, P382, DOI 10.1091/mbc.01-10-0522; Zourlidou A, 2004, J NEUROCHEM, V88, P1439, DOI 10.1046/j.1471-4159.2003.02273.x	64	89	91	0	3	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2006	79	2					197	213		10.1086/504411	http://dx.doi.org/10.1086/504411			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	063SR	16826512	Bronze, Green Accepted, Green Published			2022-12-18	WOS:000239040400003
J	Cassidy, AJ; van Steensel, MAM; Steijlen, PM; van Geel, M; van der Velden, J; Morley, SM; Terrinoni, A; Melino, G; Candi, E; McLean, WHI				Cassidy, AJ; van Steensel, MAM; Steijlen, PM; van Geel, M; van der Velden, J; Morley, SM; Terrinoni, A; Melino, G; Candi, E; McLean, WHI			A homozygous missense mutation in TGM5 abolishes epidermal transglutaminase 5 activity and causes acral peeling skin syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RECESSIVE LAMELLAR ICHTHYOSIS; EPIDERMOLYSIS-BULLOSA; HEMOLYTIC-ANEMIA; BARRIER FUNCTION; GENE; IDENTIFICATION; ENVELOPE; CDNA; MAPS	Peeling skin syndrome is an autosomal recessive genodermatosis characterized by the shedding of the outer epidermis. In the acral form, the dorsa of the hands and feet are predominantly affected. Ultrastructural analysis has revealed tissue separation at the junction between the granular cells and the stratum corneum in the outer epidermis. Genomewide linkage analysis in a consanguineous Dutch kindred mapped the gene to 15q15.2 in the interval between markers D15S1040 and D15S1016. Two homozygous missense mutations, T109M and G113C, were found in TGM5, which encodes transglutaminase 5 (TG5), in all affected persons in two unrelated families. The mutation was present on the same haplotype in both kindreds, indicating a probable ancestral mutation. TG5 is strongly expressed in the epidermal granular cells, where it cross-links a variety of structural proteins in the terminal differentiation of the epidermis to form the cornified cell envelope. An established, in vitro, biochemical cross-linking assay revealed that, although T109M is not pathogenic, G113C completely abolishes TG5 activity. Three-dimensional modeling of TG5 showed that G113C lies close to the catalytic domain, and, furthermore, that this glycine residue is conserved in all known transglutaminases, which is consistent with pathogenicity. Other families with more-widespread peeling skin phenotypes lacked TGM5 mutations. This study identifies the first causative gene in this heterogeneous group of skin disorders and demonstrates that the protein cross-linking function performed by TG5 is vital for maintaining cell-cell adhesion between the outermost layers of the epidermis.	Univ Dundee, Human Genet Unit, Epithelial Genet Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; Univ Dundee, Tayside Hosp, Dept Dermatol, Dundee, Scotland; Univ Hosp Maastricht, Dept Dermatol, Maastricht, Netherlands; IRCCS, IDI, Biochem Lab, Rome, Italy	University of Dundee; University of Dundee; University of Dundee; Maastricht University; Maastricht University Medical Centre (MUMC); IRCCS Istituto Dermopatico dell'Immacolata (IDI)	McLean, WHI (corresponding author), Univ Dundee, Human Genet Unit, Epithelial Genet Grp, Dundee DD1 9SY, Scotland.	w.h.i.mclean@dundee.ac.uk	van Steensel, Maurice A.M./V-3852-2019; McLean, William HI/C-6352-2009; TERRINONI, Alessandro/J-1533-2012; Steijlen, Peter/X-2729-2019	TERRINONI, Alessandro/0000-0002-7442-2252; McLean, William Henry Irwin/0000-0001-5539-5757; Cassidy, Andrew/0000-0003-4309-6981; van Steensel, Maurice/0000-0002-7507-2442	Telethon [GGP02251] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Telethon(Fondazione Telethon); Wellcome Trust(Wellcome TrustEuropean Commission)		ABDELHAFEZ K, 1983, DERMATOLOGICA, V166, P23, DOI 10.1159/000249827; BOUHASSIRA EE, 1992, BLOOD, V79, P1846; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Candi E, 2002, J INVEST DERMATOL, V119, P670, DOI 10.1046/j.1523-1747.2002.01853.x; Candi E, 2001, J BIOL CHEM, V276, P35014, DOI 10.1074/jbc.M010157200; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; Grenard P, 2001, J BIOL CHEM, V276, P33066, DOI 10.1074/jbc.M102553200; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; Hashimoto K, 2000, J AM ACAD DERMATOL, V43, P1112, DOI 10.1067/mjd.2000.103645; Horn HM, 1997, BRIT J DERMATOL, V136, P560, DOI 10.1111/j.1365-2133.1997.tb02141.x; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; JUDGE MR, 2004, ROOKS TXB DERMATOLOG, V2, P56; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; KURBAN AK, 1969, BRIT J DERMATOL, V81, P191, DOI 10.1111/j.1365-2133.1969.tb16005.x; Laiho E, 1997, AM J HUM GENET, V61, P529, DOI 10.1086/515498; Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643; LEVY SB, 1982, J AM ACAD DERMATOL, V7, P606, DOI 10.1016/S0190-9622(82)70140-9; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; MEVORAH B, 1987, BRIT J DERMATOL, V116, P117, DOI 10.1111/j.1365-2133.1987.tb05799.x; PARMENTIER L, 1995, HUM MOL GENET, V4, P1391, DOI 10.1093/hmg/4.8.1391; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; RYBICKI AC, 1988, J CLIN INVEST, V81, P893, DOI 10.1172/JCI113400; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shwayder T, 1997, ARCH DERMATOL, V133, P535, DOI 10.1001/archderm.133.4.535; SILVERMAN AK, 1986, ARCH DERMATOL, V122, P71, DOI 10.1001/archderm.122.1.71; Traupe H., 1989, ICHTHYOSES GUIDE CLI; Uitto J, 2004, AM J MED GENET C, V131C, P61, DOI 10.1002/ajmg.c.30035; van Steensel M, 1999, AM J HUM GENET, V65, P413, DOI 10.1086/302506	28	89	91	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2005	77	6					909	917		10.1086/497707	http://dx.doi.org/10.1086/497707			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	983OE	16380904	Green Published, Bronze			2022-12-18	WOS:000233241200002
J	Lemmers, RJFL; Wohlgemuth, M; Frants, RR; Padberg, GW; Morava, E; van der Maarel, SM				Lemmers, RJFL; Wohlgemuth, M; Frants, RR; Padberg, GW; Morava, E; van der Maarel, SM			Contractions of D4Z4 on 4qB subtelomeres do not cause facioscapulohumeral muscular dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WAARDENBURG-SYNDROME; MENTAL-RETARDATION; PHENOTYPIC VARIATION; DNA REARRANGEMENTS; FSHD; GENE; EXPRESSION; D4F104S1; ONSET; SIZE	Facioscapulohumeral muscular dystrophy ( FSHD) is associated with contractions of the D4Z4 repeat in the subtelomere of chromosome 4q. Two allelic variants of chromosome 4q (4qA and 4qB) exist in the region distal to D4Z4. Although both variants are almost equally frequent in the population, FSHD is associated exclusively with the 4qA allele. We identified three families with FSHD in which each proband carries two FSHD-sized alleles and is heterozygous for the 4qA/4qB polymorphism. Segregation analysis demonstrated that FSHD-sized 4qB alleles are not associated with disease, since these were present in unaffected family members. Thus, in addition to a contraction of D4Z4, additional cis-acting elements on 4qA may be required for the development of FSHD. Alternatively, 4qB subtelomeres may contain elements that prevent FSHD pathogenesis.	Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Human Genet, NL-2333 AL Leiden, Netherlands; Univ Med Ctr Nijmegen, Dept Neurol, Nijmegen, Netherlands; Univ Med Ctr Nijmegen, Dept Pediat, Nijmegen, Netherlands; Univ Pecs, Dept Med Genet, Pecs, Hungary	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen; University of Pecs	van der Maarel, SM (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Dept Human Genet, Wassenaarseweg 72, NL-2333 AL Leiden, Netherlands.	maarel@lumc.nl	van der Maarel, Silvere/X-3631-2018; Padberg, G.W.A.M./H-8079-2014; Morava, E./L-4529-2015	van der Maarel, Silvere/0000-0001-8103-711X; 				ARAHATA K, 1995, MUSCLE NERVE, pS56; Auer-Grumbach M, 2000, MUSCLE NERVE, V23, P1243, DOI 10.1002/1097-4598(200008)23:8<1243::AID-MUS13>3.0.CO;2-Z; BAKKER E, 1995, MUSCLE NERVE, pS39; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; COPPEE F, 2004, FACIOSCAPULOHUMERAL; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; DeStefano AL, 1998, HUM GENET, V102, P499, DOI 10.1007/s004390050732; FLINT J, 1995, NAT GENET, V9, P132, DOI 10.1038/ng0295-132; Funakoshi M, 1998, NEUROLOGY, V50, P1791, DOI 10.1212/WNL.50.6.1791; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabellini D, 2004, CURR OPIN GENET DEV, V14, P301, DOI 10.1016/j.gde.2004.04.010; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Lemmers RJLF, 2003, NEUROLOGY, V61, P178, DOI 10.1212/01.WNL.0000078889.51444.81; Lemmers RJLF, 2002, NAT GENET, V32, P235, DOI 10.1038/ng999; Lemmers RJLF, 1998, HUM MOL GENET, V7, P1207, DOI 10.1093/hmg/7.8.1207; Lernmers RJLF, 2001, ANN NEUROL, V50, P816, DOI 10.1002/ana.10057; LUNT P, 2000, NEUROMUSCULAR DIS BA, V18; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; MACINA RA, 1994, HUM MOL GENET, V3, P1847, DOI 10.1093/hmg/3.10.1847; Masny PS, 2004, HUM MOL GENET, V13, P1857, DOI 10.1093/hmg/ddh205; Mefford HC, 2002, NAT REV GENET, V3, P91, DOI 10.1038/nrg727; Miura K, 1998, NEUROPEDIATRICS, V29, P239, DOI 10.1055/s-2007-973568; Padberg G.W., 2004, FACIOSCAPULOHUMERAL; Pandya A, 1996, HUM MOL GENET, V5, P497, DOI 10.1093/hmg/5.4.497; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; TAWIL R, 1993, NEUROLOGY, V43, P345, DOI 10.1212/WNL.43.2.345; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Tonini MMO, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.010637; Tonini MMO, 2004, NEUROMUSCULAR DISORD, V14, P33, DOI 10.1016/j.nmd.2003.07.001; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; Tupler R, 1998, J MED GENET, V35, P778, DOI 10.1136/jmg.35.9.778; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; van Overveld PGM, 2000, HUM MOL GENET, V9, P2879; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; WILKIE AOM, 1991, CELL, V64, P595, DOI 10.1016/0092-8674(91)90243-R; Wohlgemuth M, 2003, NEUROLOGY, V61, P909, DOI 10.1212/WNL.61.7.909; Zhang YZ, 2001, ANN GENET-PARIS, V44, P105, DOI 10.1016/S0003-3995(01)01075-9	42	89	93	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					1124	1130		10.1086/426035	http://dx.doi.org/10.1086/426035			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15467981	Bronze, Green Published			2022-12-18	WOS:000224866400017
J	Brassington, AME; Sung, SS; Toydemir, RM; Le, T; Roeder, AD; Rutherford, AE; Whitby, FG; Jorde, LB; Bamshad, MJ				Brassington, AME; Sung, SS; Toydemir, RM; Le, T; Roeder, AD; Rutherford, AE; Whitby, FG; Jorde, LB; Bamshad, MJ			Expressivity of Holt-Oram syndrome is not predicted by TBX5 genotype	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOTOREALISTIC MOLECULAR GRAPHICS; ULNAR-MAMMARY SYNDROME; TRANSCRIPTION FACTOR; HEART-DEFECTS; MUTATIONS; LIMB; SPECTRUM; RASTER3D; PROGRAM; DISEASE	Mutations in TBX5, a T-box -containing transcription factor, cause cardiac and limb malformations in individuals with Holt-Oram syndrome (HOS). Mutations that result in haploinsufficiency of TBX5 are purported to cause cardiac and limb defects of similar severity, whereas missense mutations, depending on their location in the T box, are thought to cause either more severe heart or more severe limb abnormalities. These inferences are, however, based on the analysis of a relatively small number of independent cases of HOS. To better understand the relationship between mutations in TBX5 and the variable expressivity of HOS, we screened the coding and noncoding regions of TBX5 and SALL4 for mutations in 55 probands with HOS. Seventeen mutations, including sixmissense mutations in TBX5 and two mutations in SALL4, were found in 19 kindreds with HOS. Fewer than 50% of individuals with nonsense or frameshift mutations in TBX5 had heart and limb defects of similar severity, and only 2 of 20 individuals had heart or limb malformations of the severity predicted by the location of their mutations in the T box. These results suggest that neither the type of mutation in TBX5 nor the location of a mutation in the T box is predictive of the expressivity of malformations in individuals with HOS.	Univ Utah, Eccles Inst Human Genet, Hlth Sci Ctr, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Hlth Sci Ctr, Dept Biochem, Salt Lake City, UT 84112 USA; Univ Utah, Hlth Sci Ctr, Dept Pediat, Salt Lake City, UT 84112 USA; Shriners Hosp Children, Intermt Unit, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Bamshad, MJ (corresponding author), Univ Utah, Eccles Inst Human Genet, Hlth Sci Ctr, Dept Human Genet, 15 N 2030 E, Salt Lake City, UT 84112 USA.	mike@genetics.utah.edu	Toydemir, Reha/U-9739-2019	Toydemir, Reha M./0000-0002-0797-1999	PHS HHS [M01 00064] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Akrami S M, 2001, J Med Genet, V38, pE44, DOI 10.1136/jmg.38.12.e44; Allanson JE, 2003, AM J MED GENET A, V118A, P314, DOI 10.1002/ajmg.a.10214; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; BASSON CT, 1994, NEW ENGL J MED, V330, P885, DOI 10.1056/NEJM199403313301302; Basson CT, 1999, P NATL ACAD SCI USA, V96, P2919, DOI 10.1073/pnas.96.6.2919; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Braybrook C, 2001, NAT GENET, V29, P179, DOI 10.1038/ng730; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Burn J, 1998, LANCET, V351, P311, DOI 10.1016/S0140-6736(97)06486-6; Coll M, 2002, STRUCTURE, V10, P343, DOI 10.1016/S0969-2126(02)00722-0; Cross SJ, 2000, J MED GENET, V37, P785, DOI 10.1136/jmg.37.10.785; Fan C, 2003, J BIOL CHEM, V278, P8780, DOI 10.1074/jbc.M208120200; Ghosh TK, 2001, HUM MOL GENET, V10, P1983, DOI 10.1093/hmg/10.18.1983; Guyer B, 1998, PEDIATRICS, V102, P1333, DOI 10.1542/peds.102.6.1333; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Huang T, 2002, CURR OPIN PEDIATR, V14, P691, DOI 10.1097/00008480-200212000-00008; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Li QY, 1997, NAT GENET, V15, P21; Loffredo CA, 2000, AM J MED GENET, V97, P319, DOI 10.1002/1096-8628(200024)97:4<319::AID-AJMG1283>3.0.CO;2-E; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; Schneider MD, 1999, P NATL ACAD SCI USA, V96, P2577, DOI 10.1073/pnas.96.6.2577; Sletten LJ, 1996, AM J MED GENET, V65, P128, DOI 10.1002/(SICI)1096-8628(19961016)65:2<128::AID-AJMG9>3.0.CO;2-O; TERRETT JA, 1994, NAT GENET, V6, P401, DOI 10.1038/ng0494-401; Yang JF, 2000, AM J MED GENET, V92, P237, DOI 10.1002/(SICI)1096-8628(20000605)92:4<237::AID-AJMG2>3.0.CO;2-G	31	89	90	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	2003	73	1					74	85		10.1086/376436	http://dx.doi.org/10.1086/376436			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	696UA	12789647	Bronze, Green Published			2022-12-18	WOS:000183904900007
J	Hellemans, J; Coucke, PJ; Giedion, A; De Paepe, A; Kramer, P; Beemer, F; Mortier, GR				Hellemans, J; Coucke, PJ; Giedion, A; De Paepe, A; Kramer, P; Beemer, F; Mortier, GR			Homozygous mutations in IHH cause acrocapitofemoral dysplasia, an autosomal recessive disorder with cone- shaped epiphyses in hands and hips	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BRACHYDACTYLY TYPE-B; INDIAN HEDGEHOG; ROBINOW-SYNDROME; SONIC HEDGEHOG; PROTEIN; GENE; ROR2; DIFFERENTIATION; CHILDREN; GROWTH	Acrocapitofemoral dysplasia is a recently delineated autosomal recessive skeletal dysplasia, characterized clinically by short stature with short limbs and radiographically by cone-shaped epiphyses, mainly in hands and hips. Genome-wide homozygosity mapping in two consanguineous families linked the locus to 2q35-q36 with a maximum two-point LOD score of 8.02 at marker D2S2248. Two recombination events defined the minimal critical region between markers D2S2248 and D2S2151 (3.74 cM). Using a candidate-gene approach, we identified two missense mutations in the amino-terminal signaling domain of the gene encoding Indian hedgehog (IHH). Both affected individuals of family 1 are homozygous for a 137C-->T transition (P46L), and the three patients in family 2 are homozygous for a 569T-->C transition (V190A). The two mutant amino acids are strongly conserved and predicted to be located outside the region where brachydactyly type A-1 mutations are clustered.	Ghent Univ Hosp, Dept Med Genet, B-9000 Ghent, Belgium; Univ Zurich, Childrens Hosp, Dept Radiol, Zurich, Switzerland; Univ Med Ctr, Dept Radiol, Utrecht, Netherlands; Univ Med Ctr, Dept Med Genet, Div Biomed Genet, Utrecht, Netherlands	Ghent University; Ghent University Hospital; University Children's Hospital Zurich; University of Zurich; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Mortier, GR (corresponding author), Ghent Univ Hosp, Dept Med Genet, De Pintelaan 185, B-9000 Ghent, Belgium.	geert.mortier@rug.ac.be	Coucke, Paul J/AAO-2954-2020; Mortier, Geert/D-2542-2012	Coucke, Paul J/0000-0001-7119-586X; Mortier, Geert/0000-0001-9871-4578				Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Costa T, 1998, AM J MED GENET, V75, P523, DOI 10.1002/(SICI)1096-8628(19980217)75:5<523::AID-AJMG13>3.0.CO;2-M; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Everman DB, 2002, AM J MED GENET, V112, P291, DOI 10.1002/ajmg.10777; Faiyaz-Ul-Haque M, 2002, AM J MED GENET, V111, P31, DOI 10.1002/ajmg.10501; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Giedion A, 1998, PEDIATR RADIOL, V28, P751, DOI 10.1007/s002470050460; GROGAN DP, 1989, J BONE JOINT SURG AM, V71A, P920, DOI 10.2106/00004623-198971060-00018; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jeong J, 2002, J CLIN INVEST, V110, P591, DOI 10.1172/JCI200216506; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kindblom JM, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.174R001; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LEE JJ, 1994, SCIENCE, V266, P1528, DOI 10.1126/science.7985023; Long FX, 2001, DEVELOPMENT, V128, P5099; McCready ME, 2002, HUM GENET, V111, P368, DOI 10.1007/s00439-002-0815-2; Mortier GR, 2003, J MED GENET, V40, P201, DOI 10.1136/jmg.40.3.201; PATRIQUIN HB, 1981, RADIOLOGY, V141, P77, DOI 10.1148/radiology.141.1.7291546; PORTER JA, 1995, NATURE, V374, P363, DOI 10.1038/374363a0; Sasaki Tomoyuki, 2002, J Knee Surg, V15, P72; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613	27	89	99	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2003	72	4					1040	1046		10.1086/374318	http://dx.doi.org/10.1086/374318			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	662WT	12632327	Green Published, Bronze			2022-12-18	WOS:000181972600026
J	Endicott, P; Gilbert, MTP; Stringer, C; Lalueza-Fox, C; Willerslev, E; Hansen, AJ; Cooper, A				Endicott, P; Gilbert, MTP; Stringer, C; Lalueza-Fox, C; Willerslev, E; Hansen, AJ; Cooper, A			The genetic origins of the Andaman Islanders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POPULATION-GENETICS; DNA; SEQUENCE; INDIA	Mitochondrial sequences were retrieved from museum specimens of the enigmatic Andaman Islanders to analyze their evolutionary history. D-loop and protein-coding data reveal that phenotypic similarities with African pygmoid groups are convergent. Genetic and epigenetic data are interpreted as favoring the long-term isolation of the Andamanese, extensive population substructure, and/or two temporally distinct settlements. An early colonization featured populations bearing mtDNA lineage M2, and this lineage is hypothesized to represent the phylogenetic signal of an early southern movement of humans through Asia. The results demonstrate that Victorian anthropological collections can be used to study extinct, or seriously admixed populations, to provide new data about early human origins.	Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, Oxford OX1 3PS, England; Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Univ Barcelona, Dept Biol Anim, Barcelona, Spain; Univ Copenhagen, Inst Zool, Dept Evolutionary Biol, Copenhagen, Denmark	University of Oxford; Natural History Museum London; University of Barcelona; University of Copenhagen	Cooper, A (corresponding author), Univ Oxford, Dept Zool, Henry Wellcome Ancient Biomol Ctr, S Parks Rd, Oxford OX1 3PS, England.	alan.cooper@zoology.ox.ac.uk	Willerslev, Eske/A-9619-2011; Gilbert, Marcus TP/A-8936-2013; LALUEZA-FOX, CARLES/AAG-5341-2020; Cooper, Alan/E-8171-2012; Willerslev, Eske/AAA-5686-2019; Hansen, Anders Johannes/A-5608-2013	Willerslev, Eske/0000-0002-7081-6748; Gilbert, Marcus TP/0000-0002-5805-7195; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Cooper, Alan/0000-0002-7738-7851; Hansen, Anders Johannes/0000-0002-1890-2702; Endicott, Phillip/0000-0003-2452-8507				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Barnard-Davis J., 1867, THESAURUS CRANIORUM; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Coon C. S., 1966, LIVING RACES MAN; Cooper A, 2000, SCIENCE, V289, P1139; COOPER Z, 1993, ANTIQUITY, V67, P394, DOI 10.1017/S0003598X00045476; COOPER Z, 1988, S ASIAN STUDIES, V5, P133; Disotell TR, 1999, CURR BIOL, V9, pR925, DOI 10.1016/S0960-9822(00)80106-2; DOBSON GE, 1875, J R ANTHR SOC, V6; Ericksen P, 1975, MANKIND, V10, P105; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; FORBES HG, 1884, J R ANTHR SOC, V13; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Greenberg J. H., 1971, CURR TRENDS LINGUIST, V8, P807; Handt O, 1996, AM J HUM GENET, V59, P368; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; KIVISILD T, 1999, GENOMIC DIVERSITY AP; MACAULAY V, 2000, ARCHAEOGENETICS DNA; Majumder PP, 2001, J BIOSCIENCES, V26, P533, DOI 10.1007/BF02704750; MAN EH, 1932, ANDAMAN ISLANDERS RO; Molnar S., 1983, HUMAN VARIATION RACE; MOUNTAIN JL, 1995, AM J HUM GENET, V56, P979; PAABO S, 1990, J BIOL CHEM, V265, P4718; Passarino G, 1996, AM J HUM GENET, V59, P927; PORTMAN MV, 1990, HIST OUR RELATIONS A; Prasad BVR, 2001, HUM BIOL, V73, P715; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Radcliffe-Brown Alfred Reginald, 1914, ANTHROPOS, V9, P36; Richards M, 2001, AM J HUM GENET, V68, P1315, DOI 10.1086/320615; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Ruhlen M., 1987, GUIDE WORLDS LANGUAG; TAVARE S, 1984, THEOR POPUL BIOL, V26, P119, DOI 10.1016/0040-5809(84)90027-3; TEMPLE R, 2003, CENSUS INDIA 1901, V3; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; WALLACE AR, 1883, AUSTRALASIA; Wollaston, 1912, PYGMIES PAPUANS STON; WURM SA, 1971, CURR TRENDS LINGUIST, V8, P807; Wurm Stephen Adolphe, 1975, NEW GUINEA AREA LANG, V1	41	89	91	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					178	184		10.1086/345487	http://dx.doi.org/10.1086/345487			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12478481	Bronze, Green Published			2022-12-18	WOS:000180186800018
J	Gleeson, JG; Minnerath, S; Kuzniecky, RI; Dobyns, WB; Young, ID; Ross, ME; Walsh, CA				Gleeson, JG; Minnerath, S; Kuzniecky, RI; Dobyns, WB; Young, ID; Ross, ME; Walsh, CA			Somatic and germline mosaic mutations in the doublecortin gene are associated with variable phenotypes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SUBCORTICAL LAMINAR HETEROTOPIA; MILLER-DIEKER-SYNDROME; MICROTUBULE-ASSOCIATED PROTEIN; DOUBLE CORTEX SYNDROME; LISSENCEPHALY SYNDROME; BAND HETEROTOPIA; LINE MOSAICISM; NEURONS; BRAIN	Mutations in the X-linked gene doublecortin lead to "double cortex" syndrome (DC) in females and to X-linked lissencephaly (XLIS) in males. Because most patients with DC and XLIS are sporadic, representing de novo double-cortin mutations, we considered that some of these patients could be somatic or germline mosaics. Among a population of 20 patients and their families, we found evidence for mosaic doublecortin mutations in 6 individuals. Germline mosaicism was identified in two unaffected women, each with two affected children. Additionally, one affected male with DC was found to be a somatic mosaic, which presumably spared him from the more severe phenotype of lissencephaly. The high rate of mosaicism indicates that there may be a significant recurrence risk for DC/XLIS in families at risk, even when the mother is unaffected.	Univ Calif San Diego, Div Pediat Neurol, Med Teaching Facil, Dept Neurosci, La Jolla, CA 92093 USA; Univ Minnesota, Lab Mol Neurobiol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; City Hosp, Clin Genet Serv, Nottingham NG5 1PB, England; Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Neurol,Div Neurogenet, Boston, MA 02215 USA	University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Alabama System; University of Alabama Birmingham; University of Chicago; University of Nottingham; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Gleeson, JG (corresponding author), Univ Calif San Diego, Div Pediat Neurol, Med Teaching Facil, Dept Neurosci, Room 312,9500 Gilman Dr, La Jolla, CA 92093 USA.		Dobyns, William/AAI-2768-2020; Dobyns, William Brian/ABC-6525-2021	Dobyns, William/0000-0002-7681-2844; 	NINDS NIH HHS [R01-NS35515, R01 NS035515, P01-NS38289, R01 NS041537, R01-NS 35129, K12 NS001701, R01 NS035129] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, K12NS001701, R01NS041537, R01NS035515] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALVARADO M, 1993, AM J DIS CHILD, V147, P1291, DOI 10.1001/archpedi.1993.02160360033012; Berg MJ, 1998, NEUROLOGY, V50, P1143, DOI 10.1212/WNL.50.4.1143; Clark GD, 1999, ANN NEUROL, V45, P141, DOI 10.1002/1531-8249(199902)45:2<141::AID-ANA1>3.0.CO;2-7; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; des Portes V, 1998, CELL, V92, P51; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gleeson JG, 2000, ANN NEUROL, V47, P265, DOI 10.1002/1531-8249(200002)47:2<265::AID-ANA22>3.3.CO;2-E; GOUTIERES F, 1987, ARCH FR PEDIATR, V44, P501; HALL JG, 1988, AM J HUM GENET, V43, P355; Pilz DT, 1999, HUM MOL GENET, V8, P1757, DOI 10.1093/hmg/8.9.1757; PINARD JM, 1994, J NEUROL NEUROSUR PS, V57, P914, DOI 10.1136/jnnp.57.8.914; Pollin TI, 1999, AM J MED GENET, V85, P369; Sippel KC, 1998, AM J HUM GENET, V62, P610, DOI 10.1086/301766; Zlotogora J, 1998, HUM GENET, V102, P381, DOI 10.1007/s004390050708	17	89	90	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					574	581		10.1086/303043	http://dx.doi.org/10.1086/303043			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10915612	Green Published, Bronze			2022-12-18	WOS:000089002300004
J	Monks, SA; Kaplan, NL				Monks, SA; Kaplan, NL			Removing the sampling restrictions from family-based tests of association for a quantitative-trait locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRANSMISSION DISEQUILIBRIUM TEST; TRANSMISSION/DISEQUILIBRIUM TEST; LINKAGE DISEQUILIBRIUM; GENETIC-MARKERS; SIBSHIP TEST; PARENTS; DISEASE; TDT	One strategy for localization of a quantitative-trait locus (QTL) is to test whether the distribution of a quantitative trait depends on the number of copies of a specific genetic-marker allele that an individual possesses. This approach tests for association between alleles at the marker and the QTL, and it assumes that association is a consequence of the marker being physically close to the QTL. However, problems can occur when data are not from a homogeneous population, since associations can arise irrespective of a genetic marker being in physical proximity to the QTL-that is, no information is gained regarding localization. Methods to address this problem have recently been proposed. These proposed methods use family data for indirect stratification of a population, thereby removing the effect of associations that are due to unknown population substructure. They are, however, restricted in terms of the number of children per family that can be used in the analysis. Here we introduce tests that can be used on family data with parent and child genotypes, with child genotypes only, or with a combination of these types of families, without size restrictions. Furthermore, equations that allow one to determine the sample size needed to achieve desired power are derived. By means of simulation, we demonstrate that the existing tests have an elevated false-positive rate when the size restrictions are not followed and that a good deal of information is lost as a result of adherence to the size restrictions. Finally, we introduce permutation procedures that are recommended for small samples but that can also be used for extensions of the tests to multiallelic markers and to the simultaneous use of more than one marker.	Univ Washington, Dept Biostat, Seattle, WA 98195 USA; NIEHS, Biostat Branch, Res Triangle Pk, NC 27709 USA	University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Monks, SA (corresponding author), Univ Washington, Dept Biostat, POB 357232, Seattle, WA 98195 USA.		Santorico, Stephanie/L-7009-2015	Santorico, Stephanie/0000-0001-7846-0945				Allison DB, 1999, AM J HUM GENET, V64, P1754, DOI 10.1086/302404; Allison DB, 1997, AM J HUM GENET, V60, P676; Bickeboller H, 1995, GENET EPIDEMIOL, V12, P865, DOI 10.1002/gepi.1370120656; Boehnke M, 1998, AM J HUM GENET, V62, P950, DOI 10.1086/301787; Curtis D, 1997, ANN HUM GENET, V61, P319, DOI 10.1017/S000348009700626X; EWENS WJ, 1995, AM J HUM GENET, V57, P455; Falconer DS, 1996, INTRO QUANTITATIVE G; Horvath S, 1998, AM J HUM GENET, V63, P1886, DOI 10.1086/302137; Lazzeroni LC, 1998, HUM HERED, V48, P67, DOI 10.1159/000022784; Martin ER, 1997, AM J HUM GENET, V61, P439, DOI 10.1086/514860; MCINTYRE LM, IN PRESS GENET EPIDE; Monks SA, 1998, AM J HUM GENET, V63, P1507, DOI 10.1086/302104; Rabinowitz D, 1997, HUM HERED, V47, P342, DOI 10.1159/000154433; Schaid DJ, 1999, GENET EPIDEMIOL, V17, pS307; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Schaid DJ, 1996, GENET EPIDEMIOL, V13, P423, DOI 10.1002/(SICI)1098-2272(1996)13:5<423::AID-GEPI1>3.0.CO;2-3; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Spielman RS, 1996, AM J HUM GENET, V59, P983; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Spielman RS, 1998, AM J HUM GENET, V62, P450, DOI 10.1086/301714; Weir B., 1996, GENETIC DATA ANAL	21	89	94	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	2000	66	2					576	592		10.1086/302745	http://dx.doi.org/10.1086/302745			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	337QL	10677318	Bronze, Green Published			2022-12-18	WOS:000088373100025
J	Scozzari, R; Cruciani, F; Santolamazza, P; Malaspina, P; Torroni, A; Sellitto, D; Arredi, B; Destro-Bisol, G; De Stefano, G; Rickards, O; Martinez-Labarga, C; Modiano, D; Biondi, G; Moral, P; Olckers, A; Wallace, DC; Novelletto, A				Scozzari, R; Cruciani, F; Santolamazza, P; Malaspina, P; Torroni, A; Sellitto, D; Arredi, B; Destro-Bisol, G; De Stefano, G; Rickards, O; Martinez-Labarga, C; Modiano, D; Biondi, G; Moral, P; Olckers, A; Wallace, DC; Novelletto, A			Combined use of biallelic and microsatellite Y-chromosome polymorphisms to infer affinities among African populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GEOGRAPHIC-DISTRIBUTION; OROMO POPULATIONS; GENETIC-EVIDENCE; HAPLOTYPES; AMHARA; MUTATIONS; CAMEROON; ETHIOPIA; ORIGIN; HUMANS	To define Y-chromosome haplotypes, we studied seven biallelic polymorphic sites. We combined data with those from four dinucleotide-repeat polymorphisms, to establish Y-chromosome compound superhaplotypes. Eight biallelic haplotypes that matched the dendrogram proposed by other investigators were identified in 762 Y chromosomes from 25 African populations. For each biallelic site, coalescence time of lineages carrying the derived allele was estimated and compared with previous estimates. The "ancestral" haplotype (haplotype 1A) was observed among Ethiopians, "Khoisan" (!Kung and Khwe), and populations from northern Cameroon. Microsatellite distributions within this haplotype showed that the Khoisan haplotypes 1A are widely divergent from those of the other two groups. Populations from northern Africa and northern Cameroon share a haplotype (i.e., 1C), which is not observed in other African populations but represents a major Eurasian cluster. Haplotypes 1C of northern Cameroon are clearly distinct from those of Europe, whereas haplotypes 1C of northern African are well intermingled with those of the other two groups. Apportionment of diversity for the Y-chromosomal biallelic haplotypes was calculated after populations were clustered into different configurations. Despite some correspondence between language affiliation and genetic similarity, geographic proximity seems to be a better predictor of genetic affinity.	Univ La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; Univ La Sapienza, Dipartimenti Biol Anim & Uomo, I-00185 Rome, Italy; Univ La Sapienza, Fdn Pasteur Cenci Bolognetti, Ist Parassitol, I-00185 Rome, Italy; Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; Univ Urbino, Ist Chim Biol, I-61029 Urbino, Italy; Univ Turin, Dipartimento Biol Anim & Uomo, Turin, Italy; Univ Barcelona, Dept Biol, Barcelona, Spain; Univ Pretoria, Dept Human Genet, ZA-0002 Pretoria, South Africa; Emory Univ, Sch Med, Ctr Mol Med, Atlanta, GA 30322 USA; Univ Calabria, Dipartimento Biol Cellulare, I-87036 Cosenza, Italy	Sapienza University Rome; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Rome Tor Vergata; University of Urbino; University of Turin; University of Barcelona; University of Pretoria; Emory University; University of Calabria	Scozzari, R (corresponding author), Univ La Sapienza, Dipartimento Genet & Biol Mol, P Aldo Moro 5, I-00185 Rome, Italy.		Rickards, Olga/L-7878-2015; Moral, Pedro/K-9587-2014; Olckers, Antonel/AAW-8903-2020; MARTINEZ-LABARGA, CRISTINA M/K-6011-2014; Cruciani, Fulvio/G-6105-2012; Torroni, Antonio/E-1557-2011; Malaspina, Patrizia/G-7772-2017	Rickards, Olga/0000-0003-2880-7466; Moral, Pedro/0000-0001-5072-5892; Olckers, Antonel/0000-0002-4974-5666; MARTINEZ-LABARGA, CRISTINA M/0000-0003-0439-0379; Torroni, Antonio/0000-0002-4163-4478; Malaspina, Patrizia/0000-0002-0067-369X; Novelletto, Andrea/0000-0002-1146-7680; Cruciani, Fulvio/0000-0002-6900-024X; Destro Bisol, Giovanni/0000-0002-4232-9715				Altheide TK, 1997, AM J HUM GENET, V61, P462; Biondi G, 1996, AM J PHYS ANTHROPOL, V99, P519; BOTTEMA CDK, 1993, MUTAT RES, V288, P93, DOI 10.1016/0027-5107(93)90211-W; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Ciminelli BM, 1995, J MOL EVOL, V41, P966; Cooper G, 1996, HUM MOL GENET, V5, P1759, DOI 10.1093/hmg/5.11.1759; DESTROBISOL G, 1992, ANN HUM BIOL, V19, P185, DOI 10.1080/03014469200002062; EXCOFFIER L, 1992, GENETICS, V131, P479; FARAUT F, 1981, C INT CNRS, V551, P159; Fort M, 1998, TISSUE ANTIGENS, V51, P327; Goldstein DB, 1999, AM J HUM GENET, V64, P1071, DOI 10.1086/302313; Goldstein DB, 1996, MOL BIOL EVOL, V13, P1213, DOI 10.1093/oxfordjournals.molbev.a025686; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GREENBERG JH, 1987, STORIA GEN AFRICA, V1, P313; GRIMES BF, 1996, ETHNOLOGUE LANGUAGES; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Hammer MF, 1998, MOL BIOL EVOL, V15, P427, DOI 10.1093/oxfordjournals.molbev.a025939; Hammer MF, 1997, GENETICS, V145, P787; HAMMER MF, 1995, NATURE, V378, P376, DOI 10.1038/378376a0; HIERNAUX J, 1968, J AFR HIST, V9, P505, DOI 10.1017/S0021853700009014; Hiernaux J., 1974, PEOPLE AFRICA; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; Karafet TM, 1999, AM J HUM GENET, V64, P817, DOI 10.1086/302282; LI HH, 1990, P NATL ACAD SCI USA, V87, P4580, DOI 10.1073/pnas.87.12.4580; MACEACHERN S, 1993, J AFR HIST, V34, P247, DOI 10.1017/S002185370003334X; Malaspina P, 1997, J MOL EVOL, V44, P652; Malaspina P, 1998, AM J HUM GENET, V63, P847, DOI 10.1086/301999; MATHIAS N, 1994, HUM MOL GENET, V3, P115, DOI 10.1093/hmg/3.1.115; MBUAGBAW TE, 1990, HIST CAMEROON; MCEVEDY C, 1980, PENGUIN ATLAS AFRICA; Mveng E., 1963, HIST CAMEROUN; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; PERSICHETTI F, 1992, ANN HUM GENET, V56, P303, DOI 10.1111/j.1469-1809.1992.tb01157.x; Poloni ES, 1997, AM J HUM GENET, V61, P1015, DOI 10.1086/301602; Reich DE, 1998, P NATL ACAD SCI USA, V95, P8119, DOI 10.1073/pnas.95.14.8119; Rickards O., 1994, CONTRIBUTIONS ANIMAL, P355; Santos FR, 1996, GENOME RES, V6, P601, DOI 10.1101/gr.6.7.601; SANTOS FR, 1995, GENE, V165, P191, DOI 10.1016/0378-1119(95)00501-V; Santos FR, 1999, AM J HUM GENET, V64, P619, DOI 10.1086/302242; SCACCHI R, 1994, AM J HUM BIOL, V6, P773, DOI 10.1002/ajhb.1310060611; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; Scozzari R, 1997, AM J HUM GENET, V61, P719, DOI 10.1086/515500; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; SPEDINI G, IN PRESS AM J PHYS A; Tartaglia M, 1996, AM J HUM BIOL, V8, P505, DOI 10.1002/(SICI)1520-6300(1996)8:4<505::AID-AJHB11>3.0.CO;2-Q; TORRONI A, 1990, ANN HUM GENET, V54, P287; Underhill PA, 1997, GENOME RES, V7, P996, DOI 10.1101/gr.7.10.996; VANBAKEL MA, 1981, CURR ANTHROPOL, V22, P688, DOI 10.1086/202753; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0	51	89	90	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1999	65	3					829	846		10.1086/302538	http://dx.doi.org/10.1086/302538			18	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	233KQ	10441590	Green Published, Bronze			2022-12-18	WOS:000082426400028
J	Pulkkinen, L; Rouan, F; Bruckner-Tuderman, L; Wallerstein, R; Garzon, M; Brown, T; Smith, L; Carter, W; Uitto, J				Pulkkinen, L; Rouan, F; Bruckner-Tuderman, L; Wallerstein, R; Garzon, M; Brown, T; Smith, L; Carter, W; Uitto, J			Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: Missense versus nonsense	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INTEGRIN BETA-4 SUBUNIT; PRENATAL-DIAGNOSIS; CYTOPLASMIC DOMAIN; ALPHA-6-BETA-4 INTEGRIN; HEMIDESMOSOME FORMATION; CELL-ADHESION; GENE; LOCALIZATION; EXPRESSION; PATIENT	Epidermolysis bullosa with pyloric atresia (EB-PA), an autosomal recessive genodermatosis, manifests with neonatal cutaneous blistering associated with congenital pyloric atresia. The disease is frequently lethal, but nonlethal cases have also been reported. Expression of the alpha 6 beta 4 integrin is altered at the dermal-epidermal basement-membrane zone; recently, mutations in the corresponding genes (ITGA6 and ITGB4) have been disclosed in a limited number of patients, premature termination codons in both alleles being characteristic of lethal variants. Zn this study, we have examined the molecular basis of EB-PA In five families, two Of them with lethal and three of them with nonlethal variants of the disease. Mutation analysis disclosed novel lesions in both ITGB4 alleles of each proband. One of the patients with lethal EB-PA was a compound heterozygote for premature termination-codon mutations (C738X/4731delCA), whereas the other patient with a lethal variant was homozygous for a missense mutation involving a cysteine residue (C61Y). The three nonlethal cases had missense mutations in bath alleles (C562R/C562R, R1281W/R252C, and R1281W/R1281W), Immunofluorescence staining of skin in two of the nonlethal patients and in one of the lethal cases was positive, yet attenuated, for alpha 6 and beta 4 integrins. These results confirm that ITGB4 mutations underlie EB-PA and show that missense mutations may lead to nonlethal phenotypes.	Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; Kuopio Univ Hosp, Div Diagnost Serv, DNA & Chromosome Lab, SF-70210 Kuopio, Finland; Thomas Jefferson Univ, Jefferson Med Coll, Dept Biochem & Mol Pharmacol, Philadelphia, PA 19107 USA; Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA; Univ Munster, Dept Dermatol & Venerol, D-4400 Munster, Germany; NYU Med Ctr, Dept Pediat, Humen Genet Program, New York, NY 10016 USA; Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; Univ Washington, Fred Hutchinson Canc Res Ctr, Dept Pathol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Med, Div Dermatol, Seattle, WA USA	Jefferson University; Kuopio University Hospital; University of Eastern Finland; Jefferson University; Jefferson University; University of Munster; New York University; Columbia University; Columbia University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Uitto, J (corresponding author), Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Biol, 233 South 10th St,Suite 450,Bluemle Life Sci Bldg, Philadelphia, PA 19107 USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR038923] Funding Source: NIH RePORTER; NIAMS NIH HHS [P01-AR38923] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aho S, 1998, BIOCHEM BIOPH RES CO, V243, P694, DOI 10.1006/bbrc.1998.8162; Bhalerao J, 1997, AM J HUM GENET, V61, pA232; Borradori L, 1997, J CELL BIOL, V136, P1333, DOI 10.1083/jcb.136.6.1333; Brown TA, 1996, J INVEST DERMATOL, V107, P384, DOI 10.1111/1523-1747.ep12363370; Christiano AM, 1997, PRENATAL DIAG, V17, P343, DOI 10.1002/(SICI)1097-0223(199704)17:4<343::AID-PD73>3.0.CO;2-7; Christiano AM, 1996, MOL MED, V2, P59, DOI 10.1007/BF03402203; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; FINE JD, 1991, J AM ACAD DERMATOL, V24, P119, DOI 10.1016/0190-9622(91)70021-S; GANGULY A, 1993, P NATL ACAD SCI USA, V90, P10325, DOI 10.1073/pnas.90.21.10325; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; GIL SG, 1994, J INVEST DERMATOL, V103, pS31, DOI 10.1111/1523-1747.ep12398953; LESTRINGANT GG, 1992, ARCH DERMATOL, V128, P1083, DOI 10.1001/archderm.128.8.1083; NAZZARO V, 1990, J MED GENET, V27, P244, DOI 10.1136/jmg.27.4.244; Niessen CM, 1997, J CELL SCI, V110, P1705; Niessen CM, 1996, J CELL SCI, V109, P1695; Pulkkinen L, 1998, AM J PATHOL, V152, P157; Pulkkinen L, 1997, HUM MOL GENET, V6, P669, DOI 10.1093/hmg/6.5.669; Pulkkinen L, 1997, LAB INVEST, V76, P823; Pulkkinen L, 1998, EXP DERMATOL, V7, P46, DOI 10.1111/j.1600-0625.1998.tb00304.x; Pulkkinen L, 1998, AM J PATHOL, V152, P935; Ruzzi L, 1997, J CLIN INVEST, V99, P2826, DOI 10.1172/JCI119474; SanchezAparicio P, 1997, J CELL SCI, V110, P169; Shimizu H, 1996, ARCH DERMATOL, V132, P919, DOI 10.1001/archderm.132.8.919; SONNENBERG A, 1991, J CELL BIOL, V113, P907, DOI 10.1083/jcb.113.4.907; SPINARDI L, 1995, J CELL BIOL, V129, P473, DOI 10.1083/jcb.129.2.473; STEPP MA, 1990, P NATL ACAD SCI USA, V87, P8970, DOI 10.1073/pnas.87.22.8970; Takizawa Y, 1997, J INVEST DERMATOL, V108, P943, DOI 10.1111/1523-1747.ep12296240; THORSTEINSDOTTIR S, 1995, DEV DYNAM, V204, P240, DOI 10.1002/aja.1002040304; Uitto J, 1997, MOL MED TODAY, V3, P457; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; vanLeusden MR, 1997, BIOCHEM BIOPH RES CO, V235, P826, DOI 10.1006/bbrc.1997.6892; VIDAL F, 1995, NAT GENET, V10, P229, DOI 10.1038/ng0695-229	33	89	92	0	1	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1998	63	5					1376	1387		10.1086/302116	http://dx.doi.org/10.1086/302116			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	138QZ	9792864	Green Published, hybrid			2022-12-18	WOS:000076985200013
J	Liu, XZ; Hope, C; Walsh, J; Newton, V; Ke, XM; Liang, CY; Xu, LR; Zhou, JM; Trump, D; Steel, KP; Bundey, S; Brown, SDM				Liu, XZ; Hope, C; Walsh, J; Newton, V; Ke, XM; Liang, CY; Xu, LR; Zhou, JM; Trump, D; Steel, KP; Bundey, S; Brown, SDM			Mutations in the myosin VIIA gene cause a wide phenotypic spectrum, including atypical Usher syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							DEAFNESS; 1B; TYPE-1		MRC, Mouse Genome Ctr, Harwell OX11 0RD, Oxon, England; MRC, Mammalian Genet Unit, Harwell OX11 0RD, Oxon, England; Univ Birmingham, Clin Genet Unit, Birmingham, W Midlands, England; Univ Manchester, Ctr Audiol, Manchester, Lancs, England; Beijing Med Univ, Dept Otolaryngol, Beijing 100083, Peoples R China; W China Univ Med Sci, Dept Otolaryngol, Chengdu 610041, Peoples R China; Univ Cambridge, Dept Med Genet, Cambridge, England; MRC, Inst Hearing Res, Nottingham, England	University of Birmingham; University of Manchester; Peking University; Sichuan University; University of Cambridge	Liu, XZ (corresponding author), MRC, Mouse Genome Ctr, Harwell OX11 0RD, Oxon, England.				NIDCD NIH HHS [R01 DC012115, R01 DC005575] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005575] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adato A, 1997, AM J HUM GENET, V61, P813, DOI 10.1086/514899; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; Cope MJTV, 1996, STRUCTURE, V4, P969, DOI 10.1016/S0969-2126(96)00103-7; Hasson T, 1997, AM J HUM GENET, V61, P801, DOI 10.1086/514890; Hope CI, 1997, BRIT J OPHTHALMOL, V81, P46, DOI 10.1136/bjo.81.1.46; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Liu XZ, 1997, NAT GENET, V17, P268, DOI 10.1038/ng1197-268; Liu XZ, 1997, HUM MUTAT, V10, P168, DOI 10.1002/(SICI)1098-1004(1997)10:2<168::AID-HUMU10>3.3.CO;2-T; Mburu Philomena, 1997, Genes and Function, V1, P191; ROMEO G, 1994, NAT GENET, V7, P451, DOI 10.1038/ng0894-451; SANKILA EM, 1995, HUM MOL GENET, V4, P93, DOI 10.1093/hmg/4.1.93; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074; WETON MD, 1998, ASS RES OT ABS, P46	16	89	93	0	0	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					909	912		10.1086/302026	http://dx.doi.org/10.1086/302026			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718356	Bronze, Green Published			2022-12-18	WOS:000075919000034
J	Marchington, DR; Macaulay, V; Hartshorne, GM; Barlow, D; Poulton, J				Marchington, DR; Macaulay, V; Hartshorne, GM; Barlow, D; Poulton, J			Evidence from human oocytes for a genetic bottleneck in an mtDNA disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; CONTROL REGION; HETEROPLASMY; SEGREGATION; MUTATION; TISSUES; REPLICATION; DELETION; GENOMES	We have examined oocytes from a patient with Kearn-Sayre syndrome caused by mtDNA rearrangements. In mtDNA diseases, mutant and wild-type mtDNA frequently coexist in affected individuals (the condition of heteroplasmy). The proportion of mutant mtDNA transmitted from mother to offspring is variable because of a genetic bottleneck, and the "dose" of mutant mtDNA received influences the severity of the phenotype. The feasibility of prenatal diagnosis is critically dependent on the nature and timing of this bottleneck. Significant levels of rearranged mtDNA were detectable in the majority of the patient's oocytes, by use of multiplex PCR, with wide variation, in the levels of mutant and wildtype molecules, between individual oocytes. We also used length variation in a homopolymeric C tract, which is often heteroplasmic in normal controls, to identify founder subpopulations of mtDNAs in this patient's oocytes. We present direct evidence that the number of segregating units (n) is three to five orders of magnitude less than the number of mitochondria in the human female oocyte. In some cases, the best estimate of it may correspond to a single mitochondrion, if it is assumed that intergenerational transmission of mtDNA can be treated as a single sampling event. The bottleneck appears to contribute a major component of the variable transmission from mother to oocyte, in this patient and in a control. That this bottleneck had occurred by the time that oocytes were mature advances the prospects for prenatal diagnosis of mtDNA diseases.	Univ Oxford, Dept Paediat, Oxford, England; Univ Oxford, Dept Cellular Sci, Oxford, England; Univ Oxford, Nuffield Dept Obstet & Gynaecol, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Poulton, J (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Level 4, Oxford OX3 9DU, England.		Barlow, David/F-8738-2011	Poulton, Joanna/0000-0002-2460-5587	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BENDALL KE, 1995, AM J HUM GENET, V57, P248; Bendall KE, 1996, AM J HUM GENET, V59, P1276; BERNES SM, 1993, J PEDIATR-US, V123, P598, DOI 10.1016/S0022-3476(05)80962-X; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; CHEN X, 1995, AM J HUM GENET, V57, P239; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; DUNBAR DR, 1995, P NATL ACAD SCI USA, V92, P6562, DOI 10.1073/pnas.92.14.6562; HAUSWIRTH WW, 1985, ACHIEVEMENTS PERSPEC, V2; HOWELL N, 1992, HUM GENET, V90, P117; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Marchington DR, 1997, AM J HUM GENET, V60, P408; MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41; Meirelles FV, 1998, GENETICS, V148, P877; Nei M., 1987, MOL EVOLUTIONARY GEN; POULTON J, 1995, DIABETOLOGIA, V38, P868, DOI 10.1007/s001250050366; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; POULTON J, 1993, ANN NEUROL, V34, P116, DOI 10.1002/ana.410340124; POULTON J, 1994, NAT GENET, V8, P313, DOI 10.1038/ng1294-313; PREISS T, 1995, TRENDS GENET, V11, P211, DOI 10.1016/S0168-9525(00)89048-4; SOLIGNAC M, 1987, GENETICS, V117, P687; SUOMALAINEN A, 1993, HUM MOL GENET, V2, P525, DOI 10.1093/hmg/2.5.525; TOURTE M, 1984, EUR J CELL BIOL, V34, P171	26	89	90	0	9	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	1998	63	3					769	775		10.1086/302009	http://dx.doi.org/10.1086/302009			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	119VN	9718339	Bronze, Green Published			2022-12-18	WOS:000075919000014
J	Altare, F; Jouanguy, E; Lamhamedi-Cherradi, S; Fondaneche, MC; Fizame, C; Ribierre, F; Merlin, G; Dembic, Z; Schreiber, R; Lisowska-Grospierre, B; Fischer, A; Seboun, E; Casanova, JL				Altare, F; Jouanguy, E; Lamhamedi-Cherradi, S; Fondaneche, MC; Fizame, C; Ribierre, F; Merlin, G; Dembic, Z; Schreiber, R; Lisowska-Grospierre, B; Fischer, A; Seboun, E; Casanova, JL			A causative relationship between mutant IFNgR1 alleles and impaired cellular response to IFN gamma in a compound heterozygous child	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							MULTILOCUS LINKAGE ANALYSIS; HUMAN GENOME; HUMAN GENES; INFECTION; MAPS		Hop Necker Enfants Malad, INSERM U429, F-75015 Paris, France; Hop Necker Enfants Malad, Unite Immunol & Hematol Pediat, Paris, France; Genethon, Evry, France; Univ Bordeaux 2, CNRS, Unite 5016, F-33076 Bordeaux, France; Inst Immunol & Rheumatol, Oslo, Norway; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Washington University (WUSTL)	Casanova, JL (corresponding author), Hop Necker Enfants Malad, INSERM U429, 149 Rue de Sevres, F-75015 Paris, France.		Dembic, Zlatko/A-1833-2008; altare, frederic/K-8664-2015; Jouanguy, Emmanuelle/H-7901-2017; Casanova, Jean-Laurent/I-3418-2017; Schreiber, Robert/Q-7550-2019	Dembic, Zlatko/0000-0002-9970-6497; altare, frederic/0000-0002-5077-4616; Jouanguy, Emmanuelle/0000-0002-7358-9157; Fizames, Cecile/0000-0002-0551-8250; Schreiber, Robert/0000-0003-1590-2341; Casanova, Jean-Laurent/0000-0002-7782-4169				CASANOVA JL, 1995, LANCET, V346, P581, DOI 10.1016/S0140-6736(95)91421-8; Casanova JL, 1996, PEDIATRICS, V98, P774; COOPER DN, 1991, HUM GENET, V87, P409; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Dausset J, 1992, Behring Inst Mitt, P13; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Emile JF, 1997, J PATHOL, V181, P25, DOI 10.1002/(SICI)1096-9896(199701)181:1<25::AID-PATH747>3.0.CO;2-Z; FARRAR MA, 1991, J BIOL CHEM, V266, P19626; Jouanguy E, 1996, NEW ENGL J MED, V335, P1956, DOI 10.1056/NEJM199612263352604; KRAWCZAK M, 1992, HUM GENET, V90, P41; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LATHROP GM, 1988, AM J HUM GENET, V42, P498; LECONIAT M, 1989, HUM GENET, V84, P92, DOI 10.1007/BF00210682; LEVIN M, 1995, LANCET, V345, P79, DOI 10.1016/S0140-6736(95)90059-4; LISOWSKAGROSPIERRE B, 1994, HUM MOL GENET, V3, P953, DOI 10.1093/hmg/3.6.953; Merlin G, 1997, IMMUNOGENETICS, V45, P413, DOI 10.1007/s002510050223; Newport MJ, 1996, NEW ENGL J MED, V335, P1941, DOI 10.1056/NEJM199612263352602; Pappanicolaou GJ, 1997, CYTOGENET CELL GENET, V76, P181, DOI 10.1159/000134542; PFIZENMAIER K, 1988, J IMMUNOL, V141, P856; PierreAudigier C, 1997, CLIN INFECT DIS, V24, P982, DOI 10.1093/clinids/24.5.982; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837	21	89	90	0	2	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1998	62	3					723	726		10.1086/301750	http://dx.doi.org/10.1086/301750			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ZF407	9497247	Green Published, Bronze			2022-12-18	WOS:000072894400030
J	Manga, P; Kromberg, JGR; Box, NF; Sturm, RA; Jenkins, T; Ramsay, M				Manga, P; Kromberg, JGR; Box, NF; Sturm, RA; Jenkins, T; Ramsay, M			Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; INTRAGENIC DELETION; BROWN LOCUS; P-GENE; MOUSE; MELANOCYTES; PROTEIN; HYBRIDIZATION; PIGMENTATION; TYROSINASES	Oculocutaneous albinism (OCA) is the most common autosomal recessive disorder among southern African Blacks. There are three forms that account for almost all OCA types in this region. Tyrosinase-positive OCA (OCA2), which is the most common, affects similar to 1/3,900 newborns and has a carrier frequency of similar to 1/33. It is caused by mutations in the P gene on chromosome 15. Brown OCA (BOCA) and rufous OCA (ROCA) account for the majority of the remaining phenotypes. The prevalence of BOCA is unknown, but for ROCA it is similar to 1/8,500. Linkage analysis performed on nine ROCA families showed that ROCA was linked to an intragenic marker at the TYRP1 locus (maximum LOD score = 3.80 at theta = .00). Mutation analysis of 19 unrelated ROCA individuals revealed;a nonsense mutation at codon 166 (S166X) in 17 (45%) of 38 ROCA chromosomes, and a-second mutation (368delA) was found in an additional 19 (50%) of 38 chromosomes; mutations were not identified in the remaining 2 ROCA chromosomes. In one family, two siblings with a phenotypically unclassified form of albinism were found to be compound heterozygotes for mutations (S166X/368delA) at the TYRP1 locus and were heterozygous for a common 2.7-kb deletion in the P gene. These findings have highlighted the influence of genetic background on phenotype, in which the genotype at one locus can be influenced by the genotype at a second locus, leading to a modified phenotype. ROCA, which in southern African Blacks is caused by mutations in the TYRP1 gene, therefore should be referred to as ''OCA3,'' since this is the third locus that has been shown to cause an OCA phenotype in humans.	S AFRICAN INST MED RES, DEPT HUMAN GENET, JOHANNESBURG, SOUTH AFRICA; UNIV WITWATERSRAND, JOHANNESBURG, SOUTH AFRICA; UNIV QUEENSLAND, CTR MOL & CELLULAR BIOL, BRISBANE, QLD, AUSTRALIA	University of Witwatersrand; University of Queensland			Box, Neil/F-3591-2010; Sturm, Richard A/C-9943-2009	Box, Neil/0000-0002-3486-0346; Sturm, Richard A/0000-0003-1301-0294; Ramsay, Michele/0000-0002-4156-4801; Kromberg, Jennifer/0000-0003-0539-5681				BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; Boissy RE, 1996, AM J HUM GENET, V58, P1145; BOUCHARD B, 1994, EUR J BIOCHEM, V219, P127, DOI 10.1111/j.1432-1033.1994.tb19922.x; BOX NF, 1994, HUM MOL GENET, V3, P2270, DOI 10.1093/hmg/3.12.2270; BOX NF, 1994, COMPOUND DINUCLEOTID; CHINTAMANENI CD, 1991, BIOCHEM BIOPH RES CO, V178, P227, DOI 10.1016/0006-291X(91)91803-K; DURHAMPIERRE D, 1994, NAT GENET, V7, P176, DOI 10.1038/ng0694-176; HALABAN R, 1990, P NATL ACAD SCI USA, V87, P4809, DOI 10.1073/pnas.87.12.4809; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; JIMENEZ M, 1991, J BIOL CHEM, V266, P1147; JIMENEZCERVANTES C, 1993, EUR J BIOCHEM, V217, P549, DOI 10.1111/j.1432-1033.1993.tb18276.x; JIMENEZCERVANTES C, 1994, J BIOL CHEM, V269, P17993; KEDDA, 1994, AM J HUM GENET, V55, P602; KEDDA MA, 1994, AM J HUM GENET, V54, P1078; KIDSON SH, 1993, PIGM CELL RES, V6, P209, DOI 10.1111/j.1600-0749.1993.tb00604.x; KING RA, 1980, CLIN GENET, V17, P259; KING RA, 1985, OPHTHALMOLOGY, V92, P1496; KING RA, 1994, METABOLIC MOL BASES, V2, P4353; KROMBERG JGR, 1982, S AFR MED J, V61, P383; KROMBERG JGR, 1990, OPHTHALMIC PAED GEN, V11, P229, DOI 10.3109/13816819009020984; Manga P., 1994, American Journal of Human Genetics, V55, pA194; MORRIS SW, 1991, NUCLEIC ACIDS RES, V19, P6968, DOI 10.1093/nar/19.24.6968; MURTY VVVS, 1992, GENOMICS, V13, P227, DOI 10.1016/0888-7543(92)90228-K; MUTIRANGURA A, 1992, HUM MOL GENET, V1, P67, DOI 10.1093/hmg/1.1.67; PEARSON K, 1911, BIOMETRIC SERIES, V6; RAMSAY M, 1992, AM J HUM GENET, V51, P879; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; SPRITZ RA, 1994, ADV HUM GENET, V22, P1; Stannus HS, 1913, BIOMETRIKA, V9, P333, DOI 10.2307/2331897; STEVENS G, 1995, AM J HUM GENET, V56, P586; STURM RA, 1995, GENOMICS, V29, P24, DOI 10.1006/geno.1995.1211; STURM RA, 1994, GENOMICS, V21, P293, DOI 10.1006/geno.1994.1266; WALLACE ME, 1953, HEREDITY, V7, P435, DOI 10.1038/hdy.1953.50; WALSH RJ, 1971, ANN HUM GENET, V34, P379, DOI 10.1111/j.1469-1809.1971.tb00250.x; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2203; WILDENBERG SC, 1995, HUM GENET, V95, P247; WINDER AJ, 1993, J CELL SCI, V106, P153	37	89	97	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	1997	61	5					1095	1101		10.1086/301603	http://dx.doi.org/10.1086/301603			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YH017	9345097	Green Published, Bronze			2022-12-18	WOS:A1997YH01700014
J	Delepine, M; Pociot, F; Habita, C; Hashimoto, L; Froguel, P; Rotter, J; CambonThomsen, A; Deschamps, I; Djoulah, S; Weissenbach, J; Nerup, J; Lathrop, M; Julier, C				Delepine, M; Pociot, F; Habita, C; Hashimoto, L; Froguel, P; Rotter, J; CambonThomsen, A; Deschamps, I; Djoulah, S; Weissenbach, J; Nerup, J; Lathrop, M; Julier, C			Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REGION-ENCODED SUSCEPTIBILITY; LOD SCORE ANALYSIS; INSULIN GENE; MELLITUS; POLYMORPHISM; DISEASE; IDDM; MICROSATELLITES; MINISATELLITE; HAPLOTYPE	Linkage studies have led to the identification of several chromosome regions that may contain susceptibility loci to type I diabetes (IDDM), in addition to the HLA and INS loci. These include two on chromosome 6q, denoted IDDM5 and IDDM8, that are not linked to HLA. In a previous study, we noticed that the evidence for linkage to IDDM susceptibility around the HLA locus extended over a total distance of 100 cM, which suggested to us that another susceptibility locus could reside near HLA. We developed a statistical method to test this hypothesis in a panel of 523 multiplex families from France, the United States, and Denmark (a total of 667 affected sib pairs, 536 with both parents genotyped), and here present evidence (P = .0003) of a susceptibility locus for IDDM located 32 cM from HLA in males but not linked to HLA in females and distinct from IDDM5 and IDDM8. A new statistical method to test for the presence of a second susceptibility locus linked to a known first susceptibility locus (here HLA) is presented. In addition, we analyzed our current family panel with markers for IDDM5 and IDDM8 on chromosome 6 and found suggestions of linkage for both of these loci (P = .002 and .004, respectively, on the complete family panel). When cumulated with previously published results, with overlapping families removed, the affected-sib-pair tests had a significance of P = .0001 for IDDM5 and P = .0004 for IDDM8.	WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7BN,ENGLAND; CHU LILLE,F-59037 LILLE,FRANCE; INST PASTEUR,F-59019 LILLE,FRANCE; CEDARS SINAI MED CTR,DIV MED GENET,LOS ANGELES,CA 90048; UNIV CALIF LOS ANGELES,SCH MED,LOS ANGELES,CA; HOP PURPAN,CTR IMMUNOPATHOL & GENET HUMAINE,CNRS UPR8291,TOULOUSE,FRANCE; HOP NECKER ENFANTS MALAD,PARIS,FRANCE; HOP ST LOUIS,INSERM U93,PARIS,FRANCE; GENETHON,EVRY,FRANCE; STENO DIABET CTR,DK-2820 GENTOFTE,DENMARK	University of Oxford; Wellcome Centre for Human Genetics; Universite de Lille - ISITE; CHU Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Steno Diabetes Center			FROGUEL, Philippe/O-6799-2017; JULIER, Cécile/M-9824-2017	FROGUEL, Philippe/0000-0003-2972-0784; JULIER, Cécile/0000-0002-1538-0240; Pociot, Flemming/0000-0003-3274-5448	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABRAMOWICZ MJ, 1994, J CLIN INVEST, V94, P418, DOI 10.1172/JCI117339; BAIN SC, 1992, NAT GENET, V2, P212, DOI 10.1038/ng1192-212; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; COPEMAN JB, 1995, NAT GENET, V9, P80, DOI 10.1038/ng0195-80; CORDELL HJ, 1995, AM J HUM GENET, V57, P920; Cox DH, 1989, ANAL BINARY DATA; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; DAVIES JL, 1994, NATURE, V371, P130, DOI 10.1038/371130a0; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; FIELD LL, 1994, NAT GENET, V8, P189, DOI 10.1038/ng1094-189; Field LL, 1996, GENOMICS, V33, P1, DOI 10.1006/geno.1996.0153; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Gu LP, 1996, J CLIN INVEST, V97, P777, DOI 10.1172/JCI118477; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HASHIMOTO L, 1994, NATURE, V371, P161, DOI 10.1038/371161a0; HYER RN, 1991, AM J HUM GENET, V48, P243; IKEGAMI H, 1995, J CLIN INVEST, V96, P1936, DOI 10.1172/JCI118239; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KENNEDY GC, 1995, NAT GENET, V9, P293, DOI 10.1038/ng0395-293; KNAPP M, 1994, HUM HERED, V44, P44, DOI 10.1159/000154188; KREUTZ R, 1995, P NATL ACAD SCI USA, V92, P8778, DOI 10.1073/pnas.92.19.8778; Lathrop G. M., 1990, AM J HUM GENET S, V47, pA188; LEDBETTER DH, 1995, HUM MOL GENET, V4, P1757, DOI 10.1093/hmg/4.suppl_1.1757; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; LUCASSEN AM, 1995, HUM MOL GENET, V4, P501, DOI 10.1093/hmg/4.4.501; LUCASSEN AM, 1993, NAT GENET, V4, P305, DOI 10.1038/ng0793-305; LUO DF, 1995, AM J HUM GENET, V57, P911; Luo DF, 1996, HUM MOL GENET, V5, P693, DOI 10.1093/hmg/5.5.693; MACAUBAS C, 1995, HUM IMMUNOL, V42, P209, DOI 10.1016/0198-8859(94)00101-U; MARTIN M, 1995, HUM MOL GENET, V4, P423, DOI 10.1093/hmg/4.3.423; MCGINNIS RE, 1995, DIABETES, V44, P1296, DOI 10.2337/diabetes.44.11.1296; NEDOSPASOV SA, 1991, J IMMUNOL, V147, P1053; OWERBACH D, 1995, DIABETES, V44, P132, DOI 10.2337/diabetes.44.1.132; POCIOT F, 1993, DIABETOLOGIA, V36, P870, DOI 10.1007/BF00400364; RISCH N, 1987, AM J HUM GENET, V40, P1; ROTTER JI, 1984, CLIN GENET, V26, P529; SEQUEL A, 1982, AM J DIS CHILD, V136, P626, DOI 10.1001/archpedi.1982.03970430058015; SHE JX, 1994, AUTOIMMUNITY, V18, P195, DOI 10.3109/08916939409007996; TEMPLE IK, 1995, NAT GENET, V9, P110, DOI 10.1038/ng0295-110; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; UNDLIEN DE, 1995, DIABETES, V44, P620, DOI 10.2337/diabetes.44.6.620; VANDERAUWERA BJ, 1993, DIABETES, V42, P851, DOI 10.2337/diabetes.42.6.851	43	89	91	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					174	187						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981961				2022-12-18	WOS:A1997WA81800024
J	Thompson, EA; Neel, JV				Thompson, EA; Neel, JV			Allelic disequilibrium and allele frequency distribution as a function of social and demographic history	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; TRIBAL POPULATION; GENES; GENETICS; YANOMAMA; AMERICA	Allelic disequilibrium between closely linked genes is a common observation in human populations and often gives rise to speculation concerning the role of selective forces. In a previous treatment, we have developed a population model of the expected distribution of rare variants (including private polymorphisms) in Amerindians and have argued that, because of the great expansion of Amerindian numbers with the advent of agriculture, most of these rare variants are of relatively recent origin. Many other populations have similar histories of striking recent expansions. In this treatment, we demonstrate that, in consequence of this fact, a high degree of linkage disequilibrium between two nonhomologous alleles <0.5 cM apart is the ''normal'' expectation, even in the absence of selection. This expectation is enhanced by the previous subdivision of human populations into relatively isolated tribes characterized by a high level of endogamy and inbreeding. We also demonstrate that the alleles associated with a recessive disease phenotype are expected to exist in a population in very variable frequencies: there is no need to postulate positive selection with respect to the more common disease-associated alleles for such entities as phenylketonuria or cystic fibrosis.	UNIV MICHIGAN, DEPT HUMAN GENET, ANN ARBOR, MI 48109 USA	University of Michigan System; University of Michigan	Thompson, EA (corresponding author), UNIV WASHINGTON, DEPT STAT, BOX 354322, SEATTLE, WA 98195 USA.				NIGMS NIH HHS [GM-46255] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046255] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNASON A, 1977, NATURE, V268, P527, DOI 10.1038/268527a0; AYALA FJ, 1994, P NATL ACAD SCI USA, V91, P6787, DOI 10.1073/pnas.91.15.6787; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CHAKRABORTY R, 1988, AM J HUM GENET, V43, P709; EDWARDS JH, 1980, POPULATION STRUCTURE, P239; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; JORDE LB, 1995, AM J HUM GENET, V56, P11; KAPLAN NL, 1995, AM J HUM GENET, V56, P18; NEEL JV, 1978, P NATL ACAD SCI USA, V75, P1904, DOI 10.1073/pnas.75.4.1904; NEEL JV, 1978, ANNU REV GENET, V12, P365, DOI 10.1146/annurev.ge.12.120178.002053; NEEL JV, 1988, AM J HUM GENET, V43, P870; NEEL JV, 1975, AM J PHYS ANTHROPOL, V42, P25, DOI 10.1002/ajpa.1330420105; NEEL JV, 1980, POPULATION STRUCTURE, P173; PIAZZA A, 1995, P NATL ACAD SCI USA, V92, P5836, DOI 10.1073/pnas.92.13.5836; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; ROBERTSON A, 1971, Theoretical Population Biology, V2, P24; ROMEO G, 1994, CYSTIC FIBROSIS CURR, P75; Scriver CR, 1996, CIBA F SYMP, V197, P73; SLATKIN M, 1994, GENETICS, V137, P331; SPIELMAN RS, 1977, GENETICS, V85, P355; THOMPSON EA, 1992, AM J HUM GENET, V51, P609; THOMPSON EA, 1978, NATURE, V272, P288, DOI 10.1038/272288a0; Thompson EA, 1996, MOL PHYLOGENET EVOL, V5, P220, DOI 10.1006/mpev.1996.0015; THOMPSON EA, 1988, AM J HUM GENET, V42, P113; THOMPSON EA, 1978, P NATL ACAD SCI USA, V75, P1442, DOI 10.1073/pnas.75.3.1442	25	89	90	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					197	204						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981963				2022-12-18	WOS:A1997WA81800026
J	Gouya, L; Deybach, JC; Lamoril, J; DaSilva, V; Beaumont, C; Grandchamp, B; Nordmann, Y				Gouya, L; Deybach, JC; Lamoril, J; DaSilva, V; Beaumont, C; Grandchamp, B; Nordmann, Y			Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GRADIENT GEL-ELECTROPHORESIS; MOLECULAR DEFECT; GENE; IDENTIFICATION; MUTATIONS; DNA; EXTRACTION; SPECTRIN	Erythropoietic protoporphyria (EPP) is a monogenic inherited disorder of the heme biosynthetic pathway due to ferrochelatase (FC) deficiency. EPP is generally considered to be transmitted as an autosomal dominant disease with incomplete penetrance, although autosomal recessive inheritance has been documented at the enzymatic and molecular level in some families. In the dominant form of EPP, statistical analysis of FC activities documented a significantly lower mean value in patients than in asymptomatic carriers, suggesting a more complex mode of inheritance. To account for these findings, we rested a multiallelic inheritance model in one EPP family in which the enzymatic data were compatible with this hypothesis. In this EPP family, the specific FC gene mutation was an exon 10 skipping (Delta Ex10), resulting from a G deletion within the exon 10 consensus splice donor site. The segregation of al FC alleles within the family was followed using the Delta Ex10 mutation and a new intragenic dimorphism (1520 C/T). mRNAs transcribed from each FC allele were then subjected to relative quantification by a primer extension assay and to absolute quantification by a ribonuclease protection assay. The data support the hypothesis that in this family the EPP phenotype results from the coinheritance of a low output normal FC allele and a mutant Delta Ex10 allele.	HOP LOUIS MOURIER,INSERM U409,CTR FRANCAIS PORPHYRIES,F-92701 COLOMBES 18,FRANCE; FAC XAVIER BICHAT,INSERM U409,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite				Gouya, Laurent/0000-0002-1326-7025				ALLOISIO N, 1991, J CLIN INVEST, V87, P2169, DOI 10.1172/JCI115250; BRENNER DA, 1992, AM J HUM GENET, V50, P1203; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEYBACH JC, 1986, PORPHYRINS PORPHYRIA, P163; FAMEI L, 1987, BIOMED CHROMATOGR, V2, P164; HUTMAN T, 1989, NUCLEIC ACIDS RES, V17, P4937; LAMORIL J, 1991, BIOCHEM BIOPH RES CO, V181, P594, DOI 10.1016/0006-291X(91)91231-Z; LEE JS, 1991, P NATL ACAD SCI USA, V88, P10912, DOI 10.1073/pnas.88.23.10912; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LOPAREV VN, 1991, J VIROL METHODS, V34, P105, DOI 10.1016/0166-0934(91)90126-K; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NAKAHASHI Y, 1990, BIOCHEM BIOPH RES CO, V173, P748, DOI 10.1016/S0006-291X(05)80099-3; NAKAHASHI Y, 1992, P NATL ACAD SCI USA, V89, P281, DOI 10.1073/pnas.89.1.281; NAKAHASHI Y, 1993, HUM MOL GENET, V2, P1069, DOI 10.1093/hmg/2.7.1069; NAKAHASHI Y, 1993, HUM GENET, V91, P303; NORDMANN Y, 1989, BIOSYNTHESIS HEME CH, P491; NORRIS PG, 1990, J INVEST DERMATOL, V95, P260, DOI 10.1111/1523-1747.ep12484876; PICKETTS DJ, 1992, HUM GENET, V89, P155; PORCHER C, 1992, BIOTECHNIQUES, V13, P106; SARKANY RPE, 1994, LANCET, V343, P1394, DOI 10.1016/S0140-6736(94)92525-9; SARKANY RPE, 1992, BR J DERMATOL S40, V127, P19; STRAKA JG, 1991, J BIOL CHEM, V266, P24637; TAKETANI S, 1992, EUR J BIOCHEM, V205, P217, DOI 10.1111/j.1432-1033.1992.tb16771.x; TODD DJ, 1993, HUM MOL GENET, V2, P1495, DOI 10.1093/hmg/2.9.1495; WANG XH, 1993, BIOCHIM BIOPHYS ACTA, V1181, P198, DOI 10.1016/0925-4439(93)90112-E; WENT LN, 1984, ANN HUM GENET, V48, P105, DOI 10.1111/j.1469-1809.1984.tb01006.x; WHITCOMBE DM, 1991, GENOMICS, V11, P1152, DOI 10.1016/0888-7543(91)90044-F; WILMOTTE R, 1993, J CLIN INVEST, V91, P2091, DOI 10.1172/JCI116432	29	89	91	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1996	58	2					292	299						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TR791	8571955				2022-12-18	WOS:A1996TR79100005
J	Dobyns, WB				Dobyns, WB			Absence makes the search grow longer	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							CORPUS-CALLOSUM AGENESIS; INTERSTITIAL DELETION; MENTAL-RETARDATION; MATERNAL TRANSLOCATION; RECESSIVE INHERITANCE; MOSAIC TETRASOMY-8P; POLYCYSTIC KIDNEYS; MALFORMED NEWBORN; PARTIAL TRISOMY; NERVOUS-SYSTEM		UNIV MINNESOTA, SCH MED, DEPT PEDIAT, MINNEAPOLIS, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Dobyns, WB (corresponding author), UNIV MINNESOTA, SCH MED, DEPT NEUROL, BOX 486, 420 DELAWARE ST SE, MINNEAPOLIS, MN 55455 USA.		Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020	Dobyns, William/0000-0002-7681-2844				AICARDI J, 1965, ELECTROEN CLIN NEURO, V19, P609; ANDERMANN E, 1994, ADV BEHAV BIOL, V42, P31; ANDERMANN F, 1994, ADV BEHAV BIOL, V42, P19; ANTICH J, 1983, ACTA PAEDIATR SCAND, V72, P631, DOI 10.1111/j.1651-2227.1983.tb09785.x; Ardouin M, 1974, Rev Otoneuroophtalmol, V46, P143; AUTIO S, 1988, CLIN GENET, V34, P293; BAMFORTH F, 1988, LANCET, V2, P450; BATTISTELLA PS, 1986, 12TH NAT C NEUR CHIE; BAVEREL F, 1985, PRESSE MED, V14, P781; BLACKSHEAR PJ, 1992, GENOMICS, V14, P168, DOI 10.1016/S0888-7543(05)80300-3; BOHM N, 1982, EUR J PEDIATR, V139, P60, DOI 10.1007/BF00442082; Boyd E, 1993, Clin Dysmorphol, V2, P332; Braddock S R, 1994, Clin Dysmorphol, V3, P75; BRIMBLECOMBE FSW, 1977, J MED GENET, V14, P271, DOI 10.1136/jmg.14.4.271; BROWN GK, 1982, PEDIATRICS, V70, P532; BUNTINX I, 1990, AM J MED GENET, V36, P273, DOI 10.1002/ajmg.1320360304; Camera G, 1993, Clin Dysmorphol, V2, P317; CARPENTER S, 1994, ADV BEHAV BIOL, V42, P27; Casaubon LK, 1996, AM J HUM GENET, V58, P28; CLARK CE, 1980, AM J MED GENET, V7, P21, DOI 10.1002/ajmg.1320070106; COHEN MM, 1990, AM J MED GENET, V35, P36, DOI 10.1002/ajmg.1320350108; CONNACHER AA, 1987, J MED GENET, V24, P116, DOI 10.1136/jmg.24.2.116; COTTRALL K, 1981, J MENT DEFIC RES, V25, P1; COURTENS W, 1994, AM J MED GENET, V51, P260, DOI 10.1002/ajmg.1320510318; CURATOLO P, 1993, NEUROPEDIATRICS, V24, P77, DOI 10.1055/s-2008-1071518; Vles J. S. H., 1993, Genetic Counseling, V4, P239; DEFRANCE HF, 1984, CLIN GENET, V25, P295; DIGILIO MC, 1994, J MED GENET, V31, P238, DOI 10.1136/jmg.31.3.238; DINCSOY MY, 1995, AM J MED GENET, V56, P317, DOI 10.1002/ajmg.1320560321; DOBYNS WB, 1991, AM J HUM GENET, V48, P584; DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; DOBYNS WB, 1989, NEUROLOGY, V39, P817, DOI 10.1212/WNL.39.6.817; DOBYNS WB, IN PRESS NEUROLOGY; DODGE NN, 1995, AM J MED GENET, V56, P147, DOI 10.1002/ajmg.1320560206; DUCA D, 1980, J GENET HUM, V28, P31; ERDOHAZI M, 1976, ACTA NEUROPATHOL, V36, P315, DOI 10.1007/BF00699637; FINEMAN RM, 1979, CLIN GENET, V16, P390; Francke U, 1977, Birth Defects Orig Artic Ser, V13, P167; FRANCOIS J, 1973, AM J OPHTHALMOL, V76, P241, DOI 10.1016/0002-9394(73)90168-2; FRYDMAN M, 1989, AM J MED GENET, V34, P476, DOI 10.1002/ajmg.1320340405; FRYNS JP, 1977, HUM GENET, V37, P155, DOI 10.1007/BF00393578; FUNDERBURK SJ, 1978, ANN GENET-PARIS, V21, P219; GARANI GP, 1988, J MED GENET, V25, P211, DOI 10.1136/jmg.25.3.211; GEORMANEANU M, 1981, ANN GENET-PARIS, V24, P176; GIBBONS RJ, 1995, CELL, V80, P837, DOI 10.1016/0092-8674(95)90287-2; GLICKSTEIN J, 1995, AM J MED GENET, V56, P215, DOI 10.1002/ajmg.1320560220; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; GUIONALMEIDA ML, 1992, AM J MED GENET, V43, P929, DOI 10.1002/ajmg.1320430604; GULLOTTA F, 1974, BEITR PATHOL, V152, P74; HAUSER E, 1993, NEUROPEDIATRICS, V24, P107, DOI 10.1055/s-2008-1071524; HOLBEK S, 1974, HUMANGENETIK, V24, P191; HOO JJ, 1991, AM J MED GENET, V40, P290, DOI 10.1002/ajmg.1320400308; IONASESCU V, 1987, American Journal of Medical Genetics, V26, P189, DOI 10.1002/ajmg.1320260128; JAYARAMAN A, 1976, CHILD BRAIN, V2, P202; JERET JS, 1986, PEDIATR NEUROSCI, V12, P101, DOI 10.1159/000120229; KAPLAN P, 1983, J MED GENET, V20, P122, DOI 10.1136/jmg.20.2.122; KATAFUCHI Y, 1992, J CHILD NEUROL, V7, P114, DOI 10.1177/088307389200700120; KELLEY RI, 1986, AM J MED GENET, V23, P869, DOI 10.1002/ajmg.1320230404; KIM EH, 1992, AM J MED GENET, V44, P437, DOI 10.1002/ajmg.1320440410; KLECZKOWSKA A, 1987, CLIN GENET, V32, P49; LEE M, 1979, HUM GENET, V51, P343; LEVIN H, 1986, AM J MED GENET, V25, P281, DOI 10.1002/ajmg.1320250212; LINDSAY EA, 1994, AM J MED GENET, V49, P229, DOI 10.1002/ajmg.1320490214; LUJAN JE, 1984, AM J MED GENET, V17, P311, DOI 10.1002/ajmg.1320170124; LYNN RB, 1980, ARCH NEUROL-CHICAGO, V37, P444, DOI 10.1001/archneur.1980.00500560074011; LYON G, 1990, ANN NEUROL, V27, P193, DOI 10.1002/ana.410270216; MATHIEU J, 1990, CAN J NEUROL SCI, V17, P103, DOI 10.1017/S0317167100030298; MATTEI JF, 1980, HUM GENET, V53, P315, DOI 10.1007/BF00287049; MCCONNELL TS, 1980, HUM PATHOL, V11, P202, DOI 10.1016/S0046-8177(80)80146-8; MEINECKE P, 1991, J MED GENET, V28, P795, DOI 10.1136/jmg.28.11.795; MENKES JH, 1964, ARCH NEUROL-CHICAGO, V11, P198, DOI 10.1001/archneur.1964.00460200094009; MUENKE M, 1991, 23RD ANN MARCH DIM C; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; MURAYAMA K, 1991, AM J MED GENET, V40, P488, DOI 10.1002/ajmg.1320400424; Myrianthopoulos NC., 1977, HDB CLIN NEUROLOGY, P139; NAKAMURA Y, 1986, CLIN NEUROPATHOL, V5, P47; NEWTON D, 1993, AM J MED GENET, V46, P513, DOI 10.1002/ajmg.1320460510; Norman MG, 1995, CONGENITAL MALFORMAT, P309; OPITZ JM, 1988, AM J MED GENET, V30, P309, DOI 10.1002/ajmg.1320300132; OPITZ JM, 1987, AM J MED GENET, V28, P275, DOI 10.1002/ajmg.1320280203; OSAWA M, 1991, Acta Paediatrica Japonica, V33, P261; OSTROVSKAYA TI, 1988, AM J MED GENET, V30, P747, DOI 10.1002/ajmg.1320300308; PAAVOLA P, 1995, NAT GENET, V11, P213, DOI 10.1038/ng1095-213; PAETAU A, 1985, CLIN NEUROPATHOL, V4, P56; PEEDEN JN, 1982, AM J HUM GENET, V34, pA104; Petrij F., 1995, American Journal of Human Genetics, V57, pA3; PETTENATI MJ, 1986, AM J MED GENET, V24, P23, DOI 10.1002/ajmg.1320240104; PIHKO H, 1981, HUM GENET, V58, P129, DOI 10.1007/BF00278696; PROUD VK, 1992, AM J MED GENET, V43, P458, DOI 10.1002/ajmg.1320430169; RAMER JC, 1990, AM J MED GENET, V37, P392, DOI 10.1002/ajmg.1320370320; RAMER JC, 1989, AM J MED GENET, V32, P359, DOI 10.1002/ajmg.1320320318; RENAULT F, 1991, AUG IBRO SAT S CALL; ROBIN NH, IN PRESS NAT GENET; ROBINOW M, 1989, AM J MED GENET, V32, P320, DOI 10.1002/ajmg.1320320309; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; ROTT HD, 1972, HUMANGENETIK, V14, P300, DOI 10.1007/BF00290171; SALONEN R, 1981, CLIN GENET, V19, P321; SARAIVA JM, 1992, AM J MED GENET, V43, P726, DOI 10.1002/ajmg.1320430415; SCHINZEL A, 1980, AM J MED GENET, V6, P241, DOI 10.1002/ajmg.1320060308; SERUR D, 1988, NEUROPEDIATRICS, V19, P87, DOI 10.1055/s-2008-1052407; SHAPIRA Y, 1973, J MED GENET, V10, P266, DOI 10.1136/jmg.10.3.266; SHAPIRO WR, 1969, BRAIN, V92, P423, DOI 10.1093/brain/92.2.423; SHENSCHWARZ S, 1989, AM J MED GENET, V32, P81, DOI 10.1002/ajmg.1320320117; SHEVELL MI, 1994, PEDIATR NEUROL, V11, P224, DOI 10.1016/0887-8994(94)90107-4; SIBER M, 1984, CLIN GENET, V26, P453; SIDMAN RL, 1982, HISTOL HISTOPATHOL, P40; SONDEREGGER P, 1992, J CELL BIOL, V119, P1387, DOI 10.1083/jcb.119.6.1387; STUMPO DJ, 1995, P NATL ACAD SCI USA, V92, P944, DOI 10.1073/pnas.92.4.944; TABOR A, 1983, HUM GENET, V64, P196, DOI 10.1007/BF00327127; TODA T, 1994, AM J HUM GENET, V55, P946; TORIELLO HV, 1988, AM J MED GENET, V31, P17, DOI 10.1002/ajmg.1320310105; VALDMANI.A, 1967, ANN GENET-PARIS, V10, P159; VALERIO D, 1993, J MED GENET, V30, P697, DOI 10.1136/jmg.30.8.697; VANBALKOM IDC, 1991, GENET COUNS, V3, P83; VICI CD, 1988, AM J MED GENET, V29, P1, DOI 10.1002/ajmg.1320290102; Vles J S, 1990, Genet Couns, V1, P97; WAHLSTEN D, 1989, EXPERIENTIA, V45, P828, DOI 10.1007/BF01954057; WARBURG M, 1993, AM J DIS CHILD, V147, P1309, DOI 10.1001/archpedi.1993.02160360051017; WELEBER RG, 1976, ANN GENET-PARIS, V19, P241; WILKIE AOM, 1995, NAT GENET, V9, P165, DOI 10.1038/ng0295-165; YAMAMOTO T, 1995, AM J MED GENET, V56, P6, DOI 10.1002/ajmg.1320560103	121	89	92	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1996	58	1					7	16						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TL697	8554070				2022-12-18	WOS:A1996TL69700003
J	BERGOFFEN, J; TROFATTER, J; PERICAKVANCE, MA; HAINES, JL; CHANCE, PF; FISCHBECK, KH				BERGOFFEN, J; TROFATTER, J; PERICAKVANCE, MA; HAINES, JL; CHANCE, PF; FISCHBECK, KH			LINKAGE LOCALIZATION OF X-LINKED CHARCOT-MARIE-TOOTH DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SENSORY NEUROPATHY; HEREDITARY MOTOR; DOMINANT INHERITANCE; DNA; FAMILY; POLYMORPHISMS; POLYMERASE; PROBES; LOCUS	Charcot-Marie-Tooth disease (CMT), also known as hereditary motor and sensory neuropathy, is a heterogeneous group of slowly progressive, degenerative disorders of peripheral nerve. X-linked CMT (CMTX) (McKusick 302800), a subdivision of type I, or demyelinating, CMT is an X-linked dominant condition with variable penetrance. Previous linkage analysis using RFLPs demonstrated linkage to markers on the proximal long and short arms of the X chromosome, with the more likely localization on the proximal long arm of the X chromosome. Available variable simple-sequence repeats (VSSRs) broaden the possibilities for linkage analysis. This paper presents new linkage data and recombination analysis derived from work with four VSSR markers -AR, PGKP1, DXS453, and DXYS1X-in addition to analysis using RFLP markers described elsewhere. These studies localize the CMTX gene to the proximal Xq segment between PGKP1 (Xq11.2-12) and DXS72 (Xq21.1), with a combined maximum multipoint lod score of 15.3 at DXS453 (theta = 0).	CHILDRENS HOSP, DEPT HUMAN GENET & MOLEC BIOL, PHILADELPHIA, PA 19104 USA; MASSACHUSETTS GEN HOSP, MOLEC NEUROGENET UNIT, BOSTON, MA 02114 USA; DUKE UNIV, MED CTR, DIV NEUROL, DURHAM, NC 27710 USA; UNIV UTAH, MED CTR, DIV MED GENET, SALT LAKE CITY, UT 84112 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Massachusetts General Hospital; Duke University; Utah System of Higher Education; University of Utah	BERGOFFEN, J (corresponding author), UNIV PENN, SCH MED,DEPT NEUROL,CLIN RES BLDG,422 CURIE BLVD, ROOM 280, PHILADELPHIA, PA 19104 USA.		Chance, Phillip/AAX-5826-2020; Haines, Jonathan/C-3374-2012	Haines, Jonathan/0000-0002-4351-4728	NINDS NIH HHS [NS08075, NS26330] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS008075, P50NS008075] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allan W, 1939, ARCH INTERN MED, V63, P1123, DOI 10.1001/archinte.1939.00180230108008; BECKETT J, 1986, J NEUROGENET, V3, P225, DOI 10.3109/01677068609106852; BROWNE DL, 1992, NUCLEIC ACIDS RES, V20, P1169, DOI 10.1093/nar/20.5.1169-a; BROWNE DL, 1991, NUCLEIC ACIDS RES, V19, P1721, DOI 10.1093/nar/19.7.1721-a; Charcot JM, 1886, REV MED-PARIS, V6, P97; CONNEALLY PM, 1985, CYTOGENET CELL GENET, V40, P356, DOI 10.1159/000132186; COWCHOCK FS, 1985, AM J MED GENET, V20, P307, DOI 10.1002/ajmg.1320200214; EDWARDS A, 1991, AM J HUM GENET, V49, P746; FISCHBECK KH, 1986, ANN NEUROL, V20, P527, DOI 10.1002/ana.410200414; FISCHBECK KH, 1990, CHARCOT MARIE TOOTH, P335; GAL A, 1985, HUM GENET, V70, P38, DOI 10.1007/BF00389456; GOONEWARDENA P, 1988, CLIN GENET, V33, P435; HAHN AF, 1990, BRAIN, V113, P1511, DOI 10.1093/brain/113.5.1511; HAITES N, 1989, CLIN GENET, V35, P399; IONASESCU VV, 1988, MUSCLE NERVE, V11, P1154, DOI 10.1002/mus.880111108; IONASESCU VV, 1992, NEUROLOGY, V42, P903, DOI 10.1212/WNL.42.4.903; IONASESCU VV, 1991, AM J HUM GENET, V48, P1075; ISELIUS L, 1982, HEREDITAS, V97, P157, DOI 10.1111/j.1601-5223.1982.tb00723.x; LASPADA A, 1991, AM J HUM GENET, V49, P357; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LUTY JA, 1990, AM J HUM GENET, V46, P776; MOSTACCIUOLO ML, 1991, HUM GENET, V87, P23, DOI 10.1007/BF01213086; OTT J, 1976, AM J HUM GENET, V28, P528; PHILLIPS LH, 1985, NEUROLOGY, V35, P498, DOI 10.1212/WNL.35.4.498; ROZEAR MP, 1987, NEUROLOGY, V37, P1460, DOI 10.1212/WNL.37.9.1460; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SKRE H, 1974, CLIN GENET, V6, P98; Tooth HH, 1886, PERONEAL TYPE PROGRE; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P4037, DOI 10.1093/nar/18.13.4037; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEERDT CJD, 1978, EUR NEUROL, V17, P336, DOI 10.1159/000114972	31	89	91	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					312	318						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8430694				2022-12-18	WOS:A1993KN27500009
J	BREUNING, MH; DAUWERSE, HG; FUGAZZA, G; SARIS, JJ; SPRUIT, L; WIJNEN, H; TOMMERUP, N; VANDERHAGEN, CB; IMAIZUMI, K; KUROKI, Y; VANDENBOOGAARD, MJ; DEPATER, JM; MARIMAN, ECM; HAMEL, BCJ; HIMMELBAUER, H; FRISCHAUF, AM; STALLINGS, RL; BEVERSTOCK, GC; VANOMMEN, GJB; HENNEKAM, RCM				BREUNING, MH; DAUWERSE, HG; FUGAZZA, G; SARIS, JJ; SPRUIT, L; WIJNEN, H; TOMMERUP, N; VANDERHAGEN, CB; IMAIZUMI, K; KUROKI, Y; VANDENBOOGAARD, MJ; DEPATER, JM; MARIMAN, ECM; HAMEL, BCJ; HIMMELBAUER, H; FRISCHAUF, AM; STALLINGS, RL; BEVERSTOCK, GC; VANOMMEN, GJB; HENNEKAM, RCM			RUBINSTEIN-TAYBI SYNDROME CAUSED BY SUBMICROSCOPIC DELETIONS WITHIN 16P13.3	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; SHORT ARM; INSITU HYBRIDIZATION; CHROMOSOME-16; DNA; LOCALIZATION; LEUKEMIA; MARKERS; LOCI; GENE	The Rubinstein-Taybi syndrome (RTS) is a well-defined complex of congenital malformations characterized by facial abnormalities, broad thumbs and big toes, and mental retardation. The breakpoint of two distinct reciprocal translocations occurring in patients with a clinical diagnosis of RTS was located to the same interval on chromosome 16, between the cosmids N2 and RT1, in band 16p13.3. By using two-color fluorescence in situ hybridization, the signal from RT1 was found to be missing from one chromosome 16 in 6 of 24 patients with RTS. The parents of five of these patients did not show a deletion of RT1, indicating a de novo rearrangement. RTS is caused by submicroscopic interstitial deletions within 16p13.3 in approximately 25% of the patients. The detection of microdeletions will allow the objective confirmation of the clinical diagnosis in new patients and provides an excellent tool for the isolation of the gene causally related to the syndrome.	JOHN F KENNEDY INST,DANISH CTR HUMAN GENOME RES,GLOSTRUP,DENMARK; UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,NIJMEGEN,NETHERLANDS; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND; LOS ALAMOS NATL LAB,LOS ALAMOS,NM 87544; AVD MED GENET,OSLO,NORWAY; KANAGAWA CHILDRENS MED CTR,DIV MED GENET,YOKOHAMA,KANAGAWA,JAPAN; CLIN GENET CTR,UTRECHT,NETHERLANDS	Aarhus University; Radboud University Nijmegen; Cancer Research UK; United States Department of Energy (DOE); Los Alamos National Laboratory	BREUNING, MH (corresponding author), LEIDEN UNIV,SYLVIUS LABS,DEPT HUMAN GENET,WASSENAARSEWEG 72,2333 AL LEIDEN,NETHERLANDS.		Wijnen, Herman/N-8391-2019; Stallings, Raymond/A-7213-2008; Tommerup, Niels/T-8776-2017; Breuning, Martijn H/E-3429-2010; Wijnen, Herman/B-8860-2013	Wijnen, Herman/0000-0002-8710-5176; Tommerup, Niels/0000-0003-2304-0112; Wijnen, Herman/0000-0002-8710-5176; Himmelbauer, Heinz/0000-0001-8897-2928				BREUNING MH, 1977, HUM GENET, V38, P7, DOI 10.1007/BF00295802; BREUNING MH, 1990, J MED GENET, V27, P603, DOI 10.1136/jmg.27.10.603; BREUNING MH, 1990, PATHOGENESIS POLYCYS, P17; CALLEN DF, 1989, GENOMICS, V4, P348, DOI 10.1016/0888-7543(89)90341-8; CALLEN DF, 1990, ANN GENET-PARIS, V33, P190; CECCHERINI I, 1992, P NATL ACAD SCI USA, V89, P104, DOI 10.1073/pnas.89.1.104; DAUWERSE JG, 1992, BLOOD, V79, P1299; DAUWERSE JG, 1990, CYTOGENET CELL GENET, V53, P126, DOI 10.1159/000132911; GILLESPIE GA, 1990, NUCLEIC ACIDS RES, V18, P7071, DOI 10.1093/nar/18.23.7071; HARRIS P, 1987, HUM GENET, V77, P95, DOI 10.1007/BF00272372; HENNEKAM RCM, 1993, AM J HUM GENET, V52, P255; HENNEKAM RCM, 1991, AM J MED GENET, V38, P634, DOI 10.1002/ajmg.1320380429; HENNEKAM RCM, 1990, AM J MED GENET S, V6, P17; HIMMELBAUER H, 1991, AM J HUM GENET, V48, P325; IMAIZUMI K, 1991, AM J MED GENET, V38, P636, DOI 10.1002/ajmg.1320380430; KEITH TP, 1990, P NATL ACAD SCI USA, V87, P5754, DOI 10.1073/pnas.87.15.5754; KIEVITS T, 1990, CYTOMETRY, V11, P105, DOI 10.1002/cyto.990110112; KUWANO A, 1991, AM J HUM GENET, V49, P707; LANGER PR, 1981, P NATL ACAD SCI-BIOL, V78, P6633, DOI 10.1073/pnas.78.11.6633; MICHAIL J, 1957, Rev Chir Orthop Reparatrice Appar Mot, V43, P142; MOYZIS RK, 1987, CHROMOSOMA, V95, P375, DOI 10.1007/BF00333988; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; QUINTANA A, 1983, CLIN GENET, V23, P243; REEDERS S T, 1988, Genomics, V3, P150, DOI 10.1016/0888-7543(88)90146-2; REEDERS ST, 1985, NATURE, V317, P542, DOI 10.1038/317542a0; RUBINSTEIN JH, 1963, AM J DIS CHILD, V105, P588, DOI 10.1001/archpedi.1963.02080040590010; Schinzel A, 1984, CATALOGUE UNBALANCED; STALLINGS RL, 1990, P NATL ACAD SCI USA, V87, P6218, DOI 10.1073/pnas.87.16.6218; TOMMERUP N, 1991, CYTOGENET CELL GENET, V58, P2002; WESSELS JW, 1991, BLOOD, V77, P1555; WESSELS JW, 1991, CANCER GENET CYTOGEN, V57, P225; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112	32	89	92	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1993	52	2					249	254						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	KN275	8430691				2022-12-18	WOS:A1993KN27500001
J	YOKOTA, I; COATES, PM; HALE, DE; RINALDO, P; TANAKA, K				YOKOTA, I; COATES, PM; HALE, DE; RINALDO, P; TANAKA, K			MOLECULAR SURVEY OF A PREVALENT MUTATION, 985A-TO-G TRANSITION, AND IDENTIFICATION OF 5 INFREQUENT MUTATIONS IN THE MEDIUM-CHAIN ACYL-COA DEHYDROGENASE (MCAD) GENE IN 55 PATIENTS WITH MCAD DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COENZYME-A DEHYDROGENASE; LINKAGE DISEQUILIBRIUM; DICARBOXYLIC ACIDURIA; NUCLEOTIDE-SEQUENCE; COMMON MUTATION; LIVER; RAT; PHENYLKETONURIA; SUBSTITUTION; PURIFICATION	Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency is an inborn error of fatty-acid oxidation that is characterized by fasting intolerance and recurrent episodes of hypoglycemic coma which can be fatal. Its incidence is one of the highest among genetic metabolic disorders. Using a modified PCR and NcoI digestion method, we have surveyed 46 additional, unrelated MCAD-deficient patients for a prevalent mutation, an 985A-to-G transition (985A --> G), that we previously identified in nine MCAD-deficient patients. Among the total of 55,studied, 44 were homozygous and 10 were heterozygous for the 985G allele, whereas one did not carry this mutant allele, indicating that the prevalence of the 985G allele is 89.1%. Furthermore, we identified five other types of mutation: one each in three of the compound heterozygotes and two in the single non-985G patient. An RFLP study of 12 985G-homozygotes showed that all 24 alleles fell into a single haplotype. A questionnaire regarding the ethnic and national origin of their patients was sent to all referring investigators. All 41 patients for whom this information was provided were Caucasians. Of 29 patients whose country of origin was specified, 19 and five were from the British Isles and Germany, respectively. These data suggest that 985A --> G may have occurred in a single person in an ancient Germanic tribe.	YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,POB 3333,NEW HAVEN,CT 06510; UNIV PENN,SCH MED,DEPT PEDIAT,DIV GASTROENTEROL NUTR,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT PEDIAT,DIV ENDOCRINOL DIABET,PHILADELPHIA,PA 19104; CHILDRENS HOSP,PHILADELPHIA,PA 19104	Yale University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	TANAKA, K (corresponding author), YALE UNIV,SCH MED,DEPT HUMAN GENET,333 CEDAR ST,POB 3333,NEW HAVEN,CT 06510, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS017752] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK38154] Funding Source: Medline; NINDS NIH HHS [NS17752] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENNETT MJ, 1987, J INHERIT METAB DIS, V10, P241, DOI 10.1007/BF01800069; BLAKEMORE AIF, 1991, LANCET, V337, P298, DOI 10.1016/0140-6736(91)90907-7; COATES PM, 1985, PEDIATR RES, V19, P671, DOI 10.1203/00006450-198507000-00007; DAVIS LG, 1986, BASIC METHODS MOL BI, P129; DELVALLE JA, 1984, J INHERIT METAB DIS, V7, P62, DOI 10.1007/BF01805804; DILELLA AG, 1987, NATURE, V327, P333, DOI 10.1038/327333a0; DILELLA AG, 1986, NATURE, V322, P799, DOI 10.1038/322799a0; FINOCCHIARO G, 1987, J BIOL CHEM, V262, P7982; GREGERSEN N, 1991, HUM GENET, V86, P545; IKEDA Y, 1986, PEDIATR RES, V20, P843, DOI 10.1203/00006450-198609000-00007; IKEDA Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P662, DOI 10.1016/0003-9861(87)90072-5; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; KELLY DP, 1990, P NATL ACAD SCI USA, V87, P9236, DOI 10.1073/pnas.87.23.9236; KELLY DP, 1987, P NATL ACAD SCI USA, V84, P4068, DOI 10.1073/pnas.84.12.4068; KEREM E, 1990, NEW ENGL J MED, V323, P1517, DOI 10.1056/NEJM199011293232203; KIDD JR, 1990, GENOMICS, V6, P89, DOI 10.1016/0888-7543(90)90451-Y; KURDIHAIDAR B, 1990, AM J HUM GENET, V47, P1013; Luzzatto L., 1988, METABOLIC BASIS INHE, P2237; MATSUBARA Y, 1990, BIOCHEM BIOPH RES CO, V171, P498, DOI 10.1016/0006-291X(90)91421-N; MATSUBARA Y, 1987, J BIOL CHEM, V262, P10104; MATSUBARA Y, 1986, P NATL ACAD SCI USA, V83, P6543, DOI 10.1073/pnas.83.17.6543; MCCABE ERB, 1987, HUM GENET, V75, P213, DOI 10.1007/BF00281061; RINALDO P, 1988, NEW ENGL J MED, V319, P1308, DOI 10.1056/NEJM198811173192003; ROE CR, 1985, PEDIATR RES, V19, P459, DOI 10.1203/00006450-198505000-00011; ROE CR, 1988, METABOLIC BASIS INHE, P889; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; WANG T, 1989, AM J HUM GENET, V45, P675; YOKOTA I, 1990, LANCET, V336, P748, DOI 10.1016/0140-6736(90)92241-9; YOKOTA I, 1990, J CLIN INVEST, V86, P1000, DOI 10.1172/JCI114761	29	89	92	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1280	1291						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1684086				2022-12-18	WOS:A1991GU67200014
J	TRIGGSRAINE, BL; AKERMAN, BR; CLARKE, JTR; GRAVEL, RA				TRIGGSRAINE, BL; AKERMAN, BR; CLARKE, JTR; GRAVEL, RA			SEQUENCE OF DNA FLANKING THE EXONS OF THE HEXA GENE, AND IDENTIFICATION OF MUTATIONS IN TAY-SACHS DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEXOSAMINIDASE ALPHA-CHAIN; HUMAN BETA-HEXOSAMINIDASE; ADULT GM2 GANGLIOSIDOSIS; ASHKENAZI JEWS; FRENCH-CANADIANS; MOLECULAR-BASIS; SUBUNIT; ENZYME; DEFECT; POLYMORPHISMS	The rapid identification of mutations causing Tay-Sachs disease requires the capacity to readily screen the regions of the HEXA gene most likely to be affected by mutation. We have sequenced the portions of the introns flanking each of the 14 HEXA exons in order to specify oligonucleotide primers for the PCR-dependent amplification of each exon and splice-junction sequence. The amplified products were analyzed, by electrophoresis in nondenaturing polyacrylamide gels, for the presence of either heteroduplexes, derived from the annealing of normal and mutant DNA strands, or single-strand conformational polymorphisms (SSCP), derived from the renaturation of single-stranded DNA. Five novel mutations from Tay-Sachs disease patients were detected: a 5-bp deletion of TCTCC in IVS-9; a 2-bp deletion of TG in exon 5; G78 to A, giving a stop codon in exon 1; G533 to T in exon 5, producing the third amino acid substitution detected at this site; and G to C at position 1 of IVS-2, expected to produce abnormal splicing. In addition, two mutations, (G1496 to A in exon 13 and a 4-bp insertion in exon 11) that have previously been reported were identified.	MCGILL UNIV,MONTREAL CHILDRENS HOSP,RES INST,2300 TUPPER ST,MONTREAL H3H 1P3,QUEBEC,CANADA; HOSP SICK CHILDREN,DEPT PEDIAT,TORONTO M5G 1X8,ONTARIO,CANADA	McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)			Triggs-Raine, Barbara/AAF-6209-2021	Triggs-Raine, Barbara/0000-0003-4719-6779				ARPAIA E, 1988, NATURE, V333, P85, DOI 10.1038/333085a0; BROWN CA, 1989, J BIOL CHEM, V264, P21705; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; GELFAND MS, 1989, NUCLEIC ACIDS RES, V17, P6369, DOI 10.1093/nar/17.15.6369; GRAVEL RA, 1991, CAN J NEUROL SCI, V18, P419, DOI 10.1017/S0317167100032583; HECHTMAN P, 1990, AM J HUM GENET, V47, P815; HOAR DI, 1984, PRENATAL DIAG, V4, P241, DOI 10.1002/pd.1970040402; IKEHATA H, 1989, MOL GEN GENET, V219, P349, DOI 10.1007/BF00259606; KAPLAN F, IN PRESS J INHERITED; KAZAZIAN HH, 1990, SEMIN HEMATOL, V27, P209; KORNELUK RG, 1986, J BIOL CHEM, V261, P8407; LAU MMH, 1989, J BIOL CHEM, V264, P21376; MAHURAN D, 1985, ISOZYMES-CURR T BIOL, V12, P229; Maniatis T., 1982, MOL CLONING; MEUTH M, 1990, BIOCHIM BIOPHYS ACTA, V1032, P1, DOI 10.1016/0304-419X(90)90009-P; MYEROWITZ R, 1987, J BIOL CHEM, V262, P15396; MYEROWITZ R, 1988, J BIOL CHEM, V263, P18587; MYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955, DOI 10.1073/pnas.85.11.3955; MYEROWITZ R, 1985, P NATL ACAD SCI USA, V82, P7830, DOI 10.1073/pnas.82.23.7830; NAVON R, 1990, AM J HUM GENET, V46, P817; NAVON R, 1989, SCIENCE, V243, P1471, DOI 10.1126/science.2522679; NEUFELD EF, 1989, J BIOL CHEM, V264, P10927; OHNO K, 1988, BIOCHEM BIOPH RES CO, V153, P363; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAW BH, 1990, J BIOL CHEM, V265, P9452; PAW BH, 1989, P NATL ACAD SCI USA, V86, P2413, DOI 10.1073/pnas.86.7.2413; PROIA RL, 1987, J BIOL CHEM, V262, P5677; ROZEN R, 1985, NATURE, V313, P815, DOI 10.1038/313815a0; Sandhoff K, 1989, METABOLIC BASIS INHE, VII, P1807; TANAKA A, 1990, AM J HUM GENET, V46, P329; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; TRIGGSRAINE BL, 1990, AM J HUM GENET, V46, P183; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0	34	89	91	0	8	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1991	49	5					1041	1054						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GM873	1833974				2022-12-18	WOS:A1991GM87300015
J	RISCH, N				RISCH, N			A NOTE ON MULTIPLE TESTING PROCEDURES IN LINKAGE ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Controversy over the impact of multiple testing procedures in linkage analysis is reexamined in this report. Despite some recent claims to the contrary, it is shown that testing multiple markers decreases the posterior false-positive rate among significant tests, rather than increasing it; this is true whether the trait of interest is simply monogenic or complex, or even if the genetic model is misspecified. However, if the true mode of inheritance is complex, or if the genetic model is misspecified, the power to obtain a significant result when linkage is present may be reduced, while the significance level is not, leading to an inflation of the posterior false-positive rate. Furthermore, the posterior false-positive rate increases with decreasing sample size and may be unacceptably high for very small samples. By contrast, testing multiple genetic models, by varying either mode-of-inheritance parameters or diagnostic categories, does lead to an inflation of the posterior false-positive rate. A conservative correction for this case is to subtract log10t from the obtained maximum lod score, where t different genetic and/or diagnostic models have been tested.	YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510	Yale University	RISCH, N (corresponding author), YALE UNIV,SCH MED,DEPT EPIDEMIOL & PUBL HLTH,60 COLL ST,POB 3333,NEW HAVEN,CT 06510, USA.				NHGRI NIH HHS [HG00348] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000348] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		EDWARDS JH, 1989, PSYCHOL MED, V19, P273, DOI 10.1017/S0033291700012307; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; ELSTON RC, 1975, ANN HUM GENET, V38, P341, DOI 10.1111/j.1469-1809.1975.tb00619.x; KIDD KK, 1984, CYTOGENET CELL GENET, V37, P510; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; MORTON NE, 1955, AM J HUM GENET, V7, P277; OTT J, 1990, GENET EPIDEMIOL, V7, P35, DOI 10.1002/gepi.1370070109; OTT J, 1985, ANAL HUMAN GENETIC L; RAO DC, 1978, AM J HUM GENET, V30, P516; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; THOMPSON E A, 1984, Genetic Epidemiology, V1, P357, DOI 10.1002/gepi.1370010407; Wald A., 1947, SEQUENTIAL ANAL	12	89	92	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	1991	48	6					1058	1064						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FP092	2035526				2022-12-18	WOS:A1991FP09200005
J	SOLOMON, SD; GEISTERFERLOWRANCE, AAT; VOSBERG, HP; HILLER, G; JARCHO, JA; MORTON, CC; MCBRIDE, WO; MITCHELL, AL; BALE, AE; MCKENNA, WJ; SEIDMAN, JG; SEIDMAN, CE				SOLOMON, SD; GEISTERFERLOWRANCE, AAT; VOSBERG, HP; HILLER, G; JARCHO, JA; MORTON, CC; MCBRIDE, WO; MITCHELL, AL; BALE, AE; MCKENNA, WJ; SEIDMAN, JG; SEIDMAN, CE			A LOCUS FOR FAMILIAL HYPERTROPHIC CARDIOMYOPATHY IS CLOSELY LINKED TO THE CARDIAC MYOSIN HEAVY-CHAIN GENES, CRI-L436, AND CRI-L329 ON CHROMOSOME-14 AT Q11-Q12	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HARVARD UNIV, SCH MED, DEPT GENET, 25 SHATTUCK ST, BOSTON, MA 02115 USA; ST GEORGE HOSP, SCH MED, DEPT CARDIOL SCI, LONDON, ENGLAND; HARVARD UNIV, SCH MED, HOWARD HUGHES MED INST, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DIV CARDIOVASC, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT PATHOL, BOSTON, MA 02115 USA; MAX PLANCK INST MED RES, DEPT CELL BIOL, W-6900 HEIDELBERG 1, GERMANY; NCI, BIOCHEM LAB, CELL REGULAT SECT, BETHESDA, MD 20205 USA	Harvard University; Harvard Medical School; St Georges University London; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Max Planck Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Solomon, Scott/I-5789-2013; McKenna, William J/C-3243-2008	McKenna, William J/0000-0001-7994-2460	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008096, R01HL042467, R29HL041474] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL42467, R29-HL41474, 1F32-HL08096] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CLARK CE, 1973, NEW ENGL J MED, V289, P709, DOI 10.1056/NEJM197310042891402; COS DW, 1989, CYTOGENET CELL GENET, V51, pA2694; COX DW, 1989, CYTOGENET CELL GENET, V51, pA2695; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; EVERETT AW, 1986, J MOL CELL CARDIOL, V18, P607, DOI 10.1016/S0022-2828(86)80968-3; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; HOLCOMBE R F, 1987, Genomics, V1, P287, DOI 10.1016/0888-7543(87)90058-9; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LICHTER P, 1986, EUR J BIOCHEM, V160, P419, DOI 10.1111/j.1432-1033.1986.tb09989.x; LOMPRE AM, 1984, J BIOL CHEM, V259, P6437; MAHDAVI V, 1984, P NATL ACAD SCI-BIOL, V81, P2626, DOI 10.1073/pnas.81.9.2626; MARON BJ, 1986, ANN INTERN MED, V105, P610, DOI 10.7326/0003-4819-105-4-610; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MATSUOKA R, 1989, CYTOGENET CELL GENET, V51, P1040; MERCADIER JJ, 1983, CIRC RES, V53, P52, DOI 10.1161/01.RES.53.1.52; MERCADIER JJ, 1981, CIRC RES, V49, P525, DOI 10.1161/01.RES.49.2.525; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITCHELL AL, 1989, CYTOGENET CELL GENET, V51, pA2068; MORTON CC, 1984, AM J HUM GENET, V36, P576; RICHARDS EJ, 1987, CURRENT PROTOCOLS MO, V1; SAEZ LJ, 1987, NUCLEIC ACIDS RES, V15, P5443, DOI 10.1093/nar/15.13.5443; SCHIER JJ, 1982, J CLIN INVEST, V69, P816, DOI 10.1172/JCI110521; YAMAUCHITAKIHARA K, 1989, P NATL ACAD SCI USA, V86, P3504, DOI 10.1073/pnas.86.10.3504	25	89	94	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1990	47	3					389	394						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DX223	1975475				2022-12-18	WOS:A1990DX22300003
J	DAHL, N; LAGERSTROM, M; ERIKSON, A; PETTERSSON, U				DAHL, N; LAGERSTROM, M; ERIKSON, A; PETTERSSON, U			GAUCHER DISEASE TYPE-III (NORRBOTTNIAN TYPE) IS CAUSED BY A SINGLE MUTATION IN EXON-10 OF THE GLUCOCEREBROSIDASE GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									BODEN CTY HOSP,DEPT PEDIAT,BODEN,SWEDEN		DAHL, N (corresponding author), UNIV UPPSALA,CTR BIOMED,DEPT MED GENET,BOX 589,S-75123 UPPSALA,SWEDEN.							BRADY RO, 1965, BIOCHEM BIOPH RES CO, V18, P221, DOI 10.1016/0006-291X(65)90743-6; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; DAHL N, 1988, GENOMICS, V3, P296, DOI 10.1016/0888-7543(88)90118-8; DREBORG S, 1980, EUR J PEDIATR, V133, P107, DOI 10.1007/BF00441578; FABBRO D, 1987, AM J HUM GENET, V40, P15; GRAVES PN, 1986, AM J HUM GENET, V39, P763; GRAVES PN, 1988, DNA-J MOLEC CELL BIO, V7, P521, DOI 10.1089/dna.1.1988.7.521; HILLBORG PO, 1983, SLAKT HAVD, V3, P451; HOROWITZ M, 1989, GENOMICS, V4, P87, DOI 10.1016/0888-7543(89)90319-4; Knudson AG., 1962, CEREBRAL SPHINGOLIPI, P395; Maniatis T., 1982, MOL CLONING; PATRICK AD, 1965, BIOCHEM J, V97, pC17, DOI 10.1042/bj0970017C; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SORGE J, 1985, P NATL ACAD SCI USA, V82, P7289, DOI 10.1073/pnas.82.21.7289; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; THEOPHILUS BDM, 1989, NUCLEIC ACIDS RES, V17, P7707, DOI 10.1093/nar/17.19.7707; TSUJI S, 1988, P NATL ACAD SCI USA, V85, P2349, DOI 10.1073/pnas.85.7.2349; TSUJI S, 1987, NEW ENGL J MED, V316, P570, DOI 10.1056/NEJM198703053161002; WIGDERSON M, 1989, AM J HUM GENET, V44, P365; ZIMRAN A, 1989, LANCET, V2, P349	21	89	96	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1990	47	2					275	278						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DT871	2378352				2022-12-18	WOS:A1990DT87100012
J	WENSTRUP, RJ; WILLING, MC; STARMAN, BJ; BYERS, PH				WENSTRUP, RJ; WILLING, MC; STARMAN, BJ; BYERS, PH			DISTINCT BIOCHEMICAL PHENOTYPES PREDICT CLINICAL SEVERITY IN NONLETHAL VARIANTS OF OSTEOGENESIS IMPERFECTA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									DUKE UNIV, MED CTR, DEPT MED, DURHAM, NC 27710 USA; UNIV WASHINGTON, DEPT PEDIAT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA 98195 USA; UNIV WASHINGTON, CTR INHERITED DIS, SEATTLE, WA 98195 USA	Duke University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	WENSTRUP, RJ (corresponding author), DUKE UNIV, MED CTR, DEPT PEDIAT, DIV CARDIOL, DURHAM, NC 27710 USA.			Byers, Peter H./0000-0001-7786-7030	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R29AR038474, P01AR021557] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 21557, AR 38474] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BALDWIN CT, 1989, J BIOL CHEM, V264, P3002; BARSH GS, 1982, P NATL ACAD SCI-BIOL, V79, P3838, DOI 10.1073/pnas.79.12.3838; BATEMAN JF, 1988, J BIOL CHEM, V263, P11627; BATEMAN JF, 1987, J BIOL CHEM, V262, P7021; BONADIO J, 1985, J BIOL CHEM, V260, P1734; BONADIO J, 1985, NATURE, V316, P363, DOI 10.1038/316363a0; BYERS PH, 1988, AM J HUM GENET, V42, P237; BYERS PH, 1989, METABOLIC BASIS INHE, P2805; COHN DH, 1986, P NATL ACAD SCI USA, V83, P6045, DOI 10.1073/pnas.83.16.6045; CONSTANTINOU CD, 1989, J CLIN INVEST, V83, P574, DOI 10.1172/JCI113920; GENOVESE C, 1987, METHOD ENZYMOL, V145, P223; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; STARMAN BJ, 1989, J CLIN INVEST, V84, P1206, DOI 10.1172/JCI114286; SYKES B, 1990, AM J HUM GENET, V46, P293; SYKES B, 1986, LANCET, V2, P69; TSIPOURAS P, 1984, AM J HUM GENET, V36, P1172; TSIPOURAS P, 1983, J CLIN INVEST, V72, P1262, DOI 10.1172/JCI111082; VOGEL BE, 1987, J BIOL CHEM, V262, P14737; WALLIS G, 1986, J MED GENET, V23, P411, DOI 10.1136/jmg.23.5.411; WENSTRUP R, IN PRESS ANN NY ACAD; WENSTRUP RJ, 1988, J BIOL CHEM, V263, P7734; WENSTRUP RJ, 1986, HUM GENET, V74, P47; WILLING MC, 1990, J CLIN INVEST, V85, P282, DOI 10.1172/JCI114424	23	89	90	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1990	46	5					975	982						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DD896	2339695				2022-12-18	WOS:A1990DD89600017
J	BERTELSON, CJ; POGO, AO; CHAUDHURI, A; MARSH, WL; REDMAN, CM; BANERJEE, D; SYMMANS, WA; SIMON, T; FREY, D; KUNKEL, LM				BERTELSON, CJ; POGO, AO; CHAUDHURI, A; MARSH, WL; REDMAN, CM; BANERJEE, D; SYMMANS, WA; SIMON, T; FREY, D; KUNKEL, LM			LOCALIZATION OF THE MCLEOD LOCUS (XK) WITHIN XP21 BY DELETION ANALYSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CHILDRENS HOSP MED CTR,HOWARD HUGHES MED INST,BOSTON,MA 02115; HAMILTON MED LAB,HAMILTON,NEW ZEALAND; UNITED BLOOD SERV,ALBUQUERQUE,NM; INST MED GENET,ZURICH,SWITZERLAND; CHILDRENS HOSP MED CTR,DIV GENET,BOSTON,MA 02115; NEW YORK BLOOD CTR,LINDSLEY F KIMBALL RES INST,NEW YORK,NY 10021	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; New York Blood Center					EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD018658] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023740] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL33841] Funding Source: Medline; NICHD NIH HHS [HD18658] Funding Source: Medline; NINDS NIH HHS [NS23740] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALDRIDGE J, 1984, AM J HUM GENET, V36, P546; ALLEN FH, 1961, VOX SANG, V6, P555, DOI 10.1111/j.1423-0410.1961.tb03203.x; BAEHNER RL, 1986, P NATL ACAD SCI USA, V83, P3398, DOI 10.1073/pnas.83.10.3398; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; BERTELSON CJ, 1986, J MED GENET, V23, P531, DOI 10.1136/jmg.23.6.531; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BURGHES AHM, 1987, NATURE, V328, P434, DOI 10.1038/328434a0; BURMEISTER M, 1986, NATURE, V324, P582, DOI 10.1038/324582a0; DEMARTINVILLE B, 1985, AM J HUM GENET, V37, P235; DORKINS H, 1985, HUM GENET, V71, P103, DOI 10.1007/BF00283362; FRANCKE U, 1985, AM J HUM GENET, V37, P250; FRANCKE U, 1987, AM J HUM GENET, V40, P212; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; GOODFELLOW PN, 1985, CYTOGENET CELL GENET, V40, P296, DOI 10.1159/000132178; GREENBERG CR, 1987, AM J HUM GENET, V41, P128; KENWRICK S, 1987, CELL, V48, P351, DOI 10.1016/0092-8674(87)90438-7; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUNKEL LM, 1985, P NATL ACAD SCI USA, V82, P4778, DOI 10.1073/pnas.82.14.4778; Marsh W L, 1987, Transfus Med Rev, V1, P4; MARSH WL, 1981, VOX SANG, V40, P403, DOI 10.1111/j.1423-0410.1981.tb00728.x; MARSH WL, 1983, TRANSFUSION, V23, P336, DOI 10.1046/j.1537-2995.1983.23483276871.x; MONACO AP, 1987, HUM GENET, V75, P221, DOI 10.1007/BF00281063; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; MONACO AP, 1985, NATURE, V316, P842, DOI 10.1038/316842a0; OFARRELL P, 1982, FOCUS, V3, P1; RAY PN, 1985, NATURE, V318, P672, DOI 10.1038/318672a0; REDMAN CM, 1986, J BIOL CHEM, V261, P9521; REDMAN CM, 1988, BRIT J HAEMATOL, V68, P131, DOI 10.1111/j.1365-2141.1988.tb04191.x; REDMAN CM, 1984, TRANSFUSION, V24, P176, DOI 10.1046/j.1537-2995.1984.24284173356.x; ROYERPOKORA B, 1986, NATURE, V322, P32, DOI 10.1038/322032a0; SWASH M, 1983, BRAIN, V106, P717, DOI 10.1093/brain/106.3.717; SYMMANS WA, 1979, BRIT J HAEMATOL, V42, P575, DOI 10.1111/j.1365-2141.1979.tb01170.x; VANOMMEN GJB, 1986, CELL, V47, P499, DOI 10.1016/0092-8674(86)90614-8; WIEACKER P, 1984, AM J HUM GENET, V36, P265; WILCOX DE, 1986, HUM GENET, V73, P175, DOI 10.1007/BF00291610; WIMER BM, 1977, BRIT J HAEMATOL, V36, P219, DOI 10.1111/j.1365-2141.1977.tb00642.x	36	89	89	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	1988	42	5					703	711						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	N1438	3358422				2022-12-18	WOS:A1988N143800005
J	STEBBINS, NB; CONNEALLY, PM				STEBBINS, NB; CONNEALLY, PM			LINKAGE OF DOMINANTLY INHERITED CHARCOT MARIE TOOTH NEUROPATHY TO THE DUFFY LOCUS IN AN INDIANA FAMILY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									INDIANA UNIV,SCH MED,INDIANAPOLIS,IN 46202	Indiana University System; Indiana University-Purdue University Indianapolis								BIRD, 1980, AM J HUM GENET, V32, pA99; GUILOFF, 1982, ANN HUM GENET, V46, P25	2	89	89	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					A195	A195						1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211					2022-12-18	WOS:A1982PU21100504
J	POLLACK, MS; LEVINE, LS; ONEILL, GJ; PANG, S; LORENZEN, F; KOHN, B; RONDANINI, GF; CHIUMELLO, G; NEW, MI; DUPONT, B				POLLACK, MS; LEVINE, LS; ONEILL, GJ; PANG, S; LORENZEN, F; KOHN, B; RONDANINI, GF; CHIUMELLO, G; NEW, MI; DUPONT, B			HLA LINKAGE AND B14,DR1,BFS HAPLOTYPE ASSOCIATION WITH THE GENES FOR LATE ONSET AND CRYPTIC 21-HYDROXYLASE DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT PEDIAT ENDOCRINOL,NEW YORK,NY 10021; UNIV MILAN,OSPED L SACCO,PEDIAT CLIN,I-20133 MILAN,ITALY	Cornell University; NewYork-Presbyterian Hospital; University of Milan; Luigi Sacco Hospital	POLLACK, MS (corresponding author), SLOAN KETTERING INST CANC RES,TISSUE TYPING LAB,NEW YORK,NY 10021, USA.				NATIONAL CANCER INSTITUTE [P01CA022507, P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [CA-08748, CA-19267, NC1-CA-22507] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALPER CA, 1972, J EXP MED, V135, P68, DOI 10.1084/jem.135.1.68; Baur M.P., 1980, HISTOCOMPATIBILITY T, P955; BAUR MP, 1980, 8TH INT HIST WORKSH, P255; BEAUMONT C, 1979, NEW ENGL J MED, V301, P169, DOI 10.1056/NEJM197907263010401; BLANKSTEIN J, 1980, AM J MED, V68, P441, DOI 10.1016/0002-9343(80)90117-5; BONNETAMIR B, 1978, TISSUE ANTIGENS, V11, P235, DOI 10.1111/j.1399-0039.1978.tb01255.x; Danilovs J., 1980, HISTOCOMPATIBILITY T, P287; DUPONT B, 1977, LANCET, V2, P1309; DUPONT B, 1980, HISTOCOMPATIBILITY T, P643; FU SM, 1975, J EXP MED, V142, P495, DOI 10.1084/jem.142.2.495; GROSSEWILDE H, 1979, IMMUNOGENETICS, V8, P41, DOI 10.1007/BF01561412; KLOUDA PT, 1978, LANCET, V2, P1046; KLOUDA PT, 1980, J MED GENET, V17, P337, DOI 10.1136/jmg.17.5.337; KOMPF J, 1975, HUMANGENETIK, V27, P141; LARON Z, 1980, HUM IMMUNOL, V1, P55, DOI 10.1016/0198-8859(80)90009-9; LEVINE LS, 1980, J CLIN ENDOCR METAB, V51, P1316, DOI 10.1210/jcem-51-6-1316; LEVINE LS, 1978, NEW ENGL J MED, V299, P911, DOI 10.1056/NEJM197810262991702; MALAVASI F, 1980, 4TH INT C IMM PAR; MAYNARDSMITH S, 1961, MATH TABLES RES WORK, P47; MIGEON CJ, 1980, J CLIN ENDOCR METAB, V51, P647, DOI 10.1210/jcem-51-3-647; MORTON NE, 1955, AM J HUM GENET, V7, P277; NEW MI, 1979, J CLIN ENDOCR METAB, V48, P356, DOI 10.1210/jcem-48-2-356; ONEILL GJ, 1979, TRANSPL P, V11, P1713; PANG S, 1977, J CLIN ENDOCR METAB, V45, P1003, DOI 10.1210/jcem-45-5-1003; POLLACK MS, 1979, TRANSPLANT P, V11, P1315; PRICE DA, 1978, LANCET, V1, P930; PUCHOLT V, 1978, LANCET, V2, P1046; RAUM D, 1976, J CLIN INVEST, V58, P1240, DOI 10.1172/JCI108578; SVEJGAAR.A, 1974, TISSUE ANTIGENS, V4, P95; WEITKAMP LR, 1978, LANCET, V1, P931	30	89	90	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	4					540	550						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LZ348	6789674				2022-12-18	WOS:A1981LZ34800007
J	SHIH, VE; BERSON, EL; MANDELL, R; SCHMIDT, SY				SHIH, VE; BERSON, EL; MANDELL, R; SCHMIDT, SY			ORNITHINE KETOACID TRANSAMINASE DEFICIENCY IN GYRATE ATROPHY OF CHOROID AND RETINA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MASSACHUSETTS GEN HOSP,NEUROL SERV,JOSEPH P KENNEDY JR MEM LABS,BOSTON,MA 02114; MASSACHUSETTS GEN HOSP,MASSACHUSETTS EYE & EAR INFIRM,HARVARD MED SCH,BOSTON,MA 02114	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Massachusetts General Hospital	SHIH, VE (corresponding author), HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115, USA.							BERSON EL, 1976, BRIT J OPHTHALMOL, V60, P142, DOI 10.1136/bjo.60.2.142; Cutler CW, 1895, ARCH AUGENHEILKD, V30, P117; FRIMPTER GW, 1965, SCIENCE, V149, P1095, DOI 10.1126/science.149.3688.1095; Fuchs E., 1896, ARCH AUGENHEILKD, V32, P111; KATUNUMA N, 1964, J BIOCHEM-TOKYO, V56, P499, DOI 10.1093/oxfordjournals.jbchem.a128027; KIM YJ, 1974, P NATL ACAD SCI USA, V71, P4821, DOI 10.1073/pnas.71.12.4821; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MADOFF S, 1970, RAPID DIAGNOSTIC MET, P195; MCCULLOCH C, 1975, AM J OPHTHALMOL, V80, P1047, DOI 10.1016/0002-9394(75)90335-9; MORROW G, 1975, PEDIATR RES, V9, P641, DOI 10.1203/00006450-197508000-00006; MUDD SH, 1971, FED PROC, V30, P970; PASCAL TA, 1975, SCIENCE, V190, P1209, DOI 10.1126/science.1198108; ROSENBERG LE, 1968, SCIENCE, V162, P805, DOI 10.1126/science.162.3855.805; SENGERS RCA, 1976, PEDIATR RES, V10, P894, DOI 10.1203/00006450-197610000-00135; SHIH VE, 1970, CLIN CHIM ACTA, V27, P73, DOI 10.1016/0009-8981(70)90376-1; SIMELL O, 1973, LANCET, V1, P1030; TADA K, 1968, TOHOKU J EXP MED, V95, P107, DOI 10.1620/tjem.95.107; TAKKI K, 1974, BRIT J OPHTHALMOL, V58, P3, DOI 10.1136/bjo.58.1.3; TAKKI K, 1974, BRIT J OPHTHALMOL, V58, P907, DOI 10.1136/bjo.58.11.907; UHLENDOR.BW, 1973, PEDIATR RES, V7, P645, DOI 10.1203/00006450-197307000-00008	20	89	89	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1978	30	2					174	179						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	EV595	655164				2022-12-18	WOS:A1978EV59500009
J	GIBLETT, ER; SCOTT, NM				GIBLETT, ER; SCOTT, NM			RED CELL ACID PHOSPHATASE - RACIAL DISTRIBUTION AND REPORT OF A NEW PHENOTYPE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		HOPKINSON DA, 1964, AM J HUM GENET, V16, P141; HOPKINSON DA, 1963, NATURE, V199, P969, DOI 10.1038/199969a0; LAI L, 1964, SCIENCE, V145, P1187, DOI 10.1126/science.145.3637.1187; OSKI FA, 1963, SCIENCE, V139, P409, DOI 10.1126/science.139.3553.409	4	89	89	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1965	17	5					425	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	67851	14334742				2022-12-18	WOS:A19656785100007
J	SOHVAL, AR				SOHVAL, AR			MIXED GONADAL DYSGENESIS - A VARIETY OF HERMAPHRODITISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ALEXANDER D, 1961, PEDIATRICS, V28, P758; BLANK CE, 1960, LANCET, V2, P1450; BLOISE W, 1960, LANCET, V2, P1059; CHAPELLE ADL, 1962, LANCET, V2, P783; CONEN PE, 1961, LANCET, V2, P294; DEWHURST CJ, 1962, LANCET, V2, P783; FERGUSONSMITH MA, 1960, ANN INTERN MED, V53, P359, DOI 10.7326/0003-4819-53-2-359; FERRIER P, 1963, LANCET, V1, P54; FERRIER P, 1962, PEDIATRICS, V29, P703; HIRSCHHORN K, 1960, LANCET, V2, P319; HIRSCHHORN K, 1960, NEW ENGL J MED, V263, P1044, DOI 10.1056/NEJM196011242632102; JACOBS PA, 1961, LANCET, V1, P1183; JUDGE DLC, 1962, LANCET, V2, P407; LEWIS FJW, 1963, LANCET, V1, P221; MILLER OJ, 1961, EUGEN QUART, V8, P23, DOI 10.1080/19485565.1961.9987458; MILLER OJ, 1960, HUMAN CHROMOSOME NEW, V1, P6; MILLER OJ, UNPUBLISHED; SCHUSTER J, 1962, LANCET, V1, P1074; SCHUSTER J, 1962, CLIN RES, V10, P110; SOHVAL AR, 1963, PHYSIOL REV, V43, P306, DOI 10.1152/physrev.1963.43.2.306; SOHVAL AR, 1961, AM J MED, V31, P397, DOI 10.1016/0002-9343(61)90127-9; SOHVAL AR, IN PRESS; Wilkins L, 1944, J CLIN ENDOCRINOL, V4, P357, DOI 10.1210/jcem-4-8-357; WILLEMSE CH, 1962, LANCET, V1, P488	24	89	91	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	2					155	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2970A	13989874				2022-12-18	WOS:A19632970A00009
J	MORTON, NE; KOSOWER, N; GRAY, MP; SCHILLING, RF; MACKINNEY, AA				MORTON, NE; KOSOWER, N; GRAY, MP; SCHILLING, RF; MACKINNEY, AA			GENETICS OF SPHEROCYTOSIS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ABRAMS M, 1952, AM J HUM GENET, V4, P350; ANDERSON R, 1960, BLOOD, V15, P491, DOI 10.1182/blood.V15.4.491.491; CAMPBELL JMH, 1925, Q J MED, V19, P333; CHUNG CS, 1960, JPN J HUM GENET, V5, P124; DACIE JV, 1953, Q J MED, V22, P79; DACIE JV, 1960, HEMOLYTIC ANEMIAS; Debre R, 1938, AM J DIS CHILD, V56, P1189; DISCOMBE G, 1948, J PATHOL BACTERIOL, V60, P315, DOI 10.1002/path.1700600219; FUJII T, 1955, AM J HUM GENET, V7, P72; GANSSLEN M, 1925, DTSCH ARCH KLIN MED, V146, P1; GLASS B, 1950, AM J HUM GENET, V2, P269; KOMAI T, 1947, HOBURYUKEN; MACKINNEY AA, 1962, J CLIN INVEST; MACKLIN MT, 1960, AM J HUM GENET, V12, P1; McCarty SH, 1934, J LAB CLIN MED, V19, P0612; MEULENGRACHT E, 1921, DTSCH ARCH KLIN MED, V136, P33; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1959, AM J HUM GENET, V11, P360; MORTON NE, 1955, AM J HUM GENET, V7, P277; MORTON NE, 1962, METHODOLOGY HUMAN GE; NEEL J, 1962, METHODOLOGY HUMAN GE; NEEL JV, 1957, P NATL ACAD SCI USA, V43, P736, DOI 10.1073/pnas.43.8.736; NEEL JV, 1953, CLINICAL GENETICS; PENROSE LS, 1938, GREAT BRITAIN MEDICA, V229, P1; PLATE LG, 1913, VERERBUNGSLEHRE MIT; RACE RR, 1942, ANN EUGENIC, V11, P365; SCHACHT MW, 1961, 2 INT C HUM GEN ROM; SHAW MW, 1960, AM J HUM GENET, V12, P389; SILVESTRONI E, 1950, NATURE, V165, P682, DOI 10.1038/165682a0; VANDEPITTE J, 1955, Rev Hematol, V10, P19; Wilson C, 1890, T CLIN SOC LONDON, V23, P162; Wyandt H, 1941, ARCH INTERN MED, V68, P1043, DOI 10.1001/archinte.1941.00200120002001; YOUNG LE, 1951, BLOOD, V6, P1073, DOI 10.1182/blood.V6.11.1073.1073; YOUNG LE, 1956, BLOOD, V11, P977, DOI 10.1182/blood.V11.11.977.977; YOUNG LE, 1955, T ASSOC AM PHYSICIAN, V68, P141	37	89	92	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1962	14	2					170	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2963A	14476391				2022-12-18	WOS:A19622963A00007
J	Sang, Q; Li, B; Kuang, YP; Wang, XQ; Zhang, ZH; Chen, BB; Wu, L; Lyu, QF; Fu, YL; Yan, Z; Mao, XY; Xu, Y; Mu, J; Li, QL; Jin, L; He, L; Wang, L				Sang, Qing; Li, Bin; Kuang, Yanping; Wang, Xueqian; Zhang, Zhihua; Chen, Biaobang; Wu, Ling; Lyu, Qifeng; Fu, Yonglun; Yan, Zheng; Mao, Xiaoyan; Xu, Yao; Mu, Jian; Li, Qiaoli; Jin, Li; He, Lin; Wang, Lei			Homozygous Mutations in WEE2 Cause Fertilization Failure and Female Infertility	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAMMALIAN FERTILIZATION; MEIOTIC ARREST; OOCYTE; EGGS; MOUSE; TRANSITION; MECHANISMS; MATURATION; GENETICS; EMBRYO	Fertilization is a fundamental process of development and is a prerequisite for successful human reproduction. In mice, although several receptor proteins have been shown to play important roles in the process of fertilization, only three genes have been shown to cause fertilization failure and infertility when deleted in vivo. In clinical practice, some infertility case subjects suffer from recurrent failure of in vitro fertilization and intracytoplasmic sperm injection attempts due to fertilization failure, but the genetic basis of fertilization failure in humans remains largely unknown. Wee2 is a key oocyte-specific kinase involved in the control of meiotic arrest in mice, but WEE2 has not been associated with any diseases in humans. In this study, we identified homozygous mutations in WEE2 that are responsible for fertilization failure in humans. All four independent affected individuals had homozygous loss-of-function missense mutations or homozygous frameshift protein-truncating mutations, and the phenotype of fertilization failure was shown to follow a Mendelian recessive inheritance pattern. All four mutations significantly decreased the amount of WEE2 protein in vitro and in affected individuals' oocytes in vivo, and they all led to abnormal serine phosphorylation of WEE2 and reduced tyrosine 15 phosphorylation of Cdc2 in vitro. In addition, injection of WEE2 cRNA into affected individuals' oocytes rescued the fertilization failure phenotype and led to the formation of blastocysts in vitro. This work presents a novel gene responsible for human fertilization failure and has implications for future therapeutic treatments for infertility cases.	[Sang, Qing; Wang, Xueqian; Zhang, Zhihua; Chen, Biaobang; Xu, Yao; Mu, Jian; Li, Qiaoli; Jin, Li; Wang, Lei] Fudan Univ, Zhongshan Hosp, Inst Biomed Sci, State Key Lab Genet Engn, Shanghai 200032, Peoples R China; [Sang, Qing; Wang, Xueqian; Zhang, Zhihua; Chen, Biaobang; Xu, Yao; Mu, Jian; Li, Qiaoli; Jin, Li; Wang, Lei] Fudan Univ, Zhongshan Hosp, Inst Biomed Sci, Sch Life Sci, Shanghai 200032, Peoples R China; [Sang, Qing; Wang, Lei] Guangzhou Med Univ, GMU GIBH Joint Sch Life Sci, Guangzhou 511436, Guangdong, Peoples R China; [Li, Bin; Kuang, Yanping; Wu, Ling; Lyu, Qifeng; Fu, Yonglun; Yan, Zheng; Mao, Xiaoyan] Shanghai Jiao Tong Univ, Shanghai Hosp 9, Reprod Med Ctr, Shanghai 200011, Peoples R China; [He, Lin] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, BioX Ctr, Shanghai 200030, Peoples R China	Fudan University; Fudan University; Guangzhou Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Sang, Q; Wang, L (corresponding author), Fudan Univ, Zhongshan Hosp, Inst Biomed Sci, State Key Lab Genet Engn, Shanghai 200032, Peoples R China.; Sang, Q; Wang, L (corresponding author), Fudan Univ, Zhongshan Hosp, Inst Biomed Sci, Sch Life Sci, Shanghai 200032, Peoples R China.; Sang, Q; Wang, L (corresponding author), Guangzhou Med Univ, GMU GIBH Joint Sch Life Sci, Guangzhou 511436, Guangdong, Peoples R China.	sangqing@fudan.edu.cn; wangleiwanglei@fudan.edu.cn	Xu, Yao/AFL-6014-2022; Jin, Li/C-1468-2009; zhang, zh/GWV-4677-2022; Jin, Li/M-5063-2019; Kuang, Yanping/T-4070-2019; Fu, Yonglun/AAF-6993-2019	Xu, Yao/0000-0002-0792-1158; Jin, Li/0000-0002-4546-2415; Chen, Biaobang/0000-0002-9921-2155	National Key Research and Development Program of China [2016YFC1000600, 2017YFC1001500]; National Basic Research Program of China [2015CB943300]; National Natural Science Foundation of China [81725006, 81771581, 81571501]; Shanghai Rising-Star Program [17QA1400200]	National Key Research and Development Program of China; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by the National Key Research and Development Program of China (2016YFC1000600 and 2017YFC1001500), the National Basic Research Program of China (2015CB943300), the National Natural Science Foundation of China (81725006, 81771581, 81571501), and the Shanghai Rising-Star Program 17QA1400200.	Alazami AM, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0792-0; Bianchi E, 2016, ANNU REV GENET, V50, P93, DOI 10.1146/annurev-genet-121415-121834; Bianchi E, 2014, NATURE, V508, P483, DOI 10.1038/nature13203; Chen BB, 2017, AM J HUM GENET, V101, P609, DOI 10.1016/j.ajhg.2017.08.018; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Ducibella T, 2002, DEV BIOL, V250, P280, DOI 10.1006/dbio.2002.0788; Feng RZ, 2016, J MED GENET, V53, P662, DOI 10.1136/jmedgenet-2016-103891; Feng RZ, 2016, NEW ENGL J MED, V374, P223, DOI 10.1056/NEJMoa1510791; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Hart RJ, 2016, PHYSIOL REV, V96, P873, DOI 10.1152/physrev.00023.2015; Horner VL, 2008, DEV DYNAM, V237, P527, DOI 10.1002/dvdy.21454; Huang HL, 2014, NEW ENGL J MED, V370, P1220, DOI 10.1056/NEJMoa1308851; Ikawa M, 2010, J CLIN INVEST, V120, P984, DOI 10.1172/JCI41585; Inoue N, 2005, NATURE, V434, P234, DOI 10.1038/nature03362; Jones KT, 2004, MOL HUM REPROD, V10, P1, DOI 10.1093/molehr/gah009; Kaji K, 2000, NAT GENET, V24, P279, DOI 10.1038/73502; Layman LC, 2013, MOL CELL ENDOCRINOL, V370, P138, DOI 10.1016/j.mce.2013.02.016; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Miller BJ, 2000, J CELL BIOL, V149, P1289, DOI 10.1083/jcb.149.6.1289; Oh JS, 2011, SCIENCE, V332, P462, DOI 10.1126/science.1199211; Oh JS, 2010, J CELL BIOL, V188, P199, DOI 10.1083/jcb.200907161; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Wassarman PM, 2008, INT J DEV BIOL, V52, P665, DOI 10.1387/ijdb.072524pw; Webster A, 2017, TRENDS CELL BIOL, V27, P55, DOI 10.1016/j.tcb.2016.09.002; Xu Y, 2016, AM J HUM GENET, V99, P744, DOI 10.1016/j.ajhg.2016.06.024	26	88	91	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					649	657		10.1016/j.ajhg.2018.02.015	http://dx.doi.org/10.1016/j.ajhg.2018.02.015			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29606300	Bronze, Green Published			2022-12-18	WOS:000429340800011
J	Bras, J; Alonso, I; Barbot, C; Costa, MM; Darwent, L; Orme, T; Sequeiros, J; Hardy, J; Coutinho, P; Guerreiro, R				Bras, Jose; Alonso, Isabel; Barbot, Clara; Costa, Maria Manuela; Darwent, Lee; Orme, Tatiana; Sequeiros, Jorge; Hardy, John; Coutinho, Paula; Guerreiro, Rita			Mutations in PNKP Cause Recessive Ataxia with Oculomotor Apraxia Type 4	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							STRAND BREAK REPAIR; DNA-SEQUENCING DATA; PORTUGUESE; FRAMEWORK; SEIZURES; SPECTRUM; ENZYME; GENE; ATM	Hereditary autosomal-recessive cerebellar ataxias are a genetically and clinically heterogeneous group of disorders. We used homozygosity mapping and exome sequencing to study a cohort of nine Portuguese families who were identified during a nationwide, population-based, systematic survey as displaying a consistent phenotype of recessive ataxia with oculomotor apraxia (AOA). The integration of data from these analyses led to the identification of the same homozygous PNKP (polynucleotide kinase 30-phosphatase) mutation, c.1123G>T (p.Gly375Trp), in three of the studied families. When analyzing this particular gene in the exome sequencing data from the remaining cohort, we identified homozygous or compound-heterozygous mutations in five other families. PNKP is a dual-function enzyme with a key role in different pathways of DNA-damage repair. Mutations in this gene have previously been associated with an autosomal-recessive syndrome characterized by microcephaly; early-onset, intractable seizures; and developmental delay (MCSZ). The finding of PNKP mutations associated with recessive AOA extends the phenotype associated with this gene and identifies a fourth locus that causes AOA. These data confirm that MCSZ and some forms of ataxia share etiological features, most likely reflecting the role of PNKP in DNA-repair mechanisms.	[Bras, Jose; Darwent, Lee; Orme, Tatiana; Hardy, John; Guerreiro, Rita] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Alonso, Isabel; Barbot, Clara; Sequeiros, Jorge; Coutinho, Paula] Univ Porto, Inst Mol & Cell Biol, Ctr Predict & Prevent Genet, P-4150180 Oporto, Portugal; [Alonso, Isabel; Barbot, Clara; Sequeiros, Jorge; Coutinho, Paula] Univ Porto, Inst Mol & Cell Biol, Unidade Invest Genet & Epidemiol, Doencas Neurol Res Grp, P-4150180 Oporto, Portugal; [Alonso, Isabel; Barbot, Clara; Sequeiros, Jorge; Coutinho, Paula] Univ Porto, Inst Invest & Inovacao Saude, P-4150180 Oporto, Portugal; [Costa, Maria Manuela] Hosp Pedro Hispano, Unidade Local Saude Matosinhos, P-4454509 Matosinhos, Portugal	University of London; University College London; Universidade do Porto; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Guerreiro, R (corresponding author), UCL, Inst Neurol, Dept Mol Neurosci, Queen Sq, London WC1N 3BG, England.	r.guerreiro@ucl.ac.uk	Alonso, Isabel/I-4307-2013; Bras, Jose MT/A-1428-2011; Guerreiro, Rita J L/A-1327-2011; Hardy, John/C-2451-2009	Alonso, Isabel/0000-0001-8549-6903; Hardy, John/0000-0002-3122-0423; Bras, Jose/0000-0001-8186-0333; Guerreiro, Rita/0000-0001-5879-3486; Sequeiros, Jorge/0000-0002-9846-1037; Orme, Tatiana/0000-0002-8304-3326	Wellcome Trust/Medical Research Council Joint Call in Neurodegeneration award [WT089698]; Alzheimer's Society; Alzheimer's Research UK; MRC [MC_G1000735] Funding Source: UKRI; Medical Research Council [MC_G1000735] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish	Wellcome Trust/Medical Research Council Joint Call in Neurodegeneration award; Alzheimer's Society; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported in part by an anonymous donor, the Wellcome Trust/Medical Research Council Joint Call in Neurodegeneration award (WT089698) to the UK Parkinson's Disease Consortium (members are from the University College London Institute of Neurology, the University of Sheffield, and the Medical Research Council Protein Phosphorylation Unit at the University of Dundee), a fellowship from the Alzheimer's Society to J.B., and a fellowship from Alzheimer's Research UK to R.G.	Al Tassan N, 2012, HUM MUTAT, V33, P351, DOI 10.1002/humu.21650; Anheim M, 2009, BRAIN, V132, P2688, DOI 10.1093/brain/awp211; Barbot C, 2001, ARCH NEUROL-CHICAGO, V58, P201, DOI 10.1001/archneur.58.2.201; Bernstein NK, 2005, MOL CELL, V17, P657, DOI 10.1016/j.molcel.2005.02.012; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Carvill GL, 2013, NAT GENET, V45, P825, DOI 10.1038/ng.2646; Coutinho P, 2013, JAMA NEUROL, V70, P746, DOI 10.1001/jamaneurol.2013.1707; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; Guerreiro R, 2014, HUM MOL GENET, V23, pR47, DOI 10.1093/hmg/ddu203; Le Ber I, 2004, BRAIN, V127, P759, DOI 10.1093/brain/awh080; Le Ber I, 2003, BRAIN, V126, P2761, DOI 10.1093/brain/awg283; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Moreira MD, 2001, AM J HUM GENET, V68, P501, DOI 10.1086/318191; Poulton C, 2013, NEUROGENETICS, V14, P43, DOI 10.1007/s10048-012-0351-8; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reynolds JJ, 2012, NUCLEIC ACIDS RES, V40, P6608, DOI 10.1093/nar/gks318; Segal-Raz H, 2011, EMBO REP, V12, P713, DOI 10.1038/embor.2011.96; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Whiteside JR, 2010, DNA REPAIR, V9, P83, DOI 10.1016/j.dnarep.2009.11.004	25	88	90	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR 5	2015	96	3					474	479		10.1016/j.ajhg.2015.01.005	http://dx.doi.org/10.1016/j.ajhg.2015.01.005			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CD0GD	25728773	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000350747800020
J	Chudasama, KK; Winnay, J; Johansson, S; Claudi, T; Konig, R; Haldorsen, I; Johansson, B; Woo, JR; Aarskog, D; Sagen, JV; Kahn, CR; Molven, A; Njolstad, PR				Chudasama, Kishan Kumar; Winnay, Jonathon; Johansson, Stefan; Claudi, Tor; Koenig, Rainer; Haldorsen, Ingfrid; Johansson, Bente; Woo, Ju Rang; Aarskog, Dagfinn; Sagen, Jorn V.; Kahn, C. Ronald; Molven, Anders; Njolstad, Pal Rasmus			SHORT Syndrome with Partial Lipodystrophy Due to Impaired Phosphatidylinositol 3 Kinase Signaling	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PHOSPHOINOSITIDE 3-KINASE; REGULATORY SUBUNIT; ADIPOCYTES; MUTATIONS; P85-ALPHA; PATHWAYS; BINDING	The phosphatidylinositol 3 kinase (PI3K) pathway regulates fundamental cellular processes such as metabolism, proliferation, and survival. A central component in this pathway is the p85 alpha, regulatory subunit, encoded by PIK3R1. Using whole-exome sequencing, we identified a heterozygous PIK3R1 mutation (c.1945C>T [p.Arg649Trp]) in two unrelated families affected by partial lipodystrophy, low body mass index, short stature, progeroid face, and Rieger anomaly (SHORT syndrome). This mutation led to impaired interaction between p85 alpha and IRS-1 and reduced AKT-mediated insulin signaling in fibroblasts from affected subjects and in reconstituted Pik3r1-knockout preadipocytes. Normal PI3K activity is critical for adipose differentiation and insulin signaling; the mutated PIK3R1 therefore provides a unique link among lipodystrophy, growth, and insulin signaling.	[Chudasama, Kishan Kumar; Johansson, Stefan; Johansson, Bente; Aarskog, Dagfinn; Sagen, Jorn V.; Molven, Anders; Njolstad, Pal Rasmus] Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, N-5020 Bergen, Norway; [Chudasama, Kishan Kumar; Johansson, Stefan] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Winnay, Jonathon; Woo, Ju Rang; Kahn, C. Ronald; Molven, Anders] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Claudi, Tor] Nordlandssykehuset, Dept Med, N-8092 Bodo, Norway; [Koenig, Rainer] Goethe Univ Frankfurt, Dept Human Genet, G-60325 Frankfurt, Germany; [Haldorsen, Ingfrid; Molven, Anders] Univ Bergen, Dept Clin Med, N-5020 Bergen, Norway; [Sagen, Jorn V.] Univ Bergen, Dept Clin Sci, N-5020 Bergen, Norway; [Sagen, Jorn V.] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Njolstad, Pal Rasmus] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Njolstad, Pal Rasmus] Broad Inst Harvard & MIT, Med & Populat Genet Program, Cambridge, MA 02142 USA	University of Bergen; University of Bergen; Haukeland University Hospital; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Goethe University Frankfurt; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Njolstad, PR (corresponding author), Univ Bergen, Dept Clin Sci, KG Jebsen Ctr Diabet Res, N-5020 Bergen, Norway.	pal.njolstad@uib.no	Johansson, Bente Berg/AAE-7666-2022; Kahn, Ronald/AAY-2435-2021; Johansson, Stefan/C-4394-2011	Kahn, Ronald/0000-0002-7583-9228; Johansson, Stefan/0000-0002-2298-7008; Johansson, Bente Berg/0000-0001-8893-1915; Haldorsen, Ingfrid S./0000-0001-9313-7564	Research Council of Norway; University of Bergen; K.G. Jebsen Foundation; Helse Vest; Innovest; European Research Council; Nils Normans Foundation; National Institutes of Health [DK55545]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK055545] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); University of Bergen; K.G. Jebsen Foundation; Helse Vest; Innovest; European Research Council(European Research Council (ERC)European Commission); Nils Normans Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the families for participation, as well as Stig A. Eide and Louise Grevle for technical assistance, Francisco S. Roque and Inge Jonassen for support with computational analysis, and the University of Bergen Audiovisual Section for help with the photographs. The study was supported by the Research Council of Norway, the University of Bergen, the K.G. Jebsen Foundation, Helse Vest, Innovest, and the European Research Council (to P.R.N.), the Nils Normans Foundation (to S.J.), and National Institutes of Health grant DK55545 (to C.R.K.).	AARSKOG D, 1983, AM J MED GENET, V15, P29, DOI 10.1002/ajmg.1320150104; Aubin D, 2005, INT J OBESITY, V29, P1006, DOI 10.1038/sj.ijo.0802961; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fiorenza CG, 2011, NAT REV ENDOCRINOL, V7, P137, DOI 10.1038/nrendo.2010.199; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Garg A, 2011, J CLIN ENDOCR METAB, V96, P3313, DOI 10.1210/jc.2011-1159; Gorlin R J, 1975, Birth Defects Orig Artic Ser, V11, P39; Hussain K, 2011, SCIENCE, V334, P474, DOI 10.1126/science.1210878; Johansson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038050; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Koenig R, 2003, CLIN DYSMORPHOL, V12, P45, DOI 10.1097/00019605-200301000-00008; Lappalainen K, 2008, PROTEINS, V72, P779, DOI 10.1002/prot.21970; MARENGERE LEM, 1994, J CELL SCI, P97; Miki H, 2001, MOL CELL BIOL, V21, P2521, DOI 10.1128/MCB.21.7.2521-2532.2001; Pal A, 2012, NEW ENGL J MED, V367, P1002, DOI 10.1056/NEJMoa1113966; Pereira RI, 2005, METABOLISM, V54, P1636, DOI 10.1016/j.metabol.2005.07.002; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Rodon J, 2013, NAT REV CLIN ONCOL, V10, P143, DOI 10.1038/nrclinonc.2013.10; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ueki K, 2000, MOL CELL BIOL, V20, P8035, DOI 10.1128/MCB.20.21.8035-8046.2000; Ueki K, 2003, J BIOL CHEM, V278, P48453, DOI 10.1074/jbc.M305602200; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Winnay JN, 2010, NAT MED, V16, P438, DOI 10.1038/nm.2121; Yu WH, 2008, MOL CELL BIOCHEM, V310, P11, DOI 10.1007/s11010-007-9661-9; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	26	88	91	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 11	2013	93	1					150	157		10.1016/j.ajhg.2013.05.023	http://dx.doi.org/10.1016/j.ajhg.2013.05.023			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	183HG	23810379	Green Published, Bronze			2022-12-18	WOS:000321804500015
J	Cheung, YH; Gayden, T; Campeau, PM; LeDuc, CA; Russo, D; Nguyen, VH; Guo, JC; Qi, M; Guan, YF; Albrecht, S; Moroz, B; Eldin, KW; Lu, JT; Schwartzentruber, J; Malkin, D; Berghuis, AM; Emil, S; Gibbs, RA; Burk, DL; Vanstone, M; Lee, BH; Orchard, D; Boycott, KM; Chung, WK; Jabado, N				Cheung, Yee Him; Gayden, Tenzin; Campeau, Philippe M.; LeDuc, Charles A.; Russo, Donna; Van-Hung Nguyen; Guo, Jiancheng; Qi, Ming; Guan, Yanfang; Albrecht, Steffen; Moroz, Brenda; Eldin, Karen W.; Lu, James T.; Schwartzentruber, Jeremy; Malkin, David; Berghuis, Albert M.; Emil, Sherif; Gibbs, Richard A.; Burk, David L.; Vanstone, Megan; Lee, Brendan H.; Orchard, David; Boycott, Kym M.; Chung, Wendy K.; Jabado, Nada			A Recurrent PDGFRB Mutation Causes Familial Infantile Myofibromatosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-KIT; AUTOINHIBITION; CANCER; GENE	Infantile myofibromatosis (IM) is the most common benign fibrous tumor of soft tissues affecting young children. By using whole-exome sequencing, RNA sequencing, and targeted sequencing, we investigated germline and tumor DNA in individuals from four distinct families with the familial form of IM and in five simplex IM cases with no previous family history of this disease. We identified a germline mutation c.1681C>T (p.Arg561Cys) in platelet-derived growth factor receptor beta (PDGFRB) in all 11 affected individuals with familial IM, although none of the five individuals with nonfamilial IM had mutations in this gene. We further identified a second heterozygous mutation in PDGFRB in two myofibromas from one of the affected familial cases, indicative of a potential second hit in this gene in the tumor. PDGFR-beta promotes growth of mesenchymal cells, including blood vessels and smooth muscles, which are affected in W. Our findings indicate p.Arg561Cys substitution in PDGFR:13 as a cause of the dominant form of this disease. They provide a rationale for further investigations of this specific mutation and gene to assess the benefits of targeted therapies against PDGFR-beta in aggressive life-threatening familial forms of the disease.	[Cheung, Yee Him; LeDuc, Charles A.; Russo, Donna; Guo, Jiancheng; Chung, Wendy K.] Columbia Univ, Dept Pediat, New York, NY 10032 USA; [Gayden, Tenzin; Jabado, Nada] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Campeau, Philippe M.; Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Van-Hung Nguyen; Albrecht, Steffen] McGill Univ, Ctr Hlth, Montreal Childrens Hosp, Dept Pathol, Montreal, PQ H3H 1P3, Canada; [Qi, Ming] Zhejiang Univ, Sch Med, Ctr Genet & Genom Med, Zheijang 310058, Peoples R China; [Qi, Ming] Univ Rochester, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Qi, Ming; Guan, Yanfang] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Moroz, Brenda] Montreal Childrens Hosp, Dept Pediat Dermatol, Montreal, PQ H3H 1P3, Canada; [Eldin, Karen W.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Lu, James T.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lu, James T.] Baylor Coll Med, Dept Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Schwartzentruber, Jeremy] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Schwartzentruber, Jeremy] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Malkin, David] Univ Toronto, Hosp Sick Children, Dept Pediat, Div Hematol Oncol, Toronto, ON M5G 1X8, Canada; [Berghuis, Albert M.; Burk, David L.] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Berghuis, Albert M.; Burk, David L.] McGill Univ, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Emil, Sherif] McGill Univ, Montreal Childrens Hosp, Dept Pediat Surg, Montreal, PQ H3H 1P3, Canada; [Vanstone, Megan; Boycott, Kym M.] Univ Ottawa, Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada; [Lee, Brendan H.] Howard Hughes Med Inst, Houston, TX 77030 USA; [Orchard, David] Royal Childrens Hosp, Dept Dermatol, Melbourne, Vic 3052, Australia; [Jabado, Nada] McGill Univ, Dept Pediat, Montreal, PQ H3H 2Z3, Canada; [Jabado, Nada] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3H 2Z3, Canada	Columbia University; McGill University; Baylor College of Medicine; McGill University; Zhejiang University; University of Rochester; Beijing Genomics Institute (BGI); McGill University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; McGill University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; McGill University; University of Ottawa; Children's Hospital of Eastern Ontario; Howard Hughes Medical Institute; Royal Children's Hospital Melbourne; McGill University; McGill University	Chung, WK (corresponding author), Columbia Univ, Dept Pediat, New York, NY 10032 USA.	wkc15@mail.cumc.columbia.edu; nada.jabado@mcgill.ca	Berghuis, Albert M/A-6495-2008; Campeau, Philippe/J-8614-2015; Malkin, David/AAW-8715-2021; Jabado, Nada/AAN-4026-2020	Campeau, Philippe/0000-0001-9713-7107; LeDuc, Charles/0000-0002-2073-5050; Schwartzentruber, Jeremy/0000-0002-6183-2092; Berghuis, Albert/0000-0002-2663-025X; Nguyen, Van-Hung/0000-0001-5318-2416	Canadian Gene Cure Foundation; Fonds de la Recherche en sante au Quebec (FRSQ); National Institutes of Health [PO1 HD22657, PO1 HD070394]; Rolanette and Berdon Lawrence Bone Disease Program of Texas; NIH [U54 HG006542, U54 HG003273]; Ruth L. Kirschstein National Research Service [F30 MH098571-01]; CIHR; Government of Canada through Genome Canada; Canadian Institutes of Health Research; Ontario Genomics Institute [OGI-049]; Genome Quebec; Genome British Columbia; McLaughlin Centre; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, U54HG006542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH098571] Funding Source: NIH RePORTER	Canadian Gene Cure Foundation; Fonds de la Recherche en sante au Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rolanette and Berdon Lawrence Bone Disease Program of Texas; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Government of Canada through Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; Genome Quebec; Genome British Columbia; McLaughlin Centre; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank the study participants and their families; without their participation, this work would not have been possible. T.G. is supported by an award from the Canadian Gene Cure Foundation. N.J. is the recipient of a Chercheur Clinician Senior award from Fonds de la Recherche en sante au Quebec (FRSQ). Research funding includes National Institutes of Health grants PO1 HD22657 and PO1 HD070394 and The Rolanette and Berdon Lawrence Bone Disease Program of Texas (to B.H.L.) and NIH grants U54 HG006542 and U54 HG003273 (to R.A.G.). J.T.L. is supported by Ruth L. Kirschstein National Research Service Award F30 MH098571-01. P.M.C. is supported by a CIHR clinician-scientist training award. Part of this work was completed as a rare disease studied by the FORGE Canada Consortium, funded by the Government of Canada through Genome Canada, the Canadian Institutes of Health Research, and the Ontario Genomics Institute (OGI-049). Additional funding to FORGE was provided by Genome Quebec, Genome British Columbia, and the McLaughlin Centre. We thank Shalini N. Jhangiani for coordination of exome sequencing and Alyssa Tran for clinical research support. We also wish to acknowledge the contribution of the high-throughput sequencing platform of the McGill University and Genome Quebec Innovation Centre, Montreal, Canada.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Auriti C, 2008, J PEDIAT HEMATOL ONC, V30, P179, DOI 10.1097/MPH.0b013e31815e62bb; Azzam R, 2009, PEDIATR BLOOD CANCER, V52, P308, DOI 10.1002/pbc.21797; CHUNG EB, 1981, CANCER, V48, P1807, DOI 10.1002/1097-0142(19811015)48:8<1807::AID-CNCR2820480818>3.0.CO;2-G; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; George D, 2003, ADV EXP MED BIOL, V532, P141; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; JENNINGS TA, 1984, AM J SURG PATHOL, V8, P529, DOI 10.1097/00000478-198407000-00005; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Nicolas G, 2013, NEUROLOGY, V80, P181, DOI 10.1212/WNL.0b013e31827ccf34; QIU F, 1988, EMBO J, V7, P1003, DOI 10.1002/j.1460-2075.1988.tb02907.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger L, 2010, PYMOL MOL GRAPHICS S; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Smith A, 2011, AUSTRALAS J DERMATOL, V52, P214, DOI 10.1111/j.1440-0960.2011.00730.x; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; STOUT AP, 1954, CANCER, V7, P953, DOI 10.1002/1097-0142(195409)7:5<953::AID-CNCR2820070520>3.0.CO;2-W; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trojanowska M, 2008, RHEUMATOLOGY, V47, pV2, DOI 10.1093/rheumatology/ken265; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wilson M, 2013, J PEDIATR SURG, V48, P449, DOI 10.1016/j.jpedsurg.2012.11.041; WISWELL TE, 1988, J PEDIATR SURG, V23, P314, DOI 10.1016/S0022-3468(88)80196-9; Zand DJ, 2004, AM J MED GENET A, V126A, P261, DOI 10.1002/ajmg.a.20598	30	88	95	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					996	1000		10.1016/j.ajhg.2013.04.026	http://dx.doi.org/10.1016/j.ajhg.2013.04.026			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23731537	Green Published, Bronze			2022-12-18	WOS:000320415300017
J	Nakajima, M; Mizumoto, S; Miyake, N; Kogawa, R; Iida, A; Ito, H; Kitoh, H; Hirayama, A; Mitsubuchi, H; Miyazaki, O; Kosaki, R; Horikawa, R; Lai, A; Mendoza-Londono, R; Dupuis, L; Chitayat, D; Howard, A; Leal, GE; Cavalcanti, D; Tsurusaki, Y; Saitsu, H; Watanabe, S; Lausch, E; Unger, S; Bonafe, L; Ohashi, H; Superti-Furga, A; Matsumoto, N; Sugahara, K; Nishimura, G; Ikegawa, S				Nakajima, Masahiro; Mizumoto, Shuji; Miyake, Noriko; Kogawa, Ryo; Iida, Aritoshi; Ito, Hironori; Kitoh, Hiroshi; Hirayama, Aya; Mitsubuchi, Hiroshi; Miyazaki, Osamu; Kosaki, Rika; Horikawa, Reiko; Lai, Angeline; Mendoza-Londono, Roberto; Dupuis, Lucie; Chitayat, David; Howard, Andrew; Leal, Gabriela E.; Cavalcanti, Denise; Tsurusaki, Yoshinori; Saitsu, Hirotomo; Watanabe, Shigehiko; Lausch, Ekkehart; Unger, Sheila; Bonafe, Luisa; Ohashi, Hirofumi; Superti-Furga, Andrea; Matsumoto, Naomichi; Sugahara, Kazuyuki; Nishimura, Gen; Ikegawa, Shiro			Mutations in B3GALT6, which Encodes a Glycosaminoglycan Linker Region Enzyme, Cause a Spectrum of Skeletal and Connective Tissue Disorders	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EHLERS-DANLOS-SYNDROME; JOINT LAXITY; DYSPLASIA; PROTEOGLYCAN; BIOSYNTHESIS; FIBROBLASTS; PATIENT; VARIANT; KIF22; GENE	Proteoglycans (PGs) are a major component of the extracellular matrix in many tissues and function as structural and regulatory molecules. PGs are composed of core proteins and glycosaminoglycan (GAG) side chains. The biosynthesis of GAGs starts with the linker region that consists of four sugar residues and is followed by repeating disaccharide units. By exome sequencing, we found that B3GALT6 encoding an enzyme involved in the biosynthesis of the GAG linker region is responsible for a severe skeletal dysplasia, spondyloepimetaphyseal dysplasia with joint laxity type 1 (SEMD-JL1). B3GALT6 loss-of-function mutations were found in individuals with SEMD-JL1 from seven families. In a subsequent candidate gene study based on the phenotypic similarity, we found that B3GALT6 is also responsible for a connective tissue disease, Ehlers-Danlos syndrome (progeroid form). Recessive loss-of-function mutations in B3GALT6 result in a spectrum of disorders affecting a broad range of skeletal and connective tissues characterized by lax skin, muscle hypotonia, joint dislocation, and spinal deformity. The pleiotropic phenotypes of the disorders indicate that B3GALT6 plays a critical role in a wide range of biological processes in various tissues, including skin, bone, cartilage, tendon, and ligament.	[Nakajima, Masahiro; Iida, Aritoshi; Ikegawa, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan; [Mizumoto, Shuji; Kogawa, Ryo; Sugahara, Kazuyuki] Hokkaido Univ, Grad Sch Life Sci, Frontier Res Ctr Postgen Sci & Technol, Lab Proteoglycan Signaling & Therapeut, Sapporo, Hokkaido 0010021, Japan; [Miyake, Noriko; Tsurusaki, Yoshinori; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Dept Human Genet, Grad Sch Med, Yokohama, Kanagawa 2360004, Japan; [Ito, Hironori] Cent Hosp Kasugai, Dept Orthopaed Surg, Aichi Prefectural Colony, Kasugai, Aichi 4800392, Japan; [Kitoh, Hiroshi] Nagoya Univ, Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 4668550, Japan; [Hirayama, Aya] Akita Prefectural Ctr Dev & Disabil, Dept Pediat, Akita 0101407, Japan; [Mitsubuchi, Hiroshi] Kumamoto Univ Hosp, Dept Neonatol, Kumamoto 8608556, Japan; [Miyazaki, Osamu] Natl Ctr Child Hlth & Dev, Dept Radiol, Tokyo 1578535, Japan; [Kosaki, Rika] Natl Ctr Child Hlth & Dev, Div Med Genet, Tokyo 1578535, Japan; [Horikawa, Reiko] Natl Ctr Child Hlth & Dev, Div Endocrinol & Metab, Tokyo 1578535, Japan; [Lai, Angeline] KK Womens & Childrens Hosp, Dept Paediat Med, Singapore 229899, Singapore; [Mendoza-Londono, Roberto; Dupuis, Lucie; Chitayat, David] Hosp Sick Children, Dept Paediat, Toronto, ON M5G 1X8, Canada; [Mendoza-Londono, Roberto; Dupuis, Lucie; Chitayat, David; Howard, Andrew] Univ Toronto, Toronto, ON M5G 1X8, Canada; [Howard, Andrew] Hosp Sick Children, Dept Surg, Toronto, ON M5G 1X8, Canada; [Leal, Gabriela E.] Fernando Figueira Integral Med Inst IMIP, BR-50070550 Recife, PE, Brazil; [Cavalcanti, Denise] State Univ Campinas UNICAMP, Fac Med Sci, Dept Med Genet, Skeletal Dysplasia Grp, BR-13083970 Campinas, SP, Brazil; [Watanabe, Shigehiko; Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Saitama 3398551, Japan; [Lausch, Ekkehart] Univ Freiburg, Ctr Pediat & Adolescent Med, Div Paediat Genet, D-79106 Freiburg, Germany; [Unger, Sheila] Univ Lausanne, CHUV, Med Genet Serv, CH-1011 Lausanne, Switzerland; [Bonafe, Luisa; Superti-Furga, Andrea] Univ Lausanne, CHUV, Dept Pediat, CH-1011 Lausanne, Switzerland; [Nishimura, Gen] Tokyo Metropolitan Childrens Med Ctr, Dept Pediat Imaging, Fuchu, Tokyo 1838561, Japan	RIKEN; Hokkaido University; Yokohama City University; Nagoya University; Kumamoto University; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; KK Women's & Children's Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Universidade Estadual de Campinas; Saitama Children's Medical Center; University of Freiburg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Tokyo Metropolitan Children's Medical Center	Ikegawa, S (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Ikegawa, Shiro/N-6895-2015; superti-furga, andrea/E-9162-2015; KITOH, Hiroshi/I-7256-2014; Mizumoto, Shuji/F-8313-2018; Kitoh, Hiroshi/AAC-2093-2021; Iida, Aritoshi/CAA-1373-2022; unger, sheila/E-9177-2015; Saitsu, Hirotomo/AAM-7131-2021; Cavalcanti, Denise/D-3579-2012	Ikegawa, Shiro/0000-0003-0316-2147; superti-furga, andrea/0000-0002-3543-7531; Mizumoto, Shuji/0000-0002-4641-1505; Iida, Aritoshi/0000-0001-7538-1651; Howard, Andrew/0000-0001-7226-6471; Tsurusaki, Yoshinori/0000-0002-7240-6355; Unger, Sheila/0000-0002-9539-8941; Mendoza-Londono, Roberto/0000-0003-3542-8106; Saitsu, Hirotomo/0000-0003-0723-0960	Ministry of Health, Labor, and Welfare [23300101, 23300201]; Japan Society for the Promotion of Science [23689052, 23790066]; Matching Program for Innovations in Future Drug Discovery and Medical Care; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Akiyama Life Science Foundation; Swiss National Science Foundation [31003A_141241, 310030_132940]; CoSMO-B project (Brazil); CoSMO-B project (Switzerland); Leenaards Foundation (Switzerland); Research on intractable diseases, Health and Labour Sciences Research Grants [H23-Nanchi-Ippan-123]	Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Matching Program for Innovations in Future Drug Discovery and Medical Care; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Akiyama Life Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CoSMO-B project (Brazil); CoSMO-B project (Switzerland); Leenaards Foundation (Switzerland); Research on intractable diseases, Health and Labour Sciences Research Grants	We thank the individuals with the disease and their family for their help to the study. We also thank the Japanese Skeletal Dysplasia Consortium. This study is supported by research grants from the Ministry of Health, Labor, and Welfare (23300101 to S.I. and N. Matsumoto; 23300201 to S.I.), by Grants-in-Aid for Young Scientists (23689052 to N. Miyake and 23790066 to S.M.) from the Japan Society for the Promotion of Science; by the Matching Program for Innovations in Future Drug Discovery and Medical Care (K.S.); by The Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); by a Grant-in-aid for Encouragement from the Akiyama Life Science Foundation (S.M.); by Swiss National Science Foundation Grants (31003A_141241 and 310030_132940); by The CoSMO-B project (Brazil and Switzerland); by the Leenaards Foundation (Switzerland); and by Research on intractable diseases, Health and Labour Sciences Research Grants, H23-Nanchi-Ippan-123 (S.I.).	Baasanjav S, 2011, AM J HUM GENET, V89, P15, DOI 10.1016/j.ajhg.2011.05.021; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; BEIGHTON P, 1984, CLIN GENET, V26, P308; Boyden ED, 2011, AM J HUM GENET, V89, P767, DOI 10.1016/j.ajhg.2011.10.016; Faiyaz-Ul-Haque M, 2004, AM J MED GENET A, V128A, P39, DOI 10.1002/ajmg.a.30005; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KRESSE H, 1987, AM J HUM GENET, V41, P436; Min BJ, 2011, AM J HUM GENET, V89, P760, DOI 10.1016/j.ajhg.2011.10.015; Miyake N, 2012, J MED GENET, V49, P533, DOI 10.1136/jmedgenet-2012-101039; Miyake N, 2010, HUM MUTAT, V31, P966, DOI 10.1002/humu.21300; Mizumoto S, 2012, METHODS MOL BIOL, V836, P99, DOI 10.1007/978-1-61779-498-8_7; Nishimura G, 1998, PEDIATR RADIOL, V28, P120, DOI 10.1007/s002470050310; Okajima T, 1999, J BIOL CHEM, V274, P28841, DOI 10.1074/jbc.274.41.28841; QUENTIN E, 1990, P NATL ACAD SCI USA, V87, P1342, DOI 10.1073/pnas.87.4.1342; Saunders CJ, 2009, AM J MED GENET A, V149A, P1019, DOI 10.1002/ajmg.a.32776; Togayachi A, 2006, METHOD ENZYMOL, V416, P91, DOI 10.1016/S0076-6879(06)16006-1; Tsurusaki Y, 2012, NAT GENET, V44, P376, DOI 10.1038/ng.2219; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909	18	88	92	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN 6	2013	92	6					927	934		10.1016/j.ajhg.2013.04.003	http://dx.doi.org/10.1016/j.ajhg.2013.04.003			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	164MX	23664117	Green Published, Bronze			2022-12-18	WOS:000320415300009
J	Shi, Y; Qu, J; Zhang, DD; Zhao, PQ; Zhang, QJ; Tam, POS; Sun, LD; Zuo, XB; Zhou, XT; Xiao, XS; Hu, JB; Li, YF; Cai, L; Liu, XQ; Lu, F; Liao, SH; Chen, B; He, F; Gong, B; Lin, H; Ma, S; Cheng, J; Zhang, J; Chen, YY; Zhao, FX; Yang, X; Chen, YH; Yang, C; Lam, DSC; Li, X; Shi, FJ; Wu, ZZ; Lin, Y; Yang, JY; Li, SQ; Ren, YQ; Xue, AQ; Fan, YC; Li, D; Pang, CP; Zhang, XJ; Yang, ZL				Shi, Yi; Qu, Jia; Zhang, Dingding; Zhao, Peiquan; Zhang, Qingjiong; Tam, Pancy Oi Sin; Sun, Liangdan; Zuo, Xianbo; Zhou, Xiangtian; Xiao, Xueshan; Hu, Jianbin; Li, Yuanfeng; Cai, Li; Liu, Xiaoqi; Lu, Fang; Liao, Shihuang; Chen, Bin; He, Fei; Gong, Bo; Lin, He; Ma, Shi; Cheng, Jing; Zhang, Jie; Chen, Yiye; Zhao, Fuxin; Yang, Xian; Chen, Yuhong; Yang, Charles; Lam, Dennis Shun Chiu; Li, Xi; Shi, Fanjun; Wu, Zhengzheng; Lin, Ying; Yang, Jiyun; Li, Shiqiang; Ren, Yunqing; Xue, Anquan; Fan, Yingchuan; Li, Dean; Pang, Chi Pui; Zhang, Xuejun; Yang, Zhenglin			Genetic Variants at 13q12.12 Are Associated with High Myopia in the Han Chinese Population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; REFRACTIVE ERROR; SUSCEPTIBILITY LOCUS; PREVALENCE; HERITABILITY; POLYMORPHISM	High myopia, which is extremely prevalent in the Chinese population, is one of the leading causes of blindness in the world. Genetic factors play a critical role in the development of the condition. To identify the genetic variants associated with high myopia in the Han Chinese, we conducted a genome-wide association study (GWAS) of 493,947 SNPs in 1088 individuals (419 cases and 669 controls) from a Han Chinese cohort and followed up on signals that were associated with p < 1.0 x 10(-4) in three independent cohorts (combined, 2803 cases and 5642 controls). We identified a significant association between high myopia and a variant at 13q12.12 (rs9318086, combined p = 1.91 x 10(-16), heterozygous odds ratio = 1.32, and homozygous odds ratio = 1.64). Furthermore, five additional SNPs (rs9510902, rs3794338, rs1886970, rs7325450, and rs7331047) in the same linkage disequilibrium (LD) block with rs9318086 also proved to be significantly associated with high myopia in the Han Chinese population; p values ranged from 5.46 x 10(-11) to 6.16 x 10(-16). This associated locus contains three genes-MIPEP, C1QTNF9B-AS1, and C1QTNF9B. MIPEP and C1QTNF9B were found to be expressed in the retina and retinal pigment epithelium (RPE) and are more likely than C1QTNF9B-AS1 to be associated with high myopia given the evidence of retinal signaling that controls eye growth. Our results suggest that the variants at 13q12.12 are associated with high myopia.	[Shi, Yi; Zhang, Dingding; Li, Yuanfeng; Cai, Li; Liu, Xiaoqi; Lu, Fang; He, Fei; Gong, Bo; Lin, He; Ma, Shi; Cheng, Jing; Li, Xi; Lin, Ying; Yang, Jiyun; Yang, Zhenglin] Sichuan Prov Peoples Hosp, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu 610072, Sichuan, Peoples R China; [Shi, Yi; Zhang, Dingding; Li, Yuanfeng; Cai, Li; Liu, Xiaoqi; Lu, Fang; He, Fei; Gong, Bo; Lin, He; Ma, Shi; Cheng, Jing; Li, Xi; Lin, Ying; Yang, Jiyun; Yang, Zhenglin] Sichuan Acad Med Sci, Inst Lab Med, Chengdu 610072, Sichuan, Peoples R China; [Qu, Jia; Zhou, Xiangtian; Zhao, Fuxin; Shi, Fanjun; Xue, Anquan] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou 325035, Zhejiang, Peoples R China; [Zhao, Peiquan; Chen, Yiye] Shanghai Jiao Tong Univ, Xinhua Hosp, Dept Ophthalmol, Shanghai 200092, Peoples R China; [Zhang, Qingjiong; Xiao, Xueshan; Li, Shiqiang] Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Tam, Pancy Oi Sin; Lam, Dennis Shun Chiu; Pang, Chi Pui] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Kowloon, Hong Kong, Peoples R China; [Sun, Liangdan; Zuo, Xianbo; Ren, Yunqing; Zhang, Xuejun] Anhui Med Univ, Minist Educ, China Key Lab Dermatol, Hefei 230032, Anhui, Peoples R China; [Hu, Jianbin; Liao, Shihuang; Chen, Bin; Wu, Zhengzheng; Fan, Yingchuan] Sichuan Acad Med Sci, Dept Ophthalmol, Chengdu 610072, Anhui, Peoples R China; [Hu, Jianbin; Liao, Shihuang; Chen, Bin; Wu, Zhengzheng; Fan, Yingchuan] Sichuan Prov Peoples Hosp, Chengdu 610072, Anhui, Peoples R China; [Zhang, Jie] Shiji Eye Hosp, Chengdu 610016, Anhui, Peoples R China; [Yang, Xian] Qingdao Univ, Affiliated Hosp, Coll Med, Dept Ophthalmol, Qingdao 266003, Peoples R China; [Chen, Yuhong] Fudan Univ, Dept Ophthalmol, Shanghai 200031, Peoples R China; [Chen, Yuhong] Fudan Univ, Visual Sci Eye & ENT Hosp, Shanghai Med Sch, Shanghai 200031, Peoples R China; [Yang, Charles] W High Sch, Salt Lake City, UT 84103 USA; [Li, Dean] Univ Utah, Salt Lake City, UT 84132 USA	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Wenzhou Medical University; Shanghai Jiao Tong University; Chinese University of Hong Kong; Anhui Medical University; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Qingdao University; Fudan University; Fudan University; Utah System of Higher Education; University of Utah	Yang, ZL (corresponding author), Sichuan Prov Peoples Hosp, Sichuan Prov Key Lab Human Dis Gene Study, Chengdu 610072, Sichuan, Peoples R China.	zliny@yahoo.com	zhou, xt/GWZ-9212-2022; Lam, Dennis/AAL-1211-2020; Chen, Yi-Chen/GVU-0551-2022; Zhang, Qingjiong/AAR-6331-2021; Chen, Gang/G-2722-2010; Yang, Jiyun/AAS-3937-2020; Pang, Chi P/I-5388-2014	Zhang, Qingjiong/0000-0001-7508-848X; Zhao, Fuxin/0000-0002-1006-6180	Natural Science Foundation of China [30900809, 81025006, 81070761, 30871350, 81070751]; National Basic Research Program of China (973 project) [2011CB504604]; Department of Science and Technology of Sichuan Province, China; Zhejiang Provincial Natural Science Foundation [R205739, Z2100065]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 project)(National Basic Research Program of China); Department of Science and Technology of Sichuan Province, China; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	We thank the patients and their families for their participation. We thank Kirk Thomas for his critical reading of the manuscript. Support for this work was obtained from the Natural Science Foundation of China (grants 30900809 [Y.S.], 81025006 [Z.Y.], 81070761 [F.L], 30871350 [D.Z.], and 81070751 [J.Q.]), the National Basic Research Program of China (973 project, 2011CB504604 [Z.Y.]), the Department of Science and Technology of Sichuan Province, China (Z.Y.), and the Zhejiang Provincial Natural Science Foundation (grants R205739 and Z2100065 to X.Z.).	Andrew T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000220; Banker A S, 2001, Ophthalmol Clin North Am, V14, P695, DOI 10.1016/S0896-1549(05)70268-6; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Broustas CG, 2004, J BIOL CHEM, V279, P26780, DOI 10.1074/jbc.M400159200; Chew A, 1997, GENOMICS, V40, P493, DOI 10.1006/geno.1996.4586; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dirani M, 2006, INVEST OPHTH VIS SCI, V47, P4756, DOI 10.1167/iovs.06-0270; HAYASHI H, 2011, INVEST OPHTHALMOL VI; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; He MG, 2009, OPTOMETRY VISION SCI, V86, P40, DOI 10.1097/OPX.0b013e3181940719; Hysi PG, 2010, NAT GENET, V42, P902, DOI 10.1038/ng.664; Kempen AH, 2004, ARCH OPHTHALMOL-CHIC, V122, P495; Li YJ, 2011, OPHTHALMOLOGY, V118, P368, DOI 10.1016/j.ophtha.2010.06.016; Lopes MC, 2009, INVEST OPHTH VIS SCI, V50, P126, DOI 10.1167/iovs.08-2385; Nakanishi H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000660; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quan C, 2010, NAT GENET, V42, P614, DOI 10.1038/ng.603; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Solouki AM, 2010, NAT GENET, V42, P897, DOI 10.1038/ng.663; van der Helm-van Mil AHM, 2010, ANN RHEUM DIS, V69, P1694, DOI 10.1136/ard.2009.123828; van der Linden MPM, 2009, ARTHRITIS RHEUM, V60, P2242, DOI 10.1002/art.24721; van Sommeren S, 2011, INFLAMM BOWEL DIS, V17, P1714, DOI 10.1002/ibd.21541; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Wojciechowski R, 2010, INVEST OPHTH VIS SCI, V51, P4989, DOI 10.1167/iovs.10-5474; Wong TY, 2000, INVEST OPHTH VIS SCI, V41, P2486; Young TL, 2009, OPTOMETRY VISION SCI, V86, P8, DOI 10.1097/OPX.0b013e3181940655; Zhao FX, 2010, MOL VIS, V16, P1920	29	88	94	4	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 10	2011	88	6					805	813		10.1016/j.ajhg.2011.04.022	http://dx.doi.org/10.1016/j.ajhg.2011.04.022			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	779HK	21640322	Green Published, Bronze			2022-12-18	WOS:000291768500012
J	Pereira, L; Soares, P; Radivojac, P; Li, BA; Samuels, DC				Pereira, Luisa; Soares, Pedro; Radivojac, Predrag; Li, Biao; Samuels, David C.			Comparing Phylogeny and the Predicted Pathogenicity of Protein Variations Reveals Equal Purifying Selection across the Global Human mtDNA Diversity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA; NATURAL-SELECTION; EVOLUTION; MUTATIONS; GENOMICS	We used detailed phylogenetic trees for human nitDNA, combined with pathogenicity predictions for each amino acid change, to evaluate selection on mtDNA-encoded protein variants. Protein variants with high pathogenicity scores were significantly rarer in the older branches of the tree. Variants that have formed and survived multiple times in the human phylogenetics tree had significantly lower pathogenicity scores than those that only appear once in the tree. We compared the distribution of pathogenicity scores observed on the human phylogenetic tree to the distribution of all possible protein variations to define a measure of the effect of selection on these protein variations. The measured effect of selection increased exponentially with increasing pathogenicity score. We found no measurable difference in this measure of purifying selection in mtDNA across the global population, represented by the macrohaplogroups L, M, and N. We provide a list of all possible single amino acid variations for the human mtDNA-encoded proteins with their predicted pathogenicity scores and our measured selection effect as a tool for assessing novel protein variations that are often reported in patients with mitochondrial disease of unknown origin or for assessing somatic mutations acquired through aging or detected in tumors.	[Samuels, David C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA; [Pereira, Luisa; Soares, Pedro] Univ Porto IPATIMUP, Inst Patol & Imunol Mol, P-4200465 Oporto, Portugal; [Pereira, Luisa] Univ Porto, Fac Med, P-4200465 Oporto, Portugal; [Radivojac, Predrag; Li, Biao] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47408 USA	Vanderbilt University; Universidade do Porto; Universidade do Porto; Indiana University System; Indiana University Bloomington	Samuels, DC (corresponding author), Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Ctr Human Genet Res, Nashville, TN 37232 USA.	david.samuels@chgr.mc.vanderbilt.edu	Samuels, David C/A-5393-2008; Soares, Pedro A/G-9422-2011; Samuels, David/AHC-8381-2022; Pereira, Luisa/H-3050-2011; Samuels, David/C-1365-2012	Samuels, David C/0000-0003-3529-7791; Soares, Pedro A/0000-0002-2807-690X; Samuels, David/0000-0003-3529-7791; Pereira, Luisa/0000-0002-4271-1527; 	The Portuguese Foundation for Science and Technology (FCT) [SFRH/BPD/64233/2009]	The Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	The Portuguese Foundation for Science and Technology (FCT) supported this work through a grant to P.S. (SFRH/BPD/64233/2009). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Science, Technology and Higher Education and is partially supported by FCT.	Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Blier PU, 2001, TRENDS GENET, V17, P400, DOI 10.1016/S0168-9525(01)02338-1; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Elson JL, 2004, AM J HUM GENET, V74, P229, DOI 10.1086/381505; Endicott P, 2008, AM J HUM GENET, V82, P895, DOI 10.1016/j.ajhg.2008.01.019; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; Forster P, 1996, AM J HUM GENET, V59, P935; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Moilanen JS, 2003, MOL BIOL EVOL, V20, P1195, DOI 10.1093/molbev/msg121; Nachman MW, 1998, GENETICA, V102-3, P61, DOI 10.1023/A:1017030708374; Nachman MW, 1996, GENETICS, V142, P953; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Pereira L, 2009, AM J HUM GENET, V84, P628, DOI 10.1016/j.ajhg.2009.04.013; Rand DM, 2004, TRENDS ECOL EVOL, V19, P645, DOI 10.1016/j.tree.2004.10.003; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Subramanian S, 2009, TRENDS GENET, V25, P482, DOI 10.1016/j.tig.2009.09.005; Subramanian S, 2009, MOL BIOL EVOL, V26, P715, DOI 10.1093/molbev/msp005; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001	32	88	88	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 8	2011	88	4					433	439		10.1016/j.ajhg.2011.03.006	http://dx.doi.org/10.1016/j.ajhg.2011.03.006			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	752BY	21457906	Green Published, Bronze			2022-12-18	WOS:000289664300003
J	O'Driscoll, MC; Daly, SB; Urquhart, JE; Black, GCM; Pilz, DT; Brockmann, K; McEntagart, M; Abdel-Salam, G; Zaki, M; Wolf, NI; Ladda, RL; Sell, S; D'Arrigo, S; Squier, W; Dobyns, WB; Liyingston, JH; Crow, YJ				O'Driscoll, Mary C.; Daly, Sarah B.; Urquhart, Jill E.; Black, Graeme C. M.; Pilz, Daniela T.; Brockmann, Knut; McEntagart, Meriel; Abdel-Salam, Ghada; Zaki, Maha; Wolf, Nicole I.; Ladda, Roger L.; Sell, Susan; D'Arrigo, Stefano; Squier, Waney; Dobyns, William B.; Liyingston, John H.; Crow, Yanick J.			Recessive Mutations in the Gene Encoding the Tight Junction Protein Occludin Cause Band-like Calcification with Simplified Gyration and Polymicrogyria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CONGENITAL CYTOMEGALOVIRUS-INFECTION; POLARIZED EPITHELIAL-CELLS; BLOOD-BRAIN-BARRIER; INTRACRANIAL CALCIFICATION; NEURONAL MIGRATION; CEREBRAL-CORTEX; UNLAYERED POLYMICROGYRIA; ENDOTHELIAL-CELLS; MEMBRANE-PROTEIN; GOLGI ANALYSIS	Band-like calcification with simplified gyration and polymicrogyria (BLC-PMG) is a rare autosomal-recessive neurological disorder showing highly characteristic clinical and neuroradiological features. Affected individuals demonstrate early-onset seizures, severe microcephaly, and developmental arrest with bilateral, symmetrical polymicrogyria (PMG) and a band of gray matter calcification on brain imaging; as such, the disorder can be considered as a "pseudo-TORCH" syndrome. By using autozygosity mapping and copy number analysis we identified intragenic deletions and mutations in OCLN in nine patients from six families with BLC-PMG. The OCLN gene encodes occludin, an integral component of tight junctions. Neuropathological analysis of an affected individual showed similarity to the mouse model of occludin deficiency with calcification predominantly associated with blood vessels. Both intracranial calcification and PMG are heterogeneous in etiology. Neuropathological and clinical studies of PMG have suggested that in utero ischemic or vascular insults may contribute to this common cortical abnormality. Tight junctions are functional in cerebral blood vessels early in fetal development and continue to play a vital role in maintenance of the blood-brain barrier during postnatal life. We provide evidence that the tight junction protein occludin (encoded by the OCLN gene) is involved in the pathogenesis of malformations of cortical development.	[O'Driscoll, Mary C.; Daly, Sarah B.; Urquhart, Jill E.; Black, Graeme C. M.; Crow, Yanick J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, Univ Hosp, Manchester M13 9WL, Lancs, England; [Pilz, Daniela T.] Univ Wales Hosp, Dept Med Genet, Cardiff CF14 4XW, S Glam, Wales; [Brockmann, Knut] Univ Gottingen, Childrens Hosp, Dept Paediat & Paediat Neurol, D-37075 Gottingen, Germany; [McEntagart, Meriel] St George Hosp, Dept Clin Genet, London SW17 0RE, England; [Abdel-Salam, Ghada; Zaki, Maha] Natl Res Ctr, Human Genet & Genome Res Div, Dept Clin Genet, Cairo 12311, Egypt; [Wolf, Nicole I.] Univ Childrens Hosp, D-69120 Heidelberg, Germany; [Wolf, Nicole I.] Vrije Univ Amsterdam Med Ctr, Dept Child Neurol, NL-1007 MB Amsterdam, Netherlands; [Ladda, Roger L.; Sell, Susan] Penn State Hershey Childrens Hosp, Div Human Genet Growth & Dev, Dept Pediat, Hershey, PA 17033 USA; [D'Arrigo, Stefano] Fdn IRCCS Ist Neurol C Besta, Dev Neurol Dept, I-20133 Milan, Italy; [Squier, Waney] Radcliffe Infirm, Dept Neurol, Oxford OX3 9DU, England; [Squier, Waney] Radcliffe Infirm, Dept Neuropathol, Oxford OX3 9DU, England; [Dobyns, William B.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Dobyns, William B.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Dobyns, William B.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Liyingston, John H.] Leeds Gen Infirm, Dept Paediat Neurol, Leeds LS9 7TF, W Yorkshire, England	University of Manchester; Cardiff University; University of Gottingen; St Georges University London; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; IRCCS Istituto Neurologico Besta; Radcliffe Infirmary; Radcliffe Infirmary; University of Chicago; University of Chicago; University of Chicago; Leeds General Infirmary; University of Leeds	Crow, YJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Cent Manchester Fdn Trust, Univ Hosp, Manchester M13 9WL, Lancs, England.	yanickcrow@mac.com	Abdel-Salam, Ghada/W-1718-2017; Urquhart, Jill/G-2282-2015; Wolf, Nicole I/H-3943-2014; d'arrigo, stefano/K-3640-2016; Dobyns, William Brian/ABC-6525-2021; Dobyns, William/AAI-2768-2020; Zaki, Maha S/B-9361-2013; Crow, Yanick J/N-6120-2014; Black, Graeme/K-7374-2015	Abdel-Salam, Ghada/0000-0003-2893-8802; Urquhart, Jill/0000-0002-5788-5511; Wolf, Nicole I/0000-0003-1721-0728; d'arrigo, stefano/0000-0001-5188-9418; Dobyns, William/0000-0002-7681-2844; Crow, Yanick J/0000-0001-7211-7564; Zaki, Maha/0000-0001-7840-0002; Black, Graeme/0000-0001-8727-6592	Manchester NIHR Biomedical Research Centre; Manchester Academic Health Sciences Centre; Wellcome Trust	Manchester NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Manchester Academic Health Sciences Centre; Wellcome Trust(Wellcome TrustEuropean Commission)	We sincerely thank the families for their involvement in this work. Y.J.C. acknowledges the Manchester NIHR Biomedical Research Centre and the Manchester Academic Health Sciences Centre. M.C.O'D. is funded by the Manchester NIHR Biomedical Research Centre and the Wellcome Trust. We are grateful to Dr. E. Hellen in the Manchester National Genetics Reference Laboratory at the University of Manchester and Dr. Diana Baralle at the University of Southampton for their assistance with mutation analysis.	AakuSaraste E, 1996, DEV BIOL, V180, P664, DOI 10.1006/dbio.1996.0336; Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abdel-Salam GMH, 2008, AM J MED GENET A, V146A, P2929, DOI 10.1002/ajmg.a.32549; Abdel-Salam GMH, 2009, AM J MED GENET A, V149A, P1565, DOI 10.1002/ajmg.a.32894; Abdollahi MR, 2009, AM J HUM GENET, V85, P737, DOI 10.1016/j.ajhg.2009.10.007; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Balda MS, 1996, J CELL BIOL, V134, P1031, DOI 10.1083/jcb.134.4.1031; Ballabh P, 2005, PEDIATR RES, V58, P791, DOI 10.1203/01.PDR.0000180535.14093.FB; BARTH PG, 1985, ACTA NEUROPATHOL, V67, P345, DOI 10.1007/BF00687825; Boppana SB, 1997, PEDIATRICS, V99, P409, DOI 10.1542/peds.99.3.409; Briggs TA, 2008, AM J MED GENET A, V146A, P3173, DOI 10.1002/ajmg.a.32614; Brooks AS, 2005, AM J HUM GENET, V77, P120, DOI 10.1086/431244; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; des Portes V, 1998, CELL, V92, P51; Dobyns WB, 2008, AM J MED GENET A, V146A, P1637, DOI 10.1002/ajmg.a.32293; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; DVORAK K, 1977, ACTA NEUROPATHOL, V38, P203; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FERRER I, 1991, ANAT EMBRYOL, V184, P517, DOI 10.1007/BF01236058; FERRER I, 1984, ACTA NEUROPATHOL, V65, P69, DOI 10.1007/BF00689830; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; Geerdink N, 2002, NEUROPEDIATRICS, V33, P33, DOI 10.1055/s-2002-23598; Ghassemifar MR, 2002, J CELL SCI, V115, P3171; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; GRAFFRADFORD NR, 1986, ANN NEUROL, V20, P632, DOI 10.1002/ana.410200513; Graham JM, 2004, AM J MED GENET A, V128A, P235, DOI 10.1002/ajmg.a.30060; Gu JM, 2008, FEBS J, V275, P3145, DOI 10.1111/j.1742-4658.2008.06467.x; Hay ED, 1995, ACTA ANAT, V154, P8; Hevner RF, 2005, ACTA NEUROPATHOL, V110, P208, DOI 10.1007/s00401-005-1059-8; Hirase T, 1997, J CELL SCI, V110, P1603; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Jansen A, 2005, J MED GENET, V42, P369, DOI 10.1136/jmg.2004.023952; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Keren B, 2007, AM J MED GENET A, V143A, P1514, DOI 10.1002/ajmg.a.31784; Kohaar I, 2010, J VIROL, V84, P6987, DOI 10.1128/JVI.00196-10; Mankertz J, 2002, BIOCHEM BIOPH RES CO, V298, P657, DOI 10.1016/S0006-291X(02)02487-7; MCBRIDE MC, 1982, ACTA NEUROPATHOL, V57, P93, DOI 10.1007/BF00685375; Mitchell TN, 2003, ANN NEUROL, V53, P658, DOI 10.1002/ana.10576; Muresan Z, 2000, MOL BIOL CELL, V11, P627, DOI 10.1091/mbc.11.2.627; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Noyola DE, 2001, J PEDIATR-US, V138, P325, DOI 10.1067/mpd.2001.112061; Passemard S, 2009, NEUROLOGY, V73, P962, DOI 10.1212/WNL.0b013e3181b8799a; Raleigh DR, 2010, MOL BIOL CELL, V21, P1200, DOI 10.1091/mbc.E09-08-0734; Rao R, 2009, ANN NY ACAD SCI, V1165, P62, DOI 10.1111/j.1749-6632.2009.04054.x; Raybaud C, 2007, CHILD NERV SYST, V23, P1379, DOI 10.1007/s00381-007-0474-7; REUTENS DC, 1993, J NEUROL NEUROSUR PS, V56, P314, DOI 10.1136/jnnp.56.3.314; RICHMAN DP, 1974, J NEUROPATH EXP NEUR, V33, P374, DOI 10.1097/00005072-197407000-00004; Robin NH, 2006, AM J MED GENET A, V140A, P2416, DOI 10.1002/ajmg.a.31443; Roll P, 2006, HUM MOL GENET, V15, P1195, DOI 10.1093/hmg/ddl035; Saitou M, 1998, J CELL BIOL, V141, P397, DOI 10.1083/jcb.141.2.397; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P599, DOI 10.1016/S0968-0004(02)02229-6; Scholz M, 2007, MED RES REV, V27, P401, DOI 10.1002/med.20064; Shaffer LG, 2009, ISCN 2013 INT SYSTEM; Shimizu F, 2008, J CELL PHYSIOL, V217, P388, DOI 10.1002/jcp.21508; Shultz T, 2008, FASEB J, V22, P168, DOI 10.1096/fj.06-7786com; Steed E, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-95; Subramanian VS, 2007, AM J PHYSIOL-CELL PH, V293, pC1717, DOI 10.1152/ajpcell.00309.2007; SUZUKI M, 1991, ACTA NEUROPATHOL, V82, P93, DOI 10.1007/BF00293950; Valente EM, 2005, ANN NEUROL, V57, P513, DOI 10.1002/ana.20422; VanBogaert P, 1996, DEV MED CHILD NEUROL, V38, P166; Virgintino D, 2004, HISTOCHEM CELL BIOL, V122, P51, DOI 10.1007/s00418-004-0665-1; Virgintino Daniela, 2007, Angiogenesis, V10, P35, DOI 10.1007/s10456-006-9061-x; WILLIAMS RS, 1976, ACTA NEUROPATHOL, V36, P269, DOI 10.1007/BF00685371	70	88	91	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 10	2010	87	3					354	364		10.1016/j.ajhg.2010.07.012	http://dx.doi.org/10.1016/j.ajhg.2010.07.012			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	651JH	20727516	Green Published, Bronze			2022-12-18	WOS:000281923500004
J	Ruano, D; Abecasis, GR; Glaser, B; Lips, ES; Cornelisse, LN; de Jong, APH; Evans, DM; Smith, GD; Timpson, NJ; Smit, AB; Heutink, P; Verhage, M; Posthuma, D				Ruano, Dina; Abecasis, Goncalo R.; Glaser, Beate; Lips, Esther S.; Cornelisse, L. Niels; de Jong, Arthur P. H.; Evans, David M.; Smith, George Davey; Timpson, Nicolas J.; Smit, August B.; Heutink, Peter; Verhage, Matthijs; Posthuma, Danielle			Functional Gene Group Analysis Reveals a Role of Synaptic Heterotrimeric G Proteins in Cognitive Ability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; DEFICIT HYPERACTIVITY DISORDER; WORKING-MEMORY; DISEASE; INTELLIGENCE; PROTEOMICS; SYNAPSES; CHILDREN; LINKAGE; SPEED	Although cognitive ability is a highly heritable complex trait, only a few genes have been identified, explaining relatively low proportions of the observed trail variation. This implies that hundreds of genes of small effect may be of importance for cognitive ability. We applied an innovative method in which we tested for the effect of groups of genes defined according to cellular function (functional gene group analysis). Using an initial sample of 627 Subjects, this functional gene group analysis detected that synaptic heterotrimeric guanine nucleotide binding proteins (G proteins) play an important role in cognitive ability (P-EMP = 1.9 x 10(-4)). The association with heterotrimeric G proteins was validated in an independent population sample of 1507 subjects. Heterotrimeric G proteins are central relay factors between the activation of plasma membrane receptors by extracellular ligands and the cellular responses that these induce, and they can be considered a point of convergence, or a "signaling bottleneck." Although alterations in synaptic signaling processes may not be the exclusive explanation for the association of heterotrimeric G proteins with cognitive ability, Such alterations may prominently affect the properties of neuronal networks in the brain in such a manner that impaired cognitive ability and lower intelligence are observed. The reported association of synaptic heterotrimeric G proteins with cognitive ability clearly points to a new direction in the Study of the genetic basis of cognitive ability.	[Lips, Esther S.; Cornelisse, L. Niels; de Jong, Arthur P. H.; Verhage, Matthijs; Posthuma, Danielle] Vrije Univ Amsterdam, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; [Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; [Ruano, Dina; Heutink, Peter; Posthuma, Danielle] Vrije Univ Amsterdam, VU Med Ctr, Dept Med Genom, NL-1081 HV Amsterdam, Netherlands; [Glaser, Beate; Evans, David M.; Smith, George Davey; Timpson, Nicolas J.] Univ Bristol, Dept Social Med, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS8 2BN, Avon, England; [Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Bristol; University of Michigan System; University of Michigan	Posthuma, D (corresponding author), Vrije Univ Amsterdam, Dept Funct Genom, Neurosci Campus Amsterdam, NL-1081 HV Amsterdam, Netherlands.	danielle.posthuma@cncr.vu.nl	Timpson, Nicholas John/O-7548-2015; Davey Smith, George/A-7407-2013; Evans, David M/H-6325-2013; de Jong, Arthur PH/D-9500-2013; Fox, Laura J/C-6249-2016; Attrill, Lauren/V-1688-2018; Smit, August B/E-8410-2011; Abecasis, Goncalo R/B-7840-2010; St Pourcain, Beate/K-8004-2017	Timpson, Nicholas John/0000-0002-7141-9189; Davey Smith, George/0000-0002-1407-8314; Evans, David M/0000-0003-0663-4621; St Pourcain, Beate/0000-0002-4680-3517; Abecasis, Goncalo/0000-0003-1509-1825; Cornelisse, Lennart Niels/0000-0001-9425-2935; s, hema/0000-0002-3440-9475; de Jong, Arthur/0000-0002-7620-2704; verhage, matthijs/0000-0002-6085-7503; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Heutink, Peter/0000-0001-5218-1737; Posthuma, Danielle/0000-0001-7582-2365	Portuguese Foundation for Science and Technology [SFRH / BPD / 28725 2006]; Academy of the Royal Dutch Academy of Arts and Science; Simonsfonds; Centre for Medical Systems Biology (CMSB); Netherlands Scientific Organization (NWO) [480-05-003]; UK Medical Research Council [74882]; Wellcome Trust [076467]; University of Bristol;  [NWO/VIDI 016-065-318]; Medical Research Council [G9815508, G0600705, G0800582] Funding Source: researchfish; MRC [G0600705, G0800582] Funding Source: UKRI	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Academy of the Royal Dutch Academy of Arts and Science; Simonsfonds; Centre for Medical Systems Biology (CMSB); Netherlands Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work of D.R. is supported by the Portuguese Foundation for Science and Technology under grant no. SFRH / BPD / 28725 2006. D.P. is supported by NWO/VIDI 016-065-318. We would like to thank the Young Academy of the Royal Dutch Academy of Arts and Science and the Simonsfonds for providing funds to D.R and D.R., respectively, to facilitate collaboration with G.R.A. A.B.S. is supported by the Centre for Medical Systems Biology (CMSB). Statistical analyses were carried out on the Genetic Cluster Computer, which is financially supported by the Netherlands Scientific Organization (NWO 480-05-003). The genotyping of the samples was provided through the Genetic Association Information Network (GAIN). The data set(s) used for the analyses described in this manuscript were obtained from the dbGaP database through dbGaP accession no. phs000016.v1.p1.. Samples and associated phenotype data for the Whole-Genome Association Study of Attention Deficit Hyperactivity Disorder were provided by S Faraone. We are extremely grateful to all the families who took part in this study, to the midwives for their help in recruiting them, and to the whole ALSPAC team, which includes interviewers, computer and laboratory technicians, clerical workers, research scientists, volunteers, managers, receptionists, and nurses. The UK Medical Research Council (grant ref. 74882), the Wellcome Trust (grant ref. 076467), and the University of Bristol provided core support for ALSPAC. D.P. wishes to thank Zoltan Bochdanovits and Peter Visscher for reading earlier versions of this paper and/or for valuable discussions on the applied methods. We thank Synaptologics BV (http://www.synaptologics.com) for providing the database of functional gene groups.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2007, NAT GENET, V39, P813, DOI 10.1038/ng0707-813; Barnes M. R., 2007, BIOINFORMATICS GENET, P249; BOUCHARD TJ, 1981, SCIENCE, V212, P1055, DOI 10.1126/science.7195071; Brookes K, 2006, MOL PSYCHIATR, V11, P934, DOI 10.1038/sj.mp.4001869; de Jong APH, 2009, CURR OPIN NEUROBIOL, V19, P245, DOI 10.1016/j.conb.2009.06.005; Deary IJ, 2009, HUM GENET, V126, P215, DOI 10.1007/s00439-009-0655-4; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dickinson D, 2009, NEUROSCIENCE, V164, P72, DOI 10.1016/j.neuroscience.2009.05.014; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Emes RD, 2008, NAT NEUROSCI, V11, P799, DOI 10.1038/nn.2135; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Joinson C, 2007, PEDIATRICS, V120, pE308, DOI 10.1542/peds.2006-2891; Kuntsi Jonna, 2006, Behav Brain Funct, V2, P27, DOI 10.1186/1744-9081-2-27; Li KW, 2007, J PROTEOME RES, V6, P3127, DOI 10.1021/pr070086w; Li KW, 2005, J PROTEOME RES, V4, P725, DOI 10.1021/pr049802+; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Neale BM, 2008, GENET EPIDEMIOL, V32, P98, DOI 10.1002/gepi.20265; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Plomin R, 2005, PSYCHOL BULL, V131, P592, DOI 10.1037/0033-2909.131.4.592; Plomin R, 1999, NATURE, V402, pC25, DOI 10.1038/35011520; Posthuma D, 2003, TWIN RES, V6, P131, DOI 10.1375/136905203321536254; Posthuma D, 2001, BEHAV GENET, V31, P593, DOI 10.1023/A:1013349512683; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Rust, 1992, WISC IIIUK WECHSLER; Sattler J., 1992, ASSESSMENT CHILDREN; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sudhof TC, 2008, NEURON, V60, P469, DOI 10.1016/j.neuron.2008.10.011; Torkamani A, 2008, GENOMICS, V92, P265, DOI 10.1016/j.ygeno.2008.07.011; Verhage M, 2009, NEURON, V62, P603, DOI 10.1016/j.neuron.2009.05.019; Wechsler D, 1997, WECHSLER ADULT INTEL	38	88	89	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 12	2010	86	2					113	125		10.1016/j.ajhg.2009.12.006	http://dx.doi.org/10.1016/j.ajhg.2009.12.006			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	556ZS	20060087	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000274637200002
J	Twigg, SRF; Versnel, SL; Nurnberg, G; Lees, MM; Bhat, M; Hammond, P; Hennekam, RCM; Hoogeboom, AJM; Hurst, JA; Johnson, D; Robinson, AA; Scambler, PJ; Gerrelli, D; Nurnberg, P; Mathijssen, IMJ; Wilkie, AOM				Twigg, Stephen R. F.; Versnel, Sarah L.; Nuernberg, Gudrun; Lees, Melissa M.; Bhat, Meenakshi; Hammond, Peter; Hennekam, Raoul C. M.; Hoogeboom, A. Jeannette M.; Hurst, Jane A.; Johnson, David; Robinson, Alexis A.; Scambler, Peter J.; Gerrelli, Dianne; Nuernberg, Peter; Mathijssen, Irene M. J.; Wilkie, Andrew O. M.			Frontorhiny, a Distinctive Presentation of Frontonasal Dysplasia Caused by Recessive Mutations in the ALX3 Homeobox Gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DNA-BINDING; HOMEODOMAIN; LIP; MISSENSE; CLASSIFICATION; HYPERTELORISM; MALFORMATION; EXPANSION; SIBLINGS; DEFECT	We describe a recessively inherited frontonasal malformation characterized by a distinctive facial appearance, with hypertelorism, wide nasal bridge, short nasal ridge, bifid nasal tip, broad columella, widely separated slit-like nares, long philtrum with prominent bilateral swellings, and midline notch in the upper lip and alveolus. Additional recurrent features present in a minority of individuals have been upper eyelid ptosis and midline dermoid cysts of craniofacial structures. Assuming recessive inheritance, we mapped the locus in three families to chromosome 1 and identified mutations in ALX3, which is located at band 1p13.3 and encodes the aristaless-related ALX homeobox 3 transcription factor. In total, we identified seven different homozygous pathogenic mutations in seven families. These mutations comprise missense substitutions at critical positions within the conserved homeodomain as well as nonsense, frameshift, and splice-site mutations, all predicting severe or complete loss of function. Our findings contrast with previous studies of the orthologous murine gene, which showed no phenotype in Alx3(-/-) homozygotes, apparently as a result of functional redundancy with the paralogous Alx4 gene. We conclude that ALX3 is essential for normal facial development in humans and that deficiency causes a clinically recognizable phenotype, which we term frontorhiny.	[Twigg, Stephen R. F.; Wilkie, Andrew O. M.] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Versnel, Sarah L.; Mathijssen, Irene M. J.] Erasmus MC, Dept Plast & Reconstruct Surg, NL-3000 CB Rotterdam, Netherlands; [Hoogeboom, A. Jeannette M.] Erasmus MC, Dept Clin Genet, NL-3000 CB Rotterdam, Netherlands; [Nuernberg, Gudrun; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Lees, Melissa M.; Hennekam, Raoul C. M.] Great Ormond St Hosp Sick Children, Dept Clin Genet, London WC1N 3JH, England; [Lees, Melissa M.] Great Ormond St Hosp Sick Children, N Thames Cleft Ctr, London WC1N 3JH, England; [Bhat, Meenakshi] Ctr Human Genet, Bangalore 560066, Karnataka, India; [Hammond, Peter; Scambler, Peter J.] UCL, Mol Med Unit, London WC1N 1EH, England; [Hennekam, Raoul C. M.] UCL, Clin & Mol Genet Unit, London WC1N 1EH, England; [Robinson, Alexis A.] UCL, Neural Dev Unit, London WC1N 1EH, England; [Gerrelli, Dianne] UCL, Inst Child Hlth, London WC1N 1EH, England; [Hennekam, Raoul C. M.] Univ Amsterdam, Dept Pediat, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Hurst, Jane A.; Wilkie, Andrew O. M.] John Radcliffe Hosp NHS Trust, Dept Clin Genet, Oxford OX3 9DU, England; [Hurst, Jane A.; Johnson, David; Wilkie, Andrew O. M.] John Radcliffe Hosp NHS Trust, Dept Plast & Reconstruct Surg, Oxford OX3 9DU, England; [Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany	University of Oxford; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Cologne; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; University of Amsterdam; Academic Medical Center Amsterdam; University of Cologne	Wilkie, AOM (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	awilkie@hammer.imm.ox.ac.uk	Scambler, Peter/AAZ-6026-2020; Mathijssen, Irene M.J./B-1955-2013; Wilkie, Andrew/AAC-3820-2020; Twigg, Stephen/AAU-1135-2021	Scambler, Peter/0000-0002-1487-4628; Wilkie, Andrew/0000-0002-2972-5481; Twigg, Stephen/0000-0001-5024-049X	MRC/Wellcome Trust; MRC [G9900837, G0700089, G9901217] Funding Source: UKRI; Medical Research Council [G9900837, G0700089, G9901217] Funding Source: researchfish	MRC/Wellcome Trust(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are very grateful to M. Cunningham, A. Hing, R. Newbury-Ecob, S. Robertson, and S. Smithson for additional patient samples analyzed in this study, to C. Becker for SNP chip processing, to K. Clarke for DNA sequencing, to M. van den Elzen for help with data collection, to P. Stanier for collaboration on analysis of cleft lip and palate samples, and to N. Akarsu for discussions. Human embryonic material was provided by the MRC/Wellcome Trust-funded Human Developmental Biology Resource. This work was supported by the Wellcome Trust (Programme Grant to A.O.M.W.).	Beverdam A, 2001, DEVELOPMENT, V128, P3975; Bruun JA, 2005, NUCLEIC ACIDS RES, V33, P2661, DOI 10.1093/nar/gki562; Chi YI, 2005, HUM GENET, V116, P433, DOI 10.1007/s00439-004-1252-1; D'Elia AV, 2001, HUM MUTAT, V18, P361, DOI 10.1002/humu.1207; Debeer P, 2002, J MED GENET, V39, P852, DOI 10.1136/jmg.39.11.852; DEMYER W, 1967, NEUROLOGY, V17, P961, DOI 10.1212/WNL.17.10.961; FRYBURG JS, 1993, AM J MED GENET, V46, P712, DOI 10.1002/ajmg.1320460623; Gabbett MT, 2008, CLIN DYSMORPHOL, V17, P79, DOI 10.1097/MCD.0b013e3282f449c8; Galliot B, 1999, DEV GENES EVOL, V209, P186, DOI 10.1007/s004270050243; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; GuionAlmeida ML, 1996, INT J ORAL MAX SURG, V25, P91, DOI 10.1016/S0901-5027(96)80048-8; Hammond P, 2005, AM J HUM GENET, V77, P999, DOI 10.1086/498396; Hildebrandt F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000353; Hing AV, 2004, AM J MED GENET A, V128A, P374, DOI 10.1002/ajmg.a.30091; Holland PWH, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-47; Lees MM, 2007, AM J MED GENET A, V143A, P3290, DOI 10.1002/ajmg.a.32026; Lees MM, 2006, CLIN DYSMORPHOL, V15, P155, DOI 10.1097/01.mcd.0000204987.61990.f0; Losee JE, 2004, PLAST RECONSTR SURG, V113, P676, DOI 10.1097/01.PRS.0000101540.32533.EC; Mavrogiannis LA, 2001, NAT GENET, V27, P17, DOI 10.1038/83703; MINDIKOGLU AN, 1991, PLAST RECONSTR SURG, V88, P699, DOI 10.1097/00006534-199110000-00023; Mohammed SN, 2004, AM J MED GENET A, V130A, P384, DOI 10.1002/ajmg.a.30280; MOORE K, 2007, DEV HUMAN; Noyes MB, 2008, CELL, V133, P1277, DOI 10.1016/j.cell.2008.05.023; Perez-Villamil B, 2004, J BIOL CHEM, V279, P38062, DOI 10.1074/jbc.M400800200; Qu SM, 1999, DEVELOPMENT, V126, P359; Schneider KU, 2005, HUM MUTAT, V26, P44, DOI 10.1002/humu.20187; SEDANO HO, 1970, J PEDIATR, V76, P906, DOI 10.1016/S0022-3476(70)80374-2; SEDANO HO, 1988, ORAL SURG ORAL MED O, V65, P704, DOI 10.1016/0030-4220(88)90014-X; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Slaney SF, 1999, AM J MED GENET, V83, P109, DOI 10.1002/(SICI)1096-8628(19990312)83:2<109::AID-AJMG6>3.3.CO;2-#; Tan ST, 1997, PLAST RECONSTR SURG, V99, P317, DOI 10.1097/00006534-199702000-00004; ten Berge D, 1998, DEV BIOL, V199, P11, DOI 10.1006/dbio.1998.8921; TORIELLO HV, 1985, AM J MED GENET, V21, P131, DOI 10.1002/ajmg.1320210119; Trochet D, 2005, HUM MOL GENET, V14, P3697, DOI 10.1093/hmg/ddi401; Twigg SRF, 2004, P NATL ACAD SCI USA, V101, P8652, DOI 10.1073/pnas.0402819101; VANDERMEULEN JCH, 1989, WORLD J SURG, V13, P373, DOI 10.1007/BF01660750; Wieland I, 2004, AM J HUM GENET, V74, P1209, DOI 10.1086/421532; Wuyts W, 2000, J MED GENET, V37, P916, DOI 10.1136/jmg.37.12.916; Yoon H, 2000, YONSEI MED J, V41, P477, DOI 10.3349/ymj.2000.41.4.477	39	88	90	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 15	2009	84	5					698	705		10.1016/j.ajhg.2009.04.009	http://dx.doi.org/10.1016/j.ajhg.2009.04.009			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	449OB	19409524	Green Published, Bronze			2022-12-18	WOS:000266338800016
J	Alazami, AM; Al-Saif, A; Al-Semari, A; Bohlega, S; Zlitni, S; Alzahrani, F; Bavi, P; Kaya, N; Colak, D; Khalak, H; Baltus, A; Peterlin, B; Danda, S; Bhatia, KP; Schneider, SA; Sakati, N; Walsh, CA; Al-Mohanna, F; Meyer, B; Alkuraya, FS				Alazami, Anas M.; Al-Saif, Amr; Al-Semari, Abdulaziz; Bohlega, Saeed; Zlitni, Soumaya; Alzahrani, Fatema; Bavi, Prashant; Kaya, Namik; Colak, Dilek; Khalak, Hanif; Baltus, Andy; Peterlin, Borut; Danda, Sumita; Bhatia, Kailash P.; Schneider, Susanne A.; Sakati, Nadia; Walsh, Christopher A.; Al-Mohanna, Futwan; Meyer, Brian; Alkuraya, Fowzan S.			Mutations in C2orf37, Encoding a Nucleolar Protein, Cause Hypogonadism, Alopecia, Diabetes Mellitus, Mental Retardation, and Extrapyramidal Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WOODHOUSE-SAKATI-SYNDROME; DEAFNESS; DISEASE; FAMILY	Hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome (also referenced as Woodhouse-Sakati syndrome) is a rare autosomal recessive multisystemic disorder. We have identified a founder mutation consisting of a single base-pair deletion in C2orf37 in eight families of Saudi origin. Three other loss-of-function mutations were subsequently discovered in patients of different ethnicities. The gene encodes a nucleolar protein of unknown function, and the cellular phenotype observed in patient lymphoblasts implicates a role for the nucleolus in the pathogenesis of this disease. Our findings expand the list of human disorders linked to the nucleolus and further highlight the developmental and/or maintenance functions of this organelle.	[Alazami, Anas M.; Al-Saif, Amr; Zlitni, Soumaya; Alzahrani, Fatema; Kaya, Namik; Khalak, Hanif; Meyer, Brian; Alkuraya, Fowzan S.] King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia; [Al-Semari, Abdulaziz; Bohlega, Saeed] King Faisal Specialist Hosp & Res Ctr, Dept Neurosci, Riyadh 11211, Saudi Arabia; [Bavi, Prashant] King Faisal Specialist Hosp & Res Ctr, Biol Repository Sect, Riyadh 11211, Saudi Arabia; [Colak, Dilek] King Faisal Specialist Hosp & Res Ctr, Dept Biostat & Sci Comp, Riyadh 11211, Saudi Arabia; [Baltus, Andy; Walsh, Christopher A.; Alkuraya, Fowzan S.] Childrens Hosp, Dept Med, Div Genet & Metab, Boston, MA 02115 USA; [Baltus, Andy; Walsh, Christopher A.; Alkuraya, Fowzan S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Peterlin, Borut] Univ Med Ctr Ljubljana, Dept Obstet & Gynecol, Inst Med Genet, Ljubljana 1000, Slovenia; [Danda, Sumita] Christian Med Coll & Hosp, Clin Genet Unit, Vellore 632004, Tamil Nadu, India; [Bhatia, Kailash P.; Schneider, Susanne A.] UCL, Inst Neurol, Sobell Dept, London WC1N 3BG, England; [Sakati, Nadia] King Faisal Specialist Hosp & Res Ctr, Dept Pediat, Riyadh 11211, Saudi Arabia; [Al-Mohanna, Futwan] King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Riyadh 11211, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Riyadh 11461, Saudi Arabia; [Alkuraya, Fowzan S.] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia	King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University Medical Centre Ljubljana; Christian Medical College & Hospital (CMCH) Vellore; University of London; University College London; King Faisal Specialist Hospital & Research Center; King Faisal Specialist Hospital & Research Center; King Saud University; King Khalid University Hospital; King Saud University	Alkuraya, FS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia.	falkuraya@kfshrc.edu.sa	Alkuraya, Fowzan S./A-1542-2009; Bavi, Prashant/B-2123-2009; Zlitni, Soumaya/C-1370-2013; Peterlin, Borut/C-6086-2011	Alkuraya, Fowzan S./0000-0003-4158-341X; Bavi, Prashant/0000-0002-7711-2911; Peterlin, Borut/0000-0001-7824-4978; Colak, Dilek/0000-0001-6485-8768; Meyer, Brian/0000-0002-0388-9568	King Faisal Specialist Hospital and Research Centre;  [RAC 203-0037]	King Faisal Specialist Hospital and Research Centre; 	We are grateful to the family members for their enthusiastic and generous participation. We thank Mohammad Rajab and Shamsa Al-Enazi for help with DNA sequencing and genotyping, Abdullah Al-Jeffrey and Ranad Shaheen for expert technical assistance, Tarfa Al-Sheddi for EBV transformation of lymphocytes, AlBandary AlBakheet for RNA sample processing (gene-expression profiling), Osama Alsmadi and Osama Al-Dirbashi and their respective teams for help in acquiring normal controls, and Khalid Abu Khabar and Azhar Hussain for helpful discussions throughout the course of research. We would also like to thank Salma M. Wakil and Batoul Baz for their help in processing Affy U133 chips. This study was approved and funded by the King Faisal Specialist Hospital and Research Centre (RAC#203-0037).	Al-Semari A, 2007, AM J MED GENET A, V143A, P149, DOI 10.1002/ajmg.a.31497; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Dousset T, 2000, MOL BIOL CELL, V11, P2705, DOI 10.1091/mbc.11.8.2705; Genin E, 2004, J MED GENET, V41, P445, DOI 10.1136/jmg.2003.017962; Kerr LE, 2007, ONCOGENE, V26, P2554, DOI 10.1038/sj.onc.1210044; Koshy G, 2008, CLIN DYSMORPHOL, V17, P57, DOI 10.1097/MCD.0b013e3282beb59e; MEdica I, 2007, GENET COUNSEL, V18, P227; Nousbeck J, 2008, AM J HUM GENET, V82, P1114, DOI 10.1016/j.ajhg.2008.03.014; OCHS RL, 1985, CHROMOSOMA, V92, P330, DOI 10.1007/BF00327463; Schneider SA, 2008, MOVEMENT DISORD, V23, P592, DOI 10.1002/mds.21886; Utama B, 2002, GENES CELLS, V7, P115, DOI 10.1046/j.1356-9597.2001.00507.x; WOODHOUSE NJY, 1983, J MED GENET, V20, P216, DOI 10.1136/jmg.20.3.216	12	88	90	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC 12	2008	83	6					684	691		10.1016/j.ajhg.2008.10.018	http://dx.doi.org/10.1016/j.ajhg.2008.10.018			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	385NY	19026396	Green Published, Bronze			2022-12-18	WOS:000261822100003
J	Coppieters, F; Leroy, BP; Beysen, D; Hellemans, J; De Bosscher, K; Haegeman, G; Robberecht, K; Wuyts, W; Coucke, PJ; De Baere, E				Coppieters, Frauke; Leroy, Bart P.; Beysen, Diane; Hellemans, Jan; De Bosscher, Karolien; Haegeman, Guy; Robberecht, Kirsten; Wuyts, Wim; Coucke, Paul J.; De Baere, Elfride			Recurrent mutation in the first zinc finger of the orphan nuclear receptor NR2E3 causes autosomal dominant retinitis pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VITAMIN-D-RECEPTOR; CONE PHOTORECEPTOR DEVELOPMENT; ANDROGEN RECEPTOR; RETINAL DEGENERATION; DEOXYRIBONUCLEIC-ACID; ROD PHOTORECEPTORS; BINDING DOMAIN; GENE; TRANSCRIPTION; NRL	Autosomal dominant retinitis pigmentosa" (adRP) refers to a genetically heterogeneous group of retinal dystrophies, in which 54% of all cases can be attributed to 17 disease loci. Here, we describe the localization and identification of the photoreceptor cell-specific nuclear receptor gene NR2E3 as a novel disease locus and gene for adRP. A heterozygous mutation c. 166G -> A (p. Gly56Arg) was identified in the first zinc finger of NR2E3 in a large Belgian family affected with adRP. Overall, this missense mutation was found in 3 families affected with adRP among 87 unrelated families with potentially dominant retinal dystrophies ( 3.4%), of which 47 were affected with RP ( 6.4%). Interestingly, affected members of these families display a novel recognizable NR2E3-related clinical subtype of adRP. Other mutations of NR2E3 have previously been shown to cause autosomal recessive enhanced S-cone syndrome, a specific retinal phenotype. We propose a different pathogenetic mechanism for these distinct dominant and recessive phenotypes, which may be attributed to the dual key role of NR2E3 in the regulation of photoreceptor-specific genes during rod development and maintenance.	Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; Univ Ghent, Dept Ophthalmol, B-9000 Ghent, Belgium; Univ Ghent, Lab Eukaryot Gene Express & Signal Transduct, B-9000 Ghent, Belgium; Univ Ghent, Dept Biol Mol, B-9000 Ghent, Belgium; Ctr Med Genet, Antwerp, Belgium	Ghent University; Ghent University; Ghent University; Ghent University	De Baere, E (corresponding author), State Univ Ghent Hosp, Ctr Med Genet, De Pintelaan 185, B-9000 Ghent, Belgium.	Elfride.DeBaere@UGent.be	wuyts, wim/B-6262-2017; De Baere, Elfride/E-7405-2017; Coucke, Paul J/AAO-2954-2020	wuyts, wim/0000-0002-4349-9038; De Baere, Elfride/0000-0002-5609-6895; Coucke, Paul J/0000-0001-7119-586X; De Bosscher, Karolien/0000-0001-5059-9718; Coppieters, Frauke/0000-0001-7224-0992				Aarnisalo P, 1999, ENDOCRINOLOGY, V140, P3097, DOI 10.1210/en.140.7.3097; ALLERA A, 1995, J CLIN ENDOCR METAB, V80, P2697, DOI 10.1210/jc.80.9.2697; Auwerx J, 1999, CELL, V97, P161; Bessant DAR, 2003, ARCH OPHTHALMOL-CHIC, V121, P793, DOI 10.1001/archopht.121.6.793; BIRD AC, 1995, AM J OPHTHALMOL, V119, P543, DOI 10.1016/S0002-9394(14)70212-0; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X; HSIEH JC, 1993, J BIOL CHEM, V268, P15118; Hsieh JC, 1998, J CELL BIOCHEM, V70, P94, DOI 10.1002/(SICI)1097-4644(19980701)70:1<94::AID-JCB10>3.3.CO;2-Q; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Lobaccaro JM, 1999, ENDOCRINOLOGY, V140, P350, DOI 10.1210/en.140.1.350; LOBACCARO JM, 1994, CLIN ENDOCRINOL, V40, P297; MALLOY PJ, 1989, J CLIN ENDOCR METAB, V68, P263, DOI 10.1210/jcem-68-2-263; MARMOR MF, 1990, AM J OPHTHALMOL, V110, P124, DOI 10.1016/S0002-9394(14)76980-6; Miano MG, 2000, AM J HUM GENET, V67, P1348, DOI 10.1016/S0002-9297(07)62966-8; Mykytyn K, 2001, NAT GENET, V28, P188, DOI 10.1038/88925; Necela BM, 2004, J BIOL CHEM, V279, P39279, DOI 10.1074/jbc.M405489200; Nishiguchi KM, 2004, P NATL ACAD SCI USA, V101, P17819, DOI 10.1073/pnas.0408183101; Oh ECT, 2007, P NATL ACAD SCI USA, V104, P1679, DOI 10.1073/pnas.0605934104; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Poukka H, 2000, J BIOL CHEM, V275, P571, DOI 10.1074/jbc.275.1.571; Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656; Rivolta C, 2006, HUM MUTAT, V27, P644, DOI 10.1002/humu.20325; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; SONE T, 1989, J BIOL CHEM, V264, P20230; Srinivas M, 2006, MOL ENDOCRINOL, V20, P1728, DOI 10.1210/me.2005-0505; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Takezawa S, 2007, EMBO J, V26, P764, DOI 10.1038/sj.emboj.7601548; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3489	35	88	92	1	16	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					147	157		10.1086/518426	http://dx.doi.org/10.1086/518426			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564971	Bronze, Green Published			2022-12-18	WOS:000247039700013
J	Eidenschenk, C; Dunne, J; Jouanguy, E; Fourlinnie, C; Gineau, L; Bacq, D; McMahon, C; Smith, O; Casanova, JL; Abel, L; Feighery, C				Eidenschenk, C; Dunne, J; Jouanguy, E; Fourlinnie, C; Gineau, L; Bacq, D; McMahon, C; Smith, O; Casanova, JL; Abel, L; Feighery, C			A novel primary immunodeficiency with specific natural-killer cell deficiency maps to the centromeric region of chromosome 8	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ACTIVATION RECEPTOR; INFECTION; IMMUNITY; CYTOMEGALOVIRUS; SUSCEPTIBILITY; RECOGNITION; RESISTANCE; VARICELLA; COMPLEX	We describe four children with a novel primary immunodeficiency consisting of specific natural-killer ( NK) cell deficiency and susceptibility to viral diseases. One child developed an Epstein-Barr virus-driven lymphoproliferative disorder; two others developed severe respiratory illnesses of probable viral etiology. The four patients are related and belong to a large inbred kindred of Irish nomadic descent, which suggests autosomal recessive inheritance of this defect. A genomewide scan identified a single 12-Mb region on chromosome 8p11.23-q11.21 that was linked to this immunodeficiency ( maximum LOD score 4.51). The mapping of the disease-causing genomic region paves the way for the identification of a novel pathway governing NK cell differentiation in humans.	Univ Paris 05, INSERM U550, Fac Med Necker, Lab Genet Humaine & Malad Infect,Necker Med Sch, F-75015 Paris, France; Hop Necker Enfants Malad, Pediat Hematol Immunol Unit, Paris, France; St James Hosp, Dept Immunol, Dublin 8, Ireland; Our Ladys Hosp Sick Children, Dublin, Ireland; Natl Ctr Genotyping, Evry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Trinity College Dublin; Our Ladys Children Hospital Crumlin	Eidenschenk, C (corresponding author), Univ Paris 05, INSERM U550, Fac Med Necker, Lab Genet Humaine & Malad Infect,Necker Med Sch, 156 Rue Vaugirard, F-75015 Paris, France.	casanova@necker.fr	Abel, Laurent/H-8888-2017; Casanova, Jean-Laurent/I-3418-2017; Smith, Owen/AAU-8929-2020; Gineau, Laure/G-2446-2016; Jouanguy, Emmanuelle/H-7901-2017	Abel, Laurent/0000-0001-7016-6493; Jouanguy, Emmanuelle/0000-0002-7358-9157; McMahon, Corrina/0000-0001-7011-0158; Casanova, Jean-Laurent/0000-0002-7782-4169; McMahon, Corrina/0000-0001-9799-5312; Gineau, Laure/0000-0002-3863-1671				Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Bernard F, 2004, PEDIATRICS, V113, P136, DOI 10.1542/peds.113.1.136; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Casanova JL, 2005, J EXP MED, V202, P197, DOI 10.1084/jem.20050854; Casanova JL, 2004, NAT REV IMMUNOL, V4, P55, DOI 10.1038/nri1264; Casanova JL, 2001, NAT GENET, V28, P7, DOI 10.1038/ng0501-7; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Desrosiers MP, 2005, NAT GENET, V37, P593, DOI 10.1038/ng1564; Etzioni A, 2005, J PEDIATR-US, V146, P423, DOI 10.1016/j.jpeds.2004.11.022; French AR, 2003, CURR OPIN IMMUNOL, V15, P45, DOI 10.1016/S095279150200002X; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/88247; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; McKusick V.A., 1998, MENDELIAN INHERITANC; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Nichols KE, 2005, IMMUNOL REV, V203, P180, DOI 10.1111/j.0105-2896.2005.00230.x; Orange JS, 2002, MICROBES INFECT, V4, P1545, DOI 10.1016/S1286-4579(02)00038-2; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Vossen MTM, 2005, J INFECT DIS, V191, P198, DOI 10.1086/426866; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055	24	88	89	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2006	78	4					721	727		10.1086/503269	http://dx.doi.org/10.1086/503269			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	032EE	16532402	Green Published, Bronze			2022-12-18	WOS:000236755900018
J	Ishikawa, K; Toru, S; Tsunemi, T; Li, MS; Kobayashi, K; Yokota, T; Amino, T; Owada, K; Fujigasaki, H; Sakamoto, M; Tomimitsu, H; Takashima, M; Kumagai, J; Noguchi, Y; Kawashima, Y; Ohkoshi, N; Ishida, G; Gomyoda, M; Yoshida, M; Hashizume, Y; Saito, Y; Murayama, S; Yamanouchi, H; Mizutani, T; Kondo, I; Toda, T; Mizusawa, H				Ishikawa, K; Toru, S; Tsunemi, T; Li, MS; Kobayashi, K; Yokota, T; Amino, T; Owada, K; Fujigasaki, H; Sakamoto, M; Tomimitsu, H; Takashima, M; Kumagai, J; Noguchi, Y; Kawashima, Y; Ohkoshi, N; Ishida, G; Gomyoda, M; Yoshida, M; Hashizume, Y; Saito, Y; Murayama, S; Yamanouchi, H; Mizutani, T; Kondo, I; Toda, T; Mizusawa, H			An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5 '-untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor domains	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CAG TRINUCLEOTIDE REPEAT; SPINOCEREBELLAR ATAXIA; JAPANESE FAMILIES; CALCIUM-CHANNEL; MESSENGER-RNA; MUTATIONS; EXPANSIONS; GTPASES; DEAFNESS; DISEASE	Autosomal dominant cerebellar ataxia ( ADCA) is a group of heterogeneous neurodegenerative disorders. By positional cloning, we have identified the gene strongly associated with a form of degenerative ataxia ( chromosome 16q22.1-linked ADCA) that clinically shows progressive pure cerebellar ataxia. Detailed examination by use of audiogram suggested that sensorineural hearing impairment may be associated with ataxia in our families. After restricting the candidate region in chromosome 16q22.1 by haplotype analysis, we found that all patients from 52 unrelated Japanese families harbor a heterozygous C -> T single-nucleotide substitution, 16 nt upstream of the putative translation initiation site of the gene for a hypothetical protein DKFZP434I216, which we have called "puratrophin-1" ( Purkinje cell atrophy associated protein-1). The full-length puratrophin-1 mRNA had an open reading frame of 3,576 nt, predicted to contain important domains, including the spectrin repeat and the guanine-nucleotide exchange factor (GEF) for Rho GTPases, followed by the Dbl-homologous domain, which indicates the role of puratrophin-1 in intracellular signaling and actin dynamics at the Golgi apparatus. Puratrophin-1- normally expressed in a wide range of cells, including epithelial hair cells in the cochlea - was aggregated in Purkinje cells of the chromosome 16q22.1 - linked ADCA brains. Consistent with the protein prediction data of puratrophin-1, the Golgi-apparatus membrane protein and spectrin also formed aggregates in Purkinje cells. The present study highlights the importance of the 5' untranslated region ( UTR) in identification of genes of human disease, suggests that a single-nucleotide substitution in the 5' UTR could be associated with protein aggregation, and indicates that the GEF protein is associated with cerebellar degeneration in humans.	Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Grad Sch, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Dept Pathol, Grad Sch, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Dept Audiovestibular Sci, Grad Sch, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Med & Dent Univ, Century Ctr Excellence 21, Program Brain Integrat & Disorders, Bunkyo Ku, Tokyo 1138519, Japan; Tokyo Metropolitan Inst Gerontol, Dept Neuropathol, Tokyo, Japan; Tokyo Metropolitan Geriatr Hosp, Dept Neurol, Tokyo 173, Japan; Tokyo Metropolitan Neurol Hosp, Dept Pathol, Tokyo, Japan; Osaka Univ, Grad Sch Med, Div Funct Genom, Dept Postgenom & Dis,Course Adv Med, Osaka, Japan; Univ Tsukuba, Inst Clin Med, Dept Neurol, Tsukuba, Ibaraki 305, Japan; Natl Matsue Hosp, Dept Neurol, Matsue, Shimane, Japan; Natl Matsue Hosp, Dept Clin Lab, Matsue, Shimane, Japan; Aichi Med Univ, Dept Neuropathol, Inst Med Sci Aging, Aichi, Japan; Ehime Univ, Sch Med, Dept Med Genet, Matsuyama, Ehime 790, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute for Neuroscience; Osaka University; University of Tsukuba; Aichi Medical University; Ehime University	Mizusawa, H (corresponding author), Tokyo Med & Dent Univ, Dept Neurol & Neurol Sci, Grad Sch, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	h-mizusawa.nuro@tmd.ac.jp	Kobayashi, Kazuhiro/AAH-8638-2021	Kobayashi, Kazuhiro/0000-0001-7801-147X; Yokota, Takanori/0000-0002-6490-3263				BERGERON C, 1994, J NEUROPATH EXP NEUR, V53, P221, DOI 10.1097/00005072-199405000-00002; Charron AJ, 2000, TRAFFIC, V1, P675, DOI 10.1034/j.1600-0854.2000.010811.x; Chen DH, 2003, AM J HUM GENET, V72, P839, DOI 10.1086/373883; Estrach S, 2002, CURR BIOL, V12, P307, DOI 10.1016/S0960-9822(02)00658-9; Flanigan K, 1996, AM J HUM GENET, V59, P392; Fucini RV, 2000, J BIOL CHEM, V275, P18824, DOI 10.1074/jbc.M000024200; Ge WW, 2003, J BIOL CHEM, V278, P26558, DOI 10.1074/jbc.M302886200; Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607; Graham D. I., 2002, GREENFIELDS NEUROPAT; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Hellenbroich Y, 2003, J NEUROL, V250, P668, DOI 10.1007/s00415-003-1052-x; Hirano R, 2004, NEUROGENETICS, V5, P215, DOI 10.1007/s10048-004-0194-z; Holmes SE, 1999, NAT GENET, V23, P391, DOI 10.1038/70493; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Ishikawa K, 1999, HUM MOL GENET, V8, P1185, DOI 10.1093/hmg/8.7.1185; Ishikawa K, 1997, AM J HUM GENET, V61, P336, DOI 10.1086/514867; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Koide R, 1999, HUM MOL GENET, V8, P2047, DOI 10.1093/hmg/8.11.2047; Kollmar R, 1999, CURR OPIN NEUROBIOL, V9, P394, DOI 10.1016/S0959-4388(99)80059-2; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Kutsche K, 2000, NAT GENET, V26, P247, DOI 10.1038/80002; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Li M, 2003, J HUM GENET, V48, P111, DOI 10.1007/s100380300017; Margolis Russell L, 2002, Curr Neurol Neurosci Rep, V2, P447, DOI 10.1007/s11910-002-0072-8; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Nagaoka U, 2000, NEUROLOGY, V54, P1971, DOI 10.1212/WNL.54.10.1971; OWADA K, IN PRESS NEUROLOGY; PASTERIS NG, 1994, CELL, V79, P669; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sasaki H, 2003, CYTOGENET GENOME RES, V100, P198, DOI 10.1159/000072855; Sgourou A, 2004, BRIT J HAEMATOL, V124, P828, DOI 10.1111/j.1365-2141.2004.04835.x; Stevanin G, 2000, EUR J HUM GENET, V8, P4, DOI 10.1038/sj.ejhg.5200403; Stevanin G, 2004, ANN NEUROL, V55, P97, DOI 10.1002/ana.10798; Tsuiki T., 2002, AUDIOL JAPAN, V45, P241, DOI [10.4295/audiology.45.241, DOI 10.4295/AUDIOLOGY.45.241]; Tsunemi T, 2002, J BIOL CHEM, V277, P7214, DOI 10.1074/jbc.M108222200; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Verhoeven K, 2003, AM J HUM GENET, V73, P926, DOI 10.1086/378159; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yu GY, 2005, ANN NEUROL, V57, P349, DOI 10.1002/ana.20371; Zhu M, 2003, AM J HUM GENET, V73, P1082, DOI 10.1086/379286; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	43	88	95	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2005	77	2					280	296		10.1086/432518	http://dx.doi.org/10.1086/432518			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	943WW	16001362	Bronze, Green Published			2022-12-18	WOS:000230387200009
J	Evans, DM; Cardon, LR				Evans, DM; Cardon, LR			A comparison of linkage disequilibrium patterns and estimated population recombination rates across multiple populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MODERN HUMAN ORIGINS; HUMAN GENOME; HAPLOTYPE BLOCKS; LOCUS; POLYMORPHISM; RECONSTRUCTION; LOCATION; DISEASES; HUMANS; MAP	Large-scale studies of linkage disequilibrium (LD) have shown considerable variation in the extent and distribution of pairwise LD within and between populations. Taken at face value, these results suggest that genomewide LD maps for one population may not be generalizable to other populations. However, at least part of this diversity is due to some undesirable features of pairwise LD measures, which are well documented for the and measures. In this report, we compare patterns of LD derived from pairwise measures with statistical estimates of population recombination rates (rho) along a 10-Mb stretch of chromosome 20 in four population samples, comprising East Asians, African Americans, and U. K. and U. S. individuals of western European descent. The results reveal the expected variability of D' within and between populations but show better concordance in estimates of r(2) for the same markers across the population samples. Estimates of rho correlate well across populations, but there is still evidence of population-specific spikes and troughs in rho values. We conclude that it is unlikely that a single haplotype map will provide a definitive guide for association studies of many populations; rather, multiple maps will need to be constructed to provide the best-possible guides for gene mapping.	Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Evans, DM (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	davide@well.ox.ac.uk	Evans, David M/H-6325-2013	Evans, David M/0000-0003-0663-4621	NEI NIH HHS [EY-126562] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abecasis GR, 2001, AM J HUM GENET, V68, P191, DOI 10.1086/316944; Cardon LR, 2003, TRENDS GENET, V19, P135, DOI 10.1016/S0168-9525(03)00022-2; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Dawson E, 2002, NATURE, V418, P544, DOI 10.1038/nature00864; Fearnhead P, 2001, GENETICS, V159, P1299; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; HEDRICK PW, 1987, GENETICS, V117, P331; HILL WG, 1994, AM J HUM GENET, V54, P705; Hudson RR, 2001, GENETICS, V159, P1805; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Ke XY, 2004, HUM MOL GENET, V13, P577, DOI 10.1093/hmg/ddh060; Kidd JR, 2000, AM J HUM GENET, V66, P1882, DOI 10.1086/302952; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Li N, 2003, GENETICS, V165, P2213; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Pritchard JK, 2001, AM J HUM GENET, V69, P1, DOI 10.1086/321275; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Risch NJ, 2000, NATURE, V405, P847, DOI 10.1038/35015718; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tishkoff SA, 2000, AM J HUM GENET, V67, P901, DOI 10.1086/303068; Tishkoff SA, 1998, AM J HUM GENET, V62, P1389, DOI 10.1086/301861; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; WATKINS WS, 1994, AM J HUM GENET, V55, P348; Weiss KM, 2002, TRENDS GENET, V18, P19, DOI 10.1016/S0168-9525(01)02550-1	36	88	91	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR	2005	76	4					681	687		10.1086/429274	http://dx.doi.org/10.1086/429274			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	904RS	15719321	Green Published, Bronze			2022-12-18	WOS:000227516000014
J	Lamb, NE; Yu, K; Shaffer, J; Feingold, E; Sherman, SL				Lamb, NE; Yu, K; Shaffer, J; Feingold, E; Sherman, SL			Association between maternal age and meiotic recombination for trisomy 21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHROMOSOME NONDISJUNCTION; DROSOPHILA-MELANOGASTER; GENETIC MAPS; MEIOSIS I; HUMANS; CONFIGURATIONS; SEGREGATION; MUTATION; YEAST; RISK	Altered genetic recombination has been identified as the first molecular correlate of chromosome nondisjunction in both humans and model organisms. Little evidence has emerged to link maternal age - long recognized as the primary risk factor for nondisjunction - with altered recombination, although some studies have provided hints of such a relationship. To determine whether an association does exist, chromosome 21 recombination patterns were examined in 400 trisomy 21 cases of maternal meiosis I origin, grouped by maternal age. These recombination patterns were used to predict the chromosome 21 exchange patterns established during meiosis I. There was no statistically significant association between age and overall rate of exchange. The placement of meiotic exchange, however, differed significantly among the age groups. Susceptible patterns (pericentromeric and telomeric exchanges) accounted for 34% of all exchanges among the youngest class of women but only 10% of those among the oldest class. The pattern of exchanges among the oldest age group mimicked the pattern observed among normally disjoining chromosomes 21. These results suggest that the greatest risk factor for nondisjunction among younger women is the presence of a susceptible exchange pattern. We hypothesize that environmental and age-related insults accumulate in the ovary as a woman ages, leading to malsegregation of oocytes with stable exchange patterns. It is this risk, due to recombination-independent factors, that would be most influenced by increasing age, leading to the observed maternal age effect.	Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; Washington Univ, Div Biostat, St Louis, MO USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA	Emory University; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lamb, NE (corresponding author), Emory Univ, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	nlamb@genetics.emory.edu		Feingold, Eleanor/0000-0003-2898-6484; Shaffer, John/0000-0003-1897-1131	NCRR NIH HHS [M01 RR 00039, M01 RR000039] Funding Source: Medline; NICHD NIH HHS [R01 HD 38979, P01 HD 32111, R01 HD038979] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038979] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032111] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000039] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Bugge M, 1998, HUM MOL GENET, V7, P661, DOI 10.1093/hmg/7.4.661; Feingold E, 2000, AM J HUM GENET, V66, P958, DOI 10.1086/302799; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HASSOLD T, 1995, AM J HUM GENET, V57, P867; HASSOLD T, 1985, HUM GENET, V70, P11, DOI 10.1007/BF00389450; HASSOLD TJ, 1991, AM J HUM GENET, V49, P253; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Krawchuk MD, 1999, GENETICS, V153, P49; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lamb NE, 1997, GENETICS, V146, P1011; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; MOORE DP, 1994, GENETICS, V136, P953; MORTON NE, 1988, ANN HUM GENET, V52, P227, DOI 10.1111/j.1469-1809.1988.tb01100.x; RASOOLY RS, 1991, GENETICS, V129, P409; RISCH N, 1986, AM J HUM GENET, V39, P68; Robinson WP, 1998, HUM MOL GENET, V7, P1011, DOI 10.1093/hmg/7.6.1011; Ross LO, 1996, P NATL ACAD SCI USA, V93, P4979, DOI 10.1073/pnas.93.10.4979; Savage AR, 1998, HUM MOL GENET, V7, P1221, DOI 10.1093/hmg/7.8.1221; SEARS DD, 1995, GENETICS, V139, P1159; Thomas NS, 2001, HUM MOL GENET, V10, P243, DOI 10.1093/hmg/10.3.243; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; Yu K, 2002, BIOMETRICS, V58, P369, DOI 10.1111/j.0006-341X.2002.00369.x; Yu K, 2001, BIOMETRICS, V57, P427, DOI 10.1111/j.0006-341X.2001.00427.x; ZETKA MC, 1995, GENETICS, V141, P1339	28	88	95	0	6	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2005	76	1					91	99		10.1086/427266	http://dx.doi.org/10.1086/427266			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	878JR	15551222	Bronze, Green Published			2022-12-18	WOS:000225643600008
J	Kunst, CB				Kunst, CB			Complex genetics of amyotrophic lateral sclerosis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review							CU/ZN-SUPEROXIDE-DISMUTASE; ALS-LINKED SOD1; NUCLEOTIDE EXCHANGE FACTOR; MOTOR-NEURON DEGENERATION; TRANSGENIC MOUSE MODEL; FRONTOTEMPORAL DEMENTIA; GLUTAMATE TRANSPORTER; NITRIC-OXIDE; SPINAL-CORD; AGGREGATE FORMATION		Univ Colorado, Eleanor Roosevelt Inst, Denver, CO 80206 USA	University of Colorado System; University of Colorado Denver	Kunst, CB (corresponding author), Univ Colorado, Eleanor Roosevelt Inst, 1899 Gaylord St, Denver, CO 80206 USA.	ckunst@du.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041646] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041646, NS041646] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abalkhail H, 2003, AM J HUM GENET, V73, P383, DOI 10.1086/377156; Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; Al-Chalabi A, 1998, HUM MOL GENET, V7, P2045, DOI 10.1093/hmg/7.13.2045; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Armon C., 2003, MOTOR NEURON DISORDE, P167; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Banack SA, 2003, NEUROLOGY, V61, P387, DOI 10.1212/01.WNL.0000078320.18564.9F; Beal MF, 1997, ANN NEUROL, V42, P644, DOI 10.1002/ana.410420416; BRANNSTROM T, 1998, ANN M SOC NEUR LOS A; Browne SE, 1998, J NEUROCHEM, V71, P281; Bruijn LI, 1997, P NATL ACAD SCI USA, V94, P7606, DOI 10.1073/pnas.94.14.7606; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2002, BIOTECHNIQUES, V32, P1112, DOI 10.2144/02325dd01; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cai H, 2003, AMYOTROPH LATERAL S1, V4, P11; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Corcia P, 2002, ANN NEUROL, V51, P243, DOI 10.1002/ana.10104; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Crow JP, 1997, J NEUROCHEM, V69, P1936; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; De Jonghe P, 2002, BRAIN, V125, P1320, DOI 10.1093/brain/awf127; Deng HX, 1999, AM J HUM GENET, V65, pA292; Drory VE, 2001, J NEUROL SCI, V190, P17, DOI 10.1016/S0022-510X(01)00569-X; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; Estevez AG, 1998, J NEUROSCI, V18, P923; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Facchinetti F, 1999, NEUROSCIENCE, V90, P1483, DOI 10.1016/S0306-4522(98)00492-8; Flowers JM, 2001, ANN NEUROL, V49, P643, DOI 10.1002/ana.1029; Giess R, 2002, AM J HUM GENET, V70, P1277, DOI 10.1086/340427; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Groeneveld GJ, 2003, ANN NEUROL, V53, P437, DOI 10.1002/ana.10554; Gurney ME, 1998, NEUROLOGY, V50, P62, DOI 10.1212/WNL.50.1.62; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Haley RW, 2003, NEUROLOGY, V61, P750, DOI 10.1212/WNL.61.6.750; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; Hand CK, 2002, MUSCLE NERVE, V25, P135; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ince P, 2000, AMYOTROPHIC LATERAL, P83; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Jung CW, 2002, J NEUROSCI METH, V114, P165, DOI 10.1016/S0165-0270(01)00524-6; Kamel F, 2003, ENVIRON HEALTH PERSP, V111, P1335, DOI 10.1289/ehp.6109; Kamel F, 1999, NEUROEPIDEMIOLOGY, V18, P194, DOI 10.1159/000026211; Kanekura K, 2004, J BIOL CHEM, V279, P19247, DOI 10.1074/jbc.M313236200; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Klivenyi P, 2004, J NEUROCHEM, V88, P576, DOI 10.1046/j.1471-4159.2003.02160.x; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Kong JM, 1998, J NEUROSCI, V18, P3241; Kowalska A, 2003, FOLIA NEUROPATHOL, V41, P59; KRIZ J, 2003, AMYOTROPH LATERAL S1, V4, P11; Kunita R, 2004, J BIOL CHEM, V279, P38626, DOI 10.1074/jbc.M406120200; Kunst CB, 2000, GENOMICS, V70, P181, DOI 10.1006/geno.2000.6379; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lariviere RC, 2004, J NEUROBIOL, V58, P131, DOI 10.1002/neu.10270; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; Meyer T, 2003, NEUROLOGY, V60, P1348, DOI 10.1212/01.WNL.0000055088.52681.F1; Miller RG, 2003, AMYOTROPH LATERAL SC, V4, P191; MITCHELL JD, 2002, COCHRANE DB SYST REV, V3; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nelson LM, 2000, AM J EPIDEMIOL, V151, P156, DOI 10.1093/oxfordjournals.aje.a010183; Nelson LM, 1996, CLIN NEUROSCI, V3, P327; Nelson LM, 2000, AM J EPIDEMIOL, V151, P164, DOI 10.1093/oxfordjournals.aje.a010184; Nishimura AL, 2004, J MED GENET, V41, P315, DOI 10.1136/jmg.2003.013029; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Obal I, 2001, NEUROREPORT, V12, P2449, DOI 10.1097/00001756-200108080-00032; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Ostojic J, 2003, NEUROSCI LETT, V340, P245, DOI 10.1016/S0304-3940(03)00126-5; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Parton MJ, 2002, HUM MUTAT, V20, DOI 10.1002/humu.9081; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Prudlo J, 2004, ANN NEUROL, V55, P134, DOI 10.1002/ana.10822; Przedborski S, 2003, J CLIN INVEST, V111, P3, DOI 10.1172/JCI200317522; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Puttaparthi K, 2003, J NEUROCHEM, V87, P851, DOI 10.1046/j.1471-4159.2003.02028.x; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Rezania K, 2003, AMYOTROPH LATERAL SC, V4, P162, DOI 10.1080/aml.4.3.162.166; RIGGS JE, 1992, J CLIN EPIDEMIOL, V45, P1007, DOI 10.1016/0895-4356(92)90116-5; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Roy J, 1998, J NEUROSCI, V18, P9673; Ruddy DM, 2003, AM J HUM GENET, V73, P390, DOI 10.1086/377157; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Scarmeas N, 2002, NEUROLOGY, V59, P773, DOI 10.1212/WNL.59.5.773; Siddique T, 1998, NEUROGENETICS, V1, P213, DOI 10.1007/s100480050031; SIDDIQUE T, 1998, AM J HUM GENET, V63, pA308; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Takeuchi H, 2002, BRAIN RES, V949, P11, DOI 10.1016/S0006-8993(02)02568-4; Topp JD, 2004, J BIOL CHEM, V279, P24612, DOI 10.1074/jbc.M313504200; Veldink JH, 2001, NEUROLOGY, V56, P749, DOI 10.1212/WNL.56.6.749; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WEISSKOPF M, 2004, 56 ANN M AM AC NEUR; Wilhelmsen KC, 2004, ARCH NEUROL-CHICAGO, V61, P398, DOI 10.1001/archneur.61.3.398; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Wilson JMB, 2003, NEUROMOL MED, V3, P105, DOI 10.1385/NMM:3:2:105; Wilson JMB, 2002, NEUROMOL MED, V1, P207; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160	126	88	95	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	DEC	2004	75	6					933	947		10.1086/426001	http://dx.doi.org/10.1086/426001			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	867TW	15478096	Bronze, Green Published			2022-12-18	WOS:000224866400001
J	Borrego, S; Wright, FA; Fernandez, RM; Williams, N; Lopez-Alonso, M; Davuluri, R; Antinolo, G; Eng, C				Borrego, S; Wright, FA; Fernandez, RM; Williams, N; Lopez-Alonso, M; Davuluri, R; Antinolo, G; Eng, C			A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschsprung disease and a subset of cases of sporadic medullary thyroid carcinoma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENDOCRINE NEOPLASIA TYPE-2; TYROSINE KINASE DOMAIN; LINKAGE DISEQUILIBRIUM; PROTOONCOGENE MUTATIONS; MULTIGENIC INHERITANCE; PHENOTYPIC-EXPRESSION; ENDOTHELIN-3 GENE; SEQUENCE VARIANT; RECEPTOR; APOPTOSIS	Hirschsprung disease (HSCR) is a common congenital disorder characterized by aganglionosis of the gut. The seemingly unrelated multiple endocrine neoplasia type 2 (MEN 2) is an autosomal dominant disorder characterized by medullary thyroid carcinoma (MTC), pheochromocytoma, and hyperparathyroidism. Yet, germline mutations in the RET proto-oncogene are associated with both MEN 2 and HSCR. In the former, gain-of-function mutations in a limited set of codons is found, whereas, in the latter, loss-of-function mutations are found. However, germline RET mutation is associated with only 3% of a population-based series of isolated HSCR, and little is known about susceptibility to sporadic MTC. We have found previously that specific haplotypes comprising RET coding single-nucleotide polymorphisms (SNPs) comprising exon 2 SNP A45A were strongly associated with HSCR, whereas haplotypes associated with exon 14 SNP S836S were associated with MTC. In this study, we describe three novel intron 1 SNPs, and, together with the coding SNP haplotypes, the data suggest the presence of distinct ancestral haplotypes for HSCR and sporadic MTC in linkage disequilibrium with a putative founding susceptibility locus/loci. The data are consistent with the presence of a very ancient, low-penetrance founder locus similar to20-30 kb upstream of SNP A45A, but the failure of the SNPs to span the locus presents challenges in modeling mode of transmission or ancestry. We postulate that this founding locus is germane to both isolated HSCR and MTC but also that different mutations in this locus would predispose to one or the other.	Hosp Univ Virgen del Rocio, Unidad Genet & Diagnost Prenatal, Seville, Spain; Hosp Univ Virgen del Rocio, Serv Cirugia Infantil, Seville, Spain; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; Univ Cambridge, Canc Res UK Human Canc Genet Res Grp, Cambridge, England	Virgen del Rocio University Hospital; Virgen del Rocio University Hospital; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of Cambridge	Borrego, S (corresponding author), Hosp Univ Virgen del Rocio, Unidad Genet & Diagnost Prenatal, Seville, Spain.		IBIS, REPRODUCCION/P-3399-2015; Borrego, Salud/M-6314-2015; IBIS, GENETICA/P-3384-2015	Antinolo Gil, Guillermo/0000-0002-2113-074X; Eng, Charis/0000-0002-3693-5145	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039058] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA016058, P30CA16058] Funding Source: Medline; NICHD NIH HHS [R01 HD039058, R01HD39058] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Amiel J, 2001, AM J HUM GENET, V69, P1370, DOI 10.1086/324342; Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; ANGRIST M, 1995, HUM MOL GENET, V4, P821, DOI 10.1093/hmg/4.5.821; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ATTIE T, 1995, HUM MOL GENET, V4, P1381, DOI 10.1093/hmg/4.8.1381; Auricchio A, 1996, HUM MOL GENET, V5, P351, DOI 10.1093/hmg/5.3.351; BADNER JA, 1990, AM J HUM GENET, V46, P568; Bidaud C, 1997, EUR J HUM GENET, V5, P247, DOI 10.1159/000484771; Bolk S, 2000, P NATL ACAD SCI USA, V97, P268, DOI 10.1073/pnas.97.1.268; Bordeaux MC, 2000, EMBO J, V19, P4056, DOI 10.1093/emboj/19.15.4056; Borrego S, 1998, J CLIN ENDOCR METAB, V83, P3361, DOI 10.1210/jc.83.9.3361; Borrego S, 1999, J MED GENET, V36, P771, DOI 10.1136/jmg.36.10.771; Borrego S, 2000, J MED GENET, V37, P572, DOI 10.1136/jmg.37.8.572; Capes-Davis A, 1999, GENE EXPRESSION, V8, P311; CARSON EB, 1995, CANCER RES, V55, P2048; Chakravarti A, 1996, HUM MOL GENET, V5, P303; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; De La Chapelle A, 1998, P NATL ACAD SCI USA, V95, P12416, DOI 10.1073/pnas.95.21.12416; Del Tito BJ, 1998, CLIN CHEM, V44, P731; Doray B, 1998, HUM MOL GENET, V7, P1449, DOI 10.1093/hmg/7.9.1449; DRACOPOLI NC, 1994, CURRENT PROTOCOLS HU, V1; EDERY P, 1994, HUM GENET, V94, P579; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Eng C, 1996, NEW ENGL J MED, V335, P943, DOI 10.1056/NEJM199609263351307; Eng C, 1996, CANCER RES, V56, P2167; Eng C, 1999, J CLIN ONCOL, V17, P380, DOI 10.1200/JCO.1999.17.1.380; ENG C, 1994, HUM MOL GENET, V3, P237, DOI 10.1093/hmg/3.2.237; ENG C, 1995, GENE CHROMOSOME CANC, V12, P209, DOI 10.1002/gcc.2870120308; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Fitze G, 1999, AM J HUM GENET, V65, P1469, DOI 10.1086/302618; Gao X, 1999, AM J HUM GENET, V65, pA250; Gimm O, 1999, ONCOGENE, V18, P1369, DOI 10.1038/sj.onc.1202418; Griseri P, 2000, EUR J HUM GENET, V8, P721, DOI 10.1038/sj.ejhg.5200521; Griseri P, 2002, AM J HUM GENET, V71, P969, DOI 10.1086/342774; HASTBACKA J, 1992, NAT GENET, V2, P204, DOI 10.1038/ng1192-204; HOFSTRA RMW, 1994, NATURE, V367, P375, DOI 10.1038/367375a0; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lang D, 2000, J CLIN INVEST, V106, P963, DOI 10.1172/JCI10828; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; Marcus GH, 2000, PROG NUCL ENERG, V37, P5, DOI 10.1016/S0149-1970(00)00016-0; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; MULLIGAN LM, 1993, GENE CHROMOSOME CANC, V6, P166, DOI 10.1002/gcc.2870060307; Ott J, 1999, ANAL HUMAN GENETIC L; PASINI B, 1995, NAT GENET, V10, P35, DOI 10.1038/ng0595-35; PASSARGE E, 1967, NEW ENGL J MED, V276, P138, DOI 10.1056/NEJM196701192760303; Pelet A, 1998, J CLIN INVEST, V101, P1415, DOI 10.1172/JCI375; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Ruiz A, 2001, CLIN ENDOCRINOL, V55, P399, DOI 10.1046/j.1365-2265.2001.01328.x; SANTORO M, 1990, ONCOGENE, V5, P1595; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Svensson PJ, 1998, CLIN GENET, V54, P39; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; Wakamatsu N, 2001, NAT GENET, V27, P369, DOI 10.1038/86860	60	88	89	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2003	72	1					88	100		10.1086/345466	http://dx.doi.org/10.1086/345466			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	631VE	12474140	Green Published, Bronze			2022-12-18	WOS:000180186800009
J	Hocking, LJ; Herbert, CA; Nicholls, RK; Williams, F; Bennett, ST; Cundy, T; Nicholson, GC; Wuyts, W; Van Hul, W; Ralston, SH				Hocking, LJ; Herbert, CA; Nicholls, RK; Williams, F; Bennett, ST; Cundy, T; Nicholson, GC; Wuyts, W; Van Hul, W; Ralston, SH			Genomewide search in familial Paget disease of bone shows evidence of genetic heterogeneity with candidate loci on chromosomes 2q36, 10p13, and 5q35	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							EXPANSILE OSTEOLYSIS; LINKAGE; 18Q; EPIDEMIOLOGY; AGGREGATION; FREQUENCY; ETIOLOGY	Paget disease of bone (PDB) is a common disorder characterized by focal abnormalities of increased and disorganized bone turnover. Genetic factors are important in the pathogenesis of PDB, and previous studies have shown that the PDB-like bone dysplasia familial expansile osteolysis is caused by activating mutations in the TNFRSF11A gene that encodes receptor activator of nuclear factor kappaB (RANK); however, linkage studies, coupled with mutation screening, have excluded involvement of RANK in the vast majority of patients with PDB. To identify other candidate loci for PDB, we conducted a genomewide search in 319 individuals, from 62 kindreds with familial PDB, who were predominantly of British descent. The pattern of inheritance in the study group as a whole was consistent with autosomal dominant transmission of the disease. Parametric multipoint linkage analysis, under a model of heterogeneity, identified three chromosomal regions with LOD scores above the threshold for suggestive linkage. These were on chromosomes 2q36 (LOD score 2.7 at 218.24 cM), 5q35 (LOD score 3.0 at 189.63 cM), and 10p13 (LOD score 2.6 at 41.43 cM). For each of these loci, formal heterogeneity testing with HOMOG supported a model of linkage with heterogeneity, as opposed to no linkage or linkage with homogeneity. Two-point linkage analysis with a series of markers from the 5q35 region in another large kindred with autosomal dominant familial PDB also supported linkage to the candidate region with a maximum LOD score of 3.47 at D5S2034 (187.8 cM). These data indicate the presence of several susceptibility loci for PDB and identify a strong candidate locus for the disease, on chromosome 5q35.	Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland; Oxagen Ltd, Abingdon, Oxon, England; Univ Auckland, Dept Med, Auckland, New Zealand; Univ Melbourne, Geelong Hosp, Barwon Hlth, Dept Clin & Biomed Sci, Melbourne, Vic, Australia; Univ Antwerp, Dept Med Genet, B-2020 Antwerp, Belgium	University of Aberdeen; Oxagen Limited; University of Auckland; Geelong Hospital; University of Melbourne; University of Antwerp	Ralston, SH (corresponding author), Univ Aberdeen, Sch Med, Dept Med & Therapeut, Aberdeen AB25 2ZD, Scotland.		wuyts, wim/B-6262-2017; wuyts, wim/B-1346-2012; Nicholson, Geoffrey C/F-1901-2010	wuyts, wim/0000-0002-4349-9038; wuyts, wim/0000-0002-4349-9038; Nicholson, Geoffrey C/0000-0002-0152-1153; Van Hul, Wim/0000-0002-5065-7858; Cundy, Timothy/0000-0003-4890-9400; McDonald, Fiona/0000-0002-3732-8814; Hocking, Lynne J/0000-0002-2414-2826; Williams, Frances/0000-0002-2998-2744				BARKER DJP, 1984, BRIT MED BULL, V40, P396, DOI 10.1093/oxfordjournals.bmb.a072011; Cody JD, 1997, AM J HUM GENET, V61, P1117, DOI 10.1086/301601; Cooper C, 1999, J BONE MINER RES, V14, P192, DOI 10.1359/jbmr.1999.14.2.192; Good D, 2001, J BONE MINER RES, V16, P33, DOI 10.1359/jbmr.2001.16.1.33; Haslam SI, 1998, J BONE MINER RES, V13, P911, DOI 10.1359/jbmr.1998.13.6.911; Helfrich MH, 2000, J BONE MINER RES, V15, P2315, DOI 10.1359/jbmr.2000.15.12.2315; Hocking L, 2000, BONE, V26, P577, DOI 10.1016/S8756-3282(00)00278-7; Hofbauer LC, 2000, J BONE MINER RES, V15, P2, DOI 10.1359/jbmr.2000.15.1.2; HUGHES AE, 1994, HUM MOL GENET, V3, P359, DOI 10.1093/hmg/3.2.359; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; HUVOS AG, 1986, CANCER, V57, P1442, DOI 10.1002/1097-0142(19860401)57:7<1442::AID-CNCR2820570734>3.0.CO;2-3; Kanis JA, 1992, PATHOPHYSIOLOGY TREA; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kurihara N, 2000, J CLIN INVEST, V105, P607, DOI 10.1172/JCI8489; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Laurin N, 2001, AM J HUM GENET, V69, P528, DOI 10.1086/322975; MCKUSICK VA, 1976, HERITABLE DISORDERS, P687; MORALESPIGA AA, 1995, J BONE MINER RES, V10, P663; Nance MA, 2000, AM J MED GENET, V92, P303, DOI 10.1002/1096-8628(20000619)92:5<303::AID-AJMG2>3.0.CO;2-E; Siris ES, 1996, J BONE MINER RES, V11, P1599; SIRIS ES, 1994, SEMIN ARTHRITIS RHEU, V23, P222, DOI 10.1016/0049-0172(94)90037-X; SIRIS ES, 1991, J BONE MINER RES, V6, P495; SOFAER JA, 1983, J EPIDEMIOL COMMUN H, V37, P226, DOI 10.1136/jech.37.3.226; SOLOMON LR, 1979, BRIT MED J, V1, P931, DOI 10.1136/bmj.1.6168.931; Sparks AB, 2001, CALCIFIED TISSUE INT, V68, P151, DOI 10.1007/s002230001211; Tiegs RD, 2000, BONE, V27, P423, DOI 10.1016/S8756-3282(00)00333-1; WALLACE RGH, 1989, CLIN ORTHOP RELAT R, P265; Wuyts W, 2001, BONE, V28, P104, DOI 10.1016/S8756-3282(00)00411-7	28	88	92	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2001	69	5					1055	1061		10.1086/323798	http://dx.doi.org/10.1086/323798			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	479PU	11555792	Green Published, Bronze			2022-12-18	WOS:000171413400013
J	Graham, JM; Anyane-Yeboa, K; Raams, A; Appeldoorn, E; Kleijer, WJ; Garritsen, VH; Busch, D; Edersheim, TG; Jaspers, NGJ				Graham, JM; Anyane-Yeboa, K; Raams, A; Appeldoorn, E; Kleijer, WJ; Garritsen, VH; Busch, D; Edersheim, TG; Jaspers, NGJ			Cerebro-oculo-facio-skeletal syndrome with a nucleotide excision-repair defect and a mutated XPD gene, with prenatal diagnosis in a triplet pregnancy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PIGMENTOSUM GROUP-G; COCKAYNE-SYNDROME; XERODERMA-PIGMENTOSUM; COFS SYNDROME; NEUROPATHOLOGICAL FINDINGS; MENTAL-RETARDATION; MARTSOLFS SYNDROME; MICRO SYNDROME; CATARACTS; INHERITANCE	Cerebro-oculo-facio-skeletal (COFS) syndrome is a recessively inherited rapidly progressive neurologic disorder leading to brain atrophy, with calcifications, cataracts, microcornea, optic atrophy, progressive joint contractures, and growth failure. Cockayne syndrome (CS) is a recessively inherited neurodegenerative disorder characterized by low to normal birth weight, growth failure, brain dysmyelination with calcium deposits, cutaneous photosensitivity, pigmentary retinopathy and/or cataracts, and sensorineural hearing loss. Cultured CS cells are hypersensitive to UV radiation, because of impaired nucleotide-excision repair (NER) of UV-induced damage in actively transcribed DNA, whereas global genome NER is unaffected. The abnormalities in CS are caused by mutated CSA or CSB genes. Another class of patients with CS symptoms have mutations in the XPB, XPD, or XPG genes, which result in UV hypersensitivity as well as defective global NER; such patients may concurrently have clinical features of another NER syndrome, xeroderma pigmentosum (XP). Clinically observed similarities between COFS syndrome and CS have been followed by discoveries of cases of COFS syndrome that are associated with mutations in the XPG and CSB genes. Here we report the first involvement of the XPD gene in a new case of UV-sensitive COFS syndrome, with heterozygous substitutions-a R616W null mutation (previously seen in patients in XP complementation group D) and a unique D681N mutation-demonstrating that a third gene can be involved in COFS syndrome. We propose that COFS syndrome be included within the already known spectrum of NER disorders: XP, CS, and trichothiodystrophy. We predict that future patients with COFS syndrome will be found to have mutations in the CSA or XPB genes, and we document successful use of DNA repair for prenatal diagnosis in triplet and singleton pregnancies at risk for COFS syndrome. This result strongly underlines the need for screening of patients with COFS syndrome, for either UV sensitivity or DNA-repair abnormalities.	Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Ctr Med Genet Birth Defects, Los Angeles, CA 90048 USA; Columbia Univ, New York Presbyterian Hosp, New York, NY USA; Erasmus Univ, Dept Cell Biol & Genet, NL-3000 DR Rotterdam, Netherlands; Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands; Armed Forces Inst Pathol, Dept Environm & Toxicol Pathol, Washington, DC 20306 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Columbia University; NewYork-Presbyterian Hospital; Erasmus University Rotterdam; Erasmus University Rotterdam; United States Department of Defense	Graham, JM (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Ctr Med Genet Birth Defects, 444 S San Vicente Blvd,Room 1001, Los Angeles, CA 90048 USA.		Graham, John M./J-1429-2019	Anyane-Yeboa, Kwame/0000-0002-4977-9719	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD022657] Funding Source: Medline; NIGMS NIH HHS [T32 GM008243] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		DelBigio MR, 1997, J NEUROPATH EXP NEUR, V56, P1147, DOI 10.1097/00005072-199710000-00009; Hamel BCK, 1996, J MED GENET, V33, P607, DOI 10.1136/jmg.33.7.607; HARBORD MG, 1989, J MED GENET, V26, P397, DOI 10.1136/jmg.26.6.397; HENNEKAM RCM, 1988, EUR J PEDIATR, V147, P539, DOI 10.1007/BF00441986; Lehmann AR, 2001, GENE DEV, V15, P15, DOI 10.1101/gad.859501; LERMANSAGIE T, 1987, AM J MED GENET, V28, P137, DOI 10.1002/ajmg.1320280120; LINNA SL, 1982, PEDIATR RADIOL, V12, P28, DOI 10.1007/BF01221707; LIU Q, 1995, BIOTECHNIQUES, V18, P470; LOWRY RB, 1971, J PEDIATR-US, V79, P282, DOI 10.1016/S0022-3476(71)80114-2; LOWRY RB, 1982, AM J MED GENET, V13, P209, DOI 10.1002/ajmg.1320130211; LURIE IW, 1976, CLIN GENET, V10, P343; MARTSOLF JT, 1978, AM J MED GENET, V1, P291, DOI 10.1002/ajmg.1320010305; Meira LB, 2000, AM J HUM GENET, V66, P1221, DOI 10.1086/302867; Moriwaki SI, 1996, J INVEST DERMATOL, V107, P647, DOI 10.1111/1523-1747.ep12584287; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Nassogne MC, 2000, NEUROPEDIATRICS, V31, P218, DOI 10.1055/s-2000-7463; Nouspikel T, 1997, P NATL ACAD SCI USA, V94, P3116, DOI 10.1073/pnas.94.7.3116; PATTON MA, 1989, J MED GENET, V26, P154, DOI 10.1136/jmg.26.3.154; Pena S D, 1978, Birth Defects Orig Artic Ser, V14, P205; PENA SDJ, 1974, CLIN GENET, V5, P285; Powell C. M., 2000, Genetics in Medicine, V2, P85, DOI 10.1097/00125817-200001000-00121; PREUS M, 1974, CLIN GENET, V5, P294; Sakai T, 1997, BRAIN DEV-JPN, V19, P58, DOI 10.1016/S0387-7604(96)00057-5; SANCHEZ JM, 1985, J MED GENET, V22, P308, DOI 10.1136/jmg.22.4.308; SCOTTEMUAKPOR AB, 1977, AM J DIS CHILD, V131, P167, DOI 10.1001/archpedi.1977.02120150049010; SIGMUNDSSON J, 1998, AM J HUM GENET S, V63, pA120; Sijbers AM, 1998, J INVEST DERMATOL, V110, P832, DOI 10.1046/j.1523-1747.1998.00171.x; STRISCIUGLIO P, 1988, J MED GENET, V25, P267, DOI 10.1136/jmg.25.4.267; TALWAR D, 1989, AM J MED GENET, V34, P194, DOI 10.1002/ajmg.1320340212; van den Berg C, 1999, PRENATAL DIAG, V19, P234, DOI 10.1002/(SICI)1097-0223(199903)19:3<234::AID-PD516>3.3.CO;2-Z; Vermeulen W, 2001, NAT GENET, V27, P299, DOI 10.1038/85864; VERMEULEN W, 1993, AM J HUM GENET, V53, P185; WARBURG M, 1993, AM J DIS CHILD, V147, P1309, DOI 10.1001/archpedi.1993.02160360051017; WINTER RM, 1981, J MED GENET, V18, P129, DOI 10.1136/jmg.18.2.129	34	88	89	0	2	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2001	69	2					291	300		10.1086/321295	http://dx.doi.org/10.1086/321295			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	456XN	11443545	Green Published, Bronze			2022-12-18	WOS:000170108200005
J	Fukami, M; Kirsch, S; Schiller, S; Richter, A; Benes, V; Franco, B; Muroya, K; Rao, E; Merker, S; Niesler, B; Ballabio, A; Ansorge, W; Ogata, T; Rappold, GA				Fukami, M; Kirsch, S; Schiller, S; Richter, A; Benes, V; Franco, B; Muroya, K; Rao, E; Merker, S; Niesler, B; Ballabio, A; Ansorge, W; Ogata, T; Rappold, GA			A member of a gene family on Xp22.3, VCX-A, is deleted in patients with X-linked nonspecific mental retardation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DISTAL SHORT ARM; STEROID SULFATASE; INTERSTITIAL DELETION; FREQUENT DELETIONS; Y-CHROMOSOME; REGION; LINKAGE; LOCUS; MRX; LOCALIZATION	X-linked nonspecific mental retardation (MRX) has a frequency of 0.15% in the male population and is caused by defects in several different genes on the human X chromosome. Genotype-phenotype correlations in male patients with a partial nullisomy of the X chromosome have suggested that at least one locus involved in MRX is on Xp22.3. Previous deletion mapping has shown that this gene resides between markers DXS1060 and DXS1139, a region encompassing similar to 1.5 Mb of DNA. Analyzing the DNA of 15 males with Xp deletions, we were able to narrow this MRX critical interval to similar to 15 kb of DNA. Only one gene, VCX-A (variably charged, ii chromosome mRNA on CRI-S232A), was shown to reside in this interval. Because of a variable number of tandem 30-bp repeats in the VCX-A gene, the size of the predicted protein is 186-226 amino acids. VCX-A belongs to a gene family containing at least four nearly identical paralogues on Xp22.3 (VCX-A, -B, -B1, and -C) and two on Yq11.2 (VCY-D, VCY-E), suggesting that the X and Y copies were created by duplication events. We have found that VCX-A is retained in all patients with normal intelligence and is deleted in all patients with mental retardation. There is no correlation between the presence or absence of VCX-B1, -B, and VCX-C and mental status in our patients. These results suggest that VCX-A is sufficient to maintain normal mental development.	Univ Heidelberg, Inst Human Genet, D-69120 Heidelberg, Germany; European Mol Biol Lab, Heidelberg, Germany; Telethon Inst Genet & Med, Milan, Italy; Keio Univ, Dept Pediat, Tokyo 108, Japan	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Keio University	Rappold, GA (corresponding author), Univ Heidelberg, Inst Human Genet, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.		BALLABIO, Andrea/AAL-2672-2020; Muroya, Koji/J-1304-2016; Ansorge, Wilhelm/AAN-8780-2020; FRANCO, Brunella/S-2882-2018	BALLABIO, Andrea/0000-0003-1381-4604; Muroya, Koji/0000-0002-1810-9894; Benes, Vladimir/0000-0002-0352-2547; FRANCO, Brunella/0000-0001-5588-4569; Ogata, Tsutomu/0000-0001-7178-9991	Telethon [TGM00P11, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		AGEMATSU K, 1988, HUM GENET, V80, P105, DOI 10.1007/BF00451470; BALLABIO A, 1990, GENOMICS, V8, P263, DOI 10.1016/0888-7543(90)90281-X; BALLABIO A, 1989, P NATL ACAD SCI USA, V86, P10001, DOI 10.1073/pnas.86.24.10001; Ballabio Andrea, 1992, Human Molecular Genetics, V1, P221, DOI 10.1093/hmg/1.4.221; BarDavid S, 1996, AM J MED GENET, V64, P83, DOI 10.1002/(SICI)1096-8628(19960712)64:1<83::AID-AJMG15>3.0.CO;2-O; BARDONI B, 1991, GENOMICS, V11, P443, DOI 10.1016/0888-7543(91)90153-6; BURN TC, 1995, GENE, V161, P183, DOI 10.1016/0378-1119(95)00223-S; Chelly J, 1999, HUM MOL GENET, V8, P1833, DOI 10.1093/hmg/8.10.1833; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Claes S, 1996, AM J MED GENET, V64, P137, DOI 10.1002/(SICI)1096-8628(19960712)64:1<137::AID-AJMG24>3.0.CO;2-N; Claes S, 1997, AM J MED GENET, V73, P474; Erfle H, 1997, NUCLEIC ACIDS RES, V25, P2229, DOI 10.1093/nar/25.11.2229; FERRERO GB, 1995, HUM MOL GENET, V4, P1821, DOI 10.1093/hmg/4.10.1821; Gecz J, 2000, GENOME RES, V10, P157, DOI 10.1101/gr.10.2.157; Gedeon AK, 1996, AM J MED GENET, V64, P158, DOI 10.1002/(SICI)1096-8628(19960712)64:1<158::AID-AJMG26>3.3.CO;2-V; HERRELL S, 1995, GENOMICS, V25, P526, DOI 10.1016/0888-7543(95)80054-P; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; KOZAK L, 1993, J MED GENET, V30, P866, DOI 10.1136/jmg.30.10.866; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lahn BT, 2000, HUM MOL GENET, V9, P311, DOI 10.1093/hmg/9.2.311; LI XM, 1992, NUCLEIC ACIDS RES, V20, P1117, DOI 10.1093/nar/20.5.1117; LICHTER P, 1992, HUMAN CYTOGENETICS P; Mandel JL, 1997, NATURE, V386, P767, DOI 10.1038/386767a0; MARTIN B, 1995, LAB ANIMAL, V24, P22; Merienne K, 1999, NAT GENET, V22, P13, DOI 10.1038/8719; Muroya K, 1996, AM J MED GENET, V64, P583, DOI 10.1002/(SICI)1096-8628(19960906)64:4<583::AID-AJMG11>3.0.CO;2-D; NELSON DL, 1995, CYTOGENET CELL GENET, V71, P307; NISHIMURA S, 1991, AM J MED GENET, V40, P260, DOI 10.1002/ajmg.1320400303; OGATA T, 1990, AM J MED GENET, V35, P241, DOI 10.1002/ajmg.1320350219; SCHAAKEKONING CCE, 1993, DIAGN ONCOL, V3, P272; SCHNUR RE, 1990, GENOMICS, V8, P255, DOI 10.1016/0888-7543(90)90280-8; SHAPIRO LJ, 1989, P NATL ACAD SCI USA, V86, P8477, DOI 10.1073/pnas.86.21.8477; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; TURNER G, 1980, AM J MED GENET, V7, P407, DOI 10.1002/ajmg.1320070403; VANSLEGTENHORST MA, 1994, HUM MOL GENET, V3, P547; Weissortel R, 1998, CLIN GENET, V54, P45; WIEMANN S, 1995, ANAL BIOCHEM, V224, P117, DOI 10.1006/abio.1995.1015; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	38	88	94	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2000	67	3					563	573		10.1086/303047	http://dx.doi.org/10.1086/303047			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	348TJ	10903929	Green Published, Bronze			2022-12-18	WOS:000089002300003
J	Disse-Nicodeme, S; Achard, JM; Desitter, I; Houot, AM; Fournier, A; Corvol, P; Jeunemaitre, X				Disse-Nicodeme, S; Achard, JM; Desitter, I; Houot, AM; Fournier, A; Corvol, P; Jeunemaitre, X			A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, autosomal dominant form of hypertension	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FAMILIAL ESSENTIAL-HYPERTENSION; MULTILOCUS LINKAGE; ALDOSTERONE LEVELS; HYPERKALEMIA; MUTATIONS; VARIANT; DEFECT; REGION	Pseudohypoaldosteronism type II (PHA2) is a rare autosomal dominant form of volume-dependent low-renin hypertension characterized by hyperkalemia and hyperchloremic acidosis but also by a normal glomerular filtration rate. These features, together with the correction of blood pressure and metabolic abnormalities by small doses of thiazide diuretics, suggest a primary renal tubular defect. Two loci have previously been mapped at low resolution to chromosome 1q31-42 (PHA2A) and 17p11-q21 (PHA2B). We have now analyzed a new large French pedigree, in which 12 affected members over three generations confirmed the autosomal dominant inheritance. Affected subjects had hypertension together with long-term hyperkalemia (range 5.2-6.2 mmol/liter), hyperchloremia (range: 100-109 mmol/liter), normal plasma creatinine (range: 63-129 mmol/liter) and low renin levels. Genetic linkage was excluded for both PHA2A and PHA2B loci (all LOD scores Z < -3.2 at recombination fraction [theta] 0), as well as for the thiazide-sensitive sodium-chloride cotransporter gene. A genome-wide scan using 383 microsatellite markers showed a strong linkage with the chromosome 12p13 region (maximum LOD score Z = 6.18, theta = 0, at D12S99). Haplotype analysis using 10 additional polymorphic markers led to a minimum 13-cM interval flanked by D12S1652 and D12S336, thus defining a new PHA2C locus. Analysis of two obvious candidate genes (SCNN1A and GNb3) located within the interval showed no deleterious mutation. In conclusion, we hereby demonstrate further genetic heterogeneity of this Mendelian form of hypertension and identify a new PHA2C locus, the most compelling and precise linkage interval described to date.	Coll France, INSERM, U36, F-75005 Paris, France; Hop Broussais, Genet Mol Lab, Assistance Publ Hop Paris, F-75674 Paris, France; Hop Amiens Sud, Serv Nephrol, Amiens, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Jeunemaitre, X (corresponding author), Coll France, INSERM, U36, 3 Rue Ulm, F-75005 Paris, France.		JEUNEMAITRE, Xavier/AAQ-4853-2021	JEUNEMAITRE, Xavier/0000-0001-5925-381X				ANDRE JL, 1982, REV EPIDEMIOL SANTE, V30, P1; ARNOLD JE, 1969, AM J MED, V47, P461, DOI 10.1016/0002-9343(69)90230-7; BRAUTBAR N, 1978, ARCH INTERN MED, V138, P607, DOI 10.1001/archinte.138.4.607; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Chalmers J, 1999, J HYPERTENS, V17, P151; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; FARFEL Z, 1978, ARCH INTERN MED, V138, P1828, DOI 10.1001/archinte.138.12.1828; GORDON RD, 1970, AUSTRALAS ANN MED, V19, P287; Gordon Richard D., 1995, P2111; Julier C, 1997, HUM MOL GENET, V6, P2077, DOI 10.1093/hmg/6.12.2077; LATHROP GM, 1985, AM J HUM GENET, V37, P482; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; Mansfield TA, 1997, NAT GENET, V16, P202, DOI 10.1038/ng0697-202; O'Shaughnessy KM, 1998, J HUM HYPERTENS, V12, P675, DOI 10.1038/sj.jhh.1000705; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Schuster H, 1996, NAT GENET, V13, P98, DOI 10.1038/ng0596-98; Siffert W, 1998, NAT GENET, V18, P45, DOI 10.1038/ng0198-45; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; WEEKS DE, 1990, GENET EPIDEMIOL, V7, P237, DOI 10.1002/gepi.1370070402	21	88	94	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2000	67	2					302	310		10.1086/303020	http://dx.doi.org/10.1086/303020			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354YA	10869238	Bronze, Green Published			2022-12-18	WOS:000089357800007
J	Moolman-Smook, JC; De Lange, WJ; Bruwer, ECD; Brink, PA; Corfield, VA				Moolman-Smook, JC; De Lange, WJ; Bruwer, ECD; Brink, PA; Corfield, VA			The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: A unique profile of both independent and founder events	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HEAVY-CHAIN GENE; BINDING-PROTEIN-C; TROPONIN-T MUTATIONS; BETA-CARDIAC MYOSIN; MISSENSE MUTATION; IDENTIFICATION; POPULATION; FAMILIES; DISEASE; SEQUENCE	Hypertrophic cardiomyopathy (HCM) is an autosomal dominantly inherited disease of the cardiac sarcomere, caused by numerous mutations in genes encoding protein components of this structure. Mutation carriers are at risk of sudden cardiac death, mostly as adolescents or young adults. The reproductive disadvantage incurred may explain both the global occurrence of diverse independent HCM-associated mutations and the rare reports of founder effects within populations. We have investigated whether this holds true for two South African subpopulations, one of mixed ancestry and one of northern-European descent. Previously, we had detected three novel mutations-Ala797Thr in the beta-myosin heavy-chain gene (beta MHC), Arg92Trp in the cardiac troponin T gene (cTnT), and Arg645His in the myosin-binding protein C gene (MyBPC)-and two documented beta MHC mutations (Arg403Trp and Arg249Gln). Here we report three additional novel mutations-Gln499Lys in beta MHC and Val896Met and Delta c756 in MyBPC-and the documented beta MHC Arg719Gln mutation. Seven of the nine HCM-causing mutations arose independently; no conclusions can be drawn for the remaining two. However, the beta MHC Arg403Trp and Ala797Thr and cTnT Arg92Trp mutations were detected in another one, eight, and four probands, respectively, and haplotype analysis in families carrying these recurring mutations inferred their origin from three common ancestors. The milder phenotype of the beta MHC mutations may account for the presence of these founder effects, whereas population dynamics alone may have overridden the reproductive disadvantage incurred by the more lethal, cTnT Arg92Trp mutation.	Univ Stellenbosch, US MRC, Ctr Cellular & Mol Biol, Dept Med Biochem,Sch Med, ZA-7505 Tygerberg, South Africa; Univ Stellenbosch, Dept Internal Med, Sch Med, ZA-7505 Tygerberg, South Africa; Tygerberg Hosp, Tygerberg, South Africa	Stellenbosch University; Stellenbosch University; Tygerberg Hospital	Corfield, VA (corresponding author), Univ Stellenbosch, US MRC, Ctr Cellular & Mol Biol, Dept Med Biochem,Sch Med, POB 19063, ZA-7505 Tygerberg, South Africa.			Brink, Paul/0000-0001-8538-5824				ALMAHDAWI S, 1994, BRIT HEART J, V72, P105; Bonne G, 1998, CIRC RES, V83, P580, DOI 10.1161/01.RES.83.6.580; BOTHA MC, 1983, S AFR MED J, V64, P609; BRINK PA, 1995, CIRCULATION, V91, P1633, DOI 10.1161/01.CIR.91.6.1633; CAMERON T, 1992, NUWE GESKIEDENIS S A; Carrier L, 1997, CIRC RES, V80, P427, DOI 10.1161/01.res.0000435859.24609.b3; CONSEVAGE MW, 1994, HUM MOL GENET, V3, P1025, DOI 10.1093/hmg/3.6.1025; CORFIELD VA, 1993, TRANSFUSION, V33, P119, DOI 10.1046/j.1537-2995.1993.33293158042.x; DAUSSE E, 1993, J CLIN INVEST, V92, P2807, DOI 10.1172/JCI116900; deJager T, 1996, J MED GENET, V33, P567, DOI 10.1136/jmg.33.7.567; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; FEIGENBAUM H, 1981, ECHOCARDIOGRAPHY; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Jaaskelainen P, 1998, J AM COLL CARDIOL, V32, P1709, DOI 10.1016/S0735-1097(98)00448-3; JAENICKE T, 1990, GENOMICS, V8, P194, DOI 10.1016/0888-7543(90)90272-V; KOTZE MJ, 1991, ANN HUM GENET, V55, P115, DOI 10.1111/j.1469-1809.1991.tb00404.x; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; MAY RM, 1989, S AFR MED J, V76, P647; Mogensen J, 1999, J CLIN INVEST, V103, pR39, DOI 10.1172/JCI6460; Moolman JC, 1997, J AM COLL CARDIOL, V29, P549, DOI 10.1016/S0735-1097(96)00530-X; MOOLMAN JC, 1993, HUM MOL GENET, V2, P1731, DOI 10.1093/hmg/2.10.1731; MOOLMAN JC, 1995, HUM MUTAT, V6, P197, DOI 10.1002/humu.1380060219; Moolman-Smook JC, 1998, J MED GENET, V35, P253, DOI 10.1136/jmg.35.3.253; Niimura H, 1998, NEW ENGL J MED, V338, P1248, DOI 10.1056/NEJM199804303381802; POSEN BM, 1995, BRIT HEART J, V74, P40; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; TEARE D, 1958, BRIT HEART J, V20, P1; THEAL GM, 1922, HIST S AFRICA, V3; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Vikstrom KL, 1996, CURR OPIN CELL BIOL, V8, P97, DOI 10.1016/S0955-0674(96)80053-6; Warnich L, 1996, HUM MOL GENET, V5, P981, DOI 10.1093/hmg/5.7.981; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; WATKINS H, 1993, AM J HUM GENET, V53, P1180; [No title captured]	36	88	92	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1999	65	5					1308	1320		10.1086/302623	http://dx.doi.org/10.1086/302623			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	252YZ	10521296	Green Published, Bronze			2022-12-18	WOS:000083531000012
J	Whatley, SD; Puy, H; Morgan, RR; Robreau, AM; Roberts, AG; Nordmann, Y; Elder, GH; Deybach, JC				Whatley, SD; Puy, H; Morgan, RR; Robreau, AM; Roberts, AG; Nordmann, Y; Elder, GH; Deybach, JC			Variegate porphyria in western Europe: Identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PROTOPORPHYRINOGEN OXIDASE GENE; GRADIENT GEL-ELECTROPHORESIS; MISSENSE MUTATION; MOLECULAR-BASIS; PLASMA; EXPRESSION; LOCATION; ENZYME	Variegate porphyria (VP) is a low-penetrance, autosomal dominant disorder characterized clinically by skin lesions and acute neurovisceral attacks that occur separately or together. It results from partial deficiency of protoporphyrinogen oxidase encoded by the PPOX gene. VP is relatively common in South Africa, where most patients have inherited the same mutation in the PPOX gene from a common ancestor, but few families from elsewhere have been studied. Here we describe the molecular basis and clinical features of 108 unrelated patients from France and the United Kingdom. Mutations in the PPOX gene were identified by a combination of screening (denaturing gradient gel electrophoresis, heteroduplex analysis, or denaturing high-performance liquid chromatography) and direct automated sequencing of amplified genomic DNA. A total of GO novel and 6 previously reported mutations (25 missense, 24 frameshift, 10 splice site, and 7 nonsense) were identified in 104 (96%) of these unrelated patients, together with 3 previously unrecognized single-nucleotide polymorphisms. VP is less heterogeneous than other acute porphyrias; 5 mutations were present in 28 (26%) of the families, whereas 47 mutations were restricted to 1 family; only 2 mutations were found in both countries. The pattern of clinical presentation was identical to that reported from South Africa and was not influenced by type of mutation. Our results define the molecular genetics of VP in western Europe, demonstrate its allelic heterogeneity outside South Africa, and show that genotype is not a significant determinant of mode of presentation.	Univ Wales Coll Med, Dept Med Biochem, Cardiff CF4 4XN, S Glam, Wales; Univ Wales Hosp, NHS Healthcare Trust, Cardiff CF4 4XW, S Glam, Wales; Univ Paris 07, Hop Louis Mourier, Ctr Francais Porphyries, Colombes, France; Univ Paris 07, Hop Louis Mourier, INSERM, U409, Colombes, France	Cardiff University; Cardiff University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Elder, GH (corresponding author), Univ Wales Coll Med, Dept Med Biochem, Heath Pk, Cardiff CF4 4XN, S Glam, Wales.		PUY, HERVE/O-1785-2017	PUY, HERVE/0000-0003-3362-2634				ARMAS R, 1992, REV MED CHILE, V120, P259; BRENNER DA, 1980, NEW ENGL J MED, V302, P765, DOI 10.1056/NEJM198004033021401; Cooper D. N., 1993, HUMAN GENE MUTATION; Corrigall AV, 1998, HUM MUTAT, V12, P403, DOI 10.1002/(SICI)1098-1004(1998)12:6<403::AID-HUMU6>3.3.CO;2-O; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Dailey TA, 1998, J BIOL CHEM, V273, P13658, DOI 10.1074/jbc.273.22.13658; Dailey TA, 1996, PROTEIN SCI, V5, P98; DASILVA V, 1995, CLIN CHIM ACTA, V238, P163, DOI 10.1016/0009-8981(95)06085-R; de Rooij FWM, 1997, ACTA HAEMATOL S1, V98, P103; Dean G, 1971, PORPHYRIAS STORY INH; DEYBACH JC, 1985, EUR J BIOCHEM, V149, P431, DOI 10.1111/j.1432-1033.1985.tb08943.x; Deybach JC, 1996, HUM MOL GENET, V5, P407, DOI 10.1093/hmg/5.3.407; EALES L, 1980, INT J BIOCHEM, V12, P837; Elder GH, 1997, LANCET, V349, P1613, DOI 10.1016/S0140-6736(96)09070-8; Frank J, 1998, J INVEST DERMATOL, V110, P452, DOI 10.1046/j.1523-1747.1998.00148.x; Frank J, 1998, ARCH DERMATOL RES, V290, P441, DOI 10.1007/s004030050333; Frank J, 1998, J MED GENET, V35, P244, DOI 10.1136/jmg.35.3.244; Frank J, 1998, J INVEST DERMATOL, V110, P449, DOI 10.1046/j.1523-1747.1998.00147.x; Frank J, 1998, AM J MED GENET, V79, P22, DOI 10.1002/(SICI)1096-8628(19980827)79:1<22::AID-AJMG6>3.3.CO;2-O; FRANK J, 1997, ACTA HAEMATOL S1, V98, P96; FRANK J, 1997, ACTA HAEMATOL S1, V98, P97; FRANK J, 1997, RETINOIDS, V13, P88; Groenewald JZ, 1998, AM J HUM GENET, V62, P1254, DOI 10.1086/301833; Jenkins T, 1996, NAT GENET, V13, P7, DOI 10.1038/ng0596-7; KAUPPINEN R, 1997, ACTA HAEMATOL S1, V98, P96; Kirsch RE, 1998, SEMIN LIVER DIS, V18, P33, DOI 10.1055/s-2007-1007138; Kotze MJ, 1998, MOL CELL PROBE, V12, P293, DOI 10.1006/mcpr.1998.0188; Lam HM, 1997, HUM GENET, V99, P126; LAM HM, 1996, J INVEST DERMATOL, V107, P144; LERMAN LS, 1987, METHOD ENZYMOL, V155, P482; LONG C, 1993, BRIT J DERMATOL, V129, P9, DOI 10.1111/j.1365-2133.1993.tb03303.x; Meissner PN, 1996, NAT GENET, V13, P95, DOI 10.1038/ng0596-95; MUSTAJOKI P, 1980, Q J MED, V49, P191; MYERS RM, 1987, METHOD ENZYMOL, V155, P501; NISHIMURA K, 1995, J BIOL CHEM, V270, P8076, DOI 10.1074/jbc.270.14.8076; O'Donovan MC, 1998, GENOMICS, V52, P44, DOI 10.1006/geno.1998.5411; POHFITZPATRICK MB, 1980, ARCH DERMATOL, V116, P543, DOI 10.1001/archderm.116.5.543; Puy H, 1997, AM J HUM GENET, V60, P1373, DOI 10.1086/515455; PUY H, 1996, BIOCHEM BIOPH RES CO, V226, P227; Roberts AG, 1998, HUM MOL GENET, V7, P1921, DOI 10.1093/hmg/7.12.1921; ROBERTS AG, 1995, HUM MOL GENET, V4, P2387, DOI 10.1093/hmg/4.12.2387; Rosipal R, 1999, HUM MUTAT, V13, P44, DOI 10.1002/(SICI)1098-1004(1999)13:1<44::AID-HUMU5>3.0.CO;2-Q; TAKETANI S, 1995, GENOMICS, V29, P698, DOI 10.1006/geno.1995.9949; Tchernitchko D, 1999, CLIN CHIM ACTA, V279, P133, DOI 10.1016/S0009-8981(98)00056-4; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian H, 1998, J BIOL CHEM, V273, P27953, DOI 10.1074/jbc.273.43.27953; Warnich L, 1996, HUM MOL GENET, V5, P981, DOI 10.1093/hmg/5.7.981; Whatley SD, 1999, HUM GENET, V104, P505, DOI 10.1007/s004390050995	48	88	90	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1999	65	4					984	994		10.1086/302586	http://dx.doi.org/10.1086/302586			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	241XW	10486317	Bronze, Green Published			2022-12-18	WOS:000082910000007
J	Evans, AL; Brice, G; Sotirova, V; Mortimer, P; Beninson, J; Burnand, K; Rosbotham, J; Child, A; Sarfarazi, M				Evans, AL; Brice, G; Sotirova, V; Mortimer, P; Beninson, J; Burnand, K; Rosbotham, J; Child, A; Sarfarazi, M			Mapping of primary congenital lymphedema to the 5q35.3 region	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MANAGING LYMPHEDEMA; PRIMARY LYMPHOEDEMA; DISTICHIASIS	Primary lymphedema is a chronic tissue swelling, most frequently of the lower limbs, resulting from deficient lymphatic drainage. The variability of the affected phenotype, incomplete penetrance, lack of large families, and possible genetic heterogeneity have hampered the identification of causative genes until now We carried out a genomewide search, using a four-generation North American family with dominantly inherited primary congenital lymphedema (PCL), otherwise known as "Milroy disease," or "hereditary lymphedema type I" (MIM 153100). Linkage to markers from the 5q35.3 region in this and four additional, British families was established. A minimum of 79 directly scorable haplotypes (37 affected) in five families conspicuously segregated with the most telomeric region of 5q35.3, thus suggesting a major locus for PCL in this vicinity. No recombination was observed with D5S408 (Z = 10.03) and D5S2006 (Z = 8.46) with a combined multipoint score of 16.55. While D5S2073 and WIAF-2213 defined the upper centromeric boundary, no recombinants were obtained for the last telomeric marker of D5S2006. Four unaffected subjects were identified as gene carriers and provided an estimated penetrance ratio of .84 for this condition. A few of the positionally mapped genes in the 5q35 region that may potentially be involved in the etiology of this condition are CANX, FGFR4, HK3, and hnRPH1.	Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr, Farmington, CT 06030 USA; St George Hosp, Sch Med, Dept Med Dermatol, London, England; St Thomas Hosp, Acad Dept Surg, London, England; Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA	University of Connecticut; St Georges University London; Guy's & St Thomas' NHS Foundation Trust; Henry Ford Health System; Henry Ford Hospital	Sarfarazi, M (corresponding author), Univ Connecticut, Ctr Hlth, Dept Surg, Surg Res Ctr, 263 Farmington Ave, Farmington, CT 06030 USA.	msarfara@cortex.uchc.edu						BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; BENINSON J, 1967, Vascular Surgery, V1, P43, DOI 10.1177/153857446700100106; BROWSE NL, 1985, J CARDIOVASC SURG, V26, P91; CORBETT CRR, 1982, LYMPHOLOGY, V15, P85; DALE RF, 1985, J MED GENET, V22, P274, DOI 10.1136/jmg.22.4.274; DALE RF, 1987, J MED GENET, V24, P170, DOI 10.1136/jmg.24.3.170; FALLS H F, 1964, Trans Am Ophthalmol Soc, V62, P248; GREENLEE R, 1993, LYMPHOLOGY, V26, P156; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; Irons MB, 1996, AM J MED GENET, V66, P69, DOI 10.1002/(SICI)1096-8628(19961202)66:1<69::AID-AJMG15>3.3.CO;2-0; Jones AL, 1996, SCOT MED J, V41, P22, DOI 10.1177/003693309604100109; KLEMMER S, 1997, INT J ANGIOL, V6, P146; KOLIN T, 1991, ARCH OPHTHALMOL-CHIC, V109, P980, DOI 10.1001/archopht.1991.01080070092042; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MILROY WF, 1892, NY MED J, V56, P503; MOORE D, 1994, CURRENT PROTOCOLS MO; MORTIMER PS, 1995, CLIN EXP DERMATOL, V20, P98, DOI 10.1111/j.1365-2230.1995.tb02665.x; Mortimer PS, 1995, CLIN DERMATOL, V13, P499, DOI 10.1016/0738-081X(95)00095-W; Nonne M, 1891, ARCH PATHOLOGISCHE A, V125, P189; STEMMER R, 1976, Vasa, V5, P261; TOBIN M, 1993, CANCER, V1, P64; VANDERPUTTE SCJ, 1978, LYMPHOLOGY, V11, P1; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WELLS GC, 1966, P ROY SOC MED, V59, P447, DOI 10.1177/003591576605900529; WITTE M, 1997, PHLEBOLYMPHOLOGY, P19	26	88	97	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					547	555		10.1086/302248	http://dx.doi.org/10.1086/302248			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973292	Green Published, Bronze			2022-12-18	WOS:000078740600024
J	Zu, L; Figueroa, KP; Grewal, R; Pulst, SM				Zu, L; Figueroa, KP; Grewal, R; Pulst, SM			Mapping of a new autosomal dominant spinocerebellar ataxia to chromosome 22	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ALPHA(1A)-VOLTAGE-DEPENDENT CALCIUM-CHANNEL; MACHADO-JOSEPH DISEASE; CEREBELLAR-ATAXIA; TRINUCLEOTIDE REPEAT; RETINAL DEGENERATION; CAG EXPANSIONS; GENE; CLONING; TYPE-2; LOCUS	The autosomal dominant cerebellar ataxias (ADCAs) are a clinically and genetically heterogeneous group of disorders. The clinical symptoms include cerebellar dysfunction and associated signs from dysfunction in other parts of the nervous system. So far, five spinocerebellar ataxia (SCA) genes have been identified: SCA1, SCA2, SCA3, SCA6, and SCA7. Loci for SCA4 and SCA5 have been mapped. However, approximately one-third of SCAs have remained unassigned. We have identified a Mexican American pedigree that segregates a new form of ataxia clinically characterized by gait and limb ataxia, dysarthria, and nystagmus. Two individuals have seizures. After excluding all known genetic loci for linkage, we performed a genomewide search and identified linkage to a 15-cM region on chromosome 22q13. A maximum LOD score of 4.3 (recombination fraction 0) was obtained for D22S928 and D22S1161. This distinct form of ataxia has been designated "SCA10." Anticipation was observed in the available parent-child pairs, suggesting that trinucleotide-repeat expansion may be the mutagenic mechanism.	Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Neurol, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med,Burns & Allen Res Inst, Rose Moss Lab Parkinsons & Neurodegenerat Dis, Los Angeles, CA 90048 USA; Univ So Calif, Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California	Pulst, SM (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Neurol, 8631 W 3rd St 1145E, Los Angeles, CA 90048 USA.							BENOMAR A, 1995, NAT GENET, V10, P84, DOI 10.1038/ng0595-84; David G, 1996, AM J HUM GENET, V59, P1328; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Del-Favero J, 1998, HUM MOL GENET, V7, P177, DOI 10.1093/hmg/7.2.177; Flanigan K, 1996, AM J HUM GENET, V59, P392; Geschwind DH, 1997, AM J HUM GENET, V60, P842; GOUW LG, 1995, NAT GENET, V10, P89, DOI 10.1038/ng0595-89; Grewal RP, 1998, NEUROLOGY, V51, P1423, DOI 10.1212/WNL.51.5.1423; HARDING AE, 1993, ADV NEUROL, V61, P1; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; HOLMBERG M, 1995, HUM MOL GENET, V4, P1441, DOI 10.1093/hmg/4.8.1441; Imbert G, 1996, NAT GENET, V14, P285, DOI 10.1038/ng1196-285; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Koob MD, 1998, NAT GENET, V18, P72, DOI 10.1038/ng0198-72; Krols L, 1997, HUM GENET, V99, P225, DOI 10.1007/s004390050344; LATHROP GM, 1984, AM J HUM GENET, V36, P460; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PENROSE LS, 1948, ANN EUGENIC, V14, P125; Pulst SM, 1996, NAT GENET, V14, P269, DOI 10.1038/ng1196-269; RANUM LPW, 1995, AM J HUM GENET, V57, P603; RANUM LPW, 1994, NAT GENET, V8, P280, DOI 10.1038/ng1194-280; Riess O, 1997, HUM MOL GENET, V6, P1289, DOI 10.1093/hmg/6.8.1289; Sanpei K, 1996, NAT GENET, V14, P277, DOI 10.1038/ng1196-277; SCHALLING M, 1993, NAT GENET, V4, P135, DOI 10.1038/ng0693-135; Schols L, 1997, ANN NEUROL, V42, P924, DOI 10.1002/ana.410420615; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	27	88	91	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1999	64	2					594	599		10.1086/302247	http://dx.doi.org/10.1086/302247			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	169HA	9973298	Green Published, Bronze			2022-12-18	WOS:000078740600030
J	Lum, JK; Cann, RL; Martinson, JJ; Jorde, LB				Lum, JK; Cann, RL; Martinson, JJ; Jorde, LB			Mitochondrial and nuclear genetic relationships among Pacific Island and Asian populations	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN OCCUPATION SITE; TANDEM REPEAT LOCI; PAPUA-NEW-GUINEA; DNA; ORIGINS; HISTORY; POLYNESIANS; AFFINITIES; MELANESIA; SEQUENCES	Mitochondrial and autosomal short tandem-repeat (STR) genetic distances among 28 Pacific Island and Asian populations are significantly correlated (r = .25, P < .01) but describe distinct patterns of relationships. Maternally inherited-mtDNA data suggest that Remote Oceanic Islanders originated in island Southeast Asia. In contrast, biparental STR data reveal substantial genetic affinities between Remote Oceanic Islanders and Near Oceanic populations from highland Papua New Guinea and Australia. The low correlation between maternal and biparental genetic markers from the same individuals may reflect differences in genome-effective population sizes or in sex-biased gene flow. To explore these possibilities, we have examined genetic diversity, gene flow, and correlations among genetic, linguistic, and geographic distances within four sets of populations representing potential geographic and cultural spheres of interaction. G(ST) estimates (a measure of genetic differentiation inversely proportional to gene flow) from mtDNA sequences vary between 0.13 and 0.39 and are typically five times greater than G(ST) estimates from STR loci (0.05-0.08), Significant correlations (r > .5, P < .05) between maternal genetic and linguistic distances are coincident with high mtDNA G(ST) estimates (>0.38). Thus, genetic and linguistic distances may coevolve, and their correspondence may be preserved under conditions of genetic isolation. A significant correlation (r = .65, P < .01) between biparental genetic and geographic distances is coincident with a low STR G(ST) estimate (0.05), indicating that isolation by distance is observed under conditions of high nuclear-gene flow. These results are consistent with an initial settlement of Remote Oceania from island Southeast Asia and with extensive postcolonization male-biased gene flow with Near Oceania.	Inst Stat Math, Minato Ku, Tokyo 1068569, Japan; Univ Hawaii Manoa, John A Burns Sch Med, Dept Genet, Honolulu, HI 96822 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; Univ Utah, Hlth Sci Ctr, Dept Human Genet, Eccles Inst Human Genet, Salt Lake City, UT 84132 USA	Research Organization of Information & Systems (ROIS); Institute of Statistical Mathematics (ISM) - Japan; University of Hawaii System; University of Hawaii Manoa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah	Lum, JK (corresponding author), Inst Stat Math, Minato Ku, 4-6-7 Minami Azabu, Tokyo 1068569, Japan.	lum@ism.ac.jp		Martinson, Jeremy/0000-0003-4673-7238				ALLEN J, 1988, NATURE, V331, P707, DOI 10.1038/331707a0; Bender ByronW., 1971, CURR TRENDS LINGUIST, P426, DOI 10.1515/9783111418827-014; BIRKY CW, 1983, GENETICS, V103, P513; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Darwin C., 1859, ORIGIN SPECIES MEANS; DIAMOND JM, 1988, NATURE, V336, P307, DOI 10.1038/336307a0; EDWARDS A, 1992, GENOMICS, V12, P241, DOI 10.1016/0888-7543(92)90371-X; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Finney B., 1994, VOYAGE REDISCOVERY C; GANCZAKOWSKI M, 1995, BRIT J HAEMATOL, V89, P485, DOI 10.1111/j.1365-2141.1995.tb08353.x; Green R.C., 1991, MAN HALF ESSAYS PACI, P491; GROUBE L, 1986, NATURE, V324, P453, DOI 10.1038/324453a0; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; Higuchi R, 1989, PCR TECHNOLOGY PRINC, P31; Howell N, 1996, AM J HUM GENET, V59, P501; Ikea Manny, 1994, ISLA J MICRONESIAN S, V2, P181; Intoh M, 1997, ANTHROPOL SCI, V105, P15, DOI 10.1537/ase.105.15; Irwin G., 1992, PREHISTORIC EXPLORAT; JACKSON FH, 1986, PACIFIC LINGUISTIC C, P201; Jackson Frederick., 1983, THESIS U HAWAII MANO; Jorde LB, 1997, P NATL ACAD SCI USA, V94, P3100, DOI 10.1073/pnas.94.7.3100; JORDE LB, 1995, AM J HUM GENET, V57, P523; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lalouel J. M., 1973, Genetic structure of populations. Proceedings of a conference sponsored by the University of Hawaii, 1973., P139; LONG JC, 1996, MATRIX CORRELATION A; Lum JK, 1998, AM J PHYS ANTHROPOL, V105, P109, DOI 10.1002/(SICI)1096-8644(199802)105:2<109::AID-AJPA1>3.0.CO;2-Q; LUM JK, 1994, HUM BIOL, V66, P567; LUM JK, IN PRESS MAN CULTURE; MANTEL N, 1967, CANCER RES, V27, P209; MARCK JC, 1986, J POLYNESIAN SOC, V95, P253; MERRIWETHER DA, 1991, J MOL EVOL, V33, P543, DOI 10.1007/BF02102807; Nei M., 1987, MOL EVOLUTIONARY GEN; NEITINSON JJ, 1996, MOL BIOL HUMAN DIVER, P171; OSHAUGHNESSY DF, 1990, AM J HUM GENET, V46, P144; Parsons TJ, 1997, NAT GENET, V15, P363, DOI 10.1038/ng0497-363; PAWLEY A, 1993, ANNU REV ANTHROPOL, V22, P425; Pawley A, 1973, OCEAN LINGUIST, V12, P1, DOI DOI 10.2307/3622852; PIETRUSEWSKY M, 1990, MICRONESICA S, V2, P373; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Rehg KL, 1995, OCEAN LINGUIST, V34, P305, DOI [10.2307/3623046, DOI 10.2307/3623046]; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; RobertsThomson JM, 1996, AM J HUM GENET, V58, P1017; Ross M. D., 1996, RECONSTRUCTION CLASS, P121; SERJEANTSON SW, 1983, J HUM EVOL, V12, P77, DOI 10.1016/S0047-2484(83)80014-1; SERJEANTSON SW, 1985, OUT ASIA PEOPLING AM, P133; SHERRY ST, 1994, HUM BIOL, V66, P761; SHRIVER MD, 1995, MOL BIOL EVOL, V12, P914; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; SMOUSE PE, 1992, YEARB PHYS ANTHROPOL, V35, P187; STONEKING M, 1990, GENETICS, V124, P717; SYKES B, 1995, AM J HUM GENET, V57, P1463; TAJIMA F, 1990, GENETICS, V126, P231; TERRELL J, 1988, ANTIQUITY, V62, P642, DOI 10.1017/S0003598X00075049; Terrell JE, 1997, CURR ANTHROPOL, V38, P155, DOI 10.1086/204604; VIGILANT L, 1989, P NATL ACAD SCI USA, V86, P9350, DOI 10.1073/pnas.86.23.9350; WADE MJ, 1994, EVOLUTION, V48, P1114, DOI 10.2307/2410371; WEBER JL, 1993, HUM MOL GENET, V2, P1123, DOI 10.1093/hmg/2.8.1123; WELSCH RL, 1992, AM ANTHROPOL, V94, P568, DOI 10.1525/aa.1992.94.3.02a00030; WICKLER S, 1988, ANTIQUITY, V62, P703, DOI 10.1017/S0003598X00075104; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1943, GENETICS, V28, P114; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	62	88	91	0	5	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1998	63	2					613	624		10.1086/301949	http://dx.doi.org/10.1086/301949			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	110CB	9683581	Green Published, Bronze			2022-12-18	WOS:000075360800037
J	Sakul, H; Pratley, R; Cardon, L; Ravussin, E; Mott, D; Bogardus, C				Sakul, H; Pratley, R; Cardon, L; Ravussin, E; Mott, D; Bogardus, C			Familiar ty of physical and metabolic characteristics that predict the development of non-insulin-dependent diabetes mellitus in pima Indians	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MAXIMUM-LIKELIHOOD; MALE TWINS; BODY-FAT; RESISTANCE; OBESITY; LINKAGE; CONCORDANCE; POPULATION	Susceptibility to non-insulin-dependent diabetes mellitus (NIDDM) is largely genetically determined. In Pima Indians, obesity, insulin resistance, and a low acute insulin response (AIR) to an intravenous glucose infusion are each predictors of the disease. To ascertain whether these phenotypes are genetically determined, we estimated their familiality in nondiabetic Pima Indians with a maximum-likelihood method. Percentage body fat (PFAT) was highly familial (h(2) = .76), whereas waist/thigh circumference ratio (WIT ratio) was not significantly familial after controlling for PFAT (h(2) = .16). AIR was also highly familial (h(2) = .80 at 10 min), even after controlling for PFAT and insulin action (h(2) = .70). Insulin action at physiologic plasma insulin concentrations was familial(h(2) = .61) but less so after controlling for PFAT and W/T ratio (h(2) = .38). At maximally stimulating insulin concentrations, insulin action was familial (h(2) = .45) and was less influenced by controlling for PFAT and W/T ratio (h(2) = .49). We conclude that in Pima Indians (1) PFAT and ATR are highly familial traits, (2) central distribution of fat is not a familial trait when controlled for PFAT, (3) 38%-49% of the variance in insulin action, independent of the effect of obesity, is familial, and (4) PFAT, AIR, and insulin action are useful traits to study genetic susceptibility to NIDDM. Because genetic parameter estimates are applicable only to the populations from which they were estimated, it is important to determine whether these estimates of familialities in Pima Indians can be confirmed in other populations before the utility of these traits in searching for NIDDM susceptibility genes in those populations can be fully advocated.	NIDDKD, CLIN DIABET & NUTR SECT, NIH, PHOENIX, AZ 85016 USA; SEQUANA THERAPEUT INC, LA JOLLA, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Ravussin, Eric/N-1985-2017; Steib, Lori/B-6628-2014	Ravussin, Eric/0000-0003-2129-547X; Steib, Lori/0000-0001-8274-318X				BAIER LJ, 1995, J CLIN INVEST, V95, P1281, DOI 10.1172/JCI117778; BEST JD, 1981, DIABETES, V30, P847, DOI 10.2337/diabetes.30.10.847; BOGARDUS C, 1989, DIABETES, V38, P1423, DOI 10.2337/diabetes.38.11.1423; Bogardus Clifton, 1996, P459; Boldman K. G., 1993, MANUAL USE MTDFREML; BORECKI IB, 1995, OBES RES, V3, P1; BOUCHARD C, 1988, INT J OBESITY, V12, P205; CARMELLI D, 1994, AM J HUM GENET, V55, P566; CHEN M, 1976, J CLIN ENDOCR METAB, V42, P1168, DOI 10.1210/jcem-42-6-1168; FALCONER DS, 1985, INTRO QUANTITATIVE G; GOTTESMAN I, 1983, AM J PHYSIOL, V244, pE632, DOI 10.1152/ajpendo.1983.244.6.E632; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HASSTEDT SJ, 1994, PEDIGREE ANAL PACKAG; HENDERSON CR, 1950, ANN MATH STAT, V21, P309; JANSSEN RC, 1994, DIABETES, V43, P558, DOI 10.2337/diabetes.43.4.558; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; KNOWLER WC, 1991, AM J CLIN NUTR, V53, pS1543, DOI 10.1093/ajcn/53.6.1543S; LILLIOJA S, 1991, J CLIN ENDOCR METAB, V73, P866, DOI 10.1210/jcem-73-4-866; LILLIOJA S, 1988, DIABETES METAB REV, V4, P517, DOI 10.1002/dmr.5610040508; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; LILLIOJA S, 1987, DIABETES, V36, P1329, DOI 10.2337/diabetes.36.11.1329; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; NORMAN RA, 1995, J CLIN INVEST, V96, P158, DOI 10.1172/JCI118016; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.2307/2334389; SCHUMACHER MC, 1992, DIABETES, V41, P416, DOI 10.2337/diabetes.41.4.416; SELBY JV, 1989, HUM BIOL, V61, P179; SMITH SP, 1986, J DAIRY SCI, V69, P1156, DOI 10.3168/jds.S0022-0302(86)80516-1; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; THOMPSON DB, 1995, DIABETES, V44, P478, DOI 10.2337/diabetes.44.4.478; *WHO STUD GROUP, 1985, ORGAN TECH REP SER, V727, P9	31	88	93	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	1997	60	3					651	656						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WK403	9042926				2022-12-18	WOS:A1997WK40300023
J	McInnis, MG				McInnis, MG			Anticipation: An old idea in new genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material							BIPOLAR AFFECTIVE-DISORDER; EXPANDED CAG REPEATS; AGE-OF-ONSET; MYOTONIC-DYSTROPHY; PARKINSONS-DISEASE; CTG REPEAT; SCHIZOPHRENIA; EXPANSION; MUTATIONS; FAMILIES				McInnis, MG (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,600 N WOLFE ST,BALTIMORE,MD 21287, USA.		McInnis, Melvin G/F-6963-2012	McInnis, Melvin G/0000-0002-0375-6247				ASHERSON P, 1994, BRIT J PSYCHIAT, V164, P619, DOI 10.1192/bjp.164.5.619; BASSETT AS, 1994, AM J HUM GENET, V54, P864; Bayertz K., 1994, GENETHICS; BELL J, 1947, TREASURY HUMAN INHER, V4, P343; BLEYL S, 1995, AM J HUM GENET, V56, P408; BONIFATI V, 1995, CAN J NEUROL SCI, V22, P272, DOI 10.1017/S0317167100039469; BORGAONKAR DS, 1974, PROG MED GENET, V10, P135; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cheng JT, 1996, NEUROLOGY, V47, P215, DOI 10.1212/WNL.47.1.215; ENGSTROM C, 1995, J AFFECT DISORDERS, V35, P31, DOI 10.1016/0165-0327(95)00035-L; Filla A, 1996, AM J HUM GENET, V59, P554; Fleiseher B., 1918, ALBRECHT GRAEFES ARC, V96, P91, DOI DOI 10.1007/BF02018704; FREIDLANDER R, 1973, THESIS U CALIFORNIA; Galton Francis, 1909, ESSAYS EUGENICS; GISPERT S, 1995, AM J HUM GENET, V56, P183; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; HODGE SE, 1995, PSYCHIATR GENET, V5, P43, DOI 10.1097/00041444-199521000-00007; HOLMBERG M, 1995, HUM MOL GENET, V4, P1441, DOI 10.1093/hmg/4.8.1441; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; KOIDE R, 1994, NAT GENET, V6, P9, DOI 10.1038/ng0194-9; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lezin A, 1996, HUM GENET, V97, P671; LINDBLAD K, 1995, NEUROBIOL DIS, V2, P55, DOI 10.1006/nbdi.1995.0006; LINDBLAD K, 1996, ACTA PAEDIAT, P265; Lombroso C., 1911, CRIME ITS CAUSES REM; LOYD JE, 1995, AM J RESP CRIT CARE, V152, P93, DOI 10.1164/ajrccm.152.1.7599869; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MAUDSLEY H, 1890, PATHOLOGY MIND; MCINNIS MG, 1993, AM J HUM GENET, V53, P385; MCINNIS MG, 1994, AM J HUM GENET, V55, P590; Morel BA, 1857, TRAITE DEGENERESCENC; MORRIS AG, 1995, HUM MOL GENET, V4, P1957, DOI 10.1093/hmg/4.10.1957; MORRISON AW, 1995, J LARYNGOL OTOL, V109, P499, DOI 10.1017/S0022215100130567; Mott FW, 1911, LANCET, V1, P1251; NewburyEcob RA, 1996, J MED GENET, V33, P300, DOI 10.1136/jmg.33.4.300; NYLANDER PO, 1994, J MED GENET, V31, P686, DOI 10.1136/jmg.31.9.686; ODONOVAN MC, 1995, NAT GENET, V10, P380, DOI 10.1038/ng0895-380; ORR HT, 1993, NAT GENET, V4, P221, DOI 10.1038/ng0793-221; PENROSE LS, 1948, ANN EUGENIC, V14, P125; Peral B, 1996, HUM MOL GENET, V5, P539, DOI 10.1093/hmg/5.4.539; Pick, 1989, FACES DEGENERATION; PIERPONT JW, 1995, CLIN GENET, V47, P139; PLANTEBORDENEUVE V, 1995, J NEUROL SCI, V133, P164, DOI 10.1016/0022-510X(95)00190-D; Polito JMII, 1996, LANCET, V347, P798, DOI 10.1016/S0140-6736(96)90870-3; PRESCIUTTINI S, 1994, ANN HUM GENET, V58, P331, DOI 10.1111/j.1469-1809.1994.tb00730.x; RANEN NG, 1995, AM J HUM GENET, V57, P593; ROSS CA, 1993, TRENDS NEUROSCI, V16, P254, DOI 10.1016/0166-2236(93)90175-L; SCHEFFER IE, 1995, ANN NEUROL, V38, P633, DOI 10.1002/ana.410380412; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Thibaut F, 1995, PSYCHIAT RES, V59, P25, DOI 10.1016/0165-1781(95)02778-5; Thom D., 1996, TROUBLED HELIX SOCIA, p[211, 228]; Trenkwalder C, 1996, MOVEMENT DISORD, V11, P389, DOI 10.1002/mds.870110407; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VOGEL F, 1986, HUMAN GENETICS; ZATZ M, 1995, AM J HUM GENET, V56, P99; 1993, CELL, V72, P971	59	88	91	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1996	59	5					973	979						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VN900	8900222				2022-12-18	WOS:A1996VN90000001
J	Bjorses, P; Aaltonen, J; Vikman, A; Perheentupa, J; BenZion, G; Chiumello, G; Heideman, P; HoorwegNijman, JJG; Mathivon, L; Mullis, PE; Pohl, M; Ritzen, M; Romeo, G; Shapiro, MS; Smith, CS; Solyom, J; Zlotogora, J; Peltonen, L				Bjorses, P; Aaltonen, J; Vikman, A; Perheentupa, J; BenZion, G; Chiumello, G; Heideman, P; HoorwegNijman, JJG; Mathivon, L; Mullis, PE; Pohl, M; Ritzen, M; Romeo, G; Shapiro, MS; Smith, CS; Solyom, J; Zlotogora, J; Peltonen, L			Genetic homogeneity of autoimmune polyglandular disease type I	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; CHROMOSOME-21; LOCUS; ASSIGNMENT; DNA	Autoimmune polyglandular disease type I (APECED) is an autosomal recessive autoimmune disease (MIM 240300) characterized by hypoparathyroidism, primary adrenocortical failure, and chronic mucocutaneous candidiasis. The disease is highly prevalent in two isolated populations, the Finnish population and the Iranian Jewish one. Sporadic cases have been identified in many other countries, including almost all European countries. The APECED locus has previously been assigned to chromosome 21q22.3 by linkage analyses in 14 Finnish families. Locus heterogeneity is a highly relevant question in this disease affecting multiple tissues and with great phenotypic diversity. To solve this matter, we performed linkage and haplotype analyses on APECED families rising from different populations. Six microsatellite markers on the critical chromosomal region of 2.6 cM on 21q22.3 were analyzed. Pairwise linkage analyses revealed significant LOD scores for all these markers, maximum LOD score being 10.23. The obtained haplotype data and the geographic distribution of the great-grandparents of the Finnish APECED patients suggest the presence of one major, relatively old mutation responsible for similar to 90% of the Finnish cases. Similar evidence for one founder mutation was also found in analyses of Iranian Jewish APECED haplotypes. These haplotypes, however, differed totally from the Finnish ones. The linkage analyses in 21 non-Finnish APECED families originating from several European countries provided independent evidence for linkage to the same chromosomal region on 21q22.3 and revealed no evidence for locus heterogeneity. The haplotype analyses of APECED chromosomes suggest that in different populations APECED is due to a spectrum of mutations in a still unknown gene on chromosome 21.	NATL PUBL HLTH INST,DEPT MOL GENET,FIN-00300 HELSINKI,FINLAND; UNIV HELSINKI,CHILDRENS HOSP,FIN-00014 HELSINKI,FINLAND; SCHNEIDER CHILDRENS MED CTR ISRAEL,DEPT PEDIAT,PETAH TIQWA,ISRAEL; UNIV MILAN,PEDIAT CLIN,MILAN,ITALY; UNIV HOSP,DEPT CLIN GENET & PEDIAT,UPPSALA,SWEDEN; UNIV MUNICH,LEHRKRANKENHAUS,KINDERKLIN,MUNICH,GERMANY; VRIJE UNIV AMSTERDAM,ACAD ZIEKENHUIS,AFDELING KINDERGENEESKUNDE,AMSTERDAM,NETHERLANDS; HOP ST VINCENT DE PAUL,ASSISTANCE PUBL HOSP PARIS,PARIS,FRANCE; UNIV BERN,DEPT PEDIAT,BERN,SWITZERLAND; UNIV FREIBURG,KINDERKLIN,D-7800 FREIBURG,GERMANY; KAROLINSKA HOSP,PEDIAT ENDOCRINOL UNIT,S-10401 STOCKHOLM,SWEDEN; MEIR HOSP,ENDOCRINE UNIT,KVAR SAAVA,ISRAEL; IST GIANNINA GASLINI,MOL GENET LAB,I-16148 GENOA,ITALY; ALDER HEY CHILDRENS HOSP,LIVERPOOL L12 2AP,MERSEYSIDE,ENGLAND; SEMMELWEIS UNIV MED,DEPT PEDIAT 2,H-1085 BUDAPEST,HUNGARY; HADASSAH MED ORG,DEPT HUMAN GENET,JERUSALEM,ISRAEL	Finland National Institute for Health & Welfare; University of Helsinki; University of Milan; Uppsala University; Uppsala University Hospital; University of Munich; Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Bern; University of Freiburg; Karolinska Institutet; Karolinska University Hospital; Tel Aviv University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; Semmelweis University; Hebrew University of Jerusalem; Hadassah University Medical Center								AALTONEN J, 1994, NAT GENET, V8, P83, DOI 10.1038/ng0994-83; AHONEN P, 1985, CLIN GENET, V27, P535, DOI 10.1111/j.1399-0004.1985.tb02037.x; AHONEN P, 1990, NEW ENGL J MED, V322, P1829, DOI 10.1056/NEJM199006283222601; AHONEN P, 1988, J CLIN ENDOCR METAB, V66, P1152, DOI 10.1210/jcem-66-6-1152; IKONEN E, 1991, P NATL ACAD SCI USA, V88, P11222, DOI 10.1073/pnas.88.24.11222; JARVELA I, 1991, GENOMICS, V10, P333, DOI 10.1016/0888-7543(91)90316-7; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LAWRENCE S, 1993, P NATL ACAD SCI USA, V90, P7210, DOI 10.1073/pnas.90.15.7210; LEHESJOKI AE, 1993, HUM MOL GENET, V2, P1229, DOI 10.1093/hmg/2.8.1229; McKusick V.A., 1992, MENDELIAN INHERITANC; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NIKALI K, 1995, AM J HUM GENET, V56, P1088; Norio R., 1981, BIOCULTURAL ASPECTS, P359; Ott J., 1991, ANAL HUMAN GENETIC L; SAVUKOSKI M, 1994, AM J HUM GENET, V55, P695; SCHLEUTKER J, 1995, GENOMICS, V27, P1; TERWILLIGER JD, 1995, AM J HUM GENET, V56, P777; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; Varilo T, 1996, AM J HUM GENET, V58, P506; ZLOTOGORA J, 1992, J MED GENET, V29, P824, DOI 10.1136/jmg.29.11.824	21	88	95	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1996	59	4					879	886						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL283	8808604				2022-12-18	WOS:A1996VL28300018
J	Sutherland, HF; Wadey, R; McKie, JM; Taylor, C; Atif, U; Johnstone, KA; Halford, S; Kim, UJ; Goodship, J; Baldini, A; Scambler, PJ				Sutherland, HF; Wadey, R; McKie, JM; Taylor, C; Atif, U; Johnstone, KA; Halford, S; Kim, UJ; Goodship, J; Baldini, A; Scambler, PJ			Identification of a novel transcript disrupted by a balanced translocation associated with DiGeorge syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CARDIO-FACIAL SYNDROME; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; CAMPOMELIC DYSPLASIA; BITHORAX COMPLEX; XIST GENE; HUMAN DNA; 22Q11; REGION; MICRODELETIONS	Most cases of DiGeorge syndrome (DGS) and related abnormalities are associated with deletions within 22q11. Shortest region of deletion overlap (SRO) mapping previously identified a critical region (the DGCR) of 500 kb, which was presumed to contain a gene or genes of major effect in the haploinsufficiency syndromes. The DGCR also contains sequences disrupted by a balanced translocation that is associated with DGS-the ADU breakpoint. We have cloned sequences at the breakpoint and screened for novel genes in its vicinity. A series of alternatively spliced transcripts expressed during human and murine embryogenesis, but with no obvious protein encoding potential, were identified. The gene encoding these RNAs has been named DGCR5 and it is disrupted by the patient ADU breakpoint. DGCR5 is distinct from the DGCR3 open reading frame (ORF) previously shown to be interrupted by the ADU translocation, although DGCR3 is embedded within a DGCR5 intron and in the same (predicted) transcriptional orientation. No mutations of DGCR5 have yet been detected. By analogy to other loci encoding conserved, nontranslated RNAs, it is possible that DGCR5 originates from a cis-acting transcriptional control element in the vicinity of the ADU/VDU breakpoint. Disruption of such an element would result in altered transcription of neighboring genes secondary to a position effect, a hypothesis in keeping with recent refinement of the SRO placing the ADU breakpoint outside the DGCR.	INST CHILD HLTH, MOL MED UNIT, LONDON WC1N 1EH, ENGLAND; CALTECH, DIV BIOL, PASADENA, CA 91125 USA; UNIV NEWCASTLE UPON TYNE, DIV HUMAN GENET, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND; BAYLOR COLL MED, MOL GENET INST T936, HOUSTON, TX 77030 USA	University of London; University College London; California Institute of Technology; Newcastle University - UK; Baylor College of Medicine			Scambler, Peter/AAZ-6026-2020; Halford, Stephanie/AAJ-1375-2020; Clelland, Catherine/AAZ-8551-2021; genes, anthony/F-2541-2012; Scambler, Peter J/C-4998-2008; Baldini, Antonio/M-2355-2015	Scambler, Peter/0000-0002-1487-4628; Halford, Stephanie/0000-0003-2179-907X; Scambler, Peter J/0000-0002-1487-4628; Johnstone, Karen/0000-0002-3183-8397; Baldini, Antonio/0000-0002-5330-0256	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; AUGUSSEAU S, 1986, HUM GENET, V74, P206, DOI 10.1007/BF00282098; BENTLEY DR, 1992, GENOMICS, V12, P534, DOI 10.1016/0888-7543(92)90445-X; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BUDARF ML, 1995, NAT GENET, V10, P269, DOI 10.1038/ng0795-269; BURN J, 1993, J MED GENET, V30, P822, DOI 10.1136/jmg.30.10.822; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; CUMBERLEDGE S, 1990, P NATL ACAD SCI USA, V87, P3259, DOI 10.1073/pnas.87.9.3259; DEMCZUK S, 1995, HUM MOL GENET, V4, P551, DOI 10.1093/hmg/4.4.551; DRISCOLL DA, 1992, AM J MED GENET, V44, P261, DOI 10.1002/ajmg.1320440237; DRISCOLL DA, 1992, AM J HUM GENET, V50, P924; EMI M, 1988, GENE, V62, P229, DOI 10.1016/0378-1119(88)90561-6; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; GIANNOTTI A, 1994, AM J MED GENET, V53, P303, DOI 10.1002/ajmg.1320530320; HALFORD S, 1993, HUM MOL GENET, V2, P2099, DOI 10.1093/hmg/2.12.2099; HALFORD S, 1993, HUM MOL GENET, V2, P191, DOI 10.1093/hmg/2.2.191; HOGAN NC, 1994, J CELL BIOL, V125, P21, DOI 10.1083/jcb.125.1.21; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; KIM UJ, 1992, NUCLEIC ACIDS RES, V20, P1083, DOI 10.1093/nar/20.5.1083; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; LEVY A, 1995, HUM MOL GENET, V4, P2417, DOI 10.1093/hmg/4.12.2417; LINDSAY EA, 1993, GENOMICS, V17, P403, DOI 10.1006/geno.1993.1339; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; MCDONALDMCGINN DM, 1995, AM J MED GENET, V59, P103, DOI 10.1002/ajmg.1320590122; Ninomiya S, 1996, HUM MOL GENET, V5, P69, DOI 10.1093/hmg/5.1.69; RAVNIKGLAVAC M, 1994, HUM MOL GENET, V3, P801, DOI 10.1093/hmg/3.5.801; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; SARGENT CA, 1994, MAMM GENOME, V5, P791, DOI 10.1007/BF00292015; SCAMBLER PJ, 1991, GENOMICS, V10, P201, DOI 10.1016/0888-7543(91)90501-5; SCAMBLER PJ, 1992, LANCET, V339, P1138, DOI 10.1016/0140-6736(92)90734-K; WADEY R, 1995, HUM MOL GENET, V4, P1027, DOI 10.1093/hmg/4.6.1027; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; WEVRICK R, 1994, HUM MOL GENET, V3, P1877, DOI 10.1093/hmg/3.10.1877; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852	38	88	91	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL	1996	59	1					23	31						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	VL455	8659529				2022-12-18	WOS:A1996VL45500005
J	STEIN, J; MULLIKEN, JB; STAL, S; GASSER, DL; MALCOLM, S; WINTER, R; BLANTON, SH; AMOS, C; SEEMANOVA, E; HECHT, JT				STEIN, J; MULLIKEN, JB; STAL, S; GASSER, DL; MALCOLM, S; WINTER, R; BLANTON, SH; AMOS, C; SEEMANOVA, E; HECHT, JT			NONSYNDROMIC CLEFT-LIP WITH OR WITHOUT CLEFT-PALATE - EVIDENCE OF LINKAGE TO BCL3 IN 17 MULTIGENERATIONAL FAMILIES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CANDIDATE PROTOONCOGENE BCL-3; AUTOSOMAL MAJOR LOCUS; KAPPA-B P50; SEGREGATION ANALYSIS; POLYMORPHISM; BINDING; ENCODES; INDIA	Nonsyndromic cleft lip with or without cleft palate (CL/P) is a common craniofacial developmental defect. Recent segregation analyses have suggested that major genes play a role in the etiology of CL/P. Linkage to 22 candidate genes was tested in 11 multigenerational families with CL/P, and 21 of these candidates were excluded. APOC2, 19q13.1, which is linked to the proto-oncogene BCL3, gave suggestive evidence for linkage to CL/P. The study was expanded to include a total of 39 multigenerational CL/P families. Linkage was tested in all families, using an anonymous marker, D19S178, and intragenic markers in BCL3 and APOC2. Linkage was rested under two models, autosomal dominant with reduced penetrance and affecteds only. Homogeneity testing on the two-point data gave evidence of heterogeneity at APOC2 under the affecteds-only model. Both models showed evidence of heterogeneity, with 43% of families linked at zero recombination to BCL3 when marker data from BCL3 and APOC2 were included. A maximum multipoint LOD score of 7.00 at BCL3 was found among the 17 families that had posterior probabilities greater than or equal to 50% in favor of linkage. The transmission disequilibrium test provided additional evidence for linkage with the 3 allele of BCL3 more often transmitted to affected children. These results suggest that BCL3, or a nearby gene, plays a role in the etiology of CL/P in some families.	UNIV TEXAS,SCH MED,DEPT PEDIAT,HOUSTON,TX 77225; TEXAS CHILDRENS HOSP,HOUSTON,TX 77030; UNIV TEXAS,MD ANDERSON CANC CTR,HOUSTON,TX; CHILDRENS HOSP,BOSTON,MA; UNIV PENN,SCH MED,PHILADELPHIA,PA 19104; INST CHILD HLTH,LONDON,ENGLAND; UNIV VIRGINIA,CHARLOTTESVILLE,VA; UNIV HOSP PRAGUE,PRAGUE,CZECH REPUBLIC	University of Texas System; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Boston Children's Hospital; University of Pennsylvania; University of London; University College London; University of Virginia; General University Hospital Prague			Blanton, Susan Halloran/ABF-1323-2021		NCI NIH HHS [CA16672] Funding Source: Medline; NIDCR NIH HHS [5R29 DE09954-03, DE09164] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE009954, P50DE009164] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ADAMSON ED, 1987, DEVELOPMENT, V99, P449; BLANCO R, 1993, REV MED CHILE, V121, P1258; BUETOW KH, 1994, SCIENCE, V265, P2050; CARINCI F, 1995, AM J HUM GENET, V56, P337; CHUNG CS, 1986, AM J HUM GENET, V39, P603; DAVIES AF, 1995, HUM MOL GENET, V4, P121; DEPAEPE A, 1989, J MED GENET, V26, P794, DOI 10.1136/jmg.26.12.794; DIXON WJ, 1992, BMDP STATISTICAL SOF, V1; EIBERG H, 1987, CLIN GENET, V32, P129; FARRALL M, 1992, AM J HUM GENET, V50, P270; FERGUSON MWJ, 1992, J ANAT, V181, P219; FERGUSON MWJ, 1987, IRISH J MED SCI, V156, P309, DOI 10.1007/BF02951261; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FRASER FC, 1970, AM J HUM GENET, V22, P336; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; HATADA EN, 1992, P NATL ACAD SCI USA, V89, P2489, DOI 10.1073/pnas.89.6.2489; HECHT JT, 1993, AM J HUM GENET, V52, P1230; HECHT JT, 1991, AM J HUM GENET, V49, P674; HECHT JT, 1990, J MED GENET, V27, P597, DOI 10.1136/jmg.27.9.597; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARAZITA ML, 1992, AM J HUM GENET, V51, P648; MURRAY JC, 1994, SCIENCE, V265, P2049, DOI 10.1126/science.8091227; NEMANA LJ, 1992, AM J MED GENET, V42, P5, DOI 10.1002/ajmg.1320420103; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; NOLAN GP, 1993, MOL CELL BIOL, V13, P3557, DOI 10.1128/MCB.13.6.3557; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; OTT J, 1991, ANAL HUMAN LINKAGE; RAY AK, 1993, AM J HUM GENET, V52, P1006; RICE JP, IN PRESS GENET EPIDE; Sambrook J., 1989, MOL CLONING LAB MANU; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SMEETS HJM, 1991, GENOMICS, V9, P257, DOI 10.1016/0888-7543(91)90250-I; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; STEIN JD, 1995, J MED GENET, V32, P78, DOI 10.1136/jmg.32.1.78; STGEORGEHYSLOP PH, 1992, NUCLEIC ACIDS RES, V20, P927, DOI 10.1093/nar/20.4.927; STOLL C, 1992, AM J HUM GENET, V50, P870; TEMPLE K, 1989, J MED GENET, V26, P386, DOI 10.1136/jmg.26.6.386; VIKKULA M, 1995, CELL, P80431; VOLZ A, 1994, GENOMICS, V21, P464, DOI 10.1006/geno.1994.1302; WEBER JL, 1989, AM J HUM GENET, V44, P388	41	88	93	1	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1995	57	2					257	272						16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	RL771	7668251				2022-12-18	WOS:A1995RL77100008
J	SHERRAT, TG; VULLIAMY, T; DUBOWITZ, V; SEWRY, CA; STRONG, PN				SHERRAT, TG; VULLIAMY, T; DUBOWITZ, V; SEWRY, CA; STRONG, PN			EXON SKIPPING AND TRANSLATION IN PATIENTS WITH FRAMESHIFT DELETIONS IN THE DYSTROPHIN GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SOMATIC REVERSION SUPPRESSION; SKELETAL-MUSCLE; MOLECULAR-BASIS; MONOCLONAL-ANTIBODY; POSITIVE FIBERS; MESSENGER-RNA; DMD GENE; PROTEIN; SEQUENCE	Although many Duchenne muscular dystrophy patients have a deletion in the dystrophin gene which disrupts the translational reading frame, they express dystrophin in a small proportion of skeletal muscle fibers (''revertant fibers''). Antibody studies have shown, indirectly, that dystrophin synthesis in revertant fibers is facilitated by a frame-restoring mechanism; in the present study, the feasibility of mRNA splicing was investigated. Dystrophin transcripts were analyzed in skeletal muscle from individuals possessing revertant fibers and a frameshift deletion in the dystrophin gene. In each case a minor in-frame transcript was detected, in which exons adjacent to those deleted from the genome had been skipped. There appeared to be some correlation between the levels of in-frame transcripts and the predicted translation products. Low levels of alternatively spliced transcripts were also present in normal muscle. The results provide further evidence of exon skipping in the dystrophin gene and indicate that this may be involved in the synthesis of dystrophin by revertant fibers.	HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HAEMATOL,LONDON W12 0HS,ENGLAND	Imperial College London	SHERRAT, TG (corresponding author), HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT PAEDIAT & NEONATAL MED,NEUROMUSCULAR UNIT,LONDON W12 0NN,ENGLAND.							ABBS S, 1991, J MED GENET, V28, P304, DOI 10.1136/jmg.28.5.304; ARAHATA K, 1991, J NEUROL SCI, V101, P148, DOI 10.1016/0022-510X(91)90039-A; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; BAUMBACH LL, 1989, NEUROLOGY, V39, P465, DOI 10.1212/WNL.39.4.465; BEGGS AH, 1991, AM J HUM GENET, V49, P54; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; CHELLY J, 1990, CELL, V63, P1239, DOI 10.1016/0092-8674(90)90419-F; CHELLY J, 1991, J CLIN INVEST, V88, P1161, DOI 10.1172/JCI115417; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLERK A, 1992, DEVELOPMENT, V114, P395; DUBOWITZ V, 1989, MUSCLE BIOPSY MODERN; DUBOWITZ V, 1985, MUSCLE BIOPSY MODERN; DUBOWITZ V, 1989, COLOUR ATLAS MUSCLE; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; ERVASTI JM, 1991, J BIOL CHEM, V266, P9161; FANIN M, 1992, NEUROMUSCULAR DISORD, V2, P41, DOI 10.1016/0960-8966(92)90025-2; GANGOPADHYAY SB, 1992, AM J HUM GENET, V51, P562; GILLARD EF, 1989, AM J HUM GENET, V45, P507; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1990, J NEUROL SCI, V99, P9, DOI 10.1016/0022-510X(90)90195-S; KLEIN CJ, 1992, AM J HUM GENET, V50, P950; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LIECHTIGALLATI S, 1989, HUM GENET, V81, P343, DOI 10.1007/BF00283688; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALHOTRA SB, 1988, SCIENCE, V242, P755, DOI 10.1126/science.3055295; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; NICHOLSON LVB, 1989, J NEUROL SCI, V94, P137, DOI 10.1016/0022-510X(89)90224-4; NICHOLSON LVB, 1992, ACTA NEUROL SCAND, V86, P8, DOI 10.1111/j.1600-0404.1992.tb08046.x; NICHOLSON LVB, 1992, J MED GENET, V29, P892, DOI 10.1136/jmg.29.12.892; NICHOLSON LVB, 1989, J NEUROL SCI, V94, P125, DOI 10.1016/0022-510X(89)90223-2; PATEL K, 1988, J NEUROL SCI, V87, P315, DOI 10.1016/0022-510X(88)90256-0; ROBERTS RG, 1992, GENOMICS, V13, P942, DOI 10.1016/0888-7543(92)90005-D; ROBERTS RG, 1991, AM J HUM GENET, V49, P298; ROBERTS RG, 1992, P NATL ACAD SCI USA, V88, P39; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SEWRY CA, 1987, J NEUROL SCI, V81, P141, DOI 10.1016/0022-510X(87)90091-8; SHERRATT TG, 1992, BIOCHEM J, V287, P755, DOI 10.1042/bj2870755; SHIMIZU T, 1988, P JPN ACAD B-PHYS, V64, P205, DOI 10.2183/pjab.64.205; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; THEIN SL, 1991, BRIT J HAEMATOL, V79, P113, DOI 10.1111/j.1365-2141.1991.tb08016.x; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; ZUBRZYCKAGAARN EF, 1988, NATURE, V333, P466, DOI 10.1038/333466a0	45	88	109	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1007	1015						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213828				2022-12-18	WOS:A1993MC33300004
J	HARDING, AE; HOLT, IJ; SWEENEY, MG; BROCKINGTON, M; DAVIS, MB				HARDING, AE; HOLT, IJ; SWEENEY, MG; BROCKINGTON, M; DAVIS, MB			PRENATAL-DIAGNOSIS OF MITOCHONDRIAL DNA8993 T-]G DISEASE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							KEARNS-SAYRE SYNDROME; HEREDITARY OPTIC NEUROPATHY; GENETIC-HETEROGENEITY; DNA HETEROPLASMY; DELETIONS; MUTATION; NEURORETINOPATHY; SEGREGATION; TISSUES	We have previously described a family with a neurological syndrome comprising neurogenic muscle weakness, ataxia, retinitis pigmentosa, and variable sensory neuropathy, seizures, and mental retardation or dementia. This is associated with a heteroplasmic point mutation of mtDNA at bp 8993. The mother of a severely affected child underwent prenatal diagnosis in two further pregnancies. Analysis of chorionic villus samples showed a higher proportion of mutant mtDNA on both occasions, and this was reflected in the majority of fetal tissues, including brain and muscle. Prenatal diagnosis is a rational approach to the prevention of severe diseases caused by point mutations of mtDNA but is currently hampered by incomplete knowledge concerning the proportion of mutant mtDNA: its relationship to disease severity, how it may change during fetal and postnatal development, and its tissue distribution.			HARDING, AE (corresponding author), UNIV LONDON,INST NEUROL,DEPT CLIN NEUROL,LONDON,ENGLAND.			holt, ian/0000-0001-5468-0193				ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; HAMMANS SR, 1991, LANCET, V337, P1311, DOI 10.1016/0140-6736(91)92981-7; HOLT IJ, 1989, ANN NEUROL, V26, P699, DOI 10.1002/ana.410260603; HOLT IJ, 1990, AM J HUM GENET, V46, P428; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; LARSSON NG, 1990, PEDIATR RES, V28, P131, DOI 10.1203/00006450-199028020-00011; MCSHANE MA, 1991, AM J HUM GENET, V48, P39; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; OBERMAIERKUSSER B, 1990, BIOCHEM BIOPH RES CO, V169, P1007, DOI 10.1016/0006-291X(90)91994-4; Old JM, 1986, HUMAN GENETIC DISEAS, P1; PONZETTO C, 1990, J NEUROL SCI, V96, P207, DOI 10.1016/0022-510X(90)90133-8; SHANSKE S, 1990, NEUROLOGY, V40, P24, DOI 10.1212/WNL.40.1.24; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; VILKKI J, 1991, American Journal of Human Genetics, V48, P486; VILKKI J, 1990, AM J HUM GENET, V47, P95; VILKKI J, 1989, AM J HUM GENET, V45, P206; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; ZEVIANI M, 1991, LANCET, V338, P143, DOI 10.1016/0140-6736(91)90136-D; ZEVIANI M, 1991, AM J HUM GENET, V48, P203	22	88	88	0	3	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR	1992	50	3					629	633						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HH974	1539598				2022-12-18	WOS:A1992HH97400023
J	ZIELENSKI, J; MARKIEWICZ, D; RININSLAND, F; ROMMENS, J; TSUI, LC				ZIELENSKI, J; MARKIEWICZ, D; RININSLAND, F; ROMMENS, J; TSUI, LC			A CLUSTER OF HIGHLY POLYMORPHIC DINUCLEOTIDE REPEATS IN INTRON-17B OF THE CYSTIC-FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) GENE	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							POLYMERASE CHAIN-REACTION; ENZYMATIC AMPLIFICATION; DNA; IDENTIFICATION; MUTATIONS; CHROMOSOME; SEQUENCES; PROTEIN; INVITRO; REGION	A cluster of highly polymorphic dinucleotide repeats has been detected in intron 17b of the CFTR gene, 200 bp downstream from the preceding exon. At least 24 alleles, with sizes ranging from 7 to 56 units of a TA repeat, have been identified in a panel of 92 unrelated carriers of cystic fibrosis (CF). The common ones are those with 7, 30, and 31 dinucleotide units, with frequencies of .22, .19, and .12, respectively, among the non-CF chromosomes. Mendelian, codominant segregation of the alleles has been demonstrated in family studies, as expected. A less polymorphic dinucleotide (CA repeat) cluster has also been detected in a region 167 bp downstream from the TA repeat. The length of the CA repeat cluster varies from 11 to 17 dinucleotide units, and it appears to have an inverse relationship to that of the TA repeats. These dinucleotide repeats should be useful in genetic linkage studies, in counseling for CF families with unknown mutations, and in tracing the origins of the various mutant CF alleles.	HOSP SICK CHILDREN,RES INST,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,DEPT MOLEC GENET,TORONTO M5S 1A1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	TSUI, LC (corresponding author), HOSP SICK CHILDREN,RES INST,DEPT GENET,555 UNIV AVE,TORONTO M5G 1X8,ONTARIO,CANADA.		Tsui, Lap-chee/A-1081-2010		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034944] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK34944] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOWCOCK AM, 1989, NUCLEIC ACIDS RES, V17, P6855, DOI 10.1093/nar/17.17.6855; BOYLAN KB, 1990, GENOMICS, V6, P16, DOI 10.1016/0888-7543(90)90443-X; CHEHAB FF, 1991, AM J HUM GENET, V48, P223; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; CUTTING GR, 1990, NEW ENGL J MED, V323, P1685, DOI 10.1056/NEJM199012133232407; Cystic Fibrosis Genetic Anal Consortium, 1990, AM J HUM GENET, V47, P354; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; ECONOMOU EP, 1990, P NATL ACAD SCI USA, V87, P2951, DOI 10.1073/pnas.87.8.2951; FREUND AM, 1989, P NATL ACAD SCI USA, V86, P7465, DOI 10.1073/pnas.86.19.7465; GUILLERMIT H, 1990, HUM GENET, V85, P450, DOI 10.1007/BF02428306; HAMADA H, 1982, P NATL ACAD SCI-BIOL, V79, P6465, DOI 10.1073/pnas.79.21.6465; HANCOCK JM, 1990, NUCLEIC ACIDS RES, V18, P5949, DOI 10.1093/nar/18.20.5949; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kornberg A., 1980, DNA REPLICATION; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; LITT M, 1989, AM J HUM GENET, V44, P397; LUTY JA, 1990, AM J HUM GENET, V46, P776; MORRAL N, 1991, GENOMICS, V10, P692, DOI 10.1016/0888-7543(91)90454-M; MORRAL N, UNPUB HUM GENET; MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEMENZA GL, 1984, J BIOL CHEM, V259, P6045; SMITH CAB, 1986, ANN HUM GENET, V50, P163, DOI 10.1111/j.1469-1809.1986.tb01035.x; STOKER NG, 1985, NUCLEIC ACIDS RES, V13, P4613, DOI 10.1093/nar/13.13.4613; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; TSUI LC, 1986, COLD SPRING HARB SYM, V51, P325, DOI 10.1101/SQB.1986.051.01.038; VIDAUD M, 1990, HUM GENET, V85, P434, DOI 10.1007/BF02428302; WEBER JL, 1989, AM J HUM GENET, V44, P388; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; WILLIAMSON R, 1990, CYTOGENET CELL GENET, V55, P457, DOI 10.1159/000133027; ZIELENSKI J, 1991, GENOMICS, V10, P229, DOI 10.1016/0888-7543(91)90504-8; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	36	88	89	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1991	49	6					1256	1262						7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GU672	1720926				2022-12-18	WOS:A1991GU67200012
J	REISS, AL; FREUND, L; TSENG, JE; JOSHI, PK				REISS, AL; FREUND, L; TSENG, JE; JOSHI, PK			NEUROANATOMY IN FRAGILE-X FEMALES - THE POSTERIOR-FOSSA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AUTISM; INHERITANCE; HYPOPLASIA; DISABILITY; CARRIERS	The relative homogeneity of the neuropsychiatric phenotype in individuals with fragile (fra) X syndrome suggests that there are consistent central nervous system (CNS) abnormalities underlying the observed cognitive and behavioral abnormalities. In this study, the neuroanatomy of the posterior fossa and other selected CNS regions in 12 young fra X females were compared with those of a group of 12 age-, sex-, and IQ-matched females without evidence of the fra X syndrome. Fra X females were shown to have decreased size of the posterior cerebellar vermis and increased size of the fourth ventricle, findings that are identical to those previously reported for fra X males. When compared with fra X male and nonfra X control groups, the distribution of the posterior-vermis and fourth-ventricle variables for the fra X female group was intermediate. These results support the hypothesis that the fra X genetic abnormality leads to hypoplasia of the posterior cerebellar vermis, a neuroanatomical variation of potential importance to both developmental and neuropsychiatric syndromes.	JOHNS HOPKINS UNIV,SCH MED,BEHAV GENET RES CTR,BALTIMORE,MD 21205; JOHNS HOPKINS UNIV,SCH MED,DEPT PSYCHIAT,DIV CHILD PSYCHIAT,BALTIMORE,MD 21205	Johns Hopkins University; Johns Hopkins University	REISS, AL (corresponding author), KENNEDY INST,BEHAV GENET RES CTR,ROOM 507,550 N BROADWAY,BALTIMORE,MD 21205, USA.		Freund, Lisa/ABD-8855-2020	Freund, Lisa/0000-0003-2095-4023	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K11MH000726] Funding Source: NIH RePORTER; NICHD NIH HHS [HD24061] Funding Source: Medline; NIMH NIH HHS [MH00726] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AYLWARD E, IN PRESS J PSYCHIATR; BORGHGRAEF M, 1990, CLIN GENET, V37, P341; BROWN WT, 1986, AM J MED GENET, V23, P341, DOI 10.1002/ajmg.1320230126; COHEN IL, 1988, AM J MENT RETARD, V92, P436; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; COURCHESNE E, 1989, AM J ROENTGENOL, V153, P829, DOI 10.2214/ajr.153.4.829; CURATOLO P, 1982, NEUROPEDIATRICS, V13, P50; DUNN HG, 1962, JAM J MENT DEFIC, V67, P827; FREUND LS, 1991, AM J MED GENET, V38, P542, DOI 10.1002/ajmg.1320380409; HAGERMAN RJ, 1986, AM J MED GENET, V23, P375, DOI 10.1002/ajmg.1320230129; HAGERMAN RJ, 1983, FRAGILE X SYNDROME D, P83; KEMPER MB, 1988, AM J MED GENET, V30, P191, DOI 10.1002/ajmg.1320300118; KEMPER MB, 1986, AM J MED GENET, V23, P139, DOI 10.1002/ajmg.1320230109; LAIRD CD, 1987, GENETICS, V117, P587; MIEZEJESKI CM, 1986, NEUROPSYCHOLOGIA, V24, P405, DOI 10.1016/0028-3932(86)90026-6; MURAKAMI JW, 1989, ARCH NEUROL-CHICAGO, V46, P689, DOI 10.1001/archneur.1989.00520420111032; MUSUMECI SA, 1988, EPILEPSIA, V29, P41, DOI 10.1111/j.1528-1157.1988.tb05096.x; PROUTY LA, 1988, AM J MED GENET, V30, P123, DOI 10.1002/ajmg.1320300111; RASBAND W, 1990, IMAGE; REISS AL, 1990, J AM ACAD CHILD PSY, V29, P885, DOI 10.1097/00004583-199011000-00007; REISS AL, 1989, AM J HUM GENET, V45, P697; REISS AL, 1988, ARCH GEN PSYCHIAT, V45, P25; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; REISS AL, 1990, BIOL PSYCHIAT, V27, P223, DOI 10.1016/0006-3223(90)90652-I; REISS AL, 1991, BRAIN DYSFUNCTION, V3, P9; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; Sattler J. M., 1986, GUIDE ADMINISTERING, VFourth; SCHNITZLEIN HN, 1990, IMAGING ANATOMY HEAD, V2; SIMON VA, 1990, CURR OPIN PSYCHIATR, V3, P581; THEOBALD TM, 1987, AM J MED GENET, V28, P1, DOI 10.1002/ajmg.1320280102; VEENEMA H, 1987, J MED GENET, V24, P23, DOI 10.1136/jmg.24.1.23; WEBB T, 1989, FRAGILE X SYNDROME, P40; Wechsler D., 1997, WAIS 3 WECHSLER ADUL; WISNIEWSKI KE, 1985, ANN NEUROL, V18, P665, DOI 10.1002/ana.410180607	34	88	88	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	1991	49	2					279	288						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GA866	1867191				2022-12-18	WOS:A1991GA86600004
J	WILSON, AF; ELSTON, RC; TRAN, LD; SIERVOGEL, RM				WILSON, AF; ELSTON, RC; TRAN, LD; SIERVOGEL, RM			USE OF THE ROBUST SIB-PAIR METHOD TO SCREEN FOR SINGLE-LOCUS, MULTIPLE-LOCUS, AND PLEIOTROPIC EFFECTS - APPLICATION TO TRAITS RELATED TO HYPERTENSION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DOPAMINE-BETA-HYDROXYLASE; SODIUM-LITHIUM COUNTERTRANSPORT; O-METHYLTRANSFERASE ACTIVITY; BLOOD-PRESSURE; GENETIC-ANALYSIS; QUANTITATIVE TRAITS; THERMAL-STABILITY; MAJOR GENE; LINKAGE; PEDIGREES	Robust sib-pair linkage analysis can be used as a screening tool in the search for the potential involvement of single-loci, multiple-loci, and pleiotropic effects of single loci underlying phenotypic variation. Four large families were each ascertained through one adult white male with essential hypertension. The robust sib-pair method was used to screen these families for evidence of linkage between 39 quantitative traits related to hypertension and 25 genetic marker loci. All traits were analyzed on the untransformed, square-root and log-transformed scales. Among other findings, there is a suggestion of linkage between the 6-phosphogluconate dehydrogenase locus on chromosome 1p36 and mean fifth-phase diastolic blood pressure. There may also be linkage between the following markers and traits: the adenylate kinase-1 marker and/or the Lewis blood group marker and the traits height, weight, and biacromial breadth; the glyoxylase I marker and the traits upper-arm circumference and suprailiac skinfold thickness; the ABO blood group and adenylate kinase-1 markers on chromosome 9q34 and the third component of complement marker on chromosome 19p13 and dopamine-beta-hydroxylase; and the P1 blood group and the traits weight and 1-h postload serum glucose level.	WRIGHT STATE UNIV, SCH MED, DEPT COMMUNITY HLTH, DIV HUMAN BIOL, YELLOW SPRINGS, OH USA	University System of Ohio; Wright State University Dayton	WILSON, AF (corresponding author), LOUISIANA STATE UNIV, MED CTR, DEPT BIOMETRY & GENET, 1901 PERDIDO ST, NEW ORLEANS, LA 70112 USA.		Wilson, Alexander/C-2320-2009; Wilson, Alexander F./Q-6910-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028356, R01GM028356] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL28522, HL23194] Funding Source: Medline; NIGMS NIH HHS [GM28356] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMOS CI, 1989, GENET EPIDEMIOL, V6, P435, DOI 10.1002/gepi.1370060306; AMOS CI, 1988, THESIS LOUISIANA STA; BIRON P, 1975, EPIDEMIOLOGY CONTROL, P397; BLACKWELDER WC, 1982, COMMUN STAT A-THEOR, V11, P449, DOI 10.1080/03610928208828250; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; BONNEY GE, 1988, AM J HUM GENET, V43, P29; BORHANI NO, 1976, ACTA GENET MED GEMEL, V25, P137, DOI 10.1017/S0001566000014008; CARTER C, 1984, GENETIC EPIDEMIOLOGY, P79; CRAIG SP, 1988, CYTOGENET CELL GENET, V48, P48, DOI 10.1159/000132584; DADONE MM, 1984, AM J MED GENET, V17, P565, DOI 10.1002/ajmg.1320170304; DEMENAIS FM, 1989, PROG CLIN BIOL RES, V329, P201; DUNNETTE J, 1979, MOL PHARMACOL, V15, P649; DUNNETTE J, 1982, AM J HUM GENET, V34, P84; Elston R C, 1984, Genet Epidemiol, V1, P175, DOI 10.1002/gepi.1370010210; ELSTON RC, 1990, GENET EPIDEMIOL, V7, P17, DOI 10.1002/gepi.1370070104; Feinleib M, 1975, EPIDEMIOLOGY CONTROL, P3; GEORGE VT, 1987, GENET EPIDEMIOL, V4, P193, DOI 10.1002/gepi.1370040304; GOLDIN LR, 1980, AM J MED GENET, V6, P279, DOI 10.1002/ajmg.1320060405; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HASSTEDT SJ, 1989, AM J HUM GENET, V45, P917; HASSTEDT SJ, 1988, AM J HUM GENET, V43, P14; KHAN PM, 1984, CYTOGENET CELL GENET, V37, P71; MARAZITA ML, 1987, AM J MED GENET, V26, P511, DOI 10.1002/ajmg.1320260302; MCALPINE PJ, 1985, CYTOGENET CELL GENET, V40, P8, DOI 10.1159/000132168; MOLL PP, 1986, AM J HUM GENET, V38, P361; MORTON NE, 1990, GENET EPIDEMIOL, V7, P33, DOI 10.1002/gepi.1370070108; MORTON NE, 1980, HUM GENET, V53, P261; MYERS RH, 1990, AM J HUM GENET, V47, pA141; PENROSE LS, 1953, ANN EUGENIC, V18, P120; PICKERING G, 1968, HIGH BLOOD PRESSURE; RICE T, 1990, AM J HUM GENET, V46, P37; SIERVOGEL RM, 1983, YEARB PHYS ANTHROPOL, V26, P37; SIERVOGEL RM, 1984, AM J MED GENET, V19, P315, DOI 10.1002/ajmg.1320190214; SIERVOGEL RM, 1980, HYPERTENSION, V2, pI83, DOI 10.1161/01.HYP.2.4_Pt_2.I83; SIERVOGEL RM, 1984, NATIONAL HEART LUNG, P111; SLATTERY ML, 1988, GENET EPIDEMIOL, V5, P277, DOI 10.1002/gepi.1370050409; THOMAS CB, 1964, B JOHNS HOPKINS HOSP, V115, P245; THOMAS CB, 1955, ANN INTERN MED, V42, P90, DOI 10.7326/0003-4819-42-1-90; VANDERMOLEN R, 1970, AM HEART J, V79, P454, DOI 10.1016/0002-8703(70)90249-8; WILSON AF, 1988, AM J HUM GENET, V42, P160; WILSON AF, 1984, AM J MED GENET, V19, P525, DOI 10.1002/ajmg.1320190314; WILSON AF, 1990, AM J MED GENET, V35, P425, DOI 10.1002/ajmg.1320350321; ZLOTNIK LH, 1983, AM J MED GENET, V15, P307, DOI 10.1002/ajmg.1320150214	43	88	89	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1991	48	5					862	872						11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FK897	2018038				2022-12-18	WOS:A1991FK89700005
J	BLOCH, M; HAYDEN, MR				BLOCH, M; HAYDEN, MR			PREDICTIVE TESTING FOR HUNTINGTON DISEASE IN CHILDHOOD - CHALLENGES AND IMPLICATIONS - OPINION	AMERICAN JOURNAL OF HUMAN GENETICS			English	Editorial Material									UNIV BRITISH COLUMBIA,DEPT MED GENET,F168 UNIV HOSP,2211 WESBROOK MALL,VANCOUVER V6T 2B5,BC,CANADA	University of British Columbia			Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419				BRANDT J, 1989, JAMA-J AM MED ASSOC, V261, P3108, DOI 10.1001/jama.261.21.3108; CONNEALLY PM, 1989, GENOMICS, V5, P304, DOI 10.1016/0888-7543(89)90062-1; FAHY M, 1989, J MED GENET, V26, P353, DOI 10.1136/jmg.26.6.353; FOX S, 1988, AM J MED GENET, V32, P211; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HAYDEN MR, 1988, AM J HUM GENET, V43, P689; Hayden MR., 1981, HUNTINGTONS CHOREA, P45; MEISSEN GJ, 1988, NEW ENGL J MED, V318, P533; MORRIS M, 1988, LANCET, V2, P1069, DOI 10.1016/S0140-6736(88)90078-5; QUARRELL OWJ, 1987, LANCET, V1, P1281; WASMUTH JJ, 1988, NATURE, V332, P734, DOI 10.1038/332734a0	11	88	88	0	4	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1990	46	1					1	4						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CJ043	2136787				2022-12-18	WOS:A1990CJ04300001
J	LEPENDU, J; CARTRON, JP; LEMIEUX, RU; ORIOL, R				LEPENDU, J; CARTRON, JP; LEMIEUX, RU; ORIOL, R			THE PRESENCE OF AT LEAST 2 DIFFERENT H-BLOOD-GROUP-RELATED BETA-D-GAL ALPHA-2-L-FUCOSYLTRANSFERASES IN HUMAN-SERUM AND THE GENETICS OF BLOOD GROUP-H SUBSTANCES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CTR NATL TRANSFUS SANGUINE,BIOCHIM GENET LAB,F-75739 PARIS 15,FRANCE; UNIV ALBERTA,DEPT CHEM,EDMONTON T6G 2G2,ALBERTA,CANADA	University of Alberta	LEPENDU, J (corresponding author), HOP BROUSSAIS,INST IMMUNOBIOL,F-75674 PARIS 14,FRANCE.		Le Pendu, Jacques/F-4760-2013	Le Pendu, Jacques/0000-0002-4856-0387				BETTERIDGE A, 1983, 7TH P INT S GLYC, P749; BEYER TA, 1980, J BIOL CHEM, V255, P5373; CARTRON JP, 1978, J IMMUNOGENET, V5, P107; CHESTER MA, 1976, EUR J BIOCHEM, V69, P583, DOI 10.1111/j.1432-1033.1976.tb10944.x; CLAMAGIRANDMULET C, 1981, FEBS LETT, V126, P123, DOI 10.1016/0014-5793(81)81049-6; DONALD ASR, 1981, EUR J BIOCHEM, V120, P243, DOI 10.1111/j.1432-1033.1981.tb05695.x; HINDSGAUL O, 1982, CARBOHYD RES, V109, P109, DOI 10.1016/0008-6215(82)84034-2; JOHNSON PH, 1981, BIOCHEM BIOPH RES CO, V100, P1611, DOI 10.1016/0006-291X(81)90703-8; KUMAZAKI T, 1984, P NATL ACAD SCI-BIOL, V81, P4193, DOI 10.1073/pnas.81.13.4193; LEMIEUX RU, 1978, CHEM SOC REV, V7, P423, DOI 10.1039/cs9780700423; LEPENDU J, 1982, AM J HUM GENET, V34, P402; LEPENDU J, 1983, VOX SANG, V44, P360; LEPENDU J, 1983, AM J HUM GENET, V35, P484; LEPENDU J, 1983, 7TH P INT S GLYC, P748; MULET C, 1977, FEBS LETT, V84, P74, DOI 10.1016/0014-5793(77)81060-0; MULET C, 1978, FEBS LETT, V90, P233, DOI 10.1016/0014-5793(78)80375-5; ORIOL R, 1981, AM J HUM GENET, V33, P421; ORIOL R, 1980, TRANSPLANTATION, V29, P184, DOI 10.1097/00007890-198003000-00003; SCHENKELBRUNNER H, 1972, EUR J BIOCHEM, V30, P269, DOI 10.1111/j.1432-1033.1972.tb02095.x; SCUDDER PR, 1981, BIOCHIM BIOPHYS ACTA, V660, P128, DOI 10.1016/0005-2744(81)90117-0; Socha WW, 1983, BLOOD GROUPS PRIMATE; SOLOMON JM, 1965, BLOOD-J HEMATOL, V25, P470, DOI 10.1182/blood.V25.4.470.470; Watkins W M, 1980, Adv Hum Genet, V10, P1; WATKINS WM, 1978, REV FR TRANSFUS IMMU, V21, P201, DOI 10.1016/S0338-4535(78)80043-9	24	88	89	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	4					749	760						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	APR18	9556663				2022-12-18	WOS:A1985APR1800012
J	IMPRAIM, C; WANG, G; YOSHIDA, A				IMPRAIM, C; WANG, G; YOSHIDA, A			STRUCTURAL MUTATION IN A MAJOR HUMAN ALDEHYDE DEHYDROGENASE GENE RESULTS IN LOSS OF ENZYME-ACTIVITY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									CITY HOPE RES INST,DEPT BIOCHEM GENET,DUARTE,CA 91010	City of Hope					NHLBI NIH HHS [HL-15125] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CROW KE, 1974, BIOCHIM BIOPHYS ACTA, V350, P121, DOI 10.1016/0005-2744(74)90209-5; ECKFELDT JH, 1976, ARCH BIOCHEM BIOPHYS, V175, P717, DOI 10.1016/0003-9861(76)90564-6; GOEDDE HW, 1979, HUM GENET, V51, P331; GREENFIELD NJ, 1977, BIOCHIM BIOPHYS ACTA, V483, P35, DOI 10.1016/0005-2744(77)90005-5; HARADA S, 1979, H-S Z PHYSIOL CHEM, V360, P278; HARADA S, 1978, HUM GENET, V44, P181, DOI 10.1007/BF00295411; LAURELL CB, 1965, ANAL BIOCHEM, V10, P358, DOI 10.1016/0003-2697(65)90278-2; STAMATOYANNOPOULOS G, 1975, AM J HUM GENET, V27, P789; TENG YS, 1981, BIOCHEM GENET, V19, P107, DOI 10.1007/BF00486141; WOLFF PH, 1972, SCIENCE, V175, P449, DOI 10.1126/science.175.4020.449; WOLFF PH, 1973, AM J HUM GENET, V25, P193; YOSHIDA A, 1981, J BIOL CHEM, V256	12	88	89	0	6	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1982	34	6					837	841						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PU211	7180842				2022-12-18	WOS:A1982PU21100001
J	ALVESALO, L; TAMMISALO, E				ALVESALO, L; TAMMISALO, E			ENAMEL THICKNESS IN 45,X FEMALES PERMANENT TEETH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									UNIV KUOPIO,INST DENT,SF-70101 KUOPIO 10,FINLAND	University of Eastern Finland	ALVESALO, L (corresponding author), UNIV TURKU,INST DENT,SF-20500 TURKU 50,FINLAND.							ALVESALO L, 1979, ANN HUM GENET, V43, P97, DOI 10.1111/j.1469-1809.1979.tb02001.x; ALVESALO L, 1980, AM J HUM GENET, V32, P736; ALVESALO L, 1980, AM J HUM GENET, V32, P955; ALVESALO L, 1975, AM J HUM GENET, V27, P53; ALVESALO L, 1977, AM J HUM GENET, V29, P486; ALVESALO L, ANN HUM GENET; FILIPSSON R, 1965, ACTA ENDOCRINOL-COP, V48, P91, DOI 10.1530/acta.0.0480091; GARN SM, 1962, NATURE, V196, P695, DOI 10.1038/196695a0; GORLIN RJ, 1965, J DENT RES, V44, P269, DOI 10.1177/00220345650440012201; KARI M, 1980, J DENT RES, V59, P1382, DOI 10.1177/00220345800590080401; Kraus BS, 1965, HUMAN DENTITION BIRT; SHAPIRO BL, 1966, THESIS U MINNESOTA; Stewart RE, 1976, ORAL FACIAL GENETICS; TANNER JM, 1959, LANCET, V2, P141; [No title captured]	15	88	90	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1981	33	3					464	469						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	LT725	7246547				2022-12-18	WOS:A1981LT72500014
J	CASTILLA, E; PAZ, J; MUTCHINICK, O; MUNOZ, E; GIORGIUTTI, E; GELMAN, Z				CASTILLA, E; PAZ, J; MUTCHINICK, O; MUNOZ, E; GIORGIUTTI, E; GELMAN, Z			POLYDACTYLY - GENETIC STUDY IN SOUTH-AMERICA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									MED GENET CTR, BUENOS AIRES, ARGENTINA									ALTEMUS LA, 1965, PEDIATRICS, V36, P56; CASTILLA E, IN PRESS; CROW JF, 1961, PROGRESS MEDICAL GEN; FRAZIER TM, 1960, AM J OBSTET GYNECOL, V80, P184; GREBE H, 1963, GENETICA HUMANA, V2; HANDFORTH JR, 1950, ANAT REC, V106, P119, DOI 10.1002/ar.1091060202; MANDILOFF EO, 1931, AM J PHYS ANTHROPOL, V15, P503; MCKUSICK VA, 1967, J CHRON DIS, V20, P115, DOI 10.1016/0021-9681(67)90045-8; STEVENSON AC, 1966, B WHO              S, V34, P1; SVEDRUP A, 1922, J GENET, V12, P217; TEMTAMY S, 1969, BIRTH DEFECTS OAS, V5; WOOLF CM, 1970, AM J HUM GENET, V22, P75	12	88	89	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	4					405	412						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	Q0158	4716659				2022-12-18	WOS:A1973Q015800007
J	CAVALLISFORZA, LL				CAVALLISFORZA, LL			SOME CURRENT PROBLEMS OF HUMAN POPULATION GENETICS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Review									STANFORD UNIV, SCH MED, DEPT GENET, STANFORD, CA 94305 USA	Stanford University								AMMERMAN AJ, 1971, MAN, V6, P674, DOI 10.2307/2799190; AMMERMAN AJ, 1973, 1971 P RES SEM ARCH; AZEVEDO E, 1969, AM J HUM GENET, V21, P1; BARRAI I, 1964, HEREDITY, V19, P651, DOI 10.1038/hdy.1964.76; BODMER JG, 1970, AM J HUM GENET, V22, P396; BODMER W, 1973, 4 P INT C HUM GEN PA; BODMER WF, 1968, GENETICS, V59, P565; BODMER WF, 1973, 6 P BERK S MATH STAT; CANNINGS C, IN PRESS; Cavalli-Sforza L. L, 1971, MATH ARCHAEOLOGICAL, P535; Cavalli-Sforza Luigi., 1971, GENETICS HUMAN POPUL; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; CAVALLISFORZA LL, IN PRESS; CAVALLISFORZA LL, 1963, GENETICS TODAY; CAVALLISFORZA LL, 1968, 12 P INT C GEN TOKY, V3, P405; CAVALLISFORZA LL, 1967, 3 WORLD C HUM GEN P, P473; CHASE GA, 1972, AM J HUM GENET, V24, P339; DAMON A, 1969, SOC BIOL, V16, P69, DOI 10.1080/19485565.1969.9987804; DRONAMRAJU K. R., 1960, JOUR HEREDITY, V51, P239; EDWARDS AWF, 1965, BIOMETRICS, V21, P362, DOI 10.2307/2528096; EDWARDS AWF, 1970, J ROY STAT SOC B, V32, P155; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; FELSENSTEIN J, TO BE PUBLISHED; FITCH WM, 1969, AM J HUM GENET, V21, P384; FRANKLIN I, 1970, GENETICS, V65, P707; FRIEDLAENDER JS, 1971, P NATL ACAD SCI USA, V68, P704, DOI 10.1073/pnas.68.4.704; Gower J.C, 1971, MATH ARCHAEOLOGICAL, P138; HARRIS H, 1966, PROC R SOC SER B-BIO, V164, P298, DOI 10.1098/rspb.1966.0032; HARRIS H, 1972, ANN HUM GENET, V36, P9, DOI 10.1111/j.1469-1809.1972.tb00578.x; IMAIZUMI Y, 1970, GENETICS, V66, P569; KIDD KK, 1971, AM J HUM GENET, V23, P235; KIDD KK, 1971, MATHEMATICS ARCHAEOL, P319; KIDD KK, 1973, GENETIC DISTANCE; KIDD KK, 1973, 4 P INT C HUM GEN PA; KIMURA M, 1964, GENETICS, V49, P561; KIMURA M, 1954, GENETICS, V39, P280; LALOUEL JM, 1973, AM J HUM GENET, V25, P62; Lerner IM, 1954, GENETIC HOMEOSTASIS; LEWONTIN RC, 1966, GENETICS, V54, P595; LEWONTIN RC, IN PRESS; LITWIN SD, 1972, AM J HUM GENET, V24, pA45; MALECOT G, 1966, PROBABILITES HEREDIT; MALECOT G, 1969, MATHEMATICS HEREDITY; MALECOT G, 1950, ANN U LYON SCIENCE A, V13, P37; MCDEVITT HO, 1972, AM J MED, V52, P1, DOI 10.1016/0002-9343(72)90002-2; MORONI A, 1967, ARCH ANTROPOLOGIA ET, V98, P135; MORONI ANTONIO, 1967, ATTI ASS GENET ITAL, V12, P202; MORTON N E, 1971, Theoretical Population Biology, V2, P507, DOI 10.1016/0040-5809(71)90038-4; MORTON NE, 1960, AM J HUM GENET, V12, P348; MORTON NE, 1972, PROG MED GENET, V8, P103; MORTON NE, 1967, 3 P INT C HUM GEN CH, P249; Mourant A., 1954, DISTRIBUTION HUMAN B; MYRIANTHOPOULOS NC, 1972, AM J HUM GENET, V24, P341; MYRIANTHOPOULOS NC, 1966, AM J HUM GENET, V18, P313; NEEL JV, 1970, P NATL ACAD SCI USA, V67, P908, DOI 10.1073/pnas.67.2.908; OMENN GS, 1971, EXCERPTA MEDICA  233, P135; RANSOMEKUTI O, 1972, MAY P ANN M SOC PED; REICH T, IN PRESS; RENWICK JH, 1971, ANNU REV GENET, V5, P81, DOI 10.1146/annurev.ge.05.120171.000501; SCHULL WJ, 1972, AM J HUM GENET, V24, P425; Schull WJ, 1965, EFFECTS INBREEDING J; SGARAMELLAZONTA L, 1972, WORKSHOP POPULATION; SIMOONS FJ, 1970, AM J DIG DIS, V15, P695, DOI 10.1007/BF02235991; Sokal R, 1963, PRINCIPLES NUMERICAL; SPUHLER JN, IN PRESS; WAGENER DK, 1973, AM J HUM GENET, V25, P47; WARD RH, 1970, AM J HUM GENET, V22, P538; WEINER JS, 1972, ASSESSMENT POPULATIO; WELLS JV, 1971, J IMMUNOL, V107, P1505; WOLF AP, 1970, AM ANTHROPOL, V72, P503, DOI 10.1525/aa.1970.72.3.02a00010; WRIGHT S, 1946, GENETICS, V31, P39; YASUDA N, 1971, AM J HUM GENET, V23, P303; [No title captured]	74	88	89	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1973	25	1					82	104						23	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	O5774	4567614				2022-12-18	WOS:A1973O577400011
J	CHUNG, CS; MORTON, NE				CHUNG, CS; MORTON, NE			DISCRIMINATION OF GENETIC ENTITIES IN MUSCULAR DYSTROPHY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		ARBUSE DI, 1937, N YORK STATE J M, V37, P1111; ASMUNDSON V. S., 1956, JOUR HEREDITY, V47, P248; BARTLETT MS, 1951, ANN EUGENIC, V16, P199, DOI 10.1111/j.1469-1809.1951.tb02472.x; BATTEN FE, 1903, BRAIN, V26, P151; BECKER P E, 1957, Acta Genet Stat Med, V7, P303; BELL J, 1943, TREASURY HUMAN INHER, V4; BREGMAN LE, 1899, DEUT ZSCHR NERVENH, V14, P254; CHUNG CS, 1958, 10 P INT C GEN MONTR, V2, P51; DEGROUCHY J, 1953, CONTRIBUTION ETUDE H; Dystrophia musculorum progressiva, 1954, J AMER MED ASSOC, V154, DOI [10.1001/jama.1954.02940490080030, DOI 10.1001/JAMA.1954.02940490080030]; ERB W, 1884, DTSCH ARCH KLIN MED, V34, P467; ESHNER AA, 1902, PHILADELPHIA M J, V9, P1023; Fisher RA, 1938, ANN EUGENIC, V8, P376, DOI 10.1111/j.1469-1809.1938.tb02189.x; GROTHAUS E, 1935, ARCH KLIN CHIR, V181, P344; Herndon CN, 1953, RES PUBL ASSOC RES N, V33, P239; KLOEPFER HW, 1957, ANN HUM GENET, V22, P138, DOI 10.1111/j.1469-1809.1957.tb01928.x; KNOX WE, 1958, AM J HUM GENET, V10, P53; KOLLARITS J, 1906, DTSCH Z NERVENHEILK, V30, P293; KOSTAKOW S, 1938, DTSCH ARCH KLIN MED, V181, P611; Kryschowa N, 1934, Z GESAMTE NEUROL PSY, V150, P421, DOI 10.1007/BF02890922; LAMY MAURICE, 1954, JOUR GENET HUMAINE, V3, P219; LEVISON H, 1951, OPERA DOMO BIOL HERE, V26; MICHELSON AM, 1955, P NATL ACAD SCI USA, V41, P1079, DOI 10.1073/pnas.41.12.1079; Mills HP, 1924, ARCH NEURO PSYCHIATR, V11, P43, DOI 10.1001/archneurpsyc.1924.02190310049003; MORTON NE, 1957, AM J HUM GENET, V9, P55; MORTON NE, 1956, AM J HUM GENET, V8, P80; MORTON NE, 1959, AM J HUM GENET, V11, P360; MORTON NE, 1955, AM J HUM GENET, V7, P277; ORANSKY W., 1927, DEUTSCHE ZEITSCHR NERVENHEILK, V99, P147, DOI 10.1007/BF01669014; ORMEROD JA, 1903, BRAIN, V26, P144; Pearson K, 1933, ANN EUGENIC, V5, P179, DOI 10.1111/j.1469-1809.1933.tb02091.x; RACE RR, 1955, ANN HUM GENET, V20, P13; RAO CR, 1952, ADV STATISTICAL METH; RIESE W, 1922, DTSCH Z NERVENH, V75, P214; SJOVALL B, 1936, DYSTROPHIA MUSCULORU; STEVENSON A. C., 1955, ANN HUMAN GENETICS, V19, P159, DOI 10.1111/j.1469-1809.1955.tb01340.x; STEVENSON A. C., 1955, ANN HUMAN GENETICS, V19, P165, DOI 10.1111/j.1469-1809.1955.tb01341.x; STEVENSON AC, 1953, ANN EUGENIC, V18, P50; Stone S, 1940, J AMER MED ASSOC, V114, P2187; TYLER FH, 1950, ANN INTERN MED, V32, P72, DOI 10.7326/0003-4819-32-1-72; WALTON J N, 1957, Acta Genet Stat Med, V7, P318; WALTON JN, 1955, ANN HUM GENET, V20, P1, DOI 10.1111/j.1469-1809.1955.tb01274.x; WALTON JN, 1954, BRAIN, V77, P169, DOI 10.1093/brain/77.2.169; WALTON JN, 1956, ANN HUM GENET, V21, P40, DOI 10.1111/j.1469-1809.1971.tb00264.x; WINOCOUROFF J, 1907, ARCH KINDERHEILKD, V46, P109	45	88	88	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.		1959	11	4					339	359						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WF076	13810212				2022-12-18	WOS:A1959WF07600005
J	Rafehi, H; Szmulewicz, DJ; Bennett, MF; Sobreira, NLM; Pope, K; Smith, KR; Gillies, G; Diakumis, P; Dolzhenko, E; Eberle, MA; Barcina, MG; Breen, DP; Chancellor, AM; Cremer, PD; Delatycki, MB; Fogel, BL; Hackett, A; Halmagyi, GM; Kapetanovic, S; Lang, A; Mossman, S; Mu, WY; Patrikios, P; Perlman, SL; Rosemergy, I; Storey, E; Watson, SRD; Wilson, MA; Zee, DS; Valle, D; Amor, DJ; Bahlo, M; Lockhart, PJ				Rafehi, Haloom; Szmulewicz, David J.; Bennett, Mark F.; Sobreira, Nara L. M.; Pope, Kate; Smith, Katherine R.; Gillies, Greta; Diakumis, Peter; Dolzhenko, Egor; Eberle, Michael A.; Garcia Barcina, Maria; Breen, David P.; Chancellor, Andrew M.; Cremer, Phillip D.; Delatycki, Martin B.; Fogel, Brent L.; Hackett, Anna; Halmagyi, G. Michael; Kapetanovic, Solange; Lang, Anthony; Mossman, Stuart; Mu, Weiyi; Patrikios, Peter; Perlman, Susan L.; Rosemergy, Ian; Storey, Elsdon; Watson, Shaun R. D.; Wilson, Michael A.; Zee, David S.; Valle, David; Amor, David J.; Bahlo, Melanie; Lockhart, Paul J.			Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CEREBELLAR-ATAXIA; TANDEM REPEATS; GENE-EXPRESSION; NEUROPATHY; DISEASE; GENOME; ONSET; ASSOCIATION; MECHANISMS; PROGRAM	Genomic technologies such as next-generation sequencing (NGS) are revolutionizing molecular diagnostics and clinical medicine. However, these approaches have proven inefficient at identifying pathogenic repeat expansions. Here, we apply a collection of bioinformatics tools that can be utilized to identify either known or novel expanded repeat sequences in NGS data. We performed genetic studies of a cohort of 35 individuals from 22 families with a clinical diagnosis of cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome (CANVAS). Analysis of whole-genome sequence (WGS) data with five independent algorithms identified a recessively inherited intronic repeat expansion [(AAGGG)(exp)] in the gene encoding Replication Factor C1 (RFC1). This motif, not reported in the reference sequence, localized to an Alu element and replaced the reference (AAAAG)(11) short tandem repeat. Genetic analyses confirmed the pathogenic expansion in 18 of 22 CANVAS-affected families and identified a core ancestral haplotype, estimated to have arisen in Europe more than twenty-five thousand years ago. WGS of the four RFC1-negative CANVAS-affected families identified plausible variants in three, with genomic re-diagnosis of SCA3, spastic ataxia of the Charlevoix-Saguenay type, and SCA45. This study identified the genetic basis of CANVAS and demonstrated that these improved bioinformatics tools increase the diagnostic utility of WGS to determine the genetic basis of a heterogeneous group of clinically overlapping neurogenetic disorders.	[Rafehi, Haloom; Bennett, Mark F.; Smith, Katherine R.; Bahlo, Melanie] Walter & Eliza Hall Inst Med Res, Populat Hlth & Immun Div, 1G Royal Parade, Parkville, Vic 3052, Australia; [Rafehi, Haloom; Bennett, Mark F.; Bahlo, Melanie] Univ Melbourne, Dept Med Biol, 1G Royal Parade, Parkville, Vic 3052, Australia; [Szmulewicz, David J.] Alfred Hlth, Cerebellar Ataxia Clin, Dept Neurosci, Melbourne, Vic 3004, Australia; [Szmulewicz, David J.] Royal Victorian Eye & Ear Hosp, Balance Disorders & Ataxia Serv, East Melbourne, Vic 3002, Australia; [Bennett, Mark F.] Univ Melbourne, Austin Hlth, Dept Med, Epilepsy Res Ctr, 245 Burgundy St, Melbourne, Vic 3084, Australia; [Sobreira, Nara L. M.; Mu, Weiyi; Valle, David] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Pope, Kate; Gillies, Greta; Delatycki, Martin B.; Wilson, Michael A.; Amor, David J.; Lockhart, Paul J.] Murdoch Childrens Res Inst, Bruce Lefroy Ctr, Flemington Rd, Parkville, Vic 3052, Australia; [Diakumis, Peter] Univ Melbourne, Ctr Canc Res, Victorian Comprehens Canc Ctr, 305 Grattan St, Melbourne, Vic 3000, Australia; [Dolzhenko, Egor; Eberle, Michael A.] Illumina Inc, 5200 Illumina Way, San Diego, CA 92122 USA; [Garcia Barcina, Maria] Basurto Univ Hosp, OSI Bilbao Basurto, Genet Unit, Ave Montevideo 18, Bilbao 48013, Spain; [Breen, David P.] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh EH16 4SB, Midlothian, Scotland; [Breen, David P.] Univ Edinburgh, Anne Rowling Regenerat Neurol Clin, Edinburgh EH16 4SB, Midlothian, Scotland; [Breen, David P.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh EH16 4UX, Midlothian, Scotland; [Chancellor, Andrew M.] Tauranga Hosp, Dept Neurol, Cameron Rd, Tauranga 3171, New Zealand; [Cremer, Phillip D.] Univ Sydney, Camperdown, NSW 2006, Australia; [Cremer, Phillip D.] Royal North Shore Hosp, Pacific Hwy, St Leonards, NSW 2065, Australia; [Delatycki, Martin B.; Amor, David J.; Lockhart, Paul J.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Flemington Rd, Parkville, Vic 3052, Australia; [Fogel, Brent L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Fogel, Brent L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Hackett, Anna] Hunter New England Hlth Serv, Hunter Genet, Newcastle, NSW 2300, Australia; [Hackett, Anna] Univ Newcastle, Newcastle, NSW 2300, Australia; [Halmagyi, G. Michael] Royal Prince Alfred Hosp, Dept Neurol, Camperdown, NSW 2050, Australia; [Halmagyi, G. Michael] Univ Sydney, Cent Clin Sch, Camperdown, NSW 2050, Australia; [Kapetanovic, Solange] Hosp Basurto, Serv Neurol, Ave Montevideo 18, Bilbao 48013, Bizkaia, Spain; [Lang, Anthony] Toronto Western Hosp, Edmond J Safra Program Parkinson Dis, Toronto, ON M5T 2S8, Canada; [Lang, Anthony] Toronto Western Hosp, Morton & Gloria Shulman Movement Disorders Clin, Toronto, ON M5T 2S8, Canada; [Lang, Anthony] Univ Hlth Network, Div Neurol, Dept Med, Toronto, ON M5T 2S8, Canada; [Lang, Anthony] Univ Toronto, Toronto, ON M5T 2S8, Canada; [Mossman, Stuart] Wellington Hosp, Dept Neurol, Wellington 6021, New Zealand; [Patrikios, Peter] Sunshine Neurol, Maroochydore, Qld 4558, Australia; [Perlman, Susan L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Rosemergy, Ian] Wellington Hosp, Dept Neurol, Wellington 6021, New Zealand; [Storey, Elsdon] Monash Univ, Cent Clin Sch, Dept Neurosci, Alfred Hosp Campus,Commercial Rd, Melbourne, Vic 3004, Australia; [Watson, Shaun R. D.] Prince Wales Hosp, Inst Neurol Sci, Randwick, NSW 2031, Australia; [Zee, David S.] Johns Hopkins Univ Hosp, Dept Neurol, Baltimore, MD 21287 USA	Walter & Eliza Hall Institute; University of Melbourne; Royal Victorian Eye & Ear Hospital; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Johns Hopkins University; Murdoch Children's Research Institute; University of Melbourne; Illumina; Basurto Hospital; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Sydney; Royal North Shore Hospital; Royal Children's Hospital Melbourne; University of Melbourne; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Newcastle; University of Sydney; University of Sydney; Basurto Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Monash University; Johns Hopkins University; Johns Hopkins Medicine	Lockhart, PJ (corresponding author), Murdoch Childrens Res Inst, Bruce Lefroy Ctr, Flemington Rd, Parkville, Vic 3052, Australia.; Lockhart, PJ (corresponding author), Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Flemington Rd, Parkville, Vic 3052, Australia.	paul.lockhart@mcri.edu.au	Lang, Anthony/ABF-8114-2021; Amor, David J/A-6478-2018; Resource Center, NINDS Human Genetics/AGF-2474-2022; Lockhart, Paul J/E-7753-2011; Sander-Effron, Samuel/AAX-2231-2020	Amor, David J/0000-0001-7191-8511; Lockhart, Paul J/0000-0003-2531-8413; Eberle, Michael/0000-0001-8965-1253; Bennett, Mark/0000-0002-3561-6804; Diakumis, Peter/0000-0002-7502-7545; Bahlo, Melanie/0000-0001-5132-0774	Australian Government National Health and Medical Research Council [1054618]; NIH (NINDS) [R01NS082094]; Murdoch Children's Research Institute; NHMRC Senior Research Fellowship [1102971]; Wellcome Clinical Research Career Development Fellowship; Independent Research Institute Infrastructure Support Scheme; Victorian State Government Operational Infrastructure Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082094] Funding Source: NIH RePORTER	Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NIH (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Murdoch Children's Research Institute; NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Clinical Research Career Development Fellowship; Independent Research Institute Infrastructure Support Scheme; Victorian State Government Operational Infrastructure Program; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge access to the dataset EGA00001003562 from the European Genome-Phenome Archive. This work was supported by the Australian Government National Health and Medical Research Council (Program Grant 1054618 to M.B.), the NIH (NINDS grant R01NS082094 to B.L.F.), and the Murdoch Children's Research Institute. M.B. was supported by an NHMRC Senior Research Fellowship (1102971) and D.P.B. was supported by a Wellcome Clinical Research Career Development Fellowship. Additional funding was provided by the Independent Research Institute Infrastructure Support Scheme and the Victorian State Government Operational Infrastructure Program.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ahmad H, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00085; Bahlo M, 2009, BIOINFORMATICS, V25, P1961, DOI 10.1093/bioinformatics/btp313; Bahlo M, 2018, F1000RES, V7, pF1000; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bird TD, 2018, GENEREVIEWS; Bushara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081342; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cha Yoon-Hee, 2012, Continuum (Minneap Minn), V18, P1142, DOI 10.1212/01.CON.0000421623.56525.11; Cortese A, 2019, NAT GENET, V51, P649, DOI 10.1038/s41588-019-0372-4; Dashnow H, 2018, DETECTING TANDEM REP, V19, P121, DOI DOI 10.1186/; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dolzhenko E, 2017, GENOME RES, V27, P1895, DOI 10.1101/gr.225672.117; Gagnon C, 2004, INT J REHABIL RES, V27, P253, DOI 10.1097/00004356-200409000-00013; Galatolo D, 2018, NEUROGENETICS, V19, P1, DOI 10.1007/s10048-017-0532-6; Gandolfo LC, 2014, GENETICS, V197, P1315, DOI 10.1534/genetics.114.164616; Gordon CR, 2014, J VESTIBUL RES-EQUIL, V24, P351, DOI 10.3233/VES-140527; Gymrek M, 2016, NAT GENET, V48, P22, DOI 10.1038/ng.3461; Hannan AJ, 2018, NAT REV GENET, V19, P286, DOI 10.1038/nrg.2017.115; HARDING AE, 1981, J NEUROL SCI, V51, P259, DOI 10.1016/0022-510X(81)90104-0; Ishiura H, 2018, NAT GENET, V50, P581, DOI 10.1038/s41588-018-0067-2; Jardim LB, 2001, ARCH NEUROL-CHICAGO, V58, P899, DOI 10.1001/archneur.58.6.899; Kraus-Perrotta Cara, 2016, Cerebellum Ataxias, V3, P20; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Maruta Kyoko, 2019, Rinsho Shinkeigaku, V59, P27, DOI 10.5692/clinicalneurol.cn-001209; Mateo I, 2003, NEUROLOGY, V61, P274, DOI 10.1212/01.WNL.0000073537.08141.77; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Mousavi N, 2018, BIORXIV, DOI [10.1101/361162, DOI 10.1101/361162]; Nibbeling EAR, 2017, BRAIN, V140, P2860, DOI 10.1093/brain/awx251; Pedersen BS, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0973-5; Petersen JA, 2013, NEUROLOGY, V81, P1642, DOI 10.1212/WNL.0b013e3182a9f435; Quilez J, 2016, NUCLEIC ACIDS RES, V44, P3750, DOI 10.1093/nar/gkw219; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rinne T, 1998, J NEUROL, V245, P314, DOI 10.1007/s004150050225; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Ruano L, 2014, NEUROEPIDEMIOLOGY, V42, P174, DOI 10.1159/000358801; Sato N, 2009, AM J HUM GENET, V85, P544, DOI 10.1016/j.ajhg.2009.09.019; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Seixas AI, 2017, AM J HUM GENET, V101, P87, DOI 10.1016/j.ajhg.2017.06.007; Smith KR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r85; Subramanian S, 2003, BIOINFORMATICS, V19, P549, DOI 10.1093/bioinformatics/btg029; Sullivan R, 2019, J NEUROL, V266, P533, DOI 10.1007/s00415-018-9076-4; Szmulewicz D, 2014, NEUROLOGY, V82, pS19; Szmulewicz DJ, 2011, NEUROLOGY, V76, P1903, DOI 10.1212/WNL.0b013e31821d746e; Szmulewicz D.J., 2017, CURR OTORHINOL REP, V5, P167, DOI DOI 10.1007/s40136-017-0161-5; Szmulewicz DJ, 2016, NEUROL-CLIN PRACT, V6, P61, DOI 10.1212/CPJ.0000000000000215; Szmulewicz DJ, 2015, MUSCLE NERVE, V51, P600, DOI 10.1002/mus.24422; Szmulewicz DJ, 2014, J VESTIBUL RES-EQUIL, V24, P465, DOI 10.3233/VES-140536; Szmulewicz DJ, 2014, NEUROLOGY, V82, P1410, DOI 10.1212/WNL.0000000000000352; Szmulewicz DJ, 2011, ANN NY ACAD SCI, V1233, P139, DOI 10.1111/j.1749-6632.2011.06158.x; Szmulewicz DJ, 2011, OTOL NEUROTOL, V32, pE63, DOI 10.1097/MAO.0b013e318210b719; Taki M, 2018, AURIS NASUS LARYNX, V45, P866, DOI 10.1016/j.anl.2017.10.008; Tang HB, 2017, AM J HUM GENET, V101, P700, DOI 10.1016/j.ajhg.2017.09.013; Tankard RM, 2018, AM J HUM GENET, V103, P858, DOI 10.1016/j.ajhg.2018.10.015; Vill K, 2018, HUM GENET, V137, P911, DOI 10.1007/s00439-018-1952-6; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yoon Grace, 2018, Handb Clin Neurol, V155, P105, DOI 10.1016/B978-0-444-64189-2.00007-X; Zhang G, 1999, P NATL ACAD SCI USA, V96, P1869, DOI 10.1073/pnas.96.5.1869	62	87	90	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUL 3	2019	105	1					151	165		10.1016/j.ajhg.2019.05.016	http://dx.doi.org/10.1016/j.ajhg.2019.05.016			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	IG3RM	31230722	Green Published, hybrid			2022-12-18	WOS:000473723000012
J	Ferreira, MAR; Mathur, R; Vonk, JM; Szwajda, A; Brumpton, B; Granell, R; Brew, BK; Ullemar, V; Lu, Y; Jiang, YX; Magnusson, PKE; Karlsson, R; Hinds, DA; Paternoster, L; Koppelman, GH; Almqvist, C				Ferreira, Manuel A. R.; Mathur, Riddhima; Vonk, Judith M.; Szwajda, Agnieszka; Brumpton, Ben; Granell, Raquel; Brew, Bronwyn K.; Ullemar, Vilhelmina; Lu, Yi; Jiang, Yunxuan; Magnusson, Patrik K. E.; Karlsson, Robert; Hinds, David A.; Paternoster, Lavinia; Koppelman, Gerard H.; Almqvist, Catarina		23andMe Res Team; eQTLGen Consortium; BIOS Consortium	Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HISTONE DEACETYLASE ACTIVITY; LD SCORE REGRESSION; LINKAGE DISEQUILIBRIUM; ALLERGIC DISEASE; CLUSTER-ANALYSIS; LUNG-FUNCTION; HAY-FEVER; ASSOCIATION; IDENTIFICATION; PHENOTYPES	The extent to which genetic risk factors are shared between childhood-onset (COA) and adult-onset (AOA) asthma has not been estimated. On the basis of data from the UK Biobank study (n = 447,628), we found that the variance in disease liability explained by common variants is higher for COA (onset at ages between 0 and 19 years; h(g)(2) = 25.6%) than for AOA (onset at ages between 20 and 60 years; h(g)(2) = 10.6%). The genetic correlation (r(g)) between COA and AOA was 0.67. Variation in age of onset among COA-affected individuals had a low heritability (h(g)(2) = 5%), which we confirmed in independent studies and also among AOA-affected individuals. To identify subtype-specific genetic associations, we performed a genome-wide association study (GWAS) in the UK Biobank for COA (13,962 affected individuals) and a separate GWAS for AOA (26,582 affected individuals) by using a common set of 300,671 controls for both studies. We identified 123 independent associations for COA and 56 for AOA (37 overlapped); of these, 98 and 34, respectively, were reproducible in an independent study (n = 262,767). Collectively, 28 associations were not previously reported. For 96 COA-associated variants, including five variants that represent COA-specific risk factors, the risk allele was more common in COA-than in AOA-affected individuals. Conversely, we identified three variants that are stronger risk factors for AOA. Variants associated with obesity and smoking had a stronger contribution to the risk of AOA than to the risk of COA. Lastly, we identified 109 likely target genes of the associated variants, primarily on the basis of correlated expression quantitative trait loci (up to n = 31,684). GWAS informed by age of onset can identify subtype-specific risk variants, which can help us understand differences in pathophysiology between COA and AOA and so can be informative for drug development.	[Ferreira, Manuel A. R.; Mathur, Riddhima] QIMR Berghofer Med Res Inst, Genet & Computat Biol, Brisbane, Qld 4006, Australia; [Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 Groningen, Netherlands; [Szwajda, Agnieszka; Brew, Bronwyn K.; Ullemar, Vilhelmina; Lu, Yi; Magnusson, Patrik K. E.; Karlsson, Robert; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Szwajda, Agnieszka; Brew, Bronwyn K.; Ullemar, Vilhelmina; Lu, Yi; Magnusson, Patrik K. E.; Karlsson, Robert; Almqvist, Catarina] Karolinska Inst, Swedish Twin Registry, S-17177 Stockholm, Sweden; [Brumpton, Ben; Granell, Raquel; Paternoster, Lavinia] Univ Bristol, Populat Hlth Sci, Med Reserve Corps Integrat Epidemiol Unit, Bristol BS8 1TH, Avon, England; [Brumpton, Ben] Norwegian Univ Sci & Technol, KG Jebsen Ctr Genet Epidemiol, Dept Publ Hlth & Nursing, Norges Teknisk Nat Vitenskapelige Univ, N-7491 Trondheim, Norway; [Brumpton, Ben] Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Thorac & Occupat Med, N-7030 Trondheim, Norway; [Jiang, Yunxuan; Hinds, David A.; 23andMe Res Team] 23andMe, Mountain View, CA 94041 USA; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, NL-9713 Groningen, Netherlands; [Vonk, Judith M.; Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD, NL-9713 Groningen, Netherlands; [Almqvist, Catarina] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Pediat Allergy & Pulmonol Unit, S-17176 Stockholm, Sweden	QIMR Berghofer Medical Research Institute; University of Groningen; Karolinska Institutet; Karolinska Institutet; University of Bristol; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Groningen; University of Groningen; Karolinska Institutet; Karolinska University Hospital	Ferreira, MAR (corresponding author), QIMR Berghofer Med Res Inst, Genet & Computat Biol, Brisbane, Qld 4006, Australia.	manuel.ferreira@qimrberghofer.edu.au	Magnusson, Patrik KE/C-4458-2017; Granell, Raquel/AAB-5256-2022; Granell, Raquel/AAY-4846-2020; Koppelman, Gerard/AAG-9187-2020; Brew, Bronwyn K/AAV-5289-2020; Lu, Yi/G-9292-2018	Magnusson, Patrik KE/0000-0002-7315-7899; Granell, Raquel/0000-0002-4890-4012; Brew, Bronwyn K/0000-0002-9885-8261; Lu, Yi/0000-0001-9933-3654; Koppelman, Gerard/0000-0001-8567-3252	National Health and Medical Research Council (NHMRC) of Australia; UK Medical Research Council (UK MRC) [MR/J012165/1]; UK MRC [MC_UU_12013, MC_UU_00011/1]; MRC [MC_UU_00011/1, MR/J012165/1] Funding Source: UKRI	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); UK Medical Research Council (UK MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research has been conducted through use of the UK Biobank Resource (application 10074). MARF was supported by a senior research fellowship (APP1124501) from the National Health and Medical Research Council (NHMRC) of Australia. LP was funded by a UK Medical Research Council (UK MRC) fellowship award (MR/J012165/1) and LP and RG work in a unit funded by the UK MRC (MC_UU_12013 and MC_UU_00011/1). Study-specific acknowledgments are listed in the Supplemental Data.	Alasoo K, 2018, NAT GENET, V50, P424, DOI 10.1038/s41588-018-0046-7; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barbu EA, 2012, J IMMUNOL, V188, P6278, DOI 10.4049/jimmunol.1102660; Barneda-Zahonero B, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003503; Belsky DW, 2013, LANCET RESP MED, V1, P453, DOI 10.1016/S2213-2600(13)70101-2; Bleecker E. R., 2018, EUR RESPIR J, P52; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brumpton B, 2013, EUR RESPIR J, V41, P323, DOI 10.1183/09031936.00012112; Brusselle G, 2017, PULM PHARMACOL THER, V43, P39, DOI 10.1016/j.pupt.2017.01.011; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; CAREY G, 1988, BEHAV GENET, V18, P329, DOI 10.1007/BF01260933; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chang X, 2012, J MED GENET, V49, P433, DOI 10.1136/jmedgenet-2012-100918; Chen YC, 2019, INT J OBESITY, V43, P73, DOI 10.1038/s41366-018-0160-8; Clingan JM, 2013, J IMMUNOL, V191, P810, DOI 10.4049/jimmunol.1300244; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Davidson S, 2011, J IMMUNOL, V186, P5938, DOI 10.4049/jimmunol.1002635; Davis JR, 2016, AM J HUM GENET, V98, P216, DOI 10.1016/j.ajhg.2015.11.021; de Marco R, 2004, J ALLERGY CLIN IMMUN, V113, P845, DOI 10.1016/j.jaci.2004.01.780; de Nijs SB, 2013, EUR RESPIR REV, V22, P44, DOI 10.1183/09059180.00007112; Deliu M, 2018, CLIN EXP ALLERGY, V48, P39, DOI 10.1111/cea.13014; Fadista J, 2016, EUR J HUM GENET, V24, P1202, DOI 10.1038/ejhg.2015.269; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Ferreira MAR, 2014, TWIN RES HUM GENET, V17, P505, DOI 10.1017/thg.2014.59; Ferry OR, 2014, IMMUN INFLAMM DIS, V2, P141, DOI 10.1002/iid3.27; Gaynor EC, 1999, MOL BIOL CELL, V10, P627, DOI 10.1091/mbc.10.3.627; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Ghosh RE, 2013, THORAX, V68, P365, DOI 10.1136/thoraxjnl-2012-202151; Granell R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001669; Gunawardhana LP, 2014, CLIN EXP ALLERGY, V44, P47, DOI 10.1111/cea.12168; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Holt PG, 2015, J ALLERGY CLIN IMMUN, V136, P15, DOI 10.1016/j.jaci.2015.05.011; Holt PG, 2012, NAT MED, V18, P726, DOI 10.1038/nm.2768; Ilmarinen P, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/514868; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; JENKINS MA, 1994, BRIT MED J, V309, P90, DOI 10.1136/bmj.309.6947.90; Joehanes R, 2016, CIRC-CARDIOVASC GENE, V9, P436, DOI 10.1161/CIRCGENETICS.116.001506; Karjalainen A, 2002, EUR RESPIR J, V19, P90, DOI 10.1183/09031936.02.00201002; Kim TB, 2013, EUR RESPIR J, V41, P1308, DOI 10.1183/09031936.00100811; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lee-Sarwar K, 2018, J ALLER CL IMM-PRACT, V6, P711, DOI 10.1016/j.jaip.2018.01.026; Litonjua AA, 2002, J ALLERGY CLIN IMMUN, V110, P736, DOI 10.1067/mai.2002.128948; Liu Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000041; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Lu L, 2017, NAT REV IMMUNOL, V17, P703, DOI 10.1038/nri.2017.75; Lynch JP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00156; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Marquez A, 2017, ANN RHEUM DIS, V76, P286, DOI 10.1136/annrheumdis-2016-209436; Mazurek JM, 2012, AM J EPIDEMIOL, V175, P279, DOI 10.1093/aje/kwr300; Midodzi WK, 2010, J ASTHMA, V47, P7, DOI 10.3109/02770900903380996; Minelli C, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002634; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Nedelec Y, 2016, CELL, V167, P657, DOI 10.1016/j.cell.2016.09.025; Newby C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102987; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Ortqvist AK, 2009, PEDIATRICS, V124, pE737, DOI 10.1542/peds.2009-0305; OSWALD H, 1994, BRIT MED J, V309, P95, DOI 10.1136/bmj.309.6947.95; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pierce BL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004818; Rohrmann S, 2012, EUR J CLIN NUTR, V66, P957, DOI 10.1038/ejcn.2012.55; Rymen D, 2015, MOL GENET METAB, V116, P163, DOI 10.1016/j.ymgme.2015.07.003; Sarnowski C, 2016, J ALLERGY CLIN IMMUN, V138, P1071, DOI 10.1016/j.jaci.2016.03.018; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; Scott M, 2012, THORAX, V67, P1046, DOI 10.1136/thoraxjnl-2012-202150; Skaaby T, 2018, ALLERGY, V73, P153, DOI 10.1111/all.13242; Skaaby T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01977-w; Sood Akshay, 2013, Ann Am Thorac Soc, V10, P188, DOI 10.1513/AnnalsATS.201212-115OC; Strachan DP, 1996, BRIT MED J, V312, P1195; Sturdy P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043977; Tan DJ, 2015, EXPERT REV RESP MED, V9, P109, DOI 10.1586/17476348.2015.1000311; Tedner SG, 2012, CLIN EXP ALLERGY, V42, P1430, DOI 10.1111/j.1365-2222.2012.03997.x; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; Wain LV, 2015, LANCET RESP MED, V3, P769, DOI 10.1016/S2213-2600(15)00283-0; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu W, 2014, J ALLERGY CLIN IMMUN, V133, P1280, DOI 10.1016/j.jaci.2013.11.042; Wu XD, 2016, P NATL ACAD SCI USA, V113, P14775, DOI 10.1073/pnas.1611408114; Yadav U, 2018, PATHOG GLOB HEALTH, V112, P115, DOI 10.1080/20477724.2018.1442764; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613; Zhong XT, 2003, J BIOL CHEM, V278, P33436, DOI 10.1074/jbc.M305785200; Zuccaro L, 2016, ALLERGY, V71, P571, DOI 10.1111/all.12831	87	87	87	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2019	104	4					665	684		10.1016/j.ajhg.2019.02.022	http://dx.doi.org/10.1016/j.ajhg.2019.02.022			20	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HR9JE	30929738	Green Submitted, Green Published, Bronze			2022-12-18	WOS:000463474700008
J	Schwartz, MLB; McCormick, CZ; Lazzeri, AL; Lindbuchler, DM; Hallquist, MLG; Manickam, K; Buchanan, AH; Rahm, AK; Giovanni, MA; Frisbie, L; Flansburg, CN; Davis, FD; Sturm, AC; Nicastro, C; Lebo, MS; Mason-Suares, H; Mahanta, LM; Carey, DJ; Williams, JL; Williams, MS; Ledbetter, DH; Faucett, WA; Murray, MF				Schwartz, Marci L. B.; McCormick, Cara Zayac; Lazzeri, Amanda L.; Lindbuchler, D'Andra M.; Hallquist, Miranda L. G.; Manickam, Kandamurugu; Buchanan, Adam H.; Rahm, Alanna Kulchak; Giovanni, Monica A.; Frisbie, Lauren; Flansburg, Carroll N.; Davis, F. Daniel; Sturm, Amy C.; Nicastro, Christine; Lebo, Matthew S.; Mason-Suares, Heather; Mahanta, Lisa Marie; Carey, David J.; Williams, Janet L.; Williams, Marc S.; Ledbetter, David H.; Faucett, W. Andrew; Murray, Michael F.			A Model for Genome-First Care: Returning Secondary Genomic Findings to Participants and Their Healthcare Providers in a Large Research Cohort	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INCIDENTAL FINDINGS; PRECISION MEDICINE; LABORATORY REPORTS; AMERICAN-COLLEGE; CLINICAL EXOME; RECOMMENDATIONS; GEISINGER; GENETICS; RECORDS; BIOBANK	There is growing interest in communicating clinically relevant DNA sequence findings to research participants who join projects with a primary research goal other than the clinical return of such results. Since Geisinger's MyCode Community Health Initiative (MyCode) was launched in 2007, more than 200,000 participants have been broadly consented for discovery research. In 2013 the MyCode consent was amended to include a secondary analysis of research genomic sequences that allows for delivery of clinical results. Since May 2015, pathogenic and likely pathogenic variants from a set list of genes associated with monogenic conditions have prompted "genomefirst'' clinical encounters. The encounters are described as genome-first because they are identified independent of any clinical parameters. This article (1) details our process for generating clinical results from research data, delivering results to participants and providers, facilitating condition-specific clinical evaluations, and promoting cascade testing of relatives, and (2) summarizes early results and participant uptake. We report on 542 participants who had results uploaded to the electronic health record as of February 1, 2018 and 291 unique clinical providers notified with one or more participant results. Of these 542 participants, 515 (95.0%) were reached to disclose their results and 27 (5.0%) were lost to follow-up. We describe an exportable model for delivery of clinical care through secondary use of research data. In addition, subject and provider participation data from the initial phase of these efforts can inform other institutions planning similar programs.	[Schwartz, Marci L. B.; McCormick, Cara Zayac; Lazzeri, Amanda L.; Lindbuchler, D'Andra M.; Hallquist, Miranda L. G.; Manickam, Kandamurugu; Buchanan, Adam H.; Rahm, Alanna Kulchak; Giovanni, Monica A.; Frisbie, Lauren; Flansburg, Carroll N.; Davis, F. Daniel; Sturm, Amy C.; Nicastro, Christine; Carey, David J.; Williams, Janet L.; Williams, Marc S.; Ledbetter, David H.; Faucett, W. Andrew; Murray, Michael F.] Geisinger, Danville, PA 17822 USA; [Lebo, Matthew S.; Mason-Suares, Heather; Mahanta, Lisa Marie] Mol Med Lab, Cambridge, MA 02139 USA; [Lindbuchler, D'Andra M.] Wilkes Barre Area Career & Tech Ctr, Plains Township, PA 18705 USA; [Manickam, Kandamurugu] Nationwide Childrens Hosp, Columbus, OH 43205 USA; [Murray, Michael F.] Yale Sch Med, New Haven, CT 06510 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Yale University	Murray, MF (corresponding author), Geisinger, Danville, PA 17822 USA.; Murray, MF (corresponding author), Yale Sch Med, New Haven, CT 06510 USA.	michael.murray@yale.edu	Mason-Suares, Heather/AAW-6668-2020; Rahm, Alanna Kulchak/AAG-1967-2021	Mason-Suares, Heather/0000-0002-0146-4881; Rahm, Alanna Kulchak/0000-0003-2513-9298; Lebo, Matthew/0000-0002-9733-5207; Schwartz, Marci/0000-0002-7643-0862	Robert Wood Johnson Foundation, Pioneer Award [72832]; Commonwealth of Pennsylvania, Department of Community and Economic Development [C000058400]; Frontier Communications; Horace W. Goldsmith Foundation; Mericle Foundation	Robert Wood Johnson Foundation, Pioneer Award; Commonwealth of Pennsylvania, Department of Community and Economic Development; Frontier Communications; Horace W. Goldsmith Foundation; Mericle Foundation	Robert Wood Johnson Foundation, Pioneer Award, Award #72832; Commonwealth of Pennsylvania, Department of Community and Economic Development, Award #C000058400; Frontier Communications; The Horace W. Goldsmith Foundation; and Mericle Foundation.	Abul-Husn NS, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7000; Amendola LM, 2015, GENOME RES, V25, P305, DOI 10.1101/gr.183483.114; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Chambers DA, 2016, JAMA-J AM MED ASSOC, V315, P1941, DOI 10.1001/jama.2016.3867; Coorevits P, 2013, J INTERN MED, V274, P547, DOI 10.1111/joim.12119; Dewey FE, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6814; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Faucett WA, 2016, APPL TRANSL GENOM, V8, P33, DOI 10.1016/j.atg.2016.01.003; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Green RC, 2012, GENET MED, V14, P405, DOI 10.1038/gim.2012.21; Haggerty CM, 2017, GENET MED, V19, P1245, DOI 10.1038/gim.2017.40; IOM, 2015, GEN EN LEARN HLTH CA; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Murray MF, 2016, GENET MED, V18, P765, DOI 10.1038/gim.2015.134; Psek Wayne A, 2015, EGEMS (Wash DC), V3, P1122, DOI 10.13063/2327-9214.1122; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schoenbaum Stephen C, 2006, Healthc Financ Manage, V60, P60; Stuckey H, 2015, AM J MED GENET A, V167, P2238, DOI 10.1002/ajmg.a.37174; Wetterstrand K. A., 2016, DNA SEQUENCING COSTS; Williams JL, 2016, AM J MED GENET A, V170, P1134, DOI 10.1002/ajmg.a.37573; Williams MS, 2018, HEALTH AFFAIR, V37, P757, DOI 10.1377/hlthaff.2017.1557; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	24	87	87	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP 6	2018	103	3					328	337		10.1016/j.ajhg.2018.07.009	http://dx.doi.org/10.1016/j.ajhg.2018.07.009			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GS6PJ	30100086	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000443819500002
J	Kury, S; van Woerden, GM; Besnard, T; Onori, MP; Latypova, X; Towne, MC; Cho, MT; Prescott, TE; Ploeg, MA; Sanders, S; Stessman, HAF; Pujol, A; Ben Distel,; Robak, LA; Bernstein, JA; Denomme-Pichon, AS; Lesca, G; Sellars, EA; Berg, J; Carre, W; Busk, OL; van Bon, BWM; Waugh, JL; Deardorff, M; Hoganson, GE; Bosanko, KB; Johnson, DS; Dabir, T; Holla, OL; Sarkar, A; Tveten, K; de Bellescize, J; Braathen, GJ; Terhal, PA; Grange, DK; van Haeringen, A; Lam, C; Mirzaa, G; Burton, J; Bhoj, EJ; Douglas, J; Santani, AB; Nesbitt, AI; Helbig, KL; Andrews, MV; Begtrup, A; Tang, S; van Gassen, KLI; Juusola, J; Foss, K; Enns, GM; Moog, U; Hinderhofer, K; Paramasivam, N; Lincoln, S; Kusako, BH; Lindenbaum, P; Charpentier, E; Nowak, CB; Cherot, E; Simonet, T; Ruivenkamp, CAL; Hahn, S; Brownstein, CA; Xia, F; Schmitt, S; Deb, W; Bonneau, D; Nizon, M; Quinquis, D; Chelly, J; Rudolf, G; Sanlaville, D; Parent, P; Gilbert-Dussardier, B; Toutain, A; Sutton, VR; Thies, J; Peart-Vissers, LELM; Boisseau, P; Vincent, M; Grabrucker, AM; Dubourg, C; Tan, WH; Verbeek, NE; Granzow, M; Santen, GWE; Shendure, J; Isidor, B; Pasquier, L; Redon, R; Yang, YP; State, MW; Kleefstra, T; Cogne, B; Petrovski, S; Retterer, K; Eichler, EE; Rosenfeld, JA; Agrawal, PB; Bezieau, S; Odent, S; Elgersma, Y; Mercier, S				Kury, Sebastien; van Woerden, Geeske M.; Besnard, Thomas; Onori, Martina Proietti; Latypova, Xenia; Towne, Meghan C.; Cho, Megan T.; Prescott, Trine E.; Ploeg, Melissa A.; Sanders, Stephan; Stessman, Holly A. F.; Pujol, Aurora; Ben Distel; Robak, Laurie A.; Bernstein, Jonathan A.; Denomme-Pichon, Anne-Sophie; Lesca, Gaetan; Sellars, Elizabeth A.; Berg, Jonathan; Carre, Wilfrid; Busk, Oyvind Lovold; van Bon, Bregje W. M.; Waugh, Jeff L.; Deardorff, Matthew; Hoganson, George E.; Bosanko, Katherine B.; Johnson, Diana S.; Dabir, Tabib; Holla, Oystein Lunde; Sarkar, Ajoy; Tveten, Kristian; de Bellescize, Julitta; Braathen, Geir J.; Terhal, Paulien A.; Grange, Dorothy K.; van Haeringen, Arie; Lam, Christina; Mirzaa, Ghayda; Burton, Jennifer; Bhoj, Elizabeth J.; Douglas, Jessica; Santani, Avni B.; Nesbitt, Addie I.; Helbig, Katherine L.; Andrews, Marisa V.; Begtrup, Amber; Tang, Sha; van Gassen, Koen L. I.; Juusola, Jane; Foss, Kimberly; Enns, Gregory M.; Moog, Ute; Hinderhofer, Katrin; Paramasivam, Nagarajan; Lincoln, Sharyn; Kusako, Brandon H.; Lindenbaum, Pierre; Charpentier, Eric; Nowak, Catherine B.; Cherot, Elouan; Simonet, Thomas; Ruivenkamp, Claudia A. L.; Hahn, Sihoun; Brownstein, Catherine A.; Xia, Fan; Schmitt, Sebastien; Deb, Wallid; Bonneau, Dominique; Nizon, Mathilde; Quinquis, Delphine; Chelly, Jamel; Rudolf, Gabrielle; Sanlaville, Damien; Parent, Philippe; Gilbert-Dussardier, Brigitte; Toutain, Annick; Sutton, Vernon R.; Thies, Jenny; Peart-Vissers, Lisenka E. L. M.; Boisseau, Pierre; Vincent, Marie; Grabrucker, Andreas M.; Dubourg, Christele; Tan, Wen-Hann; Verbeek, Nienke E.; Granzow, Martin; Santen, Gijs W. E.; Shendure, Jay; Isidor, Bertrand; Pasquier, Laurent; Redon, Richard; Yang, Yaping; State, Matthew W.; Kleefstra, Tjitske; Cogne, Benjamin; Petrovski, Slave; Retterer, Kyle; Eichler, Evan E.; Rosenfeld, Jill A.; Agrawal, Pankaj B.; Bezieau, Stephane; Odent, Sylvie; Elgersma, Ype; Mercier, Sandra		Undiagnosed Dis Network; GEM HUGO; Deciphering Dev Dis Study	De Novo Mutations in Protein Kinase Genes CAMK2A and CAMK2B Cause Intellectual Disability	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REGION-SPECIFIC REQUIREMENTS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; ALPHA-CAMKII; GRIN2A MUTATIONS; II ISOFORMS; IN-VIVO; EPILEPSY; IMPACT; AUTOPHOSPHORYLATION	Calcium/calmodulin-dependent protein kinase II (CAMK2) is one of the first proteins shown to be essential for normal learning and synaptic plasticity in mice, but its requirement for human brain development has not yet been established. Through a multi-center collaborative study based on a whole-exome sequencing approach, we identified 19 exceedingly rare de novo CAMK2A or CAMK2B variants in 24 unrelated individuals with intellectual disability. Variants were assessed for their effect on CAMK2 function and on neuronal migration. For both CAMK2A and CAMK2B, we identified mutations that decreased or increased CAMK2 auto-phosphorylation at Thr286/Thr287. We further found that all mutations affecting auto-phosphorylation also affected neuronal migration, highlighting the importance of tightly regulated CAMK2 auto-phosphorylation in neuronal function and neurodevelopment. Our data establish the importance of CAMK2A and CAMK2B and their auto-phosphorylation in human brain function and expand the phenotypic spectrum of the disorders caused by variants in key players of the glutamatergic signaling pathway.	[Kury, Sebastien; Besnard, Thomas; Latypova, Xenia; Schmitt, Sebastien; Deb, Wallid; Nizon, Mathilde; Quinquis, Delphine; Boisseau, Pierre; Vincent, Marie; Isidor, Bertrand; Cogne, Benjamin; Bezieau, Stephane; Mercier, Sandra] CHU Nantes, Serv Genet Med, 9 Quai Moncousu, F-44093 Nantes 1, France; [van Woerden, Geeske M.; Onori, Martina Proietti; Ploeg, Melissa A.; Ben Distel; Elgersma, Ype] Erasmus Univ, Med Ctr, Dept Neurosci, NL-3015 CN Rotterdam, Netherlands; [van Woerden, Geeske M.; Onori, Martina Proietti; Ploeg, Melissa A.; Ben Distel; Elgersma, Ype] Erasmus Univ, Med Ctr, ENCORE Expertise Ctr Neurodev Disorder, NL-3015 CN Rotterdam, Netherlands; [Towne, Meghan C.; Douglas, Jessica; Lincoln, Sharyn; Kusako, Brandon H.; Nowak, Catherine B.; Brownstein, Catherine A.; Tan, Wen-Hann] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Douglas, Jessica; Lincoln, Sharyn; Kusako, Brandon H.; Nowak, Catherine B.; Brownstein, Catherine A.; Tan, Wen-Hann; Agrawal, Pankaj B.] Harvard Med Sch, Boston, MA 02115 USA; [Towne, Meghan C.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Gene Discovery Core, Boston, MA 02115 USA; [Cho, Megan T.; Begtrup, Amber; Juusola, Jane; Retterer, Kyle] GeneDx, Gaithersburg, MD 20877 USA; [Prescott, Trine E.; Busk, Oyvind Lovold; Holla, Oystein Lunde; Tveten, Kristian; Braathen, Geir J.] Telemark Hosp Trust, Dept Med Genet, N-3710 Skien, Norway; [Sanders, Stephan; State, Matthew W.] Univ Calif San Francisco, Weill Inst Neurosci, Dept Psychiat, San Francisco, CA 94158 USA; [Stessman, Holly A. F.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA 98195 USA; [Stessman, Holly A. F.] Creighton Univ, Sch Med, Dept Pharmacol, Omaha, NE 68178 USA; [Pujol, Aurora] IDIBELL, Neurometabol Dis Lab, Gran Via 199, Barcelona 08908, Spain; [Pujol, Aurora] Ctr Biomed Res Rare Dis, CIBERER U759, Barcelona 08908, Spain; [Pujol, Aurora] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain; [Ben Distel] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105AZ Amsterdam, Netherlands; [Robak, Laurie A.; Xia, Fan; Yang, Yaping; Rosenfeld, Jill A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Bernstein, Jonathan A.; Enns, Gregory M.; Yang, Yaping] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Denomme-Pichon, Anne-Sophie; Bonneau, Dominique] CHU Angers, Dept Biochimie & Genet, F-49933 Angers 9, France; [Denomme-Pichon, Anne-Sophie; Bonneau, Dominique] CNRS 6015, UMR INSERM 1083, F-49933 Angers 9, France; [Lesca, Gaetan; Sanlaville, Damien] Hosp Civils Lyon, Ctr Reference Anomalies Dev, Serv Genet, F-69288 Lyon, France; [Lesca, Gaetan; Sanlaville, Damien] INSERM, Ctr Rech Neurosci Lyon, U1028, CNRS UMR5292, F-69675 Bron, France; [Sellars, Elizabeth A.; Bosanko, Katherine B.] Arkansas Childrens Hosp, Sect Genet & Metab, Little Rock, AR 72202 USA; [Berg, Jonathan] Univ Dundee, Sch Med, Mol & Clin Med, Ninewells Hosp, Dundee DD1 9SY, Scotland; [Berg, Jonathan] Med Sch, Dundee DD1 9SY, Scotland; [Carre, Wilfrid; Cherot, Elouan] CHU Rennes, Lab Genet Mol & Genom, F-35033 Rennes, France; [van Bon, Bregje W. M.; Peart-Vissers, Lisenka E. L. M.; Kleefstra, Tjitske] Radboud Univ Nijmegen, Dept Human Genet, Nijmegen Ctr Mol Life Sci, Inst Genet & Metab Dis,Med Ctr, NL-6525 GA Nijmegen, Netherlands; [Waugh, Jeff L.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Deardorff, Matthew] Childrens Hosp Philadelphia, Div Genet, Dept Pediat, Philadelphia, PA 19104 USA; [Hoganson, George E.; Burton, Jennifer] Univ Illinois, Dept Pediat, Coll Med, Chicago, IL 60612 USA; [Johnson, Diana S.] Sheffield Childrens Hosp, Western Bank, Sheffield S10 2TH, S Yorkshire, England; [Dabir, Tabib] Belfast City Hosp, Northern Ireland Reg Genet Ctr, Belfast Hlth & Social Care Trust, Lisburn Rd, Belfast BT9 7AB, Antrim, North Ireland; [Sarkar, Ajoy] Univ Nottingham Hosp, NHS Trust, Nottingham Reg Genet Serv, City Hosp Campus,Hucknall Rd, Nottingham NG5 1PB, England; [de Bellescize, Julitta] Hosp Civils, Epilepsy Sleep & Pediat Neurophysiol Dept, F-69677 Lyon, France; [Terhal, Paulien A.; van Gassen, Koen L. I.; Verbeek, Nienke E.] Univ Med Ctr Utrecht, Dept Genet, NL-3584 Utrecht, Netherlands; [Grange, Dorothy K.; Andrews, Marisa V.] Washington Univ, Dept Pediat, Sch Med, Div Genet & Genom Med, St Louis, MO 63110 USA; [van Haeringen, Arie; Ruivenkamp, Claudia A. L.; Santen, Gijs W. E.] LUMC, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands; [Mirzaa, Ghayda; Hahn, Sihoun] Univ Washington, Sch Med, Dept Pediat, Div Genet Med, Seattle, WA 98105 USA; [Mirzaa, Ghayda; Hahn, Sihoun] Seattle Childrens Hosp, Seattle, WA 98105 USA; [Mirzaa, Ghayda; Foss, Kimberly] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Bhoj, Elizabeth J.] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Bhoj, Elizabeth J.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Santani, Avni B.; Nesbitt, Addie I.] Childrens Hosp Philadelphia, Dept Path & Lab Med, Div Genom Diagnost, Philadelphia, PA 19104 USA; [Santani, Avni B.] Univ Penn, Sch Med, Dept Path & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Helbig, Katherine L.; Tang, Sha] Div Clin Genom Ambry Genet, 15 Argonaut, Aliso Viejo, CA 92656 USA; [Helbig, Katherine L.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Moog, Ute; Hinderhofer, Katrin; Granzow, Martin] Heidelberg Univ, Inst Human Genet, Neuenheimer Feld 366, D-69120 Heidelberg, Germany; [Paramasivam, Nagarajan] Heidelberg Univ, Med Fac Heidelberg, D-69120 Heidelberg, Germany; [Paramasivam, Nagarajan] German Canc Res Ctr, Div Theoret Bioinformat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Lindenbaum, Pierre; Charpentier, Eric; Redon, Richard] Univ Nantes, CNRS, INSERM, Inst Thorax, F-44007 Nantes, France; [Lindenbaum, Pierre; Charpentier, Eric; Redon, Richard] CHU Nantes, Inst Thorax, F-44093 Nantes, France; [Xia, Fan] Baylor Genet, Houston, TX 77030 USA; [Chelly, Jamel] Hop Univ Strasbourg, Lab Diagnost Genet, Nouvel Hop Civil, F-67091 Strasbourg, France; [Chelly, Jamel; Rudolf, Gabrielle] Univ Strasbourg, FMTS, F-67000 Strasbourg, France; [Chelly, Jamel; Rudolf, Gabrielle] Univ Strasbourg, IGBMC, INSERM U964, CNRS UMR 7104, F-67404 Illkirch Graffenstaden, France; [Rudolf, Gabrielle] Univ Hosp Strasbourg, Hosp Hautepierre, Serv Neurol, 1 Ave Moliere, F-67098 Strasbourg, France; [Parent, Philippe] CHU Brest, Genet Med, F-29609 Brest, France; [Gilbert-Dussardier, Brigitte] CHU Poitiers, Serv Genet, BP577, F-86021 Poitiers, France; [Gilbert-Dussardier, Brigitte] Univ Poitiers, EA 3808, Poitiers, France; [Toutain, Annick] CHU Tours, Serv Genet, 2 Blvd Tonnelle, F-37044 Tours, France; [Thies, Jenny] Seattle Childrens Hosp, Dept Pediat, Div Genet Med, Seattle, WA 98105 USA; [Grabrucker, Andreas M.] Univ Limerick, Dept Biol Sci, Limerick V94 T9PX, Ireland; [Grabrucker, Andreas M.] Univ Limerick, Bernal Inst, Limerick V94 T9PX, Ireland; [Pasquier, Laurent] CHU Rennes, Serv Genet Clin, CNRS UMR6290, Univ Rennesl, F-35203 Rennes, France; [GEM HUGO] CHU Rennes, Reseau Genet & Genom Med, Serv Genet Clin, Hop Univ Grand Ouest, F-35203 Rennes, France; [Deciphering Dev Dis Study] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, England; [Petrovski, Slave] Univ Melbourne, Dept Med, Austin Hlth & Royal Melbourne Hosp, Melbourne, Vic 3010, Australia; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Agrawal, Pankaj B.] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Bezieau, Stephane] Univ Nantes, INSERM, CRCINA, Univ Angers, F-44000 Nantes, France	Nantes Universite; CHU de Nantes; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Telemark Hospital Trust; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; Creighton University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; ICREA; University of Amsterdam; Baylor College of Medicine; Stanford University; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Arkansas Children's Hospital; University of Dundee; University of Dundee; CHU Rennes; Radboud University Nijmegen; Harvard University; Boston Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Belfast City Hospital; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; CHU Lyon; Utrecht University; Utrecht University Medical Center; Washington University (WUSTL); Leiden University; Leiden University Medical Center (LUMC); University of Washington; University of Washington Seattle; Seattle Children's Hospital; Seattle Children's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; CHU Brest; CHU Poitiers; Universite de Poitiers; Universite de Poitiers; CHU Tours; Seattle Children's Hospital; University of Limerick; University of Limerick; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Rennes; CHU Rennes; Wellcome Trust Sanger Institute; Royal Melbourne Hospital; University of Melbourne; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers	Kury, S (corresponding author), CHU Nantes, Serv Genet Med, 9 Quai Moncousu, F-44093 Nantes 1, France.; Elgersma, Y (corresponding author), Erasmus Univ, Med Ctr, Dept Neurosci, NL-3015 CN Rotterdam, Netherlands.; Elgersma, Y (corresponding author), Erasmus Univ, Med Ctr, ENCORE Expertise Ctr Neurodev Disorder, NL-3015 CN Rotterdam, Netherlands.	sebastien.kury@chu-nantes.fr; y.elgersma@erasmusmc.nl	Agrawal, Pankaj/ABG-8957-2021; Shendure, Jay/AAU-3684-2021; Pujol, Aurora/N-4990-2014; State, Matthew/W-2256-2019; Mercier, Sandra/E-8922-2018; Lindenbaum, Pierre/A-7154-2008; Isidor, Bertrand/AAJ-3456-2021; Yamamoto, Shinya/ABB-2837-2021; Redon, Richard/F-3303-2014; Lesca, Gaetan/C-6111-2019; KÜRY, Sébastien/G-5971-2015; Kleefstra, Tjitske/G-2619-2012; Besnard, Thomas/L-2303-2019; Xia, Fan/GQP-4575-2022; Elgersma, Ype/F-5164-2013; Pasquier, Laurent/AAN-4081-2020; Sanders, Stephan/S-8645-2019; van Bon, Bregje/Q-2445-2015; Sanlaville, Damien/M-4716-2014; Vincent, Marie/K-7342-2018; Helbig, Katherine/B-7454-2012	Pujol, Aurora/0000-0002-9606-0600; Lindenbaum, Pierre/0000-0003-0148-9787; Isidor, Bertrand/0000-0001-6480-126X; Yamamoto, Shinya/0000-0003-2172-8036; Redon, Richard/0000-0001-7751-2280; KÜRY, Sébastien/0000-0001-5497-0465; Besnard, Thomas/0000-0003-4804-5147; Elgersma, Ype/0000-0002-3758-1297; Pasquier, Laurent/0000-0003-3985-1286; van Bon, Bregje/0000-0003-2234-0105; Sanlaville, Damien/0000-0001-9939-2849; Andrews, Marisa/0000-0002-5448-1204; Vincent, Marie/0000-0003-1010-5618; Tan, Wen-Hann/0000-0002-1593-6149; Grabrucker, Andreas/0000-0003-0005-4810; Helbig, Katherine/0000-0001-8249-0549; Brown, Donna/0000-0002-8805-7225; Foss, Kimberly/0000-0003-3996-7895; Bonneau, Dominique/0000-0002-6886-0969; Sanders, Stephan/0000-0001-9112-5148; Lesca, Gaetan/0000-0001-7691-9492; Waugh, Jeff/0000-0001-7526-1342; State, Matthew/0000-0003-1624-8302; van Gassen, Koen/0000-0001-7934-0662; Toutain, Annick/0000-0002-5999-5300; GILBERT-DUSSARDIER, Brigitte/0000-0001-7182-9914; Towne, Meghan/0000-0001-9460-2368; Proietti Onori, Martina/0000-0003-0360-2894; Rudolf, Gabrielle/0000-0002-2050-3911; Stessman, Holly/0000-0002-0764-3493; Charpentier, Eric/0000-0002-8571-7603; Denomme-Pichon, Anne-Sophie/0000-0002-8986-8222	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS092898] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR068429] Funding Source: Medline; NICHD NIH HHS [U19 HD077671] Funding Source: Medline; NIMH NIH HHS [R01 MH101221] Funding Source: Medline; NINDS NIH HHS [K08 NS092898] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achterberg KG, 2014, J NEUROSCI, V34, P11180, DOI 10.1523/JNEUROSCI.0640-14.2014; Ament SA, 2015, P NATL ACAD SCI USA, V112, P3576, DOI 10.1073/pnas.1424958112; Bachstetter AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105191; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Banker G., 1991, CULTURING NERVE CELL; Barcomb K, 2016, J BIOL CHEM, V291, P16082, DOI 10.1074/jbc.M116.734822; Barkus C, 2014, MOL PSYCHIATR, V19, P1060, DOI 10.1038/mp.2014.91; Bayer KU, 1999, MOL BRAIN RES, V70, P147, DOI 10.1016/S0169-328X(99)00131-X; Bliss TVP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0129; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Brownstein CA, 2016, NEUROGENETICS, V17, P11, DOI 10.1007/s10048-015-0460-2; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Carvill GL, 2013, NAT GENET, V45, P1073, DOI 10.1038/ng.2727; Che FY, 2015, J AFFECT DISORDERS, V187, P62, DOI 10.1016/j.jad.2015.07.036; CHEN C, 1994, SCIENCE, V266, P291, DOI 10.1126/science.7939668; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Evers C, 2017, MOL GENET METAB, V121, P297, DOI 10.1016/j.ymgme.2017.06.014; Fan XL, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00160; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; GRANT SGN, 1994, TRENDS NEUROSCI, V17, P71, DOI 10.1016/0166-2236(94)90077-9; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Hell JW, 2014, NEURON, V81, P249, DOI 10.1016/j.neuron.2013.12.024; Hempel M, 2015, AM J HUM GENET, V97, P493, DOI 10.1016/j.ajhg.2015.08.003; Hoffman L, 2013, BIOCHEMISTRY-US, V52, P1198, DOI 10.1021/bi3016586; Holla OL, 2015, TIDSSKR NORSKE LAEGE, V135, P1833, DOI 10.4045/tidsskr.14.1442; Iossifov I, 2014, NATURE, V515, P216, DOI 10.1038/nature13908; Isidor B, 2016, HUM MUTAT, V37, P354, DOI 10.1002/humu.22952; Kim K, 2016, J NEUROCHEM, V139, P959, DOI 10.1111/jnc.13672; Kool MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26989; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lemke JR, 2014, ANN NEUROL, V75, P147, DOI 10.1002/ana.24073; Lemke JR, 2013, NAT GENET, V45, P1067, DOI 10.1038/ng.2728; Lesca G, 2013, NAT GENET, V45, P1061, DOI 10.1038/ng.2726; Li D, 2016, AM J HUM GENET, V99, P802, DOI 10.1016/j.ajhg.2016.07.013; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mcrae JF, 2017, NATURE, V542, P433, DOI 10.1038/nature21062; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; Nesbitt A, 2015, AM J MED GENET A, V167, P2548, DOI 10.1002/ajmg.a.37221; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; PAN YC, 2015, SCI REP UK, V5; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Philips AK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-49; Retterer K, 2016, GENET MED, V18, P696, DOI 10.1038/gim.2015.148; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Santen GWE, 2012, NAT GENET, V44, P379, DOI 10.1038/ng.2217; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMITH MK, 1992, J BIOL CHEM, V267, P1761; Sobreira Nara, 2015, Hum Mutat, V36, P928, DOI 10.1002/humu.22844; Stephenson JR, 2017, J NEUROSCI, V37, P2216, DOI 10.1523/JNEUROSCI.2068-16.2017; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takemoto-Kimura S, 2017, J NEUROCHEM, V141, P808, DOI 10.1111/jnc.14020; Taniguchi Y, 2012, NEUROSCIENTIST, V18, P169, DOI 10.1177/1073858411399925; Traynelis J, 2017, GENOME RES, V27, P1715, DOI 10.1101/gr.226589.117; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; van Woerden GM, 2009, NAT NEUROSCI, V12, P823, DOI 10.1038/nn.2329; Vincent M, 2014, EUR J HUM GENET, V22, P52, DOI 10.1038/ejhg.2013.98; Ware J. S., 2015, CURRENT PROT HUMAN G, V87, P21; Wu Y, 2007, P NATL ACAD SCI USA, V104, P18163, DOI 10.1073/pnas.0708699104; Yamagata Y, 2009, J NEUROSCI, V29, P7607, DOI 10.1523/JNEUROSCI.0707-09.2009; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Yang YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125925; Zhang JL, 2013, REV NEUROSCIENCE, V24, P499, DOI 10.1515/revneuro-2013-0021; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	78	87	88	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2017	101	5					768	788		10.1016/j.ajhg.2017.10.003	http://dx.doi.org/10.1016/j.ajhg.2017.10.003			21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	FL5DL	29100089	Green Published, Bronze			2022-12-18	WOS:000414251600009
J	Ayturk, UM; Couto, JA; Hann, S; Mulliken, JB; Williams, KL; Huang, AY; Fishman, SJ; Boyd, TK; Kozakewich, HPW; Bischoff, J; Greene, AK; Warman, ML				Ayturk, Ugur M.; Couto, Javier A.; Hann, Steven; Mulliken, John B.; Williams, Kaitlin L.; Huang, August Yue; Fishman, Steven J.; Boyd, Theonia K.; Kozakewich, Harry P. W.; Bischoff, Joyce; Greene, Arin K.; Warman, Matthew L.			Somatic Activating Mutations in GNAQ and GNA11 Are Associated with Congenital Hemangioma	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LYMPHATIC ENDOTHELIAL-CELLS; STURGE-WEBER SYNDROME; UVEAL MELANOMA; VENOUS MALFORMATION; GERMLINE MUTATIONS; SEQUENCING DATA; PIK3CA CAUSE; CANCER	Congenital hemangioma is a rare vascular tumor that forms in utero. Postnatally, the tumor either involutes quickly (i.e., rapidly involuting congenital hemangioma [RICH]) or partially regresses and stabilizes (i.e., non-involuting congenital hemangioma [NICH]). We hypothesized that congenital hemangiomas arise due to somatic mutation and performed massively parallel mRNA sequencing on affected tissue from eight participants. We identified mutually exclusive, mosaic missense mutations that alter glutamine at amino acid 209 (Glu209) in GNAQ or GNA11 in all tested samples, at variant allele frequencies (VAF) ranging from 3% to 33%. We verified the presence of the mutations in genomic DNA using a combination of molecular inversion probe sequencing (MIP-seq) and digital droplet PCR (ddPCR). The Glu209 GNAQ and GNA11 missense variants we identified are common in uveal melanoma and have been shown to constitutively activate MAPK and/or YAP signaling. When we screened additional archival formalin-fixed paraffin embedded (FFPE) congenital cutaneous and hepatic hemangiomas, 4/8 had GNAQ or GNA11 Glu209 variants. The same GNAQ or GNA11 mutation is found in both NICH and RICH, so other factors must account for these tumors' different postnatal behaviors.	[Ayturk, Ugur M.; Hann, Steven; Williams, Kaitlin L.; Huang, August Yue; Warman, Matthew L.] Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA; [Ayturk, Ugur M.; Huang, August Yue; Warman, Matthew L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Couto, Javier A.; Mulliken, John B.] Boston Childrens Hosp, Dept Plast & Oral Surg, Boston, MA 02115 USA; [Mulliken, John B.; Fishman, Steven J.; Kozakewich, Harry P. W.; Greene, Arin K.; Warman, Matthew L.] Boston Childrens Hosp, Vasc Anomalies Ctr, Boston, MA 02115 USA; [Fishman, Steven J.; Bischoff, Joyce] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Boyd, Theonia K.; Kozakewich, Harry P. W.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bischoff, Joyce] Boston Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Warman, Matthew L.] Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Warman, ML (corresponding author), Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA.; Warman, ML (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.; Warman, ML (corresponding author), Boston Childrens Hosp, Vasc Anomalies Ctr, Boston, MA 02115 USA.; Warman, ML (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	matthew.warman@childrens.harvard.edu	Huang, August Yue/E-9983-2016; BISCHOFF, JOYCE/K-3354-2019	Huang, August Yue/0000-0002-0416-2854; BISCHOFF, JOYCE/0000-0002-6367-1974	NIH [R01-AR064231, R01-HL096384, R21-HD081004]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD081004] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096384, R01HL127030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful for the contributions of the participants to this study. This work was supported by NIH grants R01-AR064231 (to M.L.W.), R01-HL096384 (to J.B.), and R21-HD081004 (to A.K.G.).	Berenguer B, 2003, PEDIATR DEVEL PATHOL, V6, P495, DOI 10.1017/s10024-003-2134-6; Boon LM, 1996, J PEDIATR-US, V128, P329, DOI 10.1016/S0022-3476(96)70276-7; Boscolo E, 2015, ANGIOGENESIS, V18, P151, DOI 10.1007/s10456-014-9453-2; Couto J.A., 2015, PLAST RECONSTR SUR S, V136, P72; Couto JA, 2016, PLAST RECONSTR SURG, V137, p77E, DOI 10.1097/PRS.0000000000001868; Couto JA, 2015, AM J HUM GENET, V96, P480, DOI 10.1016/j.ajhg.2015.01.007; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eerola I, 2003, AM J HUM GENET, V73, P1240, DOI 10.1086/379793; Enjolras O, 2001, PLAST RECONSTR SURG, V107, P1647, DOI 10.1097/00006534-200106000-00002; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Fishman S.J., 2013, MULLIKEN YOUNGS VASC, P242; Gorvin C.M., 2016, J BONE MINER RES; Groesser L, 2016, J INVEST DERMATOL, V136, P481, DOI 10.1038/JID.2015.376; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kurek KC, 2012, AM J HUM GENET, V90, P1108, DOI 10.1016/j.ajhg.2012.05.006; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lim YH, 2015, J INVEST DERMATOL, V135, P1698, DOI 10.1038/jid.2015.55; Limaye N, 2015, AM J HUM GENET, V97, P914, DOI 10.1016/j.ajhg.2015.11.011; Lindhurst MJ, 2011, NEW ENGL J MED, V365, P611, DOI 10.1056/NEJMoa1104017; Luks VL, 2015, J PEDIATR-US, V166, P1048, DOI 10.1016/j.jpeds.2014.12.069; Mannstadt M, 2013, NEW ENGL J MED, V368, P2532, DOI 10.1056/NEJMc1300278; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mulliken JB, 2007, AM J MED GENET A, V143A, P3038, DOI 10.1002/ajmg.a.31964; Mulliken J.B., 2013, MULLIKEN YOUNGS VASC, P69; Mulliken JB, 2004, J AM ACAD DERMATOL, V50, P875, DOI 10.1016/j.jaad.2003.10.670; Nakashima M, 2014, J HUM GENET, V59, P691, DOI 10.1038/jhg.2014.95; Nasseri E, 2014, J AM ACAD DERMATOL, V70, P75, DOI 10.1016/j.jaad.2013.09.018; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; North PE, 2000, HUM PATHOL, V31, P11, DOI 10.1016/S0046-8177(00)80192-6; Osborn AJ, 2015, HUM MOL GENET, V24, P926, DOI 10.1093/hmg/ddu505; Piret S.E., 2016, J BONE MINER RES; Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331; Shirley MD, 2013, NEW ENGL J MED, V368, P1971, DOI 10.1056/NEJMoa1213507; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Thomas AC, 2016, J INVEST DERMATOL, V136, P770, DOI 10.1016/j.jid.2015.11.027; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yu FX, 2014, CANCER CELL, V25, P822, DOI 10.1016/j.ccr.2014.04.017	41	87	91	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 7	2016	98	4					789	795		10.1016/j.ajhg.2016.03.009	http://dx.doi.org/10.1016/j.ajhg.2016.03.009			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DJ4UO	27058448	Bronze, Green Published			2022-12-18	WOS:000374203800017
J	Palla, L; Dudbridge, F				Palla, Luigi; Dudbridge, Frank			A Fast Method that Uses Polygenic Scores to Estimate the Variance Explained by Genome-wide Marker Panels and the Proportion of Variants Affecting a Trait	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MISSING HERITABILITY; ADAPTATION; SUSCEPTIBILITY; SCHIZOPHRENIA; ARCHITECTURE; ASSOCIATION; PREDICTION	Several methods have been proposed to estimate the variance in disease liability explained by large sets of genetic markers. However, current methods do not scale up well to large sample sizes. Linear mixed models require solving high-dimensional matrix equations, and methods that use polygenic scores are very computationally intensive. Here we propose a fast analytic method that uses polygenic scores, based on the formula for the non-centrality parameter of the association test of the score. We estimate model parameters from the results of multiple polygenic score tests based on markers with p values in different intervals. We estimate parameters by maximum likelihood and use profile likelihood to compute confidence intervals. We compare various options for constructing polygenic scores, based on nested or disjoint intervals of p values, weighted or unweighted effect sizes, and different numbers of intervals, in estimating the variance explained by a set of markers, the proportion of markers with effects, and the genetic covariance between a pair of traits. Our method provides nearly unbiased estimates and confidence intervals with good coverage, although estimation of the variance is less reliable when jointly estimated with the covariance. We find that disjoint p value intervals perform better than nested intervals, but the weighting did not affect our results. A particular advantage of our method is that it can be applied to summary statistics from single markers, and so can be quickly applied to large consortium datasets. Our method, named AVENGEME (Additive Variance Explained and Number of Genetic Effects Method of Estimation), is implemented in R software.	[Palla, Luigi; Dudbridge, Frank] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Dudbridge, F (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	frank.dudbridge@lshtm.ac.uk	Palla, Luigi/Q-4950-2016	Palla, Luigi/0000-0001-6944-1750	MRC [K006215]; Medical Research Council [MR/K006215/1] Funding Source: researchfish; MRC [MR/K006215/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Eli Stahl, Stephan Ripke, and Dominika Sieradzka for discussions. This work was funded by the MRC (K006215).	Bulik-Sullivan B, 2015, BIORXIV; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dastani Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002607; Davison A., 2003, STAT MODELS; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Furrow RE, 2011, GENETICS, V189, P1377, DOI 10.1534/genetics.111.131912; Gamazon ER, 2014, AM J HUM GENET, V95, P477, DOI 10.1016/j.ajhg.2014.09.009; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2013, NAT GENET, V45, P984, DOI 10.1038/ng.2711; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lynch M, 1998, GENETICS ANAL QUANTI; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Maier R, 2015, AM J HUM GENET, V96, P283, DOI 10.1016/j.ajhg.2014.12.006; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Pritchard JK, 2010, NAT REV GENET, V11, P665, DOI 10.1038/nrg2880; Pritchard JK, 2010, CURR BIOL, V20, pR208, DOI 10.1016/j.cub.2009.11.055; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Robinson MR, 2014, TRENDS GENET, V30, P124, DOI 10.1016/j.tig.2014.02.003; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; Speed D, 2014, GENOME RES, V24, P1550, DOI 10.1101/gr.169375.113; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Visscher PM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004269; Wray NR, 2014, J CHILD PSYCHOL PSYC, V55, P1068, DOI 10.1111/jcpp.12295; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	35	87	87	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG 6	2015	97	2					250	259		10.1016/j.ajhg.2015.06.005	http://dx.doi.org/10.1016/j.ajhg.2015.06.005			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CO7GY	26189816	Bronze, Green Submitted, Green Accepted, Green Published			2022-12-18	WOS:000359328800005
J	Zhang, XC; Ling, JQ; Barcia, G; Jing, LL; Wu, J; Barry, BJ; Mochida, GH; Hill, RS; Weimer, JM; Stein, Q; Poduri, A; Partlow, JN; Ville, D; Dulac, O; Yu, TW; Lam, ATN; Servattalab, S; Rodriguez, J; Boddaert, N; Munnich, A; Colleaux, L; Zon, LI; Soll, D; Walsh, CA; Nabbout, R				Zhang, Xiaochang; Ling, Jiqiang; Barcia, Giulia; Jing, Lili; Wu, Jiang; Barry, Brenda J.; Mochida, Ganeshwaran H.; Hill, R. Sean; Weimer, Jill M.; Stein, Quinn; Poduri, Annapurna; Partlow, Jennifer N.; Ville, Dorothee; Dulac, Olivier; Yu, Tim W.; Lam, Anh-Thu N.; Servattalab, Sarah; Rodriguez, Jacqueline; Boddaert, Nathalie; Munnich, Arnold; Colleaux, Laurence; Zon, Leonard I.; Soell, Dieter; Walsh, Christopher A.; Nabbout, Rima			Mutations in QARS, Encoding Glutaminyl-tRNA Synthetase, Cause Progressive Microcephaly, Cerebral-Cerebellar Atrophy, and Intractable Seizures	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MARIE-TOOTH-DISEASE; PONTOCEREBELLAR HYPOPLASIA; MAJOR DETERMINANT; PERRAULT SYNDROME; HEARING-LOSS; COMPLEX; PROTEIN; CLASSIFICATION; ORGANIZATION; DISSECTION	Progressive microcephaly is a heterogeneous condition with causes including mutations in genes encoding regulators of neuronal survival. Here, we report the identification of mutations in QARS (encoding glutaminyl-tRNA synthetase [QARS]) as the causative variants in two unrelated families affected by progressive microcephaly, severe seizures in infancy, atrophy of the cerebral cortex and cerebellar vermis, and mild atrophy of the cerebellar hemispheres. Whole-exome sequencing of individuals from each family independently identified compound-heterozygous mutations in QARS as the only candidate causative variants. QARS was highly expressed in the developing fetal human cerebral cortex in many cell types. The four QARS mutations altered highly conserved amino acids, and the aminoacylation activity of QARS was significantly impaired in mutant cell lines. Variants p. Gly45Val and p.Tyr57His were located in the N-terminal domain required for QARS interaction with proteins in the multisynthetase complex and potentially with glutamine tRNA, and recombinant QARS proteins bearing either substitution showed an over 10-fold reduction in aminoacylation activity. Conversely, variants p.Arg403Trp and p.Arg515Trp, each occurring in a different family, were located in the catalytic core and completely disrupted QARS aminoacylation activity in vitro. Furthermore, p.Arg403Trp and p.Arg515Trp rendered QARS less soluble, and p.Arg403Trp disrupted QARS-RARS (arginyl-tRNA synthetase 1) interaction. In zebrafish, homozygous qars loss of function caused decreased brain and eye size and extensive cell death in the brain. Our results highlight the importance of QARS during brain development and that epilepsy due to impairment of QARS activity is unusually severe in comparison to other aminoacyl-tRNA synthetase disorders.	[Zhang, Xiaochang; Barry, Brenda J.; Mochida, Ganeshwaran H.; Hill, R. Sean; Partlow, Jennifer N.; Yu, Tim W.; Lam, Anh-Thu N.; Servattalab, Sarah; Rodriguez, Jacqueline; Walsh, Christopher A.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Zhang, Xiaochang; Barry, Brenda J.; Mochida, Ganeshwaran H.; Hill, R. Sean; Partlow, Jennifer N.; Yu, Tim W.; Lam, Anh-Thu N.; Servattalab, Sarah; Rodriguez, Jacqueline; Walsh, Christopher A.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Zhang, Xiaochang; Jing, Lili; Barry, Brenda J.; Hill, R. Sean; Partlow, Jennifer N.; Lam, Anh-Thu N.; Servattalab, Sarah; Rodriguez, Jacqueline; Zon, Leonard I.; Walsh, Christopher A.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Ling, Jiqiang; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Ling, Jiqiang; Wu, Jiang] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Barcia, Giulia; Dulac, Olivier; Nabbout, Rima] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Ctr Reference Epilepsies Rares, Dept Pediat Neurol, F-75015 Paris, France; [Barcia, Giulia; Dulac, Olivier; Nabbout, Rima] Univ Paris 05, INSERM, U1129, F-75006 Paris, France; [Barcia, Giulia; Dulac, Olivier; Nabbout, Rima] Commissariat Energie Atom & Energies Alternat, INSERM, U1129, F-91191 Gif Sur Yvette, France; [Jing, Lili; Zon, Leonard I.] Harvard Univ, Sch Med, Boston Childrens Hosp, Harvard Stem Cell Inst,Stem Cell Program, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Mochida, Ganeshwaran H.] Massachusetts Gen Hosp, Dept Neurol, Pediat Neurol Unit, Boston, MA 02114 USA; [Weimer, Jill M.] Sanford Res, Sanford Childrens Hlth Res Ctr, Sioux Falls, SD 57104 USA; [Stein, Quinn] Sanford Sch Med, Dept Pediat, Sioux Falls, SD 57105 USA; [Stein, Quinn] Sanford Sch Med, Dept Ob Gyn, Sioux Falls, SD 57105 USA; [Poduri, Annapurna; Yu, Tim W.] Boston Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Poduri, Annapurna; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Ville, Dorothee] Ctr Hosp Univ Lyon, Dept Pediat Neurol, F-69007 Lyon, France; [Boddaert, Nathalie] Univ Paris 05, Hop Necker Enfants Malades, Imagine Inst, INSERM,U781,Dept Pediat Radiol, F-75006 Paris, France; [Munnich, Arnold; Colleaux, Laurence] Univ Paris 05, Hop Necker Enfants Malades, Imagine Inst, INSERM,U781,Dept Genet, F-75006 Paris, France; [Walsh, Christopher A.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Yale University; University of Texas System; University of Texas Health Science Center Houston; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Sanford Health; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Walsh, CA (corresponding author), Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu; rima.nabbout@nck.aphp.fr	zhang, xiaochang/G-4857-2014; Wu, Jiang/N-3838-2014; boddaert, nathalie/GWV-2865-2022; COLLEAUX, LAURENCE/AAA-8144-2022; Ling, Jiqiang/AAU-1097-2021; Stein, Quinn/AAJ-4738-2021; Yu, Timothy W./AAF-5738-2019; Barcia, Giulia/H-7907-2017; COLLEAUX, Laurence/H-6455-2017	zhang, xiaochang/0000-0001-5768-7470; Wu, Jiang/0000-0002-9336-457X; COLLEAUX, LAURENCE/0000-0002-0987-7648; Ling, Jiqiang/0000-0003-4466-8304; Stein, Quinn/0000-0002-7670-9281; Yu, Timothy W./0000-0003-2988-7701; Barcia, Giulia/0000-0001-6657-5040; Walsh, Christopher/0000-0002-0156-2238; Mochida, Ganeshwaran/0000-0001-7912-4097; boddaert, nathalie/0000-0003-0991-7774	National Institute of Neurological Disorders and Stroke [R01 NS35129, K23 NS069784]; Manton Center for Orphan Disease Research; Foundation Maladies Rares; F. Hoffmann-La Roche Ltd.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129, K23NS069784] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Manton Center for Orphan Disease Research; Foundation Maladies Rares; F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Nancy Mendelsohn and Janice Baker at Children's Hospitals and Clinics of Minnesota for organizing clinical visits and information; Wen Fan Hu and Divya Jayaraman for editing the paper; and Aldo Rozzo, Byoung-Il Bae, Xuyu Cai, all C.A.W. lab members, and Chris Cho (Yale University) for helpful discussions and technical assistance. Human tissue was obtained from the National Institute of Child Health and Human Development Brain and Tissue Bank for Developmental Disorders at the University of Maryland, Baltimore. This project was supported by grants from the National Institute of Neurological Disorders and Stroke (R01 NS35129 to C.A.W. and K23 NS069784 to A. P.), the Manton Center for Orphan Disease Research (to C. A. W.), and Foundation Maladies Rares (to R.N.). G.H.M. is the recipient of a research grant from F. Hoffmann-La Roche Ltd. L.I.Z. is a founder and stockholder of Fate Therapeutics Inc. and Scholar Rock. C.A.W. is a Distinguished Investigator of the Paul G. Allen Foundation and a Howard Hughes Medical Institute Investigator.	Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003; Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2008, ANNU REV GENOM HUM G, V9, P87, DOI 10.1146/annurev.genom.9.081307.164204; Barcia G, 2012, NAT GENET, V44, P1255, DOI 10.1038/ng.2441; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Bayat V, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001288; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Cassandrini D, 2013, J INHERIT METAB DIS, V36, P43, DOI 10.1007/s10545-012-9487-9; Chihara T, 2007, NAT NEUROSCI, V10, P828, DOI 10.1038/nn1910; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Grant TD, 2012, NUCLEIC ACIDS RES, V40, P3723, DOI 10.1093/nar/gkr1223; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Harlow E, 1998, SPRING; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; Kaufmann R, 2010, AM J HUM GENET, V87, P667, DOI 10.1016/j.ajhg.2010.09.016; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Latour P, 2010, AM J HUM GENET, V86, P77, DOI 10.1016/j.ajhg.2009.12.005; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; LUDMERER SW, 1993, J BIOL CHEM, V268, P5519; McLaughlin HM, 2010, AM J HUM GENET, V87, P560, DOI 10.1016/j.ajhg.2010.09.008; Megraw TL, 2011, TRENDS CELL BIOL, V21, P470, DOI 10.1016/j.tcb.2011.04.007; Nagao A, 2009, P NATL ACAD SCI USA, V106, P16209, DOI 10.1073/pnas.0907602106; Namavar Y, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-50; Norcum MT, 1998, PROTEIN SCI, V7, P79, DOI 10.1002/pro.5560070108; Pierce SB, 2013, AM J HUM GENET, V92, P614, DOI 10.1016/j.ajhg.2013.03.007; Pierce SB, 2011, P NATL ACAD SCI USA, V108, P6543, DOI 10.1073/pnas.1103471108; Rho SB, 1999, P NATL ACAD SCI USA, V96, P4488, DOI 10.1073/pnas.96.8.4488; Riley LG, 2010, AM J HUM GENET, V87, P52, DOI 10.1016/j.ajhg.2010.06.001; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Santos-Cortez RLP, 2013, AM J HUM GENET, V93, P132, DOI 10.1016/j.ajhg.2013.05.018; Taft RJ, 2013, AM J HUM GENET, V92, P774, DOI 10.1016/j.ajhg.2013.04.006; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683	41	87	95	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 3	2014	94	4					547	558		10.1016/j.ajhg.2014.03.003	http://dx.doi.org/10.1016/j.ajhg.2014.03.003			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AE1XC	24656866	Green Published, Bronze			2022-12-18	WOS:000333765300006
J	Nota, B; Struys, EA; Pop, A; Jansen, EE; Ojeda, MRF; Kanhai, WA; Kranendijk, M; van Dooren, SJM; Bevova, MR; Sistermans, EA; Nieuwint, AWM; Barth, M; Ben-Omran, T; Hoffmann, GF; de Lonlay, P; McDonald, MT; Meberg, A; Muntau, AC; Nuoffer, JM; Parini, R; Read, MH; Renneberg, A; Santer, R; Strahleck, T; van Schaftingen, E; van der Knaap, MS; Jakobs, C; Salomons, GS				Nota, Benjamin; Struys, Eduard A.; Pop, Ana; Jansen, Erwin E.; Ojeda, Matilde R. Fernandez; Kanhai, Warsha A.; Kranendijk, Martijn; van Dooren, Silvy J. M.; Bevova, Marianna R.; Sistermans, Erik A.; Nieuwint, Aggie W. M.; Barth, Magalie; Ben-Omran, Tawfeg; Hoffmann, Georg F.; de Lonlay, Pascale; McDonald, Marie T.; Meberg, Alf; Muntau, Ania C.; Nuoffer, Jean-Marc; Parini, Rossella; Read, Marie-Helene; Renneberg, Axel; Santer, Rene; Strahleck, Thomas; van Schaftingen, Emile; van der Knaap, Marjo S.; Jakobs, Cornelis; Salomons, Gajja S.			Deficiency in SLC25A1, Encoding the Mitochondrial Citrate Carrier, Causes Combined D-2-and L-2-Hydroxyglutaric Aciduria	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							D-2-HYDROXYGLUTARIC ACIDURIA; DIGEORGE-SYNDROME; TRANSPORTER; GENE; METABOLISM; MUTATIONS; 22Q11; DEHYDROGENASE; VARIANT; CANCER	The Krebs cycle is of fundamental importance for the generation of the energetic and molecular needs of both prokaryotic and eukaryotic cells. Both enantiomers of metabolite 2-hydroxyglutarate are directly linked to this pivotal biochemical pathway and are found elevated not only in several cancers, but also in different variants of the neurometabolic disease 2-hydroxyglutaric aciduria. Recently we showed that cancer-associated IDH2 germline mutations cause one variant of 2-hydroxyglutaric aciduria. Complementary to these findings, we now report recessive mutations in SLC25A1, the mitochondrial citrate carrier, in 12 out of 12 individuals with combined D-2- and L-2-hydroxyglutaric aciduria. Impaired mitochondrial citrate efflux, demonstrated by stable isotope labeling experiments and the absence of SLC25A1 in fibroblasts harboring certain mutations, suggest that SLC25A1 deficiency is pathogenic. Our results identify defects in SLC25A1 as a cause of combined D-2- and L-2-hydroxyglutaric aciduria.	[Nota, Benjamin; Struys, Eduard A.; Pop, Ana; Jansen, Erwin E.; Ojeda, Matilde R. Fernandez; Kanhai, Warsha A.; Kranendijk, Martijn; van Dooren, Silvy J. M.; Jakobs, Cornelis; Salomons, Gajja S.] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Metab Unit, NL-1081 HV Amsterdam, Netherlands; [Bevova, Marianna R.; Sistermans, Erik A.; Nieuwint, Aggie W. M.] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 HV Amsterdam, Netherlands; [Barth, Magalie] Genet CHU Angers, F-49000 Angers, France; [Ben-Omran, Tawfeg] Hamad Med Corp, Dept Pediat, Clin & Metab Genet, Doha, Qatar; [Ben-Omran, Tawfeg] Weill Cornell Med Coll, Doha, Qatar; [Hoffmann, Georg F.] Univ Childrens Hosp, Div Inherited Metab Dis, Dept Gen Pediat, D-69120 Heidelberg, Germany; [de Lonlay, Pascale] Univ Paris Descartes Sorbonne Paris Cite, Hop Necker Enfants Malad, F-75015 Paris, France; [McDonald, Marie T.] Duke Univ, Div Med Genet, Dept Pediat, Durham, NC 27710 USA; [Meberg, Alf] Vestfold Hosp Trust, Neonatal Unit, N-3103 Tonsberg, Norway; [Muntau, Ania C.] Univ Munich, Dept Mol Paediat, Dr von Hauner Childrens Hosp, D-80337 Munich, Germany; [Nuoffer, Jean-Marc] Univ Bern, Inselspital, Univ Hosp, Div Pediat Endocrinol Diabetol & Metab, CH-3010 Bern, Switzerland; [Nuoffer, Jean-Marc] Univ Bern, Inselspital, Univ Hosp, Univ Inst Clin Chem, CH-3010 Bern, Switzerland; [Parini, Rossella] Azienda Osped San Gerardo, Fdn MBBM, Dept Pediat, Unita Operat Semplice Malattie Metabol Rare, I-20900 Monza, Italy; [Read, Marie-Helene] CHU Caen, Biochim Lab, F-14033 Caen, France; [Renneberg, Axel] Klin Burgerpk, Dept Pediat & Neuropediat, D-27574 Bremerhaven, Germany; [Santer, Rene] Univ Childrens Hosp, Dept Pediat, D-20246 Hamburg, Germany; [Strahleck, Thomas] Olga Hosp, Dept Neonatol, Klinikum Stuttgart, D-70176 Stuttgart, Germany; Catholic Univ Louvain, Physiol Chem Lab, de Duve Inst, B-1200 Brussels, Belgium; [van der Knaap, Marjo S.] Vrije Univ Amsterdam Med Ctr, Dept Child Neurol, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Universite d'Angers; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Duke University; University of Munich; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; CHU de Caen NORMANDIE; Universite de Caen Normandie; University of Hamburg; University Medical Center Hamburg-Eppendorf; General Hospital of N. Ionia Agia Olga; Klinikum Stuttgart; Universite Catholique Louvain; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Nota, B (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Metab Unit, Neurosci Campus Amsterdam, NL-1081 HV Amsterdam, Netherlands.	benjamin.nota@gmail.com; g.salomons@vumc.nl	Parini, Rossella/J-9202-2018; Van+Schaftingen, Emile/AAF-5532-2020; Sistermans, Erik/B-1109-2009; Nuoffer, Jean-Marc/C-8936-2009	Parini, Rossella/0000-0003-4505-1306; Sistermans, Erik/0000-0001-7187-4563; van der Knaap, Marjo/0000-0001-8912-0954; Van Schaftingen, Emile/0000-0002-6199-7647; Nota, Benjamin/0000-0001-7500-5760; Nuoffer, Jean-Marc/0000-0003-3650-6153				Aghili M, 2009, J NEURO-ONCOL, V91, P233, DOI 10.1007/s11060-008-9706-2; Briere JJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1114, DOI 10.1152/ajpcell.00216.2006; Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220; Dang LN, 2010, TRENDS MOL MED, V16, P387, DOI 10.1016/j.molmed.2010.07.002; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; HEISTERKAMP N, 1995, GENOMICS, V29, P451, DOI 10.1006/geno.1995.9982; Huizing M, 1998, J BIOENERG BIOMEMBR, V30, P277, DOI 10.1023/A:1020501021222; Icard P, 2012, BBA-REV CANCER, V1825, P111, DOI 10.1016/j.bbcan.2011.10.007; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kranendijk M, 2012, J INHERIT METAB DIS, V35, P571, DOI 10.1007/s10545-012-9462-5; Kranendijk M, 2010, SCIENCE, V330, P336, DOI 10.1126/science.1192632; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Morciano P, 2009, HUM MOL GENET, V18, P4180, DOI 10.1093/hmg/ddp370; Muntau AC, 2000, NEUROPEDIATRICS, V31, P137, DOI 10.1055/s-2000-7497; Mycielska ME, 2009, BIOESSAYS, V31, P10, DOI 10.1002/bies.080137; Oskarsdottir S, 2004, ARCH DIS CHILD, V89, P148, DOI 10.1136/adc.2003.026880; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; Raimundo N, 2011, TRENDS MOL MED, V17, P641, DOI 10.1016/j.molmed.2011.06.001; Rakheja D, 2011, TUMOR BIOL, V32, P325, DOI 10.1007/s13277-010-0125-6; Rzem R, 2004, P NATL ACAD SCI USA, V101, P16849, DOI 10.1073/pnas.0404840101; Stoffel M, 1996, HUM GENET, V98, P113, DOI 10.1007/s004390050169; Struys EA, 2005, AM J HUM GENET, V76, P358, DOI 10.1086/427890; Struys EA, 2003, CLIN CHEM, V49, P1133, DOI 10.1373/49.7.1133; Topcu M, 2004, HUM MOL GENET, V13, P2803, DOI 10.1093/hmg/ddh300; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097	29	87	90	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					627	631		10.1016/j.ajhg.2013.03.009	http://dx.doi.org/10.1016/j.ajhg.2013.03.009			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23561848	Green Published, Bronze			2022-12-18	WOS:000317449700016
J	Hammer, MB; Eleuch-Fayache, G; Schottlaender, LV; Nehdi, H; Gibbs, JR; Arepalli, SK; Chong, SB; Hernandez, DG; Sailer, A; Liu, GX; Mistry, PK; Cai, HB; Shrader, G; Sassi, C; Bouhlal, Y; Houlden, H; Hentati, F; Amouri, R; Singleton, AB				Hammer, Monia B.; Eleuch-Fayache, Ghada; Schottlaender, Lucia V.; Nehdi, Houda; Gibbs, J. Raphael; Arepalli, Sampath K.; Chong, Sean B.; Hernandez, Dena G.; Sailer, Anna; Liu, Guoxiang; Mistry, Pramod K.; Cai, Huaibin; Shrader, Ginamarie; Sassi, Celeste; Bouhlal, Yosr; Houlden, Henry; Hentati, Faycal; Amouri, Rim; Singleton, Andrew B.			Mutations in GBA2 Cause Autosomal-Recessive Cerebellar Ataxia with Spasticity	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BETA-GLUCOSIDASE-2; DISEASE	Autosomal-recessive cerebellar ataxia (ARCA) comprises a large and heterogeneous group of neurodegenerative disorders with more than 20 different forms currently recognized, many of which are also associated with increased tone and some of which have limb spasticity. Gaucher disease is a lysosomal storage disease resulting from a defect in the enzyme acid beta-glucosidase 1. beta-glucosidase 2 is an enzyme with similar glucosylceramidase activity but to date has not been associated with a monogenic disorder. We studied four unrelated consanguineous families of Tunisian decent diagnosed with cerebellar ataxia of unknown origin. We performed homozygosity mapping and whole-exome sequencing in an attempt to identify the genetic origin of their disorder. We were able to identify mutations responsible for autosomal-recessive ataxia in these families within the gene encoding beta-glucosidase 2, GBA2. Two nonsense mutations (c.363C>A [p.Tyr121*] and c.1018C>T [p.Arg340*]) and a substitution (c.2618G>A [p.Arg873His]) were identified, probably resulting in nonfunctional enzyme. This study suggests GBA2 mutations are a cause of recessive spastic ataxia and responsible for a form of glucosylceramide storage disease in humans.	[Hammer, Monia B.; Gibbs, J. Raphael; Arepalli, Sampath K.; Chong, Sean B.; Hernandez, Dena G.; Liu, Guoxiang; Cai, Huaibin; Shrader, Ginamarie; Sassi, Celeste; Singleton, Andrew B.] NIA, Mol Genet Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Hammer, Monia B.; Eleuch-Fayache, Ghada; Nehdi, Houda; Hentati, Faycal; Amouri, Rim] Natl Inst Neurol, Dept Mol Neurobiol & Neuropathol, Tunis 1007, Tunisia; [Schottlaender, Lucia V.; Gibbs, J. Raphael; Hernandez, Dena G.; Sailer, Anna; Sassi, Celeste; Houlden, Henry] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Schottlaender, Lucia V.; Sailer, Anna; Houlden, Henry] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Schottlaender, Lucia V.; Sailer, Anna; Houlden, Henry] Natl Hosp Neurol & Neurosurg, London WC1N 3BG, England; [Gibbs, J. Raphael; Hernandez, Dena G.; Sassi, Celeste] UCL Inst Neurol, Reta Lila Weston Labs, London WC1N 3BG, England; [Mistry, Pramod K.] Yale Univ, Dept Pediat & Med, Sch Med, Sect Pediat Gastroenterol & Hepatol, New Haven, CT 06520 USA; [Bouhlal, Yosr] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Universite de Tunis-El-Manar; Institut National de Neurologie; University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Yale University; University of California System; University of California San Francisco	Singleton, AB (corresponding author), NIA, Mol Genet Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA.	singleta@mail.nih.gov	Gibbs, J. Raphael/A-3984-2010; Cai, Huaibin/H-3359-2013; Houlden, Henry J/C-1532-2008; liu, guoxiang/I-8174-2013; Singleton, Andrew B/C-3010-2009	Gibbs, J. Raphael/0000-0002-6985-0658; Cai, Huaibin/0000-0002-8596-6108; Houlden, Henry J/0000-0002-2866-7777; AMOURI, RIM/0000-0001-5641-5748	National Institute on Aging, National Institutes of Health, part of the Department of Health and Human Services [ZIA AG000958-09]; National Ataxia Foundation; Medical Research Council (MRC); Brain Research Trust; NORD; MRC/Wellcome Trust Parkinson's disease consortium; UCLH/UCL Department of Health's NIHR Biomedical Research Centres; MRC [G0802760, MC_G1000735, G1001253, G108/638, MR/J004758/1] Funding Source: UKRI; Medical Research Council [G1001253, G0802760, MC_G1000735, G108/638, MR/J004758/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [ZIAAG000958, ZIAAG000928] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health, part of the Department of Health and Human Services; National Ataxia Foundation; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Brain Research Trust; NORD; MRC/Wellcome Trust Parkinson's disease consortium; UCLH/UCL Department of Health's NIHR Biomedical Research Centres; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank J. Hammer for his contribution in the correction of the manuscript and his help with the figures. We also thank the affected individuals and their families for taking part in this work. This work was supported in part by the Intramural Research Program of the National Institute on Aging, National Institutes of Health, part of the Department of Health and Human Services (project number ZIA AG000958-09) and the National Ataxia Foundation. We are also grateful to the Medical Research Council (MRC), the Brain Research Trust, and NORD for funding to H.H., L.V.S., and A.S. and also the MRC/Wellcome Trust Parkinson's disease consortium grant and the UCLH/UCL Department of Health's NIHR Biomedical Research Centres funding scheme.	Aureli M, 2012, NEUROCHEM RES, V37, P1344, DOI 10.1007/s11064-012-0719-z; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Bouhlal Y, 2005, Acta Myol, V24, P155; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; de Bot ST, 2012, NEUROLOGY, V79, P1507, DOI 10.1212/WNL.0b013e31826d5fb0; De Michele G, 2004, J NEUROL, V251, P913, DOI 10.1007/s00415-004-0484-2; Embirucu EK, 2009, ARQ NEURO-PSIQUIAT, V67, P1143, DOI 10.1590/S0004-282X2009000600036; Fogel BL, 2007, LANCET NEUROL, V6, P245, DOI 10.1016/S1474-4422(07)70054-6; Gibbs JR, 2006, PLOS GENET, V2, P1511, DOI 10.1371/journal.pgen.0020150; GRABOWSKI GA, 1990, CRIT REV BIOCHEM MOL, V25, P385, DOI 10.3109/10409239009090616; Lachmann RH, 2000, QJM-MON J ASSOC PHYS, V93, P237, DOI 10.1093/qjmed/93.4.237; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matern H, 2001, J BIOL CHEM, V276, P37929; Overkleeft HS, 1998, J BIOL CHEM, V273, P26522, DOI 10.1074/jbc.273.41.26522; Palau F, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-47; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sailer A, 2012, CURR NEUROL NEUROSCI, V12, P227, DOI 10.1007/s11910-012-0267-6; Seelow D, 2009, NUCLEIC ACIDS RES, V37, pW593, DOI 10.1093/nar/gkp369; Walden CM, 2007, J BIOL CHEM, V282, P32655, DOI 10.1074/jbc.M702387200; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224	20	87	88	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 7	2013	92	2					245	251		10.1016/j.ajhg.2012.12.012	http://dx.doi.org/10.1016/j.ajhg.2012.12.012			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	093GL	23332917	Green Published, Bronze			2022-12-18	WOS:000315179600008
J	Zhang, J; Fang, Z; Jud, C; Vansteensel, MJ; Kaasik, K; Lee, CC; Albrecht, U; Tamanini, F; Meijer, JH; Oostra, BA; Nelson, DL				Zhang, Jing; Fang, Zhe; Jud, Corinne; Vansteensel, Mariska J.; Kaasik, Krista; Lee, Cheng Chi; Albrecht, Urs; Tamanini, Filippo; Meijer, Johanna H.; Oostra, Ben A.; Nelson, David L.			Fragile X-related proteins regulate mammalian circadian behavioral rhythms	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MENTAL-RETARDATION PROTEIN; KNOCKOUT MICE; IN-VIVO; CLOCK; FMR1; GENE; FXR1; POLYRIBOSOMES; EXPRESSION; HOMOLOG	Fragile X syndrome results from the absence of the fragile X mental retardation 1 (FMR1) gene product (FMRP). FMR1 has two paralogs in vertebrates: fragile X related gene 1 and 2 (FXR1 and FXR2). Here we show that Fmr1/Fxr2 double knockout (KO) and Fmr1 KO/Fxr2 heterozygous animals exhibit a loss of rhythmic activity in a light:dark (LD) cycle, and that Fmr1 or Fxr2 KO mice display a shorter free-running period of locomotor activity in total darkness (DD). Molecular analysis and in vitro electrophysiological studies suggest essentially normal function of cells in the suprachiasmatic nucleus (SCN) in Fmr1/Fxr2 double KO mice. However, the cyclical patterns of abundance of several core clock component messenger (m) RNAs are altered in the livers of double KO mice. Furthermore, FXR2P alone or FMRP and FXR2P together can increase PER1- or PER2-mediated BMAL1-Neuronal PAS2 (NPAS2) transcriptional activity in a dose-dependent manner. These data collectively demonstrate that FMR1 and FXR2 are required for the presence of rhythmic circadian behavior in mammals and suggest that this role may be relevant to sleep and other behavioral alterations observed in fragile X patients.	[Zhang, Jing; Fang, Zhe; Nelson, David L.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Jud, Corinne; Albrecht, Urs] Univ Fribourg, Dept Med, Div Biochem, CH-1700 Fribourg, Switzerland; [Vansteensel, Mariska J.; Meijer, Johanna H.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, NL-2300 RC Leiden, Netherlands; [Kaasik, Krista; Lee, Cheng Chi] Univ Texas Houston, Hlth Sci Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Tamanini, Filippo] Erasmus Univ, MGC, Dept Genet, Med Ctr, NL-3000 CA Rotterdam, Netherlands; [Oostra, Ben A.] Erasmus Univ, Dept Clin Genet, Med Ctr, NL-3000 CA Rotterdam, Netherlands	Baylor College of Medicine; University of Fribourg; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Texas System; University of Texas Health Science Center Houston; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Nelson, DL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	nelson@bcm.tmc.edu	Vansteensel, Mariska/K-8015-2019; Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676; Vansteensel, Mariska/0000-0002-9252-5116	NICHD NIH HHS [P30 HD024064, R01 HD038038, HD38038, HD24064] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038038] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; BAKKER CE, 1994, CELL, V78, P23; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bontekoe CJM, 2002, HUM MOL GENET, V11, P487, DOI 10.1093/hmg/11.5.487; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Corbin F, 1997, HUM MOL GENET, V6, P1465, DOI 10.1093/hmg/6.9.1465; D'Hulst C, 2006, BRAIN RES, V1121, P238, DOI 10.1016/j.brainres.2006.08.115; De Leersnyder H, 2006, MOL CELL ENDOCRINOL, V252, P88, DOI 10.1016/j.mce.2006.03.043; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gould EL, 2000, AM J MED GENET, V95, P307; HAGERMAN RJ, 1996, FRAGILE X SYNDROME D, P3; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kirkpatrick LL, 2001, GENOMICS, V78, P169, DOI 10.1006/geno.2001.6667; Lamont Elaine Waddington, 2007, Dialogues Clin Neurosci, V9, P333; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Meijer JH, 1997, BRAIN RES, V753, P322, DOI 10.1016/S0006-8993(97)00150-9; Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101; Mientjes EJ, 2004, HUM MOL GENET, V13, P1291, DOI 10.1093/hmg/ddh150; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; SCHWARTZ WJ, 1987, P NATL ACAD SCI USA, V84, P1694, DOI 10.1073/pnas.84.6.1694; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Spencer CM, 2006, HUM MOL GENET, V15, P1984, DOI 10.1093/hmg/ddl121; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x	37	87	87	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2008	83	1					43	52		10.1016/j.ajhg.2008.06.003	http://dx.doi.org/10.1016/j.ajhg.2008.06.003			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	328FO	18589395	Green Published, Bronze, Green Submitted			2022-12-18	WOS:000257784000006
J	Karkera, JD; Lee, JS; Roessler, E; Banerjee-Basu, S; Ouspenskaia, MV; Mez, J; Goldmuntz, E; Bowers, P; Towbin, J; Belmont, JW; Baxevanis, AD; Schier, AF; Muenke, M				Karkera, J. D.; Lee, J. S.; Roessler, E.; Banerjee-Basu, S.; Ouspenskaia, M. V.; Mez, J.; Goldmuntz, E.; Bowers, P.; Towbin, J.; Belmont, J. W.; Baxevanis, A. D.; Schier, A. F.; Muenke, M.			Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; NODAL SIGNALS; EXPRESSION; PROTEIN; XENOPUS; GENE; VG1; SPECIFICATION; ESTABLISHMENT	Congenital heart defects (CHDs) are among the most common birth defects in humans (incidence 8-10 per 1,000 live births). Although their etiology is often poorly understood, most are considered to arise from multifactorial influences, including environmental and genetic components, as well as from less common syndromic forms. We hypothesized that disturbances in left-right patterning could contribute to the pathogenesis of selected cardiac defects by interfering with the extrinsic cues leading to the proper looping and vessel remodeling of the normally asymmetrically developed heart and vessels. Here, we show that heterozygous loss-of-function mutations in the human GDF1 gene contribute to cardiac defects ranging from tetralogy of Fallot to transposition of the great arteries and that decreased TGF-beta signaling provides a framework for understanding their pathogenesis. These findings implicate perturbations of the TGF-beta signaling pathway in the causation of a major subclass of human CHDs.	NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; Harvard Univ, Dept Mol & Cellular Biol, Harvard Stem Cell Inst, Broat Inst, Cambridge, MA 02138 USA; Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA; Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; Baylor Coll Med, Dept Pediat, Div Cardiol, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yale University; Baylor College of Medicine	Muenke, M (corresponding author), NHGRI, Med Genet Branch, NIH, 35 Convent Dr,MSC 3717,Bldg 35,Room 1B-203, Bethesda, MD 20892 USA.	mmuenke@nhgri.nih.gov	Belmont, John/AAH-6084-2021; Towbin, Jeffrey A./J-5595-2019; Belmont, John W/AAI-2494-2019	Towbin, Jeffrey A./0000-0002-6585-714X; Belmont, John W/0000-0001-7409-3578; Schier, Alexander Franz/0000-0001-7645-5325; Baxevanis, Andy/0000-0002-5370-0014; Mez, Jesse/0000-0003-1438-5442; Muenke, Maximilian/0000-0002-7719-6545	Intramural NIH HHS Funding Source: Medline; PHS HHS [PSOHL74731] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ai D, 2006, DEV BIOL, V296, P437, DOI 10.1016/j.ydbio.2006.06.009; Andersson O, 2006, DEV BIOL, V293, P370, DOI 10.1016/j.ydbio.2006.02.002; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; Birsoy B, 2006, DEVELOPMENT, V133, P15, DOI 10.1242/dev.02144; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Burn J, 1996, CURR OPIN GENET DEV, V6, P322, DOI 10.1016/S0959-437X(96)80009-8; Cheng SK, 2004, PLOS BIOL, V2, P215, DOI 10.1371/journal.pbio.0020030; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; Constam DB, 2000, GENE DEV, V14, P1146; de la Cruz JM, 2002, HUM GENET, V110, P422, DOI 10.1007/s00439-002-0709-3; Frank B, 2003, TAPPI J, V2, P13; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Goldmuntz E, 2002, AM J HUM GENET, V70, P776, DOI 10.1086/339079; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Gritsman K, 2000, DEVELOPMENT, V127, P921; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; LEE SJ, 1991, P NATL ACAD SCI USA, V88, P4250, DOI 10.1073/pnas.88.10.4250; LEE SJ, 1990, MOL ENDOCRINOL, V4, P1034, DOI 10.1210/mend-4-7-1034; MACDONALD NQ, 1993, CELL, V73, P421; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MICHIOTTI G, 2001, DEVELOPMENT, V128, P4501; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Norris DP, 2002, DEVELOPMENT, V129, P3455; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; THOMSEN GH, 1993, CELL, V74, P433, DOI 10.1016/0092-8674(93)80045-G; TOYAMA R, 1995, DEVELOPMENT, V121, P383; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Wall NA, 2000, DEV BIOL, V227, P495, DOI 10.1006/dbio.2000.9926; Yamamoto M, 2003, DEVELOPMENT, V130, P1795, DOI 10.1242/dev.00408; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; Zhu LR, 2006, EUR J HUM GENET, V14, P17, DOI 10.1038/sj.ejhg.5201506	42	87	94	1	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	2007	81	5					987	994		10.1086/522890	http://dx.doi.org/10.1086/522890			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	224XE	17924340	Green Published, Bronze			2022-12-18	WOS:000250480900010
J	Delnatte, C; Sanlaville, D; Mougenot, JF; Vermeesch, JR; Houdayer, C; de Blois, MC; Genevieve, D; Goulet, O; Fryns, JP; Jaubert, F; Vekemans, M; Lyonnet, S; Romana, S; Eng, C; Stoppa-Lyonnet, D				Delnatte, Capucine; Sanlaville, Damien; Mougenot, Jean-Francois; Vermeesch, Joris-Robert; Houdayer, Claude; de Blois, Marie-Christine; Genevieve, David; Goulet, Olivier; Fryns, Jean-Pierre; Jaubert, Francis; Vekemans, Michel; Lyonnet, Stanislas; Romana, Serge; Eng, Charis; Stoppa-Lyonnet, Dominique			Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INOSITOL POLYPHOSPHATE PHOSPHATASE; ALPHA-ACTIN GENE; COWDEN-SYNDROME; GASTROINTESTINAL POLYPOSIS; IN-VIVO; MUTATIONS; PROTEIN; DISEASE; EXPRESSION; PATIENT	We describe four unrelated children who were referred to two tertiary referral medical genetics units between 1991 and 2005 and who are affected with juvenile polyposis of infancy. We show that these children are heterozygous for a germline deletion encompassing two contiguous genes, PTEN and BMPR1A. We hypothesize that juvenile polyposis of infancy is caused by the deletion of these two genes and that the severity of the disease reflects cooperation between these two tumor-suppressor genes.	Inst Curie, Dept Genet, Paris, France; Hop Necker Enfants Malad, AP HP, Dept Genet, Paris, France; Hop Necker Enfants Malad, AP HP, Dept Pediat, Paris, France; Hop Necker Enfants Malad, AP HP, Dept Pathol, Paris, France; INSERM, E0210, Equipe Mixte, Paris, France; Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; Case Western Reserve Univ, Sch Med, Cleveland Clin, Genom Med Inst, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); KU Leuven; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	Stoppa-Lyonnet, D (corresponding author), 26 Rue Ulm, F-75248 Paris 5, France.	dominique.stoppa-lyonnet@curie.net	Sanlaville, Damien/M-4716-2014; Lyonnet, Stanislas/H-5483-2017	Sanlaville, Damien/0000-0001-9939-2849; Lyonnet, Stanislas/0000-0001-5426-9417; Vermeesch, Joris/0000-0002-3071-1191; Eng, Charis/0000-0002-3693-5145; Houdayer, Claude/0000-0002-5190-0389; Romana, Serge Pierrick/0000-0003-3435-239X				Arch EM, 1997, AM J MED GENET, V71, P489, DOI 10.1002/(SICI)1096-8628(19970905)71:4<489::AID-AJMG24>3.0.CO;2-B; Arimura T, 2004, J BIOL CHEM, V279, P6746, DOI 10.1074/jbc.M311849200; Braghetta P, 2004, MATRIX BIOL, V22, P549, DOI 10.1016/j.matbio.2003.10.005; Bronner MP, 2003, AM J MED GENET A, V122A, P335, DOI 10.1002/ajmg.a.20476; BROOKCARTER PT, 1994, NAT GENET, V8, P328, DOI 10.1038/ng1294-328; Chaponnier C, 2004, J PATHOL, V204, P386, DOI 10.1002/path.1635; Chi HB, 2000, MOL CELL BIOL, V20, P6496, DOI 10.1128/MCB.20.17.6496-6507.2000; Chi HB, 1999, GENOMICS, V56, P324, DOI 10.1006/geno.1998.5736; COBURN MC, 1995, ANN SURG ONCOL, V2, P386, DOI 10.1007/BF02306370; Comer KA, 1998, ONCOGENE, V16, P1299, DOI 10.1038/sj.onc.1201645; Dehainault C, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh137; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Friedman WA, 2002, RADIOSURG, V4, P1, DOI 10.1159/000062359; Gimm O, 2001, J CLIN ENDOCR METAB, V86, P1801, DOI 10.1210/jc.86.4.1801; GROTSKY HW, 1982, GASTROENTEROLOGY, V82, P494; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Howe JR, 2004, J MED GENET, V41, P484, DOI 10.1136/jmg.2004.018598; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Jacoby RF, 1997, AM J MED GENET, V70, P361, DOI 10.1002/(SICI)1096-8628(19970627)70:4<361::AID-AJMG6>3.0.CO;2-W; Jiang YF, 2004, CANCER RES, V64, P4539, DOI 10.1158/0008-5472.CAN-03-3650; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; Marsh DJ, 1998, GENE CHROMOSOME CANC, V21, P61, DOI 10.1002/(SICI)1098-2264(199801)21:1<61::AID-GCC8>3.0.CO;2-6; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; MCCOLL I, 1964, P ROY SOC MED, V57, P896; Merg A, 2004, AM J MED GENET C, V129C, P44, DOI 10.1002/ajmg.c.30020; Nassif NT, 2004, ONCOGENE, V23, P617, DOI 10.1038/sj.onc.1207059; Pilarski R, 2004, J MED GENET, V41, P323, DOI 10.1136/jmg.2004.018036; Reifenberger J, 2003, BRIT J DERMATOL, V148, P1040, DOI 10.1046/j.1365-2133.2003.05322.x; Romano PR, 1998, J CELL SCI, V111, P803; SACHATELLO CR, 1975, AM J SURG, V129, P198, DOI 10.1016/0002-9610(75)90298-6; SACHATELLO CR, 1974, SURGERY, V75, P107; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; STEMPER TJ, 1975, ANN INTERN MED, V83, P639, DOI 10.7326/0003-4819-83-5-639; Sweet K, 2005, JAMA-J AM MED ASSOC, V294, P2465, DOI 10.1001/jama.294.19.2465; Tsuchiya KD, 1998, GENE CHROMOSOME CANC, V21, P113, DOI 10.1002/(SICI)1098-2264(199802)21:2<113::AID-GCC6>3.0.CO;2-3; Ul Haque MF, 1998, NAT GENET, V20, P157, DOI 10.1038/2458; Vermeesch JR, 2005, J HISTOCHEM CYTOCHEM, V53, P413, DOI 10.1369/jhc.4A6436.2005; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9; Zigman AF, 1997, GASTROENTEROLOGY, V113, P1433, DOI 10.1053/gast.1997.v113.pm9352843	46	87	88	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN	2006	78	6					1066	1074		10.1086/504301	http://dx.doi.org/10.1086/504301			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	042TZ	16685657	Bronze, Green Published			2022-12-18	WOS:000237553800016
J	Huck, JHJ; Verhoeven, NM; Struys, EA; Salomons, GS; Jakobs, C; van der Knaap, MS				Huck, JHJ; Verhoeven, NM; Struys, EA; Salomons, GS; Jakobs, C; van der Knaap, MS			Ribose-5-phosphate isomerase deficiency: New inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							VANISHING WHITE-MATTER; INITIATION-FACTOR EIF2B; TRANSALDOLASE DEFICIENCY; CEREBROSPINAL-FLUID; POLYOLS; CHILDREN; PLASMA; ENCEPHALOPATHY; NEUROPATHY; MUTATIONS	The present article describes the first patient with a deficiency of ribose-5-phosphate isomerase (RPI) ( Enzyme Commission number 5.3.1.6) who presented with leukoencephalopathy and peripheral neuropathy. Proton magnetic resonance spectroscopy of the brain revealed highly elevated levels of the polyols ribitol and D-arabitol, which were subsequently also found in high concentrations in body fluids. Deficient activity of RPI, one of the pentose-phosphate-pathway (PPP) enzymes, was demonstrated in fibroblasts. RPI gene - sequence analysis revealed a frameshift and a missense mutation. Recently, we described a patient with liver cirrhosis and abnormal polyol levels in body fluids, related to a deficiency of transaldolase, another enzyme in the PPP. RPI is the second known inborn error in the reversible phase of the PPP, confirming that defects in pentose and polyol metabolism constitute a new area of inborn metabolic disorders.	Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, NL-1007 MB Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Clin Chem, Metab Unit, NL-1007 MB Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van der Knaap, MS (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Child Neurol, POB 7057, NL-1007 MB Amsterdam, Netherlands.	ms.vanderknaap@vumc.nl	Huck, Jojanneke/B-1534-2013	Huck, Jojanneke/0000-0002-3853-8581				APEL TW, 1995, GENE, V156, P191, DOI 10.1016/0378-1119(94)00901-4; BERRY GT, 1995, EUR J PEDIATR, V154, pS53, DOI 10.1007/BF02143805; Berry GT, 2001, J PEDIATR-US, V138, P260, DOI 10.1067/mpd.2001.110423; GREENE DA, 1988, DIABETES, V37, P688, DOI 10.2337/diabetes.37.6.688; Greene Douglas A., 1996, P801; HANEFELD F, 1993, NEUROPEDIATRICS, V24, P244, DOI 10.1055/s-2008-1071551; Huck JHJ, 2003, CLIN CHEM, V49, P1375, DOI 10.1373/49.8.1375; JANSEN G, 1986, CLIN CHIM ACTA, V157, P277, DOI 10.1016/0009-8981(86)90303-7; KINOSHIT.JH, 1974, INVEST OPHTH VISUAL, V13, P713; Kristjansdottir R, 1996, NEUROPEDIATRICS, V27, P295, DOI 10.1055/s-2007-973797; KUSMIERZ J, 1989, J CHROMATOGR-BIOMED, V497, P39, DOI 10.1016/0378-4347(89)80003-9; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; SCHIFFMANN R, 1994, ANN NEUROL, V35, P331, DOI 10.1002/ana.410350314; SHETTY HU, 1995, ANAL BIOCHEM, V224, P279, DOI 10.1006/abio.1995.1041; SREDY J, 1991, Journal of Diabetic Complications, V5, P42, DOI 10.1016/0891-6632(91)90010-M; Sundkvist G, 2000, DIABETIC MED, V17, P259, DOI 10.1046/j.1464-5491.2000.00261.x; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; van der Knaap MS, 2003, ANN NEUROL, V53, P252, DOI 10.1002/ana.10456; van der Knaap MS, 1999, RADIOLOGY, V213, P121, DOI 10.1148/radiology.213.1.r99se01121; van der Knaap MS, 1999, ANN NEUROL, V46, P925, DOI 10.1002/1531-8249(199912)46:6<925::AID-ANA18>3.0.CO;2-J; vanderKnaap MS, 1997, NEUROLOGY, V48, P845, DOI 10.1212/WNL.48.4.845; VANDERKNAAP MS, 1995, ANN NEUROL, V37, P324, DOI 10.1002/ana.410370308; Verhoeven NM, 2001, AM J HUM GENET, V68, P1086, DOI 10.1086/320108	24	87	89	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2004	74	4					745	751		10.1086/383204	http://dx.doi.org/10.1086/383204			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	804EA	14988808	Green Published, Bronze			2022-12-18	WOS:000220280800014
J	Fullerton, SM; Bartoszewicz, A; Ybazeta, G; Horikawa, Y; Bell, GI; Kidd, KK; Cox, NJ; Hudson, RR; Di Rienzo, A				Fullerton, SM; Bartoszewicz, A; Ybazeta, G; Horikawa, Y; Bell, GI; Kidd, KK; Cox, NJ; Hudson, RR; Di Rienzo, A			Geographic and haplotype structure of candidate type 2 diabetes-susceptibility variants at the calpain-10 locus	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; SELECTION; FREQUENCIES; POLYMORPHISMS; POPULATIONS; ADMIXTURE	Recently, a positional cloning study proposed that haplotypes at the calpain-10 locus (CAPN10) are associated with increased risk of type 2 diabetes, or non-insulin-dependent diabetes mellitus, in Mexican Americans, Finns, and Germans. To inform the interpretation of the original mapping results and to look for evidence for the action of natural selection on CAPN10, we undertook a population-based genotyping survey of the candidate susceptibility variants. First, we genotyped sites 43, 19, and 63 (the haplotype-defining variants previously proposed) and four closely linked SNPs, in 561 individuals from 11 populations from five continents, and we examined the linkage disequilibrium among them. We then examined the ancestral state of these sites by sequencing orthologous portions of CAPN10 in chimpanzee and orangutan (the identity of sites 43 and 19 was further investigated in a limited sample of other great apes and Old World and New World monkeys). Our survey suggests larger-than-expected differences in the distribution of CAPN10 susceptibility variants between African and non-African populations, with common, derived haplotypes in European and Asian samples (including one of two proposed risk haplotypes) being rare or absent in African samples. These results suggest a history of positive natural selection at the locus, resulting in significant geographic differences in polymorphism frequencies. The relationship of these differences to disease risk is discussed.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; Yale University	Di Rienzo, A (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 507F, Chicago, IL 60637 USA.		Fullerton, Stephanie Malia/H-8696-2019	Fullerton, Stephanie Malia/0000-0002-0938-6048; Di Rienzo, Anna/0000-0002-8982-9098; Ybazeta, Gustavo/0000-0002-0761-9813	NIDDK NIH HHS [R01 DK055889, R01 DK047486, DK55889, DK47486, R01 DK056670, DK20595, DK56670, P60 DK020595, P30 DK020595] Funding Source: Medline; NIGMS NIH HHS [P01 GM057672, GM57672] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056670, P60DK020595, R01DK047486, R01DK055889, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM057672] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baier LJ, 2000, J CLIN INVEST, V106, pR69, DOI 10.1172/JCI10665; BERRY A, 1993, GENETICS, V134, P869; Bowcock A M, 1987, Gene Geogr, V1, P47; Bowcock A M, 1991, Gene Geogr, V5, P151; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Cavalli-Sforza L L, 1994, HIST GEOGRAPHY HUMAN; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; CHAKRABORTY R, 1986, AM J PHYS ANTHROPOL, V70, P489, DOI 10.1002/ajpa.1330700408; Chen XN, 1999, GENOME RES, V9, P492; Cox NJ, 1999, NAT GENET, V21, P213, DOI 10.1038/6002; Evans JC, 2001, AM J HUM GENET, V69, P544, DOI 10.1086/323315; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Garant MJ, 2002, DIABETES, V51, P231, DOI 10.2337/diabetes.51.1.231; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hegele RA, 2001, DIABETES CARE, V24, P1498, DOI 10.2337/diacare.24.8.1498-a; HILL WG, 1974, HEREDITY, V33, P229, DOI 10.1038/hdy.1974.89; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; HUDSON RR, 2001, HDB STAT GENETICS, P309; KARL SA, 1992, SCIENCE, V256, P100, DOI 10.1126/science.1348870; Kidd KK, 1998, HUM GENET, V103, P211, DOI 10.1007/s004390050809; LEWONTIN RC, 1973, GENETICS, V74, P175; Long J, 1999, MULTIPLE LOCUS HAPLO; LONG JC, 1995, AM J HUM GENET, V56, P799; Lynn S, 2002, DIABETES, V51, P247, DOI 10.2337/diabetes.51.1.247; Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200; NEEL JV, 1962, AM J HUM GENET, V14, P353; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Peterson RJ, 1999, GENOME RES, V9, P844, DOI 10.1101/gr.9.9.844; TAYLOR MFJ, 1995, SCIENCE, V270, P1497, DOI 10.1126/science.270.5241.1497; Tishkoff SA, 2000, AM J HUM GENET, V67, P518, DOI 10.1086/303000; Tsai HJ, 2001, AM J HUM GENET, V69, P1236, DOI 10.1086/324646; WEIR, 1996, GENETIC DATA ANAL, V2	32	87	92	0	9	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAY	2002	70	5					1096	1106		10.1086/339930	http://dx.doi.org/10.1086/339930			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	541XT	11891618	Green Published, Bronze			2022-12-18	WOS:000175012400003
J	Piao, XH; Basel-Vanagaite, L; Straussberg, R; Grant, PE; Pugh, EW; Doheny, K; Doan, B; Hong, SE; Shugart, YY; Walsh, CA				Piao, XH; Basel-Vanagaite, L; Straussberg, R; Grant, PE; Pugh, EW; Doheny, K; Doan, B; Hong, SE; Shugart, YY; Walsh, CA			An autosomal recessive form of bilateral frontoparietal polymicrogyria maps to chromosome 16q12.2-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							PERISYLVIAN POLYMICROGYRIA; LINKAGE ANALYSIS; EPILEPSY	Polymicrogyria is a cerebral cortical malformation that is grossly characterized by excessive cortical folding and microscopically characterized by abnormal cortical layering. Although polymicrogyria appears to have one or more genetic causes, no polymicrogyria loci have been identified. Here we describe the clinical and radiographic features of a new genetic form of polymicrogyria and localize the responsible gene. We studied two consanguineous Palestinian pedigrees with an autosomal recessive form of bilateral frontoparietal polymicrogyria (BFPP), using linkage analysis. Five affected children had moderate-to-severe mental retardation, developmental delay, and esotropia, and four of the five affected children developed seizures. Brain magnetic-resonance imaging revealed polymicrogyria that was most prominent in the frontal and parietal lobes but involved other cortical areas as well. A genomewide linkage screen revealed a single locus that was identical by descent in affected children in both families and showed a single disease-associated haplotype, suggesting a common founder mutation. The locus for BFPP maps to chromosome 16q12.2-21, with a minimal interval of 17 cM. For D16S514, the maximal pooled two-point LOD score was 3.98, and the maximal multipoint LOD score was 4.57. This study provides the first genetic evidence that BFPP is an autosomal recessive disorder and serves as a starting point for the identification of the responsible gene.	Harvard Univ, Inst Med 816, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Neurogenet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Radiol, Serv Neuroradiol, Boston, MA 02114 USA; Rabin Med Ctr, Dept Med Genet, Petah Tiqwa, Israel; Schneider Childrens Med Ctr, Dept Child Neurol, Neurogenet Clin, Petah Tiqwa, Israel; Johns Hopkins Univ, Sch Med, Ctr Inherited Dis Res, Baltimore, MD USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Rabin Medical Center; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Walsh, CA (corresponding author), Harvard Univ, Inst Med 816, Beth Israel Deaconess Med Ctr, Dept Neurol,Div Neurogenet, 4 Blackfan Circle, Boston, MA 02115 USA.			Grant, Patricia/0000-0003-1005-4013; YAO, YIN/0000-0003-3053-8429; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Piao, Xianhua/0000-0001-7540-6767	NHGRI NIH HHS [N01 HG 65403, N01HG65403] Funding Source: Medline; NICHD NIH HHS [HD 07466, T32 HD007466] Funding Source: Medline; NINDS NIH HHS [R01 NS035129, R01 NS 35129] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barkovich AJ, 1999, AM J NEURORADIOL, V20, P1814; BARKOVICH AJ, 1995, AM J NEURORADIOL, V16, P822; BARTH PG, 1987, CAN J NEUROL SCI, V14, P1; Borgatti R, 1999, NEUROLOGY, V52, P1910, DOI 10.1212/WNL.52.9.1910; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Guerreiro MM, 2000, ANN NEUROL, V48, P39, DOI 10.1002/1531-8249(200007)48:1<39::AID-ANA7>3.0.CO;2-X; Guerrini R, 1997, ANN NEUROL, V41, P65, DOI 10.1002/ana.410410112; Guerrini R, 2000, NEUROLOGY, V54, P909, DOI 10.1212/WNL.54.4.909; KUZNIECKY R, 1993, LANCET, V341, P608, DOI 10.1016/0140-6736(93)90363-L; Kuzniecky RI, 2001, BRAIN DEV-JPN, V23, P2, DOI 10.1016/S0387-7604(00)00195-9; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Raybaud C, 1996, DYSPLASIAS OF CEREBRAL CORTEX AND EPILEPSY, P131; Straussberg R, 1996, CLIN GENET, V50, P498; Sztriha L, 2000, PEDIATR NEUROL, V22, P240, DOI 10.1016/S0887-8994(99)00142-3; Yoshimura K, 1998, PEDIATR NEUROL, V18, P435, DOI 10.1016/S0887-8994(97)00214-2	16	87	88	0	5	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2002	70	4					1028	1033		10.1086/339552	http://dx.doi.org/10.1086/339552			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	528PL	11845408	Green Published, Bronze			2022-12-18	WOS:000174252100021
J	Goobie, S; Popovic, M; Morrison, J; Ellis, L; Ginzberg, H; Boocock, GRB; Ehtesham, N; Betard, C; Brewer, CG; Roslin, NM; Hudson, TJ; Morgan, K; Fujiwara, TM; Durie, PR; Rommens, JM				Goobie, S; Popovic, M; Morrison, J; Ellis, L; Ginzberg, H; Boocock, GRB; Ehtesham, N; Betard, C; Brewer, CG; Roslin, NM; Hudson, TJ; Morgan, K; Fujiwara, TM; Durie, PR; Rommens, JM			Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; HUMAN GENOME; GENE; TRANSLOCATION; MONOSOMY-7; INSUFFICIENCY; DUPLICATIONS; NEOPLASIA; LEUKEMIA; CLUSTER	Shwachman-Diamond syndrome (SDS) is an autosomal recessive disorder characterized by exocrine pancreatic insufficiency and hematologic and skeletal abnormalities. A genomewide scan of families with SDS was terminated at similar to 50% completion, with the identification of chromosome 7 markers that showed linkage with the disease. Finer mapping revealed significant linkage across a broad interval that included the centromere. The maximum two-point LOD score was 8.7, with D7S473, at a recombination fraction of 0. The maximum multipoint LOD score was 10, in the interval between D7S499 and D7S482 (5.4 cM on the female map and 0 cM on the male map), a region delimited by recombinant events detected in affected children. Evidence from all 15 of the multiplex families analyzed provided support for the linkage, consistent with a single locus for SDS. However, the presence of several different mutations is suggested by the heterogeneity of disease-associated haplotypes in the candidate region.	Hosp Sick Children, Program Genet & Genom Biol, Res Inst, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Integrat Biol, Res Inst, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Gastroenterol & Nutr, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON, Canada; Univ Toronto, Dept Paediat, Toronto, ON, Canada; McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada; Montreal Genome Ctr, Montreal, PQ, Canada; McGill Univ, Dept Human Genet, Montreal, PQ, Canada; McGill Univ, Dept Med, Montreal, PQ, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; McGill University; McGill University; McGill University	Rommens, JM (corresponding author), Hosp Sick Children, Program Genet & Genom Biol, Res Inst, Room 11-109A,Elm Wing,Annex,555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Rommens, Johanna/AAT-7465-2021	Roslin, Nicole/0000-0002-4609-8299				AGGETT PJ, 1980, ARCH DIS CHILD, V55, P331, DOI 10.1136/adc.55.5.331; BODIAN M, 1964, ACTA PAEDIATR, V53, P282, DOI 10.1111/j.1651-2227.1964.tb07237.x; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; BURKE V, 1967, ARCH DIS CHILD, V42, P147, DOI 10.1136/adc.42.222.147; Collins A, 1996, P NATL ACAD SCI USA, V93, P14771, DOI 10.1073/pnas.93.25.14771; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DHAR S, 1994, J BONE JOINT SURG AM, V76A, P278, DOI 10.2106/00004623-199402000-00018; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dror Y, 1998, LEUKEMIA, V12, P1591, DOI 10.1038/sj.leu.2401147; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; Duval A, 2000, CANCER GENET CYTOGEN, V119, P67, DOI 10.1016/S0165-4608(99)00204-6; Eichler EE, 1999, HUM MOL GENET, V8, P151, DOI 10.1093/hmg/8.2.151; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Ginzberg H, 1999, J PEDIATR-US, V135, P81, DOI 10.1016/S0022-3476(99)70332-X; Ginzberg H, 2000, AM J HUM GENET, V66, P1413, DOI 10.1086/302856; Goobie S, 1999, AM J MED GENET, V85, P171, DOI 10.1002/(SICI)1096-8628(19990716)85:2<171::AID-AJMG12>3.0.CO;2-K; HILL RE, 1982, GASTROENTEROLOGY, V83, P22; HUDSON TJ, 1997, CURRENT PROTOCOLS HU; HUIJGENS PC, 1977, SCAND J HAEMATOL, V18, P20; Ikegawa S, 1999, CLIN GENET, V55, P466, DOI 10.1034/j.1399-0004.1999.550612.x; Jackson MS, 1999, HUM MOL GENET, V8, P205, DOI 10.1093/hmg/8.2.205; KENT A, 1990, ARCH DIS CHILD, V65, P1349, DOI 10.1136/adc.65.12.1349; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEAL SM, 1990, AM J HUM GENET S, V47, pA188; Lo AWI, 1999, GENOME RES, V9, P895, DOI 10.1101/gr.9.10.895; LUNAFINEMAN S, 1995, BLOOD, V85, P1985, DOI 10.1182/blood.V85.8.1985.bloodjournal8581985; Mack DR, 1996, GASTROENTEROLOGY, V111, P1593, DOI 10.1016/S0016-5085(96)70022-7; Maserati E, 2000, CANCER GENET CYTOGEN, V121, P167, DOI 10.1016/S0165-4608(00)00246-6; MASUNO M, 1995, J MED GENET, V32, P894, DOI 10.1136/jmg.32.11.894; MERTENS F, 1994, GENE CHROMOSOME CANC, V10, P221, DOI 10.1002/gcc.2870100402; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Rioux JD, 1998, AM J HUM GENET, V63, P1086, DOI 10.1086/302053; Ritchie RJ, 1998, HUM MOL GENET, V7, P1253, DOI 10.1093/hmg/7.8.1253; SAVILAHTI E, 1984, ACTA PAEDIATR SCAND, V73, P642, DOI 10.1111/j.1651-2227.1984.tb09989.x; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHMERLIN.DH, 1969, HELV PAEDIATR ACTA, V24, P547; SHWACHMAN H, 1964, J PEDIATR, V65, P645; Smith OP, 1996, BRIT J HAEMATOL, V94, P279, DOI 10.1046/j.1365-2141.1996.d01-1788.x; Sokolic RA, 1999, CANCER GENET CYTOGEN, V115, P106, DOI 10.1016/S0165-4608(99)00098-9; Stewart EA, 1997, GENOME RES, V7, P422, DOI 10.1101/gr.7.5.422; WEVRICK R, 1991, NUCLEIC ACIDS RES, V19, P2295, DOI 10.1093/nar/19.9.2295; WOODS WG, 1981, J PEDIATR-US, V99, P425, DOI 10.1016/S0022-3476(81)80336-8	45	87	97	0	4	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	2001	68	4					1048	1054		10.1086/319505	http://dx.doi.org/10.1086/319505			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	414KQ	11254457	Green Published, Bronze			2022-12-18	WOS:000167666000025
J	Periquet, M; Lucking, CB; Vaughan, JR; Bonifati, V; Durr, A; De Michele, G; Horstink, MW; Farrer, M; Illarioshkin, SN; Pollak, P; Borg, M; Brefel-Courbon, C; Denefle, P; Meco, G; Gasser, T; Breteler, MMB; Wood, NW; Agid, Y; Brice, A				Periquet, M; Lucking, CB; Vaughan, JR; Bonifati, V; Durr, A; De Michele, G; Horstink, MW; Farrer, M; Illarioshkin, SN; Pollak, P; Borg, M; Brefel-Courbon, C; Denefle, P; Meco, G; Gasser, T; Breteler, MMB; Wood, NW; Agid, Y; Brice, A		French Parkinsons Dis Genetics Stu; European Consortium Genetic Suscep	Origin of the mutations in the parkin gene in europe: Exon rearrangements are independent recurrent events, whereas point mutations may result from founder effects	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							JUVENILE PARKINSONISM; HOMOZYGOUS DELETIONS; JAPANESE FAMILIES; DISEASE; ONSET; CMT1A; RECOMBINATION; BREAKPOINTS; LINKAGE	A wide variety of mutations in the parkin gene, including exon deletions and duplications, as well as point mutations, result in autosomal recessive early-onset parkinsonism. Interestingly, several of these anomalies were found repeatedly in unrelated patients and may therefore result from recurrent, de novo mutational events or from founder effects. In the present study, haplotype analysis, using 10 microsatellite markers covering a 4.7-cM region known to contain the parkin gene, was performed in 48 families, mostly from European countries, with early-onset autosomal recessive parkinsonism. The patients carried 14 distinct mutations in the parkin gene, and each mutation was detected in more than one family. Our results support the hypothesis that exon rearrangements occurred independently, whereas some point mutations, found in families from different geographic origins, may have been transmitted by a common founder.	Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris 13, France; Hop La Pitie Salpetriere, Consultat Genet Med, F-75651 Paris 13, France; Hop La Pitie Salpetriere, Federat Neurol, F-75651 Paris 13, France; Inst Neurol, London WC1N 3BG, England; Univ Roma La Sapienza, Dipartimento Sci Neurol, Rome, Italy; Univ Naples Federico II, Dipartimento Sci Neurol, Naples, Italy; Acad Ziekenhuis, Nijmegen, Netherlands; Mayo Clin, Neurogenet Lab, Dept Neurosci, Jacksonville, FL 32224 USA; Mayo Clin, Neurogenet Lab, Dept Neurol, Jacksonville, FL 32224 USA; Inst Neurol, Dept Neurogenet, Moscow, Russia; CHU Grenoble, Neurol Clin, F-38043 Grenoble, France; Hop Louis Pasteur, Serv Neurol, F-06002 Nice, France; Fac Med Toulouse, INSERM, Serv Pharmacol Clin, U317, F-31073 Toulouse, France; Aventis Pharma, Dept Biotechnol, Vitry Sur Seine, France; Univ Munich, Neurol Klin, Munich, Germany; Dept Epidemiol & Biostat, Rotterdam, Netherlands	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Sapienza University Rome; University of Naples Federico II; Mayo Clinic; Mayo Clinic; Research Center of Neurology; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); Sanofi-Aventis; Sanofi France; University of Munich	Brice, A (corresponding author), Hop La Pitie Salpetriere, INSERM, U289, 47 Blvd Hop, F-75651 Paris 13, France.	brice@ccr.jussieu.fr	brice, alexis/AAE-8275-2019; Illarioshkin, Sergey N/C-4728-2012; Illarioshkin, Sergey N/C-9033-2012; Wood, Nicholas W/C-2505-2009; Breteler, Monique M.B./J-5058-2014; Gasser, Thomas/GNH-5293-2022; Brice, Alexis/A-2170-2009	brice, alexis/0000-0002-0941-3990; Wood, Nicholas W/0000-0002-9500-3348; Breteler, Monique M.B./0000-0002-0626-9305; Gasser, Thomas/0000-0002-1069-1146; tranchant, christine/0000-0002-2895-1292; Farrer, Matthew/0000-0003-1159-5321; Illarioshkin, Sergey/0000-0002-2704-6282				Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Asakawa S, 2000, AM J HUM GENET, V67, P398; CHANCE PF, 1993, CELL, V72, P143, DOI 10.1016/0092-8674(93)90058-X; de Silva HA, 2000, CURR OPIN GENET DEV, V10, P292; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Deragon JM, 2000, ANN MED, V32, P264, DOI 10.3109/07853890009011771; Elbaz A, 1999, NEUROLOGY, V52, P1876, DOI 10.1212/WNL.52.9.1876; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Hattori N, 1998, ANN NEUROL, V44, P935, DOI 10.1002/ana.410440612; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Ishikawa A, 1996, NEUROLOGY, V47, P160, DOI 10.1212/WNL.47.1.160; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; KIYOSAWA H, 1995, HUM MOL GENET, V4, P2327, DOI 10.1093/hmg/4.12.2327; Klein C, 2000, ANN NEUROL, V48, P65, DOI 10.1002/1531-8249(200007)48:1<65::AID-ANA10>3.0.CO;2-L; Leroy E, 1998, HUM GENET, V103, P424, DOI 10.1007/s004390050845; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Lopes J, 1999, HUM MOL GENET, V8, P2285, DOI 10.1093/hmg/8.12.2285; Lucking CB, 1998, LANCET, V352, P1355, DOI 10.1016/S0140-6736(05)60746-5; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Maruyama M, 2000, ANN NEUROL, V48, P245, DOI 10.1002/1531-8249(200008)48:2<245::AID-ANA15>3.0.CO;2-2; Mori H, 1998, NEUROLOGY, V51, P890, DOI 10.1212/WNL.51.3.890; Munoz E, 2000, NEUROSCI LETT, V289, P66, DOI 10.1016/S0304-3940(00)01248-9; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Stevanin G, 1999, EUR J HUM GENET, V7, P889, DOI 10.1038/sj.ejhg.5200392; TAKAHASHI H, 1994, NEUROLOGY, V44, P437, DOI 10.1212/WNL.44.3_Part_1.437; Tassin J, 1998, AM J HUM GENET, V63, P88, DOI 10.1086/301934; VANDEWARRENBURG BP, IN PRESS NEUROLOGY; Yamamura Y, 2000, BRAIN DEV-JPN, V22, pS87; YEN PH, 1990, CELL, V61, P603, DOI 10.1016/0092-8674(90)90472-Q	32	87	96	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAR	2001	68	3					617	626		10.1086/318791	http://dx.doi.org/10.1086/318791			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	402ND	11179010	Green Published, Bronze			2022-12-18	WOS:000166994200007
J	Klomp, LWJ; de Koning, TJ; Malingre, HEM; van Beurden, EACM; Brink, M; Opdam, FL; Duran, M; Jaeken, J; Pineda, M; van Maldergem, L; Poll-The, BT; van den Berg, IET; Berger, R				Klomp, LWJ; de Koning, TJ; Malingre, HEM; van Beurden, EACM; Brink, M; Opdam, FL; Duran, M; Jaeken, J; Pineda, M; van Maldergem, L; Poll-The, BT; van den Berg, IET; Berger, R			Molecular characterization of 3-phosphoglycerate dehydrogenase deficiency - A neurometabolic disorder associated with reduced L-serine biosynthesis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							BLOOD-BRAIN-BARRIER; HIPPOCAMPAL-NEURONS; ENZYMIC IMBALANCE; RAT-LIVER; METABOLISM; GLYCINE; EXPRESSION; RECEPTORS; RACEMASE; TISSUES	3-phosphoglycerate dehydrogenase (PHGDH) deficiency is a disorder of L-serine biosynthesis that is characterized by congenital microcephaly, psychomotor retardation, and seizures. To investigate the molecular basis for this disorder, the PHGDH mRNA sequence was characterized, and six patients from four families were analyzed for sequence variations. Five patients from three different families were homozygous for a single nucleotide substitution predicted to change valine at position 490 to methionine. The sixth patient was homozygous for a valine to methionine substitution at position 425; both mutations are located in the carboxyterminal part of PHGDH. In vitro expression of these mutant proteins resulted in significant reduction of PHGDH enzyme activities. RNA-blot analysis indicated abundant expression of PHGDH in adult and fetal brain tissue. Taken together with the severe neurological impairment in our patients, the data presented in this paper suggest an important role for PHGDH activity and L-serine biosynthesis in the metabolism, development, and function of the central nervous system.	Univ Utrecht, Med Ctr, Dept Metab Dis, NL-3584 AE Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Pediat Gastroenterol, NL-3584 AE Utrecht, Netherlands; Katholieke Univ Leuven, Dept Pediat, Louvain, Belgium; Univ Barcelona, Hosp St Joan Deu, Barcelona, Spain; Ctr Genet Humaine, Inst Pathol & Genet, Loverval, Belgium	Utrecht University; Utrecht University; KU Leuven; University of Barcelona	Klomp, LWJ (corresponding author), Univ Utrecht, Med Ctr, Dept Metab Dis, Wilhelmina Childrens Hosp, Room KC-02-069-1,Lundlaan 6, NL-3584 AE Utrecht, Netherlands.		Van Maldergem, Lionel/G-9849-2017; Van Maldergem, Lionel/O-3242-2019; De Koning, Tom J/AAE-1323-2020	Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; De Koning, Tom J/0000-0001-5609-1309; Poll-The, Bwee Tien/0000-0002-8118-5419				Achouri Y, 1997, BIOCHEM J, V323, P365, DOI 10.1042/bj3230365; Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; COX DR, 1990, SCIENCE, V250, P245, DOI 10.1126/science.2218528; DALY EC, 1974, J NEUROCHEM, V22, P877, DOI 10.1111/j.1471-4159.1974.tb04312.x; de Koning TJ, 1999, NEUROPEDIATRICS, V30, P1, DOI 10.1055/s-2007-973447; de Koning TJ, 1998, ANN NEUROL, V44, P261, DOI 10.1002/ana.410440219; Grant GA, 1996, PROTEIN SCI, V5, P34; Ho CL, 1999, J BIOL CHEM, V274, P397, DOI 10.1074/jbc.274.1.397; Jaeken J, 1996, ARCH DIS CHILD, V74, P542, DOI 10.1136/adc.74.6.542; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; MATSUI T, 1995, J NEUROCHEM, V65, P454; Mitoma J, 1998, J BIOL CHEM, V273, P19363, DOI 10.1074/jbc.273.31.19363; Mitoma J, 1998, NEUROSCI RES, V30, P195, DOI 10.1016/S0168-0102(97)00113-2; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; Narkewicz MR, 1996, BIOCHEM J, V313, P991, DOI 10.1042/bj3130991; Pineda M, 2000, DEV MED CHILD NEUROL, V42, P629, DOI 10.1017/S0012162200001171; PINEDA M, 1986, TRENDS BIOCHEM SCI, V11, P241; SAVOCA R, 1995, J NEUROSCI METH, V61, P159, DOI 10.1016/0165-0270(95)00038-V; SCHULLER DJ, 1995, NAT STRUCT BIOL, V2, P69, DOI 10.1038/nsb0195-69; SMITH QR, 1987, J NEUROCHEM, V49, P1651, DOI 10.1111/j.1471-4159.1987.tb01039.x; SNELL K, 1984, ADV ENZYME REGUL, V22, P325, DOI 10.1016/0065-2571(84)90021-9; SNELL K, 1988, BRIT J CANCER, V57, P87, DOI 10.1038/bjc.1988.15; SNELL K, 1987, BIOCHEM J, V245, P609, DOI 10.1042/bj2450609; SNELL K, 1986, BIOCHEM J, V233, P617, DOI 10.1042/bj2330617; TOBEY KL, 1986, J BIOL CHEM, V261, P2179; WALTER MA, 1994, NAT GENET, V7, P22, DOI 10.1038/ng0594-22; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Xue HH, 1999, J BIOL CHEM, V274, P16028, DOI 10.1074/jbc.274.23.16028; Xue HH, 1999, J BIOL CHEM, V274, P16020, DOI 10.1074/jbc.274.23.16020; YOUSSOUFIAN H, 1988, AM J HUM GENET, V42, P718	31	87	90	0	7	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	2000	67	6					1389	1399		10.1086/316886	http://dx.doi.org/10.1086/316886			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	378WE	11055895	Green Published, Bronze			2022-12-18	WOS:000165607600004
J	Knoblauch, H; Muller-Myhsok, B; Busjahn, A; Ben Avi, L; Bahring, S; Baron, H; Heath, SC; Uhlmann, R; Faulhaber, HD; Shpitzen, S; Aydin, A; Reshef, A; Rosenthal, M; Eliav, O; Muhl, A; Lowe, A; Schurr, D; Harats, D; Jeschke, E; Friedlander, Y; Schuster, H; Luft, FC; Leitersdorf, E				Knoblauch, H; Muller-Myhsok, B; Busjahn, A; Ben Avi, L; Bahring, S; Baron, H; Heath, SC; Uhlmann, R; Faulhaber, HD; Shpitzen, S; Aydin, A; Reshef, A; Rosenthal, M; Eliav, O; Muhl, A; Lowe, A; Schurr, D; Harats, D; Jeschke, E; Friedlander, Y; Schuster, H; Luft, FC; Leitersdorf, E			A cholesterol-lowering gene maps to chromosome 13q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MULTIPOINT LINKAGE ANALYSIS; LDL-RECEPTOR GENE; SIB-PAIR ANALYSIS; FAMILIAL HYPERCHOLESTEROLEMIA; QUANTITATIVE TRAITS; HOMEOSTASIS; PHENOTYPE; PLASMA; TWINS; LOCI	A cholesterol-lowering gene has been postulated from familial hypercholesterolemia (FH) families having heterozygous persons with normal LDL levels and homozygous individuals with LDL levels similar to those in persons with heterozygous FH. We studied such a family with FH thar also had members without FH and with lower-than-normal LDL levels. We performed linkage analyses and identified a locus at 13q, defined by markers D13S156 and D13S158. FASTLINK and GENE-HUNTER yielded LOD scores >5 and >4, respectively, whereas an affected-sib-pair analysis gave a peak multipoint LOD score of 4.8, corresponding to a P value of 1.26 x 10(-6). A multipoint quantitative-trait-locus (QTL) linkage analysis with maximum-likelihood binomial QTL verified this locus as a QTL for LDL levels. To test the relevance of this QTL in an independent normal population, we studied MZ and DZ twin subjects. An MZ-DZ comparison confirmed genetic variance with regard to lipid concentrations. We then performed an identity-by-descent linkage analysis on the DZ twins, with markers at the 13q locus. We found strong:evidence for linkage at this locus with LDL (P<.0002), HDL (P<.004), total cholesterol (P<.0002), and body-mass index (P<.0001). These data provide support for the existence of a new gene influencing lipid concentrations in humans.	Franz Volhard Clin, D-13125 Berlin, Germany; Max Delbruck Ctr Mol Med, Hamburg, Germany; Bernhard Nocht Inst Trop Med, Hamburg, Germany; Hadassah Univ Hosp, Dept Med, Ctr Res Prevent & treatment Atherosclerosis, IL-91240 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Publ Hlth, Dept Social Med, Hadassah Sch Publ Hlth, Jerusalem, Israel; Rockefeller Univ, Lab State Genet, New York, NY 10021 USA; PE Biosyst, Foster City, CA USA; Chaim Sheba Med Ctr, Inst Lipid & Atherosclerosis Res, IL-52621 Tel Hashomer, Israel	Franz-Volhard Clinical Research Center; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Bernhard Nocht Institut fur Tropenmedizin; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Rockefeller University; Chaim Sheba Medical Center	Luft, FC (corresponding author), Franz Volhard Clin, Wiltberg Str 50, D-13125 Berlin, Germany.		Busjahn, Andreas/F-9936-2011; Heath, Simon C/J-4138-2012; Busjahn, Andreas/P-5023-2019; Müller-Myhsok, Bertram/A-3289-2013	Heath, Simon C/0000-0002-9550-0897; Busjahn, Andreas/0000-0001-9650-6919; Luft, Friedrich/0000-0002-8635-1199				Abel L, 1998, AM J HUM GENET, V63, P638, DOI 10.1086/301958; Aksentijevich I, 1999, AM J HUM GENET, V64, P949, DOI 10.1086/302327; Alcais A, 1999, GENET EPIDEMIOL, V17, P102, DOI 10.1002/(SICI)1098-2272(1999)17:2<102::AID-GEPI2>3.0.CO;2-6; Austin MA, 1998, AM J HUM GENET, V62, P406, DOI 10.1086/301712; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Busjahn A, 1999, CIRCULATION, V99, P3161, DOI 10.1161/01.CIR.99.24.3161; COLLINS DR, 1988, NUCLEIC ACIDS RES, V16, P8361, DOI 10.1093/nar/16.17.8361; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DAVIS CG, 1986, CELL, V45, P15, DOI 10.1016/0092-8674(86)90533-7; Eaves LJ, 1996, BEHAV GENET, V26, P519, DOI 10.1007/BF02359757; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fulker DW, 1996, BEHAV GENET, V26, P527, DOI 10.1007/BF02359758; Gould AL, 1998, CIRCULATION, V97, P946; Grundy SM, 1997, ARCH INTERN MED, V157, P1177, DOI 10.1001/archinte.157.11.1177; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; HIXON JE, 1990, J LIPID RES, V31, P545; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; HOBBS HH, 1989, J CLIN INVEST, V84, P656, DOI 10.1172/JCI114212; KHACHADURIAN AK, 1964, AM J MED, V37, P402, DOI 10.1016/0002-9343(64)90196-2; Knoblauch H, 1997, ARTERIOSCL THROM VAS, V17, P2054, DOI 10.1161/01.ATV.17.10.2054; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; KRUGLYAK L, 1995, AM J HUM GENET, V57, P439; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEITERSDORF E, 1991, J LIPID RES, V32, P1513; Neale M.C.C.L., 2013, METHODOLOGY GENETIC, V67, DOI DOI 10.1007/978-94-015-8018-2; NEALE MC, 1997, MX STAT MODELING; NORA JJ, 1985, AM J MED GENET, V22, P585, DOI 10.1002/ajmg.1320220317; SLIMANE MN, 1993, ATHEROSCLEROSIS, V104, P153, DOI 10.1016/0021-9150(93)90186-X; SPRECHER DL, 1984, AM J CARDIOL, V54, P20, DOI 10.1016/0002-9149(84)90298-4; SUN XM, 1994, ARTERIOSCLER THROMB, V14, P85, DOI 10.1161/01.ATV.14.1.85; Veske A, 1996, HUM MOL GENET, V5, P165, DOI 10.1093/hmg/5.1.165; Welch CL, 1996, J LIPID RES, V37, P1406; WILLIAMS RR, 1996, MEDPED INTEGRATED GE	34	87	89	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2000	66	1					157	166		10.1086/302704	http://dx.doi.org/10.1086/302704			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279FK	10631147	Green Published, Bronze			2022-12-18	WOS:000085033600018
J	Arredondo-Vega, FX; Santisteban, I; Daniels, S; Toutain, S; Hershfield, MS				Arredondo-Vega, FX; Santisteban, I; Daniels, S; Toutain, S; Hershfield, MS			Adenosine deaminase deficiency: Genotype-phenotype correlations based on expressed activity of 29 mutant alleles	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; LYMPHOBLAST CELL-LINES; 5' SPLICE-SITE; MISSENSE MUTATION; ESCHERICHIA-COLI; DEOXYADENOSINE TRIPHOSPHATE; GUANOSINE KINASE; ADA DEFICIENCY; MESSENGER-RNA; GENE	Adenosine deaminase (ADA) deficiency causes lymphopenia and immunodeficiency due to toxic effects of its substrates. Most patients are infants with severe combined immunodeficiency disease (SCID), but others are diagnosed later in childhood (delayed onset) or as adults (late onset); healthy individuals with "partial" ADA deficiency have been identified. More than 50 ADA mutations are known; most patients are heteroallelic, and most alleles are rare. To analyze the relationship of genotype to phenotype, we quantitated the expression of 29 amino acid sequence-altering alleles in the ADA-deleted Escherichia coli strain SO3834. Expressed ADA activity of wild-type and mutant alleles ranged over five orders of magnitude. The 26 disease-associated alleles expressed 0.001%-0.6% of wild-type activity, versus 5%-28% for 3 alleles from "partials." We related these data to the clinical phenotypes and erythrocyte deoxyadenosine nucleotide (dAXP) levels of 52 patients (49 immunodeficient and 3 with partial deficiency) who had 43 genotypes derived from 42 different mutations, including 28 of the expressed alleles. We reduced this complexity to 13 "genotype categories," ranked according to the potential of their constituent alleles to provide ADA activity. Of 31 SCID patients, 28 fell into 3 genotype categories that could express less than or equal to 0.05% of wildtype ADA activity. Only 2 of 21 patients with delayed, late-onset, or partial phenotypes had one of these "severe" genotypes. Among 37 patients for whom pretreatment metabolic data were available, we found a strong inverse correlation between red-cell dAXP level and total ADA activity expressed by each patient's alleles in S circle divide 3834. Our system provides a quantitative framework and ranking system for relating genotype to phenotype.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Duke University	Hershfield, MS (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3049, Durham, NC 27710 USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020902] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK20902] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AKESON AL, 1987, P NATL ACAD SCI USA, V84, P5947, DOI 10.1073/pnas.84.16.5947; AKESON AL, 1988, J BIOL CHEM, V263, P16291; ARREDONDOVEGA FX, 1990, J CLIN INVEST, V86, P444, DOI 10.1172/JCI114730; ARREDONDOVEGA FX, 1994, AM J HUM GENET, V54, P820; Arrendondo-Vega F X, 1998, Hum Mutat, V11, P482, DOI 10.1002/(SICI)1098-1004(1998)11:6<482::AID-HUMU14>3.0.CO;2-H; ATASOY U, 1993, HUM MOL GENET, V2, P1307, DOI 10.1093/hmg/2.8.1307; BAGNARA AS, 1982, P NATL ACAD SCI-BIOL, V79, P2673, DOI 10.1073/pnas.79.8.2673; Bollinger ME, 1996, NEW ENGL J MED, V334, P1367, DOI 10.1056/NEJM199605233342104; BONTHRON DT, 1985, J CLIN INVEST, V76, P894, DOI 10.1172/JCI112050; BORY C, 1990, PEDIATR RES, V28, P127, DOI 10.1203/00006450-199028020-00010; Buckley RH, 1997, J PEDIATR-US, V130, P378, DOI 10.1016/S0022-3476(97)70199-9; CHANG Z, 1991, BIOCHEMISTRY-US, V30, P2273, DOI 10.1021/bi00222a033; COHEN A, 1978, P NATL ACAD SCI USA, V75, P472, DOI 10.1073/pnas.75.1.472; DADDONA PE, 1985, J BIOL CHEM, V260, P3875; GEFFNER ME, 1986, AM J DIS CHILD, V140, P1194, DOI 10.1001/archpedi.1986.02140250120047; GIBLETT ER, 1972, LANCET, V2, P1067; GOSSAGE DL, 1993, HUM MOL GENET, V2, P1493, DOI 10.1093/hmg/2.9.1493; HERSHFIELD MS, 1993, PEDIATR RES, V33, pS42; HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005; Hershfield MS, 1995, METABOLIC MOL BASES, V2, P1725; HIRSCHHORN R, 1992, J IMMUNOL, V149, P3107; HIRSCHHORN R, 1990, P NATL ACAD SCI USA, V87, P6171, DOI 10.1073/pnas.87.16.6171; HIRSCHHORN R, 1991, AM J HUM GENET, V49, P878; HIRSCHHORN R, 1995, CLIN IMMUNOL IMMUNOP, V76, pS219, DOI 10.1016/S0090-1229(95)90288-0; Hirschhorn R., 1992, Human Mutation, V1, P166, DOI 10.1002/humu.1380010214; HIRSCHHORN R, 1979, J CLIN INVEST, V64, P1130, DOI 10.1172/JCI109552; HIRSCHHORN R, 1994, AM J HUM GENET, V55, P59; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; Hirschhorn R, 1997, HUM GENET, V100, P22, DOI 10.1007/s004390050460; HIRSCHHORN R, 1993, CELL IMMUNOL, V152, P383, DOI 10.1006/cimm.1993.1299; HIRSCHHORN R, 1986, AM J HUM GENET, V38, P13; HIRSCHHORN R, 1979, CIBA F S, V68, P35; HOVEJENSEN B, 1989, J GEN MICROBIOL, V135, P1263; IBRAHIM MM, 1995, BIOCHEM BIOPH RES CO, V209, P407, DOI 10.1006/bbrc.1995.1518; JENKINS T, 1976, J PEDIATR-US, V89, P732, DOI 10.1016/S0022-3476(76)80792-5; JOCHIMSEN B, 1975, MOL GEN GENET, V143, P85, DOI 10.1007/BF00269424; LEVY Y, 1988, J PEDIATR-US, V113, P312, DOI 10.1016/S0022-3476(88)80271-3; MARKERT ML, 1988, J CLIN INVEST, V81, P1323, DOI 10.1172/JCI113458; MARKERT ML, 1987, J CLIN IMMUNOL, V7, P389, DOI 10.1007/BF00917017; MIGCHIELSEN AAJ, 1995, NAT GENET, V10, P279, DOI 10.1038/ng0795-279; Ozsahin H, 1997, BLOOD, V89, P2849, DOI 10.1182/blood.V89.8.2849; SANTISTEBAN I, 1995, HUM MOL GENET, V4, P2081, DOI 10.1093/hmg/4.11.2081; SANTISTEBAN I, 1993, J CLIN INVEST, V92, P2291, DOI 10.1172/JCI116833; SANTISTEBAN I, 1995, HUM MUTAT, V5, P243, DOI 10.1002/humu.1380050309; SHOVLIN CL, 1993, LANCET, V341, P1471, DOI 10.1016/0140-6736(93)90910-9; SHOVLIN CL, 1994, J IMMUNOL, V153, P2331; SIAW MFE, 1980, P NATL ACAD SCI-BIOL, V77, P6157, DOI 10.1073/pnas.77.10.6157; SPENCER N, 1968, ANN HUM GENET, V32, P9, DOI 10.1111/j.1469-1809.1968.tb00044.x; STEPHAN JL, 1993, J PEDIATR-US, V123, P564, DOI 10.1016/S0022-3476(05)80951-5; UMETSU DT, 1994, J ALLERGY CLIN IMMUN, V93, P543, DOI 10.1016/0091-6749(94)90365-4; WAKAMIYA M, 1995, P NATL ACAD SCI USA, V92, P3673, DOI 10.1073/pnas.92.9.3673; WEINBERG K, 1993, J CLIN INVEST, V92, P596, DOI 10.1172/JCI116626; WIGINTON DA, 1982, J BIOL CHEM, V257, P3211; WIGINTON DA, 1984, NUCLEIC ACIDS RES, V12, P2439, DOI 10.1093/nar/12.5.2439; WIGINTON DA, 1986, BIOCHEMISTRY-US, V25, P8234, DOI 10.1021/bi00373a017; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539	56	87	90	0	7	UNIV CHICAGO PRESS	CHICAGO	5801 S ELLIS AVENUE, CHICAGO, IL 60637 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1998	63	4					1049	1059		10.1086/302054	http://dx.doi.org/10.1086/302054			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	131LP	9758612	Bronze, Green Published			2022-12-18	WOS:000076577800017
J	Adato, A; Weil, D; Kalinski, H; PelOr, Y; Ayadi, H; Petit, C; Korostishevsky, M; BonneTamir, B				Adato, A; Weil, D; Kalinski, H; PelOr, Y; Ayadi, H; Petit, C; Korostishevsky, M; BonneTamir, B			Mutation profile of all 49 exons of the human myosin VIIA gene, and haplotype analysis, in Usher 1B families from diverse origins	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SYNDROME TYPE-I; DOMAIN-STRUCTURE; CHROMOSOME-11; SUBSTITUTIONS; LOCALIZATION; SUPERFAMILY; SHAKER-1; LINKAGE	Usher syndrome types I (USH1A-USH1E) are a group of autosomal recessive diseases characterized by profound congenital hearing loss, vestibular areflexia, and progressive visual loss due to retinitis pigmentosa. The human myosin VIIA gene, located on 11q14, has been shown to be responsible for Usher syndrome type 1B (USH1B). Haplotypes were constructed in 28 USH1 families by use of the following polymorphic markers spanning the USH1B locus: D11S787, D11S527, D11S1783, D11S906, D11S4186, and OMP. Affected individuals and members of their families from 12 different ethnic origins were screened for the presence of mutations in all 49 exons of the myosin VIIA gene. In 15 families myosin VIIA mutations were detected, verifying their classification as USH1B. All these mutations are novel, including three missense mutations, one premature stop codon, two splicing mutations, one frameshift, and one deletion of >2 kb comprising exons 47 and 48, a part of exon 43, and the introns between them. Three mutations were shared by more than one family, consistent with haplotype similarities. Altogether, 16 USH1B haplotypes were observed in the 15 families; most haplotypes were population specific. Several exonic and intronic polymorphisms were also detected. None of the 20 known USH1B mutations reported so far in other world populations were identified in our families.	SACKLER SCH MED, DEPT HUMAN GENET, IL-69978 RAMAT AVIV, ISRAEL; INST PASTEUR, CNRS, UNITE GENET MOL HUMAINE, PARIS, FRANCE; FAC MED, LAB IMMUNOL & BIOL MOL, SFAX, TUNISIA	Tel Aviv University; Sackler Faculty of Medicine; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Universite de Sfax				Petit, Christine/0000-0002-9069-002X				BONNETAMIR B, 1994, GENOMICS, V20, P36, DOI 10.1006/geno.1994.1124; Chaib H, 1997, HUM MOL GENET, V6, P27, DOI 10.1093/hmg/6.1.27; Chen ZY, 1996, GENOMICS, V36, P440, DOI 10.1006/geno.1996.0489; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; DAVENPORT SLH, 1977, INT C SER, V215, P87; ElAmraoui A, 1996, HUM MOL GENET, V5, P1171, DOI 10.1093/hmg/5.8.1171; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; Kelley Philip M., 1996, American Journal of Human Genetics, V59, pA152; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; KRAWCZAK M, 1992, HUM GENET, V90, P41; Levy G, 1997, HUM MOL GENET, V6, P111, DOI 10.1093/hmg/6.1.111; Liu XZ, 1997, HUM MUTAT, V10, P168, DOI 10.1002/(SICI)1098-1004(1997)10:2<168::AID-HUMU10>3.3.CO;2-T; MOLLER CG, 1989, LARYNGOSCOPE, V99, P73; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd; Sankila E.-M., 1994, American Journal of Human Genetics, V55, pA15; SEROUSSI E, 1994, 4 CHROM 11 WORKSH ST; SHEFFIELD VC, 1993, GENOMICS, V16, P325, DOI 10.1006/geno.1993.1193; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; SMITH RJH, 1992, AM J MED GENET, V43, P964, DOI 10.1002/ajmg.1320430612; TAKEUCHI K, 1994, J CELL SCI, V107, P1921; Titus MA, 1997, TRENDS CELL BIOL, V7, P119, DOI 10.1016/S0962-8924(97)01019-2; Usher C. H., 1914, ROY LOND OPHTHAL HOS, V19, P130; Wayne S, 1996, HUM MOL GENET, V5, P1689, DOI 10.1093/hmg/5.10.1689; Weil D, 1996, P NATL ACAD SCI USA, V93, P3232, DOI 10.1073/pnas.93.8.3232; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 1996, AM J HUM GENET, V59, P1074; WHITNEY MA, 1993, NAT GENET, V4, P202, DOI 10.1038/ng0693-202; WOLENSKI JS, 1995, TRENDS CELL BIOL, V5, P310, DOI 10.1016/S0962-8924(00)89053-4	32	87	89	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	1997	61	4					813	821		10.1086/514899	http://dx.doi.org/10.1086/514899			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	YA591	9382091	Green Published, Bronze			2022-12-18	WOS:A1997YA59100007
J	Laiho, E; Ignatius, J; Mikkola, H; Yee, VC; Teller, DC; Niemi, KM; SaarialhoKere, U; Kere, J; Palotie, A				Laiho, E; Ignatius, J; Mikkola, H; Yee, VC; Teller, DC; Niemi, KM; SaarialhoKere, U; Kere, J; Palotie, A			Transglutaminase 1 mutations in autosomal recessive congenital ichthyosis: Private and recurrent mutations in an isolated population	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COAGULATION-FACTOR-XIII; LAMELLAR ICHTHYOSIS; EPIDERMAL-KERATINOCYTES; APOLIPOPROTEIN-E; CROSS-LINKING; A-SUBUNIT; HUMAN DNA; PROTEIN; ENVELOPE; EXPRESSION	Autosomal recessive congenital ichthyosis (ARCI) is a rare, heterogenous keratinization disorder of the skin, classically divided into two clinical subtypes, lamellar ichthyosis (LI) and nonbullous congenital ichthyosiformis erythroderma (CIE). Recently, strong evidence for the involvement of the transglutaminase 1 gene (TGM1) in LI has evolved. We have studied ARCI in the isolated Finnish population, in which recessive disorders are often caused by single mutations enriched by a founder effect. Surprisingly, five different mutations of TGM1 (Arg141His, Arg142Cys, Gly217Ser, Val378Leu, and Arg395Leu) were found in Finnish ARCI patients. In addition to affected LI patients, we also identified TGM1 mutations in CIE patients. Moreover, haplotype analysis of the chromosomes carrying the most common mutation, a C-->T transition changing Arg142 to Cys, revealed that the same mutation has been introduced twice in the Finnish population. In addition to this Arg142Cys mutation, three other mutations, in Arg141 and Arg142, have been described elsewhere, in other populations. These findings suggest that this region of TGM1 is more susceptible to mutation. The corresponding amino acid sequence is conserved in other transglutaminases, but, for example, coagulation factor XIII (FXIII) mutations do not cluster in this region. Protein modeling of the Arg142Cys mutation suggested disruption or destabilization of the protein. In transfection studies, the closely related transglutaminase FXIII protein with the corresponding mutation was shown to be susceptible to degradation in COS cells, further supporting evidence of the destabilizing effect of the Arg142Cys mutation in TGM1.	UNIV HELSINKI, CENT HOSP, GENET MOL LAB, DEPT LAB, SF-00290 HELSINKI, FINLAND; UNIV HELSINKI, CENT HOSP, DEPT DERMATOL, SF-00290 HELSINKI, FINLAND; UNIV HELSINKI, DEPT CLIN CHEM, SF-00290 HELSINKI, FINLAND; HAARTMAN INST, DEPT MED GENET, HELSINKI, FINLAND; UNIV WASHINGTON, DEPT BIOCHEM, SEATTLE, WA 98195 USA	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Washington; University of Washington Seattle			Kere, Juha/A-9179-2008; Kere, Juha/AAX-9117-2021	Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Palotie, Aarno/0000-0002-2527-5874	NHLBI NIH HHS [HL-50355] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050355] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; BALE SJ, 1994, J INVEST DERMATOL, V102, pS49, DOI 10.1111/1523-1747.ep12388591; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; DELACHAPELLE A, 1993, J MED GENET, V30, P857, DOI 10.1136/jmg.30.10.857; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; GHADIALLY R, 1992, J INVEST DERMATOL, V99, P755, DOI 10.1111/1523-1747.ep12614489; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; HUBER M, 1995, SCIENCE, V267, P525, DOI 10.1126/science.7824952; ICHINOSE A, 1986, BIOCHEMISTRY-US, V25, P6900, DOI 10.1021/bi00370a025; IKONEN E, 1991, EMBO J, V10, P51, DOI 10.1002/j.1460-2075.1991.tb07920.x; JALANKO A, 1995, HUM MOL GENET, V4, P435, DOI 10.1093/hmg/4.3.435; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KERE J, 1994, HUM GENET, V93, P162, DOI 10.1007/BF00210603; KIM SY, 1995, J BIOL CHEM, V270, P18026, DOI 10.1074/jbc.270.30.18026; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Mckusick V.A., 1994, MENDELIAN INHERITANC; MEHREL T, 1990, CELL, V61, P1103, DOI 10.1016/0092-8674(90)90073-N; Mikkola H, 1996, BLOOD, V87, P141; MIKKOLA H, 1994, BLOOD, V84, P517; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PARMENTIER L, 1995, HUM MOL GENET, V4, P1391, DOI 10.1093/hmg/4.8.1391; Parmentier L, 1996, HUM MOL GENET, V5, P555, DOI 10.1093/hmg/5.4.555; PAUNIO T, 1994, HUM MOL GENET, V3, P2223, DOI 10.1093/hmg/3.12.2223; PROIA RL, 1984, J BIOL CHEM, V259, P3350; RICE RH, 1977, CELL, V11, P417, DOI 10.1016/0092-8674(77)90059-9; RICE RH, 1979, CELL, V18, P681, DOI 10.1016/0092-8674(79)90123-5; RUSSELL LJ, 1994, AM J HUM GENET, V55, P1146; RUSSELL LJ, 1995, NAT GENET, V9, P279, DOI 10.1038/ng0395-279; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J, 1987, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; STACEY A, 1990, NUCLEIC ACIDS RES, V18, P2829, DOI 10.1093/nar/18.9.2829; SYVANEN AC, 1992, GENOMICS, V12, P590, DOI 10.1016/0888-7543(92)90452-X; SYVANEN AC, 1990, GENOMICS, V8, P684, DOI 10.1016/0888-7543(90)90255-S; SYVANEN AC, 1989, FEBS LETT, V258, P71, DOI 10.1016/0014-5793(89)81618-7; VESA J, 1995, NATURE, V376, P584, DOI 10.1038/376584a0; WILLIAMS ML, 1985, ARCH DERMATOL, V121, P477, DOI 10.1001/archderm.121.4.477; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	38	87	90	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	1997	61	3					529	538		10.1086/515498	http://dx.doi.org/10.1086/515498			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	XY523	9326318	Bronze, Green Published			2022-12-18	WOS:A1997XY52300010
J	Yuan, B; Vaske, D; Weber, JL; Beck, J; Sheffield, VC				Yuan, B; Vaske, D; Weber, JL; Beck, J; Sheffield, VC			Improved set of short-tandem-repeat polymorphisms for screening the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Letter							LINKAGE		MARSHFIELD MED RES FDN,CTR MED GENET,MARSHFIELD,WI 54449; UNIV IOWA,IOWA CITY,IA	University of Iowa				Sheffield, Val/0000-0002-6282-0835	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000835, R01HG000457] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00835, HG00457] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; DUBOVSKY J, 1995, HUM MOL GENET, V4, P449, DOI 10.1093/hmg/4.3.449; OTT J, 1991, ANAL HUMAN GENETIC L, P54; REED PW, 1994, NAT GENET, V7, P390, DOI 10.1038/ng0794-390; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; *UT MARK DEV GROUP, 1995, AM J HUM GENET, V57, P619; WEBER JL, 1993, AM J HUM GENET, V53, P1079	7	87	92	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	FEB	1997	60	2					459	460						2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WE931	9012420				2022-12-18	WOS:A1997WE93100026
J	Burglen, L; Seroz, T; Miniou, P; Lefebvre, S; Burlet, P; Munnich, A; Pequignot, EV; Egly, JM; Melki, J				Burglen, L; Seroz, T; Miniou, P; Lefebvre, S; Burlet, P; Munnich, A; Pequignot, EV; Egly, JM; Melki, J			The gene encoding p44, a subunit of the transcription factor TFIIH, is involved in large-scale deletions associated with Werdnig-Hoffmann disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SPINAL MUSCULAR-ATROPHY; DNA-REPAIR; FREQUENCY; PROTEIN; REGION; BTF2	Mutations of the survival motor neurone gene (SMN) are associated with spinal muscular atrophy (SMA), a frequent lethal autosomal recessive disorder, In spite of this, no phenotype-genotype correlation was observed, since the SMN gene is lacking in the majority of patients affected with either the severe form (type I) or the milder forms (types II and III). Here, we show that the gene encoding p44, a subunit of the basal transcription factor TFIIH, is duplicated in the SMA region and that the p44 gene products (p44t and p44c) differ by three amino acid changes, Gene analysis of a total of 94 unrelated SMA patients revealed that the p44t gene is involved in large-scale deletions associated with Werdnig-Hoffmann disease (type I), The TFIIH polypeptide composition as well as transcription and DNA repair activities are normal in patients lacking the p44t gene on both. mutant chromosomes, suggesting that the p44t gene is not critical for the development of SMA.	HOP NECKER ENFANTS MALAD,INSERM U393,UNITE RECH HANDICAPS GENET ENFANT,F-75743 PARIS,FRANCE; HOP NECKER ENFANTS MALAD,INSERM U393,IFREM,INST NECKER,F-75743 PARIS,FRANCE; INST GENET & BIOL MOL & CELLULAIRE,CNRS,INSERM,ILLKIRCH GRAFFENS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)			Lefebvre, Suzie/D-5092-2017					BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; Burlet P, 1996, J MED GENET, V33, P281, DOI 10.1136/jmg.33.4.281; BUSSAGLIA E, 1995, NAT GENET, V11, P335, DOI 10.1038/ng1195-335; CARLOCK LR, 1985, AM J HUM GENET, V37, P839; CZEIZEL A, 1989, J MED GENET, V26, P761, DOI 10.1136/jmg.26.12.761; GERARD M, 1991, J BIOL CHEM, V266, P20940; GILLIAM TC, 1990, NATURE, V345, P823, DOI 10.1038/345823a0; Hoeijmakers JHJ, 1996, CURR OPIN GENET DEV, V6, P26, DOI 10.1016/S0959-437X(96)90006-4; HUMBERT S, 1994, EMBO J, V13, P2393, DOI 10.1002/j.1460-2075.1994.tb06523.x; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; MELKI J, 1990, LANCET, V336, P271, DOI 10.1016/0140-6736(90)91803-I; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; MELKI J, 1994, SCIENCE, V264, P1474, DOI 10.1126/science.7910982; Munsat TL., 1991, NEUROMUSCUL DISORD, V1, P81, DOI [10.1016/0960-8966(91)90052-t, DOI 10.1016/0960-8966(91)90052-T]; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; PEARN JH, 1973, J MED GENET, V10, P260, DOI 10.1136/jmg.10.3.260; Rodrigues NR, 1996, J MED GENET, V33, P93, DOI 10.1136/jmg.33.2.93; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; VANDERSTEEGE G, 1995, EUR J HUM GENET, V3, P87; WOOD RD, 1988, CELL, V53, P97, DOI 10.1016/0092-8674(88)90491-6	22	87	88	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1997	60	1					72	79						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	WA818	8981949				2022-12-18	WOS:A1997WA81800012
J	Barrientos, A; Casademont, J; Saiz, A; Cardellach, F; Volpini, V; Solans, A; Tolosa, E; UrbanoMarquez, A; Estivill, X; Nunes, V				Barrientos, A; Casademont, J; Saiz, A; Cardellach, F; Volpini, V; Solans, A; Tolosa, E; UrbanoMarquez, A; Estivill, X; Nunes, V			Autosomal recessive Wolfram syndrome associated with an 8.5-kb mtDNA single deletion	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MITOCHONDRIAL-DNA DELETION; MULTIPLE DELETIONS; EXTERNAL OPHTHALMOPLEGIA; RESPIRATORY-CHAIN; DIABETES-MELLITUS; DIDMOAD SYNDROME; DISEASE; REPLICATION; MUTATION; MYOPATHY	Wolfram syndrome (MIM 222300) is characterized by optic atrophy, diabetes mellitus, diabetes insipidus, neurosensory hearing loss, urinary tract abnormalities, and neurological dysfunction. The association of clinical manifestations in tissues and organs unrelated functionally or embryologically suggested the possibility of a mitochondrial implication in the disease, which has been demonstrated in two sporadic cases. Nonetheless, familial studies suggested an autosomal recessive mode of transmission, and recent data demonstrated linkage with markers on the short arm of human chromosome 4. The patient reported here, as well as her parents and unaffected sister, carried a heteroplasmic 8.5-kb deletion in mtDNA. The deletion accounted for 23% of mitochondrial genomes in lymphocytes from the patient and similar to 5% in the tissues studied from members of her family. The presence of the deletion in the patient in a proportion higher than in her unaffected parents suggests a putative defect in a nuclear gene that acts at the mitochondrial level.	INST REC ONCOL, DEPT GENET MOLEC, E-08907 LHOSPITALET DE LLOBREGAT, BARCELONA, SPAIN; HOSP CLIN BARCELONA, DEPT MED, GRP INVEST MUSCULAR, BARCELONA, SPAIN; HOSP CLIN BARCELONA, DEPT MED, SERV NEUROL, BARCELONA, SPAIN; UNIV BARCELONA, BARCELONA, SPAIN	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona			Estivill, Xavier/E-2957-2012; Casademont, Jordi/GPK-8669-2022; Casademont, Jordi/A-6828-2010; Estivill, Xavier/A-3125-2013; Nunes, Virginia/AAD-1014-2019	Casademont, Jordi/0000-0002-8100-1827; Casademont, Jordi/0000-0002-8100-1827; Estivill, Xavier/0000-0002-0723-2256; Nunes, Virginia/0000-0002-5747-9310				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BALLINGER SW, 1992, NAT GENET, V1, P11, DOI 10.1038/ng0492-11; BORGNAPIGNATTI C, 1989, J PEDIATR-US, V114, P405, DOI 10.1016/S0022-3476(89)80558-X; BUNDEY S, 1992, J INHERIT METAB DIS, V15, P315, DOI 10.1007/BF02435965; CASADEMONT J, 1994, HUM MOL GENET, V3, P1945, DOI 10.1093/hmg/3.11.1945; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CORMIER V, 1991, AM J HUM GENET, V48, P643; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; CREMERS C W R J, 1977, Acta Paediatrica Scandinavica Supplement, P1; DIDONATO S, 1993, NEUROLOGY, V43, P2262, DOI 10.1212/WNL.43.11.2262; DUNBAR DR, 1993, HUM MOL GENET, V2, P1619, DOI 10.1093/hmg/2.10.1619; GILES RE, 1980, P NATL ACAD SCI USA, V83, P9611; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; GYAPAY G, 1994, NAT GENET, V7, P246, DOI 10.1038/ng0694supp-246; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; HOLT IJ, 1990, AM J HUM GENET, V46, P428; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; McKusick V.A., 1992, MENDELIAN INHERITANC; Ott J., 1991, ANAL HUMAN GENETIC L; PAGE MM, 1976, Q J MED, V45, P505; POLYMEROPOULOS MH, 1993, PSYCHIAT RES, V48, P27, DOI 10.1016/0165-1781(93)90110-3; POLYMEROPOULOS MH, 1994, NAT GENET, V8, P95, DOI 10.1038/ng0994-95; ROTIG A, 1990, J CLIN INVEST, V86, P1601, DOI 10.1172/JCI114881; ROTIG A, 1993, J CLIN INVEST, V91, P1095, DOI 10.1172/JCI116267; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; RUSTIN P, 1991, LANCET, V338, P60, DOI 10.1016/0140-6736(91)90057-V; Saiz A, 1995, Neurologia, V10, P107; SCHON EA, 1989, SCIENCE, V244, P346, DOI 10.1126/science.2711184; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; SWIFT RG, 1990, LANCET, V336, P667, DOI 10.1016/0140-6736(90)92157-D; TAGLE DA, 1992, HUM MOL GENET, V1, P215, DOI 10.1093/hmg/1.3.215; TRITSCHLER HJ, 1992, NEUROLOGY, V42, P209, DOI 10.1212/WNL.42.1.209; Wolfram DJ, 1938, P MAYO CLIN, V13, P715; YUZAKI M, 1989, BIOCHEM BIOPH RES CO, V164, P1352, DOI 10.1016/0006-291X(89)91818-4; ZEVIANI M, 1990, AM J HUM GENET, V47, P904; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0	39	87	88	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	1996	58	5					963	970						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	UH192	8651280				2022-12-18	WOS:A1996UH19200008
J	MCKENZIE, CA; JULIER, C; FORRESTER, T; MCFARLANEANDERSON, N; KEAVNEY, B; LATHROP, GM; RATCLIFFE, PJ; FARRALL, M				MCKENZIE, CA; JULIER, C; FORRESTER, T; MCFARLANEANDERSON, N; KEAVNEY, B; LATHROP, GM; RATCLIFFE, PJ; FARRALL, M			SEGREGATION AND LINKAGE ANALYSIS OF SERUM ANGIOTENSIN-I-CONVERTING ENZYME LEVELS - EVIDENCE FOR 2 QUANTITATIVE-TRAIT LOCI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INSERTION DELETION POLYMORPHISM; BLOOD-PRESSURE; COMPLEX SEGREGATION; REGRESSIVE MODELS; UNIFIED MODEL; GENE; RESEMBLANCE; VARIANCE; SYSTEM	Human serum angiotensin I-converting enzyme (ACE) levels vary substantially between individuals and are highly heritable. Segregation analysis in European families has shown that more than half of the total variability in ACE levels is influenced by quantitative-trait loci (QTL). One of these QTLs is located within or close to the ACE locus itself, Combined segregation/linkage analysis in a series of African Caribbean families from Jamaica shows that the ACE insertion-deletion polymorphism is in moderate linkage disequilibrium with an ACE-linked QTL. Linkage analysis with a highly informative polymorphism at the neighboring growth-hormone gene (GH) shows surprisingly little support for linkage (LOD score [Z] = 0.12). An extended analysis with a two-QTL model, where an ACE-linked QTL interacts additively with an unlinked QTL, significantly improves both the fit of the model (P = .002) and the support for linkage between the ACE-linked QTL and GH polymorphism (Z = 5.0). We conclude that two QTLs jointly influence serum ACE levels in this population. One QTL is located within or close to the ACE locus and explains 27% of the total variability; the second QTL is unlinked to the ACE locus and explains 52% of the variability. The identification of the molecular mechanisms underlying both QTLs is necessary in order to interpret the role of ACE in cardiovascular disease.	UNIV OXFORD,WELLCOME TRUST CTR HUMAN GENET,OXFORD OX3 7BN,ENGLAND; UNIV OXFORD,INST MOLEC MED,OXFORD OX3 7BN,ENGLAND; HOP ST LOUIS,INSERM,U358,PARIS,FRANCE; UNIV W INDIES,TROP METAB RES UNIT,MONA,JAMAICA	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University West Indies Mona Jamaica			JULIER, Cécile/M-9824-2017	JULIER, Cécile/0000-0002-1538-0240; Ratcliffe, Peter/0000-0002-2853-806X; Keavney, Bernard/0000-0001-9573-0812	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; BENETEAU B, 1986, CLIN CHEM, V32, P884; BOHN M, 1993, CLIN GENET, V44, P292; BONNEY GE, 1988, AM J HUM GENET, V43, P29; CAMBIEN F, 1988, AM J HUM GENET, V43, P774; CAMBIEN F, 1992, NATURE, V359, P588; CLELAND JGF, 1994, EUR HEART J, V15, P125, DOI 10.1093/oxfordjournals.eurheartj.a060364; DEMENAIS F, 1993, GENET EPIDEMIOL, V10, P587, DOI 10.1002/gepi.1370100643; DEMENAIS F, 1986, AM J HUM GENET, V38, P228; DEMENAIS FM, 1992, GENET EPIDEMIOL, V9, P419, DOI 10.1002/gepi.1370090605; DIZIER MH, 1993, AM J HUM GENET, V53, P1338; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ERDOS EG, 1990, HYPERTENSION, V16, P363, DOI 10.1161/01.HYP.16.4.363; ERTL G, 1982, CIRCULATION, V65, P40, DOI 10.1161/01.CIR.65.1.40; HARRAP SB, 1993, HYPERTENSION, V21, P455, DOI 10.1161/01.HYP.21.4.455; HASSTEDT SJ, 1993, GENET EPIDEMIOL, V10, P145, DOI 10.1002/gepi.1370100302; HASSTEDT SJ, 1994, PEDIGREE ANAL PACKAG; IRIARTE M, 1995, AM J CARDIOL, V75, P850, DOI 10.1016/S0002-9149(99)80431-7; JEUNEMAITRE X, 1992, NAT GENET, V1, P72, DOI 10.1038/ng0492-72; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LALOUEL JM, 1979, 14 U UT DEP MED BIOP; LARAGH JH, 1989, HYPERTENSION, V13, P1103; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; MACGREGOR GA, 1981, NATURE, V291, P329, DOI 10.1038/291329a0; MACLEAN CJ, 1976, BIOMETRICS, V32, P695, DOI 10.2307/2529760; MARTINEZ MM, 1991, AM J HUM GENET, V49, P350; MORTON NE, 1974, AM J HUM GENET, V26, P489; MORTON NE, 1979, GENETIC ANAL COMMON, P431; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; RAYNOLDS MV, 1993, LANCET, V342, P1073, DOI 10.1016/0140-6736(93)92061-W; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; Sambrook J., 1989, MOL CLONING LAB MANU; SCHUNKERT H, 1994, NEW ENGL J MED, V330, P1634, DOI 10.1056/NEJM199406093302302; SEALEY JE, 1990, HYPERTENSION PATHOPH; SOUBRIER F, 1994, EUR HEART J, V15, P24, DOI 10.1093/eurheartj/15.suppl_D.24; THEIN SL, 1994, AM J HUM GENET, V54, P214; TIRET L, 1994, LANCET, V344, P910, DOI 10.1016/S0140-6736(94)92268-3; TIRET L, 1992, AM J HUM GENET, V51, P197; WATT GCM, 1992, J HYPERTENS, V10, P473, DOI 10.1097/00004872-199205000-00011; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; WEI L, 1991, J BIOL CHEM, V266, P5540; 1981, PHS811671 US DEP HLT	44	87	88	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	DEC	1995	57	6					1426	1435						10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	TE655	8533773				2022-12-18	WOS:A1995TE65500021
J	GODWIN, AK; VANDERVEER, L; SCHULTZ, DC; LYNCH, HT; ALTOMARE, DA; BUETOW, KH; DALY, M; GETTS, LA; MASNY, A; ROSENBLUM, N; HOGAN, M; OZOLS, RF; HAMILTON, TC				GODWIN, AK; VANDERVEER, L; SCHULTZ, DC; LYNCH, HT; ALTOMARE, DA; BUETOW, KH; DALY, M; GETTS, LA; MASNY, A; ROSENBLUM, N; HOGAN, M; OZOLS, RF; HAMILTON, TC			A COMMON REGION OF DELETION ON CHROMOSOME 17Q IN BOTH SPORADIC AND FAMILIAL EPITHELIAL OVARIAN-TUMORS DISTAL TO BRCAI	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							DINUCLEOTIDE REPEAT POLYMORPHISM; BREAST-CANCER; ALLELIC LOSS; P53 GENE; RECEPTOR GENE; FREQUENT LOSS; LOW-GRADE; HETEROZYGOSITY; CARCINOMAS; LINKAGE	Linkage analysis in familial breast and ovarian cancer and studies of allelic deletion in sporadic ovarian tumors have identified a region on chromosome 17q containing a candidate tumor-suppressor gene (referred to as BRCA1) of likely importance in ovarian carcinogenesis. We have examined normal and tumor DNA samples from 32 patients with sporadic and 8 patients with familial forms of the disease, for loss of heterozygosity (LOH) at 21. loci on chromosome 17 (7 on 17p and 14 on 17q). LOH on 17p was 55% (22/40) for informative 17p13.1 and 17p13.3 markers. When six polymorphic markers flanking the familial breast/ovarian cancer susceptibility locus on 17q12-q21 were used, LOH was 58% (23/40), with one tumor showing telomeric retention. Evaluation of a set of markers positioned telomeric to BRCA1 resulted in the highest degree of LOH, 73% (29/40), indicating that a candidate locus involved in ovarian cancer may reside distal to BRCA1. Five of the tumors demonstrating allelic loss for 17q markers were from individuals with a strong family history of breast and ovarian cancer. More important, two of these tumors (unique patient number [UPN] 57 and UPN 79) retained heterozygosity for all informative markers spanning the BRCA1 locus but showed LOH at loci distal to but not including the anonymous markers CMM86 (D17S74) and 42D6 (D17S588), respectively. Deletion mapping of seven cases (two familial and five sporadic) showing limited LOH on 17q revealed a common region of deletion, distal to GH and proximal to D17S4, that spans similar to 25 cM. These results suggest that a potential tumor-suppressor gene involved in both sporadic and familial ovarian cancer may reside on the distal portion of chromosome 17q and is distinct from the BRCA1 gene.	FOX CHASE CANC CTR,DEPT POPULAT SCI,PHILADELPHIA,PA 19111; FOX CHASE CANC CTR,DEPT SURG,PHILADELPHIA,PA 19111; CREIGHTON UNIV,DEPT PREVENT MED & PUBL HLTH,OMAHA,NE 68178	Fox Chase Cancer Center; Fox Chase Cancer Center; Creighton University	GODWIN, AK (corresponding author), FOX CHASE CANC CTR,DEPT MED ONCOL,7701 BURHOLME AVE,PHILADELPHIA,PA 19111, USA.				NCI NIH HHS [CA60643, P30 CA006927] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA060643, P30CA006927] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSON LA, 1993, GENOMICS, V17, P618, DOI 10.1006/geno.1993.1381; BERCHUCK A, 1990, CANCER RES, V50, P4087; BEVILACQUA G, 1989, CANCER RES, V49, P5185; BOWCOCK AM, 1993, AM J HUM GENET, V52, P718; CARROZZO R, 1993, HUM MOL GENET, V2, P615, DOI 10.1093/hmg/2.5.615; COLLINS FS, 1989, TRENDS GENET, V5, P217, DOI 10.1016/0168-9525(89)90085-1; EASTON DF, 1993, AM J HUM GENET, V52, P678; ECCLES DM, 1992, ONCOGENE, V7, P2069; ECCLES DM, 1990, ONCOGENE, V5, P1599; EHLEN T, 1990, ONCOGENE, V5, P219; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEUNTEUN J, 1993, AM J HUM GENET, V52, P736; FLEJTER WL, 1993, HUM MOL GENET, V2, P1080, DOI 10.1093/hmg/2.7.1080; FOULKES W, 1993, BRIT MED J, V307, P1009, DOI 10.1136/bmj.307.6910.1009-b; FOULKES WD, 1993, INT J CANCER, V54, P220, DOI 10.1002/ijc.2910540210; FUTREAL PA, 1992, CANCER RES, V52, P2624; GODWIN AK, 1992, GYNECOL ONCOL, P87; GOLDGAR DE, 1993, AM J HUM GENET, V52, P743; HALL JM, 1992, AM J HUM GENET, V50, P1235; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; JACOBS IJ, 1993, CANCER RES, V53, P1218; JOLLY KW, 1994, ONCOGENE, V9, P97; JONES MH, 1992, GENE CHROMOSOME CANC, V5, P89, DOI 10.1002/gcc.2870050113; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; KELSELL DP, 1993, HUM MOL GENET, V2, P1823; KING MC, 1992, NAT GENET, V2, P89, DOI 10.1038/ng1092-89; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; KNUDSON AG, 1993, NAT GENET, V5, P103, DOI 10.1038/ng1093-103; KOHLER MF, 1993, J NATL CANCER I, V85, P1513, DOI 10.1093/jnci/85.18.1513; LEE JH, 1990, CANCER RES, V50, P2724; LINDBLOM A, 1993, CANCER RES, V53, P4356; LOBACCARO JM, 1993, NAT GENET, V5, P109, DOI 10.1038/ng1093-109; LYNCH HT, 1993, ARCH INTERN MED, V153, P1979; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; MARKS JR, 1991, CANCER RES, V51, P2979; MILNER BJ, 1993, AM J HUM GENET, V52, P761; NAROD SA, 1991, LANCET, V338, P82; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OCONNELL P, 1993, GENOMICS, V15, P38, DOI 10.1006/geno.1993.1007; OKAMOTO A, 1991, CANCER RES, V51, P5171; OLIPHANT AR, 1993, NUCLEIC ACIDS RES, V19, P4794; PHILLIPS N, 1993, INT J CANCER, V54, P85, DOI 10.1002/ijc.2910540115; RUSSELL SEH, 1990, ONCOGENE, V5, P1581; SAITO H, 1993, CANCER RES, V53, P3382; SATO T, 1991, CANCER RES, V51, P5794; SATO T, 1991, CANCER RES, V51, P5118; SIMARD J, 1993, HUM MOL GENET, V2, P1193, DOI 10.1093/hmg/2.8.1193; SMITH SA, 1992, NAT GENET, V2, P128, DOI 10.1038/ng1092-128; SMITH SA, 1993, AM J HUM GENET, V52, P767; TAVASSOLI M, 1993, GENE CHROMOSOME CANC, V8, P195, DOI 10.1002/gcc.2870080310; TONIN P, 1993, GENOMICS, V18, P414, DOI 10.1006/geno.1993.1487; Ullrich Axel, 1989, SCIENCE, V244, P707, DOI DOI 10.1126/SCIENCE.2470152; VARESCO L, 1992, GENE CHROMOSOME CANC, V4, P84, DOI 10.1002/gcc.2870040113; VILE RG, 1993, BRIT MED J, V307, P1226, DOI 10.1136/bmj.307.6914.1226; YANGFENG TL, 1993, INT J CANCER, V54, P546, DOI 10.1002/ijc.2910540405; ZHENG JP, 1991, CANCER RES, V51, P4045; ZHENG JP, 1993, CANCER RES, V53, P4138; ZUPPAN P, 1991, AM J HUM GENET, V48, P1065	58	87	89	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	1994	55	4					666	677						12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	PJ027	7942844				2022-12-18	WOS:A1994PJ02700009
J	BRUNNER, HG; BRUGGENWIRTH, HT; NILLESEN, W; JANSEN, G; HAMEL, BCJ; HOPPE, RLE; DEDIE, CEM; HOWELER, CJ; VANOOST, BA; WIERINGA, B; ROPERS, HH; SMEETS, HJM				BRUNNER, HG; BRUGGENWIRTH, HT; NILLESEN, W; JANSEN, G; HAMEL, BCJ; HOPPE, RLE; DEDIE, CEM; HOWELER, CJ; VANOOST, BA; WIERINGA, B; ROPERS, HH; SMEETS, HJM			INFLUENCE OF SEX OF THE TRANSMITTING PARENT AS WELL AS OF PARENTAL ALLELE SIZE ON THE CTG EXPANSION IN MYOTONIC-DYSTROPHY (DM)	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							FRAGILE-X SYNDROME; UNSTABLE DNA; REPEAT; ANTICIPATION; REGION	In patients with myotonic dystrophy (DM), the severity of clinical signs is correlated with the length of a (CTG)n trinucleotide repeat sequence. This sequence tends to expand in subsequent generations. In order to examine the kinetics of this process and, in particular, the influence of the mutant-allele size and the sex of the transmitting parent, we have studied (CTG)n repeat lengths in the offspring of 38 healthy carriers with small mutations (less than 100 CTG trinucleotides, mean length [CTG]67). In these studies, we found a weakly positive correlation between the size of the mutation in the carrier parents and that in their offspring. Furthermore, we observed that, in the offspring of male transmitters, repeat lengths exceeding 100 CTG trinucleotides were much more frequent than in the offspring of carrier females (48 [92%] of 52 vs. 7 [44%] of 16, P = .0002). Similarly, in genealogical studies performed in 38 Dutch DM kindreds, an excess of nonmanifesting male transmitters was noted, which was most conspicuous in the generation immediately preceding that with phenotypic expression of DM. Thus, two separate lines of evidence suggest that the sex of the transmitting parent is an important factor that determines DM allele size in the offspring. On the basis of our data, we estimate that when both parents are asymptomatic, the odds are approximately 2:1 that the father carries the DM mutation. Because expansion of the CTG repeat is more rapid with male transmission, negative selection during spermatogenesis may be required to explain the exclusive maternal inheritance of severe congenital onset DM.	UNIV HOSP NIJMEGEN,DEPT NEUROL,6500 HB NIJMEGEN,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT CELL BIOL & HISTOL,6500 HB NIJMEGEN,NETHERLANDS; UNIV LIMBURG HOSP,DEPT CLIN GENET,MAASTRICHT,NETHERLANDS	Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University; Maastricht University Medical Centre (MUMC)	BRUNNER, HG (corresponding author), UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.		Wieringa, Berend/A-5346-2011; Brunner, Han/C-9928-2013	Wieringa, Berend/0000-0001-9192-8020; Jansen, Gert/0000-0002-7524-171X				ABELIOVICH D, 1993, AM J HUM GENET, V52, P1175; ASHIZAWA T, 1992, NEUROLOGY, V42, P1871; ASHIZAWA T, 1992, NEUROLOGY, V42, P1877; BELL J, 1947, HUM INHERITANCE, V4, P342; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; BRUNNER HG, 1992, J MED GENET, V29, P780, DOI 10.1136/jmg.29.11.780; BRUNNER HG, 1993, NEW ENGL J MED, V328, P476, DOI 10.1056/NEJM199302183280705; BRUNNER HG, 1991, BRAIN, V114, P2303, DOI 10.1093/brain/114.5.2303; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Fleiseher B., 1918, ALBRECHT GRAEFES ARC, V96, P91, DOI DOI 10.1007/BF02018704; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; GRIGGS RC, 1989, NEUROLOGY, V39, P420, DOI 10.1212/WNL.39.3.420; HARLEY HG, 1992, NATURE, V355, P545, DOI 10.1038/355545a0; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper P.S., 1989, MYOTONIC DYSTROPHY; HEITZ D, 1992, J MED GENET, V29, P794, DOI 10.1136/jmg.29.11.794; HOWELER CJ, 1989, BRAIN, V112, P779, DOI 10.1093/brain/112.3.779; Howeler CJ, 1986, THESIS ERASMUS U ROT; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; HUNTER AGW, 1993, AM J MED GENET, V45, P401, DOI 10.1002/ajmg.1320450330; JANSEN G, 1992, NAT GENET, V1, P261, DOI 10.1038/ng0792-261; JANSEN G, 1993, HUM MOL GENET, V2, P1221, DOI 10.1093/hmg/2.8.1221; KLEIN D., 1958, JOUR GENET HUMAINE, V7, P1; LAVEDAN C, 1993, AM J HUM GENET, V52, P875; LESKE MC, 1983, AM J EPIDEMIOL, V118, P152, DOI 10.1093/oxfordjournals.aje.a113625; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; MATHIEU J, 1990, NEUROLOGY, V40, P839, DOI 10.1212/WNL.40.5.839; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; OHOY KL, 1993, SCIENCE, V259, P809, DOI 10.1126/science.8094260; Ravin A, 1939, AM J MED SCI, V197, P593, DOI 10.1097/00000441-193905000-00001; REARDON W, 1992, J MED GENET, V29, P770, DOI 10.1136/jmg.29.11.770; REDMAN JB, 1993, JAMA-J AM MED ASSOC, V269, P1960, DOI 10.1001/jama.269.15.1960; REIK W, 1989, TRENDS GENET, V5, P331, DOI 10.1016/0168-9525(89)90138-8; SHELBOURNE P, 1992, HUM MOL GENET, V1, P467, DOI 10.1093/hmg/1.7.467; SLANIDIS C, 1992, NATURE, V355, P549; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; van Straaten A, 1986, Ned Tijdschr Geneeskd, V130, P1984; YU S, 1992, AM J HUM GENET, V50, P968	41	87	89	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1993	53	5					1016	1023						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	MC333	8213829				2022-12-18	WOS:A1993MC33300005
J	SPRITZ, RA; HOLMES, SA; RAMESAR, R; GREENBERG, J; CURTIS, D; BEIGHTON, P				SPRITZ, RA; HOLMES, SA; RAMESAR, R; GREENBERG, J; CURTIS, D; BEIGHTON, P			MUTATIONS OF THE KIT (MAST STEM-CELL GROWTH-FACTOR RECEPTOR) PROTOONCOGENE ACCOUNT FOR A CONTINUOUS RANGE OF PHENOTYPES IN HUMAN PIEBALDISM	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							C-KIT; INTERSTITIAL DELETION; SIGNAL TRANSDUCTION; TYROSINE KINASE; RETARDED-CHILD; TRAIT; GENE; CHROMOSOME-4; MOUSE; DNA	Piebaldism is a rare autosomal dominant disorder of pigmentation, characterized by congenital patches of white skin and hair from which melanocytes are absent. We have previously shown that piebaldism can result from missense and frameshift mutations of the KIT proto-oncogene, which encodes the cellular receptor tyrosine kinase for the mast / stem cell growth factor. Here, we report two novel KIT mutations associated with human piebaldism. A proximal frameshift is associated with a mild piebald phenotype, and a splice-junction mutation is associated with a highly variable piebald phenotype. We discuss the apparent relationship between the predicted impact of specific KIT mutations on total KIT-dependent signal transduction and the severity of the resultant piebald phenotypes.	UNIV WISCONSIN,DEPT MED GENET,MADISON,WI 53706; UNIV WISCONSIN,DEPT PEDIAT,MADISON,WI 53706; UNIV CAPE TOWN,SCH MED,DEPT HUMAN GENET,CAPE TOWN,SOUTH AFRICA; CTR HUMAN GENET,SHEFFIELD,ENGLAND	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Cape Town			Ramesar, Raj S/I-6941-2015	Ramesar, Raj S/0000-0001-5688-1634	NIAMS NIH HHS [AR 39892] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039892] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; BERDAHL LD, 1988, NUCLEIC ACIDS RES, V16, P4740, DOI 10.1093/nar/16.10.4740; BREATHNACH AS, 1965, J INVEST DERMATOL, V45, P28, DOI 10.1038/jid.1965.87; COOKE JV, 1952, J PEDIATR-US, V41, P1, DOI 10.1016/S0022-3476(52)80022-8; CURTIS D, 1991, NUCLEIC ACIDS RES, V19, P1352, DOI 10.1093/nar/19.6.1352; FLEISCHMAN RA, 1992, J CLIN INVEST, V89, P1713, DOI 10.1172/JCI115772; FLEISCHMAN RA, 1991, P NATL ACAD SCI USA, V88, P10885, DOI 10.1073/pnas.88.23.10885; FOWLER HW, 1905, WORKS LUCIAN SAMOSAT, V1; FROGGAT P, 1951, IRISH J MED SCI, V398, P86; FUNDERBURK SJ, 1974, AM J HUM GENET, V26, P715; GIEBEL LB, 1991, P NATL ACAD SCI USA, V88, P8696, DOI 10.1073/pnas.88.19.8696; GIEBEL LB, IN PRESS ONCOGENE; HAYASHI SI, 1991, NUCLEIC ACIDS RES, V19, P1267, DOI 10.1093/nar/19.6.1267; HOO JJ, 1986, HUM GENET, V73, P230, DOI 10.1007/BF00401233; JIMBOW K, 1975, J INVEST DERMATOL, V64, P50, DOI 10.1111/1523-1747.ep12540914; KASHLES O, 1991, MOL CELL BIOL, V11, P1454, DOI 10.1128/MCB.11.3.1454; LACASSIE Y, 1977, AM J HUM GENET, V29, P641; LATHROP GM, 1984, AM J HUM GENET, V36, P460; MORGAN J, 1786, T AM PHILOS SOC PHIL, V2, P392; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SMITH EA, 1991, P NATL ACAD SCI USA, V88, P4811, DOI 10.1073/pnas.88.11.4811; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPRITZ RA, 1992, AM J HUM GENET, V50, P261; SPRITZ RA, IN PRESS AM J MED GE; STEPHENSON DA, 1991, P NATL ACAD SCI USA, V88, P6, DOI 10.1073/pnas.88.1.6; UENO H, 1991, SCIENCE, V252, P844, DOI 10.1126/science.1851331; UENO H, 1992, J BIOL CHEM, V267, P1470; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANDENPLAS S, 1984, J MED GENET, V21, P164, DOI 10.1136/jmg.21.3.164; WINSHIP I, 1991, CLIN GENET, V39, P330; YAMAMOTO Y, 1989, AM J MED GENET, V32, P520, DOI 10.1002/ajmg.1320320419; YARDEN Y, 1988, ANNU REV BIOCHEM, V57, P443, DOI 10.1146/annurev.bi.57.070188.002303; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x	34	87	93	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	NOV	1992	51	5					1058	1065						8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	JU840	1384325				2022-12-18	WOS:A1992JU84000015
J	MCGINNISS, MJ; KAZAZIAN, HH; STETTEN, G; PETERSEN, MB; BOMAN, H; ENGEL, E; GREENBERG, F; HERTZ, JM; JOHNSON, A; LACA, Z; MIKKELSEN, M; PATIL, SR; SCHINZEL, AA; TRANEBJAERG, L; ANTONARAKIS, SE				MCGINNISS, MJ; KAZAZIAN, HH; STETTEN, G; PETERSEN, MB; BOMAN, H; ENGEL, E; GREENBERG, F; HERTZ, JM; JOHNSON, A; LACA, Z; MIKKELSEN, M; PATIL, SR; SCHINZEL, AA; TRANEBJAERG, L; ANTONARAKIS, SE			MECHANISMS OF RING CHROMOSOME FORMATION IN 11 CASES OF HUMAN RING CHROMOSOME-21	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GT DINUCLEOTIDE REPEAT; REGION; MARKER	We studied the mechanism of ring chromosome 21 (r(21)) formation in 13 patients (11 unique r(21)s), consisting of 7 from five families with familial r(21) and 6 with de novo r(21). The copy number of chromosome 21 sequences in the rings of these patients was determined by quantitative dosage analyses for 13 loci on 21q. Nine of 11 r(21)s, including the 5 familial r(21)s, showed no evidence for duplication of 21q sequences but did show molecular evidence of partial deletion of 21q. These data were consistent with the breakage and reunion of short- and long-arm regions to form the r(21), resulting in deletion of varying amounts of 21q22.1 to 21qter. The data from one individual who had a Down syndrome phenotype were consistent with asymmetric breakage and reunion of 21q sequences from an intermediate isochromosome or Robertsonian translocation chromosome as reported by Wong et al. Another patient, who also exhibited Down syndrome, showed evidence of a third mechanism of ring formation. The likely initial event was breakage and reunion of the short and long arms, resulting in a small r(21), followed by a sister-chromatid exchange resulting in a double-sized and symmetrically dicentric r(21). The phenotype of patients correlated well with the extent of deletion or duplication of chromosome 21 sequences. These data demonstrate three mechanisms of r(21) formation and show that the phenotype of r(21) patients varies with the extent of chromosome 21 monosomy or trisomy.	UNIV BERGEN, DEPT MED GENET, N-5014 BERGEN, NORWAY; UNIV GENEVA, INST MED GENET, CH-1211 GENEVA 4, SWITZERLAND; BAYLOR COLL MED, INST MOLEC GENET, HOUSTON, TX 77030 USA; AARHUS UNIV, INST HUMAN GENET, DK-8000 AARHUS, DENMARK; UNIV ZURICH, DEPT MED GENET, CH-8006 ZURICH, SWITZERLAND; JOHNS HOPKINS UNIV, SCH MED, CTR MED GENET, DEPT PEDIAT & MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT MED GENET, BALTIMORE, MD 21205 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DEPT MED GENET, PHILADELPHIA, PA 19107 USA; INST MENTAL HLTH, CTR MED GENET, BELGRADE, YUGOSLAVIA; JOHN F KENNEDY INST, DEPT MED GENET, GLOSTRUP, DENMARK; UNIV IOWA, DEPT PEDIAT, IOWA CITY, IA 52242 USA	University of Bergen; University of Geneva; Baylor College of Medicine; Aarhus University; University of Zurich; Johns Hopkins University; Johns Hopkins University; Jefferson University; University of Iowa			Hertz, Jens Michael/H-6269-2014; Petersen, Michael Bjørn B/D-1483-2017; Antonarakis, Stylianos E/N-8866-2014	Hertz, Jens Michael/0000-0003-0087-4739; Petersen, Michael Bjørn B/0000-0003-0316-8207; Antonarakis, Stylianos E/0000-0001-8907-5823	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM009706] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLORE RJ, 1990, J BIOL CHEM, V265, P15537; BURMEISTER M, 1991, GENOMICS, V9, P19, DOI 10.1016/0888-7543(91)90216-2; BURMELSTER M, 1990, NUCLEIC ACIDS RES, V18, P4969, DOI 10.1093/nar/18.16.4969; FALIKBORENSTEIN TC, IN PRESS AM J MED GE; GARDINER K, 1990, EMBO J, V9, P25, DOI 10.1002/j.1460-2075.1990.tb08076.x; GARDNER RJM, 1989, OXFORD MONOGRAPHS ME, V17; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; HERTZ JM, 1987, CLIN GENET, V32, P35; IESHIMA A, 1980, HUM GENET, V55, P65, DOI 10.1007/BF00329128; JACKSON JF, 1976, CLIN GENET, V9, P483; JACOBS PA, 1981, AM J HUM GENET, V33, P44; JONES KL, 1988, SMITHS RECOGNIZABLE, P584; KORENBERG JR, 1990, AM J HUM GENET, V47, P236; KOSZTOLANYI G, 1987, HUM GENET, V75, P174, DOI 10.1007/BF00591082; LEJEUNE J, 1968, ANN GENET-PARIS, V11, P71; LEWIS JG, 1990, GENOMICS, V8, P400, DOI 10.1016/0888-7543(90)90300-J; MCCORMICK MK, 1989, GENOMICS, V5, P325, DOI 10.1016/0888-7543(89)90065-7; MCGINNISS MJ, IN PRESS NUCLEIC ACI; NIELSEN F, 1984, J MED GENET, V21, P218, DOI 10.1136/jmg.21.3.218; PETERSEN MB, 1990, GENOMICS, V7, P136, DOI 10.1016/0888-7543(90)90531-X; PETERSEN MB, 1991, AM J HUM GENET, V48, P65; PETERSEN MB, 1991, GENOMICS, V9, P407, DOI 10.1016/0888-7543(91)90406-5; RAHMANI Z, 1989, P NATL ACAD SCI USA, V86, P5958, DOI 10.1073/pnas.86.15.5958; RUDDLE FH, 1989, CYTOGENET CELL GENET, V51, P1, DOI 10.1159/000132773; SAHAKIAN S, 1990, 15TH ANN M ASS CYT T; Sambrook J., 1989, MOL CLONING LAB MANU; Schinzel A, 1984, CATALOGUE UNBALANCED; STETTEN G, 1984, HUM GENET, V68, P310, DOI 10.1007/BF00292590; STETTEN G, 1990, MOL BIOL MED, V7, P479; SUMNER AT, 1972, EXP CELL RES, V75, P304, DOI 10.1016/0014-4827(72)90558-7; THERMAN E, 1986, HUMAN CHROMSOSOMES; WONG C, 1989, P NATL ACAD SCI USA, V86, P1914, DOI 10.1073/pnas.86.6.1914	32	87	89	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	1992	50	1					15	28						14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	HA040	1346075				2022-12-18	WOS:A1992HA04000003
J	INGLEHEARN, CF; BASHIR, R; LESTER, DH; JAY, M; BIRD, AC; BHATTACHARYA, SS				INGLEHEARN, CF; BASHIR, R; LESTER, DH; JAY, M; BIRD, AC; BHATTACHARYA, SS			A 3-BP DELETION IN THE RHODOPSIN GENE IN A FAMILY WITH AUTOSOMAL DOMINANT RETINITIS-PIGMENTOSA	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							ENZYMATIC AMPLIFICATION; SENSITIVITY; DNA	Autosomal dominant retinitis pigmentosa (ADRP) has recently been linked to locus D3S47 (probe C17), with no recombination, in a single large Irish family. Other ADRP pedigrees have shown linkage at zero recombination, linkage with recombination, and no linkage, demonstrating genetic heterogeneity. The gene encoding rhodopsin, the rod photoreceptor pigment, is closely linked to locus D3S47 on chromosome 3q. A point mutation changing a conserved proline to histidine in the 23d codon of the gene has been demonstrated in affected members of one ADRP family and in 17 of 148 unrelated ADRP patients. We have sequenced the rhodopsin gene in a C17-linked ADRP family and have identified in the 4th exon an in-frame 3-bp deletion which deletes one of the two isoleucine monomers at codons 255 and 256. This mutation was not found in 30 other unrelated ADRP families. The deletion has arisen in the sequence TCATCAT-CAT, deleting one of a run of three x 3-bp repeats. The mechanism by which this occurred may be similar to that which creates length variation in so-called mini- and microsatellites. Thus ADRP is an extremely heterogeneous disorder which can result from a range of defects in rhodopsin and which can have a locus or loci elsewhere in the genome.	UNIV NEWCASTLE UPON TYNE,DEPT HUMAN GENET,NEWCASTLE TYNE NE1 7RU,TYNE & WEAR,ENGLAND; MOORFIELDS EYE HOSP,DEPT CLIN OPHTHALMOL,LONDON WC1V 7AN,ENGLAND	Newcastle University - UK; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust			Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344				ALEXANDER KR, 1984, BRIT J OPHTHALMOL, V68, P561, DOI 10.1136/bjo.68.8.561; APPLEBURY ML, 1986, VISION RES, V26, P1881, DOI 10.1016/0042-6989(86)90115-X; BERSON EL, 1969, ARCH OPHTHALMOL-CHIC, V89, P226; BUNDEY S, 1984, J MED GENET, V21, P421, DOI 10.1136/jmg.21.6.421; Chaconas G, 1980, Methods Enzymol, V65, P75; DANCIGER M, 1989, GENOMICS, V5, P378, DOI 10.1016/0888-7543(89)90075-X; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; FULTON AB, 1988, AM J OPHTHALMOL, V105, P132, DOI 10.1016/0002-9394(88)90175-4; HERMAN BG, 1987, GUIDE MOL CLONING TE, P180; INGLEHEARN CF, 1990, GENOMICS, V6, P168, DOI 10.1016/0888-7543(90)90462-4; JARMAN AP, 1989, TRENDS GENET, V5, P367, DOI 10.1016/0168-9525(89)90171-6; KOBILKA BK, 1987, NATURE, V329, P75, DOI 10.1038/329075a0; LESTER DH, 1990, AM J HUM GENET, V47, P536; LYNESS AL, 1985, BRIT J OPHTHALMOL, V69, P326, DOI 10.1136/bjo.69.5.326; MASSOF RW, 1981, DOC OPHTHALMOL, V51, P289, DOI 10.1007/BF00143336; MASSOF RW, 1979, INVEST OPHTH VIS SCI, V18, P263; MCWILLIAM P, 1989, GENOMICS, V5, P619, DOI 10.1016/0888-7543(89)90031-1; MERIN S, 1976, Survey of Ophthalmology, V20, P303, DOI 10.1016/S0039-6257(96)90001-6; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; OLSSON JE, 1990, AM J MED GENET, V35, P595, DOI 10.1002/ajmg.1320350434; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Thein SI., 1986, HUMAN GENETIC DIS PR, P33; YANDELL DW, 1989, AM J HUM GENET, V45, P547; 1989, CYTOGENET CELL GENET, V51, P1	24	87	90	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	1991	48	1					26	30						5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ET188	1985460				2022-12-18	WOS:A1991ET18800004
J	DEEB, SS; TAKATA, K; PENG, R; KAJIYAMA, G; ALBERS, JJ				DEEB, SS; TAKATA, K; PENG, R; KAJIYAMA, G; ALBERS, JJ			A SPLICE-JUNCTION MUTATION RESPONSIBLE FOR FAMILIAL APOLIPOPROTEIN A-II DEFICIENCY	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									HIROSHIMA UNIV,DEPT INTERNAL MED 1,HIROSHIMA 730,JAPAN; UNIV WASHINGTON,SCH MED,DEPT PATHOL,SEATTLE,WA 98195; UNIV WASHINGTON,HARBORVIEW MED CTR,NW LIPID RES CTR,SEATTLE,WA 98104	Hiroshima University; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle	DEEB, SS (corresponding author), UNIV WASHINGTON,SCH MED,DEPT MED,DIV MED GENET,RG-25,SEATTLE,WA 98195, USA.				NHLBI NIH HHS [HL 30086] Funding Source: Medline; NIGMS NIH HHS [GM 15253] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM015253] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBERS JJ, 1975, METABOLISM, V24, P1339, DOI 10.1016/0026-0495(75)90050-5; ALBERS JJ, 1985, J JPN ATHEROSCLER SO, V13, P751; BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V142, P63, DOI 10.1016/0006-291X(87)90451-7; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; CARSON SD, 1987, J BIOL CHEM, V262, P718; CHAPMAN MJ, 1986, METHOD ENZYMOL, V128, P70; Cheung M C, 1986, Methods Enzymol, V129, P130; CHEUNG MC, 1977, J CLIN INVEST, V60, P43, DOI 10.1172/JCI108767; CHEUNG MC, 1984, J BIOL CHEM, V259, P2201; CHEUNG MC, 1987, J LIPID RES, V28, P913; DEEB SS, 1986, COLD SPRING HARB SYM, V51, P405; FIELDING CJ, 1972, BIOCHIM BIOPHYS ACTA, V270, P513, DOI 10.1016/0005-2760(72)90116-6; FRAGER G, 1979, ARTERY, V6, P188; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GORDON JI, 1983, J BIOL CHEM, V258, P4037; HERBERT PN, 1983, METABOLIC BASIS INHE, P589; JAHN CE, 1983, EUR J BIOCHEM, V131, P25, DOI 10.1111/j.1432-1033.1983.tb07227.x; KNOTT TJ, 1985, NUCLEIC ACIDS RES, V13, P6387, DOI 10.1093/nar/13.17.6387; LACKNER KJ, 1985, J BIOL CHEM, V260, P703; LOGOCKI P, 1980, J BIOL CHEM, V255, P3701; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MANIATIS T., 1982, MOL CLONING LABORATO, P382; MIDDLETONPRICE HR, 1988, HUM GENET, V79, P283, DOI 10.1007/BF00366253; MILLER GJ, 1975, LANCET, V1, P16; MOUNT SM, 1982, NUCLEIC ACIDS RES, V10, P459, DOI 10.1093/nar/10.2.459; ORKIN S, 1988, MOL BASIS BLOOD DISE, P106; PUNNONEN R, 1987, ATHEROSCLEROSIS, V68, P241, DOI 10.1016/0021-9150(87)90203-6; REICHL D, 1986, CLIN SCI, V70, P221, DOI 10.1042/cs0700221; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; TAKATA K, 1988, 8TH INT S ATH ROM; TSAO YK, 1985, J BIOL CHEM, V260, P5222; WARNICK R, 1986, METHOD ENZYMOL, V29, P101	33	87	88	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1990	46	4					822	827						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CW549	2107739				2022-12-18	WOS:A1990CW54900022
J	CHAMBERLAIN, S; SHAW, J; WALLIS, J; ROWLAND, A; CHOW, L; FARRALL, M; KEATS, B; RICHTER, A; ROY, M; MELANCON, S; DEUFEL, T; BERCIANO, J; WILLIAMSON, R				CHAMBERLAIN, S; SHAW, J; WALLIS, J; ROWLAND, A; CHOW, L; FARRALL, M; KEATS, B; RICHTER, A; ROY, M; MELANCON, S; DEUFEL, T; BERCIANO, J; WILLIAMSON, R			GENETIC HOMOGENEITY AT THE FRIEDREICH ATAXIA LOCUS ON CHROMOSOME-9	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									INST KLIN CHEM,MUNICH,FED REP GER; LOUISIANA STATE UNIV,MED CTR,DEPT BIOMETRY & GENET,NEW ORLEANS,LA 70112; HOP ST JUSTINE,GENET SECT,MONTREAL H3T 1C5,QUEBEC,CANADA; NATL HOSP MARQUES VALDECILLA,DEPT MED,NEUROL SECT,SANTANDER,SPAIN	Louisiana State University System; Universite de Montreal; Hospital Universitario Marques de Valdecilla (HUMV)	CHAMBERLAIN, S (corresponding author), UNIV LONDON,ST MARYS HOSP,SCH MED,DEPT BIOCHEM & MOLEC GENET,NORFOLK PL,LONDON W2 1PG,ENGLAND.		Chow, Larry/C-2639-2009	Chow, Larry/0000-0002-9222-8322; Shaw, Jacqui/0000-0003-4227-503X; Deufel, Thomas/0000-0003-4839-3117	NIGMS NIH HHS [GM 32793] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032793] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARSENAULT B, 1978, HIST ACADIENS, V1; BARBEAU A, 1984, CAN J NEUROL SCI, V11, P526, DOI 10.1017/S0317167100034995; BOUCHARD JP, 1979, CAN J NEUROL SCI, V6, P205, DOI 10.1017/S0317167100119651; CARLSON M, 1987, NUCLEIC ACIDS RES, V15, P10614, DOI 10.1093/nar/15.24.10614-a; CHAMBERLAIN S, 1988, NATURE, V334, P248, DOI 10.1038/334248a0; GEOFFROY G, 1976, Canadian Journal of Neurological Sciences, V3, P279; GILLIAM TC, 1984, HUM GENET, V68, P154, DOI 10.1007/BF00279306; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; [No title captured]	11	87	88	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR	1989	44	4					518	521						4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	T8109	2929596				2022-12-18	WOS:A1989T810900011
J	KUBBIES, M; SCHINDLER, D; HOEHN, H; SCHINZEL, A; RABINOVITCH, PS				KUBBIES, M; SCHINDLER, D; HOEHN, H; SCHINZEL, A; RABINOVITCH, PS			ENDOGENOUS BLOCKAGE AND DELAY OF THE CHROMOSOME CYCLE DESPITE NORMAL RECRUITMENT AND GROWTH-PHASE EXPLAIN POOR PROLIFERATION AND FREQUENT EDOMITOSIS IN FANCONI ANEMIA CELLS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV ZURICH,DEPT MED GENET,CH-8006 ZURICH,SWITZERLAND; UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195	University of Zurich; University of Washington; University of Washington Seattle	KUBBIES, M (corresponding author), UNIV WURZBURG,DEPT HUMAN GENET,D-8700 WURZBURG,FED REP GER.				NIA NIH HHS [AG-10751] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BASERGA R, 1984, EXP CELL RES, V151, P1, DOI 10.1016/0014-4827(84)90349-5; BERGER NA, 1982, NATURE, V299, P271, DOI 10.1038/299271a0; DUTRILLAUX B, 1982, HUM GENET, V62, P327, DOI 10.1007/BF00304549; FUJIWARA Y, 1977, J MOL BIOL, V113, P635, DOI 10.1016/0022-2836(77)90227-3; GERMAN JL, 1983, CHROMOSOME MUTATION, P149; HEDDLE JA, 1978, CANCER RES, V38, P2983; HIRSCHKAUFFMANN M, 1978, HUM GENET, V45, P25, DOI 10.1007/BF00277570; JOENJE H, 1981, NATURE, V290, P142, DOI 10.1038/290142a0; JOHNSTON GC, 1983, EXP CELL RES, V149, P1, DOI 10.1016/0014-4827(83)90375-0; KUBBIES M, 1983, CYTOMETRY, V3, P276, DOI 10.1002/cyto.990030408; KUBBIES M, 1985, CELL TISSUE KINET; LATT SA, 1973, P NATL ACAD SCI USA, V70, P3395, DOI 10.1073/pnas.70.12.3395; LATT SA, 1982, CYTOGENET CELL GENET, V33, P133, DOI 10.1159/000131737; PARSHAD R, 1983, P NATL ACAD SCI-BIOL, V80, P5612, DOI 10.1073/pnas.80.18.5612; RABINOVITCH PS, 1983, P NATL ACAD SCI-BIOL, V80, P2951, DOI 10.1073/pnas.80.10.2951; SASAKI MS, 1975, NATURE, V257, P501, DOI 10.1038/257501a0; SCHMID W, 1965, SCHWEIZ MED WSCHR, V95, P1461; SHIELDS R, 1978, CELL, V15, P469, DOI 10.1016/0092-8674(78)90016-8; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; STANCEL GM, 1981, P NATL ACAD SCI-BIOL, V78, P6295, DOI 10.1073/pnas.78.10.6295; WEKSBERG R, 1979, J CELL PHYSIOL, V101, P311, DOI 10.1002/jcp.1041010211	21	87	87	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	5					1022	1030						9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	ASD55	4050789				2022-12-18	WOS:A1985ASD5500019
J	MERRY, DE; PATHAK, S; HSU, TC; BRINKLEY, BR				MERRY, DE; PATHAK, S; HSU, TC; BRINKLEY, BR			ANTI-KINETOCHORE ANTIBODIES - USE AS PROBES FOR INACTIVE CENTROMERES	AMERICAN JOURNAL OF HUMAN GENETICS			English	Note									UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT GENET,HOUSTON,TX 77030; UNIV TEXAS,GRAD SCH BIOMED SCI,HOUSTON,TX 77030	University of Texas System; UTMD Anderson Cancer Center; University of Texas System					NCI NIH HHS [CA-23022] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRENNER S, 1981, J CELL BIOL, V91, P95, DOI 10.1083/jcb.91.1.95; COX JV, 1983, CELL, V35, P331, DOI 10.1016/0092-8674(83)90236-2; DEWALD GW, 1979, CYTOGENET CELL GENET, V24, P15, DOI 10.1159/000131352; EARNSHAW WC, 1984, J CELL BIOL, V98, P352, DOI 10.1083/jcb.98.1.352; EIBERG H, 1974, NATURE, V248, P55, DOI 10.1038/248055a0; HSU TC, 1975, CYTOGENET CELL GENET, V15, P41, DOI 10.1159/000130497; HSU TC, 1978, CYTOGENET CELL GENET, V21, P86, DOI 10.1159/000130881; HSU TC, 1973, NOBEL S, V23, P32; JOHNSON GD, 1981, J IMMUNOL METHODS, V43, P349, DOI 10.1016/0022-1759(81)90183-6; LICA L, 1983, CHROMOSOMA, V88, P42, DOI 10.1007/BF00329502; MARASCHIO P, 1980, HUM GENET, V54, P265, DOI 10.1007/BF00278982; MOROI Y, 1980, P NATL ACAD SCI-BIOL, V77, P1627, DOI 10.1073/pnas.77.3.1627; NAKAGOME Y, 1984, AM J HUM GENET, V36, P398; NIEBUHR E, 1972, HUMANGENETIK, V16, P217, DOI 10.1007/BF00273467; SEABRIGH.M, 1971, LANCET, V2, P971; SEKHON GS, 1977, MAMMALIAN CHROMOSOME, V18, P46; SINHA AK, 1976, HUM GENET, V32, P295, DOI 10.1007/BF00295819; STENMAN S, 1975, EXP CELL RES, V90, P87, DOI 10.1016/0014-4827(75)90360-2; THERMAN E, 1974, AM J HUM GENET, V26, P83	19	87	89	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1985	37	2					425	430						6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AGY59	3885726				2022-12-18	WOS:A1985AGY5900016
J	RISCH, N; BARON, M				RISCH, N; BARON, M			SEGREGATION ANALYSIS OF SCHIZOPHRENIA AND RELATED DISORDERS	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article									NEW YORK STATE PSYCHIAT INST,DEPT MED GENET,DIV PSYCHOGENET,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,SCH PUBL HLTH,DIV BIOSTAT,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY 10032	New York State Psychiatry Institute; Columbia University; Columbia University					NICHD NIH HHS [HD00477] Funding Source: Medline; NIMH NIH HHS [MH00176, MH-30608] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAMS R, 1983, AM J PSYCHIAT, V140, P171; BARON M, 1981, PSYCHIAT RES, V4, P213, DOI 10.1016/0165-1781(81)90024-X; BARON M, 1983, AM J PSYCHIAT, V140, P1437; BARON M, 1983, AM J HUM GENET, V35, pA35; BARON M, 1980, SCHEDULE INTERVIEWIN; BARON M, 1984, J PSYCHIAT RES; BARON M, UNPUB FAMILY STUDY S; CANNINGS C, 1977, CLIN GENET, V12, P208; CARTER CL, 1980, HUM HERED, V30, P350, DOI 10.1159/000153156; DAVIE AM, 1979, ANN HUM GENET, V42, P507, DOI 10.1111/j.1469-1809.1979.tb00683.x; DEBRAY Q, 1978, NEUROPSYCHOBIOLOGY, V4, P257, DOI 10.1159/000117639; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; ELSTON RC, 1973, BEHAV GENET, V3, P101, DOI 10.1007/BF01067650; ELSTON RC, 1979, AM J HUM GENET, V31, P62; ELSTON RC, 1978, NEUROPSYCHOBIOLOGY, V4, P193, DOI 10.1159/000117633; ELSTON RC, 1970, BEHAV GENET, V1, P3, DOI 10.1007/BF01067366; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; ESSEN-MOLLER E, 1955, Acta Genet Stat Med, V5, P334; GO RCP, 1978, AM J HUM GENET, V30, P28; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; HUXLEY J, 1964, NATURE, V204, P220, DOI 10.1038/204220a0; KALLMANN FJ, 1946, AM J PSYCHIAT, V103, P309, DOI 10.1176/ajp.103.3.309; KAPLAN EB, 1972, I STATISTICS MIMEO S, V823; KARLSSON JL, 1976, GENETIC FACTORS SCHI, P246; KENDLER KS, 1981, ARCH GEN PSYCHIAT, V38, P982; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LI CC, 1968, AM J HUM GENET, V20, P61; LIDZ T, 1981, AM J PSYCHIAT, V138, P1063; LIDZ T, 1983, AM J PSYCHIAT, V140, P426; MCGUE M, 1983, AM J HUM GENET, V35, P1161; MCGUFFIN P, 1983, PSYCHOL MED, V13, P31, DOI 10.1017/S0033291700050042; MORTON NE, 1971, AM J HUM GENET, V23, P602; MORTON NE, 1959, AM J HUM GENET, V11, P1; MORTON NE, 1967, AM J HUM GENET, V19, P23; MORTON NE, 1974, AM J HUM GENET, V26, P489; NEEL JV, 1965, GENETICS EPIDEMIOLOG, P105; OROURKE DH, 1982, AM J HUM GENET, V34, P630; RAO DC, 1981, HUM HERED, V31, P325, DOI 10.1159/000153233; RISCH N, 1983, BIOMETRICS, V39, P929, DOI 10.2307/2531328; RISCH N, 1983, BEHAV GENET, V13, P441, DOI 10.1007/BF01065920; RISCH N, 1983, UNPUB FORTRAN PROGRA; Shields J, 1982, SCHIZOPHRENIA EPIGEN; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; SZASZ TS, 1960, AM PSYCHOL, V15, P113, DOI 10.1037/h0046535; TSUANG MT, 1980, BRIT J PSYCHIAT, V137, P497, DOI 10.1192/bjp.137.6.497; TSUANG MT, 1982, BRIT J PSYCHIAT, V140, P595, DOI 10.1192/bjp.140.6.595; TURNER WJ, 1979, BIOL PSYCHIAT, V14, P177; 1980, DIAGNOSTIC STATISTIC	49	87	87	0	1	UNIV CHICAGO PRESS	CHICAGO	5720 S WOODLAWN AVE, CHICAGO, IL 60637	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1984	36	5					1039	1059						21	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Genetics & Heredity	TS302	6496472				2022-12-18	WOS:A1984TS30200010
J	WOOLF, CM; BROADBENT, TR; WOOLF, RM				WOOLF, CM; BROADBENT, TR; WOOLF, RM			A GENETIC STUDY OF CLEFT LIP AND PALATE IN UTAH	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article																		CANICK ML, 1954, PLAST RECONSTR SURG, V14, P30, DOI 10.1097/00006534-195407000-00003; CURTIS EJ, 1961, AM J DIS CHILD, V102, P853, DOI 10.1001/archpedi.1961.02080010855007; FAINSTAT T, 1954, ENDOCRINOLOGY, V55, P502, DOI 10.1210/endo-55-4-502; Fogh-Anderson P., 1942, INHERITANCE HARELIP; FRASER F C, 1955, Acta Genet Stat Med, V5, P358; FRASER FC, 1962, CAN MED ASSOC J, V87, P683; MACMAHON B, 1953, AM J HUM GENET, V5, P176; METRAKOS J D, 1958, Plast Reconstr Surg Transplant Bull, V22, P109, DOI 10.1097/00006534-195808000-00003; NELSON MM, 1957, J NUTR, V62, P395; PLEYDELL MJ, 1960, BMJ-BRIT MED J, V1, P309, DOI 10.1136/bmj.1.5169.309; VANDERWOUDE A, 1954, AM J HUM GENET, V6, P244; Warkany J, 1943, AM J DIS CHILD, V65, P882, DOI 10.1001/archpedi.1943.02010180058007; Wright S, 1934, GENETICS, V19, P0537	13	87	87	0	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.		1963	15	2					209	&						0	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	2970A	14001834				2022-12-18	WOS:A19632970A00010
J	Dong, FN; Amiri-Yekta, A; Martinez, G; Saut, A; Tek, J; Stouvenel, L; Lores, P; Karaouzene, T; Thierry-Mieg, N; Satre, V; Brouillet, S; Daneshipour, A; Hosseini, SH; Bonhivers, M; Gourabi, H; Dulioust, E; Arnoult, C; Toure, A; Ray, PF; Zhao, HQ; Coutton, C				Dong, Frederick N.; Amiri-Yekta, Amir; Martinez, Guillaume; Saut, Antoine; Tek, Julie; Stouvenel, Laurence; Lores, Patrick; Karaouzene, Thomas; Thierry-Mieg, Nicolas; Satre, Veronique; Brouillet, Sophie; Daneshipour, Abbas; Hosseini, Seyedeh Hanieh; Bonhivers, Melanie; Gourabi, Hamid; Dulioust, Emmanuel; Arnoult, Christophe; Toure, Aminata; Ray, Pierre F.; Zhao, Haiqing; Coutton, Charles			Absence of CFAP69 Causes Male Infertility due to Multiple Morphological Abnormalities of the Flagella in Human and Mouse	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							WORLD-HEALTH-ORGANIZATION; SPERM FLAGELLA; MUTATIONS; DEFECTS; EXPRESSION; DNAH1; SPEF2; SPERMATOGENESIS; TRANSPORT	The multiple morphological abnormalities of the flagella (MMAF) phenotype is among the most severe forms of sperm defects responsible for male infertility. The phenotype is characterized by the presence in the ejaculate of immotile spermatozoa with severe flagellar abnormalities including flagella being short, coiled, absent, and of irregular caliber. Recent studies have demonstrated that MMAF is genetically heterogeneous, and genes thus far associated with MMAF account for only one-third of cases. Here we report the identification of homozygous truncating mutations (one stop-gain and one splicing variant) in CFAP69 of two unrelated individuals by whole-exome sequencing of a cohort of 78 infertile men with MMAF. CFAP69 encodes an evolutionarily conserved protein found at high levels in the testis. Immunostaining experiments in sperm from fertile control individuals showed that CFAP69 localized to the midpiece of the flagellum, and the absence of CFAP69 was confirmed in both individuals carrying CFPA69 mutations. Additionally, we found that sperm from a Cfap69 knockout mouse model recapitulated the MMAF phenotype. Ultrastructural analysis of testicular sperm from the knockout mice showed severe disruption of flagellum structure, but histological analysis of testes from these mice revealed the presence of all stages of the seminiferous epithelium, indicating that the overall progression of spermatogenesis is preserved and that the sperm defects likely arise during spermiogenesis. Together, our data indicate that CFAP69 is necessary for flagellum assembly/ stability and that in both humans and mice, biallelic truncating mutations in CFAP69 cause autosomal-recessive MMAF and primary male infertility.	[Dong, Frederick N.; Zhao, Haiqing] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; [Amiri-Yekta, Amir; Daneshipour, Abbas; Gourabi, Hamid] ACECR, Royan Inst Reprod Biomed, Reprod Biomed Res Ctr, Dept Genet, Tehran, Iran; [Amiri-Yekta, Amir; Martinez, Guillaume; Saut, Antoine; Karaouzene, Thomas; Satre, Veronique; Arnoult, Christophe; Ray, Pierre F.; Coutton, Charles] Univ Grenoble Alpes, Inst Adv Biosci, Team Genet Epigenet & Therapies Infertil, INSERM,CNRS,U1209,UMR 5309, F-38000 Grenoble, France; [Martinez, Guillaume; Saut, Antoine; Satre, Veronique; Coutton, Charles] CHU Grenoble Alpes, UM Genet Chromosom, F-38000 Grenoble, France; [Stouvenel, Laurence; Lores, Patrick; Toure, Aminata] INSERM, Inst Cochin, U1016, F-75014 Paris, France; [Tek, Julie; Stouvenel, Laurence; Lores, Patrick; Toure, Aminata] CNRS, UMR8104, F-75014 Paris, France; [Tek, Julie; Stouvenel, Laurence; Lores, Patrick; Dulioust, Emmanuel; Toure, Aminata] Univ Paris 05, Fac Med, Sorbonne Paris Cite, F-75014 Paris, France; [Karaouzene, Thomas; Ray, Pierre F.] CHU Grenoble, UM GI DPI, F-38000 Grenoble, France; [Karaouzene, Thomas; Thierry-Mieg, Nicolas] Univ Grenoble Alpes, CNRS, TIMC IMAG, F-38000 Grenoble, France; [Brouillet, Sophie] Univ Grenoble Alpes, CHU Grenoble Alpes, Lab AMP CECOS, INSERM,UGA,CEA,CNRS,U1036, F-38000 Grenoble, France; [Hosseini, Seyedeh Hanieh] ACECR, Royan Inst Reprod Biomed, Reprod Biomed Res Ctr, Dept Androl, Tehran, Iran; [Bonhivers, Melanie] Univ Bordeaux, CNRS, Microbiol Fondamentale & Pathogenicite, UMR 5234, F-33000 Bordeaux, France; [Bonhivers, Melanie] Inst Polytech Bordeaux, CNRS, Microbiol Fondamentale & Pathogenicite, UMR 5234, F-33000 Bordeaux, France; [Dulioust, Emmanuel] GH Cochin Broca, Hotel Dieu, AP HP, Lab Histol Embryol, F-75014 Paris, France	Johns Hopkins University; Academic Center for Education, Culture & Research (ACECR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Academic Center for Education, Culture & Research (ACECR); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite	Zhao, HQ (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.; Coutton, C (corresponding author), Univ Grenoble Alpes, Inst Adv Biosci, Team Genet Epigenet & Therapies Infertil, INSERM,CNRS,U1209,UMR 5309, F-38000 Grenoble, France.; Coutton, C (corresponding author), CHU Grenoble Alpes, UM Genet Chromosom, F-38000 Grenoble, France.	hzhao@jhu.edu; ccoutton@chu-grenoble.fr	TOURE, Aminata/B-3236-2018; Amiri-Yekta, Amir/AAF-1062-2020; Ray, Pierre F/D-7315-2019; COUTTON, Charles/G-2859-2014; SATRE, Véronique/G-2864-2014; Thierry-Mieg, Nicolas/M-6007-2014; Bonhivers, Melanie/Z-5889-2019; Martinez, Guillaume/O-3959-2018; ARNOULT, christophe/E-8312-2013	TOURE, Aminata/0000-0001-5629-849X; Ray, Pierre F/0000-0003-1544-7449; SATRE, Véronique/0000-0001-7852-8591; Thierry-Mieg, Nicolas/0000-0002-7667-2853; Bonhivers, Melanie/0000-0001-9179-8473; Amiri-Yekta, Amir/0000-0002-8099-7984; Martinez, Guillaume/0000-0002-7572-9096; Coutton, Charles/0000-0002-8873-8098; Brouillet, Sophie/0000-0003-3354-1551; ARNOULT, christophe/0000-0002-3753-5901; Lores, Patrick/0000-0002-3191-9488	French ANR; DGOS; "Whole genome sequencing of patients with Flagellar Growth Defects (FGD)'' - fondation maladies rares (FMR); USA NIH grant [DC007395]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007395] Funding Source: NIH RePORTER	French ANR(French National Research Agency (ANR)); DGOS; "Whole genome sequencing of patients with Flagellar Growth Defects (FGD)'' - fondation maladies rares (FMR); USA NIH grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank all individuals for their participation. This work was mainly supported by the following grants: the "MAS-Flagella'' project financed by French ANR and the DGOS for the program PRTS 2014 (P.F.R.), the "Whole genome sequencing of patients with Flagellar Growth Defects (FGD)'' financed by the fondation maladies rares (FMR) for the program Sequencage a haut debit 2012 (P.F.R.), and the USA NIH grant DC007395 (H.Z.).	Amiri-Yekta A, 2016, HUM REPROD, V31, P2872, DOI 10.1093/humrep/dew262; Auger J, 2016, HUM REPROD, V31, P10, DOI 10.1093/humrep/dev251; Ben Khelifa M, 2014, AM J HUM GENET, V94, P95, DOI 10.1016/j.ajhg.2013.11.017; Bjorkgren I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038457; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Coutton C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02792-7; Coutton C, 2015, HUM REPROD UPDATE, V21, P455, DOI 10.1093/humupd/dmv020; da Cruz I, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2618-1; de Boer P, 2015, ANDROLOGY-US, V3, P174, DOI 10.1111/andr.300; Farwell KD, 2015, GENET MED, V17, P578, DOI 10.1038/gim.2014.154; FAWCETT DW, 1975, DEV BIOL, V44, P394, DOI 10.1016/0012-1606(75)90411-X; Fogel BL, 2016, ANN NY ACAD SCI, V1366, P49, DOI 10.1111/nyas.12850; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Lee L, 2011, GENE, V473, P57, DOI 10.1016/j.gene.2010.11.006; Lehti MS, 2016, REPRODUCTION, V151, pR43, DOI 10.1530/REP-15-0310; Lehti MS, 2017, DEVELOPMENT, V144, P2683, DOI 10.1242/dev.152108; Levitsky KL, 2013, SCI REP-UK, V3, DOI 10.1038/srep02937; Liu H, 2017, BIOL REPROD, V96, DOI 10.1093/biolre/iox029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnoni R, 2014, FREE RADICAL RES, V48, P168, DOI 10.3109/10715762.2013.858147; Margolin G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-39; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Merkwitz C, 2016, J HISTOCHEM CYTOCHEM, V64, P579, DOI 10.1369/0022155416665337; Mitchell MJ, 2017, CLIN GENET, V91, P208, DOI 10.1111/cge.12900; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; Ray PF, 2017, CLIN GENET, V91, P217, DOI 10.1111/cge.12905; San Agustin JT, 2015, MOL BIOL CELL, V26, P4358, DOI 10.1091/mbc.E15-08-0578; Sapiro R, 2000, BIOL REPROD, V62, P511, DOI 10.1095/biolreprod62.3.511; Sha YW, 2017, FERTIL STERIL, V107, P1312, DOI 10.1016/j.fertnstert.2017.04.007; Sharlip ID, 2002, FERTIL STERIL, V77, P873, DOI 10.1016/S0015-0282(02)03105-9; Sironen A, 2006, P NATL ACAD SCI USA, V103, P5006, DOI 10.1073/pnas.0506318103; Sironen A, 2011, BIOL REPROD, V85, P690, DOI 10.1095/biolreprod.111.091132; Sironen A, 2010, BIOL REPROD, V82, P580, DOI 10.1095/biolreprod.108.074971; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Talaga AK, 2017, J NEUROSCI, V37, P5699, DOI 10.1523/JNEUROSCI.0392-17.2017; Tang SY, 2017, AM J HUM GENET, V100, P854, DOI 10.1016/j.ajhg.2017.04.012; Tewari R, 2010, TRENDS CELL BIOL, V20, P470, DOI 10.1016/j.tcb.2010.05.003; Wang X, 2017, CLIN GENET, V91, P313, DOI 10.1111/cge.12857; Wang YX, 2014, FERTIL STERIL, V101, P945, DOI 10.1016/j.fertnstert.2013.12.047; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Zhang Z, 2016, MOL BIOL CELL; Zorrilla Michelle, 2013, Curr Genet Med Rep, V1, DOI 10.1007/s40142-013-0027-1	43	86	92	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 5	2018	102	4					636	648		10.1016/j.ajhg.2018.03.007	http://dx.doi.org/10.1016/j.ajhg.2018.03.007			13	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	GB8QQ	29606301	Green Published, Bronze			2022-12-18	WOS:000429340800010
J	Keum, JW; Shin, A; Gillis, T; Mysore, JS; Abu Elneel, K; Lucente, D; Hadzi, T; Holmans, P; Jones, L; Orth, M; Kwak, S; MacDonald, ME; Gusella, JF; Lee, JM				Keum, Jae Whan; Shin, Aram; Gillis, Tammy; Mysore, Jayalakshmi Srinidhi; Abu Elneel, Kawther; Lucente, Diane; Hadzi, Tiffany; Holmans, Peter; Jones, Lesley; Orth, Michael; Kwak, Seung; MacDonald, Marcy E.; Gusella, James F.; Lee, Jong-Min			The HTT CAG-Expansion Mutation Determines Age at Death but Not Disease Duration in Huntington Disease	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							REPEAT LENGTH; OF-ONSET; SCAN INVESTIGATIONS; DIABETES-MELLITUS; WEIGHT-LOSS; HD; METABOLISM; GENETICS; FEATURES; BRAINS	Huntington disease (HD) is caused by an expanded HTT CAG repeat that leads in a length-dependent, completely dominant manner to onset of a characteristic movement disorder. HD also displays early mortality, so we tested whether the expanded CAG repeat exerts a dominant influence on age at death and on the duration of clinical disease. We found that, as with clinical onset, HD age at death is determined by expanded CAG-repeat length and has no contribution from the normal CAG allele. Surprisingly, disease duration is independent of the mutation's length. It is also unaffected by a strong genetic modifier of HD motor onset. These findings suggest two parsimonious alternatives. (1) HD pathogenesis is driven by mutant huntingtin, but before or near motor onset, sufficient CAG-driven damage occurs to permit CAG-independent processes and then lead to eventual death. In this scenario, some pathological changes and their clinical correlates could still worsen in a CAG-driven manner after disease onset, but these CAG-related progressive changes do not themselves determine duration. Alternatively, (2) HD pathogenesis is driven by mutant huntingtin acting in a CAG-dependent manner with different time courses in multiple cell types, and the cellular targets that lead to motor onset and death are different and independent. In this scenario, processes driven by HTT CAG length lead directly to death but not via the striatal pathology associated with motor manifestations. Each scenario has important ramifications for the design and testing of potential therapeutics, especially those aimed at preventing or delaying characteristic motor manifestations.	[Keum, Jae Whan; Shin, Aram; Gillis, Tammy; Mysore, Jayalakshmi Srinidhi; Abu Elneel, Kawther; Lucente, Diane; MacDonald, Marcy E.; Gusella, James F.; Lee, Jong-Min] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Hadzi, Tiffany] GNS Healthcare Inc, One Charles Pk, Cambridge, MA 02142 USA; [Holmans, Peter; Jones, Lesley] Cardiff Univ, Sch Med, MRC, Ctr Neuropsychiat Genet & Genom,Dept Psychol Med, Cardiff CF24 4HQ, S Glam, Wales; [Orth, Michael] Univ Ulm, Dept Neurol, D-089081 Ulm, Germany; [Kwak, Seung] CHDI Fdn, Princeton, NJ 08540 USA; [MacDonald, Marcy E.; Lee, Jong-Min] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [MacDonald, Marcy E.; Gusella, James F.; Lee, Jong-Min] Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA; [Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Holmans, Peter; Jones, Lesley; Orth, Michael; Kwak, Seung; MacDonald, Marcy E.; Gusella, James F.; Lee, Jong-Min] Genet Modifiers Huntingtons Dis Consortium, New York, NY USA	Harvard University; Massachusetts General Hospital; Cardiff University; Ulm University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School	Lee, JM (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.; Lee, JM (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.; Lee, JM (corresponding author), Broad Inst MIT & Harvard, Med & Populat Genet Program, Cambridge, MA 02142 USA.; Lee, JM (corresponding author), Genet Modifiers Huntingtons Dis Consortium, New York, NY USA.	jlee51@mgh.harvard.edu	Holmans, Peter/F-4518-2015	Holmans, Peter/0000-0003-0870-9412	NIH [NINDS NS16367, U01NS082079, R01NS091161]; CHDI Foundation, Inc.; Medical Research Council [MR/L010305/1] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS016367, P01NS016367, R01NS091161, U01NS082079] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation, Inc.; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge and thank the Harvard Brain Tissue Resource Center at McLean Hospital (Dr. Francine Benes, Director), the New York Brain Bank at Columbia University (Dr. Jean-Paul Vonsattel, Director), the National Neurological Research Specimen Bank at the Department of Veterans Affairs Medical Center (Dr. Wallace Tourtellotte, Director), the Neuropathology Core of the MA Alzheimer Disease Research Center (Matt Frosch, Director), and the Harvard NeuroDiscovery Center Advanced Tissue Resources Core at Massachusetts General Hospital (Dr. Charles Vanderburg, Director) for providing Huntington disease postmortem brain tissues. We also thank Dr. Richard H. Myers (Boston University School of Medicine) for helpful comments on this manuscript. This work was supported by NIH grants NINDS NS16367, U01NS082079, and R01NS091161 and the CHDI Foundation, Inc.	Andreassen OA, 2002, NEUROBIOL DIS, V11, P410, DOI 10.1006/nbdi.2002.0562; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Aziz NA, 2009, NEUROLOGY, V73, P1280, DOI 10.1212/WNL.0b013e3181bd1121; Bates GP, 2005, NAT REV GENET, V6, P766, DOI 10.1038/nrg1686; BERENT S, 1988, ANN NEUROL, V23, P541, DOI 10.1002/ana.410230603; BYERS RK, 1967, NEUROLOGY, V17, P587, DOI 10.1212/WNL.17.6.587; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Djousse L, 2003, AM J MED GENET A, V119A, P279, DOI 10.1002/ajmg.a.20190; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Foroud T, 1999, J NEUROL NEUROSUR PS, V66, P52, DOI 10.1136/jnnp.66.1.52; Guo ZH, 2012, MOVEMENT DISORD, V27, P1379, DOI 10.1002/mds.25159; Gusella J, 2002, NAT REV GENET, V3, P72, DOI 10.1038/nrg706; Hadzi TC, 2012, NEUROLOGY, V79, P1708, DOI 10.1212/WNL.0b013e31826e9a5d; Hu YQ, 2014, J ALZHEIMERS DIS, V40, P863, DOI 10.3233/JAD-131847; Huntington G., 1872, MED SURGICAL REPORTE, V26, P320; Huntington's Disease Collaborative Research Group, 1993, CELL, V72, P971, DOI DOI 10.1016/0092-8674(93)90585-E; KREMER HPH, 1992, ARCH NEUROL-CHICAGO, V49, P349, DOI 10.1001/archneur.1992.00530280029014; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; LANSKA DJ, 1988, NEUROLOGY, V38, P769, DOI 10.1212/WNL.38.5.769; LANSKA DJ, 1988, ARCH NEUROL-CHICAGO, V45, P878, DOI 10.1001/archneur.1988.00520320068017; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Lee JM, 2015, CELL, V162, P516, DOI 10.1016/j.cell.2015.07.003; Lee JM, 2012, AM J HUM GENET, V90, P434, DOI 10.1016/j.ajhg.2012.01.005; Morton AJ, 2013, EXP NEUROL, V243, P34, DOI 10.1016/j.expneurol.2012.10.014; Nahhas FA, 2005, AM J MED GENET A, V137A, P328, DOI 10.1002/ajmg.a.30891; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; Pekmezovic T, 2007, EUR J EPIDEMIOL, V22, P523, DOI 10.1007/s10654-007-9157-7; Perlis RH, 2010, AM J PSYCHIAT, V167, P574, DOI 10.1176/appi.ajp.2009.09070973; Persichetti F, 1994, Neurobiol Dis, V1, P159, DOI 10.1006/nbdi.1994.0019; Petersen A, 2012, J HUNTINGTONS DIS, V1, P5, DOI 10.3233/JHD-2012-120006; PRIDMORE SA, 1990, MED J AUSTRALIA, V153, P137, DOI 10.5694/j.1326-5377.1990.tb136831.x; Reyes A, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-89; ROOS RAC, 1993, J NEUROL NEUROSUR PS, V56, P98, DOI 10.1136/jnnp.56.1.98; Rosas HD, 2001, NEUROLOGY, V57, P1025, DOI 10.1212/WNL.57.6.1025; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; YOUNG AB, 1986, ANN NEUROL, V20, P296, DOI 10.1002/ana.410200305; YOUNG AB, 1987, ARCH NEUROL-CHICAGO, V44, P254, DOI 10.1001/archneur.1987.00520150010010	42	86	87	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB 4	2016	98	2					287	298		10.1016/j.ajhg.2015.12.018	http://dx.doi.org/10.1016/j.ajhg.2015.12.018			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	DE3BR	26849111	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000370502300005
J	White, J; Mazzeu, JF; Hoischen, A; Jhangiani, SN; Gambin, T; Alcino, MC; Penney, S; Saraiva, JM; Hove, H; Skovby, F; Kayserili, H; Estrella, E; Vulto-van Silfhout, AT; Steehouwer, M; Muzny, DM; Sutton, VR; Gibbs, RA; Lupski, JR; Brunner, HG; van Bon, BWM; Carvalho, CMB				White, Janson; Mazzeu, Juliana F.; Hoischen, Alexander; Jhangiani, Shalini N.; Gambin, Tomasz; Alcino, Michele Calijorne; Penney, Samantha; Saraiva, Jorge M.; Hove, Hanne; Skovby, Flemming; Kayserili, Hulya; Estrella, Elicia; Vulto-van Silfhout, Anneke T.; Steehouwer, Marloes; Muzny, Donna M.; Sutton, V. Reid; Gibbs, Richard A.; Lupski, James R.; Brunner, Han G.; van Bon, Bregje W. M.; Carvalho, Claudia M. B.		Baylor-Hopkins Ctr Mendelian	DVL1 Frameshift Mutations Clustering in the Penultimate Exon Cause Autosomal-Dominant Robinow Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MESSENGER-RNA DECAY; RECEPTOR TYROSINE KINASE; BRACHYDACTYLY TYPE-B; TRUNCATING MUTATIONS; SIGNALING PATHWAY; COVESDEM SYNDROME; NOTCH2 CAUSE; DROSOPHILA; ROR2; WNT	Robinow syndrome is a genetically heterogeneous disorder characterized by mesomelic limb shortening, genital hypoplasia, and distinctive facial features and for which both autosomal-recessive and autosomal-dominant inheritance patterns have been described. Causative variants in the non-canonical signaling gene WNT5A underlie a subset of autosomal-dominant Robinow syndrome (DRS) cases, but most individuals with DRS remain without a molecular diagnosis. We performed whole-exome sequencing in four unrelated DRS-affected individuals without coding mutations in WNT5A and found heterozygous DVL1 exon 14 mutations in three of them. Targeted Sanger sequencing in additional subjects with DRS uncovered DVL1 exon 14 mutations in five individuals, including a pair of monozygotic twins. In total, six distinct frameshift mutations were found in eight subjects, and all were heterozygous truncating variants within the penultimate exon of DVL1. In five families in which samples from unaffected parents were available, the variants were demonstrated to represent de novo mutations. All variant alleles are predicted to result in a premature termination codon within the last exon, escape nonsense-mediated decay (NMD), and most likely generate a C-terminally truncated protein with a distinct -1 reading-frame terminus. Study of the transcripts extracted from affected subjects' leukocytes confirmed expression of both wild-type and variant alleles, supporting the hypothesis that mutant mRNA escapes NMD. Genomic variants identified in our study suggest that truncation of the C-terminal domain of DVL1, a protein hypothesized to have a downstream role in the Wnt-5a non-canonical pathway, is a common cause of DRS.	[White, Janson; Gambin, Tomasz; Penney, Samantha; Sutton, V. Reid; Gibbs, Richard A.; Lupski, James R.; Carvalho, Claudia M. B.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Mazzeu, Juliana F.] Univ Catolica Brasilia, Programa Posgrad Ciencias Genom & Biotecnol, BR-70790160 Brasilia, DF, Brazil; [Mazzeu, Juliana F.] Robinow Syndrome Fdn, Anoka, MN 55303 USA; [Hoischen, Alexander; Vulto-van Silfhout, Anneke T.; Steehouwer, Marloes; Brunner, Han G.; van Bon, Bregje W. M.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Jhangiani, Shalini N.; Muzny, Donna M.; Gibbs, Richard A.; Lupski, James R.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gambin, Tomasz] Warsaw Univ Technol, Inst Comp Sci, PL-00661 Warsaw, Poland; [Alcino, Michele Calijorne; Carvalho, Claudia M. B.] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil; [Saraiva, Jorge M.] Ctr Hosp & Univ Coimbra, Hosp Pediat, Med Genet Unit, P-3000075 Coimbra, Portugal; [Saraiva, Jorge M.] Univ Coimbra, Univ Clin Pediat, Fac Med, P-3000354 Coimbra, Portugal; [Hove, Hanne; Skovby, Flemming] Univ Copenhagen, Rigshosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Kayserili, Hulya] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34093 Istanbul, Turkey; [Kayserili, Hulya] Koc Univ, Sch Med, Dept Med Genet, TR-34450 Sariyer, Turkey; [Estrella, Elicia] Boston Childrens Hosp, Dept Genet & Genom, Boston, MA 02115 USA; [Estrella, Elicia] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Brunner, Han G.] Maastricht Univ, Dept Clin Genet, Med Ctr, NL-6200 AZ Maastricht, Netherlands	Baylor College of Medicine; Universidade Catolica de Brasilia; Radboud University Nijmegen; Baylor College of Medicine; Warsaw University of Technology; Fundacao Oswaldo Cruz; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Rigshospitalet; University of Copenhagen; Istanbul University; Koc University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Baylor College of Medicine; Baylor College of Medicine; Maastricht University	Carvalho, CMB (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	cfonseca@bcm.edu	Gambin, Tomasz/HDN-5840-2022; van Bon, Bregje/Q-2445-2015; Hoischen, Alexander/D-1282-2013; AT, Vulto-van Silfhout/H-4199-2015; Hoischen, Alexander/AGF-7293-2022; mazzeu, Juliana f/H-4279-2016; Brunner, Han/C-9928-2013; Kayserili, Hülya/AAA-5593-2021	Gambin, Tomasz/0000-0002-0941-4571; van Bon, Bregje/0000-0003-2234-0105; Hoischen, Alexander/0000-0002-8072-4476; Hoischen, Alexander/0000-0002-8072-4476; mazzeu, Juliana f/0000-0002-6161-0510; Kayserili, Hülya/0000-0003-0376-499X; Saraiva, Jorge Manuel/0000-0002-7232-3509; White, Janson/0000-0002-5701-728X	Baylor Hopkins Center for Mendelian Genomics - National Human Genome Research Institute (NHGRI) [U54HG006542, U54HG003273]; Baylor Hopkins Center for Mendelian Genomics - NHBLI [U54HG006542, U54HG003273]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [CBB-APQ-01456-13]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [476217/2013-0]; Science without Borders program Young Investigator fellowship grant [402520/2012-2]; Netherlands Organization for Scientific Research ZonMW Veni grant [916-12-095]; Scientific and Technological Research Council of Turkey (TUBITAK) (ERA-NET project) [SBAG-112S398, CRANIRARE-2]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006542, U54HG003273, U54HG006542] Funding Source: NIH RePORTER	Baylor Hopkins Center for Mendelian Genomics - National Human Genome Research Institute (NHGRI); Baylor Hopkins Center for Mendelian Genomics - NHBLI; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Science without Borders program Young Investigator fellowship grant; Netherlands Organization for Scientific Research ZonMW Veni grant; Scientific and Technological Research Council of Turkey (TUBITAK) (ERA-NET project)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank the families and the Robinow Syndrome Foundation for their participation in the study. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about. This work was supported by the Baylor Hopkins Center for Mendelian Genomics (U54HG006542), jointly funded by the National Human Genome Research Institute (NHGRI) and NHBLI, a grant (U54HG003273) to R.A.G., the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (CBB-APQ-01456-13), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (476217/2013-0), a Science without Borders program Young Investigator fellowship grant (402520/2012-2) to C.M.B.C., the Netherlands Organization for Scientific Research ZonMW Veni grant (916-12-095) to A.H., and a Scientific and Technological Research Council of Turkey (TUBITAK) grant (SBAG-112S398, CRANIRARE-2, ERA-NET project) to H.K. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NHGRI, NHBLI, or NIH. J.R.L. holds stock ownership in 23andMe and Lasergen, is a paid consultant for Regeneron Pharmaceuticals, and is a coinventor of multiple United States and European patents related to molecular diagnostics. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from molecular genetic testing offered in the BaylorMiraca Medical Genetics Laboratories (https://www.bcm.edu/geneticlabs/).	Afzal AR, 2000, NAT GENET, V25, P419, DOI 10.1038/78107; Bainbridge MN, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r68; Ben-Shachar S, 2009, CLIN GENET, V75, P394, DOI 10.1111/j.1399-0004.2008.01114.x; Carvalho CMB, 2014, AM J HUM GENET, V95, P565, DOI 10.1016/j.ajhg.2014.10.006; Challis D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-8; Chawengsaksophak K, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095232; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Han-Xiang D, 2008, HUM MOL GENET, V17, P2310, DOI 10.1093/hmg/ddn131; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Jenkins ZA, 2009, NAT GENET, V41, P95, DOI 10.1038/ng.270; Khajavi M, 2006, EUR J HUM GENET, V14, P1074, DOI 10.1038/sj.ejhg.5201649; Kishida S, 1999, MOL CELL BIOL, V19, P4414; KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Lee YN, 2008, CELL SIGNAL, V20, P443, DOI 10.1016/j.cellsig.2007.11.005; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Mazzeu JF, 2007, AM J MED GENET A, V143A, P320, DOI 10.1002/ajmg.a.31592; MOON RT, 1993, DEVELOPMENT, V119, P97; NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Okamoto M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04493; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Patton MA, 2002, J MED GENET, V39, P305, DOI 10.1136/jmg.39.5.305; Person AD, 2010, DEV DYNAM, V239, P327, DOI 10.1002/dvdy.22156; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Reid JG, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-30; ROBINOW M, 1969, AM J DIS CHILD, V117, P645, DOI 10.1001/archpedi.1969.02100030647005; Roifman M, 2015, CLIN GENET, V87, P34, DOI 10.1111/cge.12401; Saraiva JM, 1999, CLIN DYSMORPHOL, V8, P147; Semenov MV, 1997, GENOMICS, V42, P302, DOI 10.1006/geno.1997.4713; Simpson MA, 2011, NAT GENET, V43, P303, DOI 10.1038/ng.779; Sokol S, 2000, NAT CELL BIOL, V2, pE124, DOI 10.1038/35017136; SUSSMAN DJ, 1994, DEV BIOL, V166, P73, DOI 10.1006/dbio.1994.1297; van Bokhoven H, 2000, NAT GENET, V25, P423, DOI 10.1038/78113; WADIA RS, 1979, J MED GENET, V16, P162, DOI 10.1136/jmg.16.2.162; WADIA RS, 1978, J MED GENET, V15, P123, DOI 10.1136/jmg.15.2.123; Wang Zuoheng, 2013, Frontiers in Genetics, V4, P160, DOI 10.3389/fgene.2013.00160; Xia F, 2014, AM J HUM GENET, V94, P784, DOI 10.1016/j.ajhg.2014.04.006; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Zaveri HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085600	48	86	88	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 2	2015	96	4					612	622		10.1016/j.ajhg.2015.02.015	http://dx.doi.org/10.1016/j.ajhg.2015.02.015			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	CF0DJ	25817016	Green Published, Bronze			2022-12-18	WOS:000352212600008
J	Staples, J; Qiao, DD; Cho, MH; Silverman, EK; Nickerson, DA; Below, JE				Staples, Jeffrey; Qiao, Dandi; Cho, Michael H.; Silverman, Edwin K.; Nickerson, Deborah A.; Below, Jennifer E.		Univ Washington	PRIMUS: Rapid Reconstruction of Pedigrees from Genome-wide Estimates of Identity by Descent	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							LINKAGE ANALYSIS; INFERENCE; ASSOCIATION; RARE; METAANALYSIS; INDIVIDUALS; MUTATIONS; REVEALS; SAMPLES; DISEASE	Understanding and correctly utilizing relatedness among samples is essential for genetic analysis; however, managing sample records and pedigrees can often be error prone and incomplete. Data sets ascertained by random sampling often harbor cryptic relatedness that can be leveraged in genetic analyses for maximizing power. We have developed a method that uses genome-wide estimates of pairwise identity by descent to identify families and quickly reconstruct and score all possible pedigrees that fit the genetic data by using up to third-degree relatives, and we have included it in the software package PRIMUS (Pedigree Reconstruction and Identification of the Maximally Unrelated Set). Here, we validate its performance on simulated, clinical, and HapMap pedigrees. Among these samples, we demonstrate that PRIMUS can verify reported pedigree structures and identify cryptic relationships. Finally, we show that PRIMUS reconstructed pedigrees, all of which were previously unknown, for 203 families from a cohort collected in Starr County, TX (1,890 samples).	[Staples, Jeffrey; Nickerson, Deborah A.; Univ Washington] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Qiao, Dandi; Cho, Michael H.; Silverman, Edwin K.] Harvard Univ, Sch Publ Hlth, Channing Div Network Med, Boston, MA 02115 USA; [Qiao, Dandi] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Cho, Michael H.; Silverman, Edwin K.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Below, Jennifer E.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77225 USA	University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; University of Texas System; University of Texas Health Science Center Houston	Nickerson, DA (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	debnick@uw.edu; jennifer.e.below@uth.tmc.edu	Below, Jennifer E/W-2179-2018; Qiao, Dandi/AAF-2124-2020	Below, Jennifer E/0000-0002-1346-1872; Dichgans, Martin/0000-0002-0654-387X; Below, Jennifer/0000-0002-6372-6402	Starr County Health Studies [DK073541, DK085501]; University of Washington Center for Mendelian Genomics (UW CMG) [HG006493]; National Human Genome Research Institute (NHGRI); NHLBI [HG006493, 1U54HG006493, R01 HL113264]; National Science Foundation Graduate Research Fellowship [DGE-0718124]; NHGRI; GlaxoSmithKline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000432] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113264] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073541, U01DK085501] Funding Source: NIH RePORTER	Starr County Health Studies; University of Washington Center for Mendelian Genomics (UW CMG); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); GlaxoSmithKline(GlaxoSmithKline); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Andrew Stayart, Chad Huff, William Noble, Bruce Weir, Elizabeth Thompson, Jean Morrison, Brian Browning, Jay Shendure, David Dale, Kevin Boehme, Christa Poel, Colleen Davis, and Timothy Thornton provided helpful discussion and input. We'd like to thank Craig L. Hanis and the investigators and staff of the Starr County Health Studies (grants DK073541 and DK085501) and the University of Washington Center for Mendelian Genomics (UW CMG; HG006493). Sequencing was provided by the UW CMG and was funded by National Human Genome Research Institute (NHGRI) and NHLBI grant 1U54HG006493 to D.A.N., Jay Shendure, and Michael Bamshad. J.S. is support by the National Science Foundation Graduate Research Fellowship under grant DGE-0718124. Support for D.A.N. and J.E.B. was provided by NHGRI and NHLBI grant HG006493. The Boston Early-Onset Chronic Obstructive Pulmonary Disease Study, D.Q., M.H.C., and E.K.S. are supported by NHLBI grant R01 HL113264. In the past 3 years, E.K.S. received honoraria and consulting fees from Merck and grant support and consulting fees from GlaxoSmithKline.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bella JN, 2013, INT J CARDIOL, V168, P3902, DOI 10.1016/j.ijcard.2013.06.048; Bellis MA, 2005, J EPIDEMIOL COMMUN H, V59, P749, DOI 10.1136/jech.2005.036517; Below JE, 2011, DIABETOLOGIA, V54, P2047, DOI 10.1007/s00125-011-2188-3; Below JE, 2013, AM J HUM GENET, V92, P137, DOI 10.1016/j.ajhg.2012.11.011; Bizon C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-85; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Chen CTL, 2014, HUM MOL GENET, V23, P3327, DOI 10.1093/hmg/ddu041; Cross DS, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-51; Cussens J, 2013, GENET EPIDEMIOL, V37, P69, DOI 10.1002/gepi.21686; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Day-Williams AG, 2011, GENET EPIDEMIOL, V35, P360, DOI 10.1002/gepi.20584; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; He D, 2013, J COMPUT BIOL, V20, P780, DOI 10.1089/cmb.2013.0080; Hill WG, 2011, GENET RES, V93, P47, DOI 10.1017/S0016672310000480; Hu H, 2014, NAT BIOTECHNOL, V32, P663, DOI 10.1038/nbt.2895; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Kerr SM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-38; Kirkpatrick B, 2011, J COMPUT BIOL, V18, P1481, DOI 10.1089/cmb.2011.0156; Kyriazopoulou-Panagiotopoulou S, 2011, BIOINFORMATICS, V27, pI333, DOI 10.1093/bioinformatics/btr243; Lange LA, 2014, AM J HUM GENET, V94, P233, DOI 10.1016/j.ajhg.2014.01.010; Li B, 2014, AM J MED GENET A, V164, P2407, DOI 10.1002/ajmg.a.36640; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Makaryan V, 2014, HUM MUTAT, V35, P824, DOI 10.1002/humu.22563; Makinen VP, 2005, EUR J HUM GENET, V13, P987, DOI 10.1038/sj.ejhg.5201430; Manichaikul A, 2010, BIOINFORMATICS, V26, P2867, DOI 10.1093/bioinformatics/btq559; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McMillin MJ, 2013, AM J HUM GENET, V92, P150, DOI 10.1016/j.ajhg.2012.11.014; Morrison J, 2013, GENET EPIDEMIOL, V37, P635, DOI 10.1002/gepi.21737; Nijmeijer JS, 2014, J AUTISM DEV DISORD, V44, P1671, DOI 10.1007/s10803-014-2039-4; Nolan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071779; Ott J, 2011, NAT REV GENET, V12, P465, DOI 10.1038/nrg2989; Pemberton TJ, 2010, AM J HUM GENET, V87, P457, DOI 10.1016/j.ajhg.2010.08.014; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quillen EE, 2014, AM J MED GENET B, V165, P103, DOI 10.1002/ajmg.b.32213; Riester M, 2009, BIOINFORMATICS, V25, P2134, DOI 10.1093/bioinformatics/btp064; Santorico SA, 2014, GENET EPIDEMIOL, V38, pS92, DOI 10.1002/gepi.21832; Shem-Tov D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003610; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Staples J, 2013, GENET EPIDEMIOL, V37, P136, DOI 10.1002/gepi.21684; Sun L, 2002, HUM HERED, V54, P99, DOI 10.1159/000067666; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Voight BF, 2005, PLOS GENET, V1, P302, DOI 10.1371/journal.pgen.0010032; Wolf M, 2012, HUM NATURE-INT BIOS, V23, P208, DOI 10.1007/s12110-012-9143-y; Zhu Y, 2013, AGING-US, V5, P704, DOI 10.18632/aging.100600	51	86	94	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 6	2014	95	5					553	564		10.1016/j.ajhg.2014.10.005	http://dx.doi.org/10.1016/j.ajhg.2014.10.005			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	AT3OY	25439724	Green Published, Bronze			2022-12-18	WOS:000344845000006
J	Ng, BG; Buckingham, KJ; Raymond, K; Kircher, M; Turner, EH; He, M; Smith, JD; Eroshkin, A; Szybowska, M; Losfeld, ME; Chong, JX; Kozenko, M; Li, CM; Patterson, MC; Gilbert, RD; Nickerson, DA; Shendure, J; Bamshad, MJ; Freeze, HH				Ng, Bobby G.; Buckingham, Kati J.; Raymond, Kimiyo; Kircher, Martin; Turner, Emily H.; He, Miao; Smith, Joshua D.; Eroshkin, Alexey; Szybowska, Marta; Losfeld, Marie E.; Chong, Jessica X.; Kozenko, Mariya; Li, Chumei; Patterson, Marc C.; Gilbert, Rodney D.; Nickerson, Deborah A.; Shendure, Jay; Bamshad, Michael J.; Freeze, Hudson H.		Univ Washington	Mosaicism of the UDP-Galactose Transporter SLC35A2 Causes a Congenital Disorder of Glycosylation	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article								Biochemical analysis and whole-exome sequencing identified mutations in the Golgi-localized UDP-galactose transporter SLC35A2 that define an undiagnosed X-linked congenital disorder of glycosylation (CDG) in three unrelated families. Each mutation reduced UDP-galactose transport, leading to galactose-deficient glycoproteins. Two affected males were somatic mosaics, suggesting that a wild-type SLC35A2 allele may be required for survival. In infancy, the commonly used biomarker transferrin showed abnormal glycosylation, but its appearance became normal later in childhood, without any corresponding clinical improvement. This may indicate selection against cells carrying the mutant allele. To detect other individuals with such mutations, we suggest transferrin testing in infancy. Here, we report somatic mosaicism in CDG, and our work stresses the importance of combining both genetic and biochemical diagnoses.	[Ng, Bobby G.; Eroshkin, Alexey; Losfeld, Marie E.; Freeze, Hudson H.] Sanford Childrens Hlth Res Ctr, Sanford Burnham Med Res Inst, Genet Dis Program, La Jolla, CA 92037 USA; [Buckingham, Kati J.; Chong, Jessica X.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Raymond, Kimiyo] Mayo Clin, Coll Med, Biochem Genet Lab, Rochester, MN 55905 USA; [Kircher, Martin; Turner, Emily H.; Smith, Joshua D.; Nickerson, Deborah A.; Shendure, Jay; Bamshad, Michael J.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [He, Miao] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Szybowska, Marta; Kozenko, Mariya; Li, Chumei] McMaster Univ, Dept Pediat, Hamilton, ON L8S 4L8, Canada; [Patterson, Marc C.] Mayo Clin, Childrens Ctr, Dept Neurol, Rochester, MN 55905 USA; [Patterson, Marc C.] Mayo Clin, Childrens Ctr, Dept Pediat, Rochester, MN 55905 USA; [Patterson, Marc C.] Mayo Clin, Childrens Ctr, Dept Med Genet, Rochester, MN 55905 USA; [Gilbert, Rodney D.] Southampton Childrens Hosp, Reg Paediat Nephrourol Serv, Southampton SO16 6YD, Hants, England	Sanford Burnham Prebys Medical Discovery Institute; University of Washington; University of Washington Seattle; Mayo Clinic; University of Washington; University of Washington Seattle; Emory University; McMaster University; Mayo Clinic; Mayo Clinic; Mayo Clinic	Freeze, HH (corresponding author), Sanford Childrens Hlth Res Ctr, Sanford Burnham Med Res Inst, Genet Dis Program, La Jolla, CA 92037 USA.	hudson@sanfordburnham.org	Shendure, Jay/AAU-3684-2021; Kircher, Martin/H-6909-2019; Patterson, Marc/AAI-5056-2020; Chong, Jessica/GZH-1625-2022; Patterson, Marc C./H-5331-2019; Kircher, Martin/HDL-9392-2022	Kircher, Martin/0000-0001-9278-5471; Shendure, Jay/0000-0002-1516-1865; Gilbert, Rodney/0000-0001-7426-0188; Turner, Emily/0000-0001-9040-9229; Chong, Jessica/0000-0002-1616-2448; Freeze, Hudson/0000-0001-6316-0501; Patterson, Marc/0000-0002-1116-126X	Rocket Fund; National Institutes of Health (NIH) [R01DK55615]; National Human Genome Research Institute [1U54HG006493]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006493, UM1HG006493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615] Funding Source: NIH RePORTER	Rocket Fund; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the families for their participation and support. Our work is supported by the Rocket Fund, the National Institutes of Health (NIH) (R01DK55615 to H.H.F.), and is also supported in part by grants from the NIH and the National Human Genome Research Institute (1U54HG006493 to M.J.B., D.A.N., and J.S.). We thank Stephanie Grunewald and Margaret J. McMillin for their contributions.	DEUTSCHER SL, 1986, J BIOL CHEM, V261, P96; Freeze H. H., 2013, J BIOL CHEM; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Hennet T, 2012, BBA-GEN SUBJECTS, V1820, P1306, DOI 10.1016/j.bbagen.2012.02.001; Lacey JM, 2001, CLIN CHEM, V47, P513; Maszczak-Seneczko D, 2012, FEBS LETT, V586, P4082, DOI 10.1016/j.febslet.2012.10.016; Maszczak-Seneczko D, 2011, GLYCOCONJUGATE J, V28, P481, DOI 10.1007/s10719-011-9348-z; Miera N, 1996, J BIOCHEM-TOKYO, V120, P236; National Research Council, 2012, TRANSF GLYC ROADM FU; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041	11	86	90	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	APR 4	2013	92	4					632	636		10.1016/j.ajhg.2013.03.012	http://dx.doi.org/10.1016/j.ajhg.2013.03.012			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	124FR	23561849	Green Published, Bronze			2022-12-18	WOS:000317449700017
J	Rozen, SG; Marszalek, JD; Irenze, K; Skaletsky, H; Brown, LG; Oates, RD; Silber, SJ; Ardlie, K; Page, DC				Rozen, Steven G.; Marszalek, Janet D.; Irenze, Kathryn; Skaletsky, Helen; Brown, Laura G.; Oates, Robert D.; Silber, Sherman J.; Ardlie, Kristin; Page, David C.			AZFc Deletions and Spermatogenic Failure: A Population-Based Survey of 20,000 Y Chromosomes	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COPY NUMBER VARIATION; INTRACYTOPLASMIC SPERM INJECTION; MALE-INFERTILITY; GENES; REGION; RECOMBINATION; POLYMORPHISMS; TRANSMISSION; PALINDROMES; SELECTION	Deletions involving the Y chromosome's AZFc region are the most common known genetic cause of severe spermatogenic failure (SSF). Six recurrent interstitial deletions affecting the region have been reported, but their population genetics are largely unexplored. We assessed the deletions' prevalence in 20,884 men in five populations and found four of the six deletions (presented here in descending order of prevalence): gr/gr, b2/b3, b1/b3, and b2/b4. One of every 27 men carried one of these four deletions. The 1.6 Mb gr/gr deletion, found in one of every 41 men, almost doubles the risk of SSF and accounts for similar to 2% of SSF, although <2% of men with the deletion are affected. The 1.8 Mb b2/b3 deletion, found in one of every 90 men, does not appear to be a risk factor for SSF. The 1.6 Mb b1/b3 deletion, found in one of every 994 men, appears to increase the risk of SSF by a factor of 2.5, although <2% of men with the deletion are affected, and it accounts for only 0.15% of SSF. The 3.5 Mb b2/b4 deletion, found in one of every 2,320 men, increases the risk of SSF 145 times and accounts for similar to 6% of SSF; the observed prevalence should approximate the rate at which the deletion arises anew in each generation. We conclude that a single rare variant of major effect (the b2/b4 deletion) and a single common variant of modest effect (the gr/gr deletion) are largely responsible for the AZFc region's contribution to SSF in the population.	[Rozen, Steven G.; Marszalek, Janet D.; Skaletsky, Helen; Brown, Laura G.; Page, David C.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Rozen, Steven G.] Duke NUS Grad Med Sch, Singapore 169857, Singapore; [Marszalek, Janet D.; Skaletsky, Helen; Brown, Laura G.; Page, David C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Irenze, Kathryn; Ardlie, Kristin] SeraCare Life Sci, Genom Collaborat, Cambridge, MA 02139 USA; [Oates, Robert D.] Boston Univ, Sch Med, Boston Med Ctr, Dept Urol, Boston, MA 02118 USA; [Silber, Sherman J.] St Lukes Hosp, Infertil Ctr St Louis, St Louis, MO 63017 USA; [Ardlie, Kristin] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Page, David C.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; National University of Singapore; Howard Hughes Medical Institute; Boston Medical Center; Boston University; Saint Luke's Hospital - Missouri; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Page, DC (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu	; Rozen, Steven G./J-5939-2013	Oates, Robert/0000-0003-2330-6697; Rozen, Steven G./0000-0002-4288-0056	National Institutes of Health; Howard Hughes Medical Institute; Singapore Ministry of Health and Agency for Science, Technology, and Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Singapore Ministry of Health and Agency for Science, Technology, and Research	We thank Gail Farino for many contributions to the bench work for this study; Michael C. Summers for DNA and blood samples; Jennifer Hughes for help in assembling the manuscript; and Winston Bellott, Gregoriy Dokshin, Alexander Godfrey, Yueh-Chiang Hu, Mina Kojima, Julian Lange, Amanda Larracuente, Tatyana Pyntikova, and Shirleen Soh for helpful comments. This work was supported by the National Institutes of Health, the Howard Hughes Medical Institute, and the Singapore Ministry of Health and Agency for Science, Technology, and Research.	Bellott DW, 2010, NATURE, V466, P612, DOI 10.1038/nature09172; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Fernandes S, 2004, AM J HUM GENET, V74, P180, DOI 10.1086/381132; Greenway SC, 2009, NAT GENET, V41, P931, DOI 10.1038/ng.415; Hughes JF, 2012, ANNU REV GENOM HUM G, V13, P83, DOI 10.1146/annurev-genom-090711-163855; Hughes JF, 2012, NATURE, V483, P82, DOI 10.1038/nature10843; Hughes JF, 2010, NATURE, V463, P536, DOI 10.1038/nature08700; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Jiang MC, 1999, FERTIL STERIL, V71, P1029, DOI 10.1016/S0015-0282(99)00150-8; Kamischke A, 1999, HUM REPROD, V14, P2320, DOI 10.1093/humrep/14.9.2320; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kidd JM, 2010, NAT METHODS, V7, P365, DOI 10.1038/NMETH.1451; Krausz C, 2007, ARCH ANDROLOGY, V53, P125, DOI 10.1080/01485010701271786; Lange J, 2009, CELL, V138, P855, DOI 10.1016/j.cell.2009.07.042; Nuti F, 2008, REPROD BIOMED ONLINE, V16, P504, DOI 10.1016/S1472-6483(10)60457-9; Oates RD, 2002, HUM REPROD, V17, P2813, DOI 10.1093/humrep/17.11.2813; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Repping S, 2004, GENOMICS, V83, P1046, DOI 10.1016/j.ygeno.2003.12.018; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sheskin D., 2007, HDB PARAMETRIC NONPA; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tuttelmann F, 2007, REPROD BIOMED ONLINE, V15, P643, DOI 10.1016/s1472-6483(10)60531-7; Visser L, 2009, HUM REPROD, V24, P2667, DOI 10.1093/humrep/dep243; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933	30	86	90	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV 2	2012	91	5					890	896		10.1016/j.ajhg.2012.09.003	http://dx.doi.org/10.1016/j.ajhg.2012.09.003			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	036FI	23103232	Green Published, Bronze			2022-12-18	WOS:000311011400011
J	Riazuddin, SA; Iqbal, M; Wang, Y; Masuda, T; Chen, Y; Bowne, S; Sullivan, LS; Waseem, NH; Bhattacharya, S; Daiger, SP; Zhang, K; Khan, SN; Riazuddin, S; Hejtmancik, JF; Sieving, PA; Zack, DJ; Katsanis, N				Riazuddin, S. Amer; Iqbal, Muhammad; Wang, Yue; Masuda, Tomohiro; Chen, Yuhng; Bowne, Sara; Sullivan, Lori S.; Waseem, Naushin H.; Bhattacharya, Shomi; Daiger, Stephen P.; Zhang, Kang; Khan, Shaheen N.; Riazuddin, Sheikh; Hejtmancik, J. Fielding; Sieving, Paul A.; Zack, Donald J.; Katsanis, Nicholas			A Splice-Site Mutation in a Retina-Specific Exon of BBS8 Causes Nonsyndromic Retinitis Pigmentosa	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENES; TRANSCRIPTION	Tissue-specific alternative splicing is an important mechanism for providing spatiotemporal protein diversity. Here we show that an in-frame splice mutation in BBS8, one of the genes involved in pleiotropic Bardet-Biedl syndrome (BBS), is sufficient to cause nonsyndromic retinitis pigmentosa (RP). A genome-wide scan of a consanguineous RP pedigree mapped the trait to a 5.6 Mb region; subsequent systematic sequencing of candidate transcripts identified a homozygous splice-site mutation in a previously unknown BBS8 exon. The allele segregated with the disorder, was absent from controls, was completely invariant across evolution, and was predicted to lead to the elimination of a 10 amino acid sequence from the protein. Subsequent studies showed the exon to be expressed exclusively in the retina and enriched significantly in the photoreceptor layer. Importantly, we found this exon to represent the major BBS8 mRNA species in the mammalian photoreceptor, suggesting that the encoded 10 amino acids play a pivotal role in the function of BBS8 in this organ. Understanding the role of this additional sequence might therefore inform the mechanism of retinal degeneration in patients with syndromic BBS or other related ciliopathies.	[Riazuddin, S. Amer; Wang, Yue; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Riazuddin, S. Amer; Masuda, Tomohiro; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21287 USA; [Iqbal, Muhammad; Khan, Shaheen N.; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Chen, Yuhng; Zhang, Kang] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Chen, Yuhng; Zhang, Kang] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Bowne, Sara; Sullivan, Lori S.; Daiger, Stephen P.] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; [Waseem, Naushin H.; Bhattacharya, Shomi] UCL, Inst Ophthalmol, Dept Genet, London EC1V 9EL, England; [Hejtmancik, J. Fielding; Sieving, Paul A.] NEI, Ophthalm Genet & Visual Funct Branch, NIH, Bethesda, MD 20892 USA; [Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Health Science Center Houston; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Duke University	Katsanis, N (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	katsanis@cellbio.duke.edu	Wang, Julia/M-4516-2016; Zhang, Kang/Y-2740-2019; Nasim Khan, Shaheen/F-2135-2015; Bhattacharya, Shom/N-2926-2016; Waseem, Naushin/C-9573-2013; Katsanis, Nicholas/E-1837-2012	Wang, Julia/0000-0003-2641-6904; Zhang, Kang/0000-0002-4549-1697; Bhattacharya, Shom/0000-0002-1601-6344; Katsanis, Nicholas/0000-0002-2480-0171; Zack, Don/0000-0002-7966-1973	Ministry of Science and Technology, Islamabad Pakistan; National Institutes of Health [R01HD04260, R01DK072301, R01DK075972, R01EY007142]; Macular Vision Research Foundation; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY009769, ZIAEY000272, ZIAEY000281, P30EY001765, R01EY007142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072301, R01DK075972] Funding Source: NIH RePORTER	Ministry of Science and Technology, Islamabad Pakistan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We gratefully acknowledge the family members who donated samples to make this work possible. Financial support was provided by the Ministry of Science and Technology, Islamabad Pakistan, National Institutes of Health grants R01HD04260, R01DK072301, R01DK075972 (N.K.), and R01EY007142 (S.P.D.), the Macular Vision Research Foundation, and the Foundation Fighting Blindness (N.K.). N.K. is the George R. Brumley Professor.	Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Gupta SK, 2002, AM J OPHTHALMOL, V133, P203, DOI 10.1016/S0002-9394(01)01339-3; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HECKENLIVELY JR, 1988, AM J OPHTHALMOL, V105, P504, DOI 10.1016/0002-9394(88)90242-5; Hims MM, 2003, DEV OPHTHALMOL, V37, P109; Inglehearn CF, 1998, EYE, V12, P571, DOI 10.1038/eye.1998.147; Kirschner R, 1999, HUM MOL GENET, V8, P1571, DOI 10.1093/hmg/8.8.1571; LATHROP GM, 1984, AM J HUM GENET, V36, P460; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; McAlinden A, 2008, HUM MUTAT, V29, P83, DOI 10.1002/humu.20603; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Zaghloul NA, 2009, J CLIN INVEST, V119, P428, DOI 10.1172/JCI37041	16	86	89	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY 14	2010	86	5					805	812		10.1016/j.ajhg.2010.04.001	http://dx.doi.org/10.1016/j.ajhg.2010.04.001			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	601GC	20451172	Bronze, Green Published			2022-12-18	WOS:000278045300017
J	Quintana-Murci, L; Harmant, C; Quach, H; Balanovsky, O; Zaporozhchenko, V; Bormans, C; van Helden, PD; Hoal, EG; Behar, DM				Quintana-Murci, Lluis; Harmant, Christine; Quach, Helene; Balanovsky, Oleg; Zaporozhchenko, Valery; Bormans, Connie; van Helden, Paul D.; Hoal, Eileen G.; Behar, Doron M.			Strong Maternal Khoisan Contribution to the South African Coloured Population: A Case of Gender-Biased Admixture	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN Y-CHROMOSOME; NUCLEOTIDE-POLYMORPHISM PANEL; HUMAN MITOCHONDRIAL-DNA; GENE FLOW; LINKAGE DISEQUILIBRIUM; MACROHAPLOGROUP-M; MTDNA LANDSCAPE; HUMAN-EVOLUTION; MOLECULAR-DATA; HINDU CASTES	The study of recently admixed populations provides unique tools for understanding recent population dynamics, socio-cultural factors associated with the founding of emerging populations, and the genetic basis of disease by means of admixture mapping. Historical records and recent autosomal data indicate that the South African Coloured population forms a unique highly admixed population, resulting from the encounter of different peoples from Africa, Europe, and Asia. However, little is known about the mode by which this admixed population was recently founded. Here we show, through detailed phylogeographic analyses of mitochondria! DNA and Y-chromosome variation in a large sample of South African Coloured individuals, that this population derives from at least five different parental populations (Khoisan, Bantus, Europeans, Indians, and Southeast Asians), who have differently contributed to the foundation of the South African Coloured. In addition, our analyses reveal extraordinarily unbalanced gender-specific contributions of the various population genetic components, the most striking being the massive maternal contribution of Khoisan peoples (more than 60%) and the almost negligible maternal contribution of Europeans with respect to their paternal counterparts. The overall picture of gender-biased admixture depicted in this study indicates that the modern South African Coloured population results mainly from the early encounter of European and African males with autochthonous Khoisan females of the Cape of Good Hope around 350 years ago.	[Quintana-Murci, Lluis; Harmant, Christine; Quach, Helene; Behar, Doron M.] Inst Pasteur, Dept Genomes & Genet, F-75015 Paris, France; [Quintana-Murci, Lluis; Harmant, Christine; Quach, Helene] Ctr Natl Rech Sci, URA3012, F-75015 Paris, France; [Balanovsky, Oleg; Zaporozhchenko, Valery] Russian Acad Med Sci, Med Genet Res Ctr, Moscow 115478, Russia; [Bormans, Connie] Family Tree DNA, Genom Res Ctr, Houston, TX 77008 USA; [van Helden, Paul D.; Hoal, Eileen G.] Univ Stellenbosch, Med Res Council, Ctr Mol & Cellular Biol, Fac Hlth Sci, ZA-7505 Tygerberg, South Africa; [Behar, Doron M.] Mol Med Lab, IL-31096 Haifa, Israel	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Research Centre for Medical Genetics; Russian Academy of Medical Sciences; South African Medical Research Council; Stellenbosch University; Rambam Health Care Campus	Quintana-Murci, L (corresponding author), Inst Pasteur, Dept Genomes & Genet, F-75015 Paris, France.	quintana@pasteur.fr	Balanovsky, Oleg/G-1549-2014; Quintana-Murci, Lluis/AAB-7468-2022	Quach, Helene/0000-0002-3493-0973; Hoal, Eileen/0000-0002-6444-5688; Quintana-Murci, Lluis/0000-0003-2429-6320	Institut Pasteur and by the Centre National de la Recherche Scientifique (CNRS); Russian Fund of Humanities [07-01-12114]; Department of Science and Technology (DST); National Research Foundation (NRE) Centre of Excellence for Biomedical Tuberculosis Research	Institut Pasteur and by the Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Russian Fund of Humanities; Department of Science and Technology (DST)(Department of Science & Technology (India)); National Research Foundation (NRE) Centre of Excellence for Biomedical Tuberculosis Research	We warmly thank all study participants. We are very grateful to Blandine Massonnet for help in genotyping of mtDNA. This work was supported by Institut Pasteur and by the Centre National de la Recherche Scientifique (CNRS). Mitochondrial DNA and Y chromosome databases used for comparative analyses were partly supported by the Russian Fund of Humanities (grant 07-01-12114) and created with the help of Andrey Pshenichnov, Roman Sychev, and Elena Balanovska. P.D.V.H. and E.G.H. are supported by the Department of Science and Technology (DST) and the National Research Foundation (NRE) Centre of Excellence for Biomedical Tuberculosis Research.	Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Baig MM, 2004, ANN HUM GENET, V68, P453, DOI 10.1046/j.1529-8817.2004.00108.x; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; Behar DM, 2008, AM J HUM GENET, V82, P1130, DOI 10.1016/j.ajhg.2008.04.002; Behar DM, 2007, PLOS GENET, V3, P1083, DOI 10.1371/journal.pgen.0030104; Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Deng W, 2004, J HUM GENET, V49, P339, DOI 10.1007/s10038-004-0154-3; Destro-Bisol G, 2004, MOL BIOL EVOL, V21, P1673, DOI 10.1093/molbev/msh186; Dupanloup I, 2003, J MOL EVOL, V57, P85, DOI 10.1007/s00239-003-2458-x; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Forster P, 1996, AM J HUM GENET, V59, P935; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M, 2003, AM J HUM GENET, V72, P281, DOI 10.1086/346065; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Knight A, 2003, CURR BIOL, V13, P464, DOI 10.1016/S0960-9822(03)00130-1; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Mao XY, 2007, AM J HUM GENET, V80, P1171, DOI 10.1086/518564; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mountain A., 2003, 1 PEOPLE CAPE; Nurse GT., 1985, PEOPLES SO AFRICA TH; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Patterson N, 2010, HUM MOL GENET, V19, P411, DOI 10.1093/hmg/ddp505; Pereira L, 2001, ANN HUM GENET, V65, P439, DOI 10.1017/S0003480001008855; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 2001, AM J HUM GENET, V68, P537, DOI 10.1086/318200; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosa A, 2004, ANN HUM GENET, V68, P340, DOI 10.1046/j.1529-8817.2004.00100.x; Salas A, 2002, AM J HUM GENET, V71, P1082, DOI 10.1086/344348; Salem AH, 1996, AM J HUM GENET, V59, P741; Seielstad MT, 1998, NAT GENET, V20, P278, DOI 10.1038/3088; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2002, AM J HUM GENET, V70, P265, DOI 10.1086/338306; Shell R, 1994, CHILDREN BONDAGE; Sims Lynn M, 2007, Hum Mutat, V28, P97, DOI 10.1002/humu.9469; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Smith MW, 2001, AM J HUM GENET, V69, P1080, DOI 10.1086/323922; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Tian C, 2007, AM J HUM GENET, V80, P1014, DOI 10.1086/513522; Tian C, 2006, AM J HUM GENET, V79, P640, DOI 10.1086/507954; Tishkoff SA, 2007, MOL BIOL EVOL, V24, P2180, DOI 10.1093/molbev/msm155; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Tofanelli S, 2009, MOL BIOL EVOL, V26, P2109, DOI 10.1093/molbev/msp120; Torroni A, 2000, AM J HUM GENET, V66, P1173, DOI 10.1086/302789; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; UNDERHILL PA, 2009, EUR J HUM GENET, DOI DOI 10.1038/EJHG.2009.19; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Watkins WS, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-86; Wells RS, 2001, P NATL ACAD SCI USA, V98, P10244, DOI 10.1073/pnas.171305098; Wilder JA, 2004, MOL BIOL EVOL, V21, P2047, DOI 10.1093/molbev/msh214; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Wooding S, 2004, HUM GENET, V115, P221, DOI 10.1007/s00439-004-1130-x; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Zerjal T, 2001, MOL BIOL EVOL, V18, P1077, DOI 10.1093/oxfordjournals.molbev.a003879; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911	66	86	90	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	APR 9	2010	86	4					611	620		10.1016/j.ajhg.2010.02.014	http://dx.doi.org/10.1016/j.ajhg.2010.02.014			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	583YP	20346436	Bronze, Green Published			2022-12-18	WOS:000276716800012
J	Romanoski, CE; Lee, S; Kim, MJ; Ingram-Drake, L; Plaisier, CL; Yordanova, R; Tilford, C; Guan, B; He, AQ; Gargalovic, PS; Kirchgessner, TG; Berliner, JA; Lusis, AJ				Romanoski, Casey E.; Lee, Sangderk; Kim, Michelle J.; Ingram-Drake, Leslie; Plaisier, Christopher L.; Yordanova, Roumyana; Tilford, Charles; Guan, Bo; He, Aiqing; Gargalovic, Peter S.; Kirchgessner, Todd G.; Berliner, Judith A.; Lusis, Aldons J.			Systems Genetics Analysis of Gene-by-Environment Interactions in Human Cells	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GENOME-WIDE ASSOCIATION; UNFOLDED PROTEIN RESPONSE; LOW-DENSITY-LIPOPROTEIN; OXIDIZED PHOSPHOLIPIDS; ENDOTHELIAL-CELLS; EXPRESSION; STRESS; POLYMORPHISM; PATHWAY; DISEASE	Gene by environment (GxE) interactions are clearly important in many human diseases, but they have proven to be difficult to study on a molecular level. We report genetic analysis of thousands of transcript abundance traits in human primary endothelial cell (EC) lines in response to proinflammatory oxidized phospholipids implicated in cardiovascular disease. Of the 59 most regulated transcripts, approximately one-third showed evidence of GxE interactions. The interactions resulted primarily from effects of distal-, trans-acting loci, but a striking example of a local-GxE interaction was also observed for FGD6. Some of the distal interactions were validated by siRNA knockdown experiments, including a locus involved in the regulation of multiple transcripts involved in the ER stress pathway. Our findings add to the understanding of the overall architecture of complex human traits and are consistent with the possibility that GxE interactions are responsible, in part, for the failure of association studies to more fully explain common disease variation.	[Romanoski, Casey E.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Lee, Sangderk; Ingram-Drake, Leslie; Berliner, Judith A.] Univ Calif Los Angeles, Div Cardiol, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Kim, Michelle J.; Lusis, Aldons J.] Univ Calif Los Angeles, Div Cardiol, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Plaisier, Christopher L.] Inst Syst Biol, Seattle, WA 98103 USA; [Yordanova, Roumyana; Tilford, Charles; Guan, Bo; He, Aiqing; Gargalovic, Peter S.; Kirchgessner, Todd G.] Bristol Myers Squibb Co, Pennington, NJ 08534 USA; [Berliner, Judith A.; Lusis, Aldons J.] Univ Calif Los Angeles, Div Cardiol, Dept Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Institute for Systems Biology (ISB); Bristol-Myers Squibb; University of California System; University of California Los Angeles	Romanoski, CE (corresponding author), Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA.	casey.romanoski@ucla.edu; jlusis@mednet.ucla.edu	Plaisier, Christohper L/H-3238-2019; Yordanova, Roumyana/AAR-2275-2021; Plaisier, Christopher/HGD-5631-2022	Plaisier, Christohper L/0000-0003-3273-5717; Romanoski, Casey/0000-0002-0149-225X	NIH [PO1-HL030568, HL069766]; American Heart Association pre-doctoral fellowship; American Heart Association postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, T32HL069766] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association pre-doctoral fellowship(American Heart Association); American Heart Association postdoctoral fellowship(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was funded by NIH grant PO1-HL030568 (A.J.L. and J.A.B.), NIH training grant HL069766 (C.E.R.), an American Heart Association pre-doctoral fellowship (C.E.R.) and an American Heart Association postdoctoral fellowship (S.D.L.). We would like to thank the Atherosclerosis Research Unit (ARU) at UCLA for help collecting the HAECs and Calvin Pan for data management. R.Y., C.T., B.G., A.H., RS.G., and T.G.K. are employees and shareholders of Bristol-Myers Squibb.	Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI 10.2307/2346101; Berliner JA, 2005, NEW ENGL J MED, V353, P9, DOI 10.1056/NEJMp058118; Birukova AA, 2007, MICROVASC RES, V73, P173, DOI 10.1016/j.mvr.2006.12.004; Bochkov VN, 2006, CIRC RES, V99, P900, DOI 10.1161/01.RES.0000245485.04489.ee; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cai SY, 1999, P NATL ACAD SCI USA, V96, P2828, DOI 10.1073/pnas.96.6.2828; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; DRAKE TA, 1991, AM J PATHOL, V138, P601; Duggal P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-516; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Gargalovic PS, 2006, ARTERIOSCL THROM VAS, V26, P2490, DOI 10.1161/01.ATV.0000242903.41158.a1; Gargalovic PS, 2006, P NATL ACAD SCI USA, V103, P12741, DOI 10.1073/pnas.0605457103; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Grundberg E, 2009, GENOME RES, V19, P1942, DOI 10.1101/gr.095224.109; Hardy J, 2009, NEW ENGL J MED, V360, P1759, DOI 10.1056/NEJMra0808700; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lee JI, 2008, PHYSIOL GENOMICS, V33, P218, DOI 10.1152/physiolgenomics.00263.2007; Lee S, 2009, J LIPID RES, V50, P265, DOI 10.1194/jlr.M800317-JLR200; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; NAVAB M, 1988, J CLIN INVEST, V82, P1853, DOI 10.1172/JCI113802; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Oskolkova OV, 2008, BLOOD, V112, P330, DOI 10.1182/blood-2007-09-112870; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Talmud PJ, 2007, NUTR METAB CARDIOVAS, V17, P148, DOI 10.1016/j.numecd.2006.01.008; Ulrich CM, 1999, CANCER EPIDEM BIOMAR, V8, P659; Vasques E, 2006, ENDOTHELIUM-J ENDOTH, V13, P1, DOI 10.1080/10623320600659948; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Zhang JH, 2005, GENOMICS, V85, P297, DOI 10.1016/j.ygeno.2004.11.004	57	86	88	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	MAR 12	2010	86	3					399	410		10.1016/j.ajhg.2010.02.002	http://dx.doi.org/10.1016/j.ajhg.2010.02.002			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	570LG	20170901	Green Published, Bronze			2022-12-18	WOS:000275678800011
J	Campos-Xavier, AB; Martinet, D; Bateman, J; Belluoccio, D; Rowley, L; Tan, TY; Baxova, A; Gustavson, KH; Borochowitz, ZU; Innes, AM; Unger, S; Beckmann, JS; Mittaz, L; Ballhausen, D; Superti-Furga, A; Savarirayan, R; Bonafe, L				Campos-Xavier, Ana Belinda; Martinet, Danielle; Bateman, John; Belluoccio, Dan; Rowley, Lynn; Tan, Tiong Yang; Baxova, Alica; Gustavson, Karl-Henrik; Borochowitz, Zvi U.; Innes, A. Micheil; Unger, Sheila; Beckmann, Jacques S.; Mittaz, Laureane; Ballhausen, Diana; Superti-Furga, Andrea; Savarirayan, Ravi; Bonafe, Luisa			Mutations in the Heparan-Sulfate Proteoglycan Glypican 6 (GPC6) Impair Endochondral Ossification and Cause Recessive Omodysplasia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							GOLABI-BEHMEL-SYNDROME; NONPOLYPOSIS COLORECTAL-CANCER; DROSOPHILA GLYPICAN; PRENATAL-DIAGNOSIS; GENE-CLUSTER; CELL-SURFACE; IN-VIVO; FAMILY; EXPRESSION; MEMBER	Glypicans are a family of glycosylphosphatidylinositol (GPI)-anchored, membrane-bound heparan sulfate (HS) proteoglycans. Their biological roles are only partly understood, although it is assumed that they modulate the activity of HS-binding growth factors. The involvement of glypicans in developmental morphogenesis and growth regulation has been highlighted by Drosophila mutants and by a human overgrowth syndrome with multiple malformations caused by glypican 3 mutations (Simpson-Golabi-Behmel syndrome). We now report that autosomal-recessive omodysplasia, a genetic condition characterized by short-limbed short stature, craniofacial dysmorphism, and variable developmental delay, maps to chromosome 13 (13q31.1-q32.2) and is caused by point mutations or by larger genomic rearrangements in glypican 6 (GPC6). All mutations cause truncation of the GPC6 protein and abolish both the HS-binding site and the GPI-bearing membrane-associated domain, and thus loss of function is predicted. Expression studies in microdissected mouse growth plate revealed expression of Gpc6 in proliferative chondrocytes. Thus, GPC6 seems to have a previously unsuspected role in endochondral ossification and skeletal growth, and its functional abrogation results in a short-limb phenotype.	[Campos-Xavier, Ana Belinda; Mittaz, Laureane; Ballhausen, Diana; Bonafe, Luisa] CHU Vaudois, Div Mol Pediat, CH-1011 Lausanne, Switzerland; [Martinet, Danielle; Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Bateman, John; Belluoccio, Dan; Rowley, Lynn] Royal Childrens Hosp, Dept Pediat, Parkville, Melbourne 3052, Australia; [Bateman, John; Belluoccio, Dan; Rowley, Lynn; Tan, Tiong Yang; Savarirayan, Ravi] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Melbourne 3052, Australia; [Tan, Tiong Yang; Savarirayan, Ravi] Royal Childrens Hosp, Genet Hlth Serv Victoria, Parkville, Melbourne 3052, Australia; [Baxova, Alica] First Fac Med & Gen Teaching Hosp, Inst Biol & Med Genet, Prague 12800, Czech Republic; [Gustavson, Karl-Henrik] Univ Uppsala Hosp, Rudbeck Lab, Dept Clin Genet, SE-75185 Uppsala, Sweden; [Borochowitz, Zvi U.] Technion Israel Inst Technol, Rappaport Fac Med, Simon Winter Inst Human Genet, Bnai Zion Med Ctr, IL-31048 Haifa, Israel; [Innes, A. Micheil] Univ Alberta, Dept Med Genet, Calgary, AB T3B 6A8, Canada; [Innes, A. Micheil] Alberta Childrens Prov Gen Hosp, Calgary, AB T3B 6A8, Canada; [Unger, Sheila] Univ Freiburg, Inst Human Genet, D-79106 Freiburg, Germany; [Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Unger, Sheila; Superti-Furga, Andrea] Univ Freiburg, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Charles University Prague; General University Hospital Prague; Uppsala University; Uppsala University Hospital; Bnai Zion Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Alberta; Alberta Childrens Hospital; University of Calgary; University of Freiburg; University of Lausanne; University of Freiburg	Bonafe, L (corresponding author), CHU Vaudois, Div Mol Pediat, Ave Pierre Decker 2, CH-1011 Lausanne, Switzerland.	luisa.bonafe@chuv.ch	innes, allan micheil/A-9955-2017; superti-furga, andrea/E-9162-2015; Beckmann, Jacques S/A-9772-2008; Baxova, Alice/L-7197-2017; unger, sheila/E-9177-2015; Tan, Tiong Yang/AAV-6563-2020	superti-furga, andrea/0000-0002-3543-7531; Beckmann, Jacques S/0000-0002-9741-1900; Baxova, Alice/0000-0002-0651-0410; Tan, Tiong Yang/0000-0001-8455-7778; Innes, Micheil/0000-0001-9881-5467; Unger, Sheila/0000-0002-9539-8941; Campos-Xavier, Belinda/0000-0002-6271-0724; Bateman, John/0000-0001-8542-0730; Ballhausen, Diana/0000-0003-2940-3439	Swiss National Research Foundation [320000-116S06]; Australian Research Council	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Australian Research Council(Australian Research Council)	We are grateful to the affected individuals and their families for their cooperation. We thank Carole Chiesa for excellent technical assistance, Trevor Cameron for cartilage RNA isolation, and Peter Farlie for help with immunohistochemistry. This work was supported by the Swiss National Research Foundation, grant no. 320000-116S06, to L.B. and by an Australian Research Council Discovery grant to J.B.	Bassett JHD, 2006, ENDOCRINOLOGY, V147, P295, DOI 10.1210/EN.2005-0485; BAXOVA A, 1994, AM J MED GENET, V49, P263, DOI 10.1002/ajmg.1320490303; Bendavid C, 2006, HUM GENET, V119, P1, DOI 10.1007/s00439-005-0097-6; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Borochowitz Z, 1998, AM J MED GENET, V76, P238, DOI 10.1002/(SICI)1096-8628(19980319)76:3<238::AID-AJMG7>3.0.CO;2-M; BOROCHOWITZ Z, 1991, AM J MED GENET, V39, P91, DOI 10.1002/ajmg.1320390120; BOROCHOWITZ Z, 1995, AM J MED GENET, V58, P377, DOI 10.1002/ajmg.1320580416; Charbonnier F, 2000, CANCER RES, V60, P2760; Charbonnier F, 2002, CANCER RES, V62, P848; De Cat B, 2001, SEMIN CELL DEV BIOL, V12, P117, DOI 10.1006/scdb.2000.0240; Di Luca BJ, 2001, ANAESTH INTENS CARE, V29, P71, DOI 10.1177/0310057X0102900115; Elcioglu NH, 2004, PEDIATR RADIOL, V34, P75, DOI 10.1007/s00247-003-1064-9; Filmus J, 2002, GLYCOCONJUGATE J, V19, P319, DOI 10.1023/A:1025312819804; Filmus J, 2001, J CLIN INVEST, V108, P497, DOI 10.1172/JCI13712; Filmus J, 2001, GLYCOBIOLOGY, V11, p19R, DOI 10.1093/glycob/11.3.19R; Filmus J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-224; Ford-Perriss M, 2003, DEV DYNAM, V227, P170, DOI 10.1002/dvdy.10298; Fransson LA, 2003, INT J BIOCHEM CELL B, V35, P125, DOI 10.1016/S1357-2725(02)00095-X; Furniss D, 2007, AM J MED GENET A, V143A, P3150, DOI 10.1002/ajmg.a.32097; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hufnagel L, 2006, DEV BIOL, V300, P512, DOI 10.1016/j.ydbio.2006.08.076; Khare N, 2000, MECH DEVELOP, V99, P199, DOI 10.1016/S0925-4773(00)00502-5; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Little CB, 2005, ARTHRITIS RHEUM-US, V52, P1461, DOI 10.1002/art.21022; Maria Albano L, 2007, CLINICS, V62, P531, DOI 10.1590/S1807-59322007000400023; MAROTEAUX P, 1989, AM J MED GENET, V32, P371, DOI 10.1002/ajmg.1320320321; Nakato H, 2002, J CELL SCI, V115, P123; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Niel F, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022400; Paine-Saunders S, 1999, GENOMICS, V57, P455, DOI 10.1006/geno.1999.5793; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Quelin C, 2009, EUR J MED GENET, V52, P41, DOI 10.1016/j.ejmg.2008.10.002; Sakazume S, 2007, AM J MED GENET A, V143A, P1703, DOI 10.1002/ajmg.a.31822; Tan TY, 2005, AM J MED GENET A, V135A, P324, DOI 10.1002/ajmg.a.30754; Traister A, 2008, BIOCHEM J, V410, P503, DOI 10.1042/BJ20070511; Veugelers M, 1999, J BIOL CHEM, V274, P26968, DOI 10.1074/jbc.274.38.26968; Veugelers M, 2000, HUM MOL GENET, V9, P1321, DOI 10.1093/hmg/9.9.1321; Veugelers M, 1998, GENOMICS, V53, P1, DOI 10.1006/geno.1998.5465	39	86	88	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JUN 12	2009	84	6					760	770		10.1016/j.ajhg.2009.05.002	http://dx.doi.org/10.1016/j.ajhg.2009.05.002			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	458SC	19481194	Green Published, Bronze			2022-12-18	WOS:000267042800006
J	Pezzolesi, MG; Platzer, P; Waite, KA; Eng, C				Pezzolesi, Marcus G.; Platzer, Petra; Waite, Kristin A.; Eng, Charis			Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden Syndrome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RILEY-RUVALCABA-SYNDROME; BANNAYAN-ZONANA-SYNDROME; TUMOR-SUPPRESSOR; PHOSPHATASE-ACTIVITY; PROMOTER MUTATIONS; BREAST-CANCER; PROTEIN; GENE; DISEASE; RNA	Germline mutations in the gene encoding phosphatase and tensin homolog deleted on chromosome ten (PTEN [MIM 601728]) are associated with a number of clinically distinct heritable cancer syndromes, including both Cowden syndrome (CS) and Bannayan-Riley-Ruvalcaba syndrome (BRRS). Seemingly identical pathogenic PTEN mutations have been observed in patients with CS and BRRS, as well as in patients with incomplete features of CS, referred to as CS-like (CSL) patients. These observations indicate that additional, unidentified, genetic and epigenetic factors act as phenotypic modifiers in these disorders. These genetic factors could also contribute to disease in patients with CS, CSL, or BRRS without identifiable PTEN mutations. Two potential modifiers are miR-19a and miR-21, which are previously identified PTEN-targeting miRNAs. We investigated the role of these miRNAs by characterizing their relative expression levels in PTEN-mutation-positive and PTEN-mutation-negative patients with CS, CSL, or BRRS. Interestingly, we observed differential expression of miR-19a and miR-21 in our PTEN-mutation-positive patients. Both were found to be significantly overexpressed within this group (p < 0.01) and were inversely correlated with germline PTEN protein levels. Similarly, the relative expression of miR-19a and miR-21 was differentially expressed in a series of PTEN-mutation-negative patients with CS or CSL with variable clinical phenotypes and decreased full-length PTEN protein expression. Among PTEN-mutation-positive patients with CS, both miRNAs were significantly overexpressed (p = 0.006-0.013). Taken together, our study results suggest that differential expression of PTEN-targeting miR-19a and miR-21 modulates the PTEN protein levels and the CS and CSL phenotypes, irrespective of the patient's mutation status, and support their roles as genetic modifiers in CS and CSL.	[Pezzolesi, Marcus G.; Platzer, Petra; Waite, Kristin A.; Eng, Charis] Cleveland Clin Fdn, Lerner Res Inst, Inst Med Genet, Cleveland, OH 44195 USA; [Waite, Kristin A.; Eng, Charis] Cleveland Clin Fdn, Lerner Res Inst, Inst Med Genet, Taussig Canc Inst, Cleveland, OH 44195 USA; [Eng, Charis] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA; [Eng, Charis] Case Western Reserve Univ, Dept Genet, CASE Comprehens Canc Ctr, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University	Eng, C (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Inst Med Genet, 9500 Euclid Ave, Cleveland, OH 44195 USA.	engc@ccf.org	Waite, Kristin/AAB-1031-2021	Eng, Charis/0000-0002-3693-5145	NCI NIH HHS [P01 CA124570, 1P01CA124570-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA124570] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; ECCLES DM, 1992, ONCOGENE, V7, P2069; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Freeman D, 2006, CANCER RES, V66, P6492, DOI 10.1158/0008-5472.CAN-05-4143; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lin YW, 1999, EUR J CANCER, V35, P1730, DOI 10.1016/S0959-8049(99)00205-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maehama T, 1999, TRENDS CELL BIOL, V9, P125, DOI 10.1016/S0962-8924(99)01519-6; Marsh DJ, 1998, HUM MOL GENET, V7, P507, DOI 10.1093/hmg/7.3.507; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Marsh DJ, 1999, HUM MOL GENET, V8, P1461, DOI 10.1093/hmg/8.8.1461; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316; Michael MZ, 2003, MOL CANCER RES, V1, P882; Minaguchi T, 2006, CANCER RES, V66, P11677, DOI 10.1158/0008-5472.CAN-06-2240; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Nelen MR, 1996, NAT GENET, V13, P114, DOI 10.1038/ng0596-114; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Pezzolesi MG, 2007, HUM MOL GENET, V16, P1058, DOI 10.1093/hmg/ddm053; Sarquis MS, 2006, AM J HUM GENET, V79, P23, DOI 10.1086/504392; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Teresi RE, 2007, AM J HUM GENET, V81, P756, DOI 10.1086/521051; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Weng LP, 1999, CANCER RES, V59, P5808; Zbuk KM, 2007, NAT REV CANCER, V7, P35, DOI 10.1038/nrc2037; Zhou XP, 2003, AM J HUM GENET, V73, P404, DOI 10.1086/377109	32	86	97	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	MAY	2008	82	5					1141	1149		10.1016/j.ajhg.2008.04.005	http://dx.doi.org/10.1016/j.ajhg.2008.04.005			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	301VJ	18460397	Green Published, Bronze			2022-12-18	WOS:000255923600013
J	He, M; Rutledge, SL; Kelly, DR; Palmer, CA; Murdoch, G; Majumder, N; Nicholls, RD; Pei, Z; Watkins, PA; Vockley, J				He, M.; Rutledge, S. L.; Kelly, D. R.; Palmer, C. A.; Murdoch, G.; Majumder, N.; Nicholls, R. D.; Pei, Z.; Watkins, P. A.; Vockley, J.			A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COA DEHYDROGENASE-DEFICIENCY; CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE; LONG-CHAIN; ENERGY-EXPENDITURE; RECEPTOR-ALPHA; CARDIOMYOPATHY; METABOLISM; DISEASE; IDENTIFICATION; PURIFICATION	The acyl-CoA dehydrogenases are a family of multimeric flavoenzymes that catalyze the alpha, beta-dehydrogenation of acyl-CoA esters in fatty acid beta-oxidation and amino acid catabolism. Genetic defects have been identified in most of the acyl-CoA dehydrogenases in humans. Acyl-CoA dehydrogenase 9 (ACAD9) is a recently identified acyl-CoA dehydrogenase that demonstrates maximum activity with unsaturated long-chain acyl-CoAs. We now report three cases of ACAD9 deficiency. Patient 1 was a 14-year-old, previously healthy boy who died of a Reye-like episode and cerebellar stroke triggered by a mild viral illness and ingestion of aspirin. Patient 2 was a 10-year-old girl who first presented at age 4 mo with recurrent episodes of acute liver dysfunction and hypoglycemia, with otherwise minor illnesses. Patient 3 was a 4.5-year-old girl who died of cardiomyopathy and whose sibling also died of cardiomyopathy at age 21 mo. Mild chronic neurologic dysfunction was reported in all three patients. Defects in ACAD9 mRNA were identified in the first two patients, and all patients manifested marked defects in ACAD9 protein. Despite a significant overlap of substrate specificity, it appears that ACAD9 and very-long-chain acyl-CoA dehydrogenase are unable to compensate for each other in patients with either deficiency. Studies of the tissue distribution and gene regulation of ACAD9 and very-long-chain acyl-CoA dehydrogenase identify the presence of two independently regulated functional pathways for long- chain fat metabolism, indicating that these two enzymes are likely to be involved in different physiological functions.	Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Sch Med, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15213 USA; Childrens Hosp Alabama, Dept Pathol & Lab Med, Birmingham, AL USA; Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Inst Med Genet, Baltimore, MD 21218 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Kennedy Krieger Institute	Vockley, J (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Dept Pediat, Sch Med, 3705 5th Ave, Pittsburgh, PA 15213 USA.	gerard.vockley@chp.edu	Vockley, Jerry/AAF-8523-2020; Palmer, Cheryl/H-4074-2011; Vockley, Jerry/B-5210-2016	Vockley, Jerry/0000-0002-8180-6457; Vockley, Jerry/0000-0002-8180-6457; Palmer, Cheryl/0000-0001-6088-9161; Kelly, David/0000-0001-7604-5270; Watkins, Paul A./0000-0002-3246-1405	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK078377, R01DK045482] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK045482, U54 DK078377, R01 DK45482] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; AOYAMA T, 1995, J CLIN INVEST, V95, P2465, DOI 10.1172/JCI117947; Battaile KP, 1998, BBA-LIPID LIPID MET, V1390, P333, DOI 10.1016/S0005-2760(97)00185-9; BERTINI E, 1992, EUR J PEDIATR, V151, P121, DOI 10.1007/BF01958956; Bonafe L, 2001, CLIN CHEM, V47, P477; Bzduch V, 2001, Bratisl Lek Listy, V102, P427; Carpenter K, 2001, ARCH DIS CHILD-FETAL, V85, pF105, DOI 10.1136/fn.85.2.F105; CORKEY BE, 1988, J CLIN INVEST, V82, P782, DOI 10.1172/JCI113679; Cox KB, 2001, HUM MOL GENET, V10, P2069, DOI 10.1093/hmg/10.19.2069; Cunnane SC, 2003, LIPIDS, V38, P477, DOI 10.1007/s11745-003-1087-8; Das AM, 2006, CLIN CHEM, V52, P530, DOI 10.1373/clinchem.2005.062000; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Ensenauer R, 2005, J BIOL CHEM, V280, P32309, DOI 10.1074/jbc.M504460200; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Friday RP, 2003, J BIOL CHEM, V278, P853, DOI 10.1074/jbc.M210175200; FURUTA S, 1981, J BIOCHEM, V90, P1739, DOI 10.1093/oxfordjournals.jbchem.a133651; Gilbert-Barness E, 2004, ANN CLIN LAB SCI, V34, P15; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Liebig M, 2006, PEDIATRICS, V118, P1065, DOI 10.1542/peds.2006-0666; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundy CT, 2003, J INHERIT METAB DIS, V26, P537, DOI 10.1023/A:1025995813914; Mason RJ, 2006, RESPIROLOGY, V11, pS12, DOI 10.1111/j.1440-1843.2006.00800.x; Mathur A, 1999, CIRCULATION, V99, P1337, DOI 10.1161/01.CIR.99.10.1337; Olpin SE, 2005, J INHERIT METAB DIS, V28, P533, DOI 10.1007/s10545-005-0533-8; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Spiekerkoetter U, 2003, J PEDIATR-US, V143, P335, DOI 10.1067/S0022-3476(03)00292-0; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; TEIN I, 1995, PEDIATR NEUROL, V12, P68, DOI 10.1016/0887-8994(94)00109-F; Tyni T, 1999, ACTA PAEDIATR, V88, P237, DOI 10.1080/08035259950169954; Tyni T, 2004, PEDIATR RES, V56, P744, DOI 10.1203/01.PDR.0000141967.52759.83; Tyni T, 1997, PEDIATR PATHOL LAB M, V17, P427, DOI 10.1080/107710497174732; VALLEE L, 1994, EUR J PEDIATR, V153, P598, DOI 10.1007/BF02190669; VOCKLEY J, 1992, PROG CLIN BIOL RES, V375, P533; Vockley J, 2002, NEUROMUSCULAR DISORD, V12, P235, DOI 10.1016/S0960-8966(01)00308-X; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Yoo JY, 2003, P NATL ACAD SCI USA, V100, P1157, DOI 10.1073/pnas.0336385100; YOUNG SL, 1993, AM J PHYSIOL, V265, pL19, DOI 10.1152/ajplung.1993.265.1.L19; Zhang J, 2002, BIOCHEM BIOPH RES CO, V297, P1033, DOI 10.1016/S0006-291X(02)02336-7	46	86	90	0	12	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUL	2007	81	1					87	103		10.1086/519219	http://dx.doi.org/10.1086/519219			17	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	175UO	17564966	Green Published, Bronze			2022-12-18	WOS:000247039700008
J	Chang, YPC; Liu, X; Kim, JDO; Ikeda, MA; Layton, MR; Weder, AB; Cooper, RS; Kardia, SLR; Rao, DC; Hunt, SC; Luke, A; Boerwinkle, E; Chakravarti, A				Chang, Yen-Pei Christy; Liu, Xin; Kim, James Dae Ok; Ikeda, Morna A.; Layton, Marnie R.; Weder, Alan B.; Cooper, Richard S.; Kardia, Sharon L. R.; Rao, D. C.; Hunt, Steve C.; Luke, Amy; Boerwinkle, Eric; Chakravarti, Aravinda			Multiple genes for essential-hypertension susceptibility on chromosome 1q	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							INFLUENCING BLOOD-PRESSURE; GENOME-WIDE SCAN; NATRIURETIC-PEPTIDE; LINKAGE ANALYSIS; NA,K-ATPASE; EXPRESSION; RECEPTOR; LOCI; BETA; MICE	Essential hypertension, defined as elevated levels of blood pressure (BP) without any obvious cause, is a major risk factor for coronary heart disease, stroke, and renal disease. BP levels and susceptibility to development of essential hypertension are partially determined by genetic factors that are poorly understood. Similar to other efforts to understand complex, non-Mendelian phenotypes, genetic dissection of hypertension-related traits employs genomewide linkage analyses of families and association studies of patient cohorts, to uncover rare and common disease alleles, respectively. Family-based mapping studies of elevated BP cover the large intermediate ground for identification of genes with common variants of significant effect. Our genomewide linkage and candidate-gene-based association studies demonstrate that a replicated linkage peak for BP regulation on human chromosome 1q, homologous to mouse and rat quantitative trait loci for BP, contains at least three genes associated with BP levels in multiple samples: ATP1B1, RGS5, and SELE. Individual variants in these three genes account for 2-5-mm Hg differences in mean systolic BP levels, and the cumulative effect reaches 8-10 mm Hg. Because the associated alleles in these genes are relatively common (frequency > 5%), these three genes are important contributors to elevated BP in the population at large.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Loyola Univ, Stritch Sch Med, Dept Prevent Med & Epidemiol, Chicago, IL 60611 USA; Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX USA	Johns Hopkins University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Loyola University Chicago; Washington University (WUSTL); Utah System of Higher Education; University of Utah; University of Texas System; University of Texas Health Science Center Houston	Chakravarti, A (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 733 N Broadway,BRB 579, Baltimore, MD 21205 USA.	aravinda@jhmi.edu						Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell SE, 2001, J CELL SCI, V114, P2755; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Boerwinkle E, 2002, HYPERTENSION, V39, P3; Chang YPC, 2006, EUR J HUM GENET, V14, P469, DOI 10.1038/sj.ejhg.5201582; Cooper RS, 2002, HYPERTENSION, V40, P629, DOI 10.1161/01.HYP.0000035708.02789.39; Cruz DN, 2001, HYPERTENSION, V37, P1458, DOI 10.1161/01.HYP.37.6.1458; Cui JSS, 2003, HYPERTENSION, V41, P207, DOI 10.1161/01.HYP.0000044938.94050.E3; De Caterina R, 2001, AM J HYPERTENS, V14, P259, DOI 10.1016/S0895-7061(00)01276-0; DiPetrillo K, 2004, PHYSIOL GENOMICS, V17, P215, DOI 10.1152/physiolgenomics.00212.2003; Ferrandi M, 1996, HYPERTENSION, V28, P1018, DOI 10.1161/01.HYP.28.6.1018; Furuya M, 2004, J PATHOL, V203, P551, DOI 10.1002/path.1543; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garcia EA, 2003, CURR PHARM DESIGN, V9, P1679, DOI 10.2174/1381612033454513; GICK GG, 1993, J MEMBRANE BIOL, V131, P229, DOI 10.1007/BF02260111; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; HOROWITZ B, 1990, J BIOL CHEM, V265, P14308; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Hsueh WC, 2000, CIRCULATION, V101, P2810, DOI 10.1161/01.CIR.101.24.2810; Hunt SC, 2002, HYPERTENSION, V40, P1, DOI 10.1161/01.HYP.0000022660.28915.B1; ITO M, 1995, P NATL ACAD SCI USA, V92, P3521, DOI 10.1073/pnas.92.8.3521; James K, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S83; JOHN SWM, 1995, SCIENCE, V267, P679, DOI 10.1126/science.7839143; Kardia SLR, 2003, AM J HYPERTENS, V16, P154, DOI 10.1016/S0895-7061(02)03249-1; KAWAKAMI K, 1986, NUCLEIC ACIDS RES, V14, P2833, DOI 10.1093/nar/14.7.2833; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; KIM HS, 1995, P NATL ACAD SCI USA, V92, P2735, DOI 10.1073/pnas.92.7.2735; Kirsch T, 2001, BRAIN RES, V910, P106, DOI 10.1016/S0006-8993(01)02670-1; Lange C, 2003, AM J HUM GENET, V73, P801, DOI 10.1086/378591; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; LESCALEMATYS L, 1990, J BIOL CHEM, V265, P17935; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Li J, 2004, J VASC SURG, V40, P519, DOI 10.1016/j.jvs.2004.06.021; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; LOPEZ MJ, 1995, NATURE, V378, P65, DOI 10.1038/378065a0; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oliver PM, 1998, P NATL ACAD SCI USA, V95, P2547, DOI 10.1073/pnas.95.5.2547; PANZA JA, 1993, J AM COLL CARDIOL, V21, P1145, DOI 10.1016/0735-1097(93)90238-V; Perola M, 2000, J HYPERTENS, V18, P1579, DOI 10.1097/00004872-200018110-00008; Ranade K, 2003, AM J HYPERTENS, V16, P158, DOI 10.1016/S0895-7061(02)03245-4; Rao DC, 2003, AM J HYPERTENS, V16, P148, DOI 10.1016/S0895-7061(02)03247-8; Samani NJ, 2003, AM J HYPERTENS, V16, P167, DOI 10.1016/S0895-7061(02)03244-2; Schieffer B, 1997, AM J PHYSIOL-CELL PH, V272, pC2019, DOI 10.1152/ajpcell.1997.272.6.C2019; Serne EH, 2001, HYPERTENSION, V38, P238, DOI 10.1161/01.HYP.38.2.238; Stoll M, 2000, GENOME RES, V10, P473, DOI 10.1101/gr.10.4.473; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Sugiyama F, 2001, GENOMICS, V71, P70, DOI 10.1006/geno.2000.6401; Taddei S, 1996, CIRCULATION, V94, P1298, DOI 10.1161/01.CIR.94.6.1298; TADDEI S, 1993, HYPERTENSION, V21, P929, DOI 10.1161/01.HYP.21.6.929; Thiel BA, 2003, AM J HYPERTENS, V16, P151, DOI 10.1016/S0895-7061(02)03246-6; von Wowern F, 2003, HUM MOL GENET, V12, P2077, DOI 10.1093/hmg/ddg206; WARD R, 1980, HYPERTENSION PATHOPH, P81; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2004, SCIENCE, V306, P1190, DOI 10.1126/science.1102521; Wood JN, 2003, J COGNITIVE NEUROSCI, V15, P236, DOI 10.1162/089892903321208178; Wright FA, 1999, HYPERTENSION, V34, P625, DOI 10.1161/01.HYP.34.4.625; Wu XD, 2002, AM J HUM GENET, V70, P1247, DOI 10.1086/340362	61	86	91	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	FEB	2007	80	2					253	264		10.1086/510918	http://dx.doi.org/10.1086/510918			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	129KX	17236131	Green Published, Bronze			2022-12-18	WOS:000243729500005
J	Zhou, HY; Brockington, M; Jungbluth, H; Monk, D; Stanier, P; Sewry, CA; Moore, GE; Muntoni, F				Zhou, Haiyan; Brockington, Martin; Jungbluth, Heinz; Monk, David; Stanier, Philip; Sewry, Caroline A.; Moore, Gudrun E.; Muntoni, Francesco			Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RYANODINE RECEPTOR GENE; BECKWITH-WIEDEMANN-SYNDROME; MULTI-MINICORE DISEASE; MALIGNANT HYPERTHERMIA; ANGELMAN-SYNDROME; EXPRESSION; LYMPHOCYTES; OPHTHALMOPLEGIA; METHYLATION; MECHANISMS	Epigenetic regulation of gene expression is a source of genetic variation, which can mimic recessive mutations by creating transcriptional haploinsufficiency. Germline epimutations and genomic imprinting are typical examples, although their existence can be difficult to reveal. Genomic imprinting can be tissue specific, with biallelic expression in some tissues and monoallelic expression in others or with polymorphic expression in the general population. Mutations in the skeletal-muscle ryanodine-receptor gene (RYR1) are associated with malignant hyperthermia susceptibility and the congenital myopathies central core disease and multiminicore disease. RYR1 has never been thought to be affected by epigenetic regulation. However, during the RYR1-mutation analysis of a cohort of patients with recessive core myopathies, we discovered that 6 (55%) of 11 patients had monoallelic RYR1 transcription in skeletal muscle, despite being heterozygous at the genomic level. In families for which parental DNA was available, segregation studies showed that the nonexpressed allele was maternally inherited. Transcription analysis in patients' fibroblasts and lymphoblastoid cell lines indicated biallelic expression, which suggests tissue-specific silencing. Transcription analysis of normal human fetal tissues showed that RYR1 was monoallelically expressed in skeletal and smooth muscles, brain, and eye in 10% of cases. In contrast, 25 normal adult human skeletal-muscle samples displayed only biallelic expression. Finally, the administration of the DNA methyltransferase inhibitor 5-aza-deoxycytidine to cultured patient skeletal-muscle myoblasts reactivated the transcription of the silenced allele, which suggests hypermethylation as a mechanism for RYR1 silencing. Our data indicate that RYR1 undergoes polymorphic, tissue- specific, and developmentally regulated allele silencing and that this unveils recessive mutations in patients with core myopathies. Furthermore, our data suggest that imprinting is a likely mechanism for this phenomenon and that similar mechanisms could play a role in human phenotypic heterogeneity.	Hammersmith Hosp, Imperial Coll, Dept Paediat, Dubowitzw Neuromuscular Ctr, London W12 0NN, England; St Thomas Hosp, Evelina Childrens Hosp, Dept Paediat Neurol, London, England; UCL, Inst Child Hlth, Clin & Mol Genet Unit, London, England; Robert Jones & Agnes Hunt Orthopaed Hosp, Dept Histopathol, Oswestry SY10 7AG, Shrops, England	Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; University College London; Keele University	Muntoni, F (corresponding author), Hammersmith Hosp, Imperial Coll, Dept Paediat, Dubowitzw Neuromuscular Ctr, Du Cane Rd, London W12 0NN, England.	f.muntoni@ic.ac.uk	Moore, Gudrun/A-2092-2009; Jungbluth, Heinz/B-8893-2012; Stanier, Philip/C-1593-2008	Stanier, Philip/0000-0001-9340-8117; Jungbluth, Heinz/0000-0002-7159-3427				BELLESISLES M, 1993, EUR J HISTOCHEM, V37, P375; Brannan CI, 1999, CURR OPIN GENET DEV, V9, P164, DOI 10.1016/S0959-437X(99)80025-2; Bunzel R, 1998, MOL BRAIN RES, V59, P90, DOI 10.1016/S0169-328X(98)00146-6; Callinan PA, 2006, HUM MOL GENET, V15, pR95, DOI 10.1093/hmg/ddl095; Ducreux S, 2006, BIOCHEM J, V395, P259, DOI 10.1042/BJ20051282; Galli L, 2002, CELL CALCIUM, V32, P143, DOI 10.1016/S0143-4160(02)00138-0; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P15475, DOI 10.1073/pnas.95.26.15475; Herzing LBK, 2001, AM J HUM GENET, V68, P1501, DOI 10.1086/320616; Horike S, 2000, HUM MOL GENET, V9, P2075, DOI 10.1093/hmg/9.14.2075; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Jungbluth H, 2005, NEUROLOGY, V65, P1930, DOI 10.1212/01.wnl.0000188870.37076.f2; Lee MP, 1997, NAT GENET, V15, P181, DOI 10.1038/ng0297-181; Li J, 2005, GENOMICS, V86, P489, DOI 10.1016/j.ygeno.2005.06.012; Liu J, 2000, MOL CELL BIOL, V20, P5808, DOI 10.1128/MCB.20.16.5808-5817.2000; Liu J, 2000, J CLIN INVEST, V106, P1167, DOI 10.1172/JCI10431; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Mitsuya K, 1997, HUM MOL GENET, V6, P2243, DOI 10.1093/hmg/6.13.2243; Monk D, 2006, P NATL ACAD SCI USA, V103, P6623, DOI 10.1073/pnas.0511031103; Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; OTSU K, 1991, GENOMICS, V11, P744, DOI 10.1016/0888-7543(91)90083-Q; PATTERSON VH, 1979, BRAIN, V102, P581, DOI 10.1093/brain/102.3.581; Petronis A, 2000, NEUROPSYCHOPHARMACOL, V23, P1, DOI 10.1016/S0893-133X(00)00127-5; Phillips MS, 1996, GENOMICS, V34, P24, DOI 10.1006/geno.1996.0238; QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51; Schmoelzl S, 1996, J BIOL CHEM, V271, P4763, DOI 10.1074/jbc.271.9.4763; Sei Y, 1999, J BIOL CHEM, V274, P5995, DOI 10.1074/jbc.274.9.5995; Shepherd S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014274; Spahn L, 2003, NAT GENET, V35, P11, DOI 10.1038/ng0903-11; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Tilghman SM, 1999, CELL, V96, P185, DOI 10.1016/S0092-8674(00)80559-0; Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008; VOSS R, 1989, AM J HUM GENET, V45, P373; Vu TH, 1997, NAT GENET, V17, P12, DOI 10.1038/ng0997-12; Weinstein LS, 2001, BIOL PSYCHIAT, V50, P927, DOI 10.1016/S0006-3223(01)01295-1; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yarnasaki K, 2003, HUM MOL GENET, V12, P837, DOI 10.1093/hmg/ddg106; Zhang Y, 2005, MOL CELL BIOL, V25, P7929, DOI 10.1128/MCB.25.18.7929-7939.2005	42	86	87	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2006	79	5					859	868		10.1086/508500	http://dx.doi.org/10.1086/508500			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	100KJ	17033962	Bronze, Green Published			2022-12-18	WOS:000241667400007
J	Wu, HM; Cowing, JA; Michaelides, M; Wilkie, SE; Jeffery, G; Jenkins, SA; Mester, V; Bird, AC; Robson, AG; Holder, GE; Moore, AT; Hunt, DM; Webster, AR				Wu, Huimin; Cowing, Jill A.; Michaelides, Michel; Wilkie, Susan E.; Jeffery, Glen; Jenkins, Sharon A.; Mester, Viktoria; Bird, Alan C.; Robson, Anthony G.; Holder, Graham E.; Moore, Anthony T.; Hunt, David M.; Webster, Andrew R.			Mutations in the gene KCNV2 encoding a voltage-gated potassium channel subunit cause "cone dystrophy with supernormal rod electroretinogram" in humans	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							RETINAL DEGENERATION; ION CHANNELS; ERG; DYSFUNCTION; LIGHT	"Cone dystrophy with supernormal rod electroretinogram ( ERG)" is an autosomal recessive disorder that causes lifelong visual loss combined with a supernormal ERG response to a bright flash of light. We have linked the disorder to a 0.98-cM (1.5-Mb) region on chromosome 9p24, flanked by rs1112534 and rs1074449, using homozygosity mapping in one large consanguineous pedigree. Analysis of one gene within this region, KCNV2, showed a homozygous nonsense mutation. Mutations were also found in 17 alleles of 10 other unrelated families with the same disorder. In situ hybridization demonstrated KCNV2 expression in human rod and cone photoreceptors. The precise function of KCNV2 in human photoreceptors remains to be determined, although this work suggests that mutations might perturb or abrogate I(KX), the potassium current within vertebrate photoreceptor inner segments, which has been shown to set their resting potential and voltage response.	Moorfields Eye Hosp, London, England; UCL, Inst Ophthalmol, London WC1E 6BT, England; Mafraq Hosp, Eye Dept, Abu Dhabi, U Arab Emirates	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Webster, AR (corresponding author), Moorfields Eye Hosp, City Rd, London, England.	andrew.webster@ucl.ac.uk	Hunt, David M/K-6024-2012	Hunt, David M/0000-0002-9264-3948; Robson, Anthony/0000-0002-8391-6123				BARNES S, 1994, NEUROSCIENCE, V58, P447, DOI 10.1016/0306-4522(94)90072-8; BEECH DJ, 1989, NEURON, V3, P573, DOI 10.1016/0896-6273(89)90267-5; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; GOURAS P, 1983, ARCH OPHTHALMOL-CHIC, V101, P718, DOI 10.1001/archopht.1983.01040010718003; Hood DC, 1996, VISION RES, V36, P889, DOI 10.1016/0042-6989(95)00174-3; KATO M, 1993, DOC OPHTHALMOL, V84, P71, DOI 10.1007/BF01203284; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Michaelides M, 2005, BRIT J OPHTHALMOL, V89, P332, DOI 10.1136/bjo.2004.050567; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; PAWLYK BS, 1991, VISION RES, V31, P1093, DOI 10.1016/0042-6989(91)90035-4; Pinto LH, 1998, PROG RETIN EYE RES, V17, P207; Piri N, 2005, OPHTHALMOLOGY, V112, P159, DOI 10.1016/j.ophtha.2004.07.011; ROSENBERG T, 1993, ACTA OPHTHALMOL, V71, P246; SANDBERG MA, 1990, INVEST OPHTH VIS SCI, V31, P2283; Shealy RT, 2003, BIOPHYS J, V84, P2929, DOI 10.1016/S0006-3495(03)70020-4; Waters MF, 2006, NAT GENET, V38, P447, DOI 10.1038/ng1758	16	86	92	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	SEP	2006	79	3					574	579		10.1086/507568	http://dx.doi.org/10.1086/507568			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	074RY	16909397	Green Published, Bronze			2022-12-18	WOS:000239830700021
J	Shahin, H; Walsh, T; Sobe, T; Abu Sa'ed, J; Abu Rayan, A; Lynch, ED; Lee, MK; Avraham, KB; King, MC; Kanaan, M				Shahin, H; Walsh, T; Sobe, T; Abu Sa'ed, J; Abu Rayan, A; Lynch, ED; Lee, MK; Avraham, KB; King, MC; Kanaan, M			Mutations in a novel isoform of TRIOBP that encodes a filamentous-actin binding protein are responsible for DFNB28 recessive nonsyndromic hearing loss	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HAIR-CELLS; DEAFNESS; LINKAGE; GENE; FAMILIES; DEFECTS	In a large consanguineous Palestinian kindred, we previously mapped DFNB28-a locus associated with recessively inherited, prelingual, profound sensorineural hearing impairment-to chromosome 22q13.1. We report here that mutations in a novel 218-kDa isoform of TRIOBP ( TRIO and filamentous actin [F-actin] binding protein) are associated with DFNB28 hearing loss in a total of nine Palestinian families. Two nonsense mutations (R347X and Q581X) truncate the protein, and a potentially deleterious missense mutation (G1019R) occurs in a conserved motif in a putative SH3-binding domain. In seven families, 27 deaf individuals are homozygous for one of the nonsense mutations; in two other families, 3 deaf individuals are compound heterozygous for the two nonsense mutations or for Q581X and G1019R. The novel long isoform of TRIOBP has a restricted expression profile, including cochlea, retina, and fetal brain, whereas the original short isoform is widely expressed. Antibodies to TRIOBP reveal expression in sensory cells of the inner ear and colocalization with F-actin along the length of the stereocilia.	Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Bethlehem Univ, Dept Life Sci, Bethlehem, PA USA; Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Tel Aviv University; Sackler Faculty of Medicine	King, MC (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	mcking@u.washington.edu		King, Mary-Claire/0000-0001-9426-1743; Walsh, Tom/0000-0002-8875-0310; Avraham, Karen B/0000-0002-4913-251X	NIDCD NIH HHS [R01 DC005641] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005641] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BALDWIN CT, 1995, HUM MOL GENET, V4, P1637, DOI 10.1093/hmg/4.9.1637; BonneTamir B, 1996, AM J HUM GENET, V58, P1254; Brannetti B, 2003, NUCLEIC ACIDS RES, V31, P3709, DOI 10.1093/nar/gkg592; Campbell J, 1997, J ADDICT DIS, V16, P15, DOI 10.1300/J069v16n02_02; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Greinwald JH, 1998, AM J MED GENET, V78, P107, DOI 10.1002/(SICI)1096-8628(19980630)78:2<107::AID-AJMG2>3.3.CO;2-9; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; KALTENBACH JA, 1994, J COMP NEUROL, V340, P87, DOI 10.1002/cne.903400107; Kollmar R, 1999, CURR OPIN NEUROBIOL, V9, P394, DOI 10.1016/S0959-4388(99)80059-2; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; MARAZITA ML, 1993, AM J MED GENET, V46, P486, DOI 10.1002/ajmg.1320460504; Mburu P, 2003, NAT GENET, V34, P421, DOI 10.1038/ng1208; Medlej-Hashim M, 2002, EUR J HUM GENET, V10, P391, DOI 10.1038/sj.ejhg.5200813; Muller U, 2001, TRENDS CELL BIOL, V11, P334, DOI 10.1016/S0962-8924(01)02046-3; Mustapha M, 2002, EUR J HUM GENET, V10, P210, DOI 10.1038/sj.ejhg.5200780; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Rhodes CR, 2004, MAMM GENOME, V15, P686, DOI 10.1007/s00335-004-2344-x; Scott HS, 2001, NAT GENET, V27, P59, DOI 10.1038/83768; Seipel K, 2001, J CELL SCI, V114, P389; SOBUE K, 1991, J BIOL CHEM, V266, P12115; Verpy E, 2001, NAT GENET, V29, P345, DOI 10.1038/ng726; WALSH TD, 2000, 50 ANN M AM SOC HUM; Zwaenepoel I, 2002, P NATL ACAD SCI USA, V99, P6240, DOI 10.1073/pnas.082515999	24	86	94	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2006	78	1					144	152		10.1086/499495	http://dx.doi.org/10.1086/499495			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	993CN	16385458	Green Published, Bronze			2022-12-18	WOS:000233930400015
J	Lin, Z; Altman, RB				Lin, Z; Altman, RB			Finding haplotype tagging SNPs by use of principal components analysis	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE-DISEQUILIBRIUM; GENOTYPE DATA; ASSOCIATION ANALYSES; SEQUENCE VARIATION; SELECTION; POPULATION; RECONSTRUCTION; DIVERSITY; BLOCKS	The immense volume and rapid growth of human genomic data, especially single nucleotide polymorphisms (SNPs), present special challenges for both biomedical researchers and automatic algorithms. One such challenge is to select an optimal subset of SNPs, commonly referred as "haplotype tagging SNPs" (htSNPs), to capture most of the haplotype diversity of each haplotype block or gene-specific region. This information-reduction process facilitates cost-effective genotyping and, subsequently, genotype-phenotype association studies. It also has implications for assessing the risk of identifying research subjects on the basis of SNP information deposited in public domain databases. We have investigated methods for selecting htSNPs by use of principal components analysis (PCA). These methods first identify eigenSNPs and then map them to actual SNPs. We evaluated two mapping strategies, greedy discard and varimax rotation, by assessing the ability of the selected htSNPs to reconstruct genotypes of non-htSNPs. We also compared these methods with two other htSNP finders, one of which is PCA based. We applied these methods to three experimental data sets and found that the PCA-based methods tend to select the smallest set of htSNPs to achieve a 90% reconstruction precision.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University	Altman, RB (corresponding author), Stanford Univ, Sch Med, Dept Genet, 300 Pasteur Dr L-301, Stanford, CA 94305 USA.	russ.altman@stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033] Funding Source: NIH RePORTER; NIGMS NIH HHS [U01-GM61374, U01 GM061374] Funding Source: Medline; NLM NIH HHS [T15 LM007033, LM007033] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Anderson EC, 2003, AM J HUM GENET, V73, P336, DOI 10.1086/377106; ASCHER D, 2001, NUMERICAL PHYTHON; Avi-Itzhak Hadar I, 2003, Pac Symp Biocomput, P466; BAFNA V, 2003, ANN C RES COMP MOL B; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Duda R.O., 2001, PATTERN CLASSIFICATI, V20; Dunteman G. H., 1989, PRINCIPAL COMPONENTS; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hampe J, 2003, HUM GENET, V114, P36, DOI 10.1007/s00439-003-1017-2; Horne BD, 2004, GENET EPIDEMIOL, V26, P11, DOI 10.1002/gepi.10292; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Judson R, 2002, PHARMACOGENOMICS, V3, P379, DOI 10.1517/14622416.3.3.379; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Kroetz DL, 2003, PHARMACOGENETICS, V13, P481, DOI 10.1097/00008571-200308000-00006; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lin Z, 2004, SCIENCE, V305, P183, DOI 10.1126/science.1095019; LUTZ M, 1999, LEARNING PHYTHON; Mardia KV, 1979, MULTIVARIATE ANAL; Meng ZL, 2003, AM J HUM GENET, V73, P115, DOI 10.1086/376561; Morris AP, 2004, AM J HUM GENET, V74, P945, DOI 10.1086/420773; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Rieder MJ, 1999, NAT GENET, V22, P59, DOI 10.1038/8760; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Sebastiani P, 2003, P NATL ACAD SCI USA, V100, P9900, DOI 10.1073/pnas.1633613100; Stephens JC, 2001, SCIENCE, V293, P489, DOI 10.1126/science.1059431; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STERIAN A, 1999, PYMAT INTERFACE PYTH; Stram DO, 2003, HUM HERED, V55, P27, DOI 10.1159/000071807; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Wheeler DL, 2003, NUCLEIC ACIDS RES, V31, P28, DOI 10.1093/nar/gkg033; Wu XD, 2003, J HYPERTENS, V21, P1847, DOI 10.1097/00004872-200310000-00011; Zhang K, 2004, GENOME RES, V14, P908, DOI 10.1101/gr.1837404	39	86	91	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	NOV	2004	75	5					850	861		10.1086/425587	http://dx.doi.org/10.1086/425587			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	859YE	15389393	Green Published, Bronze			2022-12-18	WOS:000224303500010
J	Duan, JB; Martinez, M; Sanders, AR; Hou, CP; Saitou, N; Kitano, T; Mowry, BJ; Crowe, RR; Silverman, JM; Levinson, DF; Gejman, PV				Duan, JB; Martinez, M; Sanders, AR; Hou, CP; Saitou, N; Kitano, T; Mowry, BJ; Crowe, RR; Silverman, JM; Levinson, DF; Gejman, PV			Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							AMINO-ACID OXIDASE; GENOME SCAN; BIPOLAR DISORDER; LINKAGE ANALYSIS; FLUORESCENCE-POLARIZATION; TRACE AMINES; 6P22.3 GENE; LOCUS; DOPAMINE; SUPPORT	Several linkage studies across multiple population groups provide convergent support for a susceptibility locus for schizophrenia - and, more recently, for bipolar disorder - on chromosome 6q13-q26. We genotyped 192 European-ancestry and African American (AA) pedigrees with schizophrenia from samples that previously showed linkage evidence to 6q13-q26, focusing on the MOXD1-STX7-TRARs gene cluster at 6q23.2, which contains a number of prime candidate genes for schizophrenia. Thirty-one screening single-nucleotide polymorphisms (SNPs) were selected, providing a minimum coverage of at least 1 SNP/20 kb. The association observed with rs4305745 (P = .0014) within the TRAR4 (trace amine receptor 4) gene remained significant after correction for multiple testing. Evidence for association was proportionally stronger in the smaller AA sample. We performed database searches and sequenced genomic DNA in a 30-proband subsample to obtain a high-density map of 23 SNPs spanning 21.6 kb of this gene. Single-SNP analyses and also haplotype analyses revealed that rs4305745 and/or two other polymorphisms in perfect linkage disequilibrium (LD) with rs4305745 appear to be the most likely variants underlying the association of the TRAR4 region with schizophrenia. Comparative genomic analyses further revealed that rs4305745 and/or the associated polymorphisms in complete LD with rs4305745 could potentially affect gene expression. Moreover, RT-PCR studies of various human tissues, including brain, confirm that TRAR4 is preferentially expressed in those brain regions that have been implicated in the pathophysiology of schizophrenia. These data provide strong preliminary evidence that TRAR4 is a candidate gene for schizophrenia; replication is currently being attempted in additional clinical samples.	Northwestern Univ, Evanston NW Healthcare,Res Inst, Dept Psychiat & Behav Sci, Ctr Psychiat Genet, Evanston, IL 60201 USA; Northwestern Univ, Feinberg Sch Med, Evanston, IL USA; INSERM, Evry, France; Natl Inst Genet, Div Populat Genet, Mishima, Shizuoka 411, Japan; Ctr Mental Hlth, Queensland Ctr Schizophrenia Res, Wacol, Australia; Univ Queensland, Dept Psychiat, Brisbane, Qld, Australia; Univ Iowa, Coll Med, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Mental Hlth Clin Res Ctr, Iowa City, IA 52242 USA; Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA	NorthShore University Health System; Northwestern University; Northwestern University; Feinberg School of Medicine; Institut National de la Sante et de la Recherche Medicale (Inserm); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Queensland; University of Iowa; University of Iowa; Icahn School of Medicine at Mount Sinai; University of Pennsylvania	Gejman, PV (corresponding author), Northwestern Univ, Evanston NW Healthcare,Res Inst, Dept Psychiat & Behav Sci, Ctr Psychiat Genet, 1001 Univ Pl, Evanston, IL 60201 USA.	pgejman@northwestern.edu	Martinez, Maria/B-3111-2013; Silverman, Jeremy M./AAO-4268-2020; Mowry, Bryan/G-5046-2010	Martinez, Maria/0000-0003-2180-4537; Mowry, Bryan/0000-0002-4115-5645	NIMH NIH HHS [U01 MH046289, U01 MH046276, U01 MH046318] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Akula N, 2002, BIOTECHNIQUES, V32, P1072, DOI 10.2144/02325rr02; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; ANGRIST B, 1974, J PSYCHIAT RES, V11, P13, DOI 10.1016/0022-3956(74)90064-8; Bailer U, 2000, NEUROPSYCHOBIOLOGY, V42, P175, DOI 10.1159/000026690; BAUD P, 1985, J PHARMACOL EXP THER, V235, P220; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; Boulton A A, 1980, Prog Clin Biol Res, V39, P291; BRAFF DL, 1992, ARCH GEN PSYCHIAT, V49, P206; Branchek TA, 2003, CURR OPIN PHARMACOL, V3, P90, DOI 10.1016/S1471-4892(02)00028-0; Brzustowicz LM, 2004, AM J HUM GENET, V74, P1057, DOI 10.1086/420774; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; Cao QH, 1997, GENOMICS, V43, P1, DOI 10.1006/geno.1997.4815; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chambers KJ, 1998, GENE, V218, P111, DOI 10.1016/S0378-1119(98)00344-8; Chen XN, 1999, GENOME RES, V9, P492; Chen YS, 2004, MOL PSYCHIATR, V9, P87, DOI 10.1038/sj.mp.4001453; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Chumakov I, 2002, P NATL ACAD SCI USA, V99, P13675, DOI 10.1073/pnas.182412499; Cloninger CR, 1998, AM J MED GENET, V81, P275, DOI 10.1002/(SICI)1096-8628(19980710)81:4<275::AID-AJMG1>3.3.CO;2-U; Connell P., 1958, AMPHETAMINE PSYCHOSI, V5; Couronne O, 2003, GENOME RES, V13, P73, DOI 10.1101/gr.762503; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Duan JB, 2003, HUM MOL GENET, V12, P205, DOI 10.1093/hmg/ddg055; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Freudenberg-Hua Y, 2003, GENOME RES, V13, P2271, DOI 10.1101/gr.1299703; Gejman PV, 2001, AM J MED GENET, V105, P789, DOI 10.1002/ajmg.1552; GERSHON ES, 1988, ARCH GEN PSYCHIAT, V45, P328; GEYER MA, 1987, SCHIZOPHRENIA BULL, V13, P643, DOI 10.1093/schbul/13.4.643; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; GOUZOULIS E, 1994, NERVENARZT, V65, P198; Grossberg S, 2000, BIOL PSYCHIAT, V48, P81, DOI 10.1016/S0006-3223(00)00903-3; Hattori E, 2003, AM J HUM GENET, V72, P1131, DOI 10.1086/374822; Hauser ER, 1997, AM J HUM GENET, V61, pA278; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Honer WG, 2002, CEREB CORTEX, V12, P349, DOI 10.1093/cercor/12.4.349; Hsueh WC, 2001, GENET EPIDEMIOL, V21, pS473, DOI 10.1002/gepi.2001.21.s1.s473; Jablensky A, 1992, Psychol Med Monogr Suppl, V20, P1; Jacquet H, 2002, HUM MOL GENET, V11, P2243, DOI 10.1093/hmg/11.19.2243; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.3.CO;2-R; Kong A, 1997, AM J HUM GENET, V61, P1179, DOI 10.1086/301592; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Laruelle M, 1999, J PSYCHOPHARMACOL, V13, P358, DOI 10.1177/026988119901300405; Laruelle M, 2003, ANN NY ACAD SCI, V1003, P138, DOI 10.1196/annals.1300.063; Lee DK, 2001, GENE, V275, P83, DOI 10.1016/S0378-1119(01)00651-5; Lerer B, 2003, MOL PSYCHIATR, V8, P488, DOI 10.1038/sj.mp.4001322; Levinson DF, 2000, AM J HUM GENET, V67, P652, DOI 10.1086/303041; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li T, 2000, MOL PSYCHIATR, V5, P77, DOI 10.1038/sj.mp.4000638; Lindholm E, 2001, AM J HUM GENET, V69, P96, DOI 10.1086/321288; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Liu YP, 1998, WORLD J GASTROENTERO, V4, P103; Martinez M, 1999, AM J MED GENET, V88, P337, DOI 10.1002/(SICI)1096-8628(19990820)88:4<337::AID-AJMG9>3.3.CO;2-1; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Mitchison NA, 2001, GENOME BIOL, V2; Morris DW, 2004, AM J MED GENET B, V125B, P50, DOI 10.1002/ajmg.b.20109; Mowry BJ, 2000, AM J MED GENET, V96, P864, DOI 10.1002/1096-8628(20001204)96:6<864::AID-AJMG35>3.3.CO;2-4; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Owen MJ, 2004, MOL PSYCHIATR, V9, P14, DOI 10.1038/sj.mp.4001444; PARKER EM, 1986, J PHARMACOL EXP THER, V237, P179; Pei L, 2004, J NEUROSCI, V24, P1149, DOI 10.1523/JNEUROSCI.3922-03.2004; Premont RT, 2001, P NATL ACAD SCI USA, V98, P9474, DOI 10.1073/pnas.181356198; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Riva A, 2002, BIOINFORMATICS, V18, P1681, DOI 10.1093/bioinformatics/18.12.1681; Rosa A, 2002, AM J MED GENET, V114, P516, DOI 10.1002/ajmg.10526; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanders AR, 2001, JAMA-J AM MED ASSOC, V285, P2831, DOI 10.1001/jama.285.22.2831; Schumacher J, 2004, MOL PSYCHIATR, V9, P203, DOI 10.1038/sj.mp.4001421; Schwab SG, 2003, AM J HUM GENET, V72, P185, DOI 10.1086/345463; Shields J, 1982, SCHIZOPHRENIA EPIGEN; Shifman S, 2002, AM J HUM GENET, V71, P1296, DOI 10.1086/344514; SNYDER SH, 1967, SCIENCE, V158, P669, DOI 10.1126/science.158.3801.669; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Teng FYH, 2001, GENOME BIOL, V2; VARDY MM, 1983, ARCH GEN PSYCHIAT, V40, P877; Wang H, 1997, GENE, V199, P39, DOI 10.1016/S0378-1119(97)00343-0; Williams NM, 2004, BIOL PSYCHIAT, V55, P192, DOI 10.1016/j.biopsych.2003.11.002; Williams NM, 2003, MOL PSYCHIATR, V8, P485, DOI 10.1038/sj.mp.4001348; Zeng ZZ, 1998, BIOCHEM BIOPH RES CO, V242, P575, DOI 10.1006/bbrc.1997.7591; Zuker M., 1999, V70, P11	88	86	94	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	OCT	2004	75	4					624	638		10.1086/424887	http://dx.doi.org/10.1086/424887			15	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	850SZ	15329799	Green Published, Bronze			2022-12-18	WOS:000223634100008
J	Barbouti, A; Stankiewicz, P; Nusbaum, C; Cuomo, C; Cook, A; Hoglund, M; Johansson, B; Hagemeijer, A; Park, SS; Mitelman, F; Lupski, JR; Fioretos, T				Barbouti, A; Stankiewicz, P; Nusbaum, C; Cuomo, C; Cook, A; Hoglund, M; Johansson, B; Hagemeijer, A; Park, SS; Mitelman, F; Lupski, JR; Fioretos, T			The breakpoint region of the most common isochromosome, i(17q), in human neoplasia is characterized by a complex genomic architecture with large, palindromic, low-copy repeats	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CHRONIC MYELOID-LEUKEMIA; IN-SITU HYBRIDIZATION; AT-RICH PALINDROMES; CHROMOSOME 17P11.2; HOMOLOGOUS RECOMBINATION; SEGMENTAL DUPLICATIONS; MOLECULAR-MECHANISM; DELETION; REARRANGEMENTS; DISORDERS	Although a great deal of information has accumulated regarding the mechanisms underlying constitutional DNA rearrangements associated with inherited disorders, virtually nothing is known about the molecular processes involved in acquired neoplasia-associated chromosomal rearrangements. Isochromosome 17q, or "i( 17q)," is one of the most common structural abnormalities observed in human neoplasms. We previously identified a breakpoint cluster region for i(17q) formation in 17p11.2 and hypothesized that genome architectural features could be responsible for this clustering. To address this hypothesis, we precisely mapped the i( 17q) breakpoints in 11 patients with different hematologic malignancies and determined the genomic structure of the involved region. Our results reveal a complex genomic architecture in the i( 17q) breakpoint cluster region, characterized by large (similar to 38 - 49-kb), palindromic, low-copy repeats, strongly suggesting that somatic rearrangements are not random events but rather reflect susceptibilities due to the genomic structure.	Univ Lund Hosp, Dept Clin Genet, SE-22185 Lund, Sweden; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA; MIT, Ctr Genome Res, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; Univ Leuven, Dept Human Genet, Louvain, Belgium	Lund University; Skane University Hospital; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Massachusetts Institute of Technology (MIT); Whitehead Institute; KU Leuven	Fioretos, T (corresponding author), Univ Lund Hosp, Dept Clin Genet, SE-22185 Lund, Sweden.	thoas.fioretos@klingen.lu.se	Stankiewicz, Paweł/AAP-7906-2021; Cuomo, Christina/L-2222-2019; Park, Sung Sup/J-2756-2012	Stankiewicz, Paweł/0000-0002-6456-7490; Cuomo, Christina/0000-0002-5778-960X; Mitelman, Felix/0000-0002-3757-7212; Fioretos, Thoas/0000-0002-3235-6154; Park, Sung Sup/0000-0003-3754-4848; Hoglund, Mattias/0000-0001-9283-4421	NICHD NIH HHS [P01 HD039420] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039420] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akgun E, 1997, MOL CELL BIOL, V17, P5559, DOI 10.1128/MCB.17.9.5559; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Barbouti A, 2002, GENE CHROMOSOME CANC, V35, P127, DOI 10.1002/gcc.10099; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Bi WM, 2002, GENOME RES, V12, P713, DOI 10.1101/gr.73702; BIEGEL JA, 1995, GENE CHROMOSOME CANC, V14, P85, DOI 10.1002/gcc.2870140202; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Fioretos T, 1999, BLOOD, V94, P225, DOI 10.1182/blood.V94.1.225.413k24_225_232; Gao LI, 1997, NUCLEIC ACIDS RES, V25, P4740, DOI 10.1093/nar/25.23.4740; HEISKANEN M, 1994, BIOTECHNIQUES, V17, P928; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Johansson B, 2002, ACTA HAEMATOL-BASEL, V107, P76, DOI 10.1159/000046636; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; KehrerSawatzki H, 1997, HUM GENET, V99, P237, DOI 10.1007/s004390050346; Kurahashi H, 2003, AM J HUM GENET, V72, P733, DOI 10.1086/368062; Kurahashi H, 2001, HUM MOL GENET, V10, P2605, DOI 10.1093/hmg/10.23.2605; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lobachev KS, 1998, GENETICS, V148, P1507; Lupski JR, 2003, AM J HUM GENET, V72, P246, DOI 10.1086/346217; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McClure RF, 1999, BRIT J HAEMATOL, V106, P445, DOI 10.1046/j.1365-2141.1999.01537.x; MERTENS F, 1994, GENE CHROMOSOME CANC, V10, P221, DOI 10.1002/gcc.2870100402; MIZUUCHI K, 1982, J MOL BIOL, V156, P229, DOI 10.1016/0022-2836(82)90325-4; NAKAI H, 1995, LEUKEMIA LYMPHOMA, V19, P213, DOI 10.3109/10428199509107891; Nasar F, 2000, MOL CELL BIOL, V20, P3449, DOI 10.1128/MCB.20.10.3449-3458.2000; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Saglio G, 2002, P NATL ACAD SCI USA, V99, P9882, DOI 10.1073/pnas.152171299; Scheurlen WG, 1999, GENE CHROMOSOME CANC, V25, P230, DOI 10.1002/(SICI)1098-2264(199907)25:3<230::AID-GCC5>3.0.CO;2-E; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, CURR OPIN GENET DEV, V12, P312, DOI 10.1016/S0959-437X(02)00304-0; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wolff DJ, 1996, AM J HUM GENET, V58, P154	39	86	88	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					1	10		10.1086/380648	http://dx.doi.org/10.1086/380648			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14666446	Green Published, Bronze			2022-12-18	WOS:000187723500001
J	Zollner, S; Wen, XQ; Hanchard, NA; Herbert, MA; Ober, C; Pritchard, JK				Zollner, S; Wen, XQ; Hanchard, NA; Herbert, MA; Ober, C; Pritchard, JK			Evidence for extensive transmission distortion in the human genome	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							MYOTONIC-DYSTROPHY LOCUS; SEGREGATION DISTORTION; RATIO DISTORTION; LINKAGE ANALYSIS; MENDELIAN SEGREGATION; NONRANDOM SEGREGATION; FOUNDER POPULATION; MEIOTIC DRIVE; GENETIC MAPS; X-CHROMOSOME	It is a basic principle of genetics that each chromosome is transmitted from parent to offspring with a probability that is given by Mendel's laws. However, several known biological processes lead to skewed transmission probabilities among surviving offspring and, therefore, to excess genetic sharing among relatives. Examples include in utero selection against deleterious mutations, meiotic drive, and maternal-fetal incompatibility. Although these processes affect our basic understanding of inheritance, little is known about their overall impact in humans or other mammals. In this study, we examined genome screen data from 148 nuclear families, collected without reference to phenotype, to look for departures from Mendelian transmission proportions. Using single-point and multipoint linkage analysis, we detected a modest but significant genomewide shift towards excess genetic sharing among siblings (average sharing of 50.43% for the autosomes; P = .009). Our calculations indicate that many loci with skewed transmission are required to produce a genomewide shift of this magnitude. Since transmission distortion loci are subject to strong selection, this raises interesting questions about the evolutionary forces that keep them polymorphic. Finally, our results also have implications for mapping disease genes and for the genetics of fertility.	Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Oxford, Dept Paediat, Oxford OX1 2JD, England	University of Chicago; University of Oxford	Pritchard, JK (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,Cummings Life Sci Ctr 507, Chicago, IL 60637 USA.		Hanchard, Neil/AAY-9075-2021; Peng, Bo/A-6920-2009	Hanchard, Neil/0000-0003-1925-2665; Peng, Bo/0000-0001-8225-2284; Wen, Xiaoquan/0000-0001-8990-2737; Ober, Carole/0000-0003-4626-9809	NHGRI NIH HHS [R01 HG002772-01, R01 HG002772] Funding Source: Medline; NHLBI NIH HHS [HL66533, HL56399, P50 HL056399, R01 HL066533] Funding Source: Medline; PHS HHS [GR 2772] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066533, P50HL056399] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002772] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Chakraborty R, 1996, AM J HUM GENET, V59, P109; CROW JF, 1991, BIOESSAYS, V13, P305, DOI 10.1002/bies.950130609; Daw EW, 2000, GENET EPIDEMIOL, V19, P366, DOI 10.1002/1098-2272(200012)19:4<366::AID-GEPI8>3.0.CO;2-F; de Villena FPM, 2000, TRENDS GENET, V16, P573, DOI 10.1016/S0168-9525(00)02134-X; de Villena FPM, 2001, MAMM GENOME, V12, P331, DOI 10.1007/s003350040003; Eaves IA, 1999, NAT GENET, V22, P324, DOI 10.1038/11890; EDMONDS DK, 1982, FERTIL STERIL, V38, P447; Edwards JH, 2003, CLIN GENET, V63, P1, DOI 10.1034/j.1399-0004.2003.630101.x; EVANS K, 1994, NAT GENET, V6, P210, DOI 10.1038/ng0294-210; Girardet A, 2000, AM J HUM GENET, V66, P167, DOI 10.1086/302715; Greenwood CMT, 2000, AM J HUM GENET, V66, P2001, DOI 10.1086/302918; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LeMaire-Adkins R, 2000, GENETICS, V156, P775; LYTTLE TW, 1993, TRENDS GENET, V9, P205, DOI 10.1016/0168-9525(93)90120-7; Macklon NS, 2002, HUM REPROD UPDATE, V8, P333, DOI 10.1093/humupd/8.4.333; Naumova AK, 1998, AM J HUM GENET, V62, P1493, DOI 10.1086/301860; Naumova AK, 2001, GENOME, V44, P311, DOI 10.1139/gen-44-3-311; Newman DL, 2003, HUM MOL GENET, V12, P137, DOI 10.1093/hmg/ddg012; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Ober C, 2000, AM J HUM GENET, V67, P1154, DOI 10.1016/S0002-9297(07)62946-2; Ober C, 1998, AM J HUM GENET, V62, P1, DOI 10.1086/301692; Ober C, 1999, AM J HUM GENET, V64, P225, DOI 10.1086/302198; Polanski A, 1998, MATH BIOSCI, V147, P93, DOI 10.1016/S0025-5564(97)00082-5; Regan L, 2000, BEST PRACT RES CL OB, V14, P839, DOI 10.1053/beog.2000.0123; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; ROBERTS CJ, 1975, LANCET, V1, P498; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; Westendorp RGJ, 2001, NAT MED, V7, P873, DOI 10.1038/90868	33	86	87	0	16	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JAN	2004	74	1					62	72		10.1086/381131	http://dx.doi.org/10.1086/381131			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	759DR	14681832	Green Published, Bronze			2022-12-18	WOS:000187723500006
J	Matise, TC; Sachidanandam, R; Clark, AG; Kruglyak, L; Wijsman, E; Kakol, J; Buyske, S; Chui, B; Cohen, P; de Toma, C; Ehm, M; Glanowski, S; He, CS; Heil, J; Markianos, K; McMullen, I; Pericak-Vance, MA; Silbergleit, A; Stein, L; Wagner, M; Wilson, AF; Winick, JD; Winn-Deen, ES; Yamashiro, CT; Cann, HM; Lai, E; Holden, AL				Matise, TC; Sachidanandam, R; Clark, AG; Kruglyak, L; Wijsman, E; Kakol, J; Buyske, S; Chui, B; Cohen, P; de Toma, C; Ehm, M; Glanowski, S; He, CS; Heil, J; Markianos, K; McMullen, I; Pericak-Vance, MA; Silbergleit, A; Stein, L; Wagner, M; Wilson, AF; Winick, JD; Winn-Deen, ES; Yamashiro, CT; Cann, HM; Lai, E; Holden, AL			A 3.9-centimorgan-resolution human single-nucleotide polymorphism linkage map and screening set	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							HUMAN GENOME; SEQUENCE VARIATION; GENOTYPING ERRORS; GENETIC MAPS; MARKERS; CONSTRUCTION; DISEQUILIBRIUM; RECOMBINATION; PROGRAM; IDENTIFICATION	Recent advances in technologies for high-throughout single-nucleotide polymorphism ( SNP) - based genotyping have improved efficiency and cost so that it is now becoming reasonable to consider the use of SNPs for genomewide linkage analysis. However, a suitable screening set of SNPs and a corresponding linkage map have yet to be described. The SNP maps described here fill this void and provide a resource for fast genome scanning for disease genes. We have evaluated 6,297 SNPs in a diversity panel composed of European Americans, African Americans, and Asians. The markers were assessed for assay robustness, suitable allele frequencies, and informativeness of multi-SNP clusters. Individuals from 56 Centre d'Etude du Polymorphisme Humain pedigrees, with 1770 potentially informative meioses altogether, were genotyped with a subset of 2,988 SNPs, for map construction. Extensive genotyping-error analysis was performed, and the resulting SNP linkage map has an average map resolution of 3.9 cM, with map positions containing either a single SNP or several tightly linked SNPs. The order of markers on this map compares favorably with several other linkage and physical maps. We compared map distances between the SNP linkage map and the interpolated SNP linkage map constructed by the deCode Genetics group. We also evaluated cM/Mb distance ratios in females and males, along each chromosome, showing broadly defined regions of increased and decreased rates of recombination. Evaluations indicate that this SNP screening set is more informative than the Marshfield Clinic's commonly used microsatellite-based screening set.	Rutgers State Univ, Dept Genet, Piscataway, NJ 08840 USA; Rutgers State Univ, Dept Stat, Piscataway, NJ 08840 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; Celera Genom, Rockville, MD USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; Amersham Biosci, Chandler, AZ USA; Fdn Jean Dausset CEPH, Paris, France; GlaxoSmithKline Inc, Res Triangle Pk, NC USA; Duke Univ, Med Ctr, Durham, NC USA; NHGRI, NIH, Baltimore, MD USA; Roche Mol Syst, Pleasanton, CA USA; First Genet Trust, Deerfield, IL USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Cold Spring Harbor Laboratory; Cornell University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Foundation Jean Dausset-CEPH; GlaxoSmithKline; Duke University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); Roche Holding	Matise, TC (corresponding author), Rutgers State Univ, Dept Genet, 604 Allison Rd, Piscataway, NJ 08840 USA.	matise@biology.rutgers.edu	sachidanandam, ravi/Q-6916-2019; Wilson, Alexander F./Q-6910-2019; Buyske, Steven/B-8130-2009; Wilson, Alexander/C-2320-2009	sachidanandam, ravi/0000-0001-9844-4459; Buyske, Steven/0000-0001-8539-5416; Markianos, Kyriacos/0000-0003-0214-6014; Wijsman, Ellen/0000-0002-2725-6669; Clark, Andrew/0000-0001-7159-8511				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Agarwala R, 2000, GENOME RES, V10, P350, DOI 10.1101/gr.10.3.350; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Clark AG, 2003, AM J HUM GENET, V73, P285, DOI 10.1086/377138; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; CRAVEN P, 1979, NUMER MATH, V31, P377, DOI 10.1007/BF01437407; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; Daw EW, 2000, GENET EPIDEMIOL, V19, P366, DOI 10.1002/1098-2272(200012)19:4<366::AID-GEPI8>3.0.CO;2-F; Dearlove Andrew M., 2002, Briefings in Functional Genomics & Proteomics, V1, P139, DOI 10.1093/bfgp/1.2.139; Goddard KAB, 1996, AM J HUM GENET, V58, P1286; Goddard KAB, 2002, GENET EPIDEMIOL, V22, P205, DOI 10.1002/gepi.0177; Gordon D, 2001, AM J HUM GENET, V69, P371, DOI 10.1086/321981; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Halpern J, 1999, HUM HERED, V49, P194, DOI 10.1159/000022874; Heil J, 2002, Pac Symp Biocomput, P30; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kruglyak L, 1997, NAT GENET, V17, P21, DOI 10.1038/ng0997-21; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lindsey JC, 2000, J MED GENET, V37, P759, DOI 10.1136/jmg.37.10.759; Loader C, 1999, LOCFIT LOCAL REGRESS; Markianos K, 2001, AM J HUM GENET, V68, P963, DOI 10.1086/319507; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Reid E, 1999, BRAIN, V122, P1741, DOI 10.1093/brain/122.9.1741; Rhodes MD, 2002, AM J HUM GENET, V71, P442; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; SHEFFIELD VC, 1995, HUM MOL GENET, V4, P1837, DOI 10.1093/hmg/4.10.1837; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; Tsuchihashi Z., 2002, Pharmacogenomics Journal, V2, P103, DOI 10.1038/sj.tpj.6500094; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Weber JL, 2001, ADV GENET, V42, P77, DOI 10.1016/S0065-2660(01)42016-5; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; Wilson AF, 2000, AM J HUM GENET, V66, P1610, DOI 10.1086/302889	46	86	87	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	AUG	2003	73	2					271	284		10.1086/377137	http://dx.doi.org/10.1086/377137			14	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	702KW	12844283	Green Published, Bronze			2022-12-18	WOS:000184223900005
J	Marazita, ML; Field, LL; Cooper, ME; Tobias, R; Maher, BS; Peanchitlertkajorn, S; Liu, YE				Marazita, ML; Field, LL; Cooper, ME; Tobias, R; Maher, BS; Peanchitlertkajorn, S; Liu, YE			Genome scan for loci involved in cleft lip with or without cleft palate, in Chinese multiplex families	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							COMPLEX SEGREGATION ANALYSIS; RECURRENCE-PATTERN ANALYSIS; GENETIC-ANALYSIS; LINKAGE ANALYSIS; SUSCEPTIBILITY LOCI; TRAITS; ASSOCIATION; ETIOLOGY; DANISH; DISEQUILIBRIUM	Cleft lip with or without cleft palate (CL/P) is a common congenital anomaly. Birth prevalences range from 1/500 to 1/1,000 and are consistently higher in Asian populations than in populations of European descent. Therefore, it is of interest to determine whether the CL/P etiological factors in Asian populations differ from those in white populations. A sample of 36 multiplex families were ascertained through probands with CL/P who were from Shanghai. This is the first reported genome-scan study of CL/P in any Asian population. Genotyping of Weber Screening Set 9 (387 short tandem-repeat polymorphisms with average spacing similar to9 cM [range 1-19 cM]) was performed by the Mammalian Genotyping Service of Marshfield Laboratory. Presented here are the results for the 366 autosomal markers. Linkage between each marker and CL/P was assessed by two-point and multipoint LOD scores, as well as with multipoint heterogeneity LOD scores (HLODs) plus model-free identity-by-descent statistics and the multipoint NPL statistic. In addition, association was assessed via the transmission/disequilibrium test. LOD-score and HLOD calculations were performed under a range of models of inheritance of CL/P. The following regions had positive multipoint results (HLODgreater than or equal to1.0 and/or NPL Pless than or equal to.05): chromosomes 1 (90-110 cM), 2 (220-250 cM), 3 (130-150 cM), 4 (140-170 cM), 6 (70-100 cM), 18 (110 cM), and 21 (30-50 cM). The most significant multipoint linkage results (HLODgreater than or equal to2.0; alpha=0.37) were for chromosomes 3q and 4q. Associations with were found for loci on chromosomes 3, 5-7, 9, 11, 12, 16, 20, and 21. The most significant association result (P=.009) was found with D16S769 (51 cM).	Univ Pittsburgh, Sch Dent Med, Div Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Univ Calgary, Dept Med Genet, Calgary, AB, Canada; Univ Texas, SW Med Ctr, Dept Orthodont, Texas Sch Dent Med, Dallas, TX USA; Zhabei Genet Res Inst, Shanghai, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Calgary; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Marazita, ML (corresponding author), Univ Pittsburgh, Sch Dent Med, Div Oral Biol, Ctr Craniofacial & Dent Genet, 693A Salk Hall,3501 Terrace St, Pittsburgh, PA 15261 USA.	marazita@sdmgenetics.pitt.edu	Peanchitlertkajorn, Supakit/AAF-8799-2021; Maher, Brion S/F-9185-2010		NCRR NIH HHS [1P41 RR 03655, P41 RR003655] Funding Source: Medline; NIDCR NIH HHS [R01 DE009886, DE 09886, R01 DE016148] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE009886] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ARDINGER HH, 1989, AM J HUM GENET, V45, P348; Bateson W., 1909, MENDELS PRINCIPLES H; BEAR JC, 1976, CLIN GENET, V9, P277; Carinci F, 2000, CLEFT PALATE-CRAN J, V37, P33, DOI 10.1597/1545-1569(2000)037<0033:GONCLA>2.3.CO;2; CARTER CO, 1976, BRIT MED BULL, V32, P21, DOI 10.1093/oxfordjournals.bmb.a071318; *CAS W RES U DEP E, 1999, SAGE STAT AN GEN EP; Christensen K, 1996, AM J HUM GENET, V58, P182; CHUNG CS, 1986, AM J HUM GENET, V39, P603; Cleves MA, 1997, GENET EPIDEMIOL, V14, P337, DOI 10.1002/(SICI)1098-2272(1997)14:4<337::AID-GEPI1>3.3.CO;2-S; Cooper ME, 2000, CLEFT PALATE-CRAN J, V37, P274, DOI 10.1597/1545-1569(2000)037<0274:DEONCL>2.3.CO;2; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DARWIN C, 1883, VARIATION ANIMALS PL, P445; Davis S, 1996, AM J HUM GENET, V58, P867; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; FARRALL M, 1992, AM J HUM GENET, V50, P270; FITZPATRICK D, 1993, J CRAN GENET DEV BIO, V13, P230; Fogh-Andersen, 1942, INHERITANCE HARELIP; FRASER FC, 1976, TERATOLOGY, V14, P267, DOI 10.1002/tera.1420140302; GORLIN RJ, 1990, OXFORD MONOGRAPHS ME, V19; Greenberg DA, 2001, GENET EPIDEMIOL, V21, P299, DOI 10.1002/gepi.1036; Hauser ER, 1996, GENET EPIDEMIOL, V13, P117, DOI 10.1002/(SICI)1098-2272(1996)13:2<117::AID-GEPI1>3.0.CO;2-5; HECHT JT, 1991, AM J HUM GENET, V49, P674; HODGE SE, 1994, GENET EPIDEMIOL, V11, P329, DOI 10.1002/gepi.1370110403; Hodge SE, 2002, AM J HUM GENET, V70, P556, DOI 10.1086/338923; JONES MC, 1988, CLEFT PALATE J, V25, P16; KHOO BC, 1966, PLAST RECONSTR SURG, V38, P89; Kruglyak L, 1998, AM J HUM GENET, V62, P994, DOI 10.1086/301792; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LALOUEL JM, 1981, HUM HERED, V31, P312, DOI 10.1159/000153231; LALOUEL JM, 1983, AM J HUM GENET, V35, P816; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lidral AC, 1997, CLEFT PALATE-CRAN J, V34, P1, DOI 10.1597/1545-1569(1997)034<0001:SOTCGT>2.3.CO;2; Marazita ML, 2002, CLEFT PALATE-CRAN J, V39, P149, DOI 10.1597/1545-1569(2002)039<0149:NCLWOW>2.0.CO;2; MARAZITA ML, 1986, J CRAN GENET DEV BIO, P89; MARAZITA ML, 1992, AM J HUM GENET, V51, P648; MARAZITA ML, 1984, AM J MED GENET, V19, P9, DOI 10.1002/ajmg.1320190104; MARAZITA ML, 2002, UNDERSTANDING CRANIO, P147; MELNICK M, 1980, AM J MED GENET, V6, P83, DOI 10.1002/ajmg.1320060108; Melnick M, 1997, J CRAN GENET DEV BIO, V17, P65; MENDELL NR, 1980, ETIOLOGY CLEFT LIP C, P387; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MITCHELL LE, 1995, AM J HUM GENET, V57, P1130; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; MORTON NE, 1974, AM J HUM GENET, V26, P489; MURRAY JC, 1995, AM J HUM GENET, V57, P227, DOI 10.2134/agronj1965.00021962005700020028x; NEMANA LJ, 1992, AM J MED GENET, V42, P5, DOI 10.1002/ajmg.1320420103; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; PLOUGHMAN LM, 1989, AM J HUM GENET, V44, P543; PRESCOTT N, 1998, AM J HUM GENET S, V63, pA1764; Prescott NJ, 2000, HUM GENET, V106, P345, DOI 10.1007/s004390051048; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rischbieth H., 1910, TREASURY HUMAN INH 4, P79; Roberts SB, 1999, AM J HUM GENET, V65, P876, DOI 10.1086/302528; Schutte BC, 1999, HUM MOL GENET, V8, P1853, DOI 10.1093/hmg/8.10.1853; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Sproule J., 1863, BMJ-BRIT MED J, V1, P412; Terwilliger J., 1994, HDB HUMAN GENETIC LI; TREW CJ, 1757, NOVA ACTA PHYS MED A, V1, P445; Wentzlaff KA, 1997, J CRAN GENET DEV BIO, V17, P141; Wyszynski DF, 1996, CLEFT PALATE-CRAN J, V33, P406, DOI 10.1597/1545-1569(1996)033<0406:GONOCR>2.3.CO;2; Yuan B, 1997, AM J HUM GENET, V60, P459	63	86	93	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	AUG	2002	71	2					349	364		10.1086/341944	http://dx.doi.org/10.1086/341944			16	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	575ZE	12087515	Green Published, Bronze			2022-12-18	WOS:000176977700013
J	Copin, B; Brezin, AP; Valtot, F; Dascotte, JC; Bechetoille, A; Garchon, HJ				Copin, B; Brezin, AP; Valtot, F; Dascotte, JC; Bechetoille, A; Garchon, HJ			Apolipoprotein E-promoter single-nucleotide polymorphisms affect the phenotype of primary open-angle glaucoma and demonstrate interaction with the myocilin gene	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							TRABECULAR MESHWORK CELLS; VISUAL-FIELD LOSS; ALZHEIMERS-DISEASE; INTRAOCULAR-PRESSURE; MACULAR DEGENERATION; OCULAR HYPERTENSION; REGULATORY REGION; INCREASED RISK; APOE; ASSOCIATION	Primary open-angle glaucoma (POAG) is an optic neuropathy that has a high worldwide prevalence and that shows strong evidence of complex inheritance. The myocilin (MYOC) gene is the only one that has thus far been shown to have mutations in patients with POAG. Apolipoprotein E (APOE) plays an essential role in lipid metabolism, and the APOE gene has been involved in neuronal degeneration that occurs in Alzheimer disease (AD). Here, we report that two APOE-promoter single-nucleotide polymorphisms (SNPs) previously associated with AD also modify the POAG phenotype. APOE(-219G) is associated with increased optic nerve damage, as reflected by increased cup: disk ratio and visual field alteration. In addition, APOE(-491T), interacting at a highly significant level with an SNP in the MYOC promoter, MYOC(-1000G), is associated with increased intraocular pressure (IOP) and with limited effectiveness of IOP-lowering treatments in patients with POAG. Together, these findings establish APOE as a potent modifier for POAG, which could explain the linkage to chromosome 19q previously observed by use of a genome scan for this condition and an increased frequency of glaucoma in patients with AD. The findings also shed new light on potential mechanisms of optic nerve damage and of IOP regulation in POAG.	CHU Cochin, INSERM, U25, Paris, France; CHU Cochin, Serv Ophtalmol, Paris, France; Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France; Inst Glaucome, Paris, France; CHU Lille, Serv Ophtalmol, F-59037 Lille, France; CHU Angers, Serv Ophtalmol, Angers, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; CHU Lille; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Garchon, HJ (corresponding author), Hop Necker Enfants Malad, INSERM, U25, 161 Rue Sevres, F-75743 Paris 15, France.							Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; ANDERSON DR, 1989, AM J OPHTHALMOL, V108, P485, DOI 10.1016/0002-9394(89)90423-6; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Baskin F, 1997, J NEUROL SCI, V148, P15, DOI 10.1016/S0022-510X(96)05335-X; Bayer AU, 2002, AM J OPHTHALMOL, V133, P135, DOI 10.1016/S0002-9394(01)01196-5; Brezin AP, 1997, J MED GENET, V34, P546, DOI 10.1136/jmg.34.7.546; Bullido MJ, 1998, NAT GENET, V18, P69, DOI 10.1038/ng0198-69; Colomb E, 2001, CLIN GENET, V60, P220, DOI 10.1034/j.1399-0004.2001.600308.x; Drance SM, 1997, AM J OPHTHALMOL, V123, P817; Fautsch MP, 2000, INVEST OPHTH VIS SCI, V41, P4163; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581; Lambert JC, 2000, HUM MOL GENET, V9, P57, DOI 10.1093/hmg/9.1.57; Lambert JC, 1998, HUM MOL GENET, V7, P1511, DOI 10.1093/hmg/7.9.1511; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; Martin ER, 2000, AM J HUM GENET, V67, P383, DOI 10.1086/303003; Martinez-Bello C, 2000, AM J OPHTHALMOL, V129, P302, DOI 10.1016/S0002-9394(99)00387-6; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Nickerson DA, 2000, GENOME RES, V10, P1532, DOI 10.1101/gr.146900; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Polansky JR, 2000, EYE, V14, P503, DOI 10.1038/eye.2000.137; QUIGLEY HA, 1994, ARCH OPHTHALMOL-CHIC, V112, P644, DOI 10.1001/archopht.1994.01090170088028; QUIGLEY HA, 1993, NEW ENGL J MED, V328, P1097, DOI 10.1056/NEJM199304153281507; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Shanmugaratnam J, 1997, MOL BRAIN RES, V50, P113, DOI 10.1016/S0169-328X(97)00176-9; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamm ER, 1999, INVEST OPHTH VIS SCI, V40, P2577; Theuns J, 2000, HUM MOL GENET, V9, P2383, DOI 10.1093/hmg/9.16.2383; Wang N, 2001, NAT MED, V7, P304, DOI 10.1038/85446; Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109	34	86	91	0	1	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	JUN	2002	70	6					1575	1581		10.1086/340733	http://dx.doi.org/10.1086/340733			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	549LP	11992263	Bronze, Green Published			2022-12-18	WOS:000175445700019
J	Wilkie, SE; Li, Y; Deery, EC; Newbold, RJ; Garibaldi, D; Bateman, JB; Zhang, H; Lin, W; Zack, DJ; Bhattacharya, SS; Warren, MJ; Hunt, DM; Zhang, K				Wilkie, SE; Li, Y; Deery, EC; Newbold, RJ; Garibaldi, D; Bateman, JB; Zhang, H; Lin, W; Zack, DJ; Bhattacharya, SS; Warren, MJ; Hunt, DM; Zhang, K			Identification and functional consequences of a new mutation (E155G) in the gene for GCAP1 that causes autosomal dominant cone dystrophy	AMERICAN JOURNAL OF HUMAN GENETICS			English	Article							CYCLASE-ACTIVATING PROTEIN; RETINAL GUANYLATE-CYCLASE; MOLECULAR CHARACTERIZATION; BETA-SUBUNIT; CALCIUM; LOCALIZATION; CLONING; EXPRESSION; RETGC; LIGHT	Mutations in the gene for guanylate cyclase-activating protein-1 (GCAP1) (GUCA1A) have been associated with autosomal dominant cone dystrophy (COD3). In the present study, a severe disease phenotype in a large white family was initially shown to map to chromosome 6p21.1, the location of GUCA1A. Subsequent single-stranded conformation polymorphism analysis and direct sequencing revealed an A464G transition, causing an E155G substitution within the EF4 domain of GCAP1. Modeling of the protein structure shows that the mutation eliminates a bidentate amino acid side chain essential for Ca2+ binding. This represents the first disease-associated mutation in GCAP1, or any neuron-specific calcium-binding protein within an EF-hand domain, that directly coordinates Ca2+. The functional consequences of this substitution were investigated in an in vitro assay of retinal guanylate cyclase activation. The mutant protein activates the cyclase at low Ca2+ concentrations but fails to inactivate at high Ca2+ concentrations. The overall effect of this would be the constitutive activation of guanylate cyclase in photoreceptors, even at the high Ca2+ concentrations of the dark-adapted state, which may explain the dominant disease phenotype.	UCL, Inst Ophthalmol, Div Mol Genet, London EC1V 9EL, England; Univ London, Queen Mary, Sch Biol Sci, London, England; Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA; Univ Colorado, Hlth Sci Ctr, Dept Ophthalmol, Aurora, CO USA; Univ Colorado, Hlth Sci Ctr, Rocky Mt Lions Eye Inst, Aurora, CO USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA	University of London; University College London; University of London; Queen Mary University London; Cleveland Clinic Foundation; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Johns Hopkins University	Hunt, DM (corresponding author), UCL, Inst Ophthalmol, Div Mol Genet, 11-43 Bath St, London EC1V 9EL, England.	d.hunt@ucl.ac.uk	Bhattacharya, Shom/N-2926-2016; Zhang, Kang/Y-2740-2019; Hunt, David M/K-6024-2012	Bhattacharya, Shom/0000-0002-1601-6344; Zhang, Kang/0000-0002-4549-1697; Hunt, David M/0000-0002-9264-3948; Zack, Don/0000-0002-7966-1973; Warren, Martin/0000-0002-6028-6456	NATIONAL EYE INSTITUTE [Z01EY000401] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 EY000401] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BALCIUNIENE J, 1995, GENOMICS, V30, P281, DOI 10.1006/geno.1995.9876; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Cuenca N, 1998, INVEST OPHTH VIS SCI, V39, P1243; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Dizhoor AM, 1999, METHODS, V19, P521, DOI 10.1006/meth.1999.0894; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P96; Duda T, 1996, BIOCHEMISTRY-US, V35, P8478, DOI 10.1021/bi960752z; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; FARBER DB, 1992, NEURON, V9, P349, DOI 10.1016/0896-6273(92)90173-B; Frins S, 1996, J BIOL CHEM, V271, P8022, DOI 10.1074/jbc.271.14.8022; GARBERS DL, 1994, J BIOL CHEM, V269, P30741; GORACZNIAK RM, 1994, BIOCHEM J, V302, P455, DOI 10.1042/bj3020455; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; GORCZYCA WA, 1994, P NATL ACAD SCI USA, V91, P4014, DOI 10.1073/pnas.91.9.4014; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; HAYASHI F, 1991, P NATL ACAD SCI USA, V88, P4746, DOI 10.1073/pnas.88.11.4746; Howes K, 1998, INVEST OPHTH VIS SCI, V39, P867; JACOBSON DM, 1989, OPHTHALMOLOGY, V96, P885; Kachi S, 1999, EXP EYE RES, V68, P465, DOI 10.1006/exer.1998.0629; Kelsell RE, 1998, HUM MOL GENET, V7, P1179, DOI 10.1093/hmg/7.7.1179; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; KRETSINGER RH, 1976, ANNU REV BIOCHEM, V45, P239, DOI 10.1146/annurev.bi.45.070176.001323; LIU XR, 1994, EXP EYE RES, V59, P761, DOI 10.1006/exer.1994.1162; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Newbold RJ, 2001, HUM MOL GENET, V10, P47, DOI 10.1093/hmg/10.1.47; NICKOLDS CE, 1972, P NATL ACAD SCI USA, V69, P581, DOI 10.1073/pnas.69.3.581; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; OttoBruc A, 1997, P NATL ACAD SCI USA, V94, P4727, DOI 10.1073/pnas.94.9.4727; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Payne AM, 1998, HUM MOL GENET, V7, P273, DOI 10.1093/hmg/7.2.273; PEACHEY NS, 1989, APPL OPTICS, V28, P1145, DOI 10.1364/AO.28.001145; Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274; Perrault I, 1998, AM J HUM GENET, V63, P651, DOI 10.1086/301985; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sampath AP, 1998, J GEN PHYSIOL, V111, P53, DOI 10.1085/jgp.111.1.53; SHYJAN AW, 1992, NEURON, V9, P727, DOI 10.1016/0896-6273(92)90035-C; SITARAMAYYA A, 1995, MOL CELL BIOCHEM, V148, P139, DOI 10.1007/BF00928151; Small KW, 1996, AM J OPHTHALMOL, V121, P13, DOI 10.1016/S0002-9394(14)70529-X; Sokal I, 1998, MOL CELL, V2, P129, DOI 10.1016/S1097-2765(00)80121-5; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; SUBBARAYA I, 1994, J BIOL CHEM, V269, P31080; Surguchov A, 1997, GENOMICS, V39, P312, DOI 10.1006/geno.1996.4513; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Weigell-Weber M, 2000, ARCH OPHTHALMOL-CHIC, V118, P300; Wilkie SE, 2000, HUM MOL GENET, V9, P3065, DOI 10.1093/hmg/9.20.3065; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602	53	86	88	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0002-9297	1537-6605		AM J HUM GENET	Am. J. Hum. Genet.	SEP	2001	69	3					471	480		10.1086/323265	http://dx.doi.org/10.1086/323265			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	459VD	11484154	Bronze, Green Published			2022-12-18	WOS:000170271400001
